STUDYID|DOMAIN|USUBJID|NHOID|ISSEQ|ISGRPID|ISREFID|ISSPID|ISTESTCD|ISTEST|ISBDAGNT|ISMSCBCE|ISCNDAGT|ISTSTDTL|ISTSTOPO|ISCAT|ISSCAT|ISORRES|ISORRESU|ISORNRLO|ISORNRHI|ISSTRESC|ISSTRESN|ISSTRESU|ISSTNRLO|ISSTNRHI|ISSTNRC|ISNRIND|ISSTAT|ISREASND|ISNAM|ISSPEC|ISSPCCND|ISSPCUFL|ISMETHOD|ISLOBXFL|ISBLFL|ISDRVFL|ISLLOQ|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|ISDTC|ISENDTC|ISDY|ISENDY|ISTPT|ISTPTNUM|ISELTM|ISTPTREF|ISRFTDTC
TRIAL STUDY 134XCP|IS|28FBEC95-59B8-4821-BD7A-125E2C87D71C||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TRACE|||||KCAL||||HIGH|NOT DONE|||PLATELET POOR PLASMA|UNEXPECTED ODOR|U|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|U|N||1||38||FOLLOW-UP|1973-07-19|1973-06-02|||||1969-12-31||1972-02-03
TRIAL STUDY 134XCP|IS|28FBEC95-59B8-4821-BD7A-125E2C87D71C||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MESF|||||/10^4||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|LIPEMIC|N|PET SCAN|U|N|NA||2||58||RUN-IN|1973-02-19|1960-12-30|||||1965-01-29||1967-04-16
TRIAL STUDY 134XCP|IS|28FBEC95-59B8-4821-BD7A-125E2C87D71C||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CD|||||/500 WBC||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|ROOM TEMPERATURE|N|RADIOIMMUNOPRECIPITATION ASSAY|N|U|Y||3||39||BLINDED TREATMENT|1961-03-28|1962-09-18|||||1970-12-22||1967-03-14
TRIAL STUDY 134XCP|IS|28FBEC95-59B8-4821-BD7A-125E2C87D71C||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/KG/H|||||CAN||||ABNORMAL|NOT DONE|||MONOCYTE|THAWED|N|TOTAL BODY IRRADIATION|U|Y|U||4||88||OBSERVATION|1960-11-03|1965-10-22|||||1969-08-12||1964-10-03
TRIAL STUDY 134XCP|IS|28FBEC95-59B8-4821-BD7A-125E2C87D71C||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^3 DNA COPIES/ML|||||IU/KG/H||||LOW|NOT DONE|||ENDOMETRIAL TISSUE|UNEXPECTED ODOR|NA|DIGITAL PCR|Y|N|U||5||7||LONG-TERM FOLLOW-UP|1972-12-26|1960-11-15|||||1965-12-23||1971-10-15
TRIAL STUDY 134XCP|IS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL/MOL|||||MG/L||||ABNORMAL|NOT DONE|||BREAST MILK|CONCENTRATED|U|MICRONEUTRALIZATION ASSAY|U|U|U||1||38||INDUCTION TREATMENT|1962-06-04|1968-03-02|||||1972-08-19||1960-10-15
TRIAL STUDY 134XCP|IS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^5/HPF|||||COPIES/UL||||LOW|NOT DONE|||EPITHELIAL CELL|FRESH|N|TOTAL BODY RADIOGRAPHY|Y|NA|N||2||58||BASELINE|1973-03-11|1962-11-13|||||1973-03-04||1973-08-22
TRIAL STUDY 134XCP|IS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||AMPULE|||||MMOL/DAY||||NORMAL|NOT DONE|||LOCHIA|SOLIDIFIED|U|BALLPOINT PEN TECHNIQUE|Y|N|N||3||39||WASHOUT|1961-07-02|1964-07-29|||||1967-01-26||1969-10-01
TRIAL STUDY 134XCP|IS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/10^5|||||EQ||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|AUTOLYZED|N|GC/FID|U|Y|N||4||88||WASHOUT|1960-12-29|1963-10-09|||||1968-02-17||1965-02-12
TRIAL STUDY 134XCP|IS|312DF5BA-05C3-49B4-AEDF-DC5F794D12C1||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%(W/V)|||||VG/KG||||ABNORMAL|NOT DONE|||LOCHIA|DRIED|U|FLUORESCEIN STAIN|U|Y|Y||5||7||SCREENING|1971-04-01|1960-10-07|||||1972-07-11||1971-03-05
TRIAL STUDY 134XCP|IS|1117C221-3530-45CB-82B2-B831C4DAD86B||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MSEC|||||PFU/ML||||HIGH|NOT DONE|||TISSUE|SOLIDIFIED|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|N|NA|N||1||38||CONTINUATION TREATMENT|1967-01-23|1972-07-14|||||1963-04-07||1969-03-11
TRIAL STUDY 134XCP|IS|1117C221-3530-45CB-82B2-B831C4DAD86B||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PFU/DOSE|||||ECL UNIT||||HIGH|NOT DONE|||ABSCESS FLUID|CALCIFIED|N|DOUBLE IMMUNODIFFUSION|U|NA|U||2||58||INDUCTION TREATMENT|1971-09-08|1963-12-21|||||1968-03-12||1962-09-24
TRIAL STUDY 134XCP|IS|1117C221-3530-45CB-82B2-B831C4DAD86B||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/L|||||INHALATION||||LOW|NOT DONE|||AMNIOTIC FLUID|CONCENTRATED|U|MACRO BROTH DILUTION|U|Y|NA||3||39||BASELINE|1972-06-22|1966-05-29|||||1962-03-12||1972-05-07
TRIAL STUDY 134XCP|IS|1117C221-3530-45CB-82B2-B831C4DAD86B||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL|||||OZ||||HIGH|NOT DONE|||VENOUS PLASMA|CONCENTRATED|Y|SPECT/CT SCAN|U|Y|NA||4||88||RUN-IN|1965-04-20|1966-12-30|||||1962-10-09||1963-11-15
TRIAL STUDY 134XCP|IS|1117C221-3530-45CB-82B2-B831C4DAD86B||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/MIN|||||GY||||ABNORMAL|NOT DONE|||SMEGMA|CONCENTRATED|NA|MAGNETIC RESONANCE ENTEROGRAPHY|NA|NA|U||5||7||FOLLOW-UP|1964-09-22|1960-12-24|||||1971-09-04||1966-06-20
TRIAL STUDY 134XCP|IS|3ACFF838-5B16-4898-9640-A60C85096F64||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||APPLICATION|||||10^9 ORGANISMS/MG||||HIGH|NOT DONE|||EMESIS|FROZEN|N|MICROBIAL CULTURE, SOLID|U|NA|NA||1||38||TREATMENT|1966-07-05|1969-08-15|||||1966-07-11||1960-12-08
TRIAL STUDY 134XCP|IS|3ACFF838-5B16-4898-9640-A60C85096F64||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GENEQ|||||U/L||||ABNORMAL|NOT DONE|||SEMINAL FLUID|AUTOLYZED|N|TEMPLATE INCISION METHOD|Y|Y|Y||2||58||LONG-TERM FOLLOW-UP|1966-02-26|1968-06-14|||||1970-02-17||1966-09-15
TRIAL STUDY 134XCP|IS|3ACFF838-5B16-4898-9640-A60C85096F64||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CMH2O/ML|||||EP U||||HIGH|NOT DONE|||SUPERNATANT, SERUM|FRESH|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|NA|Y|Y||3||39||SCREENING|1973-03-27|1969-01-09|||||1970-09-09||1973-05-31
TRIAL STUDY 134XCP|IS|3ACFF838-5B16-4898-9640-A60C85096F64||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KV|||||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE|||URINE SEDIMENT|UNEXPECTED ODOR|N|WHOLE TRANSCRIPTOME SEQUENCING|N|Y|U||4||88||CONTINUATION TREATMENT|1962-12-31|1963-10-13|||||1965-01-21||1963-03-01
TRIAL STUDY 134XCP|IS|3ACFF838-5B16-4898-9640-A60C85096F64||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/L FEU|||||/100 WBC||||HIGH|NOT DONE|||BONE|ICTERIC|Y|LC-FL|NA|Y|U||5||7||LONG-TERM FOLLOW-UP|1968-03-31|1966-09-30|||||1969-09-03||1964-05-02
TRIAL STUDY 134XCP|IS|308F422A-B02B-4C76-86E7-834AAC127FE3||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KIU|||||MOL/MOL||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|CONCENTRATED|Y|CALCOFLUOR WHITE STAIN|U|N|Y||1||38||TREATMENT|1970-08-30|1971-12-04|||||1960-01-13||1964-04-26
TRIAL STUDY 134XCP|IS|308F422A-B02B-4C76-86E7-834AAC127FE3||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IN2|||||CD||||NORMAL|NOT DONE|||SEMINAL FLUID|CONTAMINATED|U|ROMANOWSKY STAIN|N|N|Y||2||58||BLINDED TREATMENT|1963-11-09|1971-02-06|||||1969-11-26||1964-12-14
TRIAL STUDY 134XCP|IS|308F422A-B02B-4C76-86E7-834AAC127FE3||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/VF|||||UG/L DDU||||NORMAL|NOT DONE|||DIALYSIS FLUID|SOLIDIFIED|Y|TRICHROME STAIN|NA|NA|Y||3||39||TREATMENT|1966-12-24|1966-04-21|||||1964-09-11||1967-12-02
TRIAL STUDY 134XCP|IS|308F422A-B02B-4C76-86E7-834AAC127FE3||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GBQ|||||/10^3||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|THAWED|N|JAEGER EYE CHART|U|U|NA||4||88||BLINDED TREATMENT|1966-01-13|1969-05-31|||||1972-02-10||1973-07-08
TRIAL STUDY 134XCP|IS|308F422A-B02B-4C76-86E7-834AAC127FE3||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||IU/G HB|||||KN/CM2||||NORMAL|NOT DONE|||PLEURAL FLUID|CALCIFIED|U|U-HPLC/MS/MS|Y|U|U||5||7||RUN-IN|1967-11-23|1972-11-22|||||1970-08-30||1972-11-06
TRIAL STUDY 134XCP|IS|34A3AA01-3595-42C2-95C3-44E3AF77B28D||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/HPF|||||MNFI||||HIGH|NOT DONE|||CALCULUS|ICTERIC|N|PLETHYSMOGRAPHY|NA|NA|N||1||38||OBSERVATION|1964-06-21|1970-06-08|||||1967-07-21||1961-02-20
TRIAL STUDY 134XCP|IS|34A3AA01-3595-42C2-95C3-44E3AF77B28D||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/10^12 RBC|||||MMOL/G||||LOW|NOT DONE|||SWABBED MATERIAL|CLOTTED|Y|PHOTOGRAPHY|U|NA|U||2||58||BLINDED TREATMENT|1965-10-05|1965-04-06|||||1962-07-01||1964-06-10
TRIAL STUDY 134XCP|IS|34A3AA01-3595-42C2-95C3-44E3AF77B28D||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UCI/L|||||/MM2||||ABNORMAL|NOT DONE|||SEMEN|AGGLUTINATED|NA|DROPLET DIGITAL PCR|N|NA|N||3||39||BLINDED TREATMENT|1966-10-23|1970-04-12|||||1972-12-19||1965-05-08
TRIAL STUDY 134XCP|IS|34A3AA01-3595-42C2-95C3-44E3AF77B28D||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/L DDU|||||CFU/G||||LOW|NOT DONE|||ABSCESS FLUID|UNEXPECTED ODOR|N|ENZYMATIC ULTRACENTRIFUGATION|U|N|N||4||88||SCREENING|1969-03-29|1964-04-01|||||1970-01-18||1967-06-12
TRIAL STUDY 134XCP|IS|34A3AA01-3595-42C2-95C3-44E3AF77B28D||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PPTH|||||10^9/G||||HIGH|NOT DONE|||SPERMATOZOON|NON-HEMOLYZED|NA|BIOPSY|Y|NA|U||5||7||INDUCTION TREATMENT|1963-09-29|1973-04-06|||||1973-05-21||1970-08-29
TRIAL STUDY 134XCP|IS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DPM/ML|||||UL/KG/DAY||||ABNORMAL|NOT DONE|||URINE SEDIMENT|CONTAMINATED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|NA|N|U||1||38||INDUCTION TREATMENT|1968-08-08|1962-07-29|||||1962-04-30||1970-11-14
TRIAL STUDY 134XCP|IS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG2/DL2|||||KM/H||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|U|SLOAN LETTER EYE CHART 2.5%|N|NA|U||2||58||OBSERVATION|1965-12-16|1964-04-08|||||1969-02-06||1964-08-11
TRIAL STUDY 134XCP|IS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/MONTH|||||MG||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|FROZEN|N|TOTAL BODY RADIOGRAPHY|U|U|U||3||39||SCREENING|1961-10-06|1967-05-20|||||1962-12-04||1964-12-18
TRIAL STUDY 134XCP|IS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||S^-1(%O2)^-1|||||CM/MIN||||LOW|NOT DONE|||VENOUS PLASMA|CONCENTRATED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|NA|NA|Y||4||88||CONTINUATION TREATMENT|1963-11-05|1965-01-12|||||1967-01-22||1962-04-30
TRIAL STUDY 134XCP|IS|05A82CB3-4A6B-42B9-9B5F-7D48C263EC70||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/10^5|||||10^3 CFU/G||||LOW|NOT DONE|||AQUEOUS HUMOR|NON-HEMOLYZED|N|MICROARRAY|NA|Y|N||5||7||SCREENING|1968-10-16|1961-07-16|||||1973-03-25||1964-08-28
TRIAL STUDY 134XCP|IS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PM|||||CONTAINER||||HIGH|NOT DONE|||MECONIUM|DRIED|N|TWO-COLOR MICROARRAY|Y|NA|N||1||38||BASELINE|1960-08-20|1960-04-05|||||1964-04-28||1968-08-15
TRIAL STUDY 134XCP|IS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CM|||||BAG||||LOW|NOT DONE|||NAIL|NON-HEMOLYZED|N|MECHANICAL CLOT DETECTION|U|U|U||2||58||INDUCTION TREATMENT|1960-04-25|1971-01-07|||||1966-12-15||1962-02-11
TRIAL STUDY 134XCP|IS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CARTRIDGE|||||BQ/ML||||HIGH|NOT DONE|||SPERMATOZOON|CONCENTRATED|NA|MICROBIAL CONCENTRATION|N|U|N||3||39||INDUCTION TREATMENT|1962-03-06|1972-10-18|||||1970-12-26||1971-08-07
TRIAL STUDY 134XCP|IS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MV2/HZ|||||100 IU/ML||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|UNEXPECTED ODOR|U|MS/MS|U|U|NA||4||88||WASHOUT|1968-08-06|1968-08-28|||||1962-06-14||1972-09-21
TRIAL STUDY 134XCP|IS|85B73C68-6C9D-4E57-A8E1-E2221AE61E30||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 RNA COPIES/ML|||||10^7 PFU||||LOW|NOT DONE|||RETICULOCYTES|DRIED|NA|IMPULSE OSCILLOMETRY|Y|U|N||5||7||SCREENING|1962-01-03|1961-04-06|||||1965-04-25||1972-10-07
TRIAL STUDY 134XCP|IS|ECA054C6-EA0F-4D7B-905C-849EA4592624||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||SCM|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||RETICULOCYTES|NON-HEMOLYZED|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|NA|NA|Y||1||38||BASELINE|1960-10-29|1967-02-25|||||1971-02-16||1970-04-25
TRIAL STUDY 134XCP|IS|ECA054C6-EA0F-4D7B-905C-849EA4592624||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||V|||||MOSM/L||||LOW|NOT DONE|||SPUTUM|SOLIDIFIED|N|CYSTOSCOPY|Y|N|NA||2||58||BLINDED TREATMENT|1972-11-24|1973-02-22|||||1967-07-15||1970-01-09
TRIAL STUDY 134XCP|IS|ECA054C6-EA0F-4D7B-905C-849EA4592624||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FG|||||ENZYME U/G HB||||ABNORMAL|NOT DONE|||DERMAL TISSUE|CALCIFIED|N|AGAR PROPORTION|Y|N|NA||3||39||FOLLOW-UP|1973-08-13|1965-10-30|||||1972-08-24||1973-09-01
TRIAL STUDY 134XCP|IS|ECA054C6-EA0F-4D7B-905C-849EA4592624||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL BCE/NMOL|||||HENRY||||LOW|NOT DONE|||VENOUS PLASMA|AGGLUTINATED|U|KINETIC MICROPARTICLE IMMUNOASSAY|N|N|NA||4||88||INDUCTION TREATMENT|1963-07-03|1960-11-17|||||1963-03-02||1970-05-17
TRIAL STUDY 134XCP|IS|ECA054C6-EA0F-4D7B-905C-849EA4592624||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PL|||||KEV||||NORMAL|NOT DONE|||BONE MARROW|ICTERIC|N|CALCOFLUOR WHITE STAIN|N|N|N||5||7||LONG-TERM FOLLOW-UP|1971-11-12|1969-11-16|||||1967-01-13||1966-08-05
TRIAL STUDY 134XCP|IS|83823CA3-1C1D-455E-BE49-DC5E3651A939||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TUBERCULIN UNIT/ML|||||CYLINDER||||HIGH|NOT DONE|||CAPILLARY BLOOD|ICTERIC|Y|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|N|N|N||1||38||BLINDED TREATMENT|1972-12-12|1962-06-11|||||1970-08-28||1965-06-06
TRIAL STUDY 134XCP|IS|83823CA3-1C1D-455E-BE49-DC5E3651A939||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PMOL/10^10 CELLS|||||POINT||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|NA|PHOROPTER|U|U|U||2||58||OPEN LABEL TREATMENT|1972-01-28|1965-11-03|||||1963-06-23||1963-03-03
TRIAL STUDY 134XCP|IS|83823CA3-1C1D-455E-BE49-DC5E3651A939||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||RATIO|||||MMOL/S||||NORMAL|NOT DONE|||ALVEOLAR AIR|FROZEN|Y|IMMUNOPRECIPITATION|N|U|U||3||39||TREATMENT|1961-08-21|1969-01-11|||||1972-05-16||1969-07-25
TRIAL STUDY 134XCP|IS|83823CA3-1C1D-455E-BE49-DC5E3651A939||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMHG/SEC|||||MG/KG/H||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|DRIED|Y|PALM METHOD|U|Y|Y||4||88||BLINDED TREATMENT|1961-04-12|1973-05-20|||||1972-10-17||1970-09-23
TRIAL STUDY 134XCP|IS|83823CA3-1C1D-455E-BE49-DC5E3651A939||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^3 CFU|||||NM||||LOW|NOT DONE|||SUPERNATANT, PLASMA|REFRIGERATED|Y|RADIOGRAPHY|Y|U|NA||5||7||RUN-IN|1967-02-17|1971-07-29|||||1967-05-30||1964-07-05
TRIAL STUDY 134XCP|IS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 CFU/G|||||USEC||||ABNORMAL|NOT DONE|||ISOLATE|AGGLUTINATED|Y|LYMPHANGIOGRAPHY|NA|N|Y||1||38||TREATMENT|1963-11-26|1964-12-01|||||1968-11-13||1960-10-25
TRIAL STUDY 134XCP|IS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/DL|||||UG/KG/DAY||||NORMAL|NOT DONE|||SERUM|THAWED|Y|CYSTOMETRY|NA|N|NA||2||58||BLINDED TREATMENT|1960-11-22|1972-08-13|||||1963-08-01||1962-08-20
TRIAL STUDY 134XCP|IS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FOZ_US|||||/500 WBC||||NORMAL|NOT DONE|||DIALYSIS FLUID|ROOM TEMPERATURE|N|ICC|U|NA|Y||3||39||FOLLOW-UP|1963-11-19|1961-11-15|||||1965-09-27||1961-04-14
TRIAL STUDY 134XCP|IS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||L/L|||||UKAT||||LOW|NOT DONE|||SPUTUM|NON-HEMOLYZED|N|WHOLE EXOME SEQUENCING|U|N|N||4||88||TREATMENT|1966-10-29|1962-06-26|||||1966-07-13||1961-08-11
TRIAL STUDY 134XCP|IS|C04E8E9E-71C7-4595-AD9D-01A86B1AC5BB||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOL/G|||||MJOULE/CM2||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|U|NA|N||5||7||OPEN LABEL TREATMENT|1963-07-11|1969-01-12|||||1965-01-19||1962-08-29
TRIAL STUDY 134XCP|IS|9C24F018-315A-4B9C-B89B-F54CA26452E7||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/MG|||||MV2/HZ||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|LACTESCENT|N|HEMAGGLUTINATION ASSAY|Y|Y|N||1||38||OBSERVATION|1966-10-28|1971-07-16|||||1966-05-15||1960-07-18
TRIAL STUDY 134XCP|IS|9C24F018-315A-4B9C-B89B-F54CA26452E7||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MCI/L|||||U/G HB||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|NON-HEMOLYZED|U|MALDI-TOF|N|N|Y||2||58||RUN-IN|1964-01-21|1964-09-28|||||1962-02-04||1970-05-17
TRIAL STUDY 134XCP|IS|9C24F018-315A-4B9C-B89B-F54CA26452E7||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CCID 50/ML|||||MG2/DL2||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|REFRIGERATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|U|Y|NA||3||39||WASHOUT|1972-09-24|1965-08-05|||||1964-03-07||1972-05-29
TRIAL STUDY 134XCP|IS|9C24F018-315A-4B9C-B89B-F54CA26452E7||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MU/G|||||BEAM BREAKS||||HIGH|NOT DONE|||PERITONEAL FLUID|LIPEMIC|Y|MALDI|N|N|U||4||88||BASELINE|1971-03-19|1969-09-05|||||1971-07-13||1967-05-30
TRIAL STUDY 134XCP|IS|9C24F018-315A-4B9C-B89B-F54CA26452E7||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 PFU/ML|||||CI/ML||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|AUTOLYZED|NA|FLOCCULATION|NA|N|N||5||7||OPEN LABEL TREATMENT|1968-03-19|1970-12-31|||||1973-02-11||1963-12-31
TRIAL STUDY 134XCP|IS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/DAY|||||ML/M2/MIN||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|THAWED|NA|ROMANOWSKY STAIN|N|NA|U||1||38||BLINDED TREATMENT|1963-02-11|1966-04-22|||||1965-06-11||1967-10-04
TRIAL STUDY 134XCP|IS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS|||||CG||||HIGH|NOT DONE|||DISCHARGE|CALCIFIED|N|PET/SPECT SCAN|Y|N|U||2||58||OPEN LABEL TREATMENT|1969-08-26|1967-04-02|||||1961-11-27||1965-01-19
TRIAL STUDY 134XCP|IS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MIN/DAY|||||BE/ML||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|GELLED|NA|CAPILLARY ELECTROPHORESIS|N|NA|N||3||39||RUN-IN|1968-05-05|1973-03-03|||||1963-09-02||1968-11-08
TRIAL STUDY 134XCP|IS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||G/KG/DAY|||||G/DAY||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|FROZEN|NA|SEQUENCING|Y|U|Y||4||88||INDUCTION TREATMENT|1971-06-05|1971-05-06|||||1971-07-07||1962-07-12
TRIAL STUDY 134XCP|IS|AA9CE1A1-EAEF-4C04-A6BC-B56469AA236A||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/KG|||||MPL U/ML||||ABNORMAL|NOT DONE|||CALCULUS|GELLED|N|RAJI CELL RIA|NA|Y|Y||5||7||WASHOUT|1967-11-01|1960-02-01|||||1962-09-06||1962-09-05
TRIAL STUDY 134XCP|IS|8D48F229-F38B-4335-B8A7-0AA24C928707||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||OHM|||||CGY||||HIGH|NOT DONE|||SYNOVIAL FLUID|GELLED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NA|NA|N||1||38||RUN-IN|1965-09-16|1966-12-04|||||1970-06-20||1962-02-15
TRIAL STUDY 134XCP|IS|8D48F229-F38B-4335-B8A7-0AA24C928707||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^3 CFU/G|||||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE|||INFRANATANT, SERUM|CONTAMINATED|U|CYSTOSCOPY|U|N|N||2||58||BLINDED TREATMENT|1969-05-27|1971-02-05|||||1965-05-27||1960-05-13
TRIAL STUDY 134XCP|IS|8D48F229-F38B-4335-B8A7-0AA24C928707||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NU/CL|||||CD||||HIGH|NOT DONE|||WHITE MATTER TISSUE|HEMOLYZED|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|U|Y|N||3||39||RUN-IN|1961-12-17|1968-09-04|||||1969-12-11||1963-04-09
TRIAL STUDY 134XCP|IS|8D48F229-F38B-4335-B8A7-0AA24C928707||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CCID 50/DOSE|||||CIGAR||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|SOLIDIFIED|Y|OPTICAL MAPPING|N|U|NA||4||88||BLINDED TREATMENT|1973-05-02|1960-03-15|||||1970-07-17||1964-12-28
TRIAL STUDY 134XCP|IS|8D48F229-F38B-4335-B8A7-0AA24C928707||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL BCE/NMOL|||||10^6 DNA COPIES/ML||||NORMAL|NOT DONE|||TUMOR TISSUE|LACTESCENT|NA|WHOLE EXOME SEQUENCING|U|Y|U||5||7||SCREENING|1963-06-19|1970-02-10|||||1965-11-25||1969-04-05
TRIAL STUDY 134XCP|IS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KPA/L/SEC|||||MG/DL||||LOW|NOT DONE|||TUMOR TISSUE|GELLED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|NA|U|NA||1||38||OBSERVATION|1963-08-19|1973-05-26|||||1969-12-11||1960-02-07
TRIAL STUDY 134XCP|IS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/MOL|||||SPRAY||||HIGH|NOT DONE|||BUFFY COAT|PARAFFIN-EMBEDDED|NA|POTENTIOMETRY|NA|N|U||2||58||SCREENING|1963-06-16|1965-09-20|||||1964-09-30||1972-04-29
TRIAL STUDY 134XCP|IS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BREATHS/MIN|||||S/H||||ABNORMAL|NOT DONE|||SPUTUM|CALCIFIED|Y|CLIP SEQUENCING|NA|Y|Y||3||39||SCREENING|1967-12-15|1969-04-22|||||1972-06-26||1963-01-30
TRIAL STUDY 134XCP|IS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PIXELS/CM|||||FIU||||NORMAL|NOT DONE|||INFRANATANT, SERUM|CALCIFIED|U|FLOCCULATION|N|U|U||4||88||BASELINE|1973-04-22|1963-06-28|||||1966-03-16||1971-09-13
TRIAL STUDY 134XCP|IS|F89F5FD5-AF3D-435F-9ABC-58BCB89FC3C6||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMAL|||||UKAT/L||||ABNORMAL|NOT DONE|||DISCHARGE|AGGLUTINATED|NA|POLYSOMNOGRAPHY|N|NA|U||5||7||FOLLOW-UP|1963-03-15|1972-04-09|||||1960-09-05||1971-03-25
TRIAL STUDY 134XCP|IS|C882CB1F-C0DE-4BE5-B762-611333949C74||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^8/L|||||CI/MG||||LOW|NOT DONE|||DISCHARGE|THAWED|N|DROPLET DIGITAL PCR|NA|N|NA||1||38||OBSERVATION|1964-01-25|1967-06-14|||||1961-05-12||1963-06-07
TRIAL STUDY 134XCP|IS|C882CB1F-C0DE-4BE5-B762-611333949C74||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MEQ/L|||||DPM/MG||||ABNORMAL|NOT DONE|||DERMAL TISSUE|FRESH|Y|SICKLE CELL SOLUBILITY TEST|U|Y|N||2||58||OPEN LABEL TREATMENT|1963-06-01|1965-04-06|||||1962-03-23||1960-09-29
TRIAL STUDY 134XCP|IS|C882CB1F-C0DE-4BE5-B762-611333949C74||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^5/L|||||ENZYME U/L||||LOW|NOT DONE|||CORD BLOOD|LACTESCENT|N|KINYOUN STAIN|NA|Y|Y||3||39||INDUCTION TREATMENT|1968-09-12|1972-01-20|||||1960-05-25||1963-12-17
TRIAL STUDY 134XCP|IS|C882CB1F-C0DE-4BE5-B762-611333949C74||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MILE|||||UG/H||||HIGH|NOT DONE|||MECONIUM|NON-HEMOLYZED|N|THERMAL IONIZATION MASS SPECTROMETRY|NA|N|U||4||88||FOLLOW-UP|1969-05-16|1971-02-12|||||1962-02-05||1968-09-13
TRIAL STUDY 134XCP|IS|C882CB1F-C0DE-4BE5-B762-611333949C74||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KG/MOL|||||ML/S/M2||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|SOLIDIFIED|N|MICROBIAL CULTURE, SOLID|Y|NA|N||5||7||BASELINE|1964-09-02|1968-02-19|||||1973-04-05||1965-02-13
TRIAL STUDY 134XCP|IS|7F3C3801-607B-4141-AA83-383FDFFD7152||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TUBERCULIN UNIT|||||G/G||||ABNORMAL|NOT DONE|||ERYTHROCYTES|REFRIGERATED|U|POTENTIOMETRY|NA|Y|N||1||38||BASELINE|1967-12-03|1970-02-07|||||1970-11-07||1972-01-21
TRIAL STUDY 134XCP|IS|7F3C3801-607B-4141-AA83-383FDFFD7152||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PRESSOR UNITS|||||PIXELS/CM||||ABNORMAL|NOT DONE|||CERUMEN|HEMOLYZED|U|SLIT LAMP|NA|Y|U||2||58||BLINDED TREATMENT|1971-12-11|1968-07-12|||||1967-08-25||1964-05-25
TRIAL STUDY 134XCP|IS|7F3C3801-607B-4141-AA83-383FDFFD7152||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/KG/MIN|||||LOG10 PFU/ML||||LOW|NOT DONE|||GASTRIC CONTENTS|THAWED|NA|INTERRUPTER TECHNIQUE|N|N|Y||3||39||INDUCTION TREATMENT|1964-02-15|1963-05-20|||||1963-03-24||1973-09-01
TRIAL STUDY 134XCP|IS|7F3C3801-607B-4141-AA83-383FDFFD7152||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPM|||||UIU/L||||HIGH|NOT DONE|||ARTERIAL BLOOD|THAWED|N|CENTRIFUGATION|U|Y|U||4||88||OBSERVATION|1962-11-26|1965-05-18|||||1968-04-22||1965-10-06
TRIAL STUDY 134XCP|IS|7F3C3801-607B-4141-AA83-383FDFFD7152||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||OHM|||||UG/CM2||||ABNORMAL|NOT DONE|||GASTRIC CONTENTS|NON-HEMOLYZED|Y|SEQUENCING|U|U|N||5||7||BASELINE|1963-10-25|1972-12-03|||||1970-01-06||1968-02-07
TRIAL STUDY 134XCP|IS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/CM2|||||UG/KG||||ABNORMAL|NOT DONE|||PLATELET|HEMOLYZED|U|APPLANATION TONOMETRY|N|Y|U||1||38||BASELINE|1972-10-29|1967-07-10|||||1970-08-08||1971-08-25
TRIAL STUDY 134XCP|IS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS/ML|||||/4.0 ML||||HIGH|NOT DONE|||HAIR FOLLICLE|FRESH|NA|MRS|N|Y|U||2||58||BASELINE|1962-08-10|1968-02-27|||||1965-04-13||1966-08-06
TRIAL STUDY 134XCP|IS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DPM/0.5 ML|||||KCAL/DAY||||NORMAL|NOT DONE|||SEMEN|FROZEN|U|ACCELERATOR MASS SPECTROMETRY|NA|N|NA||3||39||LONG-TERM FOLLOW-UP|1969-12-26|1964-07-30|||||1967-04-04||1968-06-25
TRIAL STUDY 134XCP|IS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/KG/MIN|||||PIXEL||||HIGH|NOT DONE|||CORD SERUM|ROOM TEMPERATURE|Y|FARNSWORTH-MUNSELL 100 HUE TEST|U|N|NA||4||88||WASHOUT|1971-04-04|1963-01-03|||||1960-04-22||1970-10-20
TRIAL STUDY 134XCP|IS|0DD4FBE8-5D91-4E48-AD35-06597F95E5BB||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EQ|||||%(V/V)||||HIGH|NOT DONE|||GASTRIC CONTENTS|FRESH|NA|ANTIBIOTIC AGAR SCREEN|Y|Y|U||5||7||CONTINUATION TREATMENT|1962-11-23|1964-09-19|||||1962-09-23||1971-06-28
TRIAL STUDY 134XCP|IS|67025219-DBC0-4222-9D04-7F23EE3D5806||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||OHM|||||AG||||LOW|NOT DONE|||FLUID|NON-HEMOLYZED|U|PERIPHERAL ANGIOGRAPHY|Y|NA|NA||1||38||FOLLOW-UP|1967-04-25|1971-06-18|||||1965-01-15||1965-03-09
TRIAL STUDY 134XCP|IS|67025219-DBC0-4222-9D04-7F23EE3D5806||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||USP U|||||BAU||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|NA|Y|N||2||58||LONG-TERM FOLLOW-UP|1968-07-06|1967-05-23|||||1966-09-12||1965-05-12
TRIAL STUDY 134XCP|IS|67025219-DBC0-4222-9D04-7F23EE3D5806||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/CAGE/DAY|||||10^6 CFU/G||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|UNEXPECTED ODOR|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|NA|N|U||3||39||BASELINE|1962-05-08|1961-08-04|||||1966-10-08||1964-10-12
TRIAL STUDY 134XCP|IS|67025219-DBC0-4222-9D04-7F23EE3D5806||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE/DAY|||||U/KG/DAY||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|DRIED|N|CLIP|NA|N|Y||4||88||LONG-TERM FOLLOW-UP|1964-03-10|1971-04-16|||||1964-09-21||1970-06-18
TRIAL STUDY 134XCP|IS|67025219-DBC0-4222-9D04-7F23EE3D5806||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||RATIO|||||10^3/L||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|N|Y|N||5||7||WASHOUT|1968-08-11|1965-03-02|||||1972-02-28||1960-11-25
TRIAL STUDY 134XCP|IS|A865B860-E5F2-423D-8110-58EBF7E470F3||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/CM|||||S*KPA||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|U|NEURAMINIDASE INHIBITION ASSAY|NA|U|Y||1||38||CONTINUATION TREATMENT|1969-02-01|1970-01-19|||||1967-07-24||1973-05-16
TRIAL STUDY 134XCP|IS|A865B860-E5F2-423D-8110-58EBF7E470F3||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/100 WBC|||||PACKET||||HIGH|NOT DONE|||PLEURAL TISSUE|CALCIFIED|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|N|N|U||2||58||LONG-TERM FOLLOW-UP|1965-12-03|1968-01-16|||||1966-04-23||1964-01-09
TRIAL STUDY 134XCP|IS|A865B860-E5F2-423D-8110-58EBF7E470F3||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/DOSE|||||CD||||NORMAL|NOT DONE|||BASAL TEAR|CLOTTED|U|GC/MS/MS|U|Y|Y||3||39||CONTINUATION TREATMENT|1968-08-07|1970-04-07|||||1972-02-20||1973-02-20
TRIAL STUDY 134XCP|IS|A865B860-E5F2-423D-8110-58EBF7E470F3||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NMOL BCE/MMOL|||||L/DAY||||ABNORMAL|NOT DONE|||ERYTHROCYTES|CLOTTED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|Y|N|N||4||88||TREATMENT|1960-07-30|1968-04-05|||||1969-08-29||1973-02-16
TRIAL STUDY 134XCP|IS|A865B860-E5F2-423D-8110-58EBF7E470F3||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPL U/ML|||||10^6 CFU/ML||||NORMAL|NOT DONE|||LOCHIA|CONTAMINATED|NA|MUGA|N|NA|N||5||7||RUN-IN|1965-12-22|1972-01-31|||||1964-11-30||1966-10-29
TRIAL STUDY 134XCP|IS|E78B2C0E-81D6-4898-B78A-FE136029AEA4||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BREATHS/30S|||||CIGAR||||LOW|NOT DONE|||URINE SEDIMENT|PARAFFIN-EMBEDDED|U|SLIT LAMP|NA|Y|N||1||38||WASHOUT|1962-06-24|1962-06-11|||||1968-11-03||1969-05-09
TRIAL STUDY 134XCP|IS|E78B2C0E-81D6-4898-B78A-FE136029AEA4||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||POINT|||||10^12/L||||ABNORMAL|NOT DONE|||FLUID|CLOTTED|NA|FLUORESCEIN STAIN|N|Y|N||2||58||RUN-IN|1968-10-02|1972-03-07|||||1967-01-02||1972-01-22
TRIAL STUDY 134XCP|IS|E78B2C0E-81D6-4898-B78A-FE136029AEA4||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/DAY|||||/MONTH||||NORMAL|NOT DONE|||TISSUE|LIPEMIC|Y|HEMOCYTOMETRY|U|Y|Y||3||39||WASHOUT|1969-11-20|1970-07-22|||||1965-05-21||1964-07-28
TRIAL STUDY 134XCP|IS|E78B2C0E-81D6-4898-B78A-FE136029AEA4||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||RFU|||||DEG/S||||LOW|NOT DONE|||SKIN TISSUE|THAWED|N|TRANSVAGINAL ULTRASOUND|Y|Y|U||4||88||TREATMENT|1961-01-27|1965-11-12|||||1969-06-15||1967-01-09
TRIAL STUDY 134XCP|IS|E78B2C0E-81D6-4898-B78A-FE136029AEA4||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PNU/ML|||||V/SEC||||HIGH|NOT DONE|||TISSUE|CONCENTRATED|N|BIOPSY|NA|Y|N||5||7||LONG-TERM FOLLOW-UP|1967-08-06|1961-09-13|||||1968-01-10||1969-12-26
TRIAL STUDY 134XCP|IS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||APPLICATION|||||DROP||||LOW|NOT DONE|||LUNG SURFACTANT|THAWED|Y|FLOCCULATION, CHARCOAL ENHANCED|Y|NA|NA||1||38||RUN-IN|1966-11-25|1971-07-06|||||1960-04-16||1969-08-04
TRIAL STUDY 134XCP|IS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||COPIES/UL|||||PL||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|HEMOLYZED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|Y|Y|N||2||58||SCREENING|1969-09-10|1973-04-04|||||1964-01-25||1972-08-10
TRIAL STUDY 134XCP|IS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/MOL|||||IMPLANT||||ABNORMAL|NOT DONE|||ABSCESS FLUID|AGGLUTINATED|NA|CLINICAL EVALUATION|Y|NA|U||3||39||SCREENING|1973-07-16|1970-08-16|||||1972-08-11||1965-12-01
TRIAL STUDY 134XCP|IS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GPL U/ML|||||MAMP||||HIGH|NOT DONE|||MENSTRUAL BLOOD|UNEXPECTED ODOR|U|OPHTHALMOSCOPY|NA|NA|N||4||88||WASHOUT|1969-11-05|1966-12-24|||||1961-04-02||1972-04-11
TRIAL STUDY 134XCP|IS|512B0190-2ABD-4477-BBAA-B5C8A57B1D53||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||USEC|||||VG/KG||||HIGH|NOT DONE|||NAIL|DRIED|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|N|NA|N||5||7||LONG-TERM FOLLOW-UP|1963-03-13|1967-07-01|||||1966-12-21||1961-10-03
TRIAL STUDY 134XCP|IS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NKAT/G HB|||||U/M2||||LOW|NOT DONE|||FLUID|CONCENTRATED|U|SXA SCAN|Y|U|U||1||38||WASHOUT|1964-05-04|1972-05-30|||||1969-03-28||1963-11-23
TRIAL STUDY 134XCP|IS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KDA|||||EVENTS||||NORMAL|NOT DONE|||ISOLATE|AGGLUTINATED|NA|RADIOIMMUNOPRECIPITATION ASSAY|Y|Y|NA||2||58||SCREENING|1960-06-11|1969-04-12|||||1960-05-08||1973-03-09
TRIAL STUDY 134XCP|IS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MIN*MG/ML|||||G/ANIMAL/DAY||||LOW|NOT DONE|||SOFT TISSUE|THAWED|NA|X-RAY FLUORESCENCE SPECTROMETRY|NA|U|Y||3||39||BLINDED TREATMENT|1969-07-21|1965-10-05|||||1969-08-31||1971-04-04
TRIAL STUDY 134XCP|IS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DRINK|||||GPL U||||LOW|NOT DONE|||HAIR FOLLICLE|LACTESCENT|NA|FLOW MICROSCOPY|U|Y|N||4||88||OPEN LABEL TREATMENT|1969-08-29|1966-12-29|||||1972-04-28||1969-09-19
TRIAL STUDY 134XCP|IS|C0642FE2-8A9A-4CFA-80C1-71B884E4D8BF||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI/G|||||FINGERTIP UNIT||||ABNORMAL|NOT DONE|||TISSUE|DRIED|NA|IMMUNOFIXATION ELECTROPHORESIS|Y|N|U||5||7||TREATMENT|1963-06-03|1972-11-10|||||1965-06-19||1968-03-23
TRIAL STUDY 134XCP|IS|55210E20-F6B9-446F-994D-2D9149E33BAF||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||H/WK|||||SIEMENS||||HIGH|NOT DONE|||CAPILLARY BLOOD|FROZEN|U|MANUAL COUNT|U|Y|N||1||38||LONG-TERM FOLLOW-UP|1970-05-12|1962-09-27|||||1969-02-01||1969-10-01
TRIAL STUDY 134XCP|IS|55210E20-F6B9-446F-994D-2D9149E33BAF||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UV2|||||SPRAY||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|N|CELLULOSE TAPE|Y|N|N||2||58||LONG-TERM FOLLOW-UP|1960-08-18|1970-03-14|||||1970-11-22||1964-04-02
TRIAL STUDY 134XCP|IS|55210E20-F6B9-446F-994D-2D9149E33BAF||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/KG/H|||||UKAT/L||||HIGH|NOT DONE|||INFRANATANT, SERUM|LACTESCENT|NA|CLOT DETECTION|U|N|N||3||39||INDUCTION TREATMENT|1962-08-15|1971-05-14|||||1965-12-21||1970-07-21
TRIAL STUDY 134XCP|IS|55210E20-F6B9-446F-994D-2D9149E33BAF||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DPM/0.5 ML|||||MV*MIN||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|N|SCINTIGRAPHY|U|Y|NA||4||88||CONTINUATION TREATMENT|1961-02-06|1972-10-06|||||1971-09-28||1972-09-05
TRIAL STUDY 134XCP|IS|55210E20-F6B9-446F-994D-2D9149E33BAF||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/ANIMAL/WK|||||BEAM BREAKS||||HIGH|NOT DONE|||URINE SEDIMENT|REFRIGERATED|N|JAFFE REACTION|Y|Y|N||5||7||BLINDED TREATMENT|1960-05-14|1960-12-06|||||1972-05-26||1972-11-28
TRIAL STUDY 134XCP|IS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/500 WBC|||||FOZ_US||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|SOLIDIFIED|N|LINE PROBE ASSAY|NA|NA|N||1||38||OBSERVATION|1968-03-09|1969-10-13|||||1970-04-24||1972-03-07
TRIAL STUDY 134XCP|IS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7 CFU|||||CMH2O*S/ML||||HIGH|NOT DONE|||SEMINAL FLUID|AUTOLYZED|N|MULTIPLE BREATH WASHOUT|N|NA|N||2||58||BASELINE|1970-06-27|1968-09-29|||||1965-12-12||1969-02-03
TRIAL STUDY 134XCP|IS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TSP|||||P||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|U|PET SCAN|NA|U|NA||3||39||TREATMENT|1966-11-30|1969-10-12|||||1967-09-25||1969-08-20
TRIAL STUDY 134XCP|IS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NCI|||||DEG||||NORMAL|NOT DONE|||ABSCESS FLUID|CONTAMINATED|Y|QUANTITATIVE ULTRASOUND|NA|N|NA||4||88||INDUCTION TREATMENT|1967-12-25|1962-09-21|||||1969-01-02||1965-02-28
TRIAL STUDY 134XCP|IS|1BE8ACB9-BEE8-4AFD-B384-D4C860B12450||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EP U|||||GRAIN||||HIGH|NOT DONE|||SEMINAL FLUID|CLOTTED|NA|TURBIDIMETRY|NA|NA|N||5||7||LONG-TERM FOLLOW-UP|1960-12-01|1962-09-17|||||1972-12-26||1966-05-29
TRIAL STUDY 134XCP|IS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BEL|||||UMOL/MG/MIN||||LOW|NOT DONE|||VENOUS BLOOD|ROOM TEMPERATURE|NA|FLOCCULATION, CHARCOAL ENHANCED|U|NA|N||1||38||WASHOUT|1972-01-27|1961-05-10|||||1960-04-04||1970-12-13
TRIAL STUDY 134XCP|IS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG|||||LINEAR FT*LB||||NORMAL|NOT DONE|||SPERMATOZOON|FROZEN|U|MRI WITHOUT CONTRAST|NA|U|U||2||58||BLINDED TREATMENT|1960-12-17|1960-01-09|||||1965-05-08||1965-08-15
TRIAL STUDY 134XCP|IS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/H|||||EQ||||ABNORMAL|NOT DONE|||BREAST MILK|CONCENTRATED|NA|IMPEDANCE CONDUCTIVITY|U|U|NA||3||39||RUN-IN|1970-09-20|1961-10-26|||||1969-04-02||1961-05-30
TRIAL STUDY 134XCP|IS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/MMOL|||||C||||ABNORMAL|NOT DONE|||SERUM|FROZEN|NA|CONGO RED STAIN|NA|U|N||4||88||TREATMENT|1967-06-07|1965-05-13|||||1968-02-17||1961-07-23
TRIAL STUDY 134XCP|IS|68F4DB07-31EC-4ECA-92BF-7D6986E4B33A||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||ML||||HIGH|NOT DONE|||PLATELET RICH PLASMA|NON-HEMOLYZED|Y|IRON HEMATOXYLIN STAIN|NA|Y|NA||5||7||OPEN LABEL TREATMENT|1967-03-23|1963-06-16|||||1970-06-14||1968-02-17
TRIAL STUDY 134XCP|IS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BOLUS|||||U/G||||ABNORMAL|NOT DONE|||PLATELET|THAWED|U|ANTIBIOTIC AGAR SCREEN|N|NA|NA||1||38||BASELINE|1964-08-01|1970-07-31|||||1973-06-16||1963-10-15
TRIAL STUDY 134XCP|IS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FOZ_BR|||||ML/S/M2||||LOW|NOT DONE|||LEUKOCYTE|THAWED|U|FLUORESCENCE ANGIOGRAPHY|N|N|U||2||58||BASELINE|1961-11-14|1967-02-01|||||1971-01-04||1961-01-07
TRIAL STUDY 134XCP|IS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||SPRAY|||||UOSM||||LOW|NOT DONE|||SYNOVIAL FLUID|DRIED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y|NA|NA||3||39||INDUCTION TREATMENT|1967-03-28|1960-05-22|||||1963-01-17||1973-07-06
TRIAL STUDY 134XCP|IS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BU|||||CCID 50/DOSE||||LOW|NOT DONE|||MIXED VENOUS BLOOD|GELLED|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|N|Y||4||88||WASHOUT|1961-01-28|1961-08-30|||||1961-07-19||1968-07-27
TRIAL STUDY 134XCP|IS|C46B45B7-0CC3-4997-A6B9-DAA58B8D33D7||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MCI/L|||||UIU/DL||||HIGH|NOT DONE|||EMOTIONAL TEAR|CONTAMINATED|U|NUCLEIC ACID BASED METHOD|Y|U|U||5||7||BLINDED TREATMENT|1971-12-15|1965-12-16|||||1960-10-15||1962-04-28
TRIAL STUDY 134XCP|IS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/M2/H|||||/MS||||LOW|NOT DONE|||VITREOUS HUMOR|PARAFFIN-EMBEDDED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|U|U|U||1||38||FOLLOW-UP|1962-11-20|1968-03-31|||||1965-01-04||1970-07-25
TRIAL STUDY 134XCP|IS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/MBP|||||PPB||||LOW|NOT DONE|||MUCUS|FRESH|Y|PHOTOMETRY|N|N|Y||2||58||BLINDED TREATMENT|1969-07-18|1961-01-20|||||1962-11-12||1972-01-10
TRIAL STUDY 134XCP|IS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OD UNIT|||||L/S/KPA||||NORMAL|NOT DONE|||CORD SERUM|THAWED|N|ORCHIDOMETERY|U|Y|NA||3||39||WASHOUT|1961-07-12|1972-02-02|||||1963-09-19||1973-04-07
TRIAL STUDY 134XCP|IS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||RAD|||||10^9 CFU/G||||NORMAL|NOT DONE|||VENOUS PLASMA|LIPEMIC|N|FREEZING POINT DEPRESSION|NA|N|NA||4||88||RUN-IN|1972-06-10|1971-01-15|||||1972-06-03||1961-11-03
TRIAL STUDY 134XCP|IS|1616C5D6-32D7-4A5D-A025-59DE09E55B0D||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PM|||||PG||||NORMAL|NOT DONE|||INFRANATANT, SERUM|HEMOLYZED|Y|FORCED OSCILLATION TECHNIQUE|Y|NA|N||5||7||OPEN LABEL TREATMENT|1971-09-20|1968-04-20|||||1961-02-20||1969-07-29
TRIAL STUDY 134XCP|IS|CAD0ED37-954A-4935-8A7E-589EC108E141||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML*CMH2O|||||INHALATION||||LOW|NOT DONE|||ERYTHROCYTES|LACTESCENT|Y|ATOMIC ABSORPTION SPECTROMETRY|NA|U|N||1||38||BASELINE|1963-03-04|1972-02-25|||||1962-08-25||1967-01-04
TRIAL STUDY 134XCP|IS|CAD0ED37-954A-4935-8A7E-589EC108E141||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^4 CFU/ML|||||BISCUIT||||NORMAL|NOT DONE|||SPUTUM|CONTAMINATED|Y|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|N|U||2||58||TREATMENT|1968-08-30|1972-02-12|||||1972-02-20||1962-08-07
TRIAL STUDY 134XCP|IS|CAD0ED37-954A-4935-8A7E-589EC108E141||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^8 PFU|||||/10^5||||HIGH|NOT DONE|||TISSUE|AUTOLYZED|NA|SCINTIGRAPHY|NA|U|Y||3||39||SCREENING|1969-12-04|1972-11-19|||||1965-03-26||1973-04-04
TRIAL STUDY 134XCP|IS|CAD0ED37-954A-4935-8A7E-589EC108E141||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^3 ORGANISMS/ML|||||UG/G/MIN||||NORMAL|NOT DONE|||BLOOD|LIPEMIC|U|FISH|NA|Y|NA||4||88||TREATMENT|1968-05-12|1969-02-23|||||1965-04-01||1970-06-30
TRIAL STUDY 134XCP|IS|CAD0ED37-954A-4935-8A7E-589EC108E141||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CI/UG|||||MMU/ML||||ABNORMAL|NOT DONE|||MECONIUM|LIPEMIC|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|U|NA||5||7||BLINDED TREATMENT|1963-05-06|1968-08-23|||||1969-02-23||1973-02-26
TRIAL STUDY 134XCP|IS|BC9A31E2-100C-4AC3-8910-A04309854590||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KA_U/DL|||||EIA UNIT||||LOW|NOT DONE|||ALVEOLAR AIR|CONCENTRATED|U|U-HPLC/MS/MS|Y|Y|Y||1||38||BASELINE|1964-04-30|1963-07-25|||||1969-06-25||1966-08-15
TRIAL STUDY 134XCP|IS|BC9A31E2-100C-4AC3-8910-A04309854590||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||AGU/ML|||||PHERESIS UNIT||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|HEMOLYZED|NA|GRAM STAIN|Y|N|U||2||58||OBSERVATION|1964-04-22|1971-09-08|||||1971-08-14||1960-10-18
TRIAL STUDY 134XCP|IS|BC9A31E2-100C-4AC3-8910-A04309854590||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MEQ/KG|||||VOXEL||||LOW|NOT DONE|||MECONIUM|CONCENTRATED|Y|FUNDUS PHOTOGRAPHY|NA|Y|N||3||39||OPEN LABEL TREATMENT|1970-11-04|1971-08-10|||||1962-04-28||1960-02-06
TRIAL STUDY 134XCP|IS|BC9A31E2-100C-4AC3-8910-A04309854590||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MU/L|||||MU/L||||HIGH|NOT DONE|||ERYTHROCYTES|AGGLUTINATED|NA|TURBIDIMETRY|N|N|N||4||88||FOLLOW-UP|1971-10-01|1961-01-27|||||1960-12-31||1962-06-24
TRIAL STUDY 134XCP|IS|BC9A31E2-100C-4AC3-8910-A04309854590||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CI/MG|||||CD||||HIGH|NOT DONE|||SALIVA|NON-HEMOLYZED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|U|U|U||5||7||SCREENING|1972-03-15|1962-03-04|||||1963-03-25||1972-12-29
TRIAL STUDY 134XCP|IS|13A424BB-CC85-41EC-BDED-165A29532DFF||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SPRAY|||||GLOBULE||||HIGH|NOT DONE|||LEUKOCYTE|LIPEMIC|Y|U-HPLC/MS/MS|NA|N|NA||1||38||CONTINUATION TREATMENT|1971-08-05|1973-01-16|||||1960-10-09||1973-03-02
TRIAL STUDY 134XCP|IS|13A424BB-CC85-41EC-BDED-165A29532DFF||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TSP EQ|||||MET||||ABNORMAL|NOT DONE|||CIRCULATING TUMOR CELL|REFRIGERATED|N|ANTIMICROBIAL COMBINATION TESTING|U|U|NA||2||58||BASELINE|1967-01-31|1971-06-10|||||1960-04-28||1971-09-29
TRIAL STUDY 134XCP|IS|13A424BB-CC85-41EC-BDED-165A29532DFF||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/10^5|||||MG/G/MIN||||HIGH|NOT DONE|||MUCUS|CONTAMINATED|NA|HEMAGGLUTINATION INHIBITION ASSAY|N|N|Y||3||39||LONG-TERM FOLLOW-UP|1965-01-06|1970-06-30|||||1973-02-01||1962-11-29
TRIAL STUDY 134XCP|IS|13A424BB-CC85-41EC-BDED-165A29532DFF||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||RPM|||||U/M2/H||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|LIPEMIC|N|MAPH|Y|U|N||4||88||LONG-TERM FOLLOW-UP|1966-05-05|1963-09-13|||||1967-06-03||1963-12-24
TRIAL STUDY 134XCP|IS|13A424BB-CC85-41EC-BDED-165A29532DFF||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL/MOL|||||/40 HPFS||||NORMAL|NOT DONE|||CAPILLARY PLASMA|AGGLUTINATED|Y|PAP STAIN|Y|N|Y||5||7||RUN-IN|1970-06-22|1961-08-12|||||1964-03-25||1962-09-09
TRIAL STUDY 134XCP|IS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^9/DOSE|||||/40 HPFS||||LOW|NOT DONE|||HAIR|DRIED|NA|MICROARRAY|NA|NA|NA||1||38||RUN-IN|1968-07-04|1967-02-07|||||1969-06-10||1960-10-10
TRIAL STUDY 134XCP|IS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UMOL/DAY|||||G/ANIMAL||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|FROZEN|N|LISSAMINE GREEN STAIN|U|N|NA||2||58||OPEN LABEL TREATMENT|1968-10-05|1969-01-05|||||1972-05-21||1963-03-26
TRIAL STUDY 134XCP|IS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MET*MIN|||||UGEQ||||NORMAL|NOT DONE|||EMOTIONAL TEAR|REFRIGERATED|Y|FUNCTIONAL MRI|Y|U|N||3||39||SCREENING|1961-04-19|1972-05-27|||||1964-11-04||1970-02-12
TRIAL STUDY 134XCP|IS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BISCUIT|||||ML||||ABNORMAL|NOT DONE|||SEBUM|FROZEN|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|U|U|NA||4||88||BASELINE|1968-07-05|1961-04-10|||||1970-09-28||1966-12-11
TRIAL STUDY 134XCP|IS|154D9D23-8ABD-4B69-90A1-A3D96F4743F3||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/DL|||||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE|||DERMAL TISSUE|SOLIDIFIED|N|LIGHT MICROSCOPY|NA|NA|Y||5||7||RUN-IN|1964-06-18|1967-08-01|||||1973-08-26||1971-03-07
TRIAL STUDY 134XCP|IS|059FE504-DEE4-4E24-AA80-3C64264636BF||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/BREATH|||||PPTH||||ABNORMAL|NOT DONE|||ABSCESS FLUID|LIPEMIC|U|IMPEDANCE CONDUCTIVITY|N|U|NA||1||38||RUN-IN|1967-06-29|1973-04-05|||||1971-03-17||1960-02-04
TRIAL STUDY 134XCP|IS|059FE504-DEE4-4E24-AA80-3C64264636BF||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMOL/MOL|||||NL||||HIGH|NOT DONE|||VENOUS PLASMA|REFRIGERATED|U|MYELOPEROXIDASE STAIN|Y|N|U||2||58||SCREENING|1966-04-13|1964-07-09|||||1962-11-10||1963-10-05
TRIAL STUDY 134XCP|IS|059FE504-DEE4-4E24-AA80-3C64264636BF||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||SQU/ML|||||GBQ||||HIGH|NOT DONE|||GASTRIC FLUID|NON-HEMOLYZED|U|INDIRECT IMMUNOFLUORESCENCE|NA|U|Y||3||39||WASHOUT|1961-07-05|1967-08-19|||||1970-06-11||1960-08-09
TRIAL STUDY 134XCP|IS|059FE504-DEE4-4E24-AA80-3C64264636BF||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/MOL|||||10^6 RNA COPIES/ML||||HIGH|NOT DONE|||PERSPIRATION|AUTOLYZED|Y|FUNCTIONAL MRI|N|Y|N||4||88||OPEN LABEL TREATMENT|1967-03-30|1971-03-10|||||1966-03-31||1961-03-01
TRIAL STUDY 134XCP|IS|059FE504-DEE4-4E24-AA80-3C64264636BF||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||VG/ML|||||BREATHS/MIN||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|FRESH|U|TRIPLE-PHASE MRI SCAN|N|U|U||5||7||OBSERVATION|1971-04-08|1960-06-01|||||1965-04-27||1970-09-17
TRIAL STUDY 134XCP|IS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG2/DL2|||||U/M2||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|FRESH|N|IHC|Y|U|Y||1||38||CONTINUATION TREATMENT|1961-12-21|1970-03-12|||||1963-10-04||1964-08-15
TRIAL STUDY 134XCP|IS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DISK|||||RPM||||NORMAL|NOT DONE|||PLEURAL FLUID|CONTAMINATED|NA|JAEGER EYE CHART|U|Y|N||2||58||TREATMENT|1967-12-07|1965-09-17|||||1967-03-08||1966-06-25
TRIAL STUDY 134XCP|IS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CYCLE/MIN|||||NMOL/L||||ABNORMAL|NOT DONE|||SMEGMA|AUTOLYZED|NA|CYSTOSCOPY|N|Y|NA||3||39||RUN-IN|1960-10-07|1971-07-01|||||1963-05-05||1973-03-18
TRIAL STUDY 134XCP|IS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/MIN|||||PPTH||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|HEMOLYZED|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|U|Y||4||88||BASELINE|1964-03-24|1969-07-31|||||1961-11-29||1970-04-23
TRIAL STUDY 134XCP|IS|3F806ADA-68C3-42AD-9DB7-2CA8E3A9F236||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CARTRIDGE|||||G/CAGE||||ABNORMAL|NOT DONE|||CERUMEN|CONCENTRATED|NA|ENZYMATIC COLORIMETRY|NA|Y|N||5||7||INDUCTION TREATMENT|1969-11-18|1968-05-17|||||1962-04-30||1961-01-06
TRIAL STUDY 134XCP|IS|69BCF810-6748-43AA-BDFC-64EE1536CB47||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IN2|||||FIU||||ABNORMAL|NOT DONE|||VENOUS PLASMA|CLOTTED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|U|NA||1||38||SCREENING|1967-08-20|1970-08-24|||||1968-07-05||1967-03-19
TRIAL STUDY 134XCP|IS|69BCF810-6748-43AA-BDFC-64EE1536CB47||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MM/H|||||PMOL/G||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|Y|PATHOLOGICAL EVALUATION|NA|U|N||2||58||LONG-TERM FOLLOW-UP|1969-12-26|1972-02-11|||||1966-02-07||1965-09-06
TRIAL STUDY 134XCP|IS|69BCF810-6748-43AA-BDFC-64EE1536CB47||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GTT|||||UG/G/MIN||||LOW|NOT DONE|||BREAST MILK|HEMOLYZED|N|IVY INCISION METHOD|U|Y|U||3||39||BASELINE|1970-06-04|1960-09-03|||||1972-10-18||1973-04-17
TRIAL STUDY 134XCP|IS|69BCF810-6748-43AA-BDFC-64EE1536CB47||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/M2|||||L/DAY||||HIGH|NOT DONE|||PUS|THAWED|Y|PET/MRI SCAN|NA|N|N||4||88||CONTINUATION TREATMENT|1967-06-19|1965-10-29|||||1968-09-05||1967-05-12
TRIAL STUDY 134XCP|IS|69BCF810-6748-43AA-BDFC-64EE1536CB47||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KM|||||/H||||NORMAL|NOT DONE|||INFRANATANT, SERUM|AGGLUTINATED|N|FLUORESCENT ENZYME IMMUNOASSAY|NA|N|NA||5||7||CONTINUATION TREATMENT|1969-11-14|1972-02-09|||||1968-06-09||1962-07-07
TRIAL STUDY 134XCP|IS|DCE71DE9-8DFB-4796-BC41-21930EC21925||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/M2/MIN|||||ML/MIN/1.73M2||||HIGH|NOT DONE|||GASTRIC CONTENTS|ICTERIC|Y|DYNAMOMETRY|NA|NA|NA||1||38||TREATMENT|1971-09-18|1962-03-29|||||1962-10-14||1963-10-05
TRIAL STUDY 134XCP|IS|DCE71DE9-8DFB-4796-BC41-21930EC21925||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ECL UNIT|||||SPRAY||||NORMAL|NOT DONE|||PROSTATIC FLUID|CALCIFIED|U|ECHOCARDIOGRAPHY|NA|Y|NA||2||58||TREATMENT|1963-06-13|1972-03-01|||||1971-05-04||1966-09-13
TRIAL STUDY 134XCP|IS|DCE71DE9-8DFB-4796-BC41-21930EC21925||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GPS U|||||UG/L||||LOW|NOT DONE|||BLOOD|CALCIFIED|Y|CONTRAST ENHANCED PET/CT SCAN|U|NA|Y||3||39||OBSERVATION|1968-10-03|1972-10-03|||||1970-01-11||1962-03-21
TRIAL STUDY 134XCP|IS|DCE71DE9-8DFB-4796-BC41-21930EC21925||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DRUM|||||AGU/ML||||HIGH|NOT DONE|||CORD BLOOD|FROZEN|Y|CALCOFLUOR WHITE STAIN|N|NA|Y||4||88||OPEN LABEL TREATMENT|1970-04-03|1969-04-14|||||1961-02-13||1966-02-14
TRIAL STUDY 134XCP|IS|DCE71DE9-8DFB-4796-BC41-21930EC21925||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UMOL/H/MMOL|||||ANTI-XA IU/ML||||NORMAL|NOT DONE|||MUSCLE TISSUE|REFRIGERATED|N|ETDRS EYE CHART|NA|Y|U||5||7||TREATMENT|1972-08-18|1968-11-15|||||1961-06-19||1966-01-08
TRIAL STUDY 134XCP|IS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/10^4|||||MPH||||NORMAL|NOT DONE|||CERUMEN|CLOTTED|NA|SPIRAL CT|U|NA|N||1||38||INDUCTION TREATMENT|1965-02-18|1970-03-30|||||1965-06-06||1973-02-21
TRIAL STUDY 134XCP|IS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/MIN/MMHG|||||NMOL/L||||NORMAL|NOT DONE|||DIALYSIS FLUID|PARAFFIN-EMBEDDED|Y|TEST STRIP|U|N|NA||2||58||INDUCTION TREATMENT|1969-03-13|1960-07-10|||||1972-06-06||1971-09-04
TRIAL STUDY 134XCP|IS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CPM|||||FT3||||HIGH|NOT DONE|||STOOL|LACTESCENT|Y|ICP-MS|Y|N|N||3||39||CONTINUATION TREATMENT|1970-05-23|1960-01-29|||||1970-06-13||1966-07-09
TRIAL STUDY 134XCP|IS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CI/ML|||||PKAT||||NORMAL|NOT DONE|||CAPILLARY PLASMA|FRESH|NA|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|N|U||4||88||OPEN LABEL TREATMENT|1960-02-08|1968-01-03|||||1969-12-01||1973-08-31
TRIAL STUDY 134XCP|IS|9EE46F65-A7A1-4D18-A685-BC2EF905CC19||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HOMEOPATHIC DILUTION|||||MG/ML/MIN||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|REFRIGERATED|N|INTERRUPTER TECHNIQUE|N|U|Y||5||7||OBSERVATION|1964-07-24|1960-04-05|||||1969-05-12||1961-10-25
TRIAL STUDY 134XCP|IS|97D06076-FE6B-4C77-BD5C-2E665F707C7A||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CD|||||WATT||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|N|NA|Y||1||38||TREATMENT|1969-01-27|1972-11-30|||||1961-12-08||1961-09-07
TRIAL STUDY 134XCP|IS|97D06076-FE6B-4C77-BD5C-2E665F707C7A||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/M2/DAY|||||MMOL/G||||ABNORMAL|NOT DONE|||ABSCESS FLUID|AUTOLYZED|N|HEMAGGLUTINATION ASSAY|U|Y|Y||2||58||OPEN LABEL TREATMENT|1970-08-26|1964-07-07|||||1965-06-04||1965-05-18
TRIAL STUDY 134XCP|IS|97D06076-FE6B-4C77-BD5C-2E665F707C7A||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/U|||||DNA COPIES/ML||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|LIPEMIC|N|PERFUSION MRI|U|N|U||3||39||SCREENING|1972-12-07|1962-08-19|||||1970-01-07||1968-09-27
TRIAL STUDY 134XCP|IS|97D06076-FE6B-4C77-BD5C-2E665F707C7A||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PM|||||HPA||||NORMAL|NOT DONE|||CORD SERUM|CALCIFIED|N|MALDI-TOF|N|N|NA||4||88||OBSERVATION|1968-01-08|1967-09-04|||||1961-07-01||1966-07-07
TRIAL STUDY 134XCP|IS|97D06076-FE6B-4C77-BD5C-2E665F707C7A||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/CM|||||GMFI||||LOW|NOT DONE|||PLEURAL FLUID|HEMOLYZED|NA|PHOTOMETRIC CLOT DETECTION|U|U|Y||5||7||TREATMENT|1972-04-03|1967-08-15|||||1965-05-21||1970-07-01
TRIAL STUDY 134XCP|IS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU/MG|||||DPM/MG||||HIGH|NOT DONE|||CAPILLARY PLASMA|THAWED|Y|SMEAR|Y|NA|Y||1||38||TREATMENT|1971-05-15|1964-11-06|||||1966-06-08||1960-06-29
TRIAL STUDY 134XCP|IS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||LOG10 TCID 50/DOSE|||||SUPPOSITORY||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|SOLIDIFIED|Y|CLOT DETECTION|NA|NA|Y||2||58||TREATMENT|1968-01-09|1973-05-23|||||1971-08-03||1966-03-14
TRIAL STUDY 134XCP|IS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/G/DAY|||||PMOL/L||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|LACTESCENT|N|PET/CT SCAN WITHOUT CONTRAST|U|N|Y||3||39||BLINDED TREATMENT|1972-11-14|1971-07-12|||||1968-04-06||1972-01-03
TRIAL STUDY 134XCP|IS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/DL|||||UMOL/MOL||||LOW|NOT DONE|||TRANSUDATE|GELLED|U|FLUORESCENT SPOT TEST|Y|N|Y||4||88||BLINDED TREATMENT|1960-05-06|1968-09-01|||||1973-02-25||1973-05-15
TRIAL STUDY 134XCP|IS|E9E6E2D8-33F9-4769-B5F3-06ADB2926A9F||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UCI|||||GBQ||||LOW|NOT DONE|||BREAST MILK|THAWED|Y|PET/CT SCAN|U|U|NA||5||7||OBSERVATION|1967-05-30|1965-08-10|||||1961-11-27||1971-03-16
TRIAL STUDY 134XCP|IS|D5A1EB38-77EA-49A5-84CA-740A83D258AF||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/G|||||NG/DL||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|CLOTTED|U|MANUAL COUNT|U|U|N||1||38||TREATMENT|1969-10-01|1972-04-16|||||1973-08-03||1973-01-06
TRIAL STUDY 134XCP|IS|D5A1EB38-77EA-49A5-84CA-740A83D258AF||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/H|||||MV*MIN||||LOW|NOT DONE|||BLOOD|NON-HEMOLYZED|Y|WRIGHT STAIN|Y|N|NA||2||58||LONG-TERM FOLLOW-UP|1964-03-20|1971-07-15|||||1968-04-09||1963-03-25
TRIAL STUDY 134XCP|IS|D5A1EB38-77EA-49A5-84CA-740A83D258AF||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||APPLICATION|||||VP/ML||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|GELLED|NA|RULER MEASUREMENT METHOD|N|N|Y||3||39||RUN-IN|1970-04-01|1966-02-01|||||1961-10-22||1965-09-18
TRIAL STUDY 134XCP|IS|D5A1EB38-77EA-49A5-84CA-740A83D258AF||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MU/G|||||10^3 CFU||||HIGH|NOT DONE|||TISSUE|ROOM TEMPERATURE|Y|LEAD CITRATE STAIN|U|U|U||4||88||TREATMENT|1966-01-26|1960-02-03|||||1961-10-19||1962-04-22
TRIAL STUDY 134XCP|IS|D5A1EB38-77EA-49A5-84CA-740A83D258AF||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FOZ_US|||||L/MIN/M2||||HIGH|NOT DONE|||MENSTRUAL BLOOD|LIPEMIC|NA|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NA|N|N||5||7||BASELINE|1967-11-21|1972-09-04|||||1968-02-14||1969-08-23
TRIAL STUDY 134XCP|IS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UMOL|||||RAD||||LOW|NOT DONE|||PERITONEAL FLUID|FRESH|U|AURAMINE STAIN|NA|NA|Y||1||38||INDUCTION TREATMENT|1964-11-18|1971-07-06|||||1969-07-01||1967-10-18
TRIAL STUDY 134XCP|IS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NM|||||/4.0 ML||||HIGH|NOT DONE|||SEMINAL FLUID|LIPEMIC|N|CYSTOSCOPY|NA|Y|U||2||58||BASELINE|1973-02-10|1972-10-02|||||1960-11-02||1965-05-18
TRIAL STUDY 134XCP|IS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MOL/L|||||MAMP||||HIGH|NOT DONE|||STOOL|THAWED|N|INTRAVASCULAR ULTRASOUND|NA|NA|N||3||39||LONG-TERM FOLLOW-UP|1969-05-06|1965-08-13|||||1964-06-09||1973-08-29
TRIAL STUDY 134XCP|IS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CL|||||TRACE||||NORMAL|NOT DONE|||CELL PELLET|AUTOLYZED|NA|GRAM STAIN|NA|Y|Y||4||88||INDUCTION TREATMENT|1972-02-06|1963-01-29|||||1962-06-25||1963-03-15
TRIAL STUDY 134XCP|IS|5255639E-AC65-4DA8-85EF-4ABD53BAAED5||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE/DAY|||||TBSP||||HIGH|NOT DONE|||VITREOUS HUMOR|CONCENTRATED|U|GEL ELECTROPHORESIS|N|N|U||5||7||RUN-IN|1971-12-26|1973-03-30|||||1968-08-30||1968-10-01
TRIAL STUDY 134XCP|IS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BEATS/MIN|||||PMOL/L||||HIGH|NOT DONE|||CORD BLOOD|THAWED|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|U|Y|U||1||38||BASELINE|1966-01-05|1960-03-10|||||1964-10-09||1964-03-06
TRIAL STUDY 134XCP|IS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI|||||USIEMENS||||HIGH|NOT DONE|||BREAST MILK|HEMOLYZED|U|HANSEL STAIN|N|N|U||2||58||SCREENING|1968-04-18|1970-03-29|||||1968-07-31||1972-05-14
TRIAL STUDY 134XCP|IS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CARTRIDGE|||||LOG10 TCID 50/ML||||HIGH|NOT DONE|||GASTRIC CONTENTS|UNEXPECTED ODOR|N|MS/MS|NA|N|Y||3||39||CONTINUATION TREATMENT|1971-06-25|1972-04-13|||||1969-10-22||1960-02-01
TRIAL STUDY 134XCP|IS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MPH|||||LOG10 TCID 50/UL||||LOW|NOT DONE|||HAIR|CONTAMINATED|Y|U-HPLC/MS/MS|Y|U|Y||4||88||INDUCTION TREATMENT|1964-05-11|1961-03-24|||||1960-04-06||1967-05-27
TRIAL STUDY 134XCP|IS|99F8DAA7-F186-487C-9E5D-43E9DBFB48C6||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 ORGANISMS/G|||||MU||||NORMAL|NOT DONE|||KERATINOCYTE|LIPEMIC|U|FLUORESCENT IMMUNOASSAY|N|Y|U||5||7||RUN-IN|1966-08-28|1961-02-05|||||1972-01-15||1971-04-18
TRIAL STUDY 134XCP|IS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU/DAY|||||/LPF||||LOW|NOT DONE|||ADIPOSE TISSUE|FRESH|N|DUCTOGRAPHY|Y|U|U||1||38||BLINDED TREATMENT|1971-06-04|1966-07-21|||||1961-12-16||1964-08-29
TRIAL STUDY 134XCP|IS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||HOMEOPATHIC DILUTION|||||UMOL/MIN||||NORMAL|NOT DONE|||SYNOVIAL FLUID|CALCIFIED|U|IMPULSE OSCILLOMETRY|N|N|Y||2||58||OBSERVATION|1970-10-23|1964-04-14|||||1972-04-04||1962-09-29
TRIAL STUDY 134XCP|IS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||STRIP|||||L/H/M2||||NORMAL|NOT DONE|||LAVAGE FLUID|AUTOLYZED|N|CAPILLARY ELECTROPHORESIS|N|Y|N||3||39||OBSERVATION|1972-12-10|1970-01-09|||||1967-04-18||1971-07-21
TRIAL STUDY 134XCP|IS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MOL|||||CD/M2||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|AGGLUTINATED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|N|U|NA||4||88||CONTINUATION TREATMENT|1967-05-03|1967-01-03|||||1965-02-06||1966-05-19
TRIAL STUDY 134XCP|IS|88A1099B-F69D-4B6F-90CE-DAAE629CEACE||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LOG10 COPIES/ML|||||10^5/L||||LOW|NOT DONE|||SEMEN|UNEXPECTED ODOR|Y|ICC|N|U|N||5||7||BASELINE|1964-01-20|1963-03-16|||||1962-08-29||1960-11-10
TRIAL STUDY 134XCP|IS|640DDEF5-748A-4F92-A13D-15D1C7CE0800||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 CFU/G|||||VP/DOSE||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|AGGLUTINATED|N|VENTILATION PERFUSION LUNG SCAN|NA|Y|N||1||38||LONG-TERM FOLLOW-UP|1973-04-11|1969-12-08|||||1971-03-20||1962-06-10
TRIAL STUDY 134XCP|IS|640DDEF5-748A-4F92-A13D-15D1C7CE0800||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MM3/MM2/YEAR|||||DMOL||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|CALCIFIED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|U|NA||2||58||TREATMENT|1968-09-14|1963-11-26|||||1961-10-02||1970-09-20
TRIAL STUDY 134XCP|IS|640DDEF5-748A-4F92-A13D-15D1C7CE0800||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/200 HPFS|||||MOL/DAY||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|NON-HEMOLYZED|Y|TARGETED GENOME SEQUENCING|N|NA|U||3||39||OPEN LABEL TREATMENT|1964-01-09|1973-04-03|||||1964-09-18||1961-10-26
TRIAL STUDY 134XCP|IS|640DDEF5-748A-4F92-A13D-15D1C7CE0800||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||COULOMB|||||SPRAY||||LOW|NOT DONE|||PROSTATIC FLUID|GELLED|NA|AUSCULTATION|N|U|NA||4||88||TREATMENT|1973-03-04|1964-05-09|||||1970-02-23||1972-02-29
TRIAL STUDY 134XCP|IS|640DDEF5-748A-4F92-A13D-15D1C7CE0800||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^8/L|||||RAD||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|CLOTTED|U|EIA|U|N|U||5||7||BASELINE|1970-08-02|1964-01-03|||||1967-11-14||1967-12-08
TRIAL STUDY 134XCP|IS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/10^12 RBC|||||CCID 50/ML||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|FRESH|N|WHOLE GENOME SEQUENCING|Y|Y|U||1||38||BASELINE|1970-10-30|1968-11-19|||||1971-04-28||1962-04-02
TRIAL STUDY 134XCP|IS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GY/MIN|||||UG/ML/H||||NORMAL|NOT DONE|||SPUTUM|ROOM TEMPERATURE|NA|QUANTITATIVE ULTRASOUND|NA|U|U||2||58||SCREENING|1966-02-09|1968-03-28|||||1973-07-27||1972-09-16
TRIAL STUDY 134XCP|IS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/L|||||NGEQ/L||||LOW|NOT DONE|||URINE SEDIMENT|AUTOLYZED|U|HPLC/MS|U|U|U||3||39||CONTINUATION TREATMENT|1967-03-12|1962-07-21|||||1969-11-09||1973-04-17
TRIAL STUDY 134XCP|IS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PPM|||||10^7 CFU/ML||||ABNORMAL|NOT DONE|||BILE|CONTAMINATED|Y|MRS|NA|NA|U||4||88||LONG-TERM FOLLOW-UP|1965-01-26|1961-09-24|||||1972-07-21||1960-03-20
TRIAL STUDY 134XCP|IS|FB4290D9-A5F8-472C-8AAC-28D8A59D8FED||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||WATT|||||10^7/L||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|REFRIGERATED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|U|N|NA||5||7||WASHOUT|1963-01-25|1962-04-06|||||1967-07-08||1964-01-21
TRIAL STUDY 134XCP|IS|EBC7BF7B-18C6-463C-8500-027B2A6966DB||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||IU/L|||||/MS||||ABNORMAL|NOT DONE|||GASTRIC FLUID|GELLED|N|DYNAMIC CONTRAST ENHANCED MRI|N|N|Y||1||38||BLINDED TREATMENT|1972-07-26|1968-04-29|||||1962-12-24||1962-11-03
TRIAL STUDY 134XCP|IS|EBC7BF7B-18C6-463C-8500-027B2A6966DB||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U|||||MBP||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|LIPEMIC|Y|TRYPAN BLUE STAIN|U|N|N||2||58||OBSERVATION|1968-10-27|1968-03-19|||||1963-05-24||1968-08-18
TRIAL STUDY 134XCP|IS|EBC7BF7B-18C6-463C-8500-027B2A6966DB||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/10^3|||||ML/M2/MIN||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|U|MAGNETIC RESONANCE ELASTOGRAPHY|U|U|U||3||39||LONG-TERM FOLLOW-UP|1963-04-13|1962-01-20|||||1961-05-03||1968-03-13
TRIAL STUDY 134XCP|IS|EBC7BF7B-18C6-463C-8500-027B2A6966DB||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FT2|||||MESF||||HIGH|NOT DONE|||FLUID|SOLIDIFIED|NA|NON-INVASIVE DIELECTRIC SENSING|N|NA|N||4||88||OBSERVATION|1968-09-05|1965-06-23|||||1961-10-01||1968-09-02
TRIAL STUDY 134XCP|IS|EBC7BF7B-18C6-463C-8500-027B2A6966DB||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MASK|||||MMU/ML||||NORMAL|NOT DONE|||MUSCLE TISSUE|DRIED|N|FLOCCULATION|U|NA|N||5||7||WASHOUT|1971-03-19|1967-07-05|||||1971-03-14||1964-03-25
TRIAL STUDY 134XCP|IS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||SPRAY|||||ML/KG||||ABNORMAL|NOT DONE|||FLUID|LIPEMIC|U|NEPHELOMETRY|N|U|Y||1||38||INDUCTION TREATMENT|1971-10-27|1961-12-18|||||1967-01-28||1969-05-19
TRIAL STUDY 134XCP|IS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||%/MIN|||||PMOL/L||||ABNORMAL|NOT DONE|||VENOUS PLASMA|PARAFFIN-EMBEDDED|N|DIGITAL PCR ARRAY|NA|Y|NA||2||58||OPEN LABEL TREATMENT|1969-05-25|1973-07-23|||||1962-03-12||1971-05-26
TRIAL STUDY 134XCP|IS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PKAT|||||U/KG/DAY||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|DRIED|Y|LIGHT SCATTERING SPECTROSCOPY|NA|N|U||3||39||LONG-TERM FOLLOW-UP|1967-09-04|1962-04-30|||||1968-10-25||1969-01-16
TRIAL STUDY 134XCP|IS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UU/L|||||MESF||||HIGH|NOT DONE|||LAVAGE FLUID|CONCENTRATED|N|CLIP SEQUENCING|U|NA|NA||4||88||LONG-TERM FOLLOW-UP|1969-02-18|1965-06-24|||||1961-02-08||1961-02-03
TRIAL STUDY 134XCP|IS|3167BE9B-E72D-4011-BD2C-CB4F9F27FE2C||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MM/SEC|||||SHOCK WAVE||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|DRIED|Y|IMMUNORADIOMETRIC ASSAY|Y|U|Y||5||7||TREATMENT|1961-04-27|1972-03-22|||||1966-11-12||1970-09-16
TRIAL STUDY 134XCP|IS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/H|||||JAR||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|N|REFRACTOMETRY|N|NA|U||1||38||CONTINUATION TREATMENT|1964-12-10|1962-12-07|||||1961-09-10||1961-07-25
TRIAL STUDY 134XCP|IS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CI/ML|||||MMOL/MIN/KPA||||HIGH|NOT DONE|||DERMAL TISSUE|CONTAMINATED|Y|SINGLE-SLICE SPIRAL CT|NA|N|N||2||58||BLINDED TREATMENT|1969-10-02|1973-09-08|||||1966-09-10||1963-04-06
TRIAL STUDY 134XCP|IS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NG|||||MG/H||||LOW|NOT DONE|||BREAST MILK|ICTERIC|U|MICRO BROTH DILUTION|U|U|NA||3||39||OBSERVATION|1960-04-30|1970-05-14|||||1969-05-07||1962-03-14
TRIAL STUDY 134XCP|IS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||STEPS|||||IU/MG||||HIGH|NOT DONE|||CAPILLARY BLOOD|REFRIGERATED|NA|FUNCTIONAL MRI|Y|Y|N||4||88||INDUCTION TREATMENT|1970-06-11|1970-01-22|||||1963-06-19||1967-05-29
TRIAL STUDY 134XCP|IS|61A831EB-7AFF-47B7-A0D5-9727CC6EB9CD||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NEWTON|||||MEQ/DAY||||HIGH|NOT DONE|||LAVAGE FLUID|HEMOLYZED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NA|Y|Y||5||7||OBSERVATION|1972-04-29|1966-08-03|||||1961-10-06||1969-02-15
TRIAL STUDY 134XCP|IS|74741526-F925-4AA5-9BE3-F3B3884BEE68||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MOL|||||G||||HIGH|NOT DONE|||TISSUE|HEMOLYZED|U|CELL BASED BIOASSAY|NA|U|Y||1||38||INDUCTION TREATMENT|1967-12-01|1973-07-01|||||1963-09-11||1960-01-25
TRIAL STUDY 134XCP|IS|74741526-F925-4AA5-9BE3-F3B3884BEE68||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BEL|||||ML/S/M2||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|U|OPTICAL DENSITY MEASUREMENT|Y|N|U||2||58||BLINDED TREATMENT|1966-03-24|1970-02-25|||||1961-01-24||1964-12-21
TRIAL STUDY 134XCP|IS|74741526-F925-4AA5-9BE3-F3B3884BEE68||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ABSORBANCE U/ML|||||PL||||NORMAL|NOT DONE|||MONOCYTE|LACTESCENT|Y|JAEGER EYE CHART|Y|Y|Y||3||39||FOLLOW-UP|1967-02-17|1966-11-16|||||1964-05-28||1964-11-09
TRIAL STUDY 134XCP|IS|74741526-F925-4AA5-9BE3-F3B3884BEE68||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FRAMES/S|||||G/ANIMAL/DAY||||HIGH|NOT DONE|||ADIPOSE TISSUE|PARAFFIN-EMBEDDED|U|PERIODIC ACID SCHIFF STAIN|NA|Y|NA||4||88||BLINDED TREATMENT|1971-12-05|1964-10-23|||||1962-01-04||1964-12-26
TRIAL STUDY 134XCP|IS|74741526-F925-4AA5-9BE3-F3B3884BEE68||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/200 HPFS|||||C||||LOW|NOT DONE|||DISCHARGE|DRIED|U|DXA SCAN|NA|U|Y||5||7||SCREENING|1969-12-19|1966-07-22|||||1967-09-26||1967-05-10
TRIAL STUDY 134XCP|IS|25088C28-0FA3-4005-90C3-CCF9C6FF5851||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DRAM|||||ATM||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|NON-HEMOLYZED|Y|ICP-MS|N|NA|Y||1||38||BLINDED TREATMENT|1971-06-28|1968-09-06|||||1960-10-13||1965-12-03
TRIAL STUDY 134XCP|IS|25088C28-0FA3-4005-90C3-CCF9C6FF5851||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMAL|||||10^6 IU/ML||||ABNORMAL|NOT DONE|||LAVAGE FLUID|LIPEMIC|U|ELECTRICAL IMPEDANCE MYOGRAPHY|NA|U|U||2||58||RUN-IN|1969-08-07|1961-11-22|||||1965-06-18||1969-05-28
TRIAL STUDY 134XCP|IS|25088C28-0FA3-4005-90C3-CCF9C6FF5851||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||OI50|||||BEATS/MIN||||LOW|NOT DONE|||AQUEOUS HUMOR|AGGLUTINATED|U|NUCLEIC ACID SEQUENCING|U|NA|NA||3||39||OPEN LABEL TREATMENT|1972-06-03|1962-01-08|||||1970-01-07||1964-11-21
TRIAL STUDY 134XCP|IS|25088C28-0FA3-4005-90C3-CCF9C6FF5851||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/M2|||||MOSM||||HIGH|NOT DONE|||LOCHIA|CONTAMINATED|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|U|NA|NA||4||88||CONTINUATION TREATMENT|1968-08-29|1969-08-28|||||1973-03-10||1969-04-15
TRIAL STUDY 134XCP|IS|25088C28-0FA3-4005-90C3-CCF9C6FF5851||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU/DL|||||NM||||NORMAL|NOT DONE|||SEMEN|CALCIFIED|N|OPHTHALMOSCOPY|N|U|U||5||7||OBSERVATION|1962-04-08|1963-05-23|||||1970-07-10||1972-11-01
TRIAL STUDY 134XCP|IS|9BF13738-0A50-46E6-A3DA-AC956A361B97||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/DOSE|||||U/KG/MIN||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|NON-HEMOLYZED|NA|CORONARY ANGIOGRAPHY|N|Y|NA||1||38||CONTINUATION TREATMENT|1971-09-10|1964-06-02|||||1966-06-05||1968-06-04
TRIAL STUDY 134XCP|IS|9BF13738-0A50-46E6-A3DA-AC956A361B97||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PPTH|||||UMOL/DAY||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|REFRIGERATED|N|FARR ASSAY|U|Y|Y||2||58||OBSERVATION|1963-12-23|1962-08-21|||||1964-12-11||1970-12-06
TRIAL STUDY 134XCP|IS|9BF13738-0A50-46E6-A3DA-AC956A361B97||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MBQ/UL|||||PUFF||||LOW|NOT DONE|||MECONIUM|THAWED|NA|NUCLEIC ACID AMPLIFICATION TEST|N|U|U||3||39||OPEN LABEL TREATMENT|1962-01-30|1972-04-24|||||1960-04-13||1967-05-07
TRIAL STUDY 134XCP|IS|9BF13738-0A50-46E6-A3DA-AC956A361B97||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||STEPS/MIN|||||CI/UL||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|CONTAMINATED|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|U|N|N||4||88||OPEN LABEL TREATMENT|1962-03-15|1971-02-22|||||1965-03-20||1962-07-26
TRIAL STUDY 134XCP|IS|9BF13738-0A50-46E6-A3DA-AC956A361B97||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CFU/G|||||KG/CM2||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CLOTTED|NA|WHOLE GENOME SEQUENCING|N|N|NA||5||7||CONTINUATION TREATMENT|1970-10-31|1966-04-01|||||1968-12-12||1966-07-05
TRIAL STUDY 134XCP|IS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MV2/HZ|||||ENZYME U/M2||||HIGH|NOT DONE|||REFLEX TEAR|CALCIFIED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|U|NA|Y||1||38||BLINDED TREATMENT|1964-12-05|1971-07-04|||||1967-08-11||1962-11-07
TRIAL STUDY 134XCP|IS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/2000 RBC|||||10^7/L||||LOW|NOT DONE|||SKIN TISSUE|CONTAMINATED|Y|FUNDUS PHOTOGRAPHY|N|U|NA||2||58||TREATMENT|1963-02-21|1967-07-17|||||1972-07-06||1968-06-24
TRIAL STUDY 134XCP|IS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||HOURS|||||PKAT/L||||LOW|NOT DONE|||SMEGMA|CALCIFIED|N|MAGNETIC RESONANCE ANGIOGRAPHY|Y|Y|U||3||39||TREATMENT|1964-11-02|1960-01-23|||||1966-07-30||1972-10-07
TRIAL STUDY 134XCP|IS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FIU|||||10^3 COPIES/ML||||ABNORMAL|NOT DONE|||SPUTUM|CONCENTRATED|NA|ANTIMICROBIAL COMBINATION TESTING|Y|N|U||4||88||OBSERVATION|1964-10-07|1972-08-23|||||1971-11-13||1966-08-16
TRIAL STUDY 134XCP|IS|C7432A9E-BB47-46D1-92F6-FED7FBC627A0||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||WEEKS|||||MM/2H||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|U|DIFFUSION WEIGHTED MRI|U|U|NA||5||7||OBSERVATION|1970-05-25|1970-07-27|||||1960-05-28||1960-04-05
TRIAL STUDY 134XCP|IS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^6/EJACULATE U|||||IU/DAY||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|ICTERIC|Y|TRICHROME STAIN|NA|NA|NA||1||38||RUN-IN|1972-01-26|1960-07-12|||||1971-04-11||1969-06-06
TRIAL STUDY 134XCP|IS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS|||||%/S||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|FRESH|U|AUSCULTATION|NA|N|NA||2||58||BLINDED TREATMENT|1964-11-02|1966-12-19|||||1960-08-13||1962-12-04
TRIAL STUDY 134XCP|IS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MHZ|||||GAUSS||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|FRESH|U|CELL BASED BIOASSAY|NA|U|N||3||39||RUN-IN|1960-11-05|1963-07-08|||||1963-06-05||1968-01-16
TRIAL STUDY 134XCP|IS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MM|||||10^8 PFU||||LOW|NOT DONE|||BLOOD|NON-HEMOLYZED|Y|HEMAGGLUTINATION INHIBITION ASSAY|N|U|N||4||88||BASELINE|1969-09-29|1967-06-01|||||1967-03-07||1965-08-04
TRIAL STUDY 134XCP|IS|F6EBFB06-3EEF-4621-BDA3-36FD6D4799BF||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MEQ/ML|||||COPIES/UL||||HIGH|NOT DONE|||EMESIS|SOLIDIFIED|U|GC/MS-EI|U|NA|U||5||7||BLINDED TREATMENT|1961-05-21|1961-06-06|||||1963-10-09||1963-07-02
TRIAL STUDY 134XCP|IS|5AEA7EE9-1095-4967-B833-7665B6A71B31||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||SHOCK WAVE|||||ROENTGEN||||NORMAL|NOT DONE|||GASTRIC FLUID|SOLIDIFIED|U|SXA SCAN|N|Y|NA||1||38||CONTINUATION TREATMENT|1962-08-07|1970-10-07|||||1961-10-15||1962-11-15
TRIAL STUDY 134XCP|IS|5AEA7EE9-1095-4967-B833-7665B6A71B31||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PATCH|||||DPM/100MG||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|CLOTTED|Y|AUTOMATED COUNT|U|U|N||2||58||INDUCTION TREATMENT|1966-05-12|1973-02-16|||||1962-08-20||1973-07-13
TRIAL STUDY 134XCP|IS|5AEA7EE9-1095-4967-B833-7665B6A71B31||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 DNA COPIES/ML|||||MMAL||||NORMAL|NOT DONE|||KERATINOCYTE|ICTERIC|Y|WHOLE GENOME SEQUENCING|N|NA|NA||3||39||LONG-TERM FOLLOW-UP|1968-06-07|1972-06-03|||||1972-10-24||1970-01-30
TRIAL STUDY 134XCP|IS|5AEA7EE9-1095-4967-B833-7665B6A71B31||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||P|||||TUBERCULIN UNIT||||LOW|NOT DONE|||BUFFY COAT|SOLIDIFIED|NA|ICC|NA|NA|U||4||88||BLINDED TREATMENT|1966-04-29|1963-06-17|||||1961-06-24||1961-06-27
TRIAL STUDY 134XCP|IS|5AEA7EE9-1095-4967-B833-7665B6A71B31||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/LPF|||||UV||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CALCIFIED|U|MICRONEUTRALIZATION ASSAY|U|NA|N||5||7||TREATMENT|1966-06-21|1966-11-29|||||1963-04-12||1967-10-21
TRIAL STUDY 134XCP|IS|241CD521-D0BD-40BB-ABA2-B8C8E500B491||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MOL|||||FT||||NORMAL|NOT DONE|||SEBUM|PARAFFIN-EMBEDDED|N|CALIPER MEASUREMENT METHOD|U|Y|Y||1||38||BLINDED TREATMENT|1960-10-04|1967-10-28|||||1972-04-07||1971-09-18
TRIAL STUDY 134XCP|IS|241CD521-D0BD-40BB-ABA2-B8C8E500B491||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^9 ORGANISMS/G|||||NEBULE||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|N|DUKE INCISION METHOD|NA|U|Y||2||58||SCREENING|1963-12-11|1961-12-29|||||1968-11-23||1965-07-01
TRIAL STUDY 134XCP|IS|241CD521-D0BD-40BB-ABA2-B8C8E500B491||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 IU|||||10^3 CFU/G||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|REFRIGERATED|N|ECHOCARDIOGRAPHY|N|U|Y||3||39||OPEN LABEL TREATMENT|1961-07-28|1971-08-31|||||1966-02-12||1969-10-12
TRIAL STUDY 134XCP|IS|241CD521-D0BD-40BB-ABA2-B8C8E500B491||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ATM|||||LOG10 IU/ML||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|NA|NUCLEIC ACID BASED METHOD|N|Y|NA||4||88||WASHOUT|1971-05-30|1969-06-29|||||1964-06-27||1971-04-14
TRIAL STUDY 134XCP|IS|241CD521-D0BD-40BB-ABA2-B8C8E500B491||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CI/MG|||||PMOL/DAY||||HIGH|NOT DONE|||PLEURAL FLUID|ICTERIC|U|CALCOFLUOR WHITE STAIN|NA|N|U||5||7||SCREENING|1971-10-26|1970-03-21|||||1969-10-11||1972-02-19
TRIAL STUDY 134XCP|IS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KPA/L/SEC|||||ML/MMHG||||HIGH|NOT DONE|||PROSTATIC FLUID|LACTESCENT|N|FLUORESCENT ENZYME IMMUNOASSAY|Y|U|N||1||38||RUN-IN|1962-11-22|1964-01-03|||||1963-03-24||1973-04-06
TRIAL STUDY 134XCP|IS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/MIN|||||MM3/MM2/YEAR||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|PULSE OXIMETRY|NA|N|N||2||58||RUN-IN|1961-09-25|1971-09-01|||||1971-06-20||1966-03-10
TRIAL STUDY 134XCP|IS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG|||||NSEC||||NORMAL|NOT DONE|||BLOOD|CALCIFIED|N|PHASE-CONTRAST MRI|NA|NA|NA||3||39||OBSERVATION|1961-10-21|1970-09-02|||||1960-11-22||1964-10-03
TRIAL STUDY 134XCP|IS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^3/HPF|||||/10^4||||LOW|NOT DONE|||URINE SEDIMENT|REFRIGERATED|N|POLYMERASE CHAIN REACTION|NA|U|NA||4||88||LONG-TERM FOLLOW-UP|1971-01-04|1968-12-25|||||1971-02-03||1973-01-25
TRIAL STUDY 134XCP|IS|D37D2206-A2C1-4AC2-93B2-EDB213AF852F||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CM H2O|||||MEQ/MMOL||||NORMAL|NOT DONE|||LOCHIA|CONCENTRATED|U|SLIT LAMP|N|Y|U||5||7||BLINDED TREATMENT|1970-03-23|1971-12-18|||||1960-08-11||1965-06-29
TRIAL STUDY 134XCP|IS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PA|||||PIXELS/IN||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|ICTERIC|NA|BAC ACGH|NA|U|Y||1||38||BLINDED TREATMENT|1964-09-25|1971-02-15|||||1962-12-21||1969-08-06
TRIAL STUDY 134XCP|IS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UL/ML|||||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|NON-HEMOLYZED|Y|X-RAY|U|U|N||2||58||INDUCTION TREATMENT|1963-06-29|1968-07-21|||||1961-10-30||1971-07-24
TRIAL STUDY 134XCP|IS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||GTT|||||MBQ||||HIGH|NOT DONE|||BASAL TEAR|NON-HEMOLYZED|N|NON-CONTACT SPECULAR MICROSCOPY|Y|Y|N||3||39||RUN-IN|1967-02-17|1968-03-06|||||1966-07-15||1970-03-25
TRIAL STUDY 134XCP|IS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MEQ/G|||||CUP||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|U|MICROSCOPY|NA|NA|NA||4||88||CONTINUATION TREATMENT|1965-02-07|1968-09-03|||||1961-08-01||1961-05-30
TRIAL STUDY 134XCP|IS|FAC78D40-3CBA-4D35-8911-64C0D25C3AE8||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CCID 50/DOSE|||||POUCH||||HIGH|NOT DONE|||LOCHIA|UNEXPECTED ODOR|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|N|U||5||7||OPEN LABEL TREATMENT|1962-10-25|1963-08-28|||||1967-04-27||1970-12-04
TRIAL STUDY 134XCP|IS|FD609B1C-D1E7-4349-B036-DF0126D96A52||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ATM|||||CAPSULE||||HIGH|NOT DONE|||PERSPIRATION|NON-HEMOLYZED|N|MAMMOGRAPHY|Y|N|N||1||38||BLINDED TREATMENT|1965-04-30|1968-05-16|||||1968-03-26||1960-01-27
TRIAL STUDY 134XCP|IS|FD609B1C-D1E7-4349-B036-DF0126D96A52||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7 PFU|||||TORR||||ABNORMAL|NOT DONE|||TRANSUDATE|CLOTTED|N|MICROBIAL CONCENTRATION|U|N|U||2||58||CONTINUATION TREATMENT|1971-02-20|1972-12-20|||||1971-02-19||1972-08-03
TRIAL STUDY 134XCP|IS|FD609B1C-D1E7-4349-B036-DF0126D96A52||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL/ML|||||MG/KG/DAY||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|Y|DIGITAL PCR ARRAY|Y|NA|NA||3||39||OPEN LABEL TREATMENT|1968-10-02|1964-05-02|||||1971-07-08||1963-12-30
TRIAL STUDY 134XCP|IS|FD609B1C-D1E7-4349-B036-DF0126D96A52||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CMH2O*S/ML|||||L/L||||HIGH|NOT DONE|||MENSTRUAL BLOOD|FRESH|Y|ENZYMATIC SPECTROPHOTOMETRY|U|U|U||4||88||OPEN LABEL TREATMENT|1960-12-26|1971-09-12|||||1970-05-05||1971-12-02
TRIAL STUDY 134XCP|IS|FD609B1C-D1E7-4349-B036-DF0126D96A52||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMHG/SEC|||||KG/M2||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|FRESH|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|N|N|U||5||7||CONTINUATION TREATMENT|1966-08-20|1970-05-10|||||1969-01-14||1968-04-28
TRIAL STUDY 134XCP|IS|DEB0593B-E3FD-471C-A800-43058AC5FD86||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^11/L|||||KBQ/UL||||ABNORMAL|NOT DONE|||URINE|THAWED|Y|ELLA|NA|NA|N||1||38||RUN-IN|1968-12-31|1972-02-15|||||1972-07-14||1971-08-08
TRIAL STUDY 134XCP|IS|DEB0593B-E3FD-471C-A800-43058AC5FD86||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CAN|||||V/SEC||||ABNORMAL|NOT DONE|||CORD BLOOD|ICTERIC|Y|IMPEDANCE CONDUCTIVITY|U|Y|NA||2||58||WASHOUT|1960-11-15|1972-08-28|||||1964-10-31||1968-07-29
TRIAL STUDY 134XCP|IS|DEB0593B-E3FD-471C-A800-43058AC5FD86||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DNA COPIES/ML|||||PACK||||LOW|NOT DONE|||PERITONEAL FLUID|FRESH|N|ACID FAST STAIN|Y|Y|U||3||39||WASHOUT|1962-02-15|1965-08-28|||||1960-06-19||1973-04-22
TRIAL STUDY 134XCP|IS|DEB0593B-E3FD-471C-A800-43058AC5FD86||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/KG/DAY|||||MMHG/L/MIN||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|Y|ANTIBIOTIC AGAR SCREEN|N|U|N||4||88||WASHOUT|1965-08-17|1964-05-25|||||1966-08-18||1968-03-11
TRIAL STUDY 134XCP|IS|DEB0593B-E3FD-471C-A800-43058AC5FD86||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANTIBODY UNIT|||||ROENTGEN||||LOW|NOT DONE|||LOCHIA|REFRIGERATED|N|PERFUSION MRI|Y|U|N||5||7||TREATMENT|1960-05-04|1963-12-10|||||1966-07-30||1968-01-22
TRIAL STUDY 134XCP|IS|596BD728-2487-44E4-AFB1-8A4331EEDDF6||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PMOL/DAY|||||CY/CM||||NORMAL|NOT DONE|||ADIPOSE TISSUE|CONTAMINATED|Y|PET/CT SCAN WITHOUT CONTRAST|Y|Y|N||1||38||FOLLOW-UP|1961-11-04|1962-05-17|||||1965-12-09||1963-02-21
TRIAL STUDY 134XCP|IS|596BD728-2487-44E4-AFB1-8A4331EEDDF6||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MPL U/ML|||||BAU||||LOW|NOT DONE|||PLEURAL FLUID|AUTOLYZED|Y|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|U|NA|U||2||58||BASELINE|1968-06-26|1965-03-18|||||1961-02-20||1972-10-23
TRIAL STUDY 134XCP|IS|596BD728-2487-44E4-AFB1-8A4331EEDDF6||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MS2|||||KG/CM||||LOW|NOT DONE|||LOCHIA|UNEXPECTED ODOR|U|PULSE OXIMETRY|U|N|U||3||39||FOLLOW-UP|1970-07-16|1969-07-21|||||1964-10-09||1960-05-24
TRIAL STUDY 134XCP|IS|596BD728-2487-44E4-AFB1-8A4331EEDDF6||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/MIN|||||KS||||LOW|NOT DONE|||LEUKOCYTE|DRIED|NA|ORCHIDOMETERY|N|U|U||4||88||LONG-TERM FOLLOW-UP|1968-03-07|1960-02-12|||||1962-04-04||1963-03-14
TRIAL STUDY 134XCP|IS|596BD728-2487-44E4-AFB1-8A4331EEDDF6||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||VG/DOSE|||||PNU/ML||||LOW|NOT DONE|||ABSCESS FLUID|DRIED|NA|MICRO BROTH DILUTION|NA|Y|Y||5||7||OBSERVATION|1960-11-11|1965-03-07|||||1971-03-16||1960-06-28
TRIAL STUDY 134XCP|IS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/M2/DAY|||||U||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|CONCENTRATED|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|NA|Y|Y||1||38||LONG-TERM FOLLOW-UP|1967-10-04|1961-02-22|||||1965-11-28||1967-10-20
TRIAL STUDY 134XCP|IS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||AMU|||||ML/CM H2O||||HIGH|NOT DONE|||TUMOR TISSUE|REFRIGERATED|NA|X-RAY|U|N|N||2||58||INDUCTION TREATMENT|1965-09-01|1966-12-14|||||1964-11-30||1961-01-27
TRIAL STUDY 134XCP|IS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||L/H|||||APL U/ML||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|AUTOLYZED|NA|SNELLEN EYE CHART|Y|Y|U||3||39||BASELINE|1970-01-14|1969-07-30|||||1970-10-28||1960-05-09
TRIAL STUDY 134XCP|IS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NM|||||EID 50/DOSE||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|CALCIFIED|Y|ELECTROMYOGRAPHY|NA|U|NA||4||88||BASELINE|1972-12-13|1969-01-06|||||1962-07-06||1965-09-30
TRIAL STUDY 134XCP|IS|CAF30D22-3C56-48D4-AB55-46C09A21FDBF||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||WEEKS|||||UG/DOSE||||LOW|NOT DONE|||SALIVA|CALCIFIED|N|NEXT GENERATION SEQUENCING|Y|U|N||5||7||WASHOUT|1965-11-16|1972-05-16|||||1967-08-20||1967-01-27
TRIAL STUDY 134XCP|IS|0365EB5F-7364-4B1F-8919-543D8D21B045||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^9 CFU/G|||||10^6 ORGANISMS/MG||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|UNEXPECTED ODOR|NA|POLYMERASE CHAIN REACTION|NA|N|N||1||38||CONTINUATION TREATMENT|1960-07-24|1964-11-23|||||1967-05-06||1968-01-12
TRIAL STUDY 134XCP|IS|0365EB5F-7364-4B1F-8919-543D8D21B045||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||EP U|||||MG/KG/H||||HIGH|NOT DONE|||ISOLATE|AGGLUTINATED|N|LC-FL|N|NA|N||2||58||INDUCTION TREATMENT|1973-01-11|1960-06-04|||||1970-04-20||1968-04-01
TRIAL STUDY 134XCP|IS|0365EB5F-7364-4B1F-8919-543D8D21B045||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KDA|||||TSP||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|N|BIOPSY|Y|Y|Y||3||39||BASELINE|1973-06-07|1966-05-12|||||1973-05-09||1961-01-04
TRIAL STUDY 134XCP|IS|0365EB5F-7364-4B1F-8919-543D8D21B045||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||OSM|||||/2000 RBC||||HIGH|NOT DONE|||SERUM OR PLASMA|NON-HEMOLYZED|Y|ULTRASOUND|NA|N|NA||4||88||BLINDED TREATMENT|1967-01-04|1967-01-06|||||1968-10-14||1971-02-11
TRIAL STUDY 134XCP|IS|0365EB5F-7364-4B1F-8919-543D8D21B045||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM3/MM2/YEAR|||||M2||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|FRESH|N|MAGNETIC RESONANCE ELASTOGRAPHY|NA|U|N||5||7||BLINDED TREATMENT|1968-09-30|1972-10-18|||||1970-08-19||1973-05-14
TRIAL STUDY 134XCP|IS|364277A8-875C-4A6F-93C3-C913BB3C97CA||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/M2/H|||||BU/ML||||HIGH|NOT DONE|||CAPILLARY BLOOD|SOLIDIFIED|Y|ACID FAST STAIN|Y|N|Y||1||38||FOLLOW-UP|1968-03-25|1973-01-21|||||1968-11-04||1969-08-26
TRIAL STUDY 134XCP|IS|364277A8-875C-4A6F-93C3-C913BB3C97CA||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UCI|||||POINT||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|HEMOLYZED|U|NON-CONTACT SPECULAR MICROSCOPY|U|U|NA||2||58||FOLLOW-UP|1968-07-24|1967-01-22|||||1967-03-23||1967-06-04
TRIAL STUDY 134XCP|IS|364277A8-875C-4A6F-93C3-C913BB3C97CA||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FOZ_US|||||10^9 CFU/ML||||ABNORMAL|NOT DONE|||PLASMA|DRIED|Y|ELECTROMYOGRAPHY|NA|NA|Y||3||39||TREATMENT|1960-02-27|1965-07-11|||||1972-12-21||1969-11-24
TRIAL STUDY 134XCP|IS|364277A8-875C-4A6F-93C3-C913BB3C97CA||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||RNA COPIES/ML||||ABNORMAL|NOT DONE|||MIXED VENOUS BLOOD|GELLED|U|FLUORESCENT IMMUNOASSAY|U|Y|NA||4||88||FOLLOW-UP|1961-06-10|1973-08-08|||||1963-06-13||1973-09-01
TRIAL STUDY 134XCP|IS|364277A8-875C-4A6F-93C3-C913BB3C97CA||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MOSM|||||PACK YEAR||||NORMAL|NOT DONE|||SERUM OR PLASMA|CONTAMINATED|U|CONTRAST ENHANCED CT SCAN|U|N|NA||5||7||CONTINUATION TREATMENT|1967-03-27|1963-04-07|||||1962-01-05||1965-10-25
TRIAL STUDY 134XCP|IS|B824951F-58EE-4003-A2AD-A91AADBBAC0D||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^7 CFU|||||FMOL||||LOW|NOT DONE|||SPUTUM|HEMOLYZED|N|MICRODENSITOMETRY|Y|U|N||1||38||BLINDED TREATMENT|1964-04-27|1972-08-13|||||1971-01-25||1964-08-13
TRIAL STUDY 134XCP|IS|B824951F-58EE-4003-A2AD-A91AADBBAC0D||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UOSM|||||MG/DL||||LOW|NOT DONE|||NAIL|HEMOLYZED|U|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|N|Y||2||58||FOLLOW-UP|1973-08-09|1962-02-15|||||1965-03-06||1963-05-26
TRIAL STUDY 134XCP|IS|B824951F-58EE-4003-A2AD-A91AADBBAC0D||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/DAY|||||NFIU||||NORMAL|NOT DONE|||SERUM|DRIED|Y|ICP-MS|Y|U|U||3||39||RUN-IN|1968-08-09|1970-04-18|||||1967-07-22||1962-11-12
TRIAL STUDY 134XCP|IS|B824951F-58EE-4003-A2AD-A91AADBBAC0D||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/L|||||CUP EQ||||HIGH|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|Y|PERCUSSION|Y|Y|Y||4||88||LONG-TERM FOLLOW-UP|1965-04-08|1967-10-09|||||1963-07-29||1972-07-26
TRIAL STUDY 134XCP|IS|B824951F-58EE-4003-A2AD-A91AADBBAC0D||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G/DAY|||||VG/KG||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|PARAFFIN-EMBEDDED|Y|ULTRASOUND|NA|Y|NA||5||7||OPEN LABEL TREATMENT|1971-10-02|1972-12-26|||||1969-03-14||1970-01-26
TRIAL STUDY 134XCP|IS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6/EJACULATE U|||||TBSP||||NORMAL|NOT DONE|||EMESIS|HEMOLYZED|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|U|N|NA||1||38||OBSERVATION|1963-10-27|1968-06-25|||||1960-08-04||1967-11-30
TRIAL STUDY 134XCP|IS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/MIN/1.73M2|||||UV||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|U|NA|U||2||58||SCREENING|1968-12-29|1970-04-08|||||1960-11-12||1969-07-28
TRIAL STUDY 134XCP|IS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DNA COPIES/UG|||||RATIO||||HIGH|NOT DONE|||MONOCYTE|CONCENTRATED|N|CLINICAL EVALUATION|NA|N|U||3||39||BASELINE|1968-05-25|1960-10-17|||||1960-12-27||1969-08-13
TRIAL STUDY 134XCP|IS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ROENTGEN|||||MV2/HZ||||HIGH|NOT DONE|||ARTERIAL BLOOD|CLOTTED|N|DOPPLER ULTRASOUND|U|NA|N||4||88||RUN-IN|1964-07-29|1962-03-08|||||1969-03-09||1973-06-25
TRIAL STUDY 134XCP|IS|CEB92F29-B105-4F82-B0AC-CDDA2C7D3EE0||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^6 ORGANISMS/ML|||||MG/DOSE||||HIGH|NOT DONE|||INTERSTITIAL FLUID|UNEXPECTED ODOR|N|FLOCCULATION, CHARCOAL ENHANCED|NA|U|NA||5||7||WASHOUT|1968-03-16|1962-04-06|||||1973-01-08||1969-02-05
TRIAL STUDY 134XCP|IS|A108F408-906C-4320-965A-D5D295BC5C31||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CCID 50/DOSE|||||ML/KG/H||||LOW|NOT DONE|||BLOOD|FRESH|U|PALPATION|U|U|Y||1||38||WASHOUT|1967-06-20|1960-11-04|||||1968-04-08||1964-07-30
TRIAL STUDY 134XCP|IS|A108F408-906C-4320-965A-D5D295BC5C31||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||JAR|||||% INHIBITION||||ABNORMAL|NOT DONE|||TISSUE|LIPEMIC|N|HEMAGGLUTINATION ASSAY|N|Y|U||2||58||BLINDED TREATMENT|1960-04-07|1967-09-08|||||1968-12-23||1967-03-04
TRIAL STUDY 134XCP|IS|A108F408-906C-4320-965A-D5D295BC5C31||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/G/H|||||DAGU||||NORMAL|NOT DONE|||GASTRIC CONTENTS|CONCENTRATED|Y|X-RAY FLUORESCENCE SPECTROMETRY|N|NA|U||3||39||CONTINUATION TREATMENT|1967-10-30|1966-02-05|||||1970-11-11||1972-01-06
TRIAL STUDY 134XCP|IS|A108F408-906C-4320-965A-D5D295BC5C31||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/M2/H|||||MASK||||NORMAL|NOT DONE|||CERUMEN|FROZEN|N|OLIGO ACGH|NA|NA|Y||4||88||CONTINUATION TREATMENT|1962-09-02|1964-06-28|||||1968-05-27||1966-02-19
TRIAL STUDY 134XCP|IS|A108F408-906C-4320-965A-D5D295BC5C31||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MV*MIN|||||RING||||HIGH|NOT DONE|||GASTRIC FLUID|DRIED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NA|NA|N||5||7||BLINDED TREATMENT|1972-07-05|1972-09-26|||||1964-01-26||1967-01-28
TRIAL STUDY 134XCP|IS|8E627D27-4855-4E1B-B823-1E14368973AF||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GMFI|||||10^8 PFU||||LOW|NOT DONE|||PERITONEAL FLUID|LIPEMIC|N|ENZYMATIC SPECTROPHOTOMETRY|U|NA|NA||1||38||SCREENING|1961-08-21|1971-11-09|||||1963-05-01||1965-10-04
TRIAL STUDY 134XCP|IS|8E627D27-4855-4E1B-B823-1E14368973AF||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||VP/ML|||||PG/L||||HIGH|NOT DONE|||GASTRIC FLUID|CONCENTRATED|Y|ISHIHARA COLOR PLATES|NA|N|NA||2||58||OBSERVATION|1968-02-28|1970-08-28|||||1963-07-31||1963-03-15
TRIAL STUDY 134XCP|IS|8E627D27-4855-4E1B-B823-1E14368973AF||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||SQU/ML|||||MEQ||||HIGH|NOT DONE|||PERITONEAL FLUID|AGGLUTINATED|N|ELLA|U|N|NA||3||39||BASELINE|1969-08-02|1972-02-16|||||1966-08-16||1962-02-03
TRIAL STUDY 134XCP|IS|8E627D27-4855-4E1B-B823-1E14368973AF||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/S|||||ENZYME U/G HB||||NORMAL|NOT DONE|||NAIL|DRIED|NA|CORONARY ANGIOGRAPHY|Y|NA|N||4||88||INDUCTION TREATMENT|1968-02-02|1970-10-12|||||1967-03-04||1968-09-08
TRIAL STUDY 134XCP|IS|8E627D27-4855-4E1B-B823-1E14368973AF||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 ELISA UNIT|||||PG/L||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|PARAFFIN-EMBEDDED|Y|NEXT GENERATION TARGETED SEQUENCING|N|Y|U||5||7||OBSERVATION|1967-03-27|1964-04-18|||||1972-08-12||1970-02-26
TRIAL STUDY 134XCP|IS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||COAT|||||CI/MG||||NORMAL|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|U|PHASE-CONTRAST MRI|N|NA|N||1||38||OPEN LABEL TREATMENT|1963-06-16|1972-08-09|||||1966-12-28||1966-12-09
TRIAL STUDY 134XCP|IS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMOL/L|||||PT_BR||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|ROOM TEMPERATURE|U|SPECTROPHOTOMETRY|N|Y|Y||2||58||INDUCTION TREATMENT|1972-08-04|1961-10-05|||||1967-09-17||1961-02-16
TRIAL STUDY 134XCP|IS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||S*KPA|||||PRESSOR UNITS||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|LIPEMIC|U|WHOLE GENOME SEQUENCING|NA|Y|N||3||39||SCREENING|1973-04-15|1962-07-29|||||1960-03-08||1969-02-15
TRIAL STUDY 134XCP|IS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS/MG|||||FRAMES/S||||HIGH|NOT DONE|||URINE SEDIMENT|AGGLUTINATED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NA|Y|N||4||88||CONTINUATION TREATMENT|1968-01-13|1965-09-11|||||1968-09-17||1963-03-17
TRIAL STUDY 134XCP|IS|9D1D7F4D-D1F6-4EC8-A3FB-59BB1F596ED2||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/L|||||ML/(MIN*100ML)||||NORMAL|NOT DONE|||VITREOUS HUMOR|HEMOLYZED|Y|MICROBIAL CULTURE, LIQUID|N|NA|N||5||7||SCREENING|1972-06-26|1967-05-27|||||1971-09-21||1962-08-09
TRIAL STUDY 134XCP|IS|483D89E1-45FD-41D4-B9E0-22FFB41D323A||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FMOL|||||UMOL/MIN||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|NA|GC/FID|Y|NA|Y||1||38||OBSERVATION|1962-10-12|1965-07-25|||||1961-05-21||1967-10-23
TRIAL STUDY 134XCP|IS|483D89E1-45FD-41D4-B9E0-22FFB41D323A||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BEATS/MIN|||||OI50||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|THAWED|Y|PET/CT SCAN|N|NA|U||2||58||WASHOUT|1970-06-03|1967-02-14|||||1970-06-18||1969-06-17
TRIAL STUDY 134XCP|IS|483D89E1-45FD-41D4-B9E0-22FFB41D323A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MU/L|||||COULOMB||||ABNORMAL|NOT DONE|||RETICULOCYTES|FROZEN|NA|ANGIOGRAPHY|U|NA|N||3||39||OPEN LABEL TREATMENT|1964-07-09|1968-08-10|||||1967-10-11||1960-09-03
TRIAL STUDY 134XCP|IS|483D89E1-45FD-41D4-B9E0-22FFB41D323A||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||P|||||NEBULE||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|LACTESCENT|N|POPULATION SEQUENCING|N|NA|U||4||88||OPEN LABEL TREATMENT|1966-11-05|1973-03-02|||||1969-06-03||1961-10-31
TRIAL STUDY 134XCP|IS|483D89E1-45FD-41D4-B9E0-22FFB41D323A||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||APL U|||||LOG10 TCID 50/ML||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|UNEXPECTED ODOR|NA|STRESS ECHOCARDIOGRAPHY|Y|N|N||5||7||RUN-IN|1968-06-15|1963-04-04|||||1969-01-25||1969-02-10
TRIAL STUDY 134XCP|IS|2CCBED9D-5F24-4ED8-B575-8523C820A227||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CMOL/L|||||EID 50/DOSE||||HIGH|NOT DONE|||LAVAGE FLUID|CALCIFIED|U|MICROSCOPY|NA|Y|N||1||38||OBSERVATION|1971-10-07|1961-02-09|||||1969-03-08||1961-07-03
TRIAL STUDY 134XCP|IS|2CCBED9D-5F24-4ED8-B575-8523C820A227||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TABLET|||||UMOL/L||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|DRIED|NA|SPIROMETRY|U|N|U||2||58||RUN-IN|1960-10-22|1970-10-12|||||1964-07-10||1960-07-29
TRIAL STUDY 134XCP|IS|2CCBED9D-5F24-4ED8-B575-8523C820A227||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/L/H|||||MOL/MOL||||NORMAL|NOT DONE|||EPITHELIAL CELL|SOLIDIFIED|NA|LISSAMINE GREEN STAIN|U|Y|U||3||39||TREATMENT|1964-07-28|1971-05-17|||||1971-04-22||1963-01-27
TRIAL STUDY 134XCP|IS|2CCBED9D-5F24-4ED8-B575-8523C820A227||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FFU|||||MEQ/L||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|GELLED|Y|MICRONEUTRALIZATION ASSAY|Y|U|NA||4||88||WASHOUT|1972-06-03|1960-02-20|||||1964-11-14||1968-10-07
TRIAL STUDY 134XCP|IS|2CCBED9D-5F24-4ED8-B575-8523C820A227||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/KG|||||MM/SEC||||ABNORMAL|NOT DONE|||LYSATE|PARAFFIN-EMBEDDED|NA|TONOMETRY|Y|NA|Y||5||7||OPEN LABEL TREATMENT|1971-07-04|1963-11-09|||||1965-10-31||1967-02-04
TRIAL STUDY 134XCP|IS|F4D6A28D-569F-4639-ACE2-10EB517128B2||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||V/SEC|||||UG||||HIGH|NOT DONE|||INFRANATANT, PLASMA|NON-HEMOLYZED|Y|BETA LACTAMASE|NA|U|N||1||38||SCREENING|1973-02-14|1968-01-24|||||1971-08-09||1968-11-16
TRIAL STUDY 134XCP|IS|F4D6A28D-569F-4639-ACE2-10EB517128B2||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^4/HPF|||||U/G/DAY||||ABNORMAL|NOT DONE|||KERATINOCYTE|CLOTTED|N|CONTRAST ENHANCED PET SCAN|NA|N|U||2||58||CONTINUATION TREATMENT|1969-09-12|1972-11-14|||||1964-03-25||1969-01-23
TRIAL STUDY 134XCP|IS|F4D6A28D-569F-4639-ACE2-10EB517128B2||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SFC/10^6 PBMC|||||UM/DAY||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|FROZEN|NA|ELECTROCHEMILUMINESCENCE|N|U|N||3||39||OPEN LABEL TREATMENT|1970-08-02|1965-10-22|||||1973-07-09||1969-02-05
TRIAL STUDY 134XCP|IS|F4D6A28D-569F-4639-ACE2-10EB517128B2||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/DAY|||||COULOMB||||ABNORMAL|NOT DONE|||MONOCYTE|HEMOLYZED|Y|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|U|NA||4||88||BASELINE|1965-11-21|1960-12-23|||||1967-09-11||1970-07-12
TRIAL STUDY 134XCP|IS|F4D6A28D-569F-4639-ACE2-10EB517128B2||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||GY/H|||||QUANTITY SUFFICIENT||||LOW|NOT DONE|||URINE|DRIED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|NA|N|N||5||7||TREATMENT|1965-12-08|1967-12-10|||||1968-03-23||1967-09-02
TRIAL STUDY 134XCP|IS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ANTIBODY UNIT|||||ML/BREATH||||ABNORMAL|NOT DONE|||TRANSUDATE|NON-HEMOLYZED|U|U-HPLC/MS/MS|Y|NA|N||1||38||CONTINUATION TREATMENT|1965-04-14|1963-10-31|||||1970-02-15||1970-07-02
TRIAL STUDY 134XCP|IS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DEG/S|||||ANTI-XA IU/ML||||NORMAL|NOT DONE|||SYNOVIAL FLUID|ROOM TEMPERATURE|N|KARYOTYPING|U|NA|Y||2||58||BASELINE|1966-07-21|1973-07-27|||||1972-12-07||1970-05-13
TRIAL STUDY 134XCP|IS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BREATHS/30S|||||LOG10 IU/ML||||LOW|NOT DONE|||DERMAL TISSUE|CALCIFIED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|NA|U|U||3||39||INDUCTION TREATMENT|1963-08-25|1967-03-24|||||1971-08-23||1968-10-27
TRIAL STUDY 134XCP|IS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||K|||||NCI||||NORMAL|NOT DONE|||ARTERIAL BLOOD|AGGLUTINATED|Y|MRI WITHOUT CONTRAST|U|U|U||4||88||LONG-TERM FOLLOW-UP|1967-08-10|1962-03-16|||||1966-10-04||1969-06-19
TRIAL STUDY 134XCP|IS|7ABB925B-2CB5-498A-9E20-E1A2BE4E50DA||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||%|||||OZ EQ||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|REFRIGERATED|U|ISHIHARA COLOR PLATES|N|U|U||5||7||LONG-TERM FOLLOW-UP|1973-06-16|1967-09-09|||||1972-04-14||1969-12-05
TRIAL STUDY 134XCP|IS|415EF35E-6D99-48F8-80A1-89A4CDC621B8||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMOL/MOL|||||DDU||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|N|SPIRAL CT SCAN WITHOUT CONTRAST|U|N|NA||1||38||WASHOUT|1965-01-02|1969-12-05|||||1972-07-24||1971-03-27
TRIAL STUDY 134XCP|IS|415EF35E-6D99-48F8-80A1-89A4CDC621B8||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||V|||||10^10/L||||LOW|NOT DONE|||LUNG SURFACTANT|THAWED|NA|FLUORESCENT ENZYME IMMUNOASSAY|N|Y|NA||2||58||TREATMENT|1964-10-20|1965-03-04|||||1972-06-07||1965-02-02
TRIAL STUDY 134XCP|IS|415EF35E-6D99-48F8-80A1-89A4CDC621B8||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/KG/H|||||VIAL||||NORMAL|NOT DONE|||PLEURAL FLUID|ROOM TEMPERATURE|Y|BETA LACTAMASE|U|Y|NA||3||39||FOLLOW-UP|1968-02-19|1961-01-09|||||1960-05-24||1971-01-24
TRIAL STUDY 134XCP|IS|415EF35E-6D99-48F8-80A1-89A4CDC621B8||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM/SEC|||||COULOMB||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|NA|DIRECT SEQUENCING|U|N|N||4||88||CONTINUATION TREATMENT|1971-06-04|1971-09-24|||||1970-01-04||1962-12-11
TRIAL STUDY 134XCP|IS|415EF35E-6D99-48F8-80A1-89A4CDC621B8||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CG|||||ML/H||||HIGH|NOT DONE|||PERITONEAL FLUID|NON-HEMOLYZED|NA|KNEMOMETRY|U|N|U||5||7||SCREENING|1973-07-27|1963-12-01|||||1963-01-08||1966-01-17
TRIAL STUDY 134XCP|IS|AA0F6192-A377-43C6-8203-BDF7553AEA88||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DEG/MM|||||EVENTS||||LOW|NOT DONE|||PERSPIRATION|FRESH|U|SLOAN LETTER EYE CHART 1.25%|U|U|Y||1||38||TREATMENT|1967-10-06|1973-08-19|||||1966-01-31||1964-04-21
TRIAL STUDY 134XCP|IS|AA0F6192-A377-43C6-8203-BDF7553AEA88||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FOZ_BR|||||SHOCK WAVE||||LOW|NOT DONE|||SUPERNATANT, PLASMA|SOLIDIFIED|U|HPLC/IEX|NA|Y|N||2||58||SCREENING|1971-09-29|1969-03-06|||||1967-02-03||1966-06-07
TRIAL STUDY 134XCP|IS|AA0F6192-A377-43C6-8203-BDF7553AEA88||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^4 CFU|||||UM/DAY||||HIGH|NOT DONE|||VENOUS BLOOD|AUTOLYZED|N|COULOMETRIC TITRATION|Y|U|Y||3||39||OPEN LABEL TREATMENT|1961-01-18|1960-01-15|||||1960-08-19||1972-10-03
TRIAL STUDY 134XCP|IS|AA0F6192-A377-43C6-8203-BDF7553AEA88||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KBQ/UL|||||GLOBULE||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|LACTESCENT|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|Y||4||88||SCREENING|1971-03-25|1960-04-01|||||1964-04-11||1960-07-25
TRIAL STUDY 134XCP|IS|AA0F6192-A377-43C6-8203-BDF7553AEA88||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/DOSE|||||UIU/DL||||HIGH|NOT DONE|||SWABBED MATERIAL|CONCENTRATED|N|HPLC-UV|NA|U|N||5||7||SCREENING|1965-05-15|1963-03-10|||||1969-01-15||1961-09-01
TRIAL STUDY 134XCP|IS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TITER|||||KG/M2||||NORMAL|NOT DONE|||SPUTUM|ICTERIC|NA|WRIGHT STAIN|NA|NA|NA||1||38||LONG-TERM FOLLOW-UP|1961-01-25|1968-11-02|||||1962-09-26||1968-05-02
TRIAL STUDY 134XCP|IS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MM/H|||||EU||||ABNORMAL|NOT DONE|||VENOUS BLOOD|CALCIFIED|N|SLIT LAMP PHOTOGRAPHY|U|U|U||2||58||SCREENING|1970-05-05|1971-10-13|||||1967-08-16||1970-05-03
TRIAL STUDY 134XCP|IS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KEV|||||MOL/L||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|HEMOLYZED|N|OPTICAL DENSITY MEASUREMENT|U|Y|U||3||39||TREATMENT|1963-09-04|1969-12-15|||||1965-11-09||1970-07-05
TRIAL STUDY 134XCP|IS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PMOL/G|||||DRUM||||HIGH|NOT DONE|||LAVAGE FLUID|SOLIDIFIED|NA|GC/MS-EI|U|N|Y||4||88||FOLLOW-UP|1971-06-04|1967-01-13|||||1970-12-13||1971-07-08
TRIAL STUDY 134XCP|IS|99DEAF5F-4F2A-4BFC-ABE7-E947C8FB8162||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TSP EQ|||||IU/DL||||HIGH|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|U|SPECT/CT SCAN|NA|N|NA||5||7||BASELINE|1960-10-15|1964-10-09|||||1971-10-04||1964-10-05
TRIAL STUDY 134XCP|IS|A848B1B5-679F-4C45-AD73-6506604C835E||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/UL|||||M3||||HIGH|NOT DONE|||CORD SERUM|CLOTTED|Y|ATOMIC ABSORPTION SPECTROMETRY|U|Y|U||1||38||TREATMENT|1970-06-06|1968-04-27|||||1967-08-27||1964-11-16
TRIAL STUDY 134XCP|IS|A848B1B5-679F-4C45-AD73-6506604C835E||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U/ML|||||U/G/H||||NORMAL|NOT DONE|||GASTRIC FLUID|LIPEMIC|U|SLOAN LETTER EYE CHART 2.5%|U|N|U||2||58||BASELINE|1970-12-19|1962-05-02|||||1968-05-31||1960-02-12
TRIAL STUDY 134XCP|IS|A848B1B5-679F-4C45-AD73-6506604C835E||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BAG|||||BAR||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|THAWED|U|FLUORESCENCE ANGIOGRAPHY|Y|NA|U||3||39||FOLLOW-UP|1964-05-11|1960-06-22|||||1967-01-03||1972-07-18
TRIAL STUDY 134XCP|IS|A848B1B5-679F-4C45-AD73-6506604C835E||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9/L|||||L/MIN/M2||||ABNORMAL|NOT DONE|||KERATINOCYTE|LACTESCENT|U|NON-INVASIVE DIELECTRIC SENSING|N|N|U||4||88||LONG-TERM FOLLOW-UP|1969-02-06|1960-11-26|||||1967-12-20||1967-05-13
TRIAL STUDY 134XCP|IS|A848B1B5-679F-4C45-AD73-6506604C835E||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DAYS/WK|||||SFC/10^6 PBMC||||ABNORMAL|NOT DONE|||HAIR|SOLIDIFIED|NA|ULTRASOUND|N|Y|U||5||7||OPEN LABEL TREATMENT|1964-02-24|1973-02-04|||||1968-02-01||1962-01-05
TRIAL STUDY 134XCP|IS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/CM3/MIN|||||KG||||LOW|NOT DONE|||SKIN TISSUE|FROZEN|Y|CELLULOSE TAPE|Y|Y|Y||1||38||FOLLOW-UP|1963-10-27|1972-04-07|||||1966-08-29||1972-05-20
TRIAL STUDY 134XCP|IS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/500 WBC|||||UOSM||||ABNORMAL|NOT DONE|||EMESIS|LACTESCENT|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|N|U|NA||2||58||BLINDED TREATMENT|1969-01-27|1971-06-19|||||1969-07-30||1965-05-08
TRIAL STUDY 134XCP|IS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPTR|||||MG||||ABNORMAL|NOT DONE|||SOFT TISSUE|FROZEN|Y|FUNCTIONAL MRI|U|N|U||3||39||BLINDED TREATMENT|1965-08-04|1964-06-12|||||1964-02-01||1968-03-20
TRIAL STUDY 134XCP|IS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MKAT|||||AMP||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|Y|NEXT GENERATION SEQUENCING|Y|N|U||4||88||CONTINUATION TREATMENT|1967-04-04|1965-09-11|||||1963-07-13||1968-03-15
TRIAL STUDY 134XCP|IS|0C1AA66D-A2FC-4F68-B9B6-89F270FD4D47||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UGEQ|||||LOG10 CFU/G||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|N|IMMUNODIFFUSION|N|U|Y||5||7||INDUCTION TREATMENT|1962-06-18|1972-02-24|||||1968-03-17||1961-12-25
TRIAL STUDY 134XCP|IS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMHG|||||10^3 DNA COPIES/ML||||LOW|NOT DONE|||EMESIS|GELLED|NA|NON-CONTACT SPECULAR MICROSCOPY|Y|Y|Y||1||38||FOLLOW-UP|1966-04-15|1969-06-06|||||1960-08-01||1963-06-15
TRIAL STUDY 134XCP|IS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/MMOL|||||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE|||PLATELET|REFRIGERATED|NA|FLOCCULATION, CHARCOAL ENHANCED|U|N|U||2||58||INDUCTION TREATMENT|1963-12-16|1973-03-07|||||1972-10-15||1970-05-08
TRIAL STUDY 134XCP|IS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PPTR|||||DIP||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|SOLIDIFIED|NA|POTENTIOMETRY|NA|Y|Y||3||39||OBSERVATION|1963-04-07|1964-07-18|||||1967-03-03||1971-01-01
TRIAL STUDY 134XCP|IS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||WEBER|||||UM/S||||ABNORMAL|NOT DONE|||GASTRIC FLUID|GELLED|NA|SPECULAR MICROSCOPY|N|Y|U||4||88||TREATMENT|1972-06-21|1970-06-13|||||1971-11-20||1960-01-08
TRIAL STUDY 134XCP|IS|ABA9682E-D373-48DA-A7BD-68AB1563CFD6||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CONTAINER|||||/LSQN||||ABNORMAL|NOT DONE|||URINE|AUTOLYZED|Y|SECONDARY ION MASS SPECTOMETRY|N|NA|Y||5||7||TREATMENT|1972-05-20|1962-03-20|||||1961-03-23||1960-09-26
TRIAL STUDY 134XCP|IS|FC155F37-522F-4620-BBFF-4999D37C1379||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||M3|||||BQ||||NORMAL|NOT DONE|||KERATINOCYTE|ROOM TEMPERATURE|Y|ELISA|N|NA|Y||1||38||SCREENING|1970-05-04|1972-05-01|||||1960-11-02||1963-12-12
TRIAL STUDY 134XCP|IS|FC155F37-522F-4620-BBFF-4999D37C1379||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 ELISA UNIT|||||F||||NORMAL|NOT DONE|||COLOSTRUM|DRIED|NA|CLINICAL EVALUATION|U|N|U||2||58||INDUCTION TREATMENT|1967-06-24|1969-04-08|||||1961-01-02||1961-10-05
TRIAL STUDY 134XCP|IS|FC155F37-522F-4620-BBFF-4999D37C1379||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/G/DAY|||||CI/UG||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|CLOTTED|Y|EIA|NA|N|N||3||39||BASELINE|1970-05-26|1972-01-07|||||1971-08-09||1970-03-03
TRIAL STUDY 134XCP|IS|FC155F37-522F-4620-BBFF-4999D37C1379||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DAMOL/L|||||MG/CM2||||HIGH|NOT DONE|||DISCHARGE|HEMOLYZED|NA|DIFFUSION TENSOR MRI|NA|NA|Y||4||88||BLINDED TREATMENT|1969-02-10|1972-10-12|||||1964-08-02||1970-02-01
TRIAL STUDY 134XCP|IS|FC155F37-522F-4620-BBFF-4999D37C1379||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CCID 50/ML|||||PKAT/L||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|CALCIFIED|Y|FLUORIMETRY|Y|U|Y||5||7||CONTINUATION TREATMENT|1964-09-02|1966-05-06|||||1961-12-10||1966-04-19
TRIAL STUDY 134XCP|IS|20F817BC-4C89-4F6C-AA45-36CE786A73A8||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^9/DOSE|||||G/L||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|THAWED|NA|FLAME PHOTOMETRY|Y|N|N||1||38||OPEN LABEL TREATMENT|1960-11-07|1961-05-08|||||1961-07-25||1971-08-07
TRIAL STUDY 134XCP|IS|20F817BC-4C89-4F6C-AA45-36CE786A73A8||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/G/DAY|||||ML/MMHG||||NORMAL|NOT DONE|||BILE|GELLED|N|WHOLE EXOME SEQUENCING|Y|NA|U||2||58||SCREENING|1965-06-02|1967-11-19|||||1972-05-13||1961-07-30
TRIAL STUDY 134XCP|IS|20F817BC-4C89-4F6C-AA45-36CE786A73A8||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||V|||||KV||||HIGH|NOT DONE|||URINE|AUTOLYZED|NA|BETA LACTAMASE|NA|N|N||3||39||WASHOUT|1971-11-20|1968-07-13|||||1963-03-04||1963-03-01
TRIAL STUDY 134XCP|IS|20F817BC-4C89-4F6C-AA45-36CE786A73A8||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^10/L|||||ML/MMHG||||NORMAL|NOT DONE|||CAPILLARY BLOOD|LACTESCENT|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|U|NA||4||88||BLINDED TREATMENT|1960-02-24|1972-04-30|||||1967-12-24||1968-05-20
TRIAL STUDY 134XCP|IS|20F817BC-4C89-4F6C-AA45-36CE786A73A8||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DPM/0.5 ML|||||COPIES/UG||||NORMAL|NOT DONE|||MUCUS|AUTOLYZED|U|LINE PROBE ASSAY|Y|N|NA||5||7||CONTINUATION TREATMENT|1966-03-31|1960-09-04|||||1970-11-24||1964-08-11
TRIAL STUDY 134XCP|IS|99058E64-9873-4CD5-BB31-28C08758A1B5||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMH2O*S/ML|||||ML/SEC/1.73M2||||HIGH|NOT DONE|||CERUMEN|ROOM TEMPERATURE|U|ELISPOT|N|U|U||1||38||TREATMENT|1967-01-11|1969-12-29|||||1968-10-02||1960-02-01
TRIAL STUDY 134XCP|IS|99058E64-9873-4CD5-BB31-28C08758A1B5||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^6 CFU|||||%/MIN||||LOW|NOT DONE|||DISCHARGE|UNEXPECTED ODOR|Y|TEMPLATE INCISION METHOD|NA|U|NA||2||58||OBSERVATION|1973-08-29|1961-12-04|||||1966-05-05||1968-05-02
TRIAL STUDY 134XCP|IS|99058E64-9873-4CD5-BB31-28C08758A1B5||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MILE|||||10^7 CFU||||LOW|NOT DONE|||PLATELET|FRESH|NA|LIQUID SCINTILLATION COUNTING|U|N|Y||3||39||BLINDED TREATMENT|1960-11-25|1973-06-23|||||1964-12-14||1960-12-31
TRIAL STUDY 134XCP|IS|99058E64-9873-4CD5-BB31-28C08758A1B5||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TSP|||||USEC||||HIGH|NOT DONE|||PLASMA|THAWED|Y|RADIOGRAPHY|N|N|Y||4||88||OBSERVATION|1969-08-02|1971-01-15|||||1967-12-18||1961-01-25
TRIAL STUDY 134XCP|IS|99058E64-9873-4CD5-BB31-28C08758A1B5||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^10/L|||||L/S||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|THAWED|U|SPECTROPHOTOMETRY|Y|U|NA||5||7||INDUCTION TREATMENT|1961-12-27|1963-12-31|||||1969-10-08||1961-08-21
TRIAL STUDY 134XCP|IS|656B6693-1C1C-433B-84E3-77E89F0B543E||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/10^3|||||DAMOL/L||||LOW|NOT DONE|||SOFT TISSUE|HEMOLYZED|U|SPIROMETRY|NA|NA|N||1||38||TREATMENT|1966-12-09|1969-03-26|||||1963-12-24||1962-04-06
TRIAL STUDY 134XCP|IS|656B6693-1C1C-433B-84E3-77E89F0B543E||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/10^12 RBC|||||KIT||||ABNORMAL|NOT DONE|||GASTRIC CONTENTS|THAWED|NA|FLUORESCENT IMMUNOASSAY|N|U|U||2||58||CONTINUATION TREATMENT|1966-05-06|1971-05-30|||||1962-03-02||1962-07-16
TRIAL STUDY 134XCP|IS|656B6693-1C1C-433B-84E3-77E89F0B543E||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KV|||||ML/M2/DAY||||LOW|NOT DONE|||ADIPOSE TISSUE|CLOTTED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|Y|N||3||39||LONG-TERM FOLLOW-UP|1969-08-14|1966-05-29|||||1965-01-28||1964-08-04
TRIAL STUDY 134XCP|IS|656B6693-1C1C-433B-84E3-77E89F0B543E||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||JDF UNIT|||||MMOL2/L2||||ABNORMAL|NOT DONE|||EXUDATE|DRIED|Y|TRYPAN BLUE STAIN|U|N|Y||4||88||INDUCTION TREATMENT|1971-11-30|1969-07-16|||||1965-06-02||1971-07-19
TRIAL STUDY 134XCP|IS|656B6693-1C1C-433B-84E3-77E89F0B543E||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/ML|||||DPM/100MG||||HIGH|NOT DONE|||MUCUS|UNEXPECTED ODOR|NA|CELL OF ORIGIN ASSAY|N|NA|NA||5||7||INDUCTION TREATMENT|1970-08-05|1962-10-06|||||1968-12-18||1964-01-24
TRIAL STUDY 134XCP|IS|43C443F9-AB0F-44BE-B28B-63A60EE09205||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L|||||MV2/HZ||||NORMAL|NOT DONE|||SALIVA|FRESH|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|U|N|NA||1||38||BASELINE|1973-06-09|1967-11-15|||||1962-12-03||1962-12-18
TRIAL STUDY 134XCP|IS|43C443F9-AB0F-44BE-B28B-63A60EE09205||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/H|||||UKAT||||ABNORMAL|NOT DONE|||STOOL|ROOM TEMPERATURE|Y|RAJI CELL EIA|N|NA|N||2||58||INDUCTION TREATMENT|1969-11-10|1972-02-05|||||1967-09-11||1963-04-09
TRIAL STUDY 134XCP|IS|43C443F9-AB0F-44BE-B28B-63A60EE09205||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UKAT/L|||||10^3 CFU||||LOW|NOT DONE|||LUNG SURFACTANT|AUTOLYZED|N|MAGNETIC RESONANCE ANGIOGRAPHY|U|U|Y||3||39||WASHOUT|1971-06-05|1964-07-26|||||1969-11-19||1970-10-13
TRIAL STUDY 134XCP|IS|43C443F9-AB0F-44BE-B28B-63A60EE09205||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/KG|||||/2000 RBC||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|ICTERIC|NA|RADIATION DOSIMETRY|Y|NA|NA||4||88||FOLLOW-UP|1970-04-29|1970-07-27|||||1970-08-12||1967-07-26
TRIAL STUDY 134XCP|IS|43C443F9-AB0F-44BE-B28B-63A60EE09205||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^8 PFU|||||KV||||LOW|NOT DONE|||BASAL TEAR|UNEXPECTED ODOR|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|N|Y|Y||5||7||OPEN LABEL TREATMENT|1963-12-09|1972-02-18|||||1970-08-15||1962-09-22
TRIAL STUDY 134XCP|IS|37FF91B1-CE3C-4587-85CE-F76B880D40E7||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GBQ|||||VG/KG||||HIGH|NOT DONE|||INFRANATANT, SERUM|LACTESCENT|NA|SPIRAL CT SCAN WITHOUT CONTRAST|NA|U|NA||1||38||WASHOUT|1973-03-28|1966-09-05|||||1973-02-01||1972-12-01
TRIAL STUDY 134XCP|IS|37FF91B1-CE3C-4587-85CE-F76B880D40E7||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KIU|||||LM||||ABNORMAL|NOT DONE|||VENOUS BLOOD|CLOTTED|U|IHC|N|U|U||2||58||CONTINUATION TREATMENT|1962-11-24|1966-12-10|||||1971-01-20||1961-10-16
TRIAL STUDY 134XCP|IS|37FF91B1-CE3C-4587-85CE-F76B880D40E7||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BAR|||||DPM/0.5 ML||||ABNORMAL|NOT DONE|||SMEGMA|CLOTTED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|NA|U||3||39||FOLLOW-UP|1961-04-16|1973-08-27|||||1970-06-04||1961-09-07
TRIAL STUDY 134XCP|IS|37FF91B1-CE3C-4587-85CE-F76B880D40E7||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ARBITRARY U|||||ABSORBANCE U||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|CONTAMINATED|Y|TONOMETRY|NA|NA|U||4||88||BLINDED TREATMENT|1965-01-27|1969-07-01|||||1972-04-07||1965-05-24
TRIAL STUDY 134XCP|IS|37FF91B1-CE3C-4587-85CE-F76B880D40E7||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GLOBULE|||||MG/DOSE||||NORMAL|NOT DONE|||SWABBED MATERIAL|LIPEMIC|NA|VENTILATION PERFUSION LUNG SCAN|N|Y|N||5||7||BLINDED TREATMENT|1970-10-30|1964-08-30|||||1963-07-13||1963-11-27
TRIAL STUDY 134XCP|IS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FIU|||||GBQ/MG||||LOW|NOT DONE|||ARTERIAL BLOOD|AUTOLYZED|N|SPIRAL CT SCAN WITHOUT CONTRAST|N|N|U||1||38||OPEN LABEL TREATMENT|1969-11-18|1961-11-29|||||1966-03-27||1961-11-15
TRIAL STUDY 134XCP|IS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/2000 RBC|||||GRAIN||||LOW|NOT DONE|||PERITONEAL FLUID|REFRIGERATED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|NA|Y|Y||2||58||BLINDED TREATMENT|1967-06-19|1964-03-04|||||1972-11-06||1966-04-25
TRIAL STUDY 134XCP|IS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KM|||||KIT||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|AGGLUTINATED|NA|DISK DIFFUSION|Y|NA|NA||3||39||BASELINE|1963-02-03|1964-12-03|||||1968-06-23||1971-05-25
TRIAL STUDY 134XCP|IS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FIU|||||PACKAGE||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED|Y|SLIT LAMP PHOTOGRAPHY|U|Y|U||4||88||FOLLOW-UP|1965-05-07|1961-04-25|||||1965-06-28||1963-04-05
TRIAL STUDY 134XCP|IS|9C25B17D-2E57-4EBD-93AF-F4439EB77B03||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/CAGE|||||10^6/HPF||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|THAWED|Y|CALCULATION|U|Y|U||5||7||FOLLOW-UP|1964-08-11|1961-01-29|||||1972-03-08||1962-02-16
TRIAL STUDY 134XCP|IS|49017491-2C28-4F86-BF72-CF83651052F6||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3 CFU/G|||||M/SEC||||HIGH|NOT DONE|||PROSTATIC FLUID|UNEXPECTED ODOR|N|RYAN BLUE STAIN|U|Y|N||1||38||LONG-TERM FOLLOW-UP|1973-07-29|1963-12-03|||||1966-06-26||1970-01-11
TRIAL STUDY 134XCP|IS|49017491-2C28-4F86-BF72-CF83651052F6||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/5X10^4 WBC|||||MM3/MM2/YEAR||||LOW|NOT DONE|||TUMOR TISSUE|ICTERIC|U|MICROBIAL CONCENTRATION|N|NA|NA||2||58||BASELINE|1965-08-18|1964-05-31|||||1969-01-03||1970-02-02
TRIAL STUDY 134XCP|IS|49017491-2C28-4F86-BF72-CF83651052F6||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^4 CFU/ML|||||PFU/DOSE||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|GELLED|U|PALM METHOD|U|NA|N||3||39||RUN-IN|1973-07-23|1971-08-08|||||1965-07-27||1973-01-20
TRIAL STUDY 134XCP|IS|49017491-2C28-4F86-BF72-CF83651052F6||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||TRANSDUCING UNIT/ML|||||MV/SEC||||HIGH|NOT DONE|||TRANSUDATE|THAWED|U|FLOCCULATION|U|U|Y||4||88||WASHOUT|1961-12-25|1962-10-10|||||1970-08-24||1965-11-12
TRIAL STUDY 134XCP|IS|49017491-2C28-4F86-BF72-CF83651052F6||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NEEDLE GAUGE|||||G/DAY||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|LIPEMIC|U|PET/CT SCAN WITHOUT CONTRAST|U|Y|NA||5||7||CONTINUATION TREATMENT|1966-03-29|1966-06-20|||||1962-10-27||1969-09-18
TRIAL STUDY 134XCP|IS|DAA65EE6-66ED-4354-935B-1347E1B572A5||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ROENTGEN|||||PACKAGE||||ABNORMAL|NOT DONE|||KERATINOCYTE|AUTOLYZED|N|SLOAN LETTER EYE CHART 100%|N|U|U||1||38||OPEN LABEL TREATMENT|1966-02-03|1960-08-22|||||1968-07-22||1960-08-08
TRIAL STUDY 134XCP|IS|DAA65EE6-66ED-4354-935B-1347E1B572A5||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KS|||||LOG10 PFU||||ABNORMAL|NOT DONE|||EXUDATE|DRIED|Y|GC/MS|U|U|NA||2||58||BASELINE|1964-06-14|1964-11-15|||||1960-03-28||1961-10-12
TRIAL STUDY 134XCP|IS|DAA65EE6-66ED-4354-935B-1347E1B572A5||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/4.0 ML|||||MIU/L||||ABNORMAL|NOT DONE|||PLEURAL FLUID|AGGLUTINATED|NA|IMMUNOFLUORESCENT STAIN|Y|U|U||3||39||FOLLOW-UP|1961-05-10|1966-10-05|||||1968-10-26||1960-11-30
TRIAL STUDY 134XCP|IS|DAA65EE6-66ED-4354-935B-1347E1B572A5||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FINGERTIP UNIT|||||MET||||ABNORMAL|NOT DONE|||VENOUS PLASMA|DRIED|NA|CELL BASED BIOASSAY|Y|Y|U||4||88||CONTINUATION TREATMENT|1961-11-19|1965-01-11|||||1963-04-06||1960-11-24
TRIAL STUDY 134XCP|IS|DAA65EE6-66ED-4354-935B-1347E1B572A5||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^8 PFU|||||UG/MIN||||NORMAL|NOT DONE|||SALIVA|CONTAMINATED|U|ENDOSCOPY|NA|Y|Y||5||7||SCREENING|1964-01-15|1968-10-07|||||1961-03-21||1964-08-28
TRIAL STUDY 134XCP|IS|A440A3E5-F87D-4306-9195-3A842F0DDE33||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PG/L|||||U/L||||ABNORMAL|NOT DONE|||EXPIRED AIR|FRESH|NA|MICRO BROTH DILUTION|U|N|N||1||38||RUN-IN|1963-02-28|1962-10-22|||||1963-10-16||1972-08-08
TRIAL STUDY 134XCP|IS|A440A3E5-F87D-4306-9195-3A842F0DDE33||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 COPIES/ML|||||PMOL/DL||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|GELLED|Y|SPECULAR MICROSCOPY|NA|N|U||2||58||FOLLOW-UP|1962-05-23|1972-12-14|||||1962-08-04||1960-03-14
TRIAL STUDY 134XCP|IS|A440A3E5-F87D-4306-9195-3A842F0DDE33||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/M2/H|||||DMOL||||LOW|NOT DONE|||URINE|AGGLUTINATED|N|DISK DIFFUSION|NA|U|U||3||39||LONG-TERM FOLLOW-UP|1964-08-01|1965-11-10|||||1970-04-11||1972-11-22
TRIAL STUDY 134XCP|IS|A440A3E5-F87D-4306-9195-3A842F0DDE33||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^10/L|||||UMOL/DAY||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|UNEXPECTED ODOR|Y|ELLA|U|NA|NA||4||88||BASELINE|1970-09-29|1970-11-02|||||1966-04-29||1967-06-26
TRIAL STUDY 134XCP|IS|A440A3E5-F87D-4306-9195-3A842F0DDE33||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UV2|||||BQ/G||||NORMAL|NOT DONE|||PUS|AGGLUTINATED|N|ORCHIDOMETERY|NA|N|Y||5||7||FOLLOW-UP|1966-08-24|1965-07-11|||||1964-03-07||1969-09-28
TRIAL STUDY 134XCP|IS|48BBE085-BD68-451A-9700-6A1AB18D84EE||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PA|||||G/DL||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|AGGLUTINATED|NA|LIGHT MICROSCOPY|U|N|U||1||38||FOLLOW-UP|1965-01-21|1963-09-02|||||1967-05-25||1973-04-11
TRIAL STUDY 134XCP|IS|48BBE085-BD68-451A-9700-6A1AB18D84EE||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6/HPF|||||MONTHS||||ABNORMAL|NOT DONE|||BILE|SOLIDIFIED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|U|N||2||58||OBSERVATION|1964-04-04|1960-11-28|||||1971-02-27||1970-01-08
TRIAL STUDY 134XCP|IS|48BBE085-BD68-451A-9700-6A1AB18D84EE||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DPM/ML|||||FMOL/L/SEC||||LOW|NOT DONE|||HAIR FOLLICLE|DRIED|NA|CELLULOSE TAPE|N|N|Y||3||39||WASHOUT|1964-01-03|1961-09-08|||||1969-03-21||1964-05-22
TRIAL STUDY 134XCP|IS|48BBE085-BD68-451A-9700-6A1AB18D84EE||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL/L|||||ML/G/H||||LOW|NOT DONE|||BASAL TEAR|FROZEN|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NA|Y|N||4||88||FOLLOW-UP|1972-03-23|1970-05-17|||||1970-05-29||1964-05-14
TRIAL STUDY 134XCP|IS|48BBE085-BD68-451A-9700-6A1AB18D84EE||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PKAT|||||MESF||||HIGH|NOT DONE|||PLASMA|AUTOLYZED|N|CONTRAST ENHANCED MRI|NA|U|U||5||7||SCREENING|1971-01-23|1963-11-30|||||1960-02-17||1964-03-20
TRIAL STUDY 134XCP|IS|F38055A2-11E2-437B-BD6A-662D81521F1D||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^9 ORGANISMS/MG|||||ML/KG/H||||ABNORMAL|NOT DONE|||SYNOVIAL FLUID|THAWED|Y|POLYMERASE CHAIN REACTION|Y|Y|Y||1||38||SCREENING|1966-05-19|1965-11-13|||||1971-12-12||1964-04-24
TRIAL STUDY 134XCP|IS|F38055A2-11E2-437B-BD6A-662D81521F1D||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UIU/L|||||MBQ/UL||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|FROZEN|U|LIGHT SCATTERING SPECTROSCOPY|NA|Y|N||2||58||BASELINE|1967-12-21|1967-07-15|||||1970-05-18||1966-08-06
TRIAL STUDY 134XCP|IS|F38055A2-11E2-437B-BD6A-662D81521F1D||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UIU/L|||||APPLICATION||||NORMAL|NOT DONE|||SPUTUM|AUTOLYZED|N|ACCELERATOR MASS SPECTROMETRY|NA|U|U||3||39||LONG-TERM FOLLOW-UP|1964-01-13|1962-04-24|||||1961-01-07||1963-11-11
TRIAL STUDY 134XCP|IS|F38055A2-11E2-437B-BD6A-662D81521F1D||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LOG10 IU/ML|||||UL/KG/DAY||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|AUTOLYZED|U|PUPILLOMETRY|Y|U|NA||4||88||FOLLOW-UP|1967-05-18|1964-03-19|||||1960-10-21||1970-03-15
TRIAL STUDY 134XCP|IS|F38055A2-11E2-437B-BD6A-662D81521F1D||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/KG/WEEK|||||DEG/S||||NORMAL|NOT DONE|||ARTERIAL BLOOD|UNEXPECTED ODOR|NA|X-RAY|N|U|N||5||7||INDUCTION TREATMENT|1964-03-18|1962-10-01|||||1960-04-17||1966-04-27
TRIAL STUDY 134XCP|IS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CS|||||TORR||||NORMAL|NOT DONE|||RETICULOCYTES|REFRIGERATED|U|IN VITRO GENE EXPRESSION ASSAY|U|U|N||1||38||LONG-TERM FOLLOW-UP|1963-04-12|1963-07-31|||||1964-04-13||1963-04-18
TRIAL STUDY 134XCP|IS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HOMEOPATHIC DILUTION|||||10^6 IU/ML||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|FRESH|NA|ISHIHARA COLOR PLATES|NA|Y|Y||2||58||OBSERVATION|1962-03-27|1967-01-20|||||1970-06-12||1969-10-09
TRIAL STUDY 134XCP|IS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PIXELS/IN|||||10^6 COPIES/ML||||HIGH|NOT DONE|||EMESIS|ICTERIC|U|ENZYMATIC COLORIMETRY|U|NA|N||3||39||BLINDED TREATMENT|1962-03-19|1970-03-03|||||1968-02-11||1972-07-10
TRIAL STUDY 134XCP|IS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VOXEL|||||SBE/ML||||LOW|NOT DONE|||SUPERNATANT, PLASMA|LACTESCENT|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|U|NA||4||88||BLINDED TREATMENT|1970-01-14|1965-07-01|||||1964-01-08||1963-05-01
TRIAL STUDY 134XCP|IS|96CB86AC-5041-4FA3-8CD2-6D390B3269DC||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IMPLANT|||||MV||||HIGH|NOT DONE|||PLASMA|SOLIDIFIED|N|IMMUNOPRECIPITATION|N|U|N||5||7||CONTINUATION TREATMENT|1968-02-15|1965-01-03|||||1960-05-22||1970-09-22
TRIAL STUDY 134XCP|IS|22B0F097-D571-4E65-9B58-BEF2C3482F05||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||IMPLANT|||||L/H||||HIGH|NOT DONE|||FLUID|LACTESCENT|NA|PET/SPECT SCAN|NA|U|U||1||38||FOLLOW-UP|1960-07-31|1962-12-22|||||1967-09-18||1973-01-17
TRIAL STUDY 134XCP|IS|22B0F097-D571-4E65-9B58-BEF2C3482F05||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/MIN|||||KIU||||HIGH|NOT DONE|||TUMOR TISSUE|DRIED|N|PLETHYSMOGRAPHY|U|U|U||2||58||CONTINUATION TREATMENT|1967-06-16|1969-10-19|||||1967-10-09||1970-07-10
TRIAL STUDY 134XCP|IS|22B0F097-D571-4E65-9B58-BEF2C3482F05||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||JDF UNIT|||||NSEC||||ABNORMAL|NOT DONE|||BUFFY COAT|FRESH|N|MICROARRAY|N|N|N||3||39||OPEN LABEL TREATMENT|1966-12-20|1968-11-09|||||1969-10-27||1970-09-04
TRIAL STUDY 134XCP|IS|22B0F097-D571-4E65-9B58-BEF2C3482F05||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ROENTGEN|||||PL||||LOW|NOT DONE|||AMNIOTIC FLUID|CONCENTRATED|Y|ENZYMATIC SPECTROPHOTOMETRY|N|NA|N||4||88||OPEN LABEL TREATMENT|1960-06-30|1968-06-19|||||1968-10-27||1965-01-11
TRIAL STUDY 134XCP|IS|22B0F097-D571-4E65-9B58-BEF2C3482F05||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NG/MOL|||||PMOL/DAY||||HIGH|NOT DONE|||EXUDATE|DRIED|N|LEAD CITRATE STAIN|U|N|NA||5||7||BASELINE|1971-07-22|1963-12-15|||||1962-10-06||1968-10-09
TRIAL STUDY 134XCP|IS|F56B6C70-0513-4032-A0BE-B961F6F2EF30||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/ML/DAY|||||M/SEC||||LOW|NOT DONE|||CERUMEN|CLOTTED|Y|SCANNING ELECTRON MICROSCOPY|U|U|U||1||38||TREATMENT|1969-08-30|1962-09-05|||||1968-04-01||1960-09-13
TRIAL STUDY 134XCP|IS|F56B6C70-0513-4032-A0BE-B961F6F2EF30||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MOL/ML|||||DRAM||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|AGGLUTINATED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|U|NA|Y||2||58||FOLLOW-UP|1966-10-21|1964-06-11|||||1969-02-20||1962-08-02
TRIAL STUDY 134XCP|IS|F56B6C70-0513-4032-A0BE-B961F6F2EF30||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PG|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||BREAST MILK|REFRIGERATED|NA|FUNDUS PHOTOGRAPHY|NA|U|Y||3||39||FOLLOW-UP|1969-06-08|1960-02-18|||||1972-05-04||1970-07-12
TRIAL STUDY 134XCP|IS|F56B6C70-0513-4032-A0BE-B961F6F2EF30||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NEEDLE GAUGE|||||IMPLANT||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|AUTOLYZED|U|PEAK FLOWMETRY|NA|NA|NA||4||88||CONTINUATION TREATMENT|1961-12-21|1969-02-11|||||1965-07-24||1961-11-02
TRIAL STUDY 134XCP|IS|F56B6C70-0513-4032-A0BE-B961F6F2EF30||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/VF|||||FL||||HIGH|NOT DONE|||BONE|SOLIDIFIED|U|CLINICAL EVALUATION|N|NA|N||5||7||SCREENING|1960-04-01|1963-02-07|||||1960-03-21||1966-08-16
TRIAL STUDY 134XCP|IS|8E385A66-25C9-417E-9298-FB87A73B661F||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LINEAR FT*LB|||||RING||||ABNORMAL|NOT DONE|||GASTRIC FLUID|CONCENTRATED|NA|TARGETED TRANSCRIPTOME SEQUENCING|Y|U|NA||1||38||INDUCTION TREATMENT|1960-05-21|1966-05-04|||||1961-09-10||1967-08-28
TRIAL STUDY 134XCP|IS|8E385A66-25C9-417E-9298-FB87A73B661F||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KUSP|||||10^9 CFU||||ABNORMAL|NOT DONE|||EXPIRED AIR|HEMOLYZED|NA|HPLC/IEX|U|U|Y||2||58||OPEN LABEL TREATMENT|1972-02-27|1967-06-24|||||1964-03-22||1968-01-06
TRIAL STUDY 134XCP|IS|8E385A66-25C9-417E-9298-FB87A73B661F||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CI/UL|||||KBQ||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|GELLED|NA|ELECTROMYOGRAPHY|U|N|N||3||39||CONTINUATION TREATMENT|1964-03-01|1966-03-25|||||1972-08-26||1969-04-11
TRIAL STUDY 134XCP|IS|8E385A66-25C9-417E-9298-FB87A73B661F||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KBQ|||||UG/MIN||||LOW|NOT DONE|||SERUM|ICTERIC|N|FLUOROSCOPY|U|NA|NA||4||88||BASELINE|1971-11-29|1960-09-21|||||1965-08-02||1962-06-09
TRIAL STUDY 134XCP|IS|8E385A66-25C9-417E-9298-FB87A73B661F||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MEQ/UG|||||UG/G/H||||LOW|NOT DONE|||ISOLATE|CONTAMINATED|U|ACCELERATOR MASS SPECTROMETRY|Y|NA|Y||5||7||OPEN LABEL TREATMENT|1963-06-09|1970-12-06|||||1966-03-30||1961-10-02
TRIAL STUDY 134XCP|IS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||AMFI|||||/LPF||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|ICTERIC|N|ELECTROCHEMILUMINESCENCE|N|Y|U||1||38||LONG-TERM FOLLOW-UP|1964-12-08|1969-05-16|||||1962-12-25||1965-10-11
TRIAL STUDY 134XCP|IS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G/G/DAY|||||ML/ANIMAL/WK||||ABNORMAL|NOT DONE|||GASTRIC CONTENTS|HEMOLYZED|U|RADIAL IMMUNODIFFUSION|Y|U|Y||2||58||RUN-IN|1972-07-10|1962-07-30|||||1973-01-07||1973-04-13
TRIAL STUDY 134XCP|IS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||USIEMENS|||||UEQ||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|HEMOLYZED|NA|LYMPHANGIOGRAPHY|U|N|NA||3||39||TREATMENT|1965-07-01|1967-04-10|||||1968-01-31||1961-11-30
TRIAL STUDY 134XCP|IS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMHG*MIN/L|||||10^3 RNA COPIES/ML||||ABNORMAL|NOT DONE|||MONOCYTE|FRESH|N|STRESS ECHOCARDIOGRAPHY|N|NA|U||4||88||OBSERVATION|1965-11-03|1960-04-09|||||1966-08-01||1971-06-25
TRIAL STUDY 134XCP|IS|0471CF8F-4CA2-422C-94F5-7E8A4A5838F3||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FT|||||MG/M2||||HIGH|NOT DONE|||LUNG SURFACTANT|AGGLUTINATED|NA|OSCILLOMETRY|N|Y|U||5||7||CONTINUATION TREATMENT|1970-02-04|1965-03-19|||||1960-02-03||1968-12-12
TRIAL STUDY 134XCP|IS|D0AE2069-B430-4771-9A8C-0F5442DFCECE||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||VIAL|||||SHOCK WAVE||||ABNORMAL|NOT DONE|||LOCHIA|HEMOLYZED|Y|DXA SCAN|N|Y|NA||1||38||OBSERVATION|1963-05-13|1969-01-17|||||1962-03-19||1960-08-17
TRIAL STUDY 134XCP|IS|D0AE2069-B430-4771-9A8C-0F5442DFCECE||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MM3/MM2/YEAR|||||KBQ||||HIGH|NOT DONE|||VENOUS PLASMA|CONTAMINATED|N|IN SITU HYBRIDIZATION|NA|N|Y||2||58||RUN-IN|1967-07-05|1968-12-10|||||1972-06-26||1972-11-14
TRIAL STUDY 134XCP|IS|D0AE2069-B430-4771-9A8C-0F5442DFCECE||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CS|||||HOURS||||ABNORMAL|NOT DONE|||GASTRIC FLUID|LIPEMIC|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|NA|N|U||3||39||BASELINE|1960-07-19|1963-08-07|||||1971-10-31||1966-05-09
TRIAL STUDY 134XCP|IS|D0AE2069-B430-4771-9A8C-0F5442DFCECE||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DROP|||||PATCH||||NORMAL|NOT DONE|||LEUKOCYTE|HEMOLYZED|Y|URANYL ACETATE STAIN|N|N|N||4||88||TREATMENT|1963-11-17|1973-04-02|||||1970-04-22||1973-06-12
TRIAL STUDY 134XCP|IS|D0AE2069-B430-4771-9A8C-0F5442DFCECE||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/KG|||||IU/DL||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|LIPEMIC|U|CLAUSS METHOD|Y|Y|U||5||7||TREATMENT|1973-06-21|1972-07-24|||||1965-08-22||1967-10-21
TRIAL STUDY 134XCP|IS|CF214007-AC24-4760-AEDE-F78CDE3D9351||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||MMU/ML||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|Y|TRICHROME STAIN|U|N|NA||1||38||BLINDED TREATMENT|1971-02-20|1966-09-13|||||1973-07-17||1972-12-19
TRIAL STUDY 134XCP|IS|CF214007-AC24-4760-AEDE-F78CDE3D9351||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMOL/L|||||GBQ||||LOW|NOT DONE|||EPITHELIAL CELL|CLOTTED|U|LISSAMINE GREEN STAIN|N|Y|N||2||58||WASHOUT|1971-03-16|1968-06-17|||||1960-02-21||1961-10-04
TRIAL STUDY 134XCP|IS|CF214007-AC24-4760-AEDE-F78CDE3D9351||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6 CFU/ML|||||10^6/HPF||||HIGH|NOT DONE|||CORD SERUM|ICTERIC|Y|HIGH RESOLUTION MELT ANALYSIS|U|N|NA||3||39||INDUCTION TREATMENT|1961-05-04|1971-04-24|||||1963-10-30||1967-02-06
TRIAL STUDY 134XCP|IS|CF214007-AC24-4760-AEDE-F78CDE3D9351||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/KG/DAY|||||PMOL/L/H||||ABNORMAL|NOT DONE|||SEBUM|REFRIGERATED|NA|CLAUSS METHOD|U|U|N||4||88||INDUCTION TREATMENT|1970-08-06|1966-07-05|||||1966-06-29||1965-09-15
TRIAL STUDY 134XCP|IS|CF214007-AC24-4760-AEDE-F78CDE3D9351||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CGY|||||AMP||||HIGH|NOT DONE|||DERMAL TISSUE|CALCIFIED|N|AUDIOMETRY|U|Y|U||5||7||OBSERVATION|1966-01-26|1971-07-09|||||1967-01-16||1970-07-09
TRIAL STUDY 134XCP|IS|E996BE19-2824-49D3-944F-B777F3D8E746||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KG/CM|||||PACKAGE||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|DRIED|Y|MEDIASTINOSCOPY|Y|U|NA||1||38||BLINDED TREATMENT|1960-07-26|1972-03-22|||||1971-08-19||1968-01-26
TRIAL STUDY 134XCP|IS|E996BE19-2824-49D3-944F-B777F3D8E746||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MM/SEC|||||MBQ/UL||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|CONTAMINATED|N|PULSE OXIMETRY|U|U|NA||2||58||LONG-TERM FOLLOW-UP|1967-07-16|1971-02-28|||||1960-07-16||1968-12-09
TRIAL STUDY 134XCP|IS|E996BE19-2824-49D3-944F-B777F3D8E746||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/CM2|||||U/ANIMAL||||NORMAL|NOT DONE|||SALIVA|LACTESCENT|U|FLOCCULATION, CHARCOAL ENHANCED|NA|U|Y||3||39||BLINDED TREATMENT|1963-07-23|1962-03-08|||||1972-03-13||1962-06-09
TRIAL STUDY 134XCP|IS|E996BE19-2824-49D3-944F-B777F3D8E746||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||1/(S*KPA)|||||PACKAGE||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|Y|CISH|U|Y|U||4||88||INDUCTION TREATMENT|1972-04-24|1969-02-19|||||1969-09-09||1967-09-07
TRIAL STUDY 134XCP|IS|E996BE19-2824-49D3-944F-B777F3D8E746||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/MOL|||||PMOL/L/H||||HIGH|NOT DONE|||EPITHELIAL CELL|REFRIGERATED|Y|MICROARRAY|N|U|U||5||7||INDUCTION TREATMENT|1963-08-21|1968-04-22|||||1962-12-23||1968-10-10
TRIAL STUDY 134XCP|IS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||S*KPA|||||UG||||LOW|NOT DONE|||SERUM|SOLIDIFIED|Y|TEMPLATE INCISION METHOD|U|U|Y||1||38||LONG-TERM FOLLOW-UP|1963-03-07|1964-11-03|||||1967-05-14||1966-10-15
TRIAL STUDY 134XCP|IS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UV*SEC|||||NMOL/G||||LOW|NOT DONE|||REFLEX TEAR|PARAFFIN-EMBEDDED|Y|PLETHYSMOGRAPHY|Y|Y|Y||2||58||BLINDED TREATMENT|1966-03-16|1970-03-23|||||1962-08-12||1969-07-01
TRIAL STUDY 134XCP|IS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/DL|||||NMOL BCE/MMOL||||LOW|NOT DONE|||ARTERIAL BLOOD|AUTOLYZED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|N|Y|NA||3||39||BASELINE|1962-12-09|1962-09-10|||||1970-05-07||1969-05-08
TRIAL STUDY 134XCP|IS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACKAGE|||||AMU||||NORMAL|NOT DONE|||HAIR|PARAFFIN-EMBEDDED|N|THERMAL IONIZATION MASS SPECTROMETRY|NA|U|NA||4||88||FOLLOW-UP|1972-03-13|1965-04-14|||||1968-02-29||1962-07-21
TRIAL STUDY 134XCP|IS|B2A31803-615A-4B78-9DFD-CD6EB8ABF5AC||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UMOL/DAY|||||IU/KG/H||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|U|SINGLE-MOLECULE ARRAY|U|Y|Y||5||7||TREATMENT|1961-01-06|1965-07-22|||||1972-02-09||1970-02-16
TRIAL STUDY 134XCP|IS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GMFI|||||ML/KG||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|CONCENTRATED|NA|DIFFUSION WEIGHTED MRI|Y|U|U||1||38||CONTINUATION TREATMENT|1963-08-10|1963-06-20|||||1968-04-27||1964-04-18
TRIAL STUDY 134XCP|IS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FMOL/L/SEC|||||CY/CM||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|FROZEN|Y|PHOTOMETRY|Y|N|NA||2||58||BLINDED TREATMENT|1969-05-18|1960-10-07|||||1969-06-19||1970-11-05
TRIAL STUDY 134XCP|IS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL2/L2|||||UM||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|REFRIGERATED|N|KINYOUN STAIN|N|NA|U||3||39||TREATMENT|1968-04-19|1961-08-03|||||1971-07-01||1971-10-15
TRIAL STUDY 134XCP|IS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UCI/L|||||UM2||||NORMAL|NOT DONE|||ARTERIAL BLOOD|CONCENTRATED|N|NO INFORMATION|U|Y|Y||4||88||CONTINUATION TREATMENT|1964-12-01|1970-06-21|||||1963-10-25||1965-01-05
TRIAL STUDY 134XCP|IS|21BA7C51-E98D-4C0F-A437-8B4E05E6D6AE||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||WAFER|||||CMH2O*S/ML||||LOW|NOT DONE|||STOOL|CALCIFIED|Y|ELASTOGRAPHY|N|U|U||5||7||WASHOUT|1966-03-09|1965-12-14|||||1966-02-19||1961-03-02
TRIAL STUDY 134XCP|IS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L/H|||||MMOL/DAY||||ABNORMAL|NOT DONE|||SERUM|CLOTTED|N|MAGNETIC RESONANCE ENTEROGRAPHY|Y|N|N||1||38||BASELINE|1971-04-29|1970-08-01|||||1973-06-02||1966-11-10
TRIAL STUDY 134XCP|IS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CG|||||ENZYME U/G HB||||LOW|NOT DONE|||SPERMATOZOON|FROZEN|U|ENDOSCOPY|N|U|U||2||58||TREATMENT|1966-03-28|1970-03-09|||||1960-03-25||1963-04-22
TRIAL STUDY 134XCP|IS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||AMU|||||UG/KG/DAY||||LOW|NOT DONE|||SMEGMA|HEMOLYZED|U|CORONARY ANGIOGRAPHY|NA|NA|NA||3||39||SCREENING|1970-04-23|1962-03-16|||||1962-04-18||1961-09-06
TRIAL STUDY 134XCP|IS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KBQ|||||UG/M2||||LOW|NOT DONE|||DIALYSIS FLUID|CALCIFIED|N|MOUSE PROTECTION ASSAY|Y|U|N||4||88||CONTINUATION TREATMENT|1968-06-14|1961-07-13|||||1966-02-27||1965-09-29
TRIAL STUDY 134XCP|IS|3AD9D7F8-CD2F-4B45-AA83-20E7DBE60EA5||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL/DAY|||||LOG10 IU/ML||||NORMAL|NOT DONE|||CAPILLARY PLASMA|HEMOLYZED|Y|MIGET|Y|Y|N||5||7||FOLLOW-UP|1970-07-04|1961-02-09|||||1971-01-29||1962-09-24
TRIAL STUDY 134XCP|IS|1F75D53C-E8AA-45DA-8410-F00266080E80||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TSP|||||MG/MOL||||HIGH|NOT DONE|||BILE|SOLIDIFIED|NA|IVY INCISION METHOD|N|U|NA||1||38||WASHOUT|1971-07-14|1961-12-30|||||1961-04-19||1966-12-16
TRIAL STUDY 134XCP|IS|1F75D53C-E8AA-45DA-8410-F00266080E80||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ROENTGEN|||||/SEC||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|AGGLUTINATED|NA|TRYPAN BLUE STAIN|Y|NA|NA||2||58||FOLLOW-UP|1962-12-18|1969-12-16|||||1969-06-09||1972-09-04
TRIAL STUDY 134XCP|IS|1F75D53C-E8AA-45DA-8410-F00266080E80||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^9 ORGANISMS/ML|||||MN||||NORMAL|NOT DONE|||URINE|AGGLUTINATED|NA|IHC|NA|N|Y||3||39||RUN-IN|1968-05-04|1971-08-18|||||1966-10-23||1963-10-25
TRIAL STUDY 134XCP|IS|1F75D53C-E8AA-45DA-8410-F00266080E80||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/MMHG/MIN/L|||||MESF||||HIGH|NOT DONE|||SEMINAL FLUID|DRIED|NA|SLIT LAMP|U|U|Y||4||88||WASHOUT|1966-05-16|1972-09-30|||||1963-08-26||1960-09-02
TRIAL STUDY 134XCP|IS|1F75D53C-E8AA-45DA-8410-F00266080E80||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CAPSULE|||||/MONTH||||LOW|NOT DONE|||URINE|CONTAMINATED|U|MICROSCOPY|NA|N|N||5||7||WASHOUT|1962-07-08|1967-10-12|||||1962-06-13||1972-04-11
TRIAL STUDY 134XCP|IS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DB|||||ML/ANIMAL/WK||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|THAWED|NA|ETDRS EYE CHART|NA|NA|U||1||38||TREATMENT|1966-08-03|1965-08-27|||||1961-08-26||1960-05-19
TRIAL STUDY 134XCP|IS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/DOSE|||||10^7 TCID 50/DOSE||||ABNORMAL|NOT DONE|||BONE MARROW|AUTOLYZED|NA|MODIFIED ACID FAST STAIN|U|U|NA||2||58||LONG-TERM FOLLOW-UP|1963-05-17|1970-05-13|||||1964-11-28||1966-12-28
TRIAL STUDY 134XCP|IS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||TCID 50/DOSE|||||MG/M2/H||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|NA|MAPH|U|Y|Y||3||39||SCREENING|1965-06-22|1962-07-04|||||1973-04-17||1973-04-06
TRIAL STUDY 134XCP|IS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^9 CFU|||||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|CLOTTED|NA|FLUOROSCOPY|NA|U|Y||4||88||RUN-IN|1961-10-30|1964-02-24|||||1969-02-12||1966-05-14
TRIAL STUDY 134XCP|IS|9CEC9DDD-6ECE-46CB-9C66-C42B46245666||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/DL|||||SFC/10^6 PBMC||||NORMAL|NOT DONE|||ABSCESS FLUID|AGGLUTINATED|N|ELISPOT|Y|U|Y||5||7||INDUCTION TREATMENT|1966-04-06|1971-07-23|||||1971-12-29||1963-07-29
TRIAL STUDY 134XCP|IS|EE14E53E-19A8-4441-BF82-31444CBC8B49||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/H|||||U/KG/DAY||||HIGH|NOT DONE|||EMESIS|LIPEMIC|Y|LYMPHANGIOGRAPHY|Y|NA|Y||1||38||BLINDED TREATMENT|1962-06-08|1968-08-03|||||1962-10-01||1970-08-30
TRIAL STUDY 134XCP|IS|EE14E53E-19A8-4441-BF82-31444CBC8B49||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CARTRIDGE|||||ROENTGEN||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|HEMOLYZED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|U|Y|N||2||58||LONG-TERM FOLLOW-UP|1968-08-10|1971-10-06|||||1960-08-23||1969-09-26
TRIAL STUDY 134XCP|IS|EE14E53E-19A8-4441-BF82-31444CBC8B49||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PG|||||TAMPON||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|REFRIGERATED|NA|OPHTHALMOSCOPY|NA|U|U||3||39||INDUCTION TREATMENT|1972-08-09|1972-03-25|||||1965-06-11||1967-03-21
TRIAL STUDY 134XCP|IS|EE14E53E-19A8-4441-BF82-31444CBC8B49||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PNU/ML|||||MNFI||||HIGH|NOT DONE|||SEBUM|CONTAMINATED|U|MIGET|N|U|U||4||88||BLINDED TREATMENT|1966-03-14|1965-11-21|||||1961-09-10||1960-10-19
TRIAL STUDY 134XCP|IS|EE14E53E-19A8-4441-BF82-31444CBC8B49||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LX|||||AU/ML||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|Y|SLOAN LETTER EYE CHART 2.5%|N|N|NA||5||7||WASHOUT|1967-10-16|1967-10-06|||||1970-03-17||1963-05-29
TRIAL STUDY 134XCP|IS|DAF741EF-DCCF-4E18-844B-05640A94C181||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^3 ORGANISMS|||||UV||||LOW|NOT DONE|||MECONIUM|ICTERIC|Y|ALCIAN BLUE STAIN|U|Y|N||1||38||OBSERVATION|1961-02-24|1966-09-30|||||1969-03-14||1967-01-28
TRIAL STUDY 134XCP|IS|DAF741EF-DCCF-4E18-844B-05640A94C181||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L|||||MOL/DAY||||HIGH|NOT DONE|||GASTRIC CONTENTS|DRIED|N|COMPLEMENT FIXATION|NA|NA|N||2||58||OPEN LABEL TREATMENT|1960-05-05|1969-07-13|||||1972-12-15||1962-08-10
TRIAL STUDY 134XCP|IS|DAF741EF-DCCF-4E18-844B-05640A94C181||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ECL UNIT|||||SCOOPFUL||||HIGH|NOT DONE|||DERMAL TISSUE|CALCIFIED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|N|Y|NA||3||39||RUN-IN|1961-01-19|1968-10-27|||||1966-09-04||1973-03-22
TRIAL STUDY 134XCP|IS|DAF741EF-DCCF-4E18-844B-05640A94C181||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/UL|||||NSEC||||NORMAL|NOT DONE|||EXUDATE|CONTAMINATED|Y|EIA|Y|Y|NA||4||88||TREATMENT|1972-10-20|1969-11-13|||||1973-06-09||1964-01-03
TRIAL STUDY 134XCP|IS|DAF741EF-DCCF-4E18-844B-05640A94C181||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI/ML|||||MM2||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|CLOTTED|U|NUCLEAR RADIOLOGY|N|NA|N||5||7||SCREENING|1960-05-31|1962-03-21|||||1961-09-07||1968-02-11
TRIAL STUDY 134XCP|IS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GMFI|||||DPM/MG||||NORMAL|NOT DONE|||SWABBED MATERIAL|PARAFFIN-EMBEDDED|N|MICROBIAL CONCENTRATION|N|NA|U||1||38||OBSERVATION|1964-02-29|1967-10-05|||||1973-01-09||1962-04-12
TRIAL STUDY 134XCP|IS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||MJOULE/CM2||||HIGH|NOT DONE|||URINE SEDIMENT|CONTAMINATED|NA|NO INFORMATION|U|N|U||2||58||RUN-IN|1968-08-21|1968-04-28|||||1971-09-03||1971-12-15
TRIAL STUDY 134XCP|IS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CUP EQ|||||UMOL/MG/MIN||||ABNORMAL|NOT DONE|||CORD SERUM|FROZEN|NA|LC/MS|Y|NA|N||3||39||INDUCTION TREATMENT|1969-10-05|1972-01-04|||||1961-09-05||1962-10-07
TRIAL STUDY 134XCP|IS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/MOL|||||PRESSOR UNITS||||NORMAL|NOT DONE|||BREAST MILK|FROZEN|NA|SPECT SCAN|Y|U|Y||4||88||BLINDED TREATMENT|1965-07-22|1972-03-14|||||1962-03-10||1964-07-07
TRIAL STUDY 134XCP|IS|EBABAEE6-8EBE-4E92-9CBA-0AAE56BEAE54||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CY/CM|||||U/KG||||HIGH|NOT DONE|||SUPERNATANT, SERUM|GELLED|U|U-HPLC/MS/MS|NA|NA|Y||5||7||BASELINE|1962-02-25|1963-01-06|||||1968-08-11||1972-10-31
TRIAL STUDY 134XCP|IS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||ML/BEAT||||NORMAL|NOT DONE|||BONE MARROW|SOLIDIFIED|NA|OPTICAL MAPPING|U|NA|Y||1||38||RUN-IN|1961-11-11|1967-09-20|||||1973-01-14||1960-12-22
TRIAL STUDY 134XCP|IS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||SIEMENS|||||GPL U||||NORMAL|NOT DONE|||ISOLATE|UNEXPECTED ODOR|N|LC/MS|Y|Y|U||2||58||BLINDED TREATMENT|1965-05-28|1969-11-16|||||1972-03-15||1966-12-25
TRIAL STUDY 134XCP|IS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||EID 50/ML|||||MPH||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|UNEXPECTED ODOR|NA|OPTICAL MAPPING|Y|Y|U||3||39||BLINDED TREATMENT|1961-01-09|1964-03-31|||||1967-09-27||1960-10-26
TRIAL STUDY 134XCP|IS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/H/M2|||||MMHG||||NORMAL|NOT DONE|||ISOLATE|LIPEMIC|U|SXA SCAN|U|Y|Y||4||88||BLINDED TREATMENT|1962-06-26|1967-07-02|||||1966-01-31||1965-05-05
TRIAL STUDY 134XCP|IS|9B1490FA-9D19-4E9E-96D6-FA159E2D2B4D||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UCI/L|||||UKAT||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|FRESH|N|RADIOGRAPHY|Y|U|Y||5||7||BLINDED TREATMENT|1960-07-28|1970-10-06|||||1963-05-06||1973-08-23
TRIAL STUDY 134XCP|IS|CF3E1636-762F-4821-A44E-455F33F5E4CC||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||APS U|||||ELISA UNIT/DOSE||||LOW|NOT DONE|||HAIR FOLLICLE|SOLIDIFIED|N|X-RAY|Y|U|N||1||38||INDUCTION TREATMENT|1966-08-31|1972-09-09|||||1963-06-18||1964-04-02
TRIAL STUDY 134XCP|IS|CF3E1636-762F-4821-A44E-455F33F5E4CC||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 ELISA UNIT|||||PPM||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|AUTOLYZED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|U|NA||2||58||SCREENING|1967-02-23|1964-04-09|||||1971-08-07||1970-03-31
TRIAL STUDY 134XCP|IS|CF3E1636-762F-4821-A44E-455F33F5E4CC||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/ML/H|||||10^8/L||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|UNEXPECTED ODOR|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|N|N|NA||3||39||RUN-IN|1968-05-07|1972-09-13|||||1968-09-11||1966-03-07
TRIAL STUDY 134XCP|IS|CF3E1636-762F-4821-A44E-455F33F5E4CC||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DRUM|||||M/SEC2||||HIGH|NOT DONE|||GASTRIC CONTENTS|CONTAMINATED|Y|FLUORESCENT SPOT TEST|Y|N|NA||4||88||OPEN LABEL TREATMENT|1968-04-12|1962-07-13|||||1973-04-05||1964-07-10
TRIAL STUDY 134XCP|IS|CF3E1636-762F-4821-A44E-455F33F5E4CC||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BLOCKS|||||MOL/MG||||LOW|NOT DONE|||LYSATE|CONCENTRATED|Y|FUNDUS PHOTOGRAPHY|U|Y|U||5||7||FOLLOW-UP|1969-04-17|1966-01-24|||||1964-12-14||1970-12-02
TRIAL STUDY 134XCP|IS|3846A0A8-2D38-44C9-A579-84C66315C436||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FG|||||MCI/KG||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|AGGLUTINATED|N|TONOMETRY|Y|NA|Y||1||38||OBSERVATION|1972-10-16|1969-02-13|||||1962-06-18||1964-01-23
TRIAL STUDY 134XCP|IS|3846A0A8-2D38-44C9-A579-84C66315C436||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MET*MIN|||||MHZ||||HIGH|NOT DONE|||ERYTHROCYTES|UNEXPECTED ODOR|Y|HIGH RESOLUTION MELT ANALYSIS|N|Y|Y||2||58||FOLLOW-UP|1962-02-18|1962-06-01|||||1962-07-13||1970-06-12
TRIAL STUDY 134XCP|IS|3846A0A8-2D38-44C9-A579-84C66315C436||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG/CM2|||||10^9 ORGANISMS/ML||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|GELLED|Y|WHOLE EXOME SEQUENCING|NA|NA|NA||3||39||OBSERVATION|1969-07-01|1971-12-20|||||1963-05-27||1966-09-20
TRIAL STUDY 134XCP|IS|3846A0A8-2D38-44C9-A579-84C66315C436||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UOSM|||||CAL||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|Y|EPSILOMETER|N|N|U||4||88||BLINDED TREATMENT|1962-12-01|1962-08-27|||||1970-03-12||1971-01-29
TRIAL STUDY 134XCP|IS|3846A0A8-2D38-44C9-A579-84C66315C436||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/KG/DAY|||||UMOL/KG/MIN||||HIGH|NOT DONE|||MONOCYTE|THAWED|NA|TARGETED TRANSCRIPTOME SEQUENCING|Y|U|NA||5||7||OBSERVATION|1964-12-24|1970-04-08|||||1962-08-13||1970-02-24
TRIAL STUDY 134XCP|IS|75B429C2-E173-4F72-8D4A-76F62C97F006||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MOSM|||||UMOL/MIN||||HIGH|NOT DONE|||EPIDERMAL TISSUE|CONTAMINATED|NA|BALLPOINT PEN TECHNIQUE|NA|NA|Y||1||38||TREATMENT|1967-12-09|1962-03-14|||||1960-06-29||1967-05-03
TRIAL STUDY 134XCP|IS|75B429C2-E173-4F72-8D4A-76F62C97F006||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^4/L|||||DPM||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|THAWED|NA|ELECTROCHEMILUMINESCENCE|Y|NA|U||2||58||BASELINE|1964-10-22|1964-01-03|||||1966-04-27||1961-09-28
TRIAL STUDY 134XCP|IS|75B429C2-E173-4F72-8D4A-76F62C97F006||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MESF|||||MPL U||||LOW|NOT DONE|||ALVEOLAR AIR|CONCENTRATED|N|MRI|U|N|U||3||39||SCREENING|1971-03-17|1972-11-16|||||1970-02-07||1964-02-26
TRIAL STUDY 134XCP|IS|75B429C2-E173-4F72-8D4A-76F62C97F006||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PFU|||||KCAL||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|SOLIDIFIED|Y|GC/MS/MS|NA|NA|U||4||88||BASELINE|1966-10-08|1970-11-28|||||1966-11-22||1970-12-21
TRIAL STUDY 134XCP|IS|75B429C2-E173-4F72-8D4A-76F62C97F006||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LX|||||ML/ANIMAL/DAY||||ABNORMAL|NOT DONE|||SALIVA|PARAFFIN-EMBEDDED|Y|THERMAL IONIZATION MASS SPECTROMETRY|NA|NA|U||5||7||OBSERVATION|1970-01-11|1964-11-30|||||1962-04-25||1967-11-05
TRIAL STUDY 134XCP|IS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PACK|||||BAU/ML||||ABNORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|AGGLUTINATED|N|DIFFUSION WEIGHTED MRI|N|N|Y||1||38||SCREENING|1971-01-02|1965-05-22|||||1964-03-16||1961-07-24
TRIAL STUDY 134XCP|IS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CFU/G|||||PFU||||HIGH|NOT DONE|||PLATELET RICH PLASMA|ROOM TEMPERATURE|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|U|NA|U||2||58||BASELINE|1967-06-03|1960-01-12|||||1968-12-06||1963-03-25
TRIAL STUDY 134XCP|IS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DEG/MM|||||MU||||NORMAL|NOT DONE|||MECONIUM|FRESH|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|U|Y|N||3||39||TREATMENT|1966-12-19|1969-07-16|||||1970-02-18||1965-04-06
TRIAL STUDY 134XCP|IS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/DOSE|||||GPL U/ML||||NORMAL|NOT DONE|||AQUEOUS HUMOR|GELLED|NA|SINGLE-SLICE SPIRAL CT|Y|Y|U||4||88||WASHOUT|1961-04-04|1971-06-04|||||1960-11-14||1965-12-18
TRIAL STUDY 134XCP|IS|D0196B36-EE56-4B5E-A60C-5C6E6EAFF381||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 CFU/ML|||||DPM/0.5 ML||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|LIPEMIC|Y|MALDI|U|NA|U||5||7||BASELINE|1963-03-24|1970-08-04|||||1965-02-12||1966-01-15
TRIAL STUDY 134XCP|IS|8065F0B9-9183-43E4-998A-D2F096D87998||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/MG|||||U/MMOL||||LOW|NOT DONE|||EXPIRED AIR|HEMOLYZED|N|ELISA|U|Y|N||1||38||SCREENING|1972-07-03|1961-07-24|||||1970-04-11||1960-01-03
TRIAL STUDY 134XCP|IS|8065F0B9-9183-43E4-998A-D2F096D87998||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CMHG|||||DEG||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|AUTOLYZED|U|CLIP SEQUENCING|N|Y|Y||2||58||OPEN LABEL TREATMENT|1967-08-20|1965-02-28|||||1965-04-01||1965-08-30
TRIAL STUDY 134XCP|IS|8065F0B9-9183-43E4-998A-D2F096D87998||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG|||||SIEMENS||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|AGGLUTINATED|N|HPLC/IEX|Y|Y|Y||3||39||BASELINE|1969-03-23|1966-05-28|||||1963-02-06||1970-09-14
TRIAL STUDY 134XCP|IS|8065F0B9-9183-43E4-998A-D2F096D87998||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||OI50|||||UU/L||||HIGH|NOT DONE|||SPUTUM|AGGLUTINATED|U|ULTRASONOGRAPHIC ELASTOGRAPHY|U|Y|Y||4||88||TREATMENT|1971-09-04|1963-04-04|||||1969-10-22||1973-01-22
TRIAL STUDY 134XCP|IS|8065F0B9-9183-43E4-998A-D2F096D87998||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BOLUS|||||MMAL||||LOW|NOT DONE|||PUS|CONCENTRATED|NA|PHOROPTER|NA|Y|N||5||7||CONTINUATION TREATMENT|1967-02-04|1971-03-28|||||1973-07-28||1970-11-27
TRIAL STUDY 134XCP|IS|697EB3B7-5AD1-4D1D-BB53-BB0556915957||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||GRAVITATIONAL UNIT|||||MEQ/UL||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|FRESH|U|WHOLE TRANSCRIPTOME SEQUENCING|NA|N|U||1||38||BASELINE|1970-01-31|1961-08-31|||||1973-09-05||1969-09-17
TRIAL STUDY 134XCP|IS|697EB3B7-5AD1-4D1D-BB53-BB0556915957||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG/L|||||BQ||||LOW|NOT DONE|||MIXED VENOUS BLOOD|CONTAMINATED|U|SICKLE CELL SOLUBILITY TEST|Y|N|NA||2||58||SCREENING|1963-10-27|1966-06-29|||||1970-06-08||1971-09-20
TRIAL STUDY 134XCP|IS|697EB3B7-5AD1-4D1D-BB53-BB0556915957||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MOSM|||||ELISA UNIT||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|FRESH|U|NON-CONTACT SPECULAR MICROSCOPY|Y|NA|N||3||39||INDUCTION TREATMENT|1962-10-17|1972-03-20|||||1972-02-27||1969-08-06
TRIAL STUDY 134XCP|IS|697EB3B7-5AD1-4D1D-BB53-BB0556915957||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BAU/ML|||||10^9/DOSE||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|Y|DISK DIFFUSION|NA|Y|U||4||88||BASELINE|1967-07-06|1972-05-30|||||1971-06-06||1969-06-15
TRIAL STUDY 134XCP|IS|697EB3B7-5AD1-4D1D-BB53-BB0556915957||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MBQ/UL|||||MG/KG/DAY||||NORMAL|NOT DONE|||VENOUS BLOOD|FROZEN|Y|GC/MS-CI|U|U|N||5||7||LONG-TERM FOLLOW-UP|1971-01-16|1966-06-27|||||1963-04-27||1964-07-26
TRIAL STUDY 134XCP|IS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIXEL|||||ML/H||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|GELLED|NA|LIQUID SCINTILLATION COUNTING|Y|N|NA||1||38||OPEN LABEL TREATMENT|1969-01-20|1970-01-19|||||1960-11-20||1970-11-25
TRIAL STUDY 134XCP|IS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/H|||||/SEC||||NORMAL|NOT DONE|||MECONIUM|ROOM TEMPERATURE|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NA|NA|U||2||58||SCREENING|1961-12-23|1960-05-11|||||1962-04-28||1964-02-17
TRIAL STUDY 134XCP|IS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT/ML|||||UG/ANIMAL||||HIGH|NOT DONE|||ARTERIAL BLOOD|AUTOLYZED|U|ENDPOINT DILUTION ASSAY|U|U|Y||3||39||OBSERVATION|1963-01-19|1963-02-18|||||1962-11-14||1967-04-26
TRIAL STUDY 134XCP|IS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BREATHS/30S|||||GPL U||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|AGGLUTINATED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|N|NA|Y||4||88||WASHOUT|1971-02-09|1973-07-25|||||1964-08-22||1965-10-11
TRIAL STUDY 134XCP|IS|3DC3F05B-BA68-42F0-BC91-003D9FB00A91||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NEEDLE GAUGE|||||MMOL/MIN/KPA||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|CONCENTRATED|Y|ZIEHL NEELSEN ACID FAST STAIN|Y|N|N||5||7||FOLLOW-UP|1961-08-08|1964-08-18|||||1964-07-30||1970-07-16
TRIAL STUDY 134XCP|IS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/DAY|||||VP/ML||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|DRIED|NA|NUCLEIC ACID SEQUENCING|N|NA|U||1||38||TREATMENT|1962-07-12|1961-04-25|||||1966-03-19||1964-04-12
TRIAL STUDY 134XCP|IS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||H*%|||||GBQ/UG||||ABNORMAL|NOT DONE|||SKIN TISSUE|LIPEMIC|N|FLUORESCENT ENZYME IMMUNOASSAY|N|NA|N||2||58||BASELINE|1962-02-06|1963-12-24|||||1967-11-05||1960-12-29
TRIAL STUDY 134XCP|IS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L|||||L/H||||HIGH|NOT DONE|||PLASMA|REFRIGERATED|U|PUPILLOMETRY|NA|Y|NA||3||39||CONTINUATION TREATMENT|1971-12-24|1966-10-21|||||1963-07-02||1971-07-13
TRIAL STUDY 134XCP|IS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 CFU/G|||||DMOL||||HIGH|NOT DONE|||DISCHARGE|CLOTTED|U|PHYSICAL EXAMINATION|N|Y|NA||4||88||OBSERVATION|1965-10-07|1971-04-18|||||1966-03-13||1972-06-05
TRIAL STUDY 134XCP|IS|469A321E-3F7B-4C3E-B5CE-A6A02B8D8A94||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT/DOSE|||||10^9 ORGANISMS/G||||HIGH|NOT DONE|||PLEURAL TISSUE|CALCIFIED|U|TELLER ACUITY CARDS|Y|N|U||5||7||TREATMENT|1965-11-12|1967-01-18|||||1971-05-21||1972-11-13
TRIAL STUDY 134XCP|IS|52EC57AA-56E4-47A8-AADA-36F62653B423||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FOZ_US|||||MG/M2/MIN||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|AUTOLYZED|U|LC/MS/MS|NA|NA|NA||1||38||BASELINE|1965-04-20|1966-09-12|||||1961-09-01||1964-12-26
TRIAL STUDY 134XCP|IS|52EC57AA-56E4-47A8-AADA-36F62653B423||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||G/M2|||||MG/G/H||||HIGH|NOT DONE|||MENSTRUAL BLOOD|ROOM TEMPERATURE|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|U|NA|N||2||58||BLINDED TREATMENT|1964-04-17|1968-10-02|||||1963-04-09||1963-01-11
TRIAL STUDY 134XCP|IS|52EC57AA-56E4-47A8-AADA-36F62653B423||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DIOPTER|||||DIOPTER||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|N|SPIRAL CT SCAN WITHOUT CONTRAST|Y|N|N||3||39||SCREENING|1966-03-09|1962-03-09|||||1964-03-21||1961-04-13
TRIAL STUDY 134XCP|IS|52EC57AA-56E4-47A8-AADA-36F62653B423||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||HOURS|||||MM/2H||||LOW|NOT DONE|||BASAL TEAR|UNEXPECTED ODOR|N|TONOMETRY|NA|Y|NA||4||88||OBSERVATION|1970-02-20|1969-01-28|||||1962-03-07||1972-09-10
TRIAL STUDY 134XCP|IS|52EC57AA-56E4-47A8-AADA-36F62653B423||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL/L|||||DPM/ML||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|GELLED|U|WHOLE TRANSCRIPTOME SEQUENCING|NA|NA|Y||5||7||TREATMENT|1966-04-29|1962-10-25|||||1970-11-04||1969-03-04
TRIAL STUDY 134XCP|IS|F09C04A4-4F9E-4033-9115-81C6007DE8B4||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||APL U/ML|||||ANTI-XA IU||||LOW|NOT DONE|||CAPILLARY BLOOD|FROZEN|U|COMPUTERIZED CORNEAL TOPOGRAPHY|U|Y|Y||1||38||WASHOUT|1969-09-16|1965-12-27|||||1961-05-04||1967-04-09
TRIAL STUDY 134XCP|IS|F09C04A4-4F9E-4033-9115-81C6007DE8B4||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IMPLANT|||||UMOL/DL||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|THAWED|N|SURFACE PLASMON RESONANCE|NA|Y|Y||2||58||OPEN LABEL TREATMENT|1966-03-13|1966-08-16|||||1965-06-27||1966-04-06
TRIAL STUDY 134XCP|IS|F09C04A4-4F9E-4033-9115-81C6007DE8B4||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MMOL2/L2|||||MPL U/ML||||ABNORMAL|NOT DONE|||ERYTHROCYTES|CONTAMINATED|U|SEQUENCING|U|U|N||3||39||FOLLOW-UP|1961-04-25|1960-04-08|||||1967-01-02||1971-01-18
TRIAL STUDY 134XCP|IS|F09C04A4-4F9E-4033-9115-81C6007DE8B4||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MOL/MOL|||||10^7 CFU/ML||||LOW|NOT DONE|||REFLEX TEAR|NON-HEMOLYZED|NA|WRIGHT-GIEMSA STAIN|U|Y|U||4||88||TREATMENT|1966-07-22|1964-08-11|||||1973-02-23||1965-03-14
TRIAL STUDY 134XCP|IS|F09C04A4-4F9E-4033-9115-81C6007DE8B4||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/ML|||||MHZ||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|NON-HEMOLYZED|Y|LIGHT SCATTERING SPECTROSCOPY|U|N|NA||5||7||OPEN LABEL TREATMENT|1961-04-29|1964-03-17|||||1963-02-08||1961-06-15
TRIAL STUDY 134XCP|IS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||SPRAY|||||LOG10 CFU/ML||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|UNEXPECTED ODOR|U|OPTICAL COHERENCE TOMOGRAPHY|U|U|U||1||38||CONTINUATION TREATMENT|1962-03-01|1961-12-05|||||1962-07-31||1965-01-09
TRIAL STUDY 134XCP|IS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IU/MG|||||NKAT||||HIGH|NOT DONE|||INFRANATANT, SERUM|CONCENTRATED|NA|PET/CT SCAN WITHOUT CONTRAST|Y|N|Y||2||58||LONG-TERM FOLLOW-UP|1973-04-18|1960-08-04|||||1972-09-02||1966-05-16
TRIAL STUDY 134XCP|IS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ECL UNIT|||||ML/DAY||||HIGH|NOT DONE|||PLEURAL TISSUE|LACTESCENT|Y|LISSAMINE GREEN STAIN|Y|NA|NA||3||39||OBSERVATION|1972-09-01|1973-04-05|||||1972-09-01||1966-12-16
TRIAL STUDY 134XCP|IS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/ANIMAL|||||MM2||||HIGH|NOT DONE|||SERUM OR PLASMA|FRESH|NA|PET/CT SCAN|N|Y|Y||4||88||CONTINUATION TREATMENT|1961-07-01|1970-12-30|||||1966-10-25||1965-03-18
TRIAL STUDY 134XCP|IS|B224E72B-65ED-48A0-AB8E-A6BF0B25D8C3||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL/DAY|||||DPM/100MG||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|NA|SPIRAL CT SCAN WITHOUT CONTRAST|Y|NA|NA||5||7||OPEN LABEL TREATMENT|1967-08-30|1968-07-02|||||1967-01-16||1966-12-06
TRIAL STUDY 134XCP|IS|4779A01C-1219-46AC-B0F7-71C9717A2B45||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/10^5|||||PM||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|NA|MODIFIED ACID FAST STAIN|U|Y|NA||1||38||SCREENING|1969-08-19|1963-07-24|||||1972-12-06||1968-11-06
TRIAL STUDY 134XCP|IS|4779A01C-1219-46AC-B0F7-71C9717A2B45||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||AMU|||||PIXELS/CM||||NORMAL|NOT DONE|||DISCHARGE|DRIED|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|N|Y|N||2||58||OBSERVATION|1960-06-23|1969-01-03|||||1962-03-07||1968-10-26
TRIAL STUDY 134XCP|IS|4779A01C-1219-46AC-B0F7-71C9717A2B45||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM|||||G/CM2||||NORMAL|NOT DONE|||SPUTUM|FROZEN|N|IMMUNOFIXATION ELECTROPHORESIS|Y|U|N||3||39||FOLLOW-UP|1972-01-03|1971-09-13|||||1962-02-13||1960-06-11
TRIAL STUDY 134XCP|IS|4779A01C-1219-46AC-B0F7-71C9717A2B45||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTI-XA IU|||||RNA COPIES/ML||||NORMAL|NOT DONE|||HAIR FOLLICLE|DRIED|Y|MICRO BROTH DILUTION|NA|Y|U||4||88||TREATMENT|1962-02-05|1970-05-16|||||1964-08-30||1967-02-19
TRIAL STUDY 134XCP|IS|4779A01C-1219-46AC-B0F7-71C9717A2B45||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MV*MIN|||||U/CL||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|REFRIGERATED|N|TRANSMISSION ELECTRON MICROSCOPY|NA|Y|U||5||7||OBSERVATION|1960-07-19|1973-02-24|||||1963-06-29||1969-02-14
TRIAL STUDY 134XCP|IS|5F5C5DED-7547-40D2-9B34-77B37CCD7732||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^10/L|||||SACHET||||HIGH|NOT DONE|||COLOSTRUM|NON-HEMOLYZED|U|FLUORESCENT SPOT TEST|U|Y|U||1||38||BLINDED TREATMENT|1968-06-29|1964-02-04|||||1973-06-20||1967-01-28
TRIAL STUDY 134XCP|IS|5F5C5DED-7547-40D2-9B34-77B37CCD7732||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NG|||||10^9/DOSE||||LOW|NOT DONE|||TRANSUDATE|FRESH|N|DOUBLE IMMUNODIFFUSION|NA|N|NA||2||58||BLINDED TREATMENT|1969-02-23|1960-10-31|||||1961-11-21||1967-01-30
TRIAL STUDY 134XCP|IS|5F5C5DED-7547-40D2-9B34-77B37CCD7732||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/H|||||BQ||||HIGH|NOT DONE|||PLEURAL FLUID|FRESH|Y|IMMUNO-PET SCAN|U|N|N||3||39||OBSERVATION|1963-05-17|1964-04-17|||||1967-10-27||1969-01-18
TRIAL STUDY 134XCP|IS|5F5C5DED-7547-40D2-9B34-77B37CCD7732||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/KG/H|||||COULOMB||||NORMAL|NOT DONE|||VITREOUS HUMOR|THAWED|NA|GC/MS-CI|Y|U|U||4||88||FOLLOW-UP|1967-05-17|1961-10-25|||||1971-04-16||1968-04-27
TRIAL STUDY 134XCP|IS|5F5C5DED-7547-40D2-9B34-77B37CCD7732||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FRAMES/S|||||G/CAGE/DAY||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|FRESH|NA|NUCLEIC ACID BASED METHOD|N|NA|Y||5||7||FOLLOW-UP|1963-12-11|1960-04-08|||||1971-09-22||1963-06-23
TRIAL STUDY 134XCP|IS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MM/H|||||KG/CM2||||HIGH|NOT DONE|||DERMAL TISSUE|ICTERIC|NA|IHC|Y|NA|N||1||38||RUN-IN|1962-02-09|1960-03-25|||||1969-02-21||1964-09-20
TRIAL STUDY 134XCP|IS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/MMOL|||||UG||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|NA|FLUORESCENT IMMUNOASSAY|U|U|Y||2||58||CONTINUATION TREATMENT|1966-01-26|1961-08-12|||||1964-07-16||1972-09-04
TRIAL STUDY 134XCP|IS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L/DAY|||||MMOL/MIN/KPA/L||||HIGH|NOT DONE|||PLATELET|DRIED|Y|CELL BASED BIOASSAY|U|N|N||3||39||OPEN LABEL TREATMENT|1967-04-28|1965-10-13|||||1964-02-01||1972-03-28
TRIAL STUDY 134XCP|IS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/CAGE/DAY|||||BOTTLE||||HIGH|NOT DONE|||MUCUS|AUTOLYZED|Y|TOTAL BODY IRRADIATION|U|NA|NA||4||88||CONTINUATION TREATMENT|1963-04-15|1965-05-08|||||1970-02-03||1966-12-14
TRIAL STUDY 134XCP|IS|9EE4A7A5-2E5A-4BB0-BC6D-87D65BC76857||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/10^5|||||DMOL||||HIGH|NOT DONE|||BLOOD|DRIED|NA|BIOIMPEDANCE SPECTROSCOPY|U|Y|NA||5||7||INDUCTION TREATMENT|1970-07-03|1962-03-27|||||1967-12-19||1968-07-26
TRIAL STUDY 134XCP|IS|48348DF0-33DA-457F-86C6-797FF7B32857||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PG/CELL|||||MDFI||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|Y|OPTICAL COHERENCE TOMOGRAPHY|NA|N|U||1||38||RUN-IN|1960-09-27|1973-02-17|||||1973-01-22||1972-12-25
TRIAL STUDY 134XCP|IS|48348DF0-33DA-457F-86C6-797FF7B32857||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PMOL/DL|||||DROP||||LOW|NOT DONE|||BONE MARROW|CLOTTED|Y|ULTRASOUND|U|U|NA||2||58||RUN-IN|1960-01-25|1960-04-25|||||1971-04-14||1964-05-22
TRIAL STUDY 134XCP|IS|48348DF0-33DA-457F-86C6-797FF7B32857||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FEU|||||FFU||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|LIPEMIC|NA|LANDOLT RING|NA|NA|U||3||39||RUN-IN|1970-09-30|1971-01-12|||||1964-06-10||1962-09-04
TRIAL STUDY 134XCP|IS|48348DF0-33DA-457F-86C6-797FF7B32857||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG|||||ML/CM3/MIN||||LOW|NOT DONE|||CORD SERUM|LIPEMIC|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|U|N|NA||4||88||BLINDED TREATMENT|1972-01-05|1966-09-24|||||1965-04-02||1973-01-01
TRIAL STUDY 134XCP|IS|48348DF0-33DA-457F-86C6-797FF7B32857||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/10^5|||||MG/M2/H||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|FRESH|NA|MANUAL CLOT DETECTION|NA|U|NA||5||7||OPEN LABEL TREATMENT|1963-12-24|1969-05-26|||||1971-05-22||1970-09-25
TRIAL STUDY 134XCP|IS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/SEC|||||VG/ML||||ABNORMAL|NOT DONE|||CALCULUS|AUTOLYZED|Y|KINETIC MICROPARTICLE IMMUNOASSAY|Y|U|NA||1||38||OPEN LABEL TREATMENT|1971-11-09|1971-02-13|||||1965-11-18||1965-04-19
TRIAL STUDY 134XCP|IS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/ANIMAL/DAY|||||UL/DOSE||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|CONTAMINATED|U|TRIPLE-PHASE MRI SCAN|N|NA|U||2||58||LONG-TERM FOLLOW-UP|1973-09-06|1971-08-23|||||1960-08-16||1970-03-09
TRIAL STUDY 134XCP|IS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/MIN/1.73M2|||||MS2||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|HEMOLYZED|NA|MICROBIAL CONCENTRATION|Y|U|NA||3||39||WASHOUT|1961-04-03|1963-07-11|||||1964-10-17||1964-03-05
TRIAL STUDY 134XCP|IS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||USIEMENS|||||MCI/KG||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CLOTTED|Y|SICKLE CELL SOLUBILITY TEST|U|U|N||4||88||OPEN LABEL TREATMENT|1972-01-21|1967-10-10|||||1960-09-16||1969-02-11
TRIAL STUDY 134XCP|IS|B2D1E5B2-17A6-4677-999E-A3F3B24FBBB4||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL/G|||||ML/KG/MIN||||LOW|NOT DONE|||WHITE MATTER TISSUE|FROZEN|U|TARGETED GENOME SEQUENCING|Y|NA|Y||5||7||LONG-TERM FOLLOW-UP|1972-05-22|1965-10-14|||||1967-06-21||1969-08-26
TRIAL STUDY 134XCP|IS|396CC122-5F23-418D-A75E-572ADF4FD6C1||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MPL U|||||%/MIN||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|FRESH|N|PERIODIC ACID SCHIFF STAIN|N|Y|Y||1||38||INDUCTION TREATMENT|1962-03-21|1973-07-25|||||1961-05-10||1973-03-16
TRIAL STUDY 134XCP|IS|396CC122-5F23-418D-A75E-572ADF4FD6C1||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6 CFU/G|||||MG/DL||||NORMAL|NOT DONE|||SWABBED MATERIAL|AUTOLYZED|N|MICROBIAL CULTURE, SOLID|U|NA|NA||2||58||OBSERVATION|1969-03-07|1970-09-22|||||1966-05-13||1973-08-01
TRIAL STUDY 134XCP|IS|396CC122-5F23-418D-A75E-572ADF4FD6C1||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||APPLICATION|||||UG/M2/DAY||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|Y|TRYPAN BLUE STAIN|NA|NA|NA||3||39||OBSERVATION|1966-06-16|1962-04-01|||||1971-06-18||1971-08-14
TRIAL STUDY 134XCP|IS|396CC122-5F23-418D-A75E-572ADF4FD6C1||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL|||||ECL UNIT||||HIGH|NOT DONE|||REFLEX TEAR|ROOM TEMPERATURE|N|MAMMOGRAPHY|NA|U|N||4||88||INDUCTION TREATMENT|1963-10-29|1960-09-14|||||1962-02-23||1966-03-05
TRIAL STUDY 134XCP|IS|396CC122-5F23-418D-A75E-572ADF4FD6C1||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%/S|||||U/G HB||||LOW|NOT DONE|||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|N|CORONARY ANGIOGRAPHY|U|U|N||5||7||BLINDED TREATMENT|1973-04-05|1965-01-24|||||1972-05-25||1961-01-26
TRIAL STUDY 134XCP|IS|9CF3CD51-5D5B-40E6-8F13-B314911BE461||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||AU/ML|||||/LPF||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|LACTESCENT|U|CINEANGIOGRAPHY|U|NA|U||1||38||BLINDED TREATMENT|1960-04-08|1971-01-10|||||1963-05-22||1971-06-28
TRIAL STUDY 134XCP|IS|9CF3CD51-5D5B-40E6-8F13-B314911BE461||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||OI50|||||TROCHE||||NORMAL|NOT DONE|||PLEURAL FLUID|HEMOLYZED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|U|Y|U||2||58||RUN-IN|1963-08-04|1963-06-25|||||1973-03-16||1969-07-27
TRIAL STUDY 134XCP|IS|9CF3CD51-5D5B-40E6-8F13-B314911BE461||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MV*MIN|||||KHZ||||ABNORMAL|NOT DONE|||EXUDATE|LIPEMIC|Y|LIGHT MICROSCOPY|NA|U|NA||3||39||CONTINUATION TREATMENT|1968-09-15|1967-02-22|||||1972-06-01||1973-07-13
TRIAL STUDY 134XCP|IS|9CF3CD51-5D5B-40E6-8F13-B314911BE461||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MOSM/KG|||||LOG10 TCID 50/DOSE||||LOW|NOT DONE|||BREAST MILK|SOLIDIFIED|NA|LYMPHANGIOGRAPHY|Y|NA|U||4||88||BLINDED TREATMENT|1969-07-20|1968-07-27|||||1963-04-20||1966-07-04
TRIAL STUDY 134XCP|IS|9CF3CD51-5D5B-40E6-8F13-B314911BE461||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NMOL/L|||||KBQ||||NORMAL|NOT DONE|||EXPIRED AIR|THAWED|U|FLUORESCENT SPOT TEST|Y|U|Y||5||7||SCREENING|1964-10-04|1969-10-05|||||1970-09-25||1965-03-17
TRIAL STUDY 134XCP|IS|CB3B9054-5CDC-418D-8071-7429B1702587||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^9 ORGANISMS/ML|||||NU/CL||||NORMAL|NOT DONE|||MECONIUM|AGGLUTINATED|Y|FLAME PHOTOMETRY|NA|NA|U||1||38||WASHOUT|1963-08-18|1963-05-09|||||1963-09-21||1960-08-24
TRIAL STUDY 134XCP|IS|CB3B9054-5CDC-418D-8071-7429B1702587||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||IU/MMOL|||||MMAL||||LOW|NOT DONE|||ALVEOLAR AIR|LIPEMIC|N|DXA SCAN|N|N|U||2||58||SCREENING|1964-04-18|1972-06-30|||||1966-04-09||1967-04-18
TRIAL STUDY 134XCP|IS|CB3B9054-5CDC-418D-8071-7429B1702587||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MM3/MM2/YEAR|||||AG||||ABNORMAL|NOT DONE|||DISCHARGE|PARAFFIN-EMBEDDED|N|SLOAN LETTER EYE CHART 2.5%|U|Y|U||3||39||OBSERVATION|1971-03-04|1961-04-05|||||1968-08-02||1962-08-06
TRIAL STUDY 134XCP|IS|CB3B9054-5CDC-418D-8071-7429B1702587||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||SPRAY|||||NGEQ/L||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|CALCIFIED|Y|MAPH|N|Y|NA||4||88||BLINDED TREATMENT|1967-08-10|1973-04-01|||||1963-03-09||1964-08-29
TRIAL STUDY 134XCP|IS|CB3B9054-5CDC-418D-8071-7429B1702587||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||G/DAY|||||U/L||||NORMAL|NOT DONE|||DISCHARGE|PARAFFIN-EMBEDDED|NA|FLUORIMETRY|Y|NA|NA||5||7||BASELINE|1965-06-22|1965-09-30|||||1962-08-07||1964-03-24
TRIAL STUDY 134XCP|IS|1AC4DE34-3486-41FB-A979-8B368912F75A||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||WEBER|||||MEQ/UG||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|U|PATHOLOGICAL EVALUATION|N|NA|N||1||38||INDUCTION TREATMENT|1970-12-24|1969-10-25|||||1961-04-06||1970-02-15
TRIAL STUDY 134XCP|IS|1AC4DE34-3486-41FB-A979-8B368912F75A||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MBQ/UL|||||S*KPA||||HIGH|NOT DONE|||URINE SEDIMENT|THAWED|NA|CHROMOGENIC ASSAY|NA|NA|U||2||58||BASELINE|1968-12-07|1967-12-29|||||1961-01-20||1964-09-20
TRIAL STUDY 134XCP|IS|1AC4DE34-3486-41FB-A979-8B368912F75A||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||RAD|||||10^9/G||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|HEMOLYZED|N|REBOUND TONOMETRY|U|N|U||3||39||RUN-IN|1962-09-20|1966-04-17|||||1963-06-29||1963-09-22
TRIAL STUDY 134XCP|IS|1AC4DE34-3486-41FB-A979-8B368912F75A||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ATM|||||10^9 ORGANISMS||||NORMAL|NOT DONE|||ADIPOSE TISSUE|ICTERIC|NA|DIRECT SEQUENCING|N|NA|N||4||88||TREATMENT|1967-02-02|1968-06-16|||||1965-03-30||1970-12-02
TRIAL STUDY 134XCP|IS|1AC4DE34-3486-41FB-A979-8B368912F75A||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||HOUNSFIELD UNIT|||||10^6 U||||ABNORMAL|NOT DONE|||BREAST MILK|CLOTTED|N|TWO-COLOR MICROARRAY|NA|N|NA||5||7||BASELINE|1967-03-02|1968-09-29|||||1962-05-25||1971-05-31
TRIAL STUDY 134XCP|IS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||YD|||||MS2||||NORMAL|NOT DONE|||DIALYSIS FLUID|CLOTTED|Y|NON-INVASIVE DIELECTRIC SENSING|Y|Y|NA||1||38||TREATMENT|1967-02-17|1972-09-22|||||1964-12-27||1965-09-04
TRIAL STUDY 134XCP|IS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MEQ|||||ML/MMHG||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|LACTESCENT|Y|GC/MS/MS|NA|U|U||2||58||BASELINE|1971-11-02|1964-08-15|||||1968-07-27||1972-03-26
TRIAL STUDY 134XCP|IS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OHM|||||UG/MIN||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|CONTAMINATED|Y|SLOAN LETTER EYE CHART 2.5%|NA|U|N||3||39||OPEN LABEL TREATMENT|1964-10-07|1966-09-11|||||1973-04-20||1964-03-07
TRIAL STUDY 134XCP|IS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||SHOCK WAVE|||||DNA COPIES/UG||||HIGH|NOT DONE|||BASAL TEAR|CALCIFIED|U|CHROMATOGRAPHY|U|N|U||4||88||OPEN LABEL TREATMENT|1970-07-15|1961-11-21|||||1964-12-01||1971-10-31
TRIAL STUDY 134XCP|IS|FF8E387C-7596-4408-9B7F-5DF85EC62F2E||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/DL|||||ML/CM H2O||||LOW|NOT DONE|||URINE SEDIMENT|LACTESCENT|NA|SPECULAR MICROSCOPY|Y|NA|NA||5||7||RUN-IN|1964-02-17|1972-06-24|||||1961-06-23||1964-12-30
TRIAL STUDY 134XCP|IS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U.CARR|||||TUBERCULIN UNIT/ML||||LOW|NOT DONE|||ERYTHROCYTES|FROZEN|U|TRIPLE-PHASE MRI SCAN|NA|N|NA||1||38||TREATMENT|1967-09-27|1966-05-06|||||1972-03-04||1969-12-11
TRIAL STUDY 134XCP|IS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MSEC|||||10^6 ORGANISMS||||NORMAL|NOT DONE|||PUS|UNEXPECTED ODOR|NA|ENZYMATIC COLORIMETRY|NA|U|N||2||58||INDUCTION TREATMENT|1968-01-27|1970-02-09|||||1960-08-18||1963-08-23
TRIAL STUDY 134XCP|IS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/G|||||KM||||ABNORMAL|NOT DONE|||SOFT TISSUE|CALCIFIED|U|LIGHT MICROSCOPY|U|NA|Y||3||39||BLINDED TREATMENT|1962-07-01|1970-04-04|||||1965-10-13||1963-04-08
TRIAL STUDY 134XCP|IS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NKAT/L|||||FG||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|U|PERFUSION MRI|N|N|N||4||88||BASELINE|1972-05-13|1965-03-21|||||1970-10-17||1970-03-22
TRIAL STUDY 134XCP|IS|2276DCED-0CA7-4F0B-8FBF-5B6D50DE9585||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KCAL|||||CI/UG||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FROZEN|U|ZIEHL NEELSEN ACID FAST STAIN|Y|U|Y||5||7||FOLLOW-UP|1963-02-26|1965-11-30|||||1969-05-11||1962-02-21
TRIAL STUDY 134XCP|IS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/L|||||BQ/L||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|LACTESCENT|NA|RAJI CELL RIA|Y|Y|N||1||38||FOLLOW-UP|1967-11-16|1965-10-26|||||1961-09-19||1962-12-22
TRIAL STUDY 134XCP|IS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIPE|||||KM||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|CALCIFIED|Y|CALIPER MEASUREMENT METHOD|N|U|U||2||58||TREATMENT|1963-06-16|1960-08-15|||||1961-09-21||1965-12-10
TRIAL STUDY 134XCP|IS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/CM3/MIN|||||PELLET||||LOW|NOT DONE|||SMEGMA|DRIED|N|GC/FID|NA|U|U||3||39||WASHOUT|1964-04-09|1968-06-19|||||1973-08-06||1965-11-26
TRIAL STUDY 134XCP|IS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6/G|||||MCI/KG||||HIGH|NOT DONE|||URINE SEDIMENT|FRESH|N|MYELOPEROXIDASE STAIN|NA|Y|N||4||88||OBSERVATION|1961-03-30|1972-02-12|||||1960-04-20||1962-06-18
TRIAL STUDY 134XCP|IS|14CEF8E1-9A4F-4AC4-B452-410E24BC79EF||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NG/L|||||LOG10 CFU/ML||||LOW|NOT DONE|||TISSUE|UNEXPECTED ODOR|U|WHOLE EXOME SEQUENCING|N|N|Y||5||7||WASHOUT|1963-01-14|1966-03-26|||||1970-06-29||1968-06-27
TRIAL STUDY 134XCP|IS|0194CD2F-7ABE-4BEE-A6FC-61298880173D||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MS2|||||UMOL/KG/MIN||||HIGH|NOT DONE|||LOCHIA|CONTAMINATED|Y|KINYOUN STAIN|NA|Y|N||1||38||OBSERVATION|1961-03-21|1965-08-05|||||1969-01-07||1965-05-29
TRIAL STUDY 134XCP|IS|0194CD2F-7ABE-4BEE-A6FC-61298880173D||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6 COPIES/ML|||||IU/G||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|CONCENTRATED|Y|MS/MS|NA|U|NA||2||58||INDUCTION TREATMENT|1963-09-09|1969-07-01|||||1961-12-31||1961-12-07
TRIAL STUDY 134XCP|IS|0194CD2F-7ABE-4BEE-A6FC-61298880173D||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MGEQ|||||UG/DL||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|Y|THERMAL IONIZATION MASS SPECTROMETRY|Y|NA|U||3||39||SCREENING|1962-11-02|1966-12-29|||||1961-02-17||1973-01-04
TRIAL STUDY 134XCP|IS|0194CD2F-7ABE-4BEE-A6FC-61298880173D||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||OD UNIT|||||NKAT/L||||LOW|NOT DONE|||MONOCYTE|AUTOLYZED|Y|SPECT/CT SCAN|NA|N|N||4||88||CONTINUATION TREATMENT|1962-09-02|1968-09-06|||||1973-03-09||1969-04-21
TRIAL STUDY 134XCP|IS|0194CD2F-7ABE-4BEE-A6FC-61298880173D||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/M2/H|||||KIT||||LOW|NOT DONE|||LAVAGE FLUID|AGGLUTINATED|U|FLOW CYTOMETRY|NA|N|N||5||7||CONTINUATION TREATMENT|1968-06-12|1960-03-12|||||1970-07-28||1968-01-02
TRIAL STUDY 134XCP|IS|A6E531C7-1BC1-402E-9B2E-03B44313487B||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KIT|||||PPTH||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|NA|SCANNING ELECTRON MICROSCOPY|N|NA|NA||1||38||OPEN LABEL TREATMENT|1972-07-25|1969-02-26|||||1961-01-06||1963-06-12
TRIAL STUDY 134XCP|IS|A6E531C7-1BC1-402E-9B2E-03B44313487B||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TROCHE|||||STRIP||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|U|IODINE STAIN|Y|NA|Y||2||58||WASHOUT|1971-03-27|1966-12-14|||||1967-12-26||1969-01-19
TRIAL STUDY 134XCP|IS|A6E531C7-1BC1-402E-9B2E-03B44313487B||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NKAT/G HB|||||ML/KG/DAY||||NORMAL|NOT DONE|||SPERMATOZOON|FRESH|NA|EEG|U|U|U||3||39||LONG-TERM FOLLOW-UP|1970-11-10|1970-09-17|||||1972-07-11||1966-11-11
TRIAL STUDY 134XCP|IS|A6E531C7-1BC1-402E-9B2E-03B44313487B||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LOG10 ELISA UNIT/DOSE|||||DEG||||ABNORMAL|NOT DONE|||CELL PELLET|GELLED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|U|U|N||4||88||OPEN LABEL TREATMENT|1964-07-02|1972-11-26|||||1969-10-13||1962-11-07
TRIAL STUDY 134XCP|IS|A6E531C7-1BC1-402E-9B2E-03B44313487B||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MCI|||||MG/M2/MIN||||NORMAL|NOT DONE|||BUFFY COAT|CONTAMINATED|U|DYNAMIC LIGHT SCATTERING|NA|Y|Y||5||7||BASELINE|1971-03-28|1971-12-31|||||1967-09-16||1971-05-04
TRIAL STUDY 134XCP|IS|47C0D833-BEAB-4BF2-B028-891808E729F1||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ENZYME U|||||MEQ/UG||||HIGH|NOT DONE|||MUCUS|THAWED|N|ENZYMATIC COLORIMETRY|Y|N|Y||1||38||WASHOUT|1962-06-21|1969-09-14|||||1962-07-02||1965-02-16
TRIAL STUDY 134XCP|IS|47C0D833-BEAB-4BF2-B028-891808E729F1||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/KG/DAY|||||%(W/W)||||ABNORMAL|NOT DONE|||FLUID|CLOTTED|Y|HIGH RESOLUTION MELT ANALYSIS|NA|Y|U||2||58||LONG-TERM FOLLOW-UP|1971-12-25|1970-12-25|||||1966-04-06||1969-09-08
TRIAL STUDY 134XCP|IS|47C0D833-BEAB-4BF2-B028-891808E729F1||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CD/M2|||||MG/KG/H||||LOW|NOT DONE|||PLATELET POOR PLASMA|NON-HEMOLYZED|N|RIA|N|NA|U||3||39||WASHOUT|1966-08-13|1967-05-13|||||1973-01-04||1962-04-09
TRIAL STUDY 134XCP|IS|47C0D833-BEAB-4BF2-B028-891808E729F1||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI/G|||||YD||||ABNORMAL|NOT DONE|||NAIL|HEMOLYZED|U|ICP-MS|N|U|Y||4||88||OPEN LABEL TREATMENT|1972-10-14|1972-06-18|||||1963-04-25||1970-11-05
TRIAL STUDY 134XCP|IS|47C0D833-BEAB-4BF2-B028-891808E729F1||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||USIEMENS|||||IU||||LOW|NOT DONE|||GASTRIC CONTENTS|THAWED|NA|CELL OF ORIGIN ASSAY|NA|U|U||5||7||RUN-IN|1965-03-30|1963-04-26|||||1967-04-13||1966-07-26
TRIAL STUDY 134XCP|IS|BA1773BD-AA89-45FC-B7C6-C5267770B197||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CMH2O/ML|||||MCI||||NORMAL|NOT DONE|||VITREOUS HUMOR|HEMOLYZED|Y|SPECT/CT SCAN|U|NA|NA||1||38||FOLLOW-UP|1962-04-30|1970-12-02|||||1970-08-01||1969-12-10
TRIAL STUDY 134XCP|IS|BA1773BD-AA89-45FC-B7C6-C5267770B197||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KG/M2|||||CD/M2||||HIGH|NOT DONE|||SUPERNATANT, SERUM|AUTOLYZED|Y|SCANNING ELECTRON MICROSCOPY|NA|NA|NA||2||58||LONG-TERM FOLLOW-UP|1966-01-30|1969-02-09|||||1969-11-29||1962-02-17
TRIAL STUDY 134XCP|IS|BA1773BD-AA89-45FC-B7C6-C5267770B197||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||POUCH|||||UL||||NORMAL|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|U|FLUORIMETRY|Y|N|NA||3||39||WASHOUT|1961-02-22|1963-01-11|||||1960-06-30||1964-03-23
TRIAL STUDY 134XCP|IS|BA1773BD-AA89-45FC-B7C6-C5267770B197||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^8/L|||||PIXELS/IN||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|GELLED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|U|N||4||88||CONTINUATION TREATMENT|1966-09-12|1969-03-29|||||1962-06-24||1961-07-04
TRIAL STUDY 134XCP|IS|BA1773BD-AA89-45FC-B7C6-C5267770B197||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||SACHET|||||APL U/ML||||HIGH|NOT DONE|||MONOCYTE|ROOM TEMPERATURE|NA|NUCLEIC ACID SEQUENCING|NA|NA|U||5||7||CONTINUATION TREATMENT|1963-02-01|1964-10-06|||||1964-03-03||1964-04-24
TRIAL STUDY 134XCP|IS|03D3DDC6-03FA-469A-B8A4-D504919B68F1||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BOLUS|||||MEQ/UG||||LOW|NOT DONE|||URINE|FRESH|U|MAPH|N|U|NA||1||38||OBSERVATION|1968-04-23|1967-09-24|||||1972-03-02||1963-10-11
TRIAL STUDY 134XCP|IS|03D3DDC6-03FA-469A-B8A4-D504919B68F1||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 CFU/G|||||MEQ/G||||ABNORMAL|NOT DONE|||SEMEN|GELLED|Y|HPLC/IEX|NA|NA|Y||2||58||OBSERVATION|1967-03-23|1965-10-03|||||1971-09-26||1964-11-26
TRIAL STUDY 134XCP|IS|03D3DDC6-03FA-469A-B8A4-D504919B68F1||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/KG/MIN|||||CMH2O/ML||||LOW|NOT DONE|||INFRANATANT, SERUM|LIPEMIC|N|REFRACTOMETRY|NA|Y|Y||3||39||OPEN LABEL TREATMENT|1970-07-22|1970-09-28|||||1973-03-08||1972-10-21
TRIAL STUDY 134XCP|IS|03D3DDC6-03FA-469A-B8A4-D504919B68F1||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ABSORBANCE U/ML|||||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE|||SALIVA|REFRIGERATED|NA|SCANNING ELECTRON MICROSCOPY|N|Y|NA||4||88||CONTINUATION TREATMENT|1972-10-11|1972-05-25|||||1970-07-03||1964-05-12
TRIAL STUDY 134XCP|IS|03D3DDC6-03FA-469A-B8A4-D504919B68F1||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UL/DOSE|||||DIOPTER||||NORMAL|NOT DONE|||FLUID|LACTESCENT|Y|TRIPLE-PHASE SPIRAL CT SCAN|NA|U|N||5||7||LONG-TERM FOLLOW-UP|1966-08-18|1971-12-28|||||1964-11-15||1964-05-16
TRIAL STUDY 134XCP|IS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/KG/H|||||10^6 COPIES/ML||||LOW|NOT DONE|||LOCHIA|SOLIDIFIED|NA|WHOLE GENOME SEQUENCING|Y|Y|N||1||38||BASELINE|1960-05-15|1966-11-06|||||1971-04-25||1967-11-28
TRIAL STUDY 134XCP|IS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TITER|||||ML/ANIMAL/WK||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|CONCENTRATED|Y|HANSEL STAIN|NA|Y|Y||2||58||FOLLOW-UP|1960-01-24|1968-01-04|||||1963-12-10||1965-07-10
TRIAL STUDY 134XCP|IS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/KG|||||APL U||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|N|NA|NA||3||39||OBSERVATION|1964-11-19|1961-02-13|||||1966-10-02||1966-11-01
TRIAL STUDY 134XCP|IS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/(MIN*100ML)|||||MOSM/KG||||NORMAL|NOT DONE|||VENOUS PLASMA|CONCENTRATED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|Y|NA||4||88||LONG-TERM FOLLOW-UP|1969-07-01|1961-04-27|||||1967-02-24||1967-12-15
TRIAL STUDY 134XCP|IS|6AE1E2D2-C023-42DB-A906-39440CB6AAA8||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/200 HPFS|||||100 IU/ML||||ABNORMAL|NOT DONE|||NAIL|GELLED|Y|ROMANOWSKY STAIN|NA|Y|NA||5||7||BASELINE|1963-02-25|1965-11-28|||||1962-09-13||1964-05-19
TRIAL STUDY 134XCP|IS|1873D4CC-40B7-4303-9F07-8FE0E4595361||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TABLET|||||IU/DL||||ABNORMAL|NOT DONE|||GASTRIC FLUID|ICTERIC|Y|RADIOGRAPHY|N|N|N||1||38||RUN-IN|1972-04-22|1968-06-10|||||1968-03-09||1962-01-10
TRIAL STUDY 134XCP|IS|1873D4CC-40B7-4303-9F07-8FE0E4595361||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/10^12 RBC|||||MMHG/L/MIN||||HIGH|NOT DONE|||CELL PELLET|AGGLUTINATED|NA|CONTRAST ENHANCED CT SCAN|U|Y|N||2||58||OPEN LABEL TREATMENT|1960-11-13|1964-07-20|||||1964-01-02||1970-01-29
TRIAL STUDY 134XCP|IS|1873D4CC-40B7-4303-9F07-8FE0E4595361||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PG|||||UL/DOSE||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|U|Y|U||3||39||LONG-TERM FOLLOW-UP|1968-07-29|1961-01-18|||||1960-09-16||1967-09-12
TRIAL STUDY 134XCP|IS|1873D4CC-40B7-4303-9F07-8FE0E4595361||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CD|||||NEWTON||||ABNORMAL|NOT DONE|||CALCULUS|UNEXPECTED ODOR|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NA|N|U||4||88||OBSERVATION|1968-03-26|1966-10-28|||||1973-04-02||1967-05-25
TRIAL STUDY 134XCP|IS|1873D4CC-40B7-4303-9F07-8FE0E4595361||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MBP|||||PG/DL||||HIGH|NOT DONE|||INFRANATANT, SERUM|UNEXPECTED ODOR|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|NA|Y||5||7||SCREENING|1968-09-07|1967-12-27|||||1969-08-09||1973-08-03
TRIAL STUDY 134XCP|IS|23E5569E-B324-4399-AC8A-5EC7C343C1D3||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CMHG|||||KM||||LOW|NOT DONE|||MUCUS|FROZEN|NA|PHOTOMETRIC CLOT DETECTION|U|Y|N||1||38||BLINDED TREATMENT|1961-03-01|1960-05-01|||||1964-12-07||1971-11-20
TRIAL STUDY 134XCP|IS|23E5569E-B324-4399-AC8A-5EC7C343C1D3||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||USP U|||||ML/ANIMAL/DAY||||LOW|NOT DONE|||ISOLATE|CONCENTRATED|Y|TRYPAN BLUE STAIN|U|U|Y||2||58||RUN-IN|1961-02-04|1963-09-29|||||1971-04-25||1963-10-02
TRIAL STUDY 134XCP|IS|23E5569E-B324-4399-AC8A-5EC7C343C1D3||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 IU/ML|||||G/M2||||LOW|NOT DONE|||STOOL|REFRIGERATED|U|MICRO BROTH DILUTION|NA|Y|Y||3||39||INDUCTION TREATMENT|1966-01-10|1964-11-11|||||1962-08-21||1972-12-18
TRIAL STUDY 134XCP|IS|23E5569E-B324-4399-AC8A-5EC7C343C1D3||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/MOL|||||MS/MMHG||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|NA|MIGET|Y|NA|N||4||88||BASELINE|1970-07-14|1965-11-26|||||1963-06-02||1961-06-25
TRIAL STUDY 134XCP|IS|23E5569E-B324-4399-AC8A-5EC7C343C1D3||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/H/MMOL|||||NG/DAY||||ABNORMAL|NOT DONE|||SPUTUM|CONCENTRATED|U|RADIOIMMUNOPRECIPITATION ASSAY|U|N|Y||5||7||BLINDED TREATMENT|1962-04-21|1960-06-07|||||1967-01-10||1970-10-15
TRIAL STUDY 134XCP|IS|B349DD89-C41F-470E-8B54-B3589F0982FE||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NFIU|||||MOL/MOL||||HIGH|NOT DONE|||SERUM OR PLASMA OR BLOOD|CALCIFIED|N|GC/MS-CI|U|U|U||1||38||BASELINE|1972-11-12|1964-05-06|||||1960-11-25||1964-05-22
TRIAL STUDY 134XCP|IS|B349DD89-C41F-470E-8B54-B3589F0982FE||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MILE|||||APL U/ML||||NORMAL|NOT DONE|||LOCHIA|LIPEMIC|Y|CLINICAL EVALUATION|NA|U|Y||2||58||BASELINE|1968-03-15|1970-07-14|||||1969-05-01||1965-08-05
TRIAL STUDY 134XCP|IS|B349DD89-C41F-470E-8B54-B3589F0982FE||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CFU/G|||||UL/ML||||HIGH|NOT DONE|||CAPILLARY PLASMA|NON-HEMOLYZED|Y|BAC ACGH|Y|NA|NA||3||39||WASHOUT|1966-02-22|1970-06-14|||||1970-07-10||1973-07-01
TRIAL STUDY 134XCP|IS|B349DD89-C41F-470E-8B54-B3589F0982FE||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^9 CFU/ML|||||CCID 50/DOSE||||HIGH|NOT DONE|||URINE SEDIMENT|CALCIFIED|NA|LC/MS|Y|Y|NA||4||88||BASELINE|1963-02-14|1973-01-31|||||1969-10-15||1972-09-13
TRIAL STUDY 134XCP|IS|B349DD89-C41F-470E-8B54-B3589F0982FE||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MM2|||||AMP||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|AUTOLYZED|N|LASER CAPTURE MICRODISSECTION|Y|Y|NA||5||7||SCREENING|1961-12-26|1973-06-03|||||1964-03-06||1964-09-06
TRIAL STUDY 134XCP|IS|415D178A-275A-440C-8617-154441A48F8D||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ELISA UNIT|||||LOG10 PFU||||HIGH|NOT DONE|||VENOUS CORD BLOOD|CALCIFIED|U|ETDRS EYE CHART|U|U|Y||1||38||SCREENING|1973-05-27|1969-12-15|||||1961-08-07||1973-04-08
TRIAL STUDY 134XCP|IS|415D178A-275A-440C-8617-154441A48F8D||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOSM|||||FMOL/G||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONTAMINATED|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|NA|Y|N||2||58||BLINDED TREATMENT|1965-05-02|1973-01-27|||||1971-07-07||1968-07-27
TRIAL STUDY 134XCP|IS|415D178A-275A-440C-8617-154441A48F8D||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/CM2|||||ML/(MIN*100ML)||||LOW|NOT DONE|||BILE|GELLED|N|MEDIASTINOSCOPY|Y|Y|N||3||39||BASELINE|1962-03-17|1968-05-12|||||1972-01-15||1961-06-22
TRIAL STUDY 134XCP|IS|415D178A-275A-440C-8617-154441A48F8D||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TUBERCULIN UNIT/ML|||||VOXEL||||NORMAL|NOT DONE|||PLEURAL FLUID|FRESH|Y|PLAQUE REDUCTION NEUTRALIZATION ASSAY|NA|N|U||4||88||SCREENING|1960-09-22|1964-05-02|||||1971-01-23||1970-12-08
TRIAL STUDY 134XCP|IS|415D178A-275A-440C-8617-154441A48F8D||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^3 CFU/ML|||||UV||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|HEMOLYZED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|U|N|U||5||7||BLINDED TREATMENT|1968-05-29|1966-10-03|||||1965-02-15||1969-12-19
TRIAL STUDY 134XCP|IS|C23917E6-6CA5-4314-A59D-A0298483BF53||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM/SEC|||||VP/ML||||ABNORMAL|NOT DONE|||MECONIUM|FROZEN|U|PELLI-ROBSON EYE CHART|N|N|NA||1||38||BASELINE|1972-02-23|1966-05-22|||||1965-08-05||1971-09-02
TRIAL STUDY 134XCP|IS|C23917E6-6CA5-4314-A59D-A0298483BF53||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/DAY|||||/SEC||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|N|INCISION-INDUCED BLEEDING METHOD|N|Y|Y||2||58||FOLLOW-UP|1969-10-24|1960-01-20|||||1968-10-24||1962-06-25
TRIAL STUDY 134XCP|IS|C23917E6-6CA5-4314-A59D-A0298483BF53||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MCI|||||UV||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|AUTOLYZED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|N|N|N||3||39||BASELINE|1968-08-31|1973-07-23|||||1970-05-03||1964-01-11
TRIAL STUDY 134XCP|IS|C23917E6-6CA5-4314-A59D-A0298483BF53||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||HZ|||||NU/CL||||NORMAL|NOT DONE|||BONE MARROW|DRIED|NA|PHOTOMETRIC CLOT DETECTION|Y|Y|U||4||88||BLINDED TREATMENT|1961-12-09|1972-01-16|||||1962-04-28||1966-05-05
TRIAL STUDY 134XCP|IS|C23917E6-6CA5-4314-A59D-A0298483BF53||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||SIEMENS|||||KG/MOL||||ABNORMAL|NOT DONE|||SPERMATOZOON|FROZEN|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|U|N|NA||5||7||RUN-IN|1960-08-21|1973-05-08|||||1970-04-19||1965-03-27
TRIAL STUDY 134XCP|IS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMHG/SEC|||||AMPULE||||NORMAL|NOT DONE|||GASTRIC CONTENTS|GELLED|N|CORONARY ANGIOGRAPHY|NA|NA|N||1||38||SCREENING|1969-07-03|1962-02-14|||||1963-05-27||1962-09-02
TRIAL STUDY 134XCP|IS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CMH2O*S/ML|||||G/DL||||HIGH|NOT DONE|||EXUDATE|AGGLUTINATED|N|ETDRS EYE CHART|NA|NA|Y||2||58||WASHOUT|1969-09-15|1973-08-27|||||1969-11-28||1962-04-06
TRIAL STUDY 134XCP|IS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DIOPTER|||||ML/MMHG/MIN/L||||NORMAL|NOT DONE|||SEBUM|PARAFFIN-EMBEDDED|Y|IMMUNORADIOMETRIC ASSAY|Y|U|NA||3||39||OBSERVATION|1971-06-11|1969-05-18|||||1961-01-16||1970-05-01
TRIAL STUDY 134XCP|IS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FMOL/G|||||G/DAY||||HIGH|NOT DONE|||CALCULUS|THAWED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|U|N||4||88||TREATMENT|1969-02-16|1967-12-08|||||1972-01-27||1960-12-30
TRIAL STUDY 134XCP|IS|4F449A9E-D7BA-47D4-A4D8-5A39E698F51E||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/M2/DAY|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||SOFT TISSUE|LACTESCENT|U|MAGNETIC RESONANCE ELASTOGRAPHY|NA|N|N||5||7||OPEN LABEL TREATMENT|1965-06-25|1966-05-21|||||1971-05-06||1966-10-06
TRIAL STUDY 134XCP|IS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FMOL/L|||||MEQ/G||||NORMAL|NOT DONE|||MONOCYTE|AUTOLYZED|Y|SEQUENCING|U|U|N||1||38||TREATMENT|1962-04-07|1960-10-15|||||1968-04-13||1966-12-07
TRIAL STUDY 134XCP|IS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||AMU|||||MMU/ML||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|NA|SLOAN LETTER EYE CHART 2.5%|NA|N|U||2||58||BASELINE|1971-01-09|1967-10-26|||||1961-08-18||1971-07-03
TRIAL STUDY 134XCP|IS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/MM|||||MMU/ML||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|CONTAMINATED|Y|AUDIOMETRY|N|N|NA||3||39||BASELINE|1962-08-22|1968-09-01|||||1969-03-26||1972-10-31
TRIAL STUDY 134XCP|IS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||L/MIN|||||NCI||||HIGH|NOT DONE|||ERYTHROCYTES|CALCIFIED|NA|HPLC-FL|NA|NA|U||4||88||OBSERVATION|1973-06-20|1963-12-20|||||1963-02-22||1962-06-05
TRIAL STUDY 134XCP|IS|4AB3006A-5B82-4841-800F-D2D6DFCA0DD2||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MOSM/L|||||ML/KG/H||||LOW|NOT DONE|||BUFFY COAT|CONTAMINATED|U|TRIPLE-PHASE SPIRAL CT SCAN|Y|N|U||5||7||INDUCTION TREATMENT|1963-11-28|1960-01-11|||||1968-08-08||1968-12-20
TRIAL STUDY 134XCP|IS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PRESSOR UNITS|||||ROENTGEN||||NORMAL|NOT DONE|||ISOLATE|DRIED|U|FLUOROSCOPY|N|U|U||1||38||OPEN LABEL TREATMENT|1968-09-16|1972-10-31|||||1962-05-30||1972-10-11
TRIAL STUDY 134XCP|IS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BAU/ML|||||ABSORBANCE U/MIN||||NORMAL|NOT DONE|||LUNG SURFACTANT|LIPEMIC|Y|MEDIASTINOSCOPY|U|Y|NA||2||58||WASHOUT|1970-10-18|1962-11-06|||||1965-08-25||1970-01-26
TRIAL STUDY 134XCP|IS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/M2/MIN|||||WATT||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|HEMOLYZED|U|JAFFE REACTION|U|U|Y||3||39||RUN-IN|1965-08-16|1967-09-20|||||1963-10-21||1960-10-14
TRIAL STUDY 134XCP|IS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/KG/H|||||COPIES/UL||||HIGH|NOT DONE|||PROSTATIC FLUID|GELLED|N|ULTRASOUND|NA|U|N||4||88||WASHOUT|1965-11-05|1963-10-04|||||1962-08-03||1962-09-26
TRIAL STUDY 134XCP|IS|95EFAA78-A1BB-40D0-8A6D-B0EF20332820||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||OD UNIT|||||PIXELS/CM||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|Y|DIGITAL PCR|N|N|Y||5||7||FOLLOW-UP|1963-01-16|1970-02-07|||||1972-12-06||1961-12-15
TRIAL STUDY 134XCP|IS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UM|||||PFU/ML||||LOW|NOT DONE|||ARTERIAL BLOOD|CONCENTRATED|Y|ENZYMATIC COLORIMETRY|NA|Y|Y||1||38||WASHOUT|1962-06-18|1967-03-03|||||1963-05-14||1963-06-04
TRIAL STUDY 134XCP|IS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 ORGANISMS/G|||||UG/KG/MIN||||NORMAL|NOT DONE|||PUS|LIPEMIC|Y|IODINE STAIN|U|U|Y||2||58||WASHOUT|1967-12-05|1966-10-18|||||1960-06-07||1970-06-02
TRIAL STUDY 134XCP|IS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GPL U/ML|||||UG/M2||||HIGH|NOT DONE|||EMESIS|THAWED|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|U|NA|NA||3||39||OBSERVATION|1963-06-24|1967-12-15|||||1963-05-03||1971-09-16
TRIAL STUDY 134XCP|IS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MU|||||L/DAY||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|NA|DYNAMIC CONTRAST ENHANCED MRI|N|Y|U||4||88||WASHOUT|1968-07-02|1973-08-11|||||1961-03-08||1966-10-28
TRIAL STUDY 134XCP|IS|9E60B53A-37D9-45AE-AC8B-F3B049617CDF||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||RNA COPIES/ML|||||KBQ/UL||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|NA|COMPLEMENT FIXATION|N|Y|N||5||7||RUN-IN|1962-09-19|1963-09-11|||||1972-04-24||1960-08-28
TRIAL STUDY 134XCP|IS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||L/S/KPA|||||IU/DAY||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|LACTESCENT|Y|ICC|N|NA|NA||1||38||RUN-IN|1961-08-30|1961-03-10|||||1964-10-23||1969-02-26
TRIAL STUDY 134XCP|IS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UKAT/L|||||10^9 CFU||||HIGH|NOT DONE|||EMESIS|PARAFFIN-EMBEDDED|U|CORONARY ANGIOGRAPHY|Y|NA|N||2||58||FOLLOW-UP|1968-02-07|1973-08-24|||||1967-02-24||1972-01-10
TRIAL STUDY 134XCP|IS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PIPE|||||UCI||||ABNORMAL|NOT DONE|||BASAL TEAR|SOLIDIFIED|NA|IHC|NA|U|NA||3||39||RUN-IN|1965-05-29|1966-04-21|||||1965-09-11||1966-06-07
TRIAL STUDY 134XCP|IS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PELLET|||||ML/M2/H||||HIGH|NOT DONE|||SERUM OR PLASMA|CONTAMINATED|U|RADIAL IMMUNODIFFUSION|N|U|N||4||88||INDUCTION TREATMENT|1966-07-13|1971-09-28|||||1968-12-07||1960-07-07
TRIAL STUDY 134XCP|IS|94DD5640-E6E6-47FA-A91B-D84E330EDCC6||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GMFI|||||MEQ||||HIGH|NOT DONE|||LAVAGE FLUID|HEMOLYZED|U|OPTICAL DENSITY MEASUREMENT|Y|N|U||5||7||BLINDED TREATMENT|1970-05-24|1966-01-10|||||1962-12-13||1963-10-30
TRIAL STUDY 134XCP|IS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PKAT|||||MU||||LOW|NOT DONE|||VENOUS CORD BLOOD|SOLIDIFIED|NA|AGAR DILUTION|N|U|Y||1||38||BLINDED TREATMENT|1961-11-14|1960-10-10|||||1969-08-03||1969-04-19
TRIAL STUDY 134XCP|IS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/KG/DAY|||||MG2/DL2||||ABNORMAL|NOT DONE|||TISSUE|FRESH|NA|ICP-MS|N|Y|Y||2||58||RUN-IN|1973-07-06|1965-10-24|||||1971-04-24||1962-03-28
TRIAL STUDY 134XCP|IS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/MMHG|||||CMH2O*S/ML||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|THAWED|N|DYNAMIC LIGHT SCATTERING|U|U|N||3||39||LONG-TERM FOLLOW-UP|1971-02-13|1969-03-15|||||1969-03-03||1964-02-05
TRIAL STUDY 134XCP|IS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/DAY|||||MG/M2||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|CONCENTRATED|NA|SPECT SCAN|U|NA|NA||4||88||TREATMENT|1969-05-04|1967-09-04|||||1968-02-22||1969-02-08
TRIAL STUDY 134XCP|IS|5F1262FB-AAA2-4F2F-BF2B-F72527AFA115||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TUBE|||||G/G/DAY||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|CALCIFIED|N|REBOUND TONOMETRY|U|Y|U||5||7||BLINDED TREATMENT|1960-10-11|1970-07-21|||||1962-09-05||1966-08-09
TRIAL STUDY 134XCP|IS|EDB6B55B-7903-4F89-805C-32F067C2A230||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MEQ/MMOL|||||UM/S||||HIGH|NOT DONE|||GASTRIC CONTENTS|ROOM TEMPERATURE|Y|DYNAMOMETRY|Y|U|U||1||38||FOLLOW-UP|1962-10-29|1963-11-06|||||1962-06-06||1960-01-03
TRIAL STUDY 134XCP|IS|EDB6B55B-7903-4F89-805C-32F067C2A230||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMAL|||||RPM||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|U|ULTRASOUND|Y|U|N||2||58||TREATMENT|1960-08-01|1973-03-23|||||1971-07-12||1966-07-03
TRIAL STUDY 134XCP|IS|EDB6B55B-7903-4F89-805C-32F067C2A230||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MEQ/DAY|||||ML/DL||||LOW|NOT DONE|||PUS|AUTOLYZED|N|FLUOROSCOPY|NA|N|Y||3||39||OBSERVATION|1964-10-25|1960-08-23|||||1967-11-21||1972-05-28
TRIAL STUDY 134XCP|IS|EDB6B55B-7903-4F89-805C-32F067C2A230||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||M2|||||H/WK||||LOW|NOT DONE|||SEBUM|LACTESCENT|NA|BALLPOINT PEN TECHNIQUE|U|N|NA||4||88||BLINDED TREATMENT|1969-01-29|1962-04-12|||||1965-06-18||1972-08-29
TRIAL STUDY 134XCP|IS|EDB6B55B-7903-4F89-805C-32F067C2A230||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MANSON U/ML|||||SUPPOSITORY||||LOW|NOT DONE|||RETICULOCYTES|LIPEMIC|NA|PULSE OXIMETRY|U|U|NA||5||7||BLINDED TREATMENT|1968-01-27|1972-07-24|||||1973-07-19||1960-10-09
TRIAL STUDY 134XCP|IS|8F6772DE-E4CA-4706-8754-740D3859ABDF||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/KG/DAY|||||FMOL/G||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|SOLIDIFIED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|NA|N||1||38||CONTINUATION TREATMENT|1960-06-07|1969-02-08|||||1962-08-30||1972-10-30
TRIAL STUDY 134XCP|IS|8F6772DE-E4CA-4706-8754-740D3859ABDF||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPL U/ML|||||ML/CM||||ABNORMAL|NOT DONE|||URINE|LACTESCENT|Y|SLOAN LETTER EYE CHART 1.25%|Y|Y|U||2||58||INDUCTION TREATMENT|1964-01-12|1966-10-13|||||1966-03-24||1965-10-25
TRIAL STUDY 134XCP|IS|8F6772DE-E4CA-4706-8754-740D3859ABDF||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||TBSP|||||GRAVITATIONAL UNIT||||NORMAL|NOT DONE|||LYSATE|PARAFFIN-EMBEDDED|U|X-RAY|U|N|NA||3||39||BLINDED TREATMENT|1968-12-27|1962-05-07|||||1960-09-16||1970-04-15
TRIAL STUDY 134XCP|IS|8F6772DE-E4CA-4706-8754-740D3859ABDF||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS|||||CYLINDER||||HIGH|NOT DONE|||LUNG SURFACTANT|DRIED|NA|MULTIPLE BREATH WASHOUT|N|NA|N||4||88||LONG-TERM FOLLOW-UP|1964-03-24|1972-12-27|||||1969-06-21||1964-12-20
TRIAL STUDY 134XCP|IS|8F6772DE-E4CA-4706-8754-740D3859ABDF||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PIXELS/CM|||||10^4 CFU||||ABNORMAL|NOT DONE|||VENOUS PLASMA|FROZEN|Y|ISHIHARA COLOR PLATES|U|NA|Y||5||7||OBSERVATION|1961-08-07|1970-06-15|||||1961-07-11||1961-04-23
TRIAL STUDY 134XCP|IS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PG|||||NG||||ABNORMAL|NOT DONE|||SEMINAL FLUID|UNEXPECTED ODOR|U|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|N|Y|NA||1||38||OBSERVATION|1966-03-05|1967-05-04|||||1971-11-12||1964-03-03
TRIAL STUDY 134XCP|IS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/MIN|||||MG/ML/DAY||||HIGH|NOT DONE|||DIALYSIS FLUID, PERITONEAL|CONTAMINATED|NA|LISSAMINE GREEN STAIN|Y|N|N||2||58||INDUCTION TREATMENT|1962-08-03|1970-05-11|||||1966-08-05||1969-01-17
TRIAL STUDY 134XCP|IS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LB|||||MEQ/MMOL||||NORMAL|NOT DONE|||SEMINAL FLUID|CLOTTED|NA|CONTRAST ENHANCED CT SCAN|NA|Y|Y||3||39||CONTINUATION TREATMENT|1962-05-31|1962-12-25|||||1969-11-17||1964-04-27
TRIAL STUDY 134XCP|IS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ANTI-XA IU|||||% INHIBITION||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|THAWED|NA|SPECT/CT SCAN|Y|Y|Y||4||88||OBSERVATION|1960-04-10|1970-09-29|||||1971-12-25||1964-01-28
TRIAL STUDY 134XCP|IS|FE7829C8-7961-4169-B5DD-9DD94B8EF0CD||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/KG/MIN|||||U/G/H||||LOW|NOT DONE|||ABSCESS FLUID|CALCIFIED|U|LASER CAPTURE MICRODISSECTION|Y|NA|NA||5||7||WASHOUT|1968-08-29|1968-12-19|||||1969-03-16||1969-04-21
TRIAL STUDY 134XCP|IS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SV|||||LOG10 PFU/ML||||HIGH|NOT DONE|||LAVAGE FLUID|DRIED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|U|U|Y||1||38||LONG-TERM FOLLOW-UP|1969-02-17|1960-12-16|||||1971-05-06||1963-10-19
TRIAL STUDY 134XCP|IS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||STEPS/MIN|||||U/CL||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|NON-HEMOLYZED|U|ZIEHL NEELSEN ACID FAST STAIN|Y|Y|Y||2||58||OPEN LABEL TREATMENT|1964-03-29|1972-12-22|||||1967-10-30||1961-10-03
TRIAL STUDY 134XCP|IS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||COAT|||||PNU/ML||||LOW|NOT DONE|||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|N|NA|NA||3||39||RUN-IN|1961-09-12|1969-04-13|||||1963-06-29||1967-10-29
TRIAL STUDY 134XCP|IS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PIXEL|||||TRANSDUCING UNIT/ML||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|DRIED|Y|SPECULAR MICROSCOPY|U|N|Y||4||88||BLINDED TREATMENT|1972-12-14|1970-04-06|||||1961-10-27||1963-07-17
TRIAL STUDY 134XCP|IS|D1DEBD72-05CA-4F47-8727-73C44D6A3EFB||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KG/CM2|||||PPM||||LOW|NOT DONE|||MUCUS|CONTAMINATED|U|CONTACT SPECULAR MICROSCOPY|Y|N|N||5||7||FOLLOW-UP|1965-11-20|1968-10-30|||||1962-09-21||1972-09-09
TRIAL STUDY 134XCP|IS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IN|||||UG/MOL||||NORMAL|NOT DONE|||LOCHIA|CONCENTRATED|N|SINGLE-SLICE SPIRAL CT|U|Y|NA||1||38||WASHOUT|1965-05-08|1960-06-15|||||1971-09-05||1968-03-08
TRIAL STUDY 134XCP|IS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/MG|||||ML/G/MIN||||HIGH|NOT DONE|||BASAL TEAR|DRIED|NA|FLOCCULATION, CHARCOAL ENHANCED|N|Y|U||2||58||WASHOUT|1962-07-23|1964-10-17|||||1965-05-30||1972-03-10
TRIAL STUDY 134XCP|IS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OI50|||||L/DAY||||LOW|NOT DONE|||ARTERIAL BLOOD|SOLIDIFIED|Y|SPECTROPHOTOMETRY|U|U|N||3||39||LONG-TERM FOLLOW-UP|1967-06-07|1960-12-20|||||1962-01-15||1972-08-18
TRIAL STUDY 134XCP|IS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 CFU/ML|||||UV||||NORMAL|NOT DONE|||TUMOR TISSUE|LACTESCENT|U|TEST STRIP|NA|U|U||4||88||RUN-IN|1965-12-15|1967-04-27|||||1966-02-06||1969-02-16
TRIAL STUDY 134XCP|IS|0FF48C06-03EA-47DA-84D1-3FA28D5D39D7||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BREATHS/MIN|||||BAG||||NORMAL|NOT DONE|||SOFT TISSUE|SOLIDIFIED|U|ALCIAN BLUE STAIN|Y|U|Y||5||7||TREATMENT|1961-01-27|1968-02-24|||||1964-11-06||1969-08-21
TRIAL STUDY 134XCP|IS|B3987A78-0D92-419D-A289-039C87C6C202||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LM|||||10^9/L||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|DRIED|Y|X-RAY|N|N|U||1||38||FOLLOW-UP|1970-12-12|1961-12-28|||||1969-04-17||1970-07-23
TRIAL STUDY 134XCP|IS|B3987A78-0D92-419D-A289-039C87C6C202||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DNA COPIES/ML|||||10^10/L||||HIGH|NOT DONE|||CORD SERUM|CONCENTRATED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|U|N|Y||2||58||RUN-IN|1967-08-16|1965-04-16|||||1970-03-28||1971-09-24
TRIAL STUDY 134XCP|IS|B3987A78-0D92-419D-A289-039C87C6C202||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/G/MIN|||||MMOL/S||||ABNORMAL|NOT DONE|||BLOOD|ICTERIC|NA|PHOTOGRAPHY|N|Y|N||3||39||OPEN LABEL TREATMENT|1968-05-27|1961-05-18|||||1960-11-13||1964-11-14
TRIAL STUDY 134XCP|IS|B3987A78-0D92-419D-A289-039C87C6C202||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BQ/MG|||||10^3 CFU/G||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|DRIED|U|PLETHYSMOGRAPHY|U|NA|Y||4||88||LONG-TERM FOLLOW-UP|1961-02-23|1972-11-17|||||1963-07-21||1970-03-30
TRIAL STUDY 134XCP|IS|B3987A78-0D92-419D-A289-039C87C6C202||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VP/ML|||||FMOL||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|U|PULMONARY ANGIOGRAPHY|NA|NA|U||5||7||LONG-TERM FOLLOW-UP|1965-04-02|1968-01-30|||||1971-10-07||1963-10-19
TRIAL STUDY 134XCP|IS|2A0D27D8-EC46-4B40-B1BB-078268E03355||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^7 PFU|||||10^3 COPIES/ML||||LOW|NOT DONE|||SMEGMA|CLOTTED|N|ANGIOGRAPHY|N|Y|N||1||38||CONTINUATION TREATMENT|1968-11-18|1970-09-04|||||1966-07-18||1963-03-31
TRIAL STUDY 134XCP|IS|2A0D27D8-EC46-4B40-B1BB-078268E03355||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MIN*MG/ML|||||CI/G||||NORMAL|NOT DONE|||NAIL|CONCENTRATED|U|CRYOSCOPY|Y|N|N||2||58||LONG-TERM FOLLOW-UP|1967-10-02|1962-07-06|||||1965-03-22||1960-02-02
TRIAL STUDY 134XCP|IS|2A0D27D8-EC46-4B40-B1BB-078268E03355||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||EQ|||||10^6 U||||HIGH|NOT DONE|||CAPILLARY BLOOD|LACTESCENT|NA|WRIGHT STAIN|NA|Y|U||3||39||RUN-IN|1961-08-09|1973-01-27|||||1962-02-24||1962-05-03
TRIAL STUDY 134XCP|IS|2A0D27D8-EC46-4B40-B1BB-078268E03355||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/ANIMAL/DAY|||||/2000 RBC||||LOW|NOT DONE|||EPITHELIAL CELL|CLOTTED|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NA|NA|U||4||88||BLINDED TREATMENT|1969-05-25|1970-09-16|||||1967-06-19||1971-06-04
TRIAL STUDY 134XCP|IS|2A0D27D8-EC46-4B40-B1BB-078268E03355||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BAG|||||NMOL BCE/L||||ABNORMAL|NOT DONE|||KERATINOCYTE|AGGLUTINATED|NA|POPULATION SEQUENCING|NA|NA|NA||5||7||SCREENING|1962-12-09|1960-04-02|||||1972-11-07||1967-06-24
TRIAL STUDY 134XCP|IS|65EBB2AF-B97A-403A-9FB5-31C1559074C4||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE/WK|||||KHZ||||NORMAL|NOT DONE|||AMNIOTIC FLUID|CLOTTED|Y|FLUORIMETRY|U|NA|NA||1||38||BLINDED TREATMENT|1967-09-24|1966-10-31|||||1972-04-24||1960-12-01
TRIAL STUDY 134XCP|IS|65EBB2AF-B97A-403A-9FB5-31C1559074C4||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NG|||||FRAMES/S||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|AGGLUTINATED|Y|KINYOUN STAIN|N|NA|U||2||58||CONTINUATION TREATMENT|1962-02-01|1964-04-18|||||1970-10-17||1962-04-01
TRIAL STUDY 134XCP|IS|65EBB2AF-B97A-403A-9FB5-31C1559074C4||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PSI|||||G/ANIMAL||||ABNORMAL|NOT DONE|||CALCULUS|HEMOLYZED|NA|ELECTROCHEMILUMINESCENCE|N|Y|Y||3||39||FOLLOW-UP|1966-03-15|1967-11-21|||||1966-08-13||1972-09-02
TRIAL STUDY 134XCP|IS|65EBB2AF-B97A-403A-9FB5-31C1559074C4||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CI/G|||||DAYS||||ABNORMAL|NOT DONE|||CALCULUS|ICTERIC|NA|ULTRASOUND|Y|Y|N||4||88||CONTINUATION TREATMENT|1964-05-05|1972-12-05|||||1973-06-25||1967-06-07
TRIAL STUDY 134XCP|IS|65EBB2AF-B97A-403A-9FB5-31C1559074C4||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 DNA COPIES/ML|||||GBQ/MG||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|ICTERIC|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NA|N|NA||5||7||TREATMENT|1972-09-25|1960-02-19|||||1969-11-28||1967-01-10
TRIAL STUDY 134XCP|IS|90892428-99C3-4E7D-B3A8-3C526812EDD2||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||M/SEC2|||||CMH2O/ML||||ABNORMAL|NOT DONE|||ERYTHROCYTES|ICTERIC|NA|MULTIPLE BREATH WASHOUT|NA|NA|NA||1||38||TREATMENT|1964-07-31|1968-11-28|||||1965-05-15||1972-09-27
TRIAL STUDY 134XCP|IS|90892428-99C3-4E7D-B3A8-3C526812EDD2||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MU/G|||||FMOL/L/SEC||||LOW|NOT DONE|||MUCUS|FROZEN|U|FISH|NA|NA|N||2||58||CONTINUATION TREATMENT|1960-06-29|1966-01-23|||||1966-04-08||1962-12-03
TRIAL STUDY 134XCP|IS|90892428-99C3-4E7D-B3A8-3C526812EDD2||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IU/MMOL|||||BQ/UG||||ABNORMAL|NOT DONE|||SERUM|DRIED|NA|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|U|U||3||39||OPEN LABEL TREATMENT|1964-03-17|1970-07-08|||||1968-03-10||1961-07-03
TRIAL STUDY 134XCP|IS|90892428-99C3-4E7D-B3A8-3C526812EDD2||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MILE|||||ENZYME U/L||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|LIPEMIC|NA|LIGHT MICROSCOPY|U|NA|NA||4||88||BASELINE|1973-03-15|1971-12-11|||||1965-03-28||1969-07-05
TRIAL STUDY 134XCP|IS|90892428-99C3-4E7D-B3A8-3C526812EDD2||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6/G|||||U/M2/MIN||||NORMAL|NOT DONE|||SPERMATOZOON|REFRIGERATED|N|STATIC PERIMETRY|N|U|N||5||7||LONG-TERM FOLLOW-UP|1961-08-29|1971-10-28|||||1961-07-05||1969-10-17
TRIAL STUDY 134XCP|IS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/LSQN|||||MG/DOSE||||NORMAL|NOT DONE|||VENOUS PLASMA|LACTESCENT|NA|EEG|U|N|Y||1||38||CONTINUATION TREATMENT|1965-09-07|1970-03-09|||||1973-03-28||1968-01-12
TRIAL STUDY 134XCP|IS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LINEAR FT*LB|||||MG/G/H||||NORMAL|NOT DONE|||EXPIRED AIR|AUTOLYZED|Y|CYSTOSCOPY|NA|NA|U||2||58||LONG-TERM FOLLOW-UP|1972-05-29|1965-07-08|||||1970-05-03||1968-04-11
TRIAL STUDY 134XCP|IS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||IU|||||NGEQ/L||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|AGGLUTINATED|U|ELECTROMYOGRAPHY|Y|U|Y||3||39||OBSERVATION|1964-12-10|1972-12-15|||||1962-05-26||1963-02-10
TRIAL STUDY 134XCP|IS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GBQ/UG|||||KS||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|U|N|N||4||88||OBSERVATION|1964-10-04|1973-06-05|||||1961-03-18||1966-09-13
TRIAL STUDY 134XCP|IS|4B99A0CB-4DEA-4C46-8B01-FCC0BED015FF||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MOSM/KG|||||NMOL/DAY||||ABNORMAL|NOT DONE|||PUS|FRESH|N|PHOTOMETRY|N|NA|Y||5||7||BASELINE|1968-03-06|1969-02-24|||||1970-03-21||1964-12-23
TRIAL STUDY 134XCP|IS|2B443EEA-B98B-47D9-8D27-801582804AB5||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CFU/ML|||||ANTI-XA IU/ML||||NORMAL|NOT DONE|||ABSCESS FLUID|FRESH|N|HIGH RESOLUTION CT|N|U|U||1||38||INDUCTION TREATMENT|1968-05-09|1966-10-17|||||1968-09-10||1965-10-27
TRIAL STUDY 134XCP|IS|2B443EEA-B98B-47D9-8D27-801582804AB5||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/DL|||||FL||||ABNORMAL|NOT DONE|||PLEURAL FLUID|THAWED|NA|SCANNING ELECTRON MICROSCOPY|N|U|U||2||58||RUN-IN|1962-11-29|1971-04-26|||||1963-02-21||1973-04-24
TRIAL STUDY 134XCP|IS|2B443EEA-B98B-47D9-8D27-801582804AB5||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||RNA COPIES/ML|||||PSEC||||HIGH|NOT DONE|||EMOTIONAL TEAR|PARAFFIN-EMBEDDED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|NA|U|Y||3||39||LONG-TERM FOLLOW-UP|1971-08-30|1969-04-22|||||1965-11-28||1969-12-01
TRIAL STUDY 134XCP|IS|2B443EEA-B98B-47D9-8D27-801582804AB5||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||INHALATION|||||MEQ||||NORMAL|NOT DONE|||SERUM OR PLASMA|SOLIDIFIED|NA|PYROSEQUENCING|NA|N|Y||4||88||FOLLOW-UP|1962-02-16|1963-06-15|||||1967-11-03||1969-04-08
TRIAL STUDY 134XCP|IS|2B443EEA-B98B-47D9-8D27-801582804AB5||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SHOCK WAVE|||||IU/KG||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|LIPEMIC|N|DIFFUSION WEIGHTED MRI|NA|U|U||5||7||RUN-IN|1960-03-03|1964-10-16|||||1966-09-25||1968-05-27
TRIAL STUDY 134XCP|IS|0278D57A-30D6-4B7A-A45C-EB973F6686C6||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN/1.73M2|||||MG/L FEU||||LOW|NOT DONE|||ENDOMETRIAL TISSUE|PARAFFIN-EMBEDDED|NA|CORONARY ANGIOGRAPHY|NA|NA|Y||1||38||OBSERVATION|1973-01-29|1973-07-23|||||1968-12-31||1962-08-18
TRIAL STUDY 134XCP|IS|0278D57A-30D6-4B7A-A45C-EB973F6686C6||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MCI/L|||||CY/CM||||LOW|NOT DONE|||VITREOUS HUMOR|NON-HEMOLYZED|NA|CRYOSCOPY|N|N|U||2||58||RUN-IN|1968-12-20|1963-09-18|||||1966-05-10||1965-06-06
TRIAL STUDY 134XCP|IS|0278D57A-30D6-4B7A-A45C-EB973F6686C6||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/M2|||||UIU/L||||HIGH|NOT DONE|||SEMEN|SOLIDIFIED|U|MEDIASTINOSCOPY|U|Y|N||3||39||BASELINE|1960-07-10|1971-10-11|||||1967-01-09||1973-05-03
TRIAL STUDY 134XCP|IS|0278D57A-30D6-4B7A-A45C-EB973F6686C6||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||MOSM/L||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|U|FLOW MICROSCOPY|N|N|N||4||88||FOLLOW-UP|1964-11-05|1968-09-07|||||1964-02-10||1973-03-22
TRIAL STUDY 134XCP|IS|0278D57A-30D6-4B7A-A45C-EB973F6686C6||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/L/SEC|||||HOUNSFIELD UNIT||||HIGH|NOT DONE|||SPUTUM|HEMOLYZED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|N|NA||5||7||INDUCTION TREATMENT|1968-05-28|1962-01-01|||||1963-08-15||1969-10-04
TRIAL STUDY 134XCP|IS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PT_US|||||UMOL/L||||HIGH|NOT DONE|||SKIN TISSUE|LIPEMIC|N|PERIPHERAL ANGIOGRAPHY|N|Y|NA||1||38||INDUCTION TREATMENT|1967-01-11|1963-07-11|||||1964-09-27||1965-05-23
TRIAL STUDY 134XCP|IS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/WEEK|||||10^9/G||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|Y|ENDOSCOPY|U|NA|Y||2||58||BASELINE|1968-07-13|1968-11-17|||||1969-11-18||1960-12-04
TRIAL STUDY 134XCP|IS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NL|||||ML/SEC/1.73M2||||LOW|NOT DONE|||HAIR FOLLICLE|AGGLUTINATED|NA|AUDIOMETRY|N|U|U||3||39||OBSERVATION|1964-12-28|1972-04-14|||||1971-07-31||1967-10-14
TRIAL STUDY 134XCP|IS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||OI50|||||BE/ML||||NORMAL|NOT DONE|||PLEURAL FLUID|FRESH|N|POLYMERASE CHAIN REACTION|N|Y|U||4||88||OBSERVATION|1965-09-07|1963-06-05|||||1963-07-25||1967-09-13
TRIAL STUDY 134XCP|IS|2FE6BF52-4EA8-4AAE-865C-22BA7CD26BF6||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/L/MIN|||||USP U||||ABNORMAL|NOT DONE|||CELL PELLET|NON-HEMOLYZED|NA|RULER MEASUREMENT METHOD|NA|U|NA||5||7||FOLLOW-UP|1965-06-08|1970-05-18|||||1965-05-21||1961-07-11
TRIAL STUDY 134XCP|IS|67D6A191-10C7-4414-BA63-DB7701998DF0||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||C|||||FT||||LOW|NOT DONE|||ADIPOSE TISSUE|UNEXPECTED ODOR|NA|AGAR DILUTION|Y|NA|NA||1||38||TREATMENT|1964-02-01|1970-09-12|||||1971-05-11||1962-05-11
TRIAL STUDY 134XCP|IS|67D6A191-10C7-4414-BA63-DB7701998DF0||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/CM2|||||ARBITRARY U||||HIGH|NOT DONE|||MENSTRUAL BLOOD|FROZEN|Y|MALDI-TOF|NA|N|NA||2||58||SCREENING|1972-05-08|1972-09-29|||||1964-02-08||1968-09-07
TRIAL STUDY 134XCP|IS|67D6A191-10C7-4414-BA63-DB7701998DF0||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NKAT|||||U/M2/DAY||||HIGH|NOT DONE|||PLATELET POOR PLASMA|UNEXPECTED ODOR|NA|INFRARED SPECTROMETRY|U|Y|U||3||39||LONG-TERM FOLLOW-UP|1961-03-12|1972-07-28|||||1971-06-11||1962-10-08
TRIAL STUDY 134XCP|IS|67D6A191-10C7-4414-BA63-DB7701998DF0||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/KG|||||DAMOL/L||||LOW|NOT DONE|||MUCUS|AGGLUTINATED|U|SCINTIGRAPHY|U|U|N||4||88||CONTINUATION TREATMENT|1968-06-09|1964-04-22|||||1960-07-01||1967-03-21
TRIAL STUDY 134XCP|IS|67D6A191-10C7-4414-BA63-DB7701998DF0||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ANTI-XA IU/ML|||||TESLA||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|CLOTTED|N|IVY INCISION METHOD|N|N|U||5||7||BASELINE|1961-07-10|1966-08-16|||||1965-09-19||1964-09-25
TRIAL STUDY 134XCP|IS|499B5A47-893A-40DE-9B64-60967378C81A||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/DOSE|||||NMOL||||NORMAL|NOT DONE|||SYNOVIAL FLUID|SOLIDIFIED|Y|FLAME PHOTOMETRY|U|Y|Y||1||38||BLINDED TREATMENT|1961-08-07|1961-02-28|||||1964-10-25||1962-11-30
TRIAL STUDY 134XCP|IS|499B5A47-893A-40DE-9B64-60967378C81A||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PFU/ANIMAL|||||DRINK||||ABNORMAL|NOT DONE|||NAIL|ICTERIC|U|ECHOCARDIOGRAPHY|U|NA|U||2||58||OBSERVATION|1973-08-10|1960-05-20|||||1964-11-09||1969-01-30
TRIAL STUDY 134XCP|IS|499B5A47-893A-40DE-9B64-60967378C81A||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMHG/SEC|||||/MS||||HIGH|NOT DONE|||TRANSUDATE|CONTAMINATED|Y|PHOTOGRAPHY|U|NA|NA||3||39||SCREENING|1970-07-21|1965-06-21|||||1970-02-28||1969-02-05
TRIAL STUDY 134XCP|IS|499B5A47-893A-40DE-9B64-60967378C81A||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MU/G|||||CAPFUL||||ABNORMAL|NOT DONE|||CERUMEN|ICTERIC|NA|PHOTOMETRIC CLOT DETECTION|N|U|Y||4||88||OPEN LABEL TREATMENT|1965-12-05|1972-02-14|||||1971-04-18||1967-05-29
TRIAL STUDY 134XCP|IS|499B5A47-893A-40DE-9B64-60967378C81A||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NG|||||BQ/L||||LOW|NOT DONE|||MONOCYTE|CALCIFIED|U|SLOAN LETTER EYE CHART 2.5%|Y|NA|NA||5||7||OBSERVATION|1969-03-29|1967-12-22|||||1973-07-20||1965-08-24
TRIAL STUDY 134XCP|IS|984103CA-F301-4510-A9DD-4916FA858EA2||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CMHG|||||U/KG/MIN||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|CONCENTRATED|U|LASER CAPTURE MICRODISSECTION|N|U|NA||1||38||BLINDED TREATMENT|1972-08-12|1969-11-15|||||1967-03-21||1965-02-06
TRIAL STUDY 134XCP|IS|984103CA-F301-4510-A9DD-4916FA858EA2||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BOWL|||||PNU/ML||||LOW|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|GELLED|N|SICKLE CELL SOLUBILITY TEST|U|N|NA||2||58||CONTINUATION TREATMENT|1970-03-01|1967-03-04|||||1960-02-03||1969-02-25
TRIAL STUDY 134XCP|IS|984103CA-F301-4510-A9DD-4916FA858EA2||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BAU/ML|||||LOG10 ELISA UNIT/DOSE||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|AUTOLYZED|Y|ALCIAN BLUE STAIN|U|N|Y||3||39||WASHOUT|1971-03-08|1960-06-11|||||1965-04-30||1968-06-28
TRIAL STUDY 134XCP|IS|984103CA-F301-4510-A9DD-4916FA858EA2||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U|||||MNFI||||HIGH|NOT DONE|||SPUTUM|CALCIFIED|NA|SINGLE-MOLECULE ARRAY|NA|N|U||4||88||SCREENING|1965-03-21|1960-09-09|||||1970-06-12||1967-09-07
TRIAL STUDY 134XCP|IS|984103CA-F301-4510-A9DD-4916FA858EA2||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT/G HB|||||G/U||||HIGH|NOT DONE|||COLOSTRUM|UNEXPECTED ODOR|N|SCANNING ELECTRON MICROSCOPY|NA|U|Y||5||7||RUN-IN|1970-01-18|1968-09-06|||||1973-04-16||1967-02-25
TRIAL STUDY 134XCP|IS|50E626B3-9133-4A50-8907-2388DAC22AD1||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CP|||||BU||||NORMAL|NOT DONE|||SKIN TISSUE|UNEXPECTED ODOR|NA|FLUORESCENT ENZYME IMMUNOASSAY|NA|N|U||1||38||OPEN LABEL TREATMENT|1962-05-09|1961-01-03|||||1966-01-21||1967-08-10
TRIAL STUDY 134XCP|IS|50E626B3-9133-4A50-8907-2388DAC22AD1||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DL|||||ELISA UNIT/ML||||ABNORMAL|NOT DONE|||STOOL|UNEXPECTED ODOR|N|SPIRAL CT SCAN WITHOUT CONTRAST|Y|NA|U||2||58||CONTINUATION TREATMENT|1963-01-25|1968-09-07|||||1970-11-01||1966-01-18
TRIAL STUDY 134XCP|IS|50E626B3-9133-4A50-8907-2388DAC22AD1||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG10 IU/ML|||||DAMOL/L||||NORMAL|NOT DONE|||INFRANATANT, SERUM|REFRIGERATED|N|LC/MS/MS|U|N|NA||3||39||BLINDED TREATMENT|1970-06-20|1973-06-12|||||1967-03-23||1962-07-09
TRIAL STUDY 134XCP|IS|50E626B3-9133-4A50-8907-2388DAC22AD1||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PMOL|||||OSM||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|LACTESCENT|Y|IMMUNOFIXATION ELECTROPHORESIS|NA|NA|NA||4||88||RUN-IN|1961-10-24|1962-06-15|||||1962-06-30||1960-09-10
TRIAL STUDY 134XCP|IS|50E626B3-9133-4A50-8907-2388DAC22AD1||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PMOL|||||RATIO||||HIGH|NOT DONE|||URINE|ICTERIC|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|N|U|N||5||7||LONG-TERM FOLLOW-UP|1969-10-25|1960-03-14|||||1961-07-22||1962-07-13
TRIAL STUDY 134XCP|IS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||RFU|||||AFU||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|NA|REFLECTANCE SPECTROSCOPY|U|U|N||1||38||INDUCTION TREATMENT|1968-09-30|1971-10-24|||||1969-01-09||1971-05-10
TRIAL STUDY 134XCP|IS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BU|||||/MONTH||||NORMAL|NOT DONE|||MUSCLE TISSUE|FRESH|N|DNA MICROARRAY|N|N|N||2||58||INDUCTION TREATMENT|1969-08-19|1973-05-06|||||1967-07-14||1969-04-12
TRIAL STUDY 134XCP|IS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||APL U|||||U/M2||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|DRIED|N|REVERSE TRANSCRIPTASE PCR|NA|N|Y||3||39||OPEN LABEL TREATMENT|1962-07-01|1972-05-20|||||1963-01-20||1968-01-05
TRIAL STUDY 134XCP|IS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KG/CM|||||DRAM||||ABNORMAL|NOT DONE|||LYSATE|LACTESCENT|U|PEAK FLOWMETRY|NA|N|NA||4||88||WASHOUT|1963-05-15|1971-12-18|||||1968-03-21||1971-05-14
TRIAL STUDY 134XCP|IS|C20A4F0A-7E0A-4A53-A47D-ECFB5062FB21||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UM/S|||||10^6 U||||ABNORMAL|NOT DONE|||KERATINOCYTE|THAWED|Y|VIRUS PLAQUE ASSAY|NA|Y|N||5||7||CONTINUATION TREATMENT|1961-06-18|1968-11-28|||||1963-05-10||1963-09-15
TRIAL STUDY 134XCP|IS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/M2/MIN|||||TITER||||LOW|NOT DONE|||HAIR FOLLICLE|FRESH|Y|SPECTROPHOTOMETRY|NA|N|Y||1||38||WASHOUT|1962-09-30|1971-01-16|||||1973-01-26||1965-09-25
TRIAL STUDY 134XCP|IS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||USP U|||||/DAY||||ABNORMAL|NOT DONE|||PLASMA|AUTOLYZED|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|NA|NA|N||2||58||LONG-TERM FOLLOW-UP|1965-11-18|1960-06-24|||||1961-03-25||1967-01-17
TRIAL STUDY 134XCP|IS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 CFU|||||BLOCKS||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|HEMOLYZED|NA|INDIRECT IMMUNOFLUORESCENCE|U|U|Y||3||39||CONTINUATION TREATMENT|1965-11-07|1968-03-15|||||1968-01-16||1971-08-30
TRIAL STUDY 134XCP|IS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/M2/H|||||AG||||HIGH|NOT DONE|||EPITHELIAL CELL|CONCENTRATED|U|FLUORESCENT MICROSCOPY|NA|U|U||4||88||OBSERVATION|1965-01-18|1967-07-26|||||1971-05-12||1973-06-11
TRIAL STUDY 134XCP|IS|4D0E7297-DA42-4819-8D28-979D3D3BE1A0||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UV2|||||S*KPA||||ABNORMAL|NOT DONE|||LAVAGE FLUID|FRESH|Y|MIGET|Y|Y|N||5||7||LONG-TERM FOLLOW-UP|1961-06-17|1967-08-20|||||1966-06-04||1972-09-23
TRIAL STUDY 134XCP|IS|F8F17A43-A74B-4570-8A06-D7657A4636B4||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CONTAINER|||||OI50||||NORMAL|NOT DONE|||SYNOVIAL FLUID|AGGLUTINATED|N|IHC|NA|U|N||1||38||LONG-TERM FOLLOW-UP|1972-07-31|1973-03-22|||||1961-07-02||1973-05-09
TRIAL STUDY 134XCP|IS|F8F17A43-A74B-4570-8A06-D7657A4636B4||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||VIRTUAL PIXEL|||||MCI/KG||||ABNORMAL|NOT DONE|||BUFFY COAT|FRESH|Y|CRYOSCOPY|NA|NA|U||2||58||INDUCTION TREATMENT|1961-02-12|1961-10-03|||||1969-03-03||1962-04-02
TRIAL STUDY 134XCP|IS|F8F17A43-A74B-4570-8A06-D7657A4636B4||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||L/DAY|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||RETICULOCYTES|NON-HEMOLYZED|U|POLYMERASE CHAIN REACTION|NA|N|NA||3||39||FOLLOW-UP|1969-05-08|1960-03-14|||||1972-04-24||1960-11-07
TRIAL STUDY 134XCP|IS|F8F17A43-A74B-4570-8A06-D7657A4636B4||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^3/L|||||POINT||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|NA|WHOLE GENOME SEQUENCING|NA|N|Y||4||88||OPEN LABEL TREATMENT|1967-05-16|1971-03-22|||||1966-08-29||1972-05-03
TRIAL STUDY 134XCP|IS|F8F17A43-A74B-4570-8A06-D7657A4636B4||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANTI-XA IU/ML|||||IU/G||||LOW|NOT DONE|||PLATELET|GELLED|Y|MAMMOGRAPHY|NA|NA|NA||5||7||SCREENING|1960-11-07|1961-03-24|||||1967-02-17||1971-03-10
TRIAL STUDY 134XCP|IS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PMOL/10^9 CELLS|||||DNA COPIES/ML||||HIGH|NOT DONE|||SUPERNATANT, SERUM|REFRIGERATED|U|HPLC|U|N|Y||1||38||OPEN LABEL TREATMENT|1969-08-15|1962-05-12|||||1964-12-16||1964-01-12
TRIAL STUDY 134XCP|IS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||OI50|||||G||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|FROZEN|U|X-RAY FLUORESCENCE SPECTROMETRY|Y|U|NA||2||58||SCREENING|1964-09-29|1966-11-04|||||1968-10-21||1970-10-02
TRIAL STUDY 134XCP|IS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UMOL/L/MIN|||||U/MMOL||||LOW|NOT DONE|||VENOUS BLOOD|LACTESCENT|Y|PUPILLOMETRY|NA|Y|U||3||39||LONG-TERM FOLLOW-UP|1972-12-09|1962-05-25|||||1960-03-17||1964-02-28
TRIAL STUDY 134XCP|IS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FG|||||U/ANIMAL||||LOW|NOT DONE|||GASTRIC CONTENTS|FROZEN|U|CELL BASED BIOASSAY|Y|N|NA||4||88||RUN-IN|1963-01-28|1967-07-07|||||1965-09-01||1973-02-19
TRIAL STUDY 134XCP|IS|37EDE304-7A3A-4CC4-BD04-FD36EA27BF74||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U.CARR|||||10^3 DNA COPIES/ML||||LOW|NOT DONE|||DERMAL TISSUE|DRIED|U|IMMUNODIFFUSION|Y|N|Y||5||7||TREATMENT|1961-02-11|1960-11-21|||||1965-04-27||1973-01-14
TRIAL STUDY 134XCP|IS|1177FD36-AAE8-4139-991A-A8C98B607565||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KPA|||||MANSON U/ML||||HIGH|NOT DONE|||SOFT TISSUE|GELLED|Y|IMMUNOASSAY|N|Y|U||1||38||INDUCTION TREATMENT|1962-03-25|1965-11-15|||||1964-11-12||1966-04-24
TRIAL STUDY 134XCP|IS|1177FD36-AAE8-4139-991A-A8C98B607565||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BOTTLE|||||DB||||LOW|NOT DONE|||SEBUM|SOLIDIFIED|U|REFRACTOMETRY|N|U|NA||2||58||LONG-TERM FOLLOW-UP|1966-02-19|1965-08-20|||||1971-04-29||1962-02-20
TRIAL STUDY 134XCP|IS|1177FD36-AAE8-4139-991A-A8C98B607565||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/M2/DAY|||||CUP EQ||||ABNORMAL|NOT DONE|||SEMINAL FLUID|LIPEMIC|Y|SANGER SEQUENCING|NA|N|NA||3||39||BASELINE|1963-09-27|1965-06-27|||||1972-10-10||1969-06-21
TRIAL STUDY 134XCP|IS|1177FD36-AAE8-4139-991A-A8C98B607565||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||POINT|||||HEP||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|N|MICROBIAL CONCENTRATION|NA|U|N||4||88||OBSERVATION|1971-01-30|1971-02-16|||||1963-03-12||1963-01-13
TRIAL STUDY 134XCP|IS|1177FD36-AAE8-4139-991A-A8C98B607565||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GPL U/ML|||||KCAL/DAY||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|DRIED|N|FLUORESCENT MICROSCOPY|N|Y|NA||5||7||RUN-IN|1965-07-18|1967-02-11|||||1961-02-24||1961-11-04
TRIAL STUDY 134XCP|IS|8C57F469-7CDF-493A-9839-C179D912A8A5||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UKAT/10^12 RBC|||||JDF UNIT||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|HEMOLYZED|N|POLYGRAPHY|U|NA|Y||1||38||WASHOUT|1972-01-29|1962-01-21|||||1962-10-06||1968-03-23
TRIAL STUDY 134XCP|IS|8C57F469-7CDF-493A-9839-C179D912A8A5||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MILE|||||CCID 50/ML||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|CONTAMINATED|U|ELECTRONEUROGRAPHY|NA|U|NA||2||58||OPEN LABEL TREATMENT|1971-05-04|1966-01-25|||||1970-02-27||1964-11-25
TRIAL STUDY 134XCP|IS|8C57F469-7CDF-493A-9839-C179D912A8A5||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||G|||||/2500 WBC||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|SOLIDIFIED|NA|MOUSE PROTECTION ASSAY|Y|NA|N||3||39||OBSERVATION|1969-09-21|1965-02-27|||||1967-10-05||1962-09-05
TRIAL STUDY 134XCP|IS|8C57F469-7CDF-493A-9839-C179D912A8A5||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/DOSE|||||MEQ/DL||||ABNORMAL|NOT DONE|||PLASMA|AUTOLYZED|NA|TRICHROME STAIN|N|NA|N||4||88||INDUCTION TREATMENT|1969-08-02|1970-12-17|||||1968-05-16||1965-09-14
TRIAL STUDY 134XCP|IS|8C57F469-7CDF-493A-9839-C179D912A8A5||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||COPIES/ML|||||CIGAR||||ABNORMAL|NOT DONE|||REFLEX TEAR|CALCIFIED|N|CELLULAR PROLIFERATION ASSAY|N|N|N||5||7||LONG-TERM FOLLOW-UP|1966-03-12|1968-01-14|||||1968-08-09||1971-02-14
TRIAL STUDY 134XCP|IS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FG|||||PPTH||||LOW|NOT DONE|||BILE|HEMOLYZED|N|ERGOSPIROMETRY|N|NA|U||1||38||OBSERVATION|1971-01-26|1964-05-21|||||1973-07-02||1961-12-16
TRIAL STUDY 134XCP|IS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/G/H|||||DL||||HIGH|NOT DONE|||LEUKOCYTE|DRIED|NA|POLYGRAPHY|N|NA|N||2||58||BLINDED TREATMENT|1962-10-12|1967-02-04|||||1966-01-12||1972-07-16
TRIAL STUDY 134XCP|IS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/M2/H|||||LOG EID 50/DOSE||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|SOLIDIFIED|N|MICROBIAL CONCENTRATION|N|N|NA||3||39||FOLLOW-UP|1960-07-22|1961-07-17|||||1965-06-30||1960-10-21
TRIAL STUDY 134XCP|IS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||AMOL|||||UKAT/10^12 RBC||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|PATHOLOGICAL EVALUATION|Y|U|U||4||88||WASHOUT|1966-09-30|1965-11-18|||||1970-03-09||1969-10-26
TRIAL STUDY 134XCP|IS|8F3EA8B7-0A0B-45DE-AF82-4DD335C40FE0||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||USEC|||||OD UNIT||||LOW|NOT DONE|||PROSTATIC FLUID|ICTERIC|NA|DARK FIELD MICROSCOPY|N|NA|U||5||7||BASELINE|1972-01-21|1969-04-26|||||1964-03-13||1960-11-19
TRIAL STUDY 134XCP|IS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BAG|||||10^3/HPF||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|N|NA|N||1||38||WASHOUT|1962-03-17|1972-07-07|||||1961-07-03||1960-09-25
TRIAL STUDY 134XCP|IS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6/EJACULATE U|||||CS||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|CALCIFIED|Y|OBSERVATION|U|NA|U||2||58||FOLLOW-UP|1963-05-19|1964-05-13|||||1968-06-20||1961-10-14
TRIAL STUDY 134XCP|IS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PPB|||||DEG||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|U|TONOMETRY|U|U|N||3||39||OBSERVATION|1968-04-07|1960-02-16|||||1961-11-29||1966-10-03
TRIAL STUDY 134XCP|IS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MCI/L|||||ML/S/M2||||NORMAL|NOT DONE|||ADIPOSE TISSUE|REFRIGERATED|Y|MAGNETIC RESONANCE ENTEROGRAPHY|NA|U|N||4||88||WASHOUT|1964-08-26|1963-06-27|||||1961-01-27||1972-07-02
TRIAL STUDY 134XCP|IS|CAFEA1D3-8DB8-4CDE-89BF-FA604EE2AF9A||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KCAL|||||OD UNIT||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|THAWED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NA|U|NA||5||7||CONTINUATION TREATMENT|1960-09-11|1969-09-21|||||1970-02-28||1967-07-21
TRIAL STUDY 134XCP|IS|0AE36450-F37E-4F97-A250-79166011FCD7||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL|||||DEG2||||ABNORMAL|NOT DONE|||BILE|AGGLUTINATED|U|SECONDARY ION MASS SPECTOMETRY|Y|U|Y||1||38||FOLLOW-UP|1970-05-16|1972-12-03|||||1962-09-07||1964-10-23
TRIAL STUDY 134XCP|IS|0AE36450-F37E-4F97-A250-79166011FCD7||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMHG|||||C||||LOW|NOT DONE|||MIXED VENOUS BLOOD|AGGLUTINATED|U|CALIPER MEASUREMENT METHOD|N|N|NA||2||58||INDUCTION TREATMENT|1968-11-09|1960-03-25|||||1972-11-11||1964-05-07
TRIAL STUDY 134XCP|IS|0AE36450-F37E-4F97-A250-79166011FCD7||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BEATS/MIN|||||G/G/DAY||||HIGH|NOT DONE|||GASTRIC FLUID|FRESH|NA|CONTACT SPECULAR MICROSCOPY|N|N|Y||3||39||LONG-TERM FOLLOW-UP|1968-04-01|1970-12-02|||||1962-04-09||1963-08-26
TRIAL STUDY 134XCP|IS|0AE36450-F37E-4F97-A250-79166011FCD7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/ANIMAL|||||ML/MMHG||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|SOLIDIFIED|U|AUTOREFRACTION|Y|U|N||4||88||FOLLOW-UP|1966-01-12|1963-05-28|||||1966-10-07||1970-11-29
TRIAL STUDY 134XCP|IS|0AE36450-F37E-4F97-A250-79166011FCD7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||GMFI|||||G/M2||||HIGH|NOT DONE|||BILE|GELLED|Y|SLOAN LETTER EYE CHART 2.5%|N|U|NA||5||7||LONG-TERM FOLLOW-UP|1969-04-30|1962-12-10|||||1961-05-16||1972-12-27
TRIAL STUDY 134XCP|IS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NG/MOL|||||MIN||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|FROZEN|U|AUTOREFRACTION|Y|Y|Y||1||38||TREATMENT|1972-02-19|1965-07-09|||||1969-04-06||1970-06-07
TRIAL STUDY 134XCP|IS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MAC50|||||ML/G/MIN||||HIGH|NOT DONE|||DERMAL TISSUE|PARAFFIN-EMBEDDED|Y|RAJI CELL EIA|Y|NA|U||2||58||INDUCTION TREATMENT|1966-12-04|1967-12-05|||||1972-11-08||1972-11-29
TRIAL STUDY 134XCP|IS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DEG2|||||IU/G HB||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|LIPEMIC|N|CLAUSS METHOD|Y|Y|NA||3||39||OBSERVATION|1972-05-07|1968-02-09|||||1964-11-13||1966-03-26
TRIAL STUDY 134XCP|IS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/ML/H|||||PMOL||||NORMAL|NOT DONE|||CALCULUS|CONTAMINATED|N|ANALYTICAL ULTRACENTRIFUGATION|N|U|Y||4||88||CONTINUATION TREATMENT|1971-06-07|1966-09-28|||||1964-02-18||1968-09-09
TRIAL STUDY 134XCP|IS|8D5230FF-DE90-48E7-8CE2-F9B0ED562098||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BQ/L|||||/200 HPFS||||NORMAL|NOT DONE|||LEUKOCYTE|CONCENTRATED|Y|SPECT/CT SCAN|Y|Y|N||5||7||FOLLOW-UP|1972-06-03|1971-08-23|||||1966-11-28||1963-12-03
TRIAL STUDY 134XCP|IS|707FC46F-B8B1-456B-9E09-CABC86EA61D5||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NKAT/L|||||MM/2H||||NORMAL|NOT DONE|||SKIN TISSUE|CONCENTRATED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|Y||1||38||FOLLOW-UP|1966-04-27|1960-10-13|||||1964-12-21||1972-07-04
TRIAL STUDY 134XCP|IS|707FC46F-B8B1-456B-9E09-CABC86EA61D5||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U/ANIMAL|||||MET||||LOW|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|N|COLORIMETRY|NA|U|Y||2||58||CONTINUATION TREATMENT|1962-09-27|1962-07-24|||||1969-11-02||1972-07-07
TRIAL STUDY 134XCP|IS|707FC46F-B8B1-456B-9E09-CABC86EA61D5||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L/S|||||FT||||LOW|NOT DONE|||MUSCLE TISSUE|DRIED|U|MRI WITHOUT CONTRAST|Y|NA|Y||3||39||FOLLOW-UP|1970-06-20|1972-11-09|||||1964-04-07||1960-04-01
TRIAL STUDY 134XCP|IS|707FC46F-B8B1-456B-9E09-CABC86EA61D5||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM2|||||10^7 TCID 50/DOSE||||NORMAL|NOT DONE|||BLOOD|NON-HEMOLYZED|Y|NON-INVASIVE DIELECTRIC SENSING|NA|N|N||4||88||BLINDED TREATMENT|1962-03-18|1960-04-29|||||1973-03-14||1970-02-18
TRIAL STUDY 134XCP|IS|707FC46F-B8B1-456B-9E09-CABC86EA61D5||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SQU/ML|||||SEC||||NORMAL|NOT DONE|||EXUDATE|LACTESCENT|Y|DC SHEATH FLOW|NA|Y|NA||5||7||FOLLOW-UP|1970-01-30|1962-08-12|||||1967-03-15||1964-01-19
TRIAL STUDY 134XCP|IS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/MMOL|||||10^4/L||||LOW|NOT DONE|||FLUID|GELLED|U|POLYGRAPHY|N|N|Y||1||38||WASHOUT|1965-06-13|1965-12-23|||||1973-06-24||1963-08-17
TRIAL STUDY 134XCP|IS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UM/DAY|||||MG/MIN||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|LIPEMIC|NA|EEG|Y|NA|NA||2||58||BLINDED TREATMENT|1970-03-17|1965-06-08|||||1960-06-21||1967-05-09
TRIAL STUDY 134XCP|IS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/L|||||10^9 ORGANISMS||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|ICTERIC|U|TOLUIDINE BLUE STAIN|N|N|U||3||39||OBSERVATION|1970-08-27|1973-05-02|||||1960-09-03||1966-07-29
TRIAL STUDY 134XCP|IS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMOL/KG|||||CI/UL||||ABNORMAL|NOT DONE|||INFRANATANT, SERUM|FRESH|Y|THICK SMEAR|U|U|NA||4||88||CONTINUATION TREATMENT|1968-02-06|1960-06-09|||||1969-01-26||1967-04-20
TRIAL STUDY 134XCP|IS|E9745E48-1B55-49C6-9AB6-5EF7CC950C9F||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CIGAR|||||MG/G/H||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|Y|TOTAL BODY IRRADIATION|Y|NA|U||5||7||BASELINE|1963-07-24|1964-05-20|||||1964-09-25||1967-11-09
TRIAL STUDY 134XCP|IS|70196099-5D40-4048-AABF-EB40CE345328||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/DL|||||CMH2O*S/ML||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|SOLIDIFIED|NA|SCANNING ELECTRON MICROSCOPY|Y|NA|Y||1||38||WASHOUT|1961-12-01|1969-11-30|||||1971-10-21||1966-01-28
TRIAL STUDY 134XCP|IS|70196099-5D40-4048-AABF-EB40CE345328||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CONTAINER|||||CUP||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|CLOTTED|NA|NUCLEAR RADIOLOGY|Y|N|N||2||58||CONTINUATION TREATMENT|1971-05-23|1960-09-04|||||1961-05-06||1961-05-16
TRIAL STUDY 134XCP|IS|70196099-5D40-4048-AABF-EB40CE345328||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/CM2|||||U/KG/H||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|CONTAMINATED|NA|TRANSMISSION ELECTRON MICROSCOPY|Y|N|NA||3||39||RUN-IN|1967-07-28|1963-05-28|||||1968-12-14||1962-06-30
TRIAL STUDY 134XCP|IS|70196099-5D40-4048-AABF-EB40CE345328||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPS U|||||FRAMES/S||||ABNORMAL|NOT DONE|||CORD BLOOD|LACTESCENT|Y|WEBER GREEN STAIN|N|Y|N||4||88||BLINDED TREATMENT|1971-12-29|1961-04-12|||||1965-12-10||1970-09-15
TRIAL STUDY 134XCP|IS|70196099-5D40-4048-AABF-EB40CE345328||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/MBP|||||TITER||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|GELLED|N|CONTRAST ENHANCED MRI|N|Y|NA||5||7||BLINDED TREATMENT|1961-09-04|1970-05-26|||||1967-11-12||1965-09-07
TRIAL STUDY 134XCP|IS|F9D4C544-F217-4676-AC40-F71CC48045AF||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||VIRTUAL PIXEL|||||SQU/ML||||LOW|NOT DONE|||DIALYSIS FLUID|CONCENTRATED|NA|BAC ACGH|N|N|Y||1||38||SCREENING|1961-08-05|1971-12-13|||||1971-01-01||1972-08-19
TRIAL STUDY 134XCP|IS|F9D4C544-F217-4676-AC40-F71CC48045AF||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KG/L|||||CI/ML||||NORMAL|NOT DONE|||CORD SERUM|CONTAMINATED|Y|CORONARY ANGIOGRAPHY|U|U|U||2||58||LONG-TERM FOLLOW-UP|1970-06-28|1972-01-23|||||1967-08-04||1962-03-27
TRIAL STUDY 134XCP|IS|F9D4C544-F217-4676-AC40-F71CC48045AF||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NG|||||CI/MG||||NORMAL|NOT DONE|||BASAL TEAR|LIPEMIC|N|PERFUSION MRI|NA|N|NA||3||39||BLINDED TREATMENT|1960-03-08|1969-08-10|||||1967-03-10||1965-08-01
TRIAL STUDY 134XCP|IS|F9D4C544-F217-4676-AC40-F71CC48045AF||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GBQ/G|||||GENEQ/ML||||NORMAL|NOT DONE|||CELL PELLET|FRESH|N|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|NA|U||4||88||FOLLOW-UP|1961-06-15|1968-06-08|||||1965-07-14||1963-06-30
TRIAL STUDY 134XCP|IS|F9D4C544-F217-4676-AC40-F71CC48045AF||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/M2/MIN|||||UMOL/H/MMOL||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|CLOTTED|Y|INDIRECT IMMUNOFLUORESCENCE|Y|N|U||5||7||CONTINUATION TREATMENT|1966-05-12|1967-12-26|||||1966-12-30||1970-04-24
TRIAL STUDY 134XCP|IS|E6A42133-B082-4BD7-B840-A60E49E0562B||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/L/H|||||COAT||||HIGH|NOT DONE|||VITREOUS HUMOR|DRIED|Y|AUTOMATED COUNT|U|N|Y||1||38||TREATMENT|1964-07-20|1960-08-16|||||1966-04-22||1965-07-01
TRIAL STUDY 134XCP|IS|E6A42133-B082-4BD7-B840-A60E49E0562B||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NG/DAY|||||MAC50||||LOW|NOT DONE|||PLEURAL FLUID|HEMOLYZED|NA|PHASE-CONTRAST MRI|U|U|U||2||58||SCREENING|1971-05-31|1965-10-23|||||1960-07-22||1972-06-18
TRIAL STUDY 134XCP|IS|E6A42133-B082-4BD7-B840-A60E49E0562B||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MPL U/ML|||||MMAL||||NORMAL|NOT DONE|||SOFT TISSUE|AGGLUTINATED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|N|U|U||3||39||OPEN LABEL TREATMENT|1969-11-11|1970-05-27|||||1962-12-15||1961-12-20
TRIAL STUDY 134XCP|IS|E6A42133-B082-4BD7-B840-A60E49E0562B||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||HOURS|||||L/DAY||||ABNORMAL|NOT DONE|||LYMPH|AGGLUTINATED|Y|PERIPHERAL ANGIOGRAPHY|NA|NA|Y||4||88||OPEN LABEL TREATMENT|1970-07-12|1965-02-15|||||1962-07-28||1970-01-01
TRIAL STUDY 134XCP|IS|E6A42133-B082-4BD7-B840-A60E49E0562B||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/DAY|||||BQ/L||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|REFRIGERATED|NA|ELECTROCHEMILUMINESCENCE|Y|N|N||5||7||RUN-IN|1967-08-05|1968-01-01|||||1967-04-15||1964-04-01
TRIAL STUDY 134XCP|IS|72C9FDBC-AA86-4001-9820-90AAF5422074||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UU/L|||||10^9 CFU||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|LIPEMIC|NA|HEMAGGLUTINATION INHIBITION ASSAY|N|NA|N||1||38||OPEN LABEL TREATMENT|1962-12-25|1973-02-25|||||1962-01-11||1962-04-22
TRIAL STUDY 134XCP|IS|72C9FDBC-AA86-4001-9820-90AAF5422074||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/M2/MIN|||||OI50||||HIGH|NOT DONE|||SPERMATOZOON|GELLED|U|TRICHROME STAIN|U|U|U||2||58||BASELINE|1967-08-23|1971-12-09|||||1967-03-02||1966-07-17
TRIAL STUDY 134XCP|IS|72C9FDBC-AA86-4001-9820-90AAF5422074||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||F|||||CI/L||||LOW|NOT DONE|||DISCHARGE|DRIED|U|FLOCCULATION|N|N|N||3||39||INDUCTION TREATMENT|1966-08-27|1960-08-25|||||1963-02-06||1964-03-05
TRIAL STUDY 134XCP|IS|72C9FDBC-AA86-4001-9820-90AAF5422074||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CI/L|||||U/G/H||||ABNORMAL|NOT DONE|||URINE|AUTOLYZED|U|CONTRAST ENHANCED SPIRAL CT SCAN|NA|NA|NA||4||88||RUN-IN|1968-10-20|1961-02-11|||||1971-01-08||1967-03-01
TRIAL STUDY 134XCP|IS|72C9FDBC-AA86-4001-9820-90AAF5422074||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DNA COPIES/UG|||||KM||||ABNORMAL|NOT DONE|||URINE SEDIMENT|ICTERIC|U|POLYGRAPHY|N|NA|Y||5||7||WASHOUT|1961-03-21|1970-02-02|||||1962-11-26||1962-02-08
TRIAL STUDY 134XCP|IS|186520B9-8AAD-4063-B48F-16040EF49944||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG/CM2|||||MG/M2/H||||NORMAL|NOT DONE|||HAIR FOLLICLE|CONTAMINATED|U|FLUORESCENT MICROSCOPY|NA|NA|Y||1||38||RUN-IN|1969-08-02|1967-08-02|||||1965-01-20||1966-12-14
TRIAL STUDY 134XCP|IS|186520B9-8AAD-4063-B48F-16040EF49944||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KEV|||||PKAT||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|N|SECONDARY ION MASS SPECTOMETRY|U|Y|N||2||58||SCREENING|1961-09-16|1971-11-29|||||1967-08-03||1968-04-09
TRIAL STUDY 134XCP|IS|186520B9-8AAD-4063-B48F-16040EF49944||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L/DAY|||||10^3 ORGANISMS||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|NA|U||3||39||TREATMENT|1963-04-21|1964-05-16|||||1960-02-22||1965-03-16
TRIAL STUDY 134XCP|IS|186520B9-8AAD-4063-B48F-16040EF49944||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^12 IU/L|||||/5X10^4 WBC||||NORMAL|NOT DONE|||BONE|LIPEMIC|N|AMSLER GRID|N|NA|Y||4||88||FOLLOW-UP|1973-08-10|1964-03-06|||||1971-11-01||1972-02-25
TRIAL STUDY 134XCP|IS|186520B9-8AAD-4063-B48F-16040EF49944||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/CAGE/DAY|||||VG/ML||||NORMAL|NOT DONE|||EMESIS|CONCENTRATED|N|NUCLEIC ACID SEQUENCING|N|NA|Y||5||7||INDUCTION TREATMENT|1960-09-28|1962-03-02|||||1972-07-21||1964-08-29
TRIAL STUDY 134XCP|IS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6/HPF|||||/WK||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|REFRIGERATED|Y|POTENTIOMETRY|U|Y|U||1||38||TREATMENT|1969-05-01|1973-01-17|||||1972-05-23||1964-11-01
TRIAL STUDY 134XCP|IS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/BEAT|||||STEPS||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR|NA|CISH|Y|N|U||2||58||LONG-TERM FOLLOW-UP|1960-02-19|1967-01-10|||||1963-11-25||1968-09-04
TRIAL STUDY 134XCP|IS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG/M2|||||HR/DAY||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|HEMOLYZED|N|SIZE EXCLUSION CHROMATOGRAPHY|Y|N|U||3||39||RUN-IN|1965-08-04|1961-02-23|||||1963-01-15||1965-08-04
TRIAL STUDY 134XCP|IS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/KG|||||NMOL BCE/NMOL||||ABNORMAL|NOT DONE|||SPERMATOZOON|ROOM TEMPERATURE|Y|MICRO BROTH DILUTION|U|U|Y||4||88||BASELINE|1967-07-12|1970-03-03|||||1961-06-22||1964-02-19
TRIAL STUDY 134XCP|IS|31DD3952-685F-4941-A68A-2D0C6FB5ECEF||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/10^12 RBC|||||L||||LOW|NOT DONE|||BILE|AUTOLYZED|N|GRAM STAIN|N|Y|NA||5||7||RUN-IN|1971-02-27|1965-06-26|||||1972-05-03||1972-08-19
TRIAL STUDY 134XCP|IS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^12/L|||||CD||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|FRESH|N|AURAMINE STAIN|N|Y|U||1||38||CONTINUATION TREATMENT|1969-11-17|1971-01-14|||||1970-08-31||1972-02-23
TRIAL STUDY 134XCP|IS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG EID 50/DOSE|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|DRIED|NA|PH METER MEASUREMENT METHOD|N|N|U||2||58||CONTINUATION TREATMENT|1962-12-18|1972-12-11|||||1960-05-08||1962-02-25
TRIAL STUDY 134XCP|IS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/L/H|||||CCID 50/ML||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|NON-HEMOLYZED|NA|ELECTROPHORESIS|NA|N|N||3||39||FOLLOW-UP|1967-11-24|1970-11-21|||||1968-05-15||1969-07-24
TRIAL STUDY 134XCP|IS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BU|||||KDA||||ABNORMAL|NOT DONE|||BUFFY COAT|REFRIGERATED|N|SPECULAR MICROSCOPY|U|U|NA||4||88||FOLLOW-UP|1964-02-24|1964-07-04|||||1965-04-21||1965-03-26
TRIAL STUDY 134XCP|IS|5292AC86-EB26-4CA7-8DD0-F353948FD4B1||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/CMH2O|||||CMHG||||ABNORMAL|NOT DONE|||SKIN TISSUE|THAWED|N|VENTILATION PERFUSION LUNG SCAN|Y|U|N||5||7||WASHOUT|1964-03-09|1970-05-13|||||1970-03-29||1960-06-29
TRIAL STUDY 134XCP|IS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE/DAY|||||ML/KG/DAY||||LOW|NOT DONE|||SEMINAL FLUID|CONCENTRATED|U|IMPULSE OSCILLOMETRY|U|U|Y||1||38||OPEN LABEL TREATMENT|1965-04-13|1960-11-18|||||1966-08-19||1967-10-03
TRIAL STUDY 134XCP|IS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IN|||||U/G/DAY||||LOW|NOT DONE|||LEUKOCYTE|GELLED|U|PEAK FLOWMETRY|NA|Y|NA||2||58||CONTINUATION TREATMENT|1962-05-09|1963-06-20|||||1962-12-28||1973-01-24
TRIAL STUDY 134XCP|IS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||IU/MMOL|||||ML/KG/DAY||||HIGH|NOT DONE|||SALIVA|DRIED|NA|GRADIENT DIFFUSION|N|N|N||3||39||TREATMENT|1972-01-12|1963-03-12|||||1972-11-26||1964-08-11
TRIAL STUDY 134XCP|IS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UV2|||||ML/KG/DAY||||NORMAL|NOT DONE|||PERITONEAL FLUID|LACTESCENT|N|CONTRAST ENHANCED X-RAY|NA|N|U||4||88||INDUCTION TREATMENT|1961-02-18|1967-10-03|||||1969-05-20||1961-05-08
TRIAL STUDY 134XCP|IS|9BC8E789-B7D5-40A9-A4EE-9E88234992CB||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/DAY|||||OHM||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|CLOTTED|Y|MICROBIAL CULTURE|U|NA|N||5||7||SCREENING|1965-12-07|1967-08-28|||||1966-01-30||1971-12-05
TRIAL STUDY 134XCP|IS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PPM|||||M/SEC2||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|CALCIFIED|U|MUGA|U|NA|N||1||38||BASELINE|1961-11-24|1971-01-07|||||1960-07-06||1962-10-10
TRIAL STUDY 134XCP|IS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BQ/UG|||||CIGARETTE||||ABNORMAL|NOT DONE|||TISSUE|SOLIDIFIED|N|SICKLE CELL SOLUBILITY TEST|N|U|N||2||58||LONG-TERM FOLLOW-UP|1963-03-23|1960-03-15|||||1965-04-27||1966-12-28
TRIAL STUDY 134XCP|IS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/G/DAY|||||MG/KG||||ABNORMAL|NOT DONE|||VENOUS BLOOD|UNEXPECTED ODOR|Y|MICROPARTICLE ENZYME IMMUNOASSAY|Y|Y|U||3||39||LONG-TERM FOLLOW-UP|1968-11-01|1969-03-10|||||1964-03-18||1968-11-06
TRIAL STUDY 134XCP|IS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MILE|||||10^3 CFU/ML||||HIGH|NOT DONE|||SALIVA|UNEXPECTED ODOR|Y|JAEGER EYE CHART|NA|Y|N||4||88||OPEN LABEL TREATMENT|1962-01-01|1961-07-02|||||1969-07-16||1972-10-23
TRIAL STUDY 134XCP|IS|90176B5E-72C3-4FAB-AEF3-E75B9BCFE3CE||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM/2H|||||FFU||||ABNORMAL|NOT DONE|||VENOUS PLASMA|FRESH|U|FARNSWORTH-MUNSELL 100 HUE TEST|U|NA|U||5||7||OPEN LABEL TREATMENT|1961-05-19|1964-10-30|||||1971-05-22||1964-07-19
TRIAL STUDY 134XCP|IS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/CM3/MIN|||||U/M2/MIN||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|NON-HEMOLYZED|NA|PERIODIC ACID SCHIFF STAIN|NA|NA|Y||1||38||INDUCTION TREATMENT|1962-04-19|1963-11-23|||||1967-01-01||1972-06-20
TRIAL STUDY 134XCP|IS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT|||||U/ANIMAL||||LOW|NOT DONE|||TISSUE|DRIED|NA|IMMUNOASSAY|Y|NA|N||2||58||OPEN LABEL TREATMENT|1972-08-28|1971-11-08|||||1964-09-02||1971-07-06
TRIAL STUDY 134XCP|IS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/DL|||||NMOL/L||||NORMAL|NOT DONE|||RETICULOCYTES|AUTOLYZED|U|MECHANICAL CLOT DETECTION|NA|U|N||3||39||OPEN LABEL TREATMENT|1972-07-27|1968-02-16|||||1969-01-19||1965-11-16
TRIAL STUDY 134XCP|IS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||POUCH|||||/7.5 ML||||NORMAL|NOT DONE|||URINE SEDIMENT|FROZEN|U|PHOTOMETRY|N|NA|U||4||88||OPEN LABEL TREATMENT|1966-04-14|1961-10-19|||||1963-02-28||1961-08-09
TRIAL STUDY 134XCP|IS|20B6D4E0-EE72-467E-9A1D-DFAC0137A3BA||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||HZ/S|||||CMH2O/ML||||LOW|NOT DONE|||INTERSTITIAL FLUID|AUTOLYZED|N|CYSTOMETRY|NA|Y|NA||5||7||RUN-IN|1966-08-31|1967-11-09|||||1971-01-29||1970-01-30
TRIAL STUDY 134XCP|IS|460486B3-B7C8-4B54-848B-21BA899EAAD6||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^3 ORGANISMS/G|||||STEPS||||ABNORMAL|NOT DONE|||SEMINAL FLUID|CALCIFIED|N|IMPEDANCE CONDUCTIVITY|U|U|N||1||38||WASHOUT|1965-02-19|1972-06-17|||||1964-05-22||1966-09-09
TRIAL STUDY 134XCP|IS|460486B3-B7C8-4B54-848B-21BA899EAAD6||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MM/SEC|||||SCM||||HIGH|NOT DONE|||LYMPH|PARAFFIN-EMBEDDED|N|HEMAGGLUTINATION ASSAY|Y|NA|Y||2||58||TREATMENT|1970-07-06|1962-09-21|||||1965-10-18||1968-08-10
TRIAL STUDY 134XCP|IS|460486B3-B7C8-4B54-848B-21BA899EAAD6||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 CFU|||||IU/DAY||||ABNORMAL|NOT DONE|||GASTRIC CONTENTS|REFRIGERATED|U|HPLC|U|NA|U||3||39||BLINDED TREATMENT|1970-12-06|1967-03-20|||||1966-06-24||1971-10-30
TRIAL STUDY 134XCP|IS|460486B3-B7C8-4B54-848B-21BA899EAAD6||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/G/H|||||BQ||||NORMAL|NOT DONE|||BILE|CONTAMINATED|N|DIGITAL PCR|NA|Y|Y||4||88||WASHOUT|1968-09-27|1970-12-26|||||1961-07-22||1963-03-10
TRIAL STUDY 134XCP|IS|460486B3-B7C8-4B54-848B-21BA899EAAD6||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PPB|||||NMOL/ML/MIN||||ABNORMAL|NOT DONE|||BASAL TEAR|ROOM TEMPERATURE|Y|LC/MS|N|U|NA||5||7||LONG-TERM FOLLOW-UP|1968-12-01|1964-12-14|||||1970-10-25||1966-04-29
TRIAL STUDY 134XCP|IS|A068436F-E26E-44C5-8959-0BCBA28832D1||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NG/MOL|||||UKAT||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED|U|OPTICAL COHERENCE TOMOGRAPHY|U|N|NA||1||38||TREATMENT|1969-07-09|1962-02-28|||||1964-08-03||1963-02-22
TRIAL STUDY 134XCP|IS|A068436F-E26E-44C5-8959-0BCBA28832D1||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TRANSDUCING UNIT/ML|||||DROP||||NORMAL|NOT DONE|||MECONIUM|HEMOLYZED|Y|GIEMSA STAIN|N|N|U||2||58||CONTINUATION TREATMENT|1972-11-25|1973-09-04|||||1964-11-05||1968-08-21
TRIAL STUDY 134XCP|IS|A068436F-E26E-44C5-8959-0BCBA28832D1||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FARAD|||||G/ANIMAL||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|CONCENTRATED|U|IVY INCISION METHOD|U|N|Y||3||39||LONG-TERM FOLLOW-UP|1962-08-19|1966-01-23|||||1967-08-22||1960-02-02
TRIAL STUDY 134XCP|IS|A068436F-E26E-44C5-8959-0BCBA28832D1||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/KG/DOSE|||||CCID 50/ML||||LOW|NOT DONE|||LYMPH|GELLED|U|RADIAL IMMUNODIFFUSION|U|N|NA||4||88||FOLLOW-UP|1963-09-05|1972-11-18|||||1968-02-08||1960-12-23
TRIAL STUDY 134XCP|IS|A068436F-E26E-44C5-8959-0BCBA28832D1||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PACKET|||||POINT||||LOW|NOT DONE|||VENOUS PLASMA|CONTAMINATED|U|DOUBLE IMMUNODIFFUSION|N|N|Y||5||7||BLINDED TREATMENT|1968-01-29|1971-11-14|||||1970-11-27||1970-09-21
TRIAL STUDY 134XCP|IS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||IN|||||GBQ/G||||NORMAL|NOT DONE|||CALCULUS|UNEXPECTED ODOR|Y|BAC ACGH|Y|NA|N||1||38||TREATMENT|1965-11-29|1964-06-29|||||1971-04-20||1970-09-03
TRIAL STUDY 134XCP|IS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/H|||||10^6/EJACULATE U||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|CLOTTED|NA|REBOUND TONOMETRY|NA|U|U||2||58||TREATMENT|1964-11-08|1967-01-08|||||1964-12-21||1962-07-07
TRIAL STUDY 134XCP|IS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^11/L|||||MOL/MOL||||HIGH|NOT DONE|||PLEURAL FLUID|LIPEMIC|Y|DUKE INCISION METHOD|N|U|Y||3||39||SCREENING|1960-06-15|1963-03-27|||||1961-07-03||1966-01-29
TRIAL STUDY 134XCP|IS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KS|||||PFU||||NORMAL|NOT DONE|||PERSPIRATION|SOLIDIFIED|NA|LIGHT MICROSCOPY|NA|N|NA||4||88||LONG-TERM FOLLOW-UP|1962-10-01|1962-06-10|||||1968-12-05||1970-02-14
TRIAL STUDY 134XCP|IS|00B423B2-C33A-4EA2-A5C8-78D3C6531DD5||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV|||||PFU/ML||||ABNORMAL|NOT DONE|||BONE MARROW|FROZEN|Y|POPULATION SEQUENCING|NA|N|Y||5||7||OBSERVATION|1964-11-27|1964-01-21|||||1967-02-25||1970-06-25
TRIAL STUDY 134XCP|IS|E065D436-92D2-453F-86A7-27F70FE1FD03||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KG|||||ARBITRARY U||||HIGH|NOT DONE|||STOOL|CALCIFIED|N|FLUORESCEIN STAIN|N|N|Y||1||38||CONTINUATION TREATMENT|1961-09-06|1964-05-19|||||1973-03-08||1971-06-24
TRIAL STUDY 134XCP|IS|E065D436-92D2-453F-86A7-27F70FE1FD03||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LENS|||||MOL/L||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|LIPEMIC|NA|GC/MS/MS|NA|U|NA||2||58||OBSERVATION|1971-03-26|1960-03-28|||||1965-03-20||1966-11-15
TRIAL STUDY 134XCP|IS|E065D436-92D2-453F-86A7-27F70FE1FD03||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||HR/DAY|||||10^3 COPIES/ML||||HIGH|NOT DONE|||SPERMATOZOON|HEMOLYZED|U|PET/SPECT SCAN|Y|Y|U||3||39||OBSERVATION|1965-04-19|1970-05-26|||||1972-11-27||1972-04-04
TRIAL STUDY 134XCP|IS|E065D436-92D2-453F-86A7-27F70FE1FD03||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMHG/L/MIN|||||ABSORBANCE U/ML||||NORMAL|NOT DONE|||PLEURAL TISSUE|AUTOLYZED|U|IMMUNOFLUORESCENT STAIN|N|Y|U||4||88||FOLLOW-UP|1969-08-08|1963-05-31|||||1970-04-08||1962-09-08
TRIAL STUDY 134XCP|IS|E065D436-92D2-453F-86A7-27F70FE1FD03||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VIAL|||||MM/2H||||LOW|NOT DONE|||BLOOD|DRIED|N|KARYOTYPING|Y|N|N||5||7||WASHOUT|1966-01-18|1966-10-31|||||1960-05-22||1969-11-08
TRIAL STUDY 134XCP|IS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/G/H|||||UCI||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|THAWED|U|RADIAL IMMUNODIFFUSION|NA|Y|NA||1||38||CONTINUATION TREATMENT|1970-11-07|1973-08-10|||||1968-02-05||1968-04-14
TRIAL STUDY 134XCP|IS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VP/DOSE|||||MM||||HIGH|NOT DONE|||TUMOR TISSUE|CONCENTRATED|NA|NEXT GENERATION SEQUENCING|U|U|Y||2||58||RUN-IN|1963-04-27|1966-01-13|||||1966-10-17||1969-07-01
TRIAL STUDY 134XCP|IS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KBQ|||||MMU/ML||||ABNORMAL|NOT DONE|||BLOOD|CONTAMINATED|N|FLUORESCEIN STAIN|N|Y|U||3||39||OBSERVATION|1972-11-16|1960-04-10|||||1969-06-27||1963-04-29
TRIAL STUDY 134XCP|IS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/CM2|||||CMHG||||NORMAL|NOT DONE|||BASAL TEAR|NON-HEMOLYZED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|Y|NA|Y||4||88||SCREENING|1973-04-27|1960-02-19|||||1972-06-26||1961-09-24
TRIAL STUDY 134XCP|IS|E7F5795C-FF55-4DFF-B461-AE4F04BD52F7||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||F|||||L/MIN/M2||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|LIPEMIC|U|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|Y|NA|NA||5||7||SCREENING|1971-09-24|1965-10-15|||||1972-06-22||1970-05-15
TRIAL STUDY 134XCP|IS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/KG/H|||||LX||||LOW|NOT DONE|||SYNOVIAL FLUID|NON-HEMOLYZED|Y|PERIPHERAL ANGIOGRAPHY|U|U|NA||1||38||CONTINUATION TREATMENT|1970-07-13|1970-05-16|||||1973-01-29||1964-02-13
TRIAL STUDY 134XCP|IS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^3 ORGANISMS/ML|||||EID 50/ML||||LOW|NOT DONE|||MUCUS|UNEXPECTED ODOR|U|WHOLE GENOME SEQUENCING|N|N|NA||2||58||INDUCTION TREATMENT|1971-10-12|1964-01-16|||||1963-05-13||1968-07-05
TRIAL STUDY 134XCP|IS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TSP|||||PSEC||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|AGGLUTINATED|N|MRS|Y|NA|N||3||39||WASHOUT|1960-10-08|1971-01-21|||||1972-11-12||1965-06-06
TRIAL STUDY 134XCP|IS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CI/UG|||||FL||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|NON-HEMOLYZED|N|FLUORESCEIN STAIN|U|N|U||4||88||OPEN LABEL TREATMENT|1962-04-16|1969-06-13|||||1966-10-27||1973-04-18
TRIAL STUDY 134XCP|IS|CF5D1305-9DB3-4AA9-A3E1-DFB0BB70E77D||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BQ/G|||||EP U||||HIGH|NOT DONE|||PLASMA|REFRIGERATED|Y|POPULATION SEQUENCING|Y|NA|Y||5||7||INDUCTION TREATMENT|1967-08-30|1967-04-25|||||1963-05-17||1960-09-01
TRIAL STUDY 134XCP|IS|D108D040-7177-4A14-8CA7-748D59DC5F8B||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 IU/ML|||||10^7 TCID 50/DOSE||||ABNORMAL|NOT DONE|||CORD SERUM|LIPEMIC|NA|ROMANOWSKY STAIN|U|NA|U||1||38||OPEN LABEL TREATMENT|1971-05-31|1965-07-15|||||1964-05-01||1963-02-24
TRIAL STUDY 134XCP|IS|D108D040-7177-4A14-8CA7-748D59DC5F8B||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/G/MIN|||||MM3/MM2/YEAR||||NORMAL|NOT DONE|||LYMPH|SOLIDIFIED|NA|KARYOTYPING|U|N|Y||2||58||OPEN LABEL TREATMENT|1961-02-27|1964-03-30|||||1969-11-03||1963-02-08
TRIAL STUDY 134XCP|IS|D108D040-7177-4A14-8CA7-748D59DC5F8B||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 ORGANISMS|||||SCOOPFUL||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|UNEXPECTED ODOR|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|NA|NA|NA||3||39||OBSERVATION|1972-08-04|1973-05-18|||||1960-06-14||1962-08-22
TRIAL STUDY 134XCP|IS|D108D040-7177-4A14-8CA7-748D59DC5F8B||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||OZ EQ|||||10^9 ORGANISMS||||LOW|NOT DONE|||MENSTRUAL BLOOD|FROZEN|U|WHOLE TRANSCRIPTOME SEQUENCING|U|N|N||4||88||INDUCTION TREATMENT|1964-02-08|1970-12-15|||||1964-01-03||1962-05-11
TRIAL STUDY 134XCP|IS|D108D040-7177-4A14-8CA7-748D59DC5F8B||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MV*MIN|||||CAPLET||||ABNORMAL|NOT DONE|||SEMEN|SOLIDIFIED|N|MULTI-SLICE SPIRAL CT|N|N|U||5||7||BLINDED TREATMENT|1968-08-28|1966-05-17|||||1973-05-11||1971-02-11
TRIAL STUDY 134XCP|IS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DEG/MM|||||BQ/UG||||HIGH|NOT DONE|||EPIDERMAL TISSUE|GELLED|NA|PHYSICAL EXAMINATION|U|NA|U||1||38||RUN-IN|1960-06-12|1963-06-22|||||1966-08-29||1961-05-01
TRIAL STUDY 134XCP|IS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KDA|||||NMOL/L/H||||HIGH|NOT DONE|||PROSTATIC FLUID|CALCIFIED|NA|INTRAVASCULAR ULTRASOUND|NA|Y|U||2||58||WASHOUT|1962-06-26|1965-06-10|||||1960-09-12||1965-08-08
TRIAL STUDY 134XCP|IS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/G|||||MOL/G||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|FRESH|Y|FLUOROSCOPY|NA|Y|NA||3||39||OPEN LABEL TREATMENT|1963-11-16|1961-06-01|||||1970-07-02||1964-01-13
TRIAL STUDY 134XCP|IS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UL|||||U/ML||||LOW|NOT DONE|||ERYTHROCYTES|THAWED|Y|SNELLEN EYE CHART|NA|Y|NA||4||88||OBSERVATION|1964-09-17|1960-08-22|||||1967-08-10||1966-09-17
TRIAL STUDY 134XCP|IS|6AACC77F-96D3-472F-BDB6-90CC0AF4CAB8||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GPS U|||||GBQ/MG||||ABNORMAL|NOT DONE|||DERMAL TISSUE|FRESH|Y|MOUSE PROTECTION ASSAY|Y|NA|U||5||7||BASELINE|1962-10-25|1960-04-02|||||1960-11-23||1962-09-27
TRIAL STUDY 134XCP|IS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UOSM|||||ML/ANIMAL/WK||||HIGH|NOT DONE|||CAPILLARY PLASMA|FRESH|Y|IRON HEMATOXYLIN STAIN|NA|U|N||1||38||OBSERVATION|1972-01-31|1963-08-17|||||1964-01-20||1963-11-29
TRIAL STUDY 134XCP|IS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/KG/MIN|||||TUBE||||LOW|NOT DONE|||GASTRIC CONTENTS|AGGLUTINATED|U|ELECTROMYOGRAPHY|NA|U|U||2||58||BLINDED TREATMENT|1968-10-31|1965-06-06|||||1968-06-01||1969-12-27
TRIAL STUDY 134XCP|IS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PKAT|||||PKAT/L||||LOW|NOT DONE|||CAPILLARY PLASMA|FROZEN|N|ANGIOGRAPHY|N|Y|U||3||39||BLINDED TREATMENT|1963-01-16|1966-03-07|||||1961-05-17||1961-11-14
TRIAL STUDY 134XCP|IS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/H|||||PT_BR||||HIGH|NOT DONE|||AQUEOUS HUMOR|NON-HEMOLYZED|NA|IN SITU HYBRIDIZATION|NA|U|NA||4||88||OPEN LABEL TREATMENT|1969-11-23|1963-02-17|||||1960-12-10||1968-05-11
TRIAL STUDY 134XCP|IS|F7738305-F17D-4E83-BCD7-5ACAFE10DFD1||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FARAD|||||MG/G/H||||HIGH|NOT DONE|||PLATELET RICH PLASMA|CALCIFIED|N|CLAUSS METHOD|NA|NA|NA||5||7||OBSERVATION|1969-12-31|1972-06-11|||||1969-11-15||1972-10-18
TRIAL STUDY 134XCP|IS|580CCA66-3D51-4A5C-80E1-361A90369055||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||CD/M2||||HIGH|NOT DONE|||ALVEOLAR AIR|ROOM TEMPERATURE|N|TOTAL BODY RADIOGRAPHY|NA|NA|Y||1||38||WASHOUT|1973-08-16|1969-06-25|||||1969-10-05||1965-12-15
TRIAL STUDY 134XCP|IS|580CCA66-3D51-4A5C-80E1-361A90369055||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ROENTGEN|||||MDFI||||LOW|NOT DONE|||EXPIRED AIR|AUTOLYZED|NA|REFLECTANCE SPECTROSCOPY|NA|U|U||2||58||OBSERVATION|1964-09-04|1970-12-31|||||1966-12-11||1967-12-04
TRIAL STUDY 134XCP|IS|580CCA66-3D51-4A5C-80E1-361A90369055||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||AGU/ML|||||UM/S||||HIGH|NOT DONE|||SWABBED MATERIAL|ICTERIC|U|IRON HEMATOXYLIN STAIN|NA|N|NA||3||39||BASELINE|1967-03-10|1968-03-08|||||1965-07-19||1966-09-07
TRIAL STUDY 134XCP|IS|580CCA66-3D51-4A5C-80E1-361A90369055||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DEG2|||||V||||LOW|NOT DONE|||CERUMEN|CALCIFIED|U|NO INFORMATION|NA|U|U||4||88||TREATMENT|1961-01-22|1969-04-20|||||1972-05-05||1964-03-03
TRIAL STUDY 134XCP|IS|580CCA66-3D51-4A5C-80E1-361A90369055||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MOL/DAY|||||CI/L||||NORMAL|NOT DONE|||SEBUM|LACTESCENT|U|FORCED OSCILLATION TECHNIQUE|NA|Y|NA||5||7||LONG-TERM FOLLOW-UP|1972-03-12|1962-09-16|||||1965-07-28||1969-05-05
TRIAL STUDY 134XCP|IS|DAB276EB-3581-4C20-88AC-5A3D267E54D8||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PMOL/L/H|||||MG/L||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|UNEXPECTED ODOR|Y|ANTIMICROBIAL COMBINATION TESTING|U|NA|NA||1||38||BASELINE|1966-03-13|1962-09-25|||||1970-08-30||1963-10-19
TRIAL STUDY 134XCP|IS|DAB276EB-3581-4C20-88AC-5A3D267E54D8||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CI/ML|||||UGEQ/L||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|GELLED|Y|DUCTOGRAPHY|NA|U|NA||2||58||LONG-TERM FOLLOW-UP|1967-09-23|1971-01-26|||||1961-02-06||1962-01-13
TRIAL STUDY 134XCP|IS|DAB276EB-3581-4C20-88AC-5A3D267E54D8||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/KG/DAY|||||DROP||||LOW|NOT DONE|||WHITE MATTER TISSUE|THAWED|N|AGAR PROPORTION|N|Y|NA||3||39||SCREENING|1971-10-24|1963-12-13|||||1967-05-08||1970-12-04
TRIAL STUDY 134XCP|IS|DAB276EB-3581-4C20-88AC-5A3D267E54D8||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||%(W/V)|||||10^3 ORGANISMS/ML||||LOW|NOT DONE|||SERUM OR PLASMA|CALCIFIED|N|JAFFE REACTION|Y|N|U||4||88||OBSERVATION|1964-01-05|1960-07-04|||||1967-06-16||1964-12-02
TRIAL STUDY 134XCP|IS|DAB276EB-3581-4C20-88AC-5A3D267E54D8||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 IU|||||NKAT/L||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CLOTTED|N|GC/FID|U|Y|Y||5||7||LONG-TERM FOLLOW-UP|1963-12-10|1970-09-01|||||1966-07-27||1966-04-25
TRIAL STUDY 134XCP|IS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CM/S|||||CMHG||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED|NA|PET/MRI SCAN|NA|Y|NA||1||38||SCREENING|1973-05-23|1964-12-17|||||1972-07-31||1962-04-07
TRIAL STUDY 134XCP|IS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||C|||||UMOL/L/SEC||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|CALCIFIED|N|CELL BASED BIOASSAY|NA|U|U||2||58||SCREENING|1972-09-16|1967-01-29|||||1971-04-20||1962-08-02
TRIAL STUDY 134XCP|IS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 IU/ML|||||L/S/KPA||||NORMAL|NOT DONE|||EMOTIONAL TEAR|UNEXPECTED ODOR|U|DYNAMIC LIGHT SCATTERING|NA|U|U||3||39||TREATMENT|1972-12-05|1965-02-12|||||1969-08-09||1972-12-01
TRIAL STUDY 134XCP|IS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NKAT/L|||||%/S||||NORMAL|NOT DONE|||PERITONEAL FLUID|LACTESCENT|Y|CARDIAC THERMODILUTION|NA|NA|Y||4||88||CONTINUATION TREATMENT|1963-12-17|1971-06-15|||||1962-06-26||1968-11-15
TRIAL STUDY 134XCP|IS|D251DB10-ACF2-46DD-AC91-43D06F2C1E02||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTIBODY UNIT|||||L/S||||LOW|NOT DONE|||PLATELET RICH PLASMA|CALCIFIED|NA|MICROARRAY|U|Y|N||5||7||TREATMENT|1960-11-25|1970-04-28|||||1967-06-22||1967-03-20
TRIAL STUDY 134XCP|IS|5B703A43-A280-4D6A-AC40-FF5187521DB2||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LM|||||NCI||||HIGH|NOT DONE|||LAVAGE FLUID|DRIED|N|CONTRAST ENHANCED CT SCAN|Y|N|NA||1||38||RUN-IN|1969-11-15|1970-06-28|||||1967-11-01||1971-09-14
TRIAL STUDY 134XCP|IS|5B703A43-A280-4D6A-AC40-FF5187521DB2||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/DAY|||||CFU/ML||||HIGH|NOT DONE|||KERATINOCYTE|ROOM TEMPERATURE|Y|MICROPARTICLE ENZYME IMMUNOASSAY|N|Y|N||2||58||LONG-TERM FOLLOW-UP|1969-06-11|1971-01-19|||||1966-08-16||1965-03-27
TRIAL STUDY 134XCP|IS|5B703A43-A280-4D6A-AC40-FF5187521DB2||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/KG/DAY|||||MMHG||||LOW|NOT DONE|||RETICULOCYTES|PARAFFIN-EMBEDDED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|U|NA|Y||3||39||INDUCTION TREATMENT|1968-09-13|1968-11-15|||||1960-01-08||1962-01-26
TRIAL STUDY 134XCP|IS|5B703A43-A280-4D6A-AC40-FF5187521DB2||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||H*%|||||NM||||LOW|NOT DONE|||SYNOVIAL FLUID|CONTAMINATED|Y|GEL ELECTROPHORESIS|N|N|N||4||88||FOLLOW-UP|1968-10-27|1969-03-18|||||1969-09-07||1962-12-23
TRIAL STUDY 134XCP|IS|5B703A43-A280-4D6A-AC40-FF5187521DB2||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BOLUS|||||MOSM/KG||||LOW|NOT DONE|||VITREOUS HUMOR|THAWED|NA|ACCELERATOR MASS SPECTROMETRY|N|NA|Y||5||7||RUN-IN|1967-03-11|1966-02-23|||||1960-11-23||1973-01-01
TRIAL STUDY 134XCP|IS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UIU/DL|||||WATT||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|Y|TRIPLE-PHASE SPIRAL CT SCAN|Y|U|Y||1||38||INDUCTION TREATMENT|1965-05-04|1967-12-18|||||1961-02-25||1965-01-14
TRIAL STUDY 134XCP|IS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^4 CFU|||||TRACE||||LOW|NOT DONE|||SMEGMA|CONCENTRATED|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|N|N||2||58||FOLLOW-UP|1968-01-06|1960-12-28|||||1960-01-29||1967-08-14
TRIAL STUDY 134XCP|IS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/S/M2|||||MM/SEC||||LOW|NOT DONE|||CAPILLARY BLOOD|LACTESCENT|Y|FLOCCULATION, CHARCOAL ENHANCED|U|U|NA||3||39||LONG-TERM FOLLOW-UP|1973-05-23|1968-08-29|||||1967-11-10||1961-03-10
TRIAL STUDY 134XCP|IS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FRACTION OF 1|||||/7.5 ML||||HIGH|NOT DONE|||GASTRIC FLUID|CALCIFIED|NA|MS/MS|Y|NA|Y||4||88||LONG-TERM FOLLOW-UP|1962-09-07|1960-02-15|||||1964-05-20||1965-08-06
TRIAL STUDY 134XCP|IS|91862A60-6EB7-40AC-9B43-CCD6E75E86A4||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MV2/HZ|||||UG/MIN||||ABNORMAL|NOT DONE|||DERMAL TISSUE|NON-HEMOLYZED|NA|WHOLE EXOME SEQUENCING|U|U|NA||5||7||BASELINE|1962-03-01|1962-06-29|||||1972-02-25||1961-12-04
TRIAL STUDY 134XCP|IS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/G/MIN|||||U/ML||||LOW|NOT DONE|||CEREBROSPINAL FLUID|UNEXPECTED ODOR|Y|FLUORESCENT ENZYME IMMUNOASSAY|Y|U|Y||1||38||RUN-IN|1972-09-27|1960-05-29|||||1973-02-22||1965-06-22
TRIAL STUDY 134XCP|IS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VIRTUAL PIXEL|||||AU/ML||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|LIPEMIC|Y|TARGETED GENOME SEQUENCING|N|N|N||2||58||SCREENING|1960-12-11|1968-04-12|||||1970-10-31||1962-10-31
TRIAL STUDY 134XCP|IS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||L/MIN/M2|||||IU/DL||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|CLOTTED|U|IMMUNO-PET SCAN|NA|NA|NA||3||39||BASELINE|1960-04-21|1962-03-11|||||1973-07-08||1967-04-03
TRIAL STUDY 134XCP|IS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GPS U|||||UG/ANIMAL||||LOW|NOT DONE|||ENDOMETRIAL TISSUE|CLOTTED|Y|INCISION-INDUCED BLEEDING METHOD|N|N|NA||4||88||INDUCTION TREATMENT|1964-09-23|1970-10-08|||||1962-06-21||1967-10-17
TRIAL STUDY 134XCP|IS|7C09FD7B-2BC4-4C9F-852B-234A769F73F6||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN|||||DL||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|LIPEMIC|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|N|N|N||5||7||OBSERVATION|1962-01-29|1964-04-12|||||1961-04-01||1970-10-10
TRIAL STUDY 134XCP|IS|51F3D3C1-3361-499F-B037-CCE8AB989989||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMU/ML|||||UKAT||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|NA|DARK FIELD MICROSCOPY|N|Y|U||1||38||WASHOUT|1971-10-19|1963-02-04|||||1963-11-23||1973-06-18
TRIAL STUDY 134XCP|IS|51F3D3C1-3361-499F-B037-CCE8AB989989||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/DL|||||MM2||||ABNORMAL|NOT DONE|||BLOOD|SOLIDIFIED|N|THERMAL IONIZATION MASS SPECTROMETRY|Y|NA|U||2||58||BLINDED TREATMENT|1973-02-26|1971-04-28|||||1961-07-04||1970-01-19
TRIAL STUDY 134XCP|IS|51F3D3C1-3361-499F-B037-CCE8AB989989||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U|||||MM3/MM2/YEAR||||HIGH|NOT DONE|||TRANSUDATE|PARAFFIN-EMBEDDED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|NA|N|Y||3||39||BLINDED TREATMENT|1971-07-15|1964-09-06|||||1961-07-06||1967-05-01
TRIAL STUDY 134XCP|IS|51F3D3C1-3361-499F-B037-CCE8AB989989||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PELLET|||||CI/MG||||NORMAL|NOT DONE|||CELL PELLET|CONTAMINATED|NA|DUCTOGRAPHY|NA|NA|NA||4||88||CONTINUATION TREATMENT|1961-11-30|1962-03-24|||||1963-12-15||1966-02-24
TRIAL STUDY 134XCP|IS|51F3D3C1-3361-499F-B037-CCE8AB989989||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/BEAT|||||STRIP||||NORMAL|NOT DONE|||PUS|SOLIDIFIED|Y|COLORIMETRY|NA|NA|Y||5||7||FOLLOW-UP|1966-05-05|1969-06-04|||||1961-10-04||1961-12-27
TRIAL STUDY 134XCP|IS|231D401F-CA93-49E0-AC5C-C7F636343D2F||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG|||||%(W/W)||||LOW|NOT DONE|||PLEURAL FLUID|ROOM TEMPERATURE|Y|CELLULAR PROLIFERATION ASSAY|N|U|N||1||38||LONG-TERM FOLLOW-UP|1962-11-06|1968-02-22|||||1964-04-06||1967-09-07
TRIAL STUDY 134XCP|IS|231D401F-CA93-49E0-AC5C-C7F636343D2F||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LB|||||UG/G/MIN||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|NA|MICROBIAL CULTURE, SOLID|U|Y|Y||2||58||SCREENING|1961-08-09|1963-03-26|||||1967-10-15||1967-10-12
TRIAL STUDY 134XCP|IS|231D401F-CA93-49E0-AC5C-C7F636343D2F||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPTH|||||MMHG||||ABNORMAL|NOT DONE|||VENOUS PLASMA|FRESH|N|CHROMATOGRAPHY|U|N|U||3||39||OPEN LABEL TREATMENT|1971-05-30|1961-04-24|||||1962-11-28||1963-06-15
TRIAL STUDY 134XCP|IS|231D401F-CA93-49E0-AC5C-C7F636343D2F||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PKAT|||||DRUM||||HIGH|NOT DONE|||GASTRIC CONTENTS|FROZEN|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|NA|U||4||88||WASHOUT|1967-04-13|1967-03-13|||||1965-12-11||1966-01-24
TRIAL STUDY 134XCP|IS|231D401F-CA93-49E0-AC5C-C7F636343D2F||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||APL U|||||VOXEL||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|UNEXPECTED ODOR|NA|PULMONARY ANGIOGRAPHY|N|Y|N||5||7||BASELINE|1969-01-14|1968-12-20|||||1962-05-04||1966-01-07
TRIAL STUDY 134XCP|IS|2704A3C0-3345-48E5-AC9B-C00EA51AB085||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/MOL|||||PPTH||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|GELLED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|Y|N||1||38||OPEN LABEL TREATMENT|1971-07-30|1966-04-12|||||1972-01-30||1967-09-30
TRIAL STUDY 134XCP|IS|2704A3C0-3345-48E5-AC9B-C00EA51AB085||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MIU/L|||||PACKET||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|ROOM TEMPERATURE|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|N|Y|U||2||58||BASELINE|1966-03-27|1962-03-18|||||1966-10-27||1965-11-16
TRIAL STUDY 134XCP|IS|2704A3C0-3345-48E5-AC9B-C00EA51AB085||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MPL U|||||UU/DL||||HIGH|NOT DONE|||BONE|REFRIGERATED|N|LIQUID SCINTILLATION COUNTING|N|N|U||3||39||OBSERVATION|1961-04-07|1968-03-07|||||1964-01-11||1972-08-18
TRIAL STUDY 134XCP|IS|2704A3C0-3345-48E5-AC9B-C00EA51AB085||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/MIN|||||PUFF||||NORMAL|NOT DONE|||PLASMA|CONCENTRATED|U|GC/FID|N|N|NA||4||88||INDUCTION TREATMENT|1972-11-12|1962-11-11|||||1967-10-26||1960-05-10
TRIAL STUDY 134XCP|IS|2704A3C0-3345-48E5-AC9B-C00EA51AB085||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/MBP|||||FMOL/G||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|DRIED|NA|NON-INVASIVE DIELECTRIC SENSING|U|U|NA||5||7||BASELINE|1965-10-18|1968-08-15|||||1970-12-21||1970-11-13
TRIAL STUDY 134XCP|IS|2F636370-94FE-4BC0-9E16-DDD42D19A985||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||%/MIN|||||ML/BEAT||||HIGH|NOT DONE|||CALCULUS|PARAFFIN-EMBEDDED|NA|HIGH LEVEL AMINOGLYCOSIDE SCREEN|NA|NA|U||1||38||FOLLOW-UP|1968-08-31|1967-06-04|||||1968-03-29||1972-06-01
TRIAL STUDY 134XCP|IS|2F636370-94FE-4BC0-9E16-DDD42D19A985||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 CFU/G|||||APL U/ML||||HIGH|NOT DONE|||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|NA|NA||2||58||INDUCTION TREATMENT|1962-09-10|1963-03-01|||||1965-11-12||1962-10-14
TRIAL STUDY 134XCP|IS|2F636370-94FE-4BC0-9E16-DDD42D19A985||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/M2/H|||||ML/M2/H||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|REFRIGERATED|NA|CT SCAN|N|U|Y||3||39||BASELINE|1968-04-16|1962-01-27|||||1964-10-02||1961-02-11
TRIAL STUDY 134XCP|IS|2F636370-94FE-4BC0-9E16-DDD42D19A985||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DMOL|||||UMOL/DAY||||NORMAL|NOT DONE|||ADIPOSE TISSUE|ROOM TEMPERATURE|U|SEQUENCING|N|N|NA||4||88||OPEN LABEL TREATMENT|1964-10-13|1961-10-11|||||1968-12-11||1963-06-09
TRIAL STUDY 134XCP|IS|2F636370-94FE-4BC0-9E16-DDD42D19A985||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LINEAR FT*LB|||||/10^3||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|LACTESCENT|NA|IN VITRO GENE EXPRESSION ASSAY|Y|N|N||5||7||WASHOUT|1962-10-18|1966-08-19|||||1968-10-24||1972-09-12
TRIAL STUDY 134XCP|IS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/7.5 ML|||||10^11/L||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|FROZEN|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|NA|NA|Y||1||38||CONTINUATION TREATMENT|1966-11-06|1971-02-27|||||1969-04-05||1961-06-29
TRIAL STUDY 134XCP|IS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U|||||PACKAGE||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|ROOM TEMPERATURE|Y|AUSCULTATION|U|Y|U||2||58||BASELINE|1961-02-21|1962-03-10|||||1960-09-11||1971-11-29
TRIAL STUDY 134XCP|IS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DAGU|||||UM2||||HIGH|NOT DONE|||SEBUM|CALCIFIED|U|GRADIENT DIFFUSION|N|N|U||3||39||CONTINUATION TREATMENT|1961-08-07|1973-03-05|||||1961-05-01||1963-12-04
TRIAL STUDY 134XCP|IS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MCI|||||MPL U||||HIGH|NOT DONE|||VENOUS CORD BLOOD|HEMOLYZED|Y|GRAM STAIN|N|NA|Y||4||88||LONG-TERM FOLLOW-UP|1963-02-14|1967-11-03|||||1968-05-06||1966-06-16
TRIAL STUDY 134XCP|IS|39445F0B-0D22-4B4F-B4AE-C5A90F28F735||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||COULOMB|||||10^9 ORGANISMS||||NORMAL|NOT DONE|||BONE|CONCENTRATED|NA|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|N|N|N||5||7||INDUCTION TREATMENT|1972-09-09|1963-11-24|||||1966-07-12||1962-05-02
TRIAL STUDY 134XCP|IS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PMOL/10^10 CELLS|||||UL/ML||||LOW|NOT DONE|||SUPERNATANT, SERUM|AUTOLYZED|NA|IMMUNORADIOMETRIC ASSAY|NA|Y|Y||1||38||BLINDED TREATMENT|1972-07-27|1965-07-26|||||1970-11-10||1971-11-21
TRIAL STUDY 134XCP|IS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BU/ML|||||H*%||||HIGH|NOT DONE|||KERATINOCYTE|PARAFFIN-EMBEDDED|NA|CRYOSCOPY|NA|NA|N||2||58||INDUCTION TREATMENT|1973-02-15|1969-07-10|||||1969-08-30||1973-05-18
TRIAL STUDY 134XCP|IS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MU|||||LINEAR FT*LB||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|UNEXPECTED ODOR|U|ELISPOT|U|U|Y||3||39||INDUCTION TREATMENT|1965-08-12|1973-01-09|||||1962-12-17||1973-03-20
TRIAL STUDY 134XCP|IS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||%/MIN|||||UMOL/L||||LOW|NOT DONE|||MUCUS|NON-HEMOLYZED|U|NUCLEAR RADIOLOGY|U|Y|N||4||88||TREATMENT|1971-06-30|1970-11-21|||||1972-02-13||1964-03-19
TRIAL STUDY 134XCP|IS|BB7AC683-29D3-4EF7-BA05-A03DE1FB8966||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||MV/SEC||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|Y|X-RAY FLUORESCENCE SPECTROMETRY|U|NA|Y||5||7||BASELINE|1970-10-19|1969-01-13|||||1962-03-15||1967-09-22
TRIAL STUDY 134XCP|IS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||STRIP|||||U/KG/H||||LOW|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|NA|HPLC|U|U|NA||1||38||OPEN LABEL TREATMENT|1960-03-09|1972-10-04|||||1961-09-02||1969-01-30
TRIAL STUDY 134XCP|IS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MIN*MG/ML|||||ABSORBANCE U/MIN||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|CONCENTRATED|Y|ALCIAN BLUE STAIN|Y|NA|N||2||58||CONTINUATION TREATMENT|1960-08-28|1964-06-04|||||1965-08-19||1964-08-31
TRIAL STUDY 134XCP|IS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/CL|||||/200 HPFS||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|Y|HILLMEN COLOR CHART|N|U|N||3||39||OBSERVATION|1972-10-09|1969-07-28|||||1963-07-13||1969-06-11
TRIAL STUDY 134XCP|IS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EP U|||||SBE/ML||||NORMAL|NOT DONE|||PERSPIRATION|CLOTTED|Y|LIGHT MICROSCOPY|U|U|NA||4||88||OPEN LABEL TREATMENT|1971-05-31|1968-09-29|||||1961-03-06||1962-09-03
TRIAL STUDY 134XCP|IS|4BB1CEB1-6D60-48D8-BED0-EFA03F873B50||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CI/UL|||||DEG||||LOW|NOT DONE|||ERYTHROCYTES|CONCENTRATED|Y|IMPEDANCE CONDUCTIVITY|Y|Y|N||5||7||LONG-TERM FOLLOW-UP|1965-01-01|1963-06-02|||||1973-01-30||1960-05-25
TRIAL STUDY 134XCP|IS|A1FAB383-1757-4832-B888-90C133842EF8||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||USP U|||||VP/ML||||LOW|NOT DONE|||CORD BLOOD|SOLIDIFIED|NA|CALCOFLUOR WHITE STAIN|U|NA|N||1||38||OPEN LABEL TREATMENT|1972-05-06|1971-07-06|||||1963-05-12||1970-08-27
TRIAL STUDY 134XCP|IS|A1FAB383-1757-4832-B888-90C133842EF8||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||AMU|||||BQ/UL||||LOW|NOT DONE|||SKIN TISSUE|CONTAMINATED|N|MANUAL COUNT|Y|N|Y||2||58||RUN-IN|1971-07-04|1972-11-10|||||1972-02-11||1967-02-09
TRIAL STUDY 134XCP|IS|A1FAB383-1757-4832-B888-90C133842EF8||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/ML|||||MJOULE/CM2||||ABNORMAL|NOT DONE|||CELL PELLET|DRIED|N|BETA LACTAMASE|N|U|U||3||39||WASHOUT|1962-07-02|1970-04-28|||||1961-04-04||1961-09-25
TRIAL STUDY 134XCP|IS|A1FAB383-1757-4832-B888-90C133842EF8||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PT_BR|||||LOG10 CFU/G||||ABNORMAL|NOT DONE|||KERATINOCYTE|AUTOLYZED|NA|INTRAVASCULAR ULTRASOUND|U|Y|Y||4||88||OBSERVATION|1962-01-19|1968-02-12|||||1964-03-30||1962-03-05
TRIAL STUDY 134XCP|IS|A1FAB383-1757-4832-B888-90C133842EF8||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DEG|||||NEEDLE GAUGE||||HIGH|NOT DONE|||LUNG SURFACTANT|AGGLUTINATED|N|TARGETED TRANSCRIPTOME SEQUENCING|NA|U|Y||5||7||INDUCTION TREATMENT|1960-09-29|1971-06-07|||||1966-10-06||1972-06-05
TRIAL STUDY 134XCP|IS|72AA1945-E676-4485-BD7F-6B969E314D83||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LENS|||||ML/S/M2||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|FRESH|N|GC/MS-EI|N|NA|NA||1||38||FOLLOW-UP|1972-06-28|1969-12-13|||||1966-03-15||1969-11-12
TRIAL STUDY 134XCP|IS|72AA1945-E676-4485-BD7F-6B969E314D83||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^3 CFU/ML|||||ML/(MIN*100ML)||||ABNORMAL|NOT DONE|||CALCULUS|FROZEN|Y|MYELOPEROXIDASE STAIN|N|N|U||2||58||RUN-IN|1971-11-15|1971-12-09|||||1965-12-24||1966-01-30
TRIAL STUDY 134XCP|IS|72AA1945-E676-4485-BD7F-6B969E314D83||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GY/MIN|||||MG/KG||||LOW|NOT DONE|||ISOLATE|ICTERIC|Y|ERGOSPIROMETRY|NA|N|NA||3||39||BLINDED TREATMENT|1968-01-20|1973-07-08|||||1969-02-16||1960-06-28
TRIAL STUDY 134XCP|IS|72AA1945-E676-4485-BD7F-6B969E314D83||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG|||||SIEMENS||||ABNORMAL|NOT DONE|||BILE|FROZEN|N|MACRO BROTH DILUTION|U|NA|N||4||88||BLINDED TREATMENT|1971-01-08|1970-03-11|||||1964-11-19||1969-10-11
TRIAL STUDY 134XCP|IS|72AA1945-E676-4485-BD7F-6B969E314D83||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||COPIES/ML|||||BREATHS/MIN||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE|N|SPECT SCAN|N|Y|Y||5||7||WASHOUT|1970-05-30|1963-01-01|||||1967-09-17||1966-04-06
TRIAL STUDY 134XCP|IS|B297C689-0D99-4E36-9F27-F93D4F43E2DD||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NSEC|||||UMOL/L||||NORMAL|NOT DONE|||TUMOR TISSUE|FROZEN|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|NA|Y|N||1||38||OPEN LABEL TREATMENT|1967-04-05|1970-11-02|||||1964-09-09||1973-02-15
TRIAL STUDY 134XCP|IS|B297C689-0D99-4E36-9F27-F93D4F43E2DD||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||GENEQ/ML|||||EIA UNIT||||NORMAL|NOT DONE|||LEUKOCYTE|CONCENTRATED|Y|EEG|U|N|NA||2||58||RUN-IN|1970-09-09|1965-01-18|||||1969-09-02||1965-03-13
TRIAL STUDY 134XCP|IS|B297C689-0D99-4E36-9F27-F93D4F43E2DD||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/10^3|||||10^3 CFU||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|HEMOLYZED|NA|SLOAN LETTER EYE CHART 1.25%|N|NA|NA||3||39||FOLLOW-UP|1968-05-19|1964-03-09|||||1967-08-16||1964-08-13
TRIAL STUDY 134XCP|IS|B297C689-0D99-4E36-9F27-F93D4F43E2DD||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FINGERTIP UNIT|||||L/MIN||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CONTAMINATED|NA|FLAME PHOTOMETRY|NA|U|N||4||88||RUN-IN|1971-10-24|1964-04-13|||||1969-08-05||1966-04-07
TRIAL STUDY 134XCP|IS|B297C689-0D99-4E36-9F27-F93D4F43E2DD||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NG/MOL|||||FT3||||HIGH|NOT DONE|||VENOUS PLASMA|LIPEMIC|Y|URANYL ACETATE STAIN|N|Y|NA||5||7||LONG-TERM FOLLOW-UP|1962-10-08|1970-12-26|||||1972-11-01||1967-12-18
TRIAL STUDY 134XCP|IS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||NKAT||||ABNORMAL|NOT DONE|||ISOLATE|CONCENTRATED|U|CAPILLARY ELECTROPHORESIS|Y|NA|NA||1||38||SCREENING|1964-10-04|1967-07-13|||||1970-04-13||1968-02-25
TRIAL STUDY 134XCP|IS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LM|||||UG/L/H||||LOW|NOT DONE|||MONOCYTE|CLOTTED|NA|CELL BASED BIOASSAY|NA|U|NA||2||58||INDUCTION TREATMENT|1963-08-26|1964-11-27|||||1969-11-02||1968-07-11
TRIAL STUDY 134XCP|IS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FEU|||||10^3 ORGANISMS/ML||||ABNORMAL|NOT DONE|||PLASMA|CONCENTRATED|Y|SPECT SCAN|NA|U|Y||3||39||CONTINUATION TREATMENT|1965-02-08|1961-09-21|||||1970-12-18||1968-06-13
TRIAL STUDY 134XCP|IS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG/MOL|||||ML/G/H||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|CALCIFIED|Y|WHOLE GENOME SEQUENCING|NA|Y|U||4||88||FOLLOW-UP|1967-10-13|1965-11-21|||||1968-06-27||1964-03-27
TRIAL STUDY 134XCP|IS|BEED1D48-A50C-4B72-8815-B8CA9F90D01E||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MM/2H|||||KIT||||HIGH|NOT DONE|||SPUTUM|CONCENTRATED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|N|NA|Y||5||7||FOLLOW-UP|1963-08-12|1970-04-14|||||1971-08-06||1966-12-25
TRIAL STUDY 134XCP|IS|3F18534E-367D-45C8-BB08-C82151A0CF00||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CY/CM|||||COPIES/UG||||HIGH|NOT DONE|||PLATELET|CLOTTED|Y|KNEMOMETRY|Y|U|U||1||38||FOLLOW-UP|1965-11-02|1967-09-13|||||1963-09-07||1962-03-08
TRIAL STUDY 134XCP|IS|3F18534E-367D-45C8-BB08-C82151A0CF00||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CAN|||||MG/H||||ABNORMAL|NOT DONE|||LOCHIA|HEMOLYZED|Y|NEXT GENERATION TARGETED SEQUENCING|N|N|NA||2||58||RUN-IN|1971-06-28|1969-03-31|||||1964-11-04||1968-09-12
TRIAL STUDY 134XCP|IS|3F18534E-367D-45C8-BB08-C82151A0CF00||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/(MIN*100ML)|||||CL||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|FROZEN|N|ELLA|N|NA|N||3||39||OBSERVATION|1972-08-07|1973-04-18|||||1963-01-30||1973-02-12
TRIAL STUDY 134XCP|IS|3F18534E-367D-45C8-BB08-C82151A0CF00||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PT_US|||||MIN*MG/ML||||LOW|NOT DONE|||SERUM|CONCENTRATED|N|FLOCCULATION|U|NA|Y||4||88||TREATMENT|1968-04-13|1971-02-02|||||1961-10-30||1967-12-09
TRIAL STUDY 134XCP|IS|3F18534E-367D-45C8-BB08-C82151A0CF00||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KA_U/DL|||||/MBP||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|FROZEN|N|MICROARRAY|NA|Y|U||5||7||INDUCTION TREATMENT|1971-12-11|1963-10-17|||||1969-04-13||1973-03-17
TRIAL STUDY 134XCP|IS|81C10FB0-3B47-46D8-B8B7-9C772246CA55||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PELLET|||||/LSQN||||LOW|NOT DONE|||CORD SERUM|HEMOLYZED|U|ULTRASOUND|Y|Y|Y||1||38||LONG-TERM FOLLOW-UP|1967-08-11|1969-03-11|||||1967-03-26||1966-05-05
TRIAL STUDY 134XCP|IS|81C10FB0-3B47-46D8-B8B7-9C772246CA55||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||AMFI|||||UV2||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|HEMOLYZED|U|IMPEDANCE CONDUCTIVITY|N|N|Y||2||58||OPEN LABEL TREATMENT|1961-10-18|1966-05-31|||||1971-02-01||1970-11-01
TRIAL STUDY 134XCP|IS|81C10FB0-3B47-46D8-B8B7-9C772246CA55||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||USIEMENS|||||G/CAGE/DAY||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|UNEXPECTED ODOR|N|INDIA INK STAIN|NA|Y|Y||3||39||INDUCTION TREATMENT|1962-06-17|1968-06-26|||||1973-08-01||1968-10-05
TRIAL STUDY 134XCP|IS|81C10FB0-3B47-46D8-B8B7-9C772246CA55||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PMOL/10^9 CELLS|||||CMHG||||LOW|NOT DONE|||DERMAL TISSUE|PARAFFIN-EMBEDDED|Y|COULOMETRIC TITRATION|N|U|U||4||88||FOLLOW-UP|1966-05-27|1972-02-28|||||1971-03-25||1960-10-25
TRIAL STUDY 134XCP|IS|81C10FB0-3B47-46D8-B8B7-9C772246CA55||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DIP|||||IU/DAY||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|LIPEMIC|N|SNP ARRAY|Y|NA|U||5||7||BLINDED TREATMENT|1966-10-21|1966-11-12|||||1968-07-28||1960-04-14
TRIAL STUDY 134XCP|IS|67C99F41-D839-4B8E-9220-6EC161FCD457||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NG|||||UG/KG||||LOW|NOT DONE|||BONE|CALCIFIED|N|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|N|N|Y||1||38||FOLLOW-UP|1963-01-30|1969-05-17|||||1968-05-01||1969-05-19
TRIAL STUDY 134XCP|IS|67C99F41-D839-4B8E-9220-6EC161FCD457||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UV*SEC|||||ABSORBANCE U/MIN||||LOW|NOT DONE|||FLUID|AUTOLYZED|Y|LIQUID SCINTILLATION COUNTING|NA|Y|Y||2||58||LONG-TERM FOLLOW-UP|1962-11-27|1972-07-22|||||1963-08-24||1961-06-23
TRIAL STUDY 134XCP|IS|67C99F41-D839-4B8E-9220-6EC161FCD457||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||GAUSS||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|AUTOLYZED|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|N|U||3||39||WASHOUT|1969-03-01|1973-01-30|||||1967-03-14||1969-01-04
TRIAL STUDY 134XCP|IS|67C99F41-D839-4B8E-9220-6EC161FCD457||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/ANIMAL|||||DAYS||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|Y|KNEMOMETRY|Y|N|U||4||88||BLINDED TREATMENT|1968-07-16|1962-12-24|||||1973-05-31||1965-09-20
TRIAL STUDY 134XCP|IS|67C99F41-D839-4B8E-9220-6EC161FCD457||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/HPF|||||AFU||||LOW|NOT DONE|||EPITHELIAL CELL|HEMOLYZED|Y|DIGITAL PCR ARRAY|U|N|U||5||7||OBSERVATION|1969-06-28|1965-08-04|||||1964-09-29||1962-02-07
TRIAL STUDY 134XCP|IS|76B9C25F-B418-4979-9E18-4372C8AA700C||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||YEARS|||||UGEQ||||HIGH|NOT DONE|||BONE MARROW|NON-HEMOLYZED|U|SURFACE PLASMON RESONANCE|NA|NA|N||1||38||SCREENING|1968-07-31|1966-01-30|||||1965-02-09||1969-12-26
TRIAL STUDY 134XCP|IS|76B9C25F-B418-4979-9E18-4372C8AA700C||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MIN|||||GENEQ/ML||||HIGH|NOT DONE|||PROSTATIC FLUID|REFRIGERATED|N|FUNCTIONAL MRI|Y|NA|Y||2||58||INDUCTION TREATMENT|1961-06-27|1964-09-29|||||1963-08-02||1964-04-28
TRIAL STUDY 134XCP|IS|76B9C25F-B418-4979-9E18-4372C8AA700C||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^9/G|||||MAC50||||HIGH|NOT DONE|||MECONIUM|CONCENTRATED|N|DIPSTICK|NA|N|U||3||39||OBSERVATION|1972-07-23|1968-10-18|||||1971-12-19||1963-09-16
TRIAL STUDY 134XCP|IS|76B9C25F-B418-4979-9E18-4372C8AA700C||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DIOPTER|||||GBQ||||NORMAL|NOT DONE|||AMNIOTIC FLUID|AUTOLYZED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|NA|NA|U||4||88||BLINDED TREATMENT|1969-05-29|1973-05-30|||||1967-08-06||1965-02-02
TRIAL STUDY 134XCP|IS|76B9C25F-B418-4979-9E18-4372C8AA700C||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MJOULE/CM2|||||UM||||NORMAL|NOT DONE|||PLEURAL TISSUE|FROZEN|Y|NON-INVASIVE DIELECTRIC SENSING|NA|N|Y||5||7||INDUCTION TREATMENT|1961-12-30|1970-11-08|||||1961-11-09||1964-10-22
TRIAL STUDY 134XCP|IS|9F622B53-71F8-4362-99A5-251993E3A946||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ABSORBANCE U|||||APL U||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|LACTESCENT|U|SIZE EXCLUSION CHROMATOGRAPHY|NA|NA|U||1||38||TREATMENT|1966-04-01|1972-03-03|||||1971-11-10||1967-03-19
TRIAL STUDY 134XCP|IS|9F622B53-71F8-4362-99A5-251993E3A946||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NKAT/G HB|||||MG/KG/MIN||||ABNORMAL|NOT DONE|||CALCULUS|CALCIFIED|U|HILLMEN COLOR CHART|NA|NA|NA||2||58||WASHOUT|1968-01-15|1967-08-23|||||1971-12-15||1961-02-27
TRIAL STUDY 134XCP|IS|9F622B53-71F8-4362-99A5-251993E3A946||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IN2|||||NCI||||LOW|NOT DONE|||HAIR|ICTERIC|NA|IODINE STAIN|Y|U|N||3||39||OBSERVATION|1968-03-09|1963-05-15|||||1965-09-16||1963-12-01
TRIAL STUDY 134XCP|IS|9F622B53-71F8-4362-99A5-251993E3A946||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||RATIO|||||10^6 ORGANISMS||||HIGH|NOT DONE|||EPIDERMAL TISSUE|AGGLUTINATED|U|MEDIASTINOSCOPY|N|NA|N||4||88||CONTINUATION TREATMENT|1967-08-31|1966-10-05|||||1965-09-07||1964-07-16
TRIAL STUDY 134XCP|IS|9F622B53-71F8-4362-99A5-251993E3A946||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GBQ/UG|||||/4.0 ML||||HIGH|NOT DONE|||ARTERIAL CORD BLOOD|LIPEMIC|NA|BRDU CELLULAR PROLIFERATION ASSAY|U|U|Y||5||7||OBSERVATION|1962-10-30|1969-12-08|||||1971-01-31||1970-08-12
TRIAL STUDY 134XCP|IS|8F2DC6EB-0264-4112-B379-17896F4266E4||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MU/G|||||AMOL||||HIGH|NOT DONE|||PLASMA|AGGLUTINATED|Y|RULER MEASUREMENT METHOD|U|NA|NA||1||38||OBSERVATION|1972-07-08|1966-04-29|||||1964-07-14||1962-10-07
TRIAL STUDY 134XCP|IS|8F2DC6EB-0264-4112-B379-17896F4266E4||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMOL/S|||||CI/UL||||ABNORMAL|NOT DONE|||SEMINAL FLUID|AGGLUTINATED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|U|NA|U||2||58||FOLLOW-UP|1969-01-01|1967-05-16|||||1964-11-06||1964-07-22
TRIAL STUDY 134XCP|IS|8F2DC6EB-0264-4112-B379-17896F4266E4||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PMOL/DL|||||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE|||ISOLATE|LIPEMIC|NA|SPIRAL CT|U|N|NA||3||39||WASHOUT|1972-05-30|1964-07-27|||||1970-04-21||1963-08-31
TRIAL STUDY 134XCP|IS|8F2DC6EB-0264-4112-B379-17896F4266E4||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/ANIMAL/DAY|||||GTT||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|NA|SPECTROPHOTOMETRY|N|U|N||4||88||BASELINE|1970-05-11|1961-05-16|||||1964-07-10||1967-08-03
TRIAL STUDY 134XCP|IS|8F2DC6EB-0264-4112-B379-17896F4266E4||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||IU/G HB|||||MEQ/UG||||LOW|NOT DONE|||LAVAGE FLUID|LIPEMIC|N|HPLC-UV|N|U|Y||5||7||RUN-IN|1966-09-04|1961-10-31|||||1966-04-27||1965-12-05
TRIAL STUDY 134XCP|IS|448246D1-5625-4F69-B214-3A8848E86C28||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G|||||MMOL/S||||HIGH|NOT DONE|||PUS|ICTERIC|N|THIN SMEAR|U|N|N||1||38||WASHOUT|1967-06-12|1966-04-01|||||1960-07-01||1971-09-03
TRIAL STUDY 134XCP|IS|448246D1-5625-4F69-B214-3A8848E86C28||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/KG/MIN|||||MET*MIN||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|ICTERIC|Y|TELLER ACUITY CARDS|U|N|U||2||58||INDUCTION TREATMENT|1969-12-21|1966-10-07|||||1964-04-22||1965-04-12
TRIAL STUDY 134XCP|IS|448246D1-5625-4F69-B214-3A8848E86C28||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/10^12 RBC|||||L/S||||ABNORMAL|NOT DONE|||EXPIRED AIR|PARAFFIN-EMBEDDED|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|N|NA|U||3||39||SCREENING|1968-09-19|1969-01-14|||||1969-02-03||1961-07-17
TRIAL STUDY 134XCP|IS|448246D1-5625-4F69-B214-3A8848E86C28||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/DL|||||TUBERCULIN UNIT||||LOW|NOT DONE|||BILE|CALCIFIED|NA|PET/SPECT SCAN|Y|U|NA||4||88||RUN-IN|1972-06-13|1969-06-30|||||1965-05-27||1961-01-24
TRIAL STUDY 134XCP|IS|448246D1-5625-4F69-B214-3A8848E86C28||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MBP|||||BP||||LOW|NOT DONE|||ARTERIAL BLOOD|CONCENTRATED|NA|MICROBIAL CONCENTRATION|N|NA|Y||5||7||SCREENING|1963-07-26|1972-09-20|||||1972-12-18||1960-06-19
TRIAL STUDY 134XCP|IS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/M2/H|||||DAYS/WK||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|Y|BIOPSY|N|NA|N||1||38||SCREENING|1963-01-17|1973-02-08|||||1960-04-21||1971-02-27
TRIAL STUDY 134XCP|IS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||JAR|||||MCI/L||||ABNORMAL|NOT DONE|||SYNOVIAL FLUID|DRIED|N|PET/CT SCAN|U|N|Y||2||58||SCREENING|1964-07-09|1964-12-01|||||1969-05-16||1962-10-04
TRIAL STUDY 134XCP|IS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL/L|||||U/DL||||NORMAL|NOT DONE|||TRANSUDATE|AGGLUTINATED|NA|MAMMOGRAPHY|U|U|U||3||39||LONG-TERM FOLLOW-UP|1968-06-19|1961-11-26|||||1967-03-03||1972-12-25
TRIAL STUDY 134XCP|IS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 TCID 50/UL|||||MMOL/KG||||LOW|NOT DONE|||SERUM|FROZEN|U|MAMMOGRAPHY|N|NA|NA||4||88||OBSERVATION|1966-10-27|1963-01-17|||||1962-01-03||1971-07-13
TRIAL STUDY 134XCP|IS|F1D22A3B-8514-4036-BBE5-6765B2F0EBB6||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CM|||||LOG10 TCID 50/UL||||LOW|NOT DONE|||ARTERIAL BLOOD|NON-HEMOLYZED|N|ANTIMICROBIAL COMBINATION TESTING|N|N|NA||5||7||WASHOUT|1968-02-29|1968-12-05|||||1973-03-07||1967-03-01
TRIAL STUDY 134XCP|IS|27DDBB16-ED11-45B6-987D-FB0D8223B993||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/5X10^4 WBC|||||BU||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|ICTERIC|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|N|N|Y||1||38||FOLLOW-UP|1970-11-11|1969-03-14|||||1968-01-26||1963-03-13
TRIAL STUDY 134XCP|IS|27DDBB16-ED11-45B6-987D-FB0D8223B993||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NEEDLE GAUGE|||||MMOL/L||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|CONTAMINATED|N|VIRUS PLAQUE ASSAY|N|U|U||2||58||CONTINUATION TREATMENT|1963-09-11|1971-08-02|||||1970-09-02||1968-03-13
TRIAL STUDY 134XCP|IS|27DDBB16-ED11-45B6-987D-FB0D8223B993||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GBQ|||||GBQ||||ABNORMAL|NOT DONE|||DERMAL TISSUE|NON-HEMOLYZED|N|CONTRAST ENHANCED X-RAY|N|NA|U||3||39||FOLLOW-UP|1971-09-28|1964-03-21|||||1973-03-26||1968-01-18
TRIAL STUDY 134XCP|IS|27DDBB16-ED11-45B6-987D-FB0D8223B993||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||USIEMENS|||||IU/MMOL||||HIGH|NOT DONE|||MECONIUM|CONTAMINATED|U|MICROARRAY|NA|NA|N||4||88||BASELINE|1961-08-07|1970-01-24|||||1966-07-08||1967-12-15
TRIAL STUDY 134XCP|IS|27DDBB16-ED11-45B6-987D-FB0D8223B993||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/L|||||MG/KG/MIN||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|HEMOLYZED|NA|BETA LACTAMASE|N|NA|N||5||7||TREATMENT|1962-01-19|1967-09-18|||||1964-10-05||1969-09-18
TRIAL STUDY 134XCP|IS|5545846C-F90F-4346-A075-05999641B872||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||USP U|||||PKAT/L||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|CALCIFIED|NA|ICC|U|N|U||1||38||INDUCTION TREATMENT|1961-05-23|1964-06-16|||||1967-07-01||1963-02-14
TRIAL STUDY 134XCP|IS|5545846C-F90F-4346-A075-05999641B872||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PELLET|||||MET||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|ROOM TEMPERATURE|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|U|Y||2||58||LONG-TERM FOLLOW-UP|1966-02-05|1970-03-12|||||1963-03-15||1965-07-06
TRIAL STUDY 134XCP|IS|5545846C-F90F-4346-A075-05999641B872||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ATM|||||L/S/KPA||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|U|PHYSICAL EXAMINATION|N|Y|N||3||39||CONTINUATION TREATMENT|1972-06-01|1971-08-16|||||1965-11-16||1970-01-15
TRIAL STUDY 134XCP|IS|5545846C-F90F-4346-A075-05999641B872||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/ML/DAY|||||IU/MMOL||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|GELLED|NA|ENDOSCOPY|Y|N|Y||4||88||OPEN LABEL TREATMENT|1970-09-26|1971-06-11|||||1965-09-25||1969-07-25
TRIAL STUDY 134XCP|IS|5545846C-F90F-4346-A075-05999641B872||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GENEQ/ML|||||%(V/V)||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|U|CONTRAST ENHANCED PET SCAN|NA|NA|NA||5||7||BLINDED TREATMENT|1961-02-09|1960-10-03|||||1965-03-25||1963-09-22
TRIAL STUDY 134XCP|IS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||GPELISA UNIT/ML|||||10^3 CFU||||HIGH|NOT DONE|||CORD SERUM|PARAFFIN-EMBEDDED|NA|MAGNETIC RESONANCE ENTEROGRAPHY|NA|Y|U||1||38||FOLLOW-UP|1969-10-14|1967-12-13|||||1967-02-12||1966-01-11
TRIAL STUDY 134XCP|IS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||YEARS|||||MEQ/UL||||NORMAL|NOT DONE|||STOOL|PARAFFIN-EMBEDDED|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|N|Y|NA||2||58||INDUCTION TREATMENT|1969-11-09|1963-07-20|||||1973-01-22||1972-03-07
TRIAL STUDY 134XCP|IS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MEQ/L|||||KUSP||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|THAWED|N|RIA|NA|NA|NA||3||39||RUN-IN|1970-11-25|1968-11-23|||||1971-10-05||1960-08-06
TRIAL STUDY 134XCP|IS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||RPM|||||ML/KG/DAY||||HIGH|NOT DONE|||CAPILLARY BLOOD|ICTERIC|N|WRIGHT STAIN|NA|NA|Y||4||88||WASHOUT|1968-05-31|1962-11-26|||||1965-03-22||1973-05-27
TRIAL STUDY 134XCP|IS|F5E96D41-8C4C-45E4-9FB8-C6513C1DE4C1||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/200 HPFS|||||KG/MOL||||NORMAL|NOT DONE|||SYNOVIAL FLUID|CLOTTED|N|DOPPLER ULTRASOUND|NA|NA|Y||5||7||INDUCTION TREATMENT|1970-10-20|1962-01-01|||||1970-11-05||1970-01-28
TRIAL STUDY 134XCP|IS|111541DB-D863-4C68-9E62-B8741A62401C||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DDU|||||LENS||||LOW|NOT DONE|||URINE SEDIMENT|FRESH|U|CT SCAN|NA|U|U||1||38||TREATMENT|1966-06-15|1973-07-09|||||1965-10-31||1965-02-03
TRIAL STUDY 134XCP|IS|111541DB-D863-4C68-9E62-B8741A62401C||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IU/MMOL|||||ML/MIN||||HIGH|NOT DONE|||SYNOVIAL FLUID|NON-HEMOLYZED|Y|FUNCTIONAL MRI|N|Y|N||2||58||INDUCTION TREATMENT|1970-02-11|1963-07-21|||||1965-07-24||1964-01-06
TRIAL STUDY 134XCP|IS|111541DB-D863-4C68-9E62-B8741A62401C||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL/KG/DAY|||||UIU/L||||ABNORMAL|NOT DONE|||ISOLATE|SOLIDIFIED|U|IMMUNOTURBIDIMETRY|Y|Y|U||3||39||RUN-IN|1967-10-14|1968-10-07|||||1961-10-22||1971-12-13
TRIAL STUDY 134XCP|IS|111541DB-D863-4C68-9E62-B8741A62401C||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BQ/UG|||||NMOL BCE/L||||NORMAL|NOT DONE|||LOCHIA|ICTERIC|N|FLUORIMETRY|Y|Y|Y||4||88||WASHOUT|1961-04-20|1971-09-02|||||1961-03-27||1961-10-16
TRIAL STUDY 134XCP|IS|111541DB-D863-4C68-9E62-B8741A62401C||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/100G/MIN|||||DIP||||ABNORMAL|NOT DONE|||CIRCULATING TUMOR CELL|LIPEMIC|U|X-RAY|N|N|N||5||7||OBSERVATION|1968-12-10|1968-12-26|||||1966-08-04||1966-04-27
TRIAL STUDY 134XCP|IS|5095C113-7278-4D41-B860-0DF6B9B98738||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||COPIES/UG|||||ML||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|U|MICRO BROTH DILUTION|N|NA|Y||1||38||FOLLOW-UP|1970-02-13|1971-10-12|||||1971-04-11||1963-09-16
TRIAL STUDY 134XCP|IS|5095C113-7278-4D41-B860-0DF6B9B98738||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/MMOL|||||UG/MIN||||NORMAL|NOT DONE|||TUMOR TISSUE|FRESH|NA|MAGNETIC RESONANCE ELASTOGRAPHY|N|NA|N||2||58||BLINDED TREATMENT|1963-09-18|1967-12-06|||||1970-02-12||1970-09-22
TRIAL STUDY 134XCP|IS|5095C113-7278-4D41-B860-0DF6B9B98738||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PRESSOR UNITS|||||MEQ/MMOL||||ABNORMAL|NOT DONE|||ABSCESS FLUID|LIPEMIC|NA|IMMUNOPRECIPITATION|NA|N|N||3||39||INDUCTION TREATMENT|1964-02-29|1973-03-27|||||1963-02-26||1960-04-18
TRIAL STUDY 134XCP|IS|5095C113-7278-4D41-B860-0DF6B9B98738||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||L/S/KPA|||||CI/MG||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|CONTAMINATED|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|N|U|U||4||88||OPEN LABEL TREATMENT|1970-01-23|1972-11-12|||||1964-09-26||1960-04-16
TRIAL STUDY 134XCP|IS|5095C113-7278-4D41-B860-0DF6B9B98738||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DEG|||||U/G/MIN||||NORMAL|NOT DONE|||ERYTHROCYTES|ICTERIC|U|SINGLE-MOLECULE ARRAY|NA|N|NA||5||7||RUN-IN|1972-06-22|1964-05-08|||||1960-09-05||1972-04-23
TRIAL STUDY 134XCP|IS|61319D2E-A512-425F-9301-BAD27B5F5C9B||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||RATIO|||||CFU/ML||||LOW|NOT DONE|||MENSTRUAL BLOOD|CALCIFIED|NA|GC/FID|N|U|NA||1||38||TREATMENT|1966-09-12|1967-02-18|||||1970-08-04||1969-02-19
TRIAL STUDY 134XCP|IS|61319D2E-A512-425F-9301-BAD27B5F5C9B||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 TCID 50/UL|||||ANTI-XA IU/ML||||ABNORMAL|NOT DONE|||BUFFY COAT|CONCENTRATED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NA|NA|Y||2||58||WASHOUT|1969-08-08|1969-08-20|||||1966-12-01||1971-04-19
TRIAL STUDY 134XCP|IS|61319D2E-A512-425F-9301-BAD27B5F5C9B||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^5/HPF|||||PSEC||||ABNORMAL|NOT DONE|||LEUKOCYTE|CONCENTRATED|NA|CHROMATOGRAPHY|NA|U|Y||3||39||INDUCTION TREATMENT|1972-11-24|1969-05-25|||||1967-07-17||1967-11-19
TRIAL STUDY 134XCP|IS|61319D2E-A512-425F-9301-BAD27B5F5C9B||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EQ|||||MG/M2/H||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|NA|ELECTROCHEMILUMINESCENCE|NA|U|U||4||88||BLINDED TREATMENT|1961-11-02|1963-03-04|||||1963-07-12||1968-06-13
TRIAL STUDY 134XCP|IS|61319D2E-A512-425F-9301-BAD27B5F5C9B||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MU/G|||||DPM/MG||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|CONTAMINATED|Y|SXA SCAN|NA|U|NA||5||7||CONTINUATION TREATMENT|1960-12-18|1971-09-25|||||1961-01-08||1967-10-13
TRIAL STUDY 134XCP|IS|3B865A8F-949B-4B64-A818-85472EABB8FB||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MOL/L|||||MOSM||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|CONCENTRATED|U|INDIA INK STAIN|N|Y|NA||1||38||SCREENING|1972-08-09|1967-07-22|||||1964-07-18||1967-09-01
TRIAL STUDY 134XCP|IS|3B865A8F-949B-4B64-A818-85472EABB8FB||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||F|||||LOG10 CFU/G||||HIGH|NOT DONE|||LUNG SURFACTANT|UNEXPECTED ODOR|U|INTERRUPTER TECHNIQUE|Y|N|NA||2||58||FOLLOW-UP|1970-11-22|1964-01-11|||||1967-11-07||1962-11-13
TRIAL STUDY 134XCP|IS|3B865A8F-949B-4B64-A818-85472EABB8FB||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UCI/KG|||||DEG/S||||NORMAL|NOT DONE|||ISOLATE|THAWED|N|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|N|Y|NA||3||39||OBSERVATION|1966-04-23|1963-03-06|||||1965-10-21||1962-01-21
TRIAL STUDY 134XCP|IS|3B865A8F-949B-4B64-A818-85472EABB8FB||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FMOL|||||SV||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|UNEXPECTED ODOR|U|MANUAL COUNT|Y|U|NA||4||88||TREATMENT|1966-09-16|1960-09-30|||||1970-12-22||1963-12-24
TRIAL STUDY 134XCP|IS|3B865A8F-949B-4B64-A818-85472EABB8FB||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ELISA UNIT/ML|||||MBQ/UL||||NORMAL|NOT DONE|||SWABBED MATERIAL|HEMOLYZED|U|LAPAROSCOPY|NA|N|U||5||7||WASHOUT|1973-03-03|1966-08-16|||||1969-09-07||1970-05-16
TRIAL STUDY 134XCP|IS|A6909912-22B9-4EE7-AEDF-F791F243A6B7||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/KG/MIN|||||10^6 ORGANISMS/ML||||NORMAL|NOT DONE|||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|NUCLEIC ACID AMPLIFICATION TEST|Y|N|Y||1||38||RUN-IN|1971-05-29|1969-09-28|||||1962-12-23||1968-10-16
TRIAL STUDY 134XCP|IS|A6909912-22B9-4EE7-AEDF-F791F243A6B7||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/KG|||||ABSORBANCE U/MIN||||HIGH|NOT DONE|||CORD BLOOD|REFRIGERATED|N|ANGIOGRAPHY|NA|Y|NA||2||58||WASHOUT|1964-06-30|1965-10-26|||||1966-05-15||1967-12-17
TRIAL STUDY 134XCP|IS|A6909912-22B9-4EE7-AEDF-F791F243A6B7||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||RFU|||||UG/G/DAY||||NORMAL|NOT DONE|||MONOCYTE|HEMOLYZED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|U|Y|NA||3||39||OPEN LABEL TREATMENT|1962-12-15|1972-05-09|||||1968-08-06||1962-06-27
TRIAL STUDY 134XCP|IS|A6909912-22B9-4EE7-AEDF-F791F243A6B7||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||L/MIN/M2|||||PM||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|CALCIFIED|Y|TRANSVAGINAL ULTRASOUND|N|NA|N||4||88||RUN-IN|1973-01-24|1965-08-07|||||1960-03-16||1969-10-16
TRIAL STUDY 134XCP|IS|A6909912-22B9-4EE7-AEDF-F791F243A6B7||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/KG/MIN|||||KPA/L/SEC||||NORMAL|NOT DONE|||LYSATE|AGGLUTINATED|U|NUCLEIC ACID BASED METHOD|N|NA|Y||5||7||OPEN LABEL TREATMENT|1964-03-03|1966-01-04|||||1961-05-01||1969-08-14
TRIAL STUDY 134XCP|IS|83C8AAD3-B22D-42C6-870A-D069FAC601F3||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIXELS/CM|||||ML/100G/MIN||||ABNORMAL|NOT DONE|||INFRANATANT, SERUM|LACTESCENT|U|WESTERN BLOT|NA|U|NA||1||38||RUN-IN|1963-09-08|1972-07-29|||||1962-07-09||1961-09-29
TRIAL STUDY 134XCP|IS|83C8AAD3-B22D-42C6-870A-D069FAC601F3||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BU/ML|||||MIU/L||||NORMAL|NOT DONE|||PLATELET RICH PLASMA|DRIED|NA|DIFFUSION TENSOR MRI|U|NA|N||2||58||TREATMENT|1972-10-07|1963-01-20|||||1968-09-03||1968-05-17
TRIAL STUDY 134XCP|IS|83C8AAD3-B22D-42C6-870A-D069FAC601F3||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UMOL/DAY|||||LOG10 IU/ML||||NORMAL|NOT DONE|||BILE|PARAFFIN-EMBEDDED|Y|NEXT GENERATION SEQUENCING|NA|N|U||3||39||TREATMENT|1964-11-27|1973-03-24|||||1966-03-24||1970-01-25
TRIAL STUDY 134XCP|IS|83C8AAD3-B22D-42C6-870A-D069FAC601F3||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MET*MIN|||||MBQ/UL||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|LIPEMIC|N|IMMUNO-PET SCAN|N|N|NA||4||88||RUN-IN|1963-04-21|1964-01-09|||||1968-06-09||1960-02-23
TRIAL STUDY 134XCP|IS|83C8AAD3-B22D-42C6-870A-D069FAC601F3||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||HR/DAY|||||IMPLANT||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|DRIED|N|FORCED OSCILLATION TECHNIQUE|U|U|Y||5||7||RUN-IN|1971-06-26|1960-09-22|||||1961-09-26||1960-02-08
TRIAL STUDY 134XCP|IS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^4/HPF|||||PNU/ML||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|REFRIGERATED|Y|GRADIENT DIFFUSION|U|NA|Y||1||38||WASHOUT|1967-12-06|1968-10-06|||||1962-10-12||1960-01-22
TRIAL STUDY 134XCP|IS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DEG|||||UEQ/L||||LOW|NOT DONE|||CERUMEN|CONTAMINATED|U|SCANNING ELECTRON MICROSCOPY|U|Y|N||2||58||BLINDED TREATMENT|1971-03-06|1969-06-16|||||1961-10-15||1962-12-26
TRIAL STUDY 134XCP|IS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 CFU/ML|||||BREATHS/30S||||LOW|NOT DONE|||DISCHARGE|CLOTTED|NA|ALCIAN BLUE STAIN|N|U|N||3||39||RUN-IN|1966-05-04|1971-02-19|||||1962-06-06||1970-04-12
TRIAL STUDY 134XCP|IS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||JDF UNIT|||||STEPS/MIN||||NORMAL|NOT DONE|||BILE|LACTESCENT|N|ISHIHARA COLOR PLATES|U|U|Y||4||88||BASELINE|1970-01-16|1960-04-28|||||1960-06-17||1961-10-28
TRIAL STUDY 134XCP|IS|4EE77C34-2BA7-482D-81DE-49BBA9AEE4E5||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^9/G|||||SEC||||LOW|NOT DONE|||BASAL TEAR|AUTOLYZED|N|INFRARED SPECTROMETRY|N|Y|Y||5||7||WASHOUT|1965-02-09|1961-01-20|||||1967-09-20||1965-05-31
TRIAL STUDY 134XCP|IS|937BF41A-157D-45F6-9797-2C5D19D100E6||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PACKET|||||ML/KG/DAY||||ABNORMAL|NOT DONE|||RETICULOCYTES|SOLIDIFIED|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|N|N|N||1||38||OPEN LABEL TREATMENT|1964-02-09|1967-11-23|||||1966-11-14||1962-09-22
TRIAL STUDY 134XCP|IS|937BF41A-157D-45F6-9797-2C5D19D100E6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/UL|||||HZ/S||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|HEMOLYZED|Y|IRON HEMATOXYLIN STAIN|N|NA|Y||2||58||OPEN LABEL TREATMENT|1963-11-27|1967-11-01|||||1963-03-26||1969-05-02
TRIAL STUDY 134XCP|IS|937BF41A-157D-45F6-9797-2C5D19D100E6||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TCID 50/DOSE|||||CI/MG||||HIGH|NOT DONE|||EPIDERMAL TISSUE|DRIED|U|SISH|NA|NA|U||3||39||LONG-TERM FOLLOW-UP|1964-01-16|1972-12-15|||||1960-10-26||1960-09-11
TRIAL STUDY 134XCP|IS|937BF41A-157D-45F6-9797-2C5D19D100E6||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UM|||||PMOL/G||||HIGH|NOT DONE|||VENOUS BLOOD|REFRIGERATED|NA|ORCHIDOMETERY|N|Y|U||4||88||BLINDED TREATMENT|1972-12-20|1969-02-22|||||1973-07-17||1963-12-04
TRIAL STUDY 134XCP|IS|937BF41A-157D-45F6-9797-2C5D19D100E6||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PSI|||||HZ/S||||LOW|NOT DONE|||BILE|CLOTTED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|U|U|U||5||7||BLINDED TREATMENT|1961-02-09|1961-03-21|||||1966-03-05||1970-04-02
TRIAL STUDY 134XCP|IS|1BA56D89-E536-491E-AD6A-190A07331BEA||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PA|||||ML/100G/MIN||||LOW|NOT DONE|||SERUM OR PLASMA|HEMOLYZED|NA|TWO-COLOR MICROARRAY|U|U|N||1||38||LONG-TERM FOLLOW-UP|1965-09-10|1962-08-16|||||1963-11-10||1963-09-13
TRIAL STUDY 134XCP|IS|1BA56D89-E536-491E-AD6A-190A07331BEA||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 COPIES/ML|||||CD*S/M2||||ABNORMAL|NOT DONE|||SKIN TISSUE|THAWED|N|SCANNING ELECTRON MICROSCOPY|Y|Y|NA||2||58||FOLLOW-UP|1960-07-25|1960-07-15|||||1970-02-13||1970-10-11
TRIAL STUDY 134XCP|IS|1BA56D89-E536-491E-AD6A-190A07331BEA||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU/KG|||||MESF||||LOW|NOT DONE|||VENOUS BLOOD|NON-HEMOLYZED|N|INTRAVASCULAR ULTRASOUND|Y|Y|N||3||39||CONTINUATION TREATMENT|1964-05-06|1960-10-03|||||1967-05-19||1967-01-28
TRIAL STUDY 134XCP|IS|1BA56D89-E536-491E-AD6A-190A07331BEA||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL BCE/MMOL|||||ML/CM3/MIN||||LOW|NOT DONE|||SUPERNATANT, PLASMA|REFRIGERATED|NA|ACRIDINE ORANGE STAIN|N|U|N||4||88||BASELINE|1961-03-31|1973-01-19|||||1973-03-23||1960-09-15
TRIAL STUDY 134XCP|IS|1BA56D89-E536-491E-AD6A-190A07331BEA||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||TAMPON|||||APL U/ML||||HIGH|NOT DONE|||BLOOD|UNEXPECTED ODOR|U|CLAUSS METHOD|Y|Y|U||5||7||INDUCTION TREATMENT|1967-12-28|1968-07-17|||||1971-03-23||1964-08-03
TRIAL STUDY 134XCP|IS|BE208D93-7322-427F-A8E5-1DBE5040BE8F||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||EJACULATE U|||||MM3/MM2/YEAR||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|GELLED|NA|PET/SPECT SCAN|NA|NA|U||1||38||WASHOUT|1960-02-01|1960-10-11|||||1968-08-08||1971-05-15
TRIAL STUDY 134XCP|IS|BE208D93-7322-427F-A8E5-1DBE5040BE8F||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MEQ/L|||||UKAT/L||||HIGH|NOT DONE|||BLOOD|HEMOLYZED|N|ORCHIDOMETERY|N|NA|N||2||58||INDUCTION TREATMENT|1973-08-28|1971-04-25|||||1963-02-20||1967-07-08
TRIAL STUDY 134XCP|IS|BE208D93-7322-427F-A8E5-1DBE5040BE8F||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMOL/S|||||NEBULE||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|CONCENTRATED|Y|MICRONEUTRALIZATION ASSAY|Y|Y|NA||3||39||BLINDED TREATMENT|1972-09-23|1963-07-18|||||1968-12-01||1969-07-26
TRIAL STUDY 134XCP|IS|BE208D93-7322-427F-A8E5-1DBE5040BE8F||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EQ|||||PG/CELL||||ABNORMAL|NOT DONE|||TISSUE|LIPEMIC|U|KLEIHAUER-BETKE|NA|Y|N||4||88||FOLLOW-UP|1964-10-23|1971-03-14|||||1965-03-22||1961-12-23
TRIAL STUDY 134XCP|IS|BE208D93-7322-427F-A8E5-1DBE5040BE8F||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/KG/H|||||/10^5||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|N|KARYOTYPING|NA|N|N||5||7||FOLLOW-UP|1972-03-05|1963-01-28|||||1965-06-25||1971-12-15
TRIAL STUDY 134XCP|IS|A58C5E7B-21EC-4F59-BB74-3264AC945F61||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CM H2O|||||CARTRIDGE||||NORMAL|NOT DONE|||VITREOUS HUMOR|HEMOLYZED|N|HPLC|NA|U|NA||1||38||WASHOUT|1967-12-24|1969-12-13|||||1969-04-15||1971-01-06
TRIAL STUDY 134XCP|IS|A58C5E7B-21EC-4F59-BB74-3264AC945F61||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/2000 RBC|||||PMOL||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CLOTTED|Y|REFRACTOMETRY|U|U|NA||2||58||LONG-TERM FOLLOW-UP|1960-06-11|1969-11-14|||||1969-08-11||1968-12-30
TRIAL STUDY 134XCP|IS|A58C5E7B-21EC-4F59-BB74-3264AC945F61||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PL|||||DAMOL/L||||NORMAL|NOT DONE|||URINE SEDIMENT|THAWED|NA|MULTI-SLICE SPIRAL CT|Y|NA|N||3||39||BASELINE|1969-05-15|1962-03-22|||||1962-11-19||1960-10-12
TRIAL STUDY 134XCP|IS|A58C5E7B-21EC-4F59-BB74-3264AC945F61||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ELISA UNIT/ML|||||POINT||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|REFRIGERATED|Y|SPIRAL CT SCAN WITHOUT CONTRAST|NA|NA|U||4||88||SCREENING|1964-05-31|1973-09-05|||||1964-09-05||1962-03-04
TRIAL STUDY 134XCP|IS|A58C5E7B-21EC-4F59-BB74-3264AC945F61||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||WEEKS|||||ELISA UNIT/DOSE||||NORMAL|NOT DONE|||GASTRIC FLUID|CALCIFIED|U|DNA MICROARRAY|NA|N|U||5||7||OPEN LABEL TREATMENT|1966-08-10|1961-08-03|||||1968-05-17||1971-05-29
TRIAL STUDY 134XCP|IS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3 ORGANISMS|||||G/KG||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|DRIED|Y|FUNDUS PHOTOGRAPHY|NA|N|NA||1||38||CONTINUATION TREATMENT|1962-11-14|1969-05-07|||||1963-06-02||1969-02-09
TRIAL STUDY 134XCP|IS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/MG|||||NMOL/MOL||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|ROOM TEMPERATURE|Y|GEL ELECTROPHORESIS|N|N|U||2||58||BLINDED TREATMENT|1960-05-02|1964-03-15|||||1962-03-03||1967-09-25
TRIAL STUDY 134XCP|IS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FOZ_BR|||||DEG2||||HIGH|NOT DONE|||HAIR FOLLICLE|LIPEMIC|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|N|N|N||3||39||FOLLOW-UP|1970-10-13|1970-10-10|||||1971-08-27||1972-09-03
TRIAL STUDY 134XCP|IS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAPLET|||||AMOL||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|CLOTTED|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NA|NA|Y||4||88||OBSERVATION|1966-03-28|1962-02-19|||||1963-07-28||1966-10-03
TRIAL STUDY 134XCP|IS|470EB5DB-57D1-4D39-8C30-1444C88DB4E2||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FOZ_BR|||||STEPS||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|CONTAMINATED|N|POTENTIOMETRY|Y|Y|N||5||7||WASHOUT|1961-08-10|1965-02-26|||||1965-03-18||1970-07-27
TRIAL STUDY 134XCP|IS|434B4F6A-C436-4F92-8FA5-9C2F1964098A||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PNU/ML|||||PFU/DOSE||||LOW|NOT DONE|||PUS|NON-HEMOLYZED|Y|FLAME PHOTOMETRY|Y|NA|NA||1||38||OBSERVATION|1963-08-03|1966-02-18|||||1965-04-26||1973-05-01
TRIAL STUDY 134XCP|IS|434B4F6A-C436-4F92-8FA5-9C2F1964098A||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/S|||||G||||ABNORMAL|NOT DONE|||TISSUE|PARAFFIN-EMBEDDED|N|SPECTROPHOTOMETRY|NA|N|NA||2||58||TREATMENT|1968-05-27|1966-08-22|||||1969-02-07||1970-04-26
TRIAL STUDY 134XCP|IS|434B4F6A-C436-4F92-8FA5-9C2F1964098A||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||WAFER|||||PMOL/DAY||||ABNORMAL|NOT DONE|||MUCUS|AGGLUTINATED|U|TEST STRIP|U|NA|N||3||39||SCREENING|1962-03-22|1970-09-10|||||1961-08-09||1962-03-05
TRIAL STUDY 134XCP|IS|434B4F6A-C436-4F92-8FA5-9C2F1964098A||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/ANIMAL|||||UG/KG||||HIGH|NOT DONE|||SPERMATOZOON|HEMOLYZED|Y|DARK FIELD MICROSCOPY|Y|U|N||4||88||INDUCTION TREATMENT|1972-10-05|1971-10-04|||||1960-10-30||1967-10-24
TRIAL STUDY 134XCP|IS|434B4F6A-C436-4F92-8FA5-9C2F1964098A||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PPB|||||MOL||||HIGH|NOT DONE|||RETICULOCYTES|FROZEN|N|WHOLE EXOME SEQUENCING|Y|N|NA||5||7||WASHOUT|1965-04-05|1968-03-04|||||1972-06-25||1961-09-21
TRIAL STUDY 134XCP|IS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GPL U|||||IU||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|ROOM TEMPERATURE|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|NA|NA|U||1||38||CONTINUATION TREATMENT|1964-12-09|1963-01-13|||||1965-03-19||1961-02-03
TRIAL STUDY 134XCP|IS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PACKET|||||10^7 TCID 50/DOSE||||LOW|NOT DONE|||VENOUS BLOOD|HEMOLYZED|Y|DARK FIELD MICROSCOPY|N|NA|NA||2||58||SCREENING|1965-04-02|1973-07-17|||||1968-01-17||1964-02-28
TRIAL STUDY 134XCP|IS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CUP|||||OZ||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|LIPEMIC|Y|LINE PROBE ASSAY|N|Y|NA||3||39||CONTINUATION TREATMENT|1965-01-31|1965-05-07|||||1966-09-24||1962-10-18
TRIAL STUDY 134XCP|IS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CM H2O|||||MG/KG/WEEK||||HIGH|NOT DONE|||EMESIS|AGGLUTINATED|U|REFLECTANCE SPECTROSCOPY|Y|N|U||4||88||BASELINE|1965-06-28|1962-10-28|||||1967-07-10||1965-03-26
TRIAL STUDY 134XCP|IS|F50D12BE-0D22-4347-BE0B-A61EF6CC1FC7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/S/M2|||||MG/ML/DAY||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|NA|HPLC/MS|Y|NA|NA||5||7||RUN-IN|1966-12-03|1970-07-25|||||1973-06-24||1972-09-29
TRIAL STUDY 134XCP|IS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MOSM/L|||||SIEMENS||||NORMAL|NOT DONE|||CAPILLARY PLASMA|CLOTTED|N|ELISA|Y|U|NA||1||38||INDUCTION TREATMENT|1960-03-14|1965-10-12|||||1969-12-01||1960-06-08
TRIAL STUDY 134XCP|IS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/2500 WBC|||||MV||||HIGH|NOT DONE|||CORD SERUM|THAWED|U|GC/MS-CI|NA|U|N||2||58||SCREENING|1972-07-24|1961-09-13|||||1963-07-19||1972-11-26
TRIAL STUDY 134XCP|IS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 CFU|||||DAYS/MONTH||||NORMAL|NOT DONE|||EXUDATE|SOLIDIFIED|N|SNP ARRAY|NA|NA|NA||3||39||RUN-IN|1968-02-01|1960-09-28|||||1961-07-22||1971-05-24
TRIAL STUDY 134XCP|IS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CUP EQ|||||10^5/HPF||||NORMAL|NOT DONE|||GASTRIC FLUID|ROOM TEMPERATURE|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|NA|Y|N||4||88||BLINDED TREATMENT|1967-01-28|1964-11-13|||||1968-09-09||1964-05-31
TRIAL STUDY 134XCP|IS|EAEE4DF4-21F6-41EA-9CA0-CC49C9B323EB||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MV|||||NMOL/G||||LOW|NOT DONE|||LOCHIA|ICTERIC|Y|MAGNETIC RESONANCE ELASTOGRAPHY|NA|Y|N||5||7||CONTINUATION TREATMENT|1968-08-02|1966-03-09|||||1966-02-18||1970-10-22
TRIAL STUDY 134XCP|IS|73C4A4D7-2177-47F3-818A-C0774F5E4A08||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LOZENGE|||||U/ANIMAL||||HIGH|NOT DONE|||CELL PELLET|UNEXPECTED ODOR|N|LAPAROSCOPY|Y|NA|N||1||38||FOLLOW-UP|1960-01-15|1969-02-02|||||1973-01-25||1963-12-27
TRIAL STUDY 134XCP|IS|73C4A4D7-2177-47F3-818A-C0774F5E4A08||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G/KG/DAY|||||MMOL/KG||||NORMAL|NOT DONE|||BUFFY COAT|ROOM TEMPERATURE|NA|CALCULATION|NA|U|N||2||58||WASHOUT|1971-06-08|1968-10-14|||||1972-05-28||1962-09-26
TRIAL STUDY 134XCP|IS|73C4A4D7-2177-47F3-818A-C0774F5E4A08||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ABSORBANCE U/MIN|||||MMHG||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|GELLED|Y|ISHIHARA COLOR PLATES|U|N|N||3||39||WASHOUT|1965-04-12|1966-01-30|||||1968-09-05||1960-10-04
TRIAL STUDY 134XCP|IS|73C4A4D7-2177-47F3-818A-C0774F5E4A08||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||USIEMENS|||||UG/M2||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CALCIFIED|NA|THIN SMEAR|NA|NA|Y||4||88||SCREENING|1963-05-21|1967-06-22|||||1964-02-09||1969-06-21
TRIAL STUDY 134XCP|IS|73C4A4D7-2177-47F3-818A-C0774F5E4A08||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/CAGE|||||FMOL||||LOW|NOT DONE|||LYSATE|CLOTTED|Y|FREEZING POINT DEPRESSION|N|U|U||5||7||WASHOUT|1964-11-19|1970-08-05|||||1971-12-09||1961-01-27
TRIAL STUDY 134XCP|IS|4E3929B3-63F2-4E89-8EB4-60991E7284E1||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UM/S|||||MM||||HIGH|NOT DONE|||SALIVA|GELLED|Y|ECHOCARDIOGRAPHY|U|Y|Y||1||38||WASHOUT|1973-05-08|1969-05-03|||||1963-04-03||1962-04-07
TRIAL STUDY 134XCP|IS|4E3929B3-63F2-4E89-8EB4-60991E7284E1||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^3/HPF|||||CD*S/M2||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|AGGLUTINATED|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|N|U|Y||2||58||OBSERVATION|1969-08-31|1963-12-02|||||1967-11-08||1968-07-19
TRIAL STUDY 134XCP|IS|4E3929B3-63F2-4E89-8EB4-60991E7284E1||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3/HPF|||||SUPPOSITORY||||LOW|NOT DONE|||PLASMA|PARAFFIN-EMBEDDED|NA|PAP STAIN|NA|NA|Y||3||39||BLINDED TREATMENT|1972-11-11|1968-12-22|||||1969-10-06||1963-08-05
TRIAL STUDY 134XCP|IS|4E3929B3-63F2-4E89-8EB4-60991E7284E1||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GY|||||H*%||||LOW|NOT DONE|||EPITHELIAL CELL|DRIED|NA|MICROSCOPY|Y|N|N||4||88||TREATMENT|1973-03-25|1961-09-13|||||1972-04-30||1970-03-19
TRIAL STUDY 134XCP|IS|4E3929B3-63F2-4E89-8EB4-60991E7284E1||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||HR/DAY|||||MMOL/G||||LOW|NOT DONE|||PERSPIRATION|CALCIFIED|U|PERFUSION MRI|U|Y|Y||5||7||BLINDED TREATMENT|1962-02-03|1965-09-08|||||1964-02-18||1972-08-13
TRIAL STUDY 134XCP|IS|F26E2F67-3F90-448C-92BB-AD60E71D5664||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^3 ORGANISMS|||||MEQ||||ABNORMAL|NOT DONE|||BREAST MILK|CALCIFIED|NA|BETA LACTAMASE|Y|NA|Y||1||38||RUN-IN|1971-07-31|1970-08-30|||||1962-06-03||1972-11-24
TRIAL STUDY 134XCP|IS|F26E2F67-3F90-448C-92BB-AD60E71D5664||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PFU/ML|||||GLOBULE||||LOW|NOT DONE|||SUPERNATANT, SERUM|LIPEMIC|N|MICRODENSITOMETRY|U|Y|N||2||58||SCREENING|1962-10-31|1965-01-26|||||1965-12-23||1966-08-06
TRIAL STUDY 134XCP|IS|F26E2F67-3F90-448C-92BB-AD60E71D5664||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3 ORGANISMS|||||VG/DOSE||||LOW|NOT DONE|||BASAL TEAR|CALCIFIED|N|RAJI CELL RIA|U|U|U||3||39||BASELINE|1972-03-02|1966-07-28|||||1968-07-18||1965-09-21
TRIAL STUDY 134XCP|IS|F26E2F67-3F90-448C-92BB-AD60E71D5664||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/MIN/MMHG|||||KV||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|CONTAMINATED|NA|POLYSOMNOGRAPHY|U|U|N||4||88||RUN-IN|1965-08-17|1964-11-17|||||1962-01-07||1970-05-17
TRIAL STUDY 134XCP|IS|F26E2F67-3F90-448C-92BB-AD60E71D5664||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^9 CFU/G|||||U/G||||NORMAL|NOT DONE|||CORD BLOOD|CONCENTRATED|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|NA|N||5||7||BASELINE|1971-05-03|1967-11-12|||||1965-06-22||1970-09-07
TRIAL STUDY 134XCP|IS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TRANSDUCING UNIT|||||IU/ML||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|ICTERIC|Y|SNELLEN EYE CHART|NA|U|NA||1||38||TREATMENT|1973-03-11|1968-10-25|||||1970-08-04||1964-03-21
TRIAL STUDY 134XCP|IS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/MOL|||||DAGU/ML||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|SOLIDIFIED|U|SLIT LAMP PHOTOGRAPHY|NA|NA|Y||2||58||TREATMENT|1970-05-11|1965-10-05|||||1965-07-19||1960-12-12
TRIAL STUDY 134XCP|IS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/G/H|||||10^10/L||||HIGH|NOT DONE|||SEMEN|PARAFFIN-EMBEDDED|NA|MANUAL COUNT|NA|NA|Y||3||39||CONTINUATION TREATMENT|1963-06-09|1968-09-10|||||1961-08-26||1961-12-05
TRIAL STUDY 134XCP|IS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||OZ|||||/40 HPFS||||LOW|NOT DONE|||REFLEX TEAR|FRESH|N|ULTRASOUND|N|Y|N||4||88||BASELINE|1972-07-01|1968-11-06|||||1973-01-04||1971-07-17
TRIAL STUDY 134XCP|IS|3D3F1B3A-DDC4-43C1-A4C1-AA775C3AC980||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ANTIBODY UNIT|||||MIN/DAY||||HIGH|NOT DONE|||MUSCLE TISSUE|DRIED|Y|PUPILLOMETRY|U|Y|NA||5||7||LONG-TERM FOLLOW-UP|1973-04-12|1962-08-19|||||1967-10-27||1968-03-13
TRIAL STUDY 134XCP|IS|F2F1151C-F987-49CE-BC16-719DD339DBE7||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SBE/ML|||||DPM/100MG||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|THAWED|Y|PET/SPECT SCAN|NA|U|Y||1||38||OBSERVATION|1970-12-20|1967-02-22|||||1966-09-17||1970-04-20
TRIAL STUDY 134XCP|IS|F2F1151C-F987-49CE-BC16-719DD339DBE7||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/MG|||||10^9/DOSE||||LOW|NOT DONE|||SKIN TISSUE|CONCENTRATED|Y|SLIT LAMP PHOTOGRAPHY|U|U|U||2||58||CONTINUATION TREATMENT|1962-12-17|1961-10-28|||||1973-03-22||1967-04-16
TRIAL STUDY 134XCP|IS|F2F1151C-F987-49CE-BC16-719DD339DBE7||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NMOL/KG/DAY|||||MANSON U/ML||||LOW|NOT DONE|||PLEURAL FLUID|GELLED|Y|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|Y|N||3||39||FOLLOW-UP|1967-04-09|1961-02-15|||||1970-02-12||1961-07-24
TRIAL STUDY 134XCP|IS|F2F1151C-F987-49CE-BC16-719DD339DBE7||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MAC50|||||MPH||||HIGH|NOT DONE|||SALIVA|CONCENTRATED|NA|CHROMATOGRAPHY|U|U|NA||4||88||CONTINUATION TREATMENT|1963-03-09|1970-03-04|||||1967-05-27||1962-10-06
TRIAL STUDY 134XCP|IS|F2F1151C-F987-49CE-BC16-719DD339DBE7||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MM3/MM2/YEAR|||||U/MG||||NORMAL|NOT DONE|||VENOUS BLOOD|ICTERIC|NA|PERIODIC ACID SCHIFF STAIN|NA|U|U||5||7||SCREENING|1969-05-22|1968-08-19|||||1964-04-21||1962-06-26
TRIAL STUDY 134XCP|IS|F88FCFA6-90D7-4033-86DF-223A63A6152D||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||AG|||||UIU/DL||||HIGH|NOT DONE|||LEUKOCYTE|FROZEN|NA|DROPLET DIGITAL PCR|U|NA|Y||1||38||FOLLOW-UP|1970-03-28|1964-01-14|||||1971-12-27||1966-09-24
TRIAL STUDY 134XCP|IS|F88FCFA6-90D7-4033-86DF-223A63A6152D||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BAU|||||UG/L FEU||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|AUTOLYZED|N|SLOAN LETTER EYE CHART 100%|Y|U|NA||2||58||OPEN LABEL TREATMENT|1968-02-09|1966-06-25|||||1962-09-07||1973-07-17
TRIAL STUDY 134XCP|IS|F88FCFA6-90D7-4033-86DF-223A63A6152D||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/KG/MIN|||||DEG2||||HIGH|NOT DONE|||VITREOUS HUMOR|THAWED|Y|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|N|Y|NA||3||39||WASHOUT|1971-04-26|1971-01-07|||||1965-10-19||1966-10-06
TRIAL STUDY 134XCP|IS|F88FCFA6-90D7-4033-86DF-223A63A6152D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HOUNSFIELD UNIT|||||PMOL/DL||||NORMAL|NOT DONE|||BREAST MILK|CONCENTRATED|N|CT SCAN|N|Y|N||4||88||SCREENING|1970-12-19|1970-09-12|||||1969-05-25||1965-09-22
TRIAL STUDY 134XCP|IS|F88FCFA6-90D7-4033-86DF-223A63A6152D||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KUSP|||||AMU||||LOW|NOT DONE|||REFLEX TEAR|PARAFFIN-EMBEDDED|NA|HPLC-UV|Y|U|Y||5||7||TREATMENT|1973-02-17|1971-09-19|||||1970-08-29||1966-04-19
TRIAL STUDY 134XCP|IS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/SEC|||||IU/MMOL||||NORMAL|NOT DONE|||VITREOUS HUMOR|FRESH|NA|SURFACE PLASMON RESONANCE|Y|N|NA||1||38||OBSERVATION|1961-09-07|1962-11-16|||||1961-08-18||1966-04-02
TRIAL STUDY 134XCP|IS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/G|||||UMOL/MIN||||HIGH|NOT DONE|||SUPERNATANT, SERUM|FROZEN|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|NA|N|Y||2||58||TREATMENT|1965-02-08|1968-03-07|||||1970-01-30||1965-11-15
TRIAL STUDY 134XCP|IS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/200 HPFS|||||UEQ||||NORMAL|NOT DONE|||LEUKOCYTE|SOLIDIFIED|N|OLIGO ACGH|Y|Y|N||3||39||LONG-TERM FOLLOW-UP|1970-11-27|1964-10-16|||||1960-09-02||1972-11-02
TRIAL STUDY 134XCP|IS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DEG|||||COPIES/UG||||LOW|NOT DONE|||ABSCESS FLUID|NON-HEMOLYZED|Y|EEG|Y|N|N||4||88||LONG-TERM FOLLOW-UP|1962-01-14|1964-06-21|||||1965-10-23||1960-01-28
TRIAL STUDY 134XCP|IS|F8D7D2AA-6125-450D-B71D-6109FFA1AC3E||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UU/L|||||SUPPOSITORY||||HIGH|NOT DONE|||SERUM OR PLASMA|AGGLUTINATED|U|MICROBIAL CULTURE, SOLID|Y|Y|N||5||7||LONG-TERM FOLLOW-UP|1964-09-09|1961-10-13|||||1966-08-29||1973-03-14
TRIAL STUDY 134XCP|IS|7D35B2F5-7334-448B-B4E1-14671B850B6A||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MPL U/ML|||||EJACULATE U||||HIGH|NOT DONE|||URINE SEDIMENT|HEMOLYZED|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y|NA|Y||1||38||BASELINE|1970-04-14|1969-02-22|||||1964-07-10||1965-08-22
TRIAL STUDY 134XCP|IS|7D35B2F5-7334-448B-B4E1-14671B850B6A||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PM|||||MMOL||||ABNORMAL|NOT DONE|||BUFFY COAT|CONCENTRATED|NA|IMMUNOFIXATION ELECTROPHORESIS|N|U|N||2||58||WASHOUT|1969-01-22|1962-10-23|||||1972-08-09||1970-02-02
TRIAL STUDY 134XCP|IS|7D35B2F5-7334-448B-B4E1-14671B850B6A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV|||||ML/CAGE||||NORMAL|NOT DONE|||DISCHARGE|SOLIDIFIED|NA|WESTERGREN|Y|NA|NA||3||39||TREATMENT|1971-05-07|1972-08-24|||||1973-09-05||1970-03-22
TRIAL STUDY 134XCP|IS|7D35B2F5-7334-448B-B4E1-14671B850B6A||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ABSORBANCE U/MIN|||||APL U/ML||||ABNORMAL|NOT DONE|||VENOUS PLASMA|ICTERIC|NA|IMMUNODIFFUSION|NA|NA|NA||4||88||INDUCTION TREATMENT|1964-04-03|1971-05-07|||||1968-09-14||1962-04-05
TRIAL STUDY 134XCP|IS|7D35B2F5-7334-448B-B4E1-14671B850B6A||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||WAFER|||||/VF||||NORMAL|NOT DONE|||SERUM|HEMOLYZED|NA|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|Y|N||5||7||OBSERVATION|1969-08-27|1970-07-07|||||1965-08-17||1969-05-09
TRIAL STUDY 134XCP|IS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||APPLICATION|||||U/KG||||ABNORMAL|NOT DONE|||CELL PELLET|LACTESCENT|U|ELECTRICAL IMPEDANCE MYOGRAPHY|N|U|U||1||38||SCREENING|1970-11-08|1969-06-05|||||1960-07-08||1972-01-25
TRIAL STUDY 134XCP|IS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||HOUNSFIELD UNIT|||||/SEC||||NORMAL|NOT DONE|||SMEGMA|DRIED|Y|MAPH|NA|Y|U||2||58||FOLLOW-UP|1962-04-26|1969-07-13|||||1966-11-25||1960-01-12
TRIAL STUDY 134XCP|IS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PATCH|||||CUP EQ||||ABNORMAL|NOT DONE|||EXPIRED AIR|PARAFFIN-EMBEDDED|N|ACCELERATOR MASS SPECTROMETRY|U|U|U||3||39||RUN-IN|1972-01-15|1963-06-28|||||1969-05-08||1962-08-11
TRIAL STUDY 134XCP|IS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||V/SEC|||||DIOPTER||||ABNORMAL|NOT DONE|||DISCHARGE|CONCENTRATED|N|MRS|U|NA|NA||4||88||INDUCTION TREATMENT|1966-03-03|1969-09-02|||||1973-06-29||1969-06-06
TRIAL STUDY 134XCP|IS|8FDF7A91-BB16-4A4D-8D35-F1B1B40719E9||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/CL|||||G/ANIMAL/WK||||HIGH|NOT DONE|||SALIVA|REFRIGERATED|N|PERIODIC ACID SCHIFF STAIN|Y|NA|N||5||7||CONTINUATION TREATMENT|1961-01-06|1972-12-20|||||1969-02-07||1961-04-25
TRIAL STUDY 134XCP|IS|B09D371C-2E5C-4F84-986E-5A603C0C4A28||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANSON U|||||CI/ML||||LOW|NOT DONE|||ADIPOSE TISSUE|CONTAMINATED|Y|EEG|U|NA|U||1||38||WASHOUT|1960-12-13|1972-02-05|||||1972-11-28||1960-01-05
TRIAL STUDY 134XCP|IS|B09D371C-2E5C-4F84-986E-5A603C0C4A28||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/ANIMAL|||||ATM||||LOW|NOT DONE|||VITREOUS HUMOR|CALCIFIED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NA|NA|NA||2||58||LONG-TERM FOLLOW-UP|1965-02-07|1962-09-19|||||1973-03-31||1971-11-14
TRIAL STUDY 134XCP|IS|B09D371C-2E5C-4F84-986E-5A603C0C4A28||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/KG|||||PIPE||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|LIPEMIC|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NA|NA|U||3||39||BLINDED TREATMENT|1971-09-17|1966-10-05|||||1960-12-29||1964-02-29
TRIAL STUDY 134XCP|IS|B09D371C-2E5C-4F84-986E-5A603C0C4A28||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UEQ|||||KN/CM2||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|NON-HEMOLYZED|Y|HPLC-FL|U|U|Y||4||88||TREATMENT|1965-12-05|1960-12-17|||||1969-02-16||1972-05-11
TRIAL STUDY 134XCP|IS|B09D371C-2E5C-4F84-986E-5A603C0C4A28||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||COULOMB|||||GBQ||||ABNORMAL|NOT DONE|||SERUM|DRIED|U|MICROBIAL CULTURE, SOLID|U|Y|NA||5||7||OBSERVATION|1967-11-23|1961-10-06|||||1964-11-23||1961-06-11
TRIAL STUDY 134XCP|IS|11CB653E-F113-4639-B15C-B236A2F65F47||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PA|||||10^9 CFU/G||||NORMAL|NOT DONE|||SALIVA|CALCIFIED|U|NO INFORMATION|Y|N|NA||1||38||CONTINUATION TREATMENT|1967-06-29|1973-07-23|||||1961-12-17||1972-03-09
TRIAL STUDY 134XCP|IS|11CB653E-F113-4639-B15C-B236A2F65F47||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BREATHS/30S|||||MKAT||||LOW|NOT DONE|||PLATELET POOR PLASMA|HEMOLYZED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|NA|N||2||58||LONG-TERM FOLLOW-UP|1961-11-13|1968-12-07|||||1971-10-05||1968-02-09
TRIAL STUDY 134XCP|IS|11CB653E-F113-4639-B15C-B236A2F65F47||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||RATIO|||||CI/KG||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|REFRIGERATED|Y|MRI WITHOUT CONTRAST|Y|U|NA||3||39||LONG-TERM FOLLOW-UP|1972-10-05|1971-04-19|||||1973-07-06||1960-07-14
TRIAL STUDY 134XCP|IS|11CB653E-F113-4639-B15C-B236A2F65F47||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG10 ELISA UNIT|||||ML/S||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|N|CELLULOSE TAPE|U|NA|N||4||88||FOLLOW-UP|1973-01-30|1960-12-09|||||1963-09-24||1968-07-25
TRIAL STUDY 134XCP|IS|11CB653E-F113-4639-B15C-B236A2F65F47||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||HENRY|||||10^6/G||||HIGH|NOT DONE|||SERUM OR PLASMA OR BLOOD|REFRIGERATED|NA|TRYPAN BLUE STAIN|N|Y|NA||5||7||OBSERVATION|1971-10-17|1966-12-11|||||1963-11-29||1972-04-28
TRIAL STUDY 134XCP|IS|2AB992E7-55B7-4327-987C-47FD605B7D78||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/DOSE|||||MG/KG||||ABNORMAL|NOT DONE|||NAIL|ROOM TEMPERATURE|NA|TRICHROME STAIN|N|N|U||1||38||OBSERVATION|1968-08-22|1961-01-07|||||1966-06-26||1971-12-03
TRIAL STUDY 134XCP|IS|2AB992E7-55B7-4327-987C-47FD605B7D78||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MOSM/L|||||PATCH||||NORMAL|NOT DONE|||HAIR FOLLICLE|NON-HEMOLYZED|N|IMMUNO-PET SCAN|NA|NA|U||2||58||BLINDED TREATMENT|1965-09-29|1967-11-13|||||1971-11-12||1970-10-29
TRIAL STUDY 134XCP|IS|2AB992E7-55B7-4327-987C-47FD605B7D78||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/100 WBC|||||CM H2O||||HIGH|NOT DONE|||ADIPOSE TISSUE|CLOTTED|U|SINGLE-SLICE SPIRAL CT|NA|N|Y||3||39||BLINDED TREATMENT|1963-09-06|1961-01-21|||||1965-03-25||1964-03-20
TRIAL STUDY 134XCP|IS|2AB992E7-55B7-4327-987C-47FD605B7D78||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FL|||||SACHET||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|ICTERIC|Y|LYMPHANGIOGRAPHY|NA|NA|N||4||88||TREATMENT|1972-01-16|1964-01-13|||||1970-11-03||1967-06-07
TRIAL STUDY 134XCP|IS|2AB992E7-55B7-4327-987C-47FD605B7D78||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NL|||||MMHG*MIN/L||||LOW|NOT DONE|||CEREBROSPINAL FLUID|CONTAMINATED|Y|ETDRS EYE CHART|N|Y|Y||5||7||RUN-IN|1960-06-21|1968-09-01|||||1970-01-29||1973-01-04
TRIAL STUDY 134XCP|IS|6AF1B0B0-9923-459A-8629-5E628400AD00||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GMFI|||||MPL U||||LOW|NOT DONE|||STOOL|ICTERIC|Y|ANGIOGRAPHY|NA|N|NA||1||38||RUN-IN|1960-10-05|1973-01-15|||||1964-12-12||1971-04-07
TRIAL STUDY 134XCP|IS|6AF1B0B0-9923-459A-8629-5E628400AD00||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^8/L|||||BREATHS/MIN||||ABNORMAL|NOT DONE|||MUCUS|LIPEMIC|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|N|U|U||2||58||BLINDED TREATMENT|1968-05-19|1972-10-03|||||1964-12-22||1965-10-08
TRIAL STUDY 134XCP|IS|6AF1B0B0-9923-459A-8629-5E628400AD00||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GLOBULE|||||MV||||ABNORMAL|NOT DONE|||CALCULUS|GELLED|NA|SPECULAR MICROSCOPY|NA|N|NA||3||39||LONG-TERM FOLLOW-UP|1973-06-07|1970-11-18|||||1968-02-20||1966-12-20
TRIAL STUDY 134XCP|IS|6AF1B0B0-9923-459A-8629-5E628400AD00||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/100G/MIN|||||MEQ/UG||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|AUTOLYZED|N|MUGA|Y|N|NA||4||88||BASELINE|1966-09-27|1971-08-27|||||1972-09-17||1967-08-19
TRIAL STUDY 134XCP|IS|6AF1B0B0-9923-459A-8629-5E628400AD00||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/KG/MIN|||||AMOL||||ABNORMAL|NOT DONE|||CORD SERUM|GELLED|Y|WHOLE EXOME SEQUENCING|U|Y|N||5||7||INDUCTION TREATMENT|1963-09-16|1960-02-01|||||1962-07-30||1965-12-02
TRIAL STUDY 134XCP|IS|E1305E4E-DF64-4FD1-B0B2-131459AB629D||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AMU|||||GBQ/UG||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED|NA|HEMAGGLUTINATION ASSAY|Y|NA|U||1||38||CONTINUATION TREATMENT|1964-11-11|1967-12-31|||||1971-03-10||1966-09-22
TRIAL STUDY 134XCP|IS|E1305E4E-DF64-4FD1-B0B2-131459AB629D||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DROP|||||CD/M2||||HIGH|NOT DONE|||CORD BLOOD|FRESH|NA|TEMPLATE INCISION METHOD|Y|N|N||2||58||INDUCTION TREATMENT|1961-04-18|1971-07-27|||||1966-04-19||1973-01-18
TRIAL STUDY 134XCP|IS|E1305E4E-DF64-4FD1-B0B2-131459AB629D||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GRAIN|||||L||||LOW|NOT DONE|||GASTRIC FLUID|ICTERIC|Y|PALM METHOD|NA|Y|NA||3||39||LONG-TERM FOLLOW-UP|1971-08-19|1966-07-04|||||1967-01-04||1967-12-20
TRIAL STUDY 134XCP|IS|E1305E4E-DF64-4FD1-B0B2-131459AB629D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/CAGE|||||UG/M2/DAY||||HIGH|NOT DONE|||AQUEOUS HUMOR|CLOTTED|Y|RADIATION DOSIMETRY|N|U|NA||4||88||OBSERVATION|1960-04-11|1964-02-04|||||1964-03-15||1968-03-12
TRIAL STUDY 134XCP|IS|E1305E4E-DF64-4FD1-B0B2-131459AB629D||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VG/ML|||||KM/H||||HIGH|NOT DONE|||GASTRIC FLUID|ICTERIC|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|U|Y||5||7||WASHOUT|1967-09-09|1970-12-01|||||1963-10-16||1963-02-19
TRIAL STUDY 134XCP|IS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/CAGE/WK|||||DAGU||||HIGH|NOT DONE|||URINE SEDIMENT|DRIED|NA|SPECT SCAN|NA|N|U||1||38||FOLLOW-UP|1965-01-05|1970-05-25|||||1963-08-05||1962-08-14
TRIAL STUDY 134XCP|IS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GBQ/G|||||GRAVITATIONAL UNIT||||HIGH|NOT DONE|||CELL PELLET|FROZEN|NA|NUCLEIC ACID HYBRIDIZATION|NA|U|U||2||58||BLINDED TREATMENT|1965-01-16|1963-04-27|||||1971-03-11||1972-08-04
TRIAL STUDY 134XCP|IS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||1/(S*KPA)|||||10^3 DNA COPIES/ML||||LOW|NOT DONE|||HAIR FOLLICLE|ICTERIC|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|N|NA|N||3||39||OPEN LABEL TREATMENT|1962-01-21|1968-05-08|||||1966-08-20||1967-03-22
TRIAL STUDY 134XCP|IS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||EQ|||||ABSORBANCE U||||LOW|NOT DONE|||SUPERNATANT, PLASMA|ROOM TEMPERATURE|N|KINETIC MICROPARTICLE IMMUNOASSAY|N|NA|Y||4||88||TREATMENT|1961-08-13|1960-08-16|||||1962-06-06||1973-02-20
TRIAL STUDY 134XCP|IS|9FEA7E3E-BEB9-4FD6-930D-5D724262B066||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||WEBER|||||/MM2||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|CLOTTED|NA|TARGETED TRANSCRIPTOME SEQUENCING|NA|NA|NA||5||7||RUN-IN|1970-04-19|1961-02-03|||||1968-02-08||1964-09-30
TRIAL STUDY 134XCP|IS|0FD7F837-3D76-4A1C-B414-373B55A39506||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GBQ/UG|||||CONTAINER||||HIGH|NOT DONE|||CALCULUS|THAWED|Y|SINGLE-MOLECULE ARRAY|NA|NA|U||1||38||SCREENING|1969-04-10|1962-03-16|||||1966-10-28||1970-04-18
TRIAL STUDY 134XCP|IS|0FD7F837-3D76-4A1C-B414-373B55A39506||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IU/ML|||||ML/BEAT||||HIGH|NOT DONE|||VENOUS PLASMA|ICTERIC|NA|SECONDARY ION MASS SPECTOMETRY|NA|Y|U||2||58||TREATMENT|1966-06-19|1960-05-10|||||1965-08-28||1968-01-01
TRIAL STUDY 134XCP|IS|0FD7F837-3D76-4A1C-B414-373B55A39506||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LX|||||10^7 TCID 50/DOSE||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|HEMOLYZED|NA|GC/MS|U|NA|NA||3||39||OPEN LABEL TREATMENT|1973-06-15|1962-02-02|||||1960-03-15||1964-06-17
TRIAL STUDY 134XCP|IS|0FD7F837-3D76-4A1C-B414-373B55A39506||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CI/UL|||||MNFI||||ABNORMAL|NOT DONE|||SMEGMA|CONCENTRATED|Y|TOLUIDINE BLUE STAIN|NA|Y|Y||4||88||RUN-IN|1969-04-17|1965-09-29|||||1971-03-27||1962-04-15
TRIAL STUDY 134XCP|IS|0FD7F837-3D76-4A1C-B414-373B55A39506||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PMOL/G|||||/10^5||||HIGH|NOT DONE|||EPIDERMAL TISSUE|THAWED|U|ENDPOINT DILUTION ASSAY|N|NA|Y||5||7||RUN-IN|1971-05-27|1964-05-05|||||1965-11-02||1960-09-13
TRIAL STUDY 134XCP|IS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KM|||||LOG10 ELISA UNIT||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|AGGLUTINATED|U|FLOW CYTOMETRY|U|NA|U||1||38||WASHOUT|1961-03-31|1971-07-29|||||1968-08-06||1963-03-30
TRIAL STUDY 134XCP|IS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PA|||||MMOL/G||||NORMAL|NOT DONE|||PLEURAL FLUID|GELLED|U|TRIPLE-PHASE MRI SCAN|NA|N|U||2||58||INDUCTION TREATMENT|1968-12-14|1962-01-14|||||1970-06-06||1963-03-27
TRIAL STUDY 134XCP|IS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GBQ|||||10^6 CFU/ML||||HIGH|NOT DONE|||EXUDATE|PARAFFIN-EMBEDDED|U|INTRAVASCULAR ULTRASOUND|NA|NA|NA||3||39||INDUCTION TREATMENT|1967-06-06|1964-08-28|||||1966-03-31||1961-01-20
TRIAL STUDY 134XCP|IS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/L FEU|||||IMPLANT||||ABNORMAL|NOT DONE|||PLATELET|THAWED|NA|SECONDARY ION MASS SPECTOMETRY|U|NA|U||4||88||FOLLOW-UP|1962-04-23|1963-08-30|||||1962-12-29||1961-12-14
TRIAL STUDY 134XCP|IS|B9FE22A2-67DF-44AC-BBC6-B911BB5957AA||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||M2|||||MG/KG||||LOW|NOT DONE|||CALCULUS|LIPEMIC|Y|MICRONEUTRALIZATION ASSAY|NA|NA|U||5||7||OPEN LABEL TREATMENT|1965-12-23|1972-07-30|||||1971-08-13||1962-03-12
TRIAL STUDY 134XCP|IS|92FB0125-67D2-41CC-9116-8C949F15614A||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMHG/L/MIN|||||ABSORBANCE U/MIN||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|SOLIDIFIED|Y|PHOROPTER|N|Y|Y||1||38||INDUCTION TREATMENT|1970-01-24|1972-10-03|||||1964-11-09||1968-10-11
TRIAL STUDY 134XCP|IS|92FB0125-67D2-41CC-9116-8C949F15614A||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OI50|||||KM||||LOW|NOT DONE|||PLATELET|PARAFFIN-EMBEDDED|N|CLOT DETECTION|NA|N|U||2||58||RUN-IN|1968-01-22|1969-08-13|||||1960-06-01||1971-12-27
TRIAL STUDY 134XCP|IS|92FB0125-67D2-41CC-9116-8C949F15614A||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CD*S/M2|||||U/G HB||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|AGGLUTINATED|NA|PEAK FLOWMETRY|NA|NA|Y||3||39||TREATMENT|1964-11-14|1968-02-16|||||1973-02-05||1960-01-16
TRIAL STUDY 134XCP|IS|92FB0125-67D2-41CC-9116-8C949F15614A||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UIU/L|||||MG/M2/DAY||||LOW|NOT DONE|||DISCHARGE|PARAFFIN-EMBEDDED|NA|MICRODENSITOMETRY|N|U|NA||4||88||WASHOUT|1972-10-15|1971-11-16|||||1972-09-20||1973-04-18
TRIAL STUDY 134XCP|IS|92FB0125-67D2-41CC-9116-8C949F15614A||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/M2/H|||||10^3/HPF||||LOW|NOT DONE|||ISOLATE|UNEXPECTED ODOR|Y|SPIRAL CT|NA|N|U||5||7||BLINDED TREATMENT|1965-09-05|1963-06-20|||||1973-02-01||1973-06-08
TRIAL STUDY 134XCP|IS|7042617F-0C29-4928-B3ED-9549A53BC195||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/H|||||M/SEC2||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|ROOM TEMPERATURE|N|URANYL ACETATE STAIN|N|U|NA||1||38||BASELINE|1972-07-28|1968-09-17|||||1970-08-16||1965-06-26
TRIAL STUDY 134XCP|IS|7042617F-0C29-4928-B3ED-9549A53BC195||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LENS|||||/KG||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ICTERIC|NA|ECHOCARDIOGRAPHY|N|Y|N||2||58||BASELINE|1973-05-20|1961-08-15|||||1969-05-02||1963-10-19
TRIAL STUDY 134XCP|IS|7042617F-0C29-4928-B3ED-9549A53BC195||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 PFU|||||AMPULE||||HIGH|NOT DONE|||SERUM|CLOTTED|U|FUNCTIONAL MRI|Y|N|Y||3||39||TREATMENT|1966-08-15|1969-08-05|||||1966-07-24||1967-06-06
TRIAL STUDY 134XCP|IS|7042617F-0C29-4928-B3ED-9549A53BC195||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||RPM|||||S^-1(%O2)^-1||||LOW|NOT DONE|||SEMINAL FLUID|CONCENTRATED|Y|CONTRAST ENHANCED X-RAY|Y|Y|U||4||88||SCREENING|1960-08-22|1963-04-03|||||1961-09-20||1965-07-28
TRIAL STUDY 134XCP|IS|7042617F-0C29-4928-B3ED-9549A53BC195||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PPTR|||||10^3 CFU/ML||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|GELLED|U|GC/MS|Y|NA|U||5||7||OBSERVATION|1972-05-29|1968-11-02|||||1971-05-23||1963-02-25
TRIAL STUDY 134XCP|IS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MPA|||||MM/2H||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|FRESH|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|NA|N||1||38||OPEN LABEL TREATMENT|1961-01-13|1966-02-17|||||1965-01-07||1967-07-17
TRIAL STUDY 134XCP|IS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||EQ|||||VG/DOSE||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|CONTAMINATED|U|LC/MS/MS|Y|U|U||2||58||OBSERVATION|1964-10-28|1962-07-25|||||1971-11-03||1962-12-05
TRIAL STUDY 134XCP|IS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PKAT|||||10^7/L||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|SOLIDIFIED|NA|REVERSE TRANSCRIPTASE PCR|U|Y|NA||3||39||CONTINUATION TREATMENT|1966-02-18|1965-07-28|||||1968-10-16||1962-06-28
TRIAL STUDY 134XCP|IS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GLOBULE|||||TORR||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|REFRIGERATED|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|U|U|N||4||88||BLINDED TREATMENT|1972-02-28|1963-06-01|||||1963-12-22||1963-01-01
TRIAL STUDY 134XCP|IS|C6707A8F-FA0D-4A20-BDF3-62F12465EEDD||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/MIN/1.73M2|||||/MONTH||||HIGH|NOT DONE|||CALCULUS|PARAFFIN-EMBEDDED|U|WESTERGREN|N|Y|N||5||7||INDUCTION TREATMENT|1961-09-29|1972-04-26|||||1962-07-06||1960-01-17
TRIAL STUDY 134XCP|IS|6633CC54-D711-4780-A833-A71756D8B234||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/M2/MIN|||||VG/ML||||HIGH|NOT DONE|||CELL PELLET|LACTESCENT|N|DNA MICROARRAY|N|Y|N||1||38||FOLLOW-UP|1967-03-10|1970-07-22|||||1970-02-04||1970-11-29
TRIAL STUDY 134XCP|IS|6633CC54-D711-4780-A833-A71756D8B234||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UEQ|||||/DAY||||HIGH|NOT DONE|||CAPILLARY PLASMA|AGGLUTINATED|Y|WHOLE TRANSCRIPTOME SEQUENCING|N|NA|N||2||58||TREATMENT|1965-11-18|1964-05-16|||||1964-01-23||1967-04-30
TRIAL STUDY 134XCP|IS|6633CC54-D711-4780-A833-A71756D8B234||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MIN*MG/ML|||||IN||||HIGH|NOT DONE|||NAIL|ICTERIC|NA|FLOCCULATION, CHARCOAL ENHANCED|N|NA|N||3||39||SCREENING|1960-02-02|1967-03-29|||||1965-03-11||1960-06-03
TRIAL STUDY 134XCP|IS|6633CC54-D711-4780-A833-A71756D8B234||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FMOL/L|||||CI/L||||LOW|NOT DONE|||CEREBROSPINAL FLUID|UNEXPECTED ODOR|Y|CALCOFLUOR WHITE STAIN|U|N|U||4||88||TREATMENT|1965-06-07|1960-04-11|||||1972-12-02||1967-03-11
TRIAL STUDY 134XCP|IS|6633CC54-D711-4780-A833-A71756D8B234||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/MIN/MMHG|||||10^9/G||||LOW|NOT DONE|||PERSPIRATION|CONCENTRATED|U|SLIT LAMP PHOTOGRAPHY|NA|U|N||5||7||CONTINUATION TREATMENT|1967-03-06|1970-09-29|||||1963-01-20||1965-12-17
TRIAL STUDY 134XCP|IS|84C642FE-6D84-4525-AB1C-15FAF740D63B||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OSM|||||NMOL/KG/DAY||||HIGH|NOT DONE|||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|N|TWO-COLOR MICROARRAY|Y|U|U||1||38||RUN-IN|1961-12-24|1960-09-05|||||1965-06-04||1961-11-19
TRIAL STUDY 134XCP|IS|84C642FE-6D84-4525-AB1C-15FAF740D63B||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/5X10^4 WBC|||||MEQ/MMOL||||NORMAL|NOT DONE|||ARTERIAL BLOOD|DRIED|Y|PANENDOSCOPY|Y|NA|Y||2||58||BLINDED TREATMENT|1967-04-25|1971-11-12|||||1966-07-28||1964-11-06
TRIAL STUDY 134XCP|IS|84C642FE-6D84-4525-AB1C-15FAF740D63B||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PIXELS/IN|||||10^6 CFU||||LOW|NOT DONE|||PLASMA|AGGLUTINATED|N|URANYL ACETATE STAIN|U|U|Y||3||39||SCREENING|1967-12-25|1970-12-27|||||1972-06-09||1967-12-25
TRIAL STUDY 134XCP|IS|84C642FE-6D84-4525-AB1C-15FAF740D63B||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GRAVITATIONAL UNIT|||||G/CAGE/DAY||||HIGH|NOT DONE|||SYNOVIAL FLUID|THAWED|NA|SCINTIGRAPHY|U|N|Y||4||88||SCREENING|1971-07-25|1964-07-04|||||1962-06-26||1963-03-05
TRIAL STUDY 134XCP|IS|84C642FE-6D84-4525-AB1C-15FAF740D63B||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/CM|||||NMOL/G||||LOW|NOT DONE|||MECONIUM|DRIED|NA|VIRUS PLAQUE ASSAY|NA|Y|N||5||7||OPEN LABEL TREATMENT|1962-05-23|1965-11-27|||||1960-11-01||1972-12-24
TRIAL STUDY 134XCP|IS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/CM H2O|||||/100 HPFS||||LOW|NOT DONE|||EMOTIONAL TEAR|LACTESCENT|N|ELASTOGRAPHY|N|Y|U||1||38||BLINDED TREATMENT|1964-09-29|1970-09-05|||||1963-02-20||1969-04-02
TRIAL STUDY 134XCP|IS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DPM/100MG|||||MOL/G||||NORMAL|NOT DONE|||CAPILLARY PLASMA|CONTAMINATED|N|AUSCULTATION|Y|N|U||2||58||BASELINE|1967-09-21|1969-11-16|||||1962-10-06||1963-04-22
TRIAL STUDY 134XCP|IS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TROCHE|||||U/10^12 RBC||||LOW|NOT DONE|||TISSUE|CONTAMINATED|N|PHASE CONTRAST MICROSCOPY|NA|N|NA||3||39||BLINDED TREATMENT|1968-03-28|1961-11-24|||||1971-11-25||1960-02-08
TRIAL STUDY 134XCP|IS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/S/M2|||||BEAM BREAKS||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|NA|FORCED OSCILLATION TECHNIQUE|N|N|U||4||88||OBSERVATION|1965-03-25|1970-01-24|||||1965-01-03||1961-11-27
TRIAL STUDY 134XCP|IS|1445FD45-1E9D-41C0-B81C-37E2FD2F20D7||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UL/ML|||||MG/G/H||||ABNORMAL|NOT DONE|||MECONIUM|LACTESCENT|NA|SPECULAR MICROSCOPY|NA|NA|N||5||7||BLINDED TREATMENT|1964-09-07|1960-06-14|||||1965-07-20||1965-08-03
TRIAL STUDY 134XCP|IS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||AG|||||EVENTS||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|CALCIFIED|Y|WHOLE EXOME SEQUENCING|N|Y|N||1||38||BASELINE|1964-09-08|1973-01-01|||||1963-10-19||1969-11-10
TRIAL STUDY 134XCP|IS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT/ML|||||MBQ||||HIGH|NOT DONE|||SERUM|PARAFFIN-EMBEDDED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|NA|U|N||2||58||TREATMENT|1965-08-30|1972-11-01|||||1970-11-17||1970-06-22
TRIAL STUDY 134XCP|IS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI|||||MM3/MM2/YEAR||||LOW|NOT DONE|||DIALYSIS FLUID|FROZEN|Y|FUNDUS PHOTOGRAPHY|Y|Y|NA||3||39||WASHOUT|1968-05-28|1970-09-20|||||1969-11-14||1964-06-23
TRIAL STUDY 134XCP|IS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6/HPF|||||KIT||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|REFRIGERATED|U|RULER MEASUREMENT METHOD|N|N|Y||4||88||BASELINE|1961-09-08|1971-02-17|||||1963-04-29||1965-12-18
TRIAL STUDY 134XCP|IS|AAF75D2D-0DF1-4A15-B7FC-1EEE65FFAC62||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||EID 50/DOSE|||||PFU/ANIMAL||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|FRESH|NA|STATIC PERIMETRY|N|N|NA||5||7||OBSERVATION|1965-04-15|1968-10-18|||||1960-08-09||1966-01-28
TRIAL STUDY 134XCP|IS|A0757669-2DF6-4E78-A021-9C777BEF5697||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||TROCHE|||||VP/ML||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|CLOTTED|Y|CT SCAN WITHOUT CONTRAST|N|NA|Y||1||38||INDUCTION TREATMENT|1967-01-02|1970-09-25|||||1964-07-05||1960-02-28
TRIAL STUDY 134XCP|IS|A0757669-2DF6-4E78-A021-9C777BEF5697||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PACK|||||NU/CL||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|UNEXPECTED ODOR|U|CENTRIFUGATION|Y|Y|NA||2||58||OBSERVATION|1973-07-03|1973-03-07|||||1965-02-14||1960-01-22
TRIAL STUDY 134XCP|IS|A0757669-2DF6-4E78-A021-9C777BEF5697||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/CAGE/DAY|||||/VF||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|GELLED|N|STATIC PERIMETRY|Y|NA|NA||3||39||BLINDED TREATMENT|1966-11-13|1966-09-02|||||1965-03-01||1960-11-23
TRIAL STUDY 134XCP|IS|A0757669-2DF6-4E78-A021-9C777BEF5697||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MAC50|||||UGEQ/L||||HIGH|NOT DONE|||MENSTRUAL BLOOD|SOLIDIFIED|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|U|N|Y||4||88||OBSERVATION|1965-05-26|1972-02-20|||||1968-03-21||1972-02-01
TRIAL STUDY 134XCP|IS|A0757669-2DF6-4E78-A021-9C777BEF5697||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BQ/UG|||||G/ANIMAL/DAY||||LOW|NOT DONE|||EPIDERMAL TISSUE|REFRIGERATED|U|OSCILLOMETRY|U|Y|Y||5||7||OPEN LABEL TREATMENT|1961-11-14|1964-03-19|||||1973-07-24||1960-07-24
TRIAL STUDY 134XCP|IS|DAF7255A-888D-43D3-97B8-5E432938747F||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/KG/MIN|||||UG/H||||LOW|NOT DONE|||SERUM|LACTESCENT|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|U|N|NA||1||38||CONTINUATION TREATMENT|1963-12-14|1971-06-26|||||1970-12-16||1960-06-30
TRIAL STUDY 134XCP|IS|DAF7255A-888D-43D3-97B8-5E432938747F||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAL|||||G/CAGE/DAY||||LOW|NOT DONE|||BLOOD|REFRIGERATED|Y|PANENDOSCOPY|U|Y|N||2||58||INDUCTION TREATMENT|1960-10-27|1970-05-18|||||1966-12-03||1965-07-09
TRIAL STUDY 134XCP|IS|DAF7255A-888D-43D3-97B8-5E432938747F||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/KG/DAY|||||IN2||||LOW|NOT DONE|||LUNG SURFACTANT|CONTAMINATED|N|PULSE OXIMETRY|N|Y|U||3||39||INDUCTION TREATMENT|1960-07-03|1967-11-08|||||1968-06-08||1965-08-04
TRIAL STUDY 134XCP|IS|DAF7255A-888D-43D3-97B8-5E432938747F||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||EP U|||||10^9/L||||NORMAL|NOT DONE|||FLUID|DRIED|NA|PHYSICAL EXAMINATION|Y|NA|NA||4||88||SCREENING|1969-07-25|1966-12-19|||||1966-05-03||1961-12-07
TRIAL STUDY 134XCP|IS|DAF7255A-888D-43D3-97B8-5E432938747F||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||S/H|||||CCID 50/ML||||LOW|NOT DONE|||EMOTIONAL TEAR|GELLED|Y|PH METER MEASUREMENT METHOD|U|N|U||5||7||SCREENING|1967-08-04|1963-09-06|||||1971-09-18||1966-07-13
TRIAL STUDY 134XCP|IS|51989FEC-B63E-4F58-B748-2FF5E73E5D14||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KDA|||||M/SEC2||||LOW|NOT DONE|||PLATELET RICH PLASMA|CALCIFIED|NA|OLIGO ACGH|NA|Y|NA||1||38||TREATMENT|1963-05-16|1962-06-28|||||1966-04-14||1961-09-20
TRIAL STUDY 134XCP|IS|51989FEC-B63E-4F58-B748-2FF5E73E5D14||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FT|||||EID 50/DOSE||||NORMAL|NOT DONE|||CORD SERUM|HEMOLYZED|Y|PHYSICAL EXAMINATION|U|NA|U||2||58||TREATMENT|1968-08-17|1966-03-16|||||1962-08-13||1972-10-06
TRIAL STUDY 134XCP|IS|51989FEC-B63E-4F58-B748-2FF5E73E5D14||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/ML/MIN|||||VIAL||||NORMAL|NOT DONE|||EMESIS|AGGLUTINATED|Y|MAPH|U|U|N||3||39||OBSERVATION|1960-07-28|1963-08-15|||||1972-06-26||1969-07-10
TRIAL STUDY 134XCP|IS|51989FEC-B63E-4F58-B748-2FF5E73E5D14||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/CM2|||||PPB||||HIGH|NOT DONE|||LYSATE|FRESH|Y|GEL ELECTROPHORESIS|Y|NA|NA||4||88||LONG-TERM FOLLOW-UP|1962-04-29|1964-02-24|||||1970-12-22||1968-11-26
TRIAL STUDY 134XCP|IS|51989FEC-B63E-4F58-B748-2FF5E73E5D14||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/MG/MIN|||||10^9 ORGANISMS/G||||ABNORMAL|NOT DONE|||TUMOR TISSUE|NON-HEMOLYZED|N|MASS SPECTROMETRY|U|Y|NA||5||7||CONTINUATION TREATMENT|1968-11-18|1966-08-14|||||1965-11-15||1967-05-08
TRIAL STUDY 134XCP|IS|776299DC-1CD5-448F-82C2-C1659CEE689D||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3 COPIES/ML|||||FINGERTIP UNIT||||ABNORMAL|NOT DONE|||PLASMA|REFRIGERATED|U|SURFACE PLASMON RESONANCE|NA|N|U||1||38||SCREENING|1967-10-07|1963-02-03|||||1962-10-31||1964-12-13
TRIAL STUDY 134XCP|IS|776299DC-1CD5-448F-82C2-C1659CEE689D||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MEQ/G|||||UU/DL||||ABNORMAL|NOT DONE|||CERUMEN|DRIED|N|SPIROMETRY|Y|N|N||2||58||SCREENING|1972-08-14|1964-05-29|||||1971-09-25||1960-07-10
TRIAL STUDY 134XCP|IS|776299DC-1CD5-448F-82C2-C1659CEE689D||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GY|||||MCI||||NORMAL|NOT DONE|||CALCULUS|DRIED|Y|THICK SMEAR|N|U|NA||3||39||OPEN LABEL TREATMENT|1960-08-22|1961-12-27|||||1966-06-30||1972-09-10
TRIAL STUDY 134XCP|IS|776299DC-1CD5-448F-82C2-C1659CEE689D||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KEV|||||NCI||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|U|ELECTROCHEMILUMINESCENCE|U|U|N||4||88||TREATMENT|1969-08-19|1968-02-25|||||1965-01-27||1964-01-14
TRIAL STUDY 134XCP|IS|776299DC-1CD5-448F-82C2-C1659CEE689D||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||H/WK|||||BQ/KG||||HIGH|NOT DONE|||CAPILLARY BLOOD|AGGLUTINATED|N|TRIPLE-PHASE MRI SCAN|N|Y|N||5||7||TREATMENT|1966-09-24|1966-03-30|||||1963-06-11||1965-10-11
TRIAL STUDY 134XCP|IS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||EJACULATE U|||||G/KG/DAY||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CLOTTED|Y|IMMUNOPRECIPITATION|Y|Y|N||1||38||TREATMENT|1972-09-25|1967-10-05|||||1971-06-28||1964-02-15
TRIAL STUDY 134XCP|IS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^3 COPIES/ML|||||IU/G||||NORMAL|NOT DONE|||EPITHELIAL CELL|CONTAMINATED|U|CONGO RED STAIN|U|Y|NA||2||58||RUN-IN|1962-07-26|1970-11-23|||||1963-03-31||1960-08-25
TRIAL STUDY 134XCP|IS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MV|||||MEQ/ML||||LOW|NOT DONE|||EMESIS|THAWED|U|TOTAL BODY IRRADIATION|NA|N|Y||3||39||BASELINE|1963-03-24|1964-01-17|||||1971-07-27||1968-05-21
TRIAL STUDY 134XCP|IS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MAMP|||||MAMP||||LOW|NOT DONE|||MUSCLE TISSUE|ROOM TEMPERATURE|NA|CRYOSCOPY|NA|U|NA||4||88||FOLLOW-UP|1961-03-31|1972-05-21|||||1960-05-30||1962-01-27
TRIAL STUDY 134XCP|IS|1E9755DC-A5EA-4DAF-A95E-47D8FA3765D7||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G/DL|||||MEQ/UG||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|ICTERIC|NA|NEXT GENERATION TARGETED SEQUENCING|U|U|NA||5||7||WASHOUT|1962-12-21|1969-01-13|||||1966-08-18||1969-10-16
TRIAL STUDY 134XCP|IS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||100 IU/ML|||||PLUG||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|THAWED|Y|SMEAR|NA|Y|N||1||38||OBSERVATION|1971-03-09|1962-12-22|||||1972-05-24||1961-07-10
TRIAL STUDY 134XCP|IS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||HENRY|||||MG/H||||HIGH|NOT DONE|||WHITE MATTER TISSUE|LACTESCENT|Y|KARYOTYPING|NA|N|Y||2||58||OPEN LABEL TREATMENT|1961-01-07|1971-01-11|||||1972-02-21||1967-01-05
TRIAL STUDY 134XCP|IS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/G/H|||||AMPULE||||HIGH|NOT DONE|||ADIPOSE TISSUE|NON-HEMOLYZED|N|FLOW CYTOMETRY|N|N|U||3||39||TREATMENT|1961-06-05|1966-08-14|||||1966-06-28||1962-10-19
TRIAL STUDY 134XCP|IS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMHG/L/MIN|||||LOG10 COPIES/ML||||ABNORMAL|NOT DONE|||FLUID|CLOTTED|NA|MICROBIAL CULTURE|N|NA|N||4||88||LONG-TERM FOLLOW-UP|1965-08-07|1971-03-14|||||1971-10-19||1970-02-22
TRIAL STUDY 134XCP|IS|2844C9EF-3DEE-4C8E-A89C-0206F4073CB1||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||SACHET|||||U/ML||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|CONCENTRATED|U|IMMUNOFLUORESCENT STAIN|U|N|N||5||7||TREATMENT|1969-04-29|1971-08-04|||||1971-03-12||1969-12-22
TRIAL STUDY 134XCP|IS|054D4740-C675-4904-B912-B00A0B089F12||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PIXELS/IN|||||UCI/L||||LOW|NOT DONE|||LOCHIA|PARAFFIN-EMBEDDED|N|IMMUNO-PET SCAN|NA|U|NA||1||38||BLINDED TREATMENT|1973-03-25|1968-07-19|||||1965-02-11||1965-11-27
TRIAL STUDY 134XCP|IS|054D4740-C675-4904-B912-B00A0B089F12||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L/H|||||10^4 CFU/ML||||HIGH|NOT DONE|||EXPIRED AIR|REFRIGERATED|N|TWO-COLOR MICROARRAY|Y|NA|N||2||58||LONG-TERM FOLLOW-UP|1963-11-30|1969-07-15|||||1965-03-24||1969-08-01
TRIAL STUDY 134XCP|IS|054D4740-C675-4904-B912-B00A0B089F12||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MHZ|||||GRAIN||||LOW|NOT DONE|||EPITHELIAL CELL|DRIED|Y|VENTILATION PERFUSION LUNG SCAN|N|N|N||3||39||OPEN LABEL TREATMENT|1970-10-08|1960-08-01|||||1962-03-30||1963-02-01
TRIAL STUDY 134XCP|IS|054D4740-C675-4904-B912-B00A0B089F12||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/G/H|||||/H||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|GELLED|NA|DIGITAL PCR|NA|Y|N||4||88||FOLLOW-UP|1963-01-01|1971-09-20|||||1964-05-28||1963-12-03
TRIAL STUDY 134XCP|IS|054D4740-C675-4904-B912-B00A0B089F12||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NCI|||||LB||||HIGH|NOT DONE|||SMEGMA|LACTESCENT|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|U|U|NA||5||7||FOLLOW-UP|1971-07-03|1973-08-25|||||1966-02-22||1968-09-20
TRIAL STUDY 134XCP|IS|9548556E-EECF-4460-A7DD-D93F853E9EA8||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||OD UNIT|||||UG/L DDU||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|CONTAMINATED|N|FISH|Y|Y|NA||1||38||FOLLOW-UP|1969-10-11|1969-01-12|||||1969-06-25||1967-11-01
TRIAL STUDY 134XCP|IS|9548556E-EECF-4460-A7DD-D93F853E9EA8||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 CFU|||||TABLET||||HIGH|NOT DONE|||PERITONEAL FLUID|CONTAMINATED|Y|INFRARED SPECTROMETRY|NA|NA|N||2||58||OBSERVATION|1961-01-28|1968-05-30|||||1961-02-09||1967-04-08
TRIAL STUDY 134XCP|IS|9548556E-EECF-4460-A7DD-D93F853E9EA8||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||M/SEC|||||SEC||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|FROZEN|N|VENTILATION PERFUSION LUNG SCAN|U|U|U||3||39||WASHOUT|1967-02-11|1960-03-14|||||1962-09-28||1960-09-17
TRIAL STUDY 134XCP|IS|9548556E-EECF-4460-A7DD-D93F853E9EA8||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PIXELS/CM|||||10^6 IU/ML||||ABNORMAL|NOT DONE|||PLASMA|FROZEN|Y|RAJI CELL EIA|U|N|Y||4||88||SCREENING|1963-09-23|1969-01-27|||||1967-05-25||1972-11-28
TRIAL STUDY 134XCP|IS|9548556E-EECF-4460-A7DD-D93F853E9EA8||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL/DAY|||||KDA||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|SOLIDIFIED|Y|SLIT LAMP PHOTOGRAPHY|Y|Y|U||5||7||BASELINE|1970-07-09|1972-09-30|||||1960-01-12||1968-03-23
TRIAL STUDY 134XCP|IS|0BCF6152-3718-402C-9333-A3EFBB3086FF||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/M2/DAY|||||MIN||||ABNORMAL|NOT DONE|||STOOL|CLOTTED|U|PUPILLOMETRY|U|U|Y||1||38||SCREENING|1960-07-10|1963-11-07|||||1960-06-22||1967-03-16
TRIAL STUDY 134XCP|IS|0BCF6152-3718-402C-9333-A3EFBB3086FF||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 CFU/ML|||||PA||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|DRIED|N|HIGH RESOLUTION MELT ANALYSIS|U|Y|NA||2||58||TREATMENT|1963-03-10|1968-12-17|||||1971-11-18||1964-07-06
TRIAL STUDY 134XCP|IS|0BCF6152-3718-402C-9333-A3EFBB3086FF||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||HENRY|||||ML/DOSE||||NORMAL|NOT DONE|||PERSPIRATION|NON-HEMOLYZED|U|PHOTOGRAPHY|U|N|U||3||39||CONTINUATION TREATMENT|1970-07-03|1965-10-13|||||1960-08-25||1968-03-18
TRIAL STUDY 134XCP|IS|0BCF6152-3718-402C-9333-A3EFBB3086FF||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NG/DL|||||TORR||||HIGH|NOT DONE|||LUNG SURFACTANT|THAWED|Y|COMPLEMENT FIXATION|N|U|NA||4||88||OPEN LABEL TREATMENT|1966-02-07|1968-08-20|||||1961-07-10||1964-11-11
TRIAL STUDY 134XCP|IS|0BCF6152-3718-402C-9333-A3EFBB3086FF||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KHZ|||||MKAT||||ABNORMAL|NOT DONE|||PLEURAL FLUID|ROOM TEMPERATURE|Y|MALDI|N|N|U||5||7||SCREENING|1972-04-20|1970-08-21|||||1966-03-24||1969-10-04
TRIAL STUDY 134XCP|IS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GPS U|||||U/MG||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|LACTESCENT|Y|LIGHT MICROSCOPY|N|NA|NA||1||38||BLINDED TREATMENT|1968-01-12|1968-10-18|||||1972-08-15||1972-03-20
TRIAL STUDY 134XCP|IS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/KG|||||PT_US||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|NA|ELECTROPHORESIS|U|NA|U||2||58||BASELINE|1973-01-06|1969-08-31|||||1968-02-20||1970-08-30
TRIAL STUDY 134XCP|IS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/LPF|||||/4.0 ML||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|CLOTTED|U|CT SCAN|U|U|NA||3||39||SCREENING|1968-04-20|1970-12-27|||||1963-05-21||1971-10-11
TRIAL STUDY 134XCP|IS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG|||||MIN||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|THAWED|NA|ICP-MS|NA|NA|Y||4||88||SCREENING|1970-07-14|1966-06-09|||||1967-09-27||1971-05-26
TRIAL STUDY 134XCP|IS|3EC28B44-0649-4C7F-8840-E0E9FC404DA7||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MCI|||||DIOPTER||||HIGH|NOT DONE|||MUSCLE TISSUE|REFRIGERATED|N|NEXT GENERATION TARGETED SEQUENCING|NA|Y|Y||5||7||INDUCTION TREATMENT|1971-02-26|1972-10-17|||||1968-07-29||1973-01-20
TRIAL STUDY 134XCP|IS|EED12AC0-1CBD-4D42-8786-91834AB33A46||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IN|||||LINEAR FT*LB||||HIGH|NOT DONE|||PUS|AUTOLYZED|NA|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|U|Y||1||38||RUN-IN|1965-02-23|1966-03-11|||||1970-01-02||1963-09-01
TRIAL STUDY 134XCP|IS|EED12AC0-1CBD-4D42-8786-91834AB33A46||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL/MOL|||||UG/KG/H||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|CONTAMINATED|NA|GC/MS-CI|U|Y|Y||2||58||FOLLOW-UP|1962-01-17|1968-08-02|||||1962-05-30||1969-09-02
TRIAL STUDY 134XCP|IS|EED12AC0-1CBD-4D42-8786-91834AB33A46||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||OZ EQ|||||CYLINDER||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|THAWED|Y|SLIT LAMP PHOTOGRAPHY|Y|U|N||3||39||BLINDED TREATMENT|1965-02-28|1966-08-23|||||1962-10-25||1961-03-30
TRIAL STUDY 134XCP|IS|EED12AC0-1CBD-4D42-8786-91834AB33A46||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CMOL/L|||||EIA UNIT||||NORMAL|NOT DONE|||TUMOR TISSUE|AUTOLYZED|U|DUCTOGRAPHY|U|NA|Y||4||88||LONG-TERM FOLLOW-UP|1960-08-25|1969-12-02|||||1971-02-27||1960-05-23
TRIAL STUDY 134XCP|IS|EED12AC0-1CBD-4D42-8786-91834AB33A46||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CM|||||/HPF||||ABNORMAL|NOT DONE|||COLOSTRUM|THAWED|N|BALLPOINT PEN TECHNIQUE|Y|N|N||5||7||BASELINE|1963-03-08|1972-11-27|||||1962-06-15||1964-07-14
TRIAL STUDY 134XCP|IS|F30DC3E9-E919-4920-87FE-103CD85D89FA||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/DL|||||CI/UL||||HIGH|NOT DONE|||SMEGMA|LACTESCENT|Y|EPSILOMETER|NA|U|N||1||38||SCREENING|1960-11-10|1962-06-29|||||1965-07-14||1963-11-08
TRIAL STUDY 134XCP|IS|F30DC3E9-E919-4920-87FE-103CD85D89FA||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DDU|||||DPM/ML||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|AGGLUTINATED|N|HANSEL STAIN|N|NA|Y||2||58||TREATMENT|1969-04-27|1972-06-08|||||1973-01-07||1966-09-18
TRIAL STUDY 134XCP|IS|F30DC3E9-E919-4920-87FE-103CD85D89FA||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MAMP|||||IU/KG||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|CONCENTRATED|N|SLOAN LETTER EYE CHART 100%|Y|NA|Y||3||39||SCREENING|1966-02-04|1971-11-04|||||1963-11-13||1964-02-26
TRIAL STUDY 134XCP|IS|F30DC3E9-E919-4920-87FE-103CD85D89FA||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MEQ/KG|||||UG/ANIMAL||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|CALCIFIED|N|KINETIC CHROMOGENIC ASSAY|N|U|N||4||88||INDUCTION TREATMENT|1968-05-20|1967-04-10|||||1970-04-04||1961-03-18
TRIAL STUDY 134XCP|IS|F30DC3E9-E919-4920-87FE-103CD85D89FA||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PG/CELL|||||RING||||ABNORMAL|NOT DONE|||ERYTHROCYTES|SOLIDIFIED|NA|CARDIAC THERMODILUTION|NA|Y|U||5||7||FOLLOW-UP|1972-05-08|1967-12-12|||||1964-08-04||1966-02-13
TRIAL STUDY 134XCP|IS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LOG10 CFU/ML|||||K||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|THAWED|U|SCANNING ELECTRON MICROSCOPY|Y|N|N||1||38||RUN-IN|1967-06-04|1961-12-03|||||1966-10-12||1967-12-11
TRIAL STUDY 134XCP|IS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/KG/MIN|||||COAT||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|U|DOPPLER ULTRASOUND|N|U|NA||2||58||TREATMENT|1960-06-10|1969-09-13|||||1971-11-30||1972-02-25
TRIAL STUDY 134XCP|IS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/L/H|||||PLUG||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CALCIFIED|Y|RULER MEASUREMENT METHOD|U|U|U||3||39||SCREENING|1963-01-26|1966-05-18|||||1970-12-04||1970-10-24
TRIAL STUDY 134XCP|IS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PACK YEAR|||||MPL U/ML||||NORMAL|NOT DONE|||ABSCESS FLUID|FRESH|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|U|U||4||88||BLINDED TREATMENT|1965-12-30|1967-12-25|||||1962-12-23||1968-04-04
TRIAL STUDY 134XCP|IS|EBECDED4-D06C-49D4-95F2-C6E9CDBA802B||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LOG10 COPIES/ML|||||10^6 CFU/ML||||LOW|NOT DONE|||SUPERNATANT, SERUM|AUTOLYZED|Y|TEMPLATE INCISION METHOD|U|U|N||5||7||LONG-TERM FOLLOW-UP|1967-08-24|1961-07-01|||||1971-09-20||1969-09-04
TRIAL STUDY 134XCP|IS|729D254F-628C-4D35-8906-A1344833A610||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/7.5 ML|||||CD*S/M2||||NORMAL|NOT DONE|||CAPILLARY BLOOD|SOLIDIFIED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|N|N||1||38||WASHOUT|1963-01-18|1973-08-28|||||1971-03-18||1960-11-04
TRIAL STUDY 134XCP|IS|729D254F-628C-4D35-8906-A1344833A610||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/DL|||||/VF||||ABNORMAL|NOT DONE|||ISOLATE|AGGLUTINATED|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|Y|U||2||58||LONG-TERM FOLLOW-UP|1968-11-11|1968-12-02|||||1964-08-14||1970-11-19
TRIAL STUDY 134XCP|IS|729D254F-628C-4D35-8906-A1344833A610||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||SIEMENS|||||%(W/W)||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|FRESH|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|NA|N||3||39||LONG-TERM FOLLOW-UP|1960-03-16|1962-08-17|||||1961-05-01||1962-04-03
TRIAL STUDY 134XCP|IS|729D254F-628C-4D35-8906-A1344833A610||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TUBERCULIN UNIT/ML|||||MM/H||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|U|SPIRAL CT|NA|NA|Y||4||88||FOLLOW-UP|1963-05-20|1964-08-28|||||1960-07-26||1966-03-21
TRIAL STUDY 134XCP|IS|729D254F-628C-4D35-8906-A1344833A610||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MIU/L|||||OSM||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FRESH|Y|HPLC-UV|N|Y|U||5||7||SCREENING|1971-02-14|1964-07-26|||||1961-10-28||1971-02-12
TRIAL STUDY 134XCP|IS|A78936A2-B8B1-4D07-8679-E324F6447EFF||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DB|||||CCID 50/ML||||ABNORMAL|NOT DONE|||REFLEX TEAR|REFRIGERATED|Y|QUANTITATIVE CORONARY ANGIOGRAPHY|N|NA|U||1||38||LONG-TERM FOLLOW-UP|1960-12-20|1965-08-25|||||1973-02-16||1971-08-26
TRIAL STUDY 134XCP|IS|A78936A2-B8B1-4D07-8679-E324F6447EFF||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GY/H|||||MOL/MOL||||NORMAL|NOT DONE|||ISOLATE|REFRIGERATED|Y|FLUORIMETRY|N|NA|U||2||58||BASELINE|1972-12-15|1971-02-09|||||1971-10-30||1960-12-03
TRIAL STUDY 134XCP|IS|A78936A2-B8B1-4D07-8679-E324F6447EFF||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GPS U|||||10^7 CFU||||HIGH|NOT DONE|||SPERMATOZOON|ICTERIC|NA|CONTRAST ENHANCED PET SCAN|U|N|N||3||39||FOLLOW-UP|1967-08-14|1960-01-31|||||1963-01-03||1961-03-19
TRIAL STUDY 134XCP|IS|A78936A2-B8B1-4D07-8679-E324F6447EFF||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/MIN|||||LOG10 ELISA UNIT||||NORMAL|NOT DONE|||CORD BLOOD|HEMOLYZED|U|ICP-MS|U|NA|N||4||88||INDUCTION TREATMENT|1970-12-29|1963-11-25|||||1962-11-09||1972-12-01
TRIAL STUDY 134XCP|IS|A78936A2-B8B1-4D07-8679-E324F6447EFF||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KDA|||||PACK YEAR||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|NA|SPECT SCAN|U|N|U||5||7||CONTINUATION TREATMENT|1965-07-15|1972-12-05|||||1972-07-02||1969-04-23
TRIAL STUDY 134XCP|IS|239B331A-08CD-41D9-BBB8-CE229480FC12||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KPA|||||10^3/HPF||||HIGH|NOT DONE|||SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|U|U|NA||1||38||OPEN LABEL TREATMENT|1971-06-26|1968-11-05|||||1962-04-01||1965-05-15
TRIAL STUDY 134XCP|IS|239B331A-08CD-41D9-BBB8-CE229480FC12||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMAL|||||HZ||||NORMAL|NOT DONE|||BLOOD|ICTERIC|N|NUCLEIC ACID SEQUENCING|NA|N|Y||2||58||CONTINUATION TREATMENT|1961-06-09|1964-05-29|||||1968-01-09||1972-10-25
TRIAL STUDY 134XCP|IS|239B331A-08CD-41D9-BBB8-CE229480FC12||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DAMOL/L|||||AMOL||||LOW|NOT DONE|||MUSCLE TISSUE|THAWED|Y|CONTRAST ENHANCED X-RAY|U|NA|N||3||39||WASHOUT|1965-11-10|1971-04-07|||||1965-08-14||1964-08-20
TRIAL STUDY 134XCP|IS|239B331A-08CD-41D9-BBB8-CE229480FC12||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UKAT/10^12 RBC|||||FMOL||||HIGH|NOT DONE|||PLATELET|SOLIDIFIED|NA|TRICHROME STAIN|U|N|NA||4||88||INDUCTION TREATMENT|1969-11-11|1963-05-29|||||1966-12-27||1972-08-19
TRIAL STUDY 134XCP|IS|239B331A-08CD-41D9-BBB8-CE229480FC12||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PPTR|||||HEP||||HIGH|NOT DONE|||LYMPH|AUTOLYZED|Y|MULTIPLE BREATH WASHOUT|Y|Y|NA||5||7||CONTINUATION TREATMENT|1966-02-07|1964-04-05|||||1960-08-23||1962-04-28
TRIAL STUDY 134XCP|IS|958D39CD-D511-40C8-A0A6-8A138225470B||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||F|||||FT2||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|REFRIGERATED|U|CALIPER MEASUREMENT METHOD|U|U|Y||1||38||RUN-IN|1966-02-28|1969-07-25|||||1964-03-09||1961-09-01
TRIAL STUDY 134XCP|IS|958D39CD-D511-40C8-A0A6-8A138225470B||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL|||||CFU/ML||||NORMAL|NOT DONE|||MUSCLE TISSUE|THAWED|N|BAC ACGH|U|N|U||2||58||OBSERVATION|1970-01-06|1970-10-14|||||1966-04-18||1964-11-13
TRIAL STUDY 134XCP|IS|958D39CD-D511-40C8-A0A6-8A138225470B||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U|||||L/DAY||||LOW|NOT DONE|||INFRANATANT, PLASMA|THAWED|NA|LC/MS/MS|U|NA|U||3||39||SCREENING|1964-11-06|1968-11-22|||||1963-09-11||1962-04-12
TRIAL STUDY 134XCP|IS|958D39CD-D511-40C8-A0A6-8A138225470B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BOX|||||LOG10 PFU||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|LACTESCENT|N|URANYL ACETATE STAIN|NA|U|NA||4||88||BASELINE|1964-02-21|1970-12-26|||||1971-11-02||1966-07-07
TRIAL STUDY 134XCP|IS|958D39CD-D511-40C8-A0A6-8A138225470B||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KG/CM2|||||MCI||||NORMAL|NOT DONE|||RETICULOCYTES|FROZEN|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|U|N||5||7||OPEN LABEL TREATMENT|1973-08-12|1965-09-21|||||1966-01-30||1967-11-06
TRIAL STUDY 134XCP|IS|5DA21FE5-E5B9-4461-9509-94AA264B59A8||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TUBE|||||CD/M2||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|FROZEN|NA|FUNCTIONAL MRI|Y|U|NA||1||38||OPEN LABEL TREATMENT|1960-10-02|1969-07-08|||||1966-11-04||1966-08-22
TRIAL STUDY 134XCP|IS|5DA21FE5-E5B9-4461-9509-94AA264B59A8||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LINEAR FT*LB|||||MG/DOSE||||LOW|NOT DONE|||ERYTHROCYTES|FROZEN|Y|KLEIHAUER-BETKE|NA|NA|U||2||58||WASHOUT|1972-02-26|1964-05-02|||||1971-02-14||1963-10-07
TRIAL STUDY 134XCP|IS|5DA21FE5-E5B9-4461-9509-94AA264B59A8||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||TROCHE|||||VG/KG||||HIGH|NOT DONE|||VENOUS PLASMA|AUTOLYZED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|N|N|U||3||39||SCREENING|1964-04-27|1965-08-05|||||1968-10-01||1966-09-25
TRIAL STUDY 134XCP|IS|5DA21FE5-E5B9-4461-9509-94AA264B59A8||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PL|||||EU||||HIGH|NOT DONE|||REFLEX TEAR|FRESH|NA|DOUBLE IMMUNODIFFUSION|NA|Y|U||4||88||CONTINUATION TREATMENT|1967-11-07|1969-03-28|||||1966-11-30||1961-02-14
TRIAL STUDY 134XCP|IS|5DA21FE5-E5B9-4461-9509-94AA264B59A8||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||APL U|||||FRAMES/S||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|THAWED|N|CONTRAST ENHANCED PET/CT SCAN|Y|Y|NA||5||7||OPEN LABEL TREATMENT|1965-08-10|1970-05-19|||||1968-05-14||1970-12-24
TRIAL STUDY 134XCP|IS|B125DCB9-1705-430B-9982-A20E7C4CA6A8||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM/H|||||PHERESIS UNIT||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|GELLED|Y|CONTACT SPECULAR MICROSCOPY|NA|Y|U||1||38||SCREENING|1971-10-16|1966-03-13|||||1973-02-16||1962-08-06
TRIAL STUDY 134XCP|IS|B125DCB9-1705-430B-9982-A20E7C4CA6A8||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PA|||||TBSP||||LOW|NOT DONE|||SPERMATOZOON|GELLED|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|U|Y||2||58||INDUCTION TREATMENT|1960-08-25|1971-11-01|||||1961-01-26||1965-11-25
TRIAL STUDY 134XCP|IS|B125DCB9-1705-430B-9982-A20E7C4CA6A8||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CFU/G|||||HENRY||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ICTERIC|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|NA|Y|NA||3||39||OPEN LABEL TREATMENT|1969-11-27|1963-12-14|||||1973-06-11||1965-02-24
TRIAL STUDY 134XCP|IS|B125DCB9-1705-430B-9982-A20E7C4CA6A8||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CP|||||LOG10 TCID 50/DOSE||||ABNORMAL|NOT DONE|||SKIN TISSUE|LIPEMIC|NA|KINETIC CHROMOGENIC ASSAY|U|NA|Y||4||88||CONTINUATION TREATMENT|1973-05-10|1972-07-06|||||1967-12-26||1969-12-10
TRIAL STUDY 134XCP|IS|B125DCB9-1705-430B-9982-A20E7C4CA6A8||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NG|||||UG/DOSE||||LOW|NOT DONE|||URINE SEDIMENT|CALCIFIED|NA|INTERRUPTER TECHNIQUE|Y|U|Y||5||7||INDUCTION TREATMENT|1967-11-14|1968-03-25|||||1970-09-08||1968-10-29
TRIAL STUDY 134XCP|IS|95C72325-301E-40D4-AA2D-49B80067FE23||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CY/CM|||||VIAL||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|Y|NA|U||1||38||TREATMENT|1963-03-22|1971-10-29|||||1973-05-22||1972-05-28
TRIAL STUDY 134XCP|IS|95C72325-301E-40D4-AA2D-49B80067FE23||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FRAMES/S|||||RFU||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|Y|PET/SPECT SCAN|U|U|NA||2||58||RUN-IN|1960-06-23|1962-01-17|||||1969-11-03||1962-06-26
TRIAL STUDY 134XCP|IS|95C72325-301E-40D4-AA2D-49B80067FE23||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/ML|||||ECL UNIT||||LOW|NOT DONE|||EXPIRED AIR|THAWED|Y|TWO-COLOR MICROARRAY|NA|Y|Y||3||39||FOLLOW-UP|1968-06-18|1969-02-21|||||1964-10-24||1960-06-12
TRIAL STUDY 134XCP|IS|95C72325-301E-40D4-AA2D-49B80067FE23||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMOL/S|||||FMOL/L||||NORMAL|NOT DONE|||CERUMEN|GELLED|N|PHASE-CONTRAST MRI|NA|U|U||4||88||CONTINUATION TREATMENT|1960-03-22|1965-09-03|||||1968-02-23||1969-05-26
TRIAL STUDY 134XCP|IS|95C72325-301E-40D4-AA2D-49B80067FE23||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/MOL|||||TSP EQ||||HIGH|NOT DONE|||MUSCLE TISSUE|ROOM TEMPERATURE|NA|THICK SMEAR|U|N|NA||5||7||OPEN LABEL TREATMENT|1967-08-12|1961-01-07|||||1968-10-26||1962-03-26
TRIAL STUDY 134XCP|IS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PACKET|||||MONTHS||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|LACTESCENT|U|VIRUS PLAQUE ASSAY|N|NA|N||1||38||INDUCTION TREATMENT|1964-03-04|1968-11-01|||||1960-03-27||1964-12-09
TRIAL STUDY 134XCP|IS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||SEC|||||MOL/ML||||LOW|NOT DONE|||CORD BLOOD|HEMOLYZED|NA|FLUORESCENT IMMUNOASSAY|U|NA|NA||2||58||OBSERVATION|1960-12-07|1972-08-25|||||1962-07-20||1962-04-07
TRIAL STUDY 134XCP|IS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||M3|||||MEQ/UL||||HIGH|NOT DONE|||PERSPIRATION|LACTESCENT|U|IMPEDANCE CONDUCTIVITY|U|Y|U||3||39||BASELINE|1965-08-26|1961-03-13|||||1970-12-04||1969-11-20
TRIAL STUDY 134XCP|IS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UCI/KG|||||IU/MMOL||||ABNORMAL|NOT DONE|||KERATINOCYTE|FROZEN|NA|NUCLEIC ACID AMPLIFICATION TEST|Y|NA|U||4||88||FOLLOW-UP|1963-09-05|1961-10-11|||||1960-02-19||1962-04-05
TRIAL STUDY 134XCP|IS|7FFBD039-64CD-4D6F-85EC-83F0D11C57E5||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MM2|||||UG/M2/DAY||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|N|CHROMATOGRAPHY|N|Y|N||5||7||OBSERVATION|1968-09-11|1963-05-03|||||1965-04-11||1966-08-30
TRIAL STUDY 134XCP|IS|7DF25CA4-0846-4180-9356-F53C704F0233||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TSP|||||U/KG/DAY||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|Y|AMSLER GRID|U|N|U||1||38||LONG-TERM FOLLOW-UP|1965-12-11|1964-07-06|||||1966-09-25||1961-08-07
TRIAL STUDY 134XCP|IS|7DF25CA4-0846-4180-9356-F53C704F0233||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MM/SEC|||||U.CARR||||ABNORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AGGLUTINATED|N|IVY INCISION METHOD|Y|N|N||2||58||FOLLOW-UP|1973-05-22|1969-11-24|||||1972-08-16||1963-05-15
TRIAL STUDY 134XCP|IS|7DF25CA4-0846-4180-9356-F53C704F0233||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMHG*MIN/L|||||OD UNIT||||HIGH|NOT DONE|||SWABBED MATERIAL|REFRIGERATED|Y|PYROSEQUENCING|Y|NA|Y||3||39||BASELINE|1963-06-12|1967-11-14|||||1971-07-06||1968-06-04
TRIAL STUDY 134XCP|IS|7DF25CA4-0846-4180-9356-F53C704F0233||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/MOL|||||DROP||||NORMAL|NOT DONE|||URINE|LACTESCENT|NA|ENZYMATIC SPECTROPHOTOMETRY|U|NA|N||4||88||CONTINUATION TREATMENT|1969-06-03|1965-12-20|||||1962-10-03||1963-03-06
TRIAL STUDY 134XCP|IS|7DF25CA4-0846-4180-9356-F53C704F0233||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MEQ/ML|||||10^6 ORGANISMS||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|FROZEN|NA|WESTERGREN|N|Y|Y||5||7||OPEN LABEL TREATMENT|1961-08-18|1968-06-10|||||1962-01-28||1967-05-13
TRIAL STUDY 134XCP|IS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/CL|||||SCOOPFUL||||NORMAL|NOT DONE|||GASTRIC CONTENTS|THAWED|NA|IMMUNO-PET SCAN|U|N|U||1||38||BLINDED TREATMENT|1964-06-03|1969-03-29|||||1962-01-11||1964-10-18
TRIAL STUDY 134XCP|IS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^4/L|||||FARAD||||NORMAL|NOT DONE|||SOFT TISSUE|CALCIFIED|N|TOTAL BODY RADIOGRAPHY|N|Y|Y||2||58||CONTINUATION TREATMENT|1962-05-27|1968-10-01|||||1960-02-17||1962-06-17
TRIAL STUDY 134XCP|IS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NEWTON|||||KS||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|N|SCINTIGRAPHY|Y|NA|N||3||39||RUN-IN|1964-01-01|1971-01-20|||||1965-12-19||1963-08-25
TRIAL STUDY 134XCP|IS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MET*H|||||JOULE||||LOW|NOT DONE|||COLOSTRUM|LIPEMIC|U|FLOW MICROSCOPY|U|NA|U||4||88||BLINDED TREATMENT|1964-01-09|1967-04-16|||||1964-09-04||1970-10-03
TRIAL STUDY 134XCP|IS|92FB74AC-D410-4E35-AD9E-5F5A350B26C5||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/G|||||FOZ_US||||ABNORMAL|NOT DONE|||SKIN TISSUE|NON-HEMOLYZED|NA|FARNSWORTH-MUNSELL 100 HUE TEST|N|Y|NA||5||7||CONTINUATION TREATMENT|1968-08-21|1966-04-16|||||1966-08-16||1967-04-16
TRIAL STUDY 134XCP|IS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^3 COPIES/ML|||||UEQ||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|DARK FIELD MICROSCOPY|NA|NA|Y||1||38||FOLLOW-UP|1962-05-16|1966-03-28|||||1971-03-09||1971-07-10
TRIAL STUDY 134XCP|IS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^7 TCID 50/DOSE|||||KA_U/DL||||LOW|NOT DONE|||GASTRIC FLUID|DRIED|Y|TRIPLE-PHASE SPIRAL CT SCAN|N|NA|Y||2||58||RUN-IN|1967-01-24|1971-10-15|||||1962-11-08||1967-05-29
TRIAL STUDY 134XCP|IS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PT_US|||||UG/G/DAY||||NORMAL|NOT DONE|||COLOSTRUM|CONTAMINATED|N|DISK DIFFUSION|NA|Y|Y||3||39||BLINDED TREATMENT|1969-12-12|1969-10-20|||||1964-03-25||1971-12-29
TRIAL STUDY 134XCP|IS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ENZYME U/G HB|||||DNA COPIES/UG||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|LIPEMIC|NA|NUCLEAR RADIOLOGY|NA|N|NA||4||88||LONG-TERM FOLLOW-UP|1969-03-24|1971-07-03|||||1968-10-23||1967-06-04
TRIAL STUDY 134XCP|IS|5ABEF81B-9399-4A5D-B57B-2CD0DE531EF6||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UOSM|||||LB||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|Y|TRICHROME STAIN|N|N|Y||5||7||BASELINE|1963-03-31|1968-12-17|||||1966-03-22||1969-02-17
TRIAL STUDY 134XCP|IS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/DAY|||||GRAIN||||NORMAL|NOT DONE|||HAIR FOLLICLE|SOLIDIFIED|Y|SMEAR|NA|Y|NA||1||38||LONG-TERM FOLLOW-UP|1967-09-28|1969-09-12|||||1969-08-28||1966-08-19
TRIAL STUDY 134XCP|IS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DPM/MG|||||MOL||||LOW|NOT DONE|||SEBUM|SOLIDIFIED|Y|NUCLEIC ACID AMPLIFICATION TEST|N|N|Y||2||58||FOLLOW-UP|1965-01-13|1964-07-29|||||1961-06-06||1970-10-12
TRIAL STUDY 134XCP|IS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||WEEKS|||||UIU/DL||||NORMAL|NOT DONE|||LYSATE|UNEXPECTED ODOR|N|IHC|U|NA|U||3||39||BLINDED TREATMENT|1970-07-23|1972-07-23|||||1963-01-26||1969-02-11
TRIAL STUDY 134XCP|IS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MONTHS|||||MG/DOSE||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|CONTAMINATED|U|THICK SMEAR|N|U|N||4||88||SCREENING|1962-05-26|1963-09-23|||||1962-12-23||1965-04-13
TRIAL STUDY 134XCP|IS|895AAD86-9D50-41E1-AD1B-95CD9A7911C6||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CIGAR|||||MG/ML/DAY||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|CLOTTED|NA|FLOW MICROSCOPY|N|NA|NA||5||7||FOLLOW-UP|1964-08-27|1970-03-08|||||1970-10-14||1962-01-26
TRIAL STUDY 134XCP|IS|2C15756E-1096-403B-989D-D2C3D31396A9||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/DOSE|||||IU||||HIGH|NOT DONE|||URINE SEDIMENT|LACTESCENT|U|EIA|U|U|N||1||38||OBSERVATION|1966-07-08|1968-07-20|||||1971-02-24||1963-10-21
TRIAL STUDY 134XCP|IS|2C15756E-1096-403B-989D-D2C3D31396A9||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BREATHS/MIN|||||/WK||||NORMAL|NOT DONE|||LAVAGE FLUID|CONCENTRATED|N|IMMUNOFLUORESCENT STAIN|N|N|N||2||58||BLINDED TREATMENT|1960-01-06|1967-01-10|||||1963-02-24||1964-12-26
TRIAL STUDY 134XCP|IS|2C15756E-1096-403B-989D-D2C3D31396A9||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SBE/ML|||||MANSON U/ML||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|AUTOLYZED|N|TOTAL BODY IRRADIATION|U|Y|U||3||39||INDUCTION TREATMENT|1968-06-30|1965-04-17|||||1963-09-19||1965-06-28
TRIAL STUDY 134XCP|IS|2C15756E-1096-403B-989D-D2C3D31396A9||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NKAT/G HB|||||UIU/DL||||LOW|NOT DONE|||CELL PELLET|LIPEMIC|NA|PALM METHOD|NA|NA|N||4||88||TREATMENT|1961-06-30|1972-09-03|||||1970-06-22||1961-01-09
TRIAL STUDY 134XCP|IS|2C15756E-1096-403B-989D-D2C3D31396A9||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/G/DAY|||||/2500 WBC||||ABNORMAL|NOT DONE|||VENOUS BLOOD|CALCIFIED|N|IMMUNOFIXATION ELECTROPHORESIS|N|NA|N||5||7||BASELINE|1973-05-16|1973-06-27|||||1971-08-08||1963-01-07
TRIAL STUDY 134XCP|IS|CD103276-37FC-4E40-A0C8-8D1300D21AE1||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS/ML|||||MONTHS||||LOW|NOT DONE|||INTERSTITIAL FLUID|CONTAMINATED|U|SIZE EXCLUSION CHROMATOGRAPHY|N|Y|NA||1||38||RUN-IN|1972-11-03|1973-08-25|||||1963-07-19||1972-02-22
TRIAL STUDY 134XCP|IS|CD103276-37FC-4E40-A0C8-8D1300D21AE1||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SPRAY|||||U/KG/DAY||||LOW|NOT DONE|||BLOOD|FRESH|Y|FLUOROSCOPY|NA|NA|NA||2||58||TREATMENT|1961-01-29|1972-03-08|||||1967-04-26||1960-09-07
TRIAL STUDY 134XCP|IS|CD103276-37FC-4E40-A0C8-8D1300D21AE1||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||EID 50/DOSE|||||CAN||||NORMAL|NOT DONE|||MUCUS|THAWED|U|SICKLE CELL SOLUBILITY TEST|U|NA|U||3||39||CONTINUATION TREATMENT|1971-03-11|1965-04-23|||||1964-09-28||1964-08-30
TRIAL STUDY 134XCP|IS|CD103276-37FC-4E40-A0C8-8D1300D21AE1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/MIN|||||KUSP||||HIGH|NOT DONE|||CORD BLOOD|HEMOLYZED|NA|PET SCAN|Y|Y|NA||4||88||OBSERVATION|1963-08-02|1972-01-23|||||1965-03-20||1965-10-01
TRIAL STUDY 134XCP|IS|CD103276-37FC-4E40-A0C8-8D1300D21AE1||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L|||||DRINK||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|CLOTTED|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|NA|Y||5||7||OBSERVATION|1962-02-25|1970-04-01|||||1964-09-03||1967-07-28
TRIAL STUDY 134XCP|IS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||%(V/V)|||||ML/ANIMAL/WK||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|DRIED|U|HPLC-UV|N|N|N||1||38||LONG-TERM FOLLOW-UP|1964-10-30|1964-07-01|||||1971-01-04||1964-11-13
TRIAL STUDY 134XCP|IS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BREATHS/MIN|||||LOG10 CCID 50/DOSE||||NORMAL|NOT DONE|||NAIL|LIPEMIC|N|WHOLE TRANSCRIPTOME SEQUENCING|U|NA|N||2||58||TREATMENT|1964-06-10|1972-07-11|||||1966-08-20||1961-10-05
TRIAL STUDY 134XCP|IS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/CM2|||||MOL/MOL||||HIGH|NOT DONE|||BILE|CALCIFIED|Y|DROPLET DIGITAL PCR|U|N|U||3||39||INDUCTION TREATMENT|1968-04-30|1966-09-14|||||1967-10-15||1969-06-05
TRIAL STUDY 134XCP|IS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BP|||||NL||||NORMAL|NOT DONE|||TRANSUDATE|GELLED|Y|LINE PROBE ASSAY|NA|Y|NA||4||88||TREATMENT|1968-10-13|1961-02-09|||||1973-01-21||1961-02-01
TRIAL STUDY 134XCP|IS|B9868C79-E6CC-4588-B5FA-3C9457D3C9C9||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CS|||||ML/BEAT||||LOW|NOT DONE|||CELL PELLET|NON-HEMOLYZED|N|SIZE EXCLUSION CHROMATOGRAPHY|Y|U|NA||5||7||CONTINUATION TREATMENT|1971-10-25|1965-04-23|||||1973-03-18||1960-04-27
TRIAL STUDY 134XCP|IS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GBQ/UG|||||10^11/L||||LOW|NOT DONE|||WHITE MATTER TISSUE|LACTESCENT|NA|ANTIMICROBIAL COMBINATION TESTING|NA|N|N||1||38||OBSERVATION|1961-11-27|1971-05-21|||||1963-02-12||1965-04-23
TRIAL STUDY 134XCP|IS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DNA COPIES/ML|||||IN||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|REFRIGERATED|N|BRDU CELLULAR PROLIFERATION ASSAY|N|Y|NA||2||58||TREATMENT|1962-09-27|1967-02-26|||||1963-05-29||1972-03-07
TRIAL STUDY 134XCP|IS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/M2/H|||||ML/ANIMAL/DAY||||NORMAL|NOT DONE|||KERATINOCYTE|UNEXPECTED ODOR|U|MICRODENSITOMETRY|Y|NA|NA||3||39||LONG-TERM FOLLOW-UP|1973-05-04|1963-12-25|||||1971-07-13||1968-10-18
TRIAL STUDY 134XCP|IS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NG/DAY|||||SFC/10^6 PBMC||||HIGH|NOT DONE|||LEUKOCYTE|UNEXPECTED ODOR|U|PEAK FLOWMETRY|NA|Y|NA||4||88||RUN-IN|1973-06-12|1963-08-30|||||1968-11-28||1969-01-24
TRIAL STUDY 134XCP|IS|EBF85B6C-B5DE-4E96-A9F8-96E24920545A||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/MM|||||NMOL/DAY||||HIGH|NOT DONE|||MECONIUM|NON-HEMOLYZED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|U|Y|NA||5||7||LONG-TERM FOLLOW-UP|1965-03-05|1970-07-22|||||1960-02-10||1964-05-14
TRIAL STUDY 134XCP|IS|7B583F10-E460-4B25-8A6B-530A154442CD||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||V/SEC|||||UKAT||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|CONCENTRATED|U|SINGLE-SLICE SPIRAL CT|NA|N|N||1||38||BASELINE|1960-03-30|1966-10-29|||||1960-04-06||1972-11-04
TRIAL STUDY 134XCP|IS|7B583F10-E460-4B25-8A6B-530A154442CD||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L|||||10^7 CFU/ML||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|CONTAMINATED|Y|NEURAMINIDASE INHIBITION ASSAY|NA|U|Y||2||58||WASHOUT|1966-05-13|1970-08-15|||||1969-11-05||1962-04-07
TRIAL STUDY 134XCP|IS|7B583F10-E460-4B25-8A6B-530A154442CD||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/G|||||H/WK||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|HEMOLYZED|N|DYNAMOMETRY|NA|U|U||3||39||INDUCTION TREATMENT|1965-09-30|1962-08-09|||||1965-05-18||1960-01-16
TRIAL STUDY 134XCP|IS|7B583F10-E460-4B25-8A6B-530A154442CD||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6 CFU/ML|||||G/KG||||LOW|NOT DONE|||CORD BLOOD|REFRIGERATED|Y|NUCLEIC ACID HYBRIDIZATION|U|N|N||4||88||BLINDED TREATMENT|1973-09-02|1965-05-08|||||1960-03-12||1971-08-13
TRIAL STUDY 134XCP|IS|7B583F10-E460-4B25-8A6B-530A154442CD||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NL|||||NMOL/DAY||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|CALCIFIED|U|CONTRAST ENHANCED PET/CT SCAN|N|NA|U||5||7||CONTINUATION TREATMENT|1970-03-09|1968-10-26|||||1973-06-24||1963-12-22
TRIAL STUDY 134XCP|IS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MDFI|||||DNA COPIES/UG||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|CONTAMINATED|N|HIGH RESOLUTION CT|N|N|Y||1||38||WASHOUT|1963-08-07|1962-01-06|||||1966-04-23||1970-12-29
TRIAL STUDY 134XCP|IS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^8 PFU|||||CMHG||||ABNORMAL|NOT DONE|||CIRCULATING TUMOR CELL|REFRIGERATED|N|IMMUNO-PET SCAN|NA|Y|U||2||58||BASELINE|1967-06-18|1962-01-02|||||1973-07-13||1971-04-01
TRIAL STUDY 134XCP|IS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NG/DAY|||||FEU||||LOW|NOT DONE|||PLATELET RICH PLASMA|SOLIDIFIED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NA|Y|U||3||39||FOLLOW-UP|1964-05-27|1962-12-15|||||1963-07-24||1966-02-20
TRIAL STUDY 134XCP|IS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MKAT|||||TRANSDUCING UNIT/ML||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|N|MAMMOGRAPHY|NA|Y|U||4||88||BASELINE|1964-07-02|1972-11-14|||||1963-03-18||1967-06-21
TRIAL STUDY 134XCP|IS|85FCA6B5-F6DC-4ED6-BBFD-92DB6DC4FEC6||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ARBITRARY U|||||10^5/L||||LOW|NOT DONE|||LAVAGE FLUID|NON-HEMOLYZED|N|LASER CAPTURE MICRODISSECTION|U|N|U||5||7||RUN-IN|1961-02-06|1969-06-04|||||1964-07-01||1966-02-24
TRIAL STUDY 134XCP|IS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CM|||||KN/CM2||||NORMAL|NOT DONE|||URINE SEDIMENT|UNEXPECTED ODOR|NA|EEG|U|U|Y||1||38||BLINDED TREATMENT|1968-09-23|1961-02-25|||||1968-12-03||1962-06-05
TRIAL STUDY 134XCP|IS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GY/MIN|||||COPIES/UL||||HIGH|NOT DONE|||CELL PELLET|FRESH|U|COULOMETRIC TITRATION|U|Y|U||2||58||FOLLOW-UP|1966-09-04|1960-12-04|||||1966-06-04||1970-07-16
TRIAL STUDY 134XCP|IS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM/DAY|||||MJOULE/CM2||||LOW|NOT DONE|||PLEURAL FLUID|LIPEMIC|N|HPLC-FL|U|U|U||3||39||BASELINE|1963-11-20|1966-03-16|||||1963-03-11||1966-05-03
TRIAL STUDY 134XCP|IS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CM2|||||FG||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|AGGLUTINATED|Y|GC/MS/MS|U|Y|N||4||88||SCREENING|1967-11-03|1962-05-12|||||1971-12-05||1965-07-20
TRIAL STUDY 134XCP|IS|E8D7AE54-09E7-429B-BD5B-318A1A4923CA||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GLOBULE|||||MOSM/L||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONCENTRATED|NA|TURBIDIMETRY|Y|Y|Y||5||7||OBSERVATION|1967-02-28|1960-10-31|||||1961-10-13||1969-02-12
TRIAL STUDY 134XCP|IS|51FE575E-2161-414B-B772-9F1888E7C5CC||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/MIN|||||MG/M2/MIN||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|REFRIGERATED|U|CYSTOSCOPY|U|NA|NA||1||38||TREATMENT|1960-09-03|1969-05-13|||||1966-10-13||1973-08-06
TRIAL STUDY 134XCP|IS|51FE575E-2161-414B-B772-9F1888E7C5CC||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||YEARS|||||UIU/L||||ABNORMAL|NOT DONE|||ERYTHROCYTES|LIPEMIC|NA|SPIRAL CT SCAN WITHOUT CONTRAST|Y|U|NA||2||58||BLINDED TREATMENT|1965-09-30|1969-10-25|||||1967-06-09||1963-07-10
TRIAL STUDY 134XCP|IS|51FE575E-2161-414B-B772-9F1888E7C5CC||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DDU|||||AMOL||||NORMAL|NOT DONE|||REFLEX TEAR|SOLIDIFIED|N|ERGOSPIROMETRY|NA|U|NA||3||39||WASHOUT|1967-05-09|1966-12-13|||||1970-07-25||1970-11-17
TRIAL STUDY 134XCP|IS|51FE575E-2161-414B-B772-9F1888E7C5CC||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/KG/H|||||IU/G||||NORMAL|NOT DONE|||TUMOR TISSUE|FROZEN|NA|TARGETED TRANSCRIPTOME SEQUENCING|N|NA|Y||4||88||FOLLOW-UP|1965-09-28|1966-03-01|||||1961-12-26||1968-04-01
TRIAL STUDY 134XCP|IS|51FE575E-2161-414B-B772-9F1888E7C5CC||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UOSM|||||PG/DL||||LOW|NOT DONE|||TRANSUDATE|DRIED|NA|TRICHROME STAIN|N|U|Y||5||7||FOLLOW-UP|1970-04-01|1972-07-08|||||1972-02-12||1963-07-29
TRIAL STUDY 134XCP|IS|991C72FC-777F-4CED-824B-A4DECA57BE99||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FRACTION OF 1|||||U/G||||LOW|NOT DONE|||INTERSTITIAL FLUID|AUTOLYZED|N|INDIA INK STAIN|N|U|NA||1||38||LONG-TERM FOLLOW-UP|1960-07-01|1964-02-11|||||1968-03-18||1961-11-16
TRIAL STUDY 134XCP|IS|991C72FC-777F-4CED-824B-A4DECA57BE99||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||EU|||||JOULE||||LOW|NOT DONE|||EMOTIONAL TEAR|REFRIGERATED|Y|BETA LACTAMASE|Y|Y|NA||2||58||INDUCTION TREATMENT|1962-04-24|1965-12-25|||||1965-04-17||1971-10-06
TRIAL STUDY 134XCP|IS|991C72FC-777F-4CED-824B-A4DECA57BE99||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/KG/DAY|||||MG/M2/H||||HIGH|NOT DONE|||SEMINAL FLUID|CLOTTED|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NA|NA|U||3||39||INDUCTION TREATMENT|1969-09-08|1969-04-25|||||1960-01-14||1972-01-30
TRIAL STUDY 134XCP|IS|991C72FC-777F-4CED-824B-A4DECA57BE99||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CL|||||CS||||LOW|NOT DONE|||EMESIS|LACTESCENT|NA|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|U|N||4||88||OPEN LABEL TREATMENT|1966-04-14|1962-07-13|||||1971-04-01||1962-01-24
TRIAL STUDY 134XCP|IS|991C72FC-777F-4CED-824B-A4DECA57BE99||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PIXELS/CM|||||GY||||NORMAL|NOT DONE|||LOCHIA|REFRIGERATED|Y|NON-CONTACT SPECULAR MICROSCOPY|Y|U|NA||5||7||FOLLOW-UP|1968-12-05|1972-07-21|||||1963-11-04||1969-02-13
TRIAL STUDY 134XCP|IS|FFECA538-8D16-421C-ACA2-4A769BC15D7D||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PACK YEAR|||||BAG||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|UNEXPECTED ODOR|N|SEQUENCING|N|Y|U||1||38||WASHOUT|1972-08-27|1963-10-29|||||1967-01-17||1964-09-11
TRIAL STUDY 134XCP|IS|FFECA538-8D16-421C-ACA2-4A769BC15D7D||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U.CARR|||||LOZENGE||||NORMAL|NOT DONE|||ERYTHROCYTES|ROOM TEMPERATURE|U|CLIP|N|NA|U||2||58||RUN-IN|1967-09-17|1963-06-26|||||1962-06-29||1967-08-11
TRIAL STUDY 134XCP|IS|FFECA538-8D16-421C-ACA2-4A769BC15D7D||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/SEC|||||%||||LOW|NOT DONE|||EPIDERMAL TISSUE|LIPEMIC|Y|PERIODIC ACID SCHIFF STAIN|Y|U|N||3||39||FOLLOW-UP|1964-08-17|1971-12-23|||||1968-02-25||1960-12-14
TRIAL STUDY 134XCP|IS|FFECA538-8D16-421C-ACA2-4A769BC15D7D||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||S*KPA|||||HEP||||LOW|NOT DONE|||ALVEOLAR AIR|AUTOLYZED|Y|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|NA|NA||4||88||OBSERVATION|1967-01-08|1964-02-18|||||1960-01-21||1972-02-26
TRIAL STUDY 134XCP|IS|FFECA538-8D16-421C-ACA2-4A769BC15D7D||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/KG/H|||||CAN||||HIGH|NOT DONE|||BASAL TEAR|NON-HEMOLYZED|NA|REFRACTOMETRY|NA|U|N||5||7||INDUCTION TREATMENT|1960-06-02|1962-12-13|||||1969-10-09||1965-05-25
TRIAL STUDY 134XCP|IS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KEV|||||UG/KG/H||||HIGH|NOT DONE|||MENSTRUAL BLOOD|LIPEMIC|NA|AUSCULTATION|Y|N|U||1||38||RUN-IN|1961-02-13|1971-02-23|||||1966-01-17||1961-02-18
TRIAL STUDY 134XCP|IS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/KG|||||CM/S||||NORMAL|NOT DONE|||GASTRIC FLUID|LIPEMIC|N|TEMPLATE INCISION METHOD|Y|U|NA||2||58||CONTINUATION TREATMENT|1963-11-13|1960-03-23|||||1966-08-11||1968-02-11
TRIAL STUDY 134XCP|IS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CL|||||ANTI-XA IU||||ABNORMAL|NOT DONE|||PLASMA|FRESH|Y|PALPATION|U|U|Y||3||39||LONG-TERM FOLLOW-UP|1962-02-25|1972-03-20|||||1962-12-28||1964-05-29
TRIAL STUDY 134XCP|IS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||V/SEC|||||%/MIN||||HIGH|NOT DONE|||MUSCLE TISSUE|LACTESCENT|N|TRANSVAGINAL ULTRASOUND|U|N|U||4||88||TREATMENT|1971-05-28|1963-04-15|||||1972-02-12||1965-02-09
TRIAL STUDY 134XCP|IS|72FB03F9-3FF5-4039-98AE-8FC966A6E01E||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UIU/L|||||UU/L||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|GELLED|N|PALPATION|U|U|Y||5||7||TREATMENT|1969-09-04|1971-11-06|||||1971-09-09||1970-09-04
TRIAL STUDY 134XCP|IS|54507F00-0C16-4F35-A762-104B47390283||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||OD UNIT|||||MM2||||LOW|NOT DONE|||LEUKOCYTE|ROOM TEMPERATURE|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|NA|U||1||38||FOLLOW-UP|1971-06-28|1973-05-06|||||1971-09-12||1963-06-29
TRIAL STUDY 134XCP|IS|54507F00-0C16-4F35-A762-104B47390283||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KG/MOL|||||VG/DOSE||||LOW|NOT DONE|||GASTRIC FLUID|FROZEN|U|FLUORESCENT ENZYME IMMUNOASSAY|NA|Y|NA||2||58||RUN-IN|1962-07-13|1961-04-29|||||1961-01-27||1962-02-04
TRIAL STUDY 134XCP|IS|54507F00-0C16-4F35-A762-104B47390283||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GBQ/MG|||||MG/DL||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|THAWED|Y|ELASTOGRAPHY|N|NA|N||3||39||RUN-IN|1973-04-10|1964-02-14|||||1966-02-13||1964-07-26
TRIAL STUDY 134XCP|IS|54507F00-0C16-4F35-A762-104B47390283||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GLOBULE|||||WATT||||LOW|NOT DONE|||HAIR|UNEXPECTED ODOR|NA|NEURAMINIDASE INHIBITION ASSAY|Y|Y|N||4||88||OBSERVATION|1967-07-27|1969-09-12|||||1960-06-11||1973-04-05
TRIAL STUDY 134XCP|IS|54507F00-0C16-4F35-A762-104B47390283||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MOSM/KG|||||U/M2/H||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|LIPEMIC|NA|MAGNETIC RESONANCE ENTEROGRAPHY|NA|NA|Y||5||7||BASELINE|1967-10-11|1970-11-28|||||1969-05-14||1968-11-13
TRIAL STUDY 134XCP|IS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MN|||||PRESSOR UNITS||||LOW|NOT DONE|||SEBUM|CALCIFIED|Y|IMMUNOPRECIPITATION|U|Y|U||1||38||BLINDED TREATMENT|1967-10-26|1969-03-29|||||1962-01-04||1964-10-11
TRIAL STUDY 134XCP|IS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||EIA UNIT|||||OHM||||LOW|NOT DONE|||NAIL|NON-HEMOLYZED|N|PULMONARY ANGIOGRAPHY|N|N|U||2||58||SCREENING|1970-09-06|1969-06-10|||||1963-03-15||1972-05-18
TRIAL STUDY 134XCP|IS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SQU/ML|||||QUANTITY SUFFICIENT||||HIGH|NOT DONE|||DERMAL TISSUE|LIPEMIC|U|REBOUND TONOMETRY|U|U|N||3||39||CONTINUATION TREATMENT|1963-07-29|1971-03-21|||||1962-06-09||1964-07-25
TRIAL STUDY 134XCP|IS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KUSP|||||KBQ||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|CONCENTRATED|Y|TEST STRIP|Y|NA|Y||4||88||BASELINE|1972-07-04|1972-08-10|||||1967-08-08||1972-02-24
TRIAL STUDY 134XCP|IS|2CFF24EC-FBE1-4A45-9FCE-9DAAD35D9566||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KBQ/UL|||||ML/S||||ABNORMAL|NOT DONE|||LOCHIA|HEMOLYZED|Y|DOPPLER ULTRASOUND|NA|NA|NA||5||7||BLINDED TREATMENT|1970-01-23|1960-11-27|||||1972-03-17||1971-08-18
TRIAL STUDY 134XCP|IS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TRANSDUCING UNIT/ML|||||NMOL/MOL||||NORMAL|NOT DONE|||CELL PELLET|NON-HEMOLYZED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NA|U|Y||1||38||WASHOUT|1960-06-04|1963-03-28|||||1960-10-07||1972-05-12
TRIAL STUDY 134XCP|IS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/MMHG/MIN/L|||||AMPULE||||NORMAL|NOT DONE|||MUSCLE TISSUE|UNEXPECTED ODOR|N|MUGA|Y|Y|U||2||58||SCREENING|1969-06-04|1968-02-20|||||1961-02-16||1969-11-30
TRIAL STUDY 134XCP|IS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/10^5|||||EVENTS||||NORMAL|NOT DONE|||SKIN TISSUE|GELLED|NA|PET/SPECT SCAN|N|U|N||3||39||FOLLOW-UP|1970-04-16|1962-09-29|||||1964-06-05||1965-11-05
TRIAL STUDY 134XCP|IS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DAMOL/L|||||DPM/0.5 ML||||HIGH|NOT DONE|||BLOOD|DRIED|Y|NON-INVASIVE DIELECTRIC SENSING|Y|U|U||4||88||INDUCTION TREATMENT|1970-03-26|1967-02-12|||||1966-01-28||1967-02-05
TRIAL STUDY 134XCP|IS|C16428B9-880B-47B9-BF1D-2CF87DE8ECE1||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NM|||||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|DRIED|N|APPLANATION TONOMETRY|N|N|Y||5||7||SCREENING|1970-03-05|1972-02-02|||||1968-01-03||1972-12-14
TRIAL STUDY 134XCP|IS|CF8F9036-3380-4A0B-B17A-7EF814B02700||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PFU/ANIMAL|||||U/ML||||LOW|NOT DONE|||PROSTATIC FLUID|AGGLUTINATED|Y|CALCULATION|U|U|Y||1||38||FOLLOW-UP|1967-12-03|1970-12-29|||||1961-10-03||1966-03-09
TRIAL STUDY 134XCP|IS|CF8F9036-3380-4A0B-B17A-7EF814B02700||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KDA|||||STEPS/MIN||||ABNORMAL|NOT DONE|||CORD SERUM|LACTESCENT|Y|FLUORESCENT ENZYME IMMUNOASSAY|U|N|U||2||58||FOLLOW-UP|1971-12-16|1968-06-28|||||1969-01-02||1969-09-05
TRIAL STUDY 134XCP|IS|CF8F9036-3380-4A0B-B17A-7EF814B02700||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GTT|||||USEC||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|SOLIDIFIED|N|POTENTIOMETRY|N|NA|N||3||39||TREATMENT|1966-05-09|1968-03-05|||||1971-01-10||1966-10-06
TRIAL STUDY 134XCP|IS|CF8F9036-3380-4A0B-B17A-7EF814B02700||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/MM|||||10^11/L||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|LIPEMIC|U|REBOUND TONOMETRY|N|U|N||4||88||TREATMENT|1972-06-30|1963-12-22|||||1971-06-20||1963-04-23
TRIAL STUDY 134XCP|IS|CF8F9036-3380-4A0B-B17A-7EF814B02700||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MILE|||||/5X10^4 WBC||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|CONTAMINATED|N|IN VITRO GENE EXPRESSION ASSAY|Y|NA|Y||5||7||CONTINUATION TREATMENT|1969-12-14|1970-05-06|||||1961-04-06||1964-02-23
TRIAL STUDY 134XCP|IS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PIPE|||||BOX||||ABNORMAL|NOT DONE|||MONOCYTE|CONCENTRATED|NA|SCINTIGRAPHY|Y|U|N||1||38||BASELINE|1972-08-11|1964-10-06|||||1966-07-21||1968-09-07
TRIAL STUDY 134XCP|IS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CAPSULE|||||BOWL||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|AUTOLYZED|Y|PET SCAN|Y|Y|N||2||58||INDUCTION TREATMENT|1970-08-04|1973-03-26|||||1968-08-19||1962-04-17
TRIAL STUDY 134XCP|IS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KBQ|||||L/S/KPA||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|ICTERIC|U|GC/MS-CI|U|U|Y||3||39||CONTINUATION TREATMENT|1963-02-26|1960-01-22|||||1968-12-27||1964-01-25
TRIAL STUDY 134XCP|IS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IU/KG|||||MG/G/H||||HIGH|NOT DONE|||MUCUS|UNEXPECTED ODOR|N|MULTI-SLICE SPIRAL CT|Y|N|U||4||88||OPEN LABEL TREATMENT|1961-09-28|1963-12-13|||||1969-09-14||1964-12-12
TRIAL STUDY 134XCP|IS|0DE06EA9-D4D1-4E52-8FF6-29B334E9BB8D||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CY/CM|||||FOZ_BR||||NORMAL|NOT DONE|||SALIVA|UNEXPECTED ODOR|N|VENTILATION PERFUSION LUNG SCAN|Y|NA|Y||5||7||BLINDED TREATMENT|1971-07-15|1965-07-29|||||1964-11-26||1973-06-13
TRIAL STUDY 134XCP|IS|58360390-F6AB-41D7-9A0D-1039E795403E||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||M3|||||DAGU/ML||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|SOLIDIFIED|NA|FLUORESCENT ENZYME IMMUNOASSAY|U|U|N||1||38||BASELINE|1966-02-14|1967-11-01|||||1968-07-17||1961-08-04
TRIAL STUDY 134XCP|IS|58360390-F6AB-41D7-9A0D-1039E795403E||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PG|||||NMOL BCE/L||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|HEMOLYZED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|U|NA|NA||2||58||CONTINUATION TREATMENT|1971-09-06|1969-08-12|||||1970-03-03||1973-04-20
TRIAL STUDY 134XCP|IS|58360390-F6AB-41D7-9A0D-1039E795403E||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/DAY|||||ANTIBODY UNIT||||HIGH|NOT DONE|||VENOUS PLASMA|ICTERIC|U|DXA SCAN|N|N|Y||3||39||CONTINUATION TREATMENT|1964-10-05|1966-03-24|||||1971-05-18||1963-01-06
TRIAL STUDY 134XCP|IS|58360390-F6AB-41D7-9A0D-1039E795403E||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/DAY|||||GPELISA UNIT/ML||||LOW|NOT DONE|||SERUM OR PLASMA|CALCIFIED|U|IMMUNOBLOT|N|U|N||4||88||OBSERVATION|1961-06-09|1972-10-25|||||1960-10-18||1963-09-06
TRIAL STUDY 134XCP|IS|58360390-F6AB-41D7-9A0D-1039E795403E||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ANTI-XA IU/ML|||||PLUG||||LOW|NOT DONE|||BREAST MILK|FROZEN|N|MAGNETIC RESONANCE ELASTOGRAPHY|U|N|NA||5||7||CONTINUATION TREATMENT|1971-02-23|1960-07-29|||||1962-05-06||1972-01-29
TRIAL STUDY 134XCP|IS|61B02780-0C99-47F8-93B2-CA839876604E||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG|||||KIU||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|CONTAMINATED|U|MEDIASTINOSCOPY|U|U|U||1||38||OBSERVATION|1963-02-02|1972-03-10|||||1967-12-17||1961-12-01
TRIAL STUDY 134XCP|IS|61B02780-0C99-47F8-93B2-CA839876604E||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CUP|||||RFU||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|DRIED|U|IRON HEMATOXYLIN STAIN|Y|N|Y||2||58||SCREENING|1972-08-21|1962-06-06|||||1961-11-18||1962-11-25
TRIAL STUDY 134XCP|IS|61B02780-0C99-47F8-93B2-CA839876604E||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||RPM|||||DPM/0.5 ML||||HIGH|NOT DONE|||EXUDATE|FROZEN|U|KINETIC CHROMOGENIC ASSAY|Y|Y|U||3||39||SCREENING|1966-04-20|1960-11-11|||||1966-04-27||1969-07-19
TRIAL STUDY 134XCP|IS|61B02780-0C99-47F8-93B2-CA839876604E||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TRACE|||||10^3 CFU/ML||||NORMAL|NOT DONE|||ADIPOSE TISSUE|AGGLUTINATED|U|WESTERN BLOT|U|U|N||4||88||OBSERVATION|1970-06-20|1966-08-06|||||1961-06-26||1965-09-27
TRIAL STUDY 134XCP|IS|61B02780-0C99-47F8-93B2-CA839876604E||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||AG|||||EID 50/ML||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|THAWED|NA|HPLC/IEX|NA|Y|NA||5||7||RUN-IN|1964-09-26|1963-09-10|||||1966-12-14||1964-07-23
TRIAL STUDY 134XCP|IS|1381458A-D702-467D-ADCA-984EE7BD894D||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||YD|||||CCID 50/ML||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|FROZEN|NA|PALPATION|Y|N|N||1||38||INDUCTION TREATMENT|1961-03-31|1962-12-22|||||1971-02-06||1970-09-01
TRIAL STUDY 134XCP|IS|1381458A-D702-467D-ADCA-984EE7BD894D||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CPM|||||NSEC||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|GELLED|N|URANYL ACETATE STAIN|U|Y|N||2||58||WASHOUT|1964-11-15|1962-02-23|||||1967-11-23||1966-02-08
TRIAL STUDY 134XCP|IS|1381458A-D702-467D-ADCA-984EE7BD894D||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ABSORBANCE U/ML|||||U||||HIGH|NOT DONE|||SEMINAL FLUID|FRESH|N|MRS|NA|N|NA||3||39||CONTINUATION TREATMENT|1960-06-08|1962-01-01|||||1965-01-26||1964-10-07
TRIAL STUDY 134XCP|IS|1381458A-D702-467D-ADCA-984EE7BD894D||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/MG/MIN|||||CYCLE/MIN||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|LIPEMIC|N|TARGETED GENOME SEQUENCING|N|Y|Y||4||88||CONTINUATION TREATMENT|1973-07-10|1970-07-28|||||1960-05-01||1972-12-08
TRIAL STUDY 134XCP|IS|1381458A-D702-467D-ADCA-984EE7BD894D||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PSI|||||JOULE||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|AUTOLYZED|NA|AMSLER GRID|Y|Y|U||5||7||RUN-IN|1967-02-16|1972-09-03|||||1962-10-22||1962-12-31
TRIAL STUDY 134XCP|IS|04211DA3-CFD5-4750-9D61-C91FF7BC338A||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/KG/DOSE|||||CIGARETTE||||LOW|NOT DONE|||REFLEX TEAR|FROZEN|Y|FREEZING POINT DEPRESSION|Y|U|U||1||38||LONG-TERM FOLLOW-UP|1967-06-19|1964-01-31|||||1961-07-17||1960-09-25
TRIAL STUDY 134XCP|IS|04211DA3-CFD5-4750-9D61-C91FF7BC338A||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MOSM/L|||||10^3 DNA COPIES/ML||||NORMAL|NOT DONE|||CELL PELLET|ICTERIC|NA|GC/FID|U|N|N||2||58||BLINDED TREATMENT|1971-10-16|1963-03-01|||||1961-08-14||1962-06-10
TRIAL STUDY 134XCP|IS|04211DA3-CFD5-4750-9D61-C91FF7BC338A||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PPTH|||||BU||||HIGH|NOT DONE|||SALIVA|DRIED|Y|SISH|N|N|NA||3||39||CONTINUATION TREATMENT|1969-03-15|1965-02-15|||||1972-11-27||1970-10-16
TRIAL STUDY 134XCP|IS|04211DA3-CFD5-4750-9D61-C91FF7BC338A||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DEG/MM|||||FMOL/G||||HIGH|NOT DONE|||FLUID|AGGLUTINATED|N|INCISION-INDUCED BLEEDING METHOD|Y|U|U||4||88||OPEN LABEL TREATMENT|1972-06-11|1971-05-26|||||1964-09-30||1967-06-22
TRIAL STUDY 134XCP|IS|04211DA3-CFD5-4750-9D61-C91FF7BC338A||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UV2|||||RFU||||HIGH|NOT DONE|||PLATELET POOR PLASMA|CONTAMINATED|NA|FARR ASSAY|U|U|U||5||7||LONG-TERM FOLLOW-UP|1973-08-31|1972-09-05|||||1965-09-25||1966-08-07
TRIAL STUDY 134XCP|IS|EF707A48-6FAD-47C0-913A-5CBCACA539E0||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/L|||||U/CL||||HIGH|NOT DONE|||VENOUS BLOOD|UNEXPECTED ODOR|N|SURFACE PLASMON RESONANCE|N|U|Y||1||38||FOLLOW-UP|1965-05-07|1968-02-16|||||1966-06-05||1963-04-02
TRIAL STUDY 134XCP|IS|EF707A48-6FAD-47C0-913A-5CBCACA539E0||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LM|||||CI/G||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|AUTOLYZED|Y|LEAD CITRATE STAIN|Y|N|N||2||58||BASELINE|1962-07-22|1962-12-14|||||1972-03-24||1968-07-28
TRIAL STUDY 134XCP|IS|EF707A48-6FAD-47C0-913A-5CBCACA539E0||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/KG/H|||||MEQ/MMOL||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|DRIED|U|SANGER SEQUENCING|NA|U|U||3||39||TREATMENT|1961-04-22|1971-07-16|||||1963-07-24||1961-07-09
TRIAL STUDY 134XCP|IS|EF707A48-6FAD-47C0-913A-5CBCACA539E0||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/2500 WBC|||||ENZYME U/M2||||HIGH|NOT DONE|||COLOSTRUM|AUTOLYZED|Y|FLAME PHOTOMETRY|NA|NA|U||4||88||CONTINUATION TREATMENT|1971-03-17|1966-09-11|||||1969-02-20||1960-03-09
TRIAL STUDY 134XCP|IS|EF707A48-6FAD-47C0-913A-5CBCACA539E0||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PT_BR|||||MEQ/ML||||NORMAL|NOT DONE|||DERMAL TISSUE|GELLED|NA|SANGER SEQUENCING|N|N|N||5||7||INDUCTION TREATMENT|1967-08-08|1967-06-30|||||1965-01-18||1966-10-01
TRIAL STUDY 134XCP|IS|C896767E-2418-4226-A8AE-D875DA40F9FB||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/4.0 ML|||||HEP||||NORMAL|NOT DONE|||BONE MARROW|NON-HEMOLYZED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|NA|U|N||1||38||TREATMENT|1963-03-24|1960-12-27|||||1962-03-27||1963-05-15
TRIAL STUDY 134XCP|IS|C896767E-2418-4226-A8AE-D875DA40F9FB||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GPELISA UNIT/ML|||||BOLUS||||HIGH|NOT DONE|||INFRANATANT, PLASMA|FROZEN|N|TARGETED GENOME SEQUENCING|NA|N|NA||2||58||OBSERVATION|1964-08-25|1972-07-04|||||1963-03-14||1960-10-07
TRIAL STUDY 134XCP|IS|C896767E-2418-4226-A8AE-D875DA40F9FB||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DMOL|||||MEQ/G||||LOW|NOT DONE|||PUS|ICTERIC|N|OPTICAL DENSITY MEASUREMENT|NA|N|NA||3||39||FOLLOW-UP|1966-02-06|1960-10-05|||||1969-12-31||1966-05-05
TRIAL STUDY 134XCP|IS|C896767E-2418-4226-A8AE-D875DA40F9FB||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^5/L|||||10^6/EJACULATE U||||ABNORMAL|NOT DONE|||CIRCULATING TUMOR CELL|THAWED|N|CHROMATOGRAPHY|U|U|Y||4||88||OBSERVATION|1971-08-13|1970-04-22|||||1964-09-13||1972-02-20
TRIAL STUDY 134XCP|IS|C896767E-2418-4226-A8AE-D875DA40F9FB||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||AMOL|||||MG/G/MIN||||HIGH|NOT DONE|||SYNOVIAL FLUID|AGGLUTINATED|U|PALM METHOD|U|N|NA||5||7||BASELINE|1961-10-25|1965-07-12|||||1966-11-10||1960-07-24
TRIAL STUDY 134XCP|IS|666BC019-B828-4DB4-BD2F-973BA689C9E7||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PUFF|||||/MBP||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|NA|U|Y||1||38||CONTINUATION TREATMENT|1960-03-20|1966-08-20|||||1966-01-13||1972-08-13
TRIAL STUDY 134XCP|IS|666BC019-B828-4DB4-BD2F-973BA689C9E7||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ENZYME U/M2|||||10^6 RNA COPIES/ML||||HIGH|NOT DONE|||PLEURAL TISSUE|CONCENTRATED|U|PERIODIC ACID SCHIFF STAIN|Y|N|Y||2||58||WASHOUT|1970-02-12|1967-02-25|||||1966-05-16||1969-07-10
TRIAL STUDY 134XCP|IS|666BC019-B828-4DB4-BD2F-973BA689C9E7||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NFIU|||||CCID 50/ML||||NORMAL|NOT DONE|||PLATELET|CONTAMINATED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|N|U|Y||3||39||BASELINE|1966-01-07|1970-03-29|||||1962-09-21||1968-08-14
TRIAL STUDY 134XCP|IS|666BC019-B828-4DB4-BD2F-973BA689C9E7||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/G/MIN|||||UMOL/H/MMOL||||LOW|NOT DONE|||SEMEN|PARAFFIN-EMBEDDED|U|OSCILLOMETRY|N|N|Y||4||88||FOLLOW-UP|1967-01-02|1963-02-19|||||1967-07-06||1967-01-28
TRIAL STUDY 134XCP|IS|666BC019-B828-4DB4-BD2F-973BA689C9E7||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS|||||G/L||||HIGH|NOT DONE|||LYMPH|THAWED|NA|HPLC|Y|U|Y||5||7||OPEN LABEL TREATMENT|1967-06-18|1973-09-06|||||1965-05-18||1970-04-08
TRIAL STUDY 134XCP|IS|91282D87-4943-4527-8F33-27A5C153951C||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ABSORBANCE U/ML|||||BQ/UG||||LOW|NOT DONE|||STOOL|PARAFFIN-EMBEDDED|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|N|Y|Y||1||38||OPEN LABEL TREATMENT|1961-06-30|1969-07-26|||||1960-01-15||1962-06-22
TRIAL STUDY 134XCP|IS|91282D87-4943-4527-8F33-27A5C153951C||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 CFU|||||CAPSULE||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|THAWED|Y|FUNCTIONAL MRI|U|N|U||2||58||WASHOUT|1967-05-30|1973-07-29|||||1973-04-17||1971-06-28
TRIAL STUDY 134XCP|IS|91282D87-4943-4527-8F33-27A5C153951C||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KBQ/UL|||||LOG10 IU/ML||||ABNORMAL|NOT DONE|||ABSCESS FLUID|THAWED|Y|MANUAL CLOT DETECTION|N|NA|NA||3||39||FOLLOW-UP|1961-05-06|1967-12-03|||||1972-09-02||1965-06-25
TRIAL STUDY 134XCP|IS|91282D87-4943-4527-8F33-27A5C153951C||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||SACHET|||||/WK||||NORMAL|NOT DONE|||MECONIUM|CONTAMINATED|Y|ELASTOGRAPHY|N|NA|U||4||88||SCREENING|1971-01-27|1966-06-07|||||1966-05-01||1964-05-09
TRIAL STUDY 134XCP|IS|91282D87-4943-4527-8F33-27A5C153951C||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DPM/100MG|||||IU/L||||NORMAL|NOT DONE|||SWABBED MATERIAL|THAWED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|Y|NA||5||7||CONTINUATION TREATMENT|1970-12-01|1970-10-01|||||1962-11-07||1963-02-27
TRIAL STUDY 134XCP|IS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/7.5 ML|||||U/G||||NORMAL|NOT DONE|||BREAST MILK|REFRIGERATED|NA|FLUORESCENT SPOT TEST|U|N|U||1||38||INDUCTION TREATMENT|1971-07-09|1973-03-21|||||1962-06-04||1972-03-04
TRIAL STUDY 134XCP|IS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^5/L|||||ML/S/M2||||ABNORMAL|NOT DONE|||FLUID|LIPEMIC|NA|MICRO BROTH DILUTION|U|N|Y||2||58||TREATMENT|1966-10-24|1960-05-28|||||1971-09-20||1962-11-10
TRIAL STUDY 134XCP|IS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NSEC|||||MG/H||||ABNORMAL|NOT DONE|||CALCULUS|HEMOLYZED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|N|N||3||39||OPEN LABEL TREATMENT|1967-10-03|1967-03-19|||||1969-02-16||1973-06-08
TRIAL STUDY 134XCP|IS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/ANIMAL|||||NL||||NORMAL|NOT DONE|||INFRANATANT, SERUM|FROZEN|NA|FORCED OSCILLATION TECHNIQUE|Y|N|Y||4||88||RUN-IN|1970-07-10|1967-12-20|||||1963-07-15||1971-01-22
TRIAL STUDY 134XCP|IS|1A56C9D3-ADEE-42C0-BF43-CE42F70E9A6A||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PACK YEAR|||||ML/M2/H||||LOW|NOT DONE|||LUNG SURFACTANT|PARAFFIN-EMBEDDED|NA|ZIEHL NEELSEN ACID FAST STAIN|Y|Y|N||5||7||CONTINUATION TREATMENT|1960-12-06|1965-09-15|||||1961-04-19||1961-09-17
TRIAL STUDY 134XCP|IS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3 COPIES/ML|||||ML/MIN/1.73M2||||HIGH|NOT DONE|||EMESIS|PARAFFIN-EMBEDDED|N|NUCLEIC ACID BASED METHOD|N|N|N||1||38||BLINDED TREATMENT|1960-04-24|1960-10-23|||||1961-09-15||1972-09-25
TRIAL STUDY 134XCP|IS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||TAMPON|||||UMOL/L/MIN||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|REFRIGERATED|U|CAPILLARY ELECTROPHORESIS|N|N|NA||2||58||FOLLOW-UP|1967-07-07|1967-02-16|||||1969-07-30||1968-05-30
TRIAL STUDY 134XCP|IS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/ANIMAL/WK|||||HENRY||||NORMAL|NOT DONE|||PLASMA|AGGLUTINATED|N|FLUOROSCOPY|Y|U|U||3||39||CONTINUATION TREATMENT|1965-08-06|1970-01-28|||||1967-11-10||1963-04-10
TRIAL STUDY 134XCP|IS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CMH2O*S2/ML|||||MOL/MG||||NORMAL|NOT DONE|||BONE|HEMOLYZED|U|WRIGHT-GIEMSA STAIN|N|NA|U||4||88||BLINDED TREATMENT|1969-08-03|1968-12-11|||||1966-02-06||1970-01-06
TRIAL STUDY 134XCP|IS|0D0EC1C5-B2B7-4D1C-9986-5F9915B81DE2||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PIXEL|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||DISCHARGE|THAWED|Y|IN VITRO GENE EXPRESSION ASSAY|Y|Y|U||5||7||BASELINE|1965-02-14|1973-08-07|||||1973-02-14||1961-08-07
TRIAL STUDY 134XCP|IS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ATM|||||MG||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED|N|LISSAMINE GREEN STAIN|N|U|NA||1||38||TREATMENT|1964-07-30|1972-08-02|||||1963-01-05||1962-12-20
TRIAL STUDY 134XCP|IS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BQ/UL|||||PATCH||||LOW|NOT DONE|||INFRANATANT, PLASMA|REFRIGERATED|NA|PHOTOMETRIC CLOT DETECTION|N|NA|NA||2||58||OBSERVATION|1963-04-23|1964-03-13|||||1970-07-29||1961-05-05
TRIAL STUDY 134XCP|IS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FT3|||||NEEDLE GAUGE||||ABNORMAL|NOT DONE|||MONOCYTE|HEMOLYZED|U|CLOT DETECTION|NA|Y|Y||3||39||OBSERVATION|1964-11-02|1965-11-30|||||1961-10-21||1973-04-01
TRIAL STUDY 134XCP|IS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMU/ML|||||ABSORBANCE U||||HIGH|NOT DONE|||BASAL TEAR|SOLIDIFIED|NA|MAPH|Y|NA|Y||4||88||OBSERVATION|1966-02-23|1963-06-15|||||1963-01-28||1972-09-27
TRIAL STUDY 134XCP|IS|5A3D2F32-F73C-4ADF-988C-8AB33B0754B1||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^8/L|||||UEQ||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CLOTTED|U|SEQUENCING|Y|N|Y||5||7||OBSERVATION|1964-12-23|1966-07-11|||||1960-10-03||1966-12-19
TRIAL STUDY 134XCP|IS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UCI/KG|||||10^3 CFU||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|U|N|NA||1||38||WASHOUT|1968-03-29|1963-09-20|||||1961-03-19||1963-05-28
TRIAL STUDY 134XCP|IS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM/S|||||NG/DAY||||NORMAL|NOT DONE|||SOFT TISSUE|LIPEMIC|N|MICROARRAY|N|NA|N||2||58||FOLLOW-UP|1968-09-22|1964-09-20|||||1966-07-15||1960-09-02
TRIAL STUDY 134XCP|IS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UCI|||||CMH2O*S/ML||||HIGH|NOT DONE|||ABSCESS FLUID|LACTESCENT|NA|IN VITRO GENE EXPRESSION ASSAY|Y|NA|U||3||39||WASHOUT|1966-07-03|1963-05-02|||||1966-04-30||1964-03-17
TRIAL STUDY 134XCP|IS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||WATT|||||PLUG||||NORMAL|NOT DONE|||SOFT TISSUE|NON-HEMOLYZED|U|ELASTOGRAPHY|NA|U|NA||4||88||BLINDED TREATMENT|1970-05-27|1963-10-21|||||1962-07-22||1960-06-06
TRIAL STUDY 134XCP|IS|9D32C2B3-CC4A-4C8C-9D91-6726F4D280C6||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GPL U/ML|||||CMH2O*S2/ML||||HIGH|NOT DONE|||CORD BLOOD|UNEXPECTED ODOR|Y|PET/CT SCAN|N|U|U||5||7||OBSERVATION|1973-08-04|1969-11-08|||||1966-10-03||1965-05-02
TRIAL STUDY 134XCP|IS|0320460C-3770-486A-85EB-ECD133AE6EFA||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BQ/MG|||||/DAY||||HIGH|NOT DONE|||SERUM|SOLIDIFIED|N|LIQUID SCINTILLATION COUNTING|U|N|Y||1||38||TREATMENT|1962-09-16|1967-11-27|||||1972-06-15||1961-05-15
TRIAL STUDY 134XCP|IS|0320460C-3770-486A-85EB-ECD133AE6EFA||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MIN*MG/ML|||||SUPPOSITORY||||LOW|NOT DONE|||SUPERNATANT, PLASMA|FRESH|N|LC/MS/MS|U|Y|Y||2||58||WASHOUT|1964-12-23|1973-02-14|||||1967-06-14||1960-06-11
TRIAL STUDY 134XCP|IS|0320460C-3770-486A-85EB-ECD133AE6EFA||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FRAMES/S|||||PG/L||||NORMAL|NOT DONE|||ISOLATE|LACTESCENT|Y|AUTOREFRACTION|U|N|N||3||39||TREATMENT|1962-01-23|1965-06-18|||||1967-07-16||1963-04-16
TRIAL STUDY 134XCP|IS|0320460C-3770-486A-85EB-ECD133AE6EFA||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TUBERCULIN UNIT/ML|||||NMOL/L||||ABNORMAL|NOT DONE|||ISOLATE|UNEXPECTED ODOR|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|N|N|U||4||88||LONG-TERM FOLLOW-UP|1970-04-11|1965-08-10|||||1964-11-24||1968-06-12
TRIAL STUDY 134XCP|IS|0320460C-3770-486A-85EB-ECD133AE6EFA||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/DL|||||LM||||HIGH|NOT DONE|||URINE SEDIMENT|DRIED|N|SPIRAL CT|N|U|NA||5||7||LONG-TERM FOLLOW-UP|1960-08-30|1971-01-12|||||1963-09-29||1967-03-19
TRIAL STUDY 134XCP|IS|810B0B08-9236-41EC-8879-924661FA224E||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MEQ/L|||||MANSON U/ML||||HIGH|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CONCENTRATED|N|PH METER MEASUREMENT METHOD|N|Y|U||1||38||OBSERVATION|1965-12-11|1968-01-11|||||1967-05-12||1966-11-02
TRIAL STUDY 134XCP|IS|810B0B08-9236-41EC-8879-924661FA224E||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GBQ/G|||||UG/L DDU||||LOW|NOT DONE|||SERUM|LACTESCENT|N|KINETIC CHROMOGENIC ASSAY|U|NA|U||2||58||WASHOUT|1967-05-23|1967-01-08|||||1962-11-24||1963-10-17
TRIAL STUDY 134XCP|IS|810B0B08-9236-41EC-8879-924661FA224E||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ|||||ML/H||||LOW|NOT DONE|||SUPERNATANT, PLASMA|THAWED|Y|GRADIENT DIFFUSION|NA|Y|Y||3||39||OPEN LABEL TREATMENT|1964-07-29|1971-08-29|||||1971-07-17||1966-01-03
TRIAL STUDY 134XCP|IS|810B0B08-9236-41EC-8879-924661FA224E||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CI/UG|||||MIU/L||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|THAWED|U|X-RAY FLUORESCENCE SPECTROMETRY|Y|N|U||4||88||RUN-IN|1967-04-11|1966-10-29|||||1973-05-06||1972-01-26
TRIAL STUDY 134XCP|IS|810B0B08-9236-41EC-8879-924661FA224E||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^4 CFU/ML|||||CM2||||HIGH|NOT DONE|||CAPILLARY BLOOD|FRESH|Y|POLYSOMNOGRAPHY|Y|NA|U||5||7||SCREENING|1972-03-14|1960-12-30|||||1966-11-09||1962-11-14
TRIAL STUDY 134XCP|IS|BA3B0D91-DC95-4916-8ACA-71451447BE81||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MN|||||10^6 ORGANISMS/MG||||LOW|NOT DONE|||SEMEN|DRIED|NA|CONTRAST ENHANCED PET SCAN|NA|N|NA||1||38||BASELINE|1967-06-27|1971-11-30|||||1970-03-31||1970-03-29
TRIAL STUDY 134XCP|IS|BA3B0D91-DC95-4916-8ACA-71451447BE81||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CAPSULE|||||V/V||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ICTERIC|N|LIGHT SCATTERING SPECTROSCOPY|Y|Y|NA||2||58||INDUCTION TREATMENT|1966-05-14|1970-12-18|||||1968-08-27||1967-10-25
TRIAL STUDY 134XCP|IS|BA3B0D91-DC95-4916-8ACA-71451447BE81||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||% INHIBITION|||||PFU/DOSE||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|REFRIGERATED|U|SCINTIGRAPHY|Y|NA|U||3||39||INDUCTION TREATMENT|1971-04-02|1968-08-13|||||1967-04-12||1963-08-07
TRIAL STUDY 134XCP|IS|BA3B0D91-DC95-4916-8ACA-71451447BE81||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/H|||||SCM||||NORMAL|NOT DONE|||STOOL|PARAFFIN-EMBEDDED|NA|MRI|NA|NA|N||4||88||TREATMENT|1964-03-10|1970-12-22|||||1964-02-02||1972-05-04
TRIAL STUDY 134XCP|IS|BA3B0D91-DC95-4916-8ACA-71451447BE81||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/CM3/MIN|||||UV||||HIGH|NOT DONE|||BREAST MILK|FRESH|N|ORCHIDOMETERY|U|NA|N||5||7||RUN-IN|1965-10-16|1964-07-14|||||1960-05-07||1962-08-11
TRIAL STUDY 134XCP|IS|DE385129-5FB9-43C3-9FB1-005886674C9B||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CCID 50/ML|||||PMOL||||LOW|NOT DONE|||PLASMA|DRIED|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|U|N|Y||1||38||CONTINUATION TREATMENT|1964-01-05|1968-08-15|||||1968-03-20||1966-12-30
TRIAL STUDY 134XCP|IS|DE385129-5FB9-43C3-9FB1-005886674C9B||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/(MIN*100ML)|||||MBP||||NORMAL|NOT DONE|||EMOTIONAL TEAR|GELLED|Y|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|N|NA|U||2||58||INDUCTION TREATMENT|1963-07-13|1962-06-02|||||1964-04-30||1966-05-09
TRIAL STUDY 134XCP|IS|DE385129-5FB9-43C3-9FB1-005886674C9B||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DISK|||||PPB||||HIGH|NOT DONE|||MUCUS|NON-HEMOLYZED|NA|POLYSOMNOGRAPHY|NA|N|Y||3||39||BASELINE|1973-01-31|1971-12-28|||||1964-01-11||1973-04-10
TRIAL STUDY 134XCP|IS|DE385129-5FB9-43C3-9FB1-005886674C9B||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ANTIBODY UNIT|||||10^6 ORGANISMS||||NORMAL|NOT DONE|||EPITHELIAL CELL|HEMOLYZED|U|U-HPLC/MS/MS|N|Y|N||4||88||INDUCTION TREATMENT|1972-04-11|1970-01-21|||||1967-05-19||1970-05-25
TRIAL STUDY 134XCP|IS|DE385129-5FB9-43C3-9FB1-005886674C9B||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MM2|||||ENZYME U/L||||HIGH|NOT DONE|||TRANSUDATE|GELLED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|N|N|N||5||7||OPEN LABEL TREATMENT|1971-01-06|1968-11-06|||||1963-10-11||1962-06-23
TRIAL STUDY 134XCP|IS|8AE8077F-A13C-4593-B012-213A5EBE0A1D||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UL|||||FT||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|AUTOLYZED|NA|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|Y|U||1||38||BASELINE|1968-06-07|1960-09-07|||||1967-04-29||1965-05-10
TRIAL STUDY 134XCP|IS|8AE8077F-A13C-4593-B012-213A5EBE0A1D||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 ELISA UNIT|||||MGEQ||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|U|WHOLE EXOME SEQUENCING|N|U|N||2||58||TREATMENT|1970-08-15|1961-02-01|||||1962-06-21||1964-09-23
TRIAL STUDY 134XCP|IS|8AE8077F-A13C-4593-B012-213A5EBE0A1D||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL BCE/NMOL|||||MG/L||||LOW|NOT DONE|||CORD BLOOD|CALCIFIED|U|PHOTOMETRIC CLOT DETECTION|NA|N|U||3||39||CONTINUATION TREATMENT|1960-11-09|1963-02-26|||||1973-07-11||1968-01-24
TRIAL STUDY 134XCP|IS|8AE8077F-A13C-4593-B012-213A5EBE0A1D||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/ML/MIN|||||TAMPON||||LOW|NOT DONE|||URINE SEDIMENT|PARAFFIN-EMBEDDED|Y|GRADIENT DIFFUSION|U|NA|Y||4||88||OBSERVATION|1963-12-19|1967-03-03|||||1972-05-03||1961-09-15
TRIAL STUDY 134XCP|IS|8AE8077F-A13C-4593-B012-213A5EBE0A1D||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/L FEU|||||/WK||||HIGH|NOT DONE|||REFLEX TEAR|CONCENTRATED|U|ENZYMATIC ULTRACENTRIFUGATION|Y|U|Y||5||7||CONTINUATION TREATMENT|1962-02-05|1961-03-07|||||1962-09-08||1965-12-26
TRIAL STUDY 134XCP|IS|72FCE18B-B3D6-45AC-993F-9883E4D11313||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SACHET|||||NCI||||HIGH|NOT DONE|||SPUTUM|PARAFFIN-EMBEDDED|N|DYNAMIC CONTRAST ENHANCED MRI|Y|N|U||1||38||OPEN LABEL TREATMENT|1970-07-13|1966-05-06|||||1970-08-02||1960-06-03
TRIAL STUDY 134XCP|IS|72FCE18B-B3D6-45AC-993F-9883E4D11313||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||RNA COPIES/ML|||||G/U||||NORMAL|NOT DONE|||SALIVA|ROOM TEMPERATURE|Y|DISK DIFFUSION|NA|N|Y||2||58||FOLLOW-UP|1967-03-27|1965-07-22|||||1963-12-31||1961-05-17
TRIAL STUDY 134XCP|IS|72FCE18B-B3D6-45AC-993F-9883E4D11313||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/M2|||||BEATS/MIN||||NORMAL|NOT DONE|||PROSTATIC FLUID|ICTERIC|U|CONTRAST ENHANCED PET SCAN|Y|NA|NA||3||39||RUN-IN|1968-06-01|1963-01-25|||||1969-02-26||1972-10-15
TRIAL STUDY 134XCP|IS|72FCE18B-B3D6-45AC-993F-9883E4D11313||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FEU|||||PG/L||||LOW|NOT DONE|||LEUKOCYTE|ICTERIC|NA|ACRIDINE ORANGE STAIN|N|NA|Y||4||88||TREATMENT|1973-03-03|1970-05-22|||||1963-03-09||1973-07-29
TRIAL STUDY 134XCP|IS|72FCE18B-B3D6-45AC-993F-9883E4D11313||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG/L|||||DEG2||||NORMAL|NOT DONE|||SKIN TISSUE|AGGLUTINATED|Y|POLYGRAPHY|N|N|NA||5||7||WASHOUT|1966-11-24|1965-04-25|||||1963-10-28||1962-05-19
TRIAL STUDY 134XCP|IS|1123F894-0821-41DF-9C28-ED6BC4A7098C||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM|||||GY/MIN||||LOW|NOT DONE|||LYSATE|AUTOLYZED|U|CLINICAL EVALUATION|U|NA|N||1||38||SCREENING|1964-01-11|1968-06-08|||||1973-08-04||1961-06-10
TRIAL STUDY 134XCP|IS|1123F894-0821-41DF-9C28-ED6BC4A7098C||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/L DDU|||||ML/M2/MIN||||NORMAL|NOT DONE|||ADIPOSE TISSUE|PARAFFIN-EMBEDDED|NA|NEURAMINIDASE INHIBITION ASSAY|U|U|U||2||58||WASHOUT|1971-08-29|1961-01-13|||||1965-09-05||1969-06-18
TRIAL STUDY 134XCP|IS|1123F894-0821-41DF-9C28-ED6BC4A7098C||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||K|||||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|HEMOLYZED|Y|ALCIAN BLUE STAIN|U|U|N||3||39||TREATMENT|1967-03-25|1964-05-10|||||1963-12-11||1961-05-22
TRIAL STUDY 134XCP|IS|1123F894-0821-41DF-9C28-ED6BC4A7098C||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MBQ|||||MET*MIN||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|CONCENTRATED|N|PLETHYSMOGRAPHY|U|NA|NA||4||88||WASHOUT|1969-10-07|1961-03-01|||||1969-02-20||1969-08-15
TRIAL STUDY 134XCP|IS|1123F894-0821-41DF-9C28-ED6BC4A7098C||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PMOL/L|||||ML/100G/MIN||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|FRESH|Y|NUCLEIC ACID AMPLIFICATION TEST|N|NA|U||5||7||BLINDED TREATMENT|1971-07-25|1971-12-01|||||1962-08-19||1968-08-04
TRIAL STUDY 134XCP|IS|42DD827A-E788-4E61-8E9F-421136A16166||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ATM|||||MBQ||||NORMAL|NOT DONE|||SEMEN|THAWED|U|DUKE INCISION METHOD|Y|N|NA||1||38||OBSERVATION|1971-01-21|1960-08-14|||||1964-07-12||1969-05-23
TRIAL STUDY 134XCP|IS|42DD827A-E788-4E61-8E9F-421136A16166||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DL|||||GPL U/ML||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|LIPEMIC|NA|PET/CT SCAN WITHOUT CONTRAST|NA|Y|N||2||58||OBSERVATION|1963-01-09|1962-11-20|||||1961-05-03||1971-05-17
TRIAL STUDY 134XCP|IS|42DD827A-E788-4E61-8E9F-421136A16166||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 PFU/ML|||||ML/MMHG||||LOW|NOT DONE|||RETICULOCYTES|CONTAMINATED|Y|GC/MS-CI|N|U|NA||3||39||BASELINE|1964-07-10|1960-07-18|||||1973-01-05||1964-03-03
TRIAL STUDY 134XCP|IS|42DD827A-E788-4E61-8E9F-421136A16166||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/CM2|||||MMOL/MIN/KPA||||ABNORMAL|NOT DONE|||LYSATE|CLOTTED|U|RIA|U|Y|N||4||88||BASELINE|1964-11-03|1967-09-23|||||1969-04-30||1961-08-10
TRIAL STUDY 134XCP|IS|42DD827A-E788-4E61-8E9F-421136A16166||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/L/H|||||UG/KG/DAY||||HIGH|NOT DONE|||HAIR FOLLICLE|LACTESCENT|U|AUSCULTATION|NA|U|N||5||7||RUN-IN|1970-04-09|1970-05-30|||||1966-05-02||1963-08-01
TRIAL STUDY 134XCP|IS|CC1E2338-4454-4CBA-8848-0B994C459F05||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GBQ|||||ML/(MIN*100ML)||||LOW|NOT DONE|||SERUM OR PLASMA|PARAFFIN-EMBEDDED|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|N|NA|U||1||38||FOLLOW-UP|1968-12-13|1969-06-23|||||1962-04-14||1964-04-05
TRIAL STUDY 134XCP|IS|CC1E2338-4454-4CBA-8848-0B994C459F05||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MIN|||||BAR||||NORMAL|NOT DONE|||PROSTATIC FLUID|NON-HEMOLYZED|U|ISHIHARA COLOR PLATES|NA|N|Y||2||58||RUN-IN|1961-12-04|1964-11-23|||||1972-06-02||1972-08-14
TRIAL STUDY 134XCP|IS|CC1E2338-4454-4CBA-8848-0B994C459F05||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/KG/MIN|||||ELISA UNIT/ML||||NORMAL|NOT DONE|||SOFT TISSUE|AUTOLYZED|Y|COLORIMETRY|Y|U|Y||3||39||OBSERVATION|1973-07-03|1965-01-19|||||1964-02-08||1967-12-21
TRIAL STUDY 134XCP|IS|CC1E2338-4454-4CBA-8848-0B994C459F05||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CS|||||CUP EQ||||LOW|NOT DONE|||BILE|CONTAMINATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|U|U|U||4||88||BASELINE|1966-07-12|1971-12-14|||||1963-01-24||1964-08-03
TRIAL STUDY 134XCP|IS|CC1E2338-4454-4CBA-8848-0B994C459F05||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||AMP|||||MG/M2/MIN||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|CLOTTED|Y|LAPAROSCOPY|NA|Y|U||5||7||RUN-IN|1961-04-23|1969-08-13|||||1961-10-05||1964-04-19
TRIAL STUDY 134XCP|IS|ED04E60D-256A-4DB9-9290-4EFD0602A130||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/S|||||DPM/MG||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|ROOM TEMPERATURE|N|TELLER ACUITY CARDS|N|Y|U||1||38||OPEN LABEL TREATMENT|1973-06-30|1971-08-04|||||1969-11-28||1961-08-28
TRIAL STUDY 134XCP|IS|ED04E60D-256A-4DB9-9290-4EFD0602A130||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3 COPIES/ML|||||UG/MOL||||LOW|NOT DONE|||CORD SERUM|AUTOLYZED|U|GEL ELECTROPHORESIS|Y|U|N||2||58||INDUCTION TREATMENT|1971-06-21|1970-11-05|||||1966-04-19||1961-11-02
TRIAL STUDY 134XCP|IS|ED04E60D-256A-4DB9-9290-4EFD0602A130||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CI|||||GPL U/ML||||ABNORMAL|NOT DONE|||BASAL TEAR|CALCIFIED|U|AURAMINE STAIN|Y|U|N||3||39||INDUCTION TREATMENT|1960-01-13|1965-03-18|||||1965-07-29||1971-03-19
TRIAL STUDY 134XCP|IS|ED04E60D-256A-4DB9-9290-4EFD0602A130||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||%/MIN|||||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|UNEXPECTED ODOR|NA|NEXT GENERATION SEQUENCING|U|NA|NA||4||88||TREATMENT|1967-11-10|1970-08-07|||||1961-10-23||1972-09-06
TRIAL STUDY 134XCP|IS|ED04E60D-256A-4DB9-9290-4EFD0602A130||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||H*%|||||EQ||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|NA|X-RAY FLUORESCENCE SPECTROMETRY|Y|Y|NA||5||7||OBSERVATION|1969-12-07|1970-08-26|||||1971-12-30||1969-01-01
TRIAL STUDY 134XCP|IS|C70F82F6-3280-429D-9657-CDFBA6B7F626||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/10^12 RBC|||||AFU||||NORMAL|NOT DONE|||SWABBED MATERIAL|CLOTTED|U|CISH|Y|NA|NA||1||38||SCREENING|1965-07-25|1969-02-15|||||1970-11-18||1972-05-02
TRIAL STUDY 134XCP|IS|C70F82F6-3280-429D-9657-CDFBA6B7F626||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 CFU/ML|||||DISK||||HIGH|NOT DONE|||STOOL|CLOTTED|Y|POTENTIOMETRY|U|NA|Y||2||58||OBSERVATION|1970-08-17|1962-04-10|||||1961-08-13||1970-05-14
TRIAL STUDY 134XCP|IS|C70F82F6-3280-429D-9657-CDFBA6B7F626||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^5/HPF|||||PG||||ABNORMAL|NOT DONE|||URINE|SOLIDIFIED|NA|OPTICAL COHERENCE TOMOGRAPHY|U|N|N||3||39||OPEN LABEL TREATMENT|1962-01-23|1969-02-01|||||1965-03-25||1962-06-16
TRIAL STUDY 134XCP|IS|C70F82F6-3280-429D-9657-CDFBA6B7F626||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DRAM|||||FMOL/L/SEC||||NORMAL|NOT DONE|||SKIN TISSUE|THAWED|U|TWO-COLOR MICROARRAY|NA|U|Y||4||88||TREATMENT|1961-01-18|1966-01-22|||||1964-07-24||1969-12-02
TRIAL STUDY 134XCP|IS|C70F82F6-3280-429D-9657-CDFBA6B7F626||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UL/KG/DAY|||||NMOL/L||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|ROOM TEMPERATURE|NA|IMMUNOBLOT|U|Y|N||5||7||SCREENING|1963-08-03|1966-08-28|||||1961-10-09||1964-11-19
TRIAL STUDY 134XCP|IS|D735D137-2C27-4F27-BA18-9A0F7FF0B145||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KA_U/DL|||||10^4 CFU/ML||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NA|NA|N||1||38||OBSERVATION|1961-01-15|1969-08-15|||||1967-12-14||1960-08-28
TRIAL STUDY 134XCP|IS|D735D137-2C27-4F27-BA18-9A0F7FF0B145||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NKAT/G HB|||||MV||||HIGH|NOT DONE|||PLEURAL FLUID|HEMOLYZED|Y|GC/FID|NA|N|Y||2||58||CONTINUATION TREATMENT|1972-03-05|1970-11-01|||||1968-11-17||1970-04-28
TRIAL STUDY 134XCP|IS|D735D137-2C27-4F27-BA18-9A0F7FF0B145||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PMOL/10^10 CELLS|||||DPM/100MG||||NORMAL|NOT DONE|||CELL PELLET|DRIED|NA|SLIT LAMP|Y|U|NA||3||39||RUN-IN|1972-05-10|1972-11-20|||||1961-09-13||1969-02-17
TRIAL STUDY 134XCP|IS|D735D137-2C27-4F27-BA18-9A0F7FF0B145||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||M|||||MOSM/L||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|ICTERIC|NA|IMMUNOCHROMATOGRAPHY|NA|Y|Y||4||88||BASELINE|1962-12-27|1971-11-30|||||1969-07-18||1962-09-05
TRIAL STUDY 134XCP|IS|D735D137-2C27-4F27-BA18-9A0F7FF0B145||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MOSM/KG|||||MEQ/DAY||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|FRESH|U|INTERRUPTER TECHNIQUE|U|N|NA||5||7||WASHOUT|1964-02-26|1965-04-12|||||1971-09-05||1971-12-11
TRIAL STUDY 134XCP|IS|B00194E0-0E85-46DD-86C3-CD9048535986||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/CM3/MIN|||||UL/KG/DAY||||LOW|NOT DONE|||SEBUM|CLOTTED|U|OPTICAL DENSITY MEASUREMENT|N|N|NA||1||38||LONG-TERM FOLLOW-UP|1973-03-07|1966-08-28|||||1965-02-25||1962-02-05
TRIAL STUDY 134XCP|IS|B00194E0-0E85-46DD-86C3-CD9048535986||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/G/H|||||CI/MG||||ABNORMAL|NOT DONE|||ISOLATE|AGGLUTINATED|Y|URANYL ACETATE STAIN|N|N|NA||2||58||CONTINUATION TREATMENT|1969-08-30|1973-08-22|||||1966-09-09||1966-04-25
TRIAL STUDY 134XCP|IS|B00194E0-0E85-46DD-86C3-CD9048535986||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MN|||||FL||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|Y|PUPILLOMETRY|N|NA|N||3||39||WASHOUT|1961-08-25|1969-08-22|||||1964-08-25||1969-02-26
TRIAL STUDY 134XCP|IS|B00194E0-0E85-46DD-86C3-CD9048535986||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LOG10 CFU/G|||||IN||||HIGH|NOT DONE|||MUCUS|UNEXPECTED ODOR|N|THIN SMEAR|NA|NA|U||4||88||FOLLOW-UP|1960-02-28|1960-10-26|||||1963-10-01||1961-03-22
TRIAL STUDY 134XCP|IS|B00194E0-0E85-46DD-86C3-CD9048535986||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^10/L|||||KHZ||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|CONTAMINATED|U|THERMAL IONIZATION MASS SPECTROMETRY|N|NA|NA||5||7||TREATMENT|1967-05-09|1968-03-29|||||1961-08-30||1965-01-24
TRIAL STUDY 134XCP|IS|B4F372E9-C461-414A-95B4-93CA0221D396||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/HPF|||||DAYS/WK||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|Y|GEL ELECTROPHORESIS|Y|N|U||1||38||CONTINUATION TREATMENT|1968-09-10|1969-06-28|||||1962-05-27||1970-04-26
TRIAL STUDY 134XCP|IS|B4F372E9-C461-414A-95B4-93CA0221D396||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI|||||UG||||LOW|NOT DONE|||CERUMEN|CONCENTRATED|N|SURFACE PLASMON RESONANCE|N|U|Y||2||58||WASHOUT|1973-03-19|1971-07-06|||||1965-06-14||1965-02-23
TRIAL STUDY 134XCP|IS|B4F372E9-C461-414A-95B4-93CA0221D396||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MOL/DAY|||||L/L||||HIGH|NOT DONE|||TRANSUDATE|HEMOLYZED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|N|Y|Y||3||39||OBSERVATION|1962-06-08|1968-10-13|||||1969-12-09||1960-07-27
TRIAL STUDY 134XCP|IS|B4F372E9-C461-414A-95B4-93CA0221D396||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BQ/L|||||EP U||||LOW|NOT DONE|||DISCHARGE|CONCENTRATED|U|MASS SPECTROMETRY|NA|U|Y||4||88||CONTINUATION TREATMENT|1962-09-13|1969-06-22|||||1966-06-07||1968-06-21
TRIAL STUDY 134XCP|IS|B4F372E9-C461-414A-95B4-93CA0221D396||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||STEPS/MIN|||||CL||||NORMAL|NOT DONE|||FLUID|NON-HEMOLYZED|N|TARGETED GENOME SEQUENCING|U|Y|N||5||7||RUN-IN|1961-06-08|1966-10-27|||||1965-12-10||1960-07-20
TRIAL STUDY 134XCP|IS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^8/L|||||/MIN||||LOW|NOT DONE|||HAIR FOLLICLE|UNEXPECTED ODOR|U|HEMOCYTOMETRY|NA|NA|N||1||38||BASELINE|1969-02-19|1963-04-13|||||1962-10-13||1969-11-26
TRIAL STUDY 134XCP|IS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NEEDLE GAUGE|||||FT2||||LOW|NOT DONE|||MECONIUM|CLOTTED|U|FUNCTIONAL MRI|U|Y|N||2||58||FOLLOW-UP|1965-05-06|1972-09-23|||||1963-10-17||1961-10-25
TRIAL STUDY 134XCP|IS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/DL|||||UMOL/L||||NORMAL|NOT DONE|||BONE|CONCENTRATED|NA|CT SCAN WITHOUT CONTRAST|N|U|Y||3||39||SCREENING|1969-07-02|1969-11-16|||||1968-01-27||1965-04-26
TRIAL STUDY 134XCP|IS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/KG/MIN|||||UMOL||||HIGH|NOT DONE|||KERATINOCYTE|FRESH|Y|LIGHT MICROSCOPY|U|N|U||4||88||BLINDED TREATMENT|1968-10-08|1962-05-10|||||1971-02-19||1964-09-23
TRIAL STUDY 134XCP|IS|54C204AA-3DEF-4CB6-A0B6-3AA4090C02D7||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PIXEL|||||10^6 ORGANISMS/ML||||HIGH|NOT DONE|||ARTERIAL BLOOD|CLOTTED|Y|LANDOLT RING|NA|U|N||5||7||RUN-IN|1962-10-21|1961-01-18|||||1963-06-22||1965-10-27
TRIAL STUDY 134XCP|IS|E43169E4-8B57-47D7-9C91-D42E40DD579B||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TROCHE|||||ECL UNIT||||ABNORMAL|NOT DONE|||VENOUS BLOOD|THAWED|Y|BIOIMPEDANCE SPECTROSCOPY|Y|Y|U||1||38||BLINDED TREATMENT|1971-07-18|1960-04-22|||||1971-06-30||1973-08-28
TRIAL STUDY 134XCP|IS|E43169E4-8B57-47D7-9C91-D42E40DD579B||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||TCID 50/DOSE|||||% INHIBITION||||ABNORMAL|NOT DONE|||PLASMA|SOLIDIFIED|NA|TRICHROME STAIN|U|NA|U||2||58||INDUCTION TREATMENT|1964-10-09|1969-07-28|||||1965-12-30||1967-01-30
TRIAL STUDY 134XCP|IS|E43169E4-8B57-47D7-9C91-D42E40DD579B||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DEG|||||NSEC||||ABNORMAL|NOT DONE|||NAIL|UNEXPECTED ODOR|U|WHOLE GENOME SEQUENCING|N|U|U||3||39||FOLLOW-UP|1960-09-26|1962-11-08|||||1965-06-04||1968-12-30
TRIAL STUDY 134XCP|IS|E43169E4-8B57-47D7-9C91-D42E40DD579B||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML*CMH2O|||||CONTAINER||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|REFRIGERATED|NA|ELECTROCHEMILUMINESCENCE|NA|U|N||4||88||SCREENING|1961-07-07|1962-01-18|||||1963-10-21||1963-01-18
TRIAL STUDY 134XCP|IS|E43169E4-8B57-47D7-9C91-D42E40DD579B||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/DL|||||UG/KG/MIN||||NORMAL|NOT DONE|||MUSCLE TISSUE|CONTAMINATED|NA|BIOPSY|N|U|U||5||7||INDUCTION TREATMENT|1962-03-30|1963-01-25|||||1960-11-08||1967-07-11
TRIAL STUDY 134XCP|IS|066393EE-D112-41DD-AF8F-65EF57A4415B||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PACK YEAR|||||GTT||||NORMAL|NOT DONE|||LYSATE|AGGLUTINATED|N|DXA SCAN|NA|U|Y||1||38||OBSERVATION|1969-11-14|1969-09-04|||||1969-12-26||1962-09-24
TRIAL STUDY 134XCP|IS|066393EE-D112-41DD-AF8F-65EF57A4415B||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MCI/L|||||MPS U||||LOW|NOT DONE|||VENOUS BLOOD|GELLED|N|ROMANOWSKY STAIN|Y|U|NA||2||58||SCREENING|1960-03-23|1962-12-08|||||1971-05-26||1964-01-04
TRIAL STUDY 134XCP|IS|066393EE-D112-41DD-AF8F-65EF57A4415B||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL/DAY|||||CM||||NORMAL|NOT DONE|||COLOSTRUM|FROZEN|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NA|U|NA||3||39||OPEN LABEL TREATMENT|1967-02-08|1967-11-09|||||1968-10-15||1960-11-04
TRIAL STUDY 134XCP|IS|066393EE-D112-41DD-AF8F-65EF57A4415B||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^7 PFU|||||FMOL/L/SEC||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|SOLIDIFIED|Y|NUCLEAR RADIOLOGY|U|Y|Y||4||88||SCREENING|1962-11-07|1973-07-19|||||1961-09-09||1966-04-13
TRIAL STUDY 134XCP|IS|066393EE-D112-41DD-AF8F-65EF57A4415B||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/L/MIN|||||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE|||SMEGMA|UNEXPECTED ODOR|Y|PALPATION|Y|NA|N||5||7||FOLLOW-UP|1962-09-20|1966-08-21|||||1967-07-17||1967-08-08
TRIAL STUDY 134XCP|IS|573C9228-D341-491C-9D66-0D0435E2C631||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMHG|||||MG/M2/DAY||||NORMAL|NOT DONE|||PLASMA|THAWED|N|HEMAGGLUTINATION ASSAY|N|N|NA||1||38||WASHOUT|1963-06-08|1961-10-08|||||1972-03-09||1960-09-27
TRIAL STUDY 134XCP|IS|573C9228-D341-491C-9D66-0D0435E2C631||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L/MIN|||||UG/MOL||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|CONTAMINATED|NA|CELL BASED BIOASSAY|U|NA|NA||2||58||BLINDED TREATMENT|1972-01-27|1970-02-01|||||1970-07-30||1969-11-12
TRIAL STUDY 134XCP|IS|573C9228-D341-491C-9D66-0D0435E2C631||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/WEEK|||||/5X10^4 WBC||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|LACTESCENT|NA|PET/MRI SCAN|N|NA|U||3||39||INDUCTION TREATMENT|1971-01-15|1964-04-16|||||1969-12-15||1971-03-20
TRIAL STUDY 134XCP|IS|573C9228-D341-491C-9D66-0D0435E2C631||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/ANIMAL/DAY|||||OZ EQ||||NORMAL|NOT DONE|||CALCULUS|NON-HEMOLYZED|U|PANENDOSCOPY|NA|NA|U||4||88||SCREENING|1971-06-21|1971-11-03|||||1971-11-17||1973-09-06
TRIAL STUDY 134XCP|IS|573C9228-D341-491C-9D66-0D0435E2C631||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT|||||AMU||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|PARAFFIN-EMBEDDED|NA|ELASTOGRAPHY|N|Y|N||5||7||OPEN LABEL TREATMENT|1961-07-09|1968-06-20|||||1968-02-19||1965-12-01
TRIAL STUDY 134XCP|IS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV2|||||OHM||||NORMAL|NOT DONE|||PLATELET|DRIED|N|WRIGHT-GIEMSA STAIN|U|NA|Y||1||38||OBSERVATION|1967-02-09|1972-11-24|||||1965-07-07||1968-01-03
TRIAL STUDY 134XCP|IS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MM/H|||||FT3||||LOW|NOT DONE|||TUMOR TISSUE|HEMOLYZED|Y|RADIAL IMMUNODIFFUSION|N|U|Y||2||58||TREATMENT|1973-01-29|1961-10-04|||||1961-07-13||1965-12-24
TRIAL STUDY 134XCP|IS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/DAY|||||MG/MIN||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|CLOTTED|U|LISSAMINE GREEN STAIN|Y|N|NA||3||39||CONTINUATION TREATMENT|1964-04-24|1965-03-17|||||1961-06-17||1966-11-01
TRIAL STUDY 134XCP|IS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 PFU/ML|||||ANSON U||||HIGH|NOT DONE|||BLOOD|DRIED|NA|DC SHEATH FLOW|U|Y|N||4||88||FOLLOW-UP|1966-12-01|1969-01-09|||||1963-10-26||1967-07-16
TRIAL STUDY 134XCP|IS|7BEDACC1-33A3-4A05-BE16-5D00D7A6BE36||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 CFU/ML|||||CL||||HIGH|NOT DONE|||BREAST MILK|CONCENTRATED|U|REVERSE TRANSCRIPTASE PCR|N|NA|U||5||7||FOLLOW-UP|1973-02-11|1966-07-06|||||1965-01-24||1969-03-21
TRIAL STUDY 134XCP|IS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMAL|||||FL||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|LIPEMIC|U|WRIGHT STAIN|NA|N|U||1||38||LONG-TERM FOLLOW-UP|1963-04-02|1962-12-27|||||1961-04-03||1960-02-02
TRIAL STUDY 134XCP|IS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/MM2|||||GENEQ/ML||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|THAWED|NA|CRYOSCOPY|Y|NA|N||2||58||WASHOUT|1971-01-02|1965-01-18|||||1967-04-30||1961-03-31
TRIAL STUDY 134XCP|IS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMOL/KG|||||CMH2O*S2/ML||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|NON-HEMOLYZED|Y|IMMUNOCHROMATOGRAPHY|U|U|Y||3||39||RUN-IN|1961-07-25|1970-06-01|||||1962-08-22||1963-07-08
TRIAL STUDY 134XCP|IS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DAYS/WK|||||EID 50/ML||||ABNORMAL|NOT DONE|||LYSATE|FRESH|Y|DNA MICROARRAY|Y|N|NA||4||88||WASHOUT|1972-10-07|1970-08-01|||||1972-02-02||1971-09-30
TRIAL STUDY 134XCP|IS|9AFEAA8A-AF9C-4C16-ACFA-1E37D258F5FF||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UIU/L|||||LOG10 TCID 50/DOSE||||HIGH|NOT DONE|||SERUM|CONCENTRATED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|N|Y|Y||5||7||BASELINE|1967-01-17|1971-07-26|||||1972-08-31||1960-03-13
TRIAL STUDY 134XCP|IS|61C75130-5C1A-4B8D-804C-92D3288B55D2||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BQ/UL|||||PPTH||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|FRESH|N|PH METER MEASUREMENT METHOD|U|N|Y||1||38||WASHOUT|1962-07-08|1966-10-26|||||1960-06-24||1970-08-23
TRIAL STUDY 134XCP|IS|61C75130-5C1A-4B8D-804C-92D3288B55D2||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PMOL/10^10 CELLS|||||L/MIN||||HIGH|NOT DONE|||ADIPOSE TISSUE|AGGLUTINATED|Y|NON-INVASIVE DIELECTRIC SENSING|U|U|U||2||58||CONTINUATION TREATMENT|1964-02-03|1968-02-13|||||1960-01-05||1961-03-12
TRIAL STUDY 134XCP|IS|61C75130-5C1A-4B8D-804C-92D3288B55D2||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UKAT|||||SBE/ML||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|THAWED|Y|BRDU CELLULAR PROLIFERATION ASSAY|NA|U|Y||3||39||OBSERVATION|1966-07-28|1971-08-06|||||1966-06-08||1968-01-01
TRIAL STUDY 134XCP|IS|61C75130-5C1A-4B8D-804C-92D3288B55D2||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/MIN|||||TROCHE||||NORMAL|NOT DONE|||PUS|LACTESCENT|NA|SLOAN LETTER EYE CHART 2.5%|Y|N|NA||4||88||OPEN LABEL TREATMENT|1973-07-21|1973-01-11|||||1964-05-15||1962-06-04
TRIAL STUDY 134XCP|IS|61C75130-5C1A-4B8D-804C-92D3288B55D2||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UMOL/MOL|||||CMH2O*S/ML||||NORMAL|NOT DONE|||SEMEN|FROZEN|U|CT SCAN|U|N|Y||5||7||BLINDED TREATMENT|1967-10-28|1961-03-25|||||1972-05-28||1965-05-05
TRIAL STUDY 134XCP|IS|90AFB57A-125C-4C08-AE92-061F66FC2DAC||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS/G|||||MM/H||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|FRESH|N|FLOW CYTOMETRY|U|U|N||1||38||INDUCTION TREATMENT|1973-05-16|1973-07-26|||||1968-06-06||1963-03-05
TRIAL STUDY 134XCP|IS|90AFB57A-125C-4C08-AE92-061F66FC2DAC||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL2/L2|||||MIN/DAY||||NORMAL|NOT DONE|||RETICULOCYTES|REFRIGERATED|Y|SCANNING ELECTRON MICROSCOPY|Y|N|N||2||58||SCREENING|1968-12-15|1960-06-13|||||1961-08-14||1967-07-27
TRIAL STUDY 134XCP|IS|90AFB57A-125C-4C08-AE92-061F66FC2DAC||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/G HB|||||FMOL/L||||HIGH|NOT DONE|||VENOUS PLASMA|GELLED|NA|SINGLE-MOLECULE ARRAY|N|N|NA||3||39||CONTINUATION TREATMENT|1960-09-05|1972-12-22|||||1963-01-14||1967-06-06
TRIAL STUDY 134XCP|IS|90AFB57A-125C-4C08-AE92-061F66FC2DAC||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||M3|||||ML/ANIMAL||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|THAWED|Y|MODIFIED ACID FAST STAIN|U|Y|U||4||88||BLINDED TREATMENT|1967-12-07|1960-02-05|||||1969-09-15||1964-07-11
TRIAL STUDY 134XCP|IS|90AFB57A-125C-4C08-AE92-061F66FC2DAC||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DROP|||||MG/G/H||||ABNORMAL|NOT DONE|||SKIN TISSUE|CONTAMINATED|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NA|U|U||5||7||OPEN LABEL TREATMENT|1961-05-14|1968-05-12|||||1972-12-20||1963-11-14
TRIAL STUDY 134XCP|IS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CARTRIDGE|||||PFU||||LOW|NOT DONE|||REFLEX TEAR|PARAFFIN-EMBEDDED|Y|FLUORIMETRY|Y|N|N||1||38||SCREENING|1962-08-17|1960-08-22|||||1965-07-27||1968-04-28
TRIAL STUDY 134XCP|IS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BQ/UG|||||NL||||HIGH|NOT DONE|||PLEURAL TISSUE|THAWED|NA|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|U|U||2||58||CONTINUATION TREATMENT|1968-11-08|1963-03-08|||||1962-03-18||1973-06-20
TRIAL STUDY 134XCP|IS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||L/L|||||U/ANIMAL||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|AGGLUTINATED|U|X-RAY|N|NA|U||3||39||TREATMENT|1972-07-20|1967-10-10|||||1965-06-06||1967-10-12
TRIAL STUDY 134XCP|IS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||YD|||||PNU/ML||||HIGH|NOT DONE|||URINE SEDIMENT|FRESH|Y|TRANSVAGINAL ULTRASOUND|NA|U|U||4||88||TREATMENT|1968-02-05|1962-12-02|||||1971-06-25||1962-09-22
TRIAL STUDY 134XCP|IS|B980E6D5-3883-4A1C-A7BA-FC4BA768B3E4||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UU/DL|||||MMHG*MIN/L||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|PARAFFIN-EMBEDDED|NA|PET/SPECT SCAN|Y|Y|U||5||7||OBSERVATION|1971-10-31|1960-08-14|||||1962-12-19||1961-11-29
TRIAL STUDY 134XCP|IS|01A42FAE-1EE2-4203-A62E-E368F31434F7||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/G/MIN|||||KIT||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|LIPEMIC|N|DUKE INCISION METHOD|NA|U|U||1||38||RUN-IN|1962-01-10|1970-08-14|||||1960-11-07||1961-08-04
TRIAL STUDY 134XCP|IS|01A42FAE-1EE2-4203-A62E-E368F31434F7||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 TCID 50/UL|||||APL U/ML||||HIGH|NOT DONE|||SEMINAL FLUID|ROOM TEMPERATURE|U|HEMATOXYLIN AND EOSIN STAIN|NA|N|U||2||58||RUN-IN|1971-11-13|1962-08-15|||||1961-02-02||1962-10-06
TRIAL STUDY 134XCP|IS|01A42FAE-1EE2-4203-A62E-E368F31434F7||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KPA/L/SEC|||||ML*CMH2O||||HIGH|NOT DONE|||LYSATE|CALCIFIED|U|HPLC/IEX|Y|N|N||3||39||LONG-TERM FOLLOW-UP|1967-07-12|1965-12-02|||||1972-01-28||1960-10-18
TRIAL STUDY 134XCP|IS|01A42FAE-1EE2-4203-A62E-E368F31434F7||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^9 CFU/ML|||||USP U||||ABNORMAL|NOT DONE|||LOCHIA|THAWED|Y|DUKE INCISION METHOD|Y|NA|Y||4||88||CONTINUATION TREATMENT|1966-12-29|1963-10-22|||||1964-03-15||1962-07-08
TRIAL STUDY 134XCP|IS|01A42FAE-1EE2-4203-A62E-E368F31434F7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||RATIO|||||10^9/G||||HIGH|NOT DONE|||TRANSUDATE|NON-HEMOLYZED|NA|SPIRAL CT SCAN WITHOUT CONTRAST|U|U|NA||5||7||BASELINE|1960-04-16|1964-01-21|||||1962-03-28||1968-08-01
TRIAL STUDY 134XCP|IS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIXELS/CM|||||/WK||||ABNORMAL|NOT DONE|||LYSATE|HEMOLYZED|NA|REFLECTANCE SPECTROSCOPY|N|N|U||1||38||OPEN LABEL TREATMENT|1965-05-03|1973-04-08|||||1963-06-03||1971-01-08
TRIAL STUDY 134XCP|IS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/L|||||OSM||||LOW|NOT DONE|||AMNIOTIC FLUID|ICTERIC|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|N|NA||2||58||SCREENING|1966-04-12|1963-06-30|||||1973-01-21||1965-10-26
TRIAL STUDY 134XCP|IS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MPH|||||LOZENGE||||LOW|NOT DONE|||BUFFY COAT|THAWED|U|DOPPLER ULTRASOUND|U|U|N||3||39||LONG-TERM FOLLOW-UP|1973-06-13|1970-10-23|||||1963-07-06||1961-05-15
TRIAL STUDY 134XCP|IS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^9 ORGANISMS/ML|||||UCI||||NORMAL|NOT DONE|||SERUM OR PLASMA|ICTERIC|U|ENDPOINT DILUTION ASSAY|N|N|N||4||88||OBSERVATION|1967-04-20|1963-04-12|||||1971-02-15||1962-02-16
TRIAL STUDY 134XCP|IS|4764675D-2F2B-4CE1-AF43-E2A28A30FB74||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||COULOMB|||||SUPPOSITORY||||HIGH|NOT DONE|||HAIR|HEMOLYZED|NA|KINYOUN STAIN|U|NA|NA||5||7||RUN-IN|1966-07-21|1972-09-24|||||1970-02-28||1968-04-01
TRIAL STUDY 134XCP|IS|92232C8B-0D28-4E2A-AA56-BA938429CCBF||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^9 CFU/ML|||||MM/2H||||LOW|NOT DONE|||GASTRIC FLUID|LIPEMIC|NA|X-RAY FLUORESCENCE SPECTROMETRY|NA|U|Y||1||38||WASHOUT|1973-01-09|1972-03-03|||||1971-10-23||1968-11-27
TRIAL STUDY 134XCP|IS|92232C8B-0D28-4E2A-AA56-BA938429CCBF||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KUSP|||||POINT||||LOW|NOT DONE|||SKIN TISSUE|LIPEMIC|NA|TRIPLE-PHASE SPIRAL CT SCAN|NA|U|NA||2||58||RUN-IN|1969-01-09|1961-02-21|||||1962-06-16||1968-10-02
TRIAL STUDY 134XCP|IS|92232C8B-0D28-4E2A-AA56-BA938429CCBF||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DAYS|||||ML/DAY||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|ROOM TEMPERATURE|NA|AGAR DILUTION|Y|NA|U||3||39||LONG-TERM FOLLOW-UP|1961-07-30|1963-05-05|||||1969-02-22||1968-11-03
TRIAL STUDY 134XCP|IS|92232C8B-0D28-4E2A-AA56-BA938429CCBF||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U/MIN|||||KBQ||||LOW|NOT DONE|||BUFFY COAT|LIPEMIC|U|TRANSMISSION ELECTRON MICROSCOPY|Y|Y|U||4||88||FOLLOW-UP|1963-05-07|1962-05-22|||||1962-03-17||1964-07-18
TRIAL STUDY 134XCP|IS|92232C8B-0D28-4E2A-AA56-BA938429CCBF||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/L DDU|||||CUP EQ||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|GELLED|N|TRANSMISSION ELECTRON MICROSCOPY|NA|N|U||5||7||OBSERVATION|1960-04-24|1966-12-07|||||1968-10-07||1968-09-26
TRIAL STUDY 134XCP|IS|F4F12AAA-E825-45D7-B414-A06F2D20381A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||%(W/V)|||||FRACTION OF 1||||NORMAL|NOT DONE|||DERMAL TISSUE|CLOTTED|N|U-HPLC/MS/MS|Y|N|N||1||38||BASELINE|1965-08-14|1973-01-11|||||1969-05-03||1968-02-19
TRIAL STUDY 134XCP|IS|F4F12AAA-E825-45D7-B414-A06F2D20381A||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6 U|||||MOSM||||HIGH|NOT DONE|||EPIDERMAL TISSUE|ROOM TEMPERATURE|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|N|Y|NA||2||58||WASHOUT|1960-08-30|1960-09-08|||||1966-04-17||1973-05-22
TRIAL STUDY 134XCP|IS|F4F12AAA-E825-45D7-B414-A06F2D20381A||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CP|||||10^6 ORGANISMS||||NORMAL|NOT DONE|||DERMAL TISSUE|THAWED|NA|MYELOPEROXIDASE STAIN|Y|N|N||3||39||RUN-IN|1972-10-08|1966-11-09|||||1970-02-27||1965-05-25
TRIAL STUDY 134XCP|IS|F4F12AAA-E825-45D7-B414-A06F2D20381A||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/ANIMAL|||||LOG10 ELISA UNIT||||NORMAL|NOT DONE|||PLEURAL TISSUE|CLOTTED|U|DIRECT SEQUENCING|U|Y|N||4||88||BASELINE|1965-09-01|1965-09-19|||||1969-07-31||1962-10-06
TRIAL STUDY 134XCP|IS|F4F12AAA-E825-45D7-B414-A06F2D20381A||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMHG/SEC|||||UL/KG/DAY||||HIGH|NOT DONE|||EPIDERMAL TISSUE|CONCENTRATED|N|SPECT SCAN|Y|U|NA||5||7||CONTINUATION TREATMENT|1960-05-22|1973-07-29|||||1962-01-04||1966-04-15
TRIAL STUDY 134XCP|IS|6CF611F2-686E-4AE9-B491-32157710F46D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||HENRY|||||LB||||NORMAL|NOT DONE|||PERSPIRATION|SOLIDIFIED|NA|LYMPHANGIOGRAPHY|U|N|NA||1||38||LONG-TERM FOLLOW-UP|1962-06-14|1971-01-24|||||1964-02-03||1973-01-16
TRIAL STUDY 134XCP|IS|6CF611F2-686E-4AE9-B491-32157710F46D||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||RNA COPIES/ML|||||10^6 IU||||LOW|NOT DONE|||BUFFY COAT|UNEXPECTED ODOR|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|U|Y||2||58||BASELINE|1963-09-02|1965-02-12|||||1965-03-12||1969-10-03
TRIAL STUDY 134XCP|IS|6CF611F2-686E-4AE9-B491-32157710F46D||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GTT|||||EIA UNIT||||LOW|NOT DONE|||MUSCLE TISSUE|AGGLUTINATED|Y|STRESS ECHOCARDIOGRAPHY|U|U|U||3||39||OBSERVATION|1962-01-24|1964-05-19|||||1973-05-08||1961-12-20
TRIAL STUDY 134XCP|IS|6CF611F2-686E-4AE9-B491-32157710F46D||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SUPPOSITORY|||||EJACULATE U||||LOW|NOT DONE|||BONE|PARAFFIN-EMBEDDED|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|NA|U|N||4||88||CONTINUATION TREATMENT|1965-01-31|1970-08-26|||||1973-07-10||1970-02-27
TRIAL STUDY 134XCP|IS|6CF611F2-686E-4AE9-B491-32157710F46D||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/10^12 RBC|||||EID 50/ML||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|CLOTTED|N|IMPEDANCE CONDUCTIVITY|NA|U|N||5||7||INDUCTION TREATMENT|1961-03-17|1968-07-04|||||1966-04-11||1965-01-12
TRIAL STUDY 134XCP|IS|417DBC64-7BF9-4EB8-A14B-C5F63541F826||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ|||||UL/KG/DAY||||ABNORMAL|NOT DONE|||MECONIUM|SOLIDIFIED|U|OBSERVATION|Y|Y|U||1||38||TREATMENT|1963-12-19|1963-03-20|||||1961-04-01||1965-12-12
TRIAL STUDY 134XCP|IS|417DBC64-7BF9-4EB8-A14B-C5F63541F826||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UIU/DL|||||POINT||||HIGH|NOT DONE|||INTERSTITIAL FLUID|ICTERIC|N|HPLC-FL|N|N|N||2||58||FOLLOW-UP|1969-01-18|1970-03-29|||||1960-01-31||1967-09-19
TRIAL STUDY 134XCP|IS|417DBC64-7BF9-4EB8-A14B-C5F63541F826||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/M2/H|||||MMHG/SEC||||LOW|NOT DONE|||SKIN TISSUE|CALCIFIED|U|HPLC/MS|NA|N|NA||3||39||WASHOUT|1963-07-25|1971-02-18|||||1967-12-04||1964-10-30
TRIAL STUDY 134XCP|IS|417DBC64-7BF9-4EB8-A14B-C5F63541F826||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CI|||||10^4/HPF||||ABNORMAL|NOT DONE|||EMESIS|ICTERIC|U|CLOT DETECTION|N|Y|U||4||88||RUN-IN|1962-02-09|1969-11-16|||||1967-08-14||1972-03-16
TRIAL STUDY 134XCP|IS|417DBC64-7BF9-4EB8-A14B-C5F63541F826||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOL/L|||||MG/DL||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|GELLED|U|AGAR PROPORTION|NA|Y|N||5||7||OBSERVATION|1971-04-19|1971-08-06|||||1960-07-04||1964-06-20
TRIAL STUDY 134XCP|IS|C3EF644E-25DC-4E0D-9073-735AED77EFAF||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CMH2O/ML|||||/MIN||||HIGH|NOT DONE|||SUPERNATANT, SERUM|AGGLUTINATED|NA|X-RAY FLUORESCENCE SPECTROMETRY|NA|N|NA||1||38||BASELINE|1968-07-24|1970-06-04|||||1969-01-12||1965-01-16
TRIAL STUDY 134XCP|IS|C3EF644E-25DC-4E0D-9073-735AED77EFAF||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU|||||USP U||||NORMAL|NOT DONE|||URINE SEDIMENT|ROOM TEMPERATURE|U|SLOAN LETTER EYE CHART 1.25%|N|Y|N||2||58||INDUCTION TREATMENT|1967-10-07|1964-12-16|||||1966-07-21||1970-02-15
TRIAL STUDY 134XCP|IS|C3EF644E-25DC-4E0D-9073-735AED77EFAF||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||AMPULE|||||GPS U||||LOW|NOT DONE|||SYNOVIAL FLUID|LACTESCENT|NA|KLEIHAUER-BETKE|NA|NA|NA||3||39||LONG-TERM FOLLOW-UP|1961-05-05|1964-05-20|||||1967-08-26||1971-02-23
TRIAL STUDY 134XCP|IS|C3EF644E-25DC-4E0D-9073-735AED77EFAF||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TRANSDUCING UNIT/ML|||||PPTH||||NORMAL|NOT DONE|||PLASMA|REFRIGERATED|Y|DIGITAL PCR|Y|NA|NA||4||88||INDUCTION TREATMENT|1965-10-05|1960-06-10|||||1969-04-10||1960-02-01
TRIAL STUDY 134XCP|IS|C3EF644E-25DC-4E0D-9073-735AED77EFAF||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NEBULE|||||M/SEC2||||ABNORMAL|NOT DONE|||ABSCESS FLUID|LACTESCENT|N|DIFFUSION TENSOR MRI|Y|Y|U||5||7||BASELINE|1961-02-26|1971-08-18|||||1963-03-21||1968-11-02
TRIAL STUDY 134XCP|IS|CAE5F41C-0560-4782-BA27-E314BF7E66B6||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/MG|||||G/CAGE/WK||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|UNEXPECTED ODOR|N|ICP-MS|U|Y|U||1||38||LONG-TERM FOLLOW-UP|1972-08-10|1970-09-30|||||1971-09-21||1962-08-02
TRIAL STUDY 134XCP|IS|CAE5F41C-0560-4782-BA27-E314BF7E66B6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HEP|||||UV||||LOW|NOT DONE|||PERSPIRATION|AGGLUTINATED|N|BIOPSY|NA|N|NA||2||58||WASHOUT|1970-08-16|1969-01-28|||||1962-01-27||1970-10-14
TRIAL STUDY 134XCP|IS|CAE5F41C-0560-4782-BA27-E314BF7E66B6||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||L/DAY|||||BAR||||NORMAL|NOT DONE|||MUSCLE TISSUE|CONTAMINATED|Y|TARGETED TRANSCRIPTOME SEQUENCING|Y|NA|Y||3||39||BASELINE|1968-07-31|1971-08-22|||||1969-11-18||1970-12-06
TRIAL STUDY 134XCP|IS|CAE5F41C-0560-4782-BA27-E314BF7E66B6||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/MMOL|||||MMU/ML||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|GELLED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|N|NA|N||4||88||FOLLOW-UP|1961-03-15|1973-05-03|||||1965-01-17||1965-02-04
TRIAL STUDY 134XCP|IS|CAE5F41C-0560-4782-BA27-E314BF7E66B6||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MIN/DAY|||||PACK||||HIGH|NOT DONE|||SERUM OR PLASMA OR BLOOD|THAWED|U|WHOLE EXOME SEQUENCING|U|NA|NA||5||7||INDUCTION TREATMENT|1965-01-13|1967-05-23|||||1964-06-25||1968-07-14
TRIAL STUDY 134XCP|IS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||S^-1(%O2)^-1|||||ECL UNIT||||LOW|NOT DONE|||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|N|FLOCCULATION|U|Y|N||1||38||LONG-TERM FOLLOW-UP|1966-03-04|1968-06-14|||||1962-11-24||1965-06-05
TRIAL STUDY 134XCP|IS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CAPFUL|||||MEQ/G||||NORMAL|NOT DONE|||PLATELET|HEMOLYZED|N|ZIEHL NEELSEN ACID FAST STAIN|N|U|Y||2||58||SCREENING|1973-04-28|1960-02-10|||||1969-03-06||1965-08-25
TRIAL STUDY 134XCP|IS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MM/2H|||||ML/M2/H||||HIGH|NOT DONE|||LYSATE|HEMOLYZED|NA|SMEAR|U|N|NA||3||39||OBSERVATION|1962-07-25|1970-07-23|||||1960-08-11||1961-07-26
TRIAL STUDY 134XCP|IS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||MESF||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|CONTAMINATED|NA|BAC ACGH|U|N|Y||4||88||OBSERVATION|1973-02-15|1963-06-02|||||1967-11-14||1961-08-10
TRIAL STUDY 134XCP|IS|08CEB6E7-DE68-4F9D-902C-08F6D069EF05||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CYLINDER|||||MIU/L||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|SOLIDIFIED|NA|LINE PROBE ASSAY|U|Y|U||5||7||OBSERVATION|1969-04-04|1962-10-23|||||1973-04-14||1967-08-17
TRIAL STUDY 134XCP|IS|F34E7DCC-8637-463D-88E6-28AEBF495E9B||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L|||||FT2||||NORMAL|NOT DONE|||SEBUM|GELLED|Y|CENTRIFUGATION|N|NA|NA||1||38||OBSERVATION|1971-12-25|1969-12-28|||||1970-04-09||1960-05-17
TRIAL STUDY 134XCP|IS|F34E7DCC-8637-463D-88E6-28AEBF495E9B||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/SEC|||||IU/G||||HIGH|NOT DONE|||PLATELET|LIPEMIC|NA|PYROSEQUENCING|U|NA|U||2||58||OPEN LABEL TREATMENT|1962-05-27|1973-07-04|||||1962-06-03||1965-10-02
TRIAL STUDY 134XCP|IS|F34E7DCC-8637-463D-88E6-28AEBF495E9B||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/M2|||||MMOL/S||||LOW|NOT DONE|||PERITONEAL FLUID|CONTAMINATED|NA|DXA SCAN|N|N|Y||3||39||RUN-IN|1972-08-02|1965-02-12|||||1969-03-27||1965-05-21
TRIAL STUDY 134XCP|IS|F34E7DCC-8637-463D-88E6-28AEBF495E9B||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||H*%|||||MIU/L||||HIGH|NOT DONE|||MECONIUM|LIPEMIC|Y|DIFFUSION WEIGHTED MRI|U|NA|NA||4||88||FOLLOW-UP|1971-09-17|1967-03-12|||||1960-04-27||1973-01-16
TRIAL STUDY 134XCP|IS|F34E7DCC-8637-463D-88E6-28AEBF495E9B||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL/L|||||PFU/ANIMAL||||HIGH|NOT DONE|||SUPERNATANT, SERUM|NON-HEMOLYZED|Y|FLUORESCENT IMMUNOASSAY|NA|U|U||5||7||TREATMENT|1965-07-24|1966-10-09|||||1963-06-27||1962-10-10
TRIAL STUDY 134XCP|IS|69530FE0-6896-4585-8B20-29AE90DB91F5||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KBQ/UL|||||DRINK||||LOW|NOT DONE|||WHITE MATTER TISSUE|AGGLUTINATED|N|EIA|Y|NA|U||1||38||SCREENING|1970-04-09|1971-07-22|||||1961-08-03||1962-04-02
TRIAL STUDY 134XCP|IS|69530FE0-6896-4585-8B20-29AE90DB91F5||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/M2/MIN|||||VP/ML||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|ICTERIC|U|ELECTROCHEMILUMINESCENCE|U|U|Y||2||58||RUN-IN|1966-11-26|1968-02-15|||||1962-08-03||1966-05-16
TRIAL STUDY 134XCP|IS|69530FE0-6896-4585-8B20-29AE90DB91F5||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/L FEU|||||ML/KG/H||||LOW|NOT DONE|||SPERMATOZOON|AUTOLYZED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|N|U||3||39||INDUCTION TREATMENT|1968-09-15|1966-08-17|||||1964-11-07||1971-08-10
TRIAL STUDY 134XCP|IS|69530FE0-6896-4585-8B20-29AE90DB91F5||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KM/H|||||MEQ/DAY||||HIGH|NOT DONE|||REFLEX TEAR|FROZEN|N|DIFFUSION WEIGHTED MRI|N|U|U||4||88||OBSERVATION|1973-06-13|1967-05-04|||||1968-11-17||1966-11-06
TRIAL STUDY 134XCP|IS|69530FE0-6896-4585-8B20-29AE90DB91F5||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/M2|||||SV||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|AGGLUTINATED|Y|EEG|Y|N|Y||5||7||LONG-TERM FOLLOW-UP|1961-06-16|1965-05-04|||||1971-01-28||1960-05-14
TRIAL STUDY 134XCP|IS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MHZ|||||UMOL/MOL||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|NA|Y|U||1||38||BLINDED TREATMENT|1962-01-28|1969-08-01|||||1960-08-25||1970-04-17
TRIAL STUDY 134XCP|IS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CS|||||CG||||HIGH|NOT DONE|||WHITE MATTER TISSUE|SOLIDIFIED|NA|FUNDUS PHOTOGRAPHY|Y|U|Y||2||58||RUN-IN|1960-06-14|1964-08-31|||||1966-01-23||1973-08-16
TRIAL STUDY 134XCP|IS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOZENGE|||||ML/ANIMAL/WK||||NORMAL|NOT DONE|||BONE|CONTAMINATED|U|CALIPER MEASUREMENT METHOD|N|N|N||3||39||WASHOUT|1967-01-28|1971-05-01|||||1966-05-08||1972-01-30
TRIAL STUDY 134XCP|IS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MM/SEC|||||PLUG||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|U|MIGET|N|U|N||4||88||FOLLOW-UP|1961-04-07|1964-10-07|||||1966-08-06||1962-12-27
TRIAL STUDY 134XCP|IS|64FA868A-1774-484C-BA89-4A2ACEF3A8A6||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^3 CFU/ML|||||MCI/KG||||NORMAL|NOT DONE|||MUSCLE TISSUE|REFRIGERATED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|NA|N|Y||5||7||OPEN LABEL TREATMENT|1971-09-05|1972-03-01|||||1966-11-21||1971-01-09
TRIAL STUDY 134XCP|IS|F1EF928C-B819-4620-8991-ABDC4E182217||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 ORGANISMS/G|||||ELISA UNIT||||LOW|NOT DONE|||SUPERNATANT, SERUM|FRESH|NA|SLOAN LETTER EYE CHART 1.25%|N|NA|Y||1||38||BASELINE|1973-08-20|1971-05-16|||||1971-05-25||1962-11-06
TRIAL STUDY 134XCP|IS|F1EF928C-B819-4620-8991-ABDC4E182217||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/L|||||MPL U||||ABNORMAL|NOT DONE|||LEUKOCYTE|CONTAMINATED|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|Y|Y||2||58||FOLLOW-UP|1960-07-27|1961-01-03|||||1969-07-07||1971-03-29
TRIAL STUDY 134XCP|IS|F1EF928C-B819-4620-8991-ABDC4E182217||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UU/L|||||G/DAY||||ABNORMAL|NOT DONE|||TUMOR TISSUE|ROOM TEMPERATURE|U|IN VITRO GENE EXPRESSION ASSAY|Y|N|U||3||39||OBSERVATION|1963-03-24|1973-06-10|||||1961-01-16||1967-06-22
TRIAL STUDY 134XCP|IS|F1EF928C-B819-4620-8991-ABDC4E182217||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CI/ML|||||PPTH||||HIGH|NOT DONE|||ARTERIAL BLOOD|HEMOLYZED|NA|SEQUENCING|Y|NA|NA||4||88||OBSERVATION|1962-08-20|1973-02-05|||||1971-12-24||1962-05-24
TRIAL STUDY 134XCP|IS|F1EF928C-B819-4620-8991-ABDC4E182217||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7 CFU/ML|||||S/H||||LOW|NOT DONE|||TUMOR TISSUE|FRESH|N|CISH|NA|Y|U||5||7||LONG-TERM FOLLOW-UP|1967-07-14|1971-05-07|||||1960-08-06||1968-12-23
TRIAL STUDY 134XCP|IS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 CFU|||||UMOL/L/H||||LOW|NOT DONE|||COLOSTRUM|UNEXPECTED ODOR|NA|NUCLEIC ACID BASED METHOD|U|U|Y||1||38||CONTINUATION TREATMENT|1963-12-22|1960-06-29|||||1962-02-26||1964-12-05
TRIAL STUDY 134XCP|IS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ECL UNIT|||||JDF UNIT||||HIGH|NOT DONE|||CORD SERUM|FROZEN|Y|HEMOCYTOMETRY|N|N|N||2||58||WASHOUT|1962-10-10|1972-11-30|||||1961-10-13||1972-05-07
TRIAL STUDY 134XCP|IS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||V/V|||||IN2||||HIGH|NOT DONE|||PLATELET|AUTOLYZED|NA|OPHTHALMOSCOPY|N|NA|NA||3||39||TREATMENT|1964-11-25|1968-05-10|||||1970-02-01||1971-11-20
TRIAL STUDY 134XCP|IS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TRANSDUCING UNIT/ML|||||COPIES/UL||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|LACTESCENT|U|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|NA|NA||4||88||BASELINE|1964-02-14|1973-01-22|||||1966-01-10||1973-01-28
TRIAL STUDY 134XCP|IS|3AE9E2AF-41FA-4B19-8885-C7E9B4CAD2AC||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IMPLANT|||||MMOL/KG||||NORMAL|NOT DONE|||EMESIS|GELLED|U|REBOUND TONOMETRY|NA|NA|Y||5||7||BLINDED TREATMENT|1964-07-14|1961-04-24|||||1965-02-25||1969-03-28
TRIAL STUDY 134XCP|IS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NSEC|||||KG/L||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CONCENTRATED|U|CENTRIFUGATION|N|N|NA||1||38||INDUCTION TREATMENT|1970-12-26|1969-01-10|||||1963-08-23||1968-04-28
TRIAL STUDY 134XCP|IS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MM2|||||ML/G/H||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|CLOTTED|Y|LEAD CITRATE STAIN|U|NA|N||2||58||LONG-TERM FOLLOW-UP|1965-10-03|1966-01-26|||||1965-11-11||1970-11-09
TRIAL STUDY 134XCP|IS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||H/WK|||||PKAT/L||||NORMAL|NOT DONE|||PLASMA|THAWED|NA|GIEMSA STAIN|U|N|U||3||39||RUN-IN|1963-03-03|1971-10-03|||||1965-03-20||1969-05-17
TRIAL STUDY 134XCP|IS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/(MIN*100ML)|||||G/ANIMAL/DAY||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|DRIED|Y|MICRONEUTRALIZATION ASSAY|U|NA|Y||4||88||RUN-IN|1970-09-04|1969-09-25|||||1960-09-24||1962-05-07
TRIAL STUDY 134XCP|IS|41EF9E3A-3B71-4D35-B25F-29E6E3FC3BB1||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG/M2|||||WATT||||LOW|NOT DONE|||MECONIUM|ICTERIC|Y|CALCULATION|Y|U|N||5||7||BLINDED TREATMENT|1962-02-15|1963-12-04|||||1962-03-19||1970-10-15
TRIAL STUDY 134XCP|IS|27D5690D-BCB3-4FEC-988C-666C29D5239A||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PHERESIS UNIT|||||KHZ||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|GELLED|U|SLIT LAMP PHOTOGRAPHY|N|Y|U||1||38||INDUCTION TREATMENT|1964-08-17|1967-06-23|||||1961-01-28||1960-01-28
TRIAL STUDY 134XCP|IS|27D5690D-BCB3-4FEC-988C-666C29D5239A||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TSP EQ|||||/MONTH||||HIGH|NOT DONE|||PERITONEAL FLUID|CLOTTED|NA|IMMUNO-PET SCAN|NA|U|N||2||58||CONTINUATION TREATMENT|1964-10-22|1960-10-24|||||1966-03-29||1968-08-05
TRIAL STUDY 134XCP|IS|27D5690D-BCB3-4FEC-988C-666C29D5239A||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MGEQ|||||MESF||||ABNORMAL|NOT DONE|||LAVAGE FLUID|FRESH|U|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|Y|U||3||39||OPEN LABEL TREATMENT|1963-05-30|1965-02-28|||||1965-11-29||1963-06-23
TRIAL STUDY 134XCP|IS|27D5690D-BCB3-4FEC-988C-666C29D5239A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UOSM|||||DAYS/MONTH||||HIGH|NOT DONE|||FLUID|AGGLUTINATED|U|POLYSOMNOGRAPHY|U|Y|U||4||88||SCREENING|1971-01-24|1972-08-27|||||1969-12-31||1966-04-27
TRIAL STUDY 134XCP|IS|27D5690D-BCB3-4FEC-988C-666C29D5239A||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MM2|||||MANSON U/ML||||NORMAL|NOT DONE|||NAIL|DRIED|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|N|Y||5||7||BLINDED TREATMENT|1969-02-05|1963-07-23|||||1965-10-18||1972-06-15
TRIAL STUDY 134XCP|IS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IU/DL|||||UV2||||HIGH|NOT DONE|||DISCHARGE|CLOTTED|U|CELL BASED BIOASSAY|Y|U|U||1||38||BLINDED TREATMENT|1960-11-29|1973-01-19|||||1969-09-26||1962-04-27
TRIAL STUDY 134XCP|IS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PG/L|||||IU/ML||||NORMAL|NOT DONE|||SERUM|ICTERIC|NA|PERFUSION MRI|Y|U|NA||2||58||OBSERVATION|1969-11-16|1972-03-02|||||1970-08-22||1972-06-14
TRIAL STUDY 134XCP|IS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UIU/L|||||GY/MIN||||LOW|NOT DONE|||CEREBROSPINAL FLUID|CLOTTED|U|ANGIOGRAPHY|Y|U|U||3||39||RUN-IN|1972-08-08|1970-10-30|||||1961-12-18||1969-08-28
TRIAL STUDY 134XCP|IS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GRAVITATIONAL UNIT|||||ML/KG/H||||HIGH|NOT DONE|||EXPIRED AIR|LIPEMIC|U|HANSEL STAIN|U|N|Y||4||88||TREATMENT|1965-08-17|1960-11-04|||||1972-12-23||1963-10-31
TRIAL STUDY 134XCP|IS|7639ABA6-8AC8-4066-BF07-AEC230A2BF69||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PMOL/10^9 CELLS|||||BEL||||LOW|NOT DONE|||AQUEOUS HUMOR|DRIED|U|NUCLEIC ACID AMPLIFICATION TEST|N|N|U||5||7||BLINDED TREATMENT|1966-12-07|1961-01-09|||||1965-04-22||1961-12-10
TRIAL STUDY 134XCP|IS|8E25F21F-A565-40CB-B0D7-6CC496171293||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PNU/ML|||||UG/KG/MIN||||ABNORMAL|NOT DONE|||CERUMEN|NON-HEMOLYZED|N|DIFFUSION TENSOR MRI|Y|U|NA||1||38||OPEN LABEL TREATMENT|1960-01-01|1960-06-10|||||1966-04-06||1971-05-18
TRIAL STUDY 134XCP|IS|8E25F21F-A565-40CB-B0D7-6CC496171293||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/MG|||||PFU/ML||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|CLOTTED|N|IMMUNODIFFUSION|Y|NA|NA||2||58||OBSERVATION|1968-05-07|1966-01-23|||||1969-04-29||1962-06-22
TRIAL STUDY 134XCP|IS|8E25F21F-A565-40CB-B0D7-6CC496171293||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MPL U|||||UG/M2/MIN||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|LIPEMIC|N|MS/MS|U|U|NA||3||39||OBSERVATION|1972-03-03|1973-03-01|||||1966-12-25||1962-05-12
TRIAL STUDY 134XCP|IS|8E25F21F-A565-40CB-B0D7-6CC496171293||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||APL U|||||ROENTGEN||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|PARAFFIN-EMBEDDED|NA|BIOIMPEDANCE SPECTROSCOPY|NA|U|U||4||88||WASHOUT|1971-10-24|1971-06-03|||||1965-07-29||1960-06-27
TRIAL STUDY 134XCP|IS|8E25F21F-A565-40CB-B0D7-6CC496171293||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LINEAR FT*LB|||||UMOL/DAY||||LOW|NOT DONE|||PLATELET RICH PLASMA|ICTERIC|N|HIGH RESOLUTION CT|N|N|U||5||7||CONTINUATION TREATMENT|1972-02-24|1968-08-23|||||1973-05-29||1968-12-06
TRIAL STUDY 134XCP|IS|8CDD2247-485D-495C-9186-FF4CA3FFC32E||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/M2/MIN|||||ML/M2||||HIGH|NOT DONE|||URINE SEDIMENT|FRESH|Y|PERCUSSION|U|NA|N||1||38||FOLLOW-UP|1967-07-18|1962-10-14|||||1967-01-27||1973-03-01
TRIAL STUDY 134XCP|IS|8CDD2247-485D-495C-9186-FF4CA3FFC32E||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7 CFU|||||CFU/G||||HIGH|NOT DONE|||LOCHIA|LIPEMIC|U|IMMUNOASSAY|N|Y|Y||2||58||TREATMENT|1962-05-15|1972-12-11|||||1966-12-24||1973-08-22
TRIAL STUDY 134XCP|IS|8CDD2247-485D-495C-9186-FF4CA3FFC32E||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MJOULE/CM2|||||AMOL||||ABNORMAL|NOT DONE|||TRANSUDATE|NON-HEMOLYZED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|U|U||3||39||WASHOUT|1966-01-06|1963-03-20|||||1971-05-16||1969-08-23
TRIAL STUDY 134XCP|IS|8CDD2247-485D-495C-9186-FF4CA3FFC32E||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/MG|||||10^4 CFU||||NORMAL|NOT DONE|||HAIR FOLLICLE|GELLED|N|ZIEHL NEELSEN ACID FAST STAIN|NA|N|U||4||88||CONTINUATION TREATMENT|1970-04-24|1966-08-28|||||1962-06-28||1968-07-18
TRIAL STUDY 134XCP|IS|8CDD2247-485D-495C-9186-FF4CA3FFC32E||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/ANIMAL/WK|||||RAD||||LOW|NOT DONE|||VITREOUS HUMOR|DRIED|NA|HILLMEN COLOR CHART|Y|Y|N||5||7||BASELINE|1972-11-28|1961-02-05|||||1972-02-18||1960-09-21
TRIAL STUDY 134XCP|IS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/G/MIN|||||MMHG||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|GELLED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|NA|NA|N||1||38||OBSERVATION|1965-07-07|1972-07-13|||||1964-06-07||1962-10-18
TRIAL STUDY 134XCP|IS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/S/M2|||||10^6 IU/ML||||LOW|NOT DONE|||CORD BLOOD|LACTESCENT|Y|MAGNETIC RESONANCE ELASTOGRAPHY|U|N|U||2||58||OPEN LABEL TREATMENT|1961-12-17|1973-01-05|||||1969-08-06||1967-08-20
TRIAL STUDY 134XCP|IS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PKAT/L|||||ML/ANIMAL/WK||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|CONCENTRATED|NA|COLORIMETRY|U|Y|U||3||39||FOLLOW-UP|1973-06-07|1973-05-04|||||1966-08-04||1968-08-13
TRIAL STUDY 134XCP|IS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||RNA COPIES/ML|||||AFU||||LOW|NOT DONE|||LEUKOCYTE|AGGLUTINATED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|U|U|Y||4||88||FOLLOW-UP|1973-02-22|1962-09-04|||||1962-08-06||1971-03-25
TRIAL STUDY 134XCP|IS|E50F5B98-1DC4-41A8-8D68-A4E98D9E6B13||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 U|||||MIN*MG/ML||||NORMAL|NOT DONE|||MUCUS|CONTAMINATED|NA|MALDI|Y|N|Y||5||7||LONG-TERM FOLLOW-UP|1972-09-13|1965-03-13|||||1963-07-18||1973-05-27
TRIAL STUDY 134XCP|IS|C004A8EB-220F-4FC5-A150-B5159DCA84D9||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DROP|||||/HPF||||HIGH|NOT DONE|||BILE|CALCIFIED|N|TRIPLE-PHASE MRI SCAN|Y|U|NA||1||38||BLINDED TREATMENT|1962-02-11|1971-08-22|||||1960-10-20||1960-05-04
TRIAL STUDY 134XCP|IS|C004A8EB-220F-4FC5-A150-B5159DCA84D9||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BQ/UG|||||ML||||NORMAL|NOT DONE|||LOCHIA|DRIED|N|PHOTOMETRIC CLOT DETECTION|Y|NA|NA||2||58||RUN-IN|1964-09-14|1966-07-17|||||1960-02-01||1968-04-19
TRIAL STUDY 134XCP|IS|C004A8EB-220F-4FC5-A150-B5159DCA84D9||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6/G|||||GBQ/UG||||HIGH|NOT DONE|||AQUEOUS HUMOR|THAWED|N|LANDOLT RING|Y|N|Y||3||39||INDUCTION TREATMENT|1972-02-16|1966-03-16|||||1962-02-04||1967-09-26
TRIAL STUDY 134XCP|IS|C004A8EB-220F-4FC5-A150-B5159DCA84D9||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/HPF|||||PL||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|CALCIFIED|Y|PANENDOSCOPY|N|U|NA||4||88||WASHOUT|1961-02-27|1960-09-11|||||1972-07-24||1965-12-26
TRIAL STUDY 134XCP|IS|C004A8EB-220F-4FC5-A150-B5159DCA84D9||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MEQ/L|||||UMOL/DAY||||LOW|NOT DONE|||MECONIUM|AUTOLYZED|N|REVERSE TRANSCRIPTASE PCR|NA|N|N||5||7||BLINDED TREATMENT|1960-08-06|1969-03-06|||||1970-01-30||1972-08-14
TRIAL STUDY 134XCP|IS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PFU/ANIMAL|||||M3||||ABNORMAL|NOT DONE|||BONE|ICTERIC|Y|LIQUID SCINTILLATION COUNTING|N|N|U||1||38||SCREENING|1969-10-04|1963-03-30|||||1965-08-05||1964-06-03
TRIAL STUDY 134XCP|IS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UM/S|||||10^11/L||||LOW|NOT DONE|||EXPIRED AIR|DRIED|U|JAEGER EYE CHART|NA|NA|Y||2||58||INDUCTION TREATMENT|1973-01-18|1966-07-22|||||1972-06-03||1967-05-18
TRIAL STUDY 134XCP|IS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SCM|||||/KG||||LOW|NOT DONE|||FLUID|ICTERIC|U|AGAR PROPORTION|Y|U|N||3||39||WASHOUT|1963-10-15|1970-04-20|||||1962-12-25||1970-12-06
TRIAL STUDY 134XCP|IS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^7 TCID 50/DOSE|||||UG/M2/DAY||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|FROZEN|N|TRANSVAGINAL ULTRASOUND|U|NA|NA||4||88||OPEN LABEL TREATMENT|1963-09-04|1960-12-04|||||1971-10-13||1966-06-18
TRIAL STUDY 134XCP|IS|5F3947A1-23B5-45DD-AFF6-A9285C85CD3E||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LX|||||G/DL||||NORMAL|NOT DONE|||BLOOD|UNEXPECTED ODOR|Y|GEL ELECTROPHORESIS|Y|N|N||5||7||LONG-TERM FOLLOW-UP|1968-03-10|1973-05-20|||||1963-03-01||1962-11-05
TRIAL STUDY 134XCP|IS|AE127EDD-D708-4B1A-95F7-176A541A9584||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UKAT/L|||||RFU||||ABNORMAL|NOT DONE|||MECONIUM|THAWED|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|N|U|N||1||38||CONTINUATION TREATMENT|1965-11-13|1971-07-13|||||1963-10-08||1972-11-16
TRIAL STUDY 134XCP|IS|AE127EDD-D708-4B1A-95F7-176A541A9584||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FOZ_US|||||GPELISA UNIT/ML||||HIGH|NOT DONE|||SKIN TISSUE|PARAFFIN-EMBEDDED|Y|CELL OF ORIGIN ASSAY|NA|Y|Y||2||58||RUN-IN|1965-10-29|1962-11-14|||||1966-09-28||1964-08-06
TRIAL STUDY 134XCP|IS|AE127EDD-D708-4B1A-95F7-176A541A9584||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KAT|||||UMOL/MOL||||HIGH|NOT DONE|||SEMINAL FLUID|SOLIDIFIED|N|LIQUID SCINTILLATION COUNTING|N|U|NA||3||39||CONTINUATION TREATMENT|1961-10-31|1967-06-17|||||1967-11-21||1971-02-04
TRIAL STUDY 134XCP|IS|AE127EDD-D708-4B1A-95F7-176A541A9584||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 ELISA UNIT|||||NFIU||||ABNORMAL|NOT DONE|||SEMEN|SOLIDIFIED|U|CYSTOSCOPY|N|NA|U||4||88||CONTINUATION TREATMENT|1964-06-21|1962-04-27|||||1971-10-16||1960-11-23
TRIAL STUDY 134XCP|IS|AE127EDD-D708-4B1A-95F7-176A541A9584||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||EIA UNIT|||||MEQ||||HIGH|NOT DONE|||SUPERNATANT, SERUM|CALCIFIED|NA|SEQUENCING|Y|N|Y||5||7||OBSERVATION|1971-03-06|1962-07-17|||||1966-05-22||1970-11-20
TRIAL STUDY 134XCP|IS|F642D4A0-A67F-4A10-BB21-E4644E963D45||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KG/L|||||G/ANIMAL/WK||||NORMAL|NOT DONE|||SERUM OR PLASMA|CONCENTRATED|Y|PHOTOGRAPHY|NA|NA|Y||1||38||SCREENING|1963-08-13|1963-05-30|||||1964-08-02||1960-09-15
TRIAL STUDY 134XCP|IS|F642D4A0-A67F-4A10-BB21-E4644E963D45||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||AMPULE|||||ML/G/MIN||||LOW|NOT DONE|||ENDOMETRIAL TISSUE|LIPEMIC|U|FLUORESCENCE ANGIOGRAPHY|U|N|Y||2||58||RUN-IN|1968-02-02|1967-07-09|||||1965-07-08||1960-02-25
TRIAL STUDY 134XCP|IS|F642D4A0-A67F-4A10-BB21-E4644E963D45||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/MOL|||||U/ANIMAL||||HIGH|NOT DONE|||LYSATE|LIPEMIC|NA|FLUORESCENCE ANGIOGRAPHY|NA|Y|Y||3||39||TREATMENT|1963-07-07|1970-05-08|||||1960-09-09||1970-03-17
TRIAL STUDY 134XCP|IS|F642D4A0-A67F-4A10-BB21-E4644E963D45||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PIXELS/IN|||||RPM||||ABNORMAL|NOT DONE|||MECONIUM|LACTESCENT|Y|HPLC-UV|NA|U|Y||4||88||LONG-TERM FOLLOW-UP|1960-09-24|1961-10-03|||||1970-07-31||1973-04-05
TRIAL STUDY 134XCP|IS|F642D4A0-A67F-4A10-BB21-E4644E963D45||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NG|||||UG/KG/DAY||||HIGH|NOT DONE|||KERATINOCYTE|FROZEN|N|SLOAN LETTER EYE CHART 100%|NA|Y|U||5||7||OPEN LABEL TREATMENT|1964-08-11|1965-05-27|||||1963-04-25||1971-02-04
TRIAL STUDY 134XCP|IS|933A6DFF-D519-46F4-AB52-78E6A898E4A1||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||1/(S*KPA)|||||10^5/HPF||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CONTAMINATED|U|LYMPHANGIOGRAPHY|Y|U|U||1||38||OBSERVATION|1962-09-23|1972-03-30|||||1968-12-23||1970-03-09
TRIAL STUDY 134XCP|IS|933A6DFF-D519-46F4-AB52-78E6A898E4A1||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MAC50|||||CFU/ML||||HIGH|NOT DONE|||PUS|SOLIDIFIED|U|NON-INVASIVE DIELECTRIC SENSING|Y|Y|N||2||58||TREATMENT|1961-12-03|1972-01-06|||||1960-02-23||1968-04-27
TRIAL STUDY 134XCP|IS|933A6DFF-D519-46F4-AB52-78E6A898E4A1||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PG/DL|||||MMHG/L/MIN||||LOW|NOT DONE|||FLUID|FROZEN|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y|U|U||3||39||OPEN LABEL TREATMENT|1965-11-18|1973-06-24|||||1968-06-21||1970-02-19
TRIAL STUDY 134XCP|IS|933A6DFF-D519-46F4-AB52-78E6A898E4A1||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/LSQN|||||ML/G/DAY||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CLOTTED|N|RAJI CELL RIA|NA|N|N||4||88||RUN-IN|1960-03-23|1968-10-15|||||1970-09-04||1961-04-07
TRIAL STUDY 134XCP|IS|933A6DFF-D519-46F4-AB52-78E6A898E4A1||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LB|||||GY/MIN||||HIGH|NOT DONE|||LUNG SURFACTANT|CALCIFIED|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NA|N|U||5||7||BASELINE|1962-11-15|1960-03-10|||||1963-03-18||1965-11-15
TRIAL STUDY 134XCP|IS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/CAGE/DAY|||||L/S/KPA||||LOW|NOT DONE|||PLATELET|CALCIFIED|U|ICC|N|N|Y||1||38||CONTINUATION TREATMENT|1969-01-30|1972-01-28|||||1968-06-28||1964-12-04
TRIAL STUDY 134XCP|IS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/M2/H|||||IU/DL||||NORMAL|NOT DONE|||LUNG SURFACTANT|PARAFFIN-EMBEDDED|U|PALM METHOD|N|NA|U||2||58||SCREENING|1972-02-05|1971-10-05|||||1967-04-14||1965-08-01
TRIAL STUDY 134XCP|IS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TBSP|||||10^3/HPF||||ABNORMAL|NOT DONE|||KERATINOCYTE|DRIED|Y|SLIT LAMP PHOTOGRAPHY|U|N|N||3||39||LONG-TERM FOLLOW-UP|1963-04-25|1969-01-25|||||1961-05-29||1962-01-10
TRIAL STUDY 134XCP|IS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^4 CFU|||||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE|||URINE|ROOM TEMPERATURE|NA|PERFUSION MRI|U|N|U||4||88||CONTINUATION TREATMENT|1971-01-28|1967-03-27|||||1964-09-02||1968-10-02
TRIAL STUDY 134XCP|IS|CF880C64-8AA1-4A19-B8A3-821F3EDF83FD||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||STEPS|||||U/M2/DAY||||HIGH|NOT DONE|||CELL PELLET|LIPEMIC|NA|SCINTIGRAPHY|NA|Y|N||5||7||INDUCTION TREATMENT|1968-09-30|1962-07-19|||||1969-12-03||1964-10-20
TRIAL STUDY 134XCP|IS|38E177D4-1A58-4E78-90B7-85F76BF66826||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PA|||||SQU/ML||||HIGH|NOT DONE|||PUS|CONTAMINATED|NA|DIPSTICK|N|NA|N||1||38||INDUCTION TREATMENT|1965-08-17|1968-05-07|||||1969-05-22||1969-09-26
TRIAL STUDY 134XCP|IS|38E177D4-1A58-4E78-90B7-85F76BF66826||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/L|||||UIU/DL||||NORMAL|NOT DONE|||PERSPIRATION|LIPEMIC|Y|COULOMETRIC TITRATION|Y|N|NA||2||58||LONG-TERM FOLLOW-UP|1961-10-28|1965-12-12|||||1963-08-16||1964-05-17
TRIAL STUDY 134XCP|IS|38E177D4-1A58-4E78-90B7-85F76BF66826||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/CM2|||||MGEQ||||HIGH|NOT DONE|||BREAST MILK|LIPEMIC|U|RYAN BLUE STAIN|N|NA|Y||3||39||OPEN LABEL TREATMENT|1973-09-04|1973-02-01|||||1965-03-20||1965-06-14
TRIAL STUDY 134XCP|IS|38E177D4-1A58-4E78-90B7-85F76BF66826||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PACK YEAR|||||ECL UNIT||||ABNORMAL|NOT DONE|||TRANSUDATE|SOLIDIFIED|Y|CT SCAN WITHOUT CONTRAST|NA|Y|NA||4||88||LONG-TERM FOLLOW-UP|1971-05-01|1969-05-28|||||1961-11-06||1961-08-14
TRIAL STUDY 134XCP|IS|38E177D4-1A58-4E78-90B7-85F76BF66826||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MS2|||||NL||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|FRESH|N|CELLULAR PROLIFERATION ASSAY|Y|NA|Y||5||7||BLINDED TREATMENT|1967-07-09|1963-11-29|||||1970-08-13||1971-12-13
TRIAL STUDY 134XCP|IS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PG/CELL|||||QUANTITY SUFFICIENT||||LOW|NOT DONE|||PERITONEAL FLUID|LACTESCENT|NA|AUTOREFRACTION|U|Y|Y||1||38||OPEN LABEL TREATMENT|1970-02-17|1962-06-16|||||1965-11-09||1968-07-27
TRIAL STUDY 134XCP|IS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BREATHS/30S|||||G/CAGE||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|DRIED|NA|OBSERVATION|U|NA|U||2||58||SCREENING|1971-06-07|1968-11-12|||||1968-07-27||1963-04-20
TRIAL STUDY 134XCP|IS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LX|||||10^4 CFU/ML||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|ROOM TEMPERATURE|NA|RADIOIMMUNOPRECIPITATION ASSAY|NA|U|U||3||39||BLINDED TREATMENT|1972-09-25|1967-03-06|||||1971-01-11||1970-11-16
TRIAL STUDY 134XCP|IS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||SBE/ML|||||CAPFUL||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|ICTERIC|Y|CALCULATION|U|N|Y||4||88||INDUCTION TREATMENT|1972-04-01|1962-09-18|||||1965-04-08||1971-11-13
TRIAL STUDY 134XCP|IS|43EFF4FE-66EE-45FD-8CA1-CDE9404CA2D9||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^11/L|||||KG||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|LIPEMIC|NA|RAJI CELL EIA|NA|NA|N||5||7||TREATMENT|1968-09-12|1968-09-04|||||1961-10-30||1961-08-15
TRIAL STUDY 134XCP|IS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BLOCKS|||||DPM/100MG||||HIGH|NOT DONE|||URINE|REFRIGERATED|Y|FLUORESCENCE ANGIOGRAPHY|NA|NA|U||1||38||TREATMENT|1969-02-06|1973-06-23|||||1970-11-14||1963-01-18
TRIAL STUDY 134XCP|IS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KBQ/UL|||||KS||||NORMAL|NOT DONE|||GASTRIC FLUID|AGGLUTINATED|Y|KINETIC CHROMOGENIC ASSAY|N|N|Y||2||58||FOLLOW-UP|1969-02-21|1966-03-02|||||1963-02-24||1962-02-03
TRIAL STUDY 134XCP|IS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/MMOL|||||BP||||LOW|NOT DONE|||BUFFY COAT|CONTAMINATED|NA|SIZE EXCLUSION CHROMATOGRAPHY|Y|NA|U||3||39||RUN-IN|1971-07-19|1960-04-26|||||1966-08-04||1967-05-13
TRIAL STUDY 134XCP|IS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TUBE|||||LOG10 TCID 50/UL||||NORMAL|NOT DONE|||DERMAL TISSUE|AGGLUTINATED|NA|ELLA|NA|NA|NA||4||88||INDUCTION TREATMENT|1968-04-12|1973-02-13|||||1969-05-20||1960-10-31
TRIAL STUDY 134XCP|IS|2FC40644-58C4-44B4-AF2A-D1D2EB66980B||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PL|||||DAGU/ML||||LOW|NOT DONE|||BASAL TEAR|PARAFFIN-EMBEDDED|Y|PHASE CONTRAST MICROSCOPY|Y|Y|Y||5||7||LONG-TERM FOLLOW-UP|1969-01-28|1972-04-21|||||1961-03-20||1966-01-01
TRIAL STUDY 134XCP|IS|50CFC814-7135-4356-BAC2-3F975B9F6AE3||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IMPLANT|||||UL/DOSE||||NORMAL|NOT DONE|||LEUKOCYTE|PARAFFIN-EMBEDDED|Y|CALCULATION|NA|U|N||1||38||FOLLOW-UP|1961-06-24|1972-11-25|||||1963-10-19||1971-11-09
TRIAL STUDY 134XCP|IS|50CFC814-7135-4356-BAC2-3F975B9F6AE3||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||M2|||||IU/MMOL||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|FRESH|N|OPTICAL MAPPING|NA|NA|Y||2||58||CONTINUATION TREATMENT|1964-04-10|1960-12-04|||||1964-11-18||1966-04-25
TRIAL STUDY 134XCP|IS|50CFC814-7135-4356-BAC2-3F975B9F6AE3||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/MS|||||CI/MG||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|REFRIGERATED|N|WESTERGREN|N|Y|N||3||39||BASELINE|1967-06-10|1961-04-22|||||1970-03-17||1961-04-30
TRIAL STUDY 134XCP|IS|50CFC814-7135-4356-BAC2-3F975B9F6AE3||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/WEEK|||||/10^5||||HIGH|NOT DONE|||VITREOUS HUMOR|LACTESCENT|Y|DYNAMOMETRY|NA|NA|N||4||88||TREATMENT|1966-08-16|1970-07-08|||||1966-12-27||1964-11-12
TRIAL STUDY 134XCP|IS|50CFC814-7135-4356-BAC2-3F975B9F6AE3||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KG/CM2|||||IN2||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|CALCIFIED|N|PET/SPECT SCAN|U|Y|U||5||7||CONTINUATION TREATMENT|1960-01-25|1965-06-12|||||1966-05-17||1972-10-05
TRIAL STUDY 134XCP|IS|8A639816-D878-4FD7-AF28-CF9EA2236462||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IU/ML|||||10^9/G||||ABNORMAL|NOT DONE|||GASTRIC CONTENTS|UNEXPECTED ODOR|NA|AGAR PROPORTION|Y|N|N||1||38||OPEN LABEL TREATMENT|1961-08-13|1965-07-12|||||1966-08-23||1966-03-20
TRIAL STUDY 134XCP|IS|8A639816-D878-4FD7-AF28-CF9EA2236462||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/100 HPFS|||||UV*SEC||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|SOLIDIFIED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|Y|Y|Y||2||58||FOLLOW-UP|1967-09-25|1968-09-20|||||1972-10-28||1971-03-06
TRIAL STUDY 134XCP|IS|8A639816-D878-4FD7-AF28-CF9EA2236462||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||RAD|||||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|LACTESCENT|Y|FREEZING POINT DEPRESSION|U|Y|Y||3||39||FOLLOW-UP|1971-09-28|1968-09-02|||||1971-07-09||1969-11-23
TRIAL STUDY 134XCP|IS|8A639816-D878-4FD7-AF28-CF9EA2236462||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3 DNA COPIES/ML|||||PA||||NORMAL|NOT DONE|||VITREOUS HUMOR|CONCENTRATED|NA|JAEGER EYE CHART|U|NA|N||4||88||INDUCTION TREATMENT|1961-02-13|1973-04-24|||||1965-05-12||1962-07-18
TRIAL STUDY 134XCP|IS|8A639816-D878-4FD7-AF28-CF9EA2236462||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UIU/DL|||||NKAT||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|FRESH|U|TONOMETRY|N|NA|NA||5||7||RUN-IN|1963-01-03|1968-01-14|||||1962-10-23||1967-04-28
TRIAL STUDY 134XCP|IS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/L/MIN|||||MG/MIN||||HIGH|NOT DONE|||SYNOVIAL FLUID|CONTAMINATED|Y|PEAK FLOWMETRY|Y|N|Y||1||38||RUN-IN|1960-09-16|1969-10-18|||||1972-07-28||1964-03-23
TRIAL STUDY 134XCP|IS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||H/WK|||||UG/DL||||HIGH|NOT DONE|||INFRANATANT, PLASMA|FROZEN|Y|ZIEHL NEELSEN ACID FAST STAIN|NA|Y|N||2||58||CONTINUATION TREATMENT|1963-02-26|1968-01-30|||||1964-08-16||1969-03-02
TRIAL STUDY 134XCP|IS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/M2/DAY|||||PNU/ML||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|UNEXPECTED ODOR|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|U|NA|N||3||39||OBSERVATION|1969-07-01|1961-04-03|||||1965-05-06||1970-10-01
TRIAL STUDY 134XCP|IS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||IU|||||BQ/MG||||HIGH|NOT DONE|||REFLEX TEAR|ROOM TEMPERATURE|NA|RAJI CELL RIA|Y|Y|U||4||88||OBSERVATION|1963-05-23|1965-08-28|||||1960-09-21||1968-10-09
TRIAL STUDY 134XCP|IS|AB5AD6EB-8F8D-45B6-9FAB-9B6B43614A19||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||LOG10 CFU/ML|||||NG||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|THAWED|Y|MASS SPECTROMETRY|NA|Y|U||5||7||FOLLOW-UP|1969-12-05|1973-09-06|||||1971-01-12||1966-06-18
TRIAL STUDY 134XCP|IS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/MOL|||||CAN||||LOW|NOT DONE|||EMOTIONAL TEAR|FRESH|NA|DC SHEATH FLOW|Y|Y|Y||1||38||LONG-TERM FOLLOW-UP|1966-09-24|1970-10-04|||||1972-07-08||1973-03-29
TRIAL STUDY 134XCP|IS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^12 IU/L|||||ML/KG/DAY||||NORMAL|NOT DONE|||ADIPOSE TISSUE|DRIED|U|ANTIMICROBIAL COMBINATION TESTING|NA|N|NA||2||58||FOLLOW-UP|1968-01-20|1971-04-03|||||1972-07-04||1967-04-27
TRIAL STUDY 134XCP|IS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LOG10 CCID 50/DOSE|||||DEG2||||ABNORMAL|NOT DONE|||SPERMATOZOON|HEMOLYZED|Y|BIOPSY|U|NA|Y||3||39||FOLLOW-UP|1961-07-31|1960-12-21|||||1971-12-27||1973-01-09
TRIAL STUDY 134XCP|IS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KA_U/DL|||||OHM||||HIGH|NOT DONE|||PLASMA|ROOM TEMPERATURE|Y|TURBIDIMETRY|Y|NA|N||4||88||RUN-IN|1961-07-27|1970-07-03|||||1960-07-07||1971-10-07
TRIAL STUDY 134XCP|IS|B48ADEF8-4C6D-4DFC-8623-8C677DF57BB3||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/KG/DAY|||||JOULE||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|N|SLOAN LETTER EYE CHART 1.25%|N|U|NA||5||7||INDUCTION TREATMENT|1967-11-02|1964-01-19|||||1960-09-17||1973-07-21
TRIAL STUDY 134XCP|IS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/KG/DAY|||||OSM||||HIGH|NOT DONE|||SEMEN|CONCENTRATED|N|IN VITRO GENE EXPRESSION ASSAY|NA|U|NA||1||38||SCREENING|1969-08-11|1973-08-20|||||1970-02-05||1965-03-07
TRIAL STUDY 134XCP|IS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/100 HPFS|||||JDF UNIT||||HIGH|NOT DONE|||LYSATE|CALCIFIED|U|SINGLE-MOLECULE ARRAY|NA|NA|Y||2||58||BASELINE|1964-10-15|1960-11-15|||||1970-06-17||1968-03-13
TRIAL STUDY 134XCP|IS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L|||||WEBER||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|LACTESCENT|U|MRI WITHOUT CONTRAST|NA|N|N||3||39||WASHOUT|1967-01-01|1967-09-20|||||1969-01-04||1969-10-14
TRIAL STUDY 134XCP|IS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SV|||||L/MIN/M2||||LOW|NOT DONE|||TISSUE|FROZEN|NA|WHOLE TRANSCRIPTOME SEQUENCING|N|Y|Y||4||88||CONTINUATION TREATMENT|1970-08-07|1966-05-20|||||1972-10-31||1960-11-24
TRIAL STUDY 134XCP|IS|3BF3C4EE-9526-4E22-956C-E72A1D9D9790||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CI/L|||||CMOL/L||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|CALCIFIED|U|LASER CAPTURE MICRODISSECTION|N|U|Y||5||7||RUN-IN|1971-12-16|1972-03-05|||||1962-07-09||1970-10-01
TRIAL STUDY 134XCP|IS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||OD UNIT|||||FINGERTIP UNIT||||HIGH|NOT DONE|||SWABBED MATERIAL|FROZEN|U|LYMPHANGIOGRAPHY|U|N|Y||1||38||BLINDED TREATMENT|1966-11-14|1968-03-05|||||1971-01-30||1971-02-25
TRIAL STUDY 134XCP|IS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU|||||UG/ANIMAL||||ABNORMAL|NOT DONE|||PLATELET|REFRIGERATED|N|REVERSE TRANSCRIPTASE PCR|N|NA|Y||2||58||BASELINE|1969-08-22|1973-03-14|||||1969-04-30||1970-05-14
TRIAL STUDY 134XCP|IS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%(V/V)|||||CGY||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|CALCIFIED|NA|CALCULATION|Y|N|Y||3||39||RUN-IN|1966-04-25|1970-12-03|||||1962-03-03||1973-07-20
TRIAL STUDY 134XCP|IS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 ORGANISMS/ML|||||ML/DOSE||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|REFRIGERATED|Y|BALLPOINT PEN TECHNIQUE|Y|NA|Y||4||88||OPEN LABEL TREATMENT|1970-05-02|1965-10-13|||||1960-08-25||1961-05-19
TRIAL STUDY 134XCP|IS|0E9EBFA5-BA5B-4578-945F-4A3F5192BB43||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VG/DOSE|||||SV||||HIGH|NOT DONE|||PLEURAL TISSUE|LIPEMIC|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|Y|NA||5||7||SCREENING|1969-07-19|1969-08-03|||||1972-12-26||1968-01-21
TRIAL STUDY 134XCP|IS|30419F44-B519-488C-A505-F23D88A46024||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DMOL|||||KPA||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|REFRIGERATED|U|X-RAY FLUORESCENCE SPECTROMETRY|N|NA|NA||1||38||OBSERVATION|1961-04-13|1973-04-10|||||1969-12-16||1965-03-18
TRIAL STUDY 134XCP|IS|30419F44-B519-488C-A505-F23D88A46024||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PA|||||CCID 50/DOSE||||HIGH|NOT DONE|||AMNIOTIC FLUID|CLOTTED|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|U|N|Y||2||58||BASELINE|1965-01-26|1966-02-26|||||1966-07-14||1970-09-21
TRIAL STUDY 134XCP|IS|30419F44-B519-488C-A505-F23D88A46024||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/G|||||CD*S/M2||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|FROZEN|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|U|N|U||3||39||TREATMENT|1969-04-16|1962-10-01|||||1969-05-16||1969-08-17
TRIAL STUDY 134XCP|IS|30419F44-B519-488C-A505-F23D88A46024||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NMOL/ML/MIN|||||IU/G||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|CONTAMINATED|N|DIGITAL PCR|NA|Y|Y||4||88||BASELINE|1971-07-31|1965-06-11|||||1960-01-31||1962-01-13
TRIAL STUDY 134XCP|IS|30419F44-B519-488C-A505-F23D88A46024||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6 COPIES/ML|||||CM H2O||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|NA|POTENTIOMETRY|N|U|Y||5||7||RUN-IN|1967-12-05|1966-09-18|||||1973-08-25||1970-07-21
TRIAL STUDY 134XCP|IS|2AF06F66-5E51-4AC9-AF62-A34329724F7D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/G|||||UMOL/MG/MIN||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|DRIED|N|INFRARED SPECTROMETRY|N|U|NA||1||38||WASHOUT|1969-08-15|1964-12-05|||||1971-05-03||1964-02-15
TRIAL STUDY 134XCP|IS|2AF06F66-5E51-4AC9-AF62-A34329724F7D||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CI|||||WEEKS||||LOW|NOT DONE|||DIALYSIS FLUID|FROZEN|Y|LC-FL|U|U|NA||2||58||LONG-TERM FOLLOW-UP|1966-05-22|1965-02-04|||||1972-05-31||1962-06-05
TRIAL STUDY 134XCP|IS|2AF06F66-5E51-4AC9-AF62-A34329724F7D||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/G/DAY|||||YD||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|N|CRYOSCOPY|U|NA|Y||3||39||CONTINUATION TREATMENT|1962-08-31|1961-06-30|||||1967-06-10||1961-11-16
TRIAL STUDY 134XCP|IS|2AF06F66-5E51-4AC9-AF62-A34329724F7D||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PACK YEAR|||||WAFER||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|DRIED|U|CINEANGIOGRAPHY|NA|NA|U||4||88||CONTINUATION TREATMENT|1969-11-28|1969-06-17|||||1965-06-20||1964-08-03
TRIAL STUDY 134XCP|IS|2AF06F66-5E51-4AC9-AF62-A34329724F7D||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MET|||||TESLA||||NORMAL|NOT DONE|||ARTERIAL BLOOD|THAWED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|Y|N||5||7||LONG-TERM FOLLOW-UP|1973-01-23|1962-06-28|||||1972-01-24||1961-07-03
TRIAL STUDY 134XCP|IS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL|||||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE|||TUMOR TISSUE|SOLIDIFIED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|U|U|N||1||38||TREATMENT|1972-02-11|1963-03-30|||||1967-07-03||1969-05-28
TRIAL STUDY 134XCP|IS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CIGARETTE|||||UEQ/L||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|ICTERIC|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|N|NA|Y||2||58||CONTINUATION TREATMENT|1961-07-24|1964-07-30|||||1966-07-17||1966-12-19
TRIAL STUDY 134XCP|IS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PG/DL|||||S*KPA||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|ROOM TEMPERATURE|NA|NEXT GENERATION TARGETED SEQUENCING|N|U|U||3||39||FOLLOW-UP|1969-02-20|1962-01-31|||||1969-11-16||1971-08-16
TRIAL STUDY 134XCP|IS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KA_U/DL|||||WATT||||LOW|NOT DONE|||PLEURAL TISSUE|AGGLUTINATED|NA|CLIP|NA|U|Y||4||88||CONTINUATION TREATMENT|1960-01-06|1967-12-28|||||1971-10-06||1960-10-22
TRIAL STUDY 134XCP|IS|DAE5B7A9-FB1D-4743-B6A5-C05FFC9AF829||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LOG10 ELISA UNIT|||||UV*SEC||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|DRIED|Y|MALDI|N|NA|NA||5||7||LONG-TERM FOLLOW-UP|1972-11-18|1962-05-16|||||1967-02-09||1971-03-01
TRIAL STUDY 134XCP|IS|94F4C997-3114-4444-BF89-E762226AAC89||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NEBULE|||||ML||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|THAWED|U|IMMUNO-PET SCAN|U|N|Y||1||38||LONG-TERM FOLLOW-UP|1967-08-02|1972-01-19|||||1968-01-09||1969-06-27
TRIAL STUDY 134XCP|IS|94F4C997-3114-4444-BF89-E762226AAC89||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/H/MMOL|||||F||||ABNORMAL|NOT DONE|||CORD SERUM|LIPEMIC|N|PALM METHOD|U|Y|NA||2||58||BASELINE|1963-11-20|1962-06-05|||||1961-11-19||1963-09-16
TRIAL STUDY 134XCP|IS|94F4C997-3114-4444-BF89-E762226AAC89||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MJOULE/CM2|||||JAR||||NORMAL|NOT DONE|||MONOCYTE|AUTOLYZED|NA|DUCTOGRAPHY|Y|Y|NA||3||39||WASHOUT|1969-06-15|1965-09-15|||||1960-04-05||1962-07-23
TRIAL STUDY 134XCP|IS|94F4C997-3114-4444-BF89-E762226AAC89||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/KG/MIN|||||IU/G HB||||LOW|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|NA|FLOW CYTOMETRY|Y|Y|U||4||88||BASELINE|1970-11-28|1969-10-20|||||1963-03-08||1963-11-15
TRIAL STUDY 134XCP|IS|94F4C997-3114-4444-BF89-E762226AAC89||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BP|||||MOSM||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|FRESH|N|NEXT GENERATION SEQUENCING|NA|U|NA||5||7||FOLLOW-UP|1960-08-18|1966-01-29|||||1969-08-23||1970-05-24
TRIAL STUDY 134XCP|IS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SHOCK WAVE|||||KCAL/DAY||||HIGH|NOT DONE|||DERMAL TISSUE|ROOM TEMPERATURE|Y|BRDU CELLULAR PROLIFERATION ASSAY|NA|U|U||1||38||WASHOUT|1965-09-15|1965-06-03|||||1966-07-11||1970-11-27
TRIAL STUDY 134XCP|IS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/M2/MIN|||||HEP||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|N|U|U||2||58||RUN-IN|1966-09-25|1968-10-29|||||1969-12-11||1973-07-13
TRIAL STUDY 134XCP|IS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GBQ|||||PFU/DOSE||||ABNORMAL|NOT DONE|||BASAL TEAR|AGGLUTINATED|NA|COMPLEMENT FIXATION|N|NA|NA||3||39||LONG-TERM FOLLOW-UP|1972-01-27|1961-12-21|||||1966-02-07||1971-05-05
TRIAL STUDY 134XCP|IS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/S/M2|||||/10^4||||HIGH|NOT DONE|||INTERSTITIAL FLUID|AUTOLYZED|U|ANALYTICAL ULTRACENTRIFUGATION|U|Y|NA||4||88||OBSERVATION|1962-05-11|1972-03-27|||||1965-07-08||1965-07-10
TRIAL STUDY 134XCP|IS|5EBDAAC2-9202-4BE7-BD9A-7CCBBC963DB7||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TROCHE|||||MET||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|THAWED|N|TRANSMISSION ELECTRON MICROSCOPY|Y|U|N||5||7||RUN-IN|1961-07-02|1962-05-24|||||1970-03-30||1961-11-13
TRIAL STUDY 134XCP|IS|D20DE6F0-DA30-4453-8F80-61093BF046A6||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IU/KG|||||GBQ/MG||||NORMAL|NOT DONE|||BONE MARROW|UNEXPECTED ODOR|N|DYNAMIC LIGHT SCATTERING|N|N|NA||1||38||INDUCTION TREATMENT|1969-10-25|1971-10-24|||||1970-11-07||1969-01-18
TRIAL STUDY 134XCP|IS|D20DE6F0-DA30-4453-8F80-61093BF046A6||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UU/DL|||||AU/ML||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|GELLED|U|PET/SPECT SCAN|U|N|NA||2||58||FOLLOW-UP|1966-03-06|1967-06-26|||||1968-11-08||1961-05-27
TRIAL STUDY 134XCP|IS|D20DE6F0-DA30-4453-8F80-61093BF046A6||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||100 IU/ML|||||DNA COPIES/UG||||ABNORMAL|NOT DONE|||BONE|GELLED|Y|KLEIHAUER-BETKE|N|N|NA||3||39||RUN-IN|1963-11-16|1973-05-28|||||1969-10-11||1962-09-15
TRIAL STUDY 134XCP|IS|D20DE6F0-DA30-4453-8F80-61093BF046A6||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MIN/DAY|||||PM||||HIGH|NOT DONE|||LEUKOCYTE|REFRIGERATED|N|CONTRAST ENHANCED X-RAY|U|NA|Y||4||88||RUN-IN|1965-06-24|1969-01-11|||||1972-07-29||1966-09-01
TRIAL STUDY 134XCP|IS|D20DE6F0-DA30-4453-8F80-61093BF046A6||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIXEL|||||MJOULE/CM2||||HIGH|NOT DONE|||EXUDATE|DRIED|NA|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|N|Y|U||5||7||FOLLOW-UP|1967-05-26|1973-08-23|||||1966-11-25||1972-02-06
TRIAL STUDY 134XCP|IS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MCI|||||IU||||NORMAL|NOT DONE|||BREAST MILK|ICTERIC|N|IMMUNO-PET SCAN|U|N|Y||1||38||BLINDED TREATMENT|1961-07-02|1969-11-13|||||1961-05-01||1966-01-14
TRIAL STUDY 134XCP|IS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/ANIMAL|||||ML/M2/H||||LOW|NOT DONE|||CERUMEN|NON-HEMOLYZED|Y|RYAN BLUE STAIN|NA|Y|NA||2||58||BASELINE|1966-05-30|1961-09-20|||||1971-12-28||1968-03-07
TRIAL STUDY 134XCP|IS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||RAD|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FROZEN|U|FARR ASSAY|NA|Y|NA||3||39||TREATMENT|1972-01-01|1960-04-02|||||1972-12-15||1960-07-15
TRIAL STUDY 134XCP|IS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||P|||||ML/100G/MIN||||LOW|NOT DONE|||EPIDERMAL TISSUE|LACTESCENT|N|FLOW CYTOMETRY|NA|NA|NA||4||88||BASELINE|1967-07-04|1964-11-23|||||1962-05-19||1973-08-21
TRIAL STUDY 134XCP|IS|9F6968CB-46E4-4DF7-B07D-33355B18A5F3||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GBQ/MG|||||DDU||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|NA|CAPILLARY ELECTROPHORESIS|NA|N|NA||5||7||SCREENING|1966-10-25|1960-07-15|||||1966-06-27||1960-03-19
TRIAL STUDY 134XCP|IS|F20939CF-C668-4514-A2CF-63723560FA46||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||YD|||||WEEKS||||ABNORMAL|NOT DONE|||SEMEN|CLOTTED|Y|PALM METHOD|U|NA|N||1||38||FOLLOW-UP|1967-02-03|1964-02-20|||||1962-05-27||1973-07-16
TRIAL STUDY 134XCP|IS|F20939CF-C668-4514-A2CF-63723560FA46||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MCI/L|||||P||||HIGH|NOT DONE|||VENOUS CORD BLOOD|PARAFFIN-EMBEDDED|U|OPTICAL MAPPING|NA|N|N||2||58||LONG-TERM FOLLOW-UP|1971-02-18|1960-09-23|||||1973-02-03||1969-05-14
TRIAL STUDY 134XCP|IS|F20939CF-C668-4514-A2CF-63723560FA46||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VOXEL|||||SIEMENS||||LOW|NOT DONE|||PLATELET RICH PLASMA|CLOTTED|Y|THERMAL IONIZATION MASS SPECTROMETRY|NA|Y|U||3||39||OBSERVATION|1962-11-26|1962-05-17|||||1962-07-15||1965-09-10
TRIAL STUDY 134XCP|IS|F20939CF-C668-4514-A2CF-63723560FA46||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||EQ|||||GENEQ/ML||||NORMAL|NOT DONE|||TISSUE|LACTESCENT|U|FLUORESCENT IMMUNOASSAY|Y|Y|N||4||88||SCREENING|1967-11-19|1968-02-04|||||1971-05-02||1972-11-15
TRIAL STUDY 134XCP|IS|F20939CF-C668-4514-A2CF-63723560FA46||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^3 COPIES/ML|||||TORR||||LOW|NOT DONE|||SWABBED MATERIAL|SOLIDIFIED|NA|SPECT/CT SCAN|N|N|U||5||7||FOLLOW-UP|1973-03-10|1960-06-28|||||1963-04-29||1966-07-02
TRIAL STUDY 134XCP|IS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG/MOL|||||IU/KG/H||||HIGH|NOT DONE|||VENOUS PLASMA|HEMOLYZED|N|TELLER ACUITY CARDS|NA|NA|Y||1||38||BLINDED TREATMENT|1967-02-09|1967-07-28|||||1970-09-23||1968-06-26
TRIAL STUDY 134XCP|IS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KG/MOL|||||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|AGGLUTINATED|U|MICROBIAL CULTURE, SOLID|N|N|U||2||58||BASELINE|1968-11-25|1969-12-27|||||1972-09-13||1969-06-04
TRIAL STUDY 134XCP|IS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CI/UL|||||MIN/DAY||||LOW|NOT DONE|||DIALYSIS FLUID|CALCIFIED|NA|EPSILOMETER|NA|Y|U||3||39||RUN-IN|1963-05-31|1971-11-20|||||1973-08-09||1961-09-28
TRIAL STUDY 134XCP|IS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NG|||||UG/ANIMAL||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|FROZEN|Y|CONTRAST ENHANCED MRI|NA|NA|N||4||88||OPEN LABEL TREATMENT|1964-07-13|1970-11-27|||||1962-02-04||1972-12-26
TRIAL STUDY 134XCP|IS|CECB0ED0-5ADE-46DC-B56B-6AC63A89D791||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/DAY|||||CONTAINER||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|CONTAMINATED|U|FLOW CYTOMETRY|N|N|NA||5||7||INDUCTION TREATMENT|1972-02-10|1962-05-10|||||1973-04-01||1968-04-11
TRIAL STUDY 134XCP|IS|9A60A414-54A0-4A7F-84EE-FCB8246D2477||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MKAT|||||SHOCK WAVE||||LOW|NOT DONE|||EMESIS|CALCIFIED|U|TOTAL BODY RADIOGRAPHY|U|Y|N||1||38||OBSERVATION|1968-07-08|1965-07-27|||||1962-02-01||1966-02-09
TRIAL STUDY 134XCP|IS|9A60A414-54A0-4A7F-84EE-FCB8246D2477||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KM|||||LOG10 TCID 50/ML||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|LIPEMIC|U|CONTACT SPECULAR MICROSCOPY|NA|NA|Y||2||58||OBSERVATION|1968-01-02|1972-05-21|||||1972-07-08||1973-01-06
TRIAL STUDY 134XCP|IS|9A60A414-54A0-4A7F-84EE-FCB8246D2477||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/DOSE|||||10^6 IU/ML||||LOW|NOT DONE|||KERATINOCYTE|FRESH|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|U|N|NA||3||39||OPEN LABEL TREATMENT|1967-07-10|1966-10-20|||||1965-01-21||1964-01-30
TRIAL STUDY 134XCP|IS|9A60A414-54A0-4A7F-84EE-FCB8246D2477||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GMFI|||||10^6 RNA COPIES/ML||||LOW|NOT DONE|||DERMAL TISSUE|LACTESCENT|NA|REBOUND TONOMETRY|Y|NA|U||4||88||OPEN LABEL TREATMENT|1969-01-07|1970-06-01|||||1972-06-04||1964-10-03
TRIAL STUDY 134XCP|IS|9A60A414-54A0-4A7F-84EE-FCB8246D2477||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DAYS|||||NG/DL||||LOW|NOT DONE|||VITREOUS HUMOR|LACTESCENT|NA|SECONDARY ION MASS SPECTOMETRY|N|NA|U||5||7||INDUCTION TREATMENT|1961-06-05|1968-02-10|||||1973-02-28||1972-01-19
TRIAL STUDY 134XCP|IS|8D546F1C-E719-4C03-A66A-9916EFF2A144||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/DOSE|||||GPL U||||ABNORMAL|NOT DONE|||LYSATE|LIPEMIC|NA|HPLC|Y|Y|N||1||38||OPEN LABEL TREATMENT|1973-05-20|1960-09-18|||||1962-10-17||1963-08-15
TRIAL STUDY 134XCP|IS|8D546F1C-E719-4C03-A66A-9916EFF2A144||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MU/G|||||G/DL||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|NON-HEMOLYZED|NA|MICROBIAL CULTURE, SOLID|N|U|Y||2||58||LONG-TERM FOLLOW-UP|1964-09-08|1970-08-22|||||1964-04-05||1972-12-26
TRIAL STUDY 134XCP|IS|8D546F1C-E719-4C03-A66A-9916EFF2A144||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||OHM|||||NL||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|CONCENTRATED|NA|THERMAL IONIZATION MASS SPECTROMETRY|NA|U|NA||3||39||SCREENING|1963-03-10|1965-12-19|||||1969-07-13||1966-01-19
TRIAL STUDY 134XCP|IS|8D546F1C-E719-4C03-A66A-9916EFF2A144||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^4 CFU/ML|||||BREATHS/MIN||||NORMAL|NOT DONE|||MONOCYTE|ICTERIC|N|CLIP|N|NA|Y||4||88||BASELINE|1967-10-28|1962-04-06|||||1960-01-22||1970-05-14
TRIAL STUDY 134XCP|IS|8D546F1C-E719-4C03-A66A-9916EFF2A144||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||STEPS/MIN|||||DIP||||NORMAL|NOT DONE|||SWABBED MATERIAL|DRIED|U|DUCTOGRAPHY|NA|U|NA||5||7||WASHOUT|1973-08-25|1966-07-20|||||1963-09-28||1966-12-20
TRIAL STUDY 134XCP|IS|B998085D-F227-46C8-B2D8-37E97BA799D2||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^9/G|||||UMOL/L||||ABNORMAL|NOT DONE|||MIXED VENOUS BLOOD|AGGLUTINATED|Y|POLYGRAPHY|N|Y|NA||1||38||SCREENING|1960-10-16|1966-07-19|||||1968-03-30||1961-09-18
TRIAL STUDY 134XCP|IS|B998085D-F227-46C8-B2D8-37E97BA799D2||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MM/SEC|||||PIXELS/CM||||HIGH|NOT DONE|||EPIDERMAL TISSUE|FRESH|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|U||2||58||CONTINUATION TREATMENT|1968-03-20|1964-05-10|||||1972-10-24||1964-08-19
TRIAL STUDY 134XCP|IS|B998085D-F227-46C8-B2D8-37E97BA799D2||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PFU/ANIMAL|||||ELISA UNIT||||ABNORMAL|NOT DONE|||CERUMEN|CONCENTRATED|Y|FLUORESCENT IMMUNOASSAY|U|N|U||3||39||INDUCTION TREATMENT|1962-01-05|1960-10-16|||||1966-01-12||1973-05-28
TRIAL STUDY 134XCP|IS|B998085D-F227-46C8-B2D8-37E97BA799D2||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/(MIN*100ML)|||||MASK||||HIGH|NOT DONE|||MUSCLE TISSUE|ICTERIC|Y|MYELOPEROXIDASE STAIN|U|U|U||4||88||WASHOUT|1965-01-03|1966-10-16|||||1967-01-08||1965-11-13
TRIAL STUDY 134XCP|IS|B998085D-F227-46C8-B2D8-37E97BA799D2||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMU/ML|||||PMOL||||NORMAL|NOT DONE|||SKIN TISSUE|REFRIGERATED|N|LASER CAPTURE MICRODISSECTION|NA|Y|U||5||7||OBSERVATION|1963-08-22|1965-02-10|||||1961-10-21||1967-01-07
TRIAL STUDY 134XCP|IS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||COPIES/UG|||||LOZENGE||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|AUTOLYZED|N|WESTERN BLOT|NA|N|NA||1||38||INDUCTION TREATMENT|1970-07-15|1961-05-01|||||1964-10-20||1969-01-22
TRIAL STUDY 134XCP|IS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PFU|||||MSEC||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|AGGLUTINATED|U|IMMUNOASSAY|Y|Y|NA||2||58||CONTINUATION TREATMENT|1968-12-16|1966-04-04|||||1966-03-15||1972-10-15
TRIAL STUDY 134XCP|IS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MM/H|||||CL||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|REFRIGERATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|Y|Y||3||39||TREATMENT|1970-09-23|1971-05-18|||||1971-04-19||1972-04-07
TRIAL STUDY 134XCP|IS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/G/H|||||IU/KG||||LOW|NOT DONE|||DERMAL TISSUE|GELLED|N|GC/MS-EI|U|U|Y||4||88||SCREENING|1967-11-21|1972-12-12|||||1963-02-20||1970-04-09
TRIAL STUDY 134XCP|IS|DDAF2BC7-9329-4528-B1D5-00C8E0D284D9||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MASK|||||UG/L DDU||||LOW|NOT DONE|||SUPERNATANT, SERUM|THAWED|Y|CLAUSS METHOD|N|N|N||5||7||WASHOUT|1968-04-23|1965-05-20|||||1972-07-24||1968-07-06
TRIAL STUDY 134XCP|IS|537CE647-EA58-430C-B37B-F56BF20B5AF0||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GRAVITATIONAL UNIT|||||U/M2||||HIGH|NOT DONE|||SPERMATOZOON|NON-HEMOLYZED|Y|EEG|NA|U|U||1||38||INDUCTION TREATMENT|1964-02-21|1968-07-30|||||1973-05-13||1971-06-18
TRIAL STUDY 134XCP|IS|537CE647-EA58-430C-B37B-F56BF20B5AF0||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BE/ML|||||UG/ML/H||||LOW|NOT DONE|||BILE|THAWED|Y|ICP-MS|U|Y|Y||2||58||RUN-IN|1966-11-29|1973-07-12|||||1965-11-14||1972-01-25
TRIAL STUDY 134XCP|IS|537CE647-EA58-430C-B37B-F56BF20B5AF0||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PPM|||||JAR||||LOW|NOT DONE|||PLEURAL TISSUE|ROOM TEMPERATURE|U|FISH|Y|NA|Y||3||39||INDUCTION TREATMENT|1964-01-14|1971-03-28|||||1968-06-01||1972-03-30
TRIAL STUDY 134XCP|IS|537CE647-EA58-430C-B37B-F56BF20B5AF0||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PIXELS/CM|||||G/ANIMAL/WK||||HIGH|NOT DONE|||LOCHIA|AGGLUTINATED|NA|CHROMATOGRAPHY|NA|NA|U||4||88||CONTINUATION TREATMENT|1961-01-17|1963-06-05|||||1964-06-26||1960-07-03
TRIAL STUDY 134XCP|IS|537CE647-EA58-430C-B37B-F56BF20B5AF0||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/M2/MIN|||||MMOL/L||||NORMAL|NOT DONE|||PERITONEAL FLUID|GELLED|NA|DXA SCAN|U|U|N||5||7||TREATMENT|1971-03-10|1961-07-04|||||1972-09-26||1968-10-28
TRIAL STUDY 134XCP|IS|3464201C-9704-40B6-B3B3-2BADE02BD58F||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/ML/DAY|||||DPM/0.5 ML||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|ICTERIC|NA|DC SHEATH FLOW|U|U|U||1||38||TREATMENT|1965-02-07|1967-07-03|||||1962-12-04||1962-03-01
TRIAL STUDY 134XCP|IS|3464201C-9704-40B6-B3B3-2BADE02BD58F||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6 DNA COPIES/ML|||||DEG||||ABNORMAL|NOT DONE|||MONOCYTE|LIPEMIC|U|PERCUSSION|NA|U|U||2||58||SCREENING|1966-11-21|1961-10-13|||||1969-03-08||1971-07-25
TRIAL STUDY 134XCP|IS|3464201C-9704-40B6-B3B3-2BADE02BD58F||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMOL/MOL|||||MPH||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|FRESH|Y|MICROBIAL CONCENTRATION|NA|U|U||3||39||OPEN LABEL TREATMENT|1964-03-20|1967-02-02|||||1968-12-14||1972-03-02
TRIAL STUDY 134XCP|IS|3464201C-9704-40B6-B3B3-2BADE02BD58F||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ENZYME U/L|||||CM2||||NORMAL|NOT DONE|||LOCHIA|NON-HEMOLYZED|N|SECONDARY ION MASS SPECTOMETRY|Y|U|NA||4||88||OPEN LABEL TREATMENT|1966-07-14|1972-01-15|||||1961-01-19||1965-06-28
TRIAL STUDY 134XCP|IS|3464201C-9704-40B6-B3B3-2BADE02BD58F||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ARBITRARY U|||||MMHG*MIN/L||||ABNORMAL|NOT DONE|||BONE MARROW|LACTESCENT|N|IN VITRO GENE EXPRESSION ASSAY|NA|Y|U||5||7||OPEN LABEL TREATMENT|1971-01-05|1969-09-12|||||1964-01-28||1963-07-25
TRIAL STUDY 134XCP|IS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CS|||||/H||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|THAWED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|NA|N||1||38||SCREENING|1962-11-07|1969-06-11|||||1970-06-19||1967-06-24
TRIAL STUDY 134XCP|IS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MM3/MM2/YEAR|||||APS U||||NORMAL|NOT DONE|||TISSUE|HEMOLYZED|Y|ACCELERATOR MASS SPECTROMETRY|U|U|U||2||58||CONTINUATION TREATMENT|1967-12-25|1969-05-08|||||1963-09-27||1960-07-05
TRIAL STUDY 134XCP|IS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NG/DAY|||||%||||ABNORMAL|NOT DONE|||URINE SEDIMENT|DRIED|NA|MRI|NA|Y|U||3||39||OPEN LABEL TREATMENT|1960-01-06|1966-06-27|||||1971-05-30||1960-08-08
TRIAL STUDY 134XCP|IS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PACKAGE|||||MMOL/G||||NORMAL|NOT DONE|||PUS|AUTOLYZED|NA|HEMAGGLUTINATION ASSAY|N|U|N||4||88||OPEN LABEL TREATMENT|1961-09-20|1969-08-16|||||1971-03-24||1962-07-18
TRIAL STUDY 134XCP|IS|1CB9F8AF-8CC3-44B2-8B93-24CADF4225C7||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FIU|||||MEQ/UG||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|SIZE EXCLUSION CHROMATOGRAPHY|Y|NA|U||5||7||BLINDED TREATMENT|1961-02-17|1962-11-07|||||1961-04-06||1969-09-21
TRIAL STUDY 134XCP|IS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/G/H|||||CIGAR||||NORMAL|NOT DONE|||LAVAGE FLUID|CONCENTRATED|N|ACCELERATOR MASS SPECTROMETRY|N|N|U||1||38||RUN-IN|1966-08-25|1966-11-14|||||1968-01-01||1967-03-19
TRIAL STUDY 134XCP|IS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KAT|||||UL||||ABNORMAL|NOT DONE|||BREAST MILK|HEMOLYZED|N|OBSERVATION|U|Y|U||2||58||TREATMENT|1961-06-18|1960-05-24|||||1961-02-21||1961-05-07
TRIAL STUDY 134XCP|IS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML*CMH2O|||||CM/S||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|NA|ALCIAN BLUE STAIN|NA|N|NA||3||39||OBSERVATION|1971-08-05|1970-07-22|||||1969-06-12||1966-10-14
TRIAL STUDY 134XCP|IS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FRACTION OF 1|||||M/SEC2||||HIGH|NOT DONE|||CORD BLOOD|AGGLUTINATED|NA|MICRO BROTH DILUTION|U|N|Y||4||88||TREATMENT|1968-12-03|1963-10-02|||||1964-07-01||1972-08-01
TRIAL STUDY 134XCP|IS|7E66F52C-0967-4F56-9E1D-C3C3DC7F76FB||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PG|||||MOL/DAY||||ABNORMAL|NOT DONE|||EXUDATE|CONTAMINATED|U|MULTIPLE BREATH WASHOUT|N|Y|U||5||7||BLINDED TREATMENT|1969-12-18|1967-01-27|||||1965-09-18||1960-08-17
TRIAL STUDY 134XCP|IS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UIU/L|||||UV2||||NORMAL|NOT DONE|||BONE|LIPEMIC|U|CONTRAST ENHANCED X-RAY|N|Y|U||1||38||INDUCTION TREATMENT|1964-10-28|1969-05-14|||||1963-09-04||1962-11-03
TRIAL STUDY 134XCP|IS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MPH|||||CAPSULE||||LOW|NOT DONE|||DISCHARGE|ROOM TEMPERATURE|U|TOLUIDINE BLUE STAIN|Y|U|N||2||58||FOLLOW-UP|1973-03-06|1963-03-27|||||1963-07-31||1970-11-21
TRIAL STUDY 134XCP|IS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/CAGE/WK|||||ML/G/MIN||||NORMAL|NOT DONE|||VITREOUS HUMOR|DRIED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|U||3||39||OBSERVATION|1969-12-18|1966-04-14|||||1961-04-25||1961-06-13
TRIAL STUDY 134XCP|IS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CMH2O/ML|||||DRAM||||LOW|NOT DONE|||PERSPIRATION|FRESH|NA|DIGITAL PCR|Y|NA|N||4||88||OBSERVATION|1965-06-19|1962-12-04|||||1970-07-05||1963-09-16
TRIAL STUDY 134XCP|IS|916EA783-F2CD-4C42-BA37-EF0F86C2F5DD||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/M2|||||/KG||||NORMAL|NOT DONE|||SPUTUM|UNEXPECTED ODOR|NA|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|NA|N||5||7||RUN-IN|1961-11-06|1965-11-23|||||1972-12-03||1964-07-14
TRIAL STUDY 134XCP|IS|11A6144A-895B-4143-85D2-69952C6D452C||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||INHALATION|||||G/CM2||||LOW|NOT DONE|||CAPILLARY PLASMA|CONTAMINATED|NA|STRESS ECHOCARDIOGRAPHY|U|Y|N||1||38||WASHOUT|1964-08-23|1968-05-07|||||1962-09-02||1968-07-20
TRIAL STUDY 134XCP|IS|11A6144A-895B-4143-85D2-69952C6D452C||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GAUSS|||||VG/KG||||HIGH|NOT DONE|||FLUID|NON-HEMOLYZED|N|PHYSICAL EXAMINATION|NA|N|Y||2||58||LONG-TERM FOLLOW-UP|1963-04-24|1961-05-25|||||1960-11-06||1961-03-15
TRIAL STUDY 134XCP|IS|11A6144A-895B-4143-85D2-69952C6D452C||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||YEARS|||||ML/MMHG||||LOW|NOT DONE|||GASTRIC FLUID|FRESH|N|MICROSCOPY|U|NA|U||3||39||OBSERVATION|1963-09-15|1963-07-18|||||1963-08-23||1969-09-18
TRIAL STUDY 134XCP|IS|11A6144A-895B-4143-85D2-69952C6D452C||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LOG10 PFU/ML|||||KEV||||HIGH|NOT DONE|||LAVAGE FLUID|CALCIFIED|NA|FUNCTIONAL MRI|N|U|NA||4||88||CONTINUATION TREATMENT|1966-04-09|1973-06-21|||||1960-01-05||1960-02-14
TRIAL STUDY 134XCP|IS|11A6144A-895B-4143-85D2-69952C6D452C||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/ML/DAY|||||WEBER||||LOW|NOT DONE|||URINE|CALCIFIED|N|ULTRASOUND|NA|Y|U||5||7||OBSERVATION|1972-01-10|1968-06-13|||||1970-10-21||1967-08-01
TRIAL STUDY 134XCP|IS|8958D35E-F685-4542-AE01-625133F1EF7D||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/KG/MIN|||||10^6 IU||||HIGH|NOT DONE|||SALIVA|UNEXPECTED ODOR|Y|ENDPOINT DILUTION ASSAY|N|Y|N||1||38||OBSERVATION|1965-01-14|1969-08-27|||||1969-09-22||1964-05-28
TRIAL STUDY 134XCP|IS|8958D35E-F685-4542-AE01-625133F1EF7D||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||WEEKS|||||CMH2O/ML||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|CONTAMINATED|Y|SLIT LAMP|U|U|NA||2||58||WASHOUT|1961-04-29|1969-08-20|||||1962-09-22||1971-11-14
TRIAL STUDY 134XCP|IS|8958D35E-F685-4542-AE01-625133F1EF7D||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BQ/UL|||||MMOL/G||||LOW|NOT DONE|||ARTERIAL BLOOD|HEMOLYZED|U|DROPLET DIGITAL PCR|Y|U|U||3||39||FOLLOW-UP|1963-09-18|1973-01-30|||||1966-08-01||1973-03-09
TRIAL STUDY 134XCP|IS|8958D35E-F685-4542-AE01-625133F1EF7D||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/L|||||G/ANIMAL/WK||||HIGH|NOT DONE|||SPERMATOZOON|HEMOLYZED|N|CONTRAST ENHANCED PET/CT SCAN|NA|NA|Y||4||88||BASELINE|1968-02-01|1968-07-24|||||1964-03-20||1966-06-11
TRIAL STUDY 134XCP|IS|8958D35E-F685-4542-AE01-625133F1EF7D||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NCI|||||UMOL/MOL||||LOW|NOT DONE|||PLATELET|CLOTTED|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|Y|U||5||7||CONTINUATION TREATMENT|1973-06-14|1967-07-23|||||1971-08-28||1968-01-03
TRIAL STUDY 134XCP|IS|00982640-C826-4CD4-B927-A311227E63CC||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/CAGE/DAY|||||SCM||||NORMAL|NOT DONE|||SKIN TISSUE|REFRIGERATED|NA|X-RAY|U|N|Y||1||38||BASELINE|1962-01-05|1973-06-20|||||1964-01-11||1964-06-19
TRIAL STUDY 134XCP|IS|00982640-C826-4CD4-B927-A311227E63CC||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KM/H|||||10^6 CFU/ML||||HIGH|NOT DONE|||SEMEN|AGGLUTINATED|U|REVERSE TRANSCRIPTASE PCR|U|N|U||2||58||WASHOUT|1966-11-16|1971-04-10|||||1964-05-26||1967-09-03
TRIAL STUDY 134XCP|IS|00982640-C826-4CD4-B927-A311227E63CC||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DAMOL/L|||||UG/G/H||||LOW|NOT DONE|||ADIPOSE TISSUE|LIPEMIC|N|DXA SCAN|NA|N|Y||3||39||RUN-IN|1964-11-25|1966-01-06|||||1966-09-21||1963-10-18
TRIAL STUDY 134XCP|IS|00982640-C826-4CD4-B927-A311227E63CC||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BU/ML|||||COAT||||HIGH|NOT DONE|||EPIDERMAL TISSUE|HEMOLYZED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|U|Y|N||4||88||OBSERVATION|1963-07-22|1960-10-26|||||1962-04-22||1969-03-09
TRIAL STUDY 134XCP|IS|00982640-C826-4CD4-B927-A311227E63CC||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^9/G|||||MMOL/MIN/KPA||||HIGH|NOT DONE|||BLOOD|AGGLUTINATED|NA|ORCHIDOMETERY|NA|U|Y||5||7||INDUCTION TREATMENT|1964-04-18|1965-04-12|||||1970-12-09||1970-06-30
TRIAL STUDY 134XCP|IS|C213CAA8-2FAC-402C-A19E-11A60708A71A||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DB|||||DL||||LOW|NOT DONE|||CAPILLARY BLOOD|THAWED|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|N|N|N||1||38||TREATMENT|1966-11-02|1967-06-09|||||1969-01-08||1966-04-12
TRIAL STUDY 134XCP|IS|C213CAA8-2FAC-402C-A19E-11A60708A71A||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||OSM|||||HZ/S||||ABNORMAL|NOT DONE|||TISSUE|SOLIDIFIED|NA|TARGETED GENOME SEQUENCING|Y|N|N||2||58||OPEN LABEL TREATMENT|1963-09-14|1964-11-24|||||1972-08-17||1962-02-21
TRIAL STUDY 134XCP|IS|C213CAA8-2FAC-402C-A19E-11A60708A71A||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||L/H/M2|||||MMHG/SEC||||ABNORMAL|NOT DONE|||SPUTUM|ROOM TEMPERATURE|NA|TRANSVAGINAL ULTRASOUND|NA|U|N||3||39||CONTINUATION TREATMENT|1960-05-19|1963-10-12|||||1969-07-19||1972-06-08
TRIAL STUDY 134XCP|IS|C213CAA8-2FAC-402C-A19E-11A60708A71A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ROENTGEN|||||MU/L||||HIGH|NOT DONE|||HAIR|UNEXPECTED ODOR|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|U|N|N||4||88||INDUCTION TREATMENT|1967-08-28|1966-05-29|||||1962-12-09||1966-12-17
TRIAL STUDY 134XCP|IS|C213CAA8-2FAC-402C-A19E-11A60708A71A||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||% INHIBITION|||||CI/MG||||HIGH|NOT DONE|||VENOUS PLASMA|THAWED|U|TELLER ACUITY CARDS|U|U|N||5||7||TREATMENT|1963-02-19|1960-03-01|||||1967-07-10||1960-02-11
TRIAL STUDY 134XCP|IS|F0559682-CD36-4ED0-8082-A54D40305512||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MM/MIN|||||AFU||||NORMAL|NOT DONE|||KERATINOCYTE|UNEXPECTED ODOR|N|GIEMSA STAIN|Y|NA|Y||1||38||OBSERVATION|1965-04-01|1962-01-26|||||1965-02-14||1964-07-18
TRIAL STUDY 134XCP|IS|F0559682-CD36-4ED0-8082-A54D40305512||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/M2|||||PIXELS/IN||||NORMAL|NOT DONE|||DISCHARGE|ROOM TEMPERATURE|NA|TOLUIDINE BLUE STAIN|Y|NA|NA||2||58||BASELINE|1968-09-05|1963-08-29|||||1960-06-26||1966-07-09
TRIAL STUDY 134XCP|IS|F0559682-CD36-4ED0-8082-A54D40305512||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||S*KPA|||||HOMEOPATHIC DILUTION||||HIGH|NOT DONE|||BUFFY COAT|DRIED|N|CARDIAC THERMODILUTION|U|NA|N||3||39||CONTINUATION TREATMENT|1971-08-04|1968-01-11|||||1970-04-15||1971-04-05
TRIAL STUDY 134XCP|IS|F0559682-CD36-4ED0-8082-A54D40305512||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MM|||||NMOL/KG/DAY||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|AGGLUTINATED|N|CALCULATION|NA|Y|N||4||88||RUN-IN|1961-02-12|1966-05-11|||||1964-10-24||1967-07-19
TRIAL STUDY 134XCP|IS|F0559682-CD36-4ED0-8082-A54D40305512||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^5/HPF|||||ELISA UNIT||||NORMAL|NOT DONE|||SEMINAL FLUID|HEMOLYZED|NA|IMMUNOPRECIPITATION|NA|Y|U||5||7||INDUCTION TREATMENT|1967-12-26|1972-01-27|||||1960-07-18||1962-03-18
TRIAL STUDY 134XCP|IS|C004A4D5-DBD0-4967-9597-8C1653AB8298||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/KG/H|||||VIRTUAL PIXEL||||HIGH|NOT DONE|||SOFT TISSUE|SOLIDIFIED|NA|PULSE OXIMETRY|Y|Y|Y||1||38||WASHOUT|1971-02-25|1970-12-06|||||1963-11-08||1964-08-20
TRIAL STUDY 134XCP|IS|C004A4D5-DBD0-4967-9597-8C1653AB8298||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/CM2|||||CIGARETTE||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|CLOTTED|U|CELL OF ORIGIN ASSAY|U|N|U||2||58||FOLLOW-UP|1964-12-09|1964-11-25|||||1970-09-09||1965-02-09
TRIAL STUDY 134XCP|IS|C004A4D5-DBD0-4967-9597-8C1653AB8298||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 CFU|||||JDF UNIT||||LOW|NOT DONE|||AQUEOUS HUMOR|PARAFFIN-EMBEDDED|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NA|Y|Y||3||39||OPEN LABEL TREATMENT|1967-07-26|1967-06-21|||||1963-01-16||1968-08-03
TRIAL STUDY 134XCP|IS|C004A4D5-DBD0-4967-9597-8C1653AB8298||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||M|||||GPL U||||LOW|NOT DONE|||EMOTIONAL TEAR|LIPEMIC|N|FLUORESCENCE ANGIOGRAPHY|NA|N|NA||4||88||RUN-IN|1969-08-10|1963-05-27|||||1973-06-01||1964-01-23
TRIAL STUDY 134XCP|IS|C004A4D5-DBD0-4967-9597-8C1653AB8298||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/DAY|||||G/ANIMAL/WK||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|FRESH|Y|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|Y|N||5||7||OBSERVATION|1964-10-21|1967-04-28|||||1969-05-22||1970-05-24
TRIAL STUDY 134XCP|IS|ABB838A1-2387-471E-8F50-1F48205BC8EE||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/M2|||||MMOL/G||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|GELLED|NA|SCANNING ELECTRON MICROSCOPY|NA|N|N||1||38||INDUCTION TREATMENT|1965-08-16|1973-06-13|||||1972-12-13||1969-12-07
TRIAL STUDY 134XCP|IS|ABB838A1-2387-471E-8F50-1F48205BC8EE||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MN|||||NEBULE||||NORMAL|NOT DONE|||CELL PELLET|CALCIFIED|N|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|U|U|NA||2||58||CONTINUATION TREATMENT|1960-03-11|1966-04-13|||||1965-06-08||1967-10-22
TRIAL STUDY 134XCP|IS|ABB838A1-2387-471E-8F50-1F48205BC8EE||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/MIN|||||PG/DL||||LOW|NOT DONE|||TISSUE|REFRIGERATED|Y|RADIOGRAPHY|U|NA|NA||3||39||CONTINUATION TREATMENT|1967-11-20|1972-01-04|||||1961-03-20||1970-02-28
TRIAL STUDY 134XCP|IS|ABB838A1-2387-471E-8F50-1F48205BC8EE||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MBQ/UL|||||TUBERCULIN UNIT||||NORMAL|NOT DONE|||EMOTIONAL TEAR|CALCIFIED|Y|GC/FID|NA|U|Y||4||88||RUN-IN|1973-04-01|1965-06-22|||||1972-05-20||1970-12-23
TRIAL STUDY 134XCP|IS|ABB838A1-2387-471E-8F50-1F48205BC8EE||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||100 IU/ML|||||ECL UNIT||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|THAWED|Y|DC SHEATH FLOW|Y|U|U||5||7||OPEN LABEL TREATMENT|1970-08-04|1964-08-04|||||1972-12-16||1960-08-05
TRIAL STUDY 134XCP|IS|88126417-8564-4659-AA60-63642067113D||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MCI/KG|||||RAD||||HIGH|NOT DONE|||SEMINAL FLUID|DRIED|N|SICKLE CELL SOLUBILITY TEST|N|N|Y||1||38||SCREENING|1960-07-26|1965-03-09|||||1963-06-20||1968-01-25
TRIAL STUDY 134XCP|IS|88126417-8564-4659-AA60-63642067113D||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CD*S/M2|||||NG/L||||ABNORMAL|NOT DONE|||SERUM|PARAFFIN-EMBEDDED|NA|AUSCULTATION|Y|NA|Y||2||58||CONTINUATION TREATMENT|1968-06-07|1960-11-28|||||1964-12-06||1969-12-27
TRIAL STUDY 134XCP|IS|88126417-8564-4659-AA60-63642067113D||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||OZ EQ|||||PM||||ABNORMAL|NOT DONE|||LYMPH|PARAFFIN-EMBEDDED|Y|IODINE STAIN|Y|Y|U||3||39||LONG-TERM FOLLOW-UP|1962-09-13|1960-04-20|||||1967-09-03||1965-12-18
TRIAL STUDY 134XCP|IS|88126417-8564-4659-AA60-63642067113D||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TRACE|||||NM||||LOW|NOT DONE|||PERSPIRATION|DRIED|NA|AUTOREFRACTION|NA|N|NA||4||88||TREATMENT|1966-12-10|1964-12-02|||||1966-07-04||1966-08-18
TRIAL STUDY 134XCP|IS|88126417-8564-4659-AA60-63642067113D||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7/L|||||CM||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|U|PATHOLOGICAL EVALUATION|N|U|NA||5||7||INDUCTION TREATMENT|1971-02-27|1964-12-29|||||1968-03-16||1967-02-18
TRIAL STUDY 134XCP|IS|6ADA444E-F1B4-4E59-9F2D-26DC78845397||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/WK|||||CD||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|NA|CYSTOSCOPY|U|N|Y||1||38||LONG-TERM FOLLOW-UP|1968-04-26|1968-10-10|||||1968-04-01||1961-03-05
TRIAL STUDY 134XCP|IS|6ADA444E-F1B4-4E59-9F2D-26DC78845397||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GTT|||||MG/ANIMAL||||LOW|NOT DONE|||PERSPIRATION|CONTAMINATED|U|REFLECTANCE SPECTROSCOPY|U|U|NA||2||58||BLINDED TREATMENT|1968-01-12|1966-10-13|||||1972-09-27||1961-09-26
TRIAL STUDY 134XCP|IS|6ADA444E-F1B4-4E59-9F2D-26DC78845397||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VIAL|||||U/MG||||LOW|NOT DONE|||ARTERIAL BLOOD|GELLED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|U|U|U||3||39||SCREENING|1972-05-17|1970-11-27|||||1969-11-24||1962-02-06
TRIAL STUDY 134XCP|IS|6ADA444E-F1B4-4E59-9F2D-26DC78845397||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MIN/KPA/L|||||ML/CM||||ABNORMAL|NOT DONE|||CORD BLOOD|FROZEN|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|U|U|Y||4||88||TREATMENT|1962-10-13|1960-02-28|||||1973-07-29||1963-04-20
TRIAL STUDY 134XCP|IS|6ADA444E-F1B4-4E59-9F2D-26DC78845397||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/M2/DAY|||||MG/KG/H||||LOW|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|NA|IRON HEMATOXYLIN STAIN|U|U|N||5||7||LONG-TERM FOLLOW-UP|1960-10-17|1970-02-03|||||1962-04-19||1960-10-03
TRIAL STUDY 134XCP|IS|85060A90-92F7-4440-AD1C-62A70C2FD5CB||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACK|||||CMH2O/ML||||NORMAL|NOT DONE|||SERUM OR PLASMA|CALCIFIED|U|CLIP|Y|NA|NA||1||38||BASELINE|1964-02-28|1972-06-15|||||1960-11-01||1966-11-22
TRIAL STUDY 134XCP|IS|85060A90-92F7-4440-AD1C-62A70C2FD5CB||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||S*KPA|||||NG/DL||||NORMAL|NOT DONE|||TRANSUDATE|DRIED|NA|LIQUID SCINTILLATION COUNTING|NA|U|U||2||58||WASHOUT|1961-05-26|1962-02-26|||||1967-11-06||1972-08-18
TRIAL STUDY 134XCP|IS|85060A90-92F7-4440-AD1C-62A70C2FD5CB||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MIN/DAY|||||TSP EQ||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|CLOTTED|NA|TURBIDIMETRY|U|NA|U||3||39||INDUCTION TREATMENT|1960-07-28|1966-09-10|||||1961-05-12||1971-04-21
TRIAL STUDY 134XCP|IS|85060A90-92F7-4440-AD1C-62A70C2FD5CB||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PATCH|||||UG/DOSE||||HIGH|NOT DONE|||MUSCLE TISSUE|CALCIFIED|NA|NUCLEIC ACID HYBRIDIZATION|N|N|Y||4||88||FOLLOW-UP|1964-08-10|1971-05-28|||||1965-09-12||1970-07-19
TRIAL STUDY 134XCP|IS|85060A90-92F7-4440-AD1C-62A70C2FD5CB||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||USEC|||||DRUM||||NORMAL|NOT DONE|||DIALYSIS FLUID|HEMOLYZED|Y|MICRO BROTH DILUTION|N|N|U||5||7||OPEN LABEL TREATMENT|1966-01-21|1963-09-28|||||1962-07-10||1961-05-04
TRIAL STUDY 134XCP|IS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||M/SEC|||||DAYS||||HIGH|NOT DONE|||BASAL TEAR|CONTAMINATED|NA|COLORIMETRY|NA|Y|Y||1||38||WASHOUT|1966-10-11|1968-11-02|||||1964-12-04||1964-06-04
TRIAL STUDY 134XCP|IS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MMOL/MIN/KPA|||||UG/DAY||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|CLOTTED|NA|IMMUNOFLUORESCENT STAIN|Y|U|N||2||58||LONG-TERM FOLLOW-UP|1962-06-13|1961-09-18|||||1964-07-03||1968-12-18
TRIAL STUDY 134XCP|IS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 COPIES/ML|||||DNA COPIES/ML||||NORMAL|NOT DONE|||LAVAGE FLUID|HEMOLYZED|Y|SPECTROPHOTOMETRY|N|U|U||3||39||OPEN LABEL TREATMENT|1969-02-11|1970-11-03|||||1969-07-22||1970-11-23
TRIAL STUDY 134XCP|IS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/L/H|||||MMOL/G||||NORMAL|NOT DONE|||BREAST MILK|NON-HEMOLYZED|U|CONTRAST ENHANCED X-RAY|U|U|U||4||88||SCREENING|1968-12-15|1965-03-11|||||1963-05-30||1965-01-15
TRIAL STUDY 134XCP|IS|719D483D-67B4-49DE-A86A-CBE7D4CBB8D0||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TCID 50/DOSE|||||KG/CM||||LOW|NOT DONE|||INFRANATANT, SERUM|FRESH|U|MULTIPLE BREATH WASHOUT|U|N|Y||5||7||OPEN LABEL TREATMENT|1967-08-31|1970-05-16|||||1964-01-19||1963-07-04
TRIAL STUDY 134XCP|IS|170052E6-031C-48EF-9CE4-CA84ED6B77FF||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||%/S|||||ANTIBODY UNIT||||NORMAL|NOT DONE|||TUMOR TISSUE|FROZEN|N|GC/MS-EI|N|NA|N||1||38||TREATMENT|1962-07-08|1967-02-02|||||1965-08-24||1970-05-23
TRIAL STUDY 134XCP|IS|170052E6-031C-48EF-9CE4-CA84ED6B77FF||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EVENTS|||||U/KG/DAY||||LOW|NOT DONE|||VENOUS PLASMA|DRIED|N|OPTICAL COHERENCE TOMOGRAPHY|U|U|N||2||58||SCREENING|1964-04-27|1964-07-23|||||1960-04-07||1967-10-23
TRIAL STUDY 134XCP|IS|170052E6-031C-48EF-9CE4-CA84ED6B77FF||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CMH2O*S/ML|||||TUBERCULIN UNIT||||LOW|NOT DONE|||CAPILLARY PLASMA|CONCENTRATED|U|CONTRAST ENHANCED SPIRAL CT SCAN|NA|Y|N||3||39||BLINDED TREATMENT|1962-12-10|1967-05-07|||||1963-05-13||1970-02-10
TRIAL STUDY 134XCP|IS|170052E6-031C-48EF-9CE4-CA84ED6B77FF||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/KG|||||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|HEMOLYZED|Y|PEAK FLOWMETRY|N|NA|U||4||88||INDUCTION TREATMENT|1964-02-20|1971-11-29|||||1966-08-19||1966-04-23
TRIAL STUDY 134XCP|IS|170052E6-031C-48EF-9CE4-CA84ED6B77FF||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS/G|||||/200 HPFS||||ABNORMAL|NOT DONE|||CORD BLOOD|ICTERIC|U|SCANNING ELECTRON MICROSCOPY|N|NA|U||5||7||CONTINUATION TREATMENT|1965-06-21|1964-06-06|||||1969-01-15||1962-11-06
TRIAL STUDY 134XCP|IS|D3F628DE-8358-4C2C-B474-763E48719E5E||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SV|||||U/G HB||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|UNEXPECTED ODOR|U|NEXT GENERATION TARGETED SEQUENCING|Y|NA|U||1||38||BASELINE|1971-07-24|1962-07-06|||||1966-08-01||1971-10-14
TRIAL STUDY 134XCP|IS|D3F628DE-8358-4C2C-B474-763E48719E5E||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FMOL/G|||||U/MG||||ABNORMAL|NOT DONE|||NAIL|AUTOLYZED|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|N|Y||2||58||INDUCTION TREATMENT|1960-07-08|1960-06-24|||||1971-12-01||1971-09-09
TRIAL STUDY 134XCP|IS|D3F628DE-8358-4C2C-B474-763E48719E5E||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MM|||||DAGU||||HIGH|NOT DONE|||ADIPOSE TISSUE|THAWED|N|MS/MS|U|U|N||3||39||LONG-TERM FOLLOW-UP|1971-09-19|1961-07-29|||||1963-01-09||1963-10-19
TRIAL STUDY 134XCP|IS|D3F628DE-8358-4C2C-B474-763E48719E5E||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MNFI|||||DROP||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|DRIED|U|NON-CONTACT SPECULAR MICROSCOPY|Y|Y|Y||4||88||WASHOUT|1962-09-09|1960-06-29|||||1971-04-08||1961-12-23
TRIAL STUDY 134XCP|IS|D3F628DE-8358-4C2C-B474-763E48719E5E||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/KG/MIN|||||SACHET||||NORMAL|NOT DONE|||CAPILLARY PLASMA|FROZEN|NA|SPECT SCAN|Y|N|U||5||7||OBSERVATION|1963-12-19|1960-12-11|||||1967-01-15||1972-07-25
TRIAL STUDY 134XCP|IS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LX|||||MM2||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|LIPEMIC|N|NON-INVASIVE DIELECTRIC SENSING|Y|N|N||1||38||WASHOUT|1965-05-18|1960-03-15|||||1972-06-25||1970-02-23
TRIAL STUDY 134XCP|IS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UKAT/10^12 RBC|||||CM H2O||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|PARAFFIN-EMBEDDED|Y|AUSCULTATION|NA|U|Y||2||58||RUN-IN|1962-02-19|1969-04-22|||||1970-04-27||1960-08-02
TRIAL STUDY 134XCP|IS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CYCLE/MIN|||||M/SEC||||NORMAL|NOT DONE|||TISSUE|CLOTTED|NA|OPTICAL COHERENCE TOMOGRAPHY|NA|N|NA||3||39||RUN-IN|1965-09-30|1961-09-19|||||1971-10-14||1962-12-20
TRIAL STUDY 134XCP|IS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||L/MIN|||||DAYS||||HIGH|NOT DONE|||SERUM OR PLASMA|ROOM TEMPERATURE|U|KINETIC MICROPARTICLE IMMUNOASSAY|Y|U|U||4||88||INDUCTION TREATMENT|1969-05-01|1968-08-10|||||1972-09-19||1961-09-04
TRIAL STUDY 134XCP|IS|33137C67-0DA6-49EB-AF5D-6B6AFB44738F||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 PFU|||||OZ||||ABNORMAL|NOT DONE|||URINE SEDIMENT|SOLIDIFIED|NA|HEMATOXYLIN AND EOSIN STAIN|NA|N|N||5||7||CONTINUATION TREATMENT|1964-08-03|1970-04-03|||||1963-07-15||1963-10-05
TRIAL STUDY 134XCP|IS|4395486D-C521-4478-9442-68CF0344C6FB||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||QUANTITY SUFFICIENT|||||HOUNSFIELD UNIT||||NORMAL|NOT DONE|||BASAL TEAR|CONCENTRATED|Y|JAFFE REACTION|Y|NA|NA||1||38||INDUCTION TREATMENT|1970-07-06|1960-12-09|||||1962-12-16||1971-06-04
TRIAL STUDY 134XCP|IS|4395486D-C521-4478-9442-68CF0344C6FB||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KG/L|||||% INHIBITION||||HIGH|NOT DONE|||VENOUS CORD BLOOD|REFRIGERATED|NA|DIRECT SEQUENCING|NA|U|N||2||58||OBSERVATION|1971-01-06|1966-08-27|||||1968-06-21||1964-11-10
TRIAL STUDY 134XCP|IS|4395486D-C521-4478-9442-68CF0344C6FB||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL/G|||||PPB||||NORMAL|NOT DONE|||CELL PELLET|SOLIDIFIED|N|SXA SCAN|N|U|U||3||39||SCREENING|1965-08-17|1967-07-08|||||1961-10-04||1960-12-19
TRIAL STUDY 134XCP|IS|4395486D-C521-4478-9442-68CF0344C6FB||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/G/DAY|||||%(W/W)||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|UNEXPECTED ODOR|N|AUDIOMETRY|N|NA|U||4||88||OPEN LABEL TREATMENT|1961-09-06|1961-05-14|||||1970-01-26||1969-08-25
TRIAL STUDY 134XCP|IS|4395486D-C521-4478-9442-68CF0344C6FB||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MV2/HZ|||||10^9 ORGANISMS||||HIGH|NOT DONE|||CAPILLARY PLASMA|LIPEMIC|NA|SNELLEN EYE CHART|Y|U|Y||5||7||TREATMENT|1967-12-11|1971-09-05|||||1965-08-02||1967-06-07
TRIAL STUDY 134XCP|IS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CARTRIDGE|||||CYCLE/MIN||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|FROZEN|N|ELISPOT|Y|N|Y||1||38||TREATMENT|1965-09-13|1961-05-29|||||1970-02-22||1962-05-31
TRIAL STUDY 134XCP|IS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CARTRIDGE|||||ML/KG/H||||LOW|NOT DONE|||ISOLATE|UNEXPECTED ODOR|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|NA|N|Y||2||58||RUN-IN|1965-04-05|1972-07-18|||||1967-02-04||1971-01-10
TRIAL STUDY 134XCP|IS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/MS|||||U/G/DAY||||HIGH|NOT DONE|||PLEURAL FLUID|LIPEMIC|N|MICROBIAL CULTURE|N|N|N||3||39||BLINDED TREATMENT|1973-05-11|1960-03-14|||||1967-03-21||1969-02-23
TRIAL STUDY 134XCP|IS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HZ/S|||||DIOPTER||||HIGH|NOT DONE|||URINE|GELLED|Y|ZIEHL NEELSEN ACID FAST STAIN|Y|NA|Y||4||88||OPEN LABEL TREATMENT|1969-12-24|1967-01-18|||||1965-04-05||1962-05-05
TRIAL STUDY 134XCP|IS|4818BCD8-8B7B-46B1-86C5-F5D2067FD317||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UV2|||||PPB||||ABNORMAL|NOT DONE|||LOCHIA|CONCENTRATED|N|LANDOLT RING|NA|Y|Y||5||7||INDUCTION TREATMENT|1967-07-05|1968-12-04|||||1969-04-06||1960-11-20
TRIAL STUDY 134XCP|IS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MCI/KG|||||HR/DAY||||NORMAL|NOT DONE|||BASAL TEAR|CLOTTED|NA|MICROARRAY|NA|NA|NA||1||38||BASELINE|1970-08-06|1972-11-10|||||1961-09-30||1964-01-10
TRIAL STUDY 134XCP|IS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PPM|||||CPM||||LOW|NOT DONE|||VENOUS CORD BLOOD|NON-HEMOLYZED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|NA|Y|Y||2||58||WASHOUT|1970-10-15|1970-06-23|||||1965-04-15||1963-06-06
TRIAL STUDY 134XCP|IS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^8 PFU|||||KDA||||HIGH|NOT DONE|||EPITHELIAL CELL|DRIED|Y|IMMUNE REPERTOIRE DEEP SEQUENCING|NA|NA|Y||3||39||OPEN LABEL TREATMENT|1963-11-01|1967-03-30|||||1963-10-22||1973-08-23
TRIAL STUDY 134XCP|IS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||APS U|||||GBQ/UG||||NORMAL|NOT DONE|||EPITHELIAL CELL|HEMOLYZED|NA|AURAMINE STAIN|NA|NA|N||4||88||SCREENING|1964-05-02|1967-01-18|||||1967-07-19||1965-01-19
TRIAL STUDY 134XCP|IS|2E2BF203-2C02-4D9A-AA64-7AE7968282A1||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/L/H|||||PSI||||LOW|NOT DONE|||SWABBED MATERIAL|HEMOLYZED|NA|HILLMEN COLOR CHART|NA|N|N||5||7||LONG-TERM FOLLOW-UP|1960-06-18|1964-07-19|||||1965-02-18||1969-10-06
TRIAL STUDY 134XCP|IS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NSEC|||||DPM/MG||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|LACTESCENT|U|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|U|Y|NA||1||38||INDUCTION TREATMENT|1967-03-14|1964-04-04|||||1969-03-20||1964-03-18
TRIAL STUDY 134XCP|IS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||RPM|||||MBQ||||HIGH|NOT DONE|||PLEURAL FLUID|CALCIFIED|NA|MYELOPEROXIDASE STAIN|NA|NA|NA||2||58||CONTINUATION TREATMENT|1969-05-19|1967-11-11|||||1965-01-06||1969-06-18
TRIAL STUDY 134XCP|IS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MEQ/DL|||||10^8 PFU||||NORMAL|NOT DONE|||SEBUM|HEMOLYZED|Y|JAEGER EYE CHART|U|U|U||3||39||WASHOUT|1972-11-11|1969-12-28|||||1964-12-27||1966-07-02
TRIAL STUDY 134XCP|IS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/MG/MIN|||||K||||LOW|NOT DONE|||PUS|PARAFFIN-EMBEDDED|NA|DC SHEATH FLOW|U|NA|U||4||88||BLINDED TREATMENT|1965-07-26|1965-05-14|||||1969-05-29||1970-05-18
TRIAL STUDY 134XCP|IS|8C5C83B7-2373-4A72-8E55-A779EB08D9A9||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PMOL/G|||||PT_US||||NORMAL|NOT DONE|||BASAL TEAR|ICTERIC|NA|IMPULSE OSCILLOMETRY|NA|N|N||5||7||LONG-TERM FOLLOW-UP|1960-10-06|1969-08-03|||||1962-10-14||1967-10-12
TRIAL STUDY 134XCP|IS|19394300-46A6-484F-AE02-50BDD39096E3||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BREATHS/MIN|||||FL||||LOW|NOT DONE|||PLATELET RICH PLASMA|LACTESCENT|N|CENTRIFUGATION|U|N|NA||1||38||OBSERVATION|1971-03-15|1971-11-05|||||1971-11-07||1972-02-12
TRIAL STUDY 134XCP|IS|19394300-46A6-484F-AE02-50BDD39096E3||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CCID 50/DOSE|||||10^4 CFU||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|NON-HEMOLYZED|NA|DUCTOGRAPHY|Y|Y|N||2||58||RUN-IN|1969-01-16|1960-10-14|||||1972-08-05||1960-03-27
TRIAL STUDY 134XCP|IS|19394300-46A6-484F-AE02-50BDD39096E3||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MV*MIN|||||DPM/100MG||||HIGH|NOT DONE|||LOCHIA|CONCENTRATED|NA|BIOPSY|NA|Y|NA||3||39||FOLLOW-UP|1971-05-06|1968-07-26|||||1971-02-23||1969-01-05
TRIAL STUDY 134XCP|IS|19394300-46A6-484F-AE02-50BDD39096E3||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PFU/ML|||||ENZYME U/G HB||||LOW|NOT DONE|||LAVAGE FLUID|AUTOLYZED|NA|POLYSOMNOGRAPHY|U|N|NA||4||88||OBSERVATION|1968-06-18|1968-04-02|||||1967-02-12||1967-01-02
TRIAL STUDY 134XCP|IS|19394300-46A6-484F-AE02-50BDD39096E3||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IN2|||||MNFI||||ABNORMAL|NOT DONE|||SPERMATOZOON|HEMOLYZED|N|CT SCAN|N|NA|U||5||7||SCREENING|1965-07-15|1971-03-22|||||1965-09-13||1968-08-11
TRIAL STUDY 134XCP|IS|8C89BD60-3504-4F8B-8F33-7F0C949DB407||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NU/CL|||||ENZYME U/M2||||LOW|NOT DONE|||FLUID|CONCENTRATED|NA|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|U|NA|NA||1||38||INDUCTION TREATMENT|1961-06-30|1973-08-07|||||1960-08-16||1966-07-15
TRIAL STUDY 134XCP|IS|8C89BD60-3504-4F8B-8F33-7F0C949DB407||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TCID 50/DOSE|||||BQ||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|DRIED|NA|CELLULOSE TAPE|Y|Y|N||2||58||INDUCTION TREATMENT|1966-06-29|1961-03-03|||||1966-08-29||1969-06-24
TRIAL STUDY 134XCP|IS|8C89BD60-3504-4F8B-8F33-7F0C949DB407||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CY/CM|||||APL U||||LOW|NOT DONE|||TISSUE|AUTOLYZED|Y|MRI WITHOUT CONTRAST|N|U|Y||3||39||OBSERVATION|1966-03-30|1966-11-24|||||1965-07-27||1964-12-08
TRIAL STUDY 134XCP|IS|8C89BD60-3504-4F8B-8F33-7F0C949DB407||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KIT|||||JAR||||LOW|NOT DONE|||LEUKOCYTE|ICTERIC|U|IVY INCISION METHOD|U|U|NA||4||88||RUN-IN|1967-06-06|1968-01-29|||||1967-02-24||1966-03-15
TRIAL STUDY 134XCP|IS|8C89BD60-3504-4F8B-8F33-7F0C949DB407||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MKAT|||||UG/L DDU||||LOW|NOT DONE|||LOCHIA|DRIED|Y|PET/SPECT SCAN|Y|N|Y||5||7||TREATMENT|1965-02-06|1972-03-24|||||1966-06-13||1965-02-25
TRIAL STUDY 134XCP|IS|4746A481-011E-4376-9D2F-5E57F560A6DE||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||JAR|||||UEQ/L||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|HEMOLYZED|U|BAC ACGH|Y|U|N||1||38||TREATMENT|1969-01-17|1962-03-04|||||1962-11-14||1970-02-28
TRIAL STUDY 134XCP|IS|4746A481-011E-4376-9D2F-5E57F560A6DE||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BEATS/MIN|||||LENS||||HIGH|NOT DONE|||PLATELET|AGGLUTINATED|Y|PERCUSSION|U|Y|U||2||58||CONTINUATION TREATMENT|1961-08-06|1969-06-03|||||1966-12-02||1965-11-08
TRIAL STUDY 134XCP|IS|4746A481-011E-4376-9D2F-5E57F560A6DE||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CM2|||||PSI||||LOW|NOT DONE|||URINE SEDIMENT|CLOTTED|NA|MAGNETIC RESONANCE ENTEROGRAPHY|NA|NA|Y||3||39||INDUCTION TREATMENT|1968-02-13|1970-05-18|||||1967-03-15||1968-01-27
TRIAL STUDY 134XCP|IS|4746A481-011E-4376-9D2F-5E57F560A6DE||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6 IU|||||UV||||NORMAL|NOT DONE|||EPITHELIAL CELL|FRESH|N|THIN SMEAR|Y|NA|Y||4||88||SCREENING|1965-06-09|1968-10-23|||||1965-02-13||1968-06-17
TRIAL STUDY 134XCP|IS|4746A481-011E-4376-9D2F-5E57F560A6DE||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L/KG|||||ELISA UNIT/ML||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|NON-HEMOLYZED|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|U|N|Y||5||7||OBSERVATION|1960-07-12|1961-06-07|||||1968-10-19||1963-03-02
TRIAL STUDY 134XCP|IS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||K|||||S*KPA||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|SOLIDIFIED|U|MODIFIED ACID FAST STAIN|N|Y|Y||1||38||BASELINE|1967-07-16|1964-01-07|||||1970-10-24||1972-12-04
TRIAL STUDY 134XCP|IS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/L|||||CAPSULE||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|Y|DIGITAL PCR ARRAY|NA|Y|NA||2||58||LONG-TERM FOLLOW-UP|1963-04-21|1970-12-28|||||1969-06-19||1963-12-06
TRIAL STUDY 134XCP|IS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FRACTION OF 1|||||UG/MOL||||HIGH|NOT DONE|||VENOUS PLASMA|LIPEMIC|U|NON-CONTACT SPECULAR MICROSCOPY|U|NA|N||3||39||TREATMENT|1973-05-29|1966-09-30|||||1968-10-10||1963-01-26
TRIAL STUDY 134XCP|IS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MM2|||||KCAL/DAY||||ABNORMAL|NOT DONE|||LOCHIA|AUTOLYZED|N|GC/FID|NA|N|U||4||88||RUN-IN|1967-12-01|1966-04-26|||||1968-06-11||1968-04-18
TRIAL STUDY 134XCP|IS|CE1DB395-A3FC-4F3A-B039-411A6266F7C0||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/100 HPFS|||||MM/MIN||||NORMAL|NOT DONE|||URINE|CALCIFIED|U|SPECTROPHOTOMETRY|N|N|U||5||7||FOLLOW-UP|1966-12-15|1973-03-23|||||1973-07-06||1963-10-11
TRIAL STUDY 134XCP|IS|04F5220E-7A8C-4982-9379-496306612E33||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MU/G|||||MG/ML/MIN||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|NA|CELLULAR PROLIFERATION ASSAY|NA|N|N||1||38||INDUCTION TREATMENT|1968-07-15|1960-08-29|||||1964-07-18||1961-04-13
TRIAL STUDY 134XCP|IS|04F5220E-7A8C-4982-9379-496306612E33||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/KG/DAY|||||ML/G/DAY||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|FROZEN|U|HPLC-UV|Y|U|U||2||58||WASHOUT|1967-06-25|1969-07-18|||||1965-11-13||1968-04-11
TRIAL STUDY 134XCP|IS|04F5220E-7A8C-4982-9379-496306612E33||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GRAIN|||||ML/CAGE||||LOW|NOT DONE|||ADIPOSE TISSUE|LIPEMIC|NA|IMMUNORADIOMETRIC ASSAY|U|N|N||3||39||BLINDED TREATMENT|1970-02-22|1965-06-25|||||1960-08-27||1964-11-16
TRIAL STUDY 134XCP|IS|04F5220E-7A8C-4982-9379-496306612E33||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMU/ML|||||TITER||||HIGH|NOT DONE|||ERYTHROCYTES|UNEXPECTED ODOR|Y|NEPHELOMETRY|NA|N|N||4||88||WASHOUT|1963-05-09|1970-08-15|||||1967-02-08||1971-12-01
TRIAL STUDY 134XCP|IS|04F5220E-7A8C-4982-9379-496306612E33||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FT3|||||APS U||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|CONTAMINATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NA|Y|N||5||7||INDUCTION TREATMENT|1961-12-04|1970-09-03|||||1964-09-29||1968-08-26
TRIAL STUDY 134XCP|IS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^8/L|||||CMOL/L||||NORMAL|NOT DONE|||SALIVA|REFRIGERATED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|NA|Y|Y||1||38||LONG-TERM FOLLOW-UP|1965-10-21|1965-02-11|||||1969-10-15||1965-08-31
TRIAL STUDY 134XCP|IS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TRANSDUCING UNIT|||||MNFI||||LOW|NOT DONE|||TISSUE|CLOTTED|Y|FLUORESCENT MICROSCOPY|NA|NA|NA||2||58||LONG-TERM FOLLOW-UP|1966-01-07|1967-11-12|||||1960-06-14||1961-04-05
TRIAL STUDY 134XCP|IS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||HZ|||||PIXELS/CM||||HIGH|NOT DONE|||RETICULOCYTES|LIPEMIC|Y|DYNAMIC CONTRAST ENHANCED MRI|NA|NA|U||3||39||WASHOUT|1963-10-05|1960-04-30|||||1973-02-25||1963-09-01
TRIAL STUDY 134XCP|IS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/KG/H|||||BOWL||||ABNORMAL|NOT DONE|||ISOLATE|CLOTTED|N|NEXT GENERATION SEQUENCING|N|Y|N||4||88||SCREENING|1960-08-29|1972-04-02|||||1972-08-11||1970-02-08
TRIAL STUDY 134XCP|IS|2D77B739-5C67-443E-B7A1-5E6E11CFE19B||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||TBSP|||||MOL/ML||||LOW|NOT DONE|||CORD SERUM|DRIED|Y|RADIAL IMMUNODIFFUSION|U|U|N||5||7||INDUCTION TREATMENT|1968-11-15|1969-07-24|||||1971-04-22||1969-09-21
TRIAL STUDY 134XCP|IS|73BDFAA2-6260-4E1D-8039-7523F0C52873||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PFU/DOSE|||||FARAD||||LOW|NOT DONE|||DISCHARGE|CONCENTRATED|N|ANTIMICROBIAL COMBINATION TESTING|N|Y|NA||1||38||WASHOUT|1963-04-03|1969-03-13|||||1972-09-30||1969-03-18
TRIAL STUDY 134XCP|IS|73BDFAA2-6260-4E1D-8039-7523F0C52873||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT/ML|||||UGEQ/L||||HIGH|NOT DONE|||LOCHIA|NON-HEMOLYZED|U|ELECTROGASTROGRAPHY|U|NA|Y||2||58||RUN-IN|1963-06-18|1970-09-30|||||1965-09-24||1966-03-30
TRIAL STUDY 134XCP|IS|73BDFAA2-6260-4E1D-8039-7523F0C52873||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KM|||||MG/DL||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|THAWED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|U|N||3||39||BASELINE|1972-12-07|1960-04-18|||||1963-12-28||1967-05-16
TRIAL STUDY 134XCP|IS|73BDFAA2-6260-4E1D-8039-7523F0C52873||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||RAD|||||NMOL/L||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|REFRIGERATED|U|PHASE-CONTRAST MRI|Y|N|N||4||88||OPEN LABEL TREATMENT|1967-11-27|1960-02-01|||||1966-12-04||1963-01-24
TRIAL STUDY 134XCP|IS|73BDFAA2-6260-4E1D-8039-7523F0C52873||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML|||||USEC||||HIGH|NOT DONE|||DIALYSIS FLUID|ICTERIC|N|FUNCTIONAL MRI|N|Y|N||5||7||SCREENING|1962-07-23|1969-04-26|||||1967-06-11||1960-11-24
TRIAL STUDY 134XCP|IS|147C2E77-A2C5-4219-9BB5-D209813E563B||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CAPSULE|||||ELISA UNIT||||LOW|NOT DONE|||CORD BLOOD|LACTESCENT|N|PET SCAN|U|U|N||1||38||LONG-TERM FOLLOW-UP|1970-04-09|1962-02-28|||||1960-05-06||1969-08-29
TRIAL STUDY 134XCP|IS|147C2E77-A2C5-4219-9BB5-D209813E563B||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||100 IU/ML|||||NU/CL||||NORMAL|NOT DONE|||DISCHARGE|ROOM TEMPERATURE|U|FARR ASSAY|N|Y|Y||2||58||OBSERVATION|1965-05-02|1968-06-16|||||1963-11-16||1966-05-21
TRIAL STUDY 134XCP|IS|147C2E77-A2C5-4219-9BB5-D209813E563B||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L/H|||||BQ/G||||HIGH|NOT DONE|||URINE SEDIMENT|AUTOLYZED|Y|HPLC-FL|NA|U|U||3||39||OBSERVATION|1962-06-11|1972-08-10|||||1969-06-08||1973-01-09
TRIAL STUDY 134XCP|IS|147C2E77-A2C5-4219-9BB5-D209813E563B||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN/MMHG|||||MMHG/L/MIN||||ABNORMAL|NOT DONE|||TRANSUDATE|CLOTTED|N|MULTI-SLICE SPIRAL CT|Y|Y|Y||4||88||BLINDED TREATMENT|1962-09-03|1962-02-26|||||1965-08-22||1973-03-24
TRIAL STUDY 134XCP|IS|147C2E77-A2C5-4219-9BB5-D209813E563B||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BOX|||||BLOCKS||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|U|LANDOLT RING|NA|Y|NA||5||7||LONG-TERM FOLLOW-UP|1965-08-09|1973-04-06|||||1964-11-14||1960-10-11
TRIAL STUDY 134XCP|IS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UMOL/DL|||||U/ML||||ABNORMAL|NOT DONE|||BONE|ICTERIC|U|ORCHIDOMETERY|NA|U|N||1||38||INDUCTION TREATMENT|1969-06-21|1967-03-14|||||1972-02-14||1961-04-23
TRIAL STUDY 134XCP|IS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CUP EQ|||||OI50||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|FROZEN|Y|DIGITAL PCR ARRAY|Y|N|U||2||58||OPEN LABEL TREATMENT|1971-02-26|1969-05-05|||||1968-01-28||1961-06-03
TRIAL STUDY 134XCP|IS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SIEMENS|||||CMH2O*S2/ML||||LOW|NOT DONE|||SMEGMA|FROZEN|NA|MUGA|N|N|NA||3||39||TREATMENT|1961-07-21|1961-03-08|||||1970-06-11||1961-04-06
TRIAL STUDY 134XCP|IS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MOL/L|||||SUPPOSITORY||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|NON-HEMOLYZED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NA|NA|NA||4||88||BLINDED TREATMENT|1963-06-04|1966-01-31|||||1966-12-17||1973-09-01
TRIAL STUDY 134XCP|IS|880428B0-DFA1-4CD6-B0C5-76D1192D46D6||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FEU|||||G/M2||||HIGH|NOT DONE|||SWABBED MATERIAL|AGGLUTINATED|N|HPLC/MS|N|U|N||5||7||INDUCTION TREATMENT|1973-08-07|1960-02-04|||||1962-08-26||1964-04-17
TRIAL STUDY 134XCP|IS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CM|||||%/MIN||||NORMAL|NOT DONE|||PLATELET RICH PLASMA|REFRIGERATED|N|U-HPLC/MS/MS|Y|U|NA||1||38||OPEN LABEL TREATMENT|1966-03-20|1962-04-19|||||1963-11-03||1968-04-03
TRIAL STUDY 134XCP|IS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||M|||||ENZYME U||||ABNORMAL|NOT DONE|||LYSATE|CONTAMINATED|Y|ICC|N|Y|NA||2||58||RUN-IN|1960-01-16|1969-11-13|||||1966-10-18||1968-09-29
TRIAL STUDY 134XCP|IS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML*CMH2O|||||PMOL/10^9 CELLS||||NORMAL|NOT DONE|||PUS|LIPEMIC|NA|MASS SPECTROMETRY|U|U|N||3||39||BASELINE|1967-06-18|1964-08-27|||||1969-08-04||1965-02-17
TRIAL STUDY 134XCP|IS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KM|||||NMOL BCE/L||||NORMAL|NOT DONE|||LOCHIA|PARAFFIN-EMBEDDED|N|PALPATION|N|NA|NA||4||88||INDUCTION TREATMENT|1963-05-26|1971-10-16|||||1967-05-19||1961-06-08
TRIAL STUDY 134XCP|IS|BDDC8BA7-3EB9-44E8-91CC-D05391C1187E||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||USEC|||||10^6 U||||ABNORMAL|NOT DONE|||SPUTUM|HEMOLYZED|Y|ZIEHL NEELSEN ACID FAST STAIN|NA|NA|N||5||7||BLINDED TREATMENT|1964-11-23|1963-09-09|||||1961-07-31||1962-03-20
TRIAL STUDY 134XCP|IS|25E17A89-8A2F-4870-B076-1D32634F5620||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PIXELS/IN|||||ML/KG/DAY||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|AGGLUTINATED|N|GC/FID|NA|U|Y||1||38||OBSERVATION|1967-11-17|1970-04-15|||||1973-08-08||1960-11-21
TRIAL STUDY 134XCP|IS|25E17A89-8A2F-4870-B076-1D32634F5620||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FMOL|||||U/M2/H||||ABNORMAL|NOT DONE|||EXUDATE|CLOTTED|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|U|N|N||2||58||INDUCTION TREATMENT|1961-05-30|1965-09-30|||||1967-07-27||1961-10-31
TRIAL STUDY 134XCP|IS|25E17A89-8A2F-4870-B076-1D32634F5620||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||VIAL|||||LX||||NORMAL|NOT DONE|||CERUMEN|FRESH|N|IMMUNOCHROMATOGRAPHY|N|N|Y||3||39||SCREENING|1967-07-03|1967-11-12|||||1963-06-12||1961-11-06
TRIAL STUDY 134XCP|IS|25E17A89-8A2F-4870-B076-1D32634F5620||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FRACTION OF 1|||||ML/CAGE/WK||||HIGH|NOT DONE|||PLEURAL FLUID|FRESH|N|TWO-COLOR MICROARRAY|U|NA|Y||4||88||TREATMENT|1962-12-27|1966-01-13|||||1964-07-03||1967-02-08
TRIAL STUDY 134XCP|IS|25E17A89-8A2F-4870-B076-1D32634F5620||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/G|||||L||||LOW|NOT DONE|||PLATELET|SOLIDIFIED|Y|LIGHT MICROSCOPY|NA|Y|Y||5||7||BLINDED TREATMENT|1967-04-22|1969-03-18|||||1970-10-27||1961-05-17
TRIAL STUDY 134XCP|IS|B7B67C06-0802-4E69-A5A1-469213BE7E48||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CARTRIDGE|||||G/M2/DAY||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|FROZEN|Y|PERCUSSION|NA|Y|U||1||38||FOLLOW-UP|1970-07-18|1966-03-06|||||1961-10-08||1967-02-03
TRIAL STUDY 134XCP|IS|B7B67C06-0802-4E69-A5A1-469213BE7E48||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CI/KG|||||ML/ANIMAL||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|ICTERIC|Y|RIA|NA|U|Y||2||58||LONG-TERM FOLLOW-UP|1969-01-10|1967-03-15|||||1960-11-10||1960-06-26
TRIAL STUDY 134XCP|IS|B7B67C06-0802-4E69-A5A1-469213BE7E48||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/ML/H|||||MIN||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|Y|URANYL ACETATE STAIN|U|N|NA||3||39||SCREENING|1962-07-31|1964-10-27|||||1967-08-16||1968-02-28
TRIAL STUDY 134XCP|IS|B7B67C06-0802-4E69-A5A1-469213BE7E48||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/G/DAY|||||BOTTLE||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|CONTAMINATED|N|AURAMINE STAIN|U|N|U||4||88||WASHOUT|1963-09-23|1971-01-13|||||1962-02-23||1960-07-24
TRIAL STUDY 134XCP|IS|B7B67C06-0802-4E69-A5A1-469213BE7E48||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ANTIBODY UNIT|||||KPA||||NORMAL|NOT DONE|||PROSTATIC FLUID|FRESH|N|GC/MS-EI|N|NA|NA||5||7||WASHOUT|1962-05-09|1969-11-08|||||1964-10-28||1968-11-13
TRIAL STUDY 134XCP|IS|626E3EA7-423B-434F-89E4-CA076A39B8DB||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 IU/ML|||||CI||||NORMAL|NOT DONE|||INFRANATANT, SERUM|PARAFFIN-EMBEDDED|Y|MICROBIAL BIOCHEMICAL IDENTIFICATION|U|U|Y||1||38||INDUCTION TREATMENT|1963-01-08|1972-12-19|||||1970-08-04||1968-09-07
TRIAL STUDY 134XCP|IS|626E3EA7-423B-434F-89E4-CA076A39B8DB||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DMOL|||||AMPULE||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|NON-HEMOLYZED|U|CARDIAC THERMODILUTION|U|Y|N||2||58||FOLLOW-UP|1966-08-29|1971-08-03|||||1963-01-10||1970-12-12
TRIAL STUDY 134XCP|IS|626E3EA7-423B-434F-89E4-CA076A39B8DB||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOL/ML|||||IU/MMOL||||NORMAL|NOT DONE|||COLOSTRUM|AGGLUTINATED|Y|KLEIHAUER-BETKE|NA|U|Y||3||39||BLINDED TREATMENT|1962-04-14|1971-10-17|||||1961-06-25||1973-07-04
TRIAL STUDY 134XCP|IS|626E3EA7-423B-434F-89E4-CA076A39B8DB||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 CFU|||||CMH2O*S2/ML||||LOW|NOT DONE|||SUPERNATANT, PLASMA|LIPEMIC|NA|POLYSOMNOGRAPHY|U|U|U||4||88||CONTINUATION TREATMENT|1969-04-11|1972-12-18|||||1972-04-27||1961-06-12
TRIAL STUDY 134XCP|IS|626E3EA7-423B-434F-89E4-CA076A39B8DB||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MOSM/L|||||SCOOPFUL||||ABNORMAL|NOT DONE|||PLASMA|FROZEN|U|HPLC-UV|U|Y|N||5||7||RUN-IN|1963-12-18|1966-06-27|||||1967-08-24||1963-07-14
TRIAL STUDY 134XCP|IS|98ED3A38-1E74-470E-BF45-0D1E905BEF36||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CAPLET|||||BEL||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|LIPEMIC|N|ELECTROGASTROGRAPHY|N|Y|U||1||38||SCREENING|1963-02-23|1964-02-19|||||1960-12-06||1961-02-15
TRIAL STUDY 134XCP|IS|98ED3A38-1E74-470E-BF45-0D1E905BEF36||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT/ML|||||CUP||||NORMAL|NOT DONE|||SMEGMA|NON-HEMOLYZED|Y|SINGLE-MOLECULE ARRAY|N|U|U||2||58||BASELINE|1964-07-18|1964-07-01|||||1970-02-02||1961-01-29
TRIAL STUDY 134XCP|IS|98ED3A38-1E74-470E-BF45-0D1E905BEF36||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||FT|||||SCM||||HIGH|NOT DONE|||SPERMATOZOON|GELLED|N|SLOAN LETTER EYE CHART 2.5%|N|U|Y||3||39||WASHOUT|1963-09-13|1973-04-06|||||1972-06-02||1964-05-10
TRIAL STUDY 134XCP|IS|98ED3A38-1E74-470E-BF45-0D1E905BEF36||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 CFU/ML|||||UMOL/DL||||ABNORMAL|NOT DONE|||NAIL|HEMOLYZED|NA|HPLC-FL|N|Y|Y||4||88||OBSERVATION|1964-05-26|1971-01-20|||||1966-07-28||1968-11-13
TRIAL STUDY 134XCP|IS|98ED3A38-1E74-470E-BF45-0D1E905BEF36||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DRAM|||||10^9 ORGANISMS/MG||||ABNORMAL|NOT DONE|||CERUMEN|CALCIFIED|U|IMPEDANCE CONDUCTIVITY|NA|Y|N||5||7||LONG-TERM FOLLOW-UP|1967-09-19|1966-07-12|||||1967-04-30||1973-02-26
TRIAL STUDY 134XCP|IS|99DF7819-987E-4E55-89FD-FF49E7C02A5A||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||EU|||||ABSORBANCE U/MIN||||LOW|NOT DONE|||PLATELET POOR PLASMA|CLOTTED|Y|PET/CT SCAN|N|NA|N||1||38||SCREENING|1969-12-21|1971-11-11|||||1963-01-14||1965-09-23
TRIAL STUDY 134XCP|IS|99DF7819-987E-4E55-89FD-FF49E7C02A5A||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KUSP|||||UG||||NORMAL|NOT DONE|||SMEGMA|CALCIFIED|NA|SPECTROPHOTOMETRY|NA|N|NA||2||58||INDUCTION TREATMENT|1972-04-09|1973-04-19|||||1970-10-20||1967-01-18
TRIAL STUDY 134XCP|IS|99DF7819-987E-4E55-89FD-FF49E7C02A5A||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FT2|||||UL/ML||||LOW|NOT DONE|||RETICULOCYTES|UNEXPECTED ODOR|NA|ELECTROGASTROGRAPHY|Y|Y|Y||3||39||OPEN LABEL TREATMENT|1968-10-11|1966-03-20|||||1966-02-17||1972-12-29
TRIAL STUDY 134XCP|IS|99DF7819-987E-4E55-89FD-FF49E7C02A5A||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CP|||||10^6 ORGANISMS/G||||HIGH|NOT DONE|||PERSPIRATION|CONCENTRATED|U|CONTRAST ENHANCED PET SCAN|N|N|NA||4||88||CONTINUATION TREATMENT|1967-09-03|1971-01-06|||||1963-08-13||1971-05-11
TRIAL STUDY 134XCP|IS|99DF7819-987E-4E55-89FD-FF49E7C02A5A||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UCI/KG|||||NKAT||||ABNORMAL|NOT DONE|||SEBUM|NON-HEMOLYZED|N|NUCLEIC ACID BASED METHOD|U|N|Y||5||7||LONG-TERM FOLLOW-UP|1962-09-06|1967-10-13|||||1972-08-10||1971-09-11
TRIAL STUDY 134XCP|IS|05481BE7-9309-4356-B46E-9C2525D2C54E||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NMOL BCE/NMOL|||||GENEQ||||HIGH|NOT DONE|||SKIN TISSUE|ICTERIC|N|ELECTROPHORESIS|Y|N|N||1||38||CONTINUATION TREATMENT|1963-03-03|1963-06-22|||||1973-05-25||1969-10-09
TRIAL STUDY 134XCP|IS|05481BE7-9309-4356-B46E-9C2525D2C54E||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UKAT/10^12 RBC|||||GY||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|FROZEN|Y|NUCLEIC ACID AMPLIFICATION TEST|N|NA|NA||2||58||OPEN LABEL TREATMENT|1960-03-05|1968-08-06|||||1970-10-15||1961-06-16
TRIAL STUDY 134XCP|IS|05481BE7-9309-4356-B46E-9C2525D2C54E||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^7 CFU/ML|||||GBQ/MG||||HIGH|NOT DONE|||REFLEX TEAR|HEMOLYZED|N|MRI WITHOUT CONTRAST|NA|N|N||3||39||TREATMENT|1969-03-26|1966-03-08|||||1973-09-04||1967-05-26
TRIAL STUDY 134XCP|IS|05481BE7-9309-4356-B46E-9C2525D2C54E||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||VG/DOSE|||||G/DAY||||LOW|NOT DONE|||TUMOR TISSUE|THAWED|U|IMMUNODIFFUSION|N|Y|U||4||88||CONTINUATION TREATMENT|1963-04-19|1969-03-23|||||1971-03-07||1970-08-10
TRIAL STUDY 134XCP|IS|05481BE7-9309-4356-B46E-9C2525D2C54E||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PL|||||UG/G/H||||ABNORMAL|NOT DONE|||BLOOD|NON-HEMOLYZED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|NA|Y|N||5||7||FOLLOW-UP|1973-07-09|1961-05-28|||||1972-12-26||1965-07-16
TRIAL STUDY 134XCP|IS|2F49D512-0A23-4D2D-959B-A1756991E817||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANTI-XA IU/ML|||||BU||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|N|ICP-MS|N|Y|U||1||38||FOLLOW-UP|1960-09-01|1971-11-21|||||1961-12-25||1972-04-17
TRIAL STUDY 134XCP|IS|2F49D512-0A23-4D2D-959B-A1756991E817||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT/G HB|||||BAU/ML||||LOW|NOT DONE|||SEMINAL FLUID|PARAFFIN-EMBEDDED|NA|QUANTITATIVE COMPUTED TOMOGRAPHY|U|Y|N||2||58||CONTINUATION TREATMENT|1969-03-27|1960-01-08|||||1969-02-23||1962-09-11
TRIAL STUDY 134XCP|IS|2F49D512-0A23-4D2D-959B-A1756991E817||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FIU|||||ATM||||ABNORMAL|NOT DONE|||SALIVA|THAWED|Y|BIOIMPEDANCE SPECTROSCOPY|Y|Y|N||3||39||BLINDED TREATMENT|1960-08-31|1971-04-14|||||1968-05-14||1961-10-03
TRIAL STUDY 134XCP|IS|2F49D512-0A23-4D2D-959B-A1756991E817||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^3 ORGANISMS/ML|||||ML/M2||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|HEMOLYZED|Y|ACCELERATOR MASS SPECTROMETRY|U|N|NA||4||88||OBSERVATION|1966-09-06|1967-01-10|||||1961-04-28||1970-02-22
TRIAL STUDY 134XCP|IS|2F49D512-0A23-4D2D-959B-A1756991E817||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/CM2|||||CYLINDER||||HIGH|NOT DONE|||GASTRIC FLUID|AGGLUTINATED|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|Y|NA||5||7||TREATMENT|1965-12-30|1962-05-29|||||1961-10-21||1973-06-20
TRIAL STUDY 134XCP|IS|E884C56C-1612-49CC-A594-B65E7B354842||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||%(W/W)|||||APS U||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|LACTESCENT|Y|BRDU CELLULAR PROLIFERATION ASSAY|Y|U|Y||1||38||LONG-TERM FOLLOW-UP|1972-08-02|1970-12-31|||||1960-09-27||1968-01-16
TRIAL STUDY 134XCP|IS|E884C56C-1612-49CC-A594-B65E7B354842||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIPE|||||UKAT/L||||HIGH|NOT DONE|||WHITE MATTER TISSUE|AGGLUTINATED|NA|CONTRAST ENHANCED CT SCAN|N|U|Y||2||58||OPEN LABEL TREATMENT|1966-03-13|1967-06-21|||||1965-05-01||1965-06-09
TRIAL STUDY 134XCP|IS|E884C56C-1612-49CC-A594-B65E7B354842||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG2/DL2|||||VG/ML||||LOW|NOT DONE|||PUS|NON-HEMOLYZED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|Y|U||3||39||OPEN LABEL TREATMENT|1965-03-04|1965-11-30|||||1964-02-20||1960-10-27
TRIAL STUDY 134XCP|IS|E884C56C-1612-49CC-A594-B65E7B354842||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FMOL/L|||||PACK YEAR||||NORMAL|NOT DONE|||DIALYSIS FLUID|LIPEMIC|NA|ENZYMATIC COLORIMETRY|NA|U|NA||4||88||OBSERVATION|1963-07-11|1972-10-09|||||1965-02-04||1960-10-31
TRIAL STUDY 134XCP|IS|E884C56C-1612-49CC-A594-B65E7B354842||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/KG|||||U/DL||||LOW|NOT DONE|||BASAL TEAR|FRESH|U|ACID FAST STAIN|Y|U|N||5||7||TREATMENT|1970-06-18|1968-12-15|||||1970-03-19||1971-09-19
TRIAL STUDY 134XCP|IS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/G|||||FG||||LOW|NOT DONE|||WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|U|PLETHYSMOGRAPHY|NA|Y|NA||1||38||LONG-TERM FOLLOW-UP|1960-11-10|1960-03-25|||||1968-06-17||1962-05-13
TRIAL STUDY 134XCP|IS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/L/H|||||ABSORBANCE U/MIN||||HIGH|NOT DONE|||PLATELET RICH PLASMA|CLOTTED|Y|IMMUNOFIXATION ELECTROPHORESIS|Y|U|U||2||58||SCREENING|1967-01-31|1970-09-05|||||1968-12-29||1962-11-09
TRIAL STUDY 134XCP|IS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KG|||||U.CARR||||HIGH|NOT DONE|||MUCUS|CONCENTRATED|Y|KARYOTYPING|NA|NA|N||3||39||TREATMENT|1964-06-19|1970-10-19|||||1961-10-05||1962-04-22
TRIAL STUDY 134XCP|IS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PACK YEAR|||||10^10/L||||ABNORMAL|NOT DONE|||LYSATE|CONCENTRATED|N|TRANSVAGINAL ULTRASOUND|Y|N|Y||4||88||WASHOUT|1962-03-28|1963-01-09|||||1964-03-26||1966-04-03
TRIAL STUDY 134XCP|IS|673EFD33-EEDA-4C97-A9F0-86377D7F8CDF||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/MG|||||%/S||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|SOLIDIFIED|N|NUCLEAR RADIOLOGY|N|N|NA||5||7||FOLLOW-UP|1964-04-10|1972-06-23|||||1966-01-29||1961-05-12
TRIAL STUDY 134XCP|IS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TROCHE|||||ENZYME U||||NORMAL|NOT DONE|||EPITHELIAL CELL|THAWED|NA|AURAMINE STAIN|N|NA|Y||1||38||BLINDED TREATMENT|1972-06-12|1960-05-21|||||1968-11-09||1970-09-05
TRIAL STUDY 134XCP|IS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/L|||||MIU/L||||NORMAL|NOT DONE|||PUS|GELLED|NA|AUTOMATED COUNT|N|N|NA||2||58||INDUCTION TREATMENT|1971-12-24|1969-01-09|||||1973-03-11||1965-06-07
TRIAL STUDY 134XCP|IS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||CY/CM||||NORMAL|NOT DONE|||AQUEOUS HUMOR|ROOM TEMPERATURE|N|QUANTITATIVE ULTRASOUND|Y|NA|Y||3||39||BLINDED TREATMENT|1960-07-09|1966-11-22|||||1969-04-17||1967-12-02
TRIAL STUDY 134XCP|IS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MMAL|||||ELISA UNIT/DOSE||||LOW|NOT DONE|||PLASMA|LACTESCENT|N|SLOAN LETTER EYE CHART 2.5%|NA|N|NA||4||88||BASELINE|1969-03-14|1961-02-16|||||1961-03-22||1964-07-31
TRIAL STUDY 134XCP|IS|38AFE156-84DA-4A6D-BF49-9B634D4DD27E||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CFU/ML|||||PSEC||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|N|MACRO BROTH DILUTION|U|N|U||5||7||OBSERVATION|1973-06-22|1964-09-10|||||1966-05-17||1968-07-05
TRIAL STUDY 134XCP|IS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PACKAGE|||||DRAM||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|REFRIGERATED|NA|CONFOCAL MICROSCOPY|NA|NA|NA||1||38||CONTINUATION TREATMENT|1966-02-16|1961-11-15|||||1960-11-03||1966-07-05
TRIAL STUDY 134XCP|IS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PHERESIS UNIT|||||MCI/L||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|CLOTTED|U|PHOROPTER|NA|Y|Y||2||58||OBSERVATION|1970-01-23|1968-12-16|||||1968-08-06||1965-05-10
TRIAL STUDY 134XCP|IS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DAYS/WK|||||DPM/ML||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE|Y|AUTOREFRACTION|U|Y|U||3||39||BLINDED TREATMENT|1971-04-17|1972-03-15|||||1967-08-18||1968-06-19
TRIAL STUDY 134XCP|IS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PELLET|||||GPL U||||HIGH|NOT DONE|||HAIR|ICTERIC|N|CLAUSS METHOD|U|Y|U||4||88||WASHOUT|1971-08-09|1970-08-16|||||1972-07-28||1973-06-07
TRIAL STUDY 134XCP|IS|4E8E9ED2-EC93-4023-8F5D-BCD759F92604||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/G/DAY|||||MAMP||||HIGH|NOT DONE|||TISSUE|PARAFFIN-EMBEDDED|N|FLUORESCENT MICROSCOPY|U|N|U||5||7||FOLLOW-UP|1971-08-15|1971-01-01|||||1960-01-27||1960-11-19
TRIAL STUDY 134XCP|IS|0B140787-9458-4F66-B7E9-1FAFF239085E||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KV|||||ML/MMHG/MIN/L||||HIGH|NOT DONE|||PLATELET POOR PLASMA|SOLIDIFIED|NA|VIRUS PLAQUE ASSAY|NA|Y|N||1||38||SCREENING|1970-06-22|1972-01-19|||||1967-05-22||1961-04-03
TRIAL STUDY 134XCP|IS|0B140787-9458-4F66-B7E9-1FAFF239085E||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DDU|||||MESF||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|CONTAMINATED|NA|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|NA|U||2||58||LONG-TERM FOLLOW-UP|1963-06-18|1966-09-13|||||1968-09-21||1961-02-23
TRIAL STUDY 134XCP|IS|0B140787-9458-4F66-B7E9-1FAFF239085E||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KV|||||NMOL/L||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|CONTAMINATED|NA|ACCELERATOR MASS SPECTROMETRY|N|NA|NA||3||39||TREATMENT|1965-10-17|1970-06-07|||||1973-01-15||1967-11-12
TRIAL STUDY 134XCP|IS|0B140787-9458-4F66-B7E9-1FAFF239085E||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UV*SEC|||||MEQ/ML||||LOW|NOT DONE|||AMNIOTIC FLUID|FROZEN|Y|KINETIC CHROMOGENIC ASSAY|U|U|NA||4||88||BASELINE|1972-07-17|1968-11-18|||||1968-08-29||1970-10-01
TRIAL STUDY 134XCP|IS|0B140787-9458-4F66-B7E9-1FAFF239085E||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/KG|||||/100 WBC||||NORMAL|NOT DONE|||PERITONEAL FLUID|THAWED|U|REBOUND TONOMETRY|U|N|NA||5||7||BASELINE|1963-12-25|1961-05-31|||||1966-02-11||1967-03-23
TRIAL STUDY 134XCP|IS|FB91BADF-308B-4F6A-90D0-032E93E20C4A||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||HEP|||||UG/M2||||ABNORMAL|NOT DONE|||BASAL TEAR|ROOM TEMPERATURE|N|OPTICAL MAPPING|NA|Y|N||1||38||OBSERVATION|1966-04-09|1960-06-09|||||1972-04-22||1972-04-15
TRIAL STUDY 134XCP|IS|FB91BADF-308B-4F6A-90D0-032E93E20C4A||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^3 RNA COPIES/ML|||||U/ML||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|CLOTTED|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NA|N|U||2||58||OBSERVATION|1964-04-21|1961-11-17|||||1969-01-05||1969-09-03
TRIAL STUDY 134XCP|IS|FB91BADF-308B-4F6A-90D0-032E93E20C4A||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MM|||||MMOL/KG||||ABNORMAL|NOT DONE|||LEUKOCYTE|ICTERIC|Y|X-RAY FLUORESCENCE SPECTROMETRY|NA|N|NA||3||39||RUN-IN|1968-07-11|1960-07-27|||||1966-02-04||1962-01-02
TRIAL STUDY 134XCP|IS|FB91BADF-308B-4F6A-90D0-032E93E20C4A||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS|||||LOG10 TCID 50/ML||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|DRIED|Y|FLUORESCENT SPOT TEST|NA|U|Y||4||88||FOLLOW-UP|1972-04-04|1967-02-02|||||1972-12-21||1971-08-14
TRIAL STUDY 134XCP|IS|FB91BADF-308B-4F6A-90D0-032E93E20C4A||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^3 DNA COPIES/ML|||||U/G HB||||LOW|NOT DONE|||EMESIS|PARAFFIN-EMBEDDED|NA|RAJI CELL EIA|N|U|Y||5||7||OBSERVATION|1970-09-01|1973-04-13|||||1969-10-06||1962-05-11
TRIAL STUDY 134XCP|IS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L/H|||||MSEC||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|N|RYAN BLUE STAIN|N|Y|U||1||38||BLINDED TREATMENT|1964-05-29|1968-04-30|||||1969-08-02||1967-11-08
TRIAL STUDY 134XCP|IS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPL U|||||FARAD||||NORMAL|NOT DONE|||TISSUE|GELLED|U|CONTRAST ENHANCED PET SCAN|Y|NA|Y||2||58||WASHOUT|1970-12-13|1966-03-31|||||1962-06-14||1971-10-30
TRIAL STUDY 134XCP|IS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/VF|||||G/KG/DAY||||LOW|NOT DONE|||SPERMATOZOON|HEMOLYZED|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|N|N|Y||3||39||BASELINE|1960-04-19|1960-07-24|||||1969-05-16||1964-03-13
TRIAL STUDY 134XCP|IS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MM2|||||UG/H||||LOW|NOT DONE|||SERUM|AGGLUTINATED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|N|NA||4||88||OPEN LABEL TREATMENT|1967-10-20|1961-06-13|||||1966-09-28||1972-07-28
TRIAL STUDY 134XCP|IS|5ECBD8DD-9C87-4FEC-9BFB-4D026F7870DC||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CIGAR|||||/100 WBC||||LOW|NOT DONE|||CERUMEN|LIPEMIC|Y|PERIPHERAL ANGIOGRAPHY|U|Y|N||5||7||WASHOUT|1963-11-23|1967-01-06|||||1969-09-23||1972-02-25
TRIAL STUDY 134XCP|IS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/KG/H|||||G/KG/DAY||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|THAWED|U|MODIFIED ACID FAST STAIN|NA|U|N||1||38||TREATMENT|1961-02-09|1965-07-19|||||1966-02-25||1961-11-25
TRIAL STUDY 134XCP|IS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||RNA COPIES/ML|||||GBQ/UG||||ABNORMAL|NOT DONE|||DERMAL TISSUE|DRIED|NA|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|N|N||2||58||FOLLOW-UP|1962-10-08|1962-04-08|||||1971-07-09||1967-07-23
TRIAL STUDY 134XCP|IS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||COAT|||||DAMOL/L||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|NA|LISSAMINE GREEN STAIN|N|N|U||3||39||LONG-TERM FOLLOW-UP|1961-11-26|1967-04-28|||||1966-08-12||1961-01-19
TRIAL STUDY 134XCP|IS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LB|||||ML/CAGE/DAY||||HIGH|NOT DONE|||LUNG SURFACTANT|FRESH|N|AUSCULTATION|NA|U|N||4||88||TREATMENT|1963-06-24|1967-05-28|||||1972-03-19||1961-04-23
TRIAL STUDY 134XCP|IS|35FD6533-D67E-4A66-BB63-B9FC87E5B1D1||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||OSM|||||HENRY||||NORMAL|NOT DONE|||PLEURAL FLUID|THAWED|Y|KLEIHAUER-BETKE|Y|NA|NA||5||7||CONTINUATION TREATMENT|1964-05-08|1965-01-28|||||1960-09-26||1964-06-05
TRIAL STUDY 134XCP|IS|3B583022-3A2C-4387-80A5-035E3FD111BD||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UKAT/L|||||GPL U/ML||||NORMAL|NOT DONE|||VENOUS BLOOD|PARAFFIN-EMBEDDED|N|FLUORESCENT SPOT TEST|Y|Y|Y||1||38||CONTINUATION TREATMENT|1967-02-01|1964-05-05|||||1962-09-12||1967-08-09
TRIAL STUDY 134XCP|IS|3B583022-3A2C-4387-80A5-035E3FD111BD||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||AMPULE|||||KPA||||LOW|NOT DONE|||SERUM|AUTOLYZED|U|MAMMOGRAPHY|U|Y|Y||2||58||BLINDED TREATMENT|1963-10-13|1969-07-30|||||1972-12-27||1972-07-14
TRIAL STUDY 134XCP|IS|3B583022-3A2C-4387-80A5-035E3FD111BD||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MM2|||||CMH2O/ML||||NORMAL|NOT DONE|||SOFT TISSUE|LACTESCENT|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|U|N||3||39||OPEN LABEL TREATMENT|1962-10-12|1964-05-29|||||1963-12-05||1969-09-04
TRIAL STUDY 134XCP|IS|3B583022-3A2C-4387-80A5-035E3FD111BD||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NG|||||NCI||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CALCIFIED|N|CLIP SEQUENCING|NA|N|Y||4||88||WASHOUT|1960-09-13|1965-01-01|||||1971-05-25||1968-02-27
TRIAL STUDY 134XCP|IS|3B583022-3A2C-4387-80A5-035E3FD111BD||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ROENTGEN|||||SQU/ML||||LOW|NOT DONE|||SUPERNATANT, PLASMA|CALCIFIED|Y|APPLANATION TONOMETRY|NA|NA|Y||5||7||RUN-IN|1969-04-07|1963-06-12|||||1962-02-07||1964-04-22
TRIAL STUDY 134XCP|IS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DPM/0.5 ML|||||RATIO||||NORMAL|NOT DONE|||PERSPIRATION|FRESH|Y|CELL BASED BIOASSAY|NA|U|U||1||38||LONG-TERM FOLLOW-UP|1969-06-09|1965-12-12|||||1961-07-27||1966-10-28
TRIAL STUDY 134XCP|IS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IU/KG/H|||||UG||||HIGH|NOT DONE|||TISSUE|LIPEMIC|NA|HIGH RESOLUTION MELT ANALYSIS|N|N|N||2||58||TREATMENT|1965-08-01|1966-02-26|||||1966-12-05||1963-03-12
TRIAL STUDY 134XCP|IS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/MIN|||||HOURS||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|CLOTTED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|NA|Y||3||39||WASHOUT|1966-10-19|1970-07-05|||||1969-12-12||1969-11-16
TRIAL STUDY 134XCP|IS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U/KG|||||NG/MOL||||HIGH|NOT DONE|||TRANSUDATE|CONTAMINATED|Y|AMSLER GRID|NA|N|Y||4||88||TREATMENT|1969-03-25|1973-05-22|||||1963-01-12||1967-03-31
TRIAL STUDY 134XCP|IS|62435514-5F72-4B2C-A6CE-CD80C06BF5AC||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS/G|||||CMOL/L||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|HEMOLYZED|Y|MICRONEUTRALIZATION ASSAY|U|Y|Y||5||7||BASELINE|1973-04-13|1973-05-16|||||1963-06-27||1971-08-11
TRIAL STUDY 134XCP|IS|B5370AC4-3185-48DC-B1BC-A00AE8496783||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PMOL/DAY|||||MMOL2/L2||||HIGH|NOT DONE|||CORD SERUM|AGGLUTINATED|Y|FLAME PHOTOMETRY|Y|Y|NA||1||38||SCREENING|1971-11-12|1972-05-22|||||1960-04-12||1961-03-08
TRIAL STUDY 134XCP|IS|B5370AC4-3185-48DC-B1BC-A00AE8496783||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^7 TCID 50/DOSE|||||MOL/MOL||||LOW|NOT DONE|||WHITE MATTER TISSUE|LIPEMIC|Y|ANTIBIOTIC AGAR SCREEN|U|Y|N||2||58||WASHOUT|1967-08-02|1972-11-08|||||1972-04-25||1961-10-24
TRIAL STUDY 134XCP|IS|B5370AC4-3185-48DC-B1BC-A00AE8496783||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/M2/MIN|||||ECL UNIT||||HIGH|NOT DONE|||ALVEOLAR AIR|AUTOLYZED|N|ACID FAST STAIN|NA|NA|NA||3||39||BASELINE|1963-04-26|1968-07-05|||||1964-02-24||1972-10-16
TRIAL STUDY 134XCP|IS|B5370AC4-3185-48DC-B1BC-A00AE8496783||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LINEAR FT*LB|||||CAPSULE||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|SOLIDIFIED|NA|TOLUIDINE BLUE STAIN|Y|Y|Y||4||88||OBSERVATION|1967-10-29|1972-01-31|||||1968-04-20||1967-08-04
TRIAL STUDY 134XCP|IS|B5370AC4-3185-48DC-B1BC-A00AE8496783||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IN2|||||LX||||ABNORMAL|NOT DONE|||SEMINAL FLUID|CONTAMINATED|U|WESTERN BLOT|Y|Y|Y||5||7||BASELINE|1960-06-08|1968-07-09|||||1970-11-29||1971-11-07
TRIAL STUDY 134XCP|IS|1112A903-1F2A-4583-BB9A-41DD206D5B4A||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/M2|||||10^7 PFU||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|ICTERIC|Y|INDIRECT IMMUNOFLUORESCENCE|N|Y|NA||1||38||LONG-TERM FOLLOW-UP|1970-12-11|1961-06-16|||||1967-09-29||1962-08-11
TRIAL STUDY 134XCP|IS|1112A903-1F2A-4583-BB9A-41DD206D5B4A||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DAYS/MONTH|||||NMOL BCE/NMOL||||NORMAL|NOT DONE|||SALIVA|HEMOLYZED|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|Y|U||2||58||SCREENING|1970-12-11|1960-05-04|||||1967-07-14||1962-03-18
TRIAL STUDY 134XCP|IS|1112A903-1F2A-4583-BB9A-41DD206D5B4A||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DYN|||||COPIES/UG||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CLOTTED|N|TRANSMISSION ELECTRON MICROSCOPY|NA|N|NA||3||39||OBSERVATION|1967-01-28|1967-02-14|||||1961-11-04||1961-09-24
TRIAL STUDY 134XCP|IS|1112A903-1F2A-4583-BB9A-41DD206D5B4A||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/M2|||||PMOL/10^9 CELLS||||NORMAL|NOT DONE|||BLOOD|GELLED|U|RADIOGRAPHY|N|N|Y||4||88||WASHOUT|1964-12-14|1963-10-23|||||1961-09-21||1969-11-04
TRIAL STUDY 134XCP|IS|1112A903-1F2A-4583-BB9A-41DD206D5B4A||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MCI/KG|||||COAT||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|DRIED|NA|AGAR DILUTION|Y|Y|NA||5||7||FOLLOW-UP|1965-10-04|1963-08-24|||||1961-07-27||1962-07-07
TRIAL STUDY 134XCP|IS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/M2/MIN|||||MG/MIN||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|AGGLUTINATED|Y|MAPH|NA|NA|Y||1||38||TREATMENT|1972-02-04|1964-09-19|||||1967-10-11||1972-07-14
TRIAL STUDY 134XCP|IS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KDA|||||MOL/ML||||LOW|NOT DONE|||CELL PELLET|NON-HEMOLYZED|Y|ORCHIDOMETERY|NA|NA|N||2||58||CONTINUATION TREATMENT|1970-10-31|1973-04-26|||||1966-08-04||1964-09-24
TRIAL STUDY 134XCP|IS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^9/DOSE|||||DROP||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|U|NA|N||3||39||TREATMENT|1964-08-07|1960-08-04|||||1972-06-03||1961-05-26
TRIAL STUDY 134XCP|IS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTI-XA IU/ML|||||AMOL||||NORMAL|NOT DONE|||DERMAL TISSUE|LACTESCENT|U|MICROBIAL CULTURE|Y|N|N||4||88||INDUCTION TREATMENT|1960-04-06|1970-11-28|||||1965-12-31||1970-05-30
TRIAL STUDY 134XCP|IS|9629DBBC-72CC-4724-B78A-1B0DF9D801C8||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NMOL/ML/MIN|||||M2||||HIGH|NOT DONE|||PUS|REFRIGERATED|U|FARR ASSAY|N|U|Y||5||7||TREATMENT|1972-12-01|1966-07-06|||||1962-08-16||1963-03-28
TRIAL STUDY 134XCP|IS|D09F047E-E380-453B-875D-FF3C8C5EA839||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SQU/ML|||||UV*SEC||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|GELLED|Y|NEPHELOMETRY|NA|N|U||1||38||FOLLOW-UP|1961-04-06|1960-09-27|||||1966-04-01||1962-02-06
TRIAL STUDY 134XCP|IS|D09F047E-E380-453B-875D-FF3C8C5EA839||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 ORGANISMS/G|||||MM/MIN||||LOW|NOT DONE|||SWABBED MATERIAL|UNEXPECTED ODOR|U|CLIP|U|U|N||2||58||INDUCTION TREATMENT|1964-01-21|1960-08-11|||||1965-06-26||1971-12-01
TRIAL STUDY 134XCP|IS|D09F047E-E380-453B-875D-FF3C8C5EA839||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/SEC|||||ML/KG||||LOW|NOT DONE|||VITREOUS HUMOR|SOLIDIFIED|N|ACCELERATOR MASS SPECTROMETRY|NA|N|N||3||39||INDUCTION TREATMENT|1961-11-28|1960-03-17|||||1970-05-22||1962-06-27
TRIAL STUDY 134XCP|IS|D09F047E-E380-453B-875D-FF3C8C5EA839||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CIGARETTE|||||G/MOL||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|NON-HEMOLYZED|N|CALIPER MEASUREMENT METHOD|U|Y|NA||4||88||WASHOUT|1966-12-30|1964-11-13|||||1972-03-23||1967-07-27
TRIAL STUDY 134XCP|IS|D09F047E-E380-453B-875D-FF3C8C5EA839||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PA|||||PT_BR||||LOW|NOT DONE|||PROSTATIC FLUID|FROZEN|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|NA|N||5||7||INDUCTION TREATMENT|1972-06-30|1961-10-31|||||1965-06-21||1962-01-01
TRIAL STUDY 134XCP|IS|E1B16559-B9CA-4B14-A77A-4AD546EF5262||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FINGERTIP UNIT|||||CONTAINER||||HIGH|NOT DONE|||CAPILLARY BLOOD|CONTAMINATED|U|ANTIMICROBIAL COMBINATION TESTING|N|N|N||1||38||WASHOUT|1970-10-18|1967-09-01|||||1961-08-26||1965-10-24
TRIAL STUDY 134XCP|IS|E1B16559-B9CA-4B14-A77A-4AD546EF5262||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SIEMENS|||||PKAT/L||||NORMAL|NOT DONE|||VITREOUS HUMOR|GELLED|NA|DIFFUSION TENSOR MRI|Y|NA|NA||2||58||FOLLOW-UP|1963-12-24|1970-04-15|||||1967-02-10||1968-06-09
TRIAL STUDY 134XCP|IS|E1B16559-B9CA-4B14-A77A-4AD546EF5262||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/L|||||UG/MOL||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|NA|CALCULATION|U|NA|Y||3||39||OBSERVATION|1969-10-21|1969-12-17|||||1965-05-11||1960-05-30
TRIAL STUDY 134XCP|IS|E1B16559-B9CA-4B14-A77A-4AD546EF5262||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MIN/KPA|||||OHM||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|NON-HEMOLYZED|NA|FARR ASSAY|NA|Y|N||4||88||SCREENING|1961-09-19|1961-07-02|||||1969-09-22||1968-08-05
TRIAL STUDY 134XCP|IS|E1B16559-B9CA-4B14-A77A-4AD546EF5262||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TROCHE|||||NMOL/L/MIN||||LOW|NOT DONE|||PLEURAL TISSUE|NON-HEMOLYZED|U|DOPPLER ULTRASOUND|N|Y|U||5||7||BASELINE|1960-02-13|1963-07-02|||||1961-09-13||1964-11-04
TRIAL STUDY 134XCP|IS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||STEPS|||||BQ/ML||||ABNORMAL|NOT DONE|||VENOUS PLASMA|THAWED|U|KARYOTYPING|N|NA|Y||1||38||OBSERVATION|1961-02-02|1973-06-08|||||1965-11-02||1973-05-06
TRIAL STUDY 134XCP|IS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ELISA UNIT/DOSE|||||U/M2||||LOW|NOT DONE|||PLASMA|UNEXPECTED ODOR|N|LANDOLT RING|N|N|U||2||58||CONTINUATION TREATMENT|1970-07-30|1964-09-17|||||1960-04-19||1966-03-01
TRIAL STUDY 134XCP|IS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KG/CM|||||MBQ||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|LIPEMIC|U|IN VITRO GENE EXPRESSION ASSAY|Y|U|Y||3||39||BASELINE|1962-01-13|1972-03-10|||||1970-04-13||1961-07-16
TRIAL STUDY 134XCP|IS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 ORGANISMS|||||ML/CAGE||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|NA|AUDIOMETRY|N|U|U||4||88||TREATMENT|1972-10-18|1967-10-10|||||1960-09-03||1967-06-08
TRIAL STUDY 134XCP|IS|9B2E46E3-B769-40D8-8484-DA3D2BFF2EAA||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PL|||||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE|||EXPIRED AIR|GELLED|Y|PHASE-CONTRAST MRI|NA|Y|Y||5||7||RUN-IN|1972-02-13|1965-09-11|||||1961-02-09||1970-11-20
TRIAL STUDY 134XCP|IS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^12 IU/L|||||ML/KG/H||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|DRIED|NA|REFLECTANCE SPECTROSCOPY|NA|U|Y||1||38||INDUCTION TREATMENT|1960-12-28|1969-07-07|||||1969-10-28||1966-05-23
TRIAL STUDY 134XCP|IS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMOL/KG|||||%/S||||HIGH|NOT DONE|||PUS|DRIED|U|OBSERVATION|Y|NA|N||2||58||INDUCTION TREATMENT|1972-02-15|1964-04-08|||||1970-01-07||1962-04-13
TRIAL STUDY 134XCP|IS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CAPSULE|||||UIU/L||||ABNORMAL|NOT DONE|||REFLEX TEAR|FRESH|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|NA|N|Y||3||39||BLINDED TREATMENT|1970-12-23|1971-03-04|||||1968-01-10||1962-04-17
TRIAL STUDY 134XCP|IS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DPM/ML|||||/DAY||||HIGH|NOT DONE|||ERYTHROCYTES|AGGLUTINATED|Y|RIA|NA|Y|U||4||88||OPEN LABEL TREATMENT|1972-02-01|1972-01-30|||||1969-11-04||1969-10-26
TRIAL STUDY 134XCP|IS|7541A7A7-9A6D-4973-80B6-D4D85459C4D2||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/KG/H|||||FFU||||NORMAL|NOT DONE|||LUNG SURFACTANT|CONCENTRATED|U|RIA|Y|U|N||5||7||CONTINUATION TREATMENT|1971-03-05|1961-04-22|||||1969-07-30||1966-03-07
TRIAL STUDY 134XCP|IS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/G/DAY|||||PKAT/L||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|HEMOLYZED|NA|MALDI-TOF|N|N|N||1||38||RUN-IN|1965-05-20|1966-06-14|||||1969-03-27||1969-05-07
TRIAL STUDY 134XCP|IS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6/EJACULATE U|||||ENZYME U/G HB||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|FRESH|NA|ANGIOGRAPHY|U|U|N||2||58||OBSERVATION|1964-06-15|1968-12-03|||||1965-10-30||1961-02-11
TRIAL STUDY 134XCP|IS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KPA|||||ML/M2||||HIGH|NOT DONE|||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|U|DOPPLER ULTRASOUND|N|N|N||3||39||BASELINE|1973-05-05|1967-06-24|||||1966-11-26||1973-02-28
TRIAL STUDY 134XCP|IS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ARBITRARY U|||||10^6 U||||LOW|NOT DONE|||AMNIOTIC FLUID|LACTESCENT|N|LIGHT MICROSCOPY|N|N|Y||4||88||SCREENING|1971-08-30|1960-07-31|||||1967-03-19||1967-06-03
TRIAL STUDY 134XCP|IS|0EEE28CE-22B1-4908-9FCE-CE8BB4ED12D8||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/DAY|||||ML/MIN||||LOW|NOT DONE|||PLATELET POOR PLASMA|LACTESCENT|Y|CONGO RED STAIN|U|U|N||5||7||OBSERVATION|1973-01-21|1972-12-26|||||1962-01-09||1961-06-28
TRIAL STUDY 134XCP|IS|44199000-F1B7-4187-9E5A-AA5F69E831C3||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||COAT|||||TUBERCULIN UNIT||||LOW|NOT DONE|||BREAST MILK|CALCIFIED|NA|RAJI CELL RIA|U|N|U||1||38||LONG-TERM FOLLOW-UP|1966-04-27|1966-02-27|||||1971-07-06||1964-09-18
TRIAL STUDY 134XCP|IS|44199000-F1B7-4187-9E5A-AA5F69E831C3||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CAPLET|||||MMOL/DAY||||LOW|NOT DONE|||SEBUM|FROZEN|N|PYROSEQUENCING|U|Y|NA||2||58||SCREENING|1970-02-17|1969-01-18|||||1964-12-20||1971-03-25
TRIAL STUDY 134XCP|IS|44199000-F1B7-4187-9E5A-AA5F69E831C3||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MIN/DAY|||||GTT||||ABNORMAL|NOT DONE|||PERSPIRATION|REFRIGERATED|NA|PYROSEQUENCING|NA|Y|U||3||39||CONTINUATION TREATMENT|1972-06-23|1973-05-25|||||1969-07-28||1962-09-06
TRIAL STUDY 134XCP|IS|44199000-F1B7-4187-9E5A-AA5F69E831C3||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/M2/DAY|||||MOL/MOL||||ABNORMAL|NOT DONE|||EMESIS|REFRIGERATED|Y|SPECULAR MICROSCOPY|Y|Y|Y||4||88||LONG-TERM FOLLOW-UP|1961-12-10|1967-03-21|||||1970-10-08||1960-09-13
TRIAL STUDY 134XCP|IS|44199000-F1B7-4187-9E5A-AA5F69E831C3||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BOWL|||||MM2||||LOW|NOT DONE|||WHITE MATTER TISSUE|DRIED|Y|SEQUENCING|Y|U|Y||5||7||BASELINE|1961-04-12|1968-04-03|||||1964-10-21||1965-01-04
TRIAL STUDY 134XCP|IS|1D487F49-92DB-4132-BD95-1B8797594DE7||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CI|||||ML/ANIMAL||||HIGH|NOT DONE|||SWABBED MATERIAL|DRIED|NA|ANTIBIOTIC AGAR SCREEN|NA|Y|NA||1||38||TREATMENT|1964-11-24|1971-10-09|||||1965-03-18||1960-08-06
TRIAL STUDY 134XCP|IS|1D487F49-92DB-4132-BD95-1B8797594DE7||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/HPF|||||MHZ||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|HEMOLYZED|U|BALLPOINT PEN TECHNIQUE|U|N|U||2||58||OPEN LABEL TREATMENT|1962-09-22|1972-08-20|||||1963-09-22||1972-12-28
TRIAL STUDY 134XCP|IS|1D487F49-92DB-4132-BD95-1B8797594DE7||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||OZ|||||MMOL/S||||LOW|NOT DONE|||URINE SEDIMENT|DRIED|Y|MICROSCOPY|N|U|NA||3||39||BLINDED TREATMENT|1962-08-15|1960-10-10|||||1971-07-28||1965-04-07
TRIAL STUDY 134XCP|IS|1D487F49-92DB-4132-BD95-1B8797594DE7||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/L|||||APPLICATION||||ABNORMAL|NOT DONE|||SERUM|UNEXPECTED ODOR|NA|VENTILATION PERFUSION LUNG SCAN|Y|Y|Y||4||88||OPEN LABEL TREATMENT|1966-08-31|1965-04-29|||||1970-04-23||1966-11-21
TRIAL STUDY 134XCP|IS|1D487F49-92DB-4132-BD95-1B8797594DE7||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||SUPPOSITORY|||||CONTAINER||||HIGH|NOT DONE|||BREAST MILK|ROOM TEMPERATURE|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|U|NA|U||5||7||BASELINE|1967-11-28|1973-03-07|||||1967-06-09||1969-06-11
TRIAL STUDY 134XCP|IS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/G/H|||||/40 HPFS||||LOW|NOT DONE|||CERUMEN|CALCIFIED|Y|FLUORESCENCE ANGIOGRAPHY|Y|NA|U||1||38||RUN-IN|1972-03-28|1965-02-26|||||1963-08-03||1970-04-30
TRIAL STUDY 134XCP|IS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MCI|||||DPM||||ABNORMAL|NOT DONE|||EXPIRED AIR|PARAFFIN-EMBEDDED|N|COMPLEMENT FIXATION|U|Y|U||2||58||BASELINE|1962-09-29|1971-02-10|||||1967-03-12||1969-10-27
TRIAL STUDY 134XCP|IS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PA|||||UEQ/L||||NORMAL|NOT DONE|||INFRANATANT, SERUM|AGGLUTINATED|Y|IMMUNO-PET SCAN|N|U|U||3||39||LONG-TERM FOLLOW-UP|1971-03-13|1964-06-01|||||1967-11-18||1970-07-24
TRIAL STUDY 134XCP|IS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PACKAGE|||||MOL/L||||HIGH|NOT DONE|||GASTRIC FLUID|CONCENTRATED|NA|MODIFIED ACID FAST STAIN|U|N|N||4||88||BASELINE|1963-07-30|1967-09-23|||||1966-10-17||1968-11-02
TRIAL STUDY 134XCP|IS|D282956F-CE78-4E8D-B99C-A3D75E09D2F5||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DNA COPIES/ML|||||U/M2/H||||NORMAL|NOT DONE|||LUNG SURFACTANT|CLOTTED|NA|RADIOIMMUNOPRECIPITATION ASSAY|NA|Y|NA||5||7||BLINDED TREATMENT|1973-02-23|1967-09-24|||||1962-01-03||1972-08-18
TRIAL STUDY 134XCP|IS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TUBERCULIN UNIT|||||UG/KG/DAY||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|UNEXPECTED ODOR|N|CHROMATOGRAPHY|N|U|N||1||38||INDUCTION TREATMENT|1967-04-07|1971-01-28|||||1965-06-01||1963-01-12
TRIAL STUDY 134XCP|IS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PSI|||||SACHET||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|CONCENTRATED|Y|SNELLEN EYE CHART|N|U|NA||2||58||SCREENING|1973-07-25|1972-01-27|||||1963-02-27||1971-09-01
TRIAL STUDY 134XCP|IS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMU/ML|||||KS||||HIGH|NOT DONE|||BONE|ICTERIC|N|IMMUNORADIOMETRIC ASSAY|Y|U|Y||3||39||INDUCTION TREATMENT|1967-01-06|1960-03-03|||||1964-05-05||1966-12-20
TRIAL STUDY 134XCP|IS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/MG|||||SCM||||HIGH|NOT DONE|||BLOOD|CONCENTRATED|Y|THIN SMEAR|N|NA|NA||4||88||BLINDED TREATMENT|1965-12-22|1964-01-15|||||1961-01-27||1962-10-20
TRIAL STUDY 134XCP|IS|C0A58AAC-7317-4204-9C9D-974DB1BB38EF||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MIN*MG/ML|||||G/CAGE/WK||||ABNORMAL|NOT DONE|||TRANSUDATE|AGGLUTINATED|N|INDIA INK STAIN|NA|NA|U||5||7||OPEN LABEL TREATMENT|1965-12-26|1967-10-30|||||1966-08-24||1965-06-19
TRIAL STUDY 134XCP|IS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||STEPS/MIN|||||G/ANIMAL/WK||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|CONCENTRATED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|Y|NA||1||38||LONG-TERM FOLLOW-UP|1972-01-16|1973-01-21|||||1961-02-20||1969-01-31
TRIAL STUDY 134XCP|IS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BAG|||||MANSON U/ML||||HIGH|NOT DONE|||LUNG SURFACTANT|AGGLUTINATED|NA|MICRONEUTRALIZATION ASSAY|Y|NA|U||2||58||BASELINE|1970-06-29|1962-08-01|||||1970-06-28||1961-01-19
TRIAL STUDY 134XCP|IS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IMPLANT|||||/MM2||||NORMAL|NOT DONE|||INFRANATANT, SERUM|GELLED|NA|DOPPLER ULTRASOUND|N|U|U||3||39||INDUCTION TREATMENT|1964-05-29|1970-09-28|||||1966-08-24||1964-10-18
TRIAL STUDY 134XCP|IS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SQU/ML|||||CPM||||LOW|NOT DONE|||SKIN TISSUE|CONTAMINATED|Y|PET/CT SCAN WITHOUT CONTRAST|N|N|U||4||88||CONTINUATION TREATMENT|1967-06-06|1966-05-24|||||1972-07-04||1961-02-17
TRIAL STUDY 134XCP|IS|B4AA4759-A825-4E0A-B55D-39B8F473B6A5||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MHZ|||||U/KG/MIN||||ABNORMAL|NOT DONE|||LOCHIA|CLOTTED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|N|U|N||5||7||SCREENING|1968-10-20|1969-05-26|||||1963-04-05||1963-07-04
TRIAL STUDY 134XCP|IS|33233744-4E16-437D-852B-B5F2CCC94B1A||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||FT3|||||MAC50||||ABNORMAL|NOT DONE|||NAIL|FRESH|U|LC/MS|N|NA|U||1||38||WASHOUT|1971-04-11|1967-09-16|||||1964-05-15||1960-03-18
TRIAL STUDY 134XCP|IS|33233744-4E16-437D-852B-B5F2CCC94B1A||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MU/G|||||/MONTH||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|ROOM TEMPERATURE|N|HPLC-FL|U|U|Y||2||58||INDUCTION TREATMENT|1966-05-24|1969-11-06|||||1973-05-31||1966-05-11
TRIAL STUDY 134XCP|IS|33233744-4E16-437D-852B-B5F2CCC94B1A||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PMOL/L/H|||||ML/ANIMAL||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|THAWED|Y|PET/SPECT SCAN|N|Y|U||3||39||BASELINE|1960-11-18|1972-08-17|||||1970-11-19||1962-11-26
TRIAL STUDY 134XCP|IS|33233744-4E16-437D-852B-B5F2CCC94B1A||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/CM3/MIN|||||MG||||HIGH|NOT DONE|||TRANSUDATE|CONTAMINATED|NA|CENTRIFUGATION|Y|NA|N||4||88||TREATMENT|1970-01-21|1960-08-28|||||1966-05-29||1969-03-07
TRIAL STUDY 134XCP|IS|33233744-4E16-437D-852B-B5F2CCC94B1A||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MIN/DAY|||||MM2||||ABNORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|AGGLUTINATED|U|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|N|NA|N||5||7||SCREENING|1962-01-08|1967-06-24|||||1962-02-11||1963-12-03
TRIAL STUDY 134XCP|IS|B27DC754-F6E2-41E3-9804-0F92AE0006B4||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TUBERCULIN UNIT/ML|||||MG/M2/H||||ABNORMAL|NOT DONE|||TRANSUDATE|THAWED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NA|N|N||1||38||OBSERVATION|1973-06-21|1969-01-26|||||1966-12-06||1965-08-30
TRIAL STUDY 134XCP|IS|B27DC754-F6E2-41E3-9804-0F92AE0006B4||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/ANIMAL/WK|||||PT_US||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|CONTAMINATED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|N||2||58||OPEN LABEL TREATMENT|1963-10-20|1964-04-23|||||1966-08-08||1970-06-07
TRIAL STUDY 134XCP|IS|B27DC754-F6E2-41E3-9804-0F92AE0006B4||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MET|||||OI50||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|ICTERIC|Y|MACRO BROTH DILUTION|Y|N|NA||3||39||INDUCTION TREATMENT|1969-08-14|1971-10-18|||||1962-03-04||1961-04-07
TRIAL STUDY 134XCP|IS|B27DC754-F6E2-41E3-9804-0F92AE0006B4||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ATM|||||SACHET||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED|N|CONTRAST ENHANCED MRI|U|NA|Y||4||88||INDUCTION TREATMENT|1968-03-05|1967-12-17|||||1966-04-25||1962-10-28
TRIAL STUDY 134XCP|IS|B27DC754-F6E2-41E3-9804-0F92AE0006B4||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PACK YEAR|||||MG2/DL2||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|CONCENTRATED|N|ENDOSCOPY|N|U|NA||5||7||OBSERVATION|1967-01-30|1971-07-25|||||1967-01-03||1961-09-25
TRIAL STUDY 134XCP|IS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PNU/ML|||||G/CM2||||HIGH|NOT DONE|||DERMAL TISSUE|THAWED|U|PHOTOGRAPHY|Y|U|N||1||38||OBSERVATION|1969-10-02|1969-10-12|||||1972-09-05||1966-09-01
TRIAL STUDY 134XCP|IS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SHOCK WAVE|||||10^12 IU/L||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|NON-HEMOLYZED|N|MICRODENSITOMETRY|N|U|Y||2||58||BASELINE|1964-01-25|1964-04-08|||||1971-10-13||1967-02-04
TRIAL STUDY 134XCP|IS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PFU|||||PUFF||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|AUTOLYZED|U|PLETHYSMOGRAPHY|N|N|Y||3||39||OPEN LABEL TREATMENT|1967-09-07|1963-11-28|||||1970-06-28||1963-07-23
TRIAL STUDY 134XCP|IS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FT2|||||RAD||||HIGH|NOT DONE|||CORD BLOOD|LACTESCENT|NA|INDIA INK STAIN|NA|N|NA||4||88||BASELINE|1969-12-13|1964-06-10|||||1964-12-26||1960-10-17
TRIAL STUDY 134XCP|IS|7C02E71C-2BCF-4F4A-BC4C-1A7C72264CE6||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/KG/DAY|||||/WK||||HIGH|NOT DONE|||URINE|CALCIFIED|Y|TWO-COLOR MICROARRAY|Y|Y|N||5||7||OPEN LABEL TREATMENT|1970-03-13|1964-07-23|||||1962-02-08||1969-10-13
TRIAL STUDY 134XCP|IS|BDE843D8-2F69-4542-BC47-D52302FD4898||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EJACULATE U|||||CI/L||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|LIPEMIC|NA|SPECULAR MICROSCOPY|N|N|NA||1||38||FOLLOW-UP|1962-02-12|1960-10-22|||||1966-02-02||1963-12-16
TRIAL STUDY 134XCP|IS|BDE843D8-2F69-4542-BC47-D52302FD4898||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/G/DAY|||||POUCH||||HIGH|NOT DONE|||DISCHARGE|SOLIDIFIED|N|INFRARED SPECTROMETRY|NA|NA|N||2||58||OPEN LABEL TREATMENT|1962-05-17|1969-09-15|||||1971-09-25||1961-11-17
TRIAL STUDY 134XCP|IS|BDE843D8-2F69-4542-BC47-D52302FD4898||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMHG*MIN/L|||||DMOL||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|ROOM TEMPERATURE|NA|NUCLEIC ACID SEQUENCING|Y|U|Y||3||39||OBSERVATION|1969-04-29|1963-08-15|||||1970-06-11||1970-07-20
TRIAL STUDY 134XCP|IS|BDE843D8-2F69-4542-BC47-D52302FD4898||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/500 WBC|||||IU/KG||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|LIPEMIC|N|BALLPOINT PEN TECHNIQUE|Y|Y|N||4||88||CONTINUATION TREATMENT|1965-04-26|1968-05-17|||||1962-08-10||1960-11-04
TRIAL STUDY 134XCP|IS|BDE843D8-2F69-4542-BC47-D52302FD4898||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TRANSDUCING UNIT|||||TRANSDUCING UNIT/ML||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|DRIED|NA|RAJI CELL EIA|NA|Y|Y||5||7||WASHOUT|1968-06-28|1970-11-04|||||1966-12-17||1968-12-26
TRIAL STUDY 134XCP|IS|A8C8CB0C-C575-414C-BF1C-846361DB03BC||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SPRAY|||||UL/DOSE||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|CLOTTED|U|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|NA|NA|NA||1||38||RUN-IN|1963-05-15|1962-01-19|||||1971-12-22||1964-02-11
TRIAL STUDY 134XCP|IS|A8C8CB0C-C575-414C-BF1C-846361DB03BC||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||COPIES/UL|||||EID 50/DOSE||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|AGGLUTINATED|U|MICROBIAL CONCENTRATION|U|NA|Y||2||58||TREATMENT|1968-12-23|1968-04-28|||||1966-10-08||1969-09-29
TRIAL STUDY 134XCP|IS|A8C8CB0C-C575-414C-BF1C-846361DB03BC||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/MONTH|||||/CMH2O||||LOW|NOT DONE|||CORD BLOOD|NON-HEMOLYZED|NA|IMMUNOASSAY|U|N|Y||3||39||CONTINUATION TREATMENT|1962-08-19|1964-07-23|||||1973-03-27||1972-11-16
TRIAL STUDY 134XCP|IS|A8C8CB0C-C575-414C-BF1C-846361DB03BC||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NKAT|||||DDU||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|DRIED|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|U|NA|Y||4||88||FOLLOW-UP|1965-03-23|1972-10-10|||||1966-02-15||1971-07-25
TRIAL STUDY 134XCP|IS|A8C8CB0C-C575-414C-BF1C-846361DB03BC||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML*CMH2O|||||YD||||LOW|NOT DONE|||DISCHARGE|CLOTTED|N|SLOAN LETTER EYE CHART 2.5%|Y|NA|N||5||7||INDUCTION TREATMENT|1970-02-08|1965-12-23|||||1966-09-10||1967-02-17
TRIAL STUDY 134XCP|IS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CYLINDER|||||FIU||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|CONTAMINATED|N|IMMUNOPRECIPITATION|U|U|U||1||38||FOLLOW-UP|1971-01-27|1973-06-20|||||1964-03-19||1969-12-05
TRIAL STUDY 134XCP|IS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMOL|||||G/DL||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|ICTERIC|N|PYROSEQUENCING|N|Y|N||2||58||FOLLOW-UP|1972-07-25|1961-07-04|||||1960-05-11||1963-10-20
TRIAL STUDY 134XCP|IS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CL|||||L/S||||ABNORMAL|NOT DONE|||COLOSTRUM|ROOM TEMPERATURE|NA|CENTRIFUGATION|Y|NA|N||3||39||BLINDED TREATMENT|1967-07-23|1961-03-05|||||1966-02-03||1966-06-17
TRIAL STUDY 134XCP|IS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||TCID 50/DOSE|||||DMOL||||LOW|NOT DONE|||GASTRIC FLUID|CONTAMINATED|NA|MOUSE PROTECTION ASSAY|NA|N|U||4||88||FOLLOW-UP|1972-05-28|1968-09-12|||||1973-01-17||1965-07-30
TRIAL STUDY 134XCP|IS|77CD8958-0AEF-463F-8F72-2BD24B23AD3A||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MOSM/L|||||NMOL BCE/MMOL||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|ICTERIC|N|FLOW MICROSCOPY|NA|NA|U||5||7||OBSERVATION|1971-07-20|1970-06-09|||||1964-08-10||1973-07-08
TRIAL STUDY 134XCP|IS|86198851-0F45-45E0-A0CE-C50FEC078456||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KDA|||||G/M2/DAY||||LOW|NOT DONE|||LAVAGE FLUID|PARAFFIN-EMBEDDED|N|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|N|U|Y||1||38||LONG-TERM FOLLOW-UP|1964-06-29|1960-10-10|||||1964-03-05||1965-10-04
TRIAL STUDY 134XCP|IS|86198851-0F45-45E0-A0CE-C50FEC078456||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/KG/DAY|||||BU||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|UNEXPECTED ODOR|Y|FISH|U|U|U||2||58||OBSERVATION|1967-10-18|1961-12-09|||||1963-06-21||1961-04-08
TRIAL STUDY 134XCP|IS|86198851-0F45-45E0-A0CE-C50FEC078456||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U.CARR|||||PG||||HIGH|NOT DONE|||MECONIUM|ROOM TEMPERATURE|N|SPECT SCAN|U|Y|NA||3||39||CONTINUATION TREATMENT|1963-02-03|1963-04-27|||||1963-09-06||1966-09-10
TRIAL STUDY 134XCP|IS|86198851-0F45-45E0-A0CE-C50FEC078456||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/G/MIN|||||UG/KG||||LOW|NOT DONE|||CALCULUS|AGGLUTINATED|N|IMMUNOCHROMATOGRAPHY|NA|Y|N||4||88||BLINDED TREATMENT|1970-04-25|1965-09-16|||||1968-05-13||1971-03-17
TRIAL STUDY 134XCP|IS|86198851-0F45-45E0-A0CE-C50FEC078456||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NG/DAY|||||ELISA UNIT||||NORMAL|NOT DONE|||BASAL TEAR|SOLIDIFIED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|U|U|Y||5||7||LONG-TERM FOLLOW-UP|1962-08-19|1972-11-17|||||1971-08-26||1962-03-04
TRIAL STUDY 134XCP|IS|9CD28016-BED9-4159-9C1B-60821D74615B||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/H|||||STRIP||||ABNORMAL|NOT DONE|||URINE SEDIMENT|AUTOLYZED|NA|MECHANICAL CLOT DETECTION|NA|U|N||1||38||OBSERVATION|1965-04-18|1964-11-30|||||1964-12-28||1961-04-13
TRIAL STUDY 134XCP|IS|9CD28016-BED9-4159-9C1B-60821D74615B||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MOSM/L|||||MS/MMHG||||ABNORMAL|NOT DONE|||FLUID|GELLED|U|MICROBIAL CONCENTRATION|Y|U|N||2||58||FOLLOW-UP|1971-01-18|1969-02-09|||||1968-03-19||1968-04-13
TRIAL STUDY 134XCP|IS|9CD28016-BED9-4159-9C1B-60821D74615B||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||USEC|||||ML/ANIMAL||||HIGH|NOT DONE|||TRANSUDATE|HEMOLYZED|U|CLAUSS METHOD|U|U|N||3||39||SCREENING|1971-11-21|1963-11-25|||||1963-04-08||1969-11-10
TRIAL STUDY 134XCP|IS|9CD28016-BED9-4159-9C1B-60821D74615B||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MKAT|||||/HPF||||HIGH|NOT DONE|||LYMPH|NON-HEMOLYZED|U|NUCLEIC ACID BASED METHOD|N|Y|U||4||88||SCREENING|1970-04-23|1968-04-19|||||1962-07-15||1970-09-23
TRIAL STUDY 134XCP|IS|9CD28016-BED9-4159-9C1B-60821D74615B||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/DL|||||LOG10 TCID 50/ML||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|THAWED|Y|AUTOMATED COUNT|Y|U|N||5||7||BASELINE|1972-01-25|1965-12-06|||||1965-08-02||1963-09-07
TRIAL STUDY 134XCP|IS|BE578D25-C23E-416F-8A57-C901F7B58596||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/L|||||QUANTITY SUFFICIENT||||ABNORMAL|NOT DONE|||CELL PELLET|FROZEN|Y|PET/CT SCAN WITHOUT CONTRAST|Y|NA|NA||1||38||LONG-TERM FOLLOW-UP|1961-02-27|1966-04-28|||||1970-09-03||1968-04-25
TRIAL STUDY 134XCP|IS|BE578D25-C23E-416F-8A57-C901F7B58596||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||P|||||MU||||HIGH|NOT DONE|||HAIR FOLLICLE|SOLIDIFIED|N|APPLANATION TONOMETRY|U|N|U||2||58||LONG-TERM FOLLOW-UP|1972-07-14|1963-04-20|||||1973-06-14||1966-03-21
TRIAL STUDY 134XCP|IS|BE578D25-C23E-416F-8A57-C901F7B58596||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PFU/ML|||||PKAT||||NORMAL|NOT DONE|||GASTRIC CONTENTS|FROZEN|N|GC/FID|N|NA|NA||3||39||OPEN LABEL TREATMENT|1960-10-29|1963-02-24|||||1968-04-14||1960-04-14
TRIAL STUDY 134XCP|IS|BE578D25-C23E-416F-8A57-C901F7B58596||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BOWL|||||KIT||||LOW|NOT DONE|||AMNIOTIC FLUID|DRIED|N|ETDRS EYE CHART|Y|N|NA||4||88||BASELINE|1960-11-11|1971-01-26|||||1967-11-05||1969-06-27
TRIAL STUDY 134XCP|IS|BE578D25-C23E-416F-8A57-C901F7B58596||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||HOURS|||||ML/SEC/1.73M2||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|LIPEMIC|NA|CONTACT SPECULAR MICROSCOPY|N|NA|NA||5||7||BASELINE|1961-02-01|1961-04-25|||||1969-11-08||1968-11-26
TRIAL STUDY 134XCP|IS|A60D5FE6-26BA-487D-98E0-5F464305924C||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6/G|||||NMOL/G||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|SOLIDIFIED|NA|VENTILATION PERFUSION LUNG SCAN|Y|NA|NA||1||38||BLINDED TREATMENT|1966-12-24|1972-12-15|||||1960-11-04||1972-11-28
TRIAL STUDY 134XCP|IS|A60D5FE6-26BA-487D-98E0-5F464305924C||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ENZYME U/L|||||ENZYME U/M2||||NORMAL|NOT DONE|||EMESIS|FROZEN|NA|ELECTROCHEMILUMINESCENCE|U|NA|Y||2||58||OBSERVATION|1968-02-25|1964-08-14|||||1963-02-10||1964-06-27
TRIAL STUDY 134XCP|IS|A60D5FE6-26BA-487D-98E0-5F464305924C||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/KG/MIN|||||CI/KG||||NORMAL|NOT DONE|||SYNOVIAL FLUID|FROZEN|N|GC/MS/MS|NA|NA|NA||3||39||TREATMENT|1962-12-06|1962-07-27|||||1966-10-28||1965-02-06
TRIAL STUDY 134XCP|IS|A60D5FE6-26BA-487D-98E0-5F464305924C||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UGEQ/L|||||IU/G HB||||LOW|NOT DONE|||ADIPOSE TISSUE|CALCIFIED|U|MAGNETIC RESONANCE ENTEROGRAPHY|NA|Y|N||4||88||CONTINUATION TREATMENT|1961-10-25|1968-11-20|||||1964-01-16||1970-01-09
TRIAL STUDY 134XCP|IS|A60D5FE6-26BA-487D-98E0-5F464305924C||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/MBP|||||NMOL/MOL||||ABNORMAL|NOT DONE|||DISCHARGE|LACTESCENT|U|PANENDOSCOPY|Y|U|NA||5||7||FOLLOW-UP|1964-03-13|1972-08-14|||||1961-01-23||1971-09-12
TRIAL STUDY 134XCP|IS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 CFU/ML|||||CFU/ML||||HIGH|NOT DONE|||KERATINOCYTE|LACTESCENT|U|SPECULAR MICROSCOPY|Y|U|N||1||38||RUN-IN|1970-05-01|1964-11-19|||||1967-02-27||1971-10-08
TRIAL STUDY 134XCP|IS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/S|||||IU/L||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|SOLIDIFIED|U|AUDIOMETRY|Y|U|N||2||58||RUN-IN|1972-03-15|1961-06-16|||||1963-09-20||1968-08-27
TRIAL STUDY 134XCP|IS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/G|||||U/MMOL||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|LIPEMIC|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|NA|Y||3||39||TREATMENT|1964-06-20|1960-07-04|||||1963-01-13||1971-12-16
TRIAL STUDY 134XCP|IS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GY|||||U/MG||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|FROZEN|U|LC/MS|Y|NA|N||4||88||CONTINUATION TREATMENT|1970-12-07|1969-03-05|||||1971-10-21||1973-09-07
TRIAL STUDY 134XCP|IS|1984ECA3-6E24-44F0-AEDA-FC9772B60F82||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PMOL/L/H|||||PSEC||||NORMAL|NOT DONE|||MUCUS|FRESH|NA|PULSE OXIMETRY|N|N|U||5||7||OPEN LABEL TREATMENT|1963-08-17|1966-07-07|||||1971-04-06||1971-06-03
TRIAL STUDY 134XCP|IS|89739AE0-A8B9-44DE-970E-9D679ED58C4F||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CPM|||||UG/CM2||||NORMAL|NOT DONE|||SERUM OR PLASMA|DRIED|N|PALPATION|U|N|N||1||38||TREATMENT|1963-08-16|1968-07-27|||||1962-10-29||1973-06-12
TRIAL STUDY 134XCP|IS|89739AE0-A8B9-44DE-970E-9D679ED58C4F||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 CFU/G|||||CI/KG||||NORMAL|NOT DONE|||SERUM|AGGLUTINATED|NA|OLIGO ACGH|U|U|NA||2||58||BASELINE|1970-11-22|1960-02-05|||||1968-05-13||1962-07-17
TRIAL STUDY 134XCP|IS|89739AE0-A8B9-44DE-970E-9D679ED58C4F||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UKAT/10^12 RBC|||||ML/KG/DAY||||HIGH|NOT DONE|||BILE|SOLIDIFIED|Y|EEG|Y|Y|U||3||39||FOLLOW-UP|1960-04-20|1966-12-13|||||1964-07-31||1973-07-08
TRIAL STUDY 134XCP|IS|89739AE0-A8B9-44DE-970E-9D679ED58C4F||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI|||||HOMEOPATHIC DILUTION||||LOW|NOT DONE|||MUCUS|CLOTTED|NA|DYNAMOMETRY|NA|N|N||4||88||LONG-TERM FOLLOW-UP|1973-09-02|1969-01-04|||||1972-05-19||1964-06-22
TRIAL STUDY 134XCP|IS|89739AE0-A8B9-44DE-970E-9D679ED58C4F||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/M2|||||RATIO||||LOW|NOT DONE|||MONOCYTE|CLOTTED|Y|RADIATION DOSIMETRY|Y|N|U||5||7||OPEN LABEL TREATMENT|1970-08-05|1971-11-08|||||1966-03-31||1961-09-03
TRIAL STUDY 134XCP|IS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CIGARETTE|||||SBE/ML||||HIGH|NOT DONE|||INFRANATANT, SERUM|AUTOLYZED|N|QUANTITATIVE ULTRASOUND|NA|N|NA||1||38||WASHOUT|1962-02-04|1973-04-01|||||1966-06-13||1962-05-18
TRIAL STUDY 134XCP|IS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/ANIMAL/DAY|||||PA||||ABNORMAL|NOT DONE|||TRANSUDATE|ICTERIC|N|HEMATOXYLIN AND EOSIN STAIN|N|Y|N||2||58||BASELINE|1969-05-22|1965-06-17|||||1962-04-25||1966-08-08
TRIAL STUDY 134XCP|IS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CG|||||10^9 CFU/G||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|FROZEN|NA|RADIOIMMUNOPRECIPITATION ASSAY|N|Y|Y||3||39||SCREENING|1968-05-13|1973-05-06|||||1963-08-28||1971-03-05
TRIAL STUDY 134XCP|IS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KG/M2|||||CMH2O*S/ML||||NORMAL|NOT DONE|||SMEGMA|HEMOLYZED|N|POPULATION SEQUENCING|NA|U|U||4||88||OPEN LABEL TREATMENT|1961-10-22|1967-06-25|||||1973-01-09||1963-02-21
TRIAL STUDY 134XCP|IS|FEDCB4C0-17C0-4252-A09E-602D7D863FF8||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DAYS/MONTH|||||MBP||||HIGH|NOT DONE|||SUPERNATANT, SERUM|NON-HEMOLYZED|N|NUCLEIC ACID SEQUENCING|Y|Y|N||5||7||LONG-TERM FOLLOW-UP|1960-03-08|1969-07-23|||||1963-01-27||1961-01-31
TRIAL STUDY 134XCP|IS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PSI|||||BQ/MG||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|THAWED|U|ICC|Y|NA|NA||1||38||INDUCTION TREATMENT|1966-12-23|1968-05-27|||||1962-04-01||1965-02-20
TRIAL STUDY 134XCP|IS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BAU/ML|||||APS U||||HIGH|NOT DONE|||MUCUS|LACTESCENT|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|N|U|U||2||58||CONTINUATION TREATMENT|1963-08-30|1967-05-05|||||1969-03-12||1971-07-06
TRIAL STUDY 134XCP|IS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TORR|||||U/G/MIN||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|CONTAMINATED|NA|IN VITRO GENE EXPRESSION ASSAY|U|Y|NA||3||39||OBSERVATION|1971-03-15|1969-09-04|||||1960-10-22||1961-02-06
TRIAL STUDY 134XCP|IS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KG/MOL|||||KDA||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|LACTESCENT|U|ACID FAST STAIN|N|NA|U||4||88||CONTINUATION TREATMENT|1968-02-29|1962-03-26|||||1969-09-06||1960-04-27
TRIAL STUDY 134XCP|IS|2ABA4AB2-E2E5-4C24-B73B-389EBB7EF427||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL/DAY|||||DAGU/ML||||NORMAL|NOT DONE|||MONOCYTE|FRESH|NA|GC/MS|NA|U|Y||5||7||CONTINUATION TREATMENT|1960-12-14|1961-09-14|||||1964-07-05||1964-02-08
TRIAL STUDY 134XCP|IS|CED88848-769E-41C1-9ACD-99E45766D27B||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UEQ|||||10^3 DNA COPIES/ML||||LOW|NOT DONE|||BASAL TEAR|AUTOLYZED|U|GIEMSA STAIN|Y|N|NA||1||38||BLINDED TREATMENT|1969-07-13|1967-11-25|||||1971-01-11||1965-01-24
TRIAL STUDY 134XCP|IS|CED88848-769E-41C1-9ACD-99E45766D27B||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/H|||||CCID 50/DOSE||||NORMAL|NOT DONE|||CAPILLARY PLASMA|CLOTTED|N|KARYOTYPING|U|NA|N||2||58||RUN-IN|1961-01-24|1972-03-08|||||1960-08-12||1968-10-27
TRIAL STUDY 134XCP|IS|CED88848-769E-41C1-9ACD-99E45766D27B||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ATM|||||L/H||||HIGH|NOT DONE|||VENOUS CORD BLOOD|ROOM TEMPERATURE|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|NA|N|NA||3||39||BLINDED TREATMENT|1966-11-06|1960-06-09|||||1970-03-18||1960-08-04
TRIAL STUDY 134XCP|IS|CED88848-769E-41C1-9ACD-99E45766D27B||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOSM|||||PPM||||NORMAL|NOT DONE|||CORD BLOOD|CALCIFIED|U|CONTRAST ENHANCED SPIRAL CT SCAN|NA|NA|Y||4||88||OBSERVATION|1970-10-19|1964-02-01|||||1973-05-17||1972-10-31
TRIAL STUDY 134XCP|IS|CED88848-769E-41C1-9ACD-99E45766D27B||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MHZ|||||UIU/DL||||NORMAL|NOT DONE|||LOCHIA|ICTERIC|N|NEXT GENERATION TARGETED SEQUENCING|Y|U|NA||5||7||CONTINUATION TREATMENT|1960-12-21|1963-06-05|||||1960-04-07||1973-08-08
TRIAL STUDY 134XCP|IS|E7958F8B-D987-4929-993A-8960EB30A309||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/KG/DAY|||||BAU||||ABNORMAL|NOT DONE|||CORD SERUM|CALCIFIED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|NA|NA|NA||1||38||BLINDED TREATMENT|1966-04-02|1965-09-01|||||1962-02-09||1962-07-28
TRIAL STUDY 134XCP|IS|E7958F8B-D987-4929-993A-8960EB30A309||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/M2|||||UMOL/H/MMOL||||HIGH|NOT DONE|||BREAST MILK|PARAFFIN-EMBEDDED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|N|N|N||2||58||BASELINE|1960-02-21|1968-08-14|||||1973-08-07||1973-01-02
TRIAL STUDY 134XCP|IS|E7958F8B-D987-4929-993A-8960EB30A309||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FFU|||||UKAT/10^12 RBC||||NORMAL|NOT DONE|||SMEGMA|UNEXPECTED ODOR|Y|BIOIMPEDANCE SPECTROSCOPY|U|N|U||3||39||TREATMENT|1964-12-16|1970-03-09|||||1965-06-26||1965-03-23
TRIAL STUDY 134XCP|IS|E7958F8B-D987-4929-993A-8960EB30A309||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NMOL/L/H|||||100 IU/ML||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|FROZEN|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|U|NA|Y||4||88||WASHOUT|1973-05-12|1970-07-19|||||1961-04-16||1971-04-19
TRIAL STUDY 134XCP|IS|E7958F8B-D987-4929-993A-8960EB30A309||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UKAT/10^12 RBC|||||U.CARR||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|NON-HEMOLYZED|NA|ERGOSPIROMETRY|NA|N|N||5||7||BASELINE|1969-03-20|1971-09-27|||||1960-04-23||1960-10-25
TRIAL STUDY 134XCP|IS|A633D973-B611-4014-A43E-C8C2D21DBFC2||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||EID 50/DOSE|||||DB||||LOW|NOT DONE|||ERYTHROCYTES|DRIED|NA|CLINICAL EVALUATION|NA|NA|N||1||38||SCREENING|1967-04-28|1971-11-09|||||1967-12-12||1963-01-12
TRIAL STUDY 134XCP|IS|A633D973-B611-4014-A43E-C8C2D21DBFC2||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMU/ML|||||CI/UL||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|FRESH|U|APPLANATION TONOMETRY|Y|Y|Y||2||58||SCREENING|1960-04-25|1970-12-10|||||1968-12-12||1968-06-27
TRIAL STUDY 134XCP|IS|A633D973-B611-4014-A43E-C8C2D21DBFC2||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL/DAY|||||MG/M2||||LOW|NOT DONE|||PLEURAL TISSUE|NON-HEMOLYZED|N|SLIT LAMP PHOTOGRAPHY|NA|N|NA||3||39||TREATMENT|1961-05-09|1970-04-11|||||1960-07-04||1960-09-14
TRIAL STUDY 134XCP|IS|A633D973-B611-4014-A43E-C8C2D21DBFC2||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UU/DL|||||/10^3||||LOW|NOT DONE|||SPUTUM|LIPEMIC|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|N|Y|NA||4||88||OPEN LABEL TREATMENT|1966-11-19|1960-01-03|||||1960-04-06||1972-08-20
TRIAL STUDY 134XCP|IS|A633D973-B611-4014-A43E-C8C2D21DBFC2||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NM|||||U/CL||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|NA|AGAR PROPORTION|U|Y|N||5||7||BASELINE|1969-11-01|1970-09-30|||||1965-11-24||1971-03-03
TRIAL STUDY 134XCP|IS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/H|||||LINEAR FT*LB||||NORMAL|NOT DONE|||PLASMA|CALCIFIED|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|NA|Y|N||1||38||SCREENING|1964-09-10|1972-08-08|||||1971-11-17||1965-07-05
TRIAL STUDY 134XCP|IS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 DNA COPIES/ML|||||TABLET||||HIGH|NOT DONE|||ERYTHROCYTES|ROOM TEMPERATURE|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|U|U||2||58||TREATMENT|1961-04-13|1968-11-30|||||1962-01-21||1963-07-31
TRIAL STUDY 134XCP|IS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KAT|||||L/L||||NORMAL|NOT DONE|||CORD SERUM|SOLIDIFIED|N|IMMUNOCHROMATOGRAPHY|NA|Y|N||3||39||CONTINUATION TREATMENT|1966-09-27|1969-12-09|||||1965-01-05||1966-09-28
TRIAL STUDY 134XCP|IS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/M2|||||TRANSDUCING UNIT||||LOW|NOT DONE|||PLASMA|ICTERIC|U|ELECTRICAL IMPEDANCE MYOGRAPHY|U|NA|N||4||88||WASHOUT|1963-06-13|1969-03-16|||||1970-05-19||1962-01-10
TRIAL STUDY 134XCP|IS|6F8063F9-DA4E-42F9-941B-3AA78FDE69F7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U/M2/MIN|||||CAN||||LOW|NOT DONE|||ARTERIAL BLOOD|THAWED|N|CONGO RED STAIN|N|NA|N||5||7||FOLLOW-UP|1961-02-05|1963-07-21|||||1971-12-06||1961-04-09
TRIAL STUDY 134XCP|IS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMOL/MOL|||||10^3/L||||HIGH|NOT DONE|||KERATINOCYTE|CONTAMINATED|U|PERCUSSION|Y|N|U||1||38||CONTINUATION TREATMENT|1965-08-16|1971-07-20|||||1961-12-01||1968-01-30
TRIAL STUDY 134XCP|IS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/M2/MIN|||||MMOL2/L2||||ABNORMAL|NOT DONE|||CELL PELLET|FROZEN|U|ELISA|N|U|Y||2||58||OPEN LABEL TREATMENT|1969-02-08|1972-09-01|||||1970-09-28||1970-03-20
TRIAL STUDY 134XCP|IS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MN|||||MPS U||||LOW|NOT DONE|||DERMAL TISSUE|LIPEMIC|U|MOUSE PROTECTION ASSAY|NA|U|NA||3||39||RUN-IN|1965-09-20|1963-01-22|||||1973-07-28||1968-09-04
TRIAL STUDY 134XCP|IS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/40 HPFS|||||KUSP||||HIGH|NOT DONE|||LYMPH|SOLIDIFIED|U|IMPEDANCE CONDUCTIVITY|Y|NA|Y||4||88||INDUCTION TREATMENT|1971-07-23|1972-07-03|||||1973-05-31||1963-08-21
TRIAL STUDY 134XCP|IS|FABDB6DB-1E35-4B0E-9D79-9F1207A3B0A6||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KG/L|||||MMOL/MIN/KPA/L||||LOW|NOT DONE|||ARTERIAL BLOOD|DRIED|NA|MECHANICAL CLOT DETECTION|U|U|Y||5||7||WASHOUT|1971-04-18|1968-07-31|||||1969-05-05||1970-09-26
TRIAL STUDY 134XCP|IS|264AA652-A25E-43CE-A54F-6FEB54AB62F3||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KEV|||||GENEQ/ML||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|NON-HEMOLYZED|NA|TRYPAN BLUE STAIN|NA|U|N||1||38||FOLLOW-UP|1961-04-09|1961-11-16|||||1967-10-11||1972-08-18
TRIAL STUDY 134XCP|IS|264AA652-A25E-43CE-A54F-6FEB54AB62F3||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PT_BR|||||MDFI||||NORMAL|NOT DONE|||DIALYSIS FLUID|AGGLUTINATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|N|N|NA||2||58||LONG-TERM FOLLOW-UP|1968-02-24|1964-07-30|||||1965-02-24||1968-04-15
TRIAL STUDY 134XCP|IS|264AA652-A25E-43CE-A54F-6FEB54AB62F3||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PPTH|||||/5X10^4 WBC||||NORMAL|NOT DONE|||HAIR FOLLICLE|GELLED|NA|CENTRIFUGATION|NA|U|U||3||39||CONTINUATION TREATMENT|1968-12-23|1962-10-17|||||1969-11-06||1960-07-18
TRIAL STUDY 134XCP|IS|264AA652-A25E-43CE-A54F-6FEB54AB62F3||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OSM|||||U/DL||||NORMAL|NOT DONE|||BLOOD|THAWED|Y|CARDIAC THERMODILUTION|Y|U|N||4||88||CONTINUATION TREATMENT|1966-12-11|1972-11-11|||||1961-01-28||1962-09-15
TRIAL STUDY 134XCP|IS|264AA652-A25E-43CE-A54F-6FEB54AB62F3||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MU/L|||||IN2||||HIGH|NOT DONE|||NAIL|UNEXPECTED ODOR|Y|EPSILOMETER|U|U|N||5||7||SCREENING|1964-07-01|1963-01-19|||||1966-05-01||1961-10-22
TRIAL STUDY 134XCP|IS|4DE042DC-2F1E-425C-BA36-F64A3493CE76||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BOWL|||||NMOL/DAY||||NORMAL|NOT DONE|||BASAL TEAR|FRESH|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|N|N|N||1||38||INDUCTION TREATMENT|1960-05-23|1969-10-15|||||1963-07-30||1960-08-30
TRIAL STUDY 134XCP|IS|4DE042DC-2F1E-425C-BA36-F64A3493CE76||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 CFU/ML|||||MJOULE/CM2||||ABNORMAL|NOT DONE|||CALCULUS|CLOTTED|U|SLIT LAMP|NA|N|NA||2||58||CONTINUATION TREATMENT|1963-05-25|1961-05-30|||||1971-07-08||1965-09-22
TRIAL STUDY 134XCP|IS|4DE042DC-2F1E-425C-BA36-F64A3493CE76||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CI/G|||||DYN||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|N|DOPPLER ULTRASOUND|NA|Y|N||3||39||OBSERVATION|1970-08-19|1963-12-01|||||1962-11-09||1967-09-02
TRIAL STUDY 134XCP|IS|4DE042DC-2F1E-425C-BA36-F64A3493CE76||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BQ|||||MNFI||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|LIPEMIC|Y|OLIGO ACGH|N|Y|NA||4||88||OPEN LABEL TREATMENT|1962-07-30|1964-12-15|||||1966-05-21||1972-09-02
TRIAL STUDY 134XCP|IS|4DE042DC-2F1E-425C-BA36-F64A3493CE76||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PSEC|||||H*%||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|HEMOLYZED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NA|U|N||5||7||RUN-IN|1965-04-29|1963-11-05|||||1960-08-31||1962-08-21
TRIAL STUDY 134XCP|IS|872942E9-A575-4929-9B21-D30DE51B367B||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 CFU/G|||||BREATHS/MIN||||NORMAL|NOT DONE|||PLEURAL TISSUE|CALCIFIED|U|SMEAR|U|NA|U||1||38||BLINDED TREATMENT|1964-11-15|1972-05-27|||||1971-06-25||1969-12-22
TRIAL STUDY 134XCP|IS|872942E9-A575-4929-9B21-D30DE51B367B||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PELLET|||||KCAL||||LOW|NOT DONE|||GASTRIC CONTENTS|FROZEN|N|MALDI-TOF|N|Y|Y||2||58||RUN-IN|1960-02-29|1972-08-14|||||1969-10-07||1971-09-06
TRIAL STUDY 134XCP|IS|872942E9-A575-4929-9B21-D30DE51B367B||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU/MMOL|||||ABSORBANCE U/MIN||||LOW|NOT DONE|||SOFT TISSUE|AUTOLYZED|NA|HEMOCYTOMETRY|N|Y|N||3||39||FOLLOW-UP|1969-03-26|1962-02-28|||||1960-11-17||1967-01-22
TRIAL STUDY 134XCP|IS|872942E9-A575-4929-9B21-D30DE51B367B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PPB|||||MKAT||||HIGH|NOT DONE|||SWABBED MATERIAL|REFRIGERATED|NA|HILLMEN COLOR CHART|NA|Y|Y||4||88||BLINDED TREATMENT|1963-07-19|1966-10-16|||||1968-09-02||1969-09-16
TRIAL STUDY 134XCP|IS|872942E9-A575-4929-9B21-D30DE51B367B||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UV*SEC|||||KIT||||ABNORMAL|NOT DONE|||EXPIRED AIR|UNEXPECTED ODOR|N|CELL BASED BIOASSAY|Y|N|NA||5||7||OPEN LABEL TREATMENT|1964-09-23|1963-03-26|||||1966-07-25||1962-06-12
TRIAL STUDY 134XCP|IS|628822F3-4983-44F8-B98D-7A35AAFF2962||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MV/SEC|||||PIXELS/CM||||HIGH|NOT DONE|||AQUEOUS HUMOR|CALCIFIED|Y|ENDOSCOPY|U|U|Y||1||38||OBSERVATION|1971-04-02|1961-04-11|||||1967-09-29||1972-07-21
TRIAL STUDY 134XCP|IS|628822F3-4983-44F8-B98D-7A35AAFF2962||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL BCE/MMOL|||||MMU/ML||||HIGH|NOT DONE|||COLOSTRUM|LIPEMIC|Y|REVERSE TRANSCRIPTASE PCR|U|Y|U||2||58||INDUCTION TREATMENT|1960-08-17|1960-04-26|||||1966-04-02||1960-01-02
TRIAL STUDY 134XCP|IS|628822F3-4983-44F8-B98D-7A35AAFF2962||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BU/ML|||||PIXELS/CM||||NORMAL|NOT DONE|||LYMPH|NON-HEMOLYZED|NA|REVERSE TRANSCRIPTASE PCR|U|Y|N||3||39||BLINDED TREATMENT|1972-05-23|1966-07-12|||||1962-08-07||1968-05-31
TRIAL STUDY 134XCP|IS|628822F3-4983-44F8-B98D-7A35AAFF2962||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||S*KPA|||||MANSON U/ML||||LOW|NOT DONE|||SPERMATOZOON|REFRIGERATED|Y|ENDPOINT DILUTION ASSAY|N|Y|Y||4||88||BLINDED TREATMENT|1972-05-18|1965-11-01|||||1967-08-24||1968-08-31
TRIAL STUDY 134XCP|IS|628822F3-4983-44F8-B98D-7A35AAFF2962||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/DAY|||||CM2||||LOW|NOT DONE|||STOOL|ROOM TEMPERATURE|N|IMMUNOTURBIDIMETRY|N|Y|U||5||7||TREATMENT|1964-05-08|1966-04-23|||||1964-03-09||1963-06-18
TRIAL STUDY 134XCP|IS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 CFU/G|||||ANTI-XA IU||||NORMAL|NOT DONE|||GASTRIC FLUID|UNEXPECTED ODOR|NA|SECONDARY ION MASS SPECTOMETRY|U|Y|U||1||38||LONG-TERM FOLLOW-UP|1963-09-08|1964-09-15|||||1970-03-21||1964-10-09
TRIAL STUDY 134XCP|IS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U/G/MIN|||||BQ/UG||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|CLOTTED|NA|FARR ASSAY|N|NA|NA||2||58||INDUCTION TREATMENT|1960-04-29|1968-10-10|||||1965-11-09||1965-09-03
TRIAL STUDY 134XCP|IS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MM2|||||FT3||||NORMAL|NOT DONE|||ARTERIAL BLOOD|HEMOLYZED|U|MICRO BROTH DILUTION|N|NA|Y||3||39||OBSERVATION|1962-08-12|1967-05-24|||||1960-12-19||1964-11-16
TRIAL STUDY 134XCP|IS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PHERESIS UNIT|||||DROP||||ABNORMAL|NOT DONE|||LAVAGE FLUID|CLOTTED|NA|ENDOSCOPY|N|Y|U||4||88||CONTINUATION TREATMENT|1967-11-14|1968-05-13|||||1972-06-20||1960-05-06
TRIAL STUDY 134XCP|IS|E711F224-DE78-4B2E-9BF7-A5FEAAC4AB1A||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LOG10 COPIES/ML|||||MU/G||||ABNORMAL|NOT DONE|||BILE|AGGLUTINATED|U|ANTIMICROBIAL COMBINATION TESTING|NA|N|U||5||7||BASELINE|1969-05-10|1961-10-09|||||1966-12-22||1964-02-14
TRIAL STUDY 134XCP|IS|6045DFAB-0734-4E6D-A492-34BD613EC783||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DB|||||NGEQ/L||||HIGH|NOT DONE|||WHITE MATTER TISSUE|SOLIDIFIED|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NA|U|Y||1||38||FOLLOW-UP|1964-09-24|1964-11-05|||||1966-03-29||1969-08-17
TRIAL STUDY 134XCP|IS|6045DFAB-0734-4E6D-A492-34BD613EC783||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^7/L|||||ML||||NORMAL|NOT DONE|||BILE|THAWED|NA|GC/MS-EI|Y|U|U||2||58||OBSERVATION|1960-08-27|1962-10-08|||||1960-08-29||1963-03-01
TRIAL STUDY 134XCP|IS|6045DFAB-0734-4E6D-A492-34BD613EC783||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/H|||||MPH||||NORMAL|NOT DONE|||VITREOUS HUMOR|CONTAMINATED|N|DIPSTICK|NA|Y|Y||3||39||RUN-IN|1965-02-12|1964-12-27|||||1969-12-22||1960-11-05
TRIAL STUDY 134XCP|IS|6045DFAB-0734-4E6D-A492-34BD613EC783||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UMOL/MIN|||||KEV||||NORMAL|NOT DONE|||FLUID|CONCENTRATED|N|MUGA|Y|N|N||4||88||BLINDED TREATMENT|1973-09-07|1961-02-01|||||1968-04-20||1968-03-21
TRIAL STUDY 134XCP|IS|6045DFAB-0734-4E6D-A492-34BD613EC783||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MBQ/UL|||||IU/DAY||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|PARAFFIN-EMBEDDED|NA|FLOCCULATION|NA|U|Y||5||7||BLINDED TREATMENT|1962-12-11|1960-03-31|||||1960-11-09||1967-02-16
TRIAL STUDY 134XCP|IS|482F0519-E738-46DE-A5C4-4AC76B6E7011||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BREATHS/30S|||||10^9 CFU/G||||NORMAL|NOT DONE|||SERUM OR PLASMA|DRIED|Y|AUSCULTATION|Y|U|Y||1||38||INDUCTION TREATMENT|1966-04-03|1973-02-05|||||1963-03-23||1970-02-06
TRIAL STUDY 134XCP|IS|482F0519-E738-46DE-A5C4-4AC76B6E7011||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^12/L|||||/MS||||ABNORMAL|NOT DONE|||TUMOR TISSUE|FROZEN|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NA|NA|Y||2||58||OPEN LABEL TREATMENT|1968-02-03|1962-07-14|||||1970-02-25||1970-08-28
TRIAL STUDY 134XCP|IS|482F0519-E738-46DE-A5C4-4AC76B6E7011||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CMH2O*S/ML|||||TBSP||||HIGH|NOT DONE|||CERUMEN|FROZEN|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y|N||3||39||INDUCTION TREATMENT|1970-12-03|1960-07-08|||||1966-03-23||1969-08-11
TRIAL STUDY 134XCP|IS|482F0519-E738-46DE-A5C4-4AC76B6E7011||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/KG/H|||||DAMOL/L||||LOW|NOT DONE|||ABSCESS FLUID|ICTERIC|U|FUNCTIONAL MRI|NA|N|NA||4||88||TREATMENT|1967-12-20|1960-12-31|||||1963-04-12||1966-12-27
TRIAL STUDY 134XCP|IS|482F0519-E738-46DE-A5C4-4AC76B6E7011||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||USIEMENS|||||PA||||LOW|NOT DONE|||ERYTHROCYTES|GELLED|N|ORCHIDOMETERY|Y|U|N||5||7||CONTINUATION TREATMENT|1968-10-20|1965-11-09|||||1964-12-10||1971-10-14
TRIAL STUDY 134XCP|IS|DFDD42F5-749C-4AF0-8351-780DB9614F61||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LX|||||KA_U/DL||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|LACTESCENT|Y|IVY INCISION METHOD|NA|NA|N||1||38||BASELINE|1961-11-19|1965-09-13|||||1971-07-30||1971-02-18
TRIAL STUDY 134XCP|IS|DFDD42F5-749C-4AF0-8351-780DB9614F61||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UM|||||U/DL||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|CONTAMINATED|U|DIRECT SEQUENCING|N|N|N||2||58||OPEN LABEL TREATMENT|1973-02-15|1963-10-18|||||1970-09-27||1965-08-12
TRIAL STUDY 134XCP|IS|DFDD42F5-749C-4AF0-8351-780DB9614F61||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UL/KG/DAY|||||CAPSULE||||NORMAL|NOT DONE|||SERUM|DRIED|Y|CONTRAST ENHANCED CT SCAN|NA|Y|U||3||39||WASHOUT|1972-10-25|1966-10-10|||||1966-05-06||1969-05-31
TRIAL STUDY 134XCP|IS|DFDD42F5-749C-4AF0-8351-780DB9614F61||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU|||||APS U||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|FRESH|NA|POLYGRAPHY|U|NA|N||4||88||RUN-IN|1960-01-15|1973-05-15|||||1962-09-14||1964-03-13
TRIAL STUDY 134XCP|IS|DFDD42F5-749C-4AF0-8351-780DB9614F61||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IN2|||||NG/MOL||||NORMAL|NOT DONE|||VENOUS BLOOD|ROOM TEMPERATURE|U|OPTICAL MAPPING|U|NA|NA||5||7||OPEN LABEL TREATMENT|1968-04-08|1965-09-27|||||1962-10-04||1968-06-13
TRIAL STUDY 134XCP|IS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/G|||||G/L||||ABNORMAL|NOT DONE|||SEMINAL FLUID|CLOTTED|U|MICROBIAL CONCENTRATION|Y|NA|Y||1||38||OBSERVATION|1970-12-22|1968-11-05|||||1968-06-08||1965-06-11
TRIAL STUDY 134XCP|IS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IMPLANT|||||UG/DL||||NORMAL|NOT DONE|||FLUID|LACTESCENT|NA|PULMONARY ANGIOGRAPHY|NA|U|N||2||58||LONG-TERM FOLLOW-UP|1971-05-11|1961-04-20|||||1966-11-04||1965-04-03
TRIAL STUDY 134XCP|IS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/5X10^4 WBC|||||UKAT/10^12 RBC||||LOW|NOT DONE|||VENOUS PLASMA|CONTAMINATED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|NA|N||3||39||RUN-IN|1970-12-19|1966-02-26|||||1968-07-04||1966-11-01
TRIAL STUDY 134XCP|IS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ELISA UNIT/DOSE|||||UKAT||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|U|MRI|NA|U|U||4||88||CONTINUATION TREATMENT|1964-03-19|1968-08-06|||||1960-11-07||1972-12-02
TRIAL STUDY 134XCP|IS|34BCECC4-8420-4B88-BD2E-0A20C4DCC5E0||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||EU|||||CYLINDER||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|SOLIDIFIED|U|DOUBLE IMMUNODIFFUSION|Y|N|Y||5||7||OBSERVATION|1971-03-30|1971-11-14|||||1971-08-07||1963-04-11
TRIAL STUDY 134XCP|IS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/M2/DAY|||||FMOL/G||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|CONTAMINATED|U|X-RAY FLUORESCENCE SPECTROMETRY|NA|NA|N||1||38||BLINDED TREATMENT|1962-10-20|1971-06-27|||||1972-02-05||1965-05-09
TRIAL STUDY 134XCP|IS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||% INHIBITION|||||BQ/L||||LOW|NOT DONE|||BONE|THAWED|Y|RADIOGRAPHY|Y|U|NA||2||58||OBSERVATION|1962-10-31|1967-11-20|||||1968-12-03||1969-07-31
TRIAL STUDY 134XCP|IS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||TESLA|||||NMOL BCE/L||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|LACTESCENT|Y|TARGETED GENOME SEQUENCING|U|Y|Y||3||39||BLINDED TREATMENT|1964-04-16|1965-02-01|||||1967-02-28||1965-11-14
TRIAL STUDY 134XCP|IS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/10^3|||||EJACULATE U||||NORMAL|NOT DONE|||BASAL TEAR|CLOTTED|Y|RIA|Y|NA|NA||4||88||OBSERVATION|1960-12-19|1968-09-19|||||1968-05-03||1967-10-01
TRIAL STUDY 134XCP|IS|4C4DCB9C-A2FB-4648-B2EF-DD484D221099||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FG|||||RAD||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|ICTERIC|N|DYNAMOMETRY|NA|NA|NA||5||7||FOLLOW-UP|1962-07-13|1963-12-14|||||1964-09-11||1961-09-30
TRIAL STUDY 134XCP|IS|E0434C66-0F59-476F-9913-55766C4AED1B||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KG/CM2|||||10^3 DNA COPIES/ML||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|Y|SURFACE PLASMON RESONANCE|N|Y|Y||1||38||BLINDED TREATMENT|1970-06-26|1966-12-26|||||1960-04-18||1971-09-09
TRIAL STUDY 134XCP|IS|E0434C66-0F59-476F-9913-55766C4AED1B||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MPS U|||||ABSORBANCE U/ML||||LOW|NOT DONE|||SEBUM|DRIED|U|CALCULATION|N|Y|Y||2||58||BASELINE|1968-07-19|1972-07-21|||||1973-06-21||1973-05-15
TRIAL STUDY 134XCP|IS|E0434C66-0F59-476F-9913-55766C4AED1B||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG|||||HEP||||LOW|NOT DONE|||PLATELET POOR PLASMA|CONCENTRATED|Y|CONFOCAL MICROSCOPY|N|Y|Y||3||39||TREATMENT|1971-09-23|1960-04-09|||||1961-03-25||1966-04-18
TRIAL STUDY 134XCP|IS|E0434C66-0F59-476F-9913-55766C4AED1B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/G/DAY|||||U/M2/MIN||||LOW|NOT DONE|||VENOUS CORD BLOOD|FRESH|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y|U||4||88||BLINDED TREATMENT|1967-04-05|1970-04-11|||||1966-05-19||1967-07-31
TRIAL STUDY 134XCP|IS|E0434C66-0F59-476F-9913-55766C4AED1B||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/KG|||||UG/ML/H||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|THAWED|NA|ATOMIC ABSORPTION SPECTROMETRY|NA|NA|U||5||7||BLINDED TREATMENT|1968-05-05|1969-05-10|||||1964-07-16||1972-12-18
TRIAL STUDY 134XCP|IS|60B57F98-61FF-4322-8084-7A536964F60A||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UL|||||G/M2||||LOW|NOT DONE|||DIALYSIS FLUID|LIPEMIC|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|N|U|Y||1||38||TREATMENT|1971-02-23|1962-07-04|||||1968-07-15||1973-07-05
TRIAL STUDY 134XCP|IS|60B57F98-61FF-4322-8084-7A536964F60A||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/UL|||||WATT||||NORMAL|NOT DONE|||HAIR|CONCENTRATED|N|DC SHEATH FLOW|N|Y|Y||2||58||LONG-TERM FOLLOW-UP|1969-04-04|1960-12-26|||||1965-03-05||1970-06-30
TRIAL STUDY 134XCP|IS|60B57F98-61FF-4322-8084-7A536964F60A||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PACKAGE|||||/MIN||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|Y|HIGH LEVEL AMINOGLYCOSIDE SCREEN|NA|N|N||3||39||BLINDED TREATMENT|1972-04-05|1961-12-19|||||1966-09-27||1960-01-15
TRIAL STUDY 134XCP|IS|60B57F98-61FF-4322-8084-7A536964F60A||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/HPF|||||NMOL/L/MIN||||LOW|NOT DONE|||VENOUS PLASMA|FRESH|U|AUDIOMETRY|U|U|Y||4||88||SCREENING|1971-08-17|1964-12-03|||||1971-09-17||1960-12-01
TRIAL STUDY 134XCP|IS|60B57F98-61FF-4322-8084-7A536964F60A||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/MG/MIN|||||UU/DL||||ABNORMAL|NOT DONE|||SEBUM|DRIED|N|DIPSTICK|U|N|Y||5||7||RUN-IN|1961-09-18|1972-02-15|||||1967-07-11||1973-06-22
TRIAL STUDY 134XCP|IS|C79CA198-24E2-4A76-8C32-F3AA973EA41E||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/G/MIN|||||G/U||||LOW|NOT DONE|||SALIVA|CONCENTRATED|Y|SPECT SCAN|Y|Y|N||1||38||SCREENING|1971-01-26|1967-06-30|||||1971-10-18||1969-02-02
TRIAL STUDY 134XCP|IS|C79CA198-24E2-4A76-8C32-F3AA973EA41E||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/G/H|||||/200 HPFS||||HIGH|NOT DONE|||LUNG SURFACTANT|LACTESCENT|NA|ELECTROPHORESIS|NA|Y|Y||2||58||TREATMENT|1960-06-11|1966-07-01|||||1967-07-08||1972-11-28
TRIAL STUDY 134XCP|IS|C79CA198-24E2-4A76-8C32-F3AA973EA41E||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U/CL|||||G/M2/DAY||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|FRESH|N|DIFFUSION WEIGHTED MRI|Y|Y|U||3||39||WASHOUT|1969-02-19|1967-06-01|||||1961-12-28||1961-03-14
TRIAL STUDY 134XCP|IS|C79CA198-24E2-4A76-8C32-F3AA973EA41E||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^10/L|||||/40 HPFS||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|LIPEMIC|N|CALIPER MEASUREMENT METHOD|Y|U|Y||4||88||SCREENING|1967-08-12|1963-04-19|||||1965-12-08||1968-10-16
TRIAL STUDY 134XCP|IS|C79CA198-24E2-4A76-8C32-F3AA973EA41E||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BU/ML|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||LOCHIA|AUTOLYZED|U|IMMUNOTURBIDIMETRY|NA|Y|N||5||7||FOLLOW-UP|1969-04-04|1962-12-01|||||1970-10-09||1968-02-27
TRIAL STUDY 134XCP|IS|D250194D-9BBD-40D3-A13B-BBCEB53DB450||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/MG/MIN|||||AMOL||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|SOLIDIFIED|U|X-RAY|Y|U|NA||1||38||OPEN LABEL TREATMENT|1963-06-12|1965-05-17|||||1965-08-28||1964-06-05
TRIAL STUDY 134XCP|IS|D250194D-9BBD-40D3-A13B-BBCEB53DB450||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FRAMES/S|||||/MM||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|Y|ENZYMATIC ULTRACENTRIFUGATION|N|U|U||2||58||BLINDED TREATMENT|1971-02-12|1968-12-29|||||1966-03-14||1970-02-21
TRIAL STUDY 134XCP|IS|D250194D-9BBD-40D3-A13B-BBCEB53DB450||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GBQ/G|||||VP/ML||||ABNORMAL|NOT DONE|||SOFT TISSUE|PARAFFIN-EMBEDDED|U|MRI|NA|N|Y||3||39||BLINDED TREATMENT|1961-12-09|1970-02-14|||||1970-05-09||1962-10-15
TRIAL STUDY 134XCP|IS|D250194D-9BBD-40D3-A13B-BBCEB53DB450||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/KG/H|||||JOULE||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|GELLED|NA|X-RAY FLUORESCENCE SPECTROMETRY|N|NA|Y||4||88||RUN-IN|1972-02-14|1969-02-14|||||1970-09-06||1971-03-31
TRIAL STUDY 134XCP|IS|D250194D-9BBD-40D3-A13B-BBCEB53DB450||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||HOURS|||||ML/CAGE/WK||||ABNORMAL|NOT DONE|||KERATINOCYTE|AUTOLYZED|NA|PANENDOSCOPY|N|NA|U||5||7||TREATMENT|1963-05-19|1973-02-11|||||1970-10-27||1964-12-24
TRIAL STUDY 134XCP|IS|369AE0AF-8693-4363-9A6E-CD30567BD614||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NSEC|||||V/V||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|CLOTTED|U|COULOMETRIC TITRATION|U|U|U||1||38||FOLLOW-UP|1972-10-28|1961-03-25|||||1971-01-02||1969-12-22
TRIAL STUDY 134XCP|IS|369AE0AF-8693-4363-9A6E-CD30567BD614||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/KG|||||MET*H||||NORMAL|NOT DONE|||ADIPOSE TISSUE|HEMOLYZED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|U|Y|NA||2||58||TREATMENT|1968-10-03|1963-09-12|||||1966-02-18||1965-09-08
TRIAL STUDY 134XCP|IS|369AE0AF-8693-4363-9A6E-CD30567BD614||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ABSORBANCE U|||||IN||||LOW|NOT DONE|||PERITONEAL FLUID|DRIED|N|WHOLE EXOME SEQUENCING|N|Y|U||3||39||LONG-TERM FOLLOW-UP|1966-04-12|1965-12-26|||||1967-08-02||1970-09-07
TRIAL STUDY 134XCP|IS|369AE0AF-8693-4363-9A6E-CD30567BD614||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SFC/10^6 PBMC|||||GPS U||||LOW|NOT DONE|||ADIPOSE TISSUE|HEMOLYZED|N|SLOAN LETTER EYE CHART 100%|Y|NA|N||4||88||INDUCTION TREATMENT|1960-07-31|1966-07-07|||||1971-04-07||1961-10-17
TRIAL STUDY 134XCP|IS|369AE0AF-8693-4363-9A6E-CD30567BD614||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^12 IU/L|||||MPA||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FROZEN|N|HPLC/MS/MS|N|N|NA||5||7||INDUCTION TREATMENT|1973-03-29|1968-11-12|||||1968-12-31||1968-07-17
TRIAL STUDY 134XCP|IS|4497DB94-5B91-4169-9D73-73EE5C1D9B76||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UL/ML|||||APL U||||NORMAL|NOT DONE|||PLATELET|LACTESCENT|NA|HEMATOXYLIN AND EOSIN STAIN|Y|U|Y||1||38||OPEN LABEL TREATMENT|1962-02-13|1971-06-16|||||1973-08-25||1962-09-17
TRIAL STUDY 134XCP|IS|4497DB94-5B91-4169-9D73-73EE5C1D9B76||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BREATHS/MIN|||||KPA/L/SEC||||HIGH|NOT DONE|||LOCHIA|NON-HEMOLYZED|NA|COULOMETRIC TITRATION|Y|NA|N||2||58||RUN-IN|1971-11-24|1961-02-10|||||1970-03-02||1964-05-12
TRIAL STUDY 134XCP|IS|4497DB94-5B91-4169-9D73-73EE5C1D9B76||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IU/L|||||UG/ML/H||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|ROOM TEMPERATURE|Y|SINGLE-SLICE SPIRAL CT|U|NA|NA||3||39||BLINDED TREATMENT|1964-04-15|1964-08-18|||||1965-09-17||1960-03-18
TRIAL STUDY 134XCP|IS|4497DB94-5B91-4169-9D73-73EE5C1D9B76||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BOX|||||TSP EQ||||HIGH|NOT DONE|||SOFT TISSUE|FROZEN|Y|NEXT GENERATION SEQUENCING|U|Y|NA||4||88||WASHOUT|1967-05-20|1962-02-06|||||1972-07-25||1960-09-26
TRIAL STUDY 134XCP|IS|4497DB94-5B91-4169-9D73-73EE5C1D9B76||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PFU/DOSE|||||PACK||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONTAMINATED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|NA|N|NA||5||7||OPEN LABEL TREATMENT|1966-09-05|1969-12-08|||||1968-04-09||1961-08-24
TRIAL STUDY 134XCP|IS|487D7E2D-6E7E-4A5E-ADC7-72B888746263||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TSP EQ|||||IU/ML||||HIGH|NOT DONE|||MENSTRUAL BLOOD|CONCENTRATED|U|DARK FIELD MICROSCOPY|NA|NA|NA||1||38||CONTINUATION TREATMENT|1969-12-01|1961-06-13|||||1971-06-19||1966-07-21
TRIAL STUDY 134XCP|IS|487D7E2D-6E7E-4A5E-ADC7-72B888746263||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/G/DAY|||||MMOL/S||||HIGH|NOT DONE|||CORD BLOOD|FRESH|Y|RIA|NA|U|NA||2||58||BLINDED TREATMENT|1961-08-14|1966-02-14|||||1972-08-07||1965-06-04
TRIAL STUDY 134XCP|IS|487D7E2D-6E7E-4A5E-ADC7-72B888746263||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/KG/MIN|||||DISK||||HIGH|NOT DONE|||RETICULOCYTES|THAWED|N|ANGIOGRAPHY|U|Y|N||3||39||INDUCTION TREATMENT|1966-03-13|1960-12-06|||||1963-09-08||1963-01-23
TRIAL STUDY 134XCP|IS|487D7E2D-6E7E-4A5E-ADC7-72B888746263||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UMOL/DL|||||U/CL||||NORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|HEMOLYZED|Y|MALDI-TOF|Y|Y|Y||4||88||SCREENING|1969-01-23|1969-10-31|||||1963-03-16||1962-12-24
TRIAL STUDY 134XCP|IS|487D7E2D-6E7E-4A5E-ADC7-72B888746263||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^6 RNA COPIES/ML|||||10^7 CFU||||ABNORMAL|NOT DONE|||BREAST MILK|CLOTTED|Y|IMMUNOCHROMATOGRAPHY|N|N|U||5||7||OPEN LABEL TREATMENT|1967-04-09|1967-12-31|||||1961-09-15||1973-07-24
TRIAL STUDY 134XCP|IS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SPRAY|||||BAU||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|NON-HEMOLYZED|Y|PELLI-ROBSON EYE CHART|NA|U|U||1||38||CONTINUATION TREATMENT|1971-08-20|1964-11-22|||||1971-09-22||1970-02-10
TRIAL STUDY 134XCP|IS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NMOL/L|||||MG/KG/H||||LOW|NOT DONE|||SUPERNATANT, SERUM|AGGLUTINATED|U|IODINE STAIN|NA|U|U||2||58||OPEN LABEL TREATMENT|1971-11-16|1966-10-15|||||1960-08-27||1970-01-05
TRIAL STUDY 134XCP|IS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 CFU|||||COPIES/UG||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|FRESH|N|CINEANGIOGRAPHY|U|Y|U||3||39||CONTINUATION TREATMENT|1961-09-17|1971-11-21|||||1965-12-27||1971-11-30
TRIAL STUDY 134XCP|IS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CM/MIN|||||OHM||||NORMAL|NOT DONE|||CALCULUS|FRESH|Y|ISHIHARA COLOR PLATES|Y|U|NA||4||88||SCREENING|1961-08-30|1968-01-15|||||1962-04-28||1970-06-18
TRIAL STUDY 134XCP|IS|7A0B521C-9CAB-4415-87C3-AF7A33AE9895||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FOZ_BR|||||CI/KG||||ABNORMAL|NOT DONE|||REFLEX TEAR|UNEXPECTED ODOR|U|TWO-COLOR MICROARRAY|Y|Y|U||5||7||OBSERVATION|1965-11-02|1968-04-22|||||1965-07-01||1962-03-07
TRIAL STUDY 134XCP|IS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/M2|||||MG/M2/DAY||||ABNORMAL|NOT DONE|||SEMINAL FLUID|THAWED|U|SPIROMETRY|U|Y|NA||1||38||BLINDED TREATMENT|1962-03-08|1960-07-17|||||1960-01-06||1972-07-28
TRIAL STUDY 134XCP|IS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/L|||||MSEC||||HIGH|NOT DONE|||COLOSTRUM|LIPEMIC|NA|SICKLE CELL SOLUBILITY TEST|Y|Y|Y||2||58||OBSERVATION|1966-05-17|1967-05-12|||||1972-10-24||1962-01-29
TRIAL STUDY 134XCP|IS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BAR|||||V||||LOW|NOT DONE|||CERUMEN|FROZEN|N|AGAR PROPORTION|U|N|U||3||39||RUN-IN|1970-03-27|1961-08-16|||||1967-09-11||1962-10-09
TRIAL STUDY 134XCP|IS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6/EJACULATE U|||||STEPS||||ABNORMAL|NOT DONE|||SKIN TISSUE|THAWED|NA|GRADIENT DIFFUSION|Y|U|N||4||88||INDUCTION TREATMENT|1971-09-07|1963-08-03|||||1966-12-05||1961-06-18
TRIAL STUDY 134XCP|IS|EA12FF8E-3FA0-4C21-8FA4-FFC1D6817D3A||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TAMPON|||||UKAT||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|CONTAMINATED|U|IMMUNOASSAY|Y|N|NA||5||7||SCREENING|1967-07-22|1973-03-21|||||1967-01-26||1963-09-12
TRIAL STUDY 134XCP|IS|8BF6E538-2F39-48E4-B115-AE1693843BBC||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMAL|||||MG2/DL2||||NORMAL|NOT DONE|||FLUID|ICTERIC|U|SPIRAL CT SCAN WITHOUT CONTRAST|N|N|U||1||38||BLINDED TREATMENT|1967-02-28|1972-07-16|||||1962-03-07||1962-04-29
TRIAL STUDY 134XCP|IS|8BF6E538-2F39-48E4-B115-AE1693843BBC||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CYCLE/MIN|||||MET*H||||HIGH|NOT DONE|||SEMEN|PARAFFIN-EMBEDDED|U|CINEANGIOGRAPHY|Y|Y|NA||2||58||CONTINUATION TREATMENT|1969-09-18|1965-12-25|||||1962-03-03||1969-05-05
TRIAL STUDY 134XCP|IS|8BF6E538-2F39-48E4-B115-AE1693843BBC||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMOL/G|||||PSEC||||NORMAL|NOT DONE|||MONOCYTE|REFRIGERATED|Y|NUCLEIC ACID AMPLIFICATION TEST|U|Y|N||3||39||SCREENING|1969-12-07|1962-01-28|||||1973-06-28||1966-01-14
TRIAL STUDY 134XCP|IS|8BF6E538-2F39-48E4-B115-AE1693843BBC||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KA_U/DL|||||PT_BR||||LOW|NOT DONE|||PERSPIRATION|CALCIFIED|Y|ACRIDINE ORANGE STAIN|Y|N|Y||4||88||INDUCTION TREATMENT|1967-10-24|1973-05-18|||||1961-12-17||1964-07-17
TRIAL STUDY 134XCP|IS|8BF6E538-2F39-48E4-B115-AE1693843BBC||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TRANSDUCING UNIT|||||U/MG||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|THAWED|N|SLIT LAMP|N|U|U||5||7||SCREENING|1960-08-22|1969-04-25|||||1963-10-30||1965-01-08
TRIAL STUDY 134XCP|IS|57F001BC-36EB-44AF-9487-373FA31B7311||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG10 TCID 50/UL|||||PMOL/L||||ABNORMAL|NOT DONE|||SEMINAL FLUID|NON-HEMOLYZED|U|TURBIDIMETRY|U|U|U||1||38||CONTINUATION TREATMENT|1969-09-27|1972-07-16|||||1961-08-08||1972-05-06
TRIAL STUDY 134XCP|IS|57F001BC-36EB-44AF-9487-373FA31B7311||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||L/L|||||IU/MG||||ABNORMAL|NOT DONE|||ALVEOLAR AIR|DRIED|U|SPIROMETRY|NA|N|Y||2||58||FOLLOW-UP|1964-06-04|1961-05-29|||||1960-09-08||1965-12-17
TRIAL STUDY 134XCP|IS|57F001BC-36EB-44AF-9487-373FA31B7311||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NEBULE|||||DEG/S||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|UNEXPECTED ODOR|N|MICRODENSITOMETRY|U|N|NA||3||39||SCREENING|1960-03-18|1963-05-06|||||1960-02-23||1961-02-21
TRIAL STUDY 134XCP|IS|57F001BC-36EB-44AF-9487-373FA31B7311||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MMOL/KG|||||PPTH||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CLOTTED|Y|WHOLE TRANSCRIPTOME SEQUENCING|Y|U|Y||4||88||SCREENING|1963-07-21|1973-08-23|||||1963-05-04||1962-03-24
TRIAL STUDY 134XCP|IS|57F001BC-36EB-44AF-9487-373FA31B7311||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CM|||||DEG/MM||||LOW|NOT DONE|||CERUMEN|NON-HEMOLYZED|U|QUANTITATIVE ULTRASOUND|U|NA|N||5||7||BLINDED TREATMENT|1961-05-26|1967-08-31|||||1968-04-12||1971-08-16
TRIAL STUDY 134XCP|IS|3FBDC961-EB02-4B28-8672-2A0A0A33529E||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 TCID 50/DOSE|||||GY/MIN||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|PARAFFIN-EMBEDDED|N|X-RAY|Y|Y|U||1||38||BASELINE|1965-03-28|1961-08-18|||||1970-04-27||1961-07-18
TRIAL STUDY 134XCP|IS|3FBDC961-EB02-4B28-8672-2A0A0A33529E||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||APL U|||||10^12/L||||HIGH|NOT DONE|||SALIVA|FRESH|NA|FLUORESCENCE ANGIOGRAPHY|U|N|Y||2||58||FOLLOW-UP|1972-11-19|1961-01-07|||||1960-02-15||1973-02-11
TRIAL STUDY 134XCP|IS|3FBDC961-EB02-4B28-8672-2A0A0A33529E||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/MMOL|||||MOL/L||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|U|NUCLEIC ACID HYBRIDIZATION|U|N|U||3||39||BASELINE|1960-07-01|1960-08-01|||||1968-03-30||1960-07-26
TRIAL STUDY 134XCP|IS|3FBDC961-EB02-4B28-8672-2A0A0A33529E||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/KG/MIN|||||U/L||||NORMAL|NOT DONE|||MONOCYTE|CONCENTRATED|N|NEXT GENERATION SEQUENCING|NA|N|NA||4||88||TREATMENT|1963-09-15|1970-11-08|||||1970-12-08||1964-06-11
TRIAL STUDY 134XCP|IS|3FBDC961-EB02-4B28-8672-2A0A0A33529E||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/M2|||||HZ/S||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|LACTESCENT|Y|FLUORESCENT LIFETIME IMAGING MICROSCOPY|U|N|U||5||7||SCREENING|1964-06-18|1968-01-27|||||1964-01-13||1968-07-16
TRIAL STUDY 134XCP|IS|1B524FC4-365B-4A16-A4D7-ED818C6E6086||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||G/CAGE/DAY|||||COPIES/UG||||LOW|NOT DONE|||VENOUS CORD BLOOD|ICTERIC|U|QUANTITATIVE COMPUTED TOMOGRAPHY|N|NA|Y||1||38||LONG-TERM FOLLOW-UP|1962-12-26|1967-01-11|||||1967-04-08||1962-03-06
TRIAL STUDY 134XCP|IS|1B524FC4-365B-4A16-A4D7-ED818C6E6086||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||L/H|||||MBP||||LOW|NOT DONE|||MUCUS|CONTAMINATED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|U|U|U||2||58||OPEN LABEL TREATMENT|1962-04-02|1964-09-13|||||1962-03-10||1965-03-15
TRIAL STUDY 134XCP|IS|1B524FC4-365B-4A16-A4D7-ED818C6E6086||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CM/S|||||MV/SEC||||HIGH|NOT DONE|||URINE|FRESH|Y|SPECULAR MICROSCOPY|U|N|U||3||39||RUN-IN|1971-05-17|1965-04-13|||||1972-07-17||1963-05-07
TRIAL STUDY 134XCP|IS|1B524FC4-365B-4A16-A4D7-ED818C6E6086||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||EID 50/DOSE|||||GPL U/ML||||LOW|NOT DONE|||DERMAL TISSUE|CALCIFIED|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|U|N|N||4||88||BLINDED TREATMENT|1965-02-27|1966-09-28|||||1962-04-13||1969-02-12
TRIAL STUDY 134XCP|IS|1B524FC4-365B-4A16-A4D7-ED818C6E6086||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/KG|||||MOL||||LOW|NOT DONE|||EXUDATE|NON-HEMOLYZED|NA|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NA|U|Y||5||7||LONG-TERM FOLLOW-UP|1973-03-20|1964-01-09|||||1961-12-01||1966-02-09
TRIAL STUDY 134XCP|IS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SV|||||CM||||ABNORMAL|NOT DONE|||SMEGMA|AGGLUTINATED|Y|TURBIDIMETRY|Y|NA|N||1||38||BASELINE|1962-02-25|1970-04-15|||||1966-06-02||1962-02-04
TRIAL STUDY 134XCP|IS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/ML/DAY|||||NEBULE||||LOW|NOT DONE|||DISCHARGE|CLOTTED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|U|NA||2||58||FOLLOW-UP|1961-02-16|1968-11-05|||||1963-10-19||1969-02-04
TRIAL STUDY 134XCP|IS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||WATT|||||CP||||NORMAL|NOT DONE|||LAVAGE FLUID|REFRIGERATED|N|PHASE-CONTRAST MRI|U|U|Y||3||39||LONG-TERM FOLLOW-UP|1967-10-02|1960-12-22|||||1963-01-07||1965-01-12
TRIAL STUDY 134XCP|IS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ENZYME U|||||PLUG||||HIGH|NOT DONE|||ADIPOSE TISSUE|FRESH|U|AUSCULTATION|U|NA|N||4||88||BLINDED TREATMENT|1961-06-12|1970-04-05|||||1967-02-28||1960-01-18
TRIAL STUDY 134XCP|IS|CC020A55-6788-43C6-9D9F-91EFA1ECD46C||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GY/H|||||/MIN||||HIGH|NOT DONE|||PLATELET RICH PLASMA|ROOM TEMPERATURE|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|NA|Y|NA||5||7||TREATMENT|1963-12-13|1972-08-27|||||1970-09-11||1973-02-04
TRIAL STUDY 134XCP|IS|27671577-2C6D-429F-BED9-0EDAB15CCB33||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/M2/DAY|||||NL||||ABNORMAL|NOT DONE|||LYMPH|ROOM TEMPERATURE|U|SEQUENCING|U|U|N||1||38||RUN-IN|1969-08-31|1962-06-06|||||1967-09-19||1960-03-19
TRIAL STUDY 134XCP|IS|27671577-2C6D-429F-BED9-0EDAB15CCB33||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 ORGANISMS|||||ML/CAGE/DAY||||NORMAL|NOT DONE|||EXPIRED AIR|ICTERIC|N|SLOAN LETTER EYE CHART 2.5%|N|N|Y||2||58||LONG-TERM FOLLOW-UP|1964-04-18|1962-11-16|||||1968-08-13||1971-08-04
TRIAL STUDY 134XCP|IS|27671577-2C6D-429F-BED9-0EDAB15CCB33||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^6/G|||||UMOL/H/MMOL||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|DRIED|NA|COMPUTERIZED CORNEAL TOPOGRAPHY|N|N|Y||3||39||RUN-IN|1970-09-02|1965-05-30|||||1970-04-13||1964-10-10
TRIAL STUDY 134XCP|IS|27671577-2C6D-429F-BED9-0EDAB15CCB33||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/ML|||||KG/M2||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|HEMOLYZED|N|DYNAMOMETRY|NA|N|Y||4||88||OBSERVATION|1965-08-29|1969-02-01|||||1964-09-24||1973-07-20
TRIAL STUDY 134XCP|IS|27671577-2C6D-429F-BED9-0EDAB15CCB33||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS/G|||||DIP||||NORMAL|NOT DONE|||LAVAGE FLUID|DRIED|Y|WRIGHT-GIEMSA STAIN|N|N|N||5||7||BLINDED TREATMENT|1971-02-05|1964-08-18|||||1968-10-19||1965-06-02
TRIAL STUDY 134XCP|IS|CD69750D-957B-405C-A397-AFA331D30535||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||OSM|||||MG/ANIMAL||||LOW|NOT DONE|||CAPILLARY PLASMA|AUTOLYZED|Y|CONTRAST ENHANCED SPIRAL CT SCAN|Y|NA|N||1||38||FOLLOW-UP|1962-12-22|1964-04-15|||||1969-02-03||1961-03-01
TRIAL STUDY 134XCP|IS|CD69750D-957B-405C-A397-AFA331D30535||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/G/MIN|||||NMOL||||LOW|NOT DONE|||STOOL|CALCIFIED|Y|BIOIMPEDANCE SPECTROSCOPY|Y|U|Y||2||58||SCREENING|1972-09-22|1968-06-04|||||1968-06-28||1964-01-23
TRIAL STUDY 134XCP|IS|CD69750D-957B-405C-A397-AFA331D30535||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MCI/KG|||||MEQ/DL||||NORMAL|NOT DONE|||LYSATE|DRIED|Y|BALLPOINT PEN TECHNIQUE|Y|U|U||3||39||TREATMENT|1966-06-06|1963-02-18|||||1966-06-27||1967-01-24
TRIAL STUDY 134XCP|IS|CD69750D-957B-405C-A397-AFA331D30535||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MM/SEC|||||ML/CM||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CLOTTED|N|SIZE EXCLUSION CHROMATOGRAPHY|Y|U|Y||4||88||BLINDED TREATMENT|1961-01-31|1964-09-26|||||1960-03-05||1966-04-13
TRIAL STUDY 134XCP|IS|CD69750D-957B-405C-A397-AFA331D30535||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/L/SEC|||||DNA COPIES/ML||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|N|IVY INCISION METHOD|N|Y|N||5||7||INDUCTION TREATMENT|1963-06-16|1961-11-05|||||1972-03-21||1969-09-29
TRIAL STUDY 134XCP|IS|5BFDDFC2-7D15-4B01-8140-62376D160EF0||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CD/M2|||||%(V/V)||||NORMAL|NOT DONE|||DISCHARGE|ROOM TEMPERATURE|N|AGAR PROPORTION|Y|NA|N||1||38||FOLLOW-UP|1965-01-07|1970-06-22|||||1972-02-05||1971-08-31
TRIAL STUDY 134XCP|IS|5BFDDFC2-7D15-4B01-8140-62376D160EF0||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PG/CELL|||||PT_US||||ABNORMAL|NOT DONE|||SMEGMA|DRIED|N|ENDOSCOPY|U|NA|NA||2||58||CONTINUATION TREATMENT|1960-05-28|1972-01-23|||||1964-05-16||1961-11-13
TRIAL STUDY 134XCP|IS|5BFDDFC2-7D15-4B01-8140-62376D160EF0||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||VP/ML|||||F||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|HEMOLYZED|N|KNEMOMETRY|NA|U|NA||3||39||INDUCTION TREATMENT|1964-10-05|1967-09-18|||||1971-06-01||1960-10-06
TRIAL STUDY 134XCP|IS|5BFDDFC2-7D15-4B01-8140-62376D160EF0||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU/MG|||||MU/G||||NORMAL|NOT DONE|||LAVAGE FLUID|SOLIDIFIED|U|POLYMERASE CHAIN REACTION|Y|NA|U||4||88||LONG-TERM FOLLOW-UP|1960-05-26|1963-03-10|||||1961-02-05||1961-12-05
TRIAL STUDY 134XCP|IS|5BFDDFC2-7D15-4B01-8140-62376D160EF0||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MPL U/ML|||||PATCH||||ABNORMAL|NOT DONE|||RETICULOCYTES|CONCENTRATED|NA|GEL ELECTROPHORESIS|U|U|U||5||7||RUN-IN|1961-03-10|1963-02-21|||||1964-08-11||1964-05-08
TRIAL STUDY 134XCP|IS|DEA8E573-2709-41F9-AB0D-8C39F5169B48||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 ORGANISMS/MG|||||MG/CM2||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|FRESH|NA|MASS SPECTROMETRY|U|U|NA||1||38||LONG-TERM FOLLOW-UP|1970-10-24|1969-12-17|||||1972-07-01||1960-09-03
TRIAL STUDY 134XCP|IS|DEA8E573-2709-41F9-AB0D-8C39F5169B48||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||S^-1(%O2)^-1|||||JAR||||LOW|NOT DONE|||VENOUS PLASMA|FRESH|U|AUSCULTATION|NA|N|U||2||58||OPEN LABEL TREATMENT|1968-05-10|1961-09-16|||||1972-09-28||1972-03-09
TRIAL STUDY 134XCP|IS|DEA8E573-2709-41F9-AB0D-8C39F5169B48||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^4/L|||||NMOL/G||||NORMAL|NOT DONE|||LUNG SURFACTANT|CONCENTRATED|U|CALCULATION|NA|U|N||3||39||OBSERVATION|1966-09-03|1962-11-25|||||1968-10-02||1963-05-24
TRIAL STUDY 134XCP|IS|DEA8E573-2709-41F9-AB0D-8C39F5169B48||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/ANIMAL|||||U/G||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|NON-HEMOLYZED|Y|BALLPOINT PEN TECHNIQUE|Y|U|U||4||88||OBSERVATION|1967-03-02|1971-10-19|||||1965-03-03||1971-03-07
TRIAL STUDY 134XCP|IS|DEA8E573-2709-41F9-AB0D-8C39F5169B48||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MU|||||UMOL/L/SEC||||LOW|NOT DONE|||TRANSUDATE|LIPEMIC|NA|EEG|Y|Y|NA||5||7||RUN-IN|1962-09-28|1964-04-11|||||1973-06-05||1972-05-24
TRIAL STUDY 134XCP|IS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VOXEL|||||10^5/HPF||||HIGH|NOT DONE|||CELL PELLET|AUTOLYZED|U|CYSTOMETRY|NA|N|N||1||38||LONG-TERM FOLLOW-UP|1972-12-30|1964-06-05|||||1964-12-15||1968-03-23
TRIAL STUDY 134XCP|IS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/G/DAY|||||ML/DL||||NORMAL|NOT DONE|||FLUID|HEMOLYZED|Y|SPECT/CT SCAN|U|U|NA||2||58||OBSERVATION|1969-06-16|1966-04-25|||||1968-01-21||1970-10-16
TRIAL STUDY 134XCP|IS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/CAGE|||||LOG10 IU/ML||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|LINE PROBE ASSAY|NA|N|Y||3||39||OPEN LABEL TREATMENT|1960-06-23|1961-05-10|||||1968-05-24||1969-04-10
TRIAL STUDY 134XCP|IS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/10^3|||||V||||NORMAL|NOT DONE|||REFLEX TEAR|NON-HEMOLYZED|NA|KINYOUN STAIN|NA|U|Y||4||88||CONTINUATION TREATMENT|1964-03-16|1965-01-27|||||1961-12-28||1970-12-03
TRIAL STUDY 134XCP|IS|7A5D0D82-4B9C-47A8-8BB1-C3DB4525942F||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UCI/KG|||||/MM2||||HIGH|NOT DONE|||MENSTRUAL BLOOD|ROOM TEMPERATURE|U|GEL ELECTROPHORESIS|N|Y|U||5||7||OPEN LABEL TREATMENT|1968-09-12|1964-02-10|||||1965-12-25||1961-07-07
TRIAL STUDY 134XCP|IS|77CF8795-CFF5-40C6-A811-624972806A38||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/MIN|||||CIGAR||||LOW|NOT DONE|||ABSCESS FLUID|DRIED|U|TRANSCRIPTION-MEDIATED AMPLIFICATION|NA|Y|U||1||38||SCREENING|1966-01-05|1960-05-02|||||1966-05-12||1962-10-31
TRIAL STUDY 134XCP|IS|77CF8795-CFF5-40C6-A811-624972806A38||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||AMOL|||||MG/ML/DAY||||LOW|NOT DONE|||TISSUE|ICTERIC|N|TARGETED TRANSCRIPTOME SEQUENCING|U|NA|NA||2||58||INDUCTION TREATMENT|1965-01-09|1960-12-09|||||1965-12-23||1970-05-15
TRIAL STUDY 134XCP|IS|77CF8795-CFF5-40C6-A811-624972806A38||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MOL/DAY|||||CI/MG||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|THAWED|U|COMPUTERIZED CORNEAL TOPOGRAPHY|U|Y|U||3||39||SCREENING|1972-07-09|1970-06-05|||||1963-01-11||1971-07-30
TRIAL STUDY 134XCP|IS|77CF8795-CFF5-40C6-A811-624972806A38||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GPL U|||||UEQ/L||||LOW|NOT DONE|||DERMAL TISSUE|CALCIFIED|U|HIGH RESOLUTION CT|U|NA|Y||4||88||BASELINE|1966-03-10|1972-08-01|||||1973-07-10||1967-01-14
TRIAL STUDY 134XCP|IS|77CF8795-CFF5-40C6-A811-624972806A38||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||VG/KG|||||LOG10 ELISA UNIT||||NORMAL|NOT DONE|||AMNIOTIC FLUID|ROOM TEMPERATURE|NA|PLETHYSMOGRAPHY|N|N|N||5||7||WASHOUT|1973-01-10|1961-03-10|||||1961-01-20||1970-07-12
TRIAL STUDY 134XCP|IS|D43B827C-D393-41D4-81C5-AACB1A7673A1||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||AG|||||GPL U/ML||||NORMAL|NOT DONE|||SKIN TISSUE|ICTERIC|U|KINETIC CHROMOGENIC ASSAY|Y|U|Y||1||38||INDUCTION TREATMENT|1972-09-28|1973-01-07|||||1960-04-25||1962-12-27
TRIAL STUDY 134XCP|IS|D43B827C-D393-41D4-81C5-AACB1A7673A1||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOL/MG|||||PATCH||||LOW|NOT DONE|||ADIPOSE TISSUE|LIPEMIC|N|REFRACTOMETRY|Y|Y|NA||2||58||WASHOUT|1973-03-17|1967-02-05|||||1963-11-14||1962-01-23
TRIAL STUDY 134XCP|IS|D43B827C-D393-41D4-81C5-AACB1A7673A1||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DAGU/ML|||||10^6 U||||NORMAL|NOT DONE|||MONOCYTE|HEMOLYZED|Y|WRIGHT-GIEMSA STAIN|NA|U|Y||3||39||INDUCTION TREATMENT|1967-08-21|1960-03-08|||||1963-07-26||1960-11-03
TRIAL STUDY 134XCP|IS|D43B827C-D393-41D4-81C5-AACB1A7673A1||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/S/M2|||||MET*H||||NORMAL|NOT DONE|||BUFFY COAT|REFRIGERATED|NA|AUTOREFRACTION|Y|NA|U||4||88||TREATMENT|1962-12-20|1970-11-27|||||1969-08-09||1962-06-03
TRIAL STUDY 134XCP|IS|D43B827C-D393-41D4-81C5-AACB1A7673A1||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/H|||||CMH2O*S2/ML||||HIGH|NOT DONE|||CAPILLARY PLASMA|ICTERIC|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|N|NA|U||5||7||LONG-TERM FOLLOW-UP|1973-04-07|1971-01-26|||||1965-04-19||1971-09-30
TRIAL STUDY 134XCP|IS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MIN/KPA|||||FRACTION OF 1||||NORMAL|NOT DONE|||ARTERIAL BLOOD|FRESH|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|U|U|U||1||38||FOLLOW-UP|1963-03-03|1973-06-07|||||1961-12-26||1970-03-13
TRIAL STUDY 134XCP|IS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMOL|||||/LSQN||||HIGH|NOT DONE|||GASTRIC CONTENTS|ICTERIC|Y|DUKE INCISION METHOD|U|U|Y||2||58||FOLLOW-UP|1963-03-04|1968-08-29|||||1969-01-25||1961-05-21
TRIAL STUDY 134XCP|IS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UU/DL|||||/2500 WBC||||HIGH|NOT DONE|||SWABBED MATERIAL|NON-HEMOLYZED|U|OPTICAL COHERENCE TOMOGRAPHY|U|NA|Y||3||39||TREATMENT|1966-12-31|1963-11-19|||||1961-01-13||1963-07-20
TRIAL STUDY 134XCP|IS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UL/KG/DAY|||||ML/CAGE/WK||||NORMAL|NOT DONE|||BILE|UNEXPECTED ODOR|N|CLAUSS METHOD|N|N|NA||4||88||FOLLOW-UP|1962-02-10|1962-03-04|||||1961-05-10||1973-03-30
TRIAL STUDY 134XCP|IS|6F4B91C6-AFBB-49B6-BF12-22DD1B04F161||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DPM/MG|||||/100 WBC||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|Y|DISK DIFFUSION|N|U|N||5||7||FOLLOW-UP|1966-01-03|1960-07-27|||||1973-06-18||1962-02-01
TRIAL STUDY 134XCP|IS|0671FB62-42B8-4882-93ED-0E11CFE07DE9||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UMOL/DL|||||UG/KG/DAY||||ABNORMAL|NOT DONE|||PLATELET|UNEXPECTED ODOR|NA|PANENDOSCOPY|Y|N|NA||1||38||BLINDED TREATMENT|1960-09-29|1962-04-07|||||1960-05-19||1962-07-30
TRIAL STUDY 134XCP|IS|0671FB62-42B8-4882-93ED-0E11CFE07DE9||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BQ/UL|||||10^3/L||||NORMAL|NOT DONE|||SERUM|REFRIGERATED|N|FLUORESCENT IMMUNOASSAY|N|NA|U||2||58||WASHOUT|1964-09-08|1972-12-22|||||1970-10-16||1968-02-08
TRIAL STUDY 134XCP|IS|0671FB62-42B8-4882-93ED-0E11CFE07DE9||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EID 50/DOSE|||||CARTRIDGE||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|DRIED|N|PATHOLOGICAL EVALUATION|N|Y|N||3||39||LONG-TERM FOLLOW-UP|1963-04-03|1973-08-03|||||1971-10-24||1961-11-23
TRIAL STUDY 134XCP|IS|0671FB62-42B8-4882-93ED-0E11CFE07DE9||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^9 ORGANISMS/MG|||||PMOL/10^10 CELLS||||ABNORMAL|NOT DONE|||SPERMATOZOON|CONCENTRATED|U|AUSCULTATION|N|U|N||4||88||INDUCTION TREATMENT|1962-08-14|1967-05-12|||||1961-02-12||1966-04-07
TRIAL STUDY 134XCP|IS|0671FB62-42B8-4882-93ED-0E11CFE07DE9||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||RAD|||||NEBULE||||LOW|NOT DONE|||CELL PELLET|LACTESCENT|Y|POLYMERASE CHAIN REACTION|NA|NA|N||5||7||INDUCTION TREATMENT|1969-07-01|1970-08-12|||||1972-04-25||1965-09-28
TRIAL STUDY 134XCP|IS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DROP|||||SV||||ABNORMAL|NOT DONE|||PUS|CONTAMINATED|N|CYSTOSCOPY|Y|U|Y||1||38||LONG-TERM FOLLOW-UP|1968-11-24|1961-09-06|||||1968-09-24||1970-03-08
TRIAL STUDY 134XCP|IS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||STEPS/MIN||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|UNEXPECTED ODOR|Y|FARNSWORTH-MUNSELL 100 HUE TEST|Y|N|N||2||58||BLINDED TREATMENT|1969-06-23|1967-05-05|||||1968-08-28||1964-07-14
TRIAL STUDY 134XCP|IS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMH2O/ML|||||VIAL||||LOW|NOT DONE|||EXPIRED AIR|ICTERIC|Y|CALCULATION|NA|NA|N||3||39||CONTINUATION TREATMENT|1969-09-12|1967-12-24|||||1973-01-09||1965-06-19
TRIAL STUDY 134XCP|IS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMHG|||||PM||||HIGH|NOT DONE|||PERITONEAL FLUID|FRESH|N|GEL ELECTROPHORESIS|Y|NA|U||4||88||BLINDED TREATMENT|1968-07-09|1964-02-24|||||1964-12-01||1968-07-29
TRIAL STUDY 134XCP|IS|BB1EBF44-CC91-4B86-91E5-2B1000161DFD||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PL|||||UCI/KG||||ABNORMAL|NOT DONE|||SERUM|LACTESCENT|Y|IVY INCISION METHOD|NA|NA|NA||5||7||RUN-IN|1969-07-30|1971-07-21|||||1961-11-25||1967-04-22
TRIAL STUDY 134XCP|IS|E9161164-3B91-4855-AFBA-12C6BD93F95F||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/10^4|||||PACKET||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|NA|NEXT GENERATION TARGETED SEQUENCING|U|U|Y||1||38||OPEN LABEL TREATMENT|1963-05-01|1963-09-26|||||1964-07-19||1964-08-06
TRIAL STUDY 134XCP|IS|E9161164-3B91-4855-AFBA-12C6BD93F95F||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BREATHS/30S|||||TBSP||||HIGH|NOT DONE|||BONE MARROW|AUTOLYZED|NA|OSCILLOMETRY|NA|N|N||2||58||SCREENING|1968-02-11|1972-08-23|||||1962-05-11||1960-07-04
TRIAL STUDY 134XCP|IS|E9161164-3B91-4855-AFBA-12C6BD93F95F||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^12 IU/L|||||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|DRIED|U|IMMUNOASSAY|N|NA|U||3||39||CONTINUATION TREATMENT|1960-02-19|1966-10-12|||||1973-05-13||1970-08-17
TRIAL STUDY 134XCP|IS|E9161164-3B91-4855-AFBA-12C6BD93F95F||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||APPLICATION|||||UM||||LOW|NOT DONE|||EMESIS|ROOM TEMPERATURE|U|TRANSTHORACIC ECHOCARDIOGRAPHY|NA|Y|NA||4||88||BLINDED TREATMENT|1970-04-06|1970-05-13|||||1968-02-10||1972-11-06
TRIAL STUDY 134XCP|IS|E9161164-3B91-4855-AFBA-12C6BD93F95F||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU/MG|||||WEEKS||||HIGH|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|U|BAC ACGH|Y|Y|Y||5||7||FOLLOW-UP|1960-06-18|1962-09-20|||||1968-01-27||1960-11-28
TRIAL STUDY 134XCP|IS|FBB66C13-05F5-4337-B34A-9900EB5F50F3||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/WK|||||NM||||LOW|NOT DONE|||PROSTATIC FLUID|NON-HEMOLYZED|U|ENZYMATIC ULTRACENTRIFUGATION|N|U|Y||1||38||FOLLOW-UP|1970-08-15|1970-03-02|||||1967-11-12||1971-12-10
TRIAL STUDY 134XCP|IS|FBB66C13-05F5-4337-B34A-9900EB5F50F3||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||V/V|||||10^4 CFU/ML||||ABNORMAL|NOT DONE|||URINE SEDIMENT|FROZEN|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|NA|U||2||58||WASHOUT|1961-04-25|1966-06-24|||||1960-02-06||1971-07-23
TRIAL STUDY 134XCP|IS|FBB66C13-05F5-4337-B34A-9900EB5F50F3||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMOL/G|||||INHALATION||||NORMAL|NOT DONE|||CALCULUS|AUTOLYZED|U|ENZYMATIC COLORIMETRY|NA|U|U||3||39||BLINDED TREATMENT|1971-12-11|1966-07-05|||||1960-11-03||1969-11-19
TRIAL STUDY 134XCP|IS|FBB66C13-05F5-4337-B34A-9900EB5F50F3||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G/M2/DAY|||||MG/KG||||NORMAL|NOT DONE|||HAIR FOLLICLE|ICTERIC|NA|CONTRAST ENHANCED PET SCAN|N|N|NA||4||88||BASELINE|1964-07-01|1970-08-14|||||1962-11-28||1960-07-12
TRIAL STUDY 134XCP|IS|FBB66C13-05F5-4337-B34A-9900EB5F50F3||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^6 U|||||FRAMES/S||||LOW|NOT DONE|||PLASMA|THAWED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|NA|N|NA||5||7||RUN-IN|1971-10-20|1964-09-19|||||1960-10-07||1960-09-24
TRIAL STUDY 134XCP|IS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UM2|||||G/U||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CLOTTED|Y|ERGOSPIROMETRY|Y|N|U||1||38||BLINDED TREATMENT|1960-06-04|1972-10-21|||||1969-09-18||1963-12-17
TRIAL STUDY 134XCP|IS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||C|||||YEARS||||LOW|NOT DONE|||HAIR FOLLICLE|CLOTTED|U|MICRODENSITOMETRY|NA|NA|N||2||58||CONTINUATION TREATMENT|1967-01-15|1967-07-22|||||1960-01-07||1970-07-24
TRIAL STUDY 134XCP|IS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CM H2O|||||10^6 DNA COPIES/ML||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|REFRIGERATED|N|ORCHIDOMETERY|N|NA|NA||3||39||OPEN LABEL TREATMENT|1960-03-01|1964-09-15|||||1969-09-11||1966-09-12
TRIAL STUDY 134XCP|IS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KEV|||||UG/KG/H||||HIGH|NOT DONE|||PLATELET|LIPEMIC|Y|GC/FID|U|U|NA||4||88||INDUCTION TREATMENT|1967-10-27|1965-08-10|||||1967-01-03||1973-06-19
TRIAL STUDY 134XCP|IS|FCBAAB24-FEC0-46F2-AA07-99B20123E67C||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BAG|||||KHZ||||HIGH|NOT DONE|||SEBUM|PARAFFIN-EMBEDDED|Y|CLIP|N|N|U||5||7||WASHOUT|1968-01-03|1966-02-07|||||1966-09-29||1961-03-04
TRIAL STUDY 134XCP|IS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PIXELS/CM|||||DRINK||||LOW|NOT DONE|||VENOUS BLOOD|LACTESCENT|Y|GC/MS|N|Y|NA||1||38||CONTINUATION TREATMENT|1973-08-04|1969-09-17|||||1963-06-14||1968-11-19
TRIAL STUDY 134XCP|IS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CI/UL|||||/WK||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CALCIFIED|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|U|NA|U||2||58||FOLLOW-UP|1966-09-17|1971-08-11|||||1961-01-04||1960-04-22
TRIAL STUDY 134XCP|IS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/ANIMAL|||||MEQ/L||||HIGH|NOT DONE|||DERMAL TISSUE|CALCIFIED|N|HPLC-FL|U|Y|Y||3||39||SCREENING|1966-04-12|1968-11-14|||||1967-03-13||1962-08-05
TRIAL STUDY 134XCP|IS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UV2|||||KALLIKREIN INHIBITOR UNIT||||LOW|NOT DONE|||EPIDERMAL TISSUE|LACTESCENT|NA|PET/CT SCAN WITHOUT CONTRAST|Y|U|Y||4||88||RUN-IN|1969-07-10|1965-06-23|||||1966-03-14||1967-09-18
TRIAL STUDY 134XCP|IS|2F1EE4FC-4E1F-4BB7-81AA-5AE6133A75A9||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||AU/ML|||||ML/ANIMAL/WK||||ABNORMAL|NOT DONE|||LAVAGE FLUID|PARAFFIN-EMBEDDED|N|LEAD CITRATE STAIN|U|N|Y||5||7||TREATMENT|1961-10-18|1966-02-12|||||1963-06-16||1970-11-15
TRIAL STUDY 134XCP|IS|21223189-5527-4B3F-AFD5-21F77AC0DEBE||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/KG/H|||||FRAMES/S||||HIGH|NOT DONE|||EPITHELIAL CELL|HEMOLYZED|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|U|U||1||38||BASELINE|1961-10-14|1971-06-09|||||1963-05-03||1964-10-05
TRIAL STUDY 134XCP|IS|21223189-5527-4B3F-AFD5-21F77AC0DEBE||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||S*KPA|||||10^6/G||||ABNORMAL|NOT DONE|||TRANSUDATE|ICTERIC|U|SPIRAL CT SCAN WITHOUT CONTRAST|Y|N|U||2||58||TREATMENT|1960-07-20|1960-02-16|||||1963-09-03||1970-07-01
TRIAL STUDY 134XCP|IS|21223189-5527-4B3F-AFD5-21F77AC0DEBE||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U|||||KAT||||LOW|NOT DONE|||PUS|FRESH|U|LC/MS|N|Y|U||3||39||INDUCTION TREATMENT|1971-03-21|1968-04-19|||||1970-10-25||1960-12-21
TRIAL STUDY 134XCP|IS|21223189-5527-4B3F-AFD5-21F77AC0DEBE||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^4/L|||||CG||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|FRESH|Y|IMMUNODIFFUSION|N|U|N||4||88||WASHOUT|1966-05-09|1970-06-15|||||1965-09-14||1970-08-21
TRIAL STUDY 134XCP|IS|21223189-5527-4B3F-AFD5-21F77AC0DEBE||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||OHM|||||/KG||||HIGH|NOT DONE|||EPIDERMAL TISSUE|NON-HEMOLYZED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|Y|N|N||5||7||OPEN LABEL TREATMENT|1960-05-17|1968-05-01|||||1965-01-27||1964-11-18
TRIAL STUDY 134XCP|IS|CA6ECC17-3E3B-435C-A485-8612C267E52B||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SQU/ML|||||MMU/ML||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|FROZEN|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|NA|U||1||38||SCREENING|1971-09-10|1964-05-22|||||1965-04-21||1966-03-07
TRIAL STUDY 134XCP|IS|CA6ECC17-3E3B-435C-A485-8612C267E52B||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/KG/DAY|||||NKAT||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|CALCIFIED|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|U|NA|Y||2||58||SCREENING|1964-07-31|1961-12-04|||||1966-07-20||1964-03-31
TRIAL STUDY 134XCP|IS|CA6ECC17-3E3B-435C-A485-8612C267E52B||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CFU/ML|||||TUBERCULIN UNIT/ML||||NORMAL|NOT DONE|||EMESIS|SOLIDIFIED|NA|ENZYMATIC COLORIMETRY|U|NA|N||3||39||INDUCTION TREATMENT|1971-01-23|1969-05-01|||||1960-12-10||1970-04-16
TRIAL STUDY 134XCP|IS|CA6ECC17-3E3B-435C-A485-8612C267E52B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NKAT|||||10^7 CFU/ML||||HIGH|NOT DONE|||INTERSTITIAL FLUID|CONCENTRATED|NA|HEMATOXYLIN AND EOSIN STAIN|U|U|NA||4||88||SCREENING|1970-06-05|1968-11-29|||||1970-02-15||1970-01-29
TRIAL STUDY 134XCP|IS|CA6ECC17-3E3B-435C-A485-8612C267E52B||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||P|||||NEBULE||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|CLOTTED|Y|BETA LACTAMASE|NA|U|N||5||7||WASHOUT|1969-05-20|1966-04-23|||||1969-09-22||1969-04-12
TRIAL STUDY 134XCP|IS|BCB41507-87B3-4773-B1E5-AE039853DED0||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AMOL|||||U/ML||||LOW|NOT DONE|||LYSATE|CONTAMINATED|NA|ANALYTICAL ULTRACENTRIFUGATION|U|N|NA||1||38||RUN-IN|1971-02-02|1963-03-31|||||1964-01-07||1960-09-13
TRIAL STUDY 134XCP|IS|BCB41507-87B3-4773-B1E5-AE039853DED0||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DPM/100MG|||||L/DAY||||NORMAL|NOT DONE|||AQUEOUS HUMOR|UNEXPECTED ODOR|N|RADIAL IMMUNODIFFUSION|U|Y|U||2||58||BLINDED TREATMENT|1969-04-25|1970-02-09|||||1967-08-12||1960-12-29
TRIAL STUDY 134XCP|IS|BCB41507-87B3-4773-B1E5-AE039853DED0||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MNFI|||||CI/ML||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|GELLED|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|N|NA|NA||3||39||OBSERVATION|1970-05-08|1962-09-27|||||1966-05-04||1971-05-26
TRIAL STUDY 134XCP|IS|BCB41507-87B3-4773-B1E5-AE039853DED0||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MU/L|||||ARBITRARY U||||NORMAL|NOT DONE|||EMOTIONAL TEAR|REFRIGERATED|Y|CHROMOGENIC ASSAY|NA|Y|NA||4||88||CONTINUATION TREATMENT|1966-10-24|1972-04-26|||||1966-07-15||1964-10-12
TRIAL STUDY 134XCP|IS|BCB41507-87B3-4773-B1E5-AE039853DED0||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CYCLE/MIN|||||DRINK||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|SOLIDIFIED|N|MAMMOGRAPHY|U|N|Y||5||7||WASHOUT|1967-04-06|1961-10-05|||||1965-01-16||1962-06-25
TRIAL STUDY 134XCP|IS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/MMHG|||||FIU||||HIGH|NOT DONE|||KERATINOCYTE|GELLED|N|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|U|N||1||38||SCREENING|1973-02-19|1970-11-30|||||1963-05-26||1966-12-11
TRIAL STUDY 134XCP|IS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/KG/DOSE|||||TSP||||ABNORMAL|NOT DONE|||CORD BLOOD|CONTAMINATED|N|LC/MS/MS|U|U|N||2||58||WASHOUT|1961-04-27|1970-06-20|||||1968-08-09||1971-12-02
TRIAL STUDY 134XCP|IS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MPS U|||||ATM||||ABNORMAL|NOT DONE|||SKIN TISSUE|CLOTTED|Y|ELECTROPHORESIS|Y|NA|NA||3||39||BASELINE|1970-03-03|1973-08-17|||||1972-08-31||1973-06-11
TRIAL STUDY 134XCP|IS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MV*MIN|||||ML/KG/MIN||||LOW|NOT DONE|||PLATELET|FRESH|N|SPECT SCAN|NA|N|Y||4||88||FOLLOW-UP|1971-02-11|1971-11-06|||||1971-05-28||1966-10-05
TRIAL STUDY 134XCP|IS|A8F9A1A9-2348-4E0E-93E5-E11A9EBDE02A||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MV|||||U/G||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|NON-HEMOLYZED|NA|ACID FAST STAIN|Y|Y|U||5||7||CONTINUATION TREATMENT|1970-05-23|1960-02-17|||||1963-03-29||1972-08-10
TRIAL STUDY 134XCP|IS|EC726B09-0B0F-4933-94F4-8941DF68EDE6||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/KG|||||PFU/DOSE||||HIGH|NOT DONE|||LEUKOCYTE|CLOTTED|Y|ELECTROPHORESIS|N|Y|N||1||38||INDUCTION TREATMENT|1964-12-03|1971-09-06|||||1961-12-05||1960-08-10
TRIAL STUDY 134XCP|IS|EC726B09-0B0F-4933-94F4-8941DF68EDE6||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOSM|||||G/DAY||||LOW|NOT DONE|||SKIN TISSUE|AUTOLYZED|N|SPIROMETRY|Y|U|NA||2||58||BLINDED TREATMENT|1967-04-11|1961-02-10|||||1969-12-20||1965-09-22
TRIAL STUDY 134XCP|IS|EC726B09-0B0F-4933-94F4-8941DF68EDE6||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GRAVITATIONAL UNIT|||||BQ/L||||ABNORMAL|NOT DONE|||VENOUS PLASMA|ROOM TEMPERATURE|N|SURFACE PLASMON RESONANCE|Y|Y|N||3||39||CONTINUATION TREATMENT|1973-04-21|1961-09-14|||||1963-04-09||1964-07-09
TRIAL STUDY 134XCP|IS|EC726B09-0B0F-4933-94F4-8941DF68EDE6||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||L/KG|||||%(W/W)||||HIGH|NOT DONE|||CAPILLARY BLOOD|CONTAMINATED|NA|TOTAL BODY IRRADIATION|N|U|Y||4||88||SCREENING|1964-01-14|1965-04-21|||||1962-06-06||1966-09-04
TRIAL STUDY 134XCP|IS|EC726B09-0B0F-4933-94F4-8941DF68EDE6||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||USEC|||||APPLICATION||||NORMAL|NOT DONE|||PERSPIRATION|ROOM TEMPERATURE|Y|MICROARRAY|N|NA|Y||5||7||LONG-TERM FOLLOW-UP|1961-07-07|1966-06-02|||||1960-09-10||1966-04-11
TRIAL STUDY 134XCP|IS|9F703096-9152-422E-AEAB-AD22F00863ED||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||S/H|||||UG/CM2||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE|Y|RAJI CELL EIA|NA|N|U||1||38||BLINDED TREATMENT|1963-04-27|1971-07-07|||||1969-05-02||1961-06-10
TRIAL STUDY 134XCP|IS|9F703096-9152-422E-AEAB-AD22F00863ED||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FOZ_BR|||||10^6 ORGANISMS||||LOW|NOT DONE|||SERUM OR PLASMA|CLOTTED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|Y|U|NA||2||58||OPEN LABEL TREATMENT|1973-03-03|1972-01-02|||||1972-11-08||1964-02-12
TRIAL STUDY 134XCP|IS|9F703096-9152-422E-AEAB-AD22F00863ED||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^9 ORGANISMS|||||DROP||||NORMAL|NOT DONE|||HAIR|CLOTTED|N|ISHIHARA COLOR PLATES|U|NA|Y||3||39||RUN-IN|1960-12-02|1960-11-04|||||1964-11-02||1967-01-24
TRIAL STUDY 134XCP|IS|9F703096-9152-422E-AEAB-AD22F00863ED||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CYLINDER|||||CCID 50/ML||||NORMAL|NOT DONE|||SERUM OR PLASMA|NON-HEMOLYZED|U|SLIT LAMP PHOTOGRAPHY|NA|Y|Y||4||88||BASELINE|1971-03-11|1969-04-07|||||1970-09-17||1973-08-24
TRIAL STUDY 134XCP|IS|9F703096-9152-422E-AEAB-AD22F00863ED||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^3 COPIES/ML|||||MMOL/MIN/KPA||||HIGH|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NA|NA|Y||5||7||BLINDED TREATMENT|1966-11-01|1963-03-29|||||1972-11-26||1961-05-05
TRIAL STUDY 134XCP|IS|57455593-8872-4B17-8B3F-8A02FE855290||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/10^3|||||DIOPTER||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|DRIED|N|ELECTRONEUROGRAPHY|NA|N|U||1||38||OPEN LABEL TREATMENT|1966-11-29|1971-07-01|||||1962-09-10||1969-05-18
TRIAL STUDY 134XCP|IS|57455593-8872-4B17-8B3F-8A02FE855290||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/M2/H|||||FEU||||NORMAL|NOT DONE|||RETICULOCYTES|PARAFFIN-EMBEDDED|Y|ACID FAST STAIN|NA|U|U||2||58||INDUCTION TREATMENT|1965-04-12|1961-02-19|||||1968-01-06||1967-03-25
TRIAL STUDY 134XCP|IS|57455593-8872-4B17-8B3F-8A02FE855290||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/CAGE/WK|||||IU/KG||||NORMAL|NOT DONE|||TUMOR TISSUE|AGGLUTINATED|U|CONGO RED STAIN|Y|U|U||3||39||FOLLOW-UP|1961-04-12|1964-06-07|||||1969-01-01||1960-03-18
TRIAL STUDY 134XCP|IS|57455593-8872-4B17-8B3F-8A02FE855290||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/M2/MIN|||||PHERESIS UNIT||||LOW|NOT DONE|||CAPILLARY PLASMA|LIPEMIC|NA|AUTOREFRACTION|Y|Y|U||4||88||OPEN LABEL TREATMENT|1963-03-21|1963-02-14|||||1961-04-23||1964-08-12
TRIAL STUDY 134XCP|IS|57455593-8872-4B17-8B3F-8A02FE855290||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/S|||||MPL U/ML||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FROZEN|Y|FLOCCULATION|U|NA|U||5||7||INDUCTION TREATMENT|1967-12-12|1960-04-03|||||1963-09-17||1970-11-10
TRIAL STUDY 134XCP|IS|97F58005-7367-49DC-967B-FAD681B55DF8||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6/G|||||NG/MOL||||HIGH|NOT DONE|||BLOOD|AUTOLYZED|U|RADIOIMMUNOPRECIPITATION ASSAY|NA|NA|Y||1||38||OPEN LABEL TREATMENT|1962-08-17|1971-02-07|||||1971-09-04||1966-11-22
TRIAL STUDY 134XCP|IS|97F58005-7367-49DC-967B-FAD681B55DF8||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PPM|||||MASK||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|CONTAMINATED|N|WESTERN BLOT|NA|N|N||2||58||OPEN LABEL TREATMENT|1971-01-20|1967-07-19|||||1971-06-19||1972-02-27
TRIAL STUDY 134XCP|IS|97F58005-7367-49DC-967B-FAD681B55DF8||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NEWTON|||||CI/L||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|THAWED|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|U|U|NA||3||39||BASELINE|1971-08-08|1967-10-20|||||1967-09-26||1969-12-18
TRIAL STUDY 134XCP|IS|97F58005-7367-49DC-967B-FAD681B55DF8||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KBQ/UL|||||BISCUIT||||HIGH|NOT DONE|||SMEGMA|DRIED|U|SLOAN LETTER EYE CHART 100%|U|U|NA||4||88||INDUCTION TREATMENT|1967-06-05|1968-08-01|||||1968-11-09||1960-01-15
TRIAL STUDY 134XCP|IS|97F58005-7367-49DC-967B-FAD681B55DF8||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||STEPS|||||/MIN||||NORMAL|NOT DONE|||PLATELET|CALCIFIED|Y|GC/MS|U|NA|N||5||7||WASHOUT|1962-08-03|1970-07-04|||||1969-03-11||1961-11-28
TRIAL STUDY 134XCP|IS|83AC0828-3C22-4F7C-9D22-F044BB5B630D||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/M2/H|||||VOXEL||||ABNORMAL|NOT DONE|||BASAL TEAR|ROOM TEMPERATURE|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|U|NA|U||1||38||BLINDED TREATMENT|1973-06-01|1969-09-03|||||1967-07-16||1970-03-20
TRIAL STUDY 134XCP|IS|83AC0828-3C22-4F7C-9D22-F044BB5B630D||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||M|||||PMOL/DAY||||LOW|NOT DONE|||SPUTUM|GELLED|NA|NUCLEIC ACID BASED METHOD|NA|N|NA||2||58||BASELINE|1969-03-25|1969-01-12|||||1963-10-27||1972-07-13
TRIAL STUDY 134XCP|IS|83AC0828-3C22-4F7C-9D22-F044BB5B630D||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAPFUL|||||/MM2||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|THAWED|N|MICRONEUTRALIZATION ASSAY|U|NA|U||3||39||BASELINE|1970-07-21|1971-07-26|||||1971-08-15||1966-02-20
TRIAL STUDY 134XCP|IS|83AC0828-3C22-4F7C-9D22-F044BB5B630D||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/ANIMAL|||||/MM||||LOW|NOT DONE|||BREAST MILK|CALCIFIED|N|TRANSVAGINAL ULTRASOUND|N|U|Y||4||88||TREATMENT|1961-05-05|1961-10-23|||||1969-09-24||1965-04-18
TRIAL STUDY 134XCP|IS|83AC0828-3C22-4F7C-9D22-F044BB5B630D||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UCI|||||BISCUIT||||HIGH|NOT DONE|||CERUMEN|DRIED|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NA|U|U||5||7||OBSERVATION|1969-12-13|1963-02-15|||||1962-07-25||1967-06-29
TRIAL STUDY 134XCP|IS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/KG/MIN|||||10^4/HPF||||LOW|NOT DONE|||ENDOMETRIAL TISSUE|ICTERIC|U|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|NA|Y||1||38||TREATMENT|1961-07-10|1970-08-15|||||1968-02-18||1971-10-12
TRIAL STUDY 134XCP|IS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMU/ML|||||PPTH||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ICTERIC|Y|LC/MS|N|U|U||2||58||WASHOUT|1962-10-02|1972-09-15|||||1963-02-28||1972-02-08
TRIAL STUDY 134XCP|IS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/ANIMAL|||||GY||||ABNORMAL|NOT DONE|||REFLEX TEAR|CONTAMINATED|NA|EPSILOMETER|N|U|Y||3||39||SCREENING|1965-07-14|1965-10-12|||||1960-06-22||1973-07-27
TRIAL STUDY 134XCP|IS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/MG|||||ML/CM||||NORMAL|NOT DONE|||SEMEN|CLOTTED|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|NA|Y|N||4||88||CONTINUATION TREATMENT|1963-03-28|1967-03-08|||||1963-01-31||1968-12-30
TRIAL STUDY 134XCP|IS|1C380A81-79B1-48EA-9C50-9B1E3B401BCC||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/DL|||||10^9/DOSE||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|SOLIDIFIED|U|IN SITU HYBRIDIZATION|U|Y|U||5||7||RUN-IN|1961-02-01|1961-09-24|||||1962-06-29||1964-02-23
TRIAL STUDY 134XCP|IS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UL|||||MOSM/L||||LOW|NOT DONE|||SUPERNATANT, PLASMA|UNEXPECTED ODOR|N|LEAD CITRATE STAIN|NA|Y|U||1||38||SCREENING|1965-06-20|1972-01-08|||||1961-01-09||1961-01-10
TRIAL STUDY 134XCP|IS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PLUG|||||LX||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|U|PATHOLOGICAL EVALUATION|U|NA|N||2||58||OBSERVATION|1967-06-20|1963-11-10|||||1960-03-09||1972-02-24
TRIAL STUDY 134XCP|IS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FG|||||ATM||||NORMAL|NOT DONE|||BLOOD|ICTERIC|N|DIFFUSION WEIGHTED MRI|N|NA|U||3||39||TREATMENT|1962-07-02|1962-04-07|||||1969-06-25||1963-07-02
TRIAL STUDY 134XCP|IS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PIXELS/IN|||||PMOL/L/H||||NORMAL|NOT DONE|||LYSATE|CLOTTED|NA|JAEGER EYE CHART|Y|U|NA||4||88||RUN-IN|1962-03-03|1971-06-05|||||1966-04-29||1973-02-15
TRIAL STUDY 134XCP|IS|E22C5D53-74B1-402F-9A9C-3E48F1A9AD5E||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||JOULE|||||FIU||||NORMAL|NOT DONE|||EPITHELIAL CELL|LACTESCENT|U|QUANTITATIVE ULTRASOUND|N|N|Y||5||7||CONTINUATION TREATMENT|1966-06-24|1968-10-13|||||1965-01-23||1973-02-24
TRIAL STUDY 134XCP|IS|B386B813-1175-4421-9C86-F9AB597877FA||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ANTI-XA IU|||||U/MG||||NORMAL|NOT DONE|||LOCHIA|CONCENTRATED|U|APPLANATION TONOMETRY|N|N|U||1||38||OPEN LABEL TREATMENT|1970-03-04|1964-11-21|||||1966-07-08||1970-06-30
TRIAL STUDY 134XCP|IS|B386B813-1175-4421-9C86-F9AB597877FA||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^10/L|||||10^6 COPIES/ML||||LOW|NOT DONE|||MENSTRUAL BLOOD|CALCIFIED|U|OPTICAL COHERENCE TOMOGRAPHY|NA|NA|NA||2||58||LONG-TERM FOLLOW-UP|1968-08-15|1968-02-12|||||1963-01-14||1968-09-08
TRIAL STUDY 134XCP|IS|B386B813-1175-4421-9C86-F9AB597877FA||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/M2/MIN|||||U/M2/DAY||||HIGH|NOT DONE|||MECONIUM|THAWED|NA|OPTICAL DENSITY MEASUREMENT|NA|Y|Y||3||39||OBSERVATION|1966-03-15|1969-05-17|||||1960-03-29||1971-12-04
TRIAL STUDY 134XCP|IS|B386B813-1175-4421-9C86-F9AB597877FA||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||HOURS|||||M3||||NORMAL|NOT DONE|||EMESIS|THAWED|Y|OBSERVATION|NA|U|NA||4||88||SCREENING|1966-01-08|1964-05-01|||||1962-08-31||1960-01-19
TRIAL STUDY 134XCP|IS|B386B813-1175-4421-9C86-F9AB597877FA||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/10^5|||||MM||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|AUTOLYZED|NA|TRIPLE-PHASE MRI SCAN|N|N|Y||5||7||OBSERVATION|1973-03-20|1961-09-21|||||1972-09-20||1964-12-28
TRIAL STUDY 134XCP|IS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL|||||/WK||||NORMAL|NOT DONE|||SERUM OR PLASMA|UNEXPECTED ODOR|U|CLOT DETECTION|Y|N|N||1||38||SCREENING|1967-05-26|1965-08-04|||||1962-08-30||1960-10-21
TRIAL STUDY 134XCP|IS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^5/HPF|||||MM||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|GELLED|N|WRIGHT STAIN|NA|Y|NA||2||58||FOLLOW-UP|1962-08-14|1960-06-07|||||1966-01-06||1962-02-08
TRIAL STUDY 134XCP|IS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UGEQ|||||%/MIN||||HIGH|NOT DONE|||RETICULOCYTES|NON-HEMOLYZED|NA|DIRECT SEQUENCING|N|Y|Y||3||39||CONTINUATION TREATMENT|1964-07-15|1960-02-04|||||1964-10-24||1966-01-18
TRIAL STUDY 134XCP|IS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CMH2O*S/ML|||||SV||||ABNORMAL|NOT DONE|||SEMINAL FLUID|AGGLUTINATED|Y|MICROBIAL CULTURE, LIQUID|Y|U|NA||4||88||BASELINE|1960-10-08|1962-11-18|||||1963-03-27||1960-03-12
TRIAL STUDY 134XCP|IS|5ADBD73B-1E68-466B-8CF6-D7FB85D80906||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MM/SEC|||||DROP||||LOW|NOT DONE|||VENOUS CORD BLOOD|HEMOLYZED|NA|TARGETED TRANSCRIPTOME SEQUENCING|Y|Y|NA||5||7||BASELINE|1964-09-13|1968-05-03|||||1966-08-09||1973-08-27
TRIAL STUDY 134XCP|IS|7B33775D-1DFF-49A6-820E-7981F5C16AFF||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GTT|||||MM/H||||LOW|NOT DONE|||TUMOR TISSUE|CALCIFIED|Y|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|U|N|N||1||38||BLINDED TREATMENT|1964-01-01|1973-04-29|||||1970-10-03||1963-07-05
TRIAL STUDY 134XCP|IS|7B33775D-1DFF-49A6-820E-7981F5C16AFF||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KG/M2|||||U||||ABNORMAL|NOT DONE|||CELL PELLET|CONCENTRATED|Y|MRI WITHOUT CONTRAST|NA|N|U||2||58||OBSERVATION|1960-04-18|1969-06-02|||||1970-01-08||1963-06-23
TRIAL STUDY 134XCP|IS|7B33775D-1DFF-49A6-820E-7981F5C16AFF||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MN|||||USP U||||NORMAL|NOT DONE|||BONE MARROW|CLOTTED|NA|OPTICAL DENSITY MEASUREMENT|NA|U|U||3||39||WASHOUT|1971-12-30|1968-06-22|||||1965-06-09||1969-01-06
TRIAL STUDY 134XCP|IS|7B33775D-1DFF-49A6-820E-7981F5C16AFF||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DDU|||||INHALATION||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|FRESH|N|CONGO RED STAIN|N|NA|N||4||88||WASHOUT|1972-09-26|1969-03-24|||||1971-09-09||1966-03-15
TRIAL STUDY 134XCP|IS|7B33775D-1DFF-49A6-820E-7981F5C16AFF||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PMOL/L/H|||||DPM/ML||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|CALCIFIED|NA|SICKLE CELL SOLUBILITY TEST|NA|Y|NA||5||7||OPEN LABEL TREATMENT|1963-04-05|1970-05-16|||||1960-03-20||1966-10-13
TRIAL STUDY 134XCP|IS|DC48DD03-B87E-422D-A2EE-D87342260E19||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 IU|||||PIXEL||||LOW|NOT DONE|||PLATELET|ROOM TEMPERATURE|Y|ICP-MS|Y|N|U||1||38||LONG-TERM FOLLOW-UP|1966-01-11|1970-12-19|||||1962-10-02||1965-02-10
TRIAL STUDY 134XCP|IS|DC48DD03-B87E-422D-A2EE-D87342260E19||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BQ/KG|||||DAGU/ML||||LOW|NOT DONE|||BONE MARROW|NON-HEMOLYZED|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|U|NA|N||2||58||FOLLOW-UP|1962-05-06|1965-02-08|||||1967-09-07||1966-02-14
TRIAL STUDY 134XCP|IS|DC48DD03-B87E-422D-A2EE-D87342260E19||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MIN/KPA|||||10^7/L||||HIGH|NOT DONE|||INFRANATANT, PLASMA|AUTOLYZED|NA|INCISION-INDUCED BLEEDING METHOD|U|N|Y||3||39||TREATMENT|1966-08-13|1962-01-17|||||1967-08-13||1962-06-26
TRIAL STUDY 134XCP|IS|DC48DD03-B87E-422D-A2EE-D87342260E19||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BU/ML|||||MG/ML/DAY||||LOW|NOT DONE|||SUPERNATANT, SERUM|LIPEMIC|NA|POPULATION SEQUENCING|U|U|Y||4||88||FOLLOW-UP|1969-01-08|1970-05-28|||||1962-06-19||1971-11-21
TRIAL STUDY 134XCP|IS|DC48DD03-B87E-422D-A2EE-D87342260E19||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PL|||||F||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|AGGLUTINATED|Y|DUKE INCISION METHOD|N|U|Y||5||7||WASHOUT|1963-09-09|1967-06-15|||||1970-02-06||1961-09-01
TRIAL STUDY 134XCP|IS|2E084441-61A3-4B8B-9050-A5D7B38CA978||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/KG|||||BU||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|NA|PERIODIC ACID SCHIFF STAIN|Y|Y|Y||1||38||FOLLOW-UP|1964-02-24|1963-09-16|||||1969-02-22||1965-10-03
TRIAL STUDY 134XCP|IS|2E084441-61A3-4B8B-9050-A5D7B38CA978||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UCI/KG|||||PKAT/L||||HIGH|NOT DONE|||VITREOUS HUMOR|PARAFFIN-EMBEDDED|Y|NEXT GENERATION TARGETED SEQUENCING|NA|N|Y||2||58||FOLLOW-UP|1972-06-26|1973-04-09|||||1972-06-11||1962-06-26
TRIAL STUDY 134XCP|IS|2E084441-61A3-4B8B-9050-A5D7B38CA978||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CAPFUL|||||PRESSOR UNITS||||LOW|NOT DONE|||PLEURAL TISSUE|FROZEN|NA|HPLC/MS/MS|Y|NA|N||3||39||WASHOUT|1960-06-14|1973-06-25|||||1962-03-19||1966-05-05
TRIAL STUDY 134XCP|IS|2E084441-61A3-4B8B-9050-A5D7B38CA978||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SPRAY|||||MASK||||HIGH|NOT DONE|||LYSATE|CONCENTRATED|N|MIGET|NA|NA|Y||4||88||BASELINE|1969-03-12|1969-06-19|||||1961-11-19||1965-08-26
TRIAL STUDY 134XCP|IS|2E084441-61A3-4B8B-9050-A5D7B38CA978||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MGEQ|||||UG/L DDU||||ABNORMAL|NOT DONE|||BLOOD|PARAFFIN-EMBEDDED|N|PANENDOSCOPY|U|NA|U||5||7||OBSERVATION|1972-08-19|1968-04-18|||||1967-10-16||1963-07-10
TRIAL STUDY 134XCP|IS|601D563B-AA21-4859-A87E-B2068C1E3F53||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MPS U|||||SPRAY||||NORMAL|NOT DONE|||MECONIUM|GELLED|NA|ICC|U|Y|Y||1||38||OBSERVATION|1963-12-09|1961-05-11|||||1965-07-21||1966-10-08
TRIAL STUDY 134XCP|IS|601D563B-AA21-4859-A87E-B2068C1E3F53||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CUP|||||CI/UG||||LOW|NOT DONE|||SUPERNATANT, PLASMA|DRIED|NA|SCANNING ELECTRON MICROSCOPY|NA|N|N||2||58||INDUCTION TREATMENT|1968-08-04|1966-05-20|||||1973-06-15||1960-04-29
TRIAL STUDY 134XCP|IS|601D563B-AA21-4859-A87E-B2068C1E3F53||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GRAIN|||||FARAD||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|FRESH|Y|IMMUNOPRECIPITATION|Y|U|NA||3||39||INDUCTION TREATMENT|1963-08-06|1966-01-21|||||1966-11-28||1961-07-01
TRIAL STUDY 134XCP|IS|601D563B-AA21-4859-A87E-B2068C1E3F53||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U|||||FRACTION OF 1||||LOW|NOT DONE|||PROSTATIC FLUID|GELLED|U|INDIRECT IMMUNOFLUORESCENCE|NA|U|N||4||88||OBSERVATION|1960-06-14|1968-09-25|||||1962-08-22||1963-06-12
TRIAL STUDY 134XCP|IS|601D563B-AA21-4859-A87E-B2068C1E3F53||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SPRAY|||||UMOL/L||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|LIPEMIC|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|U|U||5||7||OPEN LABEL TREATMENT|1960-09-17|1963-01-13|||||1966-02-19||1964-05-16
TRIAL STUDY 134XCP|IS|D8FE5979-24C7-478F-8612-0102F28F5ADE||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML*CMH2O|||||LX||||NORMAL|NOT DONE|||PUS|CONTAMINATED|N|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y|Y||1||38||FOLLOW-UP|1961-08-18|1971-07-10|||||1964-05-23||1968-07-24
TRIAL STUDY 134XCP|IS|D8FE5979-24C7-478F-8612-0102F28F5ADE||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||G/CAGE/DAY||||LOW|NOT DONE|||KERATINOCYTE|UNEXPECTED ODOR|N|IMMUNOFLUORESCENT STAIN|NA|NA|N||2||58||WASHOUT|1961-02-11|1960-09-11|||||1960-11-05||1962-01-03
TRIAL STUDY 134XCP|IS|D8FE5979-24C7-478F-8612-0102F28F5ADE||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TSP|||||EJACULATE U||||HIGH|NOT DONE|||INTERSTITIAL FLUID|CONCENTRATED|U|ALCIAN BLUE STAIN|Y|Y|U||3||39||BLINDED TREATMENT|1967-10-29|1962-01-06|||||1965-06-20||1967-07-25
TRIAL STUDY 134XCP|IS|D8FE5979-24C7-478F-8612-0102F28F5ADE||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BQ/UL|||||UCI||||LOW|NOT DONE|||ENDOMETRIAL TISSUE|REFRIGERATED|Y|RAJI CELL RIA|NA|U|Y||4||88||RUN-IN|1972-06-15|1964-06-04|||||1966-11-15||1963-05-14
TRIAL STUDY 134XCP|IS|D8FE5979-24C7-478F-8612-0102F28F5ADE||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NMOL/KG/DAY|||||UOSM||||HIGH|NOT DONE|||REFLEX TEAR|NON-HEMOLYZED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|N|NA|N||5||7||TREATMENT|1965-07-23|1966-07-31|||||1965-03-11||1966-12-17
TRIAL STUDY 134XCP|IS|D275315F-D3C5-4260-8BD6-37DDB67262B0||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MV|||||GPS U||||HIGH|NOT DONE|||EPIDERMAL TISSUE|ROOM TEMPERATURE|N|POLYSOMNOGRAPHY|Y|NA|NA||1||38||RUN-IN|1971-10-16|1963-12-11|||||1969-01-11||1970-11-03
TRIAL STUDY 134XCP|IS|D275315F-D3C5-4260-8BD6-37DDB67262B0||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BLOCKS|||||UG/DAY||||HIGH|NOT DONE|||VITREOUS HUMOR|GELLED|NA|BETA LACTAMASE|N|Y|Y||2||58||INDUCTION TREATMENT|1960-01-19|1973-07-10|||||1963-05-25||1969-08-05
TRIAL STUDY 134XCP|IS|D275315F-D3C5-4260-8BD6-37DDB67262B0||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TUBERCULIN UNIT|||||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE|||LYMPH|CLOTTED|U|IMMUNOFLUORESCENT STAIN|U|Y|NA||3||39||TREATMENT|1968-12-29|1968-11-02|||||1973-07-14||1961-11-12
TRIAL STUDY 134XCP|IS|D275315F-D3C5-4260-8BD6-37DDB67262B0||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MBQ/UL|||||JAR||||HIGH|NOT DONE|||SMEGMA|SOLIDIFIED|NA|CRYOSCOPY|Y|Y|U||4||88||WASHOUT|1972-05-30|1970-08-19|||||1967-09-30||1972-07-23
TRIAL STUDY 134XCP|IS|D275315F-D3C5-4260-8BD6-37DDB67262B0||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||TSP|||||CCID 50/ML||||HIGH|NOT DONE|||EMOTIONAL TEAR|CONCENTRATED|U|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|U|NA||5||7||OPEN LABEL TREATMENT|1971-02-14|1969-04-13|||||1964-03-12||1960-04-09
TRIAL STUDY 134XCP|IS|34127CD2-378B-4335-AD4B-F305D0A21AF4||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||HENRY|||||G/ANIMAL/DAY||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|CALCIFIED|N|JAEGER EYE CHART|U|N|NA||1||38||BLINDED TREATMENT|1964-04-29|1965-10-03|||||1971-04-09||1962-01-07
TRIAL STUDY 134XCP|IS|34127CD2-378B-4335-AD4B-F305D0A21AF4||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6 RNA COPIES/ML|||||BEATS/MIN||||HIGH|NOT DONE|||SPERMATOZOON|LACTESCENT|Y|CENTRIFUGATION|U|U|NA||2||58||INDUCTION TREATMENT|1973-07-09|1968-07-20|||||1966-06-02||1972-04-03
TRIAL STUDY 134XCP|IS|34127CD2-378B-4335-AD4B-F305D0A21AF4||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||JDF UNIT|||||BOLUS||||NORMAL|NOT DONE|||VENOUS BLOOD|CALCIFIED|U|MANUAL COUNT|Y|N|N||3||39||TREATMENT|1972-01-16|1966-05-26|||||1969-02-16||1968-04-29
TRIAL STUDY 134XCP|IS|34127CD2-378B-4335-AD4B-F305D0A21AF4||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS/MG|||||DEG/MM||||LOW|NOT DONE|||TUMOR TISSUE|PARAFFIN-EMBEDDED|NA|RYAN BLUE STAIN|NA|NA|U||4||88||SCREENING|1969-10-23|1971-11-24|||||1967-01-06||1967-04-05
TRIAL STUDY 134XCP|IS|34127CD2-378B-4335-AD4B-F305D0A21AF4||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MCI/KG|||||10^6 U||||NORMAL|NOT DONE|||BILE|GELLED|Y|MODIFIED ACID FAST STAIN|U|NA|NA||5||7||FOLLOW-UP|1964-08-18|1968-08-29|||||1960-12-08||1967-09-29
TRIAL STUDY 134XCP|IS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/KG|||||STEPS||||ABNORMAL|NOT DONE|||LAVAGE FLUID|ICTERIC|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|N||1||38||LONG-TERM FOLLOW-UP|1972-12-17|1969-03-27|||||1973-05-13||1963-07-28
TRIAL STUDY 134XCP|IS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||M2|||||/LSQN||||NORMAL|NOT DONE|||CAPILLARY BLOOD|LACTESCENT|N|IMMUNO-PET SCAN|N|Y|NA||2||58||OBSERVATION|1971-05-09|1968-11-14|||||1961-10-08||1966-11-18
TRIAL STUDY 134XCP|IS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||APL U/ML|||||MG/MIN||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|U|MICROBIAL CULTURE|Y|U|NA||3||39||FOLLOW-UP|1969-10-07|1967-12-10|||||1961-10-25||1967-02-25
TRIAL STUDY 134XCP|IS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PMOL/DL|||||G||||LOW|NOT DONE|||SOFT TISSUE|ROOM TEMPERATURE|U|COLORIMETRY|NA|NA|U||4||88||OPEN LABEL TREATMENT|1968-09-25|1968-11-11|||||1970-03-19||1962-05-01
TRIAL STUDY 134XCP|IS|6A15A97E-5B6F-483A-A9C7-94AC81B977A3||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/BEAT|||||SFC/10^6 PBMC||||HIGH|NOT DONE|||BILE|ICTERIC|N|IRON HEMATOXYLIN STAIN|Y|U|U||5||7||RUN-IN|1972-06-19|1968-11-15|||||1967-10-30||1970-10-17
TRIAL STUDY 134XCP|IS|6EE04A90-681B-439E-9783-04B40A4AF240||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6/L|||||L/MIN/M2||||NORMAL|NOT DONE|||PERSPIRATION|SOLIDIFIED|Y|ENZYMATIC ULTRACENTRIFUGATION|U|U|U||1||38||LONG-TERM FOLLOW-UP|1962-02-14|1970-11-15|||||1961-05-08||1965-07-16
TRIAL STUDY 134XCP|IS|6EE04A90-681B-439E-9783-04B40A4AF240||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UIU/L|||||HR/DAY||||LOW|NOT DONE|||BONE|CONTAMINATED|Y|CT SCAN|NA|U|N||2||58||BASELINE|1961-10-23|1964-09-25|||||1970-04-10||1966-10-01
TRIAL STUDY 134XCP|IS|6EE04A90-681B-439E-9783-04B40A4AF240||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PKAT/L|||||WAFER||||ABNORMAL|NOT DONE|||MECONIUM|LACTESCENT|U|ETDRS EYE CHART|N|N|U||3||39||FOLLOW-UP|1960-06-06|1972-02-27|||||1963-11-04||1972-05-30
TRIAL STUDY 134XCP|IS|6EE04A90-681B-439E-9783-04B40A4AF240||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MCI/KG|||||MBP||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|U|Y||4||88||RUN-IN|1963-01-25|1970-12-16|||||1969-10-26||1961-07-23
TRIAL STUDY 134XCP|IS|6EE04A90-681B-439E-9783-04B40A4AF240||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||VIRTUAL PIXEL|||||KCAL||||HIGH|NOT DONE|||PLEURAL FLUID|CONTAMINATED|N|GC/MS-EI|Y|N|U||5||7||RUN-IN|1962-10-02|1965-06-09|||||1967-09-20||1965-09-03
TRIAL STUDY 134XCP|IS|A5C0B034-1226-40EE-87E3-D46A7342B550||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/KG/DAY|||||RNA COPIES/ML||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|NON-HEMOLYZED|N|LIGHT MICROSCOPY|N|U|N||1||38||TREATMENT|1969-11-12|1963-11-07|||||1969-06-10||1960-08-07
TRIAL STUDY 134XCP|IS|A5C0B034-1226-40EE-87E3-D46A7342B550||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KDA|||||NMOL BCE/L||||NORMAL|NOT DONE|||SEMEN|ICTERIC|NA|FLUORESCENCE ANGIOGRAPHY|U|NA|NA||2||58||OBSERVATION|1970-01-09|1972-07-17|||||1971-05-03||1964-01-24
TRIAL STUDY 134XCP|IS|A5C0B034-1226-40EE-87E3-D46A7342B550||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 PFU|||||DAMOL/L||||ABNORMAL|NOT DONE|||MECONIUM|CALCIFIED|NA|CLIP|Y|NA|NA||3||39||TREATMENT|1962-12-12|1973-08-02|||||1963-10-15||1972-05-26
TRIAL STUDY 134XCP|IS|A5C0B034-1226-40EE-87E3-D46A7342B550||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOL/DAY|||||G/M2/DAY||||ABNORMAL|NOT DONE|||ISOLATE|AGGLUTINATED|Y|HIGH RESOLUTION CT|Y|NA|Y||4||88||INDUCTION TREATMENT|1970-08-19|1960-12-14|||||1963-04-29||1973-01-12
TRIAL STUDY 134XCP|IS|A5C0B034-1226-40EE-87E3-D46A7342B550||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CCID 50/DOSE|||||FFU||||NORMAL|NOT DONE|||NAIL|CONTAMINATED|U|CISH|NA|NA|Y||5||7||TREATMENT|1973-08-02|1965-02-16|||||1969-11-17||1968-05-28
TRIAL STUDY 134XCP|IS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/KG/H|||||U/L||||NORMAL|NOT DONE|||CAPILLARY PLASMA|THAWED|U|FLUORESCENT ENZYME IMMUNOASSAY|U|N|U||1||38||SCREENING|1973-07-10|1970-05-07|||||1963-12-06||1968-12-01
TRIAL STUDY 134XCP|IS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^3 CFU/G|||||UMOL/KG/MIN||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|NON-HEMOLYZED|N|PHASE-CONTRAST MRI|N|NA|U||2||58||OBSERVATION|1963-10-07|1962-05-30|||||1971-08-25||1971-12-14
TRIAL STUDY 134XCP|IS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||SFC/10^6 PBMC|||||MMOL||||LOW|NOT DONE|||PERSPIRATION|PARAFFIN-EMBEDDED|N|ACRIDINE ORANGE STAIN|U|U|NA||3||39||CONTINUATION TREATMENT|1962-01-17|1965-03-20|||||1965-10-07||1962-06-08
TRIAL STUDY 134XCP|IS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CMOL/L|||||FMOL/L/SEC||||HIGH|NOT DONE|||MUCUS|NON-HEMOLYZED|Y|X-RAY FLUORESCENCE SPECTROMETRY|NA|U|NA||4||88||FOLLOW-UP|1972-07-19|1972-10-09|||||1964-09-17||1963-08-19
TRIAL STUDY 134XCP|IS|215DE9E0-6E47-448D-BE13-7CF5DB1A3865||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MBQ|||||AU/ML||||HIGH|NOT DONE|||HAIR FOLLICLE|GELLED|N|AUSCULTATION|Y|U|N||5||7||SCREENING|1961-07-12|1972-07-26|||||1962-05-28||1960-04-20
TRIAL STUDY 134XCP|IS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||HOMEOPATHIC DILUTION|||||10^6 ORGANISMS/ML||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FRESH|Y|DYNAMIC LIGHT SCATTERING|Y|U|U||1||38||TREATMENT|1965-05-18|1965-07-04|||||1971-10-14||1960-03-28
TRIAL STUDY 134XCP|IS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/MG|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||LYMPH|UNEXPECTED ODOR|NA|DOPPLER ULTRASOUND|NA|U|NA||2||58||BASELINE|1967-07-28|1966-09-13|||||1972-07-18||1964-12-08
TRIAL STUDY 134XCP|IS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TESLA|||||KAT||||HIGH|NOT DONE|||MENSTRUAL BLOOD|DRIED|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NA|Y|N||3||39||RUN-IN|1971-08-24|1961-11-28|||||1971-08-14||1969-10-14
TRIAL STUDY 134XCP|IS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FEU|||||BP||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|FROZEN|Y|FLOW CYTOMETRY|NA|N|N||4||88||TREATMENT|1972-06-11|1965-02-01|||||1960-03-08||1972-10-06
TRIAL STUDY 134XCP|IS|A99FE1E2-ED93-4550-9AE7-3AC117D8619B||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/G|||||PMOL/10^10 CELLS||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|AGGLUTINATED|U|TOLUIDINE BLUE STAIN|NA|U|NA||5||7||OPEN LABEL TREATMENT|1972-07-03|1968-06-16|||||1961-08-03||1968-12-07
TRIAL STUDY 134XCP|IS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GTT|||||ML/MIN||||LOW|NOT DONE|||EPIDERMAL TISSUE|SOLIDIFIED|U|LIQUID SCINTILLATION COUNTING|N|U|Y||1||38||SCREENING|1966-11-23|1970-12-07|||||1967-05-31||1962-06-22
TRIAL STUDY 134XCP|IS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PG|||||PL||||NORMAL|NOT DONE|||LYSATE|REFRIGERATED|N|CONTRAST ENHANCED MRI|U|N|N||2||58||TREATMENT|1962-07-15|1961-06-28|||||1970-06-02||1963-09-17
TRIAL STUDY 134XCP|IS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||AMP|||||RFU||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|HEMOLYZED|Y|INDIRECT IMMUNOFLUORESCENCE|U|NA|N||3||39||OBSERVATION|1964-12-15|1970-01-18|||||1971-03-29||1970-12-18
TRIAL STUDY 134XCP|IS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||FMOL/L/SEC|||||BQ/UG||||ABNORMAL|NOT DONE|||ABSCESS FLUID|ICTERIC|Y|PET/CT SCAN WITHOUT CONTRAST|U|Y|N||4||88||TREATMENT|1969-06-01|1967-07-03|||||1971-09-05||1968-05-14
TRIAL STUDY 134XCP|IS|2360DE4B-4EF2-4ECA-8663-9DA9306F1DB7||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MET*MIN|||||UMOL/L/H||||NORMAL|NOT DONE|||NAIL|AUTOLYZED|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y|Y|NA||5||7||CONTINUATION TREATMENT|1962-05-15|1963-03-22|||||1963-03-02||1964-07-23
TRIAL STUDY 134XCP|IS|D58A8C37-6659-4B00-8BED-256E8754F93C||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^7 CFU/ML|||||MSEC||||ABNORMAL|NOT DONE|||LOCHIA|CONCENTRATED|U|TARGETED TRANSCRIPTOME SEQUENCING|N|N|N||1||38||BLINDED TREATMENT|1971-11-16|1962-10-09|||||1969-06-22||1960-05-24
TRIAL STUDY 134XCP|IS|D58A8C37-6659-4B00-8BED-256E8754F93C||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^6 RNA COPIES/ML|||||POINT||||ABNORMAL|NOT DONE|||BASAL TEAR|UNEXPECTED ODOR|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|U|Y|NA||2||58||FOLLOW-UP|1969-12-11|1960-04-19|||||1962-10-24||1961-02-16
TRIAL STUDY 134XCP|IS|D58A8C37-6659-4B00-8BED-256E8754F93C||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/KG/DAY|||||IU/DAY||||HIGH|NOT DONE|||PLASMA|LIPEMIC|N|IMMUNOCHEMILUMINOMETRIC ASSAY|U|U|NA||3||39||LONG-TERM FOLLOW-UP|1972-10-05|1962-08-09|||||1966-08-09||1962-03-20
TRIAL STUDY 134XCP|IS|D58A8C37-6659-4B00-8BED-256E8754F93C||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MESF|||||U/ANIMAL||||HIGH|NOT DONE|||VENOUS BLOOD|AGGLUTINATED|Y|ICP-MS|U|N|Y||4||88||BASELINE|1965-12-07|1962-05-25|||||1968-05-11||1970-12-06
TRIAL STUDY 134XCP|IS|D58A8C37-6659-4B00-8BED-256E8754F93C||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UM/S|||||/MM2||||HIGH|NOT DONE|||SALIVA|AGGLUTINATED|NA|ISHIHARA COLOR PLATES|NA|U|Y||5||7||RUN-IN|1970-11-02|1968-10-07|||||1967-09-24||1961-09-03
TRIAL STUDY 134XCP|IS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/MOL|||||KS||||ABNORMAL|NOT DONE|||LYSATE|LIPEMIC|NA|REFRACTOMETRY|N|NA|NA||1||38||SCREENING|1962-04-13|1971-06-25|||||1967-04-04||1966-04-18
TRIAL STUDY 134XCP|IS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BISCUIT|||||10^9 ORGANISMS/ML||||ABNORMAL|NOT DONE|||SEMINAL FLUID|LIPEMIC|Y|IMMUNOFIXATION ELECTROPHORESIS|NA|NA|Y||2||58||OBSERVATION|1973-02-05|1972-11-01|||||1961-03-13||1963-04-27
TRIAL STUDY 134XCP|IS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||M2|||||SIEMENS||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|LIPEMIC|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|N|NA|Y||3||39||BASELINE|1968-03-15|1961-12-01|||||1964-10-27||1966-08-20
TRIAL STUDY 134XCP|IS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/S/M2|||||ML/M2/MIN||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|ROOM TEMPERATURE|NA|POTENTIOMETRY|Y|Y|Y||4||88||WASHOUT|1965-01-02|1964-03-12|||||1963-11-11||1964-01-10
TRIAL STUDY 134XCP|IS|F2649193-70EA-4B76-A08C-EBAFE4FE69BD||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CAPFUL|||||ENZYME U/G HB||||ABNORMAL|NOT DONE|||REFLEX TEAR|ICTERIC|Y|HPLC/MS/MS|NA|N|U||5||7||TREATMENT|1971-06-26|1966-01-29|||||1965-08-01||1965-01-20
TRIAL STUDY 134XCP|IS|5440F45F-C220-46E7-8354-6AF34A003E5E||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NKAT/G HB|||||UMOL/L/H||||HIGH|NOT DONE|||COLOSTRUM|DRIED|U|LC/MS|N|N|N||1||38||OBSERVATION|1965-09-21|1962-08-28|||||1964-12-04||1960-07-11
TRIAL STUDY 134XCP|IS|5440F45F-C220-46E7-8354-6AF34A003E5E||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 CFU/ML|||||UV||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|FROZEN|Y|FORCED OSCILLATION TECHNIQUE|NA|U|Y||2||58||BLINDED TREATMENT|1968-05-28|1966-05-19|||||1970-04-07||1965-05-06
TRIAL STUDY 134XCP|IS|5440F45F-C220-46E7-8354-6AF34A003E5E||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/KG/H|||||KUSP||||HIGH|NOT DONE|||ARTERIAL BLOOD|LIPEMIC|U|FLUORESCENT ENZYME IMMUNOASSAY|U|N|Y||3||39||OPEN LABEL TREATMENT|1961-09-19|1967-10-18|||||1964-01-14||1964-07-14
TRIAL STUDY 134XCP|IS|5440F45F-C220-46E7-8354-6AF34A003E5E||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IU|||||/10^4||||NORMAL|NOT DONE|||GASTRIC CONTENTS|PARAFFIN-EMBEDDED|U|NON-INVASIVE DIELECTRIC SENSING|NA|Y|NA||4||88||RUN-IN|1970-05-17|1960-10-09|||||1960-11-06||1969-08-27
TRIAL STUDY 134XCP|IS|5440F45F-C220-46E7-8354-6AF34A003E5E||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BAU/ML|||||BU||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|AUTOLYZED|Y|JAFFE REACTION|Y|U|NA||5||7||SCREENING|1963-10-03|1971-08-18|||||1969-08-02||1969-08-01
TRIAL STUDY 134XCP|IS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/KG|||||CMOL/L||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|SOLIDIFIED|U|ICC|Y|NA|Y||1||38||LONG-TERM FOLLOW-UP|1972-12-13|1971-07-30|||||1971-01-05||1966-09-27
TRIAL STUDY 134XCP|IS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^5/L|||||10^3 ORGANISMS/ML||||ABNORMAL|NOT DONE|||SEMINAL FLUID|SOLIDIFIED|NA|IMMUNODIFFUSION|NA|U|U||2||58||TREATMENT|1965-11-14|1965-09-19|||||1971-06-19||1961-05-17
TRIAL STUDY 134XCP|IS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KG/CM2|||||DEG||||NORMAL|NOT DONE|||MONOCYTE|THAWED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NA|NA|Y||3||39||INDUCTION TREATMENT|1969-07-04|1962-02-23|||||1966-07-18||1971-03-19
TRIAL STUDY 134XCP|IS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CD|||||/40 HPFS||||LOW|NOT DONE|||URINE SEDIMENT|FROZEN|NA|PHOTOMETRY|NA|Y|Y||4||88||TREATMENT|1971-09-17|1969-05-17|||||1971-09-20||1961-12-31
TRIAL STUDY 134XCP|IS|3B6FE075-9BC0-48D8-8DE9-0D3FB82B4B0C||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KPA|||||M/SEC2||||LOW|NOT DONE|||ADIPOSE TISSUE|NON-HEMOLYZED|NA|REBOUND TONOMETRY|N|U|NA||5||7||FOLLOW-UP|1968-10-01|1964-10-28|||||1970-01-26||1967-07-01
TRIAL STUDY 134XCP|IS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PACKET|||||ENZYME U||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|NA|PET/CT SCAN WITHOUT CONTRAST|U|NA|U||1||38||OPEN LABEL TREATMENT|1962-08-29|1969-06-14|||||1970-11-18||1972-07-25
TRIAL STUDY 134XCP|IS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||%(W/V)|||||SCM||||ABNORMAL|NOT DONE|||CORD BLOOD|AGGLUTINATED|N|WHOLE TRANSCRIPTOME SEQUENCING|U|U|N||2||58||LONG-TERM FOLLOW-UP|1968-06-11|1960-12-31|||||1969-01-01||1967-03-04
TRIAL STUDY 134XCP|IS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FT|||||IU/KG/H||||HIGH|NOT DONE|||VENOUS CORD BLOOD|LIPEMIC|N|TARGETED GENOME SEQUENCING|N|U|U||3||39||FOLLOW-UP|1965-01-25|1967-12-02|||||1967-11-08||1972-09-14
TRIAL STUDY 134XCP|IS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/MMOL|||||/WK||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|LIPEMIC|N|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|U|NA|N||4||88||BASELINE|1968-07-11|1972-06-14|||||1963-01-08||1972-05-10
TRIAL STUDY 134XCP|IS|A83EFC3A-F107-4FCE-96E7-0C327244F2F5||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN|||||UL||||NORMAL|NOT DONE|||TISSUE|HEMOLYZED|Y|RIA|Y|Y|N||5||7||SCREENING|1960-07-22|1963-01-29|||||1971-02-15||1972-12-04
TRIAL STUDY 134XCP|IS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||DL||||HIGH|NOT DONE|||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|N|LIGHT SCATTERING SPECTROSCOPY|U|U|Y||1||38||RUN-IN|1961-07-20|1965-02-02|||||1963-06-23||1964-09-10
TRIAL STUDY 134XCP|IS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/ANIMAL|||||KEV||||LOW|NOT DONE|||FLUID|LACTESCENT|U|SNELLEN EYE CHART|U|NA|U||2||58||BLINDED TREATMENT|1968-01-07|1966-12-11|||||1968-08-15||1972-08-27
TRIAL STUDY 134XCP|IS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PMOL/L/H|||||KBQ/UL||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|THAWED|NA|TRANSVAGINAL ULTRASOUND|NA|NA|U||3||39||RUN-IN|1968-10-18|1961-07-26|||||1973-01-10||1966-11-17
TRIAL STUDY 134XCP|IS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PMOL/L|||||NG/L||||NORMAL|NOT DONE|||MUCUS|UNEXPECTED ODOR|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|N|NA|NA||4||88||RUN-IN|1970-04-21|1960-11-25|||||1965-03-02||1969-06-25
TRIAL STUDY 134XCP|IS|274C7FAB-FC7F-4D2E-A2C4-32C202EB7A59||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||USP U|||||G/KG||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FROZEN|Y|MS/MS|N|NA|NA||5||7||LONG-TERM FOLLOW-UP|1960-02-03|1965-04-07|||||1969-01-04||1969-03-31
TRIAL STUDY 134XCP|IS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/CAGE/WK|||||MG/MIN||||ABNORMAL|NOT DONE|||ERYTHROCYTES|THAWED|NA|CISH|Y|Y|Y||1||38||BLINDED TREATMENT|1964-04-28|1962-03-27|||||1967-04-26||1965-10-05
TRIAL STUDY 134XCP|IS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DAGU|||||MMOL/MIN/KPA||||NORMAL|NOT DONE|||NAIL|FROZEN|N|ORCHIDOMETERY|NA|NA|U||2||58||WASHOUT|1961-11-15|1960-12-22|||||1970-02-20||1972-11-06
TRIAL STUDY 134XCP|IS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MEQ/DAY|||||KBQ/UL||||HIGH|NOT DONE|||PUS|GELLED|U|BETA LACTAMASE|NA|U|Y||3||39||SCREENING|1969-01-30|1964-03-10|||||1967-08-18||1971-04-03
TRIAL STUDY 134XCP|IS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMHG/SEC|||||/100 HPFS||||ABNORMAL|NOT DONE|||BLOOD|CONCENTRATED|N|ANALYTICAL ULTRACENTRIFUGATION|N|N|U||4||88||BASELINE|1972-07-21|1965-03-13|||||1973-05-05||1972-06-05
TRIAL STUDY 134XCP|IS|EA7375B6-38F0-49AE-8AD7-65CB0D30147B||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BU/ML|||||PIXEL||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|LACTESCENT|NA|MRI|Y|Y|NA||5||7||LONG-TERM FOLLOW-UP|1972-08-28|1970-02-21|||||1968-08-15||1964-04-22
TRIAL STUDY 134XCP|IS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^12 IU/L|||||DISK||||ABNORMAL|NOT DONE|||LOCHIA|LIPEMIC|NA|PUPILLOMETRY|N|NA|U||1||38||LONG-TERM FOLLOW-UP|1962-10-31|1969-10-14|||||1970-08-26||1965-02-03
TRIAL STUDY 134XCP|IS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TITER|||||10^7 CFU||||NORMAL|NOT DONE|||PROSTATIC FLUID|PARAFFIN-EMBEDDED|N|CONGO RED STAIN|U|Y|NA||2||58||INDUCTION TREATMENT|1969-08-08|1973-08-14|||||1962-11-06||1962-07-14
TRIAL STUDY 134XCP|IS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LOG10 TCID 50/ML|||||AMOL||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|N|N||3||39||FOLLOW-UP|1965-03-02|1963-08-15|||||1964-06-13||1963-05-01
TRIAL STUDY 134XCP|IS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||COAT|||||PL||||LOW|NOT DONE|||DISCHARGE|CLOTTED|Y|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NA|NA|NA||4||88||WASHOUT|1969-10-13|1967-06-18|||||1972-01-28||1972-09-30
TRIAL STUDY 134XCP|IS|78FC925A-2702-41B4-8F7D-D20AB74EE8A9||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 PFU|||||ENZYME U/M2||||HIGH|NOT DONE|||DIALYSIS FLUID|NON-HEMOLYZED|N|WEBER GREEN STAIN|N|U|NA||5||7||TREATMENT|1965-11-16|1968-10-21|||||1967-12-19||1969-10-15
TRIAL STUDY 134XCP|IS|1E9C7E41-8565-4C60-9EEB-814914081596||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PSEC|||||CUP||||HIGH|NOT DONE|||PLASMA|UNEXPECTED ODOR|N|MOUSE PROTECTION ASSAY|NA|NA|Y||1||38||CONTINUATION TREATMENT|1966-02-15|1960-05-06|||||1965-05-31||1970-09-13
TRIAL STUDY 134XCP|IS|1E9C7E41-8565-4C60-9EEB-814914081596||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^7/L|||||ML/CAGE/WK||||HIGH|NOT DONE|||CALCULUS|CONCENTRATED|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|N|N|NA||2||58||CONTINUATION TREATMENT|1960-05-28|1966-01-14|||||1961-01-24||1963-01-14
TRIAL STUDY 134XCP|IS|1E9C7E41-8565-4C60-9EEB-814914081596||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL/MOL|||||10^3 RNA COPIES/ML||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|LIPEMIC|NA|HPLC|N|Y|Y||3||39||SCREENING|1960-05-06|1961-07-28|||||1969-01-09||1973-07-05
TRIAL STUDY 134XCP|IS|1E9C7E41-8565-4C60-9EEB-814914081596||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^7 CFU|||||IU||||LOW|NOT DONE|||SUPERNATANT, PLASMA|ICTERIC|NA|SLOAN LETTER EYE CHART 1.25%|N|Y|N||4||88||CONTINUATION TREATMENT|1966-04-10|1966-06-04|||||1970-03-23||1967-01-11
TRIAL STUDY 134XCP|IS|1E9C7E41-8565-4C60-9EEB-814914081596||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TUBERCULIN UNIT|||||UMOL/L/H||||NORMAL|NOT DONE|||URINE|CALCIFIED|Y|ALCIAN BLUE STAIN|U|Y|U||5||7||OBSERVATION|1969-11-16|1965-05-31|||||1970-07-31||1961-09-24
TRIAL STUDY 134XCP|IS|D7A008CF-5990-4D74-934A-A4DD3180EBD4||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||S/H|||||IU/KG||||NORMAL|NOT DONE|||SERUM|CONTAMINATED|NA|CLIP SEQUENCING|NA|N|Y||1||38||WASHOUT|1964-10-05|1971-12-11|||||1969-04-06||1973-04-19
TRIAL STUDY 134XCP|IS|D7A008CF-5990-4D74-934A-A4DD3180EBD4||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TRANSDUCING UNIT|||||KAT||||LOW|NOT DONE|||PROSTATIC FLUID|FROZEN|Y|WESTERN BLOT|N|N|N||2||58||WASHOUT|1962-07-19|1962-11-19|||||1969-07-27||1963-04-09
TRIAL STUDY 134XCP|IS|D7A008CF-5990-4D74-934A-A4DD3180EBD4||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CAPSULE|||||EJACULATE U||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|FROZEN|Y|SMEAR|N|N|NA||3||39||CONTINUATION TREATMENT|1969-09-01|1961-08-08|||||1968-06-22||1967-06-05
TRIAL STUDY 134XCP|IS|D7A008CF-5990-4D74-934A-A4DD3180EBD4||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/KG|||||STRIP||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|CALCIFIED|N|DUCTOGRAPHY|N|Y|U||4||88||OPEN LABEL TREATMENT|1962-05-23|1970-08-18|||||1960-03-06||1966-11-12
TRIAL STUDY 134XCP|IS|D7A008CF-5990-4D74-934A-A4DD3180EBD4||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MGEQ|||||IU/DAY||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CONCENTRATED|NA|MRS|Y|NA|Y||5||7||LONG-TERM FOLLOW-UP|1964-12-05|1966-12-25|||||1971-10-19||1970-10-06
TRIAL STUDY 134XCP|IS|C168FA23-40EE-46D8-9A56-8B80490A0EFB||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/KG/DAY|||||M/SEC||||HIGH|NOT DONE|||PLATELET|UNEXPECTED ODOR|NA|CONTRAST ENHANCED X-RAY|N|Y|U||1||38||CONTINUATION TREATMENT|1971-10-06|1962-02-22|||||1969-12-25||1964-07-28
TRIAL STUDY 134XCP|IS|C168FA23-40EE-46D8-9A56-8B80490A0EFB||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||S/H|||||NG/DAY||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|CONTAMINATED|Y|HILLMEN COLOR CHART|N|U|U||2||58||WASHOUT|1960-07-23|1961-11-28|||||1961-05-21||1961-01-02
TRIAL STUDY 134XCP|IS|C168FA23-40EE-46D8-9A56-8B80490A0EFB||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||APL U|||||G/ANIMAL||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|N|WESTERN BLOT|U|N|NA||3||39||OPEN LABEL TREATMENT|1968-11-02|1972-07-03|||||1960-08-11||1964-02-19
TRIAL STUDY 134XCP|IS|C168FA23-40EE-46D8-9A56-8B80490A0EFB||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||COPIES/ML|||||/40 HPFS||||ABNORMAL|NOT DONE|||MIXED VENOUS BLOOD|FROZEN|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|U|N|Y||4||88||FOLLOW-UP|1962-01-29|1963-04-10|||||1960-05-22||1963-06-05
TRIAL STUDY 134XCP|IS|C168FA23-40EE-46D8-9A56-8B80490A0EFB||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPB|||||MG/M2/MIN||||NORMAL|NOT DONE|||LYSATE|ROOM TEMPERATURE|N|X-RAY FLUORESCENCE SPECTROMETRY|NA|N|N||5||7||OPEN LABEL TREATMENT|1960-05-14|1969-06-15|||||1966-07-10||1970-06-04
TRIAL STUDY 134XCP|IS|215E4E69-70C3-493C-9D67-F717363E8138||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CD|||||/MM2||||LOW|NOT DONE|||EXPIRED AIR|LIPEMIC|U|PEAK FLOWMETRY|N|Y|U||1||38||OBSERVATION|1970-03-29|1970-04-28|||||1967-03-22||1970-12-02
TRIAL STUDY 134XCP|IS|215E4E69-70C3-493C-9D67-F717363E8138||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/G/H|||||BEATS/MIN||||LOW|NOT DONE|||LUNG SURFACTANT|CLOTTED|N|TELLER ACUITY CARDS|NA|N|Y||2||58||WASHOUT|1970-08-10|1968-01-04|||||1969-12-25||1963-10-29
TRIAL STUDY 134XCP|IS|215E4E69-70C3-493C-9D67-F717363E8138||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/MG|||||CMOL/L||||ABNORMAL|NOT DONE|||CALCULUS|LACTESCENT|Y|POLYGRAPHY|N|Y|N||3||39||LONG-TERM FOLLOW-UP|1961-11-28|1960-08-19|||||1973-07-06||1960-04-05
TRIAL STUDY 134XCP|IS|215E4E69-70C3-493C-9D67-F717363E8138||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KV|||||UMOL/L/SEC||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|THAWED|N|REVERSE TRANSCRIPTASE PCR|U|NA|U||4||88||BLINDED TREATMENT|1968-01-06|1960-03-14|||||1970-04-06||1961-07-07
TRIAL STUDY 134XCP|IS|215E4E69-70C3-493C-9D67-F717363E8138||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/ANIMAL/DAY|||||DPM/100MG||||HIGH|NOT DONE|||AMNIOTIC FLUID|ROOM TEMPERATURE|Y|ENDOSCOPY|U|NA|N||5||7||WASHOUT|1967-04-09|1960-04-28|||||1970-04-15||1964-12-07
TRIAL STUDY 134XCP|IS|962CD4CA-AF22-42FB-ADB5-85F76850CA81||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MS/MMHG|||||PIPE||||LOW|NOT DONE|||BILE|HEMOLYZED|NA|GIEMSA STAIN|Y|U|U||1||38||INDUCTION TREATMENT|1971-08-25|1963-03-10|||||1961-10-20||1971-12-15
TRIAL STUDY 134XCP|IS|962CD4CA-AF22-42FB-ADB5-85F76850CA81||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AMPULE|||||AMP||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|CONCENTRATED|N|SECONDARY ION MASS SPECTOMETRY|U|Y|N||2||58||WASHOUT|1962-09-11|1966-04-11|||||1963-07-05||1963-06-06
TRIAL STUDY 134XCP|IS|962CD4CA-AF22-42FB-ADB5-85F76850CA81||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||%/S|||||/10^3||||LOW|NOT DONE|||STOOL|ROOM TEMPERATURE|NA|MEDIASTINOSCOPY|NA|N|Y||3||39||WASHOUT|1968-07-31|1961-07-06|||||1970-12-18||1965-04-01
TRIAL STUDY 134XCP|IS|962CD4CA-AF22-42FB-ADB5-85F76850CA81||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||VIAL|||||ML/ANIMAL/WK||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|CLOTTED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|N|NA|N||4||88||OBSERVATION|1967-06-19|1969-07-08|||||1963-12-31||1968-08-19
TRIAL STUDY 134XCP|IS|962CD4CA-AF22-42FB-ADB5-85F76850CA81||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NCI|||||LOG10 TCID 50/DOSE||||NORMAL|NOT DONE|||TUMOR TISSUE|SOLIDIFIED|Y|FLOW MICROSCOPY|U|N|NA||5||7||RUN-IN|1960-03-31|1971-05-19|||||1971-05-16||1963-01-11
TRIAL STUDY 134XCP|IS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ENZYME U/G HB|||||CI/UG||||LOW|NOT DONE|||INTERSTITIAL FLUID|AGGLUTINATED|NA|ELASTOGRAPHY|N|Y|Y||1||38||RUN-IN|1960-07-16|1972-07-30|||||1963-06-25||1969-12-03
TRIAL STUDY 134XCP|IS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/CM H2O|||||PIPE||||HIGH|NOT DONE|||PLEURAL FLUID|THAWED|U|WEBER GREEN STAIN|U|Y|Y||2||58||OPEN LABEL TREATMENT|1961-08-09|1969-09-16|||||1962-04-06||1973-03-03
TRIAL STUDY 134XCP|IS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||YEARS|||||CAPLET||||LOW|NOT DONE|||PLATELET POOR PLASMA|REFRIGERATED|U|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|NA|Y||3||39||SCREENING|1972-12-06|1967-09-13|||||1967-05-29||1973-06-23
TRIAL STUDY 134XCP|IS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/MMOL|||||AMFI||||NORMAL|NOT DONE|||BILE|AGGLUTINATED|N|CLIP SEQUENCING|Y|U|U||4||88||SCREENING|1964-10-21|1962-09-30|||||1972-07-16||1963-09-28
TRIAL STUDY 134XCP|IS|B77019D6-644D-4FAF-ACBF-B4DEB4C12792||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/ML/H|||||MESF||||LOW|NOT DONE|||EXUDATE|ICTERIC|NA|NEXT GENERATION SEQUENCING|Y|U|NA||5||7||SCREENING|1967-03-18|1961-08-30|||||1965-11-15||1966-03-02
TRIAL STUDY 134XCP|IS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/KG/DAY|||||%(V/V)||||HIGH|NOT DONE|||REFLEX TEAR|LACTESCENT|U|APPLANATION TONOMETRY|Y|NA|N||1||38||TREATMENT|1972-06-26|1972-10-29|||||1967-12-10||1965-08-31
TRIAL STUDY 134XCP|IS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/CM H2O|||||10^11/L||||NORMAL|NOT DONE|||PERSPIRATION|REFRIGERATED|Y|WESTERN BLOT|U|NA|N||2||58||INDUCTION TREATMENT|1967-06-22|1969-03-11|||||1971-05-13||1965-01-12
TRIAL STUDY 134XCP|IS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KPA/L/SEC|||||ML/DL||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|NON-HEMOLYZED|NA|HPLC|U|U|NA||3||39||WASHOUT|1969-12-19|1972-03-17|||||1963-07-26||1963-05-25
TRIAL STUDY 134XCP|IS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KG/M2|||||MMHG*MIN/L||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|AGGLUTINATED|NA|SPIROMETRY|N|NA|N||4||88||CONTINUATION TREATMENT|1961-12-08|1968-09-18|||||1961-01-11||1971-03-03
TRIAL STUDY 134XCP|IS|681FAE2B-387D-4B58-B2A6-4682B9F18EAD||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTIBODY UNIT|||||MAC50||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|LIPEMIC|U|ELECTRONEUROGRAPHY|U|NA|N||5||7||WASHOUT|1964-05-05|1971-04-07|||||1967-10-26||1962-06-15
TRIAL STUDY 134XCP|IS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CD*S/M2|||||DAYS/WK||||LOW|NOT DONE|||BREAST MILK|THAWED|U|HANSEL STAIN|NA|N|NA||1||38||BLINDED TREATMENT|1972-08-26|1967-06-04|||||1966-02-06||1963-03-05
TRIAL STUDY 134XCP|IS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/M2/MIN|||||UG/MIN||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|N|INDIRECT IMMUNOFLUORESCENCE|U|NA|N||2||58||TREATMENT|1961-12-30|1965-03-06|||||1969-09-23||1972-05-07
TRIAL STUDY 134XCP|IS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||SV|||||INHALATION||||HIGH|NOT DONE|||EXPIRED AIR|NON-HEMOLYZED|U|IN SITU HYBRIDIZATION|Y|NA|N||3||39||BLINDED TREATMENT|1972-08-04|1961-11-21|||||1967-08-05||1963-06-17
TRIAL STUDY 134XCP|IS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MOL/ML|||||UG/KG/DAY||||HIGH|NOT DONE|||PLEURAL FLUID|SOLIDIFIED|N|LISSAMINE GREEN STAIN|Y|NA|U||4||88||OPEN LABEL TREATMENT|1967-08-29|1966-01-23|||||1963-05-22||1968-10-15
TRIAL STUDY 134XCP|IS|EC3C1DFC-5FA4-4F2E-9486-C2D17486EEF7||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U|||||PFU/DOSE||||NORMAL|NOT DONE|||PERITONEAL FLUID|ROOM TEMPERATURE|N|CALIPER MEASUREMENT METHOD|U|N|NA||5||7||OBSERVATION|1964-03-15|1962-12-24|||||1969-03-15||1963-09-17
TRIAL STUDY 134XCP|IS|4A5A02C2-F875-4146-B58D-9E0E4F00527D||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MEQ/DAY|||||U/L||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|FROZEN|NA|DIRECT SEQUENCING|N|NA|NA||1||38||BLINDED TREATMENT|1973-03-01|1966-11-06|||||1967-11-02||1969-06-24
TRIAL STUDY 134XCP|IS|4A5A02C2-F875-4146-B58D-9E0E4F00527D||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/L|||||10^5/L||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|FRESH|Y|WHOLE TRANSCRIPTOME SEQUENCING|U|NA|N||2||58||SCREENING|1972-08-16|1969-07-26|||||1968-09-15||1970-06-18
TRIAL STUDY 134XCP|IS|4A5A02C2-F875-4146-B58D-9E0E4F00527D||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TSP|||||UM||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AGGLUTINATED|NA|PET/CT SCAN WITHOUT CONTRAST|N|U|U||3||39||OPEN LABEL TREATMENT|1972-11-22|1971-01-27|||||1964-05-20||1962-04-01
TRIAL STUDY 134XCP|IS|4A5A02C2-F875-4146-B58D-9E0E4F00527D||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/DOSE|||||10^3 DNA COPIES/ML||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|LACTESCENT|N|CONTACT SPECULAR MICROSCOPY|N|U|NA||4||88||BLINDED TREATMENT|1972-07-29|1962-03-08|||||1963-03-05||1973-08-21
TRIAL STUDY 134XCP|IS|4A5A02C2-F875-4146-B58D-9E0E4F00527D||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||STRIP|||||CMOL||||ABNORMAL|NOT DONE|||SEMINAL FLUID|ICTERIC|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|NA|N|NA||5||7||OPEN LABEL TREATMENT|1969-01-21|1963-12-20|||||1962-01-21||1971-02-19
TRIAL STUDY 134XCP|IS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||L/H/M2|||||ECL UNIT||||HIGH|NOT DONE|||SPERMATOZOON|AGGLUTINATED|NA|ELISPOT|NA|N|NA||1||38||FOLLOW-UP|1962-11-25|1969-03-31|||||1968-03-06||1960-12-03
TRIAL STUDY 134XCP|IS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EID 50/ML|||||BAU||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|GELLED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|NA|N||2||58||LONG-TERM FOLLOW-UP|1970-01-20|1961-04-19|||||1972-02-06||1964-10-09
TRIAL STUDY 134XCP|IS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/KG/WEEK|||||UMOL/L/SEC||||NORMAL|NOT DONE|||ALVEOLAR AIR|CLOTTED|N|CLAUSS METHOD|Y|NA|Y||3||39||INDUCTION TREATMENT|1962-01-10|1970-12-05|||||1964-03-22||1968-06-28
TRIAL STUDY 134XCP|IS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SCM|||||ROENTGEN||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|AUTOLYZED|NA|CT SCAN|NA|Y|Y||4||88||LONG-TERM FOLLOW-UP|1967-03-08|1968-12-10|||||1963-08-21||1961-06-15
TRIAL STUDY 134XCP|IS|5529CF4E-3210-4D8E-80E8-2D7DDFB81EA6||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||%(W/V)|||||OD UNIT||||HIGH|NOT DONE|||EPITHELIAL CELL|LIPEMIC|N|IMMUNOBLOT|Y|Y|Y||5||7||BLINDED TREATMENT|1961-03-09|1965-02-28|||||1972-10-02||1969-03-10
TRIAL STUDY 134XCP|IS|859D9297-58D0-4740-899D-E7BEC931D419||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BU/ML|||||MPA||||ABNORMAL|NOT DONE|||CERUMEN|AUTOLYZED|Y|PHASE-CONTRAST MRI|Y|U|N||1||38||RUN-IN|1971-01-25|1968-05-29|||||1966-11-10||1972-01-18
TRIAL STUDY 134XCP|IS|859D9297-58D0-4740-899D-E7BEC931D419||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PFU/DOSE|||||KG/M2||||NORMAL|NOT DONE|||VENOUS PLASMA|CONTAMINATED|U|DIFFUSION TENSOR MRI|Y|Y|Y||2||58||TREATMENT|1970-05-08|1969-07-08|||||1970-01-25||1965-09-20
TRIAL STUDY 134XCP|IS|859D9297-58D0-4740-899D-E7BEC931D419||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/H|||||KM||||HIGH|NOT DONE|||HAIR FOLLICLE|NON-HEMOLYZED|NA|PATHOLOGICAL EVALUATION|U|N|U||3||39||INDUCTION TREATMENT|1961-09-26|1971-07-23|||||1966-11-19||1961-03-17
TRIAL STUDY 134XCP|IS|859D9297-58D0-4740-899D-E7BEC931D419||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UCI|||||LENS||||LOW|NOT DONE|||URINE SEDIMENT|SOLIDIFIED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|N|U||4||88||BLINDED TREATMENT|1962-03-10|1968-06-17|||||1965-12-26||1966-12-31
TRIAL STUDY 134XCP|IS|859D9297-58D0-4740-899D-E7BEC931D419||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PKAT|||||UL||||HIGH|NOT DONE|||GASTRIC FLUID|SOLIDIFIED|N|BRDU CELLULAR PROLIFERATION ASSAY|N|Y|N||5||7||OBSERVATION|1966-10-16|1973-03-16|||||1969-07-31||1969-08-11
TRIAL STUDY 134XCP|IS|A1E34C29-91C2-4C2B-942E-84CD6A10A056||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MM|||||UG/DL||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|ROOM TEMPERATURE|N|COLORIMETRY|NA|NA|Y||1||38||SCREENING|1966-01-25|1968-07-24|||||1970-10-01||1967-04-23
TRIAL STUDY 134XCP|IS|A1E34C29-91C2-4C2B-942E-84CD6A10A056||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOZENGE|||||HOUNSFIELD UNIT||||LOW|NOT DONE|||BUFFY COAT|FRESH|Y|FARNSWORTH-MUNSELL 100 HUE TEST|U|Y|Y||2||58||OPEN LABEL TREATMENT|1964-01-30|1973-01-28|||||1971-04-20||1970-07-23
TRIAL STUDY 134XCP|IS|A1E34C29-91C2-4C2B-942E-84CD6A10A056||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HPA|||||APL U/ML||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|FROZEN|NA|NUCLEIC ACID SEQUENCING|Y|U|N||3||39||LONG-TERM FOLLOW-UP|1968-05-31|1970-03-20|||||1966-06-19||1967-01-18
TRIAL STUDY 134XCP|IS|A1E34C29-91C2-4C2B-942E-84CD6A10A056||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/ML/H|||||NMOL/G||||HIGH|NOT DONE|||SERUM|LACTESCENT|U|FLUOROSCOPY|U|Y|Y||4||88||OPEN LABEL TREATMENT|1964-07-27|1960-05-07|||||1969-03-03||1965-06-23
TRIAL STUDY 134XCP|IS|A1E34C29-91C2-4C2B-942E-84CD6A10A056||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ANTI-XA IU/ML|||||MMOL/L||||HIGH|NOT DONE|||TISSUE|ROOM TEMPERATURE|U|AMSLER GRID|U|Y|NA||5||7||WASHOUT|1963-08-13|1962-05-02|||||1964-07-04||1972-09-17
TRIAL STUDY 134XCP|IS|4E5FF284-E15A-421D-BC13-94655EEFE540||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BAG|||||MEQ||||LOW|NOT DONE|||DISCHARGE|CALCIFIED|Y|JAEGER EYE CHART|Y|Y|N||1||38||SCREENING|1961-07-12|1966-09-10|||||1962-12-17||1965-06-07
TRIAL STUDY 134XCP|IS|4E5FF284-E15A-421D-BC13-94655EEFE540||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MEQ/UG|||||UMOL/H/MMOL||||LOW|NOT DONE|||PERITONEAL FLUID|CLOTTED|Y|IMMUNORADIOMETRIC ASSAY|U|N|Y||2||58||OPEN LABEL TREATMENT|1961-08-15|1961-12-20|||||1968-03-21||1960-01-16
TRIAL STUDY 134XCP|IS|4E5FF284-E15A-421D-BC13-94655EEFE540||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DAGU|||||MEQ/G||||NORMAL|NOT DONE|||FLUID|FROZEN|U|TRANSVAGINAL ULTRASOUND|N|U|U||3||39||CONTINUATION TREATMENT|1964-11-12|1967-03-03|||||1962-11-03||1963-06-20
TRIAL STUDY 134XCP|IS|4E5FF284-E15A-421D-BC13-94655EEFE540||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML|||||10^6 IU/ML||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|ROOM TEMPERATURE|Y|ELECTROMYOGRAPHY|Y|Y|N||4||88||FOLLOW-UP|1973-06-06|1972-04-14|||||1963-05-25||1961-10-16
TRIAL STUDY 134XCP|IS|4E5FF284-E15A-421D-BC13-94655EEFE540||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||CI/UG||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|ROOM TEMPERATURE|U|URANYL ACETATE STAIN|NA|NA|Y||5||7||FOLLOW-UP|1968-06-29|1973-05-01|||||1963-11-12||1969-09-06
TRIAL STUDY 134XCP|IS|30BAB760-662A-41DF-9599-CBE0BC3A57D9||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ELISA UNIT/DOSE|||||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE|||URINE|THAWED|U|DIFFUSION TENSOR MRI|Y|NA|Y||1||38||OBSERVATION|1960-04-27|1966-07-20|||||1970-05-22||1968-03-26
TRIAL STUDY 134XCP|IS|30BAB760-662A-41DF-9599-CBE0BC3A57D9||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOL/G|||||COULOMB||||HIGH|NOT DONE|||CELL PELLET|UNEXPECTED ODOR|U|CONFOCAL MICROSCOPY|NA|Y|NA||2||58||LONG-TERM FOLLOW-UP|1969-02-09|1963-06-29|||||1965-07-16||1963-01-20
TRIAL STUDY 134XCP|IS|30BAB760-662A-41DF-9599-CBE0BC3A57D9||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MM/2H|||||10^9 ORGANISMS/MG||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|CONTAMINATED|U|CONTRAST ENHANCED PET SCAN|NA|U|Y||3||39||OPEN LABEL TREATMENT|1964-10-17|1962-12-23|||||1971-03-01||1970-07-01
TRIAL STUDY 134XCP|IS|30BAB760-662A-41DF-9599-CBE0BC3A57D9||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/MG|||||IN||||LOW|NOT DONE|||SYNOVIAL FLUID|CALCIFIED|NA|WHOLE EXOME SEQUENCING|Y|NA|N||4||88||OPEN LABEL TREATMENT|1973-05-31|1961-07-10|||||1967-04-28||1965-10-18
TRIAL STUDY 134XCP|IS|30BAB760-662A-41DF-9599-CBE0BC3A57D9||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^5/HPF|||||PMOL||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|GELLED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|Y|NA||5||7||BASELINE|1969-06-06|1960-11-02|||||1969-08-12||1969-04-05
TRIAL STUDY 134XCP|IS|8747C2AB-18EB-430B-8E89-CF9183DBF322||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMOL/S|||||KCAL/DAY||||HIGH|NOT DONE|||PLATELET RICH PLASMA|FROZEN|NA|FLOCCULATION, CHARCOAL ENHANCED|Y|NA|U||1||38||OPEN LABEL TREATMENT|1960-10-30|1970-10-03|||||1965-10-15||1965-01-23
TRIAL STUDY 134XCP|IS|8747C2AB-18EB-430B-8E89-CF9183DBF322||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||L/H/M2|||||APS U||||LOW|NOT DONE|||CAPILLARY PLASMA|DRIED|U|GRAM STAIN|Y|U|U||2||58||TREATMENT|1969-10-16|1967-06-13|||||1962-05-20||1963-12-27
TRIAL STUDY 134XCP|IS|8747C2AB-18EB-430B-8E89-CF9183DBF322||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||VG/DOSE|||||ENZYME U/M2||||ABNORMAL|NOT DONE|||MUCUS|AGGLUTINATED|U|CONTRAST ENHANCED SPIRAL CT SCAN|NA|N|NA||3||39||CONTINUATION TREATMENT|1972-11-06|1961-09-04|||||1967-08-20||1960-10-22
TRIAL STUDY 134XCP|IS|8747C2AB-18EB-430B-8E89-CF9183DBF322||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/L FEU|||||U/G/H||||ABNORMAL|NOT DONE|||EXPIRED AIR|UNEXPECTED ODOR|N|CONTRAST ENHANCED SPIRAL CT SCAN|Y|U|N||4||88||SCREENING|1973-02-20|1965-04-07|||||1963-06-12||1964-03-21
TRIAL STUDY 134XCP|IS|8747C2AB-18EB-430B-8E89-CF9183DBF322||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/MMOL|||||LOZENGE||||LOW|NOT DONE|||SMEGMA|PARAFFIN-EMBEDDED|N|MICROBIAL CONCENTRATION|Y|NA|Y||5||7||OBSERVATION|1963-05-01|1969-10-26|||||1961-09-16||1967-12-17
TRIAL STUDY 134XCP|IS|5A0FF15D-E779-47BA-8D3C-247A0FA57854||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ENZYME U/L|||||BE/ML||||LOW|NOT DONE|||EXPIRED AIR|FROZEN|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|N|NA|Y||1||38||TREATMENT|1969-03-07|1969-07-25|||||1961-02-20||1968-03-08
TRIAL STUDY 134XCP|IS|5A0FF15D-E779-47BA-8D3C-247A0FA57854||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L|||||M||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|SOLIDIFIED|Y|EPSILOMETER|U|N|U||2||58||FOLLOW-UP|1971-06-29|1973-08-12|||||1963-04-13||1969-07-30
TRIAL STUDY 134XCP|IS|5A0FF15D-E779-47BA-8D3C-247A0FA57854||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||SEC|||||FMOL/L||||HIGH|NOT DONE|||URINE|LACTESCENT|NA|ENDPOINT DILUTION ASSAY|N|U|U||3||39||WASHOUT|1970-10-23|1961-01-14|||||1968-08-24||1967-08-22
TRIAL STUDY 134XCP|IS|5A0FF15D-E779-47BA-8D3C-247A0FA57854||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BREATHS/30S|||||DYN||||HIGH|NOT DONE|||VITREOUS HUMOR|AUTOLYZED|NA|PH METER MEASUREMENT METHOD|Y|U|Y||4||88||SCREENING|1966-11-13|1966-06-01|||||1965-08-15||1971-02-25
TRIAL STUDY 134XCP|IS|5A0FF15D-E779-47BA-8D3C-247A0FA57854||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MM/SEC|||||UG/H||||ABNORMAL|NOT DONE|||LAVAGE FLUID|CONCENTRATED|U|DNA MICROARRAY|U|Y|Y||5||7||BASELINE|1969-03-23|1972-05-24|||||1962-05-19||1968-11-16
TRIAL STUDY 134XCP|IS|73260E60-6ADB-44DA-9A45-776B91F8B453||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/M2/MIN|||||/MIN||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|U|TEMPLATE INCISION METHOD|U|Y|U||1||38||LONG-TERM FOLLOW-UP|1964-10-18|1961-05-18|||||1965-01-19||1970-07-10
TRIAL STUDY 134XCP|IS|73260E60-6ADB-44DA-9A45-776B91F8B453||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PG/L|||||KDA||||HIGH|NOT DONE|||SERUM|FRESH|U|MANUAL CLOT DETECTION|U|NA|Y||2||58||TREATMENT|1973-02-12|1967-12-04|||||1964-06-23||1962-09-13
TRIAL STUDY 134XCP|IS|73260E60-6ADB-44DA-9A45-776B91F8B453||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/ML/MIN|||||10^9 ORGANISMS/G||||HIGH|NOT DONE|||LYSATE|FROZEN|N|CYSTOSCOPY|U|N|Y||3||39||SCREENING|1969-07-13|1960-06-25|||||1962-03-15||1972-03-03
TRIAL STUDY 134XCP|IS|73260E60-6ADB-44DA-9A45-776B91F8B453||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FEU|||||DPM||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|ROOM TEMPERATURE|Y|TOTAL BODY RADIOGRAPHY|NA|N|U||4||88||OPEN LABEL TREATMENT|1970-08-14|1960-11-12|||||1967-07-18||1963-10-11
TRIAL STUDY 134XCP|IS|73260E60-6ADB-44DA-9A45-776B91F8B453||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN|||||MG/MOL||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|PARAFFIN-EMBEDDED|U|EPSILOMETER|NA|NA|NA||5||7||TREATMENT|1963-01-07|1962-03-27|||||1960-09-15||1960-05-22
TRIAL STUDY 134XCP|IS|7B64252E-9A08-4177-BFA9-45B0C0E53097||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU/KG|||||VG/DOSE||||HIGH|NOT DONE|||DISCHARGE|FROZEN|N|CALIPER MEASUREMENT METHOD|Y|U|Y||1||38||WASHOUT|1967-09-19|1972-12-05|||||1961-05-07||1965-04-22
TRIAL STUDY 134XCP|IS|7B64252E-9A08-4177-BFA9-45B0C0E53097||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOL/ML|||||CM2||||ABNORMAL|NOT DONE|||ISOLATE|CONTAMINATED|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|NA|Y||2||58||WASHOUT|1973-03-04|1962-06-20|||||1972-11-19||1962-02-12
TRIAL STUDY 134XCP|IS|7B64252E-9A08-4177-BFA9-45B0C0E53097||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/MIN/MMHG|||||/100 WBC||||ABNORMAL|NOT DONE|||STOOL|REFRIGERATED|N|CAPILLARY ELECTROPHORESIS|N|Y|U||3||39||FOLLOW-UP|1965-04-19|1964-01-04|||||1965-04-07||1967-05-22
TRIAL STUDY 134XCP|IS|7B64252E-9A08-4177-BFA9-45B0C0E53097||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DRUM|||||S/H||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|HEMOLYZED|N|FUNDUS PHOTOGRAPHY|NA|N|NA||4||88||LONG-TERM FOLLOW-UP|1973-07-28|1961-10-18|||||1964-09-30||1963-01-02
TRIAL STUDY 134XCP|IS|7B64252E-9A08-4177-BFA9-45B0C0E53097||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL/ML|||||FL||||NORMAL|NOT DONE|||URINE SEDIMENT|CONTAMINATED|NA|LYMPHANGIOGRAPHY|Y|Y|N||5||7||OPEN LABEL TREATMENT|1962-01-17|1964-05-21|||||1969-04-16||1960-08-24
TRIAL STUDY 134XCP|IS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MPL U/ML|||||WATT||||HIGH|NOT DONE|||NAIL|SOLIDIFIED|N|TEMPLATE INCISION METHOD|NA|NA|N||1||38||BLINDED TREATMENT|1962-01-11|1963-01-15|||||1961-03-15||1967-06-19
TRIAL STUDY 134XCP|IS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MESF|||||U/KG/H||||NORMAL|NOT DONE|||BONE MARROW|REFRIGERATED|NA|SECONDARY ION MASS SPECTOMETRY|U|NA|N||2||58||WASHOUT|1970-08-24|1970-09-02|||||1964-12-03||1961-12-23
TRIAL STUDY 134XCP|IS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||RAD|||||MMOL/MOL||||LOW|NOT DONE|||HAIR|HEMOLYZED|NA|NUCLEIC ACID BASED METHOD|NA|NA|Y||3||39||INDUCTION TREATMENT|1973-08-15|1960-05-06|||||1967-01-24||1973-04-21
TRIAL STUDY 134XCP|IS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DPM/100MG|||||MG||||HIGH|NOT DONE|||DIALYSIS FLUID|FROZEN|N|HIGH RESOLUTION MELT ANALYSIS|N|U|Y||4||88||TREATMENT|1970-04-08|1972-08-21|||||1965-01-26||1960-03-19
TRIAL STUDY 134XCP|IS|D56FE2B1-BCCC-4113-A1C1-CBFE9A46CB75||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GAUSS|||||TORR||||NORMAL|NOT DONE|||LEUKOCYTE|LACTESCENT|Y|CAPILLARY ELECTROPHORESIS|Y|Y|NA||5||7||TREATMENT|1969-06-09|1960-09-17|||||1970-09-07||1973-05-05
TRIAL STUDY 134XCP|IS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/G|||||DPM/ML||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|CALCIFIED|U|JAEGER EYE CHART|U|NA|NA||1||38||OBSERVATION|1964-08-07|1964-05-31|||||1970-08-04||1972-06-05
TRIAL STUDY 134XCP|IS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/KG|||||NSEC||||NORMAL|NOT DONE|||MECONIUM|UNEXPECTED ODOR|NA|ATOMIC ABSORPTION SPECTROMETRY|Y|Y|NA||2||58||CONTINUATION TREATMENT|1966-10-05|1968-06-06|||||1971-09-03||1967-01-08
TRIAL STUDY 134XCP|IS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U|||||PACKET||||NORMAL|NOT DONE|||DERMAL TISSUE|CALCIFIED|N|LC/MS/MS|U|Y|U||3||39||LONG-TERM FOLLOW-UP|1969-10-23|1969-11-22|||||1965-03-13||1972-05-13
TRIAL STUDY 134XCP|IS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||AMPULE|||||TRACE||||NORMAL|NOT DONE|||VENOUS PLASMA|AGGLUTINATED|Y|OBSERVATION|U|Y|U||4||88||WASHOUT|1971-10-20|1966-02-04|||||1967-05-16||1965-03-24
TRIAL STUDY 134XCP|IS|77F7428C-A160-4EC1-A2F5-96DACA1DEFA3||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||SACHET|||||RAD||||NORMAL|NOT DONE|||LYSATE|GELLED|N|APPLANATION TONOMETRY|U|NA|N||5||7||RUN-IN|1962-06-06|1969-08-05|||||1963-02-09||1970-04-29
TRIAL STUDY 134XCP|IS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CMH2O/ML|||||BISCUIT||||HIGH|NOT DONE|||PLEURAL FLUID|CALCIFIED|Y|PAP STAIN|Y|Y|U||1||38||BASELINE|1970-09-26|1968-02-25|||||1965-11-22||1962-04-30
TRIAL STUDY 134XCP|IS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/G/MIN|||||ML/BREATH||||HIGH|NOT DONE|||URINE|THAWED|NA|MICROBIAL CONCENTRATION|U|Y|NA||2||58||OPEN LABEL TREATMENT|1967-09-15|1968-08-02|||||1966-07-16||1970-11-30
TRIAL STUDY 134XCP|IS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KCAL/DAY|||||UG/M2/H||||LOW|NOT DONE|||EPITHELIAL CELL|CALCIFIED|U|NEPHELOMETRY|NA|N|N||3||39||OBSERVATION|1970-12-09|1969-04-11|||||1965-01-27||1970-04-04
TRIAL STUDY 134XCP|IS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 CFU/G|||||ROENTGEN||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|PARAFFIN-EMBEDDED|U|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|Y|Y||4||88||RUN-IN|1963-06-04|1972-01-09|||||1971-06-21||1967-02-16
TRIAL STUDY 134XCP|IS|4BB780B0-E326-44B5-8EA7-88C92CE5ABE1||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BU/ML|||||MOL/L||||NORMAL|NOT DONE|||MUSCLE TISSUE|CALCIFIED|Y|PULMONARY ANGIOGRAPHY|N|NA|N||5||7||OBSERVATION|1970-09-20|1966-01-14|||||1960-08-06||1965-03-27
TRIAL STUDY 134XCP|IS|1B0EE182-6729-4333-BB9B-5561CAB31D26||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UM2|||||U/MG||||NORMAL|NOT DONE|||MUCUS|REFRIGERATED|U|GC/MS|N|NA|NA||1||38||SCREENING|1969-12-09|1972-06-29|||||1962-06-11||1962-10-08
TRIAL STUDY 134XCP|IS|1B0EE182-6729-4333-BB9B-5561CAB31D26||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/S/M2|||||DEG2||||LOW|NOT DONE|||WHITE MATTER TISSUE|LIPEMIC|NA|COMPLEMENT FIXATION|Y|N|N||2||58||INDUCTION TREATMENT|1971-02-17|1973-03-18|||||1961-08-07||1973-06-16
TRIAL STUDY 134XCP|IS|1B0EE182-6729-4333-BB9B-5561CAB31D26||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/DAY|||||NMOL/KG/DAY||||HIGH|NOT DONE|||MUSCLE TISSUE|AGGLUTINATED|Y|PET SCAN|U|NA|U||3||39||RUN-IN|1963-04-17|1961-11-08|||||1969-02-14||1973-06-08
TRIAL STUDY 134XCP|IS|1B0EE182-6729-4333-BB9B-5561CAB31D26||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UM|||||KG/MOL||||LOW|NOT DONE|||PROSTATIC FLUID|CONTAMINATED|Y|TARGETED TRANSCRIPTOME SEQUENCING|U|N|NA||4||88||BASELINE|1966-02-10|1971-08-06|||||1973-06-17||1965-02-10
TRIAL STUDY 134XCP|IS|1B0EE182-6729-4333-BB9B-5561CAB31D26||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PT_BR|||||UG/M2/H||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|FRESH|N|TRIPLE-PHASE SPIRAL CT SCAN|N|Y|Y||5||7||BLINDED TREATMENT|1965-12-17|1967-01-07|||||1963-06-03||1965-02-24
TRIAL STUDY 134XCP|IS|1F3AD620-4B16-4EFF-8F5A-45105841BE02||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LOG10 TCID 50/DOSE|||||VP/DOSE||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|LIPEMIC|NA|SCINTIGRAPHY|Y|U|U||1||38||WASHOUT|1961-04-26|1964-07-09|||||1965-10-24||1972-10-08
TRIAL STUDY 134XCP|IS|1F3AD620-4B16-4EFF-8F5A-45105841BE02||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FG|||||10^9 CFU||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|NA|GC/MS-EI|Y|Y|NA||2||58||OPEN LABEL TREATMENT|1965-10-12|1971-03-20|||||1962-12-09||1961-11-18
TRIAL STUDY 134XCP|IS|1F3AD620-4B16-4EFF-8F5A-45105841BE02||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VG/ML|||||MMAL||||LOW|NOT DONE|||SOFT TISSUE|THAWED|Y|TRIPLE-PHASE SPIRAL CT SCAN|NA|Y|U||3||39||INDUCTION TREATMENT|1967-09-29|1967-10-25|||||1968-07-09||1960-09-03
TRIAL STUDY 134XCP|IS|1F3AD620-4B16-4EFF-8F5A-45105841BE02||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CI/UL|||||CONTAINER||||HIGH|NOT DONE|||EPITHELIAL CELL|CALCIFIED|U|HEMAGGLUTINATION INHIBITION ASSAY|U|Y|U||4||88||CONTINUATION TREATMENT|1964-02-16|1973-09-07|||||1960-12-11||1965-03-25
TRIAL STUDY 134XCP|IS|1F3AD620-4B16-4EFF-8F5A-45105841BE02||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KG/MOL|||||NG/MOL||||LOW|NOT DONE|||PROSTATIC FLUID|CLOTTED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|NA|Y|U||5||7||OPEN LABEL TREATMENT|1961-01-22|1972-11-18|||||1960-01-12||1962-01-20
TRIAL STUDY 134XCP|IS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FL|||||%/S||||LOW|NOT DONE|||KERATINOCYTE|REFRIGERATED|U|IMPULSE OSCILLOMETRY|U|N|NA||1||38||SCREENING|1968-04-14|1969-02-11|||||1964-11-15||1968-09-18
TRIAL STUDY 134XCP|IS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/KG|||||MV*MIN||||NORMAL|NOT DONE|||DERMAL TISSUE|PARAFFIN-EMBEDDED|U|MRS|Y|N|Y||2||58||BASELINE|1971-12-08|1963-06-12|||||1971-08-17||1961-02-08
TRIAL STUDY 134XCP|IS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DRUM|||||UMOL||||HIGH|NOT DONE|||DIALYSIS FLUID|LIPEMIC|NA|INDIRECT IMMUNOFLUORESCENCE|Y|U|U||3||39||BLINDED TREATMENT|1968-09-05|1961-04-13|||||1965-02-10||1961-11-08
TRIAL STUDY 134XCP|IS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 CCID 50/DOSE|||||AMFI||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|HEMOLYZED|NA|FLOCCULATION|U|N|NA||4||88||SCREENING|1972-11-19|1968-11-30|||||1972-05-18||1973-04-24
TRIAL STUDY 134XCP|IS|05C77EE2-E4D7-4C2F-AF32-55FA95F1C791||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DROP|||||MILE||||LOW|NOT DONE|||EMESIS|DRIED|N|GC/MS-EI|Y|N|N||5||7||OPEN LABEL TREATMENT|1968-07-27|1969-03-14|||||1969-09-28||1961-09-23
TRIAL STUDY 134XCP|IS|152147B0-6EAD-4124-8E1A-BD7707850B60||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/MOL|||||HPA||||LOW|NOT DONE|||CORD SERUM|AGGLUTINATED|N|MRS|NA|NA|NA||1||38||SCREENING|1963-10-26|1971-08-25|||||1968-03-08||1972-03-07
TRIAL STUDY 134XCP|IS|152147B0-6EAD-4124-8E1A-BD7707850B60||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT|||||OI50||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|GELLED|NA|INDIA INK STAIN|U|U|N||2||58||LONG-TERM FOLLOW-UP|1963-02-04|1961-09-10|||||1968-11-26||1961-12-20
TRIAL STUDY 134XCP|IS|152147B0-6EAD-4124-8E1A-BD7707850B60||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MIN|||||APPLICATION||||HIGH|NOT DONE|||EXUDATE|LIPEMIC|N|GRAM STAIN|Y|Y|NA||3||39||RUN-IN|1964-05-25|1972-10-15|||||1972-06-20||1966-10-24
TRIAL STUDY 134XCP|IS|152147B0-6EAD-4124-8E1A-BD7707850B60||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^3 CFU/G|||||%(W/W)||||LOW|NOT DONE|||MONOCYTE|ROOM TEMPERATURE|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|N|NA|N||4||88||FOLLOW-UP|1967-12-10|1972-03-30|||||1965-10-14||1960-12-24
TRIAL STUDY 134XCP|IS|152147B0-6EAD-4124-8E1A-BD7707850B60||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DAGU/ML|||||U/MG||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CLOTTED|U|PHYSICAL EXAMINATION|N|NA|U||5||7||FOLLOW-UP|1970-08-10|1964-10-10|||||1962-05-29||1960-05-28
TRIAL STUDY 134XCP|IS|3CCF019C-5663-4670-B2D1-EC01D6B58D06||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BE/ML|||||%/MIN||||LOW|NOT DONE|||PROSTATIC FLUID|AGGLUTINATED|NA|PAP STAIN|Y|Y|NA||1||38||OPEN LABEL TREATMENT|1971-08-07|1965-06-11|||||1965-11-10||1970-11-17
TRIAL STUDY 134XCP|IS|3CCF019C-5663-4670-B2D1-EC01D6B58D06||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL/ML|||||MOL/G||||LOW|NOT DONE|||RETICULOCYTES|REFRIGERATED|NA|COULOMETRIC TITRATION|Y|NA|NA||2||58||BLINDED TREATMENT|1964-11-06|1963-07-28|||||1960-03-24||1960-08-23
TRIAL STUDY 134XCP|IS|3CCF019C-5663-4670-B2D1-EC01D6B58D06||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MIN/DAY|||||CI/MG||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|ICTERIC|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NA|Y|Y||3||39||CONTINUATION TREATMENT|1970-01-24|1972-11-21|||||1964-07-01||1961-04-30
TRIAL STUDY 134XCP|IS|3CCF019C-5663-4670-B2D1-EC01D6B58D06||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BLOCKS|||||KBQ/UL||||NORMAL|NOT DONE|||BASAL TEAR|PARAFFIN-EMBEDDED|N|SPECT/CT SCAN|NA|NA|U||4||88||TREATMENT|1962-04-16|1969-06-07|||||1966-11-11||1967-10-10
TRIAL STUDY 134XCP|IS|3CCF019C-5663-4670-B2D1-EC01D6B58D06||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||VP/DOSE|||||GPL U||||NORMAL|NOT DONE|||CELL PELLET|GELLED|Y|BIOIMPEDANCE SPECTROSCOPY|NA|N|U||5||7||LONG-TERM FOLLOW-UP|1967-04-28|1965-03-08|||||1966-05-30||1968-06-24
TRIAL STUDY 134XCP|IS|6599D082-A8A0-412D-BBDF-CD786C581905||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/MIN|||||ML/S||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|GELLED|U|CHROMATOGRAPHY|U|NA|NA||1||38||INDUCTION TREATMENT|1963-07-23|1967-02-15|||||1963-12-23||1962-09-28
TRIAL STUDY 134XCP|IS|6599D082-A8A0-412D-BBDF-CD786C581905||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^6/G|||||MG/M2/DAY||||HIGH|NOT DONE|||TISSUE|FRESH|NA|RAJI CELL EIA|Y|U|N||2||58||LONG-TERM FOLLOW-UP|1969-02-16|1972-12-08|||||1966-06-20||1972-12-14
TRIAL STUDY 134XCP|IS|6599D082-A8A0-412D-BBDF-CD786C581905||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/M2/H|||||DEG/MM||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|HEMOLYZED|NA|GC/MS/MS|N|Y|NA||3||39||BASELINE|1970-09-12|1970-06-24|||||1966-02-08||1963-04-04
TRIAL STUDY 134XCP|IS|6599D082-A8A0-412D-BBDF-CD786C581905||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/M2/H|||||NEBULE||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|CLOTTED|NA|VENTILATION PERFUSION LUNG SCAN|Y|U|Y||4||88||LONG-TERM FOLLOW-UP|1965-02-06|1963-09-20|||||1961-10-27||1970-07-31
TRIAL STUDY 134XCP|IS|6599D082-A8A0-412D-BBDF-CD786C581905||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%/MIN|||||CI/L||||NORMAL|NOT DONE|||COLOSTRUM|LIPEMIC|U|MANUAL COUNT|N|NA|N||5||7||FOLLOW-UP|1960-10-31|1960-03-24|||||1965-04-03||1961-11-26
TRIAL STUDY 134XCP|IS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/MONTH|||||KV||||LOW|NOT DONE|||PLASMA|FRESH|N|SLOAN LETTER EYE CHART 1.25%|Y|N|N||1||38||OBSERVATION|1972-05-17|1969-09-14|||||1968-10-09||1960-08-20
TRIAL STUDY 134XCP|IS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NSEC|||||MEQ/ML||||ABNORMAL|NOT DONE|||CORD BLOOD|UNEXPECTED ODOR|N|HPLC|N|Y|NA||2||58||OPEN LABEL TREATMENT|1964-12-22|1964-11-15|||||1960-07-31||1972-03-05
TRIAL STUDY 134XCP|IS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KPA/L/SEC|||||NSEC||||HIGH|NOT DONE|||PLATELET POOR PLASMA|HEMOLYZED|NA|HPLC/MS|N|NA|NA||3||39||TREATMENT|1963-01-12|1962-07-13|||||1968-05-24||1972-01-15
TRIAL STUDY 134XCP|IS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL BCE/NMOL|||||PNU/ML||||NORMAL|NOT DONE|||HAIR FOLLICLE|CALCIFIED|N|IMMUNOASSAY|N|Y|U||4||88||LONG-TERM FOLLOW-UP|1968-01-14|1968-10-18|||||1964-10-19||1965-02-24
TRIAL STUDY 134XCP|IS|BC6984EB-5C48-4299-BDCB-2063BC44A1F4||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BAU/ML|||||PG/CELL||||HIGH|NOT DONE|||LOCHIA|ROOM TEMPERATURE|Y|AUTOMATED COUNT|U|U|U||5||7||INDUCTION TREATMENT|1965-12-27|1971-06-27|||||1961-11-07||1971-02-01
TRIAL STUDY 134XCP|IS|AAC3113C-793D-43F4-87E9-111246E03003||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||STRIP|||||MCI/KG||||ABNORMAL|NOT DONE|||BILE|REFRIGERATED|N|MAMMOGRAPHY|Y|Y|NA||1||38||LONG-TERM FOLLOW-UP|1965-07-30|1967-06-07|||||1964-01-15||1969-07-26
TRIAL STUDY 134XCP|IS|AAC3113C-793D-43F4-87E9-111246E03003||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IMPLANT|||||MG/M2/MIN||||HIGH|NOT DONE|||CORD SERUM|ICTERIC|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|U|N|Y||2||58||CONTINUATION TREATMENT|1964-05-03|1972-12-29|||||1966-05-29||1964-08-31
TRIAL STUDY 134XCP|IS|AAC3113C-793D-43F4-87E9-111246E03003||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||1/(S*KPA)|||||PMOL/DL||||HIGH|NOT DONE|||PROSTATIC FLUID|CLOTTED|U|SICKLE CELL SOLUBILITY TEST|N|N|NA||3||39||LONG-TERM FOLLOW-UP|1968-12-29|1968-07-18|||||1973-07-16||1963-05-23
TRIAL STUDY 134XCP|IS|AAC3113C-793D-43F4-87E9-111246E03003||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOSM/L|||||CGY||||NORMAL|NOT DONE|||NAIL|REFRIGERATED|Y|CELLULOSE TAPE|N|U|N||4||88||WASHOUT|1972-08-01|1961-09-22|||||1967-01-14||1973-05-08
TRIAL STUDY 134XCP|IS|AAC3113C-793D-43F4-87E9-111246E03003||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/KG|||||/VF||||NORMAL|NOT DONE|||LYSATE|CLOTTED|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|N|Y|Y||5||7||BLINDED TREATMENT|1960-06-30|1961-08-10|||||1965-12-16||1964-03-02
TRIAL STUDY 134XCP|IS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MGEQ|||||PACK||||HIGH|NOT DONE|||BONE|ICTERIC|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|NA|U|N||1||38||BASELINE|1960-03-25|1965-11-07|||||1972-08-05||1960-09-25
TRIAL STUDY 134XCP|IS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||V/V|||||PT_US||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|ICTERIC|U|ALCIAN BLUE STAIN|U|U|N||2||58||TREATMENT|1969-04-04|1973-08-17|||||1970-07-04||1973-04-15
TRIAL STUDY 134XCP|IS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU|||||ABSORBANCE U/MIN||||LOW|NOT DONE|||CAPILLARY PLASMA|FROZEN|Y|U-HPLC/MS/MS|Y|U|N||3||39||RUN-IN|1964-04-15|1961-10-06|||||1965-06-22||1973-06-02
TRIAL STUDY 134XCP|IS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||STRIP|||||FRAMES/S||||ABNORMAL|NOT DONE|||MIXED VENOUS BLOOD|ICTERIC|NA|ELECTROCHEMILUMINESCENCE|N|Y|U||4||88||BLINDED TREATMENT|1972-01-03|1973-07-12|||||1972-05-19||1961-02-09
TRIAL STUDY 134XCP|IS|2A6524EE-F1E9-4D0C-8CA2-E03C6350849A||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G|||||MEQ/UL||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|U|NEPHELOMETRY|N|NA|N||5||7||LONG-TERM FOLLOW-UP|1968-02-28|1966-11-19|||||1971-08-01||1960-11-08
TRIAL STUDY 134XCP|IS|941A9CF9-872C-42CF-A409-129BE5A88520||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^3 CFU/ML|||||CMHG||||HIGH|NOT DONE|||CAPILLARY PLASMA|UNEXPECTED ODOR|U|ENZYMATIC ULTRACENTRIFUGATION|N|Y|NA||1||38||WASHOUT|1968-10-23|1965-02-09|||||1971-10-26||1963-10-25
TRIAL STUDY 134XCP|IS|941A9CF9-872C-42CF-A409-129BE5A88520||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||IU/DAY|||||DYN||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|Y|LEAD CITRATE STAIN|Y|N|N||2||58||OBSERVATION|1960-06-20|1973-06-24|||||1961-07-13||1966-09-10
TRIAL STUDY 134XCP|IS|941A9CF9-872C-42CF-A409-129BE5A88520||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FARAD|||||KIU||||NORMAL|NOT DONE|||EXPIRED AIR|LIPEMIC|N|JAFFE REACTION|U|Y|U||3||39||TREATMENT|1967-06-17|1967-11-06|||||1965-12-02||1962-01-08
TRIAL STUDY 134XCP|IS|941A9CF9-872C-42CF-A409-129BE5A88520||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG EID 50/DOSE|||||AMU||||NORMAL|NOT DONE|||PLASMA|CALCIFIED|U|TOTAL BODY RADIOGRAPHY|N|N|N||4||88||LONG-TERM FOLLOW-UP|1960-04-08|1963-08-25|||||1969-10-20||1961-05-16
TRIAL STUDY 134XCP|IS|941A9CF9-872C-42CF-A409-129BE5A88520||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/DL|||||10^9/G||||NORMAL|NOT DONE|||TUMOR TISSUE|ICTERIC|N|DUKE INCISION METHOD|NA|NA|Y||5||7||INDUCTION TREATMENT|1960-04-27|1960-12-15|||||1970-01-09||1960-06-04
TRIAL STUDY 134XCP|IS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/H|||||100 IU/ML||||NORMAL|NOT DONE|||ABSCESS FLUID|THAWED|Y|MICROSCOPY|NA|NA|N||1||38||OPEN LABEL TREATMENT|1968-09-21|1972-07-18|||||1960-09-10||1965-10-24
TRIAL STUDY 134XCP|IS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/H|||||MM/MIN||||LOW|NOT DONE|||ADIPOSE TISSUE|SOLIDIFIED|Y|TARGETED TRANSCRIPTOME SEQUENCING|U|Y|N||2||58||WASHOUT|1968-02-11|1968-05-28|||||1969-10-22||1972-01-03
TRIAL STUDY 134XCP|IS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6/G|||||10^6 RNA COPIES/ML||||LOW|NOT DONE|||INFRANATANT, SERUM|AGGLUTINATED|U|ULTRASOUND|Y|NA|U||3||39||INDUCTION TREATMENT|1960-07-31|1960-07-09|||||1961-09-30||1966-06-26
TRIAL STUDY 134XCP|IS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||AMFI|||||SEC||||LOW|NOT DONE|||PLEURAL FLUID|FRESH|NA|MICRODENSITOMETRY|NA|Y|N||4||88||INDUCTION TREATMENT|1963-01-06|1972-10-12|||||1970-10-13||1964-12-09
TRIAL STUDY 134XCP|IS|D7F3E205-CF5D-4724-ABE1-CE2DD560FB38||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6/L|||||U||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|DIGITAL PCR|Y|N|N||5||7||INDUCTION TREATMENT|1967-01-17|1973-08-03|||||1968-10-22||1966-07-09
TRIAL STUDY 134XCP|IS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PATCH|||||MIN||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|CALCIFIED|Y|MALDI-TOF|N|NA|N||1||38||FOLLOW-UP|1961-05-29|1966-09-25|||||1960-11-01||1963-10-16
TRIAL STUDY 134XCP|IS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FARAD|||||V||||ABNORMAL|NOT DONE|||CORD BLOOD|CALCIFIED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|U|Y|Y||2||58||WASHOUT|1969-02-09|1966-10-18|||||1972-04-14||1964-06-25
TRIAL STUDY 134XCP|IS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/L FEU|||||UG/KG/H||||LOW|NOT DONE|||MENSTRUAL BLOOD|ICTERIC|Y|ELISPOT|Y|NA|Y||3||39||FOLLOW-UP|1967-04-08|1970-06-01|||||1967-04-14||1967-09-28
TRIAL STUDY 134XCP|IS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^9 ORGANISMS/MG|||||/100 HPFS||||HIGH|NOT DONE|||NAIL|CONCENTRATED|N|MALDI|Y|N|NA||4||88||BLINDED TREATMENT|1960-12-27|1966-11-14|||||1962-12-23||1972-01-21
TRIAL STUDY 134XCP|IS|10814ECC-AEDF-4B8C-B514-BADC4D388ADE||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BU/ML|||||L/H||||ABNORMAL|NOT DONE|||LYMPH|REFRIGERATED|N|PET/MRI SCAN|U|U|U||5||7||BLINDED TREATMENT|1973-02-04|1970-08-13|||||1970-10-02||1964-08-09
TRIAL STUDY 134XCP|IS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^3 ORGANISMS/ML|||||ABSORBANCE U||||LOW|NOT DONE|||BILE|PARAFFIN-EMBEDDED|NA|CENTRIFUGATION|N|NA|NA||1||38||CONTINUATION TREATMENT|1961-11-26|1966-06-23|||||1962-02-07||1966-06-13
TRIAL STUDY 134XCP|IS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MBQ|||||QUANTITY SUFFICIENT||||LOW|NOT DONE|||SUPERNATANT, SERUM|NON-HEMOLYZED|N|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|NA|N|N||2||58||BASELINE|1961-02-04|1963-03-16|||||1967-12-27||1964-03-09
TRIAL STUDY 134XCP|IS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||SYRINGE|||||TUBERCULIN UNIT||||HIGH|NOT DONE|||BONE|NON-HEMOLYZED|NA|REVERSE TRANSCRIPTASE PCR|Y|N|Y||3||39||OPEN LABEL TREATMENT|1970-02-05|1966-03-05|||||1967-11-08||1970-09-09
TRIAL STUDY 134XCP|IS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NFIU|||||WEEKS||||ABNORMAL|NOT DONE|||PUS|THAWED|N|ICC|N|U|Y||4||88||INDUCTION TREATMENT|1969-10-19|1964-01-12|||||1968-10-21||1968-03-12
TRIAL STUDY 134XCP|IS|06000708-8EBA-4B6C-A8D3-1D0AC4D0E202||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/ANIMAL|||||M2||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|CONTAMINATED|NA|IMPULSE OSCILLOMETRY|N|Y|NA||5||7||BLINDED TREATMENT|1965-12-28|1962-05-11|||||1966-08-22||1967-01-02
TRIAL STUDY 134XCP|IS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/M2/H|||||MIN*MG/ML||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|CALCIFIED|NA|GEL ELECTROPHORESIS|NA|N|Y||1||38||OPEN LABEL TREATMENT|1961-02-09|1968-01-27|||||1963-07-01||1973-06-05
TRIAL STUDY 134XCP|IS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FMOL/G|||||MM3/MM2/YEAR||||LOW|NOT DONE|||TRANSUDATE|NON-HEMOLYZED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|Y|U||2||58||BLINDED TREATMENT|1966-07-09|1973-01-14|||||1962-06-30||1968-09-04
TRIAL STUDY 134XCP|IS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/G/MIN|||||FMOL/G||||ABNORMAL|NOT DONE|||VENOUS BLOOD|AGGLUTINATED|Y|IMPEDANCE CONDUCTIVITY|NA|Y|U||3||39||RUN-IN|1961-04-07|1972-06-03|||||1960-10-29||1972-08-02
TRIAL STUDY 134XCP|IS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MAC50|||||RING||||LOW|NOT DONE|||LUNG SURFACTANT|AUTOLYZED|NA|FUNCTIONAL MRI|Y|NA|U||4||88||INDUCTION TREATMENT|1960-09-07|1964-07-29|||||1970-03-03||1961-04-15
TRIAL STUDY 134XCP|IS|0BD48B9C-D7D4-47CD-A61D-A4279898D87D||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/S/M2|||||GPL U/ML||||ABNORMAL|NOT DONE|||RETICULOCYTES|ICTERIC|NA|PULSE OXIMETRY|NA|U|U||5||7||RUN-IN|1963-02-22|1969-10-28|||||1963-07-12||1963-05-10
TRIAL STUDY 134XCP|IS|A4A5E66A-E65C-4234-8858-E69D04AB1593||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ELISA UNIT/DOSE|||||UG/MOL||||NORMAL|NOT DONE|||MONOCYTE|HEMOLYZED|NA|MRS|Y|Y|NA||1||38||OBSERVATION|1969-06-01|1965-01-23|||||1971-09-08||1970-12-29
TRIAL STUDY 134XCP|IS|A4A5E66A-E65C-4234-8858-E69D04AB1593||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/HPF|||||BQ/UL||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ROOM TEMPERATURE|Y|MYELOPEROXIDASE STAIN|U|U|NA||2||58||OPEN LABEL TREATMENT|1963-05-11|1973-06-21|||||1965-03-15||1967-11-30
TRIAL STUDY 134XCP|IS|A4A5E66A-E65C-4234-8858-E69D04AB1593||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||SPRAY|||||MGEQ||||LOW|NOT DONE|||SKIN TISSUE|FRESH|N|INCISION-INDUCED BLEEDING METHOD|N|Y|Y||3||39||BLINDED TREATMENT|1964-05-29|1971-10-09|||||1969-04-05||1966-07-08
TRIAL STUDY 134XCP|IS|A4A5E66A-E65C-4234-8858-E69D04AB1593||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MJOULE/CM2|||||UV2||||LOW|NOT DONE|||MECONIUM|DRIED|U|DIGITAL PCR|U|Y|Y||4||88||LONG-TERM FOLLOW-UP|1973-02-26|1961-07-27|||||1963-12-27||1971-09-11
TRIAL STUDY 134XCP|IS|A4A5E66A-E65C-4234-8858-E69D04AB1593||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CP|||||10^6 ORGANISMS/MG||||LOW|NOT DONE|||ABSCESS FLUID|CALCIFIED|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|N|NA|Y||5||7||OPEN LABEL TREATMENT|1961-05-31|1962-04-07|||||1972-05-08||1960-01-24
TRIAL STUDY 134XCP|IS|0EA46DA5-4291-4585-9745-08BFA60BED3F||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/M2/DAY|||||ANTIBODY UNIT||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|DRIED|N|CONTRAST ENHANCED MRI|NA|U|N||1||38||BLINDED TREATMENT|1971-09-17|1968-08-05|||||1967-09-09||1969-06-17
TRIAL STUDY 134XCP|IS|0EA46DA5-4291-4585-9745-08BFA60BED3F||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DPM/100MG|||||PACK YEAR||||NORMAL|NOT DONE|||BUFFY COAT|FRESH|N|IN SITU HYBRIDIZATION|Y|U|U||2||58||INDUCTION TREATMENT|1970-01-10|1963-01-16|||||1969-07-20||1973-08-05
TRIAL STUDY 134XCP|IS|0EA46DA5-4291-4585-9745-08BFA60BED3F||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ARBITRARY U|||||PMOL/DAY||||HIGH|NOT DONE|||MECONIUM|AGGLUTINATED|NA|GC/MS-CI|U|Y|N||3||39||OBSERVATION|1960-06-30|1969-10-26|||||1970-02-08||1971-10-02
TRIAL STUDY 134XCP|IS|0EA46DA5-4291-4585-9745-08BFA60BED3F||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMOL/S|||||GENEQ||||HIGH|NOT DONE|||SPUTUM|GELLED|U|PET/MRI SCAN|U|Y|Y||4||88||OPEN LABEL TREATMENT|1969-10-08|1970-08-11|||||1960-03-05||1968-04-04
TRIAL STUDY 134XCP|IS|0EA46DA5-4291-4585-9745-08BFA60BED3F||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||M|||||USEC||||LOW|NOT DONE|||PUS|CLOTTED|U|ELECTROPHORESIS|N|N|NA||5||7||FOLLOW-UP|1971-01-03|1961-11-05|||||1968-10-13||1960-09-17
TRIAL STUDY 134XCP|IS|F54E494F-7EC2-41E7-A969-DF7151EA08E9||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GLOBULE|||||BOWL||||HIGH|NOT DONE|||SPUTUM|THAWED|Y|MASS SPECTROMETRY|Y|Y|Y||1||38||RUN-IN|1971-09-30|1962-10-04|||||1972-09-21||1964-07-27
TRIAL STUDY 134XCP|IS|F54E494F-7EC2-41E7-A969-DF7151EA08E9||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BQ/UG|||||M/SEC||||ABNORMAL|NOT DONE|||TRANSUDATE|ROOM TEMPERATURE|NA|EPSILOMETER|N|Y|U||2||58||FOLLOW-UP|1962-02-15|1962-10-26|||||1969-02-28||1966-12-08
TRIAL STUDY 134XCP|IS|F54E494F-7EC2-41E7-A969-DF7151EA08E9||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/DAY|||||NMOL/ML/MIN||||LOW|NOT DONE|||PLEURAL FLUID|FRESH|N|EIA|Y|NA|Y||3||39||INDUCTION TREATMENT|1968-06-16|1960-08-05|||||1964-12-30||1966-11-20
TRIAL STUDY 134XCP|IS|F54E494F-7EC2-41E7-A969-DF7151EA08E9||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UKAT/10^12 RBC|||||DISK||||ABNORMAL|NOT DONE|||PLEURAL FLUID|ICTERIC|N|SPECULAR MICROSCOPY|U|NA|Y||4||88||SCREENING|1967-12-23|1973-04-01|||||1971-11-07||1966-08-29
TRIAL STUDY 134XCP|IS|F54E494F-7EC2-41E7-A969-DF7151EA08E9||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/G HB|||||KG/M2||||HIGH|NOT DONE|||VENOUS CORD BLOOD|GELLED|Y|RYAN BLUE STAIN|NA|U|Y||5||7||BASELINE|1967-12-08|1971-01-20|||||1969-12-12||1961-03-21
TRIAL STUDY 134XCP|IS|3C4215F7-A7FA-4177-8B84-FD26FEB43039||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PLUG|||||STRIP||||HIGH|NOT DONE|||LEUKOCYTE|FROZEN|NA|SCANNING ELECTRON MICROSCOPY|N|U|Y||1||38||LONG-TERM FOLLOW-UP|1971-01-26|1961-02-07|||||1969-11-21||1964-10-10
TRIAL STUDY 134XCP|IS|3C4215F7-A7FA-4177-8B84-FD26FEB43039||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ROENTGEN|||||UG/L||||NORMAL|NOT DONE|||GASTRIC CONTENTS|REFRIGERATED|N|INTERRUPTER TECHNIQUE|NA|U|N||2||58||FOLLOW-UP|1968-02-20|1962-05-01|||||1961-05-31||1961-01-18
TRIAL STUDY 134XCP|IS|3C4215F7-A7FA-4177-8B84-FD26FEB43039||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/CAGE/DAY|||||MMOL/DAY||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|FRESH|U|LC/MS|N|NA|U||3||39||LONG-TERM FOLLOW-UP|1971-02-18|1960-08-27|||||1965-06-27||1968-09-02
TRIAL STUDY 134XCP|IS|3C4215F7-A7FA-4177-8B84-FD26FEB43039||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UGEQ|||||/MONTH||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|CALCIFIED|NA|ICP-MS|Y|U|N||4||88||FOLLOW-UP|1961-10-08|1966-02-26|||||1966-12-26||1965-03-15
TRIAL STUDY 134XCP|IS|3C4215F7-A7FA-4177-8B84-FD26FEB43039||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMOL|||||DISK||||LOW|NOT DONE|||EPIDERMAL TISSUE|AUTOLYZED|N|SLOAN LETTER EYE CHART 2.5%|NA|NA|N||5||7||SCREENING|1971-09-25|1961-07-23|||||1964-11-03||1972-09-14
TRIAL STUDY 134XCP|IS|797C71A3-375E-466E-BDA8-A2828C9C45BB||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BEATS/MIN|||||UCI/KG||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|ICTERIC|NA|FLAME PHOTOMETRY|Y|N|N||1||38||FOLLOW-UP|1966-12-02|1968-11-26|||||1966-02-02||1966-10-12
TRIAL STUDY 134XCP|IS|797C71A3-375E-466E-BDA8-A2828C9C45BB||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/KG/MIN|||||FARAD||||HIGH|NOT DONE|||LYSATE|UNEXPECTED ODOR|Y|BIOPSY|Y|Y|NA||2||58||LONG-TERM FOLLOW-UP|1963-11-16|1963-08-14|||||1972-12-26||1967-07-19
TRIAL STUDY 134XCP|IS|797C71A3-375E-466E-BDA8-A2828C9C45BB||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FG|||||10^6/HPF||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|HEMOLYZED|NA|LC/MS/MS|U|U|N||3||39||FOLLOW-UP|1965-12-30|1967-11-13|||||1965-10-11||1965-01-27
TRIAL STUDY 134XCP|IS|797C71A3-375E-466E-BDA8-A2828C9C45BB||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MS/MMHG|||||PACKAGE||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|SOLIDIFIED|Y|QUANTITATIVE ULTRASOUND|NA|Y|Y||4||88||OBSERVATION|1967-09-22|1971-03-07|||||1969-03-08||1967-08-12
TRIAL STUDY 134XCP|IS|797C71A3-375E-466E-BDA8-A2828C9C45BB||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EU|||||G/DL||||HIGH|NOT DONE|||HAIR|AUTOLYZED|Y|KINETIC MICROPARTICLE IMMUNOASSAY|N|NA|N||5||7||FOLLOW-UP|1969-09-19|1971-09-06|||||1969-02-27||1960-10-05
TRIAL STUDY 134XCP|IS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MM/2H|||||KA_U/DL||||NORMAL|NOT DONE|||ABSCESS FLUID|ICTERIC|Y|QUANTITATIVE ULTRASOUND|Y|N|U||1||38||RUN-IN|1968-04-19|1964-03-13|||||1960-12-17||1965-06-13
TRIAL STUDY 134XCP|IS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/MIN|||||PM||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONTAMINATED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|N|N|N||2||58||BASELINE|1967-07-19|1968-12-02|||||1970-08-31||1963-07-30
TRIAL STUDY 134XCP|IS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL|||||VG/KG||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|GELLED|Y|CONTRAST ENHANCED CT SCAN|U|N|N||3||39||CONTINUATION TREATMENT|1965-04-08|1968-04-26|||||1970-10-27||1972-08-27
TRIAL STUDY 134XCP|IS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GBQ|||||KG/CM||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|ROOM TEMPERATURE|Y|CINEANGIOGRAPHY|NA|N|NA||4||88||INDUCTION TREATMENT|1966-03-21|1969-03-14|||||1961-05-07||1964-07-26
TRIAL STUDY 134XCP|IS|F70AD90E-59E4-4017-B23C-D411B5EE8BFA||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTIBODY UNIT|||||MOSM||||NORMAL|NOT DONE|||EPIDERMAL TISSUE|FRESH|U|GEL ELECTROPHORESIS|Y|NA|N||5||7||TREATMENT|1967-06-20|1967-08-30|||||1967-06-25||1968-02-18
TRIAL STUDY 134XCP|IS|5617A5B9-AEE0-4118-9113-3755ED8E961A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MONTHS|||||G/CAGE/DAY||||LOW|NOT DONE|||PLASMA|NON-HEMOLYZED|U|KINETIC MICROPARTICLE IMMUNOASSAY|N|NA|NA||1||38||OBSERVATION|1963-10-22|1971-09-04|||||1969-08-12||1970-01-30
TRIAL STUDY 134XCP|IS|5617A5B9-AEE0-4118-9113-3755ED8E961A||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/L/MIN|||||UG/KG||||NORMAL|NOT DONE|||STOOL|CLOTTED|N|MAMMOGRAPHY|Y|Y|NA||2||58||BLINDED TREATMENT|1973-07-05|1961-02-26|||||1966-12-12||1965-08-02
TRIAL STUDY 134XCP|IS|5617A5B9-AEE0-4118-9113-3755ED8E961A||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMAL|||||PL||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|ROOM TEMPERATURE|Y|COMPLEMENT FIXATION|N|U|NA||3||39||SCREENING|1972-10-04|1966-11-26|||||1971-11-10||1960-10-07
TRIAL STUDY 134XCP|IS|5617A5B9-AEE0-4118-9113-3755ED8E961A||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^4 CFU/ML|||||INHALATION||||HIGH|NOT DONE|||LAVAGE FLUID|THAWED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|N|NA|NA||4||88||BASELINE|1969-07-02|1961-03-12|||||1965-11-22||1961-03-24
TRIAL STUDY 134XCP|IS|5617A5B9-AEE0-4118-9113-3755ED8E961A||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/L|||||PPM||||HIGH|NOT DONE|||LYMPH|HEMOLYZED|NA|ELISPOT|NA|NA|Y||5||7||WASHOUT|1970-04-05|1964-03-23|||||1965-07-10||1961-08-22
TRIAL STUDY 134XCP|IS|7ECE0F95-910A-4FB3-9435-73805E498415||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DNA COPIES/UG|||||GPL U||||NORMAL|NOT DONE|||FLUID|CALCIFIED|Y|FLUORESCEIN STAIN|NA|U|N||1||38||SCREENING|1968-07-24|1960-12-09|||||1973-08-29||1972-11-07
TRIAL STUDY 134XCP|IS|7ECE0F95-910A-4FB3-9435-73805E498415||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UU/L|||||P||||NORMAL|NOT DONE|||SERUM|ROOM TEMPERATURE|N|COMPUTERIZED CORNEAL TOPOGRAPHY|U|NA|N||2||58||CONTINUATION TREATMENT|1961-12-28|1961-12-31|||||1969-04-19||1967-04-21
TRIAL STUDY 134XCP|IS|7ECE0F95-910A-4FB3-9435-73805E498415||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CMH2O/ML|||||PT_US||||ABNORMAL|NOT DONE|||PUS|CLOTTED|Y|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|N|U||3||39||TREATMENT|1971-04-08|1973-07-07|||||1972-03-01||1970-07-17
TRIAL STUDY 134XCP|IS|7ECE0F95-910A-4FB3-9435-73805E498415||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL/L/H|||||CD*S/M2||||HIGH|NOT DONE|||PUS|CLOTTED|N|PH METER MEASUREMENT METHOD|U|N|NA||4||88||CONTINUATION TREATMENT|1972-04-27|1961-03-07|||||1965-10-16||1962-08-17
TRIAL STUDY 134XCP|IS|7ECE0F95-910A-4FB3-9435-73805E498415||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM/S|||||PMOL/L/H||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|LIPEMIC|N|DIFFUSION TENSOR MRI|Y|U|Y||5||7||INDUCTION TREATMENT|1964-08-04|1968-07-12|||||1962-05-08||1961-11-27
TRIAL STUDY 134XCP|IS|83EDB0FE-728D-453F-8DB2-7D44202EEB43||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GLOBULE|||||VIRTUAL PIXEL||||LOW|NOT DONE|||REFLEX TEAR|FRESH|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|NA|U||1||38||TREATMENT|1962-01-24|1967-10-21|||||1971-05-31||1968-04-27
TRIAL STUDY 134XCP|IS|83EDB0FE-728D-453F-8DB2-7D44202EEB43||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DRAM|||||BAR||||LOW|NOT DONE|||PLATELET RICH PLASMA|HEMOLYZED|N|ANTIMICROBIAL COMBINATION TESTING|Y|N|NA||2||58||TREATMENT|1960-09-01|1963-09-02|||||1969-07-30||1966-08-25
TRIAL STUDY 134XCP|IS|83EDB0FE-728D-453F-8DB2-7D44202EEB43||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SIEMENS|||||BE/ML||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|HEMOLYZED|NA|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|N|Y|Y||3||39||BASELINE|1961-03-12|1970-03-04|||||1968-09-06||1967-11-25
TRIAL STUDY 134XCP|IS|83EDB0FE-728D-453F-8DB2-7D44202EEB43||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||OZ|||||MG/KG/H||||ABNORMAL|NOT DONE|||DERMAL TISSUE|DRIED|NA|LANDOLT RING|Y|Y|N||4||88||SCREENING|1970-07-13|1965-09-19|||||1964-01-26||1960-06-22
TRIAL STUDY 134XCP|IS|83EDB0FE-728D-453F-8DB2-7D44202EEB43||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||S^-1(%O2)^-1|||||PIXELS/IN||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|FRESH|NA|WEBER GREEN STAIN|N|Y|NA||5||7||WASHOUT|1968-07-05|1970-04-12|||||1970-12-15||1963-04-04
TRIAL STUDY 134XCP|IS|35589D89-B019-4C5E-8A4B-BFA58E894A9C||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^6/L|||||CAPFUL||||LOW|NOT DONE|||INFRANATANT, PLASMA|LIPEMIC|U|SLIT LAMP|Y|NA|N||1||38||RUN-IN|1973-07-27|1965-07-10|||||1962-05-02||1965-09-10
TRIAL STUDY 134XCP|IS|35589D89-B019-4C5E-8A4B-BFA58E894A9C||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UU/DL|||||NG/DL||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|GELLED|U|FLUORESCENT SPOT TEST|NA|N|U||2||58||BLINDED TREATMENT|1965-05-16|1968-12-08|||||1968-08-09||1968-01-23
TRIAL STUDY 134XCP|IS|35589D89-B019-4C5E-8A4B-BFA58E894A9C||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/MOL|||||10^9 CFU||||ABNORMAL|NOT DONE|||SYNOVIAL FLUID|CONTAMINATED|NA|PHOTOMETRIC CLOT DETECTION|N|NA|Y||3||39||BASELINE|1969-04-03|1971-09-04|||||1963-10-18||1968-04-20
TRIAL STUDY 134XCP|IS|35589D89-B019-4C5E-8A4B-BFA58E894A9C||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CARTRIDGE|||||U/KG||||ABNORMAL|NOT DONE|||CORD SERUM|LACTESCENT|NA|CONTRAST ENHANCED CT SCAN|U|N|U||4||88||CONTINUATION TREATMENT|1972-06-21|1967-03-30|||||1967-02-18||1969-08-19
TRIAL STUDY 134XCP|IS|35589D89-B019-4C5E-8A4B-BFA58E894A9C||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||HR/DAY|||||CMH2O/ML||||HIGH|NOT DONE|||INFRANATANT, PLASMA|LIPEMIC|U|INDIRECT IMMUNOFLUORESCENCE|NA|N|Y||5||7||LONG-TERM FOLLOW-UP|1970-06-28|1967-09-08|||||1963-09-11||1972-12-18
TRIAL STUDY 134XCP|IS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CYLINDER|||||QUANTITY SUFFICIENT||||ABNORMAL|NOT DONE|||URINE SEDIMENT|CONCENTRATED|Y|HEMOCYTOMETRY|Y|U|Y||1||38||CONTINUATION TREATMENT|1962-04-09|1961-04-13|||||1967-10-25||1965-07-10
TRIAL STUDY 134XCP|IS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/M2/H|||||IU/MG||||NORMAL|NOT DONE|||SERUM|THAWED|N|PHOROPTER|Y|Y|N||2||58||RUN-IN|1962-11-04|1963-12-14|||||1968-08-07||1967-04-24
TRIAL STUDY 134XCP|IS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 CFU/ML|||||MMOL/DAY||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE|Y|IMMUNOFIXATION ELECTROPHORESIS|NA|NA|U||3||39||TREATMENT|1962-05-25|1961-03-16|||||1971-10-15||1965-09-14
TRIAL STUDY 134XCP|IS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PA|||||UMOL/MG/MIN||||ABNORMAL|NOT DONE|||MECONIUM|AUTOLYZED|N|PET SCAN|Y|NA|U||4||88||BASELINE|1965-05-25|1966-03-26|||||1970-06-17||1970-05-23
TRIAL STUDY 134XCP|IS|45C05CC2-662A-4AB2-9342-7BE56AF1ABDF||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/KG|||||WAFER||||LOW|NOT DONE|||CORD SERUM|CONCENTRATED|U|GIEMSA STAIN|U|U|Y||5||7||SCREENING|1971-02-17|1965-06-22|||||1969-12-06||1967-10-14
TRIAL STUDY 134XCP|IS|21934F6E-8333-413B-931C-DF115519F394||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||EIA UNIT|||||UG/DOSE||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|REFRIGERATED|NA|KINYOUN STAIN|NA|N|NA||1||38||RUN-IN|1973-04-14|1972-10-13|||||1961-09-09||1971-01-23
TRIAL STUDY 134XCP|IS|21934F6E-8333-413B-931C-DF115519F394||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PL|||||EVENTS||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|LACTESCENT|NA|CHROMOGENIC ASSAY|NA|NA|NA||2||58||INDUCTION TREATMENT|1960-04-10|1973-09-03|||||1971-05-26||1965-01-02
TRIAL STUDY 134XCP|IS|21934F6E-8333-413B-931C-DF115519F394||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/KG/DOSE|||||NMOL/MOL||||ABNORMAL|NOT DONE|||MECONIUM|UNEXPECTED ODOR|NA|LANDOLT RING|N|NA|U||3||39||INDUCTION TREATMENT|1965-06-28|1963-04-30|||||1971-09-30||1969-06-13
TRIAL STUDY 134XCP|IS|21934F6E-8333-413B-931C-DF115519F394||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPTH|||||SFC/10^6 PBMC||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|LIPEMIC|U|EIA|U|NA|NA||4||88||INDUCTION TREATMENT|1960-10-22|1963-12-22|||||1964-07-15||1965-07-16
TRIAL STUDY 134XCP|IS|21934F6E-8333-413B-931C-DF115519F394||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FEU|||||TBSP||||NORMAL|NOT DONE|||SMEGMA|UNEXPECTED ODOR|N|CONTRAST ENHANCED CT SCAN|NA|Y|U||5||7||OPEN LABEL TREATMENT|1961-01-27|1964-01-07|||||1971-07-15||1962-12-12
TRIAL STUDY 134XCP|IS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/ML/MIN|||||MEQ/DAY||||NORMAL|NOT DONE|||BILE|UNEXPECTED ODOR|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|U|Y|NA||1||38||CONTINUATION TREATMENT|1965-02-04|1968-11-25|||||1966-12-06||1963-05-25
TRIAL STUDY 134XCP|IS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NEBULE|||||LOZENGE||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|ROOM TEMPERATURE|U|THERMAL IONIZATION MASS SPECTROMETRY|Y|U|N||2||58||BASELINE|1962-09-28|1960-05-01|||||1971-02-22||1971-05-06
TRIAL STUDY 134XCP|IS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 COPIES/ML|||||APS U||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CALCIFIED|NA|ENZYMATIC ULTRACENTRIFUGATION|NA|N|U||3||39||FOLLOW-UP|1971-05-22|1971-01-30|||||1962-10-17||1970-12-13
TRIAL STUDY 134XCP|IS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KBQ|||||UL/KG/DAY||||LOW|NOT DONE|||LEUKOCYTE|CALCIFIED|N|RAJI CELL RIA|N|NA|Y||4||88||LONG-TERM FOLLOW-UP|1966-07-04|1967-01-12|||||1960-08-05||1961-07-25
TRIAL STUDY 134XCP|IS|2EF614BE-3AEA-4BDA-968D-2D2F4EB9A653||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||AMU|||||BLOCKS||||NORMAL|NOT DONE|||LUNG SURFACTANT|ICTERIC|N|ANGIOGRAPHY|U|NA|Y||5||7||CONTINUATION TREATMENT|1968-10-17|1964-05-23|||||1967-06-24||1973-06-20
TRIAL STUDY 134XCP|IS|E31F3DEB-BCA2-4660-935D-BAEBC4238866||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||% INHIBITION|||||GMFI||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|CLOTTED|U|COMPUTERIZED CORNEAL TOPOGRAPHY|N|NA|N||1||38||WASHOUT|1962-02-27|1965-05-04|||||1970-03-19||1962-11-19
TRIAL STUDY 134XCP|IS|E31F3DEB-BCA2-4660-935D-BAEBC4238866||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L|||||NG/MOL||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|U|CT SCAN WITHOUT CONTRAST|U|U|U||2||58||OPEN LABEL TREATMENT|1960-06-03|1970-06-06|||||1971-06-21||1964-09-13
TRIAL STUDY 134XCP|IS|E31F3DEB-BCA2-4660-935D-BAEBC4238866||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PIXELS/IN|||||UCI/L||||NORMAL|NOT DONE|||CORD BLOOD|SOLIDIFIED|NA|BIOPSY|N|N|NA||3||39||LONG-TERM FOLLOW-UP|1972-06-01|1961-11-18|||||1972-02-20||1962-07-06
TRIAL STUDY 134XCP|IS|E31F3DEB-BCA2-4660-935D-BAEBC4238866||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/10^5|||||AG||||HIGH|NOT DONE|||PLATELET|HEMOLYZED|Y|HILLMEN COLOR CHART|Y|Y|Y||4||88||TREATMENT|1964-01-14|1960-09-11|||||1960-09-02||1970-01-27
TRIAL STUDY 134XCP|IS|E31F3DEB-BCA2-4660-935D-BAEBC4238866||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM2|||||IU||||LOW|NOT DONE|||FLUID|CONTAMINATED|NA|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|N|NA||5||7||LONG-TERM FOLLOW-UP|1963-10-12|1972-06-04|||||1964-04-26||1970-08-25
TRIAL STUDY 134XCP|IS|8310989D-82CC-456C-965A-E38AC9EA073F||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/10^5|||||DIP||||HIGH|NOT DONE|||PLEURAL TISSUE|CONCENTRATED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NA|U|U||1||38||OPEN LABEL TREATMENT|1968-01-02|1966-04-29|||||1961-12-11||1973-07-26
TRIAL STUDY 134XCP|IS|8310989D-82CC-456C-965A-E38AC9EA073F||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PFU|||||CGY||||HIGH|NOT DONE|||ARTERIAL BLOOD|CLOTTED|NA|NUCLEIC ACID BASED METHOD|U|NA|Y||2||58||LONG-TERM FOLLOW-UP|1969-05-20|1972-10-16|||||1972-10-11||1961-11-15
TRIAL STUDY 134XCP|IS|8310989D-82CC-456C-965A-E38AC9EA073F||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/H|||||MONTHS||||LOW|NOT DONE|||CELL PELLET|LIPEMIC|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|U|Y|NA||3||39||RUN-IN|1961-09-26|1968-09-15|||||1967-04-12||1962-11-15
TRIAL STUDY 134XCP|IS|8310989D-82CC-456C-965A-E38AC9EA073F||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPS U|||||U/ML||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|AGGLUTINATED|U|CELLULOSE TAPE|Y|N|N||4||88||CONTINUATION TREATMENT|1969-03-03|1964-07-14|||||1964-06-02||1960-04-27
TRIAL STUDY 134XCP|IS|8310989D-82CC-456C-965A-E38AC9EA073F||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ROENTGEN|||||MBP||||ABNORMAL|NOT DONE|||SALIVA|GELLED|U|RAJI CELL EIA|N|NA|N||5||7||CONTINUATION TREATMENT|1969-04-24|1965-11-12|||||1963-10-29||1964-01-04
TRIAL STUDY 134XCP|IS|826D8DC2-E407-481C-93D8-5169DBDF99C4||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DYN|||||MU/L||||NORMAL|NOT DONE|||SWABBED MATERIAL|THAWED|U|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|U|N|Y||1||38||RUN-IN|1966-04-29|1961-03-17|||||1967-09-25||1968-01-13
TRIAL STUDY 134XCP|IS|826D8DC2-E407-481C-93D8-5169DBDF99C4||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LX|||||MG/M2/DAY||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|GELLED|Y|MALDI|NA|U|U||2||58||LONG-TERM FOLLOW-UP|1972-08-23|1972-05-30|||||1965-10-21||1973-03-28
TRIAL STUDY 134XCP|IS|826D8DC2-E407-481C-93D8-5169DBDF99C4||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/SEC|||||FMOL/L||||HIGH|NOT DONE|||GASTRIC FLUID|SOLIDIFIED|NA|LIQUID SCINTILLATION COUNTING|N|N|N||3||39||BLINDED TREATMENT|1967-08-05|1962-03-26|||||1963-07-30||1973-03-25
TRIAL STUDY 134XCP|IS|826D8DC2-E407-481C-93D8-5169DBDF99C4||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UKAT/10^12 RBC|||||UL/DOSE||||ABNORMAL|NOT DONE|||SPERMATOZOON|LIPEMIC|U|SURFACE PLASMON RESONANCE|NA|Y|U||4||88||BASELINE|1972-11-03|1960-11-29|||||1960-07-07||1960-07-04
TRIAL STUDY 134XCP|IS|826D8DC2-E407-481C-93D8-5169DBDF99C4||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^3 ORGANISMS|||||ELISA UNIT/DOSE||||NORMAL|NOT DONE|||BUFFY COAT|THAWED|U|ANALYTICAL ULTRACENTRIFUGATION|N|NA|N||5||7||OPEN LABEL TREATMENT|1961-10-04|1964-02-02|||||1969-07-15||1971-07-18
TRIAL STUDY 134XCP|IS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MOL/DAY|||||/40 HPFS||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|ICTERIC|Y|CYSTOSCOPY|N|N|NA||1||38||WASHOUT|1966-07-12|1968-03-10|||||1973-04-16||1970-07-03
TRIAL STUDY 134XCP|IS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DNA COPIES/UG|||||G/CM2||||ABNORMAL|NOT DONE|||LOCHIA|GELLED|NA|ELISA|NA|U|N||2||58||INDUCTION TREATMENT|1972-01-28|1961-06-17|||||1966-06-27||1965-12-31
TRIAL STUDY 134XCP|IS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/L/MIN|||||ABSORBANCE U/ML||||NORMAL|NOT DONE|||CORD BLOOD|CLOTTED|N|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|NA|Y||3||39||BLINDED TREATMENT|1971-08-04|1963-05-04|||||1970-05-24||1963-08-25
TRIAL STUDY 134XCP|IS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TUBERCULIN UNIT/ML|||||APL U/ML||||NORMAL|NOT DONE|||SMEGMA|AUTOLYZED|NA|OPTICAL COHERENCE TOMOGRAPHY|N|Y|NA||4||88||SCREENING|1973-08-13|1962-02-08|||||1960-06-20||1969-06-23
TRIAL STUDY 134XCP|IS|F2CEE48B-51B0-4F3E-94B1-FBAC1D0B2CA3||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV|||||PG/L||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|CLOTTED|NA|BALLPOINT PEN TECHNIQUE|NA|N|NA||5||7||CONTINUATION TREATMENT|1963-04-25|1966-11-28|||||1964-01-12||1960-06-13
TRIAL STUDY 134XCP|IS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 RNA COPIES/ML|||||U/M2/MIN||||LOW|NOT DONE|||WHITE MATTER TISSUE|DRIED|U|ZIEHL NEELSEN ACID FAST STAIN|Y|Y|NA||1||38||TREATMENT|1969-11-09|1963-05-14|||||1961-08-30||1968-05-03
TRIAL STUDY 134XCP|IS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/ANIMAL|||||IU/MG||||LOW|NOT DONE|||DERMAL TISSUE|AGGLUTINATED|NA|CT SCAN|NA|N|NA||2||58||RUN-IN|1971-12-24|1964-12-09|||||1961-03-31||1961-03-04
TRIAL STUDY 134XCP|IS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L/SEC|||||FL||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|NON-HEMOLYZED|N|ENDOSCOPY|Y|Y|N||3||39||OPEN LABEL TREATMENT|1960-02-16|1962-10-12|||||1963-11-23||1961-05-18
TRIAL STUDY 134XCP|IS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||COPIES/ML|||||UV*SEC||||HIGH|NOT DONE|||SMEGMA|DRIED|Y|CYSTOMETRY|NA|N|U||4||88||INDUCTION TREATMENT|1962-09-21|1970-01-09|||||1970-09-22||1965-12-19
TRIAL STUDY 134XCP|IS|F8188B3C-FE9F-4589-BD6B-D313618C9FF6||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KBQ/UL|||||10^9 ORGANISMS/MG||||LOW|NOT DONE|||BILE|REFRIGERATED|Y|APPLANATION TONOMETRY|NA|N|U||5||7||LONG-TERM FOLLOW-UP|1964-09-21|1962-08-03|||||1960-03-02||1971-08-27
TRIAL STUDY 134XCP|IS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IU/DAY|||||BREATHS/MIN||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|CALCIFIED|N|SLOAN LETTER EYE CHART 1.25%|N|Y|Y||1||38||BLINDED TREATMENT|1965-03-28|1965-03-06|||||1964-01-16||1968-05-27
TRIAL STUDY 134XCP|IS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KALLIKREIN INHIBITOR UNIT|||||AFU||||NORMAL|NOT DONE|||PUS|SOLIDIFIED|U|KINETIC MICROPARTICLE IMMUNOASSAY|Y|Y|N||2||58||SCREENING|1962-12-27|1961-08-28|||||1973-02-08||1963-04-09
TRIAL STUDY 134XCP|IS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AG|||||ML/KG/H||||LOW|NOT DONE|||PLATELET|AGGLUTINATED|NA|FARR ASSAY|NA|NA|N||3||39||BASELINE|1970-03-29|1962-06-20|||||1972-10-13||1964-04-22
TRIAL STUDY 134XCP|IS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||YD|||||ML/MMHG||||NORMAL|NOT DONE|||CORD SERUM|CALCIFIED|N|SECONDARY ION MASS SPECTOMETRY|NA|Y|NA||4||88||WASHOUT|1964-02-18|1962-05-24|||||1963-11-14||1960-05-31
TRIAL STUDY 134XCP|IS|4F34B7B4-59E4-4D16-A5DD-2D41253FAD5A||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CMOL/L|||||GBQ/G||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|LIPEMIC|U|PET/CT SCAN WITHOUT CONTRAST|Y|U|N||5||7||LONG-TERM FOLLOW-UP|1962-12-20|1968-04-26|||||1968-03-06||1960-07-09
TRIAL STUDY 134XCP|IS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TUBERCULIN UNIT/ML|||||ML/M2/DAY||||HIGH|NOT DONE|||DISCHARGE|GELLED|Y|LANDOLT RING|U|N|NA||1||38||TREATMENT|1962-12-23|1970-03-05|||||1969-06-28||1969-04-22
TRIAL STUDY 134XCP|IS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||DNA COPIES/UG||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|REFRIGERATED|U|MIGET|Y|N|NA||2||58||TREATMENT|1962-09-18|1968-08-18|||||1971-01-26||1962-10-03
TRIAL STUDY 134XCP|IS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FRACTION OF 1|||||KG/MOL||||LOW|NOT DONE|||CAPILLARY PLASMA|SOLIDIFIED|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NA|N|U||3||39||SCREENING|1969-12-27|1964-08-26|||||1967-02-22||1970-06-11
TRIAL STUDY 134XCP|IS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PG/DL|||||COULOMB||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR|NA|TARGETED GENOME SEQUENCING|Y|U|N||4||88||OPEN LABEL TREATMENT|1963-02-01|1961-02-12|||||1973-01-13||1960-08-27
TRIAL STUDY 134XCP|IS|E6D1E0A4-79DF-4964-81C0-09675B53FA6D||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/DAY|||||MG/KG/H||||NORMAL|NOT DONE|||ARTERIAL BLOOD|AUTOLYZED|U|ICC|NA|NA|U||5||7||INDUCTION TREATMENT|1967-06-25|1969-11-20|||||1967-11-11||1970-02-03
TRIAL STUDY 134XCP|IS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 IU|||||JAR||||ABNORMAL|NOT DONE|||TISSUE|AGGLUTINATED|N|PAP STAIN|U|N|N||1||38||BASELINE|1967-04-04|1963-07-12|||||1969-04-07||1960-08-24
TRIAL STUDY 134XCP|IS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CM/MIN|||||%(W/V)||||LOW|NOT DONE|||PROSTATIC FLUID|LACTESCENT|NA|SURFACE PLASMON RESONANCE|U|NA|Y||2||58||OPEN LABEL TREATMENT|1968-02-29|1968-12-21|||||1970-06-12||1963-08-01
TRIAL STUDY 134XCP|IS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 ORGANISMS|||||10^3/L||||HIGH|NOT DONE|||LEUKOCYTE|UNEXPECTED ODOR|NA|FLOCCULATION|NA|NA|U||3||39||RUN-IN|1963-05-10|1961-02-17|||||1968-04-10||1968-10-26
TRIAL STUDY 134XCP|IS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CD/M2|||||BQ/L||||NORMAL|NOT DONE|||EMESIS|REFRIGERATED|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|Y|U||4||88||BLINDED TREATMENT|1962-05-19|1962-11-03|||||1964-03-25||1970-12-17
TRIAL STUDY 134XCP|IS|5BF2DD06-0BDB-4893-9EF7-9248D9DCE772||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||VG/ML|||||VIAL||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|ICTERIC|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NA|Y|Y||5||7||LONG-TERM FOLLOW-UP|1965-08-12|1962-02-11|||||1965-04-09||1962-11-23
TRIAL STUDY 134XCP|IS|B396F12E-7BF5-47CC-AFD1-1B679066B106||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CM/S|||||MOL/DAY||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|NON-HEMOLYZED|NA|ACCELERATOR MASS SPECTROMETRY|U|Y|Y||1||38||FOLLOW-UP|1969-07-06|1967-01-04|||||1964-05-12||1967-01-31
TRIAL STUDY 134XCP|IS|B396F12E-7BF5-47CC-AFD1-1B679066B106||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 PFU/ML|||||UV*SEC||||HIGH|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|Y|CELLULOSE TAPE|U|NA|NA||2||58||CONTINUATION TREATMENT|1973-05-15|1967-07-25|||||1968-11-22||1960-02-22
TRIAL STUDY 134XCP|IS|B396F12E-7BF5-47CC-AFD1-1B679066B106||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/MOL|||||CAL||||NORMAL|NOT DONE|||KERATINOCYTE|AUTOLYZED|NA|TRANSVAGINAL ULTRASOUND|U|Y|Y||3||39||LONG-TERM FOLLOW-UP|1971-01-09|1962-10-25|||||1965-08-15||1971-01-12
TRIAL STUDY 134XCP|IS|B396F12E-7BF5-47CC-AFD1-1B679066B106||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KG/CM2|||||DAMOL/L||||ABNORMAL|NOT DONE|||GASTRIC FLUID|FROZEN|N|GC/MS/MS|Y|NA|N||4||88||OPEN LABEL TREATMENT|1968-06-05|1968-06-14|||||1971-08-04||1970-11-03
TRIAL STUDY 134XCP|IS|B396F12E-7BF5-47CC-AFD1-1B679066B106||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||S*KPA|||||L/H/M2||||LOW|NOT DONE|||INFRANATANT, PLASMA|FROZEN|U|MULTIPLEXED BEAD BASED IMMUNOASSAY|NA|NA|N||5||7||OPEN LABEL TREATMENT|1964-06-28|1968-09-18|||||1972-05-04||1972-06-13
TRIAL STUDY 134XCP|IS|2936B26A-9A8D-4C28-90A7-6131837F255F||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||L/H|||||ABSORBANCE U||||ABNORMAL|NOT DONE|||URINE SEDIMENT|AGGLUTINATED|Y|HANSEL STAIN|Y|NA|U||1||38||OPEN LABEL TREATMENT|1964-01-28|1970-08-17|||||1972-08-24||1971-12-04
TRIAL STUDY 134XCP|IS|2936B26A-9A8D-4C28-90A7-6131837F255F||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LOG10 IU/ML|||||ELISA UNIT||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|FRESH|U|FLUORESCENT ENZYME IMMUNOASSAY|NA|N|NA||2||58||CONTINUATION TREATMENT|1967-04-23|1972-05-03|||||1968-02-17||1970-07-26
TRIAL STUDY 134XCP|IS|2936B26A-9A8D-4C28-90A7-6131837F255F||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PG/DL|||||M2||||NORMAL|NOT DONE|||BLOOD|AGGLUTINATED|U|KNEMOMETRY|N|NA|Y||3||39||BLINDED TREATMENT|1962-11-02|1967-10-11|||||1968-02-18||1971-05-23
TRIAL STUDY 134XCP|IS|2936B26A-9A8D-4C28-90A7-6131837F255F||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||AMP|||||U/MG||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|CONCENTRATED|NA|TRICHROME STAIN|NA|N|Y||4||88||LONG-TERM FOLLOW-UP|1969-02-13|1966-10-26|||||1964-02-24||1966-11-20
TRIAL STUDY 134XCP|IS|2936B26A-9A8D-4C28-90A7-6131837F255F||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 ORGANISMS|||||MMHG*MIN/L||||ABNORMAL|NOT DONE|||SOFT TISSUE|FRESH|U|LYMPHANGIOGRAPHY|N|U|NA||5||7||SCREENING|1964-06-02|1971-02-17|||||1964-03-05||1971-01-07
TRIAL STUDY 134XCP|IS|901A91DC-9EF3-4A20-A35D-9C426A5C640B||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 ORGANISMS|||||KPA||||NORMAL|NOT DONE|||CALCULUS|ICTERIC|U|NUCLEIC ACID AMPLIFICATION TEST|NA|N|U||1||38||BLINDED TREATMENT|1964-11-13|1972-07-18|||||1963-12-30||1966-03-23
TRIAL STUDY 134XCP|IS|901A91DC-9EF3-4A20-A35D-9C426A5C640B||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L/SEC|||||NEBULE||||LOW|NOT DONE|||MUCUS|LACTESCENT|N|PALPATION|N|U|U||2||58||CONTINUATION TREATMENT|1971-08-04|1960-10-16|||||1964-05-16||1969-05-28
TRIAL STUDY 134XCP|IS|901A91DC-9EF3-4A20-A35D-9C426A5C640B||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/KG|||||ABSORBANCE U||||NORMAL|NOT DONE|||MUSCLE TISSUE|ICTERIC|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|N|N||3||39||LONG-TERM FOLLOW-UP|1969-09-18|1967-05-19|||||1970-05-17||1969-11-23
TRIAL STUDY 134XCP|IS|901A91DC-9EF3-4A20-A35D-9C426A5C640B||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/G/DAY|||||10^10/L||||HIGH|NOT DONE|||BUFFY COAT|REFRIGERATED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|Y|N||4||88||OBSERVATION|1962-04-24|1960-06-04|||||1967-06-18||1971-07-19
TRIAL STUDY 134XCP|IS|901A91DC-9EF3-4A20-A35D-9C426A5C640B||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/CM|||||RATIO||||HIGH|NOT DONE|||TUMOR TISSUE|SOLIDIFIED|N|FUNCTIONAL MRI|NA|N|NA||5||7||BLINDED TREATMENT|1972-02-18|1961-05-19|||||1970-06-18||1968-11-20
TRIAL STUDY 134XCP|IS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||TUBERCULIN UNIT|||||MG/KG/DOSE||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|CONTAMINATED|Y|SPECULAR MICROSCOPY|NA|N|U||1||38||TREATMENT|1972-06-02|1967-04-14|||||1961-01-07||1966-03-19
TRIAL STUDY 134XCP|IS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/G/DAY|||||10^9 CFU/G||||HIGH|NOT DONE|||PLATELET|ROOM TEMPERATURE|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|U|U|N||2||58||SCREENING|1966-01-03|1967-06-06|||||1972-06-13||1968-11-11
TRIAL STUDY 134XCP|IS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||STEPS/MIN|||||/MBP||||LOW|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|DRIED|U|SLIT LAMP|Y|NA|N||3||39||OBSERVATION|1961-12-31|1966-05-03|||||1962-09-01||1964-09-06
TRIAL STUDY 134XCP|IS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/M2/MIN|||||MG/M2/H||||ABNORMAL|NOT DONE|||BREAST MILK|THAWED|U|AUDIOMETRY|N|NA|N||4||88||FOLLOW-UP|1965-12-18|1966-11-24|||||1971-01-21||1972-03-04
TRIAL STUDY 134XCP|IS|1944BDC6-B89D-4B9C-B33E-DD7D1D25E1A4||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/DL|||||UMOL/L/H||||LOW|NOT DONE|||CAPILLARY PLASMA|LIPEMIC|NA|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|NA|Y||5||7||FOLLOW-UP|1970-11-30|1973-01-28|||||1967-09-25||1969-08-25
TRIAL STUDY 134XCP|IS|5A7F2C89-5398-4119-8EA0-B432FF8942A4||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NSEC|||||M/SEC2||||LOW|NOT DONE|||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|NA|SLOAN LETTER EYE CHART 2.5%|U|NA|Y||1||38||INDUCTION TREATMENT|1967-07-16|1965-12-15|||||1964-07-23||1960-01-13
TRIAL STUDY 134XCP|IS|5A7F2C89-5398-4119-8EA0-B432FF8942A4||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TBSP|||||MG/DL||||NORMAL|NOT DONE|||CORD SERUM|HEMOLYZED|U|TOTAL BODY RADIOGRAPHY|N|U|Y||2||58||BASELINE|1966-08-13|1965-11-14|||||1965-03-17||1972-04-21
TRIAL STUDY 134XCP|IS|5A7F2C89-5398-4119-8EA0-B432FF8942A4||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SFC/10^6 PBMC|||||MNFI||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ICTERIC|U|SPECTROPHOTOMETRY|NA|Y|NA||3||39||WASHOUT|1965-09-29|1967-05-14|||||1967-05-24||1960-10-21
TRIAL STUDY 134XCP|IS|5A7F2C89-5398-4119-8EA0-B432FF8942A4||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G|||||DEG/S||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ICTERIC|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|NA|NA|N||4||88||INDUCTION TREATMENT|1973-02-13|1969-10-19|||||1965-07-09||1960-11-11
TRIAL STUDY 134XCP|IS|5A7F2C89-5398-4119-8EA0-B432FF8942A4||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||H/WK|||||CMHG||||ABNORMAL|NOT DONE|||LAVAGE FLUID|REFRIGERATED|N|ELECTROCHEMILUMINESCENCE|N|Y|U||5||7||OBSERVATION|1973-06-24|1969-11-01|||||1962-06-08||1973-08-17
TRIAL STUDY 134XCP|IS|898FB78B-63D1-4ECE-B6B8-34750E958D93||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ENZYME U/G HB|||||NGEQ/L||||HIGH|NOT DONE|||INFRANATANT, SERUM|UNEXPECTED ODOR|U|TOTAL BODY IRRADIATION|N|NA|U||1||38||TREATMENT|1962-06-21|1966-02-21|||||1963-01-12||1972-11-24
TRIAL STUDY 134XCP|IS|898FB78B-63D1-4ECE-B6B8-34750E958D93||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/MG|||||LOG10 TCID 50/UL||||HIGH|NOT DONE|||SEMEN|SOLIDIFIED|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|NA|N|U||2||58||OPEN LABEL TREATMENT|1971-02-13|1962-11-06|||||1962-02-15||1967-07-23
TRIAL STUDY 134XCP|IS|898FB78B-63D1-4ECE-B6B8-34750E958D93||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||LOG10 COPIES/ML|||||HR/DAY||||NORMAL|NOT DONE|||ERYTHROCYTES|PARAFFIN-EMBEDDED|Y|ERGOSPIROMETRY|N|NA|U||3||39||BASELINE|1965-08-15|1963-01-15|||||1967-05-19||1963-03-16
TRIAL STUDY 134XCP|IS|898FB78B-63D1-4ECE-B6B8-34750E958D93||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL/MIN/KPA|||||MG/KG||||HIGH|NOT DONE|||HAIR FOLLICLE|GELLED|N|IMMUNOFIXATION ELECTROPHORESIS|U|U|U||4||88||RUN-IN|1965-06-14|1964-07-20|||||1964-11-05||1966-02-20
TRIAL STUDY 134XCP|IS|898FB78B-63D1-4ECE-B6B8-34750E958D93||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TUBE|||||KV||||NORMAL|NOT DONE|||LUNG SURFACTANT|GELLED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|U|N|N||5||7||RUN-IN|1962-12-21|1961-09-11|||||1961-09-09||1969-06-16
TRIAL STUDY 134XCP|IS|AF1E7141-5390-4928-9F49-94E1C7464A63||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||H*%|||||UG/G/DAY||||HIGH|NOT DONE|||DERMAL TISSUE|GELLED|NA|DIRECT SEQUENCING|NA|NA|NA||1||38||OPEN LABEL TREATMENT|1969-02-04|1971-09-05|||||1970-08-25||1973-08-17
TRIAL STUDY 134XCP|IS|AF1E7141-5390-4928-9F49-94E1C7464A63||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/MG/MIN|||||10^6 IU/ML||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|CONTAMINATED|Y|ROMANOWSKY STAIN|NA|NA|Y||2||58||FOLLOW-UP|1964-09-30|1969-06-07|||||1970-09-30||1969-08-27
TRIAL STUDY 134XCP|IS|AF1E7141-5390-4928-9F49-94E1C7464A63||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MEQ/ML|||||ANTI-XA IU/ML||||NORMAL|NOT DONE|||SPERMATOZOON|CONCENTRATED|U|FORCED OSCILLATION TECHNIQUE|NA|Y|N||3||39||TREATMENT|1969-02-09|1972-06-18|||||1965-09-10||1963-03-06
TRIAL STUDY 134XCP|IS|AF1E7141-5390-4928-9F49-94E1C7464A63||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DEG|||||BQ/G||||HIGH|NOT DONE|||STOOL|REFRIGERATED|N|MEDIASTINOSCOPY|NA|N|Y||4||88||OPEN LABEL TREATMENT|1969-04-23|1962-10-22|||||1968-03-09||1968-07-21
TRIAL STUDY 134XCP|IS|AF1E7141-5390-4928-9F49-94E1C7464A63||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE/DAY|||||CD||||HIGH|NOT DONE|||PLEURAL FLUID|UNEXPECTED ODOR|N|DISK DIFFUSION|Y|NA|NA||5||7||WASHOUT|1972-02-20|1968-02-10|||||1966-03-10||1961-04-09
TRIAL STUDY 134XCP|IS|2188CADE-EE6F-4F14-8049-5EDD72020185||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||HOMEOPATHIC DILUTION|||||UG/L/H||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|ROOM TEMPERATURE|NA|NUCLEIC ACID SEQUENCING|U|Y|NA||1||38||BASELINE|1964-06-23|1960-06-09|||||1973-06-04||1963-02-04
TRIAL STUDY 134XCP|IS|2188CADE-EE6F-4F14-8049-5EDD72020185||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GRAIN|||||VG/DOSE||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|HEMOLYZED|Y|HIGH RESOLUTION CT|Y|NA|NA||2||58||BASELINE|1969-08-11|1973-08-29|||||1967-03-27||1963-11-30
TRIAL STUDY 134XCP|IS|2188CADE-EE6F-4F14-8049-5EDD72020185||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL BCE/L|||||10^8 PFU||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|THAWED|N|DIFFUSION TENSOR MRI|N|Y|N||3||39||OPEN LABEL TREATMENT|1963-12-26|1973-06-30|||||1960-04-08||1961-02-13
TRIAL STUDY 134XCP|IS|2188CADE-EE6F-4F14-8049-5EDD72020185||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CMHG|||||UG/ML/H||||HIGH|NOT DONE|||INTERSTITIAL FLUID|AGGLUTINATED|NA|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|N|U|NA||4||88||FOLLOW-UP|1965-10-25|1964-05-20|||||1965-08-26||1969-12-14
TRIAL STUDY 134XCP|IS|2188CADE-EE6F-4F14-8049-5EDD72020185||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PFU/DOSE|||||KDA||||HIGH|NOT DONE|||INTERSTITIAL FLUID|AUTOLYZED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|N|U|NA||5||7||CONTINUATION TREATMENT|1961-07-03|1961-09-22|||||1972-03-07||1963-05-09
TRIAL STUDY 134XCP|IS|DFF30783-4496-4134-8201-67C727683A7D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/ML|||||FL||||LOW|NOT DONE|||SWABBED MATERIAL|LACTESCENT|U|WHOLE GENOME SEQUENCING|N|U|N||1||38||BLINDED TREATMENT|1964-04-02|1971-11-22|||||1971-04-29||1965-10-13
TRIAL STUDY 134XCP|IS|DFF30783-4496-4134-8201-67C727683A7D||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CM/S|||||CI/G||||NORMAL|NOT DONE|||SYNOVIAL FLUID|FROZEN|Y|ELECTRONEUROGRAPHY|N|U|N||2||58||SCREENING|1962-06-22|1964-05-28|||||1970-07-26||1971-01-20
TRIAL STUDY 134XCP|IS|DFF30783-4496-4134-8201-67C727683A7D||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PMOL/10^10 CELLS|||||ML/H||||HIGH|NOT DONE|||URINE|FROZEN|Y|NUCLEIC ACID SEQUENCING|N|U|U||3||39||TREATMENT|1965-03-09|1970-06-15|||||1960-05-20||1973-03-26
TRIAL STUDY 134XCP|IS|DFF30783-4496-4134-8201-67C727683A7D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CIGARETTE|||||IU/DL||||HIGH|NOT DONE|||CAPILLARY PLASMA|UNEXPECTED ODOR|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|U|Y|Y||4||88||SCREENING|1965-07-10|1967-10-16|||||1973-09-06||1971-08-03
TRIAL STUDY 134XCP|IS|DFF30783-4496-4134-8201-67C727683A7D||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||WEEKS|||||CP||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|ICTERIC|N|TELLER ACUITY CARDS|U|NA|Y||5||7||SCREENING|1970-10-05|1964-10-08|||||1966-06-03||1969-11-24
TRIAL STUDY 134XCP|IS|970170C0-8FF0-4D24-84E8-1195272D55C0||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KBQ|||||UG||||NORMAL|NOT DONE|||NAIL|ROOM TEMPERATURE|Y|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|U|U|N||1||38||CONTINUATION TREATMENT|1967-12-16|1965-09-04|||||1960-09-03||1969-05-03
TRIAL STUDY 134XCP|IS|970170C0-8FF0-4D24-84E8-1195272D55C0||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/ANIMAL|||||S*KPA||||ABNORMAL|NOT DONE|||LYSATE|FRESH|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|NA|Y||2||58||TREATMENT|1966-02-04|1967-02-21|||||1972-08-31||1964-05-26
TRIAL STUDY 134XCP|IS|970170C0-8FF0-4D24-84E8-1195272D55C0||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/SEC/1.73M2|||||MU||||HIGH|NOT DONE|||SWABBED MATERIAL|ROOM TEMPERATURE|U|CONGO RED STAIN|U|N|NA||3||39||TREATMENT|1965-01-01|1968-06-13|||||1970-03-12||1973-06-13
TRIAL STUDY 134XCP|IS|970170C0-8FF0-4D24-84E8-1195272D55C0||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANSON U|||||CD||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AGGLUTINATED|Y|GRAM STAIN|U|NA|Y||4||88||WASHOUT|1967-09-28|1965-02-10|||||1968-11-13||1969-10-20
TRIAL STUDY 134XCP|IS|970170C0-8FF0-4D24-84E8-1195272D55C0||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KG/L|||||U||||HIGH|NOT DONE|||GASTRIC FLUID|DRIED|N|SLIT LAMP PHOTOGRAPHY|Y|U|NA||5||7||CONTINUATION TREATMENT|1963-11-24|1961-08-24|||||1968-10-17||1968-11-26
TRIAL STUDY 134XCP|IS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMHG/SEC|||||V/SEC||||LOW|NOT DONE|||MECONIUM|ICTERIC|N|DUCTOGRAPHY|N|N|NA||1||38||CONTINUATION TREATMENT|1972-07-27|1973-05-17|||||1961-06-25||1960-12-14
TRIAL STUDY 134XCP|IS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/DAY|||||10^3 RNA COPIES/ML||||ABNORMAL|NOT DONE|||MECONIUM|HEMOLYZED|U|CLIP SEQUENCING|NA|U|Y||2||58||SCREENING|1965-10-18|1972-12-01|||||1971-11-12||1972-10-31
TRIAL STUDY 134XCP|IS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MV|||||NMOL/KG/DAY||||LOW|NOT DONE|||PLATELET POOR PLASMA|CLOTTED|NA|FLUOROSCOPY|NA|U|NA||3||39||INDUCTION TREATMENT|1964-12-15|1967-11-15|||||1965-10-04||1961-10-21
TRIAL STUDY 134XCP|IS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UIU/L|||||KALLIKREIN INHIBITOR UNIT||||LOW|NOT DONE|||LOCHIA|CONCENTRATED|Y|KNEMOMETRY|NA|N|U||4||88||BASELINE|1963-04-03|1970-03-11|||||1970-12-15||1960-07-30
TRIAL STUDY 134XCP|IS|F8D52828-1C5E-4958-BFDE-77F5171FEFBE||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||USP U|||||IU||||HIGH|NOT DONE|||TISSUE|PARAFFIN-EMBEDDED|NA|RULER MEASUREMENT METHOD|N|NA|Y||5||7||INDUCTION TREATMENT|1968-09-13|1962-05-27|||||1961-04-07||1966-06-06
TRIAL STUDY 134XCP|IS|69CC47A3-DA90-4919-889E-E0008ED689FA||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/G/DAY|||||UG/L/H||||ABNORMAL|NOT DONE|||LYMPH|LACTESCENT|U|DYNAMIC CONTRAST ENHANCED MRI|U|U|Y||1||38||BASELINE|1966-05-12|1960-03-24|||||1970-10-26||1964-01-01
TRIAL STUDY 134XCP|IS|69CC47A3-DA90-4919-889E-E0008ED689FA||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MV2/HZ|||||L/S||||NORMAL|NOT DONE|||CELL PELLET|PARAFFIN-EMBEDDED|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|NA|NA|Y||2||58||FOLLOW-UP|1970-08-03|1968-08-21|||||1966-09-06||1968-03-09
TRIAL STUDY 134XCP|IS|69CC47A3-DA90-4919-889E-E0008ED689FA||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NMOL/G|||||PMOL/L/H||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|FRESH|NA|MICROARRAY|NA|Y|Y||3||39||TREATMENT|1971-02-17|1964-07-27|||||1972-11-24||1961-11-06
TRIAL STUDY 134XCP|IS|69CC47A3-DA90-4919-889E-E0008ED689FA||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/M2/DAY|||||DIP||||LOW|NOT DONE|||ISOLATE|LIPEMIC|U|JAEGER EYE CHART|N|N|NA||4||88||FOLLOW-UP|1961-07-09|1962-06-15|||||1964-12-24||1971-03-22
TRIAL STUDY 134XCP|IS|69CC47A3-DA90-4919-889E-E0008ED689FA||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L/MIN|||||%||||HIGH|NOT DONE|||PLEURAL TISSUE|DRIED|U|REFLECTANCE SPECTROSCOPY|Y|U|NA||5||7||RUN-IN|1968-07-26|1965-10-08|||||1969-06-25||1965-12-20
TRIAL STUDY 134XCP|IS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FRAMES/S|||||MEQ||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|THAWED|Y|TOTAL BODY IRRADIATION|Y|NA|NA||1||38||TREATMENT|1970-03-13|1971-07-08|||||1971-01-07||1970-06-01
TRIAL STUDY 134XCP|IS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM3/MM2/YEAR|||||NMOL/G||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|FRESH|NA|HPLC/MS|U|NA|N||2||58||BASELINE|1969-01-17|1960-04-24|||||1963-10-23||1961-12-11
TRIAL STUDY 134XCP|IS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6 U|||||ML/G/H||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|REFRIGERATED|U|FUNCTIONAL MRI|U|Y|N||3||39||CONTINUATION TREATMENT|1963-09-25|1967-08-19|||||1962-07-18||1967-10-28
TRIAL STUDY 134XCP|IS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTIBODY UNIT|||||MEQ/G||||LOW|NOT DONE|||DERMAL TISSUE|AGGLUTINATED|N|CISH|U|N|Y||4||88||RUN-IN|1971-06-30|1968-12-19|||||1964-12-24||1963-04-25
TRIAL STUDY 134XCP|IS|D4BB8CC7-4EB2-4FCA-94EB-E08D8FE00577||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^3 CFU/G|||||MET||||NORMAL|NOT DONE|||CAPILLARY PLASMA|THAWED|NA|QUANTITATIVE ULTRASOUND|U|U|NA||5||7||OPEN LABEL TREATMENT|1965-06-18|1967-01-16|||||1970-08-08||1973-09-07
TRIAL STUDY 134XCP|IS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||PIXEL||||HIGH|NOT DONE|||CALCULUS|LIPEMIC|Y|DOUBLE IMMUNODIFFUSION|N|NA|NA||1||38||BASELINE|1973-02-05|1972-04-19|||||1969-04-03||1961-05-31
TRIAL STUDY 134XCP|IS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/ANIMAL|||||10^4/L||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|FROZEN|N|MICROARRAY|U|NA|N||2||58||FOLLOW-UP|1963-07-27|1961-08-05|||||1963-10-18||1966-03-31
TRIAL STUDY 134XCP|IS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DIOPTER|||||KG/CM||||LOW|NOT DONE|||LYMPH|FROZEN|U|CLOT DETECTION|U|Y|U||3||39||FOLLOW-UP|1968-04-14|1964-11-01|||||1971-07-01||1970-07-30
TRIAL STUDY 134XCP|IS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U|||||MG/ML/DAY||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|U|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|U|NA|N||4||88||BASELINE|1962-12-17|1963-04-02|||||1965-08-08||1970-09-16
TRIAL STUDY 134XCP|IS|72FDC7C1-2734-4CA6-8A9B-CC20E39CD834||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BLOCKS|||||10^9/DOSE||||LOW|NOT DONE|||PUS|AGGLUTINATED|NA|LASER CAPTURE MICRODISSECTION|Y|N|Y||5||7||WASHOUT|1962-02-18|1969-04-15|||||1967-08-21||1971-03-28
TRIAL STUDY 134XCP|IS|0281E055-F419-4BA2-89CE-23EC7428CDA0||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||EU|||||UG/G/MIN||||NORMAL|NOT DONE|||COLOSTRUM|CONCENTRATED|NA|ACCELERATOR MASS SPECTROMETRY|N|U|Y||1||38||WASHOUT|1973-02-26|1963-09-10|||||1962-12-19||1962-01-29
TRIAL STUDY 134XCP|IS|0281E055-F419-4BA2-89CE-23EC7428CDA0||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MDFI|||||DPM/100MG||||NORMAL|NOT DONE|||MUSCLE TISSUE|CALCIFIED|NA|GRADIENT DIFFUSION|Y|NA|U||2||58||WASHOUT|1962-03-15|1968-05-22|||||1967-11-26||1962-09-28
TRIAL STUDY 134XCP|IS|0281E055-F419-4BA2-89CE-23EC7428CDA0||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CL|||||G/DL||||HIGH|NOT DONE|||BUFFY COAT|CONCENTRATED|NA|COMPLEMENT FIXATION|NA|NA|Y||3||39||BASELINE|1971-05-17|1963-09-16|||||1972-06-09||1969-08-30
TRIAL STUDY 134XCP|IS|0281E055-F419-4BA2-89CE-23EC7428CDA0||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CMOL/L|||||LOG EID 50/DOSE||||ABNORMAL|NOT DONE|||MONOCYTE|PARAFFIN-EMBEDDED|N|FLUORESCENT LIFETIME IMAGING MICROSCOPY|NA|N|Y||4||88||RUN-IN|1971-03-18|1960-08-22|||||1966-11-18||1962-09-24
TRIAL STUDY 134XCP|IS|0281E055-F419-4BA2-89CE-23EC7428CDA0||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^9 CFU/G|||||L/MIN/M2||||LOW|NOT DONE|||INFRANATANT, SERUM|THAWED|U|MECHANICAL CLOT DETECTION|U|NA|NA||5||7||BASELINE|1971-07-08|1962-10-04|||||1964-07-13||1968-01-01
TRIAL STUDY 134XCP|IS|23CE1310-DBB3-4135-8E11-2A870CE42D50||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^7 PFU|||||RNA COPIES/ML||||HIGH|NOT DONE|||SERUM OR PLASMA|UNEXPECTED ODOR|U|IMMUNOBLOT|Y|N|NA||1||38||LONG-TERM FOLLOW-UP|1973-01-21|1970-11-08|||||1968-10-31||1962-04-01
TRIAL STUDY 134XCP|IS|23CE1310-DBB3-4135-8E11-2A870CE42D50||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||S*KPA|||||MG/DL||||HIGH|NOT DONE|||CALCULUS|CONCENTRATED|N|ELISA|Y|N|U||2||58||WASHOUT|1965-06-03|1969-06-24|||||1961-11-30||1968-07-01
TRIAL STUDY 134XCP|IS|23CE1310-DBB3-4135-8E11-2A870CE42D50||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL|||||CUP||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|ICTERIC|N|OBSERVATION|U|Y|Y||3||39||CONTINUATION TREATMENT|1967-01-26|1968-03-26|||||1972-02-04||1971-09-24
TRIAL STUDY 134XCP|IS|23CE1310-DBB3-4135-8E11-2A870CE42D50||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/10^4|||||UG/G/DAY||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|THAWED|N|MANUAL CLOT DETECTION|Y|NA|Y||4||88||OBSERVATION|1961-06-08|1966-01-18|||||1972-09-28||1972-07-07
TRIAL STUDY 134XCP|IS|23CE1310-DBB3-4135-8E11-2A870CE42D50||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/G/DAY|||||UG/KG/MIN||||LOW|NOT DONE|||INTERSTITIAL FLUID|GELLED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|NA||5||7||OBSERVATION|1973-03-19|1969-10-11|||||1964-06-08||1967-02-13
TRIAL STUDY 134XCP|IS|CC80D8A2-7D71-428B-9599-C0D0312B8691||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||APS U|||||CM H2O||||NORMAL|NOT DONE|||LYSATE|AUTOLYZED|Y|MASS SPECTROMETRY|U|N|Y||1||38||OBSERVATION|1964-05-13|1962-01-03|||||1961-09-20||1963-10-01
TRIAL STUDY 134XCP|IS|CC80D8A2-7D71-428B-9599-C0D0312B8691||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KBQ/UL|||||PACKET||||ABNORMAL|NOT DONE|||PLATELET|AGGLUTINATED|NA|BIOPSY|U|U|Y||2||58||INDUCTION TREATMENT|1966-03-18|1966-01-28|||||1970-12-09||1966-09-29
TRIAL STUDY 134XCP|IS|CC80D8A2-7D71-428B-9599-C0D0312B8691||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LENS|||||MEQ/MMOL||||NORMAL|NOT DONE|||LOCHIA|FRESH|N|PET SCAN|N|Y|NA||3||39||LONG-TERM FOLLOW-UP|1962-01-31|1969-05-05|||||1969-11-05||1966-05-30
TRIAL STUDY 134XCP|IS|CC80D8A2-7D71-428B-9599-C0D0312B8691||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^6 ORGANISMS/G|||||VOXEL||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|NON-HEMOLYZED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|N|U|N||4||88||OPEN LABEL TREATMENT|1973-05-20|1968-10-17|||||1962-04-24||1969-05-30
TRIAL STUDY 134XCP|IS|CC80D8A2-7D71-428B-9599-C0D0312B8691||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NMOL|||||BEAM BREAKS||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|REFRIGERATED|N|LIQUID SCINTILLATION COUNTING|N|NA|N||5||7||CONTINUATION TREATMENT|1967-06-12|1961-06-01|||||1971-03-09||1968-03-24
TRIAL STUDY 134XCP|IS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FIU|||||MMOL/S||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|ICTERIC|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|U|U|N||1||38||CONTINUATION TREATMENT|1971-08-15|1968-04-10|||||1962-07-08||1971-10-10
TRIAL STUDY 134XCP|IS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EID 50/DOSE|||||10^6 CFU||||LOW|NOT DONE|||URINE|CALCIFIED|U|CORONARY ANGIOGRAPHY|Y|N|N||2||58||CONTINUATION TREATMENT|1971-08-15|1966-02-21|||||1972-03-19||1966-12-30
TRIAL STUDY 134XCP|IS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^7 CFU/ML|||||U/ML||||NORMAL|NOT DONE|||CAPILLARY PLASMA|CALCIFIED|Y|SICKLE CELL SOLUBILITY TEST|U|U|Y||3||39||WASHOUT|1966-06-29|1970-12-27|||||1966-01-31||1963-01-30
TRIAL STUDY 134XCP|IS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PLUG|||||UG/KG||||LOW|NOT DONE|||PLEURAL FLUID|ICTERIC|N|DIFFUSION WEIGHTED MRI|NA|U|NA||4||88||BASELINE|1970-05-18|1964-01-05|||||1963-06-23||1964-07-24
TRIAL STUDY 134XCP|IS|EB6EE887-79FE-4CD1-BA61-C5F29C54830C||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NEEDLE GAUGE|||||P||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|HEMOLYZED|NA|SCINTIGRAPHY|N|U|N||5||7||INDUCTION TREATMENT|1972-11-18|1963-06-30|||||1964-06-16||1964-07-14
TRIAL STUDY 134XCP|IS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MV*MIN|||||EJACULATE U||||NORMAL|NOT DONE|||FLUID|CALCIFIED|U|HPLC|N|NA|Y||1||38||RUN-IN|1968-05-09|1961-09-12|||||1970-01-19||1962-07-25
TRIAL STUDY 134XCP|IS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||OI50|||||MU/L||||LOW|NOT DONE|||BASAL TEAR|FRESH|U|SURFACE PLASMON RESONANCE|N|U|N||2||58||CONTINUATION TREATMENT|1960-06-26|1968-01-23|||||1966-09-12||1961-06-08
TRIAL STUDY 134XCP|IS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||AG|||||UL||||HIGH|NOT DONE|||BILE|ROOM TEMPERATURE|Y|OPHTHALMOSCOPY|N|U|NA||3||39||BASELINE|1966-05-27|1960-05-31|||||1964-01-13||1960-08-27
TRIAL STUDY 134XCP|IS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GENEQ/ML|||||G||||HIGH|NOT DONE|||SEMINAL FLUID|FROZEN|Y|PLETHYSMOGRAPHY|Y|N|U||4||88||LONG-TERM FOLLOW-UP|1968-12-08|1965-03-19|||||1969-01-04||1964-12-28
TRIAL STUDY 134XCP|IS|CFD063DA-DB51-45EC-ACCA-8AAB90DC1B82||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FOZ_US|||||PMOL/L/H||||HIGH|NOT DONE|||PLATELET|LIPEMIC|Y|BRDU CELLULAR PROLIFERATION ASSAY|NA|NA|U||5||7||CONTINUATION TREATMENT|1966-11-11|1962-01-28|||||1973-06-20||1965-11-05
TRIAL STUDY 134XCP|IS|3D25A735-6298-4AF4-91CC-AE8D481DF552||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BEATS/MIN|||||OD UNIT||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|SOLIDIFIED|NA|SURFACE PLASMON RESONANCE|U|N|N||1||38||CONTINUATION TREATMENT|1967-01-16|1966-05-27|||||1961-05-23||1960-07-16
TRIAL STUDY 134XCP|IS|3D25A735-6298-4AF4-91CC-AE8D481DF552||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NEWTON|||||FL||||ABNORMAL|NOT DONE|||DERMAL TISSUE|UNEXPECTED ODOR|N|AMSLER GRID|N|Y|NA||2||58||BASELINE|1965-06-19|1969-11-05|||||1969-09-15||1969-01-10
TRIAL STUDY 134XCP|IS|3D25A735-6298-4AF4-91CC-AE8D481DF552||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MGEQ|||||SIEMENS||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|ICTERIC|N|THERMAL IONIZATION MASS SPECTROMETRY|U|Y|N||3||39||FOLLOW-UP|1967-01-12|1964-03-16|||||1968-02-04||1969-03-11
TRIAL STUDY 134XCP|IS|3D25A735-6298-4AF4-91CC-AE8D481DF552||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||F|||||MV2/HZ||||ABNORMAL|NOT DONE|||STOOL|ICTERIC|NA|SISH|Y|U|U||4||88||INDUCTION TREATMENT|1968-06-08|1972-07-05|||||1967-05-06||1967-06-12
TRIAL STUDY 134XCP|IS|3D25A735-6298-4AF4-91CC-AE8D481DF552||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||100 IU/ML|||||MV2/HZ||||HIGH|NOT DONE|||SYNOVIAL FLUID|UNEXPECTED ODOR|U|ELISPOT|Y|N|U||5||7||LONG-TERM FOLLOW-UP|1967-01-02|1960-01-03|||||1967-04-30||1960-02-26
TRIAL STUDY 134XCP|IS|C249E38B-B454-47D9-8D8B-E2F6A434BA21||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||AMP|||||NMOL/G||||ABNORMAL|NOT DONE|||EXPIRED AIR|ICTERIC|Y|MICROBIAL CULTURE|NA|N|NA||1||38||OPEN LABEL TREATMENT|1961-07-08|1963-01-22|||||1961-05-05||1961-04-01
TRIAL STUDY 134XCP|IS|C249E38B-B454-47D9-8D8B-E2F6A434BA21||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||IU/G HB|||||COAT||||ABNORMAL|NOT DONE|||MECONIUM|LACTESCENT|Y|FLUOROSCOPY|U|NA|N||2||58||BLINDED TREATMENT|1963-04-06|1970-05-06|||||1972-06-16||1963-08-24
TRIAL STUDY 134XCP|IS|C249E38B-B454-47D9-8D8B-E2F6A434BA21||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CAPLET|||||MCI||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|AGGLUTINATED|Y|LC/MS/MS|U|NA|N||3||39||SCREENING|1970-02-24|1961-07-21|||||1969-09-09||1966-04-07
TRIAL STUDY 134XCP|IS|C249E38B-B454-47D9-8D8B-E2F6A434BA21||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KG/M2|||||G/G/DAY||||ABNORMAL|NOT DONE|||PUS|ICTERIC|NA|INCISION-INDUCED BLEEDING METHOD|Y|U|N||4||88||RUN-IN|1960-11-05|1971-04-20|||||1971-04-21||1973-01-15
TRIAL STUDY 134XCP|IS|C249E38B-B454-47D9-8D8B-E2F6A434BA21||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UOSM|||||UG/ANIMAL||||HIGH|NOT DONE|||EPIDERMAL TISSUE|ROOM TEMPERATURE|N|LEAD CITRATE STAIN|NA|NA|N||5||7||FOLLOW-UP|1972-05-14|1967-12-24|||||1965-02-17||1969-11-19
TRIAL STUDY 134XCP|IS|4540D569-1DD0-4984-89DB-6F9A391397FE||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 DNA COPIES/ML|||||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE|||MECONIUM|GELLED|N|IMMUNO-PET SCAN|U|NA|U||1||38||BASELINE|1960-07-22|1973-05-18|||||1968-08-19||1967-11-12
TRIAL STUDY 134XCP|IS|4540D569-1DD0-4984-89DB-6F9A391397FE||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMU/ML|||||CP||||HIGH|NOT DONE|||SYNOVIAL FLUID|PARAFFIN-EMBEDDED|Y|RIA|NA|N|NA||2||58||RUN-IN|1961-09-19|1969-02-26|||||1966-05-08||1972-05-26
TRIAL STUDY 134XCP|IS|4540D569-1DD0-4984-89DB-6F9A391397FE||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/DAY|||||DPM/ML||||HIGH|NOT DONE|||CERUMEN|LACTESCENT|NA|ELASTOGRAPHY|N|U|N||3||39||OPEN LABEL TREATMENT|1971-01-31|1961-06-10|||||1963-11-11||1966-08-27
TRIAL STUDY 134XCP|IS|4540D569-1DD0-4984-89DB-6F9A391397FE||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MDFI|||||PFU||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|HEMOLYZED|U|NUCLEIC ACID BASED METHOD|N|Y|N||4||88||TREATMENT|1970-09-15|1967-03-16|||||1960-08-08||1971-11-11
TRIAL STUDY 134XCP|IS|4540D569-1DD0-4984-89DB-6F9A391397FE||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UMOL/DL|||||PFU/ANIMAL||||HIGH|NOT DONE|||ALVEOLAR AIR|FRESH|NA|ALCIAN BLUE STAIN|Y|U|U||5||7||OBSERVATION|1969-12-22|1966-04-10|||||1968-06-26||1967-09-30
TRIAL STUDY 134XCP|IS|DC1D666E-4920-4B60-A520-D183BCDE0E85||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||PFU/DOSE||||NORMAL|NOT DONE|||TUMOR TISSUE|CONTAMINATED|U|CRYOSCOPY|N|N|NA||1||38||FOLLOW-UP|1967-01-31|1962-07-07|||||1969-03-13||1963-05-16
TRIAL STUDY 134XCP|IS|DC1D666E-4920-4B60-A520-D183BCDE0E85||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||PA||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|NON-HEMOLYZED|U|CONTACT SPECULAR MICROSCOPY|Y|Y|Y||2||58||BLINDED TREATMENT|1965-08-02|1967-08-18|||||1970-08-17||1967-08-11
TRIAL STUDY 134XCP|IS|DC1D666E-4920-4B60-A520-D183BCDE0E85||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FINGERTIP UNIT|||||10^3/HPF||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|CALCIFIED|NA|TONOMETRY|N|NA|Y||3||39||SCREENING|1962-04-19|1967-06-07|||||1962-09-09||1965-08-18
TRIAL STUDY 134XCP|IS|DC1D666E-4920-4B60-A520-D183BCDE0E85||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ|||||MMOL/MOL||||NORMAL|NOT DONE|||LYMPH|SOLIDIFIED|Y|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|N|N|NA||4||88||RUN-IN|1971-06-08|1965-04-22|||||1969-04-03||1969-10-06
TRIAL STUDY 134XCP|IS|DC1D666E-4920-4B60-A520-D183BCDE0E85||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT|||||OSM||||HIGH|NOT DONE|||CERUMEN|CLOTTED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|U|Y|Y||5||7||TREATMENT|1966-08-30|1970-08-05|||||1970-01-29||1963-05-30
TRIAL STUDY 134XCP|IS|A015D12B-C03B-4371-8D1F-F03D60542BA7||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 CFU/G|||||TROCHE||||LOW|NOT DONE|||INTERSTITIAL FLUID|LACTESCENT|N|CONTRAST ENHANCED MRI|NA|Y|N||1||38||INDUCTION TREATMENT|1961-06-07|1964-05-08|||||1966-06-18||1970-07-25
TRIAL STUDY 134XCP|IS|A015D12B-C03B-4371-8D1F-F03D60542BA7||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/U|||||10^7 TCID 50/DOSE||||LOW|NOT DONE|||INTERSTITIAL FLUID|CONTAMINATED|NA|PAP STAIN|NA|U|N||2||58||FOLLOW-UP|1971-08-01|1967-07-04|||||1962-07-28||1970-01-20
TRIAL STUDY 134XCP|IS|A015D12B-C03B-4371-8D1F-F03D60542BA7||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MOL/G|||||10^7 CFU/ML||||NORMAL|NOT DONE|||SERUM|ROOM TEMPERATURE|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|U|NA|Y||3||39||CONTINUATION TREATMENT|1971-02-02|1965-07-23|||||1966-09-09||1973-04-19
TRIAL STUDY 134XCP|IS|A015D12B-C03B-4371-8D1F-F03D60542BA7||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GMFI|||||/LSQN||||NORMAL|NOT DONE|||SOFT TISSUE|FROZEN|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|U|U|NA||4||88||BLINDED TREATMENT|1966-12-10|1964-12-21|||||1972-01-15||1968-06-20
TRIAL STUDY 134XCP|IS|A015D12B-C03B-4371-8D1F-F03D60542BA7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CD*S/M2|||||MAC50||||LOW|NOT DONE|||LYMPH|LIPEMIC|NA|LISSAMINE GREEN STAIN|Y|NA|N||5||7||BLINDED TREATMENT|1960-01-21|1965-04-19|||||1969-01-05||1968-02-07
TRIAL STUDY 134XCP|IS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UL/KG/DAY|||||IU/G HB||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|PARAFFIN-EMBEDDED|U|INCISION-INDUCED BLEEDING METHOD|NA|N|U||1||38||CONTINUATION TREATMENT|1971-05-14|1965-08-21|||||1966-02-22||1965-04-04
TRIAL STUDY 134XCP|IS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NEEDLE GAUGE|||||KG/MOL||||LOW|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|CALCIFIED|NA|TWO-COLOR MICROARRAY|NA|NA|N||2||58||WASHOUT|1970-03-27|1972-03-13|||||1964-09-09||1961-01-26
TRIAL STUDY 134XCP|IS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^8 PFU|||||BQ/L||||HIGH|NOT DONE|||SWABBED MATERIAL|PARAFFIN-EMBEDDED|U|CONTRAST ENHANCED SPIRAL CT SCAN|Y|U|U||3||39||BASELINE|1972-08-14|1970-10-09|||||1969-03-20||1961-04-03
TRIAL STUDY 134XCP|IS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FG|||||CAPLET||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|LIPEMIC|U|NEXT GENERATION SEQUENCING|U|N|Y||4||88||OPEN LABEL TREATMENT|1961-02-05|1972-06-11|||||1969-01-29||1960-04-13
TRIAL STUDY 134XCP|IS|EB15F3FF-8414-4D5B-A305-EA5B1FE8B8AF||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9/DOSE|||||NG||||NORMAL|NOT DONE|||CERUMEN|AUTOLYZED|NA|OLIGO ACGH|Y|Y|Y||5||7||RUN-IN|1964-12-25|1968-04-13|||||1963-09-09||1963-09-06
TRIAL STUDY 134XCP|IS|34AC7973-686F-45A2-999A-1A36C7874F91||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DROP|||||DISK||||LOW|NOT DONE|||CERUMEN|CONTAMINATED|NA|MAGNETIC RESONANCE ENTEROGRAPHY|U|Y|N||1||38||INDUCTION TREATMENT|1966-12-27|1971-12-31|||||1973-06-16||1963-02-27
TRIAL STUDY 134XCP|IS|34AC7973-686F-45A2-999A-1A36C7874F91||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/DAY|||||FL||||HIGH|NOT DONE|||DIALYSIS FLUID|THAWED|NA|BIOPSY|U|Y|NA||2||58||OPEN LABEL TREATMENT|1968-08-26|1971-08-17|||||1962-01-04||1973-03-12
TRIAL STUDY 134XCP|IS|34AC7973-686F-45A2-999A-1A36C7874F91||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GPL U|||||10^6 ORGANISMS/ML||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|ICTERIC|U|CAPILLARY ELECTROPHORESIS|Y|N|U||3||39||BLINDED TREATMENT|1972-03-26|1964-06-01|||||1961-11-16||1972-03-27
TRIAL STUDY 134XCP|IS|34AC7973-686F-45A2-999A-1A36C7874F91||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^3 ORGANISMS/ML|||||UG/DL||||NORMAL|NOT DONE|||INFRANATANT, SERUM|SOLIDIFIED|N|DIGITAL PCR ARRAY|N|N|Y||4||88||TREATMENT|1973-05-20|1972-09-05|||||1960-02-26||1970-03-18
TRIAL STUDY 134XCP|IS|34AC7973-686F-45A2-999A-1A36C7874F91||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/BEAT|||||K||||LOW|NOT DONE|||LYSATE|ICTERIC|U|ANTIBIOTIC AGAR SCREEN|NA|U|U||5||7||FOLLOW-UP|1966-11-03|1964-03-04|||||1964-01-19||1969-06-22
TRIAL STUDY 134XCP|IS|5AE66AC0-ECB6-49A2-859F-871B9A15E624||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FOZ_BR|||||CM H2O||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|AUTOLYZED|U|NON-INVASIVE DIELECTRIC SENSING|U|Y|U||1||38||OPEN LABEL TREATMENT|1968-04-02|1973-08-31|||||1967-01-07||1966-03-12
TRIAL STUDY 134XCP|IS|5AE66AC0-ECB6-49A2-859F-871B9A15E624||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^5/L|||||MG/G/MIN||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|FROZEN|U|RADIAL IMMUNODIFFUSION|U|NA|N||2||58||INDUCTION TREATMENT|1966-03-27|1967-04-07|||||1963-12-20||1963-08-01
TRIAL STUDY 134XCP|IS|5AE66AC0-ECB6-49A2-859F-871B9A15E624||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||V|||||CONTAINER||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|AUTOLYZED|Y|CONFOCAL MICROSCOPY|NA|N|N||3||39||RUN-IN|1961-06-03|1966-12-27|||||1967-11-10||1970-06-06
TRIAL STUDY 134XCP|IS|5AE66AC0-ECB6-49A2-859F-871B9A15E624||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/ANIMAL|||||/MONTH||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|CALCIFIED|Y|HPLC/MS|Y|U|NA||4||88||CONTINUATION TREATMENT|1965-05-02|1963-03-14|||||1968-02-04||1961-01-29
TRIAL STUDY 134XCP|IS|5AE66AC0-ECB6-49A2-859F-871B9A15E624||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||L/S/KPA|||||10^6/L||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|THAWED|N|NEXT GENERATION TARGETED SEQUENCING|Y|Y|U||5||7||LONG-TERM FOLLOW-UP|1961-02-13|1960-08-09|||||1970-05-10||1973-09-05
TRIAL STUDY 134XCP|IS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ARBITRARY U|||||/MIN||||NORMAL|NOT DONE|||ISOLATE|REFRIGERATED|Y|GC/FID|N|Y|Y||1||38||LONG-TERM FOLLOW-UP|1968-01-22|1969-10-25|||||1969-02-15||1965-04-21
TRIAL STUDY 134XCP|IS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/DOSE|||||CFU/G||||LOW|NOT DONE|||EMESIS|PARAFFIN-EMBEDDED|N|PHASE CONTRAST MICROSCOPY|Y|NA|NA||2||58||LONG-TERM FOLLOW-UP|1962-11-02|1961-07-30|||||1970-06-06||1970-04-01
TRIAL STUDY 134XCP|IS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BISCUIT|||||U/G/DAY||||LOW|NOT DONE|||PLEURAL FLUID|AGGLUTINATED|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|Y|NA||3||39||TREATMENT|1963-04-11|1965-03-27|||||1961-12-29||1963-03-16
TRIAL STUDY 134XCP|IS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NMOL BCE/L|||||10^6 IU||||NORMAL|NOT DONE|||SYNOVIAL FLUID|AGGLUTINATED|NA|CONTRAST ENHANCED SPIRAL CT SCAN|N|U|U||4||88||OPEN LABEL TREATMENT|1969-07-11|1970-06-02|||||1973-09-08||1973-08-18
TRIAL STUDY 134XCP|IS|31C4E0AA-B36B-411C-ABAA-CDEE1190AA22||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PG/DL|||||KEV||||HIGH|NOT DONE|||EXUDATE|GELLED|NA|TARGETED TRANSCRIPTOME SEQUENCING|U|N|U||5||7||CONTINUATION TREATMENT|1973-05-13|1960-08-27|||||1964-01-22||1964-08-30
TRIAL STUDY 134XCP|IS|59A9826F-4C2F-482A-8888-F649544318BE||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KV|||||%||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|N|CALIPER MEASUREMENT METHOD|Y|U|U||1||38||SCREENING|1960-09-27|1972-09-17|||||1961-10-05||1965-12-11
TRIAL STUDY 134XCP|IS|59A9826F-4C2F-482A-8888-F649544318BE||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GY/H|||||BAR||||ABNORMAL|NOT DONE|||TISSUE|REFRIGERATED|N|DIPSTICK|Y|U|U||2||58||BLINDED TREATMENT|1968-12-14|1962-12-02|||||1966-08-24||1963-07-26
TRIAL STUDY 134XCP|IS|59A9826F-4C2F-482A-8888-F649544318BE||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||VIAL|||||MEQ/MMOL||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|U|IRON HEMATOXYLIN STAIN|Y|Y|N||3||39||OBSERVATION|1973-08-12|1973-08-31|||||1964-12-31||1969-04-25
TRIAL STUDY 134XCP|IS|59A9826F-4C2F-482A-8888-F649544318BE||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/HPF|||||MG/DL||||ABNORMAL|NOT DONE|||LEUKOCYTE|CONCENTRATED|U|ENDPOINT DILUTION ASSAY|Y|U|NA||4||88||TREATMENT|1971-04-06|1960-07-24|||||1970-10-03||1971-10-15
TRIAL STUDY 134XCP|IS|59A9826F-4C2F-482A-8888-F649544318BE||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/DOSE|||||DMOL||||NORMAL|NOT DONE|||URINE SEDIMENT|AUTOLYZED|Y|THERMAL IONIZATION MASS SPECTROMETRY|N|U|N||5||7||FOLLOW-UP|1967-01-08|1966-03-14|||||1968-06-15||1971-02-16
TRIAL STUDY 134XCP|IS|B6E55A62-CF0B-4BC6-84DC-038F29518909||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG|||||PMOL/L/H||||LOW|NOT DONE|||EPITHELIAL CELL|LIPEMIC|U|DIFFUSION WEIGHTED MRI|NA|U|Y||1||38||LONG-TERM FOLLOW-UP|1968-11-17|1973-04-10|||||1970-01-02||1960-02-04
TRIAL STUDY 134XCP|IS|B6E55A62-CF0B-4BC6-84DC-038F29518909||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/KG/MIN|||||UIU/L||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|NON-HEMOLYZED|N|MICRO BROTH DILUTION|NA|U|NA||2||58||OBSERVATION|1960-08-21|1968-05-09|||||1961-07-06||1969-06-18
TRIAL STUDY 134XCP|IS|B6E55A62-CF0B-4BC6-84DC-038F29518909||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/ANIMAL/DAY|||||%(V/V)||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|UNEXPECTED ODOR|Y|HEMOCYTOMETRY|NA|N|N||3||39||RUN-IN|1970-07-19|1971-01-05|||||1962-07-18||1971-04-17
TRIAL STUDY 134XCP|IS|B6E55A62-CF0B-4BC6-84DC-038F29518909||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NMOL BCE/NMOL|||||MIN*MG/ML||||ABNORMAL|NOT DONE|||MUCUS|GELLED|NA|RADIATION DOSIMETRY|NA|Y|N||4||88||BASELINE|1970-01-11|1964-12-08|||||1963-11-07||1970-11-02
TRIAL STUDY 134XCP|IS|B6E55A62-CF0B-4BC6-84DC-038F29518909||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^9 CFU/G|||||RPM||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|AGGLUTINATED|NA|MACRO BROTH DILUTION|N|NA|Y||5||7||FOLLOW-UP|1965-02-19|1967-12-15|||||1964-09-12||1972-07-06
TRIAL STUDY 134XCP|IS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/MMOL|||||MEQ/KG||||LOW|NOT DONE|||SYNOVIAL FLUID|REFRIGERATED|N|LC/MS|U|Y|NA||1||38||INDUCTION TREATMENT|1965-09-26|1960-03-19|||||1962-02-24||1972-06-01
TRIAL STUDY 134XCP|IS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||OD UNIT|||||NMOL/ML/MIN||||HIGH|NOT DONE|||ERYTHROCYTES|AGGLUTINATED|N|SICKLE CELL SOLUBILITY TEST|Y|N|N||2||58||FOLLOW-UP|1963-08-02|1966-06-19|||||1964-04-06||1961-10-21
TRIAL STUDY 134XCP|IS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IMPLANT|||||GY||||HIGH|NOT DONE|||ARTERIAL CORD BLOOD|REFRIGERATED|N|FARR ASSAY|Y|Y|NA||3||39||TREATMENT|1961-07-15|1971-04-21|||||1961-04-26||1960-03-13
TRIAL STUDY 134XCP|IS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MV2/HZ|||||PMOL/L/H||||ABNORMAL|NOT DONE|||BASAL TEAR|GELLED|Y|INTERRUPTER TECHNIQUE|U|N|N||4||88||LONG-TERM FOLLOW-UP|1969-05-12|1968-07-22|||||1961-05-11||1966-04-27
TRIAL STUDY 134XCP|IS|3B5E776E-C267-4F99-80AB-AAD96A6B1DA7||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/CMH2O|||||H*%||||LOW|NOT DONE|||EPITHELIAL CELL|REFRIGERATED|Y|PALM METHOD|U|Y|NA||5||7||FOLLOW-UP|1965-07-12|1964-04-04|||||1967-12-18||1960-02-14
TRIAL STUDY 134XCP|IS|5577E914-C90D-4CC4-A7A8-D919C29A61D1||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KBQ|||||UL||||HIGH|NOT DONE|||SWABBED MATERIAL|CLOTTED|NA|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|U|Y|NA||1||38||TREATMENT|1961-05-11|1960-11-08|||||1966-06-27||1960-08-26
TRIAL STUDY 134XCP|IS|5577E914-C90D-4CC4-A7A8-D919C29A61D1||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||VOXEL|||||UU/L||||LOW|NOT DONE|||CALCULUS|LACTESCENT|Y|TRICHROME STAIN|N|Y|U||2||58||OBSERVATION|1968-04-16|1961-06-01|||||1961-11-09||1961-03-28
TRIAL STUDY 134XCP|IS|5577E914-C90D-4CC4-A7A8-D919C29A61D1||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||%(W/V)|||||10^3 DNA COPIES/ML||||HIGH|NOT DONE|||URINE SEDIMENT|PARAFFIN-EMBEDDED|NA|ERGOSPIROMETRY|U|N|U||3||39||OBSERVATION|1970-09-18|1966-03-21|||||1971-08-14||1971-01-26
TRIAL STUDY 134XCP|IS|5577E914-C90D-4CC4-A7A8-D919C29A61D1||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/10^3|||||UG/L/H||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|FROZEN|N|SPECT SCAN|N|NA|U||4||88||BASELINE|1968-06-23|1972-04-07|||||1961-04-07||1963-05-06
TRIAL STUDY 134XCP|IS|5577E914-C90D-4CC4-A7A8-D919C29A61D1||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UM/DAY|||||UV||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|DRIED|Y|RULER MEASUREMENT METHOD|Y|U|Y||5||7||TREATMENT|1970-04-20|1960-01-31|||||1962-02-04||1965-04-27
TRIAL STUDY 134XCP|IS|2DBA8940-F59E-4A0D-8858-408D71DD9753||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BQ/UL|||||KBQ/UL||||ABNORMAL|NOT DONE|||BILE|NON-HEMOLYZED|N|FLUORESCENT MICROSCOPY|N|U|Y||1||38||SCREENING|1961-07-06|1961-03-28|||||1968-11-12||1965-10-08
TRIAL STUDY 134XCP|IS|2DBA8940-F59E-4A0D-8858-408D71DD9753||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TAMPON|||||ML/MIN/MMHG||||NORMAL|NOT DONE|||PROSTATIC FLUID|AGGLUTINATED|U|POPULATION SEQUENCING|Y|N|N||2||58||RUN-IN|1964-11-20|1961-09-28|||||1970-06-28||1965-06-29
TRIAL STUDY 134XCP|IS|2DBA8940-F59E-4A0D-8858-408D71DD9753||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/CAGE|||||10^8/L||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|CALCIFIED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|U|Y||3||39||WASHOUT|1965-02-18|1961-02-07|||||1968-04-14||1968-10-31
TRIAL STUDY 134XCP|IS|2DBA8940-F59E-4A0D-8858-408D71DD9753||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/G/MIN|||||FL||||LOW|NOT DONE|||EPIDERMAL TISSUE|CALCIFIED|NA|DIFFUSION TENSOR MRI|N|U|U||4||88||TREATMENT|1969-05-19|1962-02-01|||||1971-05-20||1972-11-12
TRIAL STUDY 134XCP|IS|2DBA8940-F59E-4A0D-8858-408D71DD9753||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NG|||||CPM||||NORMAL|NOT DONE|||LYSATE|AUTOLYZED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|U|N|Y||5||7||BASELINE|1972-04-16|1964-08-10|||||1962-01-25||1970-05-25
TRIAL STUDY 134XCP|IS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||SACHET|||||DEG/S||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|SOLIDIFIED|N|PALM METHOD|U|Y|U||1||38||OBSERVATION|1968-01-16|1968-08-21|||||1963-03-22||1965-11-03
TRIAL STUDY 134XCP|IS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BREATHS/MIN|||||10^6 CFU/G||||HIGH|NOT DONE|||SKIN TISSUE|CONTAMINATED|NA|SLIT LAMP PHOTOGRAPHY|Y|U|U||2||58||OBSERVATION|1962-05-07|1960-08-30|||||1973-02-15||1967-10-18
TRIAL STUDY 134XCP|IS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL/L|||||MOSM/KG||||HIGH|NOT DONE|||CAPILLARY PLASMA|FROZEN|U|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|U|N||3||39||CONTINUATION TREATMENT|1971-11-12|1963-03-04|||||1966-03-12||1968-12-26
TRIAL STUDY 134XCP|IS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MHZ|||||/MM2||||LOW|NOT DONE|||BILE|NON-HEMOLYZED|Y|DYNAMOMETRY|Y|NA|NA||4||88||OBSERVATION|1966-12-20|1968-04-30|||||1972-02-10||1972-09-10
TRIAL STUDY 134XCP|IS|F62D63CA-BCD9-4D81-B789-0CABDA5F8A99||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MKAT|||||SV||||NORMAL|NOT DONE|||PROSTATIC FLUID|AGGLUTINATED|NA|PHASE-CONTRAST MRI|NA|U|NA||5||7||CONTINUATION TREATMENT|1966-01-21|1968-05-02|||||1972-11-21||1970-12-23
TRIAL STUDY 134XCP|IS|0250EC5D-B08F-4010-9653-95E20EDD0CCA||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CM2|||||10^3 RNA COPIES/ML||||ABNORMAL|NOT DONE|||BILE|AGGLUTINATED|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|NA|N||1||38||TREATMENT|1970-10-08|1965-11-01|||||1962-09-21||1964-01-05
TRIAL STUDY 134XCP|IS|0250EC5D-B08F-4010-9653-95E20EDD0CCA||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/2500 WBC|||||UM/S||||ABNORMAL|NOT DONE|||BASAL TEAR|SOLIDIFIED|Y|HEMOCYTOMETRY|NA|N|U||2||58||FOLLOW-UP|1965-01-24|1960-03-31|||||1962-08-10||1970-05-24
TRIAL STUDY 134XCP|IS|0250EC5D-B08F-4010-9653-95E20EDD0CCA||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PT_BR|||||10^12/L||||ABNORMAL|NOT DONE|||BONE MARROW|NON-HEMOLYZED|NA|ERGOSPIROMETRY|N|N|N||3||39||BASELINE|1967-08-20|1960-09-21|||||1969-03-07||1972-10-31
TRIAL STUDY 134XCP|IS|0250EC5D-B08F-4010-9653-95E20EDD0CCA||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU/DAY|||||ML/MIN||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|CALCIFIED|U|CELLULOSE TAPE|Y|NA|NA||4||88||OBSERVATION|1972-06-25|1963-07-26|||||1965-07-15||1965-01-16
TRIAL STUDY 134XCP|IS|0250EC5D-B08F-4010-9653-95E20EDD0CCA||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CI/G|||||KCAL/DAY||||ABNORMAL|NOT DONE|||HAIR|CONCENTRATED|Y|CARDIAC THERMODILUTION|N|N|N||5||7||BLINDED TREATMENT|1961-10-30|1970-03-23|||||1965-02-21||1972-04-30
TRIAL STUDY 134XCP|IS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ROENTGEN|||||JOULE||||LOW|NOT DONE|||SKIN TISSUE|THAWED|NA|PAP STAIN|N|NA|NA||1||38||OPEN LABEL TREATMENT|1971-07-30|1966-12-29|||||1970-05-17||1972-06-06
TRIAL STUDY 134XCP|IS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FIU|||||NKAT/L||||LOW|NOT DONE|||HAIR|CONTAMINATED|Y|WRIGHT-GIEMSA STAIN|Y|NA|N||2||58||BLINDED TREATMENT|1964-02-13|1966-01-16|||||1973-03-14||1972-10-21
TRIAL STUDY 134XCP|IS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KM|||||KG/L||||NORMAL|NOT DONE|||VENOUS PLASMA|REFRIGERATED|U|CONTACT SPECULAR MICROSCOPY|N|N|U||3||39||BASELINE|1972-01-09|1964-05-01|||||1971-07-08||1972-11-11
TRIAL STUDY 134XCP|IS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG|||||/10^4||||NORMAL|NOT DONE|||CAPILLARY BLOOD|NON-HEMOLYZED|U|JAEGER EYE CHART|NA|Y|Y||4||88||RUN-IN|1963-07-01|1971-11-13|||||1960-03-06||1965-06-17
TRIAL STUDY 134XCP|IS|C06524C5-BA81-4AC0-9E8A-112D7B7112A6||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SBE/ML|||||/MS||||NORMAL|NOT DONE|||CORD BLOOD|ROOM TEMPERATURE|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|U|NA||5||7||BASELINE|1968-12-27|1963-11-02|||||1972-04-16||1966-08-27
TRIAL STUDY 134XCP|IS|140FFC83-72C9-4BD4-AA44-C98CA42147F3||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/CAGE/WK|||||MHZ||||LOW|NOT DONE|||VENOUS PLASMA|NON-HEMOLYZED|U|REVERSE TRANSCRIPTASE PCR|Y|Y|Y||1||38||TREATMENT|1960-01-18|1968-08-10|||||1967-04-08||1970-12-27
TRIAL STUDY 134XCP|IS|140FFC83-72C9-4BD4-AA44-C98CA42147F3||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACKAGE|||||KHZ||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|ICTERIC|NA|OPTICAL DENSITY MEASUREMENT|NA|Y|N||2||58||RUN-IN|1970-01-13|1966-07-20|||||1970-04-23||1963-04-19
TRIAL STUDY 134XCP|IS|140FFC83-72C9-4BD4-AA44-C98CA42147F3||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||%/S|||||TUBERCULIN UNIT||||LOW|NOT DONE|||HAIR|CONTAMINATED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|N|U|NA||3||39||OBSERVATION|1971-09-16|1966-09-11|||||1971-01-16||1965-02-06
TRIAL STUDY 134XCP|IS|140FFC83-72C9-4BD4-AA44-C98CA42147F3||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6/G|||||MGEQ||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|N|COULOMETRIC TITRATION|NA|NA|NA||4||88||LONG-TERM FOLLOW-UP|1970-02-03|1970-12-26|||||1973-08-27||1961-01-02
TRIAL STUDY 134XCP|IS|140FFC83-72C9-4BD4-AA44-C98CA42147F3||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/KG|||||UG/L||||HIGH|NOT DONE|||ISOLATE|UNEXPECTED ODOR|N|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|Y|N||5||7||OBSERVATION|1973-01-04|1971-03-07|||||1969-09-03||1972-10-10
TRIAL STUDY 134XCP|IS|7BAC399A-0523-476E-A294-C57309E573AF||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/MM|||||G/KG/DAY||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|ICTERIC|NA|HPLC/MS/MS|N|N|N||1||38||LONG-TERM FOLLOW-UP|1969-01-30|1965-03-25|||||1971-05-25||1966-01-11
TRIAL STUDY 134XCP|IS|7BAC399A-0523-476E-A294-C57309E573AF||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UV2|||||G/DAY||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|CONCENTRATED|N|ELECTRONEUROGRAPHY|NA|U|NA||2||58||TREATMENT|1968-03-27|1963-11-04|||||1972-06-22||1966-03-31
TRIAL STUDY 134XCP|IS|7BAC399A-0523-476E-A294-C57309E573AF||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PNU/ML|||||UCI/KG||||LOW|NOT DONE|||INFRANATANT, SERUM|AGGLUTINATED|U|FLUORIMETRY|U|U|N||3||39||RUN-IN|1960-05-01|1961-09-12|||||1968-02-27||1966-04-22
TRIAL STUDY 134XCP|IS|7BAC399A-0523-476E-A294-C57309E573AF||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/L/H|||||UG/G/MIN||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|CALCIFIED|N|URANYL ACETATE STAIN|Y|N|U||4||88||WASHOUT|1968-06-01|1971-11-04|||||1966-02-26||1967-04-17
TRIAL STUDY 134XCP|IS|7BAC399A-0523-476E-A294-C57309E573AF||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NM|||||PPTH||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|LACTESCENT|U|GC/MS-CI|Y|N|Y||5||7||RUN-IN|1970-08-05|1965-01-06|||||1966-05-01||1962-06-20
TRIAL STUDY 134XCP|IS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PHERESIS UNIT|||||% INHIBITION||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|HEMOLYZED|NA|LANDOLT RING|N|N|Y||1||38||BLINDED TREATMENT|1973-02-18|1962-01-24|||||1966-04-04||1970-01-17
TRIAL STUDY 134XCP|IS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/HPF|||||MG/KG/DAY||||NORMAL|NOT DONE|||EXUDATE|ROOM TEMPERATURE|NA|KNEMOMETRY|N|Y|N||2||58||OBSERVATION|1971-09-14|1972-08-11|||||1962-01-05||1968-11-19
TRIAL STUDY 134XCP|IS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/S|||||DISK||||HIGH|NOT DONE|||EXUDATE|AGGLUTINATED|Y|HEMAGGLUTINATION ASSAY|U|Y|N||3||39||TREATMENT|1960-05-02|1973-01-25|||||1971-11-03||1971-11-10
TRIAL STUDY 134XCP|IS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UKAT/10^12 RBC|||||CAL||||HIGH|NOT DONE|||VITREOUS HUMOR|UNEXPECTED ODOR|U|GEL ELECTROPHORESIS|Y|NA|U||4||88||SCREENING|1965-05-15|1970-02-24|||||1969-08-02||1966-06-21
TRIAL STUDY 134XCP|IS|D23869D2-DBE2-4687-BE8C-AD4458FD49F5||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CUP EQ|||||10^6/EJACULATE U||||HIGH|NOT DONE|||VENOUS PLASMA|LACTESCENT|U|CELL BASED BIOASSAY|Y|U|U||5||7||OPEN LABEL TREATMENT|1966-08-29|1963-01-01|||||1972-11-30||1970-09-14
TRIAL STUDY 134XCP|IS|0F180E62-F840-490F-8EB3-F7DDB7132401||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BQ/ML|||||NGEQ/L||||NORMAL|NOT DONE|||ABSCESS FLUID|REFRIGERATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|N|U|U||1||38||WASHOUT|1962-02-02|1962-11-28|||||1971-06-16||1960-02-28
TRIAL STUDY 134XCP|IS|0F180E62-F840-490F-8EB3-F7DDB7132401||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL|||||JOULE||||NORMAL|NOT DONE|||PERSPIRATION|CONTAMINATED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|Y|NA|N||2||58||CONTINUATION TREATMENT|1966-08-29|1963-10-21|||||1963-06-26||1972-02-09
TRIAL STUDY 134XCP|IS|0F180E62-F840-490F-8EB3-F7DDB7132401||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/CM2|||||C||||LOW|NOT DONE|||MUSCLE TISSUE|THAWED|NA|POLYMERASE CHAIN REACTION|NA|NA|U||3||39||LONG-TERM FOLLOW-UP|1962-09-06|1962-04-02|||||1964-07-23||1968-03-14
TRIAL STUDY 134XCP|IS|0F180E62-F840-490F-8EB3-F7DDB7132401||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BU|||||10^3 CFU/ML||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|DRIED|N|LISSAMINE GREEN STAIN|NA|N|NA||4||88||OPEN LABEL TREATMENT|1963-04-06|1960-10-31|||||1964-12-18||1969-01-26
TRIAL STUDY 134XCP|IS|0F180E62-F840-490F-8EB3-F7DDB7132401||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MIN*MG/ML|||||DL||||HIGH|NOT DONE|||LYSATE|ROOM TEMPERATURE|N|SPECTROPHOTOMETRY|Y|NA|Y||5||7||CONTINUATION TREATMENT|1964-09-01|1971-03-15|||||1963-06-03||1962-02-18
TRIAL STUDY 134XCP|IS|80E7A428-CDDE-453F-B7D1-1B282A1835BF||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMHG|||||CMH2O*S2/ML||||HIGH|NOT DONE|||ALVEOLAR AIR|FRESH|Y|IMMUNOASSAY|Y|N|Y||1||38||SCREENING|1964-05-25|1963-04-26|||||1961-11-21||1962-11-18
TRIAL STUDY 134XCP|IS|80E7A428-CDDE-453F-B7D1-1B282A1835BF||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KV|||||GPELISA UNIT/ML||||HIGH|NOT DONE|||LUNG SURFACTANT|LIPEMIC|Y|SPECT SCAN|N|N|U||2||58||SCREENING|1965-04-19|1967-04-18|||||1963-06-23||1963-03-22
TRIAL STUDY 134XCP|IS|80E7A428-CDDE-453F-B7D1-1B282A1835BF||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MCI/KG|||||MMOL/MIN/KPA/L||||HIGH|NOT DONE|||VENOUS PLASMA|GELLED|Y|HPLC/IEX|Y|NA|N||3||39||FOLLOW-UP|1972-01-14|1962-12-30|||||1970-02-12||1962-06-15
TRIAL STUDY 134XCP|IS|80E7A428-CDDE-453F-B7D1-1B282A1835BF||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ATM|||||COULOMB||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|NA|DOPPLER ULTRASOUND|NA|Y|U||4||88||BASELINE|1967-11-07|1973-03-03|||||1961-04-25||1967-04-05
TRIAL STUDY 134XCP|IS|80E7A428-CDDE-453F-B7D1-1B282A1835BF||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MESF|||||CI/UG||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|CONTAMINATED|NA|QUANTITATIVE ULTRASOUND|U|NA|NA||5||7||RUN-IN|1966-05-09|1964-10-24|||||1972-03-03||1972-02-22
TRIAL STUDY 134XCP|IS|F1D265C4-B975-4E74-9545-122A10FE100F||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/KG/H|||||MG/KG/DAY||||ABNORMAL|NOT DONE|||MONOCYTE|HEMOLYZED|U|HEMAGGLUTINATION INHIBITION ASSAY|Y|N|U||1||38||WASHOUT|1965-01-04|1966-06-09|||||1973-08-08||1966-11-29
TRIAL STUDY 134XCP|IS|F1D265C4-B975-4E74-9545-122A10FE100F||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/MM|||||MM/H||||LOW|NOT DONE|||CERUMEN|CALCIFIED|N|CYSTOMETRY|NA|NA|Y||2||58||WASHOUT|1966-09-18|1971-01-17|||||1962-04-23||1972-07-28
TRIAL STUDY 134XCP|IS|F1D265C4-B975-4E74-9545-122A10FE100F||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/KG|||||%(W/V)||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONTAMINATED|Y|LC-FL|Y|U|N||3||39||INDUCTION TREATMENT|1962-08-17|1964-04-23|||||1964-08-18||1964-03-15
TRIAL STUDY 134XCP|IS|F1D265C4-B975-4E74-9545-122A10FE100F||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CMH2O*S2/ML|||||MEQ/KG||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|REFRIGERATED|N|NO INFORMATION|Y|N|Y||4||88||LONG-TERM FOLLOW-UP|1960-03-16|1969-11-22|||||1962-12-16||1961-10-10
TRIAL STUDY 134XCP|IS|F1D265C4-B975-4E74-9545-122A10FE100F||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TROCHE|||||LB||||ABNORMAL|NOT DONE|||MIXED VENOUS BLOOD|HEMOLYZED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|U|U|U||5||7||CONTINUATION TREATMENT|1964-05-31|1963-07-04|||||1966-03-07||1960-08-29
TRIAL STUDY 134XCP|IS|7A272C35-DB2C-429D-AF31-CC7386DC8F07||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MHZ|||||ABSORBANCE U/ML||||NORMAL|NOT DONE|||AQUEOUS HUMOR|CONCENTRATED|NA|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|Y|U||1||38||CONTINUATION TREATMENT|1972-04-09|1969-08-30|||||1973-07-30||1966-01-19
TRIAL STUDY 134XCP|IS|7A272C35-DB2C-429D-AF31-CC7386DC8F07||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/UL|||||PPTR||||HIGH|NOT DONE|||BREAST MILK|ICTERIC|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|N|U|U||2||58||TREATMENT|1970-05-08|1960-01-04|||||1965-07-29||1970-08-06
TRIAL STUDY 134XCP|IS|7A272C35-DB2C-429D-AF31-CC7386DC8F07||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PFU/DOSE|||||LB||||HIGH|NOT DONE|||EMESIS|UNEXPECTED ODOR|N|INFRARED SPECTROMETRY|U|U|U||3||39||SCREENING|1972-07-26|1968-10-10|||||1961-01-12||1968-01-20
TRIAL STUDY 134XCP|IS|7A272C35-DB2C-429D-AF31-CC7386DC8F07||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MHZ|||||MOL/L||||NORMAL|NOT DONE|||GASTRIC CONTENTS|GELLED|Y|GRADIENT DIFFUSION|Y|Y|NA||4||88||TREATMENT|1960-06-08|1960-11-11|||||1966-01-30||1973-01-29
TRIAL STUDY 134XCP|IS|7A272C35-DB2C-429D-AF31-CC7386DC8F07||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/ML/H|||||HR/DAY||||NORMAL|NOT DONE|||LUNG SURFACTANT|ROOM TEMPERATURE|N|SICKLE CELL SOLUBILITY TEST|NA|Y|NA||5||7||BASELINE|1969-01-31|1972-04-06|||||1969-07-31||1968-07-16
TRIAL STUDY 134XCP|IS|FBF95CF9-933D-406A-8D67-B1F643C5F554||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/H|||||RFU||||ABNORMAL|NOT DONE|||EXPIRED AIR|ICTERIC|Y|KLEIHAUER-BETKE|N|NA|N||1||38||BASELINE|1966-11-20|1973-08-11|||||1973-06-03||1961-07-20
TRIAL STUDY 134XCP|IS|FBF95CF9-933D-406A-8D67-B1F643C5F554||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HZ/S|||||10^9 CFU/ML||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|FROZEN|U|TEST STRIP|NA|Y|N||2||58||RUN-IN|1964-12-03|1971-12-24|||||1967-04-30||1971-08-02
TRIAL STUDY 134XCP|IS|FBF95CF9-933D-406A-8D67-B1F643C5F554||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||WATT|||||FARAD||||LOW|NOT DONE|||PERSPIRATION|THAWED|U|DROPLET DIGITAL PCR|Y|N|Y||3||39||BASELINE|1972-06-22|1963-06-02|||||1961-01-12||1964-12-10
TRIAL STUDY 134XCP|IS|FBF95CF9-933D-406A-8D67-B1F643C5F554||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMH2O*S2/ML|||||/100 HPFS||||LOW|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|N|RAJI CELL RIA|NA|Y|U||4||88||INDUCTION TREATMENT|1967-12-24|1966-05-01|||||1961-12-17||1971-07-01
TRIAL STUDY 134XCP|IS|FBF95CF9-933D-406A-8D67-B1F643C5F554||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CAPSULE|||||UKAT||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|FRESH|N|RADIAL IMMUNODIFFUSION|U|U|U||5||7||BLINDED TREATMENT|1965-08-15|1964-03-17|||||1969-03-26||1967-08-26
TRIAL STUDY 134XCP|IS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KM/H|||||MASK||||ABNORMAL|NOT DONE|||ERYTHROCYTES|LIPEMIC|Y|CONTRAST ENHANCED SPIRAL CT SCAN|Y|N|U||1||38||OBSERVATION|1971-09-14|1968-11-16|||||1969-12-23||1971-05-17
TRIAL STUDY 134XCP|IS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MSEC|||||CY/CM||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|AGGLUTINATED|NA|HIGH RESOLUTION MELT ANALYSIS|N|N|Y||2||58||LONG-TERM FOLLOW-UP|1964-12-04|1964-11-24|||||1968-10-01||1964-08-05
TRIAL STUDY 134XCP|IS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BOX|||||UOSM||||HIGH|NOT DONE|||EXUDATE|CALCIFIED|U|IMMUNODIFFUSION|N|U|N||3||39||RUN-IN|1966-09-03|1962-12-29|||||1961-06-02||1967-05-05
TRIAL STUDY 134XCP|IS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MET*H|||||ML/DOSE||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|NA|RYAN BLUE STAIN|Y|Y|N||4||88||BLINDED TREATMENT|1973-05-19|1969-10-21|||||1963-01-02||1968-02-20
TRIAL STUDY 134XCP|IS|21E51AFC-91F0-4187-A5DC-9DA9A8C20D09||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ELISA UNIT/DOSE|||||PMOL/DL||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|NON-HEMOLYZED|U|FORCED OSCILLATION TECHNIQUE|U|N|U||5||7||LONG-TERM FOLLOW-UP|1968-05-09|1969-12-19|||||1965-04-01||1962-03-05
TRIAL STUDY 134XCP|IS|391D2418-5359-457B-AEC5-6A48DE04DAFD||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CAPFUL|||||MG/M2/MIN||||HIGH|NOT DONE|||PUS|GELLED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|N|NA|Y||1||38||TREATMENT|1968-01-28|1973-02-26|||||1968-12-14||1966-03-09
TRIAL STUDY 134XCP|IS|391D2418-5359-457B-AEC5-6A48DE04DAFD||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PMOL/L/H|||||STRIP||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|AGGLUTINATED|N|NUCLEIC ACID BASED METHOD|N|NA|N||2||58||CONTINUATION TREATMENT|1971-10-29|1964-03-13|||||1965-06-24||1966-05-28
TRIAL STUDY 134XCP|IS|391D2418-5359-457B-AEC5-6A48DE04DAFD||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GLOBULE|||||L/MIN||||HIGH|NOT DONE|||MONOCYTE|CLOTTED|N|BRDU CELLULAR PROLIFERATION ASSAY|NA|N|NA||3||39||CONTINUATION TREATMENT|1964-09-04|1963-03-03|||||1960-10-28||1966-07-23
TRIAL STUDY 134XCP|IS|391D2418-5359-457B-AEC5-6A48DE04DAFD||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||U/G/DAY|||||10^8/L||||NORMAL|NOT DONE|||VENOUS BLOOD|NON-HEMOLYZED|N|DIGITAL PCR ARRAY|U|NA|Y||4||88||WASHOUT|1972-01-15|1965-07-14|||||1962-04-02||1968-01-24
TRIAL STUDY 134XCP|IS|391D2418-5359-457B-AEC5-6A48DE04DAFD||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||IN|||||/200 HPFS||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|FRESH|Y|PHYSICAL EXAMINATION|N|N|U||5||7||BASELINE|1960-06-15|1970-10-03|||||1967-02-03||1960-09-25
TRIAL STUDY 134XCP|IS|68F706F0-2F0B-4D50-B15C-2DFDD186112E||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TABLET|||||BLOCKS||||LOW|NOT DONE|||DIALYSIS FLUID|HEMOLYZED|NA|GIEMSA STAIN|U|U|N||1||38||OPEN LABEL TREATMENT|1964-08-06|1962-08-14|||||1970-11-05||1967-10-25
TRIAL STUDY 134XCP|IS|68F706F0-2F0B-4D50-B15C-2DFDD186112E||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/DOSE|||||MOL||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|SOLIDIFIED|NA|IMMUNORADIOMETRIC ASSAY|N|N|Y||2||58||WASHOUT|1965-01-30|1972-09-21|||||1971-04-30||1970-05-26
TRIAL STUDY 134XCP|IS|68F706F0-2F0B-4D50-B15C-2DFDD186112E||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE|||||DPM||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|LIPEMIC|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|NA|U|N||3||39||SCREENING|1960-10-20|1960-09-07|||||1972-09-22||1967-03-27
TRIAL STUDY 134XCP|IS|68F706F0-2F0B-4D50-B15C-2DFDD186112E||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GENEQ|||||FMOL/G||||ABNORMAL|NOT DONE|||SMEGMA|CONTAMINATED|U|NUCLEIC ACID AMPLIFICATION TEST|NA|Y|NA||4||88||RUN-IN|1969-04-23|1962-06-24|||||1962-02-20||1964-01-30
TRIAL STUDY 134XCP|IS|68F706F0-2F0B-4D50-B15C-2DFDD186112E||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMAL|||||NMOL/ML/MIN||||LOW|NOT DONE|||SUPERNATANT, PLASMA|HEMOLYZED|U|NEXT GENERATION TARGETED SEQUENCING|U|U|Y||5||7||BASELINE|1961-08-13|1969-05-28|||||1960-01-24||1966-10-26
TRIAL STUDY 134XCP|IS|E8D4AACE-0832-482D-8266-96B7423F9459||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||%(W/V)|||||UG/M2/H||||HIGH|NOT DONE|||SOFT TISSUE|DRIED|U|HILLMEN COLOR CHART|Y|N|U||1||38||WASHOUT|1966-03-01|1972-09-14|||||1969-03-23||1965-12-21
TRIAL STUDY 134XCP|IS|E8D4AACE-0832-482D-8266-96B7423F9459||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ECL UNIT|||||UG/KG/H||||LOW|NOT DONE|||CORD SERUM|THAWED|Y|SISH|U|Y|N||2||58||FOLLOW-UP|1972-12-12|1964-12-24|||||1966-10-18||1960-08-30
TRIAL STUDY 134XCP|IS|E8D4AACE-0832-482D-8266-96B7423F9459||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||M/SEC2|||||BOX||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|GELLED|NA|MULTI-SLICE SPIRAL CT|N|Y|N||3||39||INDUCTION TREATMENT|1965-12-15|1965-04-23|||||1963-11-01||1969-06-10
TRIAL STUDY 134XCP|IS|E8D4AACE-0832-482D-8266-96B7423F9459||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DPM/MG|||||UG/M2/DAY||||NORMAL|NOT DONE|||SEMINAL FLUID|THAWED|N|ULTRASOUND|U|N|U||4||88||BLINDED TREATMENT|1964-12-13|1972-05-27|||||1967-05-15||1965-02-11
TRIAL STUDY 134XCP|IS|E8D4AACE-0832-482D-8266-96B7423F9459||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^8 PFU|||||FFU||||NORMAL|NOT DONE|||EMOTIONAL TEAR|FROZEN|U|NUCLEIC ACID SEQUENCING|N|Y|N||5||7||RUN-IN|1961-05-16|1967-04-07|||||1962-06-06||1963-12-04
TRIAL STUDY 134XCP|IS|F358E69F-9B9A-4637-9063-B8FECFF000B2||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LOG EID 50/DOSE|||||OZ EQ||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CALCIFIED|N|REFRACTOMETRY|N|Y|N||1||38||SCREENING|1964-08-25|1965-10-25|||||1969-02-19||1964-08-07
TRIAL STUDY 134XCP|IS|F358E69F-9B9A-4637-9063-B8FECFF000B2||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/MOL|||||/100 HPFS||||HIGH|NOT DONE|||URINE SEDIMENT|HEMOLYZED|NA|MICRO BROTH DILUTION|U|U|U||2||58||BASELINE|1967-03-28|1960-06-08|||||1964-05-27||1970-08-06
TRIAL STUDY 134XCP|IS|F358E69F-9B9A-4637-9063-B8FECFF000B2||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BREATHS/30S|||||ML/DOSE||||HIGH|NOT DONE|||BONE MARROW MONONUCLEAR CELL|NON-HEMOLYZED|N|DUCTOGRAPHY|U|Y|N||3||39||OPEN LABEL TREATMENT|1965-02-03|1971-06-26|||||1961-06-20||1965-04-02
TRIAL STUDY 134XCP|IS|F358E69F-9B9A-4637-9063-B8FECFF000B2||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BREATHS/30S|||||C||||HIGH|NOT DONE|||STOOL|REFRIGERATED|NA|CLIP|U|Y|NA||4||88||BLINDED TREATMENT|1971-04-07|1970-05-11|||||1973-07-08||1972-09-27
TRIAL STUDY 134XCP|IS|F358E69F-9B9A-4637-9063-B8FECFF000B2||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/G/H|||||/VF||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|LACTESCENT|Y|STATIC PERIMETRY|Y|U|U||5||7||BASELINE|1970-02-03|1966-10-17|||||1966-12-28||1961-05-14
TRIAL STUDY 134XCP|IS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GY/H|||||U/KG/DAY||||LOW|NOT DONE|||SERUM OR PLASMA|AGGLUTINATED|N|DYNAMIC LIGHT SCATTERING|Y|NA|NA||1||38||CONTINUATION TREATMENT|1961-03-14|1966-02-03|||||1960-06-05||1973-04-29
TRIAL STUDY 134XCP|IS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||S/H|||||DPM||||LOW|NOT DONE|||EMOTIONAL TEAR|ROOM TEMPERATURE|U|ENZYMATIC SPECTROPHOTOMETRY|N|NA|Y||2||58||BASELINE|1971-09-21|1972-07-24|||||1962-07-15||1961-12-19
TRIAL STUDY 134XCP|IS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NG/DAY|||||UMOL/MOL||||LOW|NOT DONE|||MUCUS|FRESH|N|HPLC/MS/MS|N|N|NA||3||39||CONTINUATION TREATMENT|1963-03-21|1968-11-17|||||1963-02-04||1960-06-07
TRIAL STUDY 134XCP|IS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DDU|||||UG/MOL||||LOW|NOT DONE|||ADIPOSE TISSUE|AGGLUTINATED|NA|IVY INCISION METHOD|U|Y|Y||4||88||RUN-IN|1972-09-28|1970-02-23|||||1971-08-24||1966-11-26
TRIAL STUDY 134XCP|IS|A9B86D67-C9B1-471F-AC6D-2C3F9A7ECB44||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NMOL/L|||||RING||||LOW|NOT DONE|||VENOUS CORD BLOOD|CONCENTRATED|N|JAEGER EYE CHART|Y|NA|U||5||7||RUN-IN|1961-05-26|1965-02-10|||||1968-03-28||1967-03-19
TRIAL STUDY 134XCP|IS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||DL|||||MG/KG/H||||LOW|NOT DONE|||STOOL|HEMOLYZED|N|WEBER GREEN STAIN|Y|N|N||1||38||OPEN LABEL TREATMENT|1971-06-20|1969-04-27|||||1968-12-28||1973-05-29
TRIAL STUDY 134XCP|IS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/10^3|||||KIU||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|GELLED|NA|HEMAGGLUTINATION ASSAY|N|U|Y||2||58||CONTINUATION TREATMENT|1960-05-23|1973-05-29|||||1964-12-24||1960-02-22
TRIAL STUDY 134XCP|IS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPL U|||||PT_BR||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|DRIED|N|ORCHIDOMETERY|U|NA|U||3||39||CONTINUATION TREATMENT|1970-05-08|1972-03-19|||||1960-09-26||1960-12-14
TRIAL STUDY 134XCP|IS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMHG*MIN/L|||||MKAT||||HIGH|NOT DONE|||AQUEOUS HUMOR|UNEXPECTED ODOR|NA|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|NA|Y|NA||4||88||OBSERVATION|1972-10-14|1970-06-26|||||1973-01-09||1970-02-06
TRIAL STUDY 134XCP|IS|F67596BD-D8EC-4B25-A39C-BD6455F0C0F4||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/LSQN|||||TUBERCULIN UNIT||||ABNORMAL|NOT DONE|||SOFT TISSUE|LACTESCENT|Y|SPIRAL CT|N|N|N||5||7||BASELINE|1960-04-29|1962-05-15|||||1972-09-28||1963-08-02
TRIAL STUDY 134XCP|IS|586B4529-9808-4205-B3D6-5C4A1DAFA922||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UU/DL|||||MSEC||||HIGH|NOT DONE|||TISSUE|REFRIGERATED|NA|MAGNETIC RESONANCE ANGIOGRAPHY|Y|N|NA||1||38||WASHOUT|1962-03-14|1960-04-19|||||1960-04-11||1965-04-28
TRIAL STUDY 134XCP|IS|586B4529-9808-4205-B3D6-5C4A1DAFA922||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/KG|||||KG/CM2||||HIGH|NOT DONE|||WHITE MATTER TISSUE|GELLED|N|GRADIENT DIFFUSION|Y|Y|Y||2||58||SCREENING|1963-02-16|1964-03-20|||||1973-05-11||1973-01-03
TRIAL STUDY 134XCP|IS|586B4529-9808-4205-B3D6-5C4A1DAFA922||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/G/MIN|||||KBQ||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|AUTOLYZED|U|ELECTROGASTROGRAPHY|N|U|Y||3||39||CONTINUATION TREATMENT|1961-08-22|1969-10-24|||||1962-08-15||1972-01-03
TRIAL STUDY 134XCP|IS|586B4529-9808-4205-B3D6-5C4A1DAFA922||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PM|||||U||||ABNORMAL|NOT DONE|||MONOCYTE|CONCENTRATED|U|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|U|Y||4||88||BASELINE|1970-03-27|1972-06-05|||||1961-09-09||1971-03-02
TRIAL STUDY 134XCP|IS|586B4529-9808-4205-B3D6-5C4A1DAFA922||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||STRIP|||||MMOL/S||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|AUTOLYZED|Y|DUKE INCISION METHOD|N|N|NA||5||7||WASHOUT|1969-08-04|1963-08-26|||||1972-12-31||1967-11-27
TRIAL STUDY 134XCP|IS|54685EFC-EE92-4591-B059-24145A3E6D69||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||M/SEC|||||FMOL||||HIGH|NOT DONE|||PUS|ICTERIC|Y|GIEMSA STAIN|U|Y|U||1||38||RUN-IN|1967-12-27|1965-05-26|||||1970-09-13||1970-01-22
TRIAL STUDY 134XCP|IS|54685EFC-EE92-4591-B059-24145A3E6D69||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/KG|||||CFU/ML||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|AUTOLYZED|NA|WRIGHT-GIEMSA STAIN|N|U|Y||2||58||BASELINE|1966-04-03|1969-08-18|||||1968-09-18||1966-05-22
TRIAL STUDY 134XCP|IS|54685EFC-EE92-4591-B059-24145A3E6D69||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MM/H|||||TUBERCULIN UNIT||||NORMAL|NOT DONE|||CORD SERUM|LACTESCENT|Y|ELISA|N|NA|U||3||39||FOLLOW-UP|1972-07-16|1960-04-03|||||1968-02-16||1968-01-07
TRIAL STUDY 134XCP|IS|54685EFC-EE92-4591-B059-24145A3E6D69||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/G/MIN|||||BEATS/MIN||||ABNORMAL|NOT DONE|||MUCUS|UNEXPECTED ODOR|U|PET/SPECT SCAN|N|Y|U||4||88||CONTINUATION TREATMENT|1966-07-25|1961-09-19|||||1970-08-25||1969-04-22
TRIAL STUDY 134XCP|IS|54685EFC-EE92-4591-B059-24145A3E6D69||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KA_U/DL|||||UKAT/L||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|DRIED|Y|PHOTOMETRY|U|Y|Y||5||7||BLINDED TREATMENT|1969-12-15|1964-05-30|||||1966-02-14||1972-09-27
TRIAL STUDY 134XCP|IS|7BD32505-61D5-4862-8896-B3E41D3EE779||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/10^5|||||CI/KG||||LOW|NOT DONE|||GASTRIC FLUID|AUTOLYZED|Y|IN VITRO GENE EXPRESSION ASSAY|NA|NA|N||1||38||FOLLOW-UP|1967-05-26|1960-08-17|||||1965-01-03||1964-10-05
TRIAL STUDY 134XCP|IS|7BD32505-61D5-4862-8896-B3E41D3EE779||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FMOL/L/SEC|||||STEPS/MIN||||HIGH|NOT DONE|||EXUDATE|CONCENTRATED|NA|PULSE OXIMETRY|Y|N|NA||2||58||SCREENING|1966-03-26|1971-03-30|||||1968-05-08||1966-12-08
TRIAL STUDY 134XCP|IS|7BD32505-61D5-4862-8896-B3E41D3EE779||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||COPIES/ML|||||UMOL/H/MMOL||||LOW|NOT DONE|||SEMINAL FLUID|PARAFFIN-EMBEDDED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|NA|U|NA||3||39||WASHOUT|1965-05-25|1973-05-31|||||1961-06-08||1969-10-05
TRIAL STUDY 134XCP|IS|7BD32505-61D5-4862-8896-B3E41D3EE779||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CGY|||||IU/MMOL||||NORMAL|NOT DONE|||MUSCLE TISSUE|AGGLUTINATED|N|EPSILOMETER|Y|Y|N||4||88||OPEN LABEL TREATMENT|1973-02-15|1968-02-11|||||1963-06-24||1964-02-26
TRIAL STUDY 134XCP|IS|7BD32505-61D5-4862-8896-B3E41D3EE779||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||TABLET|||||DAYS/MONTH||||NORMAL|NOT DONE|||ABSCESS FLUID|UNEXPECTED ODOR|N|CENTRIFUGATION|NA|Y|N||5||7||INDUCTION TREATMENT|1970-01-10|1971-05-18|||||1963-12-25||1969-11-27
TRIAL STUDY 134XCP|IS|3461C227-E30F-482B-B404-026FE0CA3549||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KBQ|||||CIGARETTE||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|LIPEMIC|U|VIRUS PLAQUE ASSAY|U|N|Y||1||38||BASELINE|1972-10-17|1973-08-03|||||1963-04-08||1965-11-18
TRIAL STUDY 134XCP|IS|3461C227-E30F-482B-B404-026FE0CA3549||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PRESSOR UNITS|||||MPS U||||LOW|NOT DONE|||MECONIUM|GELLED|N|ORCHIDOMETERY|NA|Y|NA||2||58||RUN-IN|1964-07-20|1966-06-06|||||1969-06-24||1964-11-20
TRIAL STUDY 134XCP|IS|3461C227-E30F-482B-B404-026FE0CA3549||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/MM|||||MM3/MM2/YEAR||||NORMAL|NOT DONE|||MUCUS|CLOTTED|U|STATIC PERIMETRY|Y|Y|Y||3||39||TREATMENT|1972-05-19|1962-02-24|||||1970-12-14||1970-05-31
TRIAL STUDY 134XCP|IS|3461C227-E30F-482B-B404-026FE0CA3549||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/MIN/MMHG|||||TITER||||LOW|NOT DONE|||CORD SERUM|UNEXPECTED ODOR|NA|SNP ARRAY|Y|N|NA||4||88||OPEN LABEL TREATMENT|1965-01-09|1964-06-02|||||1969-08-23||1962-01-27
TRIAL STUDY 134XCP|IS|3461C227-E30F-482B-B404-026FE0CA3549||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UGEQ|||||MG/MOL||||LOW|NOT DONE|||PUS|CLOTTED|NA|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|N|Y|N||5||7||BLINDED TREATMENT|1965-03-11|1961-02-03|||||1962-12-20||1969-07-16
TRIAL STUDY 134XCP|IS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PSI|||||ML/CM3/MIN||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|DRIED|N|ELECTRONEUROGRAPHY|NA|N|NA||1||38||OBSERVATION|1969-02-19|1971-01-29|||||1973-08-21||1965-06-20
TRIAL STUDY 134XCP|IS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CI/MG|||||KPA/L/SEC||||ABNORMAL|NOT DONE|||CIRCULATING TUMOR CELL|DRIED|Y|CT SCAN WITHOUT CONTRAST|NA|U|U||2||58||RUN-IN|1967-02-10|1963-03-07|||||1962-02-07||1964-01-10
TRIAL STUDY 134XCP|IS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LOG10 CFU/ML|||||10^6 RNA COPIES/ML||||ABNORMAL|NOT DONE|||SKIN TISSUE|GELLED|NA|ACRIDINE ORANGE STAIN|N|NA|NA||3||39||SCREENING|1963-11-07|1967-05-19|||||1968-06-29||1962-04-17
TRIAL STUDY 134XCP|IS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/MMHG/MIN/L|||||MG/DL||||NORMAL|NOT DONE|||TUMOR TISSUE|THAWED|Y|MACRO BROTH DILUTION|NA|N|NA||4||88||RUN-IN|1961-08-06|1969-08-23|||||1972-05-24||1962-03-29
TRIAL STUDY 134XCP|IS|4688A17D-8429-4AE7-B3FB-FDCA7EE6C10F||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ECL UNIT|||||10^3 RNA COPIES/ML||||ABNORMAL|NOT DONE|||VENOUS PLASMA|AGGLUTINATED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|Y|NA||5||7||RUN-IN|1971-10-03|1969-03-21|||||1972-11-05||1970-05-02
TRIAL STUDY 134XCP|IS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EU|||||UL/KG/DAY||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|FRESH|U|TEST STRIP|N|Y|N||1||38||BLINDED TREATMENT|1964-03-10|1969-03-03|||||1963-09-30||1971-01-06
TRIAL STUDY 134XCP|IS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GRAVITATIONAL UNIT|||||ML/CAGE||||LOW|NOT DONE|||CERUMEN|AUTOLYZED|U|CINEANGIOGRAPHY|Y|Y|NA||2||58||LONG-TERM FOLLOW-UP|1960-05-22|1965-01-28|||||1964-03-15||1960-05-12
TRIAL STUDY 134XCP|IS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||AG|||||KG/M2||||HIGH|NOT DONE|||SALIVA|HEMOLYZED|N|JAFFE REACTION|N|U|U||3||39||LONG-TERM FOLLOW-UP|1969-10-20|1966-01-04|||||1961-08-13||1967-06-25
TRIAL STUDY 134XCP|IS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/SEC|||||LOG10 CFU/ML||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|DRIED|U|MICRONEUTRALIZATION ASSAY|NA|NA|Y||4||88||INDUCTION TREATMENT|1963-05-24|1961-06-06|||||1968-08-02||1966-08-18
TRIAL STUDY 134XCP|IS|5B4CCDE8-49E3-40B4-ACB8-721D9E110AB4||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6/G|||||OZ EQ||||NORMAL|NOT DONE|||SEBUM|UNEXPECTED ODOR|N|DIGITAL PCR ARRAY|N|U|Y||5||7||BASELINE|1971-12-05|1967-06-20|||||1965-02-25||1969-08-28
TRIAL STUDY 134XCP|IS|C7C91F63-87B7-4E62-B5F3-39979F74E955||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||IU/G|||||M3||||NORMAL|NOT DONE|||CERUMEN|CONTAMINATED|U|IMMUNOFIXATION ELECTROPHORESIS|Y|NA|NA||1||38||TREATMENT|1963-01-17|1969-07-04|||||1967-08-20||1964-12-06
TRIAL STUDY 134XCP|IS|C7C91F63-87B7-4E62-B5F3-39979F74E955||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KEV|||||HOURS||||LOW|NOT DONE|||SPUTUM|AUTOLYZED|NA|ELASTOGRAPHY|N|N|NA||2||58||CONTINUATION TREATMENT|1960-05-27|1967-01-06|||||1965-09-23||1960-10-07
TRIAL STUDY 134XCP|IS|C7C91F63-87B7-4E62-B5F3-39979F74E955||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PATCH|||||FMOL||||NORMAL|NOT DONE|||DIALYSIS FLUID|LACTESCENT|N|AUDIOMETRY|U|Y|NA||3||39||INDUCTION TREATMENT|1965-08-20|1962-03-11|||||1970-12-11||1969-03-13
TRIAL STUDY 134XCP|IS|C7C91F63-87B7-4E62-B5F3-39979F74E955||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/G HB|||||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE|||TUMOR TISSUE|THAWED|N|CLIP SEQUENCING|Y|NA|NA||4||88||OBSERVATION|1967-01-15|1970-08-30|||||1963-09-27||1968-06-06
TRIAL STUDY 134XCP|IS|C7C91F63-87B7-4E62-B5F3-39979F74E955||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TCID 50/DOSE|||||COPIES/ML||||HIGH|NOT DONE|||SPERMATOZOON|LIPEMIC|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|U|NA|U||5||7||SCREENING|1970-06-08|1972-08-01|||||1968-03-17||1961-09-07
TRIAL STUDY 134XCP|IS|D6659F53-6DF6-4F88-BF9A-160E2D057028||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/L DDU|||||UM/S||||LOW|NOT DONE|||TUMOR TISSUE|AGGLUTINATED|N|PET/SPECT SCAN|Y|U|U||1||38||BASELINE|1973-07-13|1962-03-23|||||1969-06-19||1971-07-24
TRIAL STUDY 134XCP|IS|D6659F53-6DF6-4F88-BF9A-160E2D057028||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MSEC|||||ML/DAY||||HIGH|NOT DONE|||BREAST MILK|LACTESCENT|U|MICRODENSITOMETRY|NA|NA|NA||2||58||INDUCTION TREATMENT|1969-10-16|1969-05-08|||||1969-08-10||1969-11-17
TRIAL STUDY 134XCP|IS|D6659F53-6DF6-4F88-BF9A-160E2D057028||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||EID 50/DOSE|||||CFU/G||||LOW|NOT DONE|||KERATINOCYTE|GELLED|U|TURBIDIMETRY|U|NA|N||3||39||INDUCTION TREATMENT|1969-12-18|1972-12-28|||||1965-09-10||1965-11-12
TRIAL STUDY 134XCP|IS|D6659F53-6DF6-4F88-BF9A-160E2D057028||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^4 CFU|||||LOG10 ELISA UNIT||||NORMAL|NOT DONE|||SYNOVIAL FLUID|CALCIFIED|Y|NUCLEAR RADIOLOGY|U|NA|N||4||88||OPEN LABEL TREATMENT|1972-05-21|1961-03-16|||||1967-05-31||1973-01-09
TRIAL STUDY 134XCP|IS|D6659F53-6DF6-4F88-BF9A-160E2D057028||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/MBP|||||MHZ||||LOW|NOT DONE|||CERUMEN|CONCENTRATED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|NA|Y||5||7||BLINDED TREATMENT|1964-11-08|1968-01-27|||||1960-11-02||1962-04-18
TRIAL STUDY 134XCP|IS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FT2|||||MG/M2||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|CONCENTRATED|Y|MICROBIAL CULTURE, SOLID|U|Y|U||1||38||TREATMENT|1969-04-28|1967-06-02|||||1966-07-16||1965-06-07
TRIAL STUDY 134XCP|IS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||EID 50/ML|||||YEARS||||NORMAL|NOT DONE|||LYSATE|PARAFFIN-EMBEDDED|NA|NEPHELOMETRY|N|Y|N||2||58||OPEN LABEL TREATMENT|1972-10-15|1971-03-21|||||1973-08-27||1972-03-15
TRIAL STUDY 134XCP|IS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL/MOL|||||NCI||||HIGH|NOT DONE|||ERYTHROCYTES|PARAFFIN-EMBEDDED|N|NUCLEIC ACID BASED METHOD|Y|NA|U||3||39||LONG-TERM FOLLOW-UP|1963-03-30|1970-03-17|||||1964-11-25||1968-12-03
TRIAL STUDY 134XCP|IS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/ANIMAL|||||BISCUIT||||ABNORMAL|NOT DONE|||MUCUS|GELLED|U|LEAD CITRATE STAIN|N|Y|U||4||88||SCREENING|1971-10-12|1965-11-18|||||1971-10-10||1965-01-05
TRIAL STUDY 134XCP|IS|AF6FDB1B-0B61-4D2A-8874-808DD5A5B286||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CMH2O*S2/ML|||||WEBER||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|ICTERIC|N|GIEMSA STAIN|N|Y|U||5||7||OBSERVATION|1963-03-25|1971-01-13|||||1968-05-20||1970-06-12
TRIAL STUDY 134XCP|IS|91B36C93-3ADF-4570-B355-BC81B097EEFC||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KDA|||||UG/ML/H||||NORMAL|NOT DONE|||SKIN TISSUE|ICTERIC|N|MS/MS|NA|Y|Y||1||38||TREATMENT|1967-11-24|1973-08-06|||||1968-07-08||1961-03-27
TRIAL STUDY 134XCP|IS|91B36C93-3ADF-4570-B355-BC81B097EEFC||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PMOL/10^10 CELLS|||||GRAVITATIONAL UNIT||||LOW|NOT DONE|||KERATINOCYTE|NON-HEMOLYZED|Y|PH METER MEASUREMENT METHOD|U|Y|N||2||58||BASELINE|1971-08-24|1969-12-25|||||1970-01-28||1966-10-09
TRIAL STUDY 134XCP|IS|91B36C93-3ADF-4570-B355-BC81B097EEFC||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||1/(S*KPA)|||||CM H2O||||LOW|NOT DONE|||ARTERIAL BLOOD|CLOTTED|N|PERIODIC ACID SCHIFF STAIN|NA|U|Y||3||39||SCREENING|1963-09-14|1963-06-18|||||1960-01-29||1967-05-05
TRIAL STUDY 134XCP|IS|91B36C93-3ADF-4570-B355-BC81B097EEFC||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EQ|||||CAPSULE||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|NON-HEMOLYZED|NA|EIA|Y|NA|N||4||88||WASHOUT|1963-12-30|1970-04-29|||||1970-08-24||1961-01-06
TRIAL STUDY 134XCP|IS|91B36C93-3ADF-4570-B355-BC81B097EEFC||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/100 HPFS|||||ML/H||||LOW|NOT DONE|||SUPERNATANT, PLASMA|CONCENTRATED|N|VENTILATION PERFUSION LUNG SCAN|U|U|NA||5||7||OBSERVATION|1967-11-17|1964-09-28|||||1972-09-25||1973-07-06
TRIAL STUDY 134XCP|IS|ADD0DDE5-166F-4C20-B3C3-31B131509771||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||WEEKS|||||COULOMB||||ABNORMAL|NOT DONE|||PLASMA|CLOTTED|U|ISHIHARA COLOR PLATES|NA|NA|N||1||38||CONTINUATION TREATMENT|1971-11-01|1960-06-27|||||1964-10-28||1961-12-24
TRIAL STUDY 134XCP|IS|ADD0DDE5-166F-4C20-B3C3-31B131509771||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MEQ/MMOL|||||/HPF||||LOW|NOT DONE|||EMOTIONAL TEAR|PARAFFIN-EMBEDDED|U|ACRIDINE ORANGE STAIN|U|U|NA||2||58||SCREENING|1963-03-23|1968-12-02|||||1961-10-22||1970-03-08
TRIAL STUDY 134XCP|IS|ADD0DDE5-166F-4C20-B3C3-31B131509771||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||COPIES/ML|||||10^6 U||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|ICTERIC|U|CONFOCAL MICROSCOPY|Y|U|N||3||39||BLINDED TREATMENT|1973-06-15|1964-10-07|||||1970-12-01||1961-07-04
TRIAL STUDY 134XCP|IS|ADD0DDE5-166F-4C20-B3C3-31B131509771||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BQ/ML|||||10^6/EJACULATE U||||LOW|NOT DONE|||SUPERNATANT, PLASMA|UNEXPECTED ODOR|Y|BIOPSY|U|NA|Y||4||88||TREATMENT|1968-04-15|1962-08-09|||||1964-03-05||1962-07-02
TRIAL STUDY 134XCP|IS|ADD0DDE5-166F-4C20-B3C3-31B131509771||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG/L|||||BQ/UG||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|GELLED|NA|BETA LACTAMASE|N|U|U||5||7||TREATMENT|1969-03-26|1971-07-27|||||1964-10-11||1964-03-06
TRIAL STUDY 134XCP|IS|4265CC9E-26AF-4A14-B9AA-04A246E2523C||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/DOSE|||||UG||||NORMAL|NOT DONE|||DISCHARGE|UNEXPECTED ODOR|Y|MULTI-SLICE SPIRAL CT|NA|NA|N||1||38||TREATMENT|1973-02-03|1966-02-16|||||1969-03-14||1972-02-12
TRIAL STUDY 134XCP|IS|4265CC9E-26AF-4A14-B9AA-04A246E2523C||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/H|||||MEQ/KG||||ABNORMAL|NOT DONE|||KERATINOCYTE|CLOTTED|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|NA|U|N||2||58||LONG-TERM FOLLOW-UP|1966-01-07|1972-05-26|||||1963-01-16||1963-12-13
TRIAL STUDY 134XCP|IS|4265CC9E-26AF-4A14-B9AA-04A246E2523C||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ARBITRARY U|||||NG||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|REFRIGERATED|Y|MICRONEUTRALIZATION ASSAY|N|Y|NA||3||39||LONG-TERM FOLLOW-UP|1973-04-06|1967-05-17|||||1962-03-19||1962-10-03
TRIAL STUDY 134XCP|IS|4265CC9E-26AF-4A14-B9AA-04A246E2523C||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/DAY|||||GBQ/G||||NORMAL|NOT DONE|||EXUDATE|AGGLUTINATED|N|SNELLEN EYE CHART|N|Y|Y||4||88||FOLLOW-UP|1971-11-01|1965-11-26|||||1965-07-11||1961-03-13
TRIAL STUDY 134XCP|IS|4265CC9E-26AF-4A14-B9AA-04A246E2523C||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CCID 50/DOSE|||||QUANTITY SUFFICIENT||||LOW|NOT DONE|||LUNG SURFACTANT|LACTESCENT|N|SEQUENCING|N|Y|N||5||7||WASHOUT|1964-10-12|1970-05-21|||||1971-11-23||1970-01-07
TRIAL STUDY 134XCP|IS|96F268D3-7441-415C-95C9-A6B70C1718D5||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NG/DAY|||||CUP||||ABNORMAL|NOT DONE|||BUFFY COAT|AUTOLYZED|N|HPLC-FL|NA|U|Y||1||38||FOLLOW-UP|1964-12-25|1971-09-17|||||1962-01-28||1973-05-08
TRIAL STUDY 134XCP|IS|96F268D3-7441-415C-95C9-A6B70C1718D5||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||V|||||CAPSULE||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|LIPEMIC|U|AURAMINE STAIN|U|NA|NA||2||58||RUN-IN|1964-07-17|1962-06-09|||||1964-01-09||1964-03-21
TRIAL STUDY 134XCP|IS|96F268D3-7441-415C-95C9-A6B70C1718D5||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DYN|||||CPM||||NORMAL|NOT DONE|||BILE|GELLED|U|IMMUNOFIXATION ELECTROPHORESIS|U|NA|U||3||39||OBSERVATION|1963-05-25|1963-10-10|||||1961-06-24||1964-11-09
TRIAL STUDY 134XCP|IS|96F268D3-7441-415C-95C9-A6B70C1718D5||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%/S|||||KUSP||||NORMAL|NOT DONE|||ISOLATE|ICTERIC|NA|AUSCULTATION|U|Y|U||4||88||TREATMENT|1962-09-25|1972-10-28|||||1968-06-08||1970-04-18
TRIAL STUDY 134XCP|IS|96F268D3-7441-415C-95C9-A6B70C1718D5||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/100 HPFS|||||PFU/ML||||NORMAL|NOT DONE|||RETICULOCYTES|THAWED|NA|GC/MS-EI|U|U|NA||5||7||BLINDED TREATMENT|1964-11-29|1966-12-28|||||1967-07-28||1969-09-09
TRIAL STUDY 134XCP|IS|15D32D1F-AEE2-474C-956E-461FB087D7B0||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CD/M2|||||FOZ_US||||NORMAL|NOT DONE|||LYMPH|AUTOLYZED|Y|MEDIASTINOSCOPY|U|U|NA||1||38||OPEN LABEL TREATMENT|1969-09-15|1962-03-23|||||1967-08-05||1963-05-05
TRIAL STUDY 134XCP|IS|15D32D1F-AEE2-474C-956E-461FB087D7B0||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/M2/H|||||ML/SEC/1.73M2||||HIGH|NOT DONE|||RETICULOCYTES|LIPEMIC|U|ELECTROMYOGRAPHY|U|NA|Y||2||58||CONTINUATION TREATMENT|1971-01-14|1970-01-28|||||1961-11-20||1966-02-26
TRIAL STUDY 134XCP|IS|15D32D1F-AEE2-474C-956E-461FB087D7B0||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3 DNA COPIES/ML|||||ELISA UNIT||||ABNORMAL|NOT DONE|||SPUTUM|ROOM TEMPERATURE|NA|FUNDUS PHOTOGRAPHY|Y|NA|N||3||39||OPEN LABEL TREATMENT|1963-09-10|1969-07-15|||||1963-11-17||1968-11-05
TRIAL STUDY 134XCP|IS|15D32D1F-AEE2-474C-956E-461FB087D7B0||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE/WK|||||G/M2/DAY||||NORMAL|NOT DONE|||EPITHELIAL CELL|LACTESCENT|Y|FLUORIMETRY|N|N|U||4||88||FOLLOW-UP|1961-11-06|1970-09-02|||||1965-09-29||1961-08-23
TRIAL STUDY 134XCP|IS|15D32D1F-AEE2-474C-956E-461FB087D7B0||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CAPLET|||||USEC||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|CONCENTRATED|NA|RADIOIMMUNOPRECIPITATION ASSAY|Y|U|N||5||7||OBSERVATION|1961-03-28|1967-08-14|||||1972-06-25||1966-03-16
TRIAL STUDY 134XCP|IS|DB42C81A-D644-455D-9D95-42131EF2BFE5||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/M2|||||MEQ/ML||||LOW|NOT DONE|||ARTERIAL BLOOD|AUTOLYZED|N|IMMUNOTURBIDIMETRY|Y|Y|N||1||38||SCREENING|1964-04-01|1972-02-29|||||1967-10-30||1971-05-09
TRIAL STUDY 134XCP|IS|DB42C81A-D644-455D-9D95-42131EF2BFE5||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MEQ/UL|||||% INHIBITION||||NORMAL|NOT DONE|||BONE MARROW|PARAFFIN-EMBEDDED|NA|CELL OF ORIGIN ASSAY|NA|U|U||2||58||BLINDED TREATMENT|1970-01-30|1960-06-17|||||1963-03-25||1971-04-18
TRIAL STUDY 134XCP|IS|DB42C81A-D644-455D-9D95-42131EF2BFE5||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/ML/H|||||GY/H||||NORMAL|NOT DONE|||SYNOVIAL FLUID|UNEXPECTED ODOR|NA|CALCULATION|U|NA|NA||3||39||LONG-TERM FOLLOW-UP|1963-09-20|1972-02-01|||||1962-04-27||1972-05-16
TRIAL STUDY 134XCP|IS|DB42C81A-D644-455D-9D95-42131EF2BFE5||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UMOL/DAY|||||APPLICATION||||NORMAL|NOT DONE|||MUCUS|NON-HEMOLYZED|U|FLUORIMETRY|N|U|U||4||88||WASHOUT|1970-11-12|1965-03-26|||||1965-11-25||1968-11-14
TRIAL STUDY 134XCP|IS|DB42C81A-D644-455D-9D95-42131EF2BFE5||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||OZ|||||U||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|PARAFFIN-EMBEDDED|U|REBOUND TONOMETRY|Y|Y|NA||5||7||LONG-TERM FOLLOW-UP|1971-02-09|1966-04-11|||||1973-05-24||1965-11-12
TRIAL STUDY 134XCP|IS|4B01CC59-51D3-4499-9AB1-DF446006CB8D||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/200 HPFS|||||G/U||||HIGH|NOT DONE|||EXPIRED AIR|ROOM TEMPERATURE|Y|SCANNING ELECTRON MICROSCOPY|NA|NA|NA||1||38||OPEN LABEL TREATMENT|1968-09-05|1967-03-09|||||1973-01-20||1967-07-12
TRIAL STUDY 134XCP|IS|4B01CC59-51D3-4499-9AB1-DF446006CB8D||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/S/M2|||||GAUSS||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|U|THICK SMEAR|U|NA|NA||2||58||LONG-TERM FOLLOW-UP|1969-02-14|1972-03-22|||||1964-04-21||1973-05-03
TRIAL STUDY 134XCP|IS|4B01CC59-51D3-4499-9AB1-DF446006CB8D||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MPL U/ML|||||10^9/L||||LOW|NOT DONE|||RETICULOCYTES|HEMOLYZED|N|PULMONARY ANGIOGRAPHY|NA|NA|Y||3||39||CONTINUATION TREATMENT|1971-07-05|1972-10-19|||||1965-06-03||1970-07-12
TRIAL STUDY 134XCP|IS|4B01CC59-51D3-4499-9AB1-DF446006CB8D||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CY/CM|||||10^7 CFU||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|FROZEN|N|EPSILOMETER|Y|NA|N||4||88||OPEN LABEL TREATMENT|1967-04-13|1971-09-24|||||1961-07-09||1972-09-12
TRIAL STUDY 134XCP|IS|4B01CC59-51D3-4499-9AB1-DF446006CB8D||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/MMHG/MIN/L|||||LOG10 IU/ML||||HIGH|NOT DONE|||ALVEOLAR AIR|CALCIFIED|NA|HILLMEN COLOR CHART|N|NA|Y||5||7||BASELINE|1968-01-07|1969-08-15|||||1968-01-19||1970-03-05
TRIAL STUDY 134XCP|IS|B69774FC-1151-45DD-B329-6C21C2F29603||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/G HB|||||ML/M2/H||||LOW|NOT DONE|||STOOL|FROZEN|NA|IMMUNOFIXATION ELECTROPHORESIS|U|NA|U||1||38||OPEN LABEL TREATMENT|1963-12-09|1965-09-29|||||1966-08-21||1967-03-17
TRIAL STUDY 134XCP|IS|B69774FC-1151-45DD-B329-6C21C2F29603||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MANSON U/ML|||||MMU/ML||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|FRESH|U|OPHTHALMOSCOPY|N|N|N||2||58||OPEN LABEL TREATMENT|1966-03-30|1964-01-17|||||1968-10-21||1972-11-10
TRIAL STUDY 134XCP|IS|B69774FC-1151-45DD-B329-6C21C2F29603||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CYCLE/MIN|||||CD*S/M2||||LOW|NOT DONE|||SOFT TISSUE|FRESH|N|DYNAMOMETRY|N|U|Y||3||39||SCREENING|1969-02-27|1962-03-05|||||1968-02-23||1963-10-04
TRIAL STUDY 134XCP|IS|B69774FC-1151-45DD-B329-6C21C2F29603||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/G|||||10^6/L||||HIGH|NOT DONE|||MUCUS|HEMOLYZED|U|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|NA|NA||4||88||TREATMENT|1968-02-01|1969-07-05|||||1968-11-17||1964-06-13
TRIAL STUDY 134XCP|IS|B69774FC-1151-45DD-B329-6C21C2F29603||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GBQ|||||MV2/HZ||||NORMAL|NOT DONE|||LOCHIA|NON-HEMOLYZED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|NA|N|N||5||7||RUN-IN|1965-06-19|1969-02-12|||||1964-02-24||1965-04-10
TRIAL STUDY 134XCP|IS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OI50|||||ELISA UNIT/DOSE||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|FRESH|Y|SPIROMETRY|U|Y|Y||1||38||OPEN LABEL TREATMENT|1966-02-02|1968-02-24|||||1973-01-27||1970-03-26
TRIAL STUDY 134XCP|IS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||VIAL|||||MEQ/UG||||LOW|NOT DONE|||AMNIOTIC FLUID|LACTESCENT|Y|RAJI CELL EIA|NA|Y|Y||2||58||OPEN LABEL TREATMENT|1966-01-17|1970-10-25|||||1963-06-21||1969-10-17
TRIAL STUDY 134XCP|IS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BAU|||||PFU/DOSE||||ABNORMAL|NOT DONE|||BASAL TEAR|FROZEN|U|PH METER MEASUREMENT METHOD|NA|Y|N||3||39||BASELINE|1961-04-18|1963-07-19|||||1968-07-26||1965-05-30
TRIAL STUDY 134XCP|IS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DIP|||||/VF||||NORMAL|NOT DONE|||VENOUS BLOOD|THAWED|NA|HPLC|N|Y|NA||4||88||LONG-TERM FOLLOW-UP|1962-05-16|1969-01-20|||||1967-09-04||1962-09-16
TRIAL STUDY 134XCP|IS|E65C6FBC-3399-4EC7-8802-8AA6BB3FA4E5||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CL|||||CD||||LOW|NOT DONE|||CELL PELLET|DRIED|U|CONTRAST ENHANCED PET SCAN|Y|U|N||5||7||OPEN LABEL TREATMENT|1960-06-29|1962-12-13|||||1964-04-04||1971-05-31
TRIAL STUDY 134XCP|IS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN|||||KS||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|REFRIGERATED|N|THERMAL IONIZATION MASS SPECTROMETRY|NA|U|N||1||38||BASELINE|1968-07-16|1961-05-23|||||1963-02-01||1963-07-10
TRIAL STUDY 134XCP|IS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 ELISA UNIT|||||UG||||ABNORMAL|NOT DONE|||MONOCYTE|AUTOLYZED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|NA|U|N||2||58||SCREENING|1968-02-12|1967-09-30|||||1966-11-24||1966-04-15
TRIAL STUDY 134XCP|IS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPS U|||||10^9 CFU||||NORMAL|NOT DONE|||SEBUM|PARAFFIN-EMBEDDED|U|CARDIAC THERMODILUTION|Y|Y|NA||3||39||BASELINE|1960-10-11|1964-07-25|||||1961-05-23||1970-02-07
TRIAL STUDY 134XCP|IS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PG/L|||||MOSM/L||||ABNORMAL|NOT DONE|||TUMOR TISSUE|AGGLUTINATED|N|CALCULATION|U|Y|U||4||88||BLINDED TREATMENT|1963-04-13|1970-07-01|||||1965-01-20||1970-01-01
TRIAL STUDY 134XCP|IS|4133B8C8-6594-4E12-81C7-0E1C1BEA59D9||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||M3|||||%/S||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|AUTOLYZED|NA|HPLC/MS|Y|Y|N||5||7||RUN-IN|1963-07-12|1964-04-19|||||1964-05-18||1967-04-10
TRIAL STUDY 134XCP|IS|674B4474-6D52-4DE2-8342-EDB28F577BB5||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||OHM|||||OD UNIT||||NORMAL|NOT DONE|||KERATINOCYTE|CLOTTED|U|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|NA|N|NA||1||38||OPEN LABEL TREATMENT|1972-05-01|1968-08-12|||||1968-04-10||1964-05-17
TRIAL STUDY 134XCP|IS|674B4474-6D52-4DE2-8342-EDB28F577BB5||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/MS|||||MEQ/L||||NORMAL|NOT DONE|||TUMOR TISSUE|ROOM TEMPERATURE|U|REVERSE TRANSCRIPTASE PCR|Y|NA|NA||2||58||BLINDED TREATMENT|1964-05-28|1970-12-23|||||1962-12-24||1963-02-20
TRIAL STUDY 134XCP|IS|674B4474-6D52-4DE2-8342-EDB28F577BB5||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NG/L|||||BP||||LOW|NOT DONE|||MENSTRUAL BLOOD|DRIED|U|TONOMETRY|NA|U|U||3||39||OBSERVATION|1968-12-20|1965-12-19|||||1962-04-27||1969-12-02
TRIAL STUDY 134XCP|IS|674B4474-6D52-4DE2-8342-EDB28F577BB5||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||INHALATION|||||/4.0 ML||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|THAWED|Y|KINETIC CHROMOGENIC ASSAY|N|N|U||4||88||FOLLOW-UP|1967-08-17|1966-09-03|||||1966-01-06||1973-08-24
TRIAL STUDY 134XCP|IS|674B4474-6D52-4DE2-8342-EDB28F577BB5||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CAL|||||FMOL||||NORMAL|NOT DONE|||PERITONEAL FLUID|ICTERIC|Y|CLAUSS METHOD|N|Y|NA||5||7||BASELINE|1970-09-06|1971-09-16|||||1969-11-25||1967-06-11
TRIAL STUDY 134XCP|IS|AF634AD4-086A-47EE-A5DB-A4B6833356C7||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||APS U|||||KM/H||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|AGGLUTINATED|N|CELL BASED BIOASSAY|NA|N|U||1||38||LONG-TERM FOLLOW-UP|1966-08-18|1961-12-24|||||1965-04-14||1963-04-02
TRIAL STUDY 134XCP|IS|AF634AD4-086A-47EE-A5DB-A4B6833356C7||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/L|||||DAGU||||ABNORMAL|NOT DONE|||ABSCESS FLUID|UNEXPECTED ODOR|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|NA|U||2||58||BLINDED TREATMENT|1970-01-12|1971-11-13|||||1965-03-17||1961-12-11
TRIAL STUDY 134XCP|IS|AF634AD4-086A-47EE-A5DB-A4B6833356C7||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/LSQN|||||UGEQ/L||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|SOLIDIFIED|U|AGAR PROPORTION|U|NA|NA||3||39||SCREENING|1962-09-08|1961-10-07|||||1963-11-16||1969-01-11
TRIAL STUDY 134XCP|IS|AF634AD4-086A-47EE-A5DB-A4B6833356C7||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^3 CFU/ML|||||PG/L||||NORMAL|NOT DONE|||LAVAGE FLUID|GELLED|Y|NEURAMINIDASE INHIBITION ASSAY|N|U|N||4||88||SCREENING|1970-04-14|1966-07-05|||||1961-08-17||1964-07-18
TRIAL STUDY 134XCP|IS|AF634AD4-086A-47EE-A5DB-A4B6833356C7||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^10/L|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||WHITE MATTER TISSUE|DRIED|NA|PERFUSION MRI|Y|Y|NA||5||7||SCREENING|1971-03-14|1972-01-22|||||1962-05-09||1968-04-07
TRIAL STUDY 134XCP|IS|89298058-EB86-4892-97D6-1B87277DF7FC||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||H/WK|||||PM||||NORMAL|NOT DONE|||STOOL|LACTESCENT|N|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|U|NA||1||38||WASHOUT|1961-10-28|1970-06-24|||||1965-04-21||1965-01-27
TRIAL STUDY 134XCP|IS|89298058-EB86-4892-97D6-1B87277DF7FC||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CFU/ML|||||FOZ_BR||||ABNORMAL|NOT DONE|||URINE|LACTESCENT|Y|NON-CONTACT SPECULAR MICROSCOPY|Y|Y|U||2||58||FOLLOW-UP|1965-12-10|1972-03-26|||||1961-05-07||1965-10-28
TRIAL STUDY 134XCP|IS|89298058-EB86-4892-97D6-1B87277DF7FC||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/KG/DAY|||||TRACE||||NORMAL|NOT DONE|||TISSUE|THAWED|Y|ATOMIC ABSORPTION SPECTROMETRY|Y|N|U||3||39||OBSERVATION|1973-07-15|1966-04-18|||||1969-04-29||1968-01-23
TRIAL STUDY 134XCP|IS|89298058-EB86-4892-97D6-1B87277DF7FC||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/H|||||SCM||||LOW|NOT DONE|||PLASMA|LIPEMIC|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|N|NA|Y||4||88||SCREENING|1966-02-11|1960-06-19|||||1961-07-19||1970-06-11
TRIAL STUDY 134XCP|IS|89298058-EB86-4892-97D6-1B87277DF7FC||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^8/L|||||GY||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|NON-HEMOLYZED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|U|N|N||5||7||LONG-TERM FOLLOW-UP|1961-06-16|1971-10-21|||||1972-10-17||1961-06-15
TRIAL STUDY 134XCP|IS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||K|||||KDA||||LOW|NOT DONE|||LOCHIA|LIPEMIC|U|JAEGER EYE CHART|U|Y|Y||1||38||OBSERVATION|1967-08-12|1962-01-03|||||1970-02-01||1961-12-24
TRIAL STUDY 134XCP|IS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CUP EQ|||||ML/H||||HIGH|NOT DONE|||URINE|GELLED|N|RAJI CELL EIA|Y|Y|Y||2||58||TREATMENT|1966-12-12|1967-02-06|||||1969-03-25||1965-02-27
TRIAL STUDY 134XCP|IS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EVENTS|||||10^4 CFU||||ABNORMAL|NOT DONE|||BLOOD|UNEXPECTED ODOR|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|NA|Y||3||39||OPEN LABEL TREATMENT|1965-01-19|1968-08-10|||||1969-01-21||1966-11-12
TRIAL STUDY 134XCP|IS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CYLINDER|||||TUBERCULIN UNIT||||ABNORMAL|NOT DONE|||BASAL TEAR|ROOM TEMPERATURE|Y|MICROARRAY|Y|N|U||4||88||BASELINE|1968-05-12|1965-05-29|||||1961-06-14||1972-05-07
TRIAL STUDY 134XCP|IS|E41FF3D9-9D68-4A3A-BBFB-B4D9030423E5||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/M2/DAY|||||10^8/L||||HIGH|NOT DONE|||BONE|GELLED|N|IMPULSE OSCILLOMETRY|Y|Y|N||5||7||SCREENING|1969-08-02|1969-08-10|||||1964-05-31||1970-06-30
TRIAL STUDY 134XCP|IS|D5235188-810B-431F-A6EF-E50DAA57F5E7||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT/L|||||CI/G||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|DRIED|Y|BIOIMPEDANCE SPECTROSCOPY|Y|N|NA||1||38||CONTINUATION TREATMENT|1966-08-20|1973-05-13|||||1965-01-19||1968-11-21
TRIAL STUDY 134XCP|IS|D5235188-810B-431F-A6EF-E50DAA57F5E7||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MV*MIN|||||OI50||||NORMAL|NOT DONE|||BLOOD|SOLIDIFIED|N|CRYOSCOPY|Y|N|NA||2||58||BLINDED TREATMENT|1973-07-08|1967-08-26|||||1971-07-17||1967-11-17
TRIAL STUDY 134XCP|IS|D5235188-810B-431F-A6EF-E50DAA57F5E7||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/L|||||MG/M2/H||||HIGH|NOT DONE|||BREAST MILK|DRIED|NA|TRANSTHORACIC ECHOCARDIOGRAPHY|NA|NA|U||3||39||OBSERVATION|1972-06-14|1965-05-19|||||1968-12-28||1967-05-07
TRIAL STUDY 134XCP|IS|D5235188-810B-431F-A6EF-E50DAA57F5E7||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UGEQ|||||UG/DAY||||HIGH|NOT DONE|||PLATELET RICH PLASMA|CONCENTRATED|NA|ACRIDINE ORANGE STAIN|NA|Y|NA||4||88||BLINDED TREATMENT|1972-05-24|1960-04-08|||||1961-01-05||1966-07-23
TRIAL STUDY 134XCP|IS|D5235188-810B-431F-A6EF-E50DAA57F5E7||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NKAT/G HB|||||EJACULATE U||||NORMAL|NOT DONE|||URINE|CONCENTRATED|N|COMPLEMENT FIXATION|NA|U|NA||5||7||RUN-IN|1970-05-16|1963-02-06|||||1960-09-30||1965-11-05
TRIAL STUDY 134XCP|IS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MPL U|||||MG/DOSE||||LOW|NOT DONE|||SEMINAL FLUID|GELLED|NA|DUCTOGRAPHY|U|N|N||1||38||BASELINE|1968-11-19|1960-08-28|||||1965-08-21||1972-02-22
TRIAL STUDY 134XCP|IS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CAL|||||GRAVITATIONAL UNIT||||NORMAL|NOT DONE|||PLEURAL FLUID|NON-HEMOLYZED|NA|X-RAY FLUORESCENCE SPECTROMETRY|U|NA|U||2||58||WASHOUT|1967-11-27|1968-06-13|||||1971-06-27||1969-11-15
TRIAL STUDY 134XCP|IS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DRUM|||||10^3 ORGANISMS||||ABNORMAL|NOT DONE|||FLUID|AGGLUTINATED|U|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|NA|N||3||39||BLINDED TREATMENT|1962-07-19|1966-05-21|||||1963-04-26||1970-10-13
TRIAL STUDY 134XCP|IS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/G/H|||||DROP||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|AGGLUTINATED|Y|HIGH RESOLUTION CT|N|NA|Y||4||88||OBSERVATION|1965-12-01|1964-07-06|||||1963-02-13||1961-06-23
TRIAL STUDY 134XCP|IS|05CEDBB3-C2F4-4069-A8B0-EF2080C7D1F1||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PG/DL|||||MOL/MOL||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|FRESH|Y|IHC|Y|N|NA||5||7||BLINDED TREATMENT|1963-07-24|1971-07-23|||||1971-05-24||1965-02-17
TRIAL STUDY 134XCP|IS|E3BB136E-0913-43FB-B760-CBE939F0C4D2||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||G/ANIMAL/DAY|||||NGEQ/L||||HIGH|NOT DONE|||SERUM|CONTAMINATED|NA|BRDU CELLULAR PROLIFERATION ASSAY|Y|U|NA||1||38||CONTINUATION TREATMENT|1967-01-26|1972-08-11|||||1965-06-27||1961-08-21
TRIAL STUDY 134XCP|IS|E3BB136E-0913-43FB-B760-CBE939F0C4D2||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||L/L|||||BQ/L||||NORMAL|NOT DONE|||ADIPOSE TISSUE|LACTESCENT|Y|LINE PROBE ASSAY|N|U|NA||2||58||FOLLOW-UP|1965-07-19|1960-10-02|||||1962-07-11||1973-01-19
TRIAL STUDY 134XCP|IS|E3BB136E-0913-43FB-B760-CBE939F0C4D2||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PRESSOR UNITS|||||PMOL/DAY||||LOW|NOT DONE|||URINE SEDIMENT|THAWED|U|CAPILLARY ELECTROPHORESIS|NA|Y|N||3||39||INDUCTION TREATMENT|1971-06-19|1962-05-06|||||1966-06-11||1972-12-02
TRIAL STUDY 134XCP|IS|E3BB136E-0913-43FB-B760-CBE939F0C4D2||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FRACTION OF 1|||||G/CM2||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|U|INDIA INK STAIN|Y|N|Y||4||88||BASELINE|1965-09-10|1968-01-12|||||1972-10-05||1972-11-12
TRIAL STUDY 134XCP|IS|E3BB136E-0913-43FB-B760-CBE939F0C4D2||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UOSM|||||GPL U||||ABNORMAL|NOT DONE|||SEBUM|AGGLUTINATED|Y|CHROMATOGRAPHY|U|N|N||5||7||BLINDED TREATMENT|1971-11-18|1969-08-22|||||1962-08-13||1963-07-18
TRIAL STUDY 134XCP|IS|60C25341-42CE-4532-8F99-25B8305C4ED5||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/M2/MIN|||||ML/G/H||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|NON-HEMOLYZED|NA|HIGH RESOLUTION MELT ANALYSIS|U|NA|NA||1||38||FOLLOW-UP|1971-06-24|1965-09-10|||||1962-09-21||1973-06-09
TRIAL STUDY 134XCP|IS|60C25341-42CE-4532-8F99-25B8305C4ED5||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG EID 50/DOSE|||||/100 HPFS||||ABNORMAL|NOT DONE|||EXPIRED AIR|FRESH|U|FLOCCULATION|N|U|NA||2||58||OBSERVATION|1966-08-31|1962-02-13|||||1961-08-15||1964-04-02
TRIAL STUDY 134XCP|IS|60C25341-42CE-4532-8F99-25B8305C4ED5||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KBQ/UL|||||ML/CAGE||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|REFRIGERATED|N|WRIGHT-GIEMSA STAIN|Y|Y|U||3||39||BASELINE|1966-03-13|1962-09-30|||||1964-05-25||1966-12-04
TRIAL STUDY 134XCP|IS|60C25341-42CE-4532-8F99-25B8305C4ED5||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VIAL|||||G/DAY||||NORMAL|NOT DONE|||BLOOD|FROZEN|NA|CHROMATOGRAPHY|NA|NA|U||4||88||OPEN LABEL TREATMENT|1967-11-04|1969-10-24|||||1961-07-19||1961-03-05
TRIAL STUDY 134XCP|IS|60C25341-42CE-4532-8F99-25B8305C4ED5||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||M/SEC|||||CMOL/L||||NORMAL|NOT DONE|||SPERMATOZOON|PARAFFIN-EMBEDDED|NA|SMEAR|N|Y|Y||5||7||FOLLOW-UP|1970-05-12|1966-05-12|||||1962-05-19||1967-10-19
TRIAL STUDY 134XCP|IS|42B54D88-E5B5-4828-958B-4B64F07E34B3||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/KG/MIN|||||HOUNSFIELD UNIT||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|REFRIGERATED|NA|PET/SPECT SCAN|NA|Y|NA||1||38||FOLLOW-UP|1971-02-16|1968-07-23|||||1968-11-12||1971-07-13
TRIAL STUDY 134XCP|IS|42B54D88-E5B5-4828-958B-4B64F07E34B3||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KS|||||10^6/L||||LOW|NOT DONE|||SOFT TISSUE|FRESH|NA|PHASE CONTRAST MICROSCOPY|U|N|Y||2||58||SCREENING|1964-12-31|1961-02-27|||||1962-10-18||1960-03-17
TRIAL STUDY 134XCP|IS|42B54D88-E5B5-4828-958B-4B64F07E34B3||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||STEPS|||||BOX||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|Y|BIOPSY|Y|Y|N||3||39||OBSERVATION|1973-07-15|1960-11-04|||||1964-06-25||1967-02-19
TRIAL STUDY 134XCP|IS|42B54D88-E5B5-4828-958B-4B64F07E34B3||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||COPIES/UL|||||DAYS||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|NON-HEMOLYZED|N|WESTERN BLOT|U|NA|NA||4||88||INDUCTION TREATMENT|1967-08-16|1961-01-25|||||1966-12-17||1969-10-30
TRIAL STUDY 134XCP|IS|42B54D88-E5B5-4828-958B-4B64F07E34B3||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||OSM|||||MG/H||||LOW|NOT DONE|||LAVAGE FLUID|THAWED|N|ANGIOGRAPHY|Y|U|NA||5||7||LONG-TERM FOLLOW-UP|1963-07-14|1960-05-23|||||1964-12-03||1967-07-18
TRIAL STUDY 134XCP|IS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KV|||||MG/H||||LOW|NOT DONE|||BASAL TEAR|AUTOLYZED|Y|SECONDARY ION MASS SPECTOMETRY|Y|U|Y||1||38||INDUCTION TREATMENT|1963-08-31|1971-03-12|||||1966-06-29||1961-02-05
TRIAL STUDY 134XCP|IS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/DL|||||UM||||LOW|NOT DONE|||PLASMA|DRIED|NA|ICP-MS|N|N|U||2||58||OPEN LABEL TREATMENT|1971-04-14|1964-03-28|||||1961-08-21||1960-12-07
TRIAL STUDY 134XCP|IS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||VIRTUAL PIXEL|||||POINT||||HIGH|NOT DONE|||SEMEN|FRESH|Y|IVY INCISION METHOD|NA|U|U||3||39||WASHOUT|1968-06-02|1962-12-30|||||1968-08-27||1964-01-25
TRIAL STUDY 134XCP|IS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||M/SEC2|||||U/M2/MIN||||ABNORMAL|NOT DONE|||BREAST MILK|DRIED|U|PULSE OXIMETRY|N|U|NA||4||88||OPEN LABEL TREATMENT|1971-06-16|1961-02-23|||||1969-05-01||1971-08-08
TRIAL STUDY 134XCP|IS|A48E4CF0-E6BA-415A-9B09-4A14C81AD7D6||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NG|||||KG/CM||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CALCIFIED|Y|ATOMIC ABSORPTION SPECTROMETRY|NA|U|U||5||7||CONTINUATION TREATMENT|1963-02-19|1966-05-28|||||1960-05-25||1963-03-25
TRIAL STUDY 134XCP|IS|1FD985ED-A573-4A00-8902-214A7F182F28||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/M2/DAY|||||PMOL/DAY||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|UNEXPECTED ODOR|NA|TWO-COLOR MICROARRAY|Y|Y|Y||1||38||BLINDED TREATMENT|1968-10-22|1967-08-22|||||1967-01-29||1972-12-29
TRIAL STUDY 134XCP|IS|1FD985ED-A573-4A00-8902-214A7F182F28||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CI/ML|||||U/G||||HIGH|NOT DONE|||AMNIOTIC FLUID|SOLIDIFIED|NA|U-HPLC/MS/MS|U|U|Y||2||58||OBSERVATION|1970-05-12|1972-12-21|||||1964-10-17||1969-05-01
TRIAL STUDY 134XCP|IS|1FD985ED-A573-4A00-8902-214A7F182F28||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^4 CFU/ML|||||/MIN||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|CONTAMINATED|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|U|NA||3||39||LONG-TERM FOLLOW-UP|1964-02-02|1964-11-26|||||1969-06-18||1972-12-08
TRIAL STUDY 134XCP|IS|1FD985ED-A573-4A00-8902-214A7F182F28||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/KG|||||KAT||||LOW|NOT DONE|||PUS|CLOTTED|Y|CALIPER MEASUREMENT METHOD|N|N|N||4||88||SCREENING|1970-01-26|1966-01-09|||||1973-02-23||1969-07-24
TRIAL STUDY 134XCP|IS|1FD985ED-A573-4A00-8902-214A7F182F28||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL|||||CGY||||NORMAL|NOT DONE|||SWABBED MATERIAL|ROOM TEMPERATURE|U|RAJI CELL RIA|N|U|NA||5||7||FOLLOW-UP|1961-06-23|1970-09-26|||||1965-01-24||1967-07-28
TRIAL STUDY 134XCP|IS|A2FD338A-F994-4399-BD02-99CB299F768E||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KG/CM|||||JDF UNIT||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|ROOM TEMPERATURE|Y|MAPH|NA|NA|Y||1||38||SCREENING|1967-12-20|1971-03-12|||||1966-10-19||1969-12-23
TRIAL STUDY 134XCP|IS|A2FD338A-F994-4399-BD02-99CB299F768E||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G/CAGE/DAY|||||AG||||NORMAL|NOT DONE|||CAPILLARY BLOOD|ROOM TEMPERATURE|U|IMPULSE OSCILLOMETRY|U|U|U||2||58||INDUCTION TREATMENT|1970-11-14|1963-08-07|||||1961-07-01||1967-02-04
TRIAL STUDY 134XCP|IS|A2FD338A-F994-4399-BD02-99CB299F768E||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BOLUS|||||G/CAGE/WK||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|REFRIGERATED|U|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|NA|NA|U||3||39||BASELINE|1966-09-30|1962-11-16|||||1971-04-30||1966-07-07
TRIAL STUDY 134XCP|IS|A2FD338A-F994-4399-BD02-99CB299F768E||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MASK|||||COPIES/UL||||LOW|NOT DONE|||BONE MARROW|CONTAMINATED|U|MRS|Y|NA|NA||4||88||BASELINE|1973-08-28|1967-08-28|||||1960-07-03||1968-03-05
TRIAL STUDY 134XCP|IS|A2FD338A-F994-4399-BD02-99CB299F768E||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||H*%|||||TSP||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|FRESH|NA|SEQUENCING|N|N|NA||5||7||OBSERVATION|1960-11-11|1972-11-06|||||1961-03-17||1964-02-23
TRIAL STUDY 134XCP|IS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MGEQ|||||UMOL||||LOW|NOT DONE|||SEMEN|AGGLUTINATED|N|ALCIAN BLUE STAIN|NA|N|NA||1||38||CONTINUATION TREATMENT|1966-01-02|1967-02-21|||||1973-01-22||1965-12-31
TRIAL STUDY 134XCP|IS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS/ML|||||CM H2O||||HIGH|NOT DONE|||EMESIS|REFRIGERATED|U|BETA LACTAMASE|NA|N|U||2||58||OPEN LABEL TREATMENT|1968-05-29|1967-10-07|||||1968-08-19||1965-05-25
TRIAL STUDY 134XCP|IS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||JOULE|||||MIN||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|Y|ELISPOT|NA|U|U||3||39||OBSERVATION|1962-06-01|1964-05-04|||||1972-08-18||1969-01-13
TRIAL STUDY 134XCP|IS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||%/MIN|||||DAGU||||LOW|NOT DONE|||SUPERNATANT, SERUM|CONCENTRATED|NA|STRESS ECHOCARDIOGRAPHY|NA|NA|N||4||88||BLINDED TREATMENT|1970-10-10|1965-12-17|||||1971-09-21||1967-01-13
TRIAL STUDY 134XCP|IS|3FE264AB-FCE4-4EEE-8550-1C43B1B1DF4E||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KALLIKREIN INHIBITOR UNIT|||||MJOULE/CM2||||HIGH|NOT DONE|||PLATELET RICH PLASMA|ICTERIC|NA|IN SITU HYBRIDIZATION|Y|Y|NA||5||7||OBSERVATION|1973-01-07|1971-06-19|||||1968-03-15||1969-05-23
TRIAL STUDY 134XCP|IS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MIN*MG/ML|||||KCAL||||LOW|NOT DONE|||SEMINAL FLUID|CLOTTED|Y|IMMUNOFLUORESCENT STAIN|Y|U|Y||1||38||FOLLOW-UP|1967-09-27|1966-09-23|||||1963-09-08||1965-10-05
TRIAL STUDY 134XCP|IS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UKAT/10^12 RBC|||||OZ EQ||||NORMAL|NOT DONE|||SALIVA|CLOTTED|Y|ENDPOINT DILUTION ASSAY|Y|Y|Y||2||58||INDUCTION TREATMENT|1960-02-16|1971-02-23|||||1964-04-07||1972-12-11
TRIAL STUDY 134XCP|IS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/SEC/1.73M2|||||MG/H||||LOW|NOT DONE|||TUMOR TISSUE|ROOM TEMPERATURE|N|HEMAGGLUTINATION INHIBITION ASSAY|N|U|U||3||39||INDUCTION TREATMENT|1971-01-08|1972-01-25|||||1964-10-22||1968-01-11
TRIAL STUDY 134XCP|IS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PIXELS/IN|||||MPL U/ML||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|ROOM TEMPERATURE|Y|MULTI-SLICE SPIRAL CT|NA|U|NA||4||88||CONTINUATION TREATMENT|1964-11-10|1962-08-08|||||1965-01-08||1966-04-06
TRIAL STUDY 134XCP|IS|284A96C9-F0ED-4B2C-BEEC-A6D24788912C||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MMOL/S|||||IU/G HB||||HIGH|NOT DONE|||PERITONEAL FLUID|SOLIDIFIED|N|FARR ASSAY|Y|U|N||5||7||LONG-TERM FOLLOW-UP|1963-03-25|1961-10-10|||||1970-12-08||1972-09-16
TRIAL STUDY 134XCP|IS|A8821AEE-49EB-4687-BB63-361BC3B8B182||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DRINK|||||ML/G/DAY||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|REFRIGERATED|NA|NUCLEAR RADIOLOGY|NA|N|Y||1||38||OPEN LABEL TREATMENT|1968-04-26|1972-05-21|||||1963-01-13||1972-11-10
TRIAL STUDY 134XCP|IS|A8821AEE-49EB-4687-BB63-361BC3B8B182||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MPA|||||BU||||ABNORMAL|NOT DONE|||NAIL|HEMOLYZED|NA|SLOAN LETTER EYE CHART 100%|N|Y|NA||2||58||TREATMENT|1970-03-17|1963-09-15|||||1963-09-08||1962-07-14
TRIAL STUDY 134XCP|IS|A8821AEE-49EB-4687-BB63-361BC3B8B182||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FMOL/L/SEC|||||UKAT/10^12 RBC||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|ICTERIC|U|RAJI CELL EIA|Y|Y|N||3||39||TREATMENT|1970-06-20|1960-05-16|||||1969-02-20||1960-05-29
TRIAL STUDY 134XCP|IS|A8821AEE-49EB-4687-BB63-361BC3B8B182||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CM/S|||||CD||||NORMAL|NOT DONE|||SERUM OR PLASMA|DRIED|Y|ECHOCARDIOGRAPHY|U|N|Y||4||88||BASELINE|1970-03-31|1965-10-14|||||1962-07-26||1964-02-18
TRIAL STUDY 134XCP|IS|A8821AEE-49EB-4687-BB63-361BC3B8B182||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MET*MIN|||||UIU/L||||LOW|NOT DONE|||INFRANATANT, SERUM|FRESH|NA|ENZYMATIC ULTRACENTRIFUGATION|Y|Y|U||5||7||CONTINUATION TREATMENT|1965-11-20|1973-07-28|||||1966-01-06||1965-04-12
TRIAL STUDY 134XCP|IS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/CAGE|||||UCI||||ABNORMAL|NOT DONE|||SEBUM|FROZEN|Y|OPTICAL MAPPING|Y|U|Y||1||38||OPEN LABEL TREATMENT|1962-07-12|1963-11-10|||||1970-09-09||1968-07-10
TRIAL STUDY 134XCP|IS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMAL|||||MG/ANIMAL||||NORMAL|NOT DONE|||SEBUM|PARAFFIN-EMBEDDED|N|ELISPOT|N|Y|NA||2||58||RUN-IN|1968-11-06|1972-10-10|||||1970-06-03||1961-01-22
TRIAL STUDY 134XCP|IS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||WEBER|||||MM2||||HIGH|NOT DONE|||SERUM OR PLASMA OR BLOOD|DRIED|U|ENDOSCOPY|NA|U|N||3||39||TREATMENT|1965-07-09|1969-06-06|||||1962-07-22||1965-08-12
TRIAL STUDY 134XCP|IS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CAPSULE|||||UV*SEC||||HIGH|NOT DONE|||ISOLATE|LIPEMIC|N|KINETIC CHROMOGENIC ASSAY|N|NA|Y||4||88||OPEN LABEL TREATMENT|1964-02-16|1963-09-20|||||1967-04-30||1967-04-03
TRIAL STUDY 134XCP|IS|B2FE7511-A275-4E2E-85C3-5454FA1C02D1||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/KG|||||UM/S||||NORMAL|NOT DONE|||CAPILLARY PLASMA|CONTAMINATED|Y|DIGITAL PCR|Y|U|U||5||7||BLINDED TREATMENT|1971-07-12|1970-02-12|||||1965-06-18||1973-08-13
TRIAL STUDY 134XCP|IS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||COPIES/UG|||||L/L||||NORMAL|NOT DONE|||SEMEN|CALCIFIED|U|RAJI CELL RIA|U|Y|Y||1||38||FOLLOW-UP|1969-05-11|1967-01-25|||||1967-11-24||1972-07-23
TRIAL STUDY 134XCP|IS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT|||||ML*CMH2O||||NORMAL|NOT DONE|||TRANSUDATE|DRIED|NA|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|NA|Y||2||58||CONTINUATION TREATMENT|1966-02-19|1961-12-24|||||1961-04-18||1969-04-19
TRIAL STUDY 134XCP|IS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/CMH2O|||||PSI||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|LIPEMIC|NA|AURAMINE STAIN|Y|NA|U||3||39||OPEN LABEL TREATMENT|1964-06-21|1970-08-07|||||1963-04-05||1962-05-23
TRIAL STUDY 134XCP|IS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/CAGE/WK|||||FRAMES/S||||NORMAL|NOT DONE|||SEBUM|UNEXPECTED ODOR|N|FUNCTIONAL MRI|N|U|NA||4||88||SCREENING|1962-10-10|1963-11-10|||||1966-05-30||1964-10-24
TRIAL STUDY 134XCP|IS|5F155D7F-6FE9-4AD2-92A2-64A009167BFC||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BEL|||||MG/G/MIN||||LOW|NOT DONE|||SPERMATOZOON|CLOTTED|Y|DUKE INCISION METHOD|N|NA|NA||5||7||INDUCTION TREATMENT|1960-05-15|1969-04-12|||||1960-12-25||1970-04-01
TRIAL STUDY 134XCP|IS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MM3/MM2/YEAR|||||10^6/HPF||||NORMAL|NOT DONE|||BONE MARROW|NON-HEMOLYZED|Y|NUCLEAR RADIOLOGY|N|Y|Y||1||38||WASHOUT|1970-10-08|1962-09-10|||||1969-05-12||1960-01-26
TRIAL STUDY 134XCP|IS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PFU|||||IU/L||||NORMAL|NOT DONE|||AQUEOUS HUMOR|REFRIGERATED|NA|APPLANATION TONOMETRY|U|NA|U||2||58||SCREENING|1972-01-30|1971-04-13|||||1964-08-14||1970-06-04
TRIAL STUDY 134XCP|IS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MU/L|||||APL U||||HIGH|NOT DONE|||LYMPH|CONTAMINATED|NA|MICRODENSITOMETRY|NA|N|NA||3||39||BASELINE|1969-06-04|1963-06-20|||||1968-08-16||1960-02-17
TRIAL STUDY 134XCP|IS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BOX|||||LOG10 PFU/ML||||HIGH|NOT DONE|||SERUM OR PLASMA OR BLOOD|CLOTTED|Y|IMMUNOPRECIPITATION|Y|Y|Y||4||88||LONG-TERM FOLLOW-UP|1970-05-12|1962-01-19|||||1970-06-29||1963-10-09
TRIAL STUDY 134XCP|IS|33CC5FBC-A2B0-4DA3-8DE7-B2281B98511B||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/5X10^4 WBC|||||ML/MIN||||HIGH|NOT DONE|||RETICULOCYTES|LIPEMIC|U|MAGNETIC RESONANCE ENTEROGRAPHY|N|Y|Y||5||7||LONG-TERM FOLLOW-UP|1960-08-15|1963-03-05|||||1973-07-07||1968-12-09
TRIAL STUDY 134XCP|IS|E711C534-E58F-4B41-95CC-24E938D89B61||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||EQ|||||PL||||ABNORMAL|NOT DONE|||PLEURAL FLUID|NON-HEMOLYZED|NA|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|N|NA|N||1||38||FOLLOW-UP|1968-06-07|1967-08-14|||||1963-06-10||1966-01-03
TRIAL STUDY 134XCP|IS|E711C534-E58F-4B41-95CC-24E938D89B61||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MJOULE/CM2|||||MOSM||||LOW|NOT DONE|||ADIPOSE TISSUE|LACTESCENT|NA|OPHTHALMOSCOPY|N|NA|N||2||58||OBSERVATION|1963-10-13|1961-10-26|||||1961-09-09||1971-12-22
TRIAL STUDY 134XCP|IS|E711C534-E58F-4B41-95CC-24E938D89B61||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IU/G HB|||||DDU||||HIGH|NOT DONE|||BUFFY COAT|PARAFFIN-EMBEDDED|NA|PATHOLOGICAL EVALUATION|U|Y|Y||3||39||LONG-TERM FOLLOW-UP|1963-01-05|1973-04-25|||||1960-04-27||1968-06-16
TRIAL STUDY 134XCP|IS|E711C534-E58F-4B41-95CC-24E938D89B61||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||S^-1(%O2)^-1|||||COPIES/ML||||LOW|NOT DONE|||HAIR FOLLICLE|PARAFFIN-EMBEDDED|Y|PET/CT SCAN WITHOUT CONTRAST|N|NA|Y||4||88||FOLLOW-UP|1970-10-20|1960-01-11|||||1962-06-25||1968-08-23
TRIAL STUDY 134XCP|IS|E711C534-E58F-4B41-95CC-24E938D89B61||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/KG/WEEK|||||G/L||||LOW|NOT DONE|||URINE|GELLED|U|KARYOTYPING|N|N|NA||5||7||FOLLOW-UP|1963-10-21|1972-06-16|||||1965-04-01||1964-01-29
TRIAL STUDY 134XCP|IS|83938342-C01F-491A-84A7-F85D327F112D||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/G/H|||||10^6 IU||||LOW|NOT DONE|||URINE SEDIMENT|FRESH|N|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|Y|Y||1||38||OPEN LABEL TREATMENT|1970-07-18|1965-04-19|||||1973-06-12||1969-11-29
TRIAL STUDY 134XCP|IS|83938342-C01F-491A-84A7-F85D327F112D||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UV|||||DPM/ML||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|PARAFFIN-EMBEDDED|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|NA|NA|N||2||58||BLINDED TREATMENT|1963-08-15|1960-08-26|||||1972-05-18||1964-09-09
TRIAL STUDY 134XCP|IS|83938342-C01F-491A-84A7-F85D327F112D||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOL/ML|||||CFU/G||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FROZEN|N|MRI|N|NA|U||3||39||LONG-TERM FOLLOW-UP|1969-07-08|1960-11-07|||||1971-10-05||1965-08-06
TRIAL STUDY 134XCP|IS|83938342-C01F-491A-84A7-F85D327F112D||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/KG/MIN|||||DAMOL/L||||NORMAL|NOT DONE|||LYMPH|SOLIDIFIED|N|VENTILATION PERFUSION LUNG SCAN|U|U|Y||4||88||INDUCTION TREATMENT|1963-05-27|1967-11-12|||||1973-01-11||1967-08-04
TRIAL STUDY 134XCP|IS|83938342-C01F-491A-84A7-F85D327F112D||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||RFU|||||PRESSOR UNITS||||NORMAL|NOT DONE|||CORD SERUM|REFRIGERATED|Y|CALCULATION|N|NA|N||5||7||OPEN LABEL TREATMENT|1971-04-09|1961-02-27|||||1969-10-11||1965-04-25
TRIAL STUDY 134XCP|IS|731665AB-4418-4943-BFC5-D78F03C8D423||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UCI/L|||||ML/MIN||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|NA|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|U|N||1||38||SCREENING|1963-11-26|1970-02-05|||||1971-12-06||1962-09-28
TRIAL STUDY 134XCP|IS|731665AB-4418-4943-BFC5-D78F03C8D423||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/KG/DAY|||||G/KG||||NORMAL|NOT DONE|||SERUM|AGGLUTINATED|NA|POLYGRAPHY|U|NA|U||2||58||OPEN LABEL TREATMENT|1965-07-25|1964-09-14|||||1962-06-26||1969-07-13
TRIAL STUDY 134XCP|IS|731665AB-4418-4943-BFC5-D78F03C8D423||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NEBULE|||||ML/ANIMAL/DAY||||LOW|NOT DONE|||SEMEN|PARAFFIN-EMBEDDED|NA|TRYPAN BLUE STAIN|NA|N|U||3||39||LONG-TERM FOLLOW-UP|1969-08-17|1960-10-08|||||1970-12-17||1968-03-20
TRIAL STUDY 134XCP|IS|731665AB-4418-4943-BFC5-D78F03C8D423||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||RPM|||||/MIN||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|GELLED|NA|MANUAL CLOT DETECTION|NA|N|NA||4||88||BASELINE|1970-02-20|1964-02-28|||||1970-09-08||1960-11-30
TRIAL STUDY 134XCP|IS|731665AB-4418-4943-BFC5-D78F03C8D423||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3/HPF|||||CAPLET||||NORMAL|NOT DONE|||DERMAL TISSUE|ROOM TEMPERATURE|N|PHOTOGRAPHY|U|NA|U||5||7||OPEN LABEL TREATMENT|1970-06-30|1967-07-06|||||1969-04-03||1964-02-27
TRIAL STUDY 134XCP|IS|3E337B9F-D718-4FE6-83D8-E05BC77CA872||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MESF|||||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE|||DISCHARGE|CLOTTED|NA|SLOAN LETTER EYE CHART 100%|N|Y|U||1||38||WASHOUT|1961-07-11|1972-07-31|||||1967-07-11||1966-03-08
TRIAL STUDY 134XCP|IS|3E337B9F-D718-4FE6-83D8-E05BC77CA872||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CAL|||||/MM||||HIGH|NOT DONE|||MUSCLE TISSUE|SOLIDIFIED|Y|INDIRECT IMMUNOFLUORESCENCE|NA|NA|Y||2||58||WASHOUT|1968-08-04|1965-04-12|||||1962-02-01||1968-05-12
TRIAL STUDY 134XCP|IS|3E337B9F-D718-4FE6-83D8-E05BC77CA872||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 TCID 50/ML|||||HOUNSFIELD UNIT||||LOW|NOT DONE|||PROSTATIC FLUID|CONTAMINATED|Y|SURFACE PLASMON RESONANCE|Y|NA|U||3||39||INDUCTION TREATMENT|1970-11-23|1970-12-20|||||1967-06-20||1968-11-22
TRIAL STUDY 134XCP|IS|3E337B9F-D718-4FE6-83D8-E05BC77CA872||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||% INHIBITION|||||MOSM/KG||||HIGH|NOT DONE|||VENOUS CORD BLOOD|CONCENTRATED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|N|U|Y||4||88||FOLLOW-UP|1970-06-11|1963-03-05|||||1969-06-12||1966-06-11
TRIAL STUDY 134XCP|IS|3E337B9F-D718-4FE6-83D8-E05BC77CA872||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KG/MOL|||||HR/DAY||||LOW|NOT DONE|||SYNOVIAL FLUID|REFRIGERATED|NA|SXA SCAN|NA|U|U||5||7||TREATMENT|1960-07-26|1972-05-10|||||1961-05-18||1960-07-16
TRIAL STUDY 134XCP|IS|D5243E6E-2521-4331-ABFB-75112D06F771||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CI/L|||||DNA COPIES/ML||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|UNEXPECTED ODOR|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|U|NA|Y||1||38||SCREENING|1960-07-01|1973-07-30|||||1970-11-14||1971-12-31
TRIAL STUDY 134XCP|IS|D5243E6E-2521-4331-ABFB-75112D06F771||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BAU|||||IU/DAY||||LOW|NOT DONE|||CERUMEN|CONCENTRATED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|N|Y||2||58||BLINDED TREATMENT|1961-05-23|1967-01-19|||||1970-08-08||1969-05-09
TRIAL STUDY 134XCP|IS|D5243E6E-2521-4331-ABFB-75112D06F771||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||SBE/ML|||||ENZYME U||||ABNORMAL|NOT DONE|||INFRANATANT, SERUM|CALCIFIED|U|DC SHEATH FLOW|Y|N|U||3||39||LONG-TERM FOLLOW-UP|1969-03-11|1973-09-05|||||1968-07-04||1967-12-31
TRIAL STUDY 134XCP|IS|D5243E6E-2521-4331-ABFB-75112D06F771||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||HPA|||||G/G/DAY||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|ICTERIC|Y|OBSERVATION|N|N|N||4||88||CONTINUATION TREATMENT|1973-01-06|1961-10-02|||||1967-11-12||1970-06-14
TRIAL STUDY 134XCP|IS|D5243E6E-2521-4331-ABFB-75112D06F771||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GMFI|||||CY/CM||||HIGH|NOT DONE|||BASAL TEAR|ROOM TEMPERATURE|U|FARR ASSAY|Y|NA|U||5||7||INDUCTION TREATMENT|1971-08-11|1963-03-09|||||1964-10-22||1972-06-04
TRIAL STUDY 134XCP|IS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PMOL/10^9 CELLS|||||BU||||NORMAL|NOT DONE|||DISCHARGE|HEMOLYZED|N|DNA MICROARRAY|NA|NA|NA||1||38||TREATMENT|1961-10-17|1970-12-21|||||1968-02-08||1970-06-07
TRIAL STUDY 134XCP|IS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PT_BR|||||CMH2O/ML||||ABNORMAL|NOT DONE|||SMEGMA|GELLED|Y|FLUORESCENT SPOT TEST|N|N|N||2||58||TREATMENT|1969-03-06|1960-10-20|||||1973-03-11||1969-12-25
TRIAL STUDY 134XCP|IS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/CAGE|||||MS/MMHG||||HIGH|NOT DONE|||URINE SEDIMENT|AUTOLYZED|NA|SPECTROPHOTOMETRY|N|NA|Y||3||39||LONG-TERM FOLLOW-UP|1966-10-06|1961-10-10|||||1971-05-14||1966-10-19
TRIAL STUDY 134XCP|IS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/CM2|||||MEQ/ML||||ABNORMAL|NOT DONE|||CERUMEN|CONTAMINATED|Y|MACRO BROTH DILUTION|Y|N|U||4||88||INDUCTION TREATMENT|1971-10-23|1961-01-25|||||1969-10-19||1966-09-05
TRIAL STUDY 134XCP|IS|AD9332D4-879F-4CD3-BA96-C6FF69CF85AC||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||L|||||ML/100G/MIN||||HIGH|NOT DONE|||EPIDERMAL TISSUE|CONTAMINATED|U|SXA SCAN|N|N|NA||5||7||WASHOUT|1962-11-26|1971-04-26|||||1967-05-08||1973-08-20
TRIAL STUDY 134XCP|IS|5B3E406E-F2A5-4F25-8271-DC1FABA40138||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||COAT|||||PNU/ML||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|FRESH|N|SLOAN LETTER EYE CHART 1.25%|U|NA|N||1||38||WASHOUT|1969-03-09|1960-01-31|||||1962-03-21||1965-10-01
TRIAL STUDY 134XCP|IS|5B3E406E-F2A5-4F25-8271-DC1FABA40138||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||L/MIN/M2|||||MOL/MG||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR|Y|MS/MS|Y|NA|U||2||58||OPEN LABEL TREATMENT|1962-11-01|1969-08-28|||||1961-03-19||1967-01-09
TRIAL STUDY 134XCP|IS|5B3E406E-F2A5-4F25-8271-DC1FABA40138||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PATCH|||||MG/M2||||HIGH|NOT DONE|||KERATINOCYTE|REFRIGERATED|U|CONGO RED STAIN|NA|NA|U||3||39||OPEN LABEL TREATMENT|1963-11-01|1966-07-09|||||1968-11-01||1969-02-05
TRIAL STUDY 134XCP|IS|5B3E406E-F2A5-4F25-8271-DC1FABA40138||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||AMU|||||10^6 DNA COPIES/ML||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|N|IMMUNOPRECIPITATION|NA|NA|U||4||88||CONTINUATION TREATMENT|1968-09-01|1972-11-07|||||1971-06-07||1973-07-27
TRIAL STUDY 134XCP|IS|5B3E406E-F2A5-4F25-8271-DC1FABA40138||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FG|||||DIP||||HIGH|NOT DONE|||BUFFY COAT|AUTOLYZED|Y|BIOIMPEDANCE SPECTROSCOPY|N|N|N||5||7||OBSERVATION|1960-05-05|1970-03-15|||||1963-01-05||1961-08-15
TRIAL STUDY 134XCP|IS|D5262627-52D7-42F5-B4BA-D7E6FA243959||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||STRIP|||||10^10/L||||HIGH|NOT DONE|||ADIPOSE TISSUE|LACTESCENT|U|IMMUNOPRECIPITATION|NA|U|NA||1||38||WASHOUT|1970-04-27|1962-05-11|||||1969-11-13||1970-06-03
TRIAL STUDY 134XCP|IS|D5262627-52D7-42F5-B4BA-D7E6FA243959||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^4 CFU/ML|||||RFU||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|THAWED|NA|FLOW CYTOMETRY|NA|N|U||2||58||BASELINE|1967-04-19|1963-08-01|||||1966-09-16||1972-04-15
TRIAL STUDY 134XCP|IS|D5262627-52D7-42F5-B4BA-D7E6FA243959||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CI/UL|||||UEQ/L||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|CLOTTED|N|DROPLET DIGITAL PCR|Y|N|NA||3||39||BLINDED TREATMENT|1972-03-02|1961-06-14|||||1972-04-20||1970-09-07
TRIAL STUDY 134XCP|IS|D5262627-52D7-42F5-B4BA-D7E6FA243959||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MPS U|||||FRAMES/S||||LOW|NOT DONE|||HAIR|FRESH|Y|ELLA|U|Y|Y||4||88||LONG-TERM FOLLOW-UP|1966-01-26|1972-08-04|||||1960-09-26||1966-04-21
TRIAL STUDY 134XCP|IS|D5262627-52D7-42F5-B4BA-D7E6FA243959||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TSP|||||GMFI||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|CALCIFIED|N|IMPULSE OSCILLOMETRY|NA|U|N||5||7||WASHOUT|1973-03-12|1970-08-01|||||1969-12-14||1964-03-19
TRIAL STUDY 134XCP|IS|C550278D-F171-42D0-8C34-D60824A3FE98||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 COPIES/ML|||||PMOL/DL||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|FRESH|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|NA|Y|Y||1||38||OPEN LABEL TREATMENT|1969-12-30|1963-10-11|||||1966-08-28||1973-04-14
TRIAL STUDY 134XCP|IS|C550278D-F171-42D0-8C34-D60824A3FE98||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UIU/L|||||ML*CMH2O||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|DRIED|Y|IHC|U|Y|U||2||58||LONG-TERM FOLLOW-UP|1965-06-27|1961-07-16|||||1969-04-13||1964-06-17
TRIAL STUDY 134XCP|IS|C550278D-F171-42D0-8C34-D60824A3FE98||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DRAM|||||M||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|AGGLUTINATED|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|Y|NA||3||39||BLINDED TREATMENT|1969-08-15|1967-08-07|||||1963-09-27||1972-04-05
TRIAL STUDY 134XCP|IS|C550278D-F171-42D0-8C34-D60824A3FE98||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BAU/ML|||||L/S/KPA||||HIGH|NOT DONE|||BONE MARROW MONONUCLEAR CELL|AGGLUTINATED|Y|LIGHT SCATTERING SPECTROSCOPY|N|NA|N||4||88||WASHOUT|1971-08-08|1964-11-19|||||1964-05-16||1967-02-23
TRIAL STUDY 134XCP|IS|C550278D-F171-42D0-8C34-D60824A3FE98||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PKAT/L|||||PIXELS/CM||||NORMAL|NOT DONE|||NAIL|SOLIDIFIED|N|DUKE INCISION METHOD|NA|NA|N||5||7||OBSERVATION|1968-01-02|1973-01-27|||||1962-10-02||1970-08-12
TRIAL STUDY 134XCP|IS|5E76262E-FE1E-40C9-B147-3C792F768F48||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||PKAT|||||MOL/ML||||ABNORMAL|NOT DONE|||LYSATE|SOLIDIFIED|NA|INTERRUPTER TECHNIQUE|Y|U|U||1||38||BLINDED TREATMENT|1963-02-03|1973-07-06|||||1966-01-07||1960-11-11
TRIAL STUDY 134XCP|IS|5E76262E-FE1E-40C9-B147-3C792F768F48||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TRACE|||||UCI/L||||ABNORMAL|NOT DONE|||PLEURAL FLUID|ICTERIC|NA|IODINE STAIN|U|N|NA||2||58||OPEN LABEL TREATMENT|1963-03-12|1961-08-12|||||1961-01-16||1965-02-01
TRIAL STUDY 134XCP|IS|5E76262E-FE1E-40C9-B147-3C792F768F48||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BAU|||||MG/MIN||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM|FROZEN|U|TOTAL BODY RADIOGRAPHY|NA|U|U||3||39||WASHOUT|1961-02-05|1968-03-21|||||1969-06-20||1960-10-07
TRIAL STUDY 134XCP|IS|5E76262E-FE1E-40C9-B147-3C792F768F48||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GRAIN|||||KM||||NORMAL|NOT DONE|||ISOLATE|REFRIGERATED|N|KINETIC MICROPARTICLE IMMUNOASSAY|U|N|N||4||88||BLINDED TREATMENT|1962-06-06|1962-01-23|||||1968-10-15||1962-11-25
TRIAL STUDY 134XCP|IS|5E76262E-FE1E-40C9-B147-3C792F768F48||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DROP|||||UOSM||||LOW|NOT DONE|||INTERSTITIAL FLUID|HEMOLYZED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|NA|NA|U||5||7||CONTINUATION TREATMENT|1971-05-02|1970-05-28|||||1962-07-24||1969-06-21
TRIAL STUDY 134XCP|IS|2F21921D-D18C-43EE-A39E-91A93B262B8C||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL|||||FG||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|DRIED|N|MICRONEUTRALIZATION ASSAY|NA|N|Y||1||38||TREATMENT|1969-01-16|1963-02-08|||||1964-12-29||1972-10-25
TRIAL STUDY 134XCP|IS|2F21921D-D18C-43EE-A39E-91A93B262B8C||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||STEPS/MIN|||||/MIN||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|FRESH|NA|DOPPLER ULTRASOUND|Y|NA|NA||2||58||TREATMENT|1971-12-30|1963-01-17|||||1968-06-06||1973-06-03
TRIAL STUDY 134XCP|IS|2F21921D-D18C-43EE-A39E-91A93B262B8C||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/KG|||||NMOL/G||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|SOLIDIFIED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|U|Y||3||39||INDUCTION TREATMENT|1966-12-31|1962-09-24|||||1970-05-09||1963-09-10
TRIAL STUDY 134XCP|IS|2F21921D-D18C-43EE-A39E-91A93B262B8C||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/DOSE|||||DPM/100MG||||NORMAL|NOT DONE|||GASTRIC FLUID|NON-HEMOLYZED|U|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|U|U|NA||4||88||WASHOUT|1968-05-28|1969-02-13|||||1969-07-22||1968-05-04
TRIAL STUDY 134XCP|IS|2F21921D-D18C-43EE-A39E-91A93B262B8C||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FEU|||||BAG||||HIGH|NOT DONE|||MECONIUM|CONCENTRATED|N|SPECT/CT SCAN|N|U|U||5||7||INDUCTION TREATMENT|1964-10-20|1960-12-01|||||1971-03-16||1968-10-30
TRIAL STUDY 134XCP|IS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG EID 50/DOSE|||||U/KG/MIN||||NORMAL|NOT DONE|||SOFT TISSUE|AGGLUTINATED|Y|PET/MRI SCAN|U|NA|N||1||38||WASHOUT|1968-07-21|1968-04-29|||||1971-11-08||1966-11-12
TRIAL STUDY 134XCP|IS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||GRAIN|||||RAD||||LOW|NOT DONE|||BASAL TEAR|CLOTTED|N|FARNSWORTH-MUNSELL 100 HUE TEST|Y|U|Y||2||58||OBSERVATION|1968-03-08|1960-12-10|||||1968-09-18||1972-06-29
TRIAL STUDY 134XCP|IS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||% INHIBITION|||||PSEC||||NORMAL|NOT DONE|||DERMAL TISSUE|PARAFFIN-EMBEDDED|U|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|NA|U||3||39||RUN-IN|1962-08-31|1965-08-24|||||1970-06-24||1969-09-15
TRIAL STUDY 134XCP|IS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EVENTS|||||SBE/ML||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|REFRIGERATED|N|CLINICAL EVALUATION|N|U|U||4||88||INDUCTION TREATMENT|1965-08-04|1962-03-23|||||1963-02-24||1969-03-13
TRIAL STUDY 134XCP|IS|B2AAF3FD-AA9B-4BA9-8DE5-4C4BA12ECEBC||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACK|||||TUBE||||LOW|NOT DONE|||TRANSUDATE|DRIED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|NA|U||5||7||CONTINUATION TREATMENT|1962-07-01|1972-06-16|||||1969-10-23||1966-09-19
TRIAL STUDY 134XCP|IS|55985646-0224-4442-90C5-EFEDF990E88C||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 DNA COPIES/ML|||||10^6 ORGANISMS||||LOW|NOT DONE|||BUFFY COAT|DRIED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|N|Y|U||1||38||TREATMENT|1964-08-27|1970-06-17|||||1966-01-22||1961-12-29
TRIAL STUDY 134XCP|IS|55985646-0224-4442-90C5-EFEDF990E88C||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CAL|||||NEBULE||||NORMAL|NOT DONE|||SPUTUM|LIPEMIC|NA|ELECTROPHORESIS|U|N|N||2||58||OBSERVATION|1970-11-23|1970-07-18|||||1965-04-12||1961-10-14
TRIAL STUDY 134XCP|IS|55985646-0224-4442-90C5-EFEDF990E88C||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/M2/H|||||MMHG/L/MIN||||LOW|NOT DONE|||VENOUS BLOOD|SOLIDIFIED|U|GC/MS|U|N|N||3||39||TREATMENT|1966-08-28|1960-01-05|||||1972-08-19||1961-03-07
TRIAL STUDY 134XCP|IS|55985646-0224-4442-90C5-EFEDF990E88C||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/ANIMAL|||||FEU||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|NA|PHOTOGRAPHY|Y|NA|NA||4||88||BASELINE|1970-01-31|1962-11-12|||||1970-07-26||1963-06-07
TRIAL STUDY 134XCP|IS|55985646-0224-4442-90C5-EFEDF990E88C||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/L|||||MEQ/UG||||NORMAL|NOT DONE|||INTERSTITIAL FLUID|CONCENTRATED|Y|SCANNING ELECTRON MICROSCOPY|U|U|U||5||7||WASHOUT|1966-11-13|1970-04-21|||||1973-04-11||1972-02-21
TRIAL STUDY 134XCP|IS|86509C90-3C57-4755-A06F-79C620779371||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MPL U|||||MG/L FEU||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|FRESH|Y|ELECTROCHEMILUMINESCENCE|U|U|NA||1||38||RUN-IN|1972-12-25|1971-09-06|||||1969-07-23||1967-11-07
TRIAL STUDY 134XCP|IS|86509C90-3C57-4755-A06F-79C620779371||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CD/M2|||||EID 50/DOSE||||NORMAL|NOT DONE|||SERUM|GELLED|U|TOTAL BODY RADIOGRAPHY|Y|NA|N||2||58||SCREENING|1971-10-09|1972-05-08|||||1961-05-21||1960-07-26
TRIAL STUDY 134XCP|IS|86509C90-3C57-4755-A06F-79C620779371||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CD/M2|||||FEU||||LOW|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|LIPEMIC|Y|FLUORESCENT SPOT TEST|Y|NA|U||3||39||OBSERVATION|1966-01-25|1969-06-23|||||1973-06-01||1972-05-18
TRIAL STUDY 134XCP|IS|86509C90-3C57-4755-A06F-79C620779371||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMOL|||||MET||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|LIPEMIC|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|Y|N||4||88||BLINDED TREATMENT|1966-04-18|1965-04-23|||||1969-06-17||1967-07-09
TRIAL STUDY 134XCP|IS|86509C90-3C57-4755-A06F-79C620779371||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FMOL|||||MGEQ||||NORMAL|NOT DONE|||PLATELET|CALCIFIED|Y|MICROARRAY|N|NA|Y||5||7||SCREENING|1965-08-12|1970-01-13|||||1964-04-26||1963-08-11
TRIAL STUDY 134XCP|IS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UEQ|||||AU/ML||||HIGH|NOT DONE|||BONE|UNEXPECTED ODOR|N|MULTIPLE BREATH WASHOUT|Y|NA|N||1||38||OBSERVATION|1964-10-23|1967-11-08|||||1962-02-27||1967-01-29
TRIAL STUDY 134XCP|IS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ELISA UNIT/ML|||||MAMP||||HIGH|NOT DONE|||MENSTRUAL BLOOD|LACTESCENT|N|SPIROMETRY|U|N|NA||2||58||BASELINE|1961-08-23|1969-12-18|||||1968-03-09||1970-05-26
TRIAL STUDY 134XCP|IS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GPL U|||||VIRTUAL PIXEL||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|FROZEN|Y|PHASE CONTRAST MICROSCOPY|U|N|U||3||39||OPEN LABEL TREATMENT|1968-04-20|1963-09-15|||||1971-06-25||1966-12-24
TRIAL STUDY 134XCP|IS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BQ/ML|||||MG/KG/DAY||||HIGH|NOT DONE|||VITREOUS HUMOR|PARAFFIN-EMBEDDED|NA|HEMAGGLUTINATION ASSAY|N|NA|N||4||88||CONTINUATION TREATMENT|1972-06-25|1967-01-08|||||1968-11-15||1964-07-30
TRIAL STUDY 134XCP|IS|8C9966BC-922D-4F74-9057-B2DE1DEF21E3||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/DAY|||||MCI||||LOW|NOT DONE|||BASAL TEAR|LACTESCENT|N|SPECT SCAN|U|Y|N||5||7||INDUCTION TREATMENT|1968-04-24|1970-10-06|||||1971-09-03||1962-09-29
TRIAL STUDY 134XCP|IS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/DL|||||LOG10 CFU/ML||||ABNORMAL|NOT DONE|||NAIL|AUTOLYZED|U|FLUORIMETRY|NA|Y|N||1||38||SCREENING|1965-12-05|1963-02-27|||||1965-09-07||1963-10-21
TRIAL STUDY 134XCP|IS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 IU/ML|||||MMOL||||HIGH|NOT DONE|||SALIVA|LACTESCENT|N|INCISION-INDUCED BLEEDING METHOD|N|U|N||2||58||FOLLOW-UP|1964-10-29|1965-08-27|||||1963-08-05||1963-06-21
TRIAL STUDY 134XCP|IS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PKAT/L|||||PUFF||||ABNORMAL|NOT DONE|||PLASMA|AGGLUTINATED|NA|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|U|Y|NA||3||39||OPEN LABEL TREATMENT|1962-02-14|1967-02-04|||||1964-11-08||1960-08-04
TRIAL STUDY 134XCP|IS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/H/MMOL|||||MPL U||||NORMAL|NOT DONE|||PLEURAL TISSUE|GELLED|N|DIGITAL PCR ARRAY|NA|N|U||4||88||INDUCTION TREATMENT|1961-04-14|1971-07-29|||||1968-03-24||1972-06-25
TRIAL STUDY 134XCP|IS|FDE870DC-5091-4CAE-9E47-88F2F4D95FE1||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPTH|||||UU/L||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|LIPEMIC|U|VENTILATION PERFUSION LUNG SCAN|U|U|U||5||7||CONTINUATION TREATMENT|1962-05-13|1971-01-22|||||1973-02-09||1970-02-09
TRIAL STUDY 134XCP|IS|0FFBFF7C-7C64-411E-8D07-C959F0886023||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MV|||||MG/H||||LOW|NOT DONE|||ERYTHROCYTES|LACTESCENT|NA|NO INFORMATION|Y|NA|NA||1||38||RUN-IN|1962-10-22|1960-11-18|||||1964-08-17||1970-11-27
TRIAL STUDY 134XCP|IS|0FFBFF7C-7C64-411E-8D07-C959F0886023||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||YEARS|||||FL||||NORMAL|NOT DONE|||INFRANATANT, SERUM|UNEXPECTED ODOR|Y|MECHANICAL CLOT DETECTION|N|N|NA||2||58||BLINDED TREATMENT|1964-07-20|1971-06-26|||||1971-11-19||1962-04-12
TRIAL STUDY 134XCP|IS|0FFBFF7C-7C64-411E-8D07-C959F0886023||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UL/DOSE|||||COULOMB||||LOW|NOT DONE|||MENSTRUAL BLOOD|DRIED|Y|JAFFE REACTION|NA|U|Y||3||39||LONG-TERM FOLLOW-UP|1968-01-13|1969-09-06|||||1963-08-21||1969-11-03
TRIAL STUDY 134XCP|IS|0FFBFF7C-7C64-411E-8D07-C959F0886023||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||USP U|||||ML/ANIMAL/WK||||NORMAL|NOT DONE|||BREAST MILK|CONCENTRATED|N|CONTRAST ENHANCED SPIRAL CT SCAN|Y|Y|N||4||88||CONTINUATION TREATMENT|1969-12-28|1965-06-02|||||1972-02-04||1973-08-30
TRIAL STUDY 134XCP|IS|0FFBFF7C-7C64-411E-8D07-C959F0886023||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^7/L|||||CCID 50/ML||||ABNORMAL|NOT DONE|||BUFFY COAT|LIPEMIC|Y|POTENTIOMETRY|N|NA|NA||5||7||CONTINUATION TREATMENT|1963-03-05|1962-10-14|||||1969-08-16||1973-05-07
TRIAL STUDY 134XCP|IS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/100 WBC|||||KG/CM||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|HEMOLYZED|Y|PET SCAN|NA|Y|NA||1||38||FOLLOW-UP|1968-11-20|1960-03-29|||||1968-03-28||1969-07-14
TRIAL STUDY 134XCP|IS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ABSORBANCE U|||||UV2||||ABNORMAL|NOT DONE|||CORD SERUM|LIPEMIC|N|DOUBLE IMMUNODIFFUSION|U|N|NA||2||58||TREATMENT|1962-10-05|1962-08-03|||||1967-02-19||1970-12-08
TRIAL STUDY 134XCP|IS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/KG/H|||||BREATHS/MIN||||ABNORMAL|NOT DONE|||STOOL|DRIED|Y|CONTACT SPECULAR MICROSCOPY|NA|N|NA||3||39||BASELINE|1970-01-26|1965-06-20|||||1962-08-10||1961-01-22
TRIAL STUDY 134XCP|IS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/7.5 ML|||||ML/S/M2||||ABNORMAL|NOT DONE|||CORD SERUM|SOLIDIFIED|U|CALCOFLUOR WHITE STAIN|Y|N|Y||4||88||BASELINE|1961-07-27|1964-09-13|||||1971-10-21||1970-05-01
TRIAL STUDY 134XCP|IS|75BC43A6-C796-48F7-9F2B-B24E7D5D5C51||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||JOULE|||||NL||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|CONCENTRATED|Y|MOUSE PROTECTION ASSAY|NA|U|U||5||7||BASELINE|1967-08-02|1960-07-23|||||1960-07-17||1972-12-25
TRIAL STUDY 134XCP|IS|5DC5F780-264A-4EB1-BEA5-28209D416FEB||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL BCE/MMOL|||||KHZ||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|ICTERIC|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|U|NA|Y||1||38||OBSERVATION|1960-07-24|1970-06-02|||||1965-08-13||1970-09-15
TRIAL STUDY 134XCP|IS|5DC5F780-264A-4EB1-BEA5-28209D416FEB||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BU|||||NMOL/L||||NORMAL|NOT DONE|||FLUID|UNEXPECTED ODOR|NA|HANSEL STAIN|N|U|Y||2||58||OPEN LABEL TREATMENT|1965-02-02|1960-11-15|||||1970-05-29||1967-09-27
TRIAL STUDY 134XCP|IS|5DC5F780-264A-4EB1-BEA5-28209D416FEB||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CAPFUL|||||LOG10 CFU/G||||NORMAL|NOT DONE|||DISCHARGE|CONTAMINATED|U|POLYGRAPHY|N|U|Y||3||39||BLINDED TREATMENT|1965-12-04|1966-07-19|||||1961-10-21||1962-07-07
TRIAL STUDY 134XCP|IS|5DC5F780-264A-4EB1-BEA5-28209D416FEB||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NMOL/G|||||ML*CMH2O||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|THAWED|Y|PERCUSSION|U|N|N||4||88||LONG-TERM FOLLOW-UP|1966-11-27|1965-01-27|||||1971-10-05||1971-03-07
TRIAL STUDY 134XCP|IS|5DC5F780-264A-4EB1-BEA5-28209D416FEB||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MN|||||USEC||||HIGH|NOT DONE|||AQUEOUS HUMOR|FRESH|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|Y|U|NA||5||7||CONTINUATION TREATMENT|1971-09-29|1962-04-27|||||1960-11-15||1972-02-24
TRIAL STUDY 134XCP|IS|DDBCA084-DD05-4FA0-9083-7CD31CECA420||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DIP|||||10^6/L||||ABNORMAL|NOT DONE|||MONOCYTE|GELLED|NA|COULOMETRIC TITRATION|U|U|NA||1||38||CONTINUATION TREATMENT|1961-01-17|1972-02-10|||||1969-09-24||1968-05-02
TRIAL STUDY 134XCP|IS|DDBCA084-DD05-4FA0-9083-7CD31CECA420||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/DAY|||||UEQ/L||||ABNORMAL|NOT DONE|||BASAL TEAR|CLOTTED|Y|ETDRS EYE CHART|Y|NA|NA||2||58||CONTINUATION TREATMENT|1970-09-18|1972-08-17|||||1972-07-24||1960-01-03
TRIAL STUDY 134XCP|IS|DDBCA084-DD05-4FA0-9083-7CD31CECA420||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BQ/G|||||UM2||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|FROZEN|U|RADIATION DOSIMETRY|U|NA|Y||3||39||SCREENING|1960-07-27|1966-12-30|||||1965-05-10||1969-12-02
TRIAL STUDY 134XCP|IS|DDBCA084-DD05-4FA0-9083-7CD31CECA420||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MONTHS|||||UG/G/MIN||||LOW|NOT DONE|||PERITONEAL FLUID|CONTAMINATED|Y|PHYSICAL EXAMINATION|U|Y|N||4||88||SCREENING|1972-02-09|1972-09-15|||||1972-07-12||1965-07-09
TRIAL STUDY 134XCP|IS|DDBCA084-DD05-4FA0-9083-7CD31CECA420||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/KG/DAY|||||10^10/L||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|HEMOLYZED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|Y|Y||5||7||BASELINE|1960-12-26|1969-06-26|||||1965-11-28||1970-07-14
TRIAL STUDY 134XCP|IS|65A5AAA6-A817-45F8-9BA8-584E9627AB26||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KPA|||||MMOL/MOL||||HIGH|NOT DONE|||LEUKOCYTE|REFRIGERATED|NA|KINETIC CHROMOGENIC ASSAY|U|U|NA||1||38||OBSERVATION|1967-09-03|1960-11-14|||||1973-04-25||1967-09-22
TRIAL STUDY 134XCP|IS|65A5AAA6-A817-45F8-9BA8-584E9627AB26||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KBQ|||||UMOL/MIN||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|AUTOLYZED|NA|MYELOPEROXIDASE STAIN|N|N|Y||2||58||WASHOUT|1971-01-08|1972-05-02|||||1968-10-19||1968-09-29
TRIAL STUDY 134XCP|IS|65A5AAA6-A817-45F8-9BA8-584E9627AB26||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||M3|||||DRUM||||LOW|NOT DONE|||MENSTRUAL BLOOD|FROZEN|U|PHOTOMETRIC CLOT DETECTION|NA|N|U||3||39||OPEN LABEL TREATMENT|1964-11-22|1968-10-09|||||1963-05-15||1962-10-20
TRIAL STUDY 134XCP|IS|65A5AAA6-A817-45F8-9BA8-584E9627AB26||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/L/H|||||PPTH||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|ICTERIC|Y|LINE PROBE ASSAY|NA|NA|NA||4||88||WASHOUT|1964-06-25|1964-03-12|||||1967-08-10||1971-02-11
TRIAL STUDY 134XCP|IS|65A5AAA6-A817-45F8-9BA8-584E9627AB26||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/MOL|||||MN||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONCENTRATED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|Y|Y||5||7||BLINDED TREATMENT|1968-12-29|1972-11-23|||||1967-07-15||1968-02-09
TRIAL STUDY 134XCP|IS|854AD9A5-A869-41C7-9AF0-43383CE64B86||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BE/ML|||||U/G/DAY||||LOW|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|Y|SCANNING ELECTRON MICROSCOPY|NA|NA|U||1||38||FOLLOW-UP|1965-02-18|1963-07-01|||||1968-07-13||1969-03-25
TRIAL STUDY 134XCP|IS|854AD9A5-A869-41C7-9AF0-43383CE64B86||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL/DAY|||||ABSORBANCE U/MIN||||ABNORMAL|NOT DONE|||SERUM|THAWED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|N|N|Y||2||58||FOLLOW-UP|1967-07-13|1972-05-09|||||1973-06-30||1968-09-10
TRIAL STUDY 134XCP|IS|854AD9A5-A869-41C7-9AF0-43383CE64B86||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/ANIMAL/DAY|||||MHZ||||HIGH|NOT DONE|||SPERMATOZOON|AUTOLYZED|N|IMMUNO-PET SCAN|Y|Y|Y||3||39||CONTINUATION TREATMENT|1970-02-14|1965-09-30|||||1965-06-15||1973-03-01
TRIAL STUDY 134XCP|IS|854AD9A5-A869-41C7-9AF0-43383CE64B86||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TRANSDUCING UNIT|||||POINT||||NORMAL|NOT DONE|||SOFT TISSUE|PARAFFIN-EMBEDDED|NA|HPLC-FL|NA|Y|NA||4||88||WASHOUT|1971-09-14|1968-11-29|||||1965-05-31||1973-03-30
TRIAL STUDY 134XCP|IS|854AD9A5-A869-41C7-9AF0-43383CE64B86||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||QUANTITY SUFFICIENT|||||MM3/MM2/YEAR||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CONTAMINATED|Y|MICROBIAL CONCENTRATION|N|Y|N||5||7||INDUCTION TREATMENT|1964-02-23|1964-02-23|||||1961-08-31||1968-05-28
TRIAL STUDY 134XCP|IS|008F02C8-B28A-490E-A77A-F32584DA06FA||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ENZYME U/M2|||||USIEMENS||||ABNORMAL|NOT DONE|||HAIR|HEMOLYZED|NA|SLIT LAMP PHOTOGRAPHY|NA|Y|NA||1||38||BLINDED TREATMENT|1972-06-02|1968-03-05|||||1971-01-17||1967-05-01
TRIAL STUDY 134XCP|IS|008F02C8-B28A-490E-A77A-F32584DA06FA||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CM|||||G/ANIMAL||||NORMAL|NOT DONE|||TISSUE|THAWED|NA|ANALYTICAL ULTRACENTRIFUGATION|Y|N|N||2||58||INDUCTION TREATMENT|1969-08-04|1963-06-08|||||1970-01-18||1970-07-14
TRIAL STUDY 134XCP|IS|008F02C8-B28A-490E-A77A-F32584DA06FA||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KG/CM|||||G/CAGE/WK||||HIGH|NOT DONE|||AMNIOTIC FLUID|SOLIDIFIED|N|DUKE INCISION METHOD|N|NA|N||3||39||OPEN LABEL TREATMENT|1971-09-13|1969-04-28|||||1960-12-09||1961-06-29
TRIAL STUDY 134XCP|IS|008F02C8-B28A-490E-A77A-F32584DA06FA||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/WEEK|||||UG/KG||||HIGH|NOT DONE|||INFRANATANT, PLASMA|HEMOLYZED|U|ELASTOGRAPHY|Y|NA|NA||4||88||LONG-TERM FOLLOW-UP|1969-03-17|1968-07-04|||||1967-02-24||1971-01-19
TRIAL STUDY 134XCP|IS|008F02C8-B28A-490E-A77A-F32584DA06FA||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MASK|||||ANSON U||||HIGH|NOT DONE|||URINE SEDIMENT|CLOTTED|NA|FLUORESCENT SPOT TEST|U|NA|N||5||7||RUN-IN|1969-05-14|1971-09-15|||||1963-02-19||1967-07-26
TRIAL STUDY 134XCP|IS|7C06549D-596C-4C47-BD0B-119DF6CD67AC||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/H|||||PACK||||NORMAL|NOT DONE|||LOCHIA|FROZEN|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|NA|U|U||1||38||SCREENING|1961-03-05|1964-06-18|||||1972-06-27||1961-09-16
TRIAL STUDY 134XCP|IS|7C06549D-596C-4C47-BD0B-119DF6CD67AC||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DPM/ML|||||G||||HIGH|NOT DONE|||HAIR FOLLICLE|CALCIFIED|U|HILLMEN COLOR CHART|U|N|N||2||58||LONG-TERM FOLLOW-UP|1961-09-04|1967-09-17|||||1966-04-26||1961-07-23
TRIAL STUDY 134XCP|IS|7C06549D-596C-4C47-BD0B-119DF6CD67AC||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS/G|||||ML/MIN/1.73M2||||LOW|NOT DONE|||TISSUE|AUTOLYZED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|N|N|N||3||39||FOLLOW-UP|1971-06-22|1972-01-07|||||1964-03-22||1967-03-14
TRIAL STUDY 134XCP|IS|7C06549D-596C-4C47-BD0B-119DF6CD67AC||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NSEC|||||MEQ/UL||||NORMAL|NOT DONE|||CORD SERUM|NON-HEMOLYZED|NA|RADIOIMMUNOPRECIPITATION ASSAY|U|NA|U||4||88||LONG-TERM FOLLOW-UP|1962-02-01|1969-11-21|||||1965-06-22||1965-01-11
TRIAL STUDY 134XCP|IS|7C06549D-596C-4C47-BD0B-119DF6CD67AC||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U|||||MMOL/MIN/KPA||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|HEMOLYZED|NA|PET/CT SCAN WITHOUT CONTRAST|N|NA|NA||5||7||WASHOUT|1969-01-29|1964-09-20|||||1964-05-03||1966-10-19
TRIAL STUDY 134XCP|IS|39A00D93-61B9-44C5-9672-005A1F9A93EB||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/M2/MIN|||||PT_US||||LOW|NOT DONE|||ABSCESS FLUID|GELLED|U|CONTRAST ENHANCED SPIRAL CT SCAN|N|N|Y||1||38||LONG-TERM FOLLOW-UP|1960-10-26|1969-10-23|||||1970-12-06||1960-05-05
TRIAL STUDY 134XCP|IS|39A00D93-61B9-44C5-9672-005A1F9A93EB||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/MMOL|||||/MONTH||||ABNORMAL|NOT DONE|||BLOOD|AUTOLYZED|N|CLIP SEQUENCING|NA|NA|U||2||58||OBSERVATION|1971-06-08|1973-07-15|||||1972-12-19||1960-07-13
TRIAL STUDY 134XCP|IS|39A00D93-61B9-44C5-9672-005A1F9A93EB||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||WEEKS|||||MASK||||HIGH|NOT DONE|||SERUM|GELLED|U|FLAME PHOTOMETRY|U|Y|NA||3||39||LONG-TERM FOLLOW-UP|1966-03-24|1964-07-16|||||1963-08-15||1969-12-31
TRIAL STUDY 134XCP|IS|39A00D93-61B9-44C5-9672-005A1F9A93EB||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3 CFU/ML|||||/VF||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|CLOTTED|Y|RAJI CELL EIA|NA|N|Y||4||88||INDUCTION TREATMENT|1967-01-21|1972-12-14|||||1964-04-18||1961-12-06
TRIAL STUDY 134XCP|IS|39A00D93-61B9-44C5-9672-005A1F9A93EB||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LOG10 IU/ML|||||SBE/ML||||HIGH|NOT DONE|||TUMOR TISSUE|UNEXPECTED ODOR|NA|SCANNING ELECTRON MICROSCOPY|NA|U|NA||5||7||BLINDED TREATMENT|1968-04-16|1970-05-16|||||1966-07-12||1971-08-10
TRIAL STUDY 134XCP|IS|71B78EFA-AE7A-4248-9A59-63885131F1D1||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/KG|||||UG/DL||||LOW|NOT DONE|||HAIR FOLLICLE|THAWED|U|ANTIBIOTIC AGAR SCREEN|Y|NA|U||1||38||OPEN LABEL TREATMENT|1968-09-26|1973-02-11|||||1970-03-26||1973-04-18
TRIAL STUDY 134XCP|IS|71B78EFA-AE7A-4248-9A59-63885131F1D1||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UKAT/L|||||V||||ABNORMAL|NOT DONE|||INFRANATANT, SERUM|AUTOLYZED|Y|SINGLE-SLICE SPIRAL CT|U|U|N||2||58||FOLLOW-UP|1967-04-07|1969-06-06|||||1965-11-25||1968-07-06
TRIAL STUDY 134XCP|IS|71B78EFA-AE7A-4248-9A59-63885131F1D1||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DPM/0.5 ML|||||DAMOL/L||||NORMAL|NOT DONE|||BUFFY COAT|CONCENTRATED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|N|U|N||3||39||WASHOUT|1960-10-25|1966-10-07|||||1970-12-31||1963-03-15
TRIAL STUDY 134XCP|IS|71B78EFA-AE7A-4248-9A59-63885131F1D1||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CI/G|||||ML/ANIMAL/DAY||||HIGH|NOT DONE|||VENOUS PLASMA|PARAFFIN-EMBEDDED|Y|FLUORESCENT ENZYME IMMUNOASSAY|U|N|Y||4||88||WASHOUT|1971-09-17|1962-05-26|||||1968-12-08||1969-01-26
TRIAL STUDY 134XCP|IS|71B78EFA-AE7A-4248-9A59-63885131F1D1||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||%/S|||||SIEMENS||||HIGH|NOT DONE|||EPIDERMAL TISSUE|AGGLUTINATED|NA|MICROBIAL CULTURE, SOLID|NA|NA|NA||5||7||BLINDED TREATMENT|1966-01-25|1965-11-05|||||1960-01-06||1960-10-03
TRIAL STUDY 134XCP|IS|CE28B885-422E-471D-895C-DE8F41CD9FE9||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||TCID 50/DOSE|||||GY||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|GELLED|Y|SLOAN LETTER EYE CHART 1.25%|N|N|N||1||38||BLINDED TREATMENT|1965-01-22|1961-12-11|||||1961-09-05||1960-03-27
TRIAL STUDY 134XCP|IS|CE28B885-422E-471D-895C-DE8F41CD9FE9||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BQ/UG|||||WEBER||||LOW|NOT DONE|||TUMOR TISSUE|UNEXPECTED ODOR|Y|PET/CT SCAN|Y|U|Y||2||58||LONG-TERM FOLLOW-UP|1960-06-13|1970-11-09|||||1973-04-11||1970-06-23
TRIAL STUDY 134XCP|IS|CE28B885-422E-471D-895C-DE8F41CD9FE9||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SEC|||||BQ/G||||LOW|NOT DONE|||PROSTATIC FLUID|DRIED|Y|MIGET|Y|U|N||3||39||BLINDED TREATMENT|1972-05-30|1963-12-22|||||1968-11-26||1964-06-16
TRIAL STUDY 134XCP|IS|CE28B885-422E-471D-895C-DE8F41CD9FE9||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT|||||OHM||||ABNORMAL|NOT DONE|||SPUTUM|UNEXPECTED ODOR|N|CLOT DETECTION|NA|N|U||4||88||OBSERVATION|1962-04-14|1967-01-17|||||1962-12-05||1967-07-16
TRIAL STUDY 134XCP|IS|CE28B885-422E-471D-895C-DE8F41CD9FE9||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOG10 PFU|||||UU/L||||NORMAL|NOT DONE|||LYSATE|THAWED|N|MICROBIAL CULTURE, LIQUID|NA|U|NA||5||7||INDUCTION TREATMENT|1961-06-26|1962-11-05|||||1973-02-27||1964-06-29
TRIAL STUDY 134XCP|IS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 COPIES/ML|||||RFU||||HIGH|NOT DONE|||SEBUM|DRIED|U|RIA|N|NA|NA||1||38||SCREENING|1963-11-15|1966-11-12|||||1969-10-13||1960-04-26
TRIAL STUDY 134XCP|IS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL|||||10^7 PFU||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|CONTAMINATED|Y|SISH|Y|NA|Y||2||58||LONG-TERM FOLLOW-UP|1971-11-14|1973-03-26|||||1970-09-10||1963-01-21
TRIAL STUDY 134XCP|IS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/2500 WBC|||||10^4 CFU/ML||||ABNORMAL|NOT DONE|||MECONIUM|DRIED|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|N|N|N||3||39||INDUCTION TREATMENT|1960-11-25|1966-03-16|||||1964-06-05||1963-11-19
TRIAL STUDY 134XCP|IS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/DL|||||LOG10 CFU/G||||LOW|NOT DONE|||PLEURAL FLUID|LACTESCENT|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|N|Y|U||4||88||WASHOUT|1965-12-20|1964-06-10|||||1965-01-04||1970-06-22
TRIAL STUDY 134XCP|IS|FF7391DA-13A3-4548-BFB3-E79A2E9698E5||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/UG|||||IU/KG/H||||NORMAL|NOT DONE|||DISCHARGE|CLOTTED|Y|DC SHEATH FLOW|Y|N|Y||5||7||OPEN LABEL TREATMENT|1964-09-13|1965-03-25|||||1963-03-20||1961-01-29
TRIAL STUDY 134XCP|IS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMHG|||||UMOL/KG/MIN||||HIGH|NOT DONE|||AMNIOTIC FLUID|AGGLUTINATED|U|RIA|N|U|Y||1||38||BLINDED TREATMENT|1965-02-05|1973-02-12|||||1971-05-16||1971-08-14
TRIAL STUDY 134XCP|IS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS|||||MG/ML/DAY||||LOW|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|ICTERIC|U|SPECT SCAN|Y|U|N||2||58||CONTINUATION TREATMENT|1965-07-14|1962-09-27|||||1966-08-21||1966-03-26
TRIAL STUDY 134XCP|IS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KHZ|||||CD*S/M2||||LOW|NOT DONE|||HAIR FOLLICLE|REFRIGERATED|NA|AMSLER GRID|Y|N|NA||3||39||OPEN LABEL TREATMENT|1966-10-13|1968-01-26|||||1960-12-18||1971-08-01
TRIAL STUDY 134XCP|IS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||NU/CL||||ABNORMAL|NOT DONE|||EMESIS|UNEXPECTED ODOR|N|EIA|N|N|Y||4||88||RUN-IN|1972-09-25|1968-09-09|||||1969-09-26||1964-10-28
TRIAL STUDY 134XCP|IS|CE23E4F1-2E6F-42A8-964C-E7D3810F3982||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BOWL|||||MU/G||||NORMAL|NOT DONE|||SPERMATOZOON|ROOM TEMPERATURE|Y|LAPAROSCOPY|U|N|NA||5||7||SCREENING|1965-02-18|1965-11-24|||||1963-09-07||1966-03-14
TRIAL STUDY 134XCP|IS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ENZYME U/L|||||NMOL/ML/MIN||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|THAWED|NA|HPLC-UV|Y|NA|Y||1||38||LONG-TERM FOLLOW-UP|1970-03-04|1963-11-24|||||1973-02-05||1966-11-03
TRIAL STUDY 134XCP|IS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||%(V/V)|||||PA||||NORMAL|NOT DONE|||LYSATE|LIPEMIC|Y|CHROMATOGRAPHY|Y|NA|Y||2||58||BASELINE|1968-02-04|1964-07-30|||||1969-08-04||1960-05-13
TRIAL STUDY 134XCP|IS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KIU|||||10^12/L||||ABNORMAL|NOT DONE|||EXPIRED AIR|PARAFFIN-EMBEDDED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y|NA|N||3||39||WASHOUT|1966-11-06|1965-03-16|||||1966-06-11||1963-09-29
TRIAL STUDY 134XCP|IS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FL|||||PMOL/DAY||||NORMAL|NOT DONE|||KERATINOCYTE|HEMOLYZED|N|SCANNING ELECTRON MICROSCOPY|Y|NA|N||4||88||TREATMENT|1963-07-10|1966-01-29|||||1969-09-10||1968-12-12
TRIAL STUDY 134XCP|IS|A9F69F2E-28FD-4581-BC39-9BAE2CFAA862||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PT_BR|||||ML/MMHG/MIN/L||||ABNORMAL|NOT DONE|||PLATELET|GELLED|N|MIGET|U|U|N||5||7||INDUCTION TREATMENT|1965-08-15|1970-05-24|||||1972-05-05||1967-11-09
TRIAL STUDY 134XCP|IS|3AA56307-0D09-4C82-91B6-717A7C503EFE||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MPA|||||KBQ||||LOW|NOT DONE|||ADIPOSE TISSUE|REFRIGERATED|Y|LC/MS|N|N|NA||1||38||INDUCTION TREATMENT|1969-04-03|1961-03-08|||||1961-12-15||1960-12-27
TRIAL STUDY 134XCP|IS|3AA56307-0D09-4C82-91B6-717A7C503EFE||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KG/CM2|||||TUBE||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CLOTTED|Y|CELLULAR PROLIFERATION ASSAY|N|U|NA||2||58||LONG-TERM FOLLOW-UP|1971-07-24|1964-10-17|||||1966-03-22||1962-10-17
TRIAL STUDY 134XCP|IS|3AA56307-0D09-4C82-91B6-717A7C503EFE||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MET*H|||||NMOL/L/H||||HIGH|NOT DONE|||PERITONEAL FLUID|NON-HEMOLYZED|Y|MULTIPLE BREATH WASHOUT|Y|Y|U||3||39||RUN-IN|1963-01-21|1962-07-05|||||1967-10-08||1963-05-17
TRIAL STUDY 134XCP|IS|3AA56307-0D09-4C82-91B6-717A7C503EFE||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/MOL|||||U.CARR||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|LACTESCENT|Y|MOUSE PROTECTION ASSAY|N|N|N||4||88||CONTINUATION TREATMENT|1964-12-28|1961-10-09|||||1972-03-14||1968-08-30
TRIAL STUDY 134XCP|IS|3AA56307-0D09-4C82-91B6-717A7C503EFE||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||APL U|||||APPLICATION||||NORMAL|NOT DONE|||INFRANATANT, SERUM|SOLIDIFIED|NA|OPHTHALMOSCOPY|U|N|N||5||7||BLINDED TREATMENT|1967-07-31|1967-12-23|||||1966-11-20||1960-03-21
TRIAL STUDY 134XCP|IS|811AE318-625A-4913-8B18-2D318AF04EAC||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/200 HPFS|||||ML/MIN||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|FRESH|Y|BETA LACTAMASE|U|U|NA||1||38||RUN-IN|1968-09-20|1968-06-12|||||1963-12-24||1972-08-18
TRIAL STUDY 134XCP|IS|811AE318-625A-4913-8B18-2D318AF04EAC||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CM H2O|||||MET*MIN||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|SOLIDIFIED|N|IVY INCISION METHOD|NA|NA|Y||2||58||TREATMENT|1963-06-13|1967-03-13|||||1972-02-01||1971-02-09
TRIAL STUDY 134XCP|IS|811AE318-625A-4913-8B18-2D318AF04EAC||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MBP|||||MBQ/UL||||HIGH|NOT DONE|||VENOUS PLASMA|CONCENTRATED|Y|ELLA|Y|N|U||3||39||LONG-TERM FOLLOW-UP|1972-03-27|1972-06-01|||||1965-11-26||1972-11-08
TRIAL STUDY 134XCP|IS|811AE318-625A-4913-8B18-2D318AF04EAC||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^6 CFU|||||MDFI||||NORMAL|NOT DONE|||SEMINAL FLUID|REFRIGERATED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|U|N|NA||4||88||BASELINE|1968-03-19|1962-05-27|||||1971-01-31||1963-09-19
TRIAL STUDY 134XCP|IS|811AE318-625A-4913-8B18-2D318AF04EAC||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FG|||||CM/MIN||||HIGH|NOT DONE|||SPUTUM|ICTERIC|Y|KLEIHAUER-BETKE|NA|U|N||5||7||RUN-IN|1971-11-02|1960-12-14|||||1965-06-23||1967-05-17
TRIAL STUDY 134XCP|IS|E8F0AF72-5DB4-41D5-814E-5E280A027E94||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MV*MIN|||||PMOL/L||||ABNORMAL|NOT DONE|||REFLEX TEAR|CALCIFIED|NA|SMEAR|Y|U|N||1||38||FOLLOW-UP|1964-02-10|1970-04-03|||||1960-02-27||1971-12-20
TRIAL STUDY 134XCP|IS|E8F0AF72-5DB4-41D5-814E-5E280A027E94||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||V|||||NG/DL||||NORMAL|NOT DONE|||SERUM|ICTERIC|NA|X-RAY|Y|N|NA||2||58||BASELINE|1963-03-23|1967-12-18|||||1963-05-29||1964-04-24
TRIAL STUDY 134XCP|IS|E8F0AF72-5DB4-41D5-814E-5E280A027E94||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMAL|||||BQ/KG||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|DRIED|N|INTRAVASCULAR ULTRASOUND|U|Y|Y||3||39||OPEN LABEL TREATMENT|1961-02-27|1970-07-19|||||1971-08-04||1971-12-06
TRIAL STUDY 134XCP|IS|E8F0AF72-5DB4-41D5-814E-5E280A027E94||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||FMOL/G|||||DAYS||||LOW|NOT DONE|||EPIDERMAL TISSUE|DRIED|NA|HPLC/IEX|NA|NA|Y||4||88||INDUCTION TREATMENT|1961-01-20|1964-06-15|||||1966-09-21||1969-03-25
TRIAL STUDY 134XCP|IS|E8F0AF72-5DB4-41D5-814E-5E280A027E94||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/M2/MIN|||||BEL||||HIGH|NOT DONE|||SUPERNATANT, SERUM|CONCENTRATED|N|ENZYMATIC SPECTROPHOTOMETRY|Y|U|N||5||7||FOLLOW-UP|1965-08-09|1961-05-08|||||1963-09-21||1969-12-10
TRIAL STUDY 134XCP|IS|3B726736-01B3-4A69-ABFB-C6255E341E69||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPL U/ML|||||PSEC||||LOW|NOT DONE|||MUSCLE TISSUE|ICTERIC|NA|ELECTROPHORESIS|N|N|U||1||38||OPEN LABEL TREATMENT|1964-11-13|1971-09-27|||||1970-09-08||1973-01-24
TRIAL STUDY 134XCP|IS|3B726736-01B3-4A69-ABFB-C6255E341E69||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CD*S/M2|||||MJOULE/CM2||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|LIPEMIC|U|NEXT GENERATION TARGETED SEQUENCING|Y|Y|U||2||58||INDUCTION TREATMENT|1973-03-10|1964-08-22|||||1971-07-30||1965-05-02
TRIAL STUDY 134XCP|IS|3B726736-01B3-4A69-ABFB-C6255E341E69||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/CAGE|||||IU/KG/H||||HIGH|NOT DONE|||BLOOD|GELLED|NA|TARGETED TRANSCRIPTOME SEQUENCING|N|U|NA||3||39||TREATMENT|1970-07-23|1972-05-07|||||1962-11-19||1960-04-20
TRIAL STUDY 134XCP|IS|3B726736-01B3-4A69-ABFB-C6255E341E69||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UM/DAY|||||MMOL/DAY||||LOW|NOT DONE|||ARTERIAL BLOOD|LIPEMIC|U|ELECTRONEUROGRAPHY|U|U|NA||4||88||OBSERVATION|1963-09-01|1971-11-07|||||1970-12-20||1960-08-12
TRIAL STUDY 134XCP|IS|3B726736-01B3-4A69-ABFB-C6255E341E69||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/MIN|||||USP U||||LOW|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|N|INCISION-INDUCED BLEEDING METHOD|Y|NA|Y||5||7||SCREENING|1969-07-13|1963-01-07|||||1965-06-10||1960-12-10
TRIAL STUDY 134XCP|IS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PKAT|||||IU/G HB||||HIGH|NOT DONE|||EMESIS|LIPEMIC|N|KLEIHAUER-BETKE|U|NA|NA||1||38||FOLLOW-UP|1965-10-10|1964-11-25|||||1971-05-03||1971-12-23
TRIAL STUDY 134XCP|IS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||S*KPA|||||10^6 ORGANISMS/MG||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|UNEXPECTED ODOR|NA|MICROBIAL CONCENTRATION|N|NA|U||2||58||BLINDED TREATMENT|1963-10-02|1961-02-21|||||1964-04-01||1972-11-20
TRIAL STUDY 134XCP|IS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||EIA UNIT|||||ML/KG/MIN||||ABNORMAL|NOT DONE|||PLATELET RICH PLASMA|SOLIDIFIED|U|IMMUNE REPERTOIRE DEEP SEQUENCING|NA|Y|N||3||39||OPEN LABEL TREATMENT|1961-06-21|1961-08-02|||||1962-12-23||1967-07-15
TRIAL STUDY 134XCP|IS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||1/(S*KPA)|||||UG/M2/H||||LOW|NOT DONE|||URINE|DRIED|NA|MICROSCOPY|NA|NA|N||4||88||SCREENING|1962-01-04|1972-01-31|||||1961-04-24||1967-07-13
TRIAL STUDY 134XCP|IS|C96A9C9D-3EFF-4675-8B75-9B38D4D94AF0||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||EID 50/DOSE|||||MG/KG||||NORMAL|NOT DONE|||PERITONEAL FLUID|AUTOLYZED|N|ACRIDINE ORANGE STAIN|N|N|NA||5||7||BLINDED TREATMENT|1962-02-14|1973-05-25|||||1971-02-20||1969-09-17
TRIAL STUDY 134XCP|IS|0535EF31-5388-4CC0-8567-44F4C20975EC||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AMU|||||10^3 DNA COPIES/ML||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|DRIED|Y|FLUORESCENCE ANGIOGRAPHY|N|Y|N||1||38||LONG-TERM FOLLOW-UP|1964-11-27|1971-03-09|||||1965-07-24||1969-01-05
TRIAL STUDY 134XCP|IS|0535EF31-5388-4CC0-8567-44F4C20975EC||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GBQ/UG|||||WAFER||||HIGH|NOT DONE|||ABSCESS FLUID|GELLED|NA|MASS SPECTROMETRY|NA|NA|N||2||58||INDUCTION TREATMENT|1961-01-22|1971-12-15|||||1966-09-06||1960-07-17
TRIAL STUDY 134XCP|IS|0535EF31-5388-4CC0-8567-44F4C20975EC||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NEEDLE GAUGE|||||LM||||HIGH|NOT DONE|||PUS|CONCENTRATED|NA|PHOTOGRAPHY|Y|N|Y||3||39||SCREENING|1961-12-18|1960-10-31|||||1965-05-04||1960-12-19
TRIAL STUDY 134XCP|IS|0535EF31-5388-4CC0-8567-44F4C20975EC||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G|||||PNU/ML||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|ICTERIC|Y|QUANTITATIVE ULTRASOUND|Y|U|Y||4||88||TREATMENT|1972-01-11|1961-02-09|||||1966-03-05||1969-11-15
TRIAL STUDY 134XCP|IS|0535EF31-5388-4CC0-8567-44F4C20975EC||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HOUNSFIELD UNIT|||||NCI||||LOW|NOT DONE|||SUPERNATANT, PLASMA|LIPEMIC|Y|TEMPLATE INCISION METHOD|U|NA|NA||5||7||OPEN LABEL TREATMENT|1972-01-05|1962-06-02|||||1964-06-06||1973-06-01
TRIAL STUDY 134XCP|IS|F149BD98-0802-4C18-8599-426C5258D513||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MOSM|||||KPA/L/SEC||||HIGH|NOT DONE|||SYNOVIAL FLUID|UNEXPECTED ODOR|U|ISHIHARA COLOR PLATES|U|N|N||1||38||CONTINUATION TREATMENT|1973-06-20|1964-05-09|||||1960-08-07||1969-10-10
TRIAL STUDY 134XCP|IS|F149BD98-0802-4C18-8599-426C5258D513||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAPLET|||||NG/MOL||||ABNORMAL|NOT DONE|||SOFT TISSUE|PARAFFIN-EMBEDDED|N|HPLC-UV|NA|N|Y||2||58||LONG-TERM FOLLOW-UP|1963-07-28|1962-04-19|||||1964-08-15||1967-12-12
TRIAL STUDY 134XCP|IS|F149BD98-0802-4C18-8599-426C5258D513||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/4.0 ML|||||MOL/MG||||LOW|NOT DONE|||LUNG SURFACTANT|FRESH|NA|MEDIASTINOSCOPY|N|U|Y||3||39||LONG-TERM FOLLOW-UP|1966-06-22|1971-12-16|||||1969-03-20||1963-03-06
TRIAL STUDY 134XCP|IS|F149BD98-0802-4C18-8599-426C5258D513||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^12 IU/L|||||PG/L||||LOW|NOT DONE|||KERATINOCYTE|FRESH|N|DC SHEATH FLOW|N|Y|NA||4||88||TREATMENT|1963-04-06|1963-07-12|||||1961-02-04||1967-05-12
TRIAL STUDY 134XCP|IS|F149BD98-0802-4C18-8599-426C5258D513||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ECL UNIT|||||UMOL/DL||||HIGH|NOT DONE|||ERYTHROCYTES|FROZEN|NA|FLOW MICROSCOPY|N|U|N||5||7||SCREENING|1970-07-23|1961-05-28|||||1963-02-22||1964-11-15
TRIAL STUDY 134XCP|IS|5A31D035-90D2-4BD0-AE08-839862D6E0DF||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||VOXEL|||||HZ||||NORMAL|NOT DONE|||DIALYSIS FLUID|CALCIFIED|N|SPECT SCAN|N|N|U||1||38||WASHOUT|1961-10-03|1971-04-27|||||1971-05-10||1961-06-06
TRIAL STUDY 134XCP|IS|5A31D035-90D2-4BD0-AE08-839862D6E0DF||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^10/L|||||PIPE||||ABNORMAL|NOT DONE|||COLOSTRUM|UNEXPECTED ODOR|Y|HEMAGGLUTINATION INHIBITION ASSAY|N|N|U||2||58||OBSERVATION|1963-09-17|1971-08-18|||||1961-10-11||1962-06-30
TRIAL STUDY 134XCP|IS|5A31D035-90D2-4BD0-AE08-839862D6E0DF||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/MIN/MMHG|||||G/M2||||HIGH|NOT DONE|||AQUEOUS HUMOR|SOLIDIFIED|Y|LC-FL|U|Y|NA||3||39||RUN-IN|1965-04-16|1960-12-04|||||1960-01-31||1964-10-30
TRIAL STUDY 134XCP|IS|5A31D035-90D2-4BD0-AE08-839862D6E0DF||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/KG|||||ML/MMHG/MIN/L||||ABNORMAL|NOT DONE|||REFLEX TEAR|NON-HEMOLYZED|Y|TRANSVAGINAL ULTRASOUND|Y|NA|NA||4||88||CONTINUATION TREATMENT|1972-09-01|1966-09-26|||||1973-07-16||1972-03-27
TRIAL STUDY 134XCP|IS|5A31D035-90D2-4BD0-AE08-839862D6E0DF||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 CFU|||||PMOL/DAY||||ABNORMAL|NOT DONE|||PERSPIRATION|CALCIFIED|Y|TOTAL BODY RADIOGRAPHY|Y|N|U||5||7||CONTINUATION TREATMENT|1972-10-23|1966-10-27|||||1964-01-15||1964-05-27
TRIAL STUDY 134XCP|IS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TSP EQ|||||/7.5 ML||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|Y|COLORIMETRY|NA|U|Y||1||38||FOLLOW-UP|1965-01-27|1969-07-14|||||1964-02-04||1968-04-19
TRIAL STUDY 134XCP|IS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DPM/ML|||||SEC||||NORMAL|NOT DONE|||MONOCYTE|THAWED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|U|N|U||2||58||CONTINUATION TREATMENT|1966-07-16|1960-02-21|||||1963-08-05||1970-02-08
TRIAL STUDY 134XCP|IS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KCAL|||||ML/H||||NORMAL|NOT DONE|||PLATELET RICH PLASMA|LIPEMIC|NA|MEDIASTINOSCOPY|N|U|NA||3||39||OBSERVATION|1964-06-25|1971-02-19|||||1973-05-27||1962-04-08
TRIAL STUDY 134XCP|IS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PA|||||EJACULATE U||||HIGH|NOT DONE|||CAPILLARY BLOOD|DRIED|NA|BAC ACGH|Y|U|Y||4||88||TREATMENT|1960-07-26|1962-06-20|||||1963-06-07||1960-07-25
TRIAL STUDY 134XCP|IS|B337DBF1-53AC-4DA1-B1AE-A023F8189A49||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KG|||||10^6 ORGANISMS/G||||NORMAL|NOT DONE|||CELL PELLET|UNEXPECTED ODOR|Y|TEMPLATE INCISION METHOD|U|U|Y||5||7||BASELINE|1970-09-17|1968-09-21|||||1961-03-16||1971-08-26
TRIAL STUDY 134XCP|IS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/MM|||||LOG10 ELISA UNIT/DOSE||||HIGH|NOT DONE|||PLATELET|LACTESCENT|N|FLUOROSCOPY|N|NA|NA||1||38||WASHOUT|1961-03-13|1973-05-30|||||1968-07-14||1971-09-03
TRIAL STUDY 134XCP|IS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/G/H|||||KM/H||||NORMAL|NOT DONE|||CALCULUS|CONTAMINATED|N|TWO-COLOR MICROARRAY|NA|Y|U||2||58||CONTINUATION TREATMENT|1964-03-09|1967-03-04|||||1963-05-03||1970-11-01
TRIAL STUDY 134XCP|IS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/M2/MIN|||||FFU||||LOW|NOT DONE|||LYSATE|GELLED|NA|IMMUNODIFFUSION|U|U|Y||3||39||SCREENING|1973-03-25|1972-02-03|||||1961-10-29||1960-02-29
TRIAL STUDY 134XCP|IS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 U|||||MG/KG||||ABNORMAL|NOT DONE|||BILE|CONTAMINATED|U|THERMAL IONIZATION MASS SPECTROMETRY|NA|Y|U||4||88||RUN-IN|1964-03-12|1966-01-17|||||1961-11-10||1968-10-03
TRIAL STUDY 134XCP|IS|A6E5EEA6-957D-40C8-9D9E-99FEB525A355||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CM2|||||100 IU/ML||||ABNORMAL|NOT DONE|||MONOCYTE|FRESH|U|SPECULAR MICROSCOPY|Y|NA|U||5||7||LONG-TERM FOLLOW-UP|1967-03-23|1970-03-30|||||1967-08-06||1962-02-09
TRIAL STUDY 134XCP|IS|9C9398A4-38BC-40A7-880D-4549A676F69B||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UV|||||IU/KG||||ABNORMAL|NOT DONE|||CALCULUS|GELLED|U|CYSTOSCOPY|NA|NA|NA||1||38||CONTINUATION TREATMENT|1972-02-22|1973-07-17|||||1967-07-26||1973-06-30
TRIAL STUDY 134XCP|IS|9C9398A4-38BC-40A7-880D-4549A676F69B||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PACK YEAR|||||RING||||NORMAL|NOT DONE|||CERUMEN|CALCIFIED|N|HPLC-UV|NA|U|N||2||58||INDUCTION TREATMENT|1969-11-03|1971-01-08|||||1961-06-03||1963-05-08
TRIAL STUDY 134XCP|IS|9C9398A4-38BC-40A7-880D-4549A676F69B||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||100 IU/ML|||||ML/ANIMAL||||HIGH|NOT DONE|||BUFFY COAT|ROOM TEMPERATURE|U|NUCLEIC ACID AMPLIFICATION TEST|U|Y|N||3||39||SCREENING|1961-03-29|1967-06-15|||||1971-07-17||1970-01-19
TRIAL STUDY 134XCP|IS|9C9398A4-38BC-40A7-880D-4549A676F69B||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^8 PFU|||||L/S/KPA||||ABNORMAL|NOT DONE|||ABSCESS FLUID|PARAFFIN-EMBEDDED|N|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|NA|Y||4||88||RUN-IN|1963-03-22|1967-05-26|||||1964-07-11||1962-09-30
TRIAL STUDY 134XCP|IS|9C9398A4-38BC-40A7-880D-4549A676F69B||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CI/L|||||MMAL||||HIGH|NOT DONE|||LAVAGE FLUID|ROOM TEMPERATURE|Y|DIGITAL PCR ARRAY|Y|U|Y||5||7||OPEN LABEL TREATMENT|1967-02-01|1967-12-09|||||1967-10-23||1973-07-27
TRIAL STUDY 134XCP|IS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NG/DAY|||||GPL U||||LOW|NOT DONE|||EPIDERMAL TISSUE|CALCIFIED|Y|AUDIOMETRY|U|NA|N||1||38||RUN-IN|1970-04-17|1961-08-24|||||1969-04-21||1969-12-25
TRIAL STUDY 134XCP|IS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ENZYME U/L|||||CCID 50/ML||||HIGH|NOT DONE|||CELL PELLET|SOLIDIFIED|N|CALIPER MEASUREMENT METHOD|Y|NA|Y||2||58||SCREENING|1972-01-09|1968-08-05|||||1965-02-28||1972-10-10
TRIAL STUDY 134XCP|IS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MOSM/L|||||DDU||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|PARAFFIN-EMBEDDED|NA|DIFFUSION WEIGHTED MRI|NA|Y|U||3||39||INDUCTION TREATMENT|1965-11-12|1963-12-28|||||1964-10-27||1963-01-04
TRIAL STUDY 134XCP|IS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MIN*MG/ML|||||G/G/DAY||||HIGH|NOT DONE|||CAPILLARY BLOOD|CONTAMINATED|N|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|N|NA||4||88||TREATMENT|1971-06-09|1969-02-08|||||1967-04-22||1965-10-28
TRIAL STUDY 134XCP|IS|4FDE7F38-E0DD-40E7-B193-E2BEC4D3B549||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/M2/DAY|||||10^9 ORGANISMS/ML||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONTAMINATED|N|IMMUNOPRECIPITATION|N|N|Y||5||7||FOLLOW-UP|1964-01-02|1964-01-21|||||1972-11-20||1961-04-06
TRIAL STUDY 134XCP|IS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DAYS/WK|||||10^4/L||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|FROZEN|NA|HIGH RESOLUTION MELT ANALYSIS|U|N|N||1||38||WASHOUT|1962-06-06|1965-06-22|||||1972-02-14||1971-04-28
TRIAL STUDY 134XCP|IS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||V/SEC|||||M2||||LOW|NOT DONE|||URINE SEDIMENT|DRIED|U|IRON HEMATOXYLIN STAIN|NA|U|NA||2||58||WASHOUT|1972-01-14|1965-03-04|||||1973-07-07||1964-11-12
TRIAL STUDY 134XCP|IS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMOL/MIN/KPA/L|||||FRACTION OF 1||||HIGH|NOT DONE|||DERMAL TISSUE|CONCENTRATED|NA|INFRARED SPECTROMETRY|Y|NA|Y||3||39||TREATMENT|1965-02-12|1966-09-01|||||1973-06-02||1962-05-30
TRIAL STUDY 134XCP|IS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GBQ/UG|||||CI/L||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|CONCENTRATED|U|SXA SCAN|U|Y|Y||4||88||BASELINE|1967-08-23|1971-11-23|||||1967-05-03||1970-04-29
TRIAL STUDY 134XCP|IS|DFFEFBCE-D68C-4BE3-99AA-5866EF7F2824||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LENS|||||VG/ML||||LOW|NOT DONE|||VENOUS PLASMA|CALCIFIED|N|FLUORESCENCE ANGIOGRAPHY|NA|N|U||5||7||BLINDED TREATMENT|1963-06-22|1964-02-28|||||1962-12-27||1968-01-30
TRIAL STUDY 134XCP|IS|1E049F70-8E29-458F-BF37-13450BC9227E||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/KG/MIN|||||ML/MIN/MMHG||||NORMAL|NOT DONE|||BASAL TEAR|SOLIDIFIED|NA|SIZE EXCLUSION CHROMATOGRAPHY|U|U|Y||1||38||SCREENING|1970-12-05|1969-04-06|||||1964-03-29||1960-11-18
TRIAL STUDY 134XCP|IS|1E049F70-8E29-458F-BF37-13450BC9227E||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^4 CFU|||||JDF UNIT||||ABNORMAL|NOT DONE|||BILE|LACTESCENT|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|U|U|N||2||58||SCREENING|1969-08-10|1966-08-26|||||1962-11-27||1961-04-13
TRIAL STUDY 134XCP|IS|1E049F70-8E29-458F-BF37-13450BC9227E||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||G/L|||||UV||||NORMAL|NOT DONE|||PLEURAL TISSUE|SOLIDIFIED|U|CALIPER MEASUREMENT METHOD|Y|Y|U||3||39||INDUCTION TREATMENT|1967-12-29|1964-06-27|||||1962-12-22||1967-07-30
TRIAL STUDY 134XCP|IS|1E049F70-8E29-458F-BF37-13450BC9227E||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/S|||||CIGARETTE||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|AUTOLYZED|Y|IVY INCISION METHOD|U|NA|NA||4||88||CONTINUATION TREATMENT|1967-10-01|1971-10-22|||||1972-12-06||1962-03-13
TRIAL STUDY 134XCP|IS|1E049F70-8E29-458F-BF37-13450BC9227E||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6/HPF|||||PMOL/DAY||||LOW|NOT DONE|||BLOOD|SOLIDIFIED|U|SLIT LAMP PHOTOGRAPHY|NA|U|NA||5||7||BLINDED TREATMENT|1968-09-24|1965-11-25|||||1968-01-29||1971-09-01
TRIAL STUDY 134XCP|IS|7A612F0F-943A-4283-9A11-B8E8E8D68D66||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/CM|||||UL||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|GELLED|Y|THICK SMEAR|Y|U|Y||1||38||SCREENING|1964-12-19|1960-04-25|||||1966-02-14||1973-03-12
TRIAL STUDY 134XCP|IS|7A612F0F-943A-4283-9A11-B8E8E8D68D66||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||K|||||ML/DL||||NORMAL|NOT DONE|||HAIR FOLLICLE|REFRIGERATED|U|IMPEDANCE CONDUCTIVITY|Y|Y|U||2||58||INDUCTION TREATMENT|1967-06-06|1964-08-16|||||1963-06-03||1970-03-22
TRIAL STUDY 134XCP|IS|7A612F0F-943A-4283-9A11-B8E8E8D68D66||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MET|||||10^7 CFU||||NORMAL|NOT DONE|||SERUM OR PLASMA|THAWED|NA|U-HPLC/MS/MS|Y|N|NA||3||39||BLINDED TREATMENT|1971-02-25|1962-08-05|||||1965-05-29||1969-10-09
TRIAL STUDY 134XCP|IS|7A612F0F-943A-4283-9A11-B8E8E8D68D66||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^8 PFU|||||UG/DL||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|THAWED|Y|BIOIMPEDANCE SPECTROSCOPY|NA|U|NA||4||88||RUN-IN|1973-02-01|1965-03-13|||||1971-01-19||1962-02-14
TRIAL STUDY 134XCP|IS|7A612F0F-943A-4283-9A11-B8E8E8D68D66||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^8 PFU|||||BAG||||NORMAL|NOT DONE|||PLEURAL FLUID|SOLIDIFIED|NA|AUTOMATED COUNT|N|NA|Y||5||7||BASELINE|1971-10-11|1964-07-28|||||1960-08-20||1964-05-11
TRIAL STUDY 134XCP|IS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/MIN/KPA|||||PSI||||ABNORMAL|NOT DONE|||TISSUE|CALCIFIED|N|QUANTITATIVE ULTRASOUND|U|NA|Y||1||38||RUN-IN|1970-02-19|1967-01-16|||||1960-06-02||1971-03-18
TRIAL STUDY 134XCP|IS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NEBULE|||||PFU/ML||||LOW|NOT DONE|||SALIVA|SOLIDIFIED|N|ICC|Y|NA|NA||2||58||WASHOUT|1964-08-18|1972-12-20|||||1963-04-06||1971-03-13
TRIAL STUDY 134XCP|IS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FG|||||UEQ||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|CLOTTED|Y|CALIPER MEASUREMENT METHOD|N|U|Y||3||39||CONTINUATION TREATMENT|1966-03-30|1962-08-22|||||1960-08-31||1966-08-08
TRIAL STUDY 134XCP|IS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/M2|||||PG/CELL||||ABNORMAL|NOT DONE|||TISSUE|ROOM TEMPERATURE|U|ERGOSPIROMETRY|U|NA|NA||4||88||RUN-IN|1962-10-09|1961-11-19|||||1969-10-13||1960-08-20
TRIAL STUDY 134XCP|IS|DBFC7D83-4E1D-47FA-9DD9-35923025B44B||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ABSORBANCE U/ML|||||UMOL/MG/MIN||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|NON-HEMOLYZED|U|MRS|N|N|Y||5||7||OPEN LABEL TREATMENT|1964-03-17|1972-12-27|||||1967-11-14||1963-03-21
TRIAL STUDY 134XCP|IS|8C86A799-2717-46E8-99C2-76D11AAB54D7||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BEAM BREAKS|||||ML/100G/MIN||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|AGGLUTINATED|NA|LIQUID SCINTILLATION COUNTING|NA|Y|N||1||38||OBSERVATION|1969-06-23|1969-01-19|||||1970-07-15||1962-08-12
TRIAL STUDY 134XCP|IS|8C86A799-2717-46E8-99C2-76D11AAB54D7||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/MIN/MMHG|||||/SEC||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|CLOTTED|U|X-RAY FLUORESCENCE SPECTROMETRY|NA|Y|Y||2||58||FOLLOW-UP|1961-05-07|1964-06-09|||||1973-05-03||1973-01-15
TRIAL STUDY 134XCP|IS|8C86A799-2717-46E8-99C2-76D11AAB54D7||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KM/H|||||UG/DL||||LOW|NOT DONE|||MECONIUM|LIPEMIC|N|BALLPOINT PEN TECHNIQUE|U|N|N||3||39||CONTINUATION TREATMENT|1965-08-07|1966-09-20|||||1963-01-21||1966-03-30
TRIAL STUDY 134XCP|IS|8C86A799-2717-46E8-99C2-76D11AAB54D7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||PACKET||||HIGH|NOT DONE|||AMNIOTIC FLUID|ICTERIC|NA|CONGO RED STAIN|NA|NA|Y||4||88||OPEN LABEL TREATMENT|1966-07-31|1971-09-12|||||1965-07-29||1969-11-05
TRIAL STUDY 134XCP|IS|8C86A799-2717-46E8-99C2-76D11AAB54D7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/MG/MIN|||||MPL U||||LOW|NOT DONE|||SEMINAL FLUID|CONCENTRATED|N|POLYGRAPHY|NA|U|U||5||7||BASELINE|1964-11-13|1968-09-19|||||1962-07-31||1971-11-23
TRIAL STUDY 134XCP|IS|727807A8-A180-4589-A553-E3C82E1D3CF2||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UV*SEC|||||ML/DOSE||||HIGH|NOT DONE|||BLOOD|REFRIGERATED|Y|CYSTOSCOPY|Y|Y|U||1||38||INDUCTION TREATMENT|1962-01-29|1963-12-29|||||1963-08-26||1967-05-24
TRIAL STUDY 134XCP|IS|727807A8-A180-4589-A553-E3C82E1D3CF2||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LOG10 PFU/ML|||||10^12/L||||ABNORMAL|NOT DONE|||COLOSTRUM|SOLIDIFIED|Y|GC/FID|Y|N|N||2||58||TREATMENT|1972-09-10|1973-04-20|||||1970-08-20||1969-05-09
TRIAL STUDY 134XCP|IS|727807A8-A180-4589-A553-E3C82E1D3CF2||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV|||||NEBULE||||LOW|NOT DONE|||GASTRIC FLUID|HEMOLYZED|U|SURFACE PLASMON RESONANCE|Y|Y|Y||3||39||CONTINUATION TREATMENT|1962-04-27|1963-01-08|||||1973-01-30||1967-12-17
TRIAL STUDY 134XCP|IS|727807A8-A180-4589-A553-E3C82E1D3CF2||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||RATIO|||||BEAM BREAKS||||ABNORMAL|NOT DONE|||PUS|UNEXPECTED ODOR|N|ELISPOT|N|N|NA||4||88||INDUCTION TREATMENT|1969-08-27|1960-09-08|||||1963-12-16||1970-02-15
TRIAL STUDY 134XCP|IS|727807A8-A180-4589-A553-E3C82E1D3CF2||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||IU/ML|||||MEQ/ML||||NORMAL|NOT DONE|||GASTRIC CONTENTS|SOLIDIFIED|NA|FUNCTIONAL MRI|U|Y|NA||5||7||RUN-IN|1970-12-03|1965-09-14|||||1965-04-03||1972-06-02
TRIAL STUDY 134XCP|IS|BFFB5321-5FC7-4465-8579-D75865306359||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MM/H|||||MILE||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|THAWED|NA|BETA LACTAMASE|Y|Y|U||1||38||FOLLOW-UP|1967-11-07|1962-08-02|||||1969-10-23||1966-09-14
TRIAL STUDY 134XCP|IS|BFFB5321-5FC7-4465-8579-D75865306359||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||HPA|||||UG/L||||HIGH|NOT DONE|||CORD BLOOD|AUTOLYZED|NA|MICRONEUTRALIZATION ASSAY|Y|Y|U||2||58||WASHOUT|1969-06-24|1967-07-17|||||1967-01-08||1966-04-18
TRIAL STUDY 134XCP|IS|BFFB5321-5FC7-4465-8579-D75865306359||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||L/H|||||MPL U||||NORMAL|NOT DONE|||PLASMA|CALCIFIED|NA|ELECTRONEUROGRAPHY|Y|NA|N||3||39||OBSERVATION|1960-09-13|1960-12-14|||||1964-02-09||1963-09-07
TRIAL STUDY 134XCP|IS|BFFB5321-5FC7-4465-8579-D75865306359||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CUP|||||MMHG*MIN/L||||HIGH|NOT DONE|||MUCUS|CONCENTRATED|N|SINGLE-MOLECULE ARRAY|N|U|Y||4||88||RUN-IN|1972-08-23|1961-04-30|||||1964-08-14||1971-09-03
TRIAL STUDY 134XCP|IS|BFFB5321-5FC7-4465-8579-D75865306359||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TORR|||||SACHET||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|CLOTTED|N|SCANNING ELECTRON MICROSCOPY|U|NA|N||5||7||BLINDED TREATMENT|1972-12-12|1969-08-14|||||1969-10-19||1969-06-11
TRIAL STUDY 134XCP|IS|12F9A745-F76D-4222-B37E-22AF93981ECE||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||VIRTUAL PIXEL|||||UG/KG/H||||LOW|NOT DONE|||BILE|SOLIDIFIED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|U|NA||1||38||SCREENING|1972-10-01|1962-06-07|||||1969-04-12||1972-07-15
TRIAL STUDY 134XCP|IS|12F9A745-F76D-4222-B37E-22AF93981ECE||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CL|||||LOG10 TCID 50/UL||||LOW|NOT DONE|||PERSPIRATION|DRIED|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|U|N||2||58||INDUCTION TREATMENT|1961-10-27|1967-01-19|||||1960-08-11||1967-04-18
TRIAL STUDY 134XCP|IS|12F9A745-F76D-4222-B37E-22AF93981ECE||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KG/M2|||||CAN||||HIGH|NOT DONE|||EMOTIONAL TEAR|CONCENTRATED|Y|IHC|Y|NA|N||3||39||SCREENING|1960-01-15|1966-03-25|||||1962-03-12||1969-09-26
TRIAL STUDY 134XCP|IS|12F9A745-F76D-4222-B37E-22AF93981ECE||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||COULOMB|||||IN2||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|UNEXPECTED ODOR|NA|GC/FID|N|U|NA||4||88||OBSERVATION|1970-06-03|1965-08-03|||||1968-01-14||1963-03-15
TRIAL STUDY 134XCP|IS|12F9A745-F76D-4222-B37E-22AF93981ECE||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||IU/L|||||10^3/HPF||||ABNORMAL|NOT DONE|||GASTRIC FLUID|ICTERIC|U|VIRUS PLAQUE ASSAY|N|N|NA||5||7||TREATMENT|1973-09-01|1967-12-26|||||1967-06-10||1960-10-28
TRIAL STUDY 134XCP|IS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||HEP|||||BQ/KG||||HIGH|NOT DONE|||LYSATE|GELLED|NA|IMMUNOCHEMILUMINOMETRIC ASSAY|NA|N|NA||1||38||SCREENING|1965-03-10|1963-06-23|||||1965-05-31||1961-05-23
TRIAL STUDY 134XCP|IS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/G|||||NMOL BCE/MMOL||||HIGH|NOT DONE|||TISSUE|LACTESCENT|U|WHOLE EXOME SEQUENCING|NA|NA|N||2||58||OPEN LABEL TREATMENT|1966-02-02|1962-11-17|||||1961-11-07||1967-06-30
TRIAL STUDY 134XCP|IS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ANTI-XA IU/ML|||||U/KG/H||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|UNEXPECTED ODOR|N|SLIT LAMP PHOTOGRAPHY|NA|N|U||3||39||BASELINE|1971-09-16|1971-03-08|||||1963-08-09||1972-10-16
TRIAL STUDY 134XCP|IS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/ANIMAL/WK|||||%||||HIGH|NOT DONE|||SEMINAL FLUID|SOLIDIFIED|N|CENTRIFUGATION|Y|Y|NA||4||88||INDUCTION TREATMENT|1972-12-21|1973-08-24|||||1963-02-26||1971-04-10
TRIAL STUDY 134XCP|IS|BA8BF93F-ECC0-4EE9-A5C0-554DC9A0D297||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^6/HPF|||||U||||ABNORMAL|NOT DONE|||TISSUE|AGGLUTINATED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|U|Y|Y||5||7||INDUCTION TREATMENT|1961-06-13|1972-07-27|||||1966-11-12||1966-11-27
TRIAL STUDY 134XCP|IS|37693A38-D8A0-4313-A4D1-56E282579636||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KEV|||||PACKAGE||||LOW|NOT DONE|||GASTRIC FLUID|SOLIDIFIED|N|PELLI-ROBSON EYE CHART|NA|Y|U||1||38||TREATMENT|1961-12-28|1963-05-15|||||1967-08-31||1960-04-13
TRIAL STUDY 134XCP|IS|37693A38-D8A0-4313-A4D1-56E282579636||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UKAT/10^12 RBC|||||MMU/ML||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|DRIED|NA|CLOT DETECTION|NA|N|N||2||58||LONG-TERM FOLLOW-UP|1969-07-19|1971-09-06|||||1963-05-04||1967-08-21
TRIAL STUDY 134XCP|IS|37693A38-D8A0-4313-A4D1-56E282579636||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||HZ/S|||||10^7 CFU||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|HEMOLYZED|NA|CYSTOMETRY|N|Y|Y||3||39||BASELINE|1961-04-26|1973-07-13|||||1972-02-09||1971-08-05
TRIAL STUDY 134XCP|IS|37693A38-D8A0-4313-A4D1-56E282579636||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MOL|||||CI/L||||LOW|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|Y|WESTERGREN|U|U|Y||4||88||WASHOUT|1962-04-22|1963-04-02|||||1967-01-19||1965-02-17
TRIAL STUDY 134XCP|IS|37693A38-D8A0-4313-A4D1-56E282579636||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||H*%|||||NMOL/L/H||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|LACTESCENT|N|NON-CONTACT SPECULAR MICROSCOPY|N|N|NA||5||7||BASELINE|1961-10-17|1963-06-29|||||1962-05-23||1961-01-17
TRIAL STUDY 134XCP|IS|5C48E0BB-FD52-47F5-8759-6126ECB47B80||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DB|||||ABSORBANCE U/MIN||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|ROOM TEMPERATURE|U|COULOMETRIC TITRATION|Y|N|NA||1||38||TREATMENT|1971-07-25|1965-02-02|||||1963-08-18||1967-08-15
TRIAL STUDY 134XCP|IS|5C48E0BB-FD52-47F5-8759-6126ECB47B80||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||COPIES/UL|||||CCID 50/ML||||LOW|NOT DONE|||LAVAGE FLUID|ROOM TEMPERATURE|U|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|NA|U||2||58||BLINDED TREATMENT|1965-10-23|1962-02-19|||||1964-01-15||1973-07-04
TRIAL STUDY 134XCP|IS|5C48E0BB-FD52-47F5-8759-6126ECB47B80||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CMH2O/ML|||||ML/MIN/1.73M2||||LOW|NOT DONE|||LUNG SURFACTANT|FRESH|U|INCISION-INDUCED BLEEDING METHOD|N|N|N||3||39||BLINDED TREATMENT|1970-04-17|1969-08-16|||||1973-06-11||1970-10-24
TRIAL STUDY 134XCP|IS|5C48E0BB-FD52-47F5-8759-6126ECB47B80||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DAGU/ML|||||FT3||||LOW|NOT DONE|||SYNOVIAL FLUID|CLOTTED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|U|Y|U||4||88||OPEN LABEL TREATMENT|1961-05-11|1969-02-18|||||1962-03-21||1961-10-06
TRIAL STUDY 134XCP|IS|5C48E0BB-FD52-47F5-8759-6126ECB47B80||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL BCE/L|||||U/L||||NORMAL|NOT DONE|||GASTRIC CONTENTS|FRESH|NA|ECHOCARDIOGRAPHY|NA|Y|U||5||7||BLINDED TREATMENT|1966-12-07|1971-11-17|||||1961-08-17||1962-07-12
TRIAL STUDY 134XCP|IS|5B420A5A-DB2C-48D2-8E9B-97639F49F182||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UM2|||||LOG10 PFU||||NORMAL|NOT DONE|||ADIPOSE TISSUE|SOLIDIFIED|Y|JAEGER EYE CHART|N|N|Y||1||38||RUN-IN|1967-07-04|1970-05-30|||||1960-01-27||1969-10-15
TRIAL STUDY 134XCP|IS|5B420A5A-DB2C-48D2-8E9B-97639F49F182||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/G/DAY|||||CIGAR||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|NA|OPTICAL COHERENCE TOMOGRAPHY|U|N|U||2||58||BLINDED TREATMENT|1966-07-07|1964-01-18|||||1971-07-12||1962-11-28
TRIAL STUDY 134XCP|IS|5B420A5A-DB2C-48D2-8E9B-97639F49F182||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/KG/H|||||ML/CAGE||||HIGH|NOT DONE|||KERATINOCYTE|SOLIDIFIED|Y|SPIROMETRY|N|NA|Y||3||39||INDUCTION TREATMENT|1963-07-29|1967-08-26|||||1971-09-28||1971-12-15
TRIAL STUDY 134XCP|IS|5B420A5A-DB2C-48D2-8E9B-97639F49F182||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6/L|||||ENZYME U/M2||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|DRIED|U|WRIGHT-GIEMSA STAIN|Y|N|NA||4||88||INDUCTION TREATMENT|1967-07-03|1967-03-10|||||1973-06-26||1973-07-24
TRIAL STUDY 134XCP|IS|5B420A5A-DB2C-48D2-8E9B-97639F49F182||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/KG/DAY|||||CD*S/M2||||NORMAL|NOT DONE|||MONOCYTE|CALCIFIED|Y|REFLECTANCE SPECTROSCOPY|N|U|U||5||7||LONG-TERM FOLLOW-UP|1967-04-22|1965-07-30|||||1964-07-03||1965-01-24
TRIAL STUDY 134XCP|IS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TAMPON|||||MEQ/UL||||NORMAL|NOT DONE|||URINE SEDIMENT|LACTESCENT|Y|PATHOLOGICAL EVALUATION|N|NA|N||1||38||RUN-IN|1963-01-23|1972-09-04|||||1963-03-07||1966-03-22
TRIAL STUDY 134XCP|IS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/CAGE/DAY|||||GRAIN||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|Y|WRIGHT STAIN|N|NA|NA||2||58||OBSERVATION|1970-01-21|1972-09-01|||||1966-03-09||1970-02-19
TRIAL STUDY 134XCP|IS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||GTT|||||MM3/MM2/YEAR||||NORMAL|NOT DONE|||SYNOVIAL FLUID|CONCENTRATED|U|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|Y|NA||3||39||WASHOUT|1963-07-19|1967-03-03|||||1970-10-09||1967-08-16
TRIAL STUDY 134XCP|IS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TESLA|||||VP/DOSE||||ABNORMAL|NOT DONE|||BREAST MILK|FROZEN|N|PANENDOSCOPY|Y|Y|N||4||88||OPEN LABEL TREATMENT|1961-05-28|1964-07-06|||||1964-02-19||1970-11-28
TRIAL STUDY 134XCP|IS|F21F3E77-82CF-44D8-AE5A-FAC04EACD019||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/MOL|||||TUBE||||HIGH|NOT DONE|||BASAL TEAR|FRESH|N|ANALYTICAL ULTRACENTRIFUGATION|U|Y|N||5||7||RUN-IN|1961-08-04|1969-10-26|||||1966-11-22||1970-10-08
TRIAL STUDY 134XCP|IS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MCI|||||DEG2||||LOW|NOT DONE|||SKIN TISSUE|FROZEN|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|U|N|Y||1||38||BLINDED TREATMENT|1970-11-13|1962-10-28|||||1960-09-03||1972-09-17
TRIAL STUDY 134XCP|IS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||IU/KG|||||L/MIN/M2||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|LIPEMIC|Y|PALM METHOD|U|U|NA||2||58||LONG-TERM FOLLOW-UP|1968-10-04|1969-05-21|||||1969-11-20||1963-11-10
TRIAL STUDY 134XCP|IS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||%(V/V)|||||DRUM||||LOW|NOT DONE|||PROSTATIC FLUID|UNEXPECTED ODOR|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|U|U|U||3||39||BASELINE|1969-05-21|1971-04-10|||||1964-01-18||1972-06-06
TRIAL STUDY 134XCP|IS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/CAGE/WK|||||SACHET||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|ICTERIC|N|RULER MEASUREMENT METHOD|Y|NA|NA||4||88||CONTINUATION TREATMENT|1971-02-19|1968-12-17|||||1960-10-01||1967-02-25
TRIAL STUDY 134XCP|IS|6AB33EBF-5C5B-4040-9A18-0AF864BC490F||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/DL|||||PM||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|CALCIFIED|NA|ATOMIC ABSORPTION SPECTROMETRY|Y|N|U||5||7||LONG-TERM FOLLOW-UP|1970-03-01|1961-04-04|||||1962-12-22||1965-08-09
TRIAL STUDY 134XCP|IS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PHERESIS UNIT|||||C||||HIGH|NOT DONE|||MENSTRUAL BLOOD|HEMOLYZED|NA|CT SCAN WITHOUT CONTRAST|NA|NA|NA||1||38||BLINDED TREATMENT|1962-01-11|1972-04-12|||||1970-09-12||1963-05-30
TRIAL STUDY 134XCP|IS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KBQ/UL|||||BOLUS||||LOW|NOT DONE|||BONE|HEMOLYZED|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|Y|U||2||58||CONTINUATION TREATMENT|1962-12-25|1968-08-28|||||1973-04-07||1961-11-30
TRIAL STUDY 134XCP|IS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UIU/DL|||||ML/MIN/MMHG||||NORMAL|NOT DONE|||BILE|PARAFFIN-EMBEDDED|N|ELASTOGRAPHY|U|NA|NA||3||39||WASHOUT|1965-05-05|1972-01-16|||||1967-05-03||1973-08-01
TRIAL STUDY 134XCP|IS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GTT|||||KHZ||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|ICTERIC|U|HIGH RESOLUTION MELT ANALYSIS|Y|NA|U||4||88||LONG-TERM FOLLOW-UP|1969-12-19|1971-02-03|||||1961-07-23||1967-04-26
TRIAL STUDY 134XCP|IS|0D4B685D-9C50-416C-B5B3-A17B7653AAEB||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UKAT|||||BOWL||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|LACTESCENT|N|DIGITAL PCR|U|U|N||5||7||LONG-TERM FOLLOW-UP|1968-12-02|1965-05-03|||||1973-02-09||1969-06-11
TRIAL STUDY 134XCP|IS|9B95CE9F-E755-463A-92EC-07A55EE8A58F||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/G HB|||||GRAVITATIONAL UNIT||||ABNORMAL|NOT DONE|||COLOSTRUM|THAWED|N|FLUORESCENT IMMUNOASSAY|NA|NA|N||1||38||LONG-TERM FOLLOW-UP|1961-01-10|1964-11-09|||||1965-07-31||1971-03-27
TRIAL STUDY 134XCP|IS|9B95CE9F-E755-463A-92EC-07A55EE8A58F||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/DAY|||||M3||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|AUTOLYZED|U|BETA LACTAMASE|Y|NA|N||2||58||OBSERVATION|1962-09-05|1964-08-18|||||1967-08-18||1967-12-11
TRIAL STUDY 134XCP|IS|9B95CE9F-E755-463A-92EC-07A55EE8A58F||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^3/L|||||GPELISA UNIT/ML||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|CONCENTRATED|U|SNP ARRAY|NA|Y|Y||3||39||FOLLOW-UP|1972-10-27|1962-01-19|||||1972-08-15||1965-10-18
TRIAL STUDY 134XCP|IS|9B95CE9F-E755-463A-92EC-07A55EE8A58F||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CI/L|||||DAGU/ML||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|LIPEMIC|N|MRS|N|N|NA||4||88||BLINDED TREATMENT|1965-06-24|1971-09-04|||||1964-09-03||1964-03-02
TRIAL STUDY 134XCP|IS|9B95CE9F-E755-463A-92EC-07A55EE8A58F||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SACHET|||||10^4 CFU/ML||||HIGH|NOT DONE|||ARTERIAL BLOOD|CLOTTED|N|IMPEDANCE CONDUCTIVITY|NA|NA|N||5||7||INDUCTION TREATMENT|1965-09-16|1973-06-16|||||1962-07-12||1970-01-26
TRIAL STUDY 134XCP|IS|ED388A78-3B06-4529-861A-0174E7F345C2||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PRESSOR UNITS|||||10^6/L||||HIGH|NOT DONE|||SERUM|GELLED|N|APPLANATION TONOMETRY|NA|U|N||1||38||SCREENING|1966-05-11|1971-10-23|||||1960-07-08||1969-04-12
TRIAL STUDY 134XCP|IS|ED388A78-3B06-4529-861A-0174E7F345C2||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/G/MIN|||||G/G||||NORMAL|NOT DONE|||EMOTIONAL TEAR|FROZEN|N|GC/MS-CI|U|N|Y||2||58||RUN-IN|1970-10-18|1964-11-25|||||1961-07-22||1967-12-21
TRIAL STUDY 134XCP|IS|ED388A78-3B06-4529-861A-0174E7F345C2||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/CM2|||||NG/DL||||HIGH|NOT DONE|||KERATINOCYTE|SOLIDIFIED|NA|FLUORESCENT MICROSCOPY|NA|Y|NA||3||39||LONG-TERM FOLLOW-UP|1964-11-11|1973-07-20|||||1973-01-30||1972-01-22
TRIAL STUDY 134XCP|IS|ED388A78-3B06-4529-861A-0174E7F345C2||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TRANSDUCING UNIT/ML|||||PA||||LOW|NOT DONE|||BILE|GELLED|Y|STRESS ECHOCARDIOGRAPHY|N|N|N||4||88||CONTINUATION TREATMENT|1965-05-22|1967-09-11|||||1971-12-08||1970-08-09
TRIAL STUDY 134XCP|IS|ED388A78-3B06-4529-861A-0174E7F345C2||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FFU|||||ML/KG||||HIGH|NOT DONE|||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|U|LAPAROSCOPY|Y|U|N||5||7||BASELINE|1973-08-12|1960-09-26|||||1962-06-18||1966-05-16
TRIAL STUDY 134XCP|IS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/ANIMAL|||||EQ||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|AGGLUTINATED|Y|RADIATION DOSIMETRY|Y|U|U||1||38||BASELINE|1967-07-23|1962-07-28|||||1968-09-16||1970-09-30
TRIAL STUDY 134XCP|IS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/LPF|||||UG/H||||NORMAL|NOT DONE|||ISOLATE|THAWED|N|NEXT GENERATION TARGETED SEQUENCING|Y|NA|Y||2||58||OBSERVATION|1972-12-26|1967-11-24|||||1971-01-13||1967-08-04
TRIAL STUDY 134XCP|IS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PACKET|||||UL/DOSE||||LOW|NOT DONE|||EXPIRED AIR|HEMOLYZED|Y|FLUORESCENT MICROSCOPY|N|NA|Y||3||39||TREATMENT|1970-01-19|1961-07-22|||||1961-07-08||1963-06-02
TRIAL STUDY 134XCP|IS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/WK|||||KG/M2||||LOW|NOT DONE|||DIALYSIS FLUID|ROOM TEMPERATURE|U|CARDIAC THERMODILUTION|Y|U|Y||4||88||RUN-IN|1966-04-27|1970-07-22|||||1971-09-08||1972-07-25
TRIAL STUDY 134XCP|IS|F73DB6D9-A860-4250-ABF8-017C4E62FCFA||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||1/(S*KPA)|||||/WK||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|NON-HEMOLYZED|N|IN SITU HYBRIDIZATION|NA|U|N||5||7||OPEN LABEL TREATMENT|1963-01-22|1961-05-19|||||1964-06-01||1964-03-05
TRIAL STUDY 134XCP|IS|172AB680-362D-488C-9DF1-E1C8E386980D||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/M2/MIN|||||G/CAGE/WK||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|LACTESCENT|NA|PLETHYSMOGRAPHY|N|Y|U||1||38||RUN-IN|1970-07-18|1966-12-20|||||1964-10-16||1963-03-08
TRIAL STUDY 134XCP|IS|172AB680-362D-488C-9DF1-E1C8E386980D||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/CM|||||/MS||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|AUTOLYZED|NA|NUCLEIC ACID SEQUENCING|U|U|U||2||58||FOLLOW-UP|1961-07-07|1966-09-02|||||1963-06-15||1973-09-04
TRIAL STUDY 134XCP|IS|172AB680-362D-488C-9DF1-E1C8E386980D||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/SEC|||||IU/MG||||ABNORMAL|NOT DONE|||CORD BLOOD|DRIED|Y|MIGET|U|NA|NA||3||39||BASELINE|1964-05-21|1973-05-01|||||1965-08-17||1965-09-14
TRIAL STUDY 134XCP|IS|172AB680-362D-488C-9DF1-E1C8E386980D||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||APL U|||||U/KG/MIN||||ABNORMAL|NOT DONE|||LYMPH|FROZEN|N|OPTICAL DENSITY MEASUREMENT|N|NA|NA||4||88||BLINDED TREATMENT|1961-12-04|1965-11-15|||||1967-05-13||1970-03-27
TRIAL STUDY 134XCP|IS|172AB680-362D-488C-9DF1-E1C8E386980D||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/KG/MIN|||||BOWL||||LOW|NOT DONE|||PLATELET RICH PLASMA|CALCIFIED|N|GC/MS/MS|N|Y|U||5||7||TREATMENT|1960-09-01|1963-11-17|||||1969-04-16||1972-01-29
TRIAL STUDY 134XCP|IS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PT_US|||||MMHG/SEC||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|Y|CELLULAR PROLIFERATION ASSAY|U|N|N||1||38||INDUCTION TREATMENT|1967-03-05|1969-10-20|||||1964-06-28||1964-02-16
TRIAL STUDY 134XCP|IS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 CFU/ML|||||SIEMENS||||LOW|NOT DONE|||ARTERIAL BLOOD|THAWED|N|ANALYTICAL ULTRACENTRIFUGATION|Y|NA|Y||2||58||BLINDED TREATMENT|1967-05-31|1962-07-28|||||1961-08-19||1970-11-07
TRIAL STUDY 134XCP|IS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CYCLE/MIN|||||EID 50/ML||||LOW|NOT DONE|||SERUM|HEMOLYZED|Y|MS/MS|Y|Y|N||3||39||BASELINE|1966-05-12|1962-01-30|||||1970-01-11||1962-04-30
TRIAL STUDY 134XCP|IS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PUFF|||||10^4/L||||NORMAL|NOT DONE|||PLEURAL TISSUE|ICTERIC|U|AGAR PROPORTION|U|N|U||4||88||BASELINE|1964-01-25|1966-02-12|||||1968-05-31||1970-02-01
TRIAL STUDY 134XCP|IS|833FAF15-E8F8-47C9-AA1A-1454DC00FA78||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/G|||||LB||||LOW|NOT DONE|||CALCULUS|ROOM TEMPERATURE|N|ENZYMATIC COLORIMETRY|NA|U|NA||5||7||WASHOUT|1966-11-21|1960-02-11|||||1965-05-27||1964-07-30
TRIAL STUDY 134XCP|IS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/M2|||||G/CM2||||LOW|NOT DONE|||SPERMATOZOON|REFRIGERATED|NA|INCISION-INDUCED BLEEDING METHOD|Y|Y|N||1||38||BASELINE|1968-05-23|1969-04-05|||||1969-06-24||1965-04-02
TRIAL STUDY 134XCP|IS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NG/DAY|||||MOL/MG||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|N|N|U||2||58||OBSERVATION|1964-07-08|1965-06-26|||||1963-12-08||1968-02-05
TRIAL STUDY 134XCP|IS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L DDU|||||G/ANIMAL||||NORMAL|NOT DONE|||HAIR|CALCIFIED|U|CLIP|NA|U|U||3||39||OPEN LABEL TREATMENT|1964-07-19|1972-12-06|||||1965-12-21||1967-03-06
TRIAL STUDY 134XCP|IS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AFU|||||G/CM2||||NORMAL|NOT DONE|||LYSATE|HEMOLYZED|N|SLOAN LETTER EYE CHART 100%|N|N|Y||4||88||OPEN LABEL TREATMENT|1962-09-20|1972-05-06|||||1973-01-03||1964-05-06
TRIAL STUDY 134XCP|IS|8317AFA6-2E45-4B5B-AFE9-31AE86761BAC||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BISCUIT|||||ML/(MIN*100ML)||||LOW|NOT DONE|||CALCULUS|DRIED|N|KINYOUN STAIN|N|U|U||5||7||SCREENING|1969-08-12|1963-02-02|||||1968-07-26||1972-04-19
TRIAL STUDY 134XCP|IS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TESLA|||||/DAY||||NORMAL|NOT DONE|||LOCHIA|CONCENTRATED|Y|PET/CT SCAN WITHOUT CONTRAST|N|Y|U||1||38||SCREENING|1970-07-21|1972-02-08|||||1964-07-23||1960-06-10
TRIAL STUDY 134XCP|IS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/M2/DAY|||||UL||||ABNORMAL|NOT DONE|||KERATINOCYTE|HEMOLYZED|U|MICROARRAY|NA|N|U||2||58||CONTINUATION TREATMENT|1964-08-19|1960-08-01|||||1971-10-06||1969-04-06
TRIAL STUDY 134XCP|IS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/ANIMAL/WK|||||KCAL/DAY||||LOW|NOT DONE|||EXUDATE|LACTESCENT|Y|RAJI CELL EIA|Y|Y|U||3||39||INDUCTION TREATMENT|1972-05-27|1967-05-19|||||1963-04-23||1966-07-15
TRIAL STUDY 134XCP|IS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KM|||||MPS U||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|NA|NO INFORMATION|NA|N|Y||4||88||BASELINE|1967-05-17|1971-04-12|||||1973-01-17||1962-01-19
TRIAL STUDY 134XCP|IS|9C06CFC3-5D87-4717-89D0-172EA17ABDAB||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMOL/G|||||UMOL||||HIGH|NOT DONE|||EXUDATE|AGGLUTINATED|NA|REFLECTANCE SPECTROSCOPY|N|Y|N||5||7||OBSERVATION|1964-10-13|1960-11-04|||||1973-02-19||1962-04-29
TRIAL STUDY 134XCP|IS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PPM|||||AMFI||||NORMAL|NOT DONE|||PERSPIRATION|NON-HEMOLYZED|U|TRANSCRIPTION-MEDIATED AMPLIFICATION|U|U|N||1||38||BASELINE|1960-11-17|1969-01-19|||||1971-10-18||1972-09-07
TRIAL STUDY 134XCP|IS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG10 ELISA UNIT|||||U/KG/DAY||||HIGH|NOT DONE|||PERSPIRATION|LIPEMIC|U|MAGNETIC RESONANCE ELASTOGRAPHY|U|U|NA||2||58||RUN-IN|1971-11-21|1968-03-02|||||1973-07-24||1960-10-10
TRIAL STUDY 134XCP|IS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CONTAINER|||||L/DAY||||HIGH|NOT DONE|||VENOUS BLOOD|CONCENTRATED|Y|ETDRS EYE CHART|NA|Y|NA||3||39||OPEN LABEL TREATMENT|1961-09-21|1970-10-28|||||1968-12-03||1960-12-03
TRIAL STUDY 134XCP|IS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DPM/100MG|||||PT_US||||ABNORMAL|NOT DONE|||BLOOD|CLOTTED|Y|CALCULATION|NA|N|Y||4||88||TREATMENT|1965-06-26|1970-10-21|||||1964-07-18||1963-08-28
TRIAL STUDY 134XCP|IS|AE7EAB81-A12F-4135-A64A-E89CD55E0AFE||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||STRIP|||||TABLET||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|SOLIDIFIED|N|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|Y|Y||5||7||OBSERVATION|1971-12-07|1963-04-13|||||1962-12-21||1961-10-27
TRIAL STUDY 134XCP|IS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UMOL/MOL|||||10^3 CFU/ML||||NORMAL|NOT DONE|||SOFT TISSUE|THAWED|Y|FLOCCULATION, CHARCOAL ENHANCED|N|U|U||1||38||LONG-TERM FOLLOW-UP|1961-02-24|1968-11-18|||||1962-05-12||1970-03-16
TRIAL STUDY 134XCP|IS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PPTR|||||G/CAGE/DAY||||LOW|NOT DONE|||ERYTHROCYTES|AGGLUTINATED|U|RADIOGRAPHY|N|Y|N||2||58||FOLLOW-UP|1961-12-07|1963-11-23|||||1965-01-14||1967-06-25
TRIAL STUDY 134XCP|IS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CD/M2|||||ML/BREATH||||NORMAL|NOT DONE|||HAIR FOLLICLE|GELLED|NA|MULTI-SLICE SPIRAL CT|NA|U|N||3||39||WASHOUT|1960-10-24|1972-07-31|||||1964-11-28||1970-08-25
TRIAL STUDY 134XCP|IS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG2/DL2|||||MPL U||||ABNORMAL|NOT DONE|||LYMPH|HEMOLYZED|Y|MOUSE PROTECTION ASSAY|U|U|U||4||88||LONG-TERM FOLLOW-UP|1967-03-02|1960-01-12|||||1972-02-06||1968-01-08
TRIAL STUDY 134XCP|IS|2DF1D841-0B0E-477D-A73E-BE3F73F0DDA3||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FT|||||MG/M2/H||||LOW|NOT DONE|||SEBUM|ICTERIC|U|WRIGHT-GIEMSA STAIN|N|Y|Y||5||7||OPEN LABEL TREATMENT|1973-08-27|1971-01-15|||||1968-10-14||1968-03-09
TRIAL STUDY 134XCP|IS|740D80F1-8BD5-4409-8087-E48F94363362||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PMOL|||||10^6 DNA COPIES/ML||||NORMAL|NOT DONE|||CAPILLARY BLOOD|CALCIFIED|N|NUCLEIC ACID HYBRIDIZATION|Y|Y|N||1||38||INDUCTION TREATMENT|1970-01-02|1964-12-30|||||1973-07-15||1965-03-25
TRIAL STUDY 134XCP|IS|740D80F1-8BD5-4409-8087-E48F94363362||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT/L|||||MMOL/KG||||NORMAL|NOT DONE|||ISOLATE|AGGLUTINATED|U|HIGH RESOLUTION MELT ANALYSIS|NA|U|Y||2||58||SCREENING|1970-12-15|1966-06-28|||||1970-05-27||1964-12-16
TRIAL STUDY 134XCP|IS|740D80F1-8BD5-4409-8087-E48F94363362||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/CM2|||||GY||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|THAWED|NA|LAPAROSCOPY|U|N|Y||3||39||OPEN LABEL TREATMENT|1962-11-15|1960-06-24|||||1966-10-11||1966-08-25
TRIAL STUDY 134XCP|IS|740D80F1-8BD5-4409-8087-E48F94363362||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BP|||||UGEQ||||HIGH|NOT DONE|||INFRANATANT, PLASMA|ROOM TEMPERATURE|U|ORCHIDOMETERY|U|Y|U||4||88||WASHOUT|1964-10-04|1969-04-15|||||1968-06-04||1971-06-27
TRIAL STUDY 134XCP|IS|740D80F1-8BD5-4409-8087-E48F94363362||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OHM|||||CGY||||NORMAL|NOT DONE|||DIALYSIS FLUID|CLOTTED|U|LANDOLT RING|U|N|N||5||7||TREATMENT|1971-01-01|1973-01-12|||||1968-07-12||1964-04-03
TRIAL STUDY 134XCP|IS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MU/L|||||/MONTH||||HIGH|NOT DONE|||LEUKOCYTE|NON-HEMOLYZED|NA|PLETHYSMOGRAPHY|U|U|NA||1||38||FOLLOW-UP|1970-11-02|1972-09-23|||||1972-12-27||1969-06-25
TRIAL STUDY 134XCP|IS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/LPF|||||LOG10 COPIES/ML||||LOW|NOT DONE|||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|N|KINETIC CHROMOGENIC ASSAY|N|U|NA||2||58||BLINDED TREATMENT|1969-10-05|1970-09-01|||||1972-02-13||1964-08-15
TRIAL STUDY 134XCP|IS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||LOG10 IU/ML|||||KG||||NORMAL|NOT DONE|||CAPILLARY PLASMA|ICTERIC|U|SLOAN LETTER EYE CHART 100%|N|N|NA||3||39||RUN-IN|1972-11-26|1965-02-06|||||1973-08-24||1964-03-29
TRIAL STUDY 134XCP|IS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MET*MIN|||||ML/G/DAY||||LOW|NOT DONE|||SEMEN|THAWED|NA|ENDOSCOPY|NA|NA|N||4||88||OPEN LABEL TREATMENT|1960-05-06|1961-11-20|||||1972-12-18||1965-10-05
TRIAL STUDY 134XCP|IS|39FB0A16-25B8-4D51-B9F5-9ADACCEF6A87||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PG|||||MG/M2/DAY||||LOW|NOT DONE|||DIALYSIS FLUID|CONTAMINATED|U|DIFFUSION WEIGHTED MRI|N|NA|NA||5||7||WASHOUT|1972-08-30|1960-06-20|||||1969-09-26||1966-11-27
TRIAL STUDY 134XCP|IS|12AD3838-F986-4A27-8AEE-59C387988B0F||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FINGERTIP UNIT|||||EJACULATE U||||HIGH|NOT DONE|||PUS|CONTAMINATED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NA|U|Y||1||38||BLINDED TREATMENT|1967-01-31|1966-10-06|||||1964-05-23||1965-07-30
TRIAL STUDY 134XCP|IS|12AD3838-F986-4A27-8AEE-59C387988B0F||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KUSP|||||UG/G/MIN||||LOW|NOT DONE|||SEMINAL FLUID|CONTAMINATED|NA|MICROBIAL CULTURE|N|U|Y||2||58||SCREENING|1969-06-03|1966-05-08|||||1969-11-06||1969-11-17
TRIAL STUDY 134XCP|IS|12AD3838-F986-4A27-8AEE-59C387988B0F||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GLOBULE|||||MET*MIN||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|REFRIGERATED|N|CORONARY ANGIOGRAPHY|U|N|N||3||39||RUN-IN|1973-03-26|1970-09-12|||||1968-04-21||1972-10-17
TRIAL STUDY 134XCP|IS|12AD3838-F986-4A27-8AEE-59C387988B0F||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SHOCK WAVE|||||/MIN||||NORMAL|NOT DONE|||CORD SERUM|HEMOLYZED|Y|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|U|Y|U||4||88||LONG-TERM FOLLOW-UP|1970-03-02|1964-07-29|||||1971-08-09||1965-02-12
TRIAL STUDY 134XCP|IS|12AD3838-F986-4A27-8AEE-59C387988B0F||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DL|||||ML/KG/DAY||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|FRESH|NA|DYNAMOMETRY|NA|Y|N||5||7||BLINDED TREATMENT|1964-06-09|1970-03-17|||||1967-01-18||1967-06-09
TRIAL STUDY 134XCP|IS|441F1A21-6350-478A-9719-75B053182B78||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MBP|||||1/(S*KPA)||||ABNORMAL|NOT DONE|||SPUTUM|AGGLUTINATED|Y|SXA SCAN|NA|U|N||1||38||SCREENING|1973-02-14|1973-04-26|||||1962-02-01||1962-09-07
TRIAL STUDY 134XCP|IS|441F1A21-6350-478A-9719-75B053182B78||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BOX|||||G/ANIMAL||||NORMAL|NOT DONE|||LOCHIA|THAWED|U|AUTOMATED COUNT|Y|U|NA||2||58||CONTINUATION TREATMENT|1963-09-07|1968-04-20|||||1962-08-30||1962-05-09
TRIAL STUDY 134XCP|IS|441F1A21-6350-478A-9719-75B053182B78||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UIU/L|||||ANSON U||||NORMAL|NOT DONE|||SPUTUM|REFRIGERATED|N|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y|Y|U||3||39||RUN-IN|1966-02-03|1962-02-28|||||1967-07-01||1966-01-12
TRIAL STUDY 134XCP|IS|441F1A21-6350-478A-9719-75B053182B78||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TSP EQ|||||CONTAINER||||NORMAL|NOT DONE|||PUS|ROOM TEMPERATURE|Y|FORCED OSCILLATION TECHNIQUE|Y|U|Y||4||88||RUN-IN|1963-07-07|1960-09-21|||||1972-08-10||1968-11-04
TRIAL STUDY 134XCP|IS|441F1A21-6350-478A-9719-75B053182B78||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 ORGANISMS|||||KG/CM||||HIGH|NOT DONE|||TRANSUDATE|FRESH|Y|LC/MS/MS|N|U|U||5||7||LONG-TERM FOLLOW-UP|1970-03-11|1973-01-23|||||1960-03-14||1973-07-11
TRIAL STUDY 134XCP|IS|A69520E2-01A5-4CBC-AFC9-00324531779F||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MONTHS|||||MN||||HIGH|NOT DONE|||BILE|SOLIDIFIED|Y|ALCIAN BLUE STAIN|U|N|NA||1||38||WASHOUT|1968-05-03|1967-11-04|||||1970-05-23||1969-09-04
TRIAL STUDY 134XCP|IS|A69520E2-01A5-4CBC-AFC9-00324531779F||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPL U/ML|||||TUBERCULIN UNIT||||LOW|NOT DONE|||WHITE MATTER TISSUE|THAWED|Y|SINGLE-MOLECULE ARRAY|Y|U|NA||2||58||WASHOUT|1960-02-06|1964-12-06|||||1970-05-31||1963-05-02
TRIAL STUDY 134XCP|IS|A69520E2-01A5-4CBC-AFC9-00324531779F||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DAYS/MONTH|||||10^6 ORGANISMS||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|NON-HEMOLYZED|U|ELECTRICAL IMPEDANCE MYOGRAPHY|N|NA|N||3||39||WASHOUT|1964-09-02|1973-03-05|||||1963-04-03||1960-08-25
TRIAL STUDY 134XCP|IS|A69520E2-01A5-4CBC-AFC9-00324531779F||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UU/DL|||||RPM||||NORMAL|NOT DONE|||GASTRIC FLUID|HEMOLYZED|U|IMMUNORADIOMETRIC ASSAY|U|NA|Y||4||88||BASELINE|1963-08-11|1970-10-07|||||1960-05-14||1964-10-13
TRIAL STUDY 134XCP|IS|A69520E2-01A5-4CBC-AFC9-00324531779F||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IU/ML|||||ENZYME U||||NORMAL|NOT DONE|||PUS|AGGLUTINATED|N|MYELOPEROXIDASE STAIN|NA|U|Y||5||7||LONG-TERM FOLLOW-UP|1970-09-07|1965-05-25|||||1963-08-06||1970-03-05
TRIAL STUDY 134XCP|IS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CFU/ML|||||NMOL/L/MIN||||HIGH|NOT DONE|||ARTERIAL BLOOD|HEMOLYZED|N|PET/SPECT SCAN|N|Y|NA||1||38||TREATMENT|1966-07-07|1962-10-25|||||1973-02-02||1971-06-11
TRIAL STUDY 134XCP|IS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/UG|||||U/ML||||HIGH|NOT DONE|||TUMOR TISSUE|DRIED|N|HEMATOXYLIN AND EOSIN STAIN|Y|NA|N||2||58||WASHOUT|1963-03-06|1960-04-13|||||1972-01-20||1970-07-01
TRIAL STUDY 134XCP|IS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/ANIMAL|||||G/M2||||NORMAL|NOT DONE|||REFLEX TEAR|PARAFFIN-EMBEDDED|U|DOUBLE IMMUNODIFFUSION|N|Y|Y||3||39||RUN-IN|1966-04-08|1967-08-08|||||1968-03-27||1971-01-14
TRIAL STUDY 134XCP|IS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/M2/H|||||UMOL/KG/MIN||||ABNORMAL|NOT DONE|||LYSATE|GELLED|Y|FARNSWORTH-MUNSELL 100 HUE TEST|Y|NA|NA||4||88||FOLLOW-UP|1965-11-28|1969-06-02|||||1964-12-24||1968-08-31
TRIAL STUDY 134XCP|IS|1BCAEE81-9148-4D99-93E7-8B9CC9C9C1E7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BE/ML|||||MOL/L||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|FRESH|U|IMMUNOBLOT|Y|Y|Y||5||7||BLINDED TREATMENT|1963-02-10|1972-11-04|||||1972-02-24||1961-10-08
TRIAL STUDY 134XCP|IS|C361B153-4623-4F03-9D81-8316B1046F35||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/M2/H|||||NU/CL||||HIGH|NOT DONE|||AMNIOTIC FLUID|DRIED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NA|NA|Y||1||38||BASELINE|1963-01-28|1972-01-08|||||1972-09-01||1973-08-15
TRIAL STUDY 134XCP|IS|C361B153-4623-4F03-9D81-8316B1046F35||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||GRAIN|||||UEQ/L||||HIGH|NOT DONE|||PUS|UNEXPECTED ODOR|NA|SPECT/CT SCAN|NA|NA|NA||2||58||LONG-TERM FOLLOW-UP|1965-09-06|1969-02-02|||||1968-07-17||1966-01-18
TRIAL STUDY 134XCP|IS|C361B153-4623-4F03-9D81-8316B1046F35||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BU/ML|||||10^9/L||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|NON-HEMOLYZED|Y|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|N|U|Y||3||39||SCREENING|1971-11-05|1967-03-16|||||1971-11-11||1970-06-15
TRIAL STUDY 134XCP|IS|C361B153-4623-4F03-9D81-8316B1046F35||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||G/MOL|||||CAL||||LOW|NOT DONE|||CORD BLOOD|CALCIFIED|NA|DYNAMOMETRY|NA|U|U||4||88||CONTINUATION TREATMENT|1969-03-17|1968-05-27|||||1966-07-09||1968-01-17
TRIAL STUDY 134XCP|IS|C361B153-4623-4F03-9D81-8316B1046F35||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CI/KG|||||CI||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|CALCIFIED|NA|MULTIPLE BREATH WASHOUT|Y|N|Y||5||7||OPEN LABEL TREATMENT|1960-07-24|1965-10-26|||||1969-05-29||1968-02-24
TRIAL STUDY 134XCP|IS|8FF0A93C-26D1-49E9-853F-B063A958FE1E||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/10^4|||||CPM||||HIGH|NOT DONE|||AQUEOUS HUMOR|CLOTTED|NA|LC/MS/MS|Y|Y|NA||1||38||BLINDED TREATMENT|1973-01-08|1965-02-08|||||1967-07-25||1963-11-21
TRIAL STUDY 134XCP|IS|8FF0A93C-26D1-49E9-853F-B063A958FE1E||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/G/H|||||G/U||||ABNORMAL|NOT DONE|||CORD SERUM|DRIED|Y|TOTAL BODY RADIOGRAPHY|U|Y|NA||2||58||INDUCTION TREATMENT|1965-12-26|1960-03-13|||||1968-01-17||1971-10-21
TRIAL STUDY 134XCP|IS|8FF0A93C-26D1-49E9-853F-B063A958FE1E||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/7.5 ML|||||/LSQN||||HIGH|NOT DONE|||CALCULUS|THAWED|N|GC/MS-CI|NA|N|U||3||39||CONTINUATION TREATMENT|1973-08-02|1961-03-16|||||1960-06-05||1970-05-26
TRIAL STUDY 134XCP|IS|8FF0A93C-26D1-49E9-853F-B063A958FE1E||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/DAY|||||10^6 IU||||LOW|NOT DONE|||SALIVA|CONCENTRATED|N|PHOROPTER|U|NA|N||4||88||TREATMENT|1964-11-05|1961-04-30|||||1966-01-31||1972-01-31
TRIAL STUDY 134XCP|IS|8FF0A93C-26D1-49E9-853F-B063A958FE1E||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||OD UNIT|||||UM||||NORMAL|NOT DONE|||REFLEX TEAR|CONTAMINATED|NA|FLOCCULATION|U|NA|U||5||7||LONG-TERM FOLLOW-UP|1972-07-13|1971-04-12|||||1967-04-11||1971-06-03
TRIAL STUDY 134XCP|IS|31D8814B-5542-4540-B955-24410D42F1EF||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MET*MIN|||||ML/100G/MIN||||HIGH|NOT DONE|||SERUM OR PLASMA|CLOTTED|Y|DIGITAL PCR ARRAY|Y|U|N||1||38||BLINDED TREATMENT|1973-01-19|1971-06-27|||||1961-04-28||1966-02-06
TRIAL STUDY 134XCP|IS|31D8814B-5542-4540-B955-24410D42F1EF||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||EID 50/ML|||||MAMP||||HIGH|NOT DONE|||SEBUM|LIPEMIC|NA|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|N|NA|N||2||58||LONG-TERM FOLLOW-UP|1966-08-08|1962-06-07|||||1961-12-14||1967-09-02
TRIAL STUDY 134XCP|IS|31D8814B-5542-4540-B955-24410D42F1EF||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/L FEU|||||PIXELS/IN||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|GELLED|N|SPECT/CT SCAN|Y|NA|NA||3||39||TREATMENT|1971-11-15|1969-04-08|||||1970-08-26||1961-04-24
TRIAL STUDY 134XCP|IS|31D8814B-5542-4540-B955-24410D42F1EF||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UKAT|||||/40 HPFS||||NORMAL|NOT DONE|||LAVAGE FLUID|FRESH|U|CALIPER MEASUREMENT METHOD|NA|NA|N||4||88||OPEN LABEL TREATMENT|1969-08-18|1963-09-03|||||1972-07-13||1965-08-29
TRIAL STUDY 134XCP|IS|31D8814B-5542-4540-B955-24410D42F1EF||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/DAY|||||OI50||||HIGH|NOT DONE|||SUPERNATANT, SERUM|ROOM TEMPERATURE|U|BALLPOINT PEN TECHNIQUE|U|Y|Y||5||7||LONG-TERM FOLLOW-UP|1973-05-05|1963-12-28|||||1969-06-25||1968-10-28
TRIAL STUDY 134XCP|IS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||SYRINGE|||||KN/CM2||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|PARAFFIN-EMBEDDED|U|APPLANATION TONOMETRY|Y|NA|U||1||38||CONTINUATION TREATMENT|1973-06-14|1964-07-06|||||1973-03-13||1970-08-06
TRIAL STUDY 134XCP|IS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||HEP|||||UL||||LOW|NOT DONE|||ERYTHROCYTES|CONTAMINATED|U|IMMUNODIFFUSION|U|NA|NA||2||58||TREATMENT|1964-12-16|1966-05-29|||||1968-05-13||1965-04-22
TRIAL STUDY 134XCP|IS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ANTI-XA IU|||||KALLIKREIN INHIBITOR UNIT||||ABNORMAL|NOT DONE|||BILE|DRIED|NA|MANUAL CLOT DETECTION|NA|N|Y||3||39||LONG-TERM FOLLOW-UP|1963-05-30|1967-03-23|||||1962-06-19||1967-08-27
TRIAL STUDY 134XCP|IS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||L/DAY|||||MOSM||||ABNORMAL|NOT DONE|||LYSATE|NON-HEMOLYZED|Y|DIFFUSION WEIGHTED MRI|N|N|U||4||88||BASELINE|1971-01-30|1965-02-12|||||1969-09-20||1963-07-26
TRIAL STUDY 134XCP|IS|F49BC9E7-45A5-4482-AA39-EC49857B2B6A||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||VP/ML|||||MG/KG/WEEK||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|AGGLUTINATED|N|PYROSEQUENCING|NA|Y|N||5||7||LONG-TERM FOLLOW-UP|1962-01-19|1965-04-16|||||1960-07-04||1967-05-10
TRIAL STUDY 134XCP|IS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UU/L|||||10^10/L||||LOW|NOT DONE|||RETICULOCYTES|SOLIDIFIED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|U|NA|NA||1||38||RUN-IN|1966-10-24|1960-06-11|||||1970-01-20||1972-05-03
TRIAL STUDY 134XCP|IS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/KG/MIN|||||G/KG||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|FRESH|NA|CLAUSS METHOD|U|NA|NA||2||58||BLINDED TREATMENT|1963-01-15|1969-09-26|||||1965-05-28||1970-12-18
TRIAL STUDY 134XCP|IS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GRAVITATIONAL UNIT|||||OHM||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|REFRIGERATED|U|PULMONARY ANGIOGRAPHY|NA|U|U||3||39||OPEN LABEL TREATMENT|1961-03-16|1961-07-11|||||1962-04-24||1967-12-27
TRIAL STUDY 134XCP|IS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||/5X10^4 WBC||||HIGH|NOT DONE|||CERVICOVAGINAL SECRETION|CLOTTED|Y|CISH|Y|N|U||4||88||CONTINUATION TREATMENT|1964-06-09|1969-01-16|||||1962-08-03||1969-03-06
TRIAL STUDY 134XCP|IS|A55BBD57-6AD2-4D49-9377-7CD13BFF800C||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^4 CFU/ML|||||NMOL BCE/L||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|SOLIDIFIED|NA|JAEGER EYE CHART|U|U|NA||5||7||OPEN LABEL TREATMENT|1964-03-06|1971-09-10|||||1964-05-13||1964-01-23
TRIAL STUDY 134XCP|IS|15BFC17A-2F55-441A-AB99-76D270D62367||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/ANIMAL|||||LB||||LOW|NOT DONE|||PLASMA|CALCIFIED|Y|ELASTOGRAPHY|N|NA|Y||1||38||OPEN LABEL TREATMENT|1965-03-24|1960-07-10|||||1970-10-07||1969-01-07
TRIAL STUDY 134XCP|IS|15BFC17A-2F55-441A-AB99-76D270D62367||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MU|||||KS||||ABNORMAL|NOT DONE|||EXPIRED AIR|GELLED|NA|RIA|N|Y|U||2||58||TREATMENT|1966-05-21|1962-01-11|||||1966-04-19||1961-07-15
TRIAL STUDY 134XCP|IS|15BFC17A-2F55-441A-AB99-76D270D62367||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PRESSOR UNITS|||||MG/MOL||||HIGH|NOT DONE|||SEMEN|FROZEN|N|PET/MRI SCAN|U|N|NA||3||39||INDUCTION TREATMENT|1966-11-06|1965-01-10|||||1964-10-15||1967-04-02
TRIAL STUDY 134XCP|IS|15BFC17A-2F55-441A-AB99-76D270D62367||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PACK|||||/10^5||||LOW|NOT DONE|||WHITE MATTER TISSUE|THAWED|Y|MICROBIAL CULTURE, LIQUID|NA|U|U||4||88||CONTINUATION TREATMENT|1967-05-09|1963-05-19|||||1961-04-04||1969-04-29
TRIAL STUDY 134XCP|IS|15BFC17A-2F55-441A-AB99-76D270D62367||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||SV|||||MG/CM2||||HIGH|NOT DONE|||HAIR FOLLICLE|AGGLUTINATED|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NA|NA|N||5||7||OPEN LABEL TREATMENT|1968-08-27|1965-01-02|||||1969-02-23||1964-07-26
TRIAL STUDY 134XCP|IS|CA231D77-1A1F-49F3-8172-06709A1330B7||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ELISA UNIT/ML|||||U/M2/H||||HIGH|NOT DONE|||LEUKOCYTE|REFRIGERATED|N|ELASTOGRAPHY|N|NA|U||1||38||CONTINUATION TREATMENT|1973-04-08|1972-08-27|||||1972-10-20||1967-01-13
TRIAL STUDY 134XCP|IS|CA231D77-1A1F-49F3-8172-06709A1330B7||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DDU|||||OZ EQ||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|FROZEN|N|PHYSICAL EXAMINATION|U|N|N||2||58||OBSERVATION|1962-09-27|1971-03-01|||||1962-01-21||1961-01-04
TRIAL STUDY 134XCP|IS|CA231D77-1A1F-49F3-8172-06709A1330B7||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CAPFUL|||||ML/M2/H||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|SOLIDIFIED|NA|QUANTITATIVE CORONARY ANGIOGRAPHY|N|Y|NA||3||39||INDUCTION TREATMENT|1964-05-07|1969-04-19|||||1965-09-13||1960-11-25
TRIAL STUDY 134XCP|IS|CA231D77-1A1F-49F3-8172-06709A1330B7||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/MIN|||||BREATHS/MIN||||LOW|NOT DONE|||SERUM|CLOTTED|Y|WESTERN BLOT|NA|NA|U||4||88||LONG-TERM FOLLOW-UP|1961-10-23|1964-06-08|||||1966-10-16||1972-01-14
TRIAL STUDY 134XCP|IS|CA231D77-1A1F-49F3-8172-06709A1330B7||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^9/DOSE|||||SHOCK WAVE||||LOW|NOT DONE|||SEBUM|ROOM TEMPERATURE|U|PET/MRI SCAN|N|Y|N||5||7||TREATMENT|1964-11-30|1967-06-18|||||1965-01-07||1966-01-17
TRIAL STUDY 134XCP|IS|7A4D6074-E870-40E8-B567-D069BCB7DA9F||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/L DDU|||||IN2||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|SOLIDIFIED|Y|PERFUSION MRI|NA|U|NA||1||38||RUN-IN|1969-05-08|1969-11-22|||||1963-06-29||1973-02-23
TRIAL STUDY 134XCP|IS|7A4D6074-E870-40E8-B567-D069BCB7DA9F||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CAPFUL|||||/MONTH||||HIGH|NOT DONE|||CORD SERUM|FROZEN|N|KINETIC MICROPARTICLE IMMUNOASSAY|Y|NA|Y||2||58||OPEN LABEL TREATMENT|1966-04-24|1968-09-17|||||1972-01-25||1966-07-14
TRIAL STUDY 134XCP|IS|7A4D6074-E870-40E8-B567-D069BCB7DA9F||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PPB|||||/LSQN||||HIGH|NOT DONE|||MONOCYTE|SOLIDIFIED|U|REFRACTOMETRY|Y|N|U||3||39||BASELINE|1964-08-10|1965-08-09|||||1964-12-09||1972-11-27
TRIAL STUDY 134XCP|IS|7A4D6074-E870-40E8-B567-D069BCB7DA9F||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GLOBULE|||||UG/L/H||||HIGH|NOT DONE|||SYNOVIAL FLUID|LACTESCENT|U|PALPATION|NA|U|NA||4||88||WASHOUT|1960-08-25|1960-04-19|||||1967-08-13||1960-03-21
TRIAL STUDY 134XCP|IS|7A4D6074-E870-40E8-B567-D069BCB7DA9F||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L DDU|||||MOL||||NORMAL|NOT DONE|||LUNG SURFACTANT|CLOTTED|N|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|Y|NA||5||7||RUN-IN|1963-11-23|1965-01-21|||||1961-06-17||1963-02-02
TRIAL STUDY 134XCP|IS|3DDD2A7E-B955-424B-B485-54E81D0E0699||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CUP|||||TRACE||||NORMAL|NOT DONE|||MUCUS|CALCIFIED|N|IN SITU HYBRIDIZATION|NA|U|U||1||38||FOLLOW-UP|1966-08-15|1966-08-12|||||1963-10-08||1968-10-26
TRIAL STUDY 134XCP|IS|3DDD2A7E-B955-424B-B485-54E81D0E0699||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TSP|||||10^9 ORGANISMS/MG||||LOW|NOT DONE|||MIXED VENOUS BLOOD|SOLIDIFIED|NA|CYSTOSCOPY|N|U|Y||2||58||RUN-IN|1968-03-21|1961-05-03|||||1968-10-13||1966-03-01
TRIAL STUDY 134XCP|IS|3DDD2A7E-B955-424B-B485-54E81D0E0699||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MPA|||||GY||||HIGH|NOT DONE|||BREAST MILK|UNEXPECTED ODOR|U|TARGETED GENOME SEQUENCING|NA|U|NA||3||39||WASHOUT|1967-01-06|1971-11-01|||||1964-12-18||1966-06-13
TRIAL STUDY 134XCP|IS|3DDD2A7E-B955-424B-B485-54E81D0E0699||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BQ/L|||||FARAD||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|GELLED|Y|ATOMIC ABSORPTION SPECTROMETRY|U|NA|U||4||88||RUN-IN|1962-10-18|1969-07-16|||||1969-03-28||1968-02-13
TRIAL STUDY 134XCP|IS|3DDD2A7E-B955-424B-B485-54E81D0E0699||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CIGARETTE|||||/5X10^4 WBC||||LOW|NOT DONE|||EMESIS|ROOM TEMPERATURE|Y|MASS SPECTROMETRY|U|U|N||5||7||OBSERVATION|1969-09-23|1960-07-09|||||1971-04-15||1970-10-11
TRIAL STUDY 134XCP|IS|D6757E79-3104-468E-BADC-8CCB51BFAE87||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^7 TCID 50/DOSE|||||DMOL||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|SOLIDIFIED|Y|LEAD CITRATE STAIN|Y|U|U||1||38||FOLLOW-UP|1965-04-26|1965-04-07|||||1970-02-12||1964-05-31
TRIAL STUDY 134XCP|IS|D6757E79-3104-468E-BADC-8CCB51BFAE87||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PMOL/10^9 CELLS|||||MPS U||||ABNORMAL|NOT DONE|||VENOUS BLOOD|REFRIGERATED|Y|FLUORESCENCE ANGIOGRAPHY|NA|Y|N||2||58||BLINDED TREATMENT|1973-08-07|1968-06-11|||||1966-11-28||1966-07-07
TRIAL STUDY 134XCP|IS|D6757E79-3104-468E-BADC-8CCB51BFAE87||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 CCID 50/DOSE|||||UMOL/MOL||||HIGH|NOT DONE|||LAVAGE FLUID|FRESH|NA|RAJI CELL RIA|N|Y|N||3||39||CONTINUATION TREATMENT|1962-04-29|1973-07-05|||||1971-06-20||1968-11-07
TRIAL STUDY 134XCP|IS|D6757E79-3104-468E-BADC-8CCB51BFAE87||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||L/H/M2|||||MEQ/UG||||ABNORMAL|NOT DONE|||BONE|FROZEN|NA|APPLANATION TONOMETRY|N|NA|U||4||88||RUN-IN|1963-11-07|1962-12-01|||||1970-11-11||1965-03-12
TRIAL STUDY 134XCP|IS|D6757E79-3104-468E-BADC-8CCB51BFAE87||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MIN*MG/ML|||||UU/L||||ABNORMAL|NOT DONE|||SPUTUM|LACTESCENT|N|DIRECT SEQUENCING|Y|U|N||5||7||BASELINE|1960-02-01|1973-08-23|||||1960-06-14||1967-08-15
TRIAL STUDY 134XCP|IS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MPS U|||||MM/2H||||HIGH|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|N|COLORIMETRY|Y|NA|N||1||38||OBSERVATION|1967-04-29|1969-11-19|||||1972-08-02||1970-04-21
TRIAL STUDY 134XCP|IS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FOZ_BR|||||AMFI||||LOW|NOT DONE|||ALVEOLAR AIR|AUTOLYZED|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|N|N|N||2||58||RUN-IN|1969-12-13|1965-12-21|||||1972-10-27||1963-09-30
TRIAL STUDY 134XCP|IS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KBQ/UL|||||UMOL/L||||NORMAL|NOT DONE|||PERITONEAL FLUID|DRIED|U|SPIRAL CT|Y|N|N||3||39||BLINDED TREATMENT|1965-06-24|1973-03-28|||||1967-02-17||1965-05-01
TRIAL STUDY 134XCP|IS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FINGERTIP UNIT|||||ML/DL||||HIGH|NOT DONE|||KERATINOCYTE|SOLIDIFIED|N|CONGO RED STAIN|N|Y|U||4||88||LONG-TERM FOLLOW-UP|1969-02-16|1962-11-24|||||1963-11-13||1968-08-15
TRIAL STUDY 134XCP|IS|1AD25253-DE25-4DB8-A2C6-04763FEEB73E||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LOG10 CCID 50/DOSE|||||EP U||||ABNORMAL|NOT DONE|||PLEURAL FLUID|PARAFFIN-EMBEDDED|N|CLAUSS METHOD|U|NA|U||5||7||RUN-IN|1966-09-02|1965-11-18|||||1971-08-02||1963-01-02
TRIAL STUDY 134XCP|IS|FBAA59F4-154C-40CC-B740-A87769BFEC45||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DPM|||||U/G/H||||LOW|NOT DONE|||KERATINOCYTE|FRESH|N|BALLPOINT PEN TECHNIQUE|U|N|N||1||38||OBSERVATION|1972-05-21|1965-08-11|||||1970-11-23||1967-07-05
TRIAL STUDY 134XCP|IS|FBAA59F4-154C-40CC-B740-A87769BFEC45||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI/UG|||||10^6/HPF||||HIGH|NOT DONE|||LOCHIA|NON-HEMOLYZED|NA|CELLULAR PROLIFERATION ASSAY|N|NA|Y||2||58||TREATMENT|1972-09-21|1964-12-22|||||1964-09-09||1964-05-11
TRIAL STUDY 134XCP|IS|FBAA59F4-154C-40CC-B740-A87769BFEC45||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DEG|||||/7.5 ML||||ABNORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|LACTESCENT|U|IRON HEMATOXYLIN STAIN|NA|U|N||3||39||LONG-TERM FOLLOW-UP|1968-06-12|1972-10-29|||||1972-09-30||1962-06-13
TRIAL STUDY 134XCP|IS|FBAA59F4-154C-40CC-B740-A87769BFEC45||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6 RNA COPIES/ML|||||PPTH||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|Y|FLOW MICROSCOPY|Y|NA|Y||4||88||CONTINUATION TREATMENT|1970-10-28|1963-09-04|||||1969-02-28||1971-12-19
TRIAL STUDY 134XCP|IS|FBAA59F4-154C-40CC-B740-A87769BFEC45||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMHG/SEC|||||MCI||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|HEMOLYZED|NA|LEAD CITRATE STAIN|NA|N|U||5||7||FOLLOW-UP|1973-01-25|1964-12-15|||||1961-04-21||1962-03-10
TRIAL STUDY 134XCP|IS|9A9E638B-426B-4F3E-8363-50DC2617FD63||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||VG/DOSE|||||MCI/L||||HIGH|NOT DONE|||PUS|ICTERIC|U|CYSTOMETRY|U|Y|N||1||38||RUN-IN|1970-07-27|1971-05-23|||||1969-11-18||1969-12-23
TRIAL STUDY 134XCP|IS|9A9E638B-426B-4F3E-8363-50DC2617FD63||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PL|||||APL U/ML||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|FRESH|Y|CELL BASED BIOASSAY|Y|Y|U||2||58||OPEN LABEL TREATMENT|1966-02-02|1963-03-18|||||1966-01-03||1967-10-10
TRIAL STUDY 134XCP|IS|9A9E638B-426B-4F3E-8363-50DC2617FD63||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||FINGERTIP UNIT|||||V||||ABNORMAL|NOT DONE|||PUS|CLOTTED|N|MICROBIAL CULTURE, LIQUID|U|Y|NA||3||39||FOLLOW-UP|1966-03-23|1963-09-08|||||1967-02-26||1965-06-03
TRIAL STUDY 134XCP|IS|9A9E638B-426B-4F3E-8363-50DC2617FD63||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CAGE|||||MMHG/L/MIN||||ABNORMAL|NOT DONE|||MECONIUM|NON-HEMOLYZED|U|PHOTOGRAPHY|Y|NA|Y||4||88||TREATMENT|1970-11-02|1962-10-28|||||1971-12-16||1960-03-13
TRIAL STUDY 134XCP|IS|9A9E638B-426B-4F3E-8363-50DC2617FD63||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||V/SEC|||||NMOL/G||||NORMAL|NOT DONE|||ADIPOSE TISSUE|CALCIFIED|NA|POPULATION SEQUENCING|Y|Y|NA||5||7||CONTINUATION TREATMENT|1963-11-15|1966-09-28|||||1961-06-06||1967-02-07
TRIAL STUDY 134XCP|IS|9995CD08-2650-4711-8F04-E41183E28B21||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||ENZYME U/G HB||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|PARAFFIN-EMBEDDED|N|TRANSVAGINAL ULTRASOUND|Y|U|U||1||38||SCREENING|1970-03-10|1960-10-21|||||1972-07-01||1969-05-23
TRIAL STUDY 134XCP|IS|9995CD08-2650-4711-8F04-E41183E28B21||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UGEQ/L|||||10^9/G||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|UNEXPECTED ODOR|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|U|N|NA||2||58||WASHOUT|1968-08-01|1966-12-29|||||1967-09-07||1965-08-23
TRIAL STUDY 134XCP|IS|9995CD08-2650-4711-8F04-E41183E28B21||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PMOL/10^9 CELLS|||||ML/G/MIN||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|FRESH|Y|MIGET|Y|N|N||3||39||BASELINE|1966-03-08|1963-04-09|||||1972-09-05||1960-11-28
TRIAL STUDY 134XCP|IS|9995CD08-2650-4711-8F04-E41183E28B21||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||RPM|||||MG/M2/H||||ABNORMAL|NOT DONE|||TRANSUDATE|DRIED|N|HPLC/IEX|Y|NA|NA||4||88||WASHOUT|1961-10-16|1971-06-12|||||1973-03-10||1962-08-12
TRIAL STUDY 134XCP|IS|9995CD08-2650-4711-8F04-E41183E28B21||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/DL|||||NMOL BCE/NMOL||||ABNORMAL|NOT DONE|||PLATELET|LIPEMIC|N|MUGA|U|Y|U||5||7||OPEN LABEL TREATMENT|1968-06-30|1962-08-04|||||1961-11-01||1969-04-27
TRIAL STUDY 134XCP|IS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PMOL/10^9 CELLS|||||MET||||NORMAL|NOT DONE|||DERMAL TISSUE|GELLED|U|CELL OF ORIGIN ASSAY|NA|U|Y||1||38||INDUCTION TREATMENT|1972-03-02|1960-05-11|||||1971-11-13||1972-05-24
TRIAL STUDY 134XCP|IS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KM/H|||||G/L||||NORMAL|NOT DONE|||FLUID|FROZEN|U|PH METER MEASUREMENT METHOD|Y|N|U||2||58||BASELINE|1965-10-12|1964-02-19|||||1967-08-17||1963-08-14
TRIAL STUDY 134XCP|IS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||EID 50/DOSE|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||VENOUS PLASMA|GELLED|U|TOLUIDINE BLUE STAIN|U|NA|U||3||39||CONTINUATION TREATMENT|1965-02-26|1968-03-08|||||1960-08-27||1967-05-21
TRIAL STUDY 134XCP|IS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CYCLE/MIN|||||INHALATION||||NORMAL|NOT DONE|||PERSPIRATION|CLOTTED|Y|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|Y|N||4||88||INDUCTION TREATMENT|1973-01-04|1961-01-04|||||1969-12-18||1970-02-11
TRIAL STUDY 134XCP|IS|B7ED8BAC-7627-43FE-AF13-DB7398A6AF9A||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^5/HPF|||||FG||||ABNORMAL|NOT DONE|||MUCUS|AGGLUTINATED|N|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|N|N||5||7||SCREENING|1972-04-29|1964-08-07|||||1963-11-22||1966-01-04
TRIAL STUDY 134XCP|IS|DE805225-C632-46E6-B673-DA0D864D47F7||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BAU/ML|||||10^3 RNA COPIES/ML||||ABNORMAL|NOT DONE|||SKIN TISSUE|GELLED|NA|ULTRASOUND|NA|U|N||1||38||LONG-TERM FOLLOW-UP|1969-04-10|1971-06-21|||||1961-05-05||1965-05-10
TRIAL STUDY 134XCP|IS|DE805225-C632-46E6-B673-DA0D864D47F7||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/MIN|||||CD||||HIGH|NOT DONE|||LUNG SURFACTANT|NON-HEMOLYZED|U|POLYGRAPHY|Y|NA|N||2||58||WASHOUT|1971-11-26|1966-01-12|||||1964-10-14||1965-11-03
TRIAL STUDY 134XCP|IS|DE805225-C632-46E6-B673-DA0D864D47F7||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CMOL|||||GRAVITATIONAL UNIT||||NORMAL|NOT DONE|||PLASMA|THAWED|Y|MULTIPLE BREATH WASHOUT|NA|NA|NA||3||39||OBSERVATION|1962-03-01|1961-09-22|||||1970-11-07||1964-07-05
TRIAL STUDY 134XCP|IS|DE805225-C632-46E6-B673-DA0D864D47F7||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/MIN|||||MPA||||HIGH|NOT DONE|||ISOLATE|REFRIGERATED|N|PET/CT SCAN WITHOUT CONTRAST|N|N|NA||4||88||FOLLOW-UP|1963-12-20|1963-07-18|||||1964-01-20||1968-06-17
TRIAL STUDY 134XCP|IS|DE805225-C632-46E6-B673-DA0D864D47F7||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CFU/ML|||||MOL/ML||||HIGH|NOT DONE|||LOCHIA|SOLIDIFIED|Y|POPULATION SEQUENCING|Y|U|Y||5||7||OPEN LABEL TREATMENT|1966-07-18|1964-05-23|||||1972-12-01||1971-09-06
TRIAL STUDY 134XCP|IS|9C921E89-706F-46E8-ADE3-A806289D43A5||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^3 CFU|||||KM/H||||ABNORMAL|NOT DONE|||CORD BLOOD|LIPEMIC|Y|MICROBIAL CONCENTRATION|NA|U|NA||1||38||SCREENING|1965-09-23|1969-01-27|||||1972-05-15||1960-01-22
TRIAL STUDY 134XCP|IS|9C921E89-706F-46E8-ADE3-A806289D43A5||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG/KG/H|||||COPIES/UG||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|ROOM TEMPERATURE|N|AURAMINE STAIN|N|NA|N||2||58||FOLLOW-UP|1965-09-03|1961-02-17|||||1969-07-16||1966-04-14
TRIAL STUDY 134XCP|IS|9C921E89-706F-46E8-ADE3-A806289D43A5||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ROENTGEN|||||UMOL||||HIGH|NOT DONE|||SPUTUM|SOLIDIFIED|U|RIA|N|N|Y||3||39||BASELINE|1963-05-16|1964-11-17|||||1970-03-02||1963-05-23
TRIAL STUDY 134XCP|IS|9C921E89-706F-46E8-ADE3-A806289D43A5||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IN2|||||10^9 CFU/G||||ABNORMAL|NOT DONE|||LYSATE|FRESH|Y|IN VITRO GENE EXPRESSION ASSAY|NA|N|Y||4||88||TREATMENT|1970-02-15|1961-11-23|||||1967-01-26||1963-02-04
TRIAL STUDY 134XCP|IS|9C921E89-706F-46E8-ADE3-A806289D43A5||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MPA|||||ML/KG/MIN||||NORMAL|NOT DONE|||LYMPH|HEMOLYZED|N|LIGHT SCATTERING SPECTROSCOPY|U|Y|N||5||7||FOLLOW-UP|1964-08-31|1972-05-30|||||1972-11-04||1971-08-21
TRIAL STUDY 134XCP|IS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BE/ML|||||PLUG||||LOW|NOT DONE|||VITREOUS HUMOR|CALCIFIED|NA|PHOTOMETRIC CLOT DETECTION|Y|NA|NA||1||38||BASELINE|1963-01-15|1969-02-17|||||1967-11-01||1973-02-23
TRIAL STUDY 134XCP|IS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/KG/MIN|||||UIU/DL||||LOW|NOT DONE|||PERITONEAL FLUID|SOLIDIFIED|Y|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|U|N|N||2||58||LONG-TERM FOLLOW-UP|1968-11-19|1967-03-20|||||1966-04-05||1968-01-30
TRIAL STUDY 134XCP|IS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ANTI-XA IU|||||LENS||||LOW|NOT DONE|||INFRANATANT, PLASMA|AUTOLYZED|U|SINGLE-SLICE SPIRAL CT|U|U|U||3||39||BASELINE|1960-04-26|1961-08-09|||||1965-07-03||1963-11-24
TRIAL STUDY 134XCP|IS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||M/SEC|||||GBQ/MG||||HIGH|NOT DONE|||INFRANATANT, SERUM|DRIED|U|SPIRAL CT SCAN WITHOUT CONTRAST|Y|NA|N||4||88||BLINDED TREATMENT|1963-03-30|1967-08-04|||||1968-11-10||1973-02-05
TRIAL STUDY 134XCP|IS|9EB82D4E-DE71-49D9-AA9E-C52EC90D64BB||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BOX|||||/LPF||||LOW|NOT DONE|||BLOOD|LIPEMIC|U|BIOIMPEDANCE SPECTROSCOPY|Y|N|N||5||7||FOLLOW-UP|1972-11-27|1973-08-09|||||1971-05-23||1968-12-10
TRIAL STUDY 134XCP|IS|17C2A52E-1232-4CBB-A809-9DC2C863366A||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CIGARETTE|||||PMOL/10^9 CELLS||||NORMAL|NOT DONE|||ADIPOSE TISSUE|NON-HEMOLYZED|Y|NUCLEIC ACID HYBRIDIZATION|NA|N|NA||1||38||WASHOUT|1968-11-11|1960-06-09|||||1965-04-13||1970-01-16
TRIAL STUDY 134XCP|IS|17C2A52E-1232-4CBB-A809-9DC2C863366A||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GRAIN|||||CUP||||ABNORMAL|NOT DONE|||RETICULOCYTES|GELLED|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|U|Y||2||58||WASHOUT|1970-05-05|1961-05-21|||||1969-02-20||1961-07-02
TRIAL STUDY 134XCP|IS|17C2A52E-1232-4CBB-A809-9DC2C863366A||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TSP|||||FOZ_US||||NORMAL|NOT DONE|||ALVEOLAR AIR|ROOM TEMPERATURE|Y|MICROPARTICLE ENZYME IMMUNOASSAY|NA|NA|N||3||39||SCREENING|1964-01-25|1965-04-14|||||1967-06-21||1960-08-22
TRIAL STUDY 134XCP|IS|17C2A52E-1232-4CBB-A809-9DC2C863366A||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BOX|||||/100 WBC||||LOW|NOT DONE|||CAPILLARY BLOOD|AGGLUTINATED|U|CARDIAC THERMODILUTION|N|N|Y||4||88||SCREENING|1969-11-01|1963-01-31|||||1966-08-18||1962-03-17
TRIAL STUDY 134XCP|IS|17C2A52E-1232-4CBB-A809-9DC2C863366A||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||M/SEC2|||||LOG10 TCID 50/ML||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|NA|MANUAL COUNT|U|NA|NA||5||7||OBSERVATION|1972-08-03|1968-04-26|||||1962-09-11||1960-07-14
TRIAL STUDY 134XCP|IS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||M2|||||BLOCKS||||LOW|NOT DONE|||DIALYSIS FLUID|CLOTTED|NA|ISHIHARA COLOR PLATES|U|N|N||1||38||LONG-TERM FOLLOW-UP|1967-08-26|1966-03-15|||||1969-09-05||1965-02-09
TRIAL STUDY 134XCP|IS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/DL|||||BEATS/MIN||||LOW|NOT DONE|||BUFFY COAT|AGGLUTINATED|U|IMMUNOFLUORESCENT STAIN|N|U|U||2||58||LONG-TERM FOLLOW-UP|1970-08-02|1968-05-13|||||1962-07-26||1969-07-01
TRIAL STUDY 134XCP|IS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/M2/MIN|||||MG/M2/MIN||||HIGH|NOT DONE|||CORD BLOOD|AUTOLYZED|Y|IMPULSE OSCILLOMETRY|N|Y|Y||3||39||SCREENING|1961-12-20|1970-02-02|||||1969-08-07||1963-04-28
TRIAL STUDY 134XCP|IS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||AMU|||||DISK||||LOW|NOT DONE|||PERITONEAL FLUID|AGGLUTINATED|Y|ECHOCARDIOGRAPHY|NA|N|NA||4||88||BLINDED TREATMENT|1963-03-30|1970-10-09|||||1970-08-12||1966-04-07
TRIAL STUDY 134XCP|IS|32B58BED-E5BF-4E10-8DBB-36DC44F68C26||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NM|||||%(V/V)||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|GELLED|N|PHOTOMETRY|U|N|Y||5||7||SCREENING|1972-07-16|1962-02-03|||||1962-08-08||1963-09-07
TRIAL STUDY 134XCP|IS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/MIN/MMHG|||||MG/G/H||||NORMAL|NOT DONE|||ISOLATE|LIPEMIC|U|COULOMETRIC TITRATION|Y|NA|Y||1||38||CONTINUATION TREATMENT|1963-07-26|1967-10-03|||||1969-05-01||1970-08-09
TRIAL STUDY 134XCP|IS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||L/S|||||CL||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|REFRIGERATED|NA|HIGH RESOLUTION MELT ANALYSIS|NA|Y|Y||2||58||LONG-TERM FOLLOW-UP|1970-03-10|1972-08-27|||||1964-05-12||1967-09-04
TRIAL STUDY 134XCP|IS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||VG/ML|||||S^-1(%O2)^-1||||LOW|NOT DONE|||LYMPH|FROZEN|N|ICP-MS|N|U|N||3||39||BASELINE|1973-06-20|1969-06-26|||||1968-02-08||1960-11-02
TRIAL STUDY 134XCP|IS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BEL|||||NG/DL||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|AGGLUTINATED|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NA|U|N||4||88||LONG-TERM FOLLOW-UP|1968-12-24|1968-03-16|||||1969-06-14||1961-06-14
TRIAL STUDY 134XCP|IS|AC14DD26-89BB-4F9D-BAD5-F2C8E62CC93B||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CIGAR|||||U/CL||||LOW|NOT DONE|||PERSPIRATION|NON-HEMOLYZED|NA|SPECULAR MICROSCOPY|Y|U|Y||5||7||FOLLOW-UP|1972-05-02|1972-12-06|||||1960-01-13||1960-04-18
TRIAL STUDY 134XCP|IS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ANTI-XA IU/ML|||||10^3 ORGANISMS/ML||||NORMAL|NOT DONE|||EMOTIONAL TEAR|AGGLUTINATED|N|TEST STRIP|U|Y|NA||1||38||BLINDED TREATMENT|1962-03-26|1969-10-24|||||1972-10-05||1969-05-06
TRIAL STUDY 134XCP|IS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/KG|||||ABSORBANCE U/ML||||NORMAL|NOT DONE|||COLOSTRUM|HEMOLYZED|U|BIOIMPEDANCE SPECTROSCOPY|N|N|N||2||58||BASELINE|1969-11-05|1971-07-21|||||1965-08-10||1973-05-10
TRIAL STUDY 134XCP|IS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/G|||||BU/ML||||ABNORMAL|NOT DONE|||ENDOMETRIAL TISSUE|AGGLUTINATED|Y|COMPLEMENT FIXATION|NA|NA|N||3||39||WASHOUT|1971-06-11|1966-03-25|||||1962-09-28||1966-08-30
TRIAL STUDY 134XCP|IS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIXEL|||||ML/G/H||||NORMAL|NOT DONE|||ARTERIAL BLOOD|ROOM TEMPERATURE|U|TARGETED GENOME SEQUENCING|Y|N|U||4||88||OPEN LABEL TREATMENT|1967-03-25|1961-11-06|||||1963-04-14||1972-08-02
TRIAL STUDY 134XCP|IS|93324DA9-7BD9-4CCA-B575-57A81E5F0C33||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||APPLICATION|||||UG/M2/MIN||||NORMAL|NOT DONE|||BASAL TEAR|CLOTTED|Y|SXA SCAN|N|NA|N||5||7||INDUCTION TREATMENT|1961-06-23|1971-05-02|||||1962-05-08||1963-09-19
TRIAL STUDY 134XCP|IS|585A17D7-12A3-40C8-811F-339497B9D09C||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 ORGANISMS/G|||||MMOL2/L2||||HIGH|NOT DONE|||PLEURAL FLUID|AUTOLYZED|NA|INDIA INK STAIN|NA|U|N||1||38||BLINDED TREATMENT|1973-03-02|1970-11-28|||||1963-07-09||1964-05-06
TRIAL STUDY 134XCP|IS|585A17D7-12A3-40C8-811F-339497B9D09C||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CUP|||||MG/KG/MIN||||ABNORMAL|NOT DONE|||SKIN TISSUE|SOLIDIFIED|N|DUKE INCISION METHOD|NA|Y|Y||2||58||LONG-TERM FOLLOW-UP|1964-03-19|1963-08-06|||||1965-10-08||1962-03-14
TRIAL STUDY 134XCP|IS|585A17D7-12A3-40C8-811F-339497B9D09C||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/DL|||||MS/MMHG||||NORMAL|NOT DONE|||SOFT TISSUE|NON-HEMOLYZED|Y|FUNDUS PHOTOGRAPHY|NA|N|Y||3||39||FOLLOW-UP|1966-07-18|1969-12-19|||||1969-08-15||1971-10-03
TRIAL STUDY 134XCP|IS|585A17D7-12A3-40C8-811F-339497B9D09C||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 TCID 50/DOSE|||||DAGU/ML||||LOW|NOT DONE|||MONOCYTE|NON-HEMOLYZED|NA|TEST STRIP|Y|Y|Y||4||88||BASELINE|1966-04-11|1961-01-24|||||1962-04-03||1961-03-04
TRIAL STUDY 134XCP|IS|585A17D7-12A3-40C8-811F-339497B9D09C||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MPL U|||||FIU||||NORMAL|NOT DONE|||SEMEN|LIPEMIC|Y|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|Y|Y||5||7||OPEN LABEL TREATMENT|1962-11-09|1968-12-04|||||1966-11-03||1964-06-28
TRIAL STUDY 134XCP|IS|D777661E-DF03-4221-88CC-34EB805EF5DB||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CD|||||APS U||||NORMAL|NOT DONE|||SMEGMA|THAWED|Y|ENZYMATIC ULTRACENTRIFUGATION|U|N|Y||1||38||SCREENING|1962-11-24|1972-11-10|||||1960-05-22||1971-11-12
TRIAL STUDY 134XCP|IS|D777661E-DF03-4221-88CC-34EB805EF5DB||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/KG|||||CM H2O||||NORMAL|NOT DONE|||LOCHIA|AGGLUTINATED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|N|N|Y||2||58||OBSERVATION|1967-04-13|1966-01-19|||||1968-10-20||1971-09-30
TRIAL STUDY 134XCP|IS|D777661E-DF03-4221-88CC-34EB805EF5DB||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ELISA UNIT/ML|||||CM2||||NORMAL|NOT DONE|||PLASMA|CLOTTED|NA|RADIOGRAPHY|N|NA|U||3||39||OPEN LABEL TREATMENT|1971-04-02|1968-12-09|||||1969-07-05||1966-03-17
TRIAL STUDY 134XCP|IS|D777661E-DF03-4221-88CC-34EB805EF5DB||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BQ/KG|||||PL||||HIGH|NOT DONE|||PERSPIRATION|PARAFFIN-EMBEDDED|U|DARK FIELD MICROSCOPY|NA|N|Y||4||88||BASELINE|1960-08-02|1969-11-14|||||1962-10-08||1972-10-10
TRIAL STUDY 134XCP|IS|D777661E-DF03-4221-88CC-34EB805EF5DB||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/40 HPFS|||||PMOL/G||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|Y|TRANSVAGINAL ULTRASOUND|Y|U|Y||5||7||LONG-TERM FOLLOW-UP|1966-06-13|1962-04-07|||||1966-09-20||1969-03-02
TRIAL STUDY 134XCP|IS|67828FC5-94DE-4A68-83DE-F86AA8F86D72||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/G/H|||||UG/M2/DAY||||HIGH|NOT DONE|||SOFT TISSUE|CONTAMINATED|Y|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|U|N||1||38||BLINDED TREATMENT|1968-12-11|1962-07-11|||||1965-05-27||1964-05-07
TRIAL STUDY 134XCP|IS|67828FC5-94DE-4A68-83DE-F86AA8F86D72||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/KG/DAY|||||10^10/L||||NORMAL|NOT DONE|||TRANSUDATE|PARAFFIN-EMBEDDED|N|CISH|N|Y|NA||2||58||LONG-TERM FOLLOW-UP|1967-12-01|1962-04-04|||||1968-06-14||1969-06-13
TRIAL STUDY 134XCP|IS|67828FC5-94DE-4A68-83DE-F86AA8F86D72||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PT_BR|||||MV/SEC||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|CONTAMINATED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|U|N|U||3||39||RUN-IN|1971-11-05|1973-05-23|||||1960-01-13||1966-09-29
TRIAL STUDY 134XCP|IS|67828FC5-94DE-4A68-83DE-F86AA8F86D72||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/MIN|||||CI/ML||||HIGH|NOT DONE|||URINE SEDIMENT|UNEXPECTED ODOR|NA|CLINICAL EVALUATION|NA|NA|Y||4||88||WASHOUT|1969-05-14|1968-05-26|||||1968-11-25||1967-07-28
TRIAL STUDY 134XCP|IS|67828FC5-94DE-4A68-83DE-F86AA8F86D72||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UKAT/10^12 RBC|||||GAUSS||||NORMAL|NOT DONE|||PLEURAL TISSUE|SOLIDIFIED|U|PET/CT SCAN WITHOUT CONTRAST|N|U|Y||5||7||INDUCTION TREATMENT|1970-04-30|1967-04-23|||||1964-02-02||1968-12-10
TRIAL STUDY 134XCP|IS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L/SEC|||||G/CAGE/WK||||ABNORMAL|NOT DONE|||URINE|NON-HEMOLYZED|NA|ACRIDINE ORANGE STAIN|NA|Y|NA||1||38||FOLLOW-UP|1971-10-22|1963-06-17|||||1963-05-23||1960-08-31
TRIAL STUDY 134XCP|IS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CAN|||||WEBER||||ABNORMAL|NOT DONE|||HAIR|CALCIFIED|N|CT SCAN WITHOUT CONTRAST|U|U|NA||2||58||OBSERVATION|1967-03-22|1972-11-15|||||1962-03-04||1963-08-07
TRIAL STUDY 134XCP|IS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PMOL/10^9 CELLS|||||NG/MOL||||NORMAL|NOT DONE|||CORD BLOOD|SOLIDIFIED|NA|NUCLEIC ACID SEQUENCING|N|NA|U||3||39||WASHOUT|1968-08-30|1973-04-05|||||1964-11-13||1970-08-31
TRIAL STUDY 134XCP|IS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^4/HPF|||||/500 WBC||||NORMAL|NOT DONE|||PLEURAL FLUID|PARAFFIN-EMBEDDED|Y|RADIAL IMMUNODIFFUSION|NA|N|NA||4||88||RUN-IN|1970-02-22|1966-06-11|||||1962-08-07||1961-10-09
TRIAL STUDY 134XCP|IS|A0DEC4FD-123D-41A0-8357-81496BB5B2DC||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FMOL/L|||||%(W/W)||||HIGH|NOT DONE|||PERITONEAL FLUID|REFRIGERATED|Y|SPIRAL CT SCAN WITHOUT CONTRAST|NA|N|N||5||7||CONTINUATION TREATMENT|1973-07-22|1973-06-13|||||1965-01-16||1971-08-08
TRIAL STUDY 134XCP|IS|650E5DFA-08CC-413C-B43D-070E61353E6E||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FIU|||||ENZYME U||||LOW|NOT DONE|||PLEURAL TISSUE|ICTERIC|N|CELL OF ORIGIN ASSAY|U|NA|Y||1||38||CONTINUATION TREATMENT|1960-12-29|1966-09-02|||||1964-08-04||1967-05-21
TRIAL STUDY 134XCP|IS|650E5DFA-08CC-413C-B43D-070E61353E6E||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CY/CM|||||DPM/100MG||||NORMAL|NOT DONE|||GASTRIC FLUID|LACTESCENT|NA|GC/MS-CI|NA|N|NA||2||58||CONTINUATION TREATMENT|1971-10-03|1962-10-06|||||1971-08-26||1966-09-12
TRIAL STUDY 134XCP|IS|650E5DFA-08CC-413C-B43D-070E61353E6E||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||USP U|||||MPL U/ML||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|ROOM TEMPERATURE|N|IODINE STAIN|N|U|N||3||39||LONG-TERM FOLLOW-UP|1963-12-30|1963-03-23|||||1967-02-08||1966-01-17
TRIAL STUDY 134XCP|IS|650E5DFA-08CC-413C-B43D-070E61353E6E||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||POUCH|||||COULOMB||||LOW|NOT DONE|||SEBUM|NON-HEMOLYZED|U|TRIPLE-PHASE MRI SCAN|Y|U|U||4||88||LONG-TERM FOLLOW-UP|1968-02-25|1960-03-07|||||1960-06-12||1964-06-20
TRIAL STUDY 134XCP|IS|650E5DFA-08CC-413C-B43D-070E61353E6E||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CFU/ML|||||RING||||NORMAL|NOT DONE|||SERUM|NON-HEMOLYZED|N|KINETIC CHROMOGENIC ASSAY|Y|NA|U||5||7||SCREENING|1970-08-31|1965-02-04|||||1971-05-19||1965-02-07
TRIAL STUDY 134XCP|IS|71716F05-3ABE-4A2A-B9DD-2201A63087ED||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PT_BR|||||KDA||||NORMAL|NOT DONE|||LYMPH|ICTERIC|NA|OPTICAL DENSITY MEASUREMENT|Y|U|Y||1||38||LONG-TERM FOLLOW-UP|1966-08-10|1973-08-08|||||1973-04-05||1970-10-29
TRIAL STUDY 134XCP|IS|71716F05-3ABE-4A2A-B9DD-2201A63087ED||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DAGU/ML|||||/WK||||ABNORMAL|NOT DONE|||DISCHARGE|FROZEN|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|N|NA||2||58||WASHOUT|1973-08-21|1964-12-31|||||1960-12-18||1972-04-22
TRIAL STUDY 134XCP|IS|71716F05-3ABE-4A2A-B9DD-2201A63087ED||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^9 CFU/G|||||MG/L||||HIGH|NOT DONE|||ERYTHROCYTES|SOLIDIFIED|U|POLYGRAPHY|Y|N|U||3||39||CONTINUATION TREATMENT|1960-12-06|1972-07-26|||||1967-05-09||1973-01-02
TRIAL STUDY 134XCP|IS|71716F05-3ABE-4A2A-B9DD-2201A63087ED||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||RAD|||||10^3 ORGANISMS/G||||ABNORMAL|NOT DONE|||DISCHARGE|DRIED|Y|ELECTROCHEMILUMINESCENCE|NA|NA|NA||4||88||FOLLOW-UP|1963-09-09|1967-03-01|||||1965-12-15||1961-07-17
TRIAL STUDY 134XCP|IS|71716F05-3ABE-4A2A-B9DD-2201A63087ED||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BQ/MG|||||MMOL/G||||LOW|NOT DONE|||VENOUS CORD BLOOD|CONCENTRATED|Y|ELECTROCHEMILUMINESCENCE|Y|NA|U||5||7||OPEN LABEL TREATMENT|1967-07-30|1968-02-03|||||1969-05-29||1964-08-31
TRIAL STUDY 134XCP|IS|EF9208B0-4DF0-4029-AB67-8F87662D3E90||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^7 CFU/ML|||||ABSORBANCE U||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|UNEXPECTED ODOR|NA|FREEZING POINT DEPRESSION|N|U|U||1||38||BASELINE|1969-04-04|1967-11-25|||||1963-07-24||1961-03-09
TRIAL STUDY 134XCP|IS|EF9208B0-4DF0-4029-AB67-8F87662D3E90||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ENZYME U|||||ELISA UNIT/ML||||LOW|NOT DONE|||BUFFY COAT|LACTESCENT|U|NO INFORMATION|N|N|U||2||58||SCREENING|1962-04-16|1966-08-25|||||1960-05-15||1967-07-27
TRIAL STUDY 134XCP|IS|EF9208B0-4DF0-4029-AB67-8F87662D3E90||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^8 PFU|||||MPH||||LOW|NOT DONE|||SERUM|PARAFFIN-EMBEDDED|N|ACRIDINE ORANGE STAIN|Y|Y|NA||3||39||INDUCTION TREATMENT|1960-04-12|1971-04-05|||||1970-04-07||1971-06-22
TRIAL STUDY 134XCP|IS|EF9208B0-4DF0-4029-AB67-8F87662D3E90||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||FARAD|||||PPB||||NORMAL|NOT DONE|||ISOLATE|LACTESCENT|U|NON-INVASIVE DIELECTRIC SENSING|Y|N|U||4||88||FOLLOW-UP|1972-09-30|1970-12-21|||||1968-12-08||1970-12-24
TRIAL STUDY 134XCP|IS|EF9208B0-4DF0-4029-AB67-8F87662D3E90||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KG/CM2|||||CCID 50/DOSE||||ABNORMAL|NOT DONE|||LEUKOCYTE|THAWED|U|REVERSE TRANSCRIPTASE PCR|U|N|U||5||7||OBSERVATION|1970-05-31|1961-02-12|||||1961-02-22||1968-01-13
TRIAL STUDY 134XCP|IS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EID 50/ML|||||MMOL/DAY||||HIGH|NOT DONE|||LEUKOCYTE|FROZEN|N|MS/MS|Y|Y|U||1||38||INDUCTION TREATMENT|1969-06-28|1963-09-30|||||1968-03-12||1966-01-27
TRIAL STUDY 134XCP|IS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||VIRTUAL PIXEL|||||FMOL||||NORMAL|NOT DONE|||EPITHELIAL CELL|THAWED|N|AUTOREFRACTION|N|Y|U||2||58||BLINDED TREATMENT|1968-08-07|1968-03-18|||||1964-11-15||1970-07-02
TRIAL STUDY 134XCP|IS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HZ/S|||||BLOCKS||||LOW|NOT DONE|||ADIPOSE TISSUE|UNEXPECTED ODOR|Y|MAMMOGRAPHY|U|N|N||3||39||INDUCTION TREATMENT|1964-09-26|1964-01-12|||||1968-12-06||1964-12-19
TRIAL STUDY 134XCP|IS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/MG|||||10^7 TCID 50/DOSE||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|CLOTTED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|Y|U|N||4||88||SCREENING|1973-08-23|1967-01-07|||||1968-03-06||1969-11-17
TRIAL STUDY 134XCP|IS|6A9F1495-1ECD-44FA-BAEE-29C96EF238E5||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 IU|||||U/M2||||HIGH|NOT DONE|||EMOTIONAL TEAR|DRIED|N|POLYMERASE CHAIN REACTION|Y|NA|U||5||7||OBSERVATION|1967-10-08|1964-10-04|||||1961-12-05||1962-12-28
TRIAL STUDY 134XCP|IS|25580765-CB09-4BE3-8DED-C0068C69E9C4||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MET|||||FT||||NORMAL|NOT DONE|||LAVAGE FLUID|FROZEN|Y|SLOAN LETTER EYE CHART 2.5%|N|Y|Y||1||38||INDUCTION TREATMENT|1963-01-11|1964-07-19|||||1964-04-01||1962-02-28
TRIAL STUDY 134XCP|IS|25580765-CB09-4BE3-8DED-C0068C69E9C4||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PRESSOR UNITS|||||K||||HIGH|NOT DONE|||AQUEOUS HUMOR|PARAFFIN-EMBEDDED|NA|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|N|U|Y||2||58||SCREENING|1972-09-29|1960-02-25|||||1973-02-10||1960-10-30
TRIAL STUDY 134XCP|IS|25580765-CB09-4BE3-8DED-C0068C69E9C4||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UCI/KG|||||HZ/S||||HIGH|NOT DONE|||MENSTRUAL BLOOD|REFRIGERATED|NA|KINETIC CHROMOGENIC ASSAY|Y|Y|Y||3||39||INDUCTION TREATMENT|1960-07-23|1969-04-27|||||1970-12-13||1971-05-08
TRIAL STUDY 134XCP|IS|25580765-CB09-4BE3-8DED-C0068C69E9C4||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PIXELS/CM|||||L/S/KPA||||HIGH|NOT DONE|||MUCUS|ROOM TEMPERATURE|U|WEBER GREEN STAIN|Y|Y|U||4||88||WASHOUT|1965-01-17|1967-07-02|||||1971-02-11||1967-10-23
TRIAL STUDY 134XCP|IS|25580765-CB09-4BE3-8DED-C0068C69E9C4||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/DL|||||PACKET||||LOW|NOT DONE|||GASTRIC FLUID|THAWED|U|MICRONEUTRALIZATION ASSAY|Y|NA|N||5||7||LONG-TERM FOLLOW-UP|1965-10-22|1966-02-10|||||1971-06-27||1969-04-26
TRIAL STUDY 134XCP|IS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CD|||||CI/G||||LOW|NOT DONE|||SMEGMA|AGGLUTINATED|NA|MULTI-SLICE SPIRAL CT|Y|U|N||1||38||SCREENING|1967-03-24|1970-06-09|||||1965-03-09||1973-05-15
TRIAL STUDY 134XCP|IS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/KG/MIN|||||MEQ/UL||||HIGH|NOT DONE|||HAIR FOLLICLE|SOLIDIFIED|N|ENZYMATIC COLORIMETRY|Y|NA|Y||2||58||INDUCTION TREATMENT|1972-03-07|1972-01-05|||||1962-08-05||1964-03-08
TRIAL STUDY 134XCP|IS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/G|||||G/CAGE||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|AUTOLYZED|NA|ELECTRONEUROGRAPHY|NA|Y|U||3||39||BLINDED TREATMENT|1968-05-16|1963-01-16|||||1971-09-01||1962-03-26
TRIAL STUDY 134XCP|IS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||U/M2/DAY|||||NKAT/L||||LOW|NOT DONE|||LEUKOCYTE|LIPEMIC|Y|FLUORESCEIN STAIN|N|N|NA||4||88||SCREENING|1972-09-17|1967-07-20|||||1960-04-23||1967-08-20
TRIAL STUDY 134XCP|IS|98A99811-9439-4BC7-BDE8-CCF6DD7DF4A3||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/M2/MIN|||||VG/ML||||NORMAL|NOT DONE|||SKIN TISSUE|FROZEN|Y|ALCIAN BLUE STAIN|N|N|Y||5||7||WASHOUT|1969-03-23|1963-05-26|||||1962-06-20||1965-02-01
TRIAL STUDY 134XCP|IS|A902F087-3BF4-4387-80F9-DDCDDCE1813E||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||RING|||||/LPF||||HIGH|NOT DONE|||MUCUS|UNEXPECTED ODOR|U|SXA SCAN|Y|N|U||1||38||BLINDED TREATMENT|1966-05-25|1964-10-05|||||1971-12-10||1973-08-24
TRIAL STUDY 134XCP|IS|A902F087-3BF4-4387-80F9-DDCDDCE1813E||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/DAY|||||PMOL/G||||HIGH|NOT DONE|||CAPILLARY BLOOD|LIPEMIC|Y|MULTIPLE BREATH WASHOUT|N|Y|N||2||58||SCREENING|1968-06-09|1960-12-24|||||1968-04-23||1966-03-13
TRIAL STUDY 134XCP|IS|A902F087-3BF4-4387-80F9-DDCDDCE1813E||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||EIA UNIT|||||FL||||HIGH|NOT DONE|||AQUEOUS HUMOR|DRIED|Y|MICROSCOPY|Y|Y|U||3||39||TREATMENT|1964-05-18|1973-05-06|||||1965-05-31||1967-09-15
TRIAL STUDY 134XCP|IS|A902F087-3BF4-4387-80F9-DDCDDCE1813E||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BAU|||||ML/KG/DAY||||NORMAL|NOT DONE|||BREAST MILK|AUTOLYZED|NA|APPLANATION TONOMETRY|N|U|NA||4||88||SCREENING|1969-12-01|1970-09-04|||||1970-10-06||1962-03-20
TRIAL STUDY 134XCP|IS|A902F087-3BF4-4387-80F9-DDCDDCE1813E||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KM|||||SACHET||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|SOLIDIFIED|Y|PHOTOMETRY|Y|N|NA||5||7||WASHOUT|1966-10-30|1972-01-09|||||1963-01-08||1971-03-02
TRIAL STUDY 134XCP|IS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MBQ/UL|||||MMHG/SEC||||ABNORMAL|NOT DONE|||BUFFY COAT|SOLIDIFIED|NA|FUNCTIONAL MRI|U|N|Y||1||38||BLINDED TREATMENT|1972-10-01|1969-09-23|||||1963-10-25||1969-03-26
TRIAL STUDY 134XCP|IS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KM/H|||||MMHG||||HIGH|NOT DONE|||BLOOD|PARAFFIN-EMBEDDED|NA|POLYSOMNOGRAPHY|Y|N|N||2||58||WASHOUT|1972-07-04|1963-11-09|||||1966-03-04||1969-04-13
TRIAL STUDY 134XCP|IS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ELISA UNIT/DOSE|||||MMOL/G||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|DRIED|N|SPECULAR MICROSCOPY|U|NA|Y||3||39||WASHOUT|1972-07-23|1972-02-04|||||1962-05-23||1966-08-09
TRIAL STUDY 134XCP|IS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MMU/ML|||||G/CAGE/DAY||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|CALCIFIED|U|NEXT GENERATION TARGETED SEQUENCING|Y|NA|U||4||88||FOLLOW-UP|1965-11-26|1960-08-25|||||1972-09-07||1973-08-31
TRIAL STUDY 134XCP|IS|BC88F32F-FEB6-46D0-8B45-4A30BA4625E9||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FL|||||UG/ML/H||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|FROZEN|N|PET/CT SCAN|NA|NA|U||5||7||SCREENING|1967-07-15|1967-11-06|||||1962-10-01||1961-04-22
TRIAL STUDY 134XCP|IS|415F9206-A793-437C-B227-BD245DBF40AB||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CIGAR|||||CMH2O*S/ML||||NORMAL|NOT DONE|||HAIR|CLOTTED|Y|X-RAY FLUORESCENCE SPECTROMETRY|N|N|Y||1||38||OBSERVATION|1972-11-04|1962-08-19|||||1968-07-09||1961-01-23
TRIAL STUDY 134XCP|IS|415F9206-A793-437C-B227-BD245DBF40AB||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/M2|||||MMU/ML||||ABNORMAL|NOT DONE|||PERSPIRATION|GELLED|U|HPLC/MS/MS|Y|N|N||2||58||OBSERVATION|1971-01-21|1968-02-09|||||1960-05-26||1972-05-16
TRIAL STUDY 134XCP|IS|415F9206-A793-437C-B227-BD245DBF40AB||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG2/DL2|||||IU/L||||HIGH|NOT DONE|||DISCHARGE|NON-HEMOLYZED|U|MEDIASTINOSCOPY|N|N|NA||3||39||TREATMENT|1972-02-18|1967-09-30|||||1965-11-09||1972-04-04
TRIAL STUDY 134XCP|IS|415F9206-A793-437C-B227-BD245DBF40AB||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DAGU|||||/CMH2O||||LOW|NOT DONE|||PROSTATIC FLUID|LACTESCENT|U|FORCED OSCILLATION TECHNIQUE|N|NA|Y||4||88||LONG-TERM FOLLOW-UP|1964-02-10|1973-04-18|||||1961-01-01||1964-06-21
TRIAL STUDY 134XCP|IS|415F9206-A793-437C-B227-BD245DBF40AB||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/L|||||AMU||||LOW|NOT DONE|||CAPILLARY PLASMA|DRIED|NA|MAPH|U|N|Y||5||7||LONG-TERM FOLLOW-UP|1967-04-29|1961-06-23|||||1961-09-27||1970-04-03
TRIAL STUDY 134XCP|IS|C580BA02-D031-4875-AC02-347AA65C4C6C||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||TITER|||||NG||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|CONCENTRATED|NA|MAMMOGRAPHY|Y|N|U||1||38||TREATMENT|1970-12-07|1968-12-08|||||1962-06-24||1973-08-06
TRIAL STUDY 134XCP|IS|C580BA02-D031-4875-AC02-347AA65C4C6C||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/CAGE/DAY|||||ECL UNIT||||LOW|NOT DONE|||SPERMATOZOON|FROZEN|Y|IN SITU HYBRIDIZATION|Y|NA|N||2||58||BASELINE|1966-12-06|1970-08-31|||||1968-11-09||1966-12-28
TRIAL STUDY 134XCP|IS|C580BA02-D031-4875-AC02-347AA65C4C6C||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/L|||||KBQ/UL||||ABNORMAL|NOT DONE|||LAVAGE FLUID|HEMOLYZED|N|SLOAN LETTER EYE CHART 100%|U|N|U||3||39||FOLLOW-UP|1966-03-31|1961-03-02|||||1971-06-02||1973-03-05
TRIAL STUDY 134XCP|IS|C580BA02-D031-4875-AC02-347AA65C4C6C||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EU|||||DAYS/WK||||HIGH|NOT DONE|||ARTERIAL BLOOD|FRESH|NA|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|U|U|U||4||88||FOLLOW-UP|1962-12-03|1961-08-25|||||1969-06-03||1971-12-30
TRIAL STUDY 134XCP|IS|C580BA02-D031-4875-AC02-347AA65C4C6C||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GPS U|||||FMOL||||NORMAL|NOT DONE|||VENOUS BLOOD|HEMOLYZED|Y|ORCHIDOMETERY|NA|U|U||5||7||OBSERVATION|1962-06-04|1962-05-03|||||1962-06-08||1969-05-25
TRIAL STUDY 134XCP|IS|4DD6944D-662E-4C9A-A663-601B657BCF5E||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/ANIMAL/DAY|||||FT||||NORMAL|NOT DONE|||LYSATE|AGGLUTINATED|U|ALCIAN BLUE STAIN|NA|Y|N||1||38||TREATMENT|1965-06-21|1966-12-23|||||1967-09-07||1960-02-16
TRIAL STUDY 134XCP|IS|4DD6944D-662E-4C9A-A663-601B657BCF5E||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/H/M2|||||LOG10 CCID 50/DOSE||||HIGH|NOT DONE|||BONE|CLOTTED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|U|NA|Y||2||58||WASHOUT|1961-05-09|1964-01-03|||||1964-04-04||1964-07-21
TRIAL STUDY 134XCP|IS|4DD6944D-662E-4C9A-A663-601B657BCF5E||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAN|||||CM H2O||||LOW|NOT DONE|||INTERSTITIAL FLUID|PARAFFIN-EMBEDDED|Y|MACRO BROTH DILUTION|NA|N|Y||3||39||RUN-IN|1967-09-25|1965-06-19|||||1973-01-08||1973-06-10
TRIAL STUDY 134XCP|IS|4DD6944D-662E-4C9A-A663-601B657BCF5E||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/M2/DAY|||||U/M2/MIN||||LOW|NOT DONE|||MUSCLE TISSUE|ROOM TEMPERATURE|NA|PH METER MEASUREMENT METHOD|Y|N|U||4||88||OBSERVATION|1970-02-17|1968-01-14|||||1970-10-19||1969-06-22
TRIAL STUDY 134XCP|IS|4DD6944D-662E-4C9A-A663-601B657BCF5E||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOZENGE|||||10^6 RNA COPIES/ML||||LOW|NOT DONE|||CELL PELLET|CONCENTRATED|Y|PERIODIC ACID SCHIFF STAIN|NA|NA|Y||5||7||OBSERVATION|1969-10-25|1967-03-16|||||1960-10-29||1967-09-13
TRIAL STUDY 134XCP|IS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU/DL|||||BISCUIT||||ABNORMAL|NOT DONE|||MENSTRUAL BLOOD|THAWED|U|DIGITAL PCR ARRAY|N|Y|U||1||38||CONTINUATION TREATMENT|1967-08-22|1969-08-28|||||1968-11-18||1970-05-21
TRIAL STUDY 134XCP|IS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/G/H|||||GY/H||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|GELLED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|N|N|NA||2||58||CONTINUATION TREATMENT|1970-01-18|1965-04-24|||||1964-08-23||1969-05-14
TRIAL STUDY 134XCP|IS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ENZYME U|||||ML/G/MIN||||ABNORMAL|NOT DONE|||PERSPIRATION|FRESH|NA|ACCELERATOR MASS SPECTROMETRY|Y|NA|N||3||39||CONTINUATION TREATMENT|1971-10-06|1966-03-07|||||1969-05-09||1971-11-09
TRIAL STUDY 134XCP|IS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PM|||||PMOL/L/H||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|FROZEN|Y|INDIRECT IMMUNOFLUORESCENCE|Y|NA|Y||4||88||TREATMENT|1961-06-07|1961-05-18|||||1969-12-12||1965-11-29
TRIAL STUDY 134XCP|IS|24DD8893-87F9-44E9-8F9D-3E8CCD5EA2AB||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PFU/ANIMAL|||||MMAL||||LOW|NOT DONE|||CORD SERUM|DRIED|NA|COULOMETRIC TITRATION|Y|N|N||5||7||RUN-IN|1973-05-10|1967-01-05|||||1969-04-02||1961-01-25
TRIAL STUDY 134XCP|IS|69A130F1-44A1-4091-BF0C-FF8087CC9940||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VG/ML|||||MOL/MG||||ABNORMAL|NOT DONE|||MECONIUM|ICTERIC|Y|LISSAMINE GREEN STAIN|NA|U|U||1||38||BASELINE|1969-10-06|1964-11-15|||||1971-04-06||1969-09-24
TRIAL STUDY 134XCP|IS|69A130F1-44A1-4091-BF0C-FF8087CC9940||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMOL/L|||||EIA UNIT||||ABNORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|NA|MRI WITHOUT CONTRAST|Y|Y|U||2||58||SCREENING|1967-03-25|1962-12-15|||||1972-07-08||1963-08-29
TRIAL STUDY 134XCP|IS|69A130F1-44A1-4091-BF0C-FF8087CC9940||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/KG/MIN|||||MOL||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|DRIED|U|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|N|Y||3||39||BASELINE|1967-04-23|1965-09-30|||||1968-08-28||1962-11-27
TRIAL STUDY 134XCP|IS|69A130F1-44A1-4091-BF0C-FF8087CC9940||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/U|||||ML/KG||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|CALCIFIED|NA|TARGETED GENOME SEQUENCING|Y|NA|NA||4||88||FOLLOW-UP|1961-06-11|1971-08-25|||||1960-07-31||1969-01-26
TRIAL STUDY 134XCP|IS|69A130F1-44A1-4091-BF0C-FF8087CC9940||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FG|||||UCI/L||||NORMAL|NOT DONE|||SERUM OR PLASMA|NON-HEMOLYZED|U|SANGER SEQUENCING|N|U|N||5||7||BASELINE|1969-11-21|1966-09-02|||||1967-03-04||1961-02-11
TRIAL STUDY 134XCP|IS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||%/MIN|||||ENZYME U/M2||||LOW|NOT DONE|||CORD BLOOD|PARAFFIN-EMBEDDED|U|TRIPLE-PHASE SPIRAL CT SCAN|U|N|N||1||38||SCREENING|1966-07-29|1971-02-11|||||1971-05-10||1961-10-09
TRIAL STUDY 134XCP|IS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMOL2/L2|||||MMHG/L/MIN||||LOW|NOT DONE|||MUCUS|SOLIDIFIED|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|N|NA|U||2||58||CONTINUATION TREATMENT|1971-12-26|1962-12-31|||||1967-04-03||1972-01-18
TRIAL STUDY 134XCP|IS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPELISA UNIT/ML|||||GPS U||||HIGH|NOT DONE|||SPUTUM|ROOM TEMPERATURE|NA|SINGLE-SLICE SPIRAL CT|N|U|NA||3||39||OPEN LABEL TREATMENT|1967-10-21|1967-03-13|||||1964-02-16||1968-07-04
TRIAL STUDY 134XCP|IS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PM|||||MBP||||HIGH|NOT DONE|||LAVAGE FLUID|UNEXPECTED ODOR|N|SANGER SEQUENCING|NA|U|N||4||88||BLINDED TREATMENT|1962-07-09|1963-04-30|||||1965-05-31||1962-04-03
TRIAL STUDY 134XCP|IS|EAEBBD6C-E86D-4865-AE17-82BF5F3823DF||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NM|||||G/ANIMAL||||HIGH|NOT DONE|||SEBUM|UNEXPECTED ODOR|NA|STRESS ECHOCARDIOGRAPHY|N|U|Y||5||7||BASELINE|1964-03-01|1961-05-23|||||1966-08-22||1964-10-25
TRIAL STUDY 134XCP|IS|96C60715-2EDE-40FD-B41C-ECD1E5065C81||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||% INHIBITION|||||CFU/ML||||NORMAL|NOT DONE|||BILE|HEMOLYZED|NA|IMMUNOFIXATION ELECTROPHORESIS|Y|Y|Y||1||38||CONTINUATION TREATMENT|1962-07-19|1973-01-20|||||1965-09-25||1962-05-02
TRIAL STUDY 134XCP|IS|96C60715-2EDE-40FD-B41C-ECD1E5065C81||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NSEC|||||ANTIBODY UNIT||||NORMAL|NOT DONE|||CAPILLARY BLOOD|PARAFFIN-EMBEDDED|Y|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|Y|NA||2||58||TREATMENT|1965-10-03|1964-06-30|||||1970-05-12||1965-08-03
TRIAL STUDY 134XCP|IS|96C60715-2EDE-40FD-B41C-ECD1E5065C81||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||HR/DAY|||||UV2||||HIGH|NOT DONE|||SPUTUM|LIPEMIC|Y|PATHOLOGICAL EVALUATION|U|Y|Y||3||39||SCREENING|1962-03-04|1973-05-12|||||1970-11-15||1971-07-24
TRIAL STUDY 134XCP|IS|96C60715-2EDE-40FD-B41C-ECD1E5065C81||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UEQ|||||GRAIN||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|NA|DIFFUSION WEIGHTED MRI|U|Y|Y||4||88||RUN-IN|1970-04-19|1968-04-26|||||1969-01-03||1964-07-03
TRIAL STUDY 134XCP|IS|96C60715-2EDE-40FD-B41C-ECD1E5065C81||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOL/DAY|||||%/S||||ABNORMAL|NOT DONE|||CORD SERUM|LIPEMIC|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|NA|N|N||5||7||CONTINUATION TREATMENT|1971-08-07|1961-02-14|||||1960-09-18||1961-10-24
TRIAL STUDY 134XCP|IS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||FIU|||||UG/L||||NORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|GELLED|Y|FLUOROSCOPY|N|U|NA||1||38||RUN-IN|1970-04-09|1963-05-09|||||1961-07-09||1969-09-23
TRIAL STUDY 134XCP|IS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||DPM/0.5 ML||||ABNORMAL|NOT DONE|||CERUMEN|FRESH|U|IN VITRO GENE EXPRESSION ASSAY|N|Y|U||2||58||SCREENING|1972-03-16|1963-06-17|||||1971-03-10||1960-01-26
TRIAL STUDY 134XCP|IS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||L/S/KPA|||||10^9 CFU/G||||HIGH|NOT DONE|||SMEGMA|SOLIDIFIED|NA|PHOROPTER|Y|N|Y||3||39||BLINDED TREATMENT|1969-09-17|1964-12-09|||||1963-07-18||1971-05-30
TRIAL STUDY 134XCP|IS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/MIN|||||SQU/ML||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|SOLIDIFIED|N|SXA SCAN|NA|NA|N||4||88||TREATMENT|1964-09-17|1962-01-03|||||1966-10-20||1972-07-14
TRIAL STUDY 134XCP|IS|61C29FFE-8EA1-47B9-A060-37D70EDCB88D||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||FOZ_US|||||G/KG/DAY||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|ROOM TEMPERATURE|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y|U|N||5||7||CONTINUATION TREATMENT|1968-10-19|1966-11-04|||||1969-05-06||1970-11-08
TRIAL STUDY 134XCP|IS|8452DD7A-4DC9-4BDF-B670-AE5B49292805||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||EVENTS|||||SCM||||NORMAL|NOT DONE|||BUFFY COAT|LIPEMIC|Y|IMMUNOBLOT|Y|N|N||1||38||TREATMENT|1972-03-11|1965-03-02|||||1960-09-03||1966-04-29
TRIAL STUDY 134XCP|IS|8452DD7A-4DC9-4BDF-B670-AE5B49292805||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||S/H|||||GPS U||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|GELLED|NA|MULTIPLE BREATH WASHOUT|NA|NA|N||2||58||CONTINUATION TREATMENT|1965-05-25|1969-11-18|||||1961-04-20||1970-08-27
TRIAL STUDY 134XCP|IS|8452DD7A-4DC9-4BDF-B670-AE5B49292805||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||SYRINGE|||||OZ||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|PARAFFIN-EMBEDDED|Y|PALM METHOD|NA|U|NA||3||39||BASELINE|1960-07-01|1961-06-16|||||1967-10-30||1970-08-11
TRIAL STUDY 134XCP|IS|8452DD7A-4DC9-4BDF-B670-AE5B49292805||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/L|||||UIU/L||||HIGH|NOT DONE|||LAVAGE FLUID|ROOM TEMPERATURE|Y|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|U|U|Y||4||88||INDUCTION TREATMENT|1960-07-10|1970-05-13|||||1972-05-11||1969-09-01
TRIAL STUDY 134XCP|IS|8452DD7A-4DC9-4BDF-B670-AE5B49292805||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^3 CFU/ML|||||IU/ML||||ABNORMAL|NOT DONE|||SEMINAL FLUID|CONTAMINATED|N|MIGET|N|U|U||5||7||FOLLOW-UP|1967-11-17|1970-06-14|||||1961-09-26||1961-07-21
TRIAL STUDY 134XCP|IS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CY/CM|||||PATCH||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|U|TEST STRIP|U|N|U||1||38||WASHOUT|1964-06-07|1964-09-11|||||1966-01-24||1968-05-22
TRIAL STUDY 134XCP|IS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SBE/ML|||||ML/MIN/MMHG||||ABNORMAL|NOT DONE|||SEMINAL FLUID|GELLED|NA|CLOT DETECTION|U|Y|Y||2||58||BASELINE|1960-05-17|1968-08-10|||||1971-09-29||1965-01-26
TRIAL STUDY 134XCP|IS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NEEDLE GAUGE|||||IU/G||||LOW|NOT DONE|||EPITHELIAL CELL|THAWED|N|PHOTOGRAPHY|NA|Y|Y||3||39||BASELINE|1965-04-10|1971-10-04|||||1961-04-17||1963-03-14
TRIAL STUDY 134XCP|IS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MCI|||||CGY||||ABNORMAL|NOT DONE|||EXUDATE|THAWED|U|EPSILOMETER|NA|N|U||4||88||TREATMENT|1972-03-29|1967-12-13|||||1961-12-01||1960-01-13
TRIAL STUDY 134XCP|IS|F955EF3A-FE2C-4F03-9384-9FBCF637DB0E||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||G/KG/DAY|||||MOL/MOL||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|THAWED|N|KARYOTYPING|Y|N|U||5||7||SCREENING|1966-11-13|1972-01-16|||||1961-12-30||1971-04-18
TRIAL STUDY 134XCP|IS|30108497-140B-499E-8924-8BFCDC57457A||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||SQU/ML|||||10^12 IU/L||||LOW|NOT DONE|||CEREBROSPINAL FLUID|NON-HEMOLYZED|N|ROMANOWSKY STAIN|N|NA|N||1||38||INDUCTION TREATMENT|1966-10-09|1968-01-10|||||1962-10-17||1961-10-03
TRIAL STUDY 134XCP|IS|30108497-140B-499E-8924-8BFCDC57457A||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MIN/DAY|||||GPELISA UNIT/ML||||NORMAL|NOT DONE|||EMESIS|DRIED|N|PEAK FLOWMETRY|N|N|NA||2||58||SCREENING|1961-03-10|1965-05-28|||||1966-12-18||1961-03-27
TRIAL STUDY 134XCP|IS|30108497-140B-499E-8924-8BFCDC57457A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^4 CFU/ML|||||OZ||||HIGH|NOT DONE|||SPERMATOZOON|CONTAMINATED|N|POLYGRAPHY|N|U|Y||3||39||OBSERVATION|1968-10-25|1967-09-30|||||1972-05-16||1970-11-19
TRIAL STUDY 134XCP|IS|30108497-140B-499E-8924-8BFCDC57457A||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DEG2|||||IN||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|CONTAMINATED|NA|ELECTROGASTROGRAPHY|U|Y|Y||4||88||FOLLOW-UP|1973-07-14|1967-01-03|||||1970-12-03||1961-03-12
TRIAL STUDY 134XCP|IS|30108497-140B-499E-8924-8BFCDC57457A||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMOL/DAY|||||TSP EQ||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|ICTERIC|Y|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|U|NA|U||5||7||OBSERVATION|1961-09-19|1961-04-14|||||1969-10-17||1972-07-05
TRIAL STUDY 134XCP|IS|5FFEF358-5014-497F-A091-6EF27A1BCF7D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||USP U|||||U/KG/DAY||||LOW|NOT DONE|||NAIL|UNEXPECTED ODOR|U|MANUAL CLOT DETECTION|NA|U|N||1||38||OPEN LABEL TREATMENT|1963-06-22|1969-03-21|||||1966-05-15||1966-05-02
TRIAL STUDY 134XCP|IS|5FFEF358-5014-497F-A091-6EF27A1BCF7D||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MG2/DL2|||||HZ||||NORMAL|NOT DONE|||ABSCESS FLUID|LACTESCENT|Y|ERGOSPIROMETRY|N|NA|N||2||58||INDUCTION TREATMENT|1972-07-28|1967-10-11|||||1961-09-03||1963-09-10
TRIAL STUDY 134XCP|IS|5FFEF358-5014-497F-A091-6EF27A1BCF7D||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||100 IU/ML|||||UG/CM2||||HIGH|NOT DONE|||EMESIS|CONCENTRATED|N|GC/MS|NA|Y|N||3||39||BASELINE|1965-08-01|1962-03-22|||||1967-08-12||1971-03-11
TRIAL STUDY 134XCP|IS|5FFEF358-5014-497F-A091-6EF27A1BCF7D||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/L/SEC|||||FMOL/L||||ABNORMAL|NOT DONE|||PLASMA|PARAFFIN-EMBEDDED|NA|RADIATION DOSIMETRY|NA|Y|NA||4||88||BASELINE|1964-10-02|1969-03-04|||||1966-02-23||1973-01-31
TRIAL STUDY 134XCP|IS|5FFEF358-5014-497F-A091-6EF27A1BCF7D||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UL/KG/DAY|||||NFIU||||ABNORMAL|NOT DONE|||PLATELET|LACTESCENT|U|ACCELERATOR MASS SPECTROMETRY|NA|N|NA||5||7||LONG-TERM FOLLOW-UP|1962-04-14|1970-10-16|||||1960-02-22||1967-07-05
TRIAL STUDY 134XCP|IS|9DFBE459-22E4-4BA7-A993-AC06D6644562||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CI/UL|||||PG/DL||||ABNORMAL|NOT DONE|||VENOUS BLOOD|GELLED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y|U||1||38||INDUCTION TREATMENT|1964-07-14|1966-06-17|||||1960-11-04||1971-10-27
TRIAL STUDY 134XCP|IS|9DFBE459-22E4-4BA7-A993-AC06D6644562||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 TCID 50/ML|||||FOZ_BR||||ABNORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y|N||2||58||LONG-TERM FOLLOW-UP|1960-03-19|1973-04-01|||||1972-12-11||1967-05-25
TRIAL STUDY 134XCP|IS|9DFBE459-22E4-4BA7-A993-AC06D6644562||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PUFF|||||COULOMB||||LOW|NOT DONE|||URINE|SOLIDIFIED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|N|NA|U||3||39||LONG-TERM FOLLOW-UP|1973-05-24|1966-10-02|||||1960-03-29||1963-09-27
TRIAL STUDY 134XCP|IS|9DFBE459-22E4-4BA7-A993-AC06D6644562||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DEG/MM|||||%/MIN||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|LIPEMIC|NA|COULOMETRIC TITRATION|NA|NA|NA||4||88||LONG-TERM FOLLOW-UP|1973-08-27|1964-06-19|||||1961-03-31||1962-08-19
TRIAL STUDY 134XCP|IS|9DFBE459-22E4-4BA7-A993-AC06D6644562||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TUBERCULIN UNIT|||||TSP||||ABNORMAL|NOT DONE|||BLOOD|HEMOLYZED|Y|MRI WITHOUT CONTRAST|Y|N|Y||5||7||BASELINE|1973-05-01|1970-10-18|||||1968-11-01||1964-07-09
TRIAL STUDY 134XCP|IS|850B35FA-69C7-44AD-A471-964C59C4CFD8||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL2/L2|||||HZ/S||||HIGH|NOT DONE|||SOFT TISSUE|LIPEMIC|NA|NUCLEIC ACID AMPLIFICATION TEST|NA|Y|NA||1||38||INDUCTION TREATMENT|1970-11-26|1971-03-20|||||1966-07-14||1966-01-08
TRIAL STUDY 134XCP|IS|850B35FA-69C7-44AD-A471-964C59C4CFD8||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KG/CM2|||||U/G/DAY||||HIGH|NOT DONE|||PERSPIRATION|LIPEMIC|N|PET/MRI SCAN|Y|N|U||2||58||RUN-IN|1961-03-18|1966-09-16|||||1961-10-23||1962-11-22
TRIAL STUDY 134XCP|IS|850B35FA-69C7-44AD-A471-964C59C4CFD8||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^10/L|||||P||||ABNORMAL|NOT DONE|||PLASMA|DRIED|Y|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|NA|U|Y||3||39||WASHOUT|1971-09-08|1969-06-06|||||1967-05-11||1969-01-13
TRIAL STUDY 134XCP|IS|850B35FA-69C7-44AD-A471-964C59C4CFD8||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MBP|||||MG||||ABNORMAL|NOT DONE|||VENOUS PLASMA|CLOTTED|Y|FLUORESCEIN STAIN|NA|Y|NA||4||88||FOLLOW-UP|1963-04-13|1964-02-13|||||1964-06-03||1970-08-03
TRIAL STUDY 134XCP|IS|850B35FA-69C7-44AD-A471-964C59C4CFD8||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||G/M2/DAY|||||MG/M2||||LOW|NOT DONE|||CORD SERUM|FROZEN|N|SNP ARRAY|NA|NA|NA||5||7||INDUCTION TREATMENT|1967-01-25|1972-02-29|||||1970-08-26||1968-03-12
TRIAL STUDY 134XCP|IS|981B890E-1257-4F04-A974-6006401F78CC||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UG/ML/H|||||KPA||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|UNEXPECTED ODOR|NA|ENZYMATIC COLORIMETRY|U|Y|U||1||38||SCREENING|1967-05-15|1972-03-13|||||1966-03-19||1962-01-09
TRIAL STUDY 134XCP|IS|981B890E-1257-4F04-A974-6006401F78CC||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/KG|||||ML/KG/H||||ABNORMAL|NOT DONE|||SKIN TISSUE|DRIED|Y|MICROPARTICLE ENZYME IMMUNOASSAY|Y|U|NA||2||58||OPEN LABEL TREATMENT|1965-07-05|1963-10-08|||||1963-02-01||1966-05-04
TRIAL STUDY 134XCP|IS|981B890E-1257-4F04-A974-6006401F78CC||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^4 CFU|||||NG||||NORMAL|NOT DONE|||SWABBED MATERIAL|GELLED|N|MIGET|Y|N|U||3||39||OBSERVATION|1970-06-30|1963-01-11|||||1963-09-30||1962-12-12
TRIAL STUDY 134XCP|IS|981B890E-1257-4F04-A974-6006401F78CC||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/DAY|||||CI/UG||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|HEMOLYZED|N|AUTOREFRACTION|NA|U|N||4||88||TREATMENT|1973-02-09|1973-03-21|||||1971-06-25||1969-06-24
TRIAL STUDY 134XCP|IS|981B890E-1257-4F04-A974-6006401F78CC||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FARAD|||||GY/H||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|FROZEN|N|MICROBIAL CONCENTRATION|NA|N|NA||5||7||BASELINE|1970-05-28|1960-04-21|||||1972-05-01||1965-10-27
TRIAL STUDY 134XCP|IS|52FF8D96-64AD-498D-8B28-3DDD015796E3||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 CFU/G|||||KG/CM2||||LOW|NOT DONE|||BASAL TEAR|NON-HEMOLYZED|N|PEAK FLOWMETRY|NA|N|U||1||38||LONG-TERM FOLLOW-UP|1970-01-06|1972-06-29|||||1960-05-04||1969-12-27
TRIAL STUDY 134XCP|IS|52FF8D96-64AD-498D-8B28-3DDD015796E3||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MEQ/L|||||GPL U/ML||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|LACTESCENT|U|SIZE EXCLUSION CHROMATOGRAPHY|NA|N|NA||2||58||SCREENING|1969-05-09|1960-10-16|||||1972-04-12||1972-06-13
TRIAL STUDY 134XCP|IS|52FF8D96-64AD-498D-8B28-3DDD015796E3||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL|||||RING||||ABNORMAL|NOT DONE|||EXUDATE|AGGLUTINATED|N|SANGER SEQUENCING|U|U|NA||3||39||RUN-IN|1968-10-02|1963-11-08|||||1963-04-19||1973-08-02
TRIAL STUDY 134XCP|IS|52FF8D96-64AD-498D-8B28-3DDD015796E3||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/MM|||||UG/DL||||ABNORMAL|NOT DONE|||BONE MARROW|ICTERIC|N|MICRODENSITOMETRY|N|N|N||4||88||OBSERVATION|1962-10-24|1965-03-07|||||1971-02-17||1962-06-11
TRIAL STUDY 134XCP|IS|52FF8D96-64AD-498D-8B28-3DDD015796E3||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TABLET|||||COPIES/ML||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|AGGLUTINATED|Y|ELASTOGRAPHY|U|NA|NA||5||7||OBSERVATION|1969-05-26|1970-04-24|||||1964-02-29||1963-12-29
TRIAL STUDY 134XCP|IS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6/HPF|||||LOG10 CFU/G||||NORMAL|NOT DONE|||CALCULUS|SOLIDIFIED|NA|SMEAR|Y|Y|Y||1||38||RUN-IN|1972-06-28|1972-02-29|||||1969-10-02||1965-08-22
TRIAL STUDY 134XCP|IS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/M2|||||MMOL/KG||||HIGH|NOT DONE|||SERUM OR PLASMA|LIPEMIC|Y|DARK FIELD MICROSCOPY|N|N|U||2||58||BLINDED TREATMENT|1973-01-24|1970-06-03|||||1964-09-27||1961-03-12
TRIAL STUDY 134XCP|IS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^5/HPF|||||MMOL2/L2||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|DRIED|Y|IMMUNOCHROMATOGRAPHY|Y|NA|NA||3||39||BLINDED TREATMENT|1971-06-01|1962-04-30|||||1973-01-05||1964-07-12
TRIAL STUDY 134XCP|IS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS/ML|||||ML/DAY||||ABNORMAL|NOT DONE|||ARTERIAL BLOOD|THAWED|NA|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NA|U|Y||4||88||OBSERVATION|1964-01-08|1968-09-25|||||1962-11-17||1966-09-05
TRIAL STUDY 134XCP|IS|B017565E-4AF2-4B01-B65A-2A9FB3B96F40||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FFU|||||DRUM||||NORMAL|NOT DONE|||MUSCLE TISSUE|AGGLUTINATED|NA|INFRARED SPECTROMETRY|Y|Y|U||5||7||OBSERVATION|1966-05-22|1968-11-03|||||1962-04-25||1968-01-09
TRIAL STUDY 134XCP|IS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||WAFER|||||ML/DAY||||ABNORMAL|NOT DONE|||NAIL|FRESH|NA|PERIODIC ACID SCHIFF STAIN|Y|Y|Y||1||38||WASHOUT|1969-03-28|1972-05-25|||||1969-10-22||1960-06-02
TRIAL STUDY 134XCP|IS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||NEBULE|||||M3||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|NON-HEMOLYZED|Y|GRAM STAIN|NA|NA|Y||2||58||OBSERVATION|1964-02-21|1964-03-30|||||1963-01-14||1972-10-02
TRIAL STUDY 134XCP|IS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UOSM|||||MPL U/ML||||ABNORMAL|NOT DONE|||EMESIS|UNEXPECTED ODOR|N|ELASTOGRAPHY|U|Y|N||3||39||INDUCTION TREATMENT|1969-11-09|1970-07-20|||||1970-12-24||1963-06-11
TRIAL STUDY 134XCP|IS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPL U|||||DPM/100MG||||HIGH|NOT DONE|||ARTERIAL CORD BLOOD|AGGLUTINATED|Y|DIRECT SEQUENCING|Y|N|NA||4||88||TREATMENT|1960-11-13|1962-10-04|||||1961-10-03||1965-08-22
TRIAL STUDY 134XCP|IS|7DC0EC29-9F24-4851-A953-1EC6490D8ACD||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||HPA|||||PG||||LOW|NOT DONE|||SMEGMA|FRESH|Y|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|N|NA|U||5||7||BASELINE|1968-04-18|1970-03-10|||||1967-09-05||1962-03-10
TRIAL STUDY 134XCP|IS|CD65CBB8-D056-4738-93A8-FF465534961B||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DEG/MM|||||UG/H||||NORMAL|NOT DONE|||VENOUS BLOOD|GELLED|Y|RADIATION DOSIMETRY|NA|NA|U||1||38||OBSERVATION|1971-12-11|1963-04-01|||||1966-06-27||1973-05-13
TRIAL STUDY 134XCP|IS|CD65CBB8-D056-4738-93A8-FF465534961B||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 CFU|||||PIXEL||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|ROOM TEMPERATURE|U|MIGET|Y|Y|Y||2||58||FOLLOW-UP|1962-12-18|1963-04-30|||||1972-07-20||1971-10-05
TRIAL STUDY 134XCP|IS|CD65CBB8-D056-4738-93A8-FF465534961B||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||1/(S*KPA)|||||TITER||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|REFRIGERATED|U|THERMAL IONIZATION MASS SPECTROMETRY|N|Y|N||3||39||OPEN LABEL TREATMENT|1962-02-23|1973-08-17|||||1968-10-03||1973-08-30
TRIAL STUDY 134XCP|IS|CD65CBB8-D056-4738-93A8-FF465534961B||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KG|||||BOLUS||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|ROOM TEMPERATURE|Y|CYSTOMETRY|N|U|U||4||88||CONTINUATION TREATMENT|1972-06-28|1960-11-07|||||1968-09-16||1968-12-13
TRIAL STUDY 134XCP|IS|CD65CBB8-D056-4738-93A8-FF465534961B||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||GLOBULE|||||ML||||ABNORMAL|NOT DONE|||SALIVA|SOLIDIFIED|NA|SMEAR|NA|U|U||5||7||TREATMENT|1966-02-28|1973-02-04|||||1965-12-25||1964-07-21
TRIAL STUDY 134XCP|IS|7F014394-ABE2-45F8-891F-2DE808762532||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KV|||||ML/G/MIN||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|CONTAMINATED|NA|NEURAMINIDASE INHIBITION ASSAY|NA|NA|U||1||38||INDUCTION TREATMENT|1964-08-20|1972-06-02|||||1969-01-19||1968-06-03
TRIAL STUDY 134XCP|IS|7F014394-ABE2-45F8-891F-2DE808762532||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||COPIES/UL|||||ML/G/DAY||||LOW|NOT DONE|||MUCUS|HEMOLYZED|NA|MICROBIAL CULTURE|N|Y|Y||2||58||OPEN LABEL TREATMENT|1966-12-19|1962-11-14|||||1972-09-01||1962-12-22
TRIAL STUDY 134XCP|IS|7F014394-ABE2-45F8-891F-2DE808762532||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BEATS/MIN|||||S/H||||ABNORMAL|NOT DONE|||EMESIS|LACTESCENT|NA|MICROPARTICLE ENZYME IMMUNOASSAY|U|N|NA||3||39||WASHOUT|1964-11-02|1971-09-12|||||1961-01-20||1973-05-13
TRIAL STUDY 134XCP|IS|7F014394-ABE2-45F8-891F-2DE808762532||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||LOG10 TCID 50/DOSE|||||BAU||||ABNORMAL|NOT DONE|||CERUMEN|THAWED|Y|PYROSEQUENCING|NA|N|U||4||88||INDUCTION TREATMENT|1960-12-24|1966-04-17|||||1972-03-09||1960-12-17
TRIAL STUDY 134XCP|IS|7F014394-ABE2-45F8-891F-2DE808762532||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TRANSDUCING UNIT|||||/DAY||||LOW|NOT DONE|||KERATINOCYTE|PARAFFIN-EMBEDDED|U|FLOCCULATION, CHARCOAL ENHANCED|NA|N|U||5||7||BASELINE|1973-07-22|1967-01-12|||||1960-12-07||1968-12-21
TRIAL STUDY 134XCP|IS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KG/CM2|||||NMOL/L/H||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|AGGLUTINATED|Y|SLOAN LETTER EYE CHART 1.25%|NA|NA|U||1||38||TREATMENT|1972-12-01|1972-05-12|||||1967-03-28||1964-12-21
TRIAL STUDY 134XCP|IS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CCID 50/DOSE|||||PMOL/DL||||NORMAL|NOT DONE|||LYMPH|REFRIGERATED|N|FLOW CYTOMETRY|U|Y|NA||2||58||OBSERVATION|1967-05-04|1965-05-25|||||1972-01-20||1968-02-29
TRIAL STUDY 134XCP|IS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/KG|||||LOG10 PFU/ML||||HIGH|NOT DONE|||ALVEOLAR AIR|CALCIFIED|NA|TRANSMISSION ELECTRON MICROSCOPY|U|N|U||3||39||TREATMENT|1972-01-13|1966-05-06|||||1971-10-23||1967-11-10
TRIAL STUDY 134XCP|IS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MOL/MOL|||||MG/ML/DAY||||NORMAL|NOT DONE|||PROSTATIC FLUID|CALCIFIED|U|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|NA|NA|Y||4||88||CONTINUATION TREATMENT|1967-10-16|1966-12-08|||||1961-02-26||1970-09-13
TRIAL STUDY 134XCP|IS|523E40AD-3C19-46E6-B839-0BF83AFB5EF4||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PFU/ANIMAL|||||U/KG/MIN||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|FROZEN|N|HANSEL STAIN|NA|U|N||5||7||BASELINE|1961-12-01|1970-03-30|||||1965-03-24||1972-05-11
TRIAL STUDY 134XCP|IS|FB781158-BB8A-4A75-BD55-00D6A5C72720||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^3 DNA COPIES/ML|||||KG/L||||ABNORMAL|NOT DONE|||SKIN TISSUE|CLOTTED|U|HPLC-UV|Y|NA|U||1||38||RUN-IN|1964-06-22|1967-06-21|||||1968-02-28||1971-01-20
TRIAL STUDY 134XCP|IS|FB781158-BB8A-4A75-BD55-00D6A5C72720||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UIU/L|||||KHZ||||LOW|NOT DONE|||LAVAGE FLUID|ROOM TEMPERATURE|N|PHOTOMETRIC CLOT DETECTION|Y|NA|N||2||58||BLINDED TREATMENT|1962-07-25|1972-10-08|||||1972-09-11||1973-05-20
TRIAL STUDY 134XCP|IS|FB781158-BB8A-4A75-BD55-00D6A5C72720||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 PFU/ML|||||BQ/ML||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|LIPEMIC|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|NA|Y||3||39||OPEN LABEL TREATMENT|1965-06-12|1967-06-05|||||1965-06-04||1971-02-27
TRIAL STUDY 134XCP|IS|FB781158-BB8A-4A75-BD55-00D6A5C72720||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||JOULE|||||U/G/DAY||||HIGH|NOT DONE|||CAPILLARY PLASMA|CONTAMINATED|NA|BIOIMPEDANCE SPECTROSCOPY|Y|NA|U||4||88||LONG-TERM FOLLOW-UP|1965-10-26|1969-12-29|||||1972-11-29||1973-05-08
TRIAL STUDY 134XCP|IS|FB781158-BB8A-4A75-BD55-00D6A5C72720||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PIXELS/CM|||||ML/CAGE/DAY||||LOW|NOT DONE|||BREAST MILK|CALCIFIED|NA|CRYOSCOPY|U|U|NA||5||7||OBSERVATION|1968-05-19|1965-02-17|||||1960-07-07||1960-02-14
TRIAL STUDY 134XCP|IS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||P|||||100 IU/ML||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|NA|PATHOLOGICAL EVALUATION|Y|U|Y||1||38||OPEN LABEL TREATMENT|1967-10-02|1973-05-10|||||1962-11-30||1962-08-02
TRIAL STUDY 134XCP|IS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||BOWL|||||WEEKS||||LOW|NOT DONE|||INFRANATANT, SERUM|FROZEN|Y|ENDPOINT DILUTION ASSAY|U|N|Y||2||58||OPEN LABEL TREATMENT|1971-02-28|1962-01-08|||||1961-10-21||1972-03-28
TRIAL STUDY 134XCP|IS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PKAT|||||MNFI||||NORMAL|NOT DONE|||CORD BLOOD|AGGLUTINATED|N|REVERSE TRANSCRIPTASE PCR|U|NA|U||3||39||FOLLOW-UP|1973-02-17|1970-06-24|||||1967-07-21||1969-03-25
TRIAL STUDY 134XCP|IS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||IU|||||MEQ/MMOL||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|PARAFFIN-EMBEDDED|U|REFLECTANCE SPECTROSCOPY|N|U|U||4||88||SCREENING|1970-03-24|1964-04-18|||||1960-03-01||1960-02-03
TRIAL STUDY 134XCP|IS|F9A4A196-CB1F-48A3-9CA7-F1F3483062F0||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/L|||||MG/MIN||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|NA|NUCLEIC ACID AMPLIFICATION TEST|NA|NA|NA||5||7||CONTINUATION TREATMENT|1961-02-06|1968-10-02|||||1970-02-21||1971-11-19
TRIAL STUDY 134XCP|IS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MV|||||ABSORBANCE U/MIN||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|CLOTTED|N|HPLC/MS|N|Y|N||1||38||SCREENING|1962-05-19|1965-01-23|||||1968-02-20||1960-07-12
TRIAL STUDY 134XCP|IS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GPL U/ML|||||EP U||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|ICTERIC|Y|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|N|NA||2||58||INDUCTION TREATMENT|1970-03-10|1968-10-12|||||1966-12-13||1962-02-10
TRIAL STUDY 134XCP|IS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CAL|||||PFU/DOSE||||LOW|NOT DONE|||LUNG SURFACTANT|ROOM TEMPERATURE|N|RYAN BLUE STAIN|Y|N|NA||3||39||BASELINE|1963-11-25|1967-06-13|||||1970-09-23||1968-09-26
TRIAL STUDY 134XCP|IS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||COPIES/UL|||||KCAL||||NORMAL|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|U|ZIEHL NEELSEN ACID FAST STAIN|NA|N|N||4||88||RUN-IN|1960-11-25|1965-02-16|||||1963-08-30||1970-03-23
TRIAL STUDY 134XCP|IS|90D79875-49B9-4EE2-A23D-5DBC7AA489FA||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||KM/H|||||IN||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|HEMOLYZED|Y|PUPILLOMETRY|N|N|NA||5||7||BLINDED TREATMENT|1968-11-08|1970-12-03|||||1970-11-05||1966-06-26
TRIAL STUDY 134XCP|IS|505A1BB6-135A-4839-BB9E-6DD37F49DC45||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||HENRY|||||BQ/UL||||ABNORMAL|NOT DONE|||PERITONEAL FLUID|UNEXPECTED ODOR|NA|MICROARRAY|U|NA|U||1||38||OBSERVATION|1967-12-16|1972-03-01|||||1960-09-08||1967-12-14
TRIAL STUDY 134XCP|IS|505A1BB6-135A-4839-BB9E-6DD37F49DC45||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MSEC|||||GRAIN||||ABNORMAL|NOT DONE|||COLOSTRUM|FRESH|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|U|N|NA||2||58||OBSERVATION|1966-04-18|1971-08-15|||||1971-08-14||1967-12-30
TRIAL STUDY 134XCP|IS|505A1BB6-135A-4839-BB9E-6DD37F49DC45||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/MIN|||||10^6/HPF||||HIGH|NOT DONE|||BONE MARROW|ICTERIC|N|PHOTOMETRIC CLOT DETECTION|N|N|N||3||39||OPEN LABEL TREATMENT|1967-11-27|1972-03-16|||||1971-10-11||1962-12-19
TRIAL STUDY 134XCP|IS|505A1BB6-135A-4839-BB9E-6DD37F49DC45||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||AU/ML|||||10^3 CFU||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CLOTTED|N|CLINICAL EVALUATION|NA|N|NA||4||88||BLINDED TREATMENT|1968-08-25|1962-12-22|||||1971-08-29||1968-06-07
TRIAL STUDY 134XCP|IS|505A1BB6-135A-4839-BB9E-6DD37F49DC45||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/HPF|||||BQ/MG||||HIGH|NOT DONE|||BASAL TEAR|PARAFFIN-EMBEDDED|N|BAC ACGH|N|U|Y||5||7||TREATMENT|1966-05-19|1966-09-07|||||1969-05-12||1968-03-24
TRIAL STUDY 134XCP|IS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3 CFU/G|||||G/G||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|ROOM TEMPERATURE|NA|ANGIOGRAPHY|U|Y|N||1||38||OPEN LABEL TREATMENT|1967-01-09|1964-07-25|||||1967-05-30||1968-10-01
TRIAL STUDY 134XCP|IS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HZ/S|||||CUP||||LOW|NOT DONE|||CERUMEN|LIPEMIC|Y|NUCLEIC ACID HYBRIDIZATION|U|U|N||2||58||SCREENING|1968-12-12|1962-08-30|||||1967-10-22||1961-07-06
TRIAL STUDY 134XCP|IS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UMOL/L/MIN|||||BAU/ML||||LOW|NOT DONE|||BONE MARROW|HEMOLYZED|Y|TEMPLATE INCISION METHOD|NA|N|Y||3||39||LONG-TERM FOLLOW-UP|1963-11-28|1973-05-12|||||1970-01-01||1965-03-28
TRIAL STUDY 134XCP|IS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/KG|||||S*KPA||||LOW|NOT DONE|||ALVEOLAR AIR|DRIED|NA|TRICHROME STAIN|Y|Y|U||4||88||RUN-IN|1966-11-23|1971-01-30|||||1967-04-17||1971-07-26
TRIAL STUDY 134XCP|IS|E0889B7B-923D-4AFF-ACB7-952B7BAF912F||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||IU/KG|||||/500 WBC||||LOW|NOT DONE|||SEMEN|DRIED|Y|MICROSCOPY|N|U|NA||5||7||BASELINE|1969-12-11|1970-09-19|||||1968-03-13||1964-08-02
TRIAL STUDY 134XCP|IS|16F375DC-DC27-461B-969E-1269DC53F4D9||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MIN/KPA|||||U/KG/H||||LOW|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|N|SCANNING ELECTRON MICROSCOPY|NA|U|N||1||38||FOLLOW-UP|1972-05-08|1971-11-29|||||1965-06-20||1960-07-19
TRIAL STUDY 134XCP|IS|16F375DC-DC27-461B-969E-1269DC53F4D9||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML|||||UMOL/KG/MIN||||HIGH|NOT DONE|||SOFT TISSUE|FROZEN|Y|TOTAL BODY RADIOGRAPHY|N|NA|N||2||58||OBSERVATION|1960-04-05|1963-11-20|||||1964-07-12||1961-01-05
TRIAL STUDY 134XCP|IS|16F375DC-DC27-461B-969E-1269DC53F4D9||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BQ/L|||||10^6 ORGANISMS/G||||HIGH|NOT DONE|||DIALYSIS FLUID|PARAFFIN-EMBEDDED|Y|AUSCULTATION|U|NA|NA||3||39||LONG-TERM FOLLOW-UP|1969-11-02|1965-05-03|||||1964-12-20||1967-11-10
TRIAL STUDY 134XCP|IS|16F375DC-DC27-461B-969E-1269DC53F4D9||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MU/L|||||NEBULE||||LOW|NOT DONE|||TRANSUDATE|AGGLUTINATED|N|CHROMATOGRAPHY|NA|U|Y||4||88||CONTINUATION TREATMENT|1960-07-24|1964-06-16|||||1968-08-02||1960-06-15
TRIAL STUDY 134XCP|IS|16F375DC-DC27-461B-969E-1269DC53F4D9||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||G/DAY|||||ML/CAGE||||ABNORMAL|NOT DONE|||CALCULUS|PARAFFIN-EMBEDDED|NA|RAJI CELL EIA|NA|Y|N||5||7||SCREENING|1961-11-16|1971-05-31|||||1961-02-04||1964-03-28
TRIAL STUDY 134XCP|IS|17BF9A68-265F-4FCC-A499-615A1B71A8D6||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MCI|||||CD||||NORMAL|NOT DONE|||RETICULOCYTES|CALCIFIED|NA|CISH|N|N|Y||1||38||INDUCTION TREATMENT|1970-06-15|1973-08-29|||||1969-07-25||1970-06-30
TRIAL STUDY 134XCP|IS|17BF9A68-265F-4FCC-A499-615A1B71A8D6||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||AGU/ML|||||SUPPOSITORY||||LOW|NOT DONE|||SERUM|SOLIDIFIED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y|Y||2||58||OPEN LABEL TREATMENT|1967-01-28|1970-05-29|||||1972-03-08||1961-08-15
TRIAL STUDY 134XCP|IS|17BF9A68-265F-4FCC-A499-615A1B71A8D6||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VIAL|||||C||||ABNORMAL|NOT DONE|||SOFT TISSUE|GELLED|NA|JAFFE REACTION|U|Y|NA||3||39||LONG-TERM FOLLOW-UP|1960-09-30|1966-11-27|||||1973-01-01||1962-11-01
TRIAL STUDY 134XCP|IS|17BF9A68-265F-4FCC-A499-615A1B71A8D6||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PMOL/G|||||NMOL/MOL||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|REFRIGERATED|N|RULER MEASUREMENT METHOD|NA|U|Y||4||88||OPEN LABEL TREATMENT|1964-07-15|1960-11-08|||||1966-11-21||1961-11-07
TRIAL STUDY 134XCP|IS|17BF9A68-265F-4FCC-A499-615A1B71A8D6||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||LOG10 TCID 50/UL|||||ML/M2/MIN||||NORMAL|NOT DONE|||PLATELET RICH PLASMA|FROZEN|U|MIGET|N|U|N||5||7||OBSERVATION|1971-02-04|1966-11-09|||||1971-03-25||1966-07-15
TRIAL STUDY 134XCP|IS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DAGU/ML|||||DAYS/WK||||LOW|NOT DONE|||MUSCLE TISSUE|REFRIGERATED|N|NUCLEIC ACID SEQUENCING|Y|NA|NA||1||38||BASELINE|1973-02-19|1966-11-04|||||1962-08-19||1968-11-28
TRIAL STUDY 134XCP|IS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MSEC|||||UIU/DL||||NORMAL|NOT DONE|||STOOL|GELLED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|U|NA|U||2||58||TREATMENT|1967-01-06|1972-02-16|||||1971-09-17||1963-05-31
TRIAL STUDY 134XCP|IS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KCAL|||||NMOL/MOL||||ABNORMAL|NOT DONE|||CORD SERUM|GELLED|NA|ELISPOT|U|NA|N||3||39||FOLLOW-UP|1964-12-17|1961-09-21|||||1962-12-07||1972-03-24
TRIAL STUDY 134XCP|IS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||GBQ/UG|||||NCI||||LOW|NOT DONE|||CIRCULATING TUMOR CELL|CONTAMINATED|Y|NEPHELOMETRY|N|U|NA||4||88||FOLLOW-UP|1967-08-07|1960-08-01|||||1961-07-31||1963-08-12
TRIAL STUDY 134XCP|IS|327E38A8-FEAD-4868-AA3B-3DF2225E7CDF||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||COAT|||||CM||||LOW|NOT DONE|||URINE|CONCENTRATED|NA|NUCLEAR RADIOLOGY|Y|U|Y||5||7||SCREENING|1971-03-21|1969-10-23|||||1972-06-22||1965-02-16
TRIAL STUDY 134XCP|IS|B842981B-AD7A-4A03-8E84-D5FC887BAD60||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^4 CFU/ML|||||STEPS/MIN||||LOW|NOT DONE|||URINE|CALCIFIED|N|TRANSMISSION ELECTRON MICROSCOPY|N|U|N||1||38||OPEN LABEL TREATMENT|1965-12-13|1972-11-09|||||1971-05-15||1971-01-04
TRIAL STUDY 134XCP|IS|B842981B-AD7A-4A03-8E84-D5FC887BAD60||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CM H2O|||||MG/ML/MIN||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|SOLIDIFIED|NA|PET/CT SCAN WITHOUT CONTRAST|Y|U|N||2||58||TREATMENT|1970-07-04|1970-01-21|||||1967-02-19||1970-10-18
TRIAL STUDY 134XCP|IS|B842981B-AD7A-4A03-8E84-D5FC887BAD60||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/S|||||EU||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|CLOTTED|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|N|U|NA||3||39||RUN-IN|1960-05-03|1970-04-16|||||1965-10-29||1970-07-16
TRIAL STUDY 134XCP|IS|B842981B-AD7A-4A03-8E84-D5FC887BAD60||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^4/HPF|||||10^8 PFU||||HIGH|NOT DONE|||COLOSTRUM|THAWED|U|CELLULOSE TAPE|NA|Y|Y||4||88||RUN-IN|1971-08-23|1967-01-30|||||1961-08-21||1972-05-29
TRIAL STUDY 134XCP|IS|B842981B-AD7A-4A03-8E84-D5FC887BAD60||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^9 CFU/G|||||PM||||ABNORMAL|NOT DONE|||PERSPIRATION|AUTOLYZED|NA|TARGETED GENOME SEQUENCING|NA|Y|U||5||7||CONTINUATION TREATMENT|1970-01-11|1960-02-23|||||1963-09-06||1973-04-16
TRIAL STUDY 134XCP|IS|07F7C4E7-7722-4916-AB89-46EF540E2BD7||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BAG|||||GPELISA UNIT/ML||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|HEMOLYZED|U|HPLC/IEX|Y|U|Y||1||38||BASELINE|1965-01-01|1967-07-12|||||1966-11-25||1960-06-26
TRIAL STUDY 134XCP|IS|07F7C4E7-7722-4916-AB89-46EF540E2BD7||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UU/DL|||||G/M2/DAY||||HIGH|NOT DONE|||RETICULOCYTES|FRESH|U|INTRAVASCULAR ULTRASOUND|U|Y|Y||2||58||INDUCTION TREATMENT|1967-04-13|1968-05-08|||||1970-07-03||1971-05-27
TRIAL STUDY 134XCP|IS|07F7C4E7-7722-4916-AB89-46EF540E2BD7||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||/5X10^4 WBC||||ABNORMAL|NOT DONE|||CORD SERUM|ICTERIC|Y|TRANSTHORACIC ECHOCARDIOGRAPHY|NA|U|Y||3||39||LONG-TERM FOLLOW-UP|1970-04-14|1965-05-21|||||1963-09-03||1970-04-14
TRIAL STUDY 134XCP|IS|07F7C4E7-7722-4916-AB89-46EF540E2BD7||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||IU/KG|||||MG/CM2||||LOW|NOT DONE|||PLATELET RICH PLASMA|FROZEN|Y|MAPH|NA|NA|U||4||88||LONG-TERM FOLLOW-UP|1968-01-05|1961-03-08|||||1969-10-23||1971-06-04
TRIAL STUDY 134XCP|IS|07F7C4E7-7722-4916-AB89-46EF540E2BD7||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/DAY|||||ROENTGEN||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|LACTESCENT|Y|DARK FIELD MICROSCOPY|Y|Y|N||5||7||SCREENING|1966-04-30|1968-02-12|||||1965-07-20||1965-01-24
TRIAL STUDY 134XCP|IS|58661394-906E-43F3-8935-150DF240A04C||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||HZ/S|||||HOMEOPATHIC DILUTION||||ABNORMAL|NOT DONE|||FLUID|NON-HEMOLYZED|Y|PHOTOMETRY|N|Y|Y||1||38||BLINDED TREATMENT|1966-03-28|1967-01-29|||||1965-05-10||1973-08-21
TRIAL STUDY 134XCP|IS|58661394-906E-43F3-8935-150DF240A04C||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL|||||KEV||||LOW|NOT DONE|||BONE MARROW|FRESH|NA|GRADIENT DIFFUSION|U|Y|Y||2||58||CONTINUATION TREATMENT|1963-12-26|1965-10-26|||||1962-09-25||1973-02-17
TRIAL STUDY 134XCP|IS|58661394-906E-43F3-8935-150DF240A04C||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/BEAT|||||FRACTION OF 1||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|AGGLUTINATED|N|CLINICAL EVALUATION|Y|NA|N||3||39||BASELINE|1965-04-05|1967-05-05|||||1962-02-22||1970-06-25
TRIAL STUDY 134XCP|IS|58661394-906E-43F3-8935-150DF240A04C||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV|||||ML/M2/H||||HIGH|NOT DONE|||VITREOUS HUMOR|ROOM TEMPERATURE|U|RAJI CELL RIA|N|Y|NA||4||88||RUN-IN|1970-08-24|1972-05-06|||||1968-03-09||1969-05-04
TRIAL STUDY 134XCP|IS|58661394-906E-43F3-8935-150DF240A04C||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPELISA UNIT/ML|||||MU/L||||ABNORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|AGGLUTINATED|U|JAEGER EYE CHART|U|Y|Y||5||7||FOLLOW-UP|1971-04-01|1962-12-27|||||1964-11-11||1970-10-20
TRIAL STUDY 134XCP|IS|B70F3694-B764-4B39-BFB9-B1281ED091B8||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MMOL/KG|||||10^3 CFU||||LOW|NOT DONE|||LYSATE|CALCIFIED|Y|OPTICAL COHERENCE TOMOGRAPHY|N|Y|Y||1||38||BASELINE|1964-12-26|1962-04-11|||||1970-08-29||1963-09-03
TRIAL STUDY 134XCP|IS|B70F3694-B764-4B39-BFB9-B1281ED091B8||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^6 DNA COPIES/ML|||||BP||||NORMAL|NOT DONE|||SEMEN|NON-HEMOLYZED|Y|ALCIAN BLUE STAIN|N|U|N||2||58||INDUCTION TREATMENT|1970-11-03|1964-03-18|||||1962-09-25||1960-07-20
TRIAL STUDY 134XCP|IS|B70F3694-B764-4B39-BFB9-B1281ED091B8||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANTI-XA IU/ML|||||LOG10 COPIES/ML||||HIGH|NOT DONE|||INFRANATANT, PLASMA|AGGLUTINATED|Y|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NA|U|N||3||39||OBSERVATION|1969-01-14|1968-03-28|||||1962-12-11||1960-07-04
TRIAL STUDY 134XCP|IS|B70F3694-B764-4B39-BFB9-B1281ED091B8||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ATM|||||UMOL||||NORMAL|NOT DONE|||BONE|GELLED|NA|PHOTOGRAPHY|NA|NA|U||4||88||TREATMENT|1963-09-22|1960-09-14|||||1963-03-02||1963-03-06
TRIAL STUDY 134XCP|IS|B70F3694-B764-4B39-BFB9-B1281ED091B8||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MM/SEC|||||PFU/ANIMAL||||NORMAL|NOT DONE|||INFRANATANT, SERUM|ICTERIC|Y|HEMATOXYLIN AND EOSIN STAIN|N|NA|NA||5||7||LONG-TERM FOLLOW-UP|1960-05-12|1961-02-25|||||1973-06-05||1963-12-06
TRIAL STUDY 134XCP|IS|5B2471DB-807A-44F8-9529-D2319CCFE017||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MPL U/ML|||||G/CAGE||||ABNORMAL|NOT DONE|||INFRANATANT, SERUM|GELLED|N|MACRO BROTH DILUTION|N|U|Y||1||38||INDUCTION TREATMENT|1965-09-08|1968-10-23|||||1969-08-27||1968-09-14
TRIAL STUDY 134XCP|IS|5B2471DB-807A-44F8-9529-D2319CCFE017||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||SPRAY|||||UM||||NORMAL|NOT DONE|||SEMEN|FROZEN|N|THICK SMEAR|N|U|NA||2||58||INDUCTION TREATMENT|1965-09-23|1963-11-25|||||1965-10-20||1962-09-15
TRIAL STUDY 134XCP|IS|5B2471DB-807A-44F8-9529-D2319CCFE017||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NL|||||UMOL/L||||ABNORMAL|NOT DONE|||LOCHIA|AUTOLYZED|Y|JAFFE REACTION|NA|Y|NA||3||39||SCREENING|1965-11-01|1967-11-07|||||1967-12-08||1964-08-17
TRIAL STUDY 134XCP|IS|5B2471DB-807A-44F8-9529-D2319CCFE017||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 COPIES/ML|||||UG/G/DAY||||NORMAL|NOT DONE|||LYMPH|FRESH|U|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|NA|NA||4||88||OBSERVATION|1963-10-13|1965-12-19|||||1962-09-15||1967-07-04
TRIAL STUDY 134XCP|IS|5B2471DB-807A-44F8-9529-D2319CCFE017||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 IU/ML|||||MILE||||HIGH|NOT DONE|||VENOUS BLOOD|CALCIFIED|NA|STATIC PERIMETRY|NA|U|NA||5||7||RUN-IN|1969-07-02|1964-08-21|||||1962-10-08||1973-02-27
TRIAL STUDY 134XCP|IS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ROENTGEN|||||MOL/ML||||NORMAL|NOT DONE|||FLUID|AGGLUTINATED|U|DUKE INCISION METHOD|NA|N|Y||1||38||BLINDED TREATMENT|1966-03-05|1967-10-19|||||1962-05-18||1971-02-13
TRIAL STUDY 134XCP|IS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||G/M2/DAY|||||MV*MIN||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|FRESH|N|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|Y|U||2||58||INDUCTION TREATMENT|1968-11-19|1969-11-18|||||1972-10-26||1961-10-01
TRIAL STUDY 134XCP|IS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UL|||||CD/M2||||LOW|NOT DONE|||BLOOD|CLOTTED|N|MULTI-SLICE SPIRAL CT|NA|NA|N||3||39||RUN-IN|1971-01-06|1966-01-25|||||1966-04-26||1970-10-02
TRIAL STUDY 134XCP|IS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/M2/MIN|||||NEBULE||||HIGH|NOT DONE|||MUCUS|CONCENTRATED|NA|INFRARED SPECTROMETRY|N|Y|U||4||88||OBSERVATION|1960-04-05|1965-04-17|||||1961-03-21||1971-01-10
TRIAL STUDY 134XCP|IS|14D63A01-8418-4F72-ABE4-6E5DE30AE4C2||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MMHG*MIN/L|||||10^3 CFU/ML||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|DRIED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NA|U|N||5||7||OBSERVATION|1968-11-12|1966-07-19|||||1971-12-28||1966-08-31
TRIAL STUDY 134XCP|IS|A6E00A2C-7DBC-4577-8873-C780F5A6B400||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||UL/DOSE||||HIGH|NOT DONE|||PLEURAL TISSUE|PARAFFIN-EMBEDDED|N|FLAME PHOTOMETRY|N|U|N||1||38||RUN-IN|1969-05-06|1963-10-08|||||1968-02-06||1970-02-06
TRIAL STUDY 134XCP|IS|A6E00A2C-7DBC-4577-8873-C780F5A6B400||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 CFU|||||MG/DAY||||HIGH|NOT DONE|||EPITHELIAL CELL|UNEXPECTED ODOR|U|CAPILLARY ELECTROPHORESIS|N|Y|Y||2||58||FOLLOW-UP|1968-07-02|1966-02-14|||||1962-10-29||1969-02-01
TRIAL STUDY 134XCP|IS|A6E00A2C-7DBC-4577-8873-C780F5A6B400||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||USP U|||||MCI/L||||HIGH|NOT DONE|||BASAL TEAR|AGGLUTINATED|Y|FLUORESCENCE ANGIOGRAPHY|U|N|Y||3||39||TREATMENT|1964-06-21|1964-12-06|||||1961-12-11||1965-06-26
TRIAL STUDY 134XCP|IS|A6E00A2C-7DBC-4577-8873-C780F5A6B400||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CAN|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||FLUID|NON-HEMOLYZED|N|ELECTROGASTROGRAPHY|U|U|NA||4||88||RUN-IN|1973-05-18|1972-12-10|||||1963-12-06||1971-02-05
TRIAL STUDY 134XCP|IS|A6E00A2C-7DBC-4577-8873-C780F5A6B400||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||YEARS|||||UG/ML/H||||HIGH|NOT DONE|||PERITONEAL FLUID|PARAFFIN-EMBEDDED|U|WRIGHT STAIN|N|N|Y||5||7||LONG-TERM FOLLOW-UP|1970-03-27|1963-11-20|||||1963-04-18||1963-12-15
TRIAL STUDY 134XCP|IS|06611015-E99C-466B-B0B3-EBE10EA9E627||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANTI-XA IU/ML|||||V||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|GELLED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|Y|N|U||1||38||TREATMENT|1967-10-12|1960-07-14|||||1964-08-26||1963-05-04
TRIAL STUDY 134XCP|IS|06611015-E99C-466B-B0B3-EBE10EA9E627||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/MMHG/MIN/L|||||CI/G||||HIGH|NOT DONE|||SEMINAL FLUID|LACTESCENT|U|ANGIOGRAPHY|U|N|NA||2||58||WASHOUT|1971-09-13|1965-08-15|||||1961-07-25||1960-02-21
TRIAL STUDY 134XCP|IS|06611015-E99C-466B-B0B3-EBE10EA9E627||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/BEAT|||||UKAT/L||||HIGH|NOT DONE|||SPUTUM|UNEXPECTED ODOR|NA|FUNDUS PHOTOGRAPHY|N|Y|NA||3||39||BASELINE|1970-01-01|1970-08-11|||||1967-07-06||1964-09-08
TRIAL STUDY 134XCP|IS|06611015-E99C-466B-B0B3-EBE10EA9E627||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LB|||||MMU/ML||||LOW|NOT DONE|||TISSUE|CALCIFIED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|N|Y||4||88||OPEN LABEL TREATMENT|1963-04-06|1960-08-23|||||1967-01-06||1972-01-27
TRIAL STUDY 134XCP|IS|06611015-E99C-466B-B0B3-EBE10EA9E627||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BEL|||||10^9 CFU/G||||ABNORMAL|NOT DONE|||MUCUS|AUTOLYZED|NA|FISH|Y|U|NA||5||7||LONG-TERM FOLLOW-UP|1964-02-14|1973-04-01|||||1964-02-04||1973-07-02
TRIAL STUDY 134XCP|IS|5AF91C46-87FC-4714-B956-A4ECFC87C30A||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UU/L|||||10^3 DNA COPIES/ML||||LOW|NOT DONE|||SPERMATOZOON|CONTAMINATED|Y|IN SITU HYBRIDIZATION|Y|Y|N||1||38||TREATMENT|1966-12-09|1966-10-25|||||1964-10-06||1966-08-24
TRIAL STUDY 134XCP|IS|5AF91C46-87FC-4714-B956-A4ECFC87C30A||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^3 ORGANISMS/G|||||U/M2||||HIGH|NOT DONE|||PLEURAL TISSUE|CLOTTED|Y|SLIT LAMP PHOTOGRAPHY|Y|Y|U||2||58||SCREENING|1962-07-10|1970-07-12|||||1967-05-02||1970-11-14
TRIAL STUDY 134XCP|IS|5AF91C46-87FC-4714-B956-A4ECFC87C30A||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KPA|||||HOMEOPATHIC DILUTION||||NORMAL|NOT DONE|||ERYTHROCYTES|DRIED|U|FARR ASSAY|N|U|NA||3||39||SCREENING|1971-09-15|1963-02-24|||||1971-05-18||1966-01-26
TRIAL STUDY 134XCP|IS|5AF91C46-87FC-4714-B956-A4ECFC87C30A||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/DAY|||||MEQ/G||||NORMAL|NOT DONE|||REFLEX TEAR|HEMOLYZED|Y|PET/CT SCAN WITHOUT CONTRAST|NA|N|N||4||88||WASHOUT|1962-11-25|1963-11-04|||||1965-11-09||1964-11-19
TRIAL STUDY 134XCP|IS|5AF91C46-87FC-4714-B956-A4ECFC87C30A||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||SFC/10^6 PBMC|||||MSEC||||LOW|NOT DONE|||BONE|CONCENTRATED|NA|EEG|U|NA|U||5||7||BLINDED TREATMENT|1970-11-30|1968-07-21|||||1962-04-20||1973-06-24
TRIAL STUDY 134XCP|IS|3DEA7E00-77B9-4710-A37E-577F925BFBD8||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NEEDLE GAUGE|||||COPIES/UG||||HIGH|NOT DONE|||URINE SEDIMENT|AUTOLYZED|NA|SNELLEN EYE CHART|U|Y|N||1||38||TREATMENT|1968-11-30|1966-09-10|||||1965-03-30||1960-02-29
TRIAL STUDY 134XCP|IS|3DEA7E00-77B9-4710-A37E-577F925BFBD8||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/M2/DAY|||||VP/DOSE||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|DRIED|U|OPTICAL COHERENCE TOMOGRAPHY|N|N|Y||2||58||OBSERVATION|1961-07-26|1965-11-26|||||1969-03-02||1969-08-22
TRIAL STUDY 134XCP|IS|3DEA7E00-77B9-4710-A37E-577F925BFBD8||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DRUM|||||AGU/ML||||ABNORMAL|NOT DONE|||EXPIRED AIR|DRIED|U|ELISA|Y|NA|N||3||39||RUN-IN|1971-11-19|1962-07-31|||||1973-06-27||1960-02-28
TRIAL STUDY 134XCP|IS|3DEA7E00-77B9-4710-A37E-577F925BFBD8||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KPA/L/SEC|||||/MM||||LOW|NOT DONE|||CAPILLARY PLASMA|UNEXPECTED ODOR|U|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|Y|Y||4||88||RUN-IN|1971-06-08|1962-12-26|||||1965-07-01||1962-10-26
TRIAL STUDY 134XCP|IS|3DEA7E00-77B9-4710-A37E-577F925BFBD8||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MEQ|||||PMOL/DAY||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|UNEXPECTED ODOR|NA|ATOMIC ABSORPTION SPECTROMETRY|U|NA|U||5||7||FOLLOW-UP|1972-10-14|1965-01-01|||||1967-10-29||1970-03-23
TRIAL STUDY 134XCP|IS|DC79E350-1B89-4518-8B42-5858F5270928||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IMPLANT|||||BLOCKS||||LOW|NOT DONE|||BUFFY COAT|GELLED|N|HPLC/MS/MS|Y|N|N||1||38||LONG-TERM FOLLOW-UP|1972-07-14|1968-11-11|||||1973-02-12||1968-11-23
TRIAL STUDY 134XCP|IS|DC79E350-1B89-4518-8B42-5858F5270928||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||AGU/ML|||||DIP||||NORMAL|NOT DONE|||VITREOUS HUMOR|FRESH|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|Y|N||2||58||INDUCTION TREATMENT|1965-07-18|1962-08-21|||||1962-05-19||1964-10-02
TRIAL STUDY 134XCP|IS|DC79E350-1B89-4518-8B42-5858F5270928||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/M2/H|||||KM||||HIGH|NOT DONE|||NAIL|FRESH|N|REVERSE TRANSCRIPTASE PCR|Y|U|Y||3||39||RUN-IN|1960-10-30|1964-03-17|||||1968-02-06||1964-05-30
TRIAL STUDY 134XCP|IS|DC79E350-1B89-4518-8B42-5858F5270928||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/KG/MIN|||||%/S||||HIGH|NOT DONE|||SERUM|CONTAMINATED|NA|ELECTRICAL IMPEDANCE MYOGRAPHY|NA|N|N||4||88||SCREENING|1966-11-03|1972-04-21|||||1962-07-14||1961-02-13
TRIAL STUDY 134XCP|IS|DC79E350-1B89-4518-8B42-5858F5270928||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TRACE|||||CGY||||LOW|NOT DONE|||HAIR|AUTOLYZED|N|TOLUIDINE BLUE STAIN|NA|NA|N||5||7||CONTINUATION TREATMENT|1966-02-16|1973-08-13|||||1969-12-28||1968-09-12
TRIAL STUDY 134XCP|IS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||AU/ML|||||10^6 U||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|DRIED|N|MICROBIAL CULTURE, SOLID|U|U|NA||1||38||WASHOUT|1971-07-30|1968-12-01|||||1967-12-24||1964-12-12
TRIAL STUDY 134XCP|IS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%(W/W)|||||M/SEC2||||HIGH|NOT DONE|||SMEGMA|REFRIGERATED|Y|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|N|U|U||2||58||OPEN LABEL TREATMENT|1968-04-08|1969-02-20|||||1968-01-31||1967-05-16
TRIAL STUDY 134XCP|IS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MMOL/MOL|||||ML/M2/MIN||||LOW|NOT DONE|||PUS|PARAFFIN-EMBEDDED|N|NEURAMINIDASE INHIBITION ASSAY|Y|U|U||3||39||CONTINUATION TREATMENT|1969-01-23|1967-06-22|||||1972-08-18||1961-10-08
TRIAL STUDY 134XCP|IS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||LOG10 TCID 50/ML|||||STRIP||||NORMAL|NOT DONE|||PERSPIRATION|UNEXPECTED ODOR|U|LAPAROSCOPY|N|NA|Y||4||88||RUN-IN|1961-05-03|1961-09-25|||||1969-02-04||1963-09-13
TRIAL STUDY 134XCP|IS|9B8B6DCE-AF08-40AC-90BB-87CCC5592726||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/L/H|||||ML/CAGE/WK||||HIGH|NOT DONE|||EPITHELIAL CELL|LACTESCENT|N|CONTACT SPECULAR MICROSCOPY|U|Y|U||5||7||OPEN LABEL TREATMENT|1961-02-02|1964-05-26|||||1966-11-03||1968-09-15
TRIAL STUDY 134XCP|IS|7F51014D-D2B5-4956-9DD6-52676EB66ED7||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPELISA UNIT/ML|||||U/G/DAY||||ABNORMAL|NOT DONE|||STOOL|THAWED|N|ULTRASOUND|NA|Y|N||1||38||RUN-IN|1967-01-29|1972-06-01|||||1967-07-21||1961-02-04
TRIAL STUDY 134XCP|IS|7F51014D-D2B5-4956-9DD6-52676EB66ED7||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||YEARS|||||PIPE||||HIGH|NOT DONE|||EXPIRED AIR|ICTERIC|Y|SCANNING ELECTRON MICROSCOPY|N|U|U||2||58||LONG-TERM FOLLOW-UP|1972-10-12|1966-06-29|||||1967-01-19||1962-10-15
TRIAL STUDY 134XCP|IS|7F51014D-D2B5-4956-9DD6-52676EB66ED7||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MGEQ|||||/2000 RBC||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|ROOM TEMPERATURE|NA|FLUORESCEIN STAIN|Y|Y|NA||3||39||BLINDED TREATMENT|1972-11-06|1967-09-02|||||1963-02-07||1965-07-26
TRIAL STUDY 134XCP|IS|7F51014D-D2B5-4956-9DD6-52676EB66ED7||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CS|||||UKAT||||NORMAL|NOT DONE|||EXUDATE|CALCIFIED|N|OSCILLOMETRY|Y|N|NA||4||88||OPEN LABEL TREATMENT|1967-09-09|1968-12-03|||||1971-01-17||1964-06-21
TRIAL STUDY 134XCP|IS|7F51014D-D2B5-4956-9DD6-52676EB66ED7||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ARBITRARY U|||||HPA||||NORMAL|NOT DONE|||BILE|SOLIDIFIED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|U|Y|U||5||7||LONG-TERM FOLLOW-UP|1961-01-31|1968-02-07|||||1967-10-26||1965-04-12
TRIAL STUDY 134XCP|IS|0568B2DD-3184-472D-89C6-66A5CE8AE00F||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MNFI|||||G/L||||ABNORMAL|NOT DONE|||CORD BLOOD|GELLED|N|ETDRS EYE CHART|U|U|N||1||38||TREATMENT|1961-05-02|1967-07-16|||||1969-07-14||1971-03-06
TRIAL STUDY 134XCP|IS|0568B2DD-3184-472D-89C6-66A5CE8AE00F||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/7.5 ML|||||COAT||||LOW|NOT DONE|||MONOCYTE|FROZEN|NA|NEURAMINIDASE INHIBITION ASSAY|NA|U|NA||2||58||SCREENING|1970-05-24|1968-09-10|||||1965-02-26||1965-06-26
TRIAL STUDY 134XCP|IS|0568B2DD-3184-472D-89C6-66A5CE8AE00F||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UMOL/H/MMOL|||||GPL U/ML||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|CONCENTRATED|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|U|N|U||3||39||WASHOUT|1972-08-11|1972-01-16|||||1962-02-23||1961-01-20
TRIAL STUDY 134XCP|IS|0568B2DD-3184-472D-89C6-66A5CE8AE00F||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PG/L|||||G/CAGE||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|GELLED|N|SICKLE CELL SOLUBILITY TEST|U|N|U||4||88||SCREENING|1968-10-19|1961-07-27|||||1971-02-12||1960-07-09
TRIAL STUDY 134XCP|IS|0568B2DD-3184-472D-89C6-66A5CE8AE00F||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PMOL/10^10 CELLS|||||H*%||||LOW|NOT DONE|||TUMOR TISSUE|FROZEN|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|N|U|Y||5||7||BLINDED TREATMENT|1962-06-08|1967-07-20|||||1961-06-15||1962-10-23
TRIAL STUDY 134XCP|IS|275DC6A6-598C-4997-A442-4A3916AC42BD||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UMOL/MG/MIN|||||UKAT/10^12 RBC||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|N|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|NA|Y|NA||1||38||BASELINE|1970-12-29|1960-06-08|||||1963-07-25||1971-06-27
TRIAL STUDY 134XCP|IS|275DC6A6-598C-4997-A442-4A3916AC42BD||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/4.0 ML|||||UG/MOL||||HIGH|NOT DONE|||SPUTUM|DRIED|NA|MAPH|Y|Y|NA||2||58||LONG-TERM FOLLOW-UP|1960-01-17|1973-04-06|||||1964-06-21||1970-09-22
TRIAL STUDY 134XCP|IS|275DC6A6-598C-4997-A442-4A3916AC42BD||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MU|||||MMOL/MIN/KPA||||NORMAL|NOT DONE|||DIALYSIS FLUID|HEMOLYZED|NA|COMPLEMENT FIXATION|U|Y|Y||3||39||SCREENING|1971-02-28|1960-03-05|||||1964-03-09||1963-09-03
TRIAL STUDY 134XCP|IS|275DC6A6-598C-4997-A442-4A3916AC42BD||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UU/L|||||U/G/DAY||||HIGH|NOT DONE|||DISCHARGE|CALCIFIED|U|THIN SMEAR|Y|NA|Y||4||88||CONTINUATION TREATMENT|1960-05-04|1960-11-18|||||1970-04-17||1969-07-07
TRIAL STUDY 134XCP|IS|275DC6A6-598C-4997-A442-4A3916AC42BD||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^3/HPF|||||MM/MIN||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|DRIED|U|OBSERVATION|U|NA|NA||5||7||CONTINUATION TREATMENT|1965-09-11|1968-05-17|||||1964-10-08||1973-03-28
TRIAL STUDY 134XCP|IS|B949F90F-524D-4494-A63C-A05F56421EA1||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UMOL/KG/MIN|||||NEWTON||||HIGH|NOT DONE|||CERUMEN|REFRIGERATED|Y|LYMPHANGIOGRAPHY|U|NA|Y||1||38||WASHOUT|1970-07-24|1972-07-16|||||1966-11-06||1969-11-29
TRIAL STUDY 134XCP|IS|B949F90F-524D-4494-A63C-A05F56421EA1||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KIT|||||EID 50/ML||||LOW|NOT DONE|||SEMINAL FLUID|PARAFFIN-EMBEDDED|NA|DXA SCAN|U|NA|Y||2||58||OBSERVATION|1963-05-10|1960-02-07|||||1968-11-02||1970-05-26
TRIAL STUDY 134XCP|IS|B949F90F-524D-4494-A63C-A05F56421EA1||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BQ/KG|||||MMOL/L||||LOW|NOT DONE|||PROSTATIC FLUID|REFRIGERATED|NA|GRAM STAIN|NA|Y|NA||3||39||BLINDED TREATMENT|1964-07-20|1970-05-20|||||1969-12-12||1969-09-02
TRIAL STUDY 134XCP|IS|B949F90F-524D-4494-A63C-A05F56421EA1||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BEL|||||MIU/L||||ABNORMAL|NOT DONE|||ISOLATE|FROZEN|U|MICROSCOPY|U|Y|NA||4||88||SCREENING|1970-09-02|1965-06-20|||||1964-05-27||1960-05-28
TRIAL STUDY 134XCP|IS|B949F90F-524D-4494-A63C-A05F56421EA1||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^5/HPF|||||BAR||||LOW|NOT DONE|||PERITONEAL FLUID|SOLIDIFIED|NA|RYAN BLUE STAIN|U|Y|NA||5||7||OPEN LABEL TREATMENT|1961-05-22|1965-05-11|||||1965-02-02||1968-04-11
TRIAL STUDY 134XCP|IS|152411EA-E7DA-4230-A8A6-163C8A8C0A58||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/SEC/1.73M2|||||UMOL/MOL||||LOW|NOT DONE|||EXPIRED AIR|HEMOLYZED|U|ENDOSCOPY|NA|Y|N||1||38||FOLLOW-UP|1960-06-09|1961-05-25|||||1971-09-19||1967-02-20
TRIAL STUDY 134XCP|IS|152411EA-E7DA-4230-A8A6-163C8A8C0A58||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/WEEK|||||ML/G/DAY||||LOW|NOT DONE|||SEMEN|GELLED|N|DXA SCAN|U|N|N||2||58||RUN-IN|1969-03-08|1965-03-28|||||1960-03-08||1965-05-07
TRIAL STUDY 134XCP|IS|152411EA-E7DA-4230-A8A6-163C8A8C0A58||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KS|||||BE/ML||||ABNORMAL|NOT DONE|||PLATELET POOR PLASMA|UNEXPECTED ODOR|N|PHOTOMETRY|N|Y|Y||3||39||BASELINE|1970-05-12|1966-12-30|||||1964-09-13||1973-07-01
TRIAL STUDY 134XCP|IS|152411EA-E7DA-4230-A8A6-163C8A8C0A58||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/H|||||UG/MOL||||NORMAL|NOT DONE|||MUSCLE TISSUE|AUTOLYZED|U|ROMANOWSKY STAIN|NA|NA|N||4||88||WASHOUT|1971-01-09|1962-06-14|||||1966-09-03||1971-11-11
TRIAL STUDY 134XCP|IS|152411EA-E7DA-4230-A8A6-163C8A8C0A58||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ABSORBANCE U|||||/CMH2O||||LOW|NOT DONE|||EXUDATE|PARAFFIN-EMBEDDED|U|SEQUENCING|Y|Y|Y||5||7||SCREENING|1965-11-01|1962-07-05|||||1968-07-25||1961-04-25
TRIAL STUDY 134XCP|IS|AB78662C-F90A-4193-9AC7-5621B497A18F||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||S^-1(%O2)^-1|||||CFU/ML||||HIGH|NOT DONE|||EPIDERMAL TISSUE|CONCENTRATED|N|LC/MS/MS|U|NA|Y||1||38||OPEN LABEL TREATMENT|1963-12-09|1972-05-20|||||1965-11-04||1968-07-18
TRIAL STUDY 134XCP|IS|AB78662C-F90A-4193-9AC7-5621B497A18F||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/L FEU|||||KM/H||||HIGH|NOT DONE|||SKELETAL MUSCLE TISSUE|HEMOLYZED|N|GC/MS-CI|Y|NA|NA||2||58||BASELINE|1971-08-18|1963-04-04|||||1973-06-08||1973-08-10
TRIAL STUDY 134XCP|IS|AB78662C-F90A-4193-9AC7-5621B497A18F||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BOTTLE|||||10^12 IU/L||||HIGH|NOT DONE|||ERYTHROCYTES|FROZEN|U|PANENDOSCOPY|U|NA|U||3||39||WASHOUT|1967-09-05|1967-09-27|||||1970-12-07||1962-06-17
TRIAL STUDY 134XCP|IS|AB78662C-F90A-4193-9AC7-5621B497A18F||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/ML|||||M/SEC2||||LOW|NOT DONE|||AQUEOUS HUMOR|UNEXPECTED ODOR|Y|KNEMOMETRY|Y|Y|U||4||88||LONG-TERM FOLLOW-UP|1960-11-13|1960-01-08|||||1961-10-16||1970-02-16
TRIAL STUDY 134XCP|IS|AB78662C-F90A-4193-9AC7-5621B497A18F||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/KG|||||L||||ABNORMAL|NOT DONE|||BREAST MILK|GELLED|N|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NA|NA|NA||5||7||TREATMENT|1964-07-12|1968-03-17|||||1961-06-05||1973-02-04
TRIAL STUDY 134XCP|IS|84CD31FD-BCB9-4439-84F7-11C63D578108||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/UL|||||ATM||||HIGH|NOT DONE|||CERUMEN|LIPEMIC|U|ACCELERATOR MASS SPECTROMETRY|Y|N|Y||1||38||OPEN LABEL TREATMENT|1965-10-24|1964-08-27|||||1967-11-30||1963-05-27
TRIAL STUDY 134XCP|IS|84CD31FD-BCB9-4439-84F7-11C63D578108||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/MONTH|||||UG/H||||LOW|NOT DONE|||PERSPIRATION|SOLIDIFIED|N|IN VITRO GENE EXPRESSION ASSAY|NA|N|U||2||58||TREATMENT|1965-04-28|1973-03-27|||||1968-05-28||1964-06-06
TRIAL STUDY 134XCP|IS|84CD31FD-BCB9-4439-84F7-11C63D578108||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^7 PFU|||||ABSORBANCE U||||HIGH|NOT DONE|||EXUDATE|AGGLUTINATED|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|NA|U||3||39||TREATMENT|1965-02-10|1972-02-16|||||1973-05-10||1965-02-27
TRIAL STUDY 134XCP|IS|84CD31FD-BCB9-4439-84F7-11C63D578108||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/100G/MIN|||||BQ||||ABNORMAL|NOT DONE|||BONE|ICTERIC|Y|HIGH RESOLUTION CT|N|N|U||4||88||LONG-TERM FOLLOW-UP|1969-12-14|1967-08-30|||||1962-10-01||1968-11-27
TRIAL STUDY 134XCP|IS|84CD31FD-BCB9-4439-84F7-11C63D578108||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||P|||||10^3 ORGANISMS/ML||||HIGH|NOT DONE|||EXUDATE|CLOTTED|U|DIFFUSION TENSOR MRI|NA|U|U||5||7||INDUCTION TREATMENT|1968-05-26|1961-05-01|||||1960-05-02||1966-09-24
TRIAL STUDY 134XCP|IS|BB9A976D-48AC-4618-9BA1-683D97240F2B||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/MM2|||||% INHIBITION||||HIGH|NOT DONE|||PLEURAL TISSUE|THAWED|U|CELL OF ORIGIN ASSAY|U|NA|NA||1||38||CONTINUATION TREATMENT|1960-11-16|1968-08-09|||||1967-03-05||1971-12-06
TRIAL STUDY 134XCP|IS|BB9A976D-48AC-4618-9BA1-683D97240F2B||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/L DDU|||||G/G||||LOW|NOT DONE|||MONOCYTE|CONCENTRATED|N|OSCILLOMETRY|N|NA|N||2||58||OBSERVATION|1971-06-16|1970-12-13|||||1972-06-21||1971-10-07
TRIAL STUDY 134XCP|IS|BB9A976D-48AC-4618-9BA1-683D97240F2B||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MPS U|||||GBQ/MG||||LOW|NOT DONE|||VENOUS CORD BLOOD|CALCIFIED|U|CONTRAST ENHANCED CT SCAN|NA|NA|U||3||39||BLINDED TREATMENT|1971-01-22|1965-04-12|||||1968-11-02||1965-01-13
TRIAL STUDY 134XCP|IS|BB9A976D-48AC-4618-9BA1-683D97240F2B||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/DAY|||||CPM||||NORMAL|NOT DONE|||PLEURAL FLUID|REFRIGERATED|Y|AGAR DILUTION|NA|N|N||4||88||SCREENING|1972-10-11|1962-07-25|||||1963-10-21||1962-03-03
TRIAL STUDY 134XCP|IS|BB9A976D-48AC-4618-9BA1-683D97240F2B||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||USP U|||||OSM||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|REFRIGERATED|NA|SLIT LAMP|NA|Y|NA||5||7||CONTINUATION TREATMENT|1972-08-15|1970-08-04|||||1964-03-29||1961-11-08
TRIAL STUDY 134XCP|IS|FA440C9B-0D7A-4656-BF17-D46289567FB0||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||BAR|||||UG/KG||||LOW|NOT DONE|||BASAL TEAR|CONCENTRATED|U|TURBIDIMETRY|Y|NA|NA||1||38||CONTINUATION TREATMENT|1963-07-30|1968-12-18|||||1963-01-14||1967-05-23
TRIAL STUDY 134XCP|IS|FA440C9B-0D7A-4656-BF17-D46289567FB0||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||CAN|||||CAN||||LOW|NOT DONE|||SUPERNATANT, SERUM|THAWED|N|RADIATION DOSIMETRY|NA|U|U||2||58||RUN-IN|1973-03-11|1964-05-15|||||1970-01-07||1969-03-09
TRIAL STUDY 134XCP|IS|FA440C9B-0D7A-4656-BF17-D46289567FB0||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 ORGANISMS/G|||||GENEQ||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|LACTESCENT|N|IMPULSE OSCILLOMETRY|NA|U|NA||3||39||INDUCTION TREATMENT|1961-01-21|1964-08-06|||||1968-11-15||1973-07-18
TRIAL STUDY 134XCP|IS|FA440C9B-0D7A-4656-BF17-D46289567FB0||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MAMP|||||S/H||||ABNORMAL|NOT DONE|||DERMAL TISSUE|AUTOLYZED|N|LINE PROBE ASSAY|NA|U|NA||4||88||TREATMENT|1961-07-28|1963-06-30|||||1963-02-12||1961-11-18
TRIAL STUDY 134XCP|IS|FA440C9B-0D7A-4656-BF17-D46289567FB0||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U.CARR|||||UG/KG||||ABNORMAL|NOT DONE|||CELL PELLET|LIPEMIC|NA|GIEMSA STAIN|Y|NA|N||5||7||RUN-IN|1961-06-23|1969-06-28|||||1972-08-02||1968-01-05
TRIAL STUDY 134XCP|IS|1706BA4E-D2AB-4877-974A-17BDBD834FFF||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||HEP|||||CI/G||||LOW|NOT DONE|||DISCHARGE|CLOTTED|Y|ENZYMATIC COLORIMETRY|NA|Y|U||1||38||INDUCTION TREATMENT|1967-03-07|1964-02-05|||||1966-11-15||1965-06-02
TRIAL STUDY 134XCP|IS|1706BA4E-D2AB-4877-974A-17BDBD834FFF||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NMOL/L|||||KS||||NORMAL|NOT DONE|||SEMINAL FLUID|CALCIFIED|N|VIRUS PLAQUE ASSAY|Y|U|Y||2||58||RUN-IN|1964-03-13|1963-01-20|||||1967-03-26||1964-03-02
TRIAL STUDY 134XCP|IS|1706BA4E-D2AB-4877-974A-17BDBD834FFF||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MMHG/L/MIN|||||ROENTGEN||||HIGH|NOT DONE|||TISSUE|FROZEN|N|ROMANOWSKY STAIN|U|NA|Y||3||39||INDUCTION TREATMENT|1968-12-13|1967-03-05|||||1971-03-11||1965-03-22
TRIAL STUDY 134XCP|IS|1706BA4E-D2AB-4877-974A-17BDBD834FFF||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||APL U/ML|||||CMH2O*S/ML||||NORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|CLOTTED|N|PHYSICAL EXAMINATION|NA|N|Y||4||88||WASHOUT|1972-07-26|1970-03-10|||||1964-10-31||1969-08-26
TRIAL STUDY 134XCP|IS|1706BA4E-D2AB-4877-974A-17BDBD834FFF||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||EQ|||||MG||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|REFRIGERATED|NA|ICP-MS|U|Y|NA||5||7||SCREENING|1970-02-21|1967-06-22|||||1963-08-28||1972-11-13
TRIAL STUDY 134XCP|IS|15E3DD06-7F28-499B-9CF5-6EE5875095B5||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 ORGANISMS/G|||||VIAL||||NORMAL|NOT DONE|||BONE MARROW|FROZEN|U|MICROBIAL BIOCHEMICAL IDENTIFICATION|N|NA|NA||1||38||BLINDED TREATMENT|1966-03-02|1969-04-11|||||1965-10-10||1966-10-01
TRIAL STUDY 134XCP|IS|15E3DD06-7F28-499B-9CF5-6EE5875095B5||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||HR/DAY|||||LOG10 ELISA UNIT||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|Y|LANDOLT RING|N|U|NA||2||58||WASHOUT|1964-10-03|1960-07-15|||||1971-02-05||1969-10-02
TRIAL STUDY 134XCP|IS|15E3DD06-7F28-499B-9CF5-6EE5875095B5||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PLUG|||||DB||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|ROOM TEMPERATURE|U|TOTAL BODY IRRADIATION|NA|Y|N||3||39||WASHOUT|1967-12-04|1962-05-25|||||1964-12-04||1968-08-29
TRIAL STUDY 134XCP|IS|15E3DD06-7F28-499B-9CF5-6EE5875095B5||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||VP/DOSE|||||MG/KG/WEEK||||ABNORMAL|NOT DONE|||LOCHIA|NON-HEMOLYZED|U|DARK FIELD MICROSCOPY|N|NA|NA||4||88||LONG-TERM FOLLOW-UP|1964-12-23|1968-05-16|||||1969-07-13||1965-08-15
TRIAL STUDY 134XCP|IS|15E3DD06-7F28-499B-9CF5-6EE5875095B5||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BAR|||||U/L||||HIGH|NOT DONE|||MENSTRUAL BLOOD|GELLED|N|CONTRAST ENHANCED CT SCAN|U|NA|NA||5||7||CONTINUATION TREATMENT|1960-11-23|1966-05-30|||||1966-12-28||1970-11-02
TRIAL STUDY 134XCP|IS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MM/2H|||||GBQ/UG||||HIGH|NOT DONE|||PLATELET RICH PLASMA|FRESH|U|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|N|Y||1||38||LONG-TERM FOLLOW-UP|1965-10-06|1961-03-09|||||1961-09-08||1960-11-21
TRIAL STUDY 134XCP|IS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||SCOOPFUL|||||DROP||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|AUTOLYZED|N|KNEMOMETRY|NA|Y|N||2||58||SCREENING|1972-05-08|1966-01-26|||||1961-02-09||1966-01-10
TRIAL STUDY 134XCP|IS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TRACE|||||BQ/UL||||HIGH|NOT DONE|||URINE SEDIMENT|GELLED|N|AUTOMATED COUNT|Y|Y|NA||3||39||RUN-IN|1963-02-11|1972-05-24|||||1970-06-20||1969-08-16
TRIAL STUDY 134XCP|IS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^5/HPF|||||SCM||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|SOLIDIFIED|NA|ANGIOGRAPHY|N|NA|U||4||88||OPEN LABEL TREATMENT|1960-04-27|1970-05-06|||||1972-02-04||1971-01-15
TRIAL STUDY 134XCP|IS|D6201F20-A9DD-4F72-9FB2-9F238819A0BD||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MEQ/L|||||MPL U/ML||||ABNORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|THAWED|N|TRANSTHORACIC ECHOCARDIOGRAPHY|N|U|N||5||7||FOLLOW-UP|1962-10-08|1961-06-20|||||1963-03-27||1968-02-15
TRIAL STUDY 134XCP|IS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||SQU/ML|||||LOG10 CFU/ML||||HIGH|NOT DONE|||EPIDERMAL TISSUE|AUTOLYZED|N|IMMUNOFLUORESCENT STAIN|NA|Y|Y||1||38||FOLLOW-UP|1971-10-15|1972-02-27|||||1961-03-18||1966-04-24
TRIAL STUDY 134XCP|IS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DPM|||||/H||||LOW|NOT DONE|||CAPILLARY BLOOD|LIPEMIC|U|WEBER GREEN STAIN|Y|NA|Y||2||58||CONTINUATION TREATMENT|1971-09-25|1969-06-21|||||1966-07-10||1964-08-31
TRIAL STUDY 134XCP|IS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CAPLET|||||INHALATION||||HIGH|NOT DONE|||KERATINOCYTE|THAWED|Y|ANTIMICROBIAL COMBINATION TESTING|U|Y|NA||3||39||RUN-IN|1967-03-22|1971-01-28|||||1968-11-20||1964-08-12
TRIAL STUDY 134XCP|IS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G/ANIMAL/DAY|||||10^9 ORGANISMS/G||||NORMAL|NOT DONE|||VENOUS BLOOD|THAWED|U|PH METER MEASUREMENT METHOD|N|NA|NA||4||88||BASELINE|1968-01-10|1973-05-30|||||1969-08-26||1969-09-05
TRIAL STUDY 134XCP|IS|787ADEF3-A20C-4977-A06E-1A4BE008C3AB||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CS|||||PRESSOR UNITS||||ABNORMAL|NOT DONE|||REFLEX TEAR|LIPEMIC|Y|NO INFORMATION|N|NA|U||5||7||LONG-TERM FOLLOW-UP|1970-11-05|1970-01-06|||||1962-03-19||1968-02-10
TRIAL STUDY 134XCP|IS|87ED1C08-AF47-4827-A897-E8FC24A69ECC||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KBQ|||||CI/UL||||HIGH|NOT DONE|||VENOUS CORD BLOOD|LACTESCENT|NA|SCANNING ELECTRON MICROSCOPY|U|NA|U||1||38||LONG-TERM FOLLOW-UP|1967-05-31|1971-03-24|||||1971-11-25||1970-09-19
TRIAL STUDY 134XCP|IS|87ED1C08-AF47-4827-A897-E8FC24A69ECC||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UV*SEC|||||ML/BREATH||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|REFRIGERATED|Y|NO INFORMATION|N|U|NA||2||58||RUN-IN|1973-01-17|1962-04-02|||||1973-06-07||1968-07-27
TRIAL STUDY 134XCP|IS|87ED1C08-AF47-4827-A897-E8FC24A69ECC||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KCAL/DAY|||||MGEQ||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|U|IHC|NA|U|N||3||39||BLINDED TREATMENT|1961-09-23|1968-10-09|||||1962-08-04||1972-06-01
TRIAL STUDY 134XCP|IS|87ED1C08-AF47-4827-A897-E8FC24A69ECC||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||SQU/ML|||||M3||||NORMAL|NOT DONE|||EMOTIONAL TEAR|CALCIFIED|U|PHYSICAL EXAMINATION|U|Y|NA||4||88||OPEN LABEL TREATMENT|1963-03-28|1967-10-20|||||1969-10-14||1969-06-06
TRIAL STUDY 134XCP|IS|87ED1C08-AF47-4827-A897-E8FC24A69ECC||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UG/M2/H|||||BQ/KG||||NORMAL|NOT DONE|||PLEURAL TISSUE|LIPEMIC|Y|FLUORESCENT SPOT TEST|NA|U|U||5||7||INDUCTION TREATMENT|1961-07-06|1972-11-21|||||1961-09-07||1960-09-02
TRIAL STUDY 134XCP|IS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^3 CFU|||||ML/ANIMAL/DAY||||LOW|NOT DONE|||ADIPOSE TISSUE|CLOTTED|NA|SPECTROPHOTOMETRY|NA|NA|NA||1||38||TREATMENT|1973-05-12|1967-03-23|||||1965-04-05||1970-10-03
TRIAL STUDY 134XCP|IS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^9/L|||||FRACTION OF 1||||LOW|NOT DONE|||PERSPIRATION|LIPEMIC|U|CONTRAST ENHANCED MRI|N|NA|U||2||58||INDUCTION TREATMENT|1973-05-24|1973-08-12|||||1972-09-27||1967-02-20
TRIAL STUDY 134XCP|IS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U/MMOL|||||MMOL2/L2||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|ICTERIC|NA|TEST STRIP|N|NA|NA||3||39||OPEN LABEL TREATMENT|1970-02-17|1963-11-27|||||1968-05-29||1971-01-30
TRIAL STUDY 134XCP|IS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^5/L|||||CFU/ML||||LOW|NOT DONE|||EXHALED BREATH CONDENSATE|FROZEN|U|BIOPSY|U|NA|Y||4||88||BLINDED TREATMENT|1967-09-03|1963-12-22|||||1972-05-21||1969-08-02
TRIAL STUDY 134XCP|IS|47389FD4-FB17-4BD9-9B08-0F2C6FF60D9A||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PIXELS/IN|||||ML/MIN/MMHG||||LOW|NOT DONE|||RETICULOCYTES|HEMOLYZED|U|MICRONEUTRALIZATION ASSAY|NA|N|Y||5||7||BASELINE|1972-10-24|1972-12-01|||||1967-07-03||1961-06-17
TRIAL STUDY 134XCP|IS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BQ/G|||||NG/MOL||||ABNORMAL|NOT DONE|||MECONIUM|AGGLUTINATED|U|ELECTROCHEMILUMINESCENCE|NA|Y|Y||1||38||FOLLOW-UP|1962-09-19|1973-04-28|||||1968-10-20||1973-01-01
TRIAL STUDY 134XCP|IS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UMOL/L/SEC|||||U/KG||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|UNEXPECTED ODOR|NA|HPLC|Y|NA|NA||2||58||INDUCTION TREATMENT|1964-11-29|1964-07-20|||||1960-08-22||1968-02-03
TRIAL STUDY 134XCP|IS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACKET|||||CI/L||||NORMAL|NOT DONE|||DIALYSIS FLUID|UNEXPECTED ODOR|Y|KNEMOMETRY|Y|Y|Y||3||39||RUN-IN|1965-11-20|1962-12-03|||||1970-09-21||1968-07-16
TRIAL STUDY 134XCP|IS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||OD UNIT|||||APL U||||NORMAL|NOT DONE|||INFRANATANT, SERUM|FRESH|NA|LINE PROBE ASSAY|NA|Y|N||4||88||BLINDED TREATMENT|1971-05-02|1966-03-16|||||1965-07-21||1970-01-21
TRIAL STUDY 134XCP|IS|719A3C37-C9C2-4A84-BEC2-CE3033AB5D2F||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DPM/MG|||||NKAT/L||||HIGH|NOT DONE|||INFRANATANT, SERUM|CONCENTRATED|Y|LASER CAPTURE MICRODISSECTION|Y|N|Y||5||7||BLINDED TREATMENT|1965-03-03|1967-12-24|||||1973-03-22||1962-11-30
TRIAL STUDY 134XCP|IS|C817A043-1331-47AB-A627-D85893F9D61A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UEQ|||||LOG10 CCID 50/DOSE||||HIGH|NOT DONE|||BASAL TEAR|THAWED|U|PELLI-ROBSON EYE CHART|NA|Y|Y||1||38||BASELINE|1966-05-11|1970-06-22|||||1967-07-23||1971-12-17
TRIAL STUDY 134XCP|IS|C817A043-1331-47AB-A627-D85893F9D61A||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/MIN/MMHG|||||10^12/L||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|UNEXPECTED ODOR|NA|WRIGHT-GIEMSA STAIN|Y|N|Y||2||58||LONG-TERM FOLLOW-UP|1966-12-25|1966-05-07|||||1964-08-29||1966-02-26
TRIAL STUDY 134XCP|IS|C817A043-1331-47AB-A627-D85893F9D61A||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/H|||||STEPS/MIN||||LOW|NOT DONE|||FLUID|SOLIDIFIED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|U|NA|N||3||39||SCREENING|1968-04-02|1960-09-21|||||1971-09-23||1965-07-05
TRIAL STUDY 134XCP|IS|C817A043-1331-47AB-A627-D85893F9D61A||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||SFC/10^6 PBMC|||||PKAT||||NORMAL|NOT DONE|||EXUDATE|CONTAMINATED|U|ENDOSCOPY|NA|U|U||4||88||SCREENING|1965-11-22|1964-12-22|||||1971-02-18||1967-06-05
TRIAL STUDY 134XCP|IS|C817A043-1331-47AB-A627-D85893F9D61A||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PA|||||UIU/DL||||LOW|NOT DONE|||VENOUS BLOOD|FRESH|U|HPLC/MS/MS|N|Y|N||5||7||SCREENING|1972-09-04|1963-07-07|||||1963-12-16||1967-03-31
TRIAL STUDY 134XCP|IS|DDD6F5D1-AE97-412C-A161-869C4178223A||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PG/DL|||||MEQ/DL||||HIGH|NOT DONE|||KERATINOCYTE|HEMOLYZED|N|EEG|N|U|Y||1||38||BASELINE|1969-11-07|1968-11-30|||||1967-01-19||1962-12-27
TRIAL STUDY 134XCP|IS|DDD6F5D1-AE97-412C-A161-869C4178223A||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ANSON U|||||UG/L||||HIGH|NOT DONE|||ERYTHROCYTES|LIPEMIC|Y|DUCTOGRAPHY|U|NA|Y||2||58||CONTINUATION TREATMENT|1968-04-13|1970-06-28|||||1962-08-05||1973-02-11
TRIAL STUDY 134XCP|IS|DDD6F5D1-AE97-412C-A161-869C4178223A||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/G|||||%||||LOW|NOT DONE|||PLEURAL TISSUE|LACTESCENT|N|HPLC-FL|NA|N|N||3||39||BASELINE|1964-11-23|1972-01-29|||||1969-10-26||1963-12-01
TRIAL STUDY 134XCP|IS|DDD6F5D1-AE97-412C-A161-869C4178223A||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||TESLA|||||ML/MIN||||ABNORMAL|NOT DONE|||EXPIRED AIR|CLOTTED|NA|ROMANOWSKY STAIN|N|U|NA||4||88||TREATMENT|1963-08-20|1969-08-06|||||1970-09-16||1963-05-12
TRIAL STUDY 134XCP|IS|DDD6F5D1-AE97-412C-A161-869C4178223A||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PMOL/L/H|||||BU/ML||||HIGH|NOT DONE|||CAPILLARY BLOOD|LIPEMIC|U|FUNDUS PHOTOGRAPHY|U|NA|N||5||7||CONTINUATION TREATMENT|1973-07-15|1960-06-12|||||1965-08-18||1961-01-28
TRIAL STUDY 134XCP|IS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||EID 50/DOSE|||||ANTI-XA IU||||NORMAL|NOT DONE|||CELL PELLET|CLOTTED|N|NEXT GENERATION TARGETED SEQUENCING|Y|N|Y||1||38||LONG-TERM FOLLOW-UP|1960-04-01|1968-09-22|||||1973-07-19||1966-10-15
TRIAL STUDY 134XCP|IS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||G/ANIMAL/WK|||||CD*S/M2||||ABNORMAL|NOT DONE|||CERUMEN|NON-HEMOLYZED|NA|URANYL ACETATE STAIN|Y|Y|Y||2||58||BASELINE|1965-07-30|1972-03-26|||||1961-06-26||1966-03-28
TRIAL STUDY 134XCP|IS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ANTIBODY UNIT|||||PPTH||||ABNORMAL|NOT DONE|||GASTRIC FLUID|UNEXPECTED ODOR|Y|PERIPHERAL ANGIOGRAPHY|U|N|U||3||39||SCREENING|1960-02-29|1973-08-13|||||1973-03-31||1961-11-30
TRIAL STUDY 134XCP|IS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MG/ANIMAL|||||UV2||||HIGH|NOT DONE|||BUFFY COAT|ICTERIC|U|WESTERN BLOT|NA|U|NA||4||88||BLINDED TREATMENT|1968-07-05|1961-12-09|||||1966-08-07||1968-09-02
TRIAL STUDY 134XCP|IS|D41D9F0A-56BF-46E5-A936-3B4AD5210C18||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 COPIES/ML|||||V||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|HEMOLYZED|Y|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|NA|NA||5||7||CONTINUATION TREATMENT|1963-12-20|1965-11-17|||||1966-01-07||1961-12-25
TRIAL STUDY 134XCP|IS|25FB07EA-3CB8-430D-B775-CA0E9918C069||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^8/L|||||ML/DAY||||HIGH|NOT DONE|||HAIR|AUTOLYZED|NA|BIOIMPEDANCE SPECTROSCOPY|Y|N|NA||1||38||INDUCTION TREATMENT|1971-04-01|1963-05-19|||||1970-09-01||1967-04-09
TRIAL STUDY 134XCP|IS|25FB07EA-3CB8-430D-B775-CA0E9918C069||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||V/SEC|||||LOG10 COPIES/ML||||ABNORMAL|NOT DONE|||SEMEN|PARAFFIN-EMBEDDED|N|MICROBIAL CONCENTRATION|Y|Y|U||2||58||FOLLOW-UP|1961-07-18|1966-08-03|||||1964-07-01||1964-02-19
TRIAL STUDY 134XCP|IS|25FB07EA-3CB8-430D-B775-CA0E9918C069||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||CCID 50/ML||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|HEMOLYZED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|NA|Y|N||3||39||INDUCTION TREATMENT|1967-08-15|1966-09-09|||||1960-01-25||1962-04-10
TRIAL STUDY 134XCP|IS|25FB07EA-3CB8-430D-B775-CA0E9918C069||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||COPIES/ML|||||PPB||||LOW|NOT DONE|||VITREOUS HUMOR|NON-HEMOLYZED|N|DNA MICROARRAY|N|U|N||4||88||LONG-TERM FOLLOW-UP|1970-05-05|1970-05-20|||||1964-03-12||1967-11-24
TRIAL STUDY 134XCP|IS|25FB07EA-3CB8-430D-B775-CA0E9918C069||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CD*S/M2|||||G/CAGE||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|GELLED|U|MICROSCOPY|U|Y|NA||5||7||LONG-TERM FOLLOW-UP|1972-01-02|1973-04-06|||||1965-09-25||1964-01-21
TRIAL STUDY 134XCP|IS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||FARAD|||||MPH||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|THAWED|Y|HPLC/MS|Y|Y|Y||1||38||LONG-TERM FOLLOW-UP|1971-09-27|1963-12-06|||||1960-01-11||1962-07-05
TRIAL STUDY 134XCP|IS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/MMHG/MIN/L|||||UMOL/DAY||||LOW|NOT DONE|||SKELETAL MUSCLE TISSUE|LACTESCENT|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|U|Y|NA||2||58||INDUCTION TREATMENT|1970-08-31|1967-11-15|||||1972-02-28||1960-12-07
TRIAL STUDY 134XCP|IS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^6 RNA COPIES/ML|||||UKAT/L||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|AGGLUTINATED|N|MICROPARTICLE ENZYME IMMUNOASSAY|U|N|NA||3||39||WASHOUT|1965-08-26|1963-02-20|||||1969-06-04||1970-11-11
TRIAL STUDY 134XCP|IS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/MG|||||HOURS||||ABNORMAL|NOT DONE|||URINE SEDIMENT|GELLED|Y|IMMUNODIFFUSION|Y|N|U||4||88||RUN-IN|1971-02-01|1965-08-27|||||1970-12-03||1973-02-22
TRIAL STUDY 134XCP|IS|21F6CB0B-3483-4BFF-AEC7-FCF14873077A||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NU/CL|||||HPA||||ABNORMAL|NOT DONE|||DISCHARGE|AUTOLYZED|U|LIGHT SCATTERING SPECTROSCOPY|N|NA|U||5||7||LONG-TERM FOLLOW-UP|1970-12-11|1960-12-24|||||1965-12-26||1969-01-20
TRIAL STUDY 134XCP|IS|B49B9695-9815-4B7B-9F96-4EE6A4432062||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||M/SEC|||||ML/DOSE||||ABNORMAL|NOT DONE|||LEUKOCYTE|FRESH|U|CORONARY ANGIOGRAPHY|N|U|Y||1||38||INDUCTION TREATMENT|1967-01-12|1961-12-05|||||1973-05-20||1973-06-06
TRIAL STUDY 134XCP|IS|B49B9695-9815-4B7B-9F96-4EE6A4432062||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||NMOL/MOL|||||PKAT/L||||NORMAL|NOT DONE|||ALVEOLAR AIR|DRIED|NA|HPLC-UV|Y|Y|Y||2||58||OBSERVATION|1964-02-17|1972-11-11|||||1968-10-03||1967-12-06
TRIAL STUDY 134XCP|IS|B49B9695-9815-4B7B-9F96-4EE6A4432062||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^3 DNA COPIES/ML|||||G/U||||NORMAL|NOT DONE|||URINE SEDIMENT|PARAFFIN-EMBEDDED|U|OPTICAL COHERENCE TOMOGRAPHY|Y|U|U||3||39||OPEN LABEL TREATMENT|1963-08-24|1968-04-14|||||1973-02-02||1972-03-21
TRIAL STUDY 134XCP|IS|B49B9695-9815-4B7B-9F96-4EE6A4432062||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CL|||||10^6 CFU/ML||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|ROOM TEMPERATURE|NA|PHOTOGRAPHY|Y|N|N||4||88||CONTINUATION TREATMENT|1970-03-06|1968-09-27|||||1970-09-12||1970-10-20
TRIAL STUDY 134XCP|IS|B49B9695-9815-4B7B-9F96-4EE6A4432062||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IMPLANT|||||10^6 ORGANISMS/MG||||ABNORMAL|NOT DONE|||VENOUS PLASMA|REFRIGERATED|U|THIN SMEAR|U|N|U||5||7||INDUCTION TREATMENT|1967-10-23|1963-09-26|||||1967-06-07||1968-04-03
TRIAL STUDY 134XCP|IS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TAMPON|||||DPM/ML||||LOW|NOT DONE|||LYSATE|ROOM TEMPERATURE|Y|PALPATION|N|N|Y||1||38||BLINDED TREATMENT|1969-04-26|1973-07-13|||||1962-10-29||1972-02-22
TRIAL STUDY 134XCP|IS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||SHOCK WAVE|||||PFU/DOSE||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|SOLIDIFIED|N|PHYSICAL EXAMINATION|U|Y|U||2||58||OPEN LABEL TREATMENT|1967-09-25|1970-09-12|||||1963-07-11||1973-06-21
TRIAL STUDY 134XCP|IS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||LENS|||||CM/S||||HIGH|NOT DONE|||CORD SERUM|AUTOLYZED|NA|WESTERN BLOT|N|U|N||3||39||FOLLOW-UP|1965-12-02|1963-01-02|||||1963-06-28||1961-08-04
TRIAL STUDY 134XCP|IS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MN|||||FMOL||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|LACTESCENT|Y|IMMUNO-PET SCAN|N|U|U||4||88||OPEN LABEL TREATMENT|1960-08-01|1964-12-16|||||1961-11-17||1962-06-18
TRIAL STUDY 134XCP|IS|E1A56CAC-35A4-4EC1-8F3C-8E117E667D44||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||VP/ML|||||UCI/KG||||NORMAL|NOT DONE|||EXUDATE|PARAFFIN-EMBEDDED|N|CONTRAST ENHANCED MRI|Y|U|N||5||7||FOLLOW-UP|1960-08-05|1965-12-13|||||1960-12-11||1969-03-22
TRIAL STUDY 134XCP|IS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL|||||1/(S*KPA)||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|LIPEMIC|U|BAC ACGH|U|Y|U||1||38||TREATMENT|1966-01-23|1971-07-10|||||1965-08-07||1967-07-21
TRIAL STUDY 134XCP|IS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MOL/ML|||||U/M2||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|CALCIFIED|U|RADIOIMMUNOPRECIPITATION ASSAY|N|U|NA||2||58||WASHOUT|1973-03-30|1967-02-09|||||1963-08-20||1969-08-24
TRIAL STUDY 134XCP|IS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CIGAR|||||WEBER||||HIGH|NOT DONE|||CORD BLOOD|AUTOLYZED|N|IMMUNE REPERTOIRE DEEP SEQUENCING|U|U|Y||3||39||LONG-TERM FOLLOW-UP|1968-07-25|1966-08-09|||||1961-08-11||1970-02-17
TRIAL STUDY 134XCP|IS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/BEAT|||||UG/DL||||ABNORMAL|NOT DONE|||MECONIUM|PARAFFIN-EMBEDDED|U|THICK SMEAR|N|Y|N||4||88||INDUCTION TREATMENT|1967-08-31|1971-05-02|||||1972-07-17||1962-01-31
TRIAL STUDY 134XCP|IS|BCA460B7-5102-41F9-BCA7-B7BC0A4A9A53||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PACKAGE|||||UG/ANIMAL||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|U|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|NA|NA|Y||5||7||LONG-TERM FOLLOW-UP|1966-05-08|1967-11-14|||||1973-05-18||1963-12-26
TRIAL STUDY 134XCP|IS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SCM|||||MS2||||NORMAL|NOT DONE|||BLOOD|LACTESCENT|U|GRAM STAIN|NA|U|N||1||38||TREATMENT|1966-09-06|1960-05-19|||||1970-04-26||1962-08-03
TRIAL STUDY 134XCP|IS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||PMOL/L|||||UMOL/MIN||||LOW|NOT DONE|||MENSTRUAL BLOOD|CONTAMINATED|Y|PERCUSSION|Y|N|U||2||58||CONTINUATION TREATMENT|1961-08-19|1965-07-15|||||1965-05-04||1962-08-02
TRIAL STUDY 134XCP|IS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FMOL/G|||||UG/M2||||ABNORMAL|NOT DONE|||CORD BLOOD|THAWED|U|ERGOSPIROMETRY|Y|U|NA||3||39||BLINDED TREATMENT|1966-04-08|1972-06-16|||||1972-10-19||1962-05-06
TRIAL STUDY 134XCP|IS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PFU|||||10^7/L||||LOW|NOT DONE|||PLEURAL FLUID|AGGLUTINATED|NA|AURAMINE STAIN|N|U|U||4||88||BASELINE|1963-05-19|1972-04-18|||||1970-12-28||1971-09-15
TRIAL STUDY 134XCP|IS|5FFAB7D3-39FC-4429-9DBA-B1A1B972708B||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU/DL|||||UGEQ/L||||HIGH|NOT DONE|||GASTRIC FLUID|REFRIGERATED|N|TELLER ACUITY CARDS|NA|N|U||5||7||OPEN LABEL TREATMENT|1971-07-07|1965-09-06|||||1970-03-01||1966-05-12
TRIAL STUDY 134XCP|IS|07A934C8-0237-4B37-9FDD-503B8BF94357||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/LSQN|||||SACHET||||LOW|NOT DONE|||INFRANATANT, SERUM|LACTESCENT|N|X-RAY FLUORESCENCE SPECTROMETRY|Y|U|Y||1||38||SCREENING|1970-06-18|1970-07-13|||||1971-01-31||1965-07-23
TRIAL STUDY 134XCP|IS|07A934C8-0237-4B37-9FDD-503B8BF94357||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/4.0 ML|||||MM/MIN||||ABNORMAL|NOT DONE|||PLATELET|AUTOLYZED|Y|ETDRS EYE CHART|N|Y|N||2||58||WASHOUT|1966-05-08|1971-09-06|||||1968-01-09||1962-08-06
TRIAL STUDY 134XCP|IS|07A934C8-0237-4B37-9FDD-503B8BF94357||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/L|||||NG||||NORMAL|NOT DONE|||URINE SEDIMENT|REFRIGERATED|N|DYNAMIC LIGHT SCATTERING|U|N|N||3||39||TREATMENT|1962-01-13|1972-04-09|||||1970-11-05||1967-07-28
TRIAL STUDY 134XCP|IS|07A934C8-0237-4B37-9FDD-503B8BF94357||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/G|||||%(V/V)||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|NON-HEMOLYZED|N|LANDOLT RING|NA|NA|NA||4||88||LONG-TERM FOLLOW-UP|1963-12-11|1972-02-28|||||1964-02-04||1964-07-05
TRIAL STUDY 134XCP|IS|07A934C8-0237-4B37-9FDD-503B8BF94357||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MEQ/DAY|||||U/KG/H||||NORMAL|NOT DONE|||HAIR FOLLICLE|GELLED|NA|HEMOCYTOMETRY|NA|NA|U||5||7||OPEN LABEL TREATMENT|1961-01-30|1962-12-30|||||1964-05-05||1967-09-20
TRIAL STUDY 134XCP|IS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||HOUNSFIELD UNIT|||||10^3 ORGANISMS||||HIGH|NOT DONE|||DIALYSIS FLUID, PERITONEAL|AGGLUTINATED|Y|NON-INVASIVE DIELECTRIC SENSING|U|U|Y||1||38||FOLLOW-UP|1963-11-28|1973-07-13|||||1968-09-26||1966-06-23
TRIAL STUDY 134XCP|IS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CM/MIN|||||PL||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|AGGLUTINATED|N|MICROBIAL CULTURE, SOLID|N|U|Y||2||58||OPEN LABEL TREATMENT|1970-12-24|1969-01-24|||||1971-08-27||1972-09-21
TRIAL STUDY 134XCP|IS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||FMOL/G|||||FFU||||NORMAL|NOT DONE|||BONE MARROW|FROZEN|Y|DIFFUSION WEIGHTED MRI|NA|N|NA||3||39||BLINDED TREATMENT|1966-11-10|1968-02-22|||||1960-03-22||1972-02-07
TRIAL STUDY 134XCP|IS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DPM|||||DISK||||NORMAL|NOT DONE|||ARTERIAL BLOOD|LIPEMIC|N|DIRECT SEQUENCING|U|N|Y||4||88||BASELINE|1966-05-12|1970-01-03|||||1969-09-24||1961-06-25
TRIAL STUDY 134XCP|IS|DB1EA2BE-FBA7-4E37-8F23-3156A349D8FF||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/G|||||CI/UG||||HIGH|NOT DONE|||CAPILLARY PLASMA|ROOM TEMPERATURE|NA|IMMUNE REPERTOIRE DEEP SEQUENCING|U|NA|N||5||7||SCREENING|1966-03-18|1968-09-05|||||1971-01-17||1968-03-03
TRIAL STUDY 134XCP|IS|10E1249E-10AC-45E8-9896-84C7B0F548BC||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GRAIN|||||ML/H||||ABNORMAL|NOT DONE|||COLOSTRUM|ROOM TEMPERATURE|N|PHYSICAL EXAMINATION|U|U|U||1||38||CONTINUATION TREATMENT|1962-03-28|1964-12-04|||||1966-07-10||1961-06-22
TRIAL STUDY 134XCP|IS|10E1249E-10AC-45E8-9896-84C7B0F548BC||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||C|||||CAL||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|GELLED|NA|MODIFIED ACID FAST STAIN|NA|N|Y||2||58||OPEN LABEL TREATMENT|1970-12-21|1961-10-10|||||1971-09-14||1969-04-26
TRIAL STUDY 134XCP|IS|10E1249E-10AC-45E8-9896-84C7B0F548BC||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ABSORBANCE U/ML|||||BQ/G||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|REFRIGERATED|Y|STATIC PERIMETRY|Y|Y|U||3||39||BASELINE|1971-10-03|1967-09-13|||||1964-08-19||1961-11-30
TRIAL STUDY 134XCP|IS|10E1249E-10AC-45E8-9896-84C7B0F548BC||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/MIN|||||MMOL/G||||ABNORMAL|NOT DONE|||TISSUE|PARAFFIN-EMBEDDED|U|AUSCULTATION|NA|Y|Y||4||88||BASELINE|1968-06-11|1972-07-10|||||1973-05-25||1964-08-09
TRIAL STUDY 134XCP|IS|10E1249E-10AC-45E8-9896-84C7B0F548BC||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||GY/H|||||ELISA UNIT/DOSE||||HIGH|NOT DONE|||TRANSUDATE|ROOM TEMPERATURE|NA|EEG|N|N|N||5||7||OPEN LABEL TREATMENT|1961-02-02|1961-05-31|||||1966-10-06||1967-05-19
TRIAL STUDY 134XCP|IS|6CA97CE0-D120-4E14-A82F-4799D2699110||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GENEQ|||||UL/ML||||HIGH|NOT DONE|||LAVAGE FLUID|CONTAMINATED|NA|DXA SCAN|NA|U|N||1||38||RUN-IN|1969-01-06|1968-06-13|||||1973-09-05||1969-06-03
TRIAL STUDY 134XCP|IS|6CA97CE0-D120-4E14-A82F-4799D2699110||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FMOL/L|||||WEEKS||||HIGH|NOT DONE|||INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE|U|ANTIBIOTIC AGAR SCREEN|NA|U|N||2||58||WASHOUT|1961-10-21|1964-07-22|||||1966-01-08||1960-05-15
TRIAL STUDY 134XCP|IS|6CA97CE0-D120-4E14-A82F-4799D2699110||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^4/HPF|||||MOL/G||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|N|FLUORESCENT SPOT TEST|U|U|Y||3||39||RUN-IN|1971-07-27|1963-06-09|||||1968-12-20||1960-08-29
TRIAL STUDY 134XCP|IS|6CA97CE0-D120-4E14-A82F-4799D2699110||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^6 RNA COPIES/ML|||||10^6 RNA COPIES/ML||||HIGH|NOT DONE|||LEUKOCYTE|DRIED|U|CARDIAC THERMODILUTION|U|NA|U||4||88||LONG-TERM FOLLOW-UP|1961-01-29|1961-02-23|||||1969-03-10||1969-03-06
TRIAL STUDY 134XCP|IS|6CA97CE0-D120-4E14-A82F-4799D2699110||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U.CARR|||||KCAL||||LOW|NOT DONE|||PROSTATIC FLUID|UNEXPECTED ODOR|N|SANGER SEQUENCING|U|Y|Y||5||7||CONTINUATION TREATMENT|1973-01-23|1968-12-25|||||1962-09-11||1971-12-08
TRIAL STUDY 134XCP|IS|D807C3F6-0955-4742-A29B-815682559530||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CMHG|||||CMOL||||HIGH|NOT DONE|||ERYTHROCYTES|AGGLUTINATED|Y|SXA SCAN|N|Y|N||1||38||OBSERVATION|1964-01-15|1970-06-19|||||1964-04-21||1968-06-25
TRIAL STUDY 134XCP|IS|D807C3F6-0955-4742-A29B-815682559530||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ELISA UNIT|||||LM||||HIGH|NOT DONE|||DISCHARGE|FROZEN|Y|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|N|Y|NA||2||58||SCREENING|1963-02-07|1965-10-15|||||1964-09-29||1961-02-08
TRIAL STUDY 134XCP|IS|D807C3F6-0955-4742-A29B-815682559530||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CD*S/M2|||||MSEC||||ABNORMAL|NOT DONE|||EMESIS|HEMOLYZED|NA|DNA MICROARRAY|U|Y|N||3||39||LONG-TERM FOLLOW-UP|1967-04-30|1962-12-20|||||1966-07-04||1967-05-28
TRIAL STUDY 134XCP|IS|D807C3F6-0955-4742-A29B-815682559530||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PKAT/L|||||CD*S/M2||||ABNORMAL|NOT DONE|||NAIL|NON-HEMOLYZED|Y|MICROARRAY|NA|U|U||4||88||BLINDED TREATMENT|1963-05-06|1967-08-11|||||1966-05-12||1961-07-15
TRIAL STUDY 134XCP|IS|D807C3F6-0955-4742-A29B-815682559530||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SIEMENS|||||CMHG||||HIGH|NOT DONE|||PLASMA|CONCENTRATED|Y|CHROMATOGRAPHY|NA|NA|Y||5||7||CONTINUATION TREATMENT|1967-09-29|1965-04-15|||||1972-10-09||1966-07-20
TRIAL STUDY 134XCP|IS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||OZ|||||MM||||LOW|NOT DONE|||SPUTUM|CONCENTRATED|NA|TOTAL BODY RADIOGRAPHY|NA|U|N||1||38||TREATMENT|1973-07-10|1965-05-14|||||1968-01-08||1973-05-24
TRIAL STUDY 134XCP|IS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/M2|||||UMOL/MG/MIN||||HIGH|NOT DONE|||MUSCLE TISSUE|CLOTTED|N|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|U|Y||2||58||BASELINE|1962-10-07|1970-09-14|||||1968-09-02||1966-11-21
TRIAL STUDY 134XCP|IS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GY/H|||||YEARS||||NORMAL|NOT DONE|||INFRANATANT, PLASMA|UNEXPECTED ODOR|NA|THERMAL IONIZATION MASS SPECTROMETRY|Y|NA|N||3||39||SCREENING|1961-05-04|1964-02-09|||||1966-03-18||1969-05-14
TRIAL STUDY 134XCP|IS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SQU/ML|||||M||||HIGH|NOT DONE|||BONE MARROW|CONCENTRATED|NA|ORCHIDOMETERY|N|N|Y||4||88||BLINDED TREATMENT|1962-03-23|1968-04-02|||||1967-03-18||1960-11-20
TRIAL STUDY 134XCP|IS|EA95AD62-1630-43A0-ABA5-ADD7C2F31F75||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||M/SEC2||||HIGH|NOT DONE|||URINE|UNEXPECTED ODOR|N|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|N|N|U||5||7||SCREENING|1962-09-11|1968-11-26|||||1962-12-23||1968-02-11
TRIAL STUDY 134XCP|IS|38C36B22-EC60-4D40-A1B6-71B17F8C8625||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/KG|||||/2500 WBC||||NORMAL|NOT DONE|||VENOUS BLOOD|CALCIFIED|U|LAPAROSCOPY|N|Y|U||1||38||OBSERVATION|1973-06-20|1961-09-10|||||1970-03-28||1972-03-15
TRIAL STUDY 134XCP|IS|38C36B22-EC60-4D40-A1B6-71B17F8C8625||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6/L|||||FFU||||LOW|NOT DONE|||BREAST MILK|AUTOLYZED|Y|CLIP SEQUENCING|N|N|N||2||58||TREATMENT|1960-06-29|1961-02-24|||||1970-05-29||1964-04-30
TRIAL STUDY 134XCP|IS|38C36B22-EC60-4D40-A1B6-71B17F8C8625||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/200 HPFS|||||ML/G/DAY||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|AGGLUTINATED|N|NEXT GENERATION TARGETED SEQUENCING|Y|U|NA||3||39||CONTINUATION TREATMENT|1961-06-06|1961-11-06|||||1961-09-21||1971-08-19
TRIAL STUDY 134XCP|IS|38C36B22-EC60-4D40-A1B6-71B17F8C8625||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PIXELS/IN|||||LOG10 CFU/G||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|NA|PET/CT SCAN WITHOUT CONTRAST|Y|N|Y||4||88||OPEN LABEL TREATMENT|1966-04-08|1971-03-10|||||1973-01-07||1973-07-21
TRIAL STUDY 134XCP|IS|38C36B22-EC60-4D40-A1B6-71B17F8C8625||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/4.0 ML|||||SUPPOSITORY||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|CALCIFIED|N|CONTRAST ENHANCED X-RAY|N|Y|NA||5||7||RUN-IN|1968-12-07|1972-03-29|||||1966-06-01||1971-08-10
TRIAL STUDY 134XCP|IS|E2F4144C-543D-4F55-A94E-58F244FB21D1||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MPA|||||CUP EQ||||ABNORMAL|NOT DONE|||LEUKOCYTE|CALCIFIED|Y|RADIAL IMMUNODIFFUSION|N|Y|N||1||38||WASHOUT|1967-07-22|1970-05-19|||||1964-06-09||1960-08-13
TRIAL STUDY 134XCP|IS|E2F4144C-543D-4F55-A94E-58F244FB21D1||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/HPF|||||KPA/L/SEC||||LOW|NOT DONE|||PUS|UNEXPECTED ODOR|NA|MRI WITHOUT CONTRAST|U|NA|NA||2||58||OPEN LABEL TREATMENT|1960-09-12|1962-11-09|||||1971-10-17||1973-07-03
TRIAL STUDY 134XCP|IS|E2F4144C-543D-4F55-A94E-58F244FB21D1||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U/ML|||||MPS U||||HIGH|NOT DONE|||ARTERIAL CORD BLOOD|CONTAMINATED|N|TURBIDIMETRY|Y|NA|NA||3||39||CONTINUATION TREATMENT|1968-09-13|1972-03-26|||||1968-04-29||1962-10-28
TRIAL STUDY 134XCP|IS|E2F4144C-543D-4F55-A94E-58F244FB21D1||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PACKET|||||ELISA UNIT/ML||||ABNORMAL|NOT DONE|||LAVAGE FLUID|CALCIFIED|NA|MAMMOGRAPHY|N|N|Y||4||88||INDUCTION TREATMENT|1962-11-28|1963-03-10|||||1966-05-26||1968-05-27
TRIAL STUDY 134XCP|IS|E2F4144C-543D-4F55-A94E-58F244FB21D1||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6 DNA COPIES/ML|||||/DAY||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|THAWED|U|COULOMETRIC TITRATION|NA|NA|Y||5||7||OBSERVATION|1962-04-06|1973-06-30|||||1970-06-10||1961-03-31
TRIAL STUDY 134XCP|IS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BOTTLE|||||ML/DAY||||LOW|NOT DONE|||BONE|PARAFFIN-EMBEDDED|Y|GC/MS-EI|NA|NA|N||1||38||BLINDED TREATMENT|1964-02-15|1970-12-27|||||1962-09-03||1967-10-20
TRIAL STUDY 134XCP|IS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||APL U|||||U/KG/H||||NORMAL|NOT DONE|||CELL PELLET|FRESH|U|OPHTHALMOSCOPY|N|Y|Y||2||58||OBSERVATION|1961-08-06|1973-05-03|||||1971-06-10||1969-09-15
TRIAL STUDY 134XCP|IS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG|||||MMOL/G||||LOW|NOT DONE|||URINE SEDIMENT|CLOTTED|N|MICROBIAL BIOCHEMICAL IDENTIFICATION|NA|Y|U||3||39||OBSERVATION|1964-10-19|1968-08-22|||||1969-06-20||1965-07-14
TRIAL STUDY 134XCP|IS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GMFI|||||MG/KG||||HIGH|NOT DONE|||LOCHIA|FRESH|NA|PERCUSSION|N|NA|U||4||88||TREATMENT|1963-04-17|1963-04-08|||||1964-09-05||1964-04-11
TRIAL STUDY 134XCP|IS|CA59C4CD-E3E7-46C8-8B88-3D00E448B1D8||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||NSEC|||||UG/L||||LOW|NOT DONE|||HAIR|LACTESCENT|N|CONTRAST ENHANCED SPIRAL CT SCAN|NA|N|N||5||7||TREATMENT|1963-09-22|1972-10-15|||||1968-06-03||1965-05-12
TRIAL STUDY 134XCP|IS|49B857CF-22F2-406F-A269-54944B23C236||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||POUCH|||||ML/MIN||||HIGH|NOT DONE|||PROSTATIC FLUID|CONTAMINATED|Y|SICKLE CELL SOLUBILITY TEST|Y|N|NA||1||38||OPEN LABEL TREATMENT|1971-01-27|1967-04-14|||||1965-02-12||1967-06-03
TRIAL STUDY 134XCP|IS|49B857CF-22F2-406F-A269-54944B23C236||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PMOL/10^10 CELLS|||||10^6 CFU||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|FROZEN|NA|NON-CONTACT SPECULAR MICROSCOPY|Y|Y|U||2||58||LONG-TERM FOLLOW-UP|1966-01-13|1971-04-04|||||1963-03-15||1964-10-11
TRIAL STUDY 134XCP|IS|49B857CF-22F2-406F-A269-54944B23C236||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/M2/MIN|||||UG/DOSE||||LOW|NOT DONE|||EMESIS|LACTESCENT|NA|PHASE CONTRAST MICROSCOPY|N|Y|NA||3||39||RUN-IN|1960-12-20|1961-03-27|||||1962-08-28||1967-08-14
TRIAL STUDY 134XCP|IS|49B857CF-22F2-406F-A269-54944B23C236||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UOSM|||||MN||||HIGH|NOT DONE|||INFRANATANT, PLASMA|CALCIFIED|N|BIOIMPEDANCE SPECTROSCOPY|U|N|U||4||88||LONG-TERM FOLLOW-UP|1963-01-05|1963-11-17|||||1968-02-16||1968-07-01
TRIAL STUDY 134XCP|IS|49B857CF-22F2-406F-A269-54944B23C236||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DPM/0.5 ML|||||MOL/DAY||||NORMAL|NOT DONE|||FLUID|CLOTTED|Y|CELLULOSE TAPE|Y|Y|NA||5||7||OBSERVATION|1968-03-24|1971-04-16|||||1969-01-13||1973-02-08
TRIAL STUDY 134XCP|IS|E09B394B-9E48-4132-B430-991DF1953A81||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/H|||||NMOL BCE/NMOL||||LOW|NOT DONE|||NAIL|GELLED|U|PUPILLOMETRY|Y|NA|Y||1||38||TREATMENT|1964-01-09|1968-07-07|||||1967-06-13||1968-09-18
TRIAL STUDY 134XCP|IS|E09B394B-9E48-4132-B430-991DF1953A81||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/DAY|||||TSP||||LOW|NOT DONE|||SPUTUM|CLOTTED|Y|KINETIC MICROPARTICLE IMMUNOASSAY|N|NA|Y||2||58||RUN-IN|1966-05-19|1966-01-16|||||1961-04-04||1960-06-29
TRIAL STUDY 134XCP|IS|E09B394B-9E48-4132-B430-991DF1953A81||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PIXEL|||||ML/MIN/MMHG||||ABNORMAL|NOT DONE|||CORD BLOOD|LACTESCENT|N|CYSTOSCOPY|U|Y|NA||3||39||LONG-TERM FOLLOW-UP|1965-04-22|1966-06-08|||||1965-02-08||1967-11-27
TRIAL STUDY 134XCP|IS|E09B394B-9E48-4132-B430-991DF1953A81||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MKAT|||||UG/DL||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|GELLED|U|WEBER GREEN STAIN|U|Y|N||4||88||BASELINE|1964-09-20|1964-09-28|||||1967-04-20||1968-12-09
TRIAL STUDY 134XCP|IS|E09B394B-9E48-4132-B430-991DF1953A81||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOZENGE|||||TBSP||||HIGH|NOT DONE|||ENDOMETRIAL TISSUE|AGGLUTINATED|N|QUANTITATIVE COMPUTED TOMOGRAPHY|U|NA|U||5||7||WASHOUT|1968-01-23|1965-12-17|||||1966-08-29||1963-05-01
TRIAL STUDY 134XCP|IS|5FB65CB2-DB12-4D00-818E-C51992DC7273||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MG/ML/DAY|||||FMOL/G||||HIGH|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|Y|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|N|Y|U||1||38||LONG-TERM FOLLOW-UP|1968-04-24|1965-05-20|||||1970-12-10||1962-11-26
TRIAL STUDY 134XCP|IS|5FB65CB2-DB12-4D00-818E-C51992DC7273||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MANSON U/ML|||||IU/G HB||||LOW|NOT DONE|||BASAL TEAR|SOLIDIFIED|N|DIGITAL PCR|U|Y|U||2||58||SCREENING|1970-02-17|1967-09-15|||||1969-04-16||1970-02-10
TRIAL STUDY 134XCP|IS|5FB65CB2-DB12-4D00-818E-C51992DC7273||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PG/DL|||||10^8/L||||HIGH|NOT DONE|||MECONIUM|REFRIGERATED|N|ECHOCARDIOGRAPHY|N|NA|NA||3||39||SCREENING|1964-07-17|1961-12-08|||||1968-07-18||1962-07-19
TRIAL STUDY 134XCP|IS|5FB65CB2-DB12-4D00-818E-C51992DC7273||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/CM2|||||NMOL BCE/L||||LOW|NOT DONE|||PLEURAL FLUID|CLOTTED|U|FUNCTIONAL MRI|N|NA|N||4||88||RUN-IN|1967-03-18|1963-01-15|||||1964-10-02||1964-02-14
TRIAL STUDY 134XCP|IS|5FB65CB2-DB12-4D00-818E-C51992DC7273||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MESF|||||UG/H||||LOW|NOT DONE|||DERMAL TISSUE|CALCIFIED|N|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|N|Y|NA||5||7||OPEN LABEL TREATMENT|1961-03-09|1970-03-23|||||1964-08-03||1961-04-07
TRIAL STUDY 134XCP|IS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^8/L|||||BAR||||LOW|NOT DONE|||SUPERNATANT, PLASMA|THAWED|N|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|N|U|U||1||38||LONG-TERM FOLLOW-UP|1961-04-13|1963-11-02|||||1972-04-13||1961-03-10
TRIAL STUDY 134XCP|IS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||LB|||||BU||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|N|SICKLE CELL SOLUBILITY TEST|NA|NA|U||2||58||WASHOUT|1967-02-26|1968-05-28|||||1966-12-30||1964-08-15
TRIAL STUDY 134XCP|IS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NEEDLE GAUGE|||||MILE||||NORMAL|NOT DONE|||GASTRIC FLUID|ROOM TEMPERATURE|N|SPECTROPHOTOMETRY|N|N|U||3||39||FOLLOW-UP|1973-07-21|1971-05-19|||||1960-10-02||1966-10-24
TRIAL STUDY 134XCP|IS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UL|||||TABLET||||ABNORMAL|NOT DONE|||REFLEX TEAR|CLOTTED|Y|THICK SMEAR|NA|U|Y||4||88||OPEN LABEL TREATMENT|1961-06-01|1970-03-05|||||1960-04-13||1962-11-28
TRIAL STUDY 134XCP|IS|ADACD31B-F89B-4920-9E0C-7C58FA00DEF6||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/40 HPFS|||||BOWL||||NORMAL|NOT DONE|||CORD BLOOD|HEMOLYZED|Y|FLUORESCENT MICROSCOPY|NA|N|N||5||7||BASELINE|1972-10-12|1961-01-22|||||1962-04-14||1964-08-14
TRIAL STUDY 134XCP|IS|CB6A1101-1EF8-476D-BD15-B60EF323D740||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/ML/DAY|||||NMOL/DAY||||HIGH|NOT DONE|||EPIDERMAL TISSUE|CALCIFIED|N|SCANNING ELECTRON MICROSCOPY|Y|NA|N||1||38||WASHOUT|1970-11-10|1971-12-24|||||1971-01-30||1962-10-25
TRIAL STUDY 134XCP|IS|CB6A1101-1EF8-476D-BD15-B60EF323D740||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ANSON U|||||BREATHS/30S||||ABNORMAL|NOT DONE|||EXPIRED AIR|HEMOLYZED|U|CORONARY ANGIOGRAPHY|NA|U|Y||2||58||INDUCTION TREATMENT|1962-11-12|1964-03-07|||||1972-08-24||1973-05-20
TRIAL STUDY 134XCP|IS|CB6A1101-1EF8-476D-BD15-B60EF323D740||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/KG/DAY|||||MMOL/MOL||||NORMAL|NOT DONE|||SOFT TISSUE|SOLIDIFIED|U|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|N|N|U||3||39||WASHOUT|1960-02-19|1961-10-17|||||1966-10-21||1969-01-21
TRIAL STUDY 134XCP|IS|CB6A1101-1EF8-476D-BD15-B60EF323D740||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MCI/L|||||RING||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|ICTERIC|NA|REVERSE TRANSCRIPTASE PCR|Y|N|U||4||88||BASELINE|1963-06-09|1960-08-19|||||1969-08-09||1967-04-19
TRIAL STUDY 134XCP|IS|CB6A1101-1EF8-476D-BD15-B60EF323D740||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FARAD|||||PG/DL||||LOW|NOT DONE|||ADIPOSE TISSUE|FROZEN|NA|MULTI-SLICE SPIRAL CT|U|U|U||5||7||LONG-TERM FOLLOW-UP|1973-04-01|1967-01-10|||||1965-01-06||1963-04-08
TRIAL STUDY 134XCP|IS|3AED1654-6D9A-40EE-A560-99F51C469D63||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/MIN/M2|||||LOG10 TCID 50/ML||||LOW|NOT DONE|||MUCUS|AGGLUTINATED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|U|N||1||38||CONTINUATION TREATMENT|1970-11-23|1970-06-16|||||1971-12-03||1972-11-23
TRIAL STUDY 134XCP|IS|3AED1654-6D9A-40EE-A560-99F51C469D63||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AGU/ML|||||UMOL/KG/MIN||||LOW|NOT DONE|||EXUDATE|FRESH|N|IVY INCISION METHOD|U|N|Y||2||58||WASHOUT|1969-06-08|1965-12-09|||||1967-05-30||1973-03-19
TRIAL STUDY 134XCP|IS|3AED1654-6D9A-40EE-A560-99F51C469D63||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NEEDLE GAUGE|||||DPM/ML||||LOW|NOT DONE|||LAVAGE FLUID|THAWED|NA|JAEGER EYE CHART|Y|NA|NA||3||39||RUN-IN|1966-06-03|1966-08-04|||||1973-01-28||1972-05-22
TRIAL STUDY 134XCP|IS|3AED1654-6D9A-40EE-A560-99F51C469D63||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CAN|||||LOG10 IU/ML||||HIGH|NOT DONE|||CALCULUS|CLOTTED|Y|TOTAL BODY RADIOGRAPHY|NA|N|Y||4||88||TREATMENT|1968-09-30|1970-08-26|||||1963-09-18||1966-08-30
TRIAL STUDY 134XCP|IS|3AED1654-6D9A-40EE-A560-99F51C469D63||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KIU|||||DAGU/ML||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|CONTAMINATED|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|U|NA|U||5||7||INDUCTION TREATMENT|1961-10-10|1961-02-09|||||1967-06-04||1966-02-03
TRIAL STUDY 134XCP|IS|4C13FD80-8950-4194-B76C-F46B643BED82||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^9 ORGANISMS/G|||||UG/KG/DAY||||HIGH|NOT DONE|||DERMAL TISSUE|PARAFFIN-EMBEDDED|N|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|NA|NA||1||38||BLINDED TREATMENT|1961-02-17|1970-01-05|||||1960-03-11||1962-10-01
TRIAL STUDY 134XCP|IS|4C13FD80-8950-4194-B76C-F46B643BED82||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOSM/L|||||VG/ML||||HIGH|NOT DONE|||LOCHIA|ICTERIC|U|DC SHEATH FLOW|NA|N|N||2||58||BASELINE|1960-10-17|1963-10-30|||||1973-03-07||1963-10-03
TRIAL STUDY 134XCP|IS|4C13FD80-8950-4194-B76C-F46B643BED82||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||RPM|||||NKAT/L||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|ROOM TEMPERATURE|U|MIGET|N|NA|NA||3||39||BLINDED TREATMENT|1961-03-10|1961-10-03|||||1967-02-14||1971-05-16
TRIAL STUDY 134XCP|IS|4C13FD80-8950-4194-B76C-F46B643BED82||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^4 CFU|||||PNU/ML||||NORMAL|NOT DONE|||STOOL|PARAFFIN-EMBEDDED|Y|LASER CAPTURE MICRODISSECTION|N|Y|U||4||88||CONTINUATION TREATMENT|1963-07-23|1967-11-17|||||1967-09-22||1971-01-30
TRIAL STUDY 134XCP|IS|4C13FD80-8950-4194-B76C-F46B643BED82||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAPFUL|||||RING||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|UNEXPECTED ODOR|Y|TOTAL BODY IRRADIATION|U|Y|U||5||7||LONG-TERM FOLLOW-UP|1965-06-02|1960-03-09|||||1963-11-17||1969-12-05
TRIAL STUDY 134XCP|IS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||VIAL|||||ML/CAGE||||HIGH|NOT DONE|||PUS|GELLED|NA|ELECTROGASTROGRAPHY|NA|NA|Y||1||38||RUN-IN|1973-01-18|1963-01-24|||||1961-10-04||1967-01-25
TRIAL STUDY 134XCP|IS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG EID 50/DOSE|||||ARBITRARY U||||HIGH|NOT DONE|||MUCUS|CONCENTRATED|Y|TOTAL BODY IRRADIATION|N|Y|N||2||58||BASELINE|1963-09-20|1965-06-08|||||1966-10-02||1972-04-04
TRIAL STUDY 134XCP|IS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DAYS/WK|||||MMOL/MIN/KPA||||LOW|NOT DONE|||EMESIS|NON-HEMOLYZED|N|IMMUNORADIOMETRIC ASSAY|N|NA|U||3||39||BASELINE|1969-03-19|1970-08-05|||||1964-04-05||1969-02-21
TRIAL STUDY 134XCP|IS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U|||||10^6 IU||||NORMAL|NOT DONE|||INFRANATANT, SERUM|CONCENTRATED|Y|ROMANOWSKY STAIN|N|U|N||4||88||TREATMENT|1963-05-04|1961-08-16|||||1961-12-31||1963-07-27
TRIAL STUDY 134XCP|IS|AE059FB8-BE8F-4F4A-88A0-4EF300F692D2||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||SCOOPFUL|||||HZ/S||||ABNORMAL|NOT DONE|||TUMOR TISSUE|DRIED|N|SPIRAL CT|Y|NA|NA||5||7||CONTINUATION TREATMENT|1965-09-28|1963-08-01|||||1963-02-26||1962-05-07
TRIAL STUDY 134XCP|IS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||RNA COPIES/ML|||||UMOL/MG/MIN||||HIGH|NOT DONE|||PLASMA|DRIED|Y|KLEIHAUER-BETKE|NA|Y|N||1||38||BLINDED TREATMENT|1966-10-14|1963-04-05|||||1966-03-22||1965-03-10
TRIAL STUDY 134XCP|IS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TUBERCULIN UNIT/ML|||||10^5/HPF||||NORMAL|NOT DONE|||ADIPOSE TISSUE|NON-HEMOLYZED|Y|ECHOCARDIOGRAPHY|Y|Y|NA||2||58||OPEN LABEL TREATMENT|1970-03-24|1963-07-24|||||1960-07-31||1961-04-14
TRIAL STUDY 134XCP|IS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL BCE/MMOL|||||DNA COPIES/UG||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|UNEXPECTED ODOR|U|CONTRAST ENHANCED MRI|Y|Y|Y||3||39||OPEN LABEL TREATMENT|1967-10-05|1961-07-31|||||1964-05-29||1964-11-25
TRIAL STUDY 134XCP|IS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||USIEMENS|||||U/M2/DAY||||LOW|NOT DONE|||NAIL|AGGLUTINATED|NA|HIGH RESOLUTION CT|N|U|N||4||88||FOLLOW-UP|1968-06-05|1968-09-21|||||1972-02-10||1962-08-12
TRIAL STUDY 134XCP|IS|2A3D5CAE-6BC2-4B96-A36C-67C885C519D2||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^9 ORGANISMS|||||AMFI||||LOW|NOT DONE|||LYSATE|CONTAMINATED|U|GC/MS|Y|Y|U||5||7||SCREENING|1963-05-08|1960-01-19|||||1972-04-25||1967-07-17
TRIAL STUDY 134XCP|IS|CFFA0003-098B-486E-82DB-30838F6541DD||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UIU/DL|||||MMHG*MIN/L||||LOW|NOT DONE|||GASTRIC FLUID|FRESH|NA|REVERSE TRANSCRIPTASE PCR|N|U|NA||1||38||SCREENING|1963-03-30|1964-04-15|||||1962-03-26||1962-08-17
TRIAL STUDY 134XCP|IS|CFFA0003-098B-486E-82DB-30838F6541DD||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ANTI-XA IU|||||UMOL||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|CLOTTED|U|SMEAR|U|NA|N||2||58||TREATMENT|1970-08-31|1973-03-13|||||1970-02-24||1969-03-30
TRIAL STUDY 134XCP|IS|CFFA0003-098B-486E-82DB-30838F6541DD||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/10^5|||||NEWTON||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|LACTESCENT|N|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|NA|Y|N||3||39||LONG-TERM FOLLOW-UP|1963-06-10|1971-04-19|||||1966-04-06||1960-06-05
TRIAL STUDY 134XCP|IS|CFFA0003-098B-486E-82DB-30838F6541DD||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/MS|||||PMOL/L||||ABNORMAL|NOT DONE|||LOCHIA|CONTAMINATED|Y|MICROBIAL BIOCHEMICAL IDENTIFICATION|U|N|U||4||88||TREATMENT|1967-07-07|1968-12-30|||||1960-06-09||1965-02-21
TRIAL STUDY 134XCP|IS|CFFA0003-098B-486E-82DB-30838F6541DD||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/KG/H|||||CCID 50/ML||||NORMAL|NOT DONE|||ATHEROSCLEROTIC PLAQUE|SOLIDIFIED|Y|PLETHYSMOGRAPHY|Y|NA|NA||5||7||SCREENING|1965-10-18|1960-02-27|||||1960-07-20||1969-04-09
TRIAL STUDY 134XCP|IS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||USP U|||||DPM/MG||||ABNORMAL|NOT DONE|||URINE SEDIMENT|CONTAMINATED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|N|N||1||38||RUN-IN|1969-08-16|1961-03-13|||||1963-08-24||1962-02-22
TRIAL STUDY 134XCP|IS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/KG/MIN|||||L/S||||NORMAL|NOT DONE|||CORD BLOOD|AGGLUTINATED|N|COMPLEMENT FIXATION|N|Y|Y||2||58||CONTINUATION TREATMENT|1966-07-04|1972-06-12|||||1965-11-22||1973-07-25
TRIAL STUDY 134XCP|IS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||ML/ANIMAL/WK||||HIGH|NOT DONE|||AQUEOUS HUMOR|AGGLUTINATED|U|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|U|Y||3||39||WASHOUT|1965-02-23|1962-12-14|||||1960-03-07||1966-02-25
TRIAL STUDY 134XCP|IS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^7 PFU|||||KG||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|CALCIFIED|Y|IRON HEMATOXYLIN STAIN|Y|U|U||4||88||SCREENING|1960-02-18|1963-12-28|||||1969-06-07||1963-03-17
TRIAL STUDY 134XCP|IS|C5505069-530E-44CE-BD90-D0F7B0CF9C2D||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MOL/MOL|||||NCI||||LOW|NOT DONE|||SPERMATOZOON|AGGLUTINATED|Y|BIOPSY|NA|Y|U||5||7||BLINDED TREATMENT|1964-07-22|1961-01-02|||||1960-03-09||1970-04-06
TRIAL STUDY 134XCP|IS|3F29184F-1963-4EC7-881A-61C9DEF95D2D||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PG/L|||||FMOL/L||||LOW|NOT DONE|||CALCULUS|AGGLUTINATED|NA|TEST STRIP|NA|N|U||1||38||OBSERVATION|1969-01-25|1965-08-09|||||1962-03-20||1968-04-20
TRIAL STUDY 134XCP|IS|3F29184F-1963-4EC7-881A-61C9DEF95D2D||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||KAT|||||ML/MMHG/MIN/L||||HIGH|NOT DONE|||EPITHELIAL CELL|CLOTTED|Y|IHC|NA|Y|Y||2||58||OBSERVATION|1971-02-07|1962-02-19|||||1960-02-19||1967-06-03
TRIAL STUDY 134XCP|IS|3F29184F-1963-4EC7-881A-61C9DEF95D2D||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/DAY|||||ENZYME U/M2||||HIGH|NOT DONE|||MONOCYTE|FROZEN|U|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|U|N|U||3||39||RUN-IN|1971-04-01|1970-03-31|||||1971-03-08||1961-09-01
TRIAL STUDY 134XCP|IS|3F29184F-1963-4EC7-881A-61C9DEF95D2D||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/L/MIN|||||MM/H||||NORMAL|NOT DONE|||BUFFY COAT|CLOTTED|U|TOTAL BODY IRRADIATION|Y|U|U||4||88||OPEN LABEL TREATMENT|1962-02-05|1973-02-09|||||1973-08-18||1966-04-02
TRIAL STUDY 134XCP|IS|3F29184F-1963-4EC7-881A-61C9DEF95D2D||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PNU/ML|||||DYN||||NORMAL|NOT DONE|||EPITHELIAL CELL|CONTAMINATED|NA|CONTRAST ENHANCED MRI|U|N|U||5||7||TREATMENT|1973-08-06|1972-11-07|||||1973-09-07||1965-05-03
TRIAL STUDY 134XCP|IS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PL|||||10^9 CFU||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|THAWED|U|FLUORESCENT MICROSCOPY|NA|U|NA||1||38||BLINDED TREATMENT|1971-05-11|1964-09-13|||||1961-11-29||1961-08-08
TRIAL STUDY 134XCP|IS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||VP/ML|||||ML/M2/H||||HIGH|NOT DONE|||SPERMATOZOON|LIPEMIC|Y|IMMUNOFLUORESCENT STAIN|N|NA|Y||2||58||SCREENING|1965-12-08|1973-03-09|||||1965-03-09||1960-07-18
TRIAL STUDY 134XCP|IS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CARTRIDGE|||||APL U/ML||||LOW|NOT DONE|||VENOUS BLOOD|LACTESCENT|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|NA|NA|Y||3||39||CONTINUATION TREATMENT|1967-03-18|1964-07-16|||||1965-07-27||1970-02-11
TRIAL STUDY 134XCP|IS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACKAGE|||||BQ/ML||||LOW|NOT DONE|||EMOTIONAL TEAR|FROZEN|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|N|N|Y||4||88||BLINDED TREATMENT|1969-09-15|1973-07-15|||||1965-04-02||1964-05-22
TRIAL STUDY 134XCP|IS|A962AE4A-1E74-4CC7-8201-A8DF9A1AA8D3||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UMOL/L/H|||||F||||LOW|NOT DONE|||SUPERNATANT, SERUM|ROOM TEMPERATURE|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|N|U|Y||5||7||SCREENING|1971-02-24|1960-12-19|||||1961-09-02||1970-08-23
TRIAL STUDY 134XCP|IS|D9C32CF1-51C7-412D-A030-682B2860F89D||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||USEC|||||CS||||LOW|NOT DONE|||PROSTATIC FLUID|ICTERIC|Y|INFRARED SPECTROMETRY|U|N|Y||1||38||SCREENING|1963-07-16|1968-10-19|||||1967-02-15||1971-05-24
TRIAL STUDY 134XCP|IS|D9C32CF1-51C7-412D-A030-682B2860F89D||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CMH2O*S2/ML|||||10^3 ORGANISMS/G||||HIGH|NOT DONE|||CERUMEN|GELLED|U|PET/CT SCAN WITHOUT CONTRAST|NA|NA|NA||2||58||BASELINE|1965-06-04|1973-08-27|||||1969-02-12||1967-03-21
TRIAL STUDY 134XCP|IS|D9C32CF1-51C7-412D-A030-682B2860F89D||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/KG/DAY|||||BEATS/MIN||||ABNORMAL|NOT DONE|||BREAST MILK|ROOM TEMPERATURE|NA|AUTOMATED COUNT|Y|Y|U||3||39||BLINDED TREATMENT|1965-01-31|1965-09-18|||||1961-11-30||1962-11-13
TRIAL STUDY 134XCP|IS|D9C32CF1-51C7-412D-A030-682B2860F89D||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DISK|||||L/KG||||LOW|NOT DONE|||BREAST MILK|UNEXPECTED ODOR|U|MS/MS|N|N|U||4||88||FOLLOW-UP|1962-09-30|1967-09-06|||||1971-05-07||1972-12-19
TRIAL STUDY 134XCP|IS|D9C32CF1-51C7-412D-A030-682B2860F89D||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ANTI-XA IU|||||DPM/100MG||||ABNORMAL|NOT DONE|||EXUDATE|LACTESCENT|N|APPLANATION TONOMETRY|U|Y|Y||5||7||RUN-IN|1973-05-18|1962-01-02|||||1964-10-26||1965-01-31
TRIAL STUDY 134XCP|IS|102F6B51-5A86-497B-A36D-13FB77928C39||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PACK|||||G||||LOW|NOT DONE|||KERATINOCYTE|SOLIDIFIED|N|MS/MS|U|NA|Y||1||38||TREATMENT|1969-05-31|1966-02-20|||||1968-12-25||1967-03-04
TRIAL STUDY 134XCP|IS|102F6B51-5A86-497B-A36D-13FB77928C39||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MEQ/DAY|||||NCI||||ABNORMAL|NOT DONE|||BLOOD|UNEXPECTED ODOR|NA|FARR ASSAY|N|U|N||2||58||CONTINUATION TREATMENT|1964-05-14|1962-05-04|||||1962-05-15||1967-02-06
TRIAL STUDY 134XCP|IS|102F6B51-5A86-497B-A36D-13FB77928C39||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UV*SEC|||||LOG10 TCID 50/UL||||HIGH|NOT DONE|||SERUM OR PLASMA|SOLIDIFIED|N|NON-CONTACT SPECULAR MICROSCOPY|U|N|N||3||39||FOLLOW-UP|1971-04-13|1966-03-16|||||1964-11-09||1971-06-12
TRIAL STUDY 134XCP|IS|102F6B51-5A86-497B-A36D-13FB77928C39||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/M2|||||10^9 CFU||||LOW|NOT DONE|||HAIR|ROOM TEMPERATURE|Y|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|Y|U||4||88||LONG-TERM FOLLOW-UP|1960-04-14|1972-08-12|||||1961-12-11||1971-11-12
TRIAL STUDY 134XCP|IS|102F6B51-5A86-497B-A36D-13FB77928C39||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/HPF|||||ARBITRARY U||||NORMAL|NOT DONE|||TUMOR TISSUE|UNEXPECTED ODOR|Y|PHYSICAL EXAMINATION|NA|U|U||5||7||OBSERVATION|1968-10-27|1971-11-19|||||1972-01-28||1972-08-31
TRIAL STUDY 134XCP|IS|C123D04C-1AA4-418D-B68C-EC9D410376F0||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/100G/MIN|||||DB||||HIGH|NOT DONE|||NAIL|FRESH|N|ELISA|N|Y|NA||1||38||CONTINUATION TREATMENT|1961-06-02|1968-10-31|||||1966-01-01||1963-07-16
TRIAL STUDY 134XCP|IS|C123D04C-1AA4-418D-B68C-EC9D410376F0||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/G/H|||||10^9/L||||ABNORMAL|NOT DONE|||TISSUE|LIPEMIC|Y|GC/MS-CI|N|U|N||2||58||BLINDED TREATMENT|1962-04-23|1962-06-02|||||1962-03-26||1966-12-11
TRIAL STUDY 134XCP|IS|C123D04C-1AA4-418D-B68C-EC9D410376F0||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BLOCKS|||||ML/CM H2O||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|SOLIDIFIED|Y|NUCLEIC ACID BASED METHOD|Y|NA|Y||3||39||BASELINE|1970-08-15|1960-07-22|||||1966-02-27||1967-06-24
TRIAL STUDY 134XCP|IS|C123D04C-1AA4-418D-B68C-EC9D410376F0||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL|||||UIU/L||||LOW|NOT DONE|||DISCHARGE|AUTOLYZED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|N|N|N||4||88||CONTINUATION TREATMENT|1961-09-16|1962-12-15|||||1962-03-11||1972-11-30
TRIAL STUDY 134XCP|IS|C123D04C-1AA4-418D-B68C-EC9D410376F0||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM/H|||||U/G/MIN||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|NON-HEMOLYZED|NA|ULTRASOUND|Y|U|NA||5||7||FOLLOW-UP|1972-11-03|1969-11-29|||||1960-12-05||1967-09-02
TRIAL STUDY 134XCP|IS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UKAT/10^12 RBC|||||BU/ML||||LOW|NOT DONE|||VENOUS CORD BLOOD|AUTOLYZED|U|VENTILATION PERFUSION LUNG SCAN|NA|NA|U||1||38||OBSERVATION|1972-01-24|1971-04-03|||||1965-09-18||1964-11-10
TRIAL STUDY 134XCP|IS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/KG/H|||||U/G/MIN||||HIGH|NOT DONE|||GASTRIC FLUID|LIPEMIC|NA|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|U|N|NA||2||58||INDUCTION TREATMENT|1966-02-10|1972-12-14|||||1962-04-25||1965-12-28
TRIAL STUDY 134XCP|IS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||WATT|||||G/CAGE/WK||||HIGH|NOT DONE|||VENOUS CORD BLOOD|AGGLUTINATED|U|CT SCAN|NA|Y|Y||3||39||OBSERVATION|1961-01-24|1960-09-11|||||1967-06-21||1970-10-11
TRIAL STUDY 134XCP|IS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MAC50|||||IU/KG||||ABNORMAL|NOT DONE|||BILE|REFRIGERATED|N|SPIROMETRY|Y|NA|U||4||88||RUN-IN|1965-09-02|1962-05-07|||||1970-08-19||1972-06-14
TRIAL STUDY 134XCP|IS|30352D31-4A96-4B1C-9BE8-BA4E0DC5A4C6||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||BQ|||||PIXELS/IN||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|DRIED|NA|MICROPARTICLE ENZYME IMMUNOASSAY|N|Y|N||5||7||LONG-TERM FOLLOW-UP|1965-11-03|1971-04-22|||||1972-10-02||1965-06-13
TRIAL STUDY 134XCP|IS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EP U|||||ML/MMHG/MIN/L||||LOW|NOT DONE|||TISSUE|FROZEN|U|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|U|NA|NA||1||38||BLINDED TREATMENT|1967-04-02|1970-09-03|||||1970-04-06||1963-05-28
TRIAL STUDY 134XCP|IS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NMOL BCE/NMOL|||||MM/H||||LOW|NOT DONE|||PLASMA|ICTERIC|NA|WEBER GREEN STAIN|Y|N|Y||2||58||INDUCTION TREATMENT|1961-05-10|1966-04-12|||||1963-05-24||1967-04-02
TRIAL STUDY 134XCP|IS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EIA UNIT|||||UMOL/H/MMOL||||HIGH|NOT DONE|||SEBUM|LIPEMIC|Y|ERGOSPIROMETRY|Y|U|U||3||39||LONG-TERM FOLLOW-UP|1962-01-05|1967-09-11|||||1964-09-04||1966-09-27
TRIAL STUDY 134XCP|IS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG EID 50/DOSE|||||LENS||||ABNORMAL|NOT DONE|||NAIL|THAWED|Y|SLOAN LETTER EYE CHART 2.5%|U|Y|NA||4||88||BLINDED TREATMENT|1973-02-14|1962-06-05|||||1966-07-28||1970-08-27
TRIAL STUDY 134XCP|IS|079A46B1-EEB3-4524-AC5F-60E2A9E16DB4||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CPM|||||F||||HIGH|NOT DONE|||SEMINAL FLUID|HEMOLYZED|U|AMSLER GRID|U|N|NA||5||7||OPEN LABEL TREATMENT|1961-04-19|1962-07-05|||||1963-12-11||1960-01-27
TRIAL STUDY 134XCP|IS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ANSON U|||||UG/H||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|CONCENTRATED|NA|TOTAL BODY RADIOGRAPHY|Y|NA|N||1||38||TREATMENT|1961-10-02|1964-08-22|||||1966-07-01||1972-07-28
TRIAL STUDY 134XCP|IS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||%(W/W)|||||VIAL||||LOW|NOT DONE|||SEBUM|PARAFFIN-EMBEDDED|NA|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|N|Y|Y||2||58||INDUCTION TREATMENT|1968-12-12|1960-06-04|||||1964-03-29||1963-01-08
TRIAL STUDY 134XCP|IS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||100 IU/ML|||||BAU||||HIGH|NOT DONE|||BONE|NON-HEMOLYZED|U|IMMUNOBLOT|Y|N|U||3||39||OBSERVATION|1963-08-09|1968-01-11|||||1966-11-04||1970-02-07
TRIAL STUDY 134XCP|IS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS/MG|||||CFU/ML||||LOW|NOT DONE|||MUCUS|GELLED|N|SNELLEN EYE CHART|N|U|NA||4||88||SCREENING|1967-05-03|1962-01-13|||||1972-01-21||1965-04-07
TRIAL STUDY 134XCP|IS|82BB0613-BBBB-4EA2-90F8-EDCA19A637A5||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NG/MOL|||||LENS||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|HEMOLYZED|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NA|Y|N||5||7||OPEN LABEL TREATMENT|1961-08-05|1965-06-30|||||1966-03-04||1972-09-21
TRIAL STUDY 134XCP|IS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^9/L|||||COULOMB||||HIGH|NOT DONE|||ADIPOSE TISSUE|LIPEMIC|U|ACRIDINE ORANGE STAIN|Y|Y|U||1||38||SCREENING|1969-01-03|1961-03-22|||||1961-05-07||1964-03-31
TRIAL STUDY 134XCP|IS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||BAR|||||10^6 ORGANISMS||||NORMAL|NOT DONE|||LYMPH|FRESH|NA|DC SHEATH FLOW|U|U|Y||2||58||BASELINE|1966-05-07|1960-11-18|||||1969-09-04||1965-10-04
TRIAL STUDY 134XCP|IS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UM|||||POINT||||HIGH|NOT DONE|||ADIPOSE TISSUE|REFRIGERATED|Y|TARGETED TRANSCRIPTOME SEQUENCING|U|U|Y||3||39||FOLLOW-UP|1966-12-03|1967-06-29|||||1965-02-24||1966-12-12
TRIAL STUDY 134XCP|IS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/ANIMAL|||||MG/ML/MIN||||ABNORMAL|NOT DONE|||KERATINOCYTE|ICTERIC|Y|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|NA|Y|Y||4||88||LONG-TERM FOLLOW-UP|1964-06-27|1962-09-07|||||1969-11-28||1960-04-22
TRIAL STUDY 134XCP|IS|5F368FD6-5F04-490E-9720-5BE0FE34C1FC||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/G/MIN|||||MMHG/SEC||||NORMAL|NOT DONE|||SEMINAL FLUID|THAWED|Y|COLORIMETRY|U|Y|NA||5||7||INDUCTION TREATMENT|1960-07-28|1970-03-06|||||1965-04-12||1964-11-25
TRIAL STUDY 134XCP|IS|E3310689-5727-4970-A675-A58931E406FA||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ENZYME U/M2|||||KCAL||||LOW|NOT DONE|||PERSPIRATION|GELLED|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|N|Y|U||1||38||OPEN LABEL TREATMENT|1965-09-22|1965-06-11|||||1973-05-15||1967-01-17
TRIAL STUDY 134XCP|IS|E3310689-5727-4970-A675-A58931E406FA||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||AMP|||||BREATHS/MIN||||ABNORMAL|NOT DONE|||URINE SEDIMENT|CALCIFIED|N|IMMUNOPRECIPITATION|U|Y|N||2||58||FOLLOW-UP|1961-05-09|1960-05-12|||||1963-07-15||1966-09-28
TRIAL STUDY 134XCP|IS|E3310689-5727-4970-A675-A58931E406FA||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||H*%|||||BLOCKS||||LOW|NOT DONE|||EMOTIONAL TEAR|CALCIFIED|N|PATHOLOGICAL EVALUATION|U|N|Y||3||39||BLINDED TREATMENT|1971-08-05|1963-04-18|||||1972-08-26||1964-01-02
TRIAL STUDY 134XCP|IS|E3310689-5727-4970-A675-A58931E406FA||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BISCUIT|||||MOL/DAY||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|SOLIDIFIED|Y|DISK DIFFUSION|NA|Y|U||4||88||BASELINE|1971-06-10|1961-11-08|||||1965-01-27||1971-06-01
TRIAL STUDY 134XCP|IS|E3310689-5727-4970-A675-A58931E406FA||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UU/DL|||||MMU/ML||||LOW|NOT DONE|||CERUMEN|THAWED|U|PHOTOMETRIC CLOT DETECTION|NA|Y|U||5||7||TREATMENT|1965-12-14|1962-02-10|||||1961-11-16||1960-08-01
TRIAL STUDY 134XCP|IS|D5359BBA-960E-4392-996A-BCDD8637894A||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MAMP|||||U/KG/MIN||||NORMAL|NOT DONE|||SUPERNATANT, PLASMA|FROZEN|U|NUCLEAR RADIOLOGY|U|N|U||1||38||WASHOUT|1966-12-08|1962-06-16|||||1960-11-14||1973-08-31
TRIAL STUDY 134XCP|IS|D5359BBA-960E-4392-996A-BCDD8637894A||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/LPF|||||UG/M2/DAY||||LOW|NOT DONE|||PLATELET RICH PLASMA|LACTESCENT|N|MS/MS|U|Y|NA||2||58||TREATMENT|1967-05-03|1964-09-27|||||1961-09-08||1972-10-21
TRIAL STUDY 134XCP|IS|D5359BBA-960E-4392-996A-BCDD8637894A||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||APPLICATION|||||PMOL/10^10 CELLS||||HIGH|NOT DONE|||ARTERIAL BLOOD|AUTOLYZED|N|HPLC-FL|U|U|U||3||39||CONTINUATION TREATMENT|1971-07-17|1971-03-14|||||1968-01-22||1972-08-21
TRIAL STUDY 134XCP|IS|D5359BBA-960E-4392-996A-BCDD8637894A||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||AMPULE|||||MG/CM2||||NORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|CLOTTED|NA|WEBER GREEN STAIN|NA|N|N||4||88||OBSERVATION|1961-08-11|1968-07-26|||||1967-10-11||1963-06-20
TRIAL STUDY 134XCP|IS|D5359BBA-960E-4392-996A-BCDD8637894A||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||TSP EQ|||||CAPLET||||ABNORMAL|NOT DONE|||URINE|CLOTTED|U|GC/MS/MS|NA|U|NA||5||7||TREATMENT|1963-03-13|1971-03-05|||||1970-05-29||1971-02-05
TRIAL STUDY 134XCP|IS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BU/ML|||||/CMH2O||||NORMAL|NOT DONE|||SPUTUM|REFRIGERATED|Y|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|NA|NA||1||38||WASHOUT|1965-02-06|1971-12-09|||||1964-09-17||1970-03-20
TRIAL STUDY 134XCP|IS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/WK|||||TROCHE||||ABNORMAL|NOT DONE|||NAIL|SOLIDIFIED|NA|MICROBIAL BIOCHEMICAL IDENTIFICATION|U|U|NA||2||58||TREATMENT|1968-06-22|1969-06-03|||||1973-03-12||1972-10-15
TRIAL STUDY 134XCP|IS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/DAY|||||VP/DOSE||||HIGH|NOT DONE|||VITREOUS HUMOR|LIPEMIC|U|PEAK FLOWMETRY|Y|U|NA||3||39||SCREENING|1961-10-24|1969-04-25|||||1960-09-25||1968-04-29
TRIAL STUDY 134XCP|IS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DRUM|||||KG/CM||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|FRESH|Y|PUPILLOMETRY|N|Y|N||4||88||BASELINE|1968-09-03|1966-06-02|||||1968-04-29||1964-11-20
TRIAL STUDY 134XCP|IS|C3022BA6-BC2B-4553-A02A-C2FB6B3CBFF5||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MEQ/L|||||GBQ/MG||||LOW|NOT DONE|||SMEGMA|PARAFFIN-EMBEDDED|Y|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|NA|NA|Y||5||7||WASHOUT|1963-08-16|1966-11-26|||||1968-04-11||1963-03-13
TRIAL STUDY 134XCP|IS|EED3F55E-892E-46C6-8B0A-30D2E1112072||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^3 CFU/ML|||||CYLINDER||||HIGH|NOT DONE|||BONE|HEMOLYZED|N|MULTIPLEXED BEAD BASED IMMUNOASSAY|NA|U|Y||1||38||LONG-TERM FOLLOW-UP|1971-01-22|1972-12-30|||||1965-10-14||1967-02-09
TRIAL STUDY 134XCP|IS|EED3F55E-892E-46C6-8B0A-30D2E1112072||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PIPE|||||PMOL||||LOW|NOT DONE|||LYSATE|FRESH|Y|CORONARY ANGIOGRAPHY|N|NA|N||2||58||BASELINE|1969-02-20|1961-10-08|||||1973-08-12||1972-09-08
TRIAL STUDY 134XCP|IS|EED3F55E-892E-46C6-8B0A-30D2E1112072||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||H*%|||||RNA COPIES/ML||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|CONCENTRATED|NA|NUCLEAR RADIOLOGY|NA|U|N||3||39||CONTINUATION TREATMENT|1961-03-16|1965-02-12|||||1971-02-22||1971-08-27
TRIAL STUDY 134XCP|IS|EED3F55E-892E-46C6-8B0A-30D2E1112072||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||TRACE|||||FIU||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|LACTESCENT|NA|FARNSWORTH-MUNSELL 100 HUE TEST|U|NA|U||4||88||OBSERVATION|1969-12-30|1966-08-28|||||1961-01-11||1972-09-11
TRIAL STUDY 134XCP|IS|EED3F55E-892E-46C6-8B0A-30D2E1112072||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NEEDLE GAUGE|||||/100 WBC||||ABNORMAL|NOT DONE|||AQUEOUS HUMOR|HEMOLYZED|N|PET/MRI SCAN|N|Y|NA||5||7||BASELINE|1964-05-09|1970-07-11|||||1960-08-30||1972-01-23
TRIAL STUDY 134XCP|IS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/DL|||||U/ANIMAL||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|CONTAMINATED|NA|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|NA|N|Y||1||38||CONTINUATION TREATMENT|1963-08-05|1966-01-02|||||1960-06-10||1962-09-03
TRIAL STUDY 134XCP|IS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||POINT|||||ANSON U||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|DRIED|N|PAP STAIN|U|U|N||2||58||BLINDED TREATMENT|1964-10-24|1970-11-25|||||1961-01-04||1970-03-11
TRIAL STUDY 134XCP|IS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||IN2|||||TBSP||||NORMAL|NOT DONE|||ALVEOLAR AIR|LACTESCENT|Y|MRI WITHOUT CONTRAST|Y|NA|U||3||39||BASELINE|1972-07-27|1960-12-25|||||1961-03-21||1969-08-29
TRIAL STUDY 134XCP|IS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CMOL|||||CI/G||||NORMAL|NOT DONE|||PERSPIRATION|SOLIDIFIED|U|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|U|U|N||4||88||WASHOUT|1973-01-25|1961-02-11|||||1962-07-08||1971-06-03
TRIAL STUDY 134XCP|IS|1CE2AE1C-B0E4-4303-AAE5-F877A133D9CF||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MU/L|||||BOWL||||LOW|NOT DONE|||FLUID|PARAFFIN-EMBEDDED|Y|OPTICAL COHERENCE TOMOGRAPHY|U|U|NA||5||7||TREATMENT|1970-04-07|1965-07-25|||||1970-07-03||1970-10-19
TRIAL STUDY 134XCP|IS|B865DADD-9A4E-4521-A2E8-104D709F4144||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UEQ/L|||||DIP||||HIGH|NOT DONE|||LUNG SURFACTANT|AGGLUTINATED|N|MICROBIAL CULTURE, SOLID|U|NA|NA||1||38||OPEN LABEL TREATMENT|1971-12-20|1968-02-15|||||1972-07-13||1972-04-22
TRIAL STUDY 134XCP|IS|B865DADD-9A4E-4521-A2E8-104D709F4144||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||FRAMES/S|||||UMOL||||HIGH|NOT DONE|||LEUKOCYTE|CALCIFIED|Y|PET/CT SCAN|Y|Y|N||2||58||SCREENING|1963-09-21|1961-12-23|||||1973-01-18||1963-02-18
TRIAL STUDY 134XCP|IS|B865DADD-9A4E-4521-A2E8-104D709F4144||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MM/MIN|||||DPM/100MG||||LOW|NOT DONE|||SKIN TISSUE|UNEXPECTED ODOR|N|KINETIC MICROPARTICLE IMMUNOASSAY|N|Y|N||3||39||WASHOUT|1968-11-06|1960-07-29|||||1968-06-30||1962-12-16
TRIAL STUDY 134XCP|IS|B865DADD-9A4E-4521-A2E8-104D709F4144||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DIOPTER|||||CI/L||||LOW|NOT DONE|||ABSCESS FLUID|LACTESCENT|N|KINETIC CHROMOGENIC ASSAY|NA|NA|U||4||88||RUN-IN|1963-06-20|1973-08-23|||||1970-07-19||1964-05-29
TRIAL STUDY 134XCP|IS|B865DADD-9A4E-4521-A2E8-104D709F4144||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||APS U|||||HZ/S||||NORMAL|NOT DONE|||LYSATE|ICTERIC|U|FORCED OSCILLATION TECHNIQUE|U|N|U||5||7||WASHOUT|1967-11-11|1972-02-14|||||1966-12-23||1971-09-28
TRIAL STUDY 134XCP|IS|D8C78860-7893-4239-8F29-A0EE98C90310||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MCI|||||UMOL/MIN||||NORMAL|NOT DONE|||MONOCYTE|LACTESCENT|Y|CLINICAL EVALUATION|N|N|Y||1||38||BASELINE|1960-02-09|1966-10-09|||||1968-04-12||1962-11-11
TRIAL STUDY 134XCP|IS|D8C78860-7893-4239-8F29-A0EE98C90310||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||NEEDLE GAUGE|||||GBQ/G||||HIGH|NOT DONE|||DIALYSIS FLUID, PERITONEAL|GELLED|Y|RADIATION DOSIMETRY|N|NA|U||2||58||FOLLOW-UP|1972-09-25|1971-09-16|||||1965-04-21||1961-10-26
TRIAL STUDY 134XCP|IS|D8C78860-7893-4239-8F29-A0EE98C90310||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CD|||||%/S||||LOW|NOT DONE|||LAVAGE FLUID|PARAFFIN-EMBEDDED|NA|KARYOTYPING|U|U|Y||3||39||INDUCTION TREATMENT|1970-11-28|1964-04-03|||||1964-12-24||1967-10-20
TRIAL STUDY 134XCP|IS|D8C78860-7893-4239-8F29-A0EE98C90310||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/KG|||||TITER||||LOW|NOT DONE|||CEREBROSPINAL FLUID|LIPEMIC|U|PULMONARY ANGIOGRAPHY|NA|U|NA||4||88||LONG-TERM FOLLOW-UP|1963-05-19|1960-03-14|||||1963-08-19||1972-10-22
TRIAL STUDY 134XCP|IS|D8C78860-7893-4239-8F29-A0EE98C90310||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||SPRAY|||||MMHG/L/MIN||||ABNORMAL|NOT DONE|||URINE|REFRIGERATED|NA|HPLC/MS|N|U|N||5||7||SCREENING|1962-10-29|1969-10-31|||||1972-04-22||1968-10-04
TRIAL STUDY 134XCP|IS|841D0118-C3F9-4169-B43E-D88CEB2795BA||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/SEC/1.73M2|||||FL||||LOW|NOT DONE|||AMNIOTIC FLUID|REFRIGERATED|N|PERCUSSION|U|U|Y||1||38||RUN-IN|1964-09-24|1964-05-11|||||1971-11-18||1967-03-10
TRIAL STUDY 134XCP|IS|841D0118-C3F9-4169-B43E-D88CEB2795BA||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/DAY|||||BE/ML||||ABNORMAL|NOT DONE|||BONE|LACTESCENT|N|CYSTOMETRY|U|NA|NA||2||58||BASELINE|1960-05-31|1967-09-19|||||1973-03-23||1963-03-25
TRIAL STUDY 134XCP|IS|841D0118-C3F9-4169-B43E-D88CEB2795BA||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UG/DOSE|||||CMH2O/ML||||LOW|NOT DONE|||CALCULUS|GELLED|U|FLOW MICROSCOPY|U|N|N||3||39||FOLLOW-UP|1970-06-04|1971-09-18|||||1969-12-09||1973-07-07
TRIAL STUDY 134XCP|IS|841D0118-C3F9-4169-B43E-D88CEB2795BA||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BOWL|||||MOL/DAY||||LOW|NOT DONE|||DISCHARGE|CONTAMINATED|NA|SPIRAL CT|U|U|Y||4||88||OPEN LABEL TREATMENT|1965-11-02|1966-08-21|||||1963-09-01||1968-05-16
TRIAL STUDY 134XCP|IS|841D0118-C3F9-4169-B43E-D88CEB2795BA||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ELISA UNIT/DOSE|||||LOG EID 50/DOSE||||NORMAL|NOT DONE|||ALVEOLAR AIR|THAWED|NA|MS/MS|N|N|NA||5||7||LONG-TERM FOLLOW-UP|1967-11-24|1969-12-18|||||1967-01-30||1960-08-05
TRIAL STUDY 134XCP|IS|9C3C0334-F7A4-4530-A6D3-574C039979E7||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^7/L|||||PMOL/10^9 CELLS||||HIGH|NOT DONE|||FLUID|LACTESCENT|U|DXA SCAN|N|Y|NA||1||38||INDUCTION TREATMENT|1970-10-14|1964-07-25|||||1973-08-16||1969-01-14
TRIAL STUDY 134XCP|IS|9C3C0334-F7A4-4530-A6D3-574C039979E7||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IU/DL|||||BEATS/MIN||||HIGH|NOT DONE|||PLEURAL TISSUE|CALCIFIED|U|INCISION-INDUCED BLEEDING METHOD|U|NA|Y||2||58||FOLLOW-UP|1967-01-05|1962-06-07|||||1961-05-01||1969-12-01
TRIAL STUDY 134XCP|IS|9C3C0334-F7A4-4530-A6D3-574C039979E7||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BEAM BREAKS|||||U/M2||||HIGH|NOT DONE|||ADIPOSE TISSUE|CLOTTED|NA|AURAMINE STAIN|Y|N|Y||3||39||CONTINUATION TREATMENT|1964-03-20|1969-02-11|||||1972-03-15||1963-11-05
TRIAL STUDY 134XCP|IS|9C3C0334-F7A4-4530-A6D3-574C039979E7||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/5X10^4 WBC|||||ENZYME U/L||||LOW|NOT DONE|||BASAL TEAR|HEMOLYZED|Y|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|NA|U|U||4||88||CONTINUATION TREATMENT|1960-09-23|1967-11-13|||||1961-02-09||1967-03-04
TRIAL STUDY 134XCP|IS|9C3C0334-F7A4-4530-A6D3-574C039979E7||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||L/MIN|||||PG/CELL||||ABNORMAL|NOT DONE|||PLATELET|CONTAMINATED|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|U|NA|U||5||7||INDUCTION TREATMENT|1962-01-22|1968-11-29|||||1961-07-03||1961-04-02
TRIAL STUDY 134XCP|IS|FE955CB9-9992-4521-8788-7597AF40F214||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||NCI|||||BEL||||LOW|NOT DONE|||SPUTUM|FRESH|Y|PERIPHERAL ANGIOGRAPHY|N|Y|Y||1||38||LONG-TERM FOLLOW-UP|1963-08-03|1971-12-13|||||1969-12-27||1968-11-14
TRIAL STUDY 134XCP|IS|FE955CB9-9992-4521-8788-7597AF40F214||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CMH2O*S/ML|||||AMFI||||HIGH|NOT DONE|||KERATINOCYTE|GELLED|NA|TRYPAN BLUE STAIN|U|NA|U||2||58||FOLLOW-UP|1960-06-07|1973-04-04|||||1966-11-16||1968-07-15
TRIAL STUDY 134XCP|IS|FE955CB9-9992-4521-8788-7597AF40F214||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U/G/H|||||BQ/KG||||ABNORMAL|NOT DONE|||LYSATE|ROOM TEMPERATURE|NA|HEMAGGLUTINATION ASSAY|N|U|Y||3||39||RUN-IN|1970-07-06|1966-03-05|||||1965-01-13||1968-02-15
TRIAL STUDY 134XCP|IS|FE955CB9-9992-4521-8788-7597AF40F214||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/KG/DAY|||||UG/KG/DAY||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|CLOTTED|U|FUNDUS PHOTOGRAPHY|U|NA|U||4||88||OBSERVATION|1963-08-16|1964-10-25|||||1972-08-03||1960-12-18
TRIAL STUDY 134XCP|IS|FE955CB9-9992-4521-8788-7597AF40F214||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SCM|||||NMOL/ML/MIN||||HIGH|NOT DONE|||CAPILLARY PLASMA|DRIED|NA|ATOMIC ABSORPTION SPECTROMETRY|Y|U|NA||5||7||INDUCTION TREATMENT|1960-11-23|1964-02-24|||||1968-06-17||1960-12-13
TRIAL STUDY 134XCP|IS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TBSP|||||MEQ/UL||||NORMAL|NOT DONE|||PUS|UNEXPECTED ODOR|NA|FLOW MICROSCOPY|Y|N|U||1||38||LONG-TERM FOLLOW-UP|1971-09-23|1966-01-07|||||1963-03-05||1968-07-25
TRIAL STUDY 134XCP|IS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/ML|||||CAPSULE||||ABNORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|DRIED|N|KARYOTYPING|U|Y|N||2||58||FOLLOW-UP|1973-07-23|1962-03-15|||||1961-12-21||1963-01-09
TRIAL STUDY 134XCP|IS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MU/L|||||UMOL/MIN||||HIGH|NOT DONE|||SPUTUM|LACTESCENT|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|U|U|Y||3||39||OPEN LABEL TREATMENT|1964-09-17|1970-10-02|||||1970-07-20||1960-12-14
TRIAL STUDY 134XCP|IS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MILE|||||ANSON U||||HIGH|NOT DONE|||TRANSUDATE|NON-HEMOLYZED|Y|ARTERIAL SPIN LABELING FUNCTIONAL MRI|NA|N|NA||4||88||TREATMENT|1963-11-06|1963-09-18|||||1973-05-11||1966-10-29
TRIAL STUDY 134XCP|IS|C4C89E29-ADFC-4883-87BA-FA0BDD37AB4D||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^3/HPF|||||MG/KG/WEEK||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|PARAFFIN-EMBEDDED|NA|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|U|NA||5||7||INDUCTION TREATMENT|1965-08-23|1972-08-14|||||1962-07-26||1964-01-03
TRIAL STUDY 134XCP|IS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TRANSDUCING UNIT/ML|||||MMOL/G||||NORMAL|NOT DONE|||PLATELET|ROOM TEMPERATURE|NA|OPTICAL COHERENCE TOMOGRAPHY|NA|N|U||1||38||FOLLOW-UP|1962-10-27|1966-06-10|||||1969-07-16||1964-02-16
TRIAL STUDY 134XCP|IS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||INHALATION|||||/100 WBC||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|FROZEN|N|ACCELERATOR MASS SPECTROMETRY|U|Y|N||2||58||INDUCTION TREATMENT|1970-09-24|1960-03-06|||||1967-05-12||1963-12-30
TRIAL STUDY 134XCP|IS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CI/MG|||||CMH2O*S2/ML||||LOW|NOT DONE|||EXUDATE|THAWED|N|MEDIASTINOSCOPY|Y|U|N||3||39||BASELINE|1965-08-17|1961-06-22|||||1967-06-21||1969-04-09
TRIAL STUDY 134XCP|IS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CM H2O|||||MV2/HZ||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|GELLED|Y|OBSERVATION|NA|U|Y||4||88||RUN-IN|1973-02-26|1969-08-14|||||1973-06-14||1972-05-09
TRIAL STUDY 134XCP|IS|FF087F6A-E9C7-4A01-B6CD-A95FF609F13E||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MV/SEC|||||M/SEC||||ABNORMAL|NOT DONE|||STOOL|GELLED|U|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NA|Y|NA||5||7||FOLLOW-UP|1968-01-21|1971-04-07|||||1962-09-16||1963-03-01
TRIAL STUDY 134XCP|IS|28B6CF51-A007-4CED-8247-37BD468F41C5||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UIU/DL|||||TBSP||||HIGH|NOT DONE|||EMOTIONAL TEAR|HEMOLYZED|Y|MICROBIAL CULTURE, LIQUID|N|U|NA||1||38||RUN-IN|1971-03-01|1967-01-25|||||1963-09-20||1970-08-10
TRIAL STUDY 134XCP|IS|28B6CF51-A007-4CED-8247-37BD468F41C5||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UG/L/H|||||LINEAR FT*LB||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|DRIED|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|N|U|N||2||58||INDUCTION TREATMENT|1964-11-08|1972-08-01|||||1970-08-29||1961-03-04
TRIAL STUDY 134XCP|IS|28B6CF51-A007-4CED-8247-37BD468F41C5||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||L/H|||||10^3/HPF||||NORMAL|NOT DONE|||PLATELET POOR PLASMA|CONCENTRATED|NA|DYNAMOMETRY|NA|N|Y||3||39||OBSERVATION|1969-10-03|1968-11-03|||||1972-05-02||1960-11-28
TRIAL STUDY 134XCP|IS|28B6CF51-A007-4CED-8247-37BD468F41C5||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||QUANTITY SUFFICIENT|||||UG/ANIMAL||||NORMAL|NOT DONE|||PLASMA|GELLED|Y|MICROBIAL CONCENTRATION|N|U|Y||4||88||OPEN LABEL TREATMENT|1973-03-26|1960-11-21|||||1965-04-03||1968-12-19
TRIAL STUDY 134XCP|IS|28B6CF51-A007-4CED-8247-37BD468F41C5||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/MIN|||||MSEC||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|CALCIFIED|N|PERIODIC ACID SCHIFF STAIN|U|NA|Y||5||7||BASELINE|1972-05-30|1960-03-30|||||1971-06-02||1963-02-18
TRIAL STUDY 134XCP|IS|4E600C41-1B27-4042-B48E-B60489701D2D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MIN/DAY|||||KPA/L/SEC||||ABNORMAL|NOT DONE|||EPITHELIAL CELL|FROZEN|NA|LISSAMINE GREEN STAIN|U|Y|Y||1||38||INDUCTION TREATMENT|1963-12-14|1973-06-21|||||1970-02-11||1973-08-14
TRIAL STUDY 134XCP|IS|4E600C41-1B27-4042-B48E-B60489701D2D||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||LOG10 PFU|||||MEQ/UL||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|CALCIFIED|U|CAPILLARY ELECTROPHORESIS|N|U|N||2||58||FOLLOW-UP|1967-09-06|1967-03-07|||||1968-10-11||1963-03-13
TRIAL STUDY 134XCP|IS|4E600C41-1B27-4042-B48E-B60489701D2D||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMOL/DAY|||||AMOL||||ABNORMAL|NOT DONE|||VENOUS CORD BLOOD|UNEXPECTED ODOR|U|QUANTITATIVE CORONARY ANGIOGRAPHY|U|U|Y||3||39||CONTINUATION TREATMENT|1969-09-08|1960-03-24|||||1970-04-23||1964-10-04
TRIAL STUDY 134XCP|IS|4E600C41-1B27-4042-B48E-B60489701D2D||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/MIN|||||LOG10 ELISA UNIT/DOSE||||LOW|NOT DONE|||SEBUM|CONTAMINATED|Y|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NA|NA|NA||4||88||RUN-IN|1967-01-07|1968-09-26|||||1967-06-28||1968-05-23
TRIAL STUDY 134XCP|IS|4E600C41-1B27-4042-B48E-B60489701D2D||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DMOL|||||UG/L FEU||||LOW|NOT DONE|||GASTRIC CONTENTS|FRESH|NA|NON-INVASIVE DIELECTRIC SENSING|NA|NA|U||5||7||TREATMENT|1964-08-06|1961-10-15|||||1971-08-09||1962-02-04
TRIAL STUDY 134XCP|IS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ML/S|||||MIN/DAY||||HIGH|NOT DONE|||STOOL|AGGLUTINATED|NA|SNELLEN EYE CHART|NA|U|Y||1||38||FOLLOW-UP|1963-04-15|1965-01-02|||||1972-02-05||1968-01-28
TRIAL STUDY 134XCP|IS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PMOL/DL|||||UG||||ABNORMAL|NOT DONE|||REFLEX TEAR|CONCENTRATED|U|GIEMSA STAIN|N|U|Y||2||58||CONTINUATION TREATMENT|1970-02-13|1969-02-25|||||1961-01-15||1966-06-29
TRIAL STUDY 134XCP|IS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/KG/DAY|||||CI/L||||NORMAL|NOT DONE|||HAIR|CALCIFIED|NA|ACCELERATOR MASS SPECTROMETRY|NA|Y|U||3||39||RUN-IN|1972-06-18|1967-04-10|||||1962-06-04||1968-10-09
TRIAL STUDY 134XCP|IS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UCI/KG|||||UG/ML/H||||ABNORMAL|NOT DONE|||SWABBED MATERIAL|GELLED|NA|ATOMIC ABSORPTION SPECTROMETRY|N|Y|Y||4||88||RUN-IN|1960-06-03|1971-07-29|||||1968-07-02||1967-08-02
TRIAL STUDY 134XCP|IS|1E162E13-C5F0-4892-BE7E-A2E6A2191DAD||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^6 CFU/ML|||||COPIES/ML||||LOW|NOT DONE|||COLOSTRUM|CALCIFIED|NA|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|U|U|U||5||7||CONTINUATION TREATMENT|1962-02-11|1967-03-29|||||1966-01-30||1963-09-20
TRIAL STUDY 134XCP|IS|00D760E7-DC21-41A8-AD28-FF48A5C21E83||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CMHG|||||NKAT/G HB||||LOW|NOT DONE|||ERYTHROCYTES|REFRIGERATED|NA|REFRACTOMETRY|Y|N|NA||1||38||BLINDED TREATMENT|1967-03-19|1966-04-23|||||1970-08-05||1969-05-14
TRIAL STUDY 134XCP|IS|00D760E7-DC21-41A8-AD28-FF48A5C21E83||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TRACE|||||L/H||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|CONTAMINATED|U|WESTERN BLOT|NA|U|Y||2||58||WASHOUT|1965-10-28|1971-12-30|||||1965-02-15||1963-01-05
TRIAL STUDY 134XCP|IS|00D760E7-DC21-41A8-AD28-FF48A5C21E83||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^9 ORGANISMS/MG|||||JAR||||LOW|NOT DONE|||INFRANATANT, SERUM|ICTERIC|N|MANUAL COUNT|NA|Y|U||3||39||OBSERVATION|1968-06-06|1961-12-12|||||1968-04-17||1962-02-01
TRIAL STUDY 134XCP|IS|00D760E7-DC21-41A8-AD28-FF48A5C21E83||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||KG/M2||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|CONCENTRATED|N|ISHIHARA COLOR PLATES|NA|U|U||4||88||BLINDED TREATMENT|1966-10-02|1961-05-22|||||1971-07-23||1966-08-22
TRIAL STUDY 134XCP|IS|00D760E7-DC21-41A8-AD28-FF48A5C21E83||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||HZ/S|||||UEQ||||HIGH|NOT DONE|||SWABBED MATERIAL|ICTERIC|Y|CENTRIFUGATION|Y|NA|NA||5||7||WASHOUT|1968-01-04|1963-07-07|||||1963-12-09||1973-06-02
TRIAL STUDY 134XCP|IS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DRUM|||||BQ/UL||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|THAWED|U|DIPSTICK|U|U|Y||1||38||FOLLOW-UP|1973-03-27|1973-06-21|||||1969-02-15||1967-02-22
TRIAL STUDY 134XCP|IS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DPM/0.5 ML|||||CMHG||||LOW|NOT DONE|||SMOOTH MUSCLE TISSUE|LIPEMIC|U|RULER MEASUREMENT METHOD|Y|U|U||2||58||OBSERVATION|1970-06-14|1973-07-15|||||1964-08-17||1967-06-22
TRIAL STUDY 134XCP|IS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PMOL/DAY|||||MV/SEC||||NORMAL|NOT DONE|||SALIVA|PARAFFIN-EMBEDDED|U|PLAQUE REDUCTION NEUTRALIZATION ASSAY|U|Y|NA||3||39||SCREENING|1963-05-20|1967-08-11|||||1973-05-11||1964-12-04
TRIAL STUDY 134XCP|IS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KG/CM|||||MONTHS||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|FROZEN|U|SINGLE-SLICE SPIRAL CT|Y|U|U||4||88||OPEN LABEL TREATMENT|1972-10-07|1969-02-07|||||1961-07-03||1971-09-07
TRIAL STUDY 134XCP|IS|946ABDE0-2C2B-48BB-8003-1BAEE37264F3||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MASK|||||NMOL BCE/MMOL||||HIGH|NOT DONE|||BONE MARROW MONONUCLEAR CELL|LIPEMIC|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|U|Y|Y||5||7||LONG-TERM FOLLOW-UP|1970-06-30|1960-05-15|||||1966-05-18||1964-05-19
TRIAL STUDY 134XCP|IS|4EC25C9E-F259-405B-8B7D-3C9640FB9748||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MMOL/DAY|||||BOTTLE||||LOW|NOT DONE|||RETICULOCYTES|UNEXPECTED ODOR|NA|NON-INVASIVE DIELECTRIC SENSING|N|NA|NA||1||38||BLINDED TREATMENT|1961-04-01|1962-03-23|||||1970-12-31||1972-02-03
TRIAL STUDY 134XCP|IS|4EC25C9E-F259-405B-8B7D-3C9640FB9748||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOSM/L|||||MG/DAY||||LOW|NOT DONE|||SYNOVIAL FLUID|UNEXPECTED ODOR|U|MULTIPLE BREATH WASHOUT|NA|N|NA||2||58||BLINDED TREATMENT|1963-08-23|1967-11-27|||||1972-06-04||1968-09-27
TRIAL STUDY 134XCP|IS|4EC25C9E-F259-405B-8B7D-3C9640FB9748||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L/S/KPA|||||CMH2O/ML||||HIGH|NOT DONE|||EXUDATE|HEMOLYZED|Y|ICP-MS|U|NA|N||3||39||LONG-TERM FOLLOW-UP|1960-09-21|1963-06-15|||||1962-01-21||1969-01-20
TRIAL STUDY 134XCP|IS|4EC25C9E-F259-405B-8B7D-3C9640FB9748||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^7 PFU|||||KS||||LOW|NOT DONE|||TUMOR TISSUE|NON-HEMOLYZED|U|CONGO RED STAIN|N|NA|NA||4||88||TREATMENT|1961-12-23|1966-03-18|||||1969-04-02||1963-03-24
TRIAL STUDY 134XCP|IS|4EC25C9E-F259-405B-8B7D-3C9640FB9748||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TUBERCULIN UNIT/ML|||||DPM/MG||||HIGH|NOT DONE|||LEUKOCYTE|UNEXPECTED ODOR|N|PHYSICAL EXAMINATION|Y|N|Y||5||7||RUN-IN|1971-12-05|1969-05-17|||||1970-09-04||1966-02-05
TRIAL STUDY 134XCP|IS|FF1CC617-040D-42E9-AD31-32E7B8DAED24||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||INHALATION|||||10^7 PFU||||ABNORMAL|NOT DONE|||MECONIUM|PARAFFIN-EMBEDDED|U|TARGETED GENOME SEQUENCING|NA|NA|N||1||38||INDUCTION TREATMENT|1972-07-22|1961-10-16|||||1967-03-26||1969-04-14
TRIAL STUDY 134XCP|IS|FF1CC617-040D-42E9-AD31-32E7B8DAED24||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UGEQ|||||TRACE||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|LIPEMIC|NA|LASER CAPTURE MICRODISSECTION|N|Y|NA||2||58||OPEN LABEL TREATMENT|1965-02-12|1964-02-09|||||1971-07-28||1965-06-04
TRIAL STUDY 134XCP|IS|FF1CC617-040D-42E9-AD31-32E7B8DAED24||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||QUANTITY SUFFICIENT|||||/10^4||||NORMAL|NOT DONE|||NAIL|HEMOLYZED|N|ACCELERATOR MASS SPECTROMETRY|Y|NA|U||3||39||OPEN LABEL TREATMENT|1969-01-26|1966-03-23|||||1960-04-23||1962-07-11
TRIAL STUDY 134XCP|IS|FF1CC617-040D-42E9-AD31-32E7B8DAED24||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/DOSE|||||MOL/DAY||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|REFRIGERATED|N|BRDU CELLULAR PROLIFERATION ASSAY|N|NA|N||4||88||BLINDED TREATMENT|1970-09-11|1971-04-19|||||1965-08-26||1964-03-16
TRIAL STUDY 134XCP|IS|FF1CC617-040D-42E9-AD31-32E7B8DAED24||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/KG/MIN|||||ECL UNIT||||NORMAL|NOT DONE|||BONE MARROW|LACTESCENT|N|MUGA|Y|U|N||5||7||CONTINUATION TREATMENT|1967-03-01|1973-01-26|||||1968-04-30||1962-04-20
TRIAL STUDY 134XCP|IS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DIP|||||MG/DL||||LOW|NOT DONE|||EXPIRED AIR|GELLED|NA|MRI|N|NA|N||1||38||OBSERVATION|1963-01-23|1961-03-27|||||1972-05-26||1964-11-30
TRIAL STUDY 134XCP|IS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MS/MMHG|||||PRESSOR UNITS||||HIGH|NOT DONE|||STOOL|ICTERIC|Y|SXA SCAN|U|U|N||2||58||OPEN LABEL TREATMENT|1969-05-19|1962-10-17|||||1973-02-07||1963-08-04
TRIAL STUDY 134XCP|IS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UEQ|||||EU||||ABNORMAL|NOT DONE|||CAPILLARY BLOOD|LACTESCENT|N|TRANSMISSION ELECTRON MICROSCOPY|Y|N|Y||3||39||WASHOUT|1960-11-28|1962-02-18|||||1963-09-13||1970-04-10
TRIAL STUDY 134XCP|IS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CMH2O/ML|||||MG/ML/MIN||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|THAWED|Y|IMMUNOTURBIDIMETRY|Y|N|U||4||88||OBSERVATION|1972-01-10|1970-10-21|||||1970-10-01||1970-07-05
TRIAL STUDY 134XCP|IS|F8A4AF92-256A-4ECF-9C87-036FA7E5BF53||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UCI|||||BQ/MG||||NORMAL|NOT DONE|||NAIL|ROOM TEMPERATURE|NA|CARDIAC THERMODILUTION|U|N|U||5||7||RUN-IN|1964-12-08|1964-07-06|||||1970-07-09||1967-10-31
TRIAL STUDY 134XCP|IS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||CI/UL||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|LACTESCENT|Y|APPLANATION TONOMETRY|NA|U|Y||1||38||CONTINUATION TREATMENT|1961-05-29|1965-07-09|||||1963-10-12||1961-07-13
TRIAL STUDY 134XCP|IS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||ENZYME U/G HB|||||/MS||||ABNORMAL|NOT DONE|||LOCHIA|LACTESCENT|U|AUTOREFRACTION|NA|N|NA||2||58||LONG-TERM FOLLOW-UP|1967-04-27|1960-01-25|||||1969-08-19||1966-04-21
TRIAL STUDY 134XCP|IS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CL|||||PM||||NORMAL|NOT DONE|||SPERMATOZOON|HEMOLYZED|Y|MANUAL CLOT DETECTION|U|Y|NA||3||39||TREATMENT|1972-02-07|1965-10-07|||||1971-10-15||1972-08-01
TRIAL STUDY 134XCP|IS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/KG|||||IU/KG||||ABNORMAL|NOT DONE|||DISCHARGE|AUTOLYZED|N|IMMUNOCHROMATOGRAPHY|NA|U|U||4||88||RUN-IN|1966-05-15|1972-09-17|||||1969-09-17||1968-05-07
TRIAL STUDY 134XCP|IS|BD3E97D8-A24F-49AA-8C3D-23C708A1B62F||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 ORGANISMS/ML|||||BQ/ML||||HIGH|NOT DONE|||DERMAL TISSUE|FRESH|NA|X-RAY|N|NA|U||5||7||LONG-TERM FOLLOW-UP|1966-01-25|1961-10-07|||||1971-06-13||1965-06-20
TRIAL STUDY 134XCP|IS|BFA83769-F31F-49AE-8C43-49046C719D69||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||EU|||||PACK YEAR||||ABNORMAL|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|ROOM TEMPERATURE|U|MICROSCOPY|U|U|NA||1||38||RUN-IN|1968-07-09|1969-08-02|||||1961-11-19||1969-02-12
TRIAL STUDY 134XCP|IS|BFA83769-F31F-49AE-8C43-49046C719D69||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BQ/UL|||||KAT||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|CONCENTRATED|U|HIGH RESOLUTION CT|U|N|U||2||58||SCREENING|1973-06-09|1960-09-09|||||1969-03-18||1963-05-18
TRIAL STUDY 134XCP|IS|BFA83769-F31F-49AE-8C43-49046C719D69||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GBQ/UG|||||PLUG||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|GELLED|NA|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|Y|NA||3||39||BLINDED TREATMENT|1970-11-30|1970-01-13|||||1973-05-27||1962-10-31
TRIAL STUDY 134XCP|IS|BFA83769-F31F-49AE-8C43-49046C719D69||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/M2|||||MESF||||ABNORMAL|NOT DONE|||EXPIRED AIR|UNEXPECTED ODOR|U|FLUORESCEIN STAIN|Y|Y|U||4||88||FOLLOW-UP|1970-12-29|1968-05-04|||||1971-04-17||1963-12-27
TRIAL STUDY 134XCP|IS|BFA83769-F31F-49AE-8C43-49046C719D69||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/G/MIN|||||ML/BEAT||||HIGH|NOT DONE|||SPERMATOZOON|ROOM TEMPERATURE|N|CRYOSCOPY|Y|NA|U||5||7||INDUCTION TREATMENT|1964-01-17|1972-08-28|||||1968-02-16||1964-03-24
TRIAL STUDY 134XCP|IS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^4 CFU/ML|||||RAD||||NORMAL|NOT DONE|||SUPERNATANT, SERUM|FRESH|N|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|U|U|Y||1||38||INDUCTION TREATMENT|1962-03-08|1960-05-10|||||1962-02-08||1968-01-29
TRIAL STUDY 134XCP|IS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||FL|||||SHOCK WAVE||||LOW|NOT DONE|||EXUDATE|SOLIDIFIED|N|FLUOROSCOPY|Y|NA|NA||2||58||BASELINE|1966-04-11|1969-06-06|||||1970-05-29||1972-04-20
TRIAL STUDY 134XCP|IS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BAR|||||GLOBULE||||HIGH|NOT DONE|||DISCHARGE|CALCIFIED|NA|CELL OF ORIGIN ASSAY|NA|N|N||3||39||RUN-IN|1962-09-13|1965-05-04|||||1966-07-05||1961-01-13
TRIAL STUDY 134XCP|IS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/KG/DOSE|||||/MIN||||ABNORMAL|NOT DONE|||PLATELET|ROOM TEMPERATURE|U|DYNAMIC LIGHT SCATTERING|Y|U|U||4||88||OPEN LABEL TREATMENT|1962-11-26|1962-08-21|||||1962-06-09||1971-05-30
TRIAL STUDY 134XCP|IS|6D52A8E1-CC3D-4D85-AAEC-264743FDA85E||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||RATIO|||||MN||||NORMAL|NOT DONE|||PERITONEAL FLUID|NON-HEMOLYZED|N|MRI|Y|U|U||5||7||CONTINUATION TREATMENT|1970-05-20|1968-04-04|||||1971-06-11||1963-04-01
TRIAL STUDY 134XCP|IS|91838668-D463-4728-A581-2E1987592885||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ML/G/DAY|||||MSEC||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|LACTESCENT|U|NON-CONTACT SPECULAR MICROSCOPY|Y|Y|NA||1||38||WASHOUT|1968-12-22|1969-01-24|||||1968-11-22||1967-01-04
TRIAL STUDY 134XCP|IS|91838668-D463-4728-A581-2E1987592885||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/M2/DAY|||||UM/S||||NORMAL|NOT DONE|||PUS|NON-HEMOLYZED|NA|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NA|NA|N||2||58||LONG-TERM FOLLOW-UP|1964-04-15|1968-01-17|||||1963-04-14||1965-11-30
TRIAL STUDY 134XCP|IS|91838668-D463-4728-A581-2E1987592885||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CI/G|||||UGEQ||||NORMAL|NOT DONE|||BLOOD|THAWED|N|COMPLEMENT FIXATION|Y|Y|N||3||39||RUN-IN|1972-10-21|1964-08-16|||||1967-07-07||1973-02-24
TRIAL STUDY 134XCP|IS|91838668-D463-4728-A581-2E1987592885||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||HENRY|||||NG/L||||LOW|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|HEMOLYZED|NA|ETDRS EYE CHART|N|U|U||4||88||RUN-IN|1971-01-13|1960-04-04|||||1970-09-12||1965-09-16
TRIAL STUDY 134XCP|IS|91838668-D463-4728-A581-2E1987592885||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DEG|||||DMOL||||LOW|NOT DONE|||CERUMEN|CLOTTED|NA|INCISION-INDUCED BLEEDING METHOD|Y|Y|U||5||7||RUN-IN|1972-06-23|1964-01-28|||||1964-02-11||1968-05-28
TRIAL STUDY 134XCP|IS|DE440A90-82D5-4269-A48B-47E2F5495440||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||EID 50/ML|||||UGEQ||||HIGH|NOT DONE|||DIALYSIS FLUID|LIPEMIC|Y|IMMUNOCHROMATOGRAPHY|NA|NA|N||1||38||LONG-TERM FOLLOW-UP|1972-01-29|1962-03-07|||||1968-12-19||1968-06-18
TRIAL STUDY 134XCP|IS|DE440A90-82D5-4269-A48B-47E2F5495440||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MMOL/L|||||ANTI-XA IU||||ABNORMAL|NOT DONE|||MONOCYTE|PARAFFIN-EMBEDDED|Y|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|NA|U||2||58||BASELINE|1969-01-10|1971-08-05|||||1963-05-09||1969-06-21
TRIAL STUDY 134XCP|IS|DE440A90-82D5-4269-A48B-47E2F5495440||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CONTAINER|||||TITER||||HIGH|NOT DONE|||PROSTATIC FLUID|CONTAMINATED|Y|THERMAL IONIZATION MASS SPECTROMETRY|NA|Y|N||3||39||INDUCTION TREATMENT|1973-04-10|1967-11-14|||||1971-10-16||1969-01-02
TRIAL STUDY 134XCP|IS|DE440A90-82D5-4269-A48B-47E2F5495440||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L|||||POUCH||||LOW|NOT DONE|||SOFT TISSUE|NON-HEMOLYZED|Y|MICROBIAL CULTURE, SOLID|NA|NA|N||4||88||TREATMENT|1968-09-28|1962-05-11|||||1972-11-10||1971-09-19
TRIAL STUDY 134XCP|IS|DE440A90-82D5-4269-A48B-47E2F5495440||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||VP/DOSE|||||UG/H||||HIGH|NOT DONE|||COLOSTRUM|FROZEN|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|NA|N|N||5||7||OBSERVATION|1973-06-27|1971-05-08|||||1971-05-24||1971-10-17
TRIAL STUDY 134XCP|IS|74CA3A61-3179-43F1-8721-2582F50C44EF||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MOL/MG|||||BQ||||LOW|NOT DONE|||MECONIUM|ROOM TEMPERATURE|U|MECHANICAL CLOT DETECTION|N|NA|N||1||38||LONG-TERM FOLLOW-UP|1962-12-23|1963-03-10|||||1967-02-04||1962-08-12
TRIAL STUDY 134XCP|IS|74CA3A61-3179-43F1-8721-2582F50C44EF||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||TSP EQ|||||PA||||LOW|NOT DONE|||COLOSTRUM|ROOM TEMPERATURE|Y|DIFFUSION WEIGHTED MRI|U|Y|N||2||58||RUN-IN|1968-03-09|1961-11-30|||||1963-02-21||1970-05-14
TRIAL STUDY 134XCP|IS|74CA3A61-3179-43F1-8721-2582F50C44EF||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||RFU|||||10^9 CFU||||HIGH|NOT DONE|||MONOCYTE|LACTESCENT|N|ACID FAST STAIN|Y|U|NA||3||39||BASELINE|1968-03-11|1965-11-06|||||1969-12-04||1972-05-25
TRIAL STUDY 134XCP|IS|74CA3A61-3179-43F1-8721-2582F50C44EF||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||M3|||||TESLA||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|DRIED|U|CRYOSCOPY|U|Y|U||4||88||FOLLOW-UP|1972-03-10|1969-10-04|||||1968-01-16||1960-10-30
TRIAL STUDY 134XCP|IS|74CA3A61-3179-43F1-8721-2582F50C44EF||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/KG|||||PACK||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CLOTTED|NA|TWO-COLOR MICROARRAY|U|U|N||5||7||SCREENING|1966-06-03|1963-11-27|||||1965-04-10||1972-08-12
TRIAL STUDY 134XCP|IS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/2500 WBC|||||U/KG||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CLOTTED|Y|NON-CONTACT SPECULAR MICROSCOPY|N|Y|U||1||38||OPEN LABEL TREATMENT|1972-08-15|1973-05-20|||||1963-11-26||1966-06-23
TRIAL STUDY 134XCP|IS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG|||||CY/CM||||ABNORMAL|NOT DONE|||VENOUS PLASMA|SOLIDIFIED|NA|ELLA|Y|Y|U||2||58||OPEN LABEL TREATMENT|1972-09-02|1973-03-23|||||1960-08-01||1971-07-26
TRIAL STUDY 134XCP|IS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DIOPTER|||||PMOL/DL||||NORMAL|NOT DONE|||SPUTUM|CONCENTRATED|NA|GC/FID|N|N|N||3||39||SCREENING|1967-02-17|1972-05-06|||||1972-02-24||1960-08-25
TRIAL STUDY 134XCP|IS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||GPELISA UNIT/ML|||||%/S||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|Y|SCINTIGRAPHY|N|U|Y||4||88||LONG-TERM FOLLOW-UP|1963-10-02|1968-01-13|||||1972-11-30||1970-02-14
TRIAL STUDY 134XCP|IS|B16F2A3D-7DA3-4E50-AC6D-CA9F209A86CE||5||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||PKAT/L|||||KM||||HIGH|NOT DONE|||MENSTRUAL BLOOD|SOLIDIFIED|Y|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|N|NA||5||7||TREATMENT|1968-04-11|1963-01-23|||||1970-07-17||1969-05-21
TRIAL STUDY 134XCP|IS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6/L|||||RING||||HIGH|NOT DONE|||BONE|CALCIFIED|N|MECHANICAL CLOT DETECTION|U|U|U||1||38||BLINDED TREATMENT|1970-01-31|1968-01-23|||||1960-05-08||1968-09-06
TRIAL STUDY 134XCP|IS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||CCID 50/ML|||||G/DAY||||HIGH|NOT DONE|||ABSCESS FLUID|AGGLUTINATED|NA|LIGHT MICROSCOPY|U|U|Y||2||58||INDUCTION TREATMENT|1963-10-29|1967-05-30|||||1965-08-16||1969-02-20
TRIAL STUDY 134XCP|IS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UMOL/DAY|||||/5X10^4 WBC||||LOW|NOT DONE|||ADIPOSE TISSUE|CONCENTRATED|Y|MULTIPLEXED BEAD BASED IMMUNOASSAY|U|U|Y||3||39||LONG-TERM FOLLOW-UP|1972-07-03|1968-11-03|||||1965-04-30||1968-05-09
TRIAL STUDY 134XCP|IS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MOL/DAY|||||PPTR||||LOW|NOT DONE|||ALVEOLAR AIR|CLOTTED|Y|SICKLE CELL SOLUBILITY TEST|NA|U|NA||4||88||INDUCTION TREATMENT|1971-11-10|1964-08-11|||||1964-05-31||1966-06-15
TRIAL STUDY 134XCP|IS|AE1FC2A0-5A47-4AB3-B1A5-0E5D033598BE||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^7 TCID 50/DOSE|||||TAMPON||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|ICTERIC|NA|DIPSTICK|U|U|Y||5||7||INDUCTION TREATMENT|1964-12-30|1961-07-15|||||1971-12-28||1972-11-12
TRIAL STUDY 134XCP|IS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||UMOL/L/H|||||SV||||ABNORMAL|NOT DONE|||LEUKOCYTE|ICTERIC|NA|FLOCCULATION, CHARCOAL ENHANCED|U|N|N||1||38||TREATMENT|1960-01-25|1966-02-11|||||1964-10-02||1962-03-05
TRIAL STUDY 134XCP|IS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMOL/MOL|||||GENEQ||||LOW|NOT DONE|||DIALYSIS FLUID|THAWED|U|MICROARRAY|U|Y|N||2||58||LONG-TERM FOLLOW-UP|1967-11-04|1970-05-23|||||1971-11-06||1969-09-19
TRIAL STUDY 134XCP|IS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||KIU|||||MMOL/G||||ABNORMAL|NOT DONE|||ERYTHROCYTES|ICTERIC|NA|ANTIBIOTIC AGAR SCREEN|U|Y|Y||3||39||OPEN LABEL TREATMENT|1962-03-25|1962-08-03|||||1960-10-23||1971-09-11
TRIAL STUDY 134XCP|IS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^6 ORGANISMS|||||QUANTITY SUFFICIENT||||HIGH|NOT DONE|||GASTRIC CONTENTS|LACTESCENT|N|ANGIOGRAPHY|U|NA|NA||4||88||TREATMENT|1965-08-13|1961-08-31|||||1965-03-09||1961-10-10
TRIAL STUDY 134XCP|IS|3F3D60F6-E32A-46FA-9A55-396F9A19AD27||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL/MOL|||||10^6 COPIES/ML||||NORMAL|NOT DONE|||VENOUS PLASMA|CALCIFIED|U|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|NA|Y||5||7||INDUCTION TREATMENT|1970-10-15|1966-07-20|||||1973-02-14||1965-03-13
TRIAL STUDY 134XCP|IS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BU|||||M3||||LOW|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CALCIFIED|N|THIN SMEAR|U|NA|NA||1||38||RUN-IN|1962-09-22|1960-04-19|||||1966-03-08||1960-02-09
TRIAL STUDY 134XCP|IS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DRAM|||||COAT||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|SOLIDIFIED|Y|PULMONARY ANGIOGRAPHY|Y|Y|N||2||58||BLINDED TREATMENT|1965-07-31|1967-07-13|||||1966-12-03||1961-12-01
TRIAL STUDY 134XCP|IS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||/7.5 ML|||||UMOL/MIN||||NORMAL|NOT DONE|||EMOTIONAL TEAR|UNEXPECTED ODOR|NA|MS/MS|Y|N|NA||3||39||RUN-IN|1960-10-11|1967-06-06|||||1960-05-04||1972-08-10
TRIAL STUDY 134XCP|IS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||KCAL/DAY|||||S^-1(%O2)^-1||||HIGH|NOT DONE|||PUS|UNEXPECTED ODOR|Y|PHASE-CONTRAST MRI|NA|U|NA||4||88||WASHOUT|1962-03-27|1961-04-29|||||1973-04-10||1960-07-09
TRIAL STUDY 134XCP|IS|7EDE94C5-F4F6-41A0-B0A8-89F5E13ACE86||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ABSORBANCE U/ML|||||ML/BEAT||||HIGH|NOT DONE|||DERMAL TISSUE|HEMOLYZED|NA|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|Y|NA|Y||5||7||OPEN LABEL TREATMENT|1966-05-05|1971-07-20|||||1970-03-19||1964-08-22
TRIAL STUDY 134XCP|IS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UL/ML|||||MEQ/KG||||LOW|NOT DONE|||PLASMA|REFRIGERATED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|NA|U||1||38||FOLLOW-UP|1970-03-06|1968-12-16|||||1964-04-30||1971-12-18
TRIAL STUDY 134XCP|IS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PPTR|||||10^6 ORGANISMS/ML||||HIGH|NOT DONE|||INFRANATANT, SERUM|FROZEN|U|AUTOMATED COUNT|N|N|NA||2||58||RUN-IN|1973-02-26|1968-10-20|||||1966-11-17||1961-12-27
TRIAL STUDY 134XCP|IS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^8/L|||||NMOL/L/H||||ABNORMAL|NOT DONE|||PLASMA|AGGLUTINATED|U|AUSCULTATION|NA|NA|NA||3||39||LONG-TERM FOLLOW-UP|1964-08-17|1966-08-18|||||1965-08-21||1971-11-01
TRIAL STUDY 134XCP|IS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/DL|||||UG/KG||||HIGH|NOT DONE|||PUS|LIPEMIC|Y|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|U|NA|N||4||88||SCREENING|1967-08-30|1970-04-07|||||1970-12-20||1966-06-15
TRIAL STUDY 134XCP|IS|70ECA05B-727E-4B2B-A9DF-7F60C40FCEE2||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MONTHS|||||GY/H||||ABNORMAL|NOT DONE|||PUS|LACTESCENT|NA|CYSTOSCOPY|Y|NA|U||5||7||BASELINE|1973-05-03|1961-09-19|||||1967-11-09||1963-03-14
TRIAL STUDY 134XCP|IS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PT_US|||||ML/KG/H||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|NON-HEMOLYZED|N|MICROBIAL CULTURE, LIQUID|N|U|N||1||38||FOLLOW-UP|1968-11-15|1964-11-19|||||1961-11-23||1963-04-20
TRIAL STUDY 134XCP|IS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PACKET|||||MOSM||||ABNORMAL|NOT DONE|||INTERSTITIAL FLUID|ICTERIC|Y|NEXT GENERATION TARGETED SEQUENCING|Y|Y|NA||2||58||OPEN LABEL TREATMENT|1966-01-07|1972-11-06|||||1964-02-17||1973-08-16
TRIAL STUDY 134XCP|IS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PA|||||UMOL/MIN||||NORMAL|NOT DONE|||VITREOUS HUMOR|PARAFFIN-EMBEDDED|Y|PHOTOMETRY|N|U|U||3||39||TREATMENT|1972-12-13|1972-08-02|||||1961-04-17||1961-01-09
TRIAL STUDY 134XCP|IS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 IU/ML|||||ARBITRARY U||||HIGH|NOT DONE|||SPUTUM|CLOTTED|NA|CONGO RED STAIN|Y|Y|U||4||88||BASELINE|1962-08-14|1962-02-28|||||1964-09-21||1963-01-14
TRIAL STUDY 134XCP|IS|C34E6498-9F9C-4F9A-82AE-6B7331AD8EE9||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMOL/KG|||||UG/L/H||||LOW|NOT DONE|||SWABBED MATERIAL|CONTAMINATED|U|MALDI-TOF|NA|Y|U||5||7||CONTINUATION TREATMENT|1965-03-20|1970-02-09|||||1968-05-15||1963-01-16
TRIAL STUDY 134XCP|IS|687E56D1-7E45-4598-819A-A0D8D770F406||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/G/H|||||CM/MIN||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|FRESH|NA|OPTICAL COHERENCE TOMOGRAPHY|Y|NA|Y||1||38||SCREENING|1969-03-29|1972-10-19|||||1960-04-16||1968-09-22
TRIAL STUDY 134XCP|IS|687E56D1-7E45-4598-819A-A0D8D770F406||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/L/SEC|||||MMOL/S||||NORMAL|NOT DONE|||SPERMATOZOON|UNEXPECTED ODOR|NA|MIGET|N|U|Y||2||58||FOLLOW-UP|1970-11-15|1969-02-16|||||1973-01-22||1971-07-31
TRIAL STUDY 134XCP|IS|687E56D1-7E45-4598-819A-A0D8D770F406||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GBQ/G|||||BP||||NORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|CLOTTED|N|PATHOLOGICAL EVALUATION|Y|N|N||3||39||BLINDED TREATMENT|1972-08-09|1968-12-27|||||1963-08-26||1965-02-12
TRIAL STUDY 134XCP|IS|687E56D1-7E45-4598-819A-A0D8D770F406||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||FOZ_US|||||MMHG*MIN/L||||LOW|NOT DONE|||ALVEOLAR AIR|CLOTTED|Y|HANSEL STAIN|Y|Y|N||4||88||FOLLOW-UP|1966-07-01|1964-08-13|||||1962-02-23||1965-10-22
TRIAL STUDY 134XCP|IS|687E56D1-7E45-4598-819A-A0D8D770F406||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/L/H|||||%||||HIGH|NOT DONE|||MENSTRUAL BLOOD|AUTOLYZED|NA|LEAD CITRATE STAIN|Y|N|NA||5||7||FOLLOW-UP|1972-08-29|1964-04-17|||||1965-12-24||1960-09-30
TRIAL STUDY 134XCP|IS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GBQ/UG|||||/CMH2O||||HIGH|NOT DONE|||LOCHIA|FROZEN|Y|NEXT GENERATION SEQUENCING|Y|U|N||1||38||WASHOUT|1966-02-09|1967-08-25|||||1969-02-27||1969-10-21
TRIAL STUDY 134XCP|IS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UGEQ|||||CCID 50/ML||||HIGH|NOT DONE|||SALIVA|PARAFFIN-EMBEDDED|Y|PAP STAIN|U|Y|N||2||58||WASHOUT|1961-11-08|1971-07-16|||||1963-01-20||1964-07-17
TRIAL STUDY 134XCP|IS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CCID 50/ML|||||MG/KG/H||||NORMAL|NOT DONE|||PERITONEAL FLUID|CLOTTED|U|MODIFIED ACID FAST STAIN|NA|NA|Y||3||39||RUN-IN|1960-05-27|1970-11-19|||||1961-07-28||1972-03-18
TRIAL STUDY 134XCP|IS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^7 TCID 50/DOSE|||||PNU/ML||||NORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|REFRIGERATED|Y|CONTRAST ENHANCED CT SCAN|U|N|Y||4||88||INDUCTION TREATMENT|1968-06-06|1969-03-12|||||1961-01-17||1970-06-07
TRIAL STUDY 134XCP|IS|FA25647C-7E2D-4FD8-9A76-83B8CF8AB849||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DRUM|||||IU/L||||HIGH|NOT DONE|||BONE MARROW|NON-HEMOLYZED|Y|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|N|U|NA||5||7||RUN-IN|1966-08-29|1966-05-05|||||1965-11-04||1967-01-19
TRIAL STUDY 134XCP|IS|F536FDD9-881B-41AD-B863-FE8AB14062A1||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PMOL|||||OHM||||ABNORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|FROZEN|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|NA|U|NA||1||38||LONG-TERM FOLLOW-UP|1967-05-12|1961-08-14|||||1973-07-16||1973-03-12
TRIAL STUDY 134XCP|IS|F536FDD9-881B-41AD-B863-FE8AB14062A1||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^9 ORGANISMS/G|||||DL||||LOW|NOT DONE|||EPIDERMAL TISSUE|AUTOLYZED|N|COMPLEMENT FIXATION|N|U|N||2||58||OBSERVATION|1966-08-10|1961-06-04|||||1970-04-17||1960-03-10
TRIAL STUDY 134XCP|IS|F536FDD9-881B-41AD-B863-FE8AB14062A1||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MMOL/MOL|||||NU/CL||||HIGH|NOT DONE|||VITREOUS HUMOR|NON-HEMOLYZED|N|TRYPAN BLUE STAIN|NA|U|U||3||39||BLINDED TREATMENT|1973-05-09|1971-09-09|||||1962-05-21||1971-07-07
TRIAL STUDY 134XCP|IS|F536FDD9-881B-41AD-B863-FE8AB14062A1||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||100 IU/ML|||||ML/MMHG/MIN/L||||NORMAL|NOT DONE|||KERATINOCYTE|THAWED|U|MANUAL COUNT|Y|U|NA||4||88||SCREENING|1968-01-13|1973-02-21|||||1965-04-17||1972-02-12
TRIAL STUDY 134XCP|IS|F536FDD9-881B-41AD-B863-FE8AB14062A1||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MG/KG/WEEK|||||10^10/L||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|PARAFFIN-EMBEDDED|NA|FLUORESCENT LIFETIME IMAGING MICROSCOPY|NA|NA|NA||5||7||TREATMENT|1960-02-17|1962-05-04|||||1967-11-07||1967-04-05
TRIAL STUDY 134XCP|IS|CB726766-A812-45B3-95CA-D1AD8F697FD3||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||VG/KG|||||MMOL/KG||||NORMAL|NOT DONE|||AQUEOUS HUMOR|FROZEN|NA|WHOLE EXOME SEQUENCING|U|U|U||1||38||OPEN LABEL TREATMENT|1970-01-03|1962-05-19|||||1961-05-29||1966-12-09
TRIAL STUDY 134XCP|IS|CB726766-A812-45B3-95CA-D1AD8F697FD3||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||INHALATION|||||MILE||||LOW|NOT DONE|||LAVAGE FLUID|FROZEN|U|BAC ACGH|NA|NA|NA||2||58||OBSERVATION|1971-10-14|1970-07-02|||||1968-07-27||1962-06-06
TRIAL STUDY 134XCP|IS|CB726766-A812-45B3-95CA-D1AD8F697FD3||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MG/CM2|||||TRANSDUCING UNIT/ML||||HIGH|NOT DONE|||PLASMA|AUTOLYZED|Y|PULMONARY ANGIOGRAPHY|NA|NA|Y||3||39||RUN-IN|1970-05-30|1964-03-01|||||1967-11-05||1965-08-27
TRIAL STUDY 134XCP|IS|CB726766-A812-45B3-95CA-D1AD8F697FD3||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PMOL|||||MV/SEC||||HIGH|NOT DONE|||BASAL TEAR|REFRIGERATED|Y|FREEZING POINT DEPRESSION|NA|NA|U||4||88||WASHOUT|1961-11-07|1965-11-13|||||1970-06-11||1962-07-30
TRIAL STUDY 134XCP|IS|CB726766-A812-45B3-95CA-D1AD8F697FD3||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||NEWTON|||||OD UNIT||||NORMAL|NOT DONE|||EMESIS|HEMOLYZED|N|CLOT DETECTION|Y|U|NA||5||7||LONG-TERM FOLLOW-UP|1965-05-01|1970-07-23|||||1969-05-13||1966-08-27
TRIAL STUDY 134XCP|IS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/M2|||||PMOL/10^9 CELLS||||LOW|NOT DONE|||CELL PELLET|AUTOLYZED|Y|PHASE-CONTRAST MRI|NA|Y|NA||1||38||BASELINE|1972-08-12|1965-05-14|||||1973-06-15||1963-02-07
TRIAL STUDY 134XCP|IS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^9 CFU|||||UV2||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|N|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|N|U|N||2||58||INDUCTION TREATMENT|1968-09-06|1972-01-17|||||1965-01-15||1965-04-20
TRIAL STUDY 134XCP|IS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MNFI|||||PRESSOR UNITS||||HIGH|NOT DONE|||MUCUS|GELLED|N|KNEMOMETRY|N|N|U||3||39||FOLLOW-UP|1964-02-16|1967-09-15|||||1961-07-25||1961-01-06
TRIAL STUDY 134XCP|IS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BEAM BREAKS|||||UG/G/MIN||||HIGH|NOT DONE|||SALIVA|DRIED|Y|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|N|NA|N||4||88||OBSERVATION|1968-11-03|1972-01-02|||||1973-07-31||1973-03-22
TRIAL STUDY 134XCP|IS|1CC00AA0-6D99-4C72-B211-A2DD3F36D830||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/L/H|||||UU/L||||LOW|NOT DONE|||ALVEOLAR AIR|NON-HEMOLYZED|Y|MAGNETIC RESONANCE ANGIOGRAPHY|Y|Y|N||5||7||LONG-TERM FOLLOW-UP|1970-02-10|1961-12-27|||||1970-04-01||1970-10-16
TRIAL STUDY 134XCP|IS|20DC654F-595C-410D-A340-465A23434D42||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UGEQ/L|||||MMU/ML||||LOW|NOT DONE|||CERVICOVAGINAL SECRETION|THAWED|NA|CT SCAN|U|N|N||1||38||CONTINUATION TREATMENT|1972-08-26|1960-03-30|||||1960-11-10||1973-06-09
TRIAL STUDY 134XCP|IS|20DC654F-595C-410D-A340-465A23434D42||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PFU/ANIMAL|||||MS2||||NORMAL|NOT DONE|||CORD BLOOD|FROZEN|NA|MICROPARTICLE ENZYME IMMUNOASSAY|U|N|U||2||58||WASHOUT|1964-09-24|1969-08-02|||||1963-06-09||1960-11-06
TRIAL STUDY 134XCP|IS|20DC654F-595C-410D-A340-465A23434D42||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UG/G/DAY|||||CFU/G||||NORMAL|NOT DONE|||TRANSUDATE|AGGLUTINATED|U|AURAMINE STAIN|Y|NA|U||3||39||CONTINUATION TREATMENT|1970-05-13|1969-04-14|||||1963-10-08||1972-02-22
TRIAL STUDY 134XCP|IS|20DC654F-595C-410D-A340-465A23434D42||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 CFU|||||DNA COPIES/UG||||NORMAL|NOT DONE|||EXPIRED AIR|CONTAMINATED|Y|HEMATOXYLIN AND EOSIN STAIN|NA|Y|NA||4||88||INDUCTION TREATMENT|1966-06-23|1972-08-23|||||1966-09-27||1970-12-25
TRIAL STUDY 134XCP|IS|20DC654F-595C-410D-A340-465A23434D42||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MIN*MG/ML|||||NSEC||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|LACTESCENT|Y|IMMUNOCHEMILUMINOMETRIC ASSAY|N|N|NA||5||7||TREATMENT|1966-01-26|1968-05-28|||||1971-06-17||1972-10-11
TRIAL STUDY 134XCP|IS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/G/H|||||SV||||LOW|NOT DONE|||BILE|AUTOLYZED|U|MASS SPECTROMETRY|Y|Y|NA||1||38||RUN-IN|1971-03-20|1966-05-05|||||1968-08-05||1963-06-03
TRIAL STUDY 134XCP|IS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DIOPTER|||||PFU||||ABNORMAL|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|AGGLUTINATED|N|INFRARED SPECTROMETRY|N|Y|N||2||58||OBSERVATION|1965-01-28|1967-02-14|||||1961-11-28||1961-05-25
TRIAL STUDY 134XCP|IS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||UCI/L|||||HENRY||||ABNORMAL|NOT DONE|||GASTRIC FLUID|SOLIDIFIED|Y|HEMATOXYLIN AND EOSIN STAIN|NA|U|U||3||39||INDUCTION TREATMENT|1969-03-26|1969-03-06|||||1962-12-19||1970-09-28
TRIAL STUDY 134XCP|IS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MU|||||AFU||||NORMAL|NOT DONE|||PERITONEAL FLUID|FROZEN|Y|CONGO RED STAIN|U|N|Y||4||88||OPEN LABEL TREATMENT|1968-09-28|1968-07-26|||||1960-12-07||1971-08-10
TRIAL STUDY 134XCP|IS|3AFCED00-B717-49B6-ADA0-5E321C97D0A1||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||10^6/L|||||LM||||HIGH|NOT DONE|||ADIPOSE TISSUE|FRESH|N|SMEAR|NA|N|NA||5||7||RUN-IN|1962-11-12|1971-04-07|||||1970-06-17||1971-09-24
TRIAL STUDY 134XCP|IS|4EA8DC88-09C8-4954-A469-D8E12F01CB56||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 ORGANISMS|||||PRESSOR UNITS||||ABNORMAL|NOT DONE|||LYMPH|PARAFFIN-EMBEDDED|Y|WHOLE EXOME SEQUENCING|N|U|NA||1||38||RUN-IN|1970-01-07|1960-11-11|||||1972-09-26||1968-06-19
TRIAL STUDY 134XCP|IS|4EA8DC88-09C8-4954-A469-D8E12F01CB56||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CI/ML|||||ML/KG||||NORMAL|NOT DONE|||INFRANATANT, PLEURAL FLUID|LIPEMIC|Y|IMMUNOASSAY|Y|NA|Y||2||58||OBSERVATION|1972-10-14|1961-12-19|||||1973-04-10||1960-04-22
TRIAL STUDY 134XCP|IS|4EA8DC88-09C8-4954-A469-D8E12F01CB56||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||V|||||USEC||||ABNORMAL|NOT DONE|||SALIVA|FROZEN|N|U-HPLC/MS/MS|Y|N|N||3||39||TREATMENT|1965-06-06|1970-12-06|||||1965-04-14||1972-09-19
TRIAL STUDY 134XCP|IS|4EA8DC88-09C8-4954-A469-D8E12F01CB56||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||KS|||||TRACE||||HIGH|NOT DONE|||WHITE MATTER TISSUE|CALCIFIED|NA|THICK SMEAR|NA|U|Y||4||88||OPEN LABEL TREATMENT|1963-07-28|1966-11-17|||||1970-09-09||1968-04-14
TRIAL STUDY 134XCP|IS|4EA8DC88-09C8-4954-A469-D8E12F01CB56||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||VIRTUAL PIXEL|||||MAMP||||NORMAL|NOT DONE|||KERATINOCYTE|FRESH|Y|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|N|U|N||5||7||OPEN LABEL TREATMENT|1969-07-08|1966-06-07|||||1973-08-24||1970-04-02
TRIAL STUDY 134XCP|IS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||L/H|||||HEP||||ABNORMAL|NOT DONE|||DISCHARGE|REFRIGERATED|NA|REBOUND TONOMETRY|N|Y|NA||1||38||LONG-TERM FOLLOW-UP|1972-05-29|1969-01-07|||||1960-04-19||1963-11-13
TRIAL STUDY 134XCP|IS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DIOPTER|||||POINT||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|SOLIDIFIED|N|ANTIMICROBIAL COMBINATION TESTING|NA|N|U||2||58||BASELINE|1971-12-20|1971-10-25|||||1972-10-08||1967-03-16
TRIAL STUDY 134XCP|IS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||S^-1(%O2)^-1|||||UGEQ/L||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|REFRIGERATED|N|PET/MRI SCAN|U|NA|U||3||39||TREATMENT|1967-01-05|1973-06-04|||||1963-02-24||1964-07-15
TRIAL STUDY 134XCP|IS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MIN|||||DAGU||||ABNORMAL|NOT DONE|||CEREBROSPINAL FLUID|FROZEN|U|TRICHROME STAIN|Y|Y|Y||4||88||OPEN LABEL TREATMENT|1966-02-10|1963-04-26|||||1960-02-08||1970-04-09
TRIAL STUDY 134XCP|IS|4D4868E9-3CAA-4BF1-A3BE-1BE3664DE6B7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PA|||||ABSORBANCE U/ML||||ABNORMAL|NOT DONE|||GASTRIC CONTENTS|CALCIFIED|U|FORCED OSCILLATION TECHNIQUE|N|U|U||5||7||RUN-IN|1969-10-28|1960-09-24|||||1966-06-06||1960-08-01
TRIAL STUDY 134XCP|IS|521B1614-9092-4F89-A47F-728C66E01B23||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UOSM|||||ML/M2/H||||HIGH|NOT DONE|||PROSTATIC FLUID|FRESH|U|DROPLET DIGITAL PCR|Y|N|NA||1||38||FOLLOW-UP|1964-03-21|1964-12-13|||||1969-12-05||1968-10-18
TRIAL STUDY 134XCP|IS|521B1614-9092-4F89-A47F-728C66E01B23||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||VG/DOSE|||||NMOL/DAY||||HIGH|NOT DONE|||MECONIUM|SOLIDIFIED|U|MICROPARTICLE ENZYME IMMUNOASSAY|U|NA|Y||2||58||OPEN LABEL TREATMENT|1965-03-17|1965-09-01|||||1968-02-26||1963-12-18
TRIAL STUDY 134XCP|IS|521B1614-9092-4F89-A47F-728C66E01B23||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||SBE/ML|||||UG/L FEU||||HIGH|NOT DONE|||SERUM|REFRIGERATED|N|NON-CONTACT SPECULAR MICROSCOPY|NA|Y|U||3||39||BLINDED TREATMENT|1963-11-17|1969-03-10|||||1961-03-27||1962-06-24
TRIAL STUDY 134XCP|IS|521B1614-9092-4F89-A47F-728C66E01B23||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||VG/KG|||||DPM/MG||||LOW|NOT DONE|||VENOUS PLASMA|CALCIFIED|N|CELLULAR PROLIFERATION ASSAY|NA|NA|N||4||88||INDUCTION TREATMENT|1960-08-03|1970-02-08|||||1964-02-29||1973-09-02
TRIAL STUDY 134XCP|IS|521B1614-9092-4F89-A47F-728C66E01B23||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MDFI|||||V/V||||ABNORMAL|NOT DONE|||ISOLATE|LIPEMIC|Y|COMPLEMENT FIXATION|N|N|U||5||7||LONG-TERM FOLLOW-UP|1967-06-24|1961-07-31|||||1965-09-23||1963-11-24
TRIAL STUDY 134XCP|IS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||U.CARR|||||MILE||||ABNORMAL|NOT DONE|||DERMAL TISSUE|CONTAMINATED|U|ACRIDINE ORANGE STAIN|Y|N|NA||1||38||SCREENING|1967-08-09|1973-05-18|||||1965-03-08||1963-02-26
TRIAL STUDY 134XCP|IS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CI/MG|||||HZ||||NORMAL|NOT DONE|||EXPIRED AIR|NON-HEMOLYZED|U|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|NA|N|N||2||58||FOLLOW-UP|1961-06-08|1973-08-28|||||1968-08-13||1969-08-21
TRIAL STUDY 134XCP|IS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UMOL/KG/MIN|||||ML/M2/MIN||||ABNORMAL|NOT DONE|||EXHALED BREATH CONDENSATE|SOLIDIFIED|Y|CLIP SEQUENCING|N|U|Y||3||39||OPEN LABEL TREATMENT|1973-04-10|1968-07-29|||||1961-08-30||1963-02-03
TRIAL STUDY 134XCP|IS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/DAY|||||10^9 ORGANISMS/G||||NORMAL|NOT DONE|||CORD SERUM|DRIED|N|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|NA|U|NA||4||88||RUN-IN|1966-04-03|1963-02-03|||||1962-03-01||1970-06-26
TRIAL STUDY 134XCP|IS|3DB9B1C5-47C4-4684-96B6-334C9C33CD0D||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||RNA COPIES/ML|||||DPM/0.5 ML||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|GELLED|Y|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|Y|U|N||5||7||WASHOUT|1963-12-01|1961-05-10|||||1968-07-25||1968-10-31
TRIAL STUDY 134XCP|IS|FF6B8B49-3C82-459D-A35D-61136FC594D2||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML|||||QUANTITY SUFFICIENT||||ABNORMAL|NOT DONE|||LOCHIA|CONTAMINATED|U|ACRIDINE ORANGE STAIN|NA|N|N||1||38||RUN-IN|1970-02-03|1961-03-03|||||1971-01-28||1971-01-20
TRIAL STUDY 134XCP|IS|FF6B8B49-3C82-459D-A35D-61136FC594D2||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||OHM|||||ANSON U||||ABNORMAL|NOT DONE|||SOFT TISSUE|DRIED|Y|HIGH RESOLUTION CT|Y|U|NA||2||58||RUN-IN|1964-08-31|1966-12-14|||||1968-04-05||1961-08-17
TRIAL STUDY 134XCP|IS|FF6B8B49-3C82-459D-A35D-61136FC594D2||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/G/H|||||VOXEL||||HIGH|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|SOLIDIFIED|N|LINE PROBE ASSAY|NA|U|Y||3||39||WASHOUT|1972-11-13|1969-11-05|||||1972-07-27||1970-03-23
TRIAL STUDY 134XCP|IS|FF6B8B49-3C82-459D-A35D-61136FC594D2||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CL|||||MOSM/KG||||LOW|NOT DONE|||BILE|UNEXPECTED ODOR|N|TELLER ACUITY CARDS|N|NA|U||4||88||LONG-TERM FOLLOW-UP|1967-09-21|1972-04-09|||||1967-10-14||1962-07-13
TRIAL STUDY 134XCP|IS|FF6B8B49-3C82-459D-A35D-61136FC594D2||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||PIXEL|||||UMOL/L/MIN||||NORMAL|NOT DONE|||MECONIUM|PARAFFIN-EMBEDDED|N|MANUAL CLOT DETECTION|N|N|N||5||7||OBSERVATION|1961-12-02|1969-03-28|||||1964-06-22||1967-10-22
TRIAL STUDY 134XCP|IS|2196D9F4-937A-4662-B24B-AC9D472E0393||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/MIN|||||CMH2O*S/ML||||HIGH|NOT DONE|||SERUM OR PLASMA|SOLIDIFIED|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|N|N|N||1||38||LONG-TERM FOLLOW-UP|1963-10-02|1964-01-28|||||1963-01-14||1961-12-12
TRIAL STUDY 134XCP|IS|2196D9F4-937A-4662-B24B-AC9D472E0393||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CD|||||MOSM/KG||||NORMAL|NOT DONE|||LYMPH|FRESH|Y|NUCLEIC ACID SEQUENCING|NA|NA|N||2||58||INDUCTION TREATMENT|1963-04-04|1971-10-13|||||1968-08-28||1968-06-30
TRIAL STUDY 134XCP|IS|2196D9F4-937A-4662-B24B-AC9D472E0393||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||GTT|||||10^6 COPIES/ML||||LOW|NOT DONE|||PERITONEAL FLUID|CONTAMINATED|U|JAEGER EYE CHART|NA|Y|NA||3||39||OPEN LABEL TREATMENT|1968-05-14|1970-03-17|||||1966-10-14||1962-04-07
TRIAL STUDY 134XCP|IS|2196D9F4-937A-4662-B24B-AC9D472E0393||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ANTI-XA IU/ML|||||% INHIBITION||||HIGH|NOT DONE|||ALVEOLAR AIR|CALCIFIED|Y|LIQUID SCINTILLATION COUNTING|N|NA|U||4||88||OPEN LABEL TREATMENT|1970-03-17|1961-05-19|||||1968-06-01||1969-02-08
TRIAL STUDY 134XCP|IS|2196D9F4-937A-4662-B24B-AC9D472E0393||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DPM/0.5 ML|||||MJOULE/CM2||||NORMAL|NOT DONE|||SERUM OR PLASMA|NON-HEMOLYZED|N|ELASTOGRAPHY|N|N|Y||5||7||RUN-IN|1973-07-13|1973-08-24|||||1962-04-13||1970-05-07
TRIAL STUDY 134XCP|IS|F192452A-4088-46AA-9DD1-8D14809E18F6||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UIU/DL|||||U/M2/MIN||||NORMAL|NOT DONE|||SEMINAL FLUID|NON-HEMOLYZED|NA|ACRIDINE ORANGE STAIN|N|N|Y||1||38||FOLLOW-UP|1967-03-27|1966-07-05|||||1960-06-04||1964-11-28
TRIAL STUDY 134XCP|IS|F192452A-4088-46AA-9DD1-8D14809E18F6||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ANTI-XA IU|||||MU/G||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|Y|AUSCULTATION|NA|N|NA||2||58||TREATMENT|1969-09-22|1966-09-14|||||1968-11-12||1973-05-30
TRIAL STUDY 134XCP|IS|F192452A-4088-46AA-9DD1-8D14809E18F6||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||BQ|||||CAPLET||||NORMAL|NOT DONE|||SOFT TISSUE|DRIED|N|RAJI CELL RIA|U|Y|U||3||39||INDUCTION TREATMENT|1963-10-25|1969-05-18|||||1962-01-10||1966-11-29
TRIAL STUDY 134XCP|IS|F192452A-4088-46AA-9DD1-8D14809E18F6||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UV2|||||LENS||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|CONTAMINATED|N|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|U|NA|N||4||88||SCREENING|1966-01-17|1964-08-12|||||1973-06-04||1973-06-06
TRIAL STUDY 134XCP|IS|F192452A-4088-46AA-9DD1-8D14809E18F6||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^3/L|||||ROENTGEN||||NORMAL|NOT DONE|||CAPILLARY BLOOD|GELLED|NA|KINETIC CHROMOGENIC ASSAY|Y|NA|Y||5||7||LONG-TERM FOLLOW-UP|1970-05-29|1961-07-12|||||1963-11-14||1973-02-16
TRIAL STUDY 134XCP|IS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||DPM/ML|||||PG/L||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|AUTOLYZED|N|SNP ARRAY|Y|U|NA||1||38||LONG-TERM FOLLOW-UP|1970-04-11|1960-01-16|||||1973-05-11||1964-06-13
TRIAL STUDY 134XCP|IS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MIN*MG/ML|||||ML/MMHG||||HIGH|NOT DONE|||SWABBED MATERIAL|NON-HEMOLYZED|N|ELISA|N|U|N||2||58||TREATMENT|1971-12-14|1960-07-26|||||1972-09-18||1965-10-31
TRIAL STUDY 134XCP|IS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/500 WBC|||||DDU||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|AUTOLYZED|Y|NUCLEIC ACID SEQUENCING|U|U|U||3||39||FOLLOW-UP|1972-03-11|1971-06-12|||||1970-12-22||1970-04-18
TRIAL STUDY 134XCP|IS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||RAD|||||LOG EID 50/DOSE||||HIGH|NOT DONE|||LEUKOCYTE|CONCENTRATED|Y|PEAK FLOWMETRY|NA|U|U||4||88||FOLLOW-UP|1962-09-24|1961-12-23|||||1966-06-14||1973-03-06
TRIAL STUDY 134XCP|IS|02FCAF7E-984A-4EF7-95C1-EF545DDFD2C5||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||AU/ML|||||L/L||||HIGH|NOT DONE|||PERITONEAL FLUID|UNEXPECTED ODOR|Y|MICRO BROTH DILUTION|Y|U|N||5||7||OBSERVATION|1964-02-10|1971-08-15|||||1967-10-28||1970-05-28
TRIAL STUDY 134XCP|IS|0D51A87E-2597-4B2D-A7B5-E533790E917D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/LSQN|||||SBE/ML||||HIGH|NOT DONE|||CAPILLARY PLASMA|CALCIFIED|U|IODINE STAIN|U|N|Y||1||38||OPEN LABEL TREATMENT|1965-03-28|1965-03-01|||||1972-06-24||1965-11-14
TRIAL STUDY 134XCP|IS|0D51A87E-2597-4B2D-A7B5-E533790E917D||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CM|||||PIXELS/CM||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|UNEXPECTED ODOR|Y|PHASE-CONTRAST MRI|NA|Y|U||2||58||CONTINUATION TREATMENT|1966-09-26|1969-02-15|||||1965-09-21||1964-12-07
TRIAL STUDY 134XCP|IS|0D51A87E-2597-4B2D-A7B5-E533790E917D||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||U/CL|||||TRACE||||HIGH|NOT DONE|||GASTRIC FLUID|FROZEN|Y|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|NA|NA||3||39||WASHOUT|1973-03-18|1969-08-11|||||1967-08-13||1973-05-19
TRIAL STUDY 134XCP|IS|0D51A87E-2597-4B2D-A7B5-E533790E917D||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||S*KPA|||||LOG10 CFU/ML||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|UNEXPECTED ODOR|NA|ETDRS EYE CHART|Y|U|Y||4||88||OPEN LABEL TREATMENT|1960-06-13|1969-03-29|||||1967-09-07||1967-11-22
TRIAL STUDY 134XCP|IS|0D51A87E-2597-4B2D-A7B5-E533790E917D||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||UCI/L|||||MESF||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|ROOM TEMPERATURE|Y|BALLPOINT PEN TECHNIQUE|Y|U|Y||5||7||BLINDED TREATMENT|1960-10-05|1966-11-13|||||1961-01-11||1962-03-29
TRIAL STUDY 134XCP|IS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||AU/ML|||||10^6/EJACULATE U||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|LIPEMIC|NA|HPLC|U|U|N||1||38||WASHOUT|1971-03-30|1965-04-08|||||1964-12-25||1961-01-12
TRIAL STUDY 134XCP|IS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CM|||||IMPLANT||||LOW|NOT DONE|||SMEGMA|AUTOLYZED|Y|ACRIDINE ORANGE STAIN|U|NA|U||2||58||WASHOUT|1965-09-26|1961-02-06|||||1968-12-19||1971-09-23
TRIAL STUDY 134XCP|IS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/G|||||PELLET||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|GELLED|U|MANUAL COUNT|Y|N|N||3||39||SCREENING|1968-11-08|1964-02-24|||||1969-08-10||1972-01-16
TRIAL STUDY 134XCP|IS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||TABLET|||||ML/100G/MIN||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|GELLED|U|PERIODIC ACID SCHIFF STAIN|NA|Y|U||4||88||BASELINE|1967-10-29|1962-04-03|||||1964-03-18||1967-02-12
TRIAL STUDY 134XCP|IS|3CD8C9A3-A0A4-4BE5-8DA9-6FDA02FC85D4||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BEAM BREAKS|||||10^6 DNA COPIES/ML||||ABNORMAL|NOT DONE|||PLASMA|AGGLUTINATED|NA|CYSTOSCOPY|U|N|U||5||7||FOLLOW-UP|1972-10-15|1972-06-05|||||1967-10-22||1964-06-14
TRIAL STUDY 134XCP|IS|16075684-F04D-4CB8-970A-0819378790EB||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||EJACULATE U|||||MMOL/L||||NORMAL|NOT DONE|||ADIPOSE TISSUE|AUTOLYZED|N|COMPLEMENT FIXATION|NA|NA|N||1||38||SCREENING|1964-05-17|1964-09-28|||||1970-12-16||1961-09-27
TRIAL STUDY 134XCP|IS|16075684-F04D-4CB8-970A-0819378790EB||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^6 RNA COPIES/ML|||||GPELISA UNIT/ML||||ABNORMAL|NOT DONE|||TISSUE|REFRIGERATED|U|SINGLE-MOLECULE ARRAY|NA|NA|Y||2||58||BLINDED TREATMENT|1969-12-08|1964-06-07|||||1971-02-24||1962-04-17
TRIAL STUDY 134XCP|IS|16075684-F04D-4CB8-970A-0819378790EB||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||BAR|||||PMOL/DL||||NORMAL|NOT DONE|||DERMAL TISSUE|PARAFFIN-EMBEDDED|Y|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|Y|NA||3||39||WASHOUT|1962-07-11|1969-10-29|||||1961-11-19||1962-01-18
TRIAL STUDY 134XCP|IS|16075684-F04D-4CB8-970A-0819378790EB||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MM2|||||/HPF||||LOW|NOT DONE|||GASTRIC CONTENTS|FROZEN|N|OBSERVATION|Y|N|Y||4||88||LONG-TERM FOLLOW-UP|1963-01-25|1970-02-08|||||1964-08-14||1971-08-04
TRIAL STUDY 134XCP|IS|16075684-F04D-4CB8-970A-0819378790EB||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||DPM/ML|||||BAU/ML||||NORMAL|NOT DONE|||SERUM|NON-HEMOLYZED|N|IRON HEMATOXYLIN STAIN|U|Y|U||5||7||OBSERVATION|1960-05-17|1972-02-26|||||1960-03-28||1963-11-04
TRIAL STUDY 134XCP|IS|3527E844-D4D5-480A-B6D6-04C5DC0A3380||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PATCH|||||U/L||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|AGGLUTINATED|N|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|U|U|NA||1||38||OBSERVATION|1968-02-23|1963-07-04|||||1972-10-17||1972-09-06
TRIAL STUDY 134XCP|IS|3527E844-D4D5-480A-B6D6-04C5DC0A3380||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CI/KG|||||TSP||||LOW|NOT DONE|||MUSCLE TISSUE|CONTAMINATED|N|CLOT DETECTION|Y|U|Y||2||58||TREATMENT|1968-01-19|1965-09-05|||||1962-04-10||1962-04-15
TRIAL STUDY 134XCP|IS|3527E844-D4D5-480A-B6D6-04C5DC0A3380||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9/L|||||UOSM||||NORMAL|NOT DONE|||KERATINOCYTE|ICTERIC|U|ELECTRONEUROGRAPHY|U|U|U||3||39||RUN-IN|1964-05-18|1961-08-26|||||1965-01-04||1967-03-18
TRIAL STUDY 134XCP|IS|3527E844-D4D5-480A-B6D6-04C5DC0A3380||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KIU|||||10^12 IU/L||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|DRIED|NA|CENTRIFUGATION|N|N|N||4||88||INDUCTION TREATMENT|1960-12-09|1963-12-15|||||1966-07-23||1968-06-16
TRIAL STUDY 134XCP|IS|3527E844-D4D5-480A-B6D6-04C5DC0A3380||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/KG/H|||||1/(S*KPA)||||NORMAL|NOT DONE|||SEMEN|CONTAMINATED|N|IODINE STAIN|U|NA|Y||5||7||INDUCTION TREATMENT|1965-02-09|1967-08-14|||||1968-09-05||1973-08-03
TRIAL STUDY 134XCP|IS|DFB0DF52-4D95-4A26-B28F-071774D78426||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||DB|||||G/G||||NORMAL|NOT DONE|||HAIR|GELLED|N|ELISPOT|NA|NA|NA||1||38||OPEN LABEL TREATMENT|1972-05-13|1973-07-04|||||1968-04-11||1965-06-02
TRIAL STUDY 134XCP|IS|DFB0DF52-4D95-4A26-B28F-071774D78426||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/10^4|||||COPIES/ML||||ABNORMAL|NOT DONE|||SPERMATOZOON|AGGLUTINATED|N|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NA|N|U||2||58||RUN-IN|1972-11-04|1969-03-14|||||1965-01-05||1962-08-17
TRIAL STUDY 134XCP|IS|DFB0DF52-4D95-4A26-B28F-071774D78426||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||GBQ/MG|||||JOULE||||LOW|NOT DONE|||LYMPH|CLOTTED|U|ELECTROCHEMILUMINESCENCE|U|Y|NA||3||39||INDUCTION TREATMENT|1966-03-26|1962-10-21|||||1963-07-01||1970-10-01
TRIAL STUDY 134XCP|IS|DFB0DF52-4D95-4A26-B28F-071774D78426||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CP|||||MG||||ABNORMAL|NOT DONE|||PLASMA ULTRAFILTRATE|AUTOLYZED|NA|MICROARRAY|NA|Y|N||4||88||RUN-IN|1971-05-11|1967-04-10|||||1967-02-02||1966-11-19
TRIAL STUDY 134XCP|IS|DFB0DF52-4D95-4A26-B28F-071774D78426||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||/MBP|||||KG/CM2||||NORMAL|NOT DONE|||CALCULUS|FROZEN|Y|LANDOLT RING|U|NA|NA||5||7||SCREENING|1971-07-03|1968-11-26|||||1961-08-07||1960-01-03
TRIAL STUDY 134XCP|IS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CD|||||CD||||HIGH|NOT DONE|||INFRANATANT, PLASMA|HEMOLYZED|N|PERFUSION MRI|U|Y|U||1||38||LONG-TERM FOLLOW-UP|1971-08-24|1965-07-07|||||1968-07-21||1972-02-12
TRIAL STUDY 134XCP|IS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||PRESSOR UNITS|||||UEQ/L||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|CALCIFIED|NA|POTENTIOMETRY|N|N|U||2||58||CONTINUATION TREATMENT|1963-09-17|1967-12-25|||||1971-07-09||1970-05-03
TRIAL STUDY 134XCP|IS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UMOL/MOL|||||VG/KG||||ABNORMAL|NOT DONE|||PLASMA|UNEXPECTED ODOR|U|IMPULSE OSCILLOMETRY|NA|N|NA||3||39||INDUCTION TREATMENT|1972-11-09|1969-12-27|||||1965-08-17||1964-07-13
TRIAL STUDY 134XCP|IS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||DNA COPIES/UG|||||MEQ/L||||LOW|NOT DONE|||SWABBED MATERIAL|FROZEN|U|NO INFORMATION|U|N|U||4||88||WASHOUT|1960-12-03|1971-12-08|||||1972-11-07||1960-06-20
TRIAL STUDY 134XCP|IS|7F7EFCD6-CFE3-4C15-B25B-0843C02CB439||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/LSQN|||||ML/CM3/MIN||||NORMAL|NOT DONE|||STOOL|REFRIGERATED|N|JAEGER EYE CHART|Y|Y|NA||5||7||BASELINE|1960-02-25|1965-09-10|||||1973-07-23||1971-06-22
TRIAL STUDY 134XCP|IS|CFF20837-0091-467E-ABDE-72645BAFC849||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MM/SEC|||||UG/G/MIN||||ABNORMAL|NOT DONE|||PUS|FRESH|N|FLUORESCENT MICROSCOPY|U|Y|U||1||38||RUN-IN|1967-03-19|1972-06-06|||||1960-10-23||1965-07-31
TRIAL STUDY 134XCP|IS|CFF20837-0091-467E-ABDE-72645BAFC849||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||M2|||||SCOOPFUL||||LOW|NOT DONE|||PLATELET|ROOM TEMPERATURE|U|IMMUNOCHROMATOGRAPHY|NA|Y|U||2||58||SCREENING|1972-06-25|1971-08-11|||||1962-05-27||1970-10-26
TRIAL STUDY 134XCP|IS|CFF20837-0091-467E-ABDE-72645BAFC849||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TESLA|||||G/M2||||HIGH|NOT DONE|||CORD SERUM|DRIED|N|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|U|U|Y||3||39||CONTINUATION TREATMENT|1963-07-16|1964-02-04|||||1966-07-08||1972-01-02
TRIAL STUDY 134XCP|IS|CFF20837-0091-467E-ABDE-72645BAFC849||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL/MOL|||||ENZYME U/M2||||NORMAL|NOT DONE|||TISSUE|ROOM TEMPERATURE|U|RYAN BLUE STAIN|NA|U|U||4||88||BASELINE|1970-06-03|1972-08-08|||||1966-12-21||1968-11-08
TRIAL STUDY 134XCP|IS|CFF20837-0091-467E-ABDE-72645BAFC849||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||ML/CM3/MIN|||||EID 50/DOSE||||NORMAL|NOT DONE|||SKIN TISSUE|AUTOLYZED|NA|MALDI|NA|Y|Y||5||7||TREATMENT|1964-03-05|1962-05-18|||||1962-10-15||1966-09-01
TRIAL STUDY 134XCP|IS|C79756C8-8601-4770-8BC2-7A530428BA82||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NMOL|||||UMOL/MOL||||HIGH|NOT DONE|||PLATELET|FRESH|U|FLUORESCENT MICROSCOPY|Y|NA|Y||1||38||BLINDED TREATMENT|1973-01-17|1970-07-10|||||1960-06-12||1969-11-15
TRIAL STUDY 134XCP|IS|C79756C8-8601-4770-8BC2-7A530428BA82||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MV|||||GMFI||||NORMAL|NOT DONE|||SERUM|REFRIGERATED|U|SXA SCAN|NA|U|NA||2||58||OPEN LABEL TREATMENT|1961-09-06|1969-08-12|||||1963-08-17||1965-02-24
TRIAL STUDY 134XCP|IS|C79756C8-8601-4770-8BC2-7A530428BA82||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||BAR|||||ML/CM H2O||||NORMAL|NOT DONE|||CERUMEN|UNEXPECTED ODOR|Y|LEAD CITRATE STAIN|Y|Y|U||3||39||OPEN LABEL TREATMENT|1972-09-08|1964-03-01|||||1961-12-01||1963-08-13
TRIAL STUDY 134XCP|IS|C79756C8-8601-4770-8BC2-7A530428BA82||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/ANIMAL|||||MMOL/S||||NORMAL|NOT DONE|||CORD SERUM|DRIED|N|ISHIHARA COLOR PLATES|Y|N|NA||4||88||OPEN LABEL TREATMENT|1960-07-10|1967-10-13|||||1962-10-12||1973-02-08
TRIAL STUDY 134XCP|IS|C79756C8-8601-4770-8BC2-7A530428BA82||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||ML/SEC/1.73M2|||||UMOL/L||||HIGH|NOT DONE|||TUMOR TISSUE|CONCENTRATED|NA|IMMUNOBLOT|U|Y|N||5||7||TREATMENT|1968-08-02|1961-09-13|||||1961-01-13||1968-10-13
TRIAL STUDY 134XCP|IS|5533A669-828B-4CA3-BEC3-849CE7384167||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||CMH2O*S2/ML|||||LOG10 PFU/ML||||NORMAL|NOT DONE|||INFRANATANT, SERUM|LACTESCENT|N|PALPATION|U|NA|NA||1||38||CONTINUATION TREATMENT|1965-08-26|1964-12-07|||||1966-10-16||1966-02-14
TRIAL STUDY 134XCP|IS|5533A669-828B-4CA3-BEC3-849CE7384167||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MG/G/MIN|||||LINEAR FT*LB||||LOW|NOT DONE|||PROSTATIC FLUID|CLOTTED|NA|KINYOUN STAIN|U|NA|NA||2||58||FOLLOW-UP|1960-02-04|1973-04-26|||||1961-06-06||1962-02-06
TRIAL STUDY 134XCP|IS|5533A669-828B-4CA3-BEC3-849CE7384167||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||/5X10^4 WBC|||||10^7 TCID 50/DOSE||||LOW|NOT DONE|||CORD SERUM|AUTOLYZED|N|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|Y|N||3||39||BLINDED TREATMENT|1967-08-19|1961-12-08|||||1961-07-02||1969-02-05
TRIAL STUDY 134XCP|IS|5533A669-828B-4CA3-BEC3-849CE7384167||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MV*MIN|||||DAGU||||HIGH|NOT DONE|||VENOUS BLOOD|AGGLUTINATED|Y|DIPSTICK|N|U|N||4||88||LONG-TERM FOLLOW-UP|1971-12-19|1970-06-01|||||1963-09-10||1969-08-30
TRIAL STUDY 134XCP|IS|5533A669-828B-4CA3-BEC3-849CE7384167||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/MIN|||||VG/DOSE||||ABNORMAL|NOT DONE|||MONOCYTE|UNEXPECTED ODOR|NA|ELISPOT|U|Y|NA||5||7||FOLLOW-UP|1966-10-31|1968-04-07|||||1963-10-29||1964-07-22
TRIAL STUDY 134XCP|IS|C711ADD3-F398-4161-BE13-B75BEDF91402||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/G|||||MOSM/L||||LOW|NOT DONE|||ALVEOLAR AIR|GELLED|NA|SICKLE CELL SOLUBILITY TEST|N|U|NA||1||38||INDUCTION TREATMENT|1967-07-23|1970-01-17|||||1969-11-10||1961-03-11
TRIAL STUDY 134XCP|IS|C711ADD3-F398-4161-BE13-B75BEDF91402||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CMH2O/ML|||||LOG10 PFU||||NORMAL|NOT DONE|||HAIR|UNEXPECTED ODOR|N|MAMMOGRAPHY|U|NA|N||2||58||TREATMENT|1966-10-31|1962-11-08|||||1969-02-14||1962-03-06
TRIAL STUDY 134XCP|IS|C711ADD3-F398-4161-BE13-B75BEDF91402||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/MG|||||APL U/ML||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|UNEXPECTED ODOR|N|KINETIC CHROMOGENIC ASSAY|N|NA|U||3||39||TREATMENT|1973-05-10|1960-09-26|||||1971-05-17||1969-10-07
TRIAL STUDY 134XCP|IS|C711ADD3-F398-4161-BE13-B75BEDF91402||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||10^6 CFU/ML|||||GRAVITATIONAL UNIT||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|REFRIGERATED|NA|PET/CT SCAN|U|Y|U||4||88||SCREENING|1972-06-05|1970-07-17|||||1968-03-09||1961-05-16
TRIAL STUDY 134XCP|IS|C711ADD3-F398-4161-BE13-B75BEDF91402||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||IU|||||LOG10 PFU||||ABNORMAL|NOT DONE|||SEMEN|FRESH|N|CELLULAR PROLIFERATION ASSAY|U|NA|NA||5||7||RUN-IN|1970-01-14|1961-10-29|||||1961-11-03||1961-12-17
TRIAL STUDY 134XCP|IS|2CD70FFA-5977-4718-961B-6D67368F99B8||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^6 CFU/ML|||||ML/M2/MIN||||NORMAL|NOT DONE|||PLEURAL FLUID|AGGLUTINATED|N|IMMUNOFLUORESCENT STAIN|Y|U|U||1||38||LONG-TERM FOLLOW-UP|1964-07-05|1968-09-26|||||1967-06-23||1965-08-17
TRIAL STUDY 134XCP|IS|2CD70FFA-5977-4718-961B-6D67368F99B8||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||M/SEC2|||||DAYS/MONTH||||HIGH|NOT DONE|||LYSATE|PARAFFIN-EMBEDDED|U|MUGA|Y|N|NA||2||58||WASHOUT|1961-10-15|1966-10-18|||||1967-08-26||1969-08-16
TRIAL STUDY 134XCP|IS|2CD70FFA-5977-4718-961B-6D67368F99B8||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UG/G/MIN|||||CMH2O/ML||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|REFRIGERATED|NA|DISK DIFFUSION|N|U|N||3||39||BLINDED TREATMENT|1964-02-06|1965-08-05|||||1969-11-02||1966-04-22
TRIAL STUDY 134XCP|IS|2CD70FFA-5977-4718-961B-6D67368F99B8||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MIN|||||UV2||||HIGH|NOT DONE|||PLEURAL TISSUE|HEMOLYZED|U|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|N|U||4||88||OPEN LABEL TREATMENT|1968-07-02|1968-09-03|||||1969-02-12||1960-04-04
TRIAL STUDY 134XCP|IS|2CD70FFA-5977-4718-961B-6D67368F99B8||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/S/M2|||||G/ANIMAL/DAY||||ABNORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|THAWED|N|OLIGO ACGH|U|NA|NA||5||7||LONG-TERM FOLLOW-UP|1964-12-25|1971-03-04|||||1965-12-28||1969-10-25
TRIAL STUDY 134XCP|IS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NG/DAY|||||10^7 PFU||||NORMAL|NOT DONE|||BILE|ICTERIC|U|NUCLEIC ACID AMPLIFICATION TEST|Y|U|U||1||38||RUN-IN|1970-04-10|1972-03-27|||||1963-08-08||1970-03-28
TRIAL STUDY 134XCP|IS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||DPM/0.5 ML|||||UL/ML||||NORMAL|NOT DONE|||PLEURAL FLUID|REFRIGERATED|N|PYROSEQUENCING|Y|U|NA||2||58||INDUCTION TREATMENT|1967-07-23|1971-12-04|||||1969-08-14||1967-02-18
TRIAL STUDY 134XCP|IS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IU/DL|||||CFU/G||||ABNORMAL|NOT DONE|||FLUID|LACTESCENT|U|ELECTROMYOGRAPHY|N|N|N||3||39||BLINDED TREATMENT|1962-04-11|1964-10-02|||||1968-11-23||1961-09-20
TRIAL STUDY 134XCP|IS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UMOL/MG/MIN|||||IU/ML||||NORMAL|NOT DONE|||INFRANATANT, SERUM|HEMOLYZED|Y|DIPSTICK|Y|Y|Y||4||88||RUN-IN|1967-03-23|1966-10-27|||||1973-06-29||1962-12-23
TRIAL STUDY 134XCP|IS|F01FF884-E12B-4C43-BB7B-5E8918B19A4A||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||/MONTH|||||MCI/KG||||ABNORMAL|NOT DONE|||PLEURAL FLUID|GELLED|NA|NON-INVASIVE DIELECTRIC SENSING|Y|N|Y||5||7||SCREENING|1969-09-29|1966-12-31|||||1971-12-16||1965-08-24
TRIAL STUDY 134XCP|IS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PACK YEAR|||||TCID 50/DOSE||||LOW|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|Y|CALCOFLUOR WHITE STAIN|U|NA|U||1||38||INDUCTION TREATMENT|1968-12-12|1968-03-20|||||1960-10-27||1964-10-02
TRIAL STUDY 134XCP|IS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAPLET|||||DIOPTER||||LOW|NOT DONE|||RETICULOCYTES|CONCENTRATED|NA|CORONARY ANGIOGRAPHY|N|Y|U||2||58||RUN-IN|1964-05-19|1970-09-20|||||1962-08-26||1961-04-01
TRIAL STUDY 134XCP|IS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOL/MOL|||||STRIP||||HIGH|NOT DONE|||BONE|SOLIDIFIED|U|RULER MEASUREMENT METHOD|NA|N|N||3||39||FOLLOW-UP|1960-04-04|1973-03-28|||||1961-10-25||1966-01-27
TRIAL STUDY 134XCP|IS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BQ/UG|||||SQU/ML||||NORMAL|NOT DONE|||URINE|NON-HEMOLYZED|NA|PULMONARY ANGIOGRAPHY|Y|NA|N||4||88||SCREENING|1964-03-27|1970-04-19|||||1972-05-04||1970-12-02
TRIAL STUDY 134XCP|IS|F82601ED-4E74-4349-8F01-2F0DA9AE4BD7||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||P|||||KCAL||||ABNORMAL|NOT DONE|||SEMEN|DRIED|Y|FLAME PHOTOMETRY|Y|Y|N||5||7||BLINDED TREATMENT|1966-06-15|1964-10-17|||||1971-05-02||1962-02-07
TRIAL STUDY 134XCP|IS|43E00B7D-684F-4BAC-A135-E65C22B191AD||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ML/M2/DAY|||||GY/H||||NORMAL|NOT DONE|||SPERMATOZOON|HEMOLYZED|Y|TOTAL BODY RADIOGRAPHY|NA|NA|U||1||38||BASELINE|1970-09-01|1972-05-18|||||1969-12-15||1971-08-29
TRIAL STUDY 134XCP|IS|43E00B7D-684F-4BAC-A135-E65C22B191AD||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||WEBER|||||MET*MIN||||HIGH|NOT DONE|||MECONIUM|FRESH|N|PYROSEQUENCING|NA|N|U||2||58||TREATMENT|1961-05-01|1965-06-13|||||1970-03-04||1972-04-26
TRIAL STUDY 134XCP|IS|43E00B7D-684F-4BAC-A135-E65C22B191AD||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^9 CFU/ML|||||UG/L DDU||||LOW|NOT DONE|||MONOCYTE|THAWED|Y|IMMUNOTURBIDIMETRY|NA|N|Y||3||39||INDUCTION TREATMENT|1967-11-01|1971-08-23|||||1961-03-15||1973-07-02
TRIAL STUDY 134XCP|IS|43E00B7D-684F-4BAC-A135-E65C22B191AD||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||U/KG|||||DEG/MM||||ABNORMAL|NOT DONE|||EXPIRED AIR|AUTOLYZED|Y|IMMUNOASSAY|U|Y|N||4||88||TREATMENT|1966-05-14|1972-04-06|||||1969-03-07||1965-12-13
TRIAL STUDY 134XCP|IS|43E00B7D-684F-4BAC-A135-E65C22B191AD||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||WEEKS|||||G/MOL||||HIGH|NOT DONE|||INFRANATANT, PLASMA|PARAFFIN-EMBEDDED|U|CELL OF ORIGIN ASSAY|NA|Y|NA||5||7||LONG-TERM FOLLOW-UP|1961-07-31|1972-11-16|||||1963-06-14||1960-11-08
TRIAL STUDY 134XCP|IS|25680BE0-7CE5-4B76-A48E-2D977A07E749||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^7/L|||||MET*MIN||||LOW|NOT DONE|||EPITHELIAL CELL|THAWED|U|CONGO RED STAIN|Y|NA|NA||1||38||OPEN LABEL TREATMENT|1973-05-30|1973-08-09|||||1972-08-23||1966-02-20
TRIAL STUDY 134XCP|IS|25680BE0-7CE5-4B76-A48E-2D977A07E749||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CGY|||||MET||||HIGH|NOT DONE|||AMNIOTIC FLUID|CONTAMINATED|N|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|NA|U|NA||2||58||SCREENING|1963-08-05|1972-05-31|||||1960-03-29||1962-04-26
TRIAL STUDY 134XCP|IS|25680BE0-7CE5-4B76-A48E-2D977A07E749||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/ANIMAL|||||PUFF||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|PARAFFIN-EMBEDDED|U|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|U|Y|NA||3||39||OPEN LABEL TREATMENT|1972-12-30|1962-12-07|||||1966-08-25||1965-03-04
TRIAL STUDY 134XCP|IS|25680BE0-7CE5-4B76-A48E-2D977A07E749||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NMOL BCE/NMOL|||||ENZYME U||||LOW|NOT DONE|||INTERSTITIAL FLUID|FROZEN|Y|KLEIHAUER-BETKE|U|N|U||4||88||RUN-IN|1971-01-23|1967-04-13|||||1962-11-04||1965-10-21
TRIAL STUDY 134XCP|IS|25680BE0-7CE5-4B76-A48E-2D977A07E749||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||RFU|||||IU/ML||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|NON-HEMOLYZED|U|URANYL ACETATE STAIN|N|U|N||5||7||OBSERVATION|1969-10-18|1963-04-02|||||1972-03-28||1962-10-20
TRIAL STUDY 134XCP|IS|67CA2619-351F-493E-93B2-5CDC9AF99C8B||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UIU/L|||||BREATHS/30S||||HIGH|NOT DONE|||CELL PELLET|FROZEN|U|MICROPARTICLE ENZYME IMMUNOASSAY|N|NA|Y||1||38||CONTINUATION TREATMENT|1971-05-14|1965-09-21|||||1963-02-19||1970-04-06
TRIAL STUDY 134XCP|IS|67CA2619-351F-493E-93B2-5CDC9AF99C8B||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||APL U/ML|||||GTT||||ABNORMAL|NOT DONE|||VENOUS BLOOD|LIPEMIC|U|RULER MEASUREMENT METHOD|U|N|Y||2||58||CONTINUATION TREATMENT|1968-12-28|1964-12-14|||||1969-06-21||1971-11-14
TRIAL STUDY 134XCP|IS|67CA2619-351F-493E-93B2-5CDC9AF99C8B||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||10^3 ORGANISMS|||||/SEC||||HIGH|NOT DONE|||SPERMATOZOON|REFRIGERATED|N|ANTIMICROBIAL COMBINATION TESTING|U|Y|Y||3||39||TREATMENT|1971-04-27|1970-01-19|||||1963-07-30||1972-01-13
TRIAL STUDY 134XCP|IS|67CA2619-351F-493E-93B2-5CDC9AF99C8B||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MOL/MOL|||||TSP||||NORMAL|NOT DONE|||SEBUM|UNEXPECTED ODOR|NA|GC/MS/MS|NA|N|N||4||88||BASELINE|1970-01-08|1961-12-23|||||1962-12-31||1965-03-02
TRIAL STUDY 134XCP|IS|67CA2619-351F-493E-93B2-5CDC9AF99C8B||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UMOL|||||MIU/L||||NORMAL|NOT DONE|||ABSCESS FLUID|UNEXPECTED ODOR|U|GRAM STAIN|NA|U|Y||5||7||FOLLOW-UP|1968-10-14|1970-01-12|||||1962-03-24||1964-09-10
TRIAL STUDY 134XCP|IS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^7/L|||||MBP||||LOW|NOT DONE|||AQUEOUS HUMOR|GELLED|Y|MIGET|U|U|N||1||38||TREATMENT|1964-12-11|1960-06-08|||||1960-05-31||1965-04-27
TRIAL STUDY 134XCP|IS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||HR/DAY|||||FOZ_BR||||HIGH|NOT DONE|||MECONIUM|AUTOLYZED|U|PHOTOMETRIC CLOT DETECTION|U|Y|N||2||58||LONG-TERM FOLLOW-UP|1970-11-25|1973-05-27|||||1970-04-22||1960-09-18
TRIAL STUDY 134XCP|IS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||KAT|||||ML/S||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|CLOTTED|N|ALCIAN BLUE STAIN|N|N|U||3||39||RUN-IN|1964-01-04|1964-03-06|||||1965-10-25||1965-04-07
TRIAL STUDY 134XCP|IS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS/ML|||||PM||||HIGH|NOT DONE|||SPUTUM|GELLED|N|SICKLE CELL SOLUBILITY TEST|U|U|NA||4||88||WASHOUT|1966-09-01|1971-12-19|||||1971-04-10||1966-01-02
TRIAL STUDY 134XCP|IS|A4E6FC7C-719C-4891-8C08-E5907F07A4EA||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||APS U|||||DRINK||||NORMAL|NOT DONE|||AMNIOTIC FLUID|NON-HEMOLYZED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|U|NA|Y||5||7||WASHOUT|1972-11-07|1968-12-17|||||1962-10-29||1973-08-27
TRIAL STUDY 134XCP|IS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||UIU/L|||||G/ANIMAL||||HIGH|NOT DONE|||PLEURAL TISSUE|HEMOLYZED|NA|CT SCAN WITHOUT CONTRAST|NA|NA|N||1||38||FOLLOW-UP|1962-12-01|1963-06-05|||||1960-07-26||1961-05-02
TRIAL STUDY 134XCP|IS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||ML/KG/DAY|||||L/KG||||ABNORMAL|NOT DONE|||CERVICOVAGINAL SECRETION|REFRIGERATED|NA|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|N|NA|NA||2||58||RUN-IN|1960-08-05|1972-01-18|||||1973-07-23||1961-08-14
TRIAL STUDY 134XCP|IS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||GY/MIN|||||KG/M2||||ABNORMAL|NOT DONE|||REFLEX TEAR|GELLED|NA|FLUORIMETRY|Y|U|Y||3||39||SCREENING|1968-02-25|1970-12-13|||||1967-04-07||1960-05-13
TRIAL STUDY 134XCP|IS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CD|||||10^3 ORGANISMS/G||||NORMAL|NOT DONE|||VENOUS CORD BLOOD|FROZEN|NA|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|NA|U||4||88||BLINDED TREATMENT|1969-06-13|1964-09-04|||||1972-11-04||1960-08-24
TRIAL STUDY 134XCP|IS|890AFEEA-4AC7-4F32-B18F-2FBD860F7B86||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||KIT|||||CAPLET||||HIGH|NOT DONE|||SUPERNATANT, SERUM|FRESH|NA|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|U|U|Y||5||7||TREATMENT|1964-01-12|1966-03-10|||||1965-09-03||1964-05-02
TRIAL STUDY 134XCP|IS|51B01BE3-230D-4AE0-A229-81EF519EA932||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||WEEKS|||||M3||||HIGH|NOT DONE|||GASTRIC FLUID|ICTERIC|NA|PERIODIC ACID SCHIFF STAIN|U|U|NA||1||38||CONTINUATION TREATMENT|1962-12-14|1972-02-27|||||1972-04-22||1965-03-05
TRIAL STUDY 134XCP|IS|51B01BE3-230D-4AE0-A229-81EF519EA932||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||RPM|||||UG/CM2||||ABNORMAL|NOT DONE|||CAPILLARY PLASMA|CLOTTED|N|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|U|N|NA||2||58||WASHOUT|1969-10-16|1967-05-07|||||1967-10-06||1971-01-03
TRIAL STUDY 134XCP|IS|51B01BE3-230D-4AE0-A229-81EF519EA932||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||TRANSDUCING UNIT|||||VP/ML||||LOW|NOT DONE|||CELL PELLET|REFRIGERATED|Y|TEST STRIP|Y|NA|U||3||39||BASELINE|1963-09-19|1966-12-03|||||1964-01-30||1971-08-11
TRIAL STUDY 134XCP|IS|51B01BE3-230D-4AE0-A229-81EF519EA932||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/MG|||||PT_US||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|SOLIDIFIED|U|AMSLER GRID|Y|Y|Y||4||88||BLINDED TREATMENT|1970-06-02|1970-04-02|||||1964-07-09||1962-11-22
TRIAL STUDY 134XCP|IS|51B01BE3-230D-4AE0-A229-81EF519EA932||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||NKAT/G HB|||||FMOL||||HIGH|NOT DONE|||INTERSTITIAL FLUID|REFRIGERATED|U|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NA|Y|U||5||7||OPEN LABEL TREATMENT|1966-11-04|1969-01-16|||||1965-04-15||1970-01-17
TRIAL STUDY 134XCP|IS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MASK|||||FOZ_BR||||NORMAL|NOT DONE|||ISOLATE|DRIED|N|FLAME PHOTOMETRY|U|Y|Y||1||38||BASELINE|1968-05-06|1973-01-03|||||1972-12-03||1962-07-29
TRIAL STUDY 134XCP|IS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||NMOL/L|||||UG/M2||||NORMAL|NOT DONE|||LYMPH|SOLIDIFIED|N|MRI|U|N|Y||2||58||INDUCTION TREATMENT|1972-03-20|1969-01-18|||||1967-04-19||1966-11-13
TRIAL STUDY 134XCP|IS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PIXELS/CM|||||CI/ML||||HIGH|NOT DONE|||REFLEX TEAR|SOLIDIFIED|Y|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y|NA||3||39||TREATMENT|1972-04-04|1961-10-25|||||1967-01-04||1972-03-12
TRIAL STUDY 134XCP|IS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^9/L|||||BQ/MG||||HIGH|NOT DONE|||INTERSTITIAL FLUID|HEMOLYZED|U|HPLC/MS/MS|NA|U|Y||4||88||WASHOUT|1963-02-06|1963-07-26|||||1962-12-28||1963-08-31
TRIAL STUDY 134XCP|IS|5665DA4F-6C20-46F3-A00B-E9688DCBF4DE||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PHERESIS UNIT|||||U/G||||ABNORMAL|NOT DONE|||WHITE MATTER TISSUE|CALCIFIED|Y|ELISA|Y|Y|NA||5||7||TREATMENT|1970-02-03|1962-01-25|||||1969-12-04||1968-08-19
TRIAL STUDY 134XCP|IS|01FD66DA-C67B-48A7-9320-F29C6C226155||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UG/G/MIN|||||CARTRIDGE||||HIGH|NOT DONE|||LEUKOCYTE|AGGLUTINATED|N|AUDIOMETRY|NA|U|U||1||38||BLINDED TREATMENT|1972-01-21|1967-12-31|||||1966-02-15||1961-09-24
TRIAL STUDY 134XCP|IS|01FD66DA-C67B-48A7-9320-F29C6C226155||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||LOG10 PFU/ML|||||CMH2O*S/ML||||LOW|NOT DONE|||EXPIRED AIR|HEMOLYZED|U|IHC|NA|NA|N||2||58||CONTINUATION TREATMENT|1971-05-10|1961-04-09|||||1965-09-08||1962-12-24
TRIAL STUDY 134XCP|IS|01FD66DA-C67B-48A7-9320-F29C6C226155||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UG/G/DAY|||||UM||||HIGH|NOT DONE|||BLOOD|CONTAMINATED|Y|CONTRAST ENHANCED X-RAY|Y|Y|Y||3||39||FOLLOW-UP|1966-03-05|1960-08-13|||||1971-08-31||1963-07-02
TRIAL STUDY 134XCP|IS|01FD66DA-C67B-48A7-9320-F29C6C226155||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/VF|||||FARAD||||HIGH|NOT DONE|||SEBUM|GELLED|Y|TRICHROME STAIN|Y|N|N||4||88||INDUCTION TREATMENT|1960-05-20|1963-04-04|||||1964-10-08||1969-09-23
TRIAL STUDY 134XCP|IS|01FD66DA-C67B-48A7-9320-F29C6C226155||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ML/M2/H|||||LOG10 TCID 50/UL||||ABNORMAL|NOT DONE|||PLEURAL TISSUE|CALCIFIED|N|ANGIOGRAPHY|NA|Y|N||5||7||INDUCTION TREATMENT|1964-07-07|1964-03-15|||||1973-07-08||1967-06-27
TRIAL STUDY 134XCP|IS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||UCI|||||PFU/ML||||ABNORMAL|NOT DONE|||EXUDATE|CONTAMINATED|Y|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|NA|N|NA||1||38||WASHOUT|1965-02-23|1964-07-23|||||1964-06-11||1964-05-20
TRIAL STUDY 134XCP|IS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MG/M2/H|||||UG/DL||||LOW|NOT DONE|||REFLEX TEAR|UNEXPECTED ODOR|U|PAP STAIN|N|NA|N||2||58||WASHOUT|1961-07-22|1966-12-02|||||1973-05-25||1970-08-11
TRIAL STUDY 134XCP|IS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||BU|||||CARTRIDGE||||NORMAL|NOT DONE|||EMESIS|CONTAMINATED|U|HEMAGGLUTINATION INHIBITION ASSAY|Y|U|NA||3||39||WASHOUT|1965-03-20|1966-11-29|||||1969-06-25||1960-09-27
TRIAL STUDY 134XCP|IS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^7 CFU/ML|||||10^4 CFU/ML||||HIGH|NOT DONE|||URINE SEDIMENT|CALCIFIED|NA|TARGETED GENOME SEQUENCING|NA|U|N||4||88||RUN-IN|1961-05-30|1968-07-30|||||1970-09-23||1973-07-28
TRIAL STUDY 134XCP|IS|DCBA9A22-BC7B-4EA1-9441-AD40D064233C||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||DB|||||ML/MMHG||||HIGH|NOT DONE|||LYMPH|AGGLUTINATED|NA|OPTICAL COHERENCE TOMOGRAPHY|NA|N|NA||5||7||TREATMENT|1963-05-03|1970-08-01|||||1964-10-26||1961-08-31
TRIAL STUDY 134XCP|IS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||G/DL|||||FOZ_BR||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE|Y|HPLC/MS|N|U|U||1||38||CONTINUATION TREATMENT|1961-01-28|1969-05-09|||||1971-11-13||1962-06-20
TRIAL STUDY 134XCP|IS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||G/ANIMAL|||||NEEDLE GAUGE||||HIGH|NOT DONE|||MONOCYTE|LACTESCENT|Y|IMPEDANCE CONDUCTIVITY|U|U|Y||2||58||RUN-IN|1972-08-26|1961-11-17|||||1969-06-03||1968-04-13
TRIAL STUDY 134XCP|IS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^12/L|||||U/ANIMAL||||LOW|NOT DONE|||CELL PELLET|AGGLUTINATED|NA|PLETHYSMOGRAPHY|NA|Y|Y||3||39||CONTINUATION TREATMENT|1968-09-23|1962-09-20|||||1969-09-25||1960-08-22
TRIAL STUDY 134XCP|IS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CARTRIDGE|||||VP/DOSE||||NORMAL|NOT DONE|||ISOLATE|LIPEMIC|U|TRICHROME STAIN|Y|U|U||4||88||TREATMENT|1969-01-04|1970-07-18|||||1971-02-10||1962-12-30
TRIAL STUDY 134XCP|IS|5D7626F9-604F-4D8B-8D39-1ACD1363CFE2||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||G/DAY|||||EIA UNIT||||NORMAL|NOT DONE|||ARTERIAL BLOOD|CALCIFIED|Y|ULTRASONOGRAPHIC ELASTOGRAPHY|NA|Y|N||5||7||RUN-IN|1965-07-27|1962-10-03|||||1961-02-14||1970-10-10
TRIAL STUDY 134XCP|IS|81E3641F-6145-4B3C-9E26-8DEC1200509D||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MMU/ML|||||CI/ML||||ABNORMAL|NOT DONE|||ENDOTRACHEAL FLUID|ICTERIC|N|PHASE-CONTRAST MRI|U|NA|N||1||38||FOLLOW-UP|1965-03-14|1970-02-04|||||1965-06-08||1961-12-14
TRIAL STUDY 134XCP|IS|81E3641F-6145-4B3C-9E26-8DEC1200509D||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MMOL2/L2|||||UG/DL||||HIGH|NOT DONE|||CARDIAC MUSCLE TISSUE|DRIED|U|ARTERIAL SPIN LABELING FUNCTIONAL MRI|U|Y|Y||2||58||SCREENING|1973-04-26|1961-08-20|||||1961-02-08||1964-12-01
TRIAL STUDY 134XCP|IS|81E3641F-6145-4B3C-9E26-8DEC1200509D||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||/LSQN|||||CI||||ABNORMAL|NOT DONE|||ERYTHROCYTES|PARAFFIN-EMBEDDED|Y|PAP STAIN|U|Y|N||3||39||OBSERVATION|1970-10-20|1961-11-24|||||1966-03-30||1960-01-28
TRIAL STUDY 134XCP|IS|81E3641F-6145-4B3C-9E26-8DEC1200509D||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MMAL|||||MG/CM2||||NORMAL|NOT DONE|||CORD BLOOD|CALCIFIED|U|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|U|Y|NA||4||88||LONG-TERM FOLLOW-UP|1966-12-29|1968-09-23|||||1960-01-16||1969-05-29
TRIAL STUDY 134XCP|IS|81E3641F-6145-4B3C-9E26-8DEC1200509D||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^6 RNA COPIES/ML|||||COAT||||HIGH|NOT DONE|||EMESIS|UNEXPECTED ODOR|NA|IMPULSE OSCILLOMETRY|N|U|N||5||7||BLINDED TREATMENT|1967-05-08|1961-11-08|||||1968-02-14||1965-07-03
TRIAL STUDY 134XCP|IS|8F3D0A71-FD09-4E43-BC54-0562AF99306E||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||PSEC|||||/DAY||||NORMAL|NOT DONE|||DIALYSIS FLUID|CLOTTED|N|OPTICAL COHERENCE TOMOGRAPHY|N|N|NA||1||38||OBSERVATION|1962-04-23|1972-11-16|||||1966-06-20||1966-02-04
TRIAL STUDY 134XCP|IS|8F3D0A71-FD09-4E43-BC54-0562AF99306E||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||DAYS/WK|||||CPM||||LOW|NOT DONE|||CAPILLARY BLOOD|CONTAMINATED|U|RAJI CELL EIA|U|NA|U||2||58||BLINDED TREATMENT|1964-05-31|1963-04-17|||||1971-10-09||1966-11-15
TRIAL STUDY 134XCP|IS|8F3D0A71-FD09-4E43-BC54-0562AF99306E||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HOURS|||||ML/MMHG/MIN/L||||HIGH|NOT DONE|||MECONIUM|AGGLUTINATED|NA|TARGETED TRANSCRIPTOME SEQUENCING|Y|Y|Y||3||39||FOLLOW-UP|1970-12-16|1963-10-18|||||1965-11-02||1967-04-01
TRIAL STUDY 134XCP|IS|8F3D0A71-FD09-4E43-BC54-0562AF99306E||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MOL/MOL|||||DEG/S||||ABNORMAL|NOT DONE|||INFRANATANT, PLASMA|GELLED|N|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|N|NA|N||4||88||RUN-IN|1963-01-22|1960-12-14|||||1962-06-07||1965-04-08
TRIAL STUDY 134XCP|IS|8F3D0A71-FD09-4E43-BC54-0562AF99306E||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NKAT|||||10^3 CFU||||NORMAL|NOT DONE|||SEBUM|ICTERIC|Y|KINETIC MICROPARTICLE IMMUNOASSAY|N|NA|NA||5||7||RUN-IN|1968-12-07|1971-01-30|||||1966-04-17||1966-04-15
TRIAL STUDY 134XCP|IS|BE750F04-5992-42B5-A084-A33D6FBBFD2E||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MG/DL|||||KA_U/DL||||NORMAL|NOT DONE|||CIRCULATING TUMOR CELL|REFRIGERATED|NA|MRI WITHOUT CONTRAST|Y|NA|Y||1||38||FOLLOW-UP|1967-09-08|1965-09-16|||||1968-04-09||1971-12-23
TRIAL STUDY 134XCP|IS|BE750F04-5992-42B5-A084-A33D6FBBFD2E||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UL/DOSE|||||CS||||ABNORMAL|NOT DONE|||SEMEN|UNEXPECTED ODOR|Y|CONTRAST ENHANCED SPIRAL CT SCAN|Y|Y|N||2||58||TREATMENT|1961-05-01|1969-06-04|||||1968-01-15||1971-01-14
TRIAL STUDY 134XCP|IS|BE750F04-5992-42B5-A084-A33D6FBBFD2E||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ARBITRARY U|||||BEL||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED|N|ORCHIDOMETERY|Y|N|U||3||39||BASELINE|1971-07-16|1973-07-16|||||1969-04-16||1971-11-10
TRIAL STUDY 134XCP|IS|BE750F04-5992-42B5-A084-A33D6FBBFD2E||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PMOL|||||10^5/HPF||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|UNEXPECTED ODOR|NA|ELECTROMYOGRAPHY|Y|U|U||4||88||LONG-TERM FOLLOW-UP|1962-04-02|1960-06-25|||||1971-05-01||1962-09-12
TRIAL STUDY 134XCP|IS|BE750F04-5992-42B5-A084-A33D6FBBFD2E||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||%(W/W)|||||PPTR||||NORMAL|NOT DONE|||GASTRIC FLUID|AUTOLYZED|Y|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|Y|NA||5||7||BASELINE|1973-03-18|1969-03-24|||||1960-10-08||1973-04-02
TRIAL STUDY 134XCP|IS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MBP|||||GY||||LOW|NOT DONE|||HAIR|FRESH|Y|NON-INVASIVE DIELECTRIC SENSING|N|N|NA||1||38||FOLLOW-UP|1969-09-02|1961-07-09|||||1969-10-12||1970-01-04
TRIAL STUDY 134XCP|IS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/MOL|||||EP U||||HIGH|NOT DONE|||LYMPH|CONTAMINATED|NA|LAPAROSCOPY|Y|N|NA||2||58||LONG-TERM FOLLOW-UP|1966-01-10|1970-07-22|||||1968-02-22||1965-12-18
TRIAL STUDY 134XCP|IS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MOL/L|||||LOG10 CFU/G||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|SOLIDIFIED|U|SANGER SEQUENCING|N|U|U||3||39||OPEN LABEL TREATMENT|1968-11-04|1972-11-29|||||1960-09-01||1961-05-09
TRIAL STUDY 134XCP|IS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MEQ/G|||||DDU||||LOW|NOT DONE|||HAIR|UNEXPECTED ODOR|U|JAEGER EYE CHART|N|N|U||4||88||OBSERVATION|1963-09-24|1969-01-21|||||1964-04-16||1961-10-03
TRIAL STUDY 134XCP|IS|4926DCA5-2DA6-4A16-8CDB-A92ABDB66B89||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 PFU|||||PIXELS/IN||||ABNORMAL|NOT DONE|||MUSCLE TISSUE|FROZEN|N|NO INFORMATION|N|N|Y||5||7||SCREENING|1961-12-16|1973-05-02|||||1969-05-17||1972-06-10
TRIAL STUDY 134XCP|IS|8417B146-336C-4777-A566-C1D086F39430||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ABSORBANCE U|||||IU/DAY||||NORMAL|NOT DONE|||FLUID|THAWED|N|PET SCAN|NA|NA|Y||1||38||BLINDED TREATMENT|1965-03-12|1969-04-27|||||1970-04-09||1966-08-13
TRIAL STUDY 134XCP|IS|8417B146-336C-4777-A566-C1D086F39430||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||EVENTS|||||MG/CM2||||HIGH|NOT DONE|||EXHALED BREATH CONDENSATE|HEMOLYZED|NA|HIGH RESOLUTION MELT ANALYSIS|Y|N|U||2||58||OBSERVATION|1964-02-14|1965-07-03|||||1969-05-13||1968-06-28
TRIAL STUDY 134XCP|IS|8417B146-336C-4777-A566-C1D086F39430||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||AMFI|||||PATCH||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|Y|SNELLEN EYE CHART|N|NA|U||3||39||OBSERVATION|1960-02-20|1966-08-22|||||1965-03-20||1962-05-20
TRIAL STUDY 134XCP|IS|8417B146-336C-4777-A566-C1D086F39430||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||CAPLET|||||ML/M2||||ABNORMAL|NOT DONE|||SUPERNATANT, PLASMA|SOLIDIFIED|U|X-RAY|NA|U|NA||4||88||LONG-TERM FOLLOW-UP|1968-01-26|1973-05-31|||||1963-06-03||1971-09-27
TRIAL STUDY 134XCP|IS|8417B146-336C-4777-A566-C1D086F39430||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CFU/G|||||DPM/MG||||NORMAL|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|REFRIGERATED|Y|QUANTITATIVE COMPUTED TOMOGRAPHY|U|U|U||5||7||RUN-IN|1971-10-29|1970-02-14|||||1965-08-09||1972-10-10
TRIAL STUDY 134XCP|IS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DAYS/MONTH|||||UG/DAY||||ABNORMAL|NOT DONE|||AMNIOTIC FLUID|LACTESCENT|NA|FLUORESCEIN STAIN|N|U|N||1||38||LONG-TERM FOLLOW-UP|1963-12-23|1960-04-29|||||1971-03-12||1969-06-30
TRIAL STUDY 134XCP|IS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||EP U|||||U/MMOL||||ABNORMAL|NOT DONE|||PROSTATIC FLUID|PARAFFIN-EMBEDDED|NA|MRS|U|U|N||2||58||OPEN LABEL TREATMENT|1971-01-27|1964-01-17|||||1968-08-28||1962-02-03
TRIAL STUDY 134XCP|IS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||AMP|||||YEARS||||LOW|NOT DONE|||EXUDATE|HEMOLYZED|NA|SIZE EXCLUSION CHROMATOGRAPHY|Y|Y|U||3||39||BLINDED TREATMENT|1961-11-09|1971-05-24|||||1966-11-07||1964-10-15
TRIAL STUDY 134XCP|IS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/G|||||/HPF||||HIGH|NOT DONE|||LUNG SURFACTANT|ROOM TEMPERATURE|N|CENTRIFUGATION|NA|N|NA||4||88||OPEN LABEL TREATMENT|1965-10-07|1966-04-10|||||1967-06-20||1963-03-10
TRIAL STUDY 134XCP|IS|FB8D36FD-B57F-4D93-AA64-2BFD130B39C7||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||U/M2/MIN|||||MPH||||HIGH|NOT DONE|||BONE|ROOM TEMPERATURE|N|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|N|U|Y||5||7||SCREENING|1964-11-26|1961-06-26|||||1965-04-19||1971-09-06
TRIAL STUDY 134XCP|IS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BQ/L|||||OSM||||NORMAL|NOT DONE|||ARTERIAL CORD BLOOD|AGGLUTINATED|N|RADIAL IMMUNODIFFUSION|U|NA|Y||1||38||INDUCTION TREATMENT|1972-01-02|1960-04-23|||||1966-12-26||1973-06-05
TRIAL STUDY 134XCP|IS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||G/KG/DAY|||||UG/G/H||||ABNORMAL|NOT DONE|||CORD SERUM|LIPEMIC|Y|MICROSCOPY|Y|U|N||2||58||OBSERVATION|1964-06-21|1968-02-19|||||1963-04-20||1970-08-19
TRIAL STUDY 134XCP|IS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||BISCUIT|||||UG/KG/DAY||||NORMAL|NOT DONE|||AMNIOTIC FLUID|FRESH|NA|BIOPSY|Y|N|N||3||39||LONG-TERM FOLLOW-UP|1966-11-24|1961-03-16|||||1964-08-27||1969-02-13
TRIAL STUDY 134XCP|IS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||ANSON U|||||JDF UNIT||||ABNORMAL|NOT DONE|||INFRANATANT, SERUM|CLOTTED|NA|ISHIHARA COLOR PLATES|U|Y|Y||4||88||FOLLOW-UP|1960-12-22|1967-03-07|||||1972-11-12||1966-02-27
TRIAL STUDY 134XCP|IS|1B82113D-E76E-45BC-8CC8-EBE3D5FB10EE||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||L|||||G/ANIMAL||||HIGH|NOT DONE|||EMOTIONAL TEAR|FRESH|Y|TARGETED GENOME SEQUENCING|NA|Y|Y||5||7||INDUCTION TREATMENT|1971-06-20|1963-03-12|||||1971-11-09||1963-01-27
TRIAL STUDY 134XCP|IS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||USP U|||||MMOL||||ABNORMAL|NOT DONE|||SERUM OR PLASMA OR BLOOD|ROOM TEMPERATURE|N|DXA SCAN|N|NA|N||1||38||SCREENING|1971-07-10|1964-02-02|||||1967-02-04||1961-03-29
TRIAL STUDY 134XCP|IS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||MIN/DAY|||||GBQ/MG||||LOW|NOT DONE|||GASTRIC FLUID|ICTERIC|N|POLYMERASE CHAIN REACTION|NA|NA|U||2||58||WASHOUT|1971-11-23|1972-09-25|||||1964-06-12||1964-09-08
TRIAL STUDY 134XCP|IS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PFU/ML|||||10^6/HPF||||HIGH|NOT DONE|||PLATELET|PARAFFIN-EMBEDDED|U|HIGH LEVEL AMINOGLYCOSIDE SCREEN|U|U|Y||3||39||SCREENING|1969-08-16|1964-09-30|||||1964-01-21||1965-07-27
TRIAL STUDY 134XCP|IS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MM3/MM2/YEAR|||||FMOL||||LOW|NOT DONE|||BONE|THAWED|Y|HEMATOXYLIN AND EOSIN STAIN|N|Y|U||4||88||FOLLOW-UP|1972-12-23|1962-09-11|||||1971-06-16||1967-08-30
TRIAL STUDY 134XCP|IS|7F6F9ECF-978B-49D7-ADD2-8403D813DFEB||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||SHOCK WAVE|||||MG/DL||||NORMAL|NOT DONE|||BASAL TEAR|CONCENTRATED|N|DROPLET DIGITAL PCR|Y|N|Y||5||7||WASHOUT|1966-01-16|1972-07-04|||||1964-11-28||1960-09-04
TRIAL STUDY 134XCP|IS|2926D795-9C17-4440-8411-68525E93E78D||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||SBE/ML|||||PIXELS/CM||||HIGH|NOT DONE|||VENOUS CORD BLOOD|HEMOLYZED|NA|CYSTOMETRY|N|NA|N||1||38||SCREENING|1970-09-20|1967-01-27|||||1965-03-16||1964-07-08
TRIAL STUDY 134XCP|IS|2926D795-9C17-4440-8411-68525E93E78D||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||CD|||||PIXELS/CM||||ABNORMAL|NOT DONE|||ABSCESS FLUID|AGGLUTINATED|U|WHOLE EXOME SEQUENCING|N|NA|N||2||58||RUN-IN|1969-01-24|1966-02-22|||||1969-02-03||1967-11-04
TRIAL STUDY 134XCP|IS|2926D795-9C17-4440-8411-68525E93E78D||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||U/ANIMAL|||||MEQ/KG||||LOW|NOT DONE|||CARDIAC MUSCLE TISSUE|FROZEN|Y|RYAN BLUE STAIN|Y|Y|N||3||39||OPEN LABEL TREATMENT|1969-07-29|1973-01-01|||||1968-12-31||1964-02-12
TRIAL STUDY 134XCP|IS|2926D795-9C17-4440-8411-68525E93E78D||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||/SEC|||||AMU||||HIGH|NOT DONE|||SERUM|AUTOLYZED|NA|TRANSMISSION ELECTRON MICROSCOPY|N|Y|N||4||88||INDUCTION TREATMENT|1962-06-05|1966-07-30|||||1962-02-04||1965-11-07
TRIAL STUDY 134XCP|IS|2926D795-9C17-4440-8411-68525E93E78D||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ROENTGEN|||||STRIP||||HIGH|NOT DONE|||SUPERNATANT, PLEURAL FLUID|PARAFFIN-EMBEDDED|NA|SEQUENCING|Y|U|N||5||7||BLINDED TREATMENT|1967-05-21|1972-06-09|||||1970-04-21||1968-08-19
TRIAL STUDY 134XCP|IS|BA3378F3-C308-469F-9818-9AD811086548||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||H/WK|||||L/S/KPA||||ABNORMAL|NOT DONE|||PLEURAL FLUID|PARAFFIN-EMBEDDED|N|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|U|N|U||1||38||OPEN LABEL TREATMENT|1970-04-04|1964-03-04|||||1960-08-08||1962-01-20
TRIAL STUDY 134XCP|IS|BA3378F3-C308-469F-9818-9AD811086548||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||RATIO|||||10^12 IU/L||||NORMAL|NOT DONE|||URINE|HEMOLYZED|N|CENTRIFUGATION|N|Y|NA||2||58||CONTINUATION TREATMENT|1972-06-27|1971-01-11|||||1963-02-28||1960-11-10
TRIAL STUDY 134XCP|IS|BA3378F3-C308-469F-9818-9AD811086548||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||CI/UL|||||CL||||NORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|N|NEXT GENERATION TARGETED SEQUENCING|NA|NA|Y||3||39||OBSERVATION|1970-06-05|1964-10-11|||||1970-01-27||1965-08-07
TRIAL STUDY 134XCP|IS|BA3378F3-C308-469F-9818-9AD811086548||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||LOG10 CFU/G|||||ML/DL||||HIGH|NOT DONE|||PLATELET|LACTESCENT|U|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|NA|U|NA||4||88||CONTINUATION TREATMENT|1962-10-10|1961-08-03|||||1969-09-25||1971-09-12
TRIAL STUDY 134XCP|IS|BA3378F3-C308-469F-9818-9AD811086548||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||FOZ_BR|||||ML/M2/H||||ABNORMAL|NOT DONE|||SOFT TISSUE|NON-HEMOLYZED|NA|THERMAL IONIZATION MASS SPECTROMETRY|U|U|U||5||7||LONG-TERM FOLLOW-UP|1969-05-28|1968-03-18|||||1971-09-13||1972-06-23
TRIAL STUDY 134XCP|IS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MEQ/DL|||||NMOL BCE/L||||ABNORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|AGGLUTINATED|Y|SISH|N|U|U||1||38||TREATMENT|1960-07-28|1966-06-10|||||1971-05-24||1965-04-16
TRIAL STUDY 134XCP|IS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||10^12/L|||||MCI||||HIGH|NOT DONE|||KERATINOCYTE|PARAFFIN-EMBEDDED|U|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|NA|N|N||2||58||BLINDED TREATMENT|1966-06-11|1967-03-20|||||1968-02-23||1966-08-21
TRIAL STUDY 134XCP|IS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CMHG|||||MV||||NORMAL|NOT DONE|||BILE|CONCENTRATED|NA|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|U|U|Y||3||39||LONG-TERM FOLLOW-UP|1961-01-17|1965-09-25|||||1960-11-29||1963-05-12
TRIAL STUDY 134XCP|IS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||KAT|||||UL/ML||||NORMAL|NOT DONE|||CELL PELLET|PARAFFIN-EMBEDDED|U|TRIPLE-PHASE SPIRAL CT SCAN|NA|NA|U||4||88||RUN-IN|1961-07-23|1963-03-27|||||1972-07-05||1965-05-19
TRIAL STUDY 134XCP|IS|D9CABD49-D3C9-4792-8110-3D48D0D11DBA||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MET*H|||||S/H||||NORMAL|NOT DONE|||RETICULOCYTES|ROOM TEMPERATURE|Y|LC/MS|U|N|N||5||7||OBSERVATION|1966-08-25|1965-07-29|||||1966-11-25||1967-01-08
TRIAL STUDY 134XCP|IS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6||1||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||FT|||||10^6 CFU/ML||||HIGH|NOT DONE|||PUS|THAWED|N|IMMUNOASSAY|N|N|U||1||38||INDUCTION TREATMENT|1971-02-03|1968-08-28|||||1967-02-27||1971-03-13
TRIAL STUDY 134XCP|IS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||EP U|||||KG/MOL||||HIGH|NOT DONE|||WHITE MATTER TISSUE|REFRIGERATED|NA|MALDI|NA|U|NA||2||58||INDUCTION TREATMENT|1968-05-10|1960-02-27|||||1963-07-17||1971-05-22
TRIAL STUDY 134XCP|IS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/ANIMAL|||||MG||||ABNORMAL|NOT DONE|||PLATELET|DRIED|N|PYROSEQUENCING|Y|Y|NA||3||39||OBSERVATION|1965-06-23|1972-10-29|||||1969-06-07||1962-11-01
TRIAL STUDY 134XCP|IS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||/100 WBC|||||NKAT||||HIGH|NOT DONE|||TISSUE|THAWED|U|PERCUSSION|N|NA|N||4||88||BASELINE|1966-04-01|1962-10-16|||||1964-04-28||1969-01-11
TRIAL STUDY 134XCP|IS|C9F6564B-D41D-406B-ABD3-5F453B66F1C6||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||M/SEC|||||TABLET||||LOW|NOT DONE|||INFRANATANT, PLEURAL FLUID|ROOM TEMPERATURE|U|ETDRS EYE CHART|Y|Y|Y||5||7||TREATMENT|1973-05-20|1960-05-26|||||1966-01-19||1973-08-31
TRIAL STUDY 134XCP|IS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||CG|||||UG/L||||HIGH|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|THAWED|N|IMMUNODIFFUSION|U|Y|N||1||38||WASHOUT|1962-07-12|1969-05-09|||||1962-01-06||1964-03-19
TRIAL STUDY 134XCP|IS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||LOG10 TCID 50/ML|||||TRACE||||NORMAL|NOT DONE|||PLEURAL FLUID|ROOM TEMPERATURE|U|APPLANATION TONOMETRY|U|U|Y||2||58||BASELINE|1972-09-23|1962-05-21|||||1972-11-03||1962-10-15
TRIAL STUDY 134XCP|IS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||FT3|||||MMOL/DAY||||HIGH|NOT DONE|||VENOUS PLASMA|REFRIGERATED|NA|WHOLE EXOME SEQUENCING|NA|NA|N||3||39||LONG-TERM FOLLOW-UP|1972-12-04|1969-11-27|||||1960-04-25||1970-05-12
TRIAL STUDY 134XCP|IS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||FEU|||||10^3 ORGANISMS/G||||LOW|NOT DONE|||SALIVA|ICTERIC|Y|AUTOMATED COUNT|NA|NA|N||4||88||RUN-IN|1967-10-03|1964-10-04|||||1960-08-31||1963-09-22
TRIAL STUDY 134XCP|IS|02AE6CFC-BC7C-49D1-8B5C-E57147B147B7||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||%/S|||||10^5/HPF||||NORMAL|NOT DONE|||NAIL|ICTERIC|U|IMPULSE OSCILLOMETRY|NA|Y|NA||5||7||SCREENING|1972-06-24|1967-04-24|||||1966-08-26||1970-01-30
TRIAL STUDY 134XCP|IS|15594D4E-1DAE-449F-AA52-9B0A926D9985||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/MIN|||||GBQ/MG||||HIGH|NOT DONE|||CEREBROSPINAL FLUID|SOLIDIFIED|NA|ICC|Y|NA|NA||1||38||INDUCTION TREATMENT|1966-01-17|1971-09-26|||||1961-04-11||1967-04-28
TRIAL STUDY 134XCP|IS|15594D4E-1DAE-449F-AA52-9B0A926D9985||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||ML/KG/DAY|||||10^6 COPIES/ML||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|FRESH|N|ENZYMATIC SPECTROPHOTOMETRY|Y|Y|Y||2||58||RUN-IN|1971-02-21|1966-08-27|||||1972-06-30||1963-02-03
TRIAL STUDY 134XCP|IS|15594D4E-1DAE-449F-AA52-9B0A926D9985||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IU/ML|||||PFU/ANIMAL||||ABNORMAL|NOT DONE|||ABSCESS FLUID|CALCIFIED|NA|NEXT GENERATION TARGETED SEQUENCING|U|NA|U||3||39||INDUCTION TREATMENT|1972-11-06|1961-05-05|||||1963-01-07||1967-03-05
TRIAL STUDY 134XCP|IS|15594D4E-1DAE-449F-AA52-9B0A926D9985||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||10^3 ORGANISMS|||||PMOL/G||||NORMAL|NOT DONE|||ENDOMETRIAL TISSUE|GELLED|N|KLEIHAUER-BETKE|NA|N|NA||4||88||INDUCTION TREATMENT|1970-06-06|1961-02-04|||||1963-11-04||1970-02-09
TRIAL STUDY 134XCP|IS|15594D4E-1DAE-449F-AA52-9B0A926D9985||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||U/M2/H|||||/MONTH||||LOW|NOT DONE|||URINE SEDIMENT|ICTERIC|NA|CONTACT SPECULAR MICROSCOPY|Y|NA|NA||5||7||INDUCTION TREATMENT|1965-03-11|1970-12-23|||||1962-11-22||1968-12-13
TRIAL STUDY 134XCP|IS|079DEA7B-A617-4787-9872-025F4248ABFF||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UM/DAY|||||10^4 CFU||||HIGH|NOT DONE|||SPUTUM|ICTERIC|Y|MECHANICAL CLOT DETECTION|NA|U|NA||1||38||BASELINE|1968-01-08|1967-07-07|||||1964-01-05||1962-05-13
TRIAL STUDY 134XCP|IS|079DEA7B-A617-4787-9872-025F4248ABFF||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MESF|||||MEQ/DL||||LOW|NOT DONE|||DIALYSIS FLUID, PERITONEAL|GELLED|N|SPIRAL CT|U|NA|U||2||58||RUN-IN|1968-06-08|1966-02-08|||||1961-03-31||1968-05-14
TRIAL STUDY 134XCP|IS|079DEA7B-A617-4787-9872-025F4248ABFF||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ML/M2/DAY|||||HENRY||||LOW|NOT DONE|||PERIPHERAL BLOOD MONONUCLEAR CELL|FROZEN|N|ELECTROPHORESIS|Y|Y|N||3||39||WASHOUT|1964-06-14|1965-01-18|||||1971-08-01||1967-01-21
TRIAL STUDY 134XCP|IS|079DEA7B-A617-4787-9872-025F4248ABFF||4||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG/DL|||||FINGERTIP UNIT||||LOW|NOT DONE|||SEMINAL FLUID|NON-HEMOLYZED|N|INTERRUPTER TECHNIQUE|Y|NA|U||4||88||INDUCTION TREATMENT|1965-05-18|1971-01-20|||||1964-02-20||1965-08-04
TRIAL STUDY 134XCP|IS|079DEA7B-A617-4787-9872-025F4248ABFF||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DIOPTER|||||G/U||||HIGH|NOT DONE|||SALIVA|THAWED|N|IMMUNOPRECIPITATION|Y|U|Y||5||7||TREATMENT|1961-10-14|1964-02-28|||||1964-06-12||1971-07-27
TRIAL STUDY 134XCP|IS|3178AE30-9653-4470-84E4-FB0E4587DF6B||1||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||FT3|||||FMOL/L/SEC||||ABNORMAL|NOT DONE|||LEUKOCYTE|LIPEMIC|U|X-RAY|N|NA|Y||1||38||TREATMENT|1966-09-19|1968-06-03|||||1969-01-18||1967-08-22
TRIAL STUDY 134XCP|IS|3178AE30-9653-4470-84E4-FB0E4587DF6B||2||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UU/L|||||LOG10 ELISA UNIT||||HIGH|NOT DONE|||SOFT TISSUE|HEMOLYZED|N|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|NA|U|Y||2||58||RUN-IN|1972-04-29|1968-03-19|||||1968-07-20||1964-12-29
TRIAL STUDY 134XCP|IS|3178AE30-9653-4470-84E4-FB0E4587DF6B||3||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MDFI|||||PMOL||||ABNORMAL|NOT DONE|||HAIR FOLLICLE|CALCIFIED|N|TRANSCRIPTION-MEDIATED AMPLIFICATION|N|Y|N||3||39||INDUCTION TREATMENT|1964-01-29|1966-01-03|||||1967-12-28||1965-06-13
TRIAL STUDY 134XCP|IS|3178AE30-9653-4470-84E4-FB0E4587DF6B||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||JAR|||||NG||||ABNORMAL|NOT DONE|||MECONIUM|SOLIDIFIED|Y|MICROBIAL CONCENTRATION|Y|Y|N||4||88||LONG-TERM FOLLOW-UP|1968-09-08|1963-05-04|||||1966-10-19||1967-01-03
TRIAL STUDY 134XCP|IS|3178AE30-9653-4470-84E4-FB0E4587DF6B||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^6 ORGANISMS|||||1/(S*KPA)||||ABNORMAL|NOT DONE|||LUNG SURFACTANT|GELLED|N|KINETIC CHROMOGENIC ASSAY|Y|U|NA||5||7||INDUCTION TREATMENT|1972-03-16|1972-04-29|||||1972-06-16||1964-10-02
TRIAL STUDY 134XCP|IS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MIU/L|||||LM||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|FRESH|U|BAC ACGH|U|N|N||1||38||LONG-TERM FOLLOW-UP|1961-12-04|1963-10-16|||||1970-11-01||1970-04-17
TRIAL STUDY 134XCP|IS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/KG/DAY|||||DRAM||||NORMAL|NOT DONE|||CELL PELLET|ICTERIC|U|GC/MS|N|U|N||2||58||FOLLOW-UP|1970-12-22|1967-06-06|||||1968-02-26||1973-03-21
TRIAL STUDY 134XCP|IS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||VOXEL|||||%(W/V)||||LOW|NOT DONE|||ADIPOSE TISSUE|SOLIDIFIED|Y|NUCLEIC ACID BASED METHOD|Y|U|NA||3||39||BASELINE|1967-07-18|1960-07-21|||||1972-07-15||1972-03-19
TRIAL STUDY 134XCP|IS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MASK|||||10^9/L||||LOW|NOT DONE|||PLASMA ULTRAFILTRATE|CLOTTED|N|GC/MS/MS|Y|N|U||4||88||CONTINUATION TREATMENT|1971-04-26|1961-01-10|||||1966-05-07||1966-11-02
TRIAL STUDY 134XCP|IS|921EE2AA-D4FB-49E1-A3CD-05B064D0E83A||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||PLUG|||||KALLIKREIN INHIBITOR UNIT||||NORMAL|NOT DONE|||SERUM OR PLASMA|PARAFFIN-EMBEDDED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|N|Y|N||5||7||SCREENING|1962-04-05|1972-12-17|||||1961-12-15||1961-12-13
TRIAL STUDY 134XCP|IS|D274C760-A607-4DA8-ACD3-346EF6E191D2||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/H|||||NMOL BCE/NMOL||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|FRESH|NA|CYSTOSCOPY|U|N|N||1||38||BLINDED TREATMENT|1968-07-22|1968-01-04|||||1960-06-03||1961-06-25
TRIAL STUDY 134XCP|IS|D274C760-A607-4DA8-ACD3-346EF6E191D2||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||LOG10 ELISA UNIT/DOSE|||||MU/G||||NORMAL|NOT DONE|||SPERMATOZOON|DRIED|U|FARNSWORTH-MUNSELL 100 HUE TEST|Y|Y|NA||2||58||SCREENING|1966-01-27|1967-06-18|||||1964-06-10||1960-07-23
TRIAL STUDY 134XCP|IS|D274C760-A607-4DA8-ACD3-346EF6E191D2||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/100G/MIN|||||CM H2O||||NORMAL|NOT DONE|||LYMPH|NON-HEMOLYZED|NA|SPIROMETRY|N|N|U||3||39||OPEN LABEL TREATMENT|1961-10-31|1969-10-02|||||1961-11-03||1967-11-30
TRIAL STUDY 134XCP|IS|D274C760-A607-4DA8-ACD3-346EF6E191D2||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^5/L|||||HEP||||NORMAL|NOT DONE|||MIXED VENOUS BLOOD|AGGLUTINATED|NA|PERCUSSION|NA|NA|Y||4||88||BASELINE|1972-06-19|1967-07-11|||||1963-06-10||1961-06-29
TRIAL STUDY 134XCP|IS|D274C760-A607-4DA8-ACD3-346EF6E191D2||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MOL/DAY|||||ML/ANIMAL/DAY||||LOW|NOT DONE|||PUS|LACTESCENT|N|DIFFUSION WEIGHTED MRI|NA|NA|Y||5||7||SCREENING|1972-04-21|1963-09-22|||||1961-10-05||1971-12-29
TRIAL STUDY 134XCP|IS|F5B7E82D-49AD-422E-9C38-5681105094AA||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/MIN|||||MM/MIN||||HIGH|NOT DONE|||LYMPH|NON-HEMOLYZED|NA|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|N|N|Y||1||38||RUN-IN|1960-04-03|1967-09-28|||||1971-02-26||1962-09-16
TRIAL STUDY 134XCP|IS|F5B7E82D-49AD-422E-9C38-5681105094AA||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||U/10^12 RBC|||||KV||||ABNORMAL|NOT DONE|||EMOTIONAL TEAR|ICTERIC|Y|RADIOGRAPHY|U|NA|NA||2||58||BLINDED TREATMENT|1961-03-09|1969-02-27|||||1964-04-02||1962-08-02
TRIAL STUDY 134XCP|IS|F5B7E82D-49AD-422E-9C38-5681105094AA||3||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||PMOL/L|||||M3||||LOW|NOT DONE|||CERUMEN|SOLIDIFIED|N|WRIGHT STAIN|N|NA|Y||3||39||BASELINE|1962-06-14|1967-11-03|||||1961-01-01||1970-02-08
TRIAL STUDY 134XCP|IS|F5B7E82D-49AD-422E-9C38-5681105094AA||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||C|||||LOG EID 50/DOSE||||ABNORMAL|NOT DONE|||CALCULUS|DRIED|NA|PHYSICAL EXAMINATION|NA|NA|N||4||88||BLINDED TREATMENT|1967-08-28|1970-06-26|||||1967-04-09||1967-11-17
TRIAL STUDY 134XCP|IS|F5B7E82D-49AD-422E-9C38-5681105094AA||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||MM3/MM2/YEAR|||||TROCHE||||NORMAL|NOT DONE|||SUPERNATANT, PLEURAL FLUID|CONCENTRATED|NA|AGAR PROPORTION|U|U|Y||5||7||OPEN LABEL TREATMENT|1969-12-13|1970-11-23|||||1970-05-27||1966-09-17
TRIAL STUDY 134XCP|IS|AF8D32B4-B2CC-4EE3-A612-179814C691B8||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||KALLIKREIN INHIBITOR UNIT|||||TROCHE||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|LACTESCENT|Y|IHC|U|U|NA||1||38||CONTINUATION TREATMENT|1964-10-24|1968-07-08|||||1969-03-15||1971-07-28
TRIAL STUDY 134XCP|IS|AF8D32B4-B2CC-4EE3-A612-179814C691B8||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||COULOMB|||||PM||||HIGH|NOT DONE|||PERITONEAL FLUID|NON-HEMOLYZED|NA|ANTIBIOTIC AGAR SCREEN|U|N|N||2||58||FOLLOW-UP|1968-11-10|1973-05-02|||||1964-01-23||1960-05-16
TRIAL STUDY 134XCP|IS|AF8D32B4-B2CC-4EE3-A612-179814C691B8||3||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||BQ/KG|||||ML/S||||NORMAL|NOT DONE|||AMNIOTIC FLUID|FRESH|N|KINYOUN STAIN|Y|N|U||3||39||OPEN LABEL TREATMENT|1966-07-31|1963-07-03|||||1967-07-22||1960-05-13
TRIAL STUDY 134XCP|IS|AF8D32B4-B2CC-4EE3-A612-179814C691B8||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^4 CFU/ML|||||MV/SEC||||HIGH|NOT DONE|||INFRANATANT, SERUM|THAWED|N|TRYPAN BLUE STAIN|N|N|NA||4||88||LONG-TERM FOLLOW-UP|1961-09-17|1969-01-29|||||1962-04-18||1964-10-17
TRIAL STUDY 134XCP|IS|AF8D32B4-B2CC-4EE3-A612-179814C691B8||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^6 IU|||||GBQ/UG||||ABNORMAL|NOT DONE|||SERUM OR PLASMA|ICTERIC|NA|HPLC|Y|Y|Y||5||7||LONG-TERM FOLLOW-UP|1966-01-14|1968-12-24|||||1969-11-12||1963-11-07
TRIAL STUDY 134XCP|IS|64153B43-9DDC-473D-97E1-0E2E8C3E8116||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||L/L|||||CMH2O/ML||||HIGH|NOT DONE|||CIRCULATING TUMOR CELL|AUTOLYZED|NA|MALDI-TOF|N|N|N||1||38||OBSERVATION|1971-07-30|1965-11-06|||||1962-02-06||1967-02-22
TRIAL STUDY 134XCP|IS|64153B43-9DDC-473D-97E1-0E2E8C3E8116||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||/MONTH|||||MV/SEC||||HIGH|NOT DONE|||STRIATED MUSCLE TISSUE|ICTERIC|NA|ELISPOT|N|U|N||2||58||CONTINUATION TREATMENT|1973-03-16|1969-11-06|||||1970-07-12||1965-12-24
TRIAL STUDY 134XCP|IS|64153B43-9DDC-473D-97E1-0E2E8C3E8116||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MGEQ|||||10^4 CFU/ML||||LOW|NOT DONE|||CERUMEN|UNEXPECTED ODOR|N|CARDIAC THERMODILUTION|NA|U|U||3||39||SCREENING|1965-06-25|1966-02-26|||||1962-04-06||1966-04-25
TRIAL STUDY 134XCP|IS|64153B43-9DDC-473D-97E1-0E2E8C3E8116||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||IN2|||||10^6 ORGANISMS||||LOW|NOT DONE|||BONE MARROW MONONUCLEAR CELL|CLOTTED|U|DUCTOGRAPHY|NA|U|NA||4||88||SCREENING|1972-08-04|1960-09-05|||||1964-01-18||1968-06-26
TRIAL STUDY 134XCP|IS|64153B43-9DDC-473D-97E1-0E2E8C3E8116||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UG/G/H|||||LOG10 CFU/G||||NORMAL|NOT DONE|||MENSTRUAL BLOOD|GELLED|N|PALM METHOD|NA|NA|NA||5||7||LONG-TERM FOLLOW-UP|1973-08-28|1970-11-29|||||1962-10-15||1973-05-18
TRIAL STUDY 134XCP|IS|0F5775AD-1D20-4B59-8558-8A41C12E03D0||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||DPM/0.5 ML|||||ML/KG/MIN||||HIGH|NOT DONE|||REFLEX TEAR|HEMOLYZED|NA|SPIROMETRY|Y|U|NA||1||38||OBSERVATION|1968-01-15|1964-08-03|||||1968-04-27||1966-09-22
TRIAL STUDY 134XCP|IS|0F5775AD-1D20-4B59-8558-8A41C12E03D0||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ANTIBODY UNIT|||||DEG||||HIGH|NOT DONE|||CAPILLARY BLOOD|LIPEMIC|U|ANTIBIOTIC AGAR SCREEN|N|N|N||2||58||INDUCTION TREATMENT|1969-10-13|1964-03-18|||||1967-05-05||1961-04-06
TRIAL STUDY 134XCP|IS|0F5775AD-1D20-4B59-8558-8A41C12E03D0||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/CAGE|||||MM/MIN||||NORMAL|NOT DONE|||ARTERIAL BLOOD|CONTAMINATED|Y|CAPILLARY ELECTROPHORESIS|U|N|Y||3||39||INDUCTION TREATMENT|1972-11-16|1969-02-05|||||1962-05-26||1960-02-17
TRIAL STUDY 134XCP|IS|0F5775AD-1D20-4B59-8558-8A41C12E03D0||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||UG/G/H|||||MIN||||HIGH|NOT DONE|||SMOOTH MUSCLE TISSUE|CONCENTRATED|N|STATIC PERIMETRY|Y|U|Y||4||88||WASHOUT|1969-03-25|1972-08-18|||||1967-07-28||1972-08-05
TRIAL STUDY 134XCP|IS|0F5775AD-1D20-4B59-8558-8A41C12E03D0||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CD*S/M2|||||NM||||HIGH|NOT DONE|||ARTERIALIZED CAPILLARY BLOOD|FRESH|NA|PERIPHERAL ANGIOGRAPHY|NA|Y|N||5||7||BASELINE|1970-03-04|1968-02-28|||||1973-07-18||1968-06-11
TRIAL STUDY 134XCP|IS|DF533087-690C-489A-9163-9D4503B7BCC9||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/KG|||||CCID 50/ML||||ABNORMAL|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|AGGLUTINATED|Y|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|N|NA|N||1||38||LONG-TERM FOLLOW-UP|1972-07-04|1969-05-04|||||1961-09-10||1971-03-31
TRIAL STUDY 134XCP|IS|DF533087-690C-489A-9163-9D4503B7BCC9||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||DPM/ML|||||U/M2||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|LACTESCENT|Y|IRON HEMATOXYLIN STAIN|N|N|N||2||58||INDUCTION TREATMENT|1966-09-28|1968-03-17|||||1971-08-05||1960-11-13
TRIAL STUDY 134XCP|IS|DF533087-690C-489A-9163-9D4503B7BCC9||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||U/G|||||/HPF||||NORMAL|NOT DONE|||CAPILLARY PLASMA|SOLIDIFIED|N|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|Y|NA||3||39||BASELINE|1973-03-17|1972-05-02|||||1970-03-05||1972-11-25
TRIAL STUDY 134XCP|IS|DF533087-690C-489A-9163-9D4503B7BCC9||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||10^4/HPF|||||MG/KG/MIN||||NORMAL|NOT DONE|||SEBUM|UNEXPECTED ODOR|N|PET/CT SCAN WITHOUT CONTRAST|NA|U|Y||4||88||RUN-IN|1960-08-08|1971-04-27|||||1961-02-24||1968-07-16
TRIAL STUDY 134XCP|IS|DF533087-690C-489A-9163-9D4503B7BCC9||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||MBQ/UL|||||UG||||LOW|NOT DONE|||ISOLATE|FROZEN|NA|SINGLE-SLICE SPIRAL CT|U|N|N||5||7||LONG-TERM FOLLOW-UP|1969-02-26|1969-01-24|||||1963-08-31||1970-03-16
TRIAL STUDY 134XCP|IS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919||1||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/MONTH|||||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|DRIED|N|POLYGRAPHY|N|NA|N||1||38||FOLLOW-UP|1970-01-01|1968-07-29|||||1965-09-10||1965-03-12
TRIAL STUDY 134XCP|IS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||/40 HPFS|||||BQ/MG||||LOW|NOT DONE|||ISOLATE|CONTAMINATED|NA|PANENDOSCOPY|N|NA|NA||2||58||LONG-TERM FOLLOW-UP|1964-02-15|1973-04-19|||||1965-07-21||1960-01-29
TRIAL STUDY 134XCP|IS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||LOG10 TCID 50/DOSE|||||TESLA||||NORMAL|NOT DONE|||CAPILLARY BLOOD|HEMOLYZED|U|ELECTROPHORESIS|NA|N|U||3||39||OPEN LABEL TREATMENT|1972-09-12|1961-11-26|||||1969-10-10||1967-10-21
TRIAL STUDY 134XCP|IS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919||4||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||KG|||||MOSM/KG||||ABNORMAL|NOT DONE|||DIALYSIS FLUID|GELLED|N|ELECTRICAL IMPEDANCE MYOGRAPHY|U|N|U||4||88||RUN-IN|1965-02-25|1962-02-03|||||1965-12-09||1970-12-08
TRIAL STUDY 134XCP|IS|D4FE3C52-9E91-47D4-89B2-E9458C6F5919||5||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MG/MOL|||||UG/L||||ABNORMAL|NOT DONE|||CERUMEN|CONCENTRATED|NA|DYNAMIC CONTRAST ENHANCED MRI|Y|N|Y||5||7||SCREENING|1963-04-26|1967-07-13|||||1972-04-07||1967-04-09
TRIAL STUDY 134XCP|IS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||TUBERCULIN UNIT/ML|||||USP U||||LOW|NOT DONE|||BONE|ROOM TEMPERATURE|Y|CELL OF ORIGIN ASSAY|U|N|U||1||38||FOLLOW-UP|1962-08-19|1972-03-13|||||1964-03-15||1967-10-17
TRIAL STUDY 134XCP|IS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||NG|||||%||||NORMAL|NOT DONE|||URINE|SOLIDIFIED|NA|LASER CAPTURE MICRODISSECTION|N|U|N||2||58||WASHOUT|1961-01-30|1964-12-18|||||1964-12-13||1969-12-28
TRIAL STUDY 134XCP|IS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L|||||IN||||LOW|NOT DONE|||LYMPH|DRIED|NA|SICKLE CELL SOLUBILITY TEST|U|U|Y||3||39||FOLLOW-UP|1968-06-10|1973-02-05|||||1968-02-09||1962-12-08
TRIAL STUDY 134XCP|IS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||WEEKS|||||PACK||||LOW|NOT DONE|||CEREBROSPINAL FLUID|HEMOLYZED|NA|FLUORESCENT ENZYME IMMUNOASSAY|Y|N|Y||4||88||BASELINE|1960-07-23|1965-02-18|||||1965-07-04||1973-04-11
TRIAL STUDY 134XCP|IS|D4D4EEF1-9188-4969-A704-4EB2DAF625B5||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||STEPS/MIN|||||UG/DAY||||HIGH|NOT DONE|||ADIPOSE TISSUE|GELLED|Y|LANDOLT RING|N|NA|U||5||7||CONTINUATION TREATMENT|1970-11-27|1967-10-29|||||1962-12-19||1966-10-09
TRIAL STUDY 134XCP|IS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ML/CAGE/DAY|||||PFU||||LOW|NOT DONE|||SUPERNATANT, PLASMA|REFRIGERATED|NA|MICROBIAL CONCENTRATION|N|NA|N||1||38||BLINDED TREATMENT|1973-04-08|1970-10-29|||||1972-12-01||1970-10-27
TRIAL STUDY 134XCP|IS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||PMOL/G|||||BQ/G||||ABNORMAL|NOT DONE|||SKIN TISSUE|LIPEMIC|Y|COMPUTERIZED CORNEAL TOPOGRAPHY|NA|NA|NA||2||58||WASHOUT|1968-11-29|1966-08-22|||||1960-02-17||1968-12-05
TRIAL STUDY 134XCP|IS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||GY|||||PIXELS/CM||||ABNORMAL|NOT DONE|||BUFFY COAT|LACTESCENT|N|IODINE STAIN|Y|N|NA||3||39||OPEN LABEL TREATMENT|1964-10-13|1969-12-04|||||1967-04-30||1971-10-02
TRIAL STUDY 134XCP|IS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4||4||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||FMOL/G|||||CMOL||||LOW|NOT DONE|||LEUKOCYTE|GELLED|Y|TRANSVAGINAL ULTRASOUND|N|U|N||4||88||FOLLOW-UP|1970-08-02|1960-05-29|||||1971-01-31||1963-01-12
TRIAL STUDY 134XCP|IS|0456B11C-D064-4E92-AA2D-12DA09F3FAF4||5||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IN2|||||UG/H||||NORMAL|NOT DONE|||ENDOTRACHEAL FLUID|CALCIFIED|U|PEAK FLOWMETRY|U|U|NA||5||7||TREATMENT|1970-09-05|1962-01-29|||||1963-07-12||1961-03-28
TRIAL STUDY 134XCP|IS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||G|||||/10^3||||NORMAL|NOT DONE|||GASTRIC CONTENTS|AUTOLYZED|N|HPLC/IEX|Y|NA|U||1||38||FOLLOW-UP|1970-07-15|1963-10-25|||||1965-06-29||1970-10-02
TRIAL STUDY 134XCP|IS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F||2||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||RNA COPIES/ML|||||USIEMENS||||NORMAL|NOT DONE|||URINE|NON-HEMOLYZED|Y|TONOMETRY|Y|Y|U||2||58||INDUCTION TREATMENT|1969-06-23|1973-01-19|||||1964-06-13||1968-11-10
TRIAL STUDY 134XCP|IS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/G/H|||||BEAM BREAKS||||HIGH|NOT DONE|||PLASMA ULTRAFILTRATE|CLOTTED|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|NA|N|Y||3||39||FOLLOW-UP|1970-09-13|1968-04-06|||||1962-11-08||1961-05-17
TRIAL STUDY 134XCP|IS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/M2/MIN|||||UM/DAY||||LOW|NOT DONE|||SUPERNATANT, SERUM OR PLASMA|CONTAMINATED|Y|SANGER SEQUENCING|Y|U|N||4||88||INDUCTION TREATMENT|1968-07-14|1972-02-14|||||1971-07-17||1972-11-21
TRIAL STUDY 134XCP|IS|D0C56E07-2ECA-4990-B7AB-6B06E5616C9F||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||%|||||MG/DAY||||ABNORMAL|NOT DONE|||EMESIS|HEMOLYZED|N|REFLECTANCE SPECTROSCOPY|Y|NA|Y||5||7||OPEN LABEL TREATMENT|1971-06-07|1971-04-07|||||1961-08-10||1964-02-05
TRIAL STUDY 134XCP|IS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E||1||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||ABSORBANCE U|||||IU||||HIGH|NOT DONE|||HAIR|DRIED|U|PERIPHERAL ANGIOGRAPHY|N|U|Y||1||38||OPEN LABEL TREATMENT|1969-03-07|1964-04-08|||||1965-10-15||1971-12-13
TRIAL STUDY 134XCP|IS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||GENEQ/ML|||||/SEC||||HIGH|NOT DONE|||CAPILLARY PLASMA|FRESH|NA|WESTERGREN|Y|U|N||2||58||BASELINE|1973-07-11|1960-02-24|||||1963-07-12||1963-08-31
TRIAL STUDY 134XCP|IS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||KALLIKREIN INHIBITOR UNIT|||||MAC50||||ABNORMAL|NOT DONE|||CORD SERUM|CONCENTRATED|Y|JAEGER EYE CHART|N|U|N||3||39||INDUCTION TREATMENT|1965-04-18|1973-07-31|||||1971-08-09||1963-01-09
TRIAL STUDY 134XCP|IS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MKAT|||||MESF||||ABNORMAL|NOT DONE|||BONE MARROW|CONCENTRATED|NA|PET/MRI SCAN|N|Y|U||4||88||RUN-IN|1971-10-29|1967-09-16|||||1963-01-23||1973-03-16
TRIAL STUDY 134XCP|IS|BCAF5E7C-8A2E-43E6-9292-95021AFDAB1E||5||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/DL|||||SIEMENS||||ABNORMAL|NOT DONE|||EMESIS|FRESH|Y|TWO-COLOR MICROARRAY|N|U|NA||5||7||CONTINUATION TREATMENT|1972-08-01|1966-06-21|||||1971-08-20||1971-07-22
TRIAL STUDY 134XCP|IS|219A70B2-48A6-407C-B901-9847583DB5F4||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||UMOL/DL|||||FMOL/G||||HIGH|NOT DONE|||SERUM OR PLASMA|LIPEMIC|NA|CONTRAST ENHANCED PET/CT SCAN|U|N|NA||1||38||INDUCTION TREATMENT|1971-09-16|1973-08-09|||||1970-08-05||1961-04-07
TRIAL STUDY 134XCP|IS|219A70B2-48A6-407C-B901-9847583DB5F4||2||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||/CMH2O|||||M/SEC2||||HIGH|NOT DONE|||ENDOTRACHEAL FLUID|CONCENTRATED|N|IMMUNOFIXATION ELECTROPHORESIS|Y|N|NA||2||58||BLINDED TREATMENT|1968-06-14|1963-03-22|||||1960-01-17||1970-09-07
TRIAL STUDY 134XCP|IS|219A70B2-48A6-407C-B901-9847583DB5F4||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||GY/MIN|||||KCAL/DAY||||NORMAL|NOT DONE|||SEMEN|LACTESCENT|U|OSCILLOMETRY|NA|N|Y||3||39||BLINDED TREATMENT|1972-09-01|1962-04-05|||||1970-08-28||1967-09-22
TRIAL STUDY 134XCP|IS|219A70B2-48A6-407C-B901-9847583DB5F4||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||COPIES/UG|||||G/M2/DAY||||HIGH|NOT DONE|||MENSTRUAL BLOOD|ICTERIC|NA|TRIPLE-PHASE MRI SCAN|U|Y|Y||4||88||INDUCTION TREATMENT|1965-10-19|1966-03-31|||||1971-12-16||1972-06-09
TRIAL STUDY 134XCP|IS|219A70B2-48A6-407C-B901-9847583DB5F4||5||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||HOMEOPATHIC DILUTION|||||NMOL||||HIGH|NOT DONE|||CALCULUS|SOLIDIFIED|N|ELECTROMYOGRAPHY|NA|Y|Y||5||7||OBSERVATION|1961-05-23|1965-03-05|||||1971-03-20||1968-11-16
TRIAL STUDY 134XCP|IS|CF3AC42D-DFBA-448E-A688-46A87D6264EB||1||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||/4.0 ML|||||L/MIN/M2||||NORMAL|NOT DONE|||STRIATED MUSCLE TISSUE|REFRIGERATED|U|PERIPHERAL ANGIOGRAPHY|U|N|NA||1||38||BLINDED TREATMENT|1963-01-11|1968-06-29|||||1966-08-05||1966-08-25
TRIAL STUDY 134XCP|IS|CF3AC42D-DFBA-448E-A688-46A87D6264EB||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^6 CFU/ML|||||G/DAY||||HIGH|NOT DONE|||DIALYSIS FLUID, PERITONEAL|FROZEN|NA|EEG|N|U|Y||2||58||CONTINUATION TREATMENT|1965-12-09|1966-07-06|||||1971-09-11||1971-10-12
TRIAL STUDY 134XCP|IS|CF3AC42D-DFBA-448E-A688-46A87D6264EB||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LINEAR FT*LB|||||MEQ/UL||||ABNORMAL|NOT DONE|||COLOSTRUM|AUTOLYZED|Y|TRANSVAGINAL ULTRASOUND|U|U|NA||3||39||RUN-IN|1962-11-21|1968-06-22|||||1960-05-15||1963-06-15
TRIAL STUDY 134XCP|IS|CF3AC42D-DFBA-448E-A688-46A87D6264EB||4||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||G|||||BOWL||||NORMAL|NOT DONE|||PLEURAL TISSUE|CONTAMINATED|N|MAGNETIC RESONANCE ENTEROGRAPHY|N|Y|Y||4||88||INDUCTION TREATMENT|1972-02-10|1961-02-28|||||1972-12-14||1960-01-05
TRIAL STUDY 134XCP|IS|CF3AC42D-DFBA-448E-A688-46A87D6264EB||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||UMOL/L/MIN|||||CIGARETTE||||NORMAL|NOT DONE|||SPERMATOZOON|FROZEN|N|AUTOREFRACTION|N|NA|NA||5||7||INDUCTION TREATMENT|1960-12-16|1972-07-12|||||1968-11-06||1967-04-26
TRIAL STUDY 134XCP|IS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||L/L|||||10^6 ORGANISMS/G||||ABNORMAL|NOT DONE|||ADIPOSE TISSUE|ICTERIC|Y|REFRACTOMETRY|N|NA|NA||1||38||BLINDED TREATMENT|1961-10-28|1961-07-09|||||1970-09-29||1963-12-20
TRIAL STUDY 134XCP|IS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^9 ORGANISMS/ML|||||U/M2||||HIGH|NOT DONE|||WHITE MATTER TISSUE|CALCIFIED|N|DIGITAL PCR ARRAY|N|Y|U||2||58||SCREENING|1973-03-23|1960-11-28|||||1971-09-28||1961-05-23
TRIAL STUDY 134XCP|IS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||MIU/L|||||PMOL/10^9 CELLS||||ABNORMAL|NOT DONE|||SEBUM|THAWED|NA|PULSE OXIMETRY|Y|N|NA||3||39||FOLLOW-UP|1969-06-30|1960-11-29|||||1961-06-05||1963-07-08
TRIAL STUDY 134XCP|IS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||KV|||||FRACTION OF 1||||ABNORMAL|NOT DONE|||GASTRIC FLUID|SOLIDIFIED|Y|ELISA|U|Y|U||4||88||RUN-IN|1971-10-10|1973-01-27|||||1966-09-29||1969-02-25
TRIAL STUDY 134XCP|IS|0FB5E37C-B78E-4EE2-A55E-9E850D680BB4||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||MMHG|||||10^9 ORGANISMS/MG||||ABNORMAL|NOT DONE|||ARTERIAL CORD BLOOD|CLOTTED|NA|PLAQUE REDUCTION NEUTRALIZATION ASSAY|U|U|N||5||7||BASELINE|1968-09-04|1962-06-12|||||1972-04-10||1960-07-31
TRIAL STUDY 134XCP|IS|D19D43A5-DFE6-415D-86B7-6A767A357BC9||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UEQ/L|||||UG/CM2||||ABNORMAL|NOT DONE|||RETICULOCYTES|THAWED|NA|BAC ACGH|U|Y|U||1||38||INDUCTION TREATMENT|1961-09-12|1973-07-07|||||1962-10-25||1964-10-06
TRIAL STUDY 134XCP|IS|D19D43A5-DFE6-415D-86B7-6A767A357BC9||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||LOZENGE|||||CARTRIDGE||||HIGH|NOT DONE|||SUPERNATANT, CEREBROSPINAL FLUID|PARAFFIN-EMBEDDED|U|KINYOUN STAIN|N|N|N||2||58||OPEN LABEL TREATMENT|1965-04-07|1968-06-09|||||1970-07-04||1960-07-14
TRIAL STUDY 134XCP|IS|D19D43A5-DFE6-415D-86B7-6A767A357BC9||3||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||UMOL/L/MIN|||||10^3 RNA COPIES/ML||||LOW|NOT DONE|||ENDOTRACHEAL FLUID|GELLED|N|MICROARRAY|Y|Y|N||3||39||FOLLOW-UP|1960-03-14|1972-09-08|||||1967-09-28||1961-01-17
TRIAL STUDY 134XCP|IS|D19D43A5-DFE6-415D-86B7-6A767A357BC9||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||VG/DOSE|||||TRANSDUCING UNIT/ML||||LOW|NOT DONE|||SERUM OR PLASMA OR BLOOD|PARAFFIN-EMBEDDED|U|ORCHIDOMETERY|U|NA|N||4||88||OPEN LABEL TREATMENT|1965-12-05|1961-11-20|||||1967-12-17||1962-05-31
TRIAL STUDY 134XCP|IS|D19D43A5-DFE6-415D-86B7-6A767A357BC9||5||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||NG/DAY|||||MOL/MOL||||HIGH|NOT DONE|||TISSUE|PARAFFIN-EMBEDDED|N|DC SHEATH FLOW|Y|U|N||5||7||BASELINE|1965-02-18|1968-10-01|||||1962-10-11||1968-04-24
TRIAL STUDY 134XCP|IS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F||1||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||EID 50/ML|||||MG/DOSE||||NORMAL|NOT DONE|||CARDIAC MUSCLE TISSUE|NON-HEMOLYZED|U|OPHTHALMOSCOPY|N|NA|U||1||38||RUN-IN|1966-04-29|1971-08-22|||||1968-07-16||1963-07-19
TRIAL STUDY 134XCP|IS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||UG/G/DAY|||||MG/H||||NORMAL|NOT DONE|||CERUMEN|REFRIGERATED|U|EEG|U|Y|Y||2||58||FOLLOW-UP|1972-05-25|1966-03-24|||||1964-03-04||1970-06-12
TRIAL STUDY 134XCP|IS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F||3||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||CMH2O/ML|||||NG/L||||NORMAL|NOT DONE|||SPUTUM|CONTAMINATED|NA|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|N|N|N||3||39||INDUCTION TREATMENT|1960-09-27|1967-04-23|||||1963-01-25||1973-07-20
TRIAL STUDY 134XCP|IS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F||4||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||MG/M2|||||ML/M2/MIN||||ABNORMAL|NOT DONE|||SMEGMA|GELLED|NA|MIGET|U|NA|Y||4||88||SCREENING|1971-02-19|1962-10-16|||||1963-12-30||1962-07-22
TRIAL STUDY 134XCP|IS|B9DDBCB0-91F7-4C06-B1E7-5577928C799F||5||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||VG/DOSE|||||/MM||||NORMAL|NOT DONE|||DISCHARGE|HEMOLYZED|Y|LC-FL|NA|N|NA||5||7||OBSERVATION|1970-11-28|1962-09-16|||||1961-08-11||1973-03-03
TRIAL STUDY 134XCP|IS|7D307F63-4A25-4E7D-9980-16764AE5C4A4||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||OZ EQ|||||ECL UNIT||||LOW|NOT DONE|||CERUMEN|HEMOLYZED|Y|MICROSCOPY|NA|U|U||1||38||BLINDED TREATMENT|1970-08-21|1972-10-25|||||1973-01-30||1966-08-28
TRIAL STUDY 134XCP|IS|7D307F63-4A25-4E7D-9980-16764AE5C4A4||2||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||CAPSULE|||||U/G HB||||NORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|AUTOLYZED|Y|HEMAGGLUTINATION ASSAY|Y|U|Y||2||58||OBSERVATION|1964-11-16|1973-03-10|||||1969-07-31||1965-06-08
TRIAL STUDY 134XCP|IS|7D307F63-4A25-4E7D-9980-16764AE5C4A4||3||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||ARBITRARY U|||||OZ EQ||||NORMAL|NOT DONE|||BONE|FRESH|NA|KARYOTYPING|U|Y|Y||3||39||OBSERVATION|1962-01-01|1969-02-05|||||1961-03-16||1964-05-02
TRIAL STUDY 134XCP|IS|7D307F63-4A25-4E7D-9980-16764AE5C4A4||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MKAT|||||TORR||||NORMAL|NOT DONE|||VENOUS PLASMA|CLOTTED|Y|CONTRAST ENHANCED PET SCAN|Y|U|U||4||88||OPEN LABEL TREATMENT|1969-08-11|1964-01-16|||||1964-02-23||1967-06-16
TRIAL STUDY 134XCP|IS|7D307F63-4A25-4E7D-9980-16764AE5C4A4||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||/LPF|||||U/KG/DAY||||HIGH|NOT DONE|||SKIN TISSUE|THAWED|NA|PEAK FLOWMETRY|Y|U|NA||5||7||WASHOUT|1970-02-15|1968-04-24|||||1970-07-22||1962-06-13
TRIAL STUDY 134XCP|IS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D||1||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||UG/G/DAY|||||MM/SEC||||HIGH|NOT DONE|||EMESIS|FROZEN|Y|POPULATION SEQUENCING|N|N|NA||1||38||RUN-IN|1969-05-29|1965-09-13|||||1963-07-10||1965-01-08
TRIAL STUDY 134XCP|IS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D||2||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NMOL/DAY|||||MG/MIN||||HIGH|NOT DONE|||TRANSUDATE|HEMOLYZED|U|MECHANICAL CLOT DETECTION|NA|U|U||2||58||RUN-IN|1960-03-25|1968-06-18|||||1967-05-11||1967-01-11
TRIAL STUDY 134XCP|IS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/KG|||||SV||||LOW|NOT DONE|||GASTRIC CONTENTS|GELLED|N|PHOTOMETRY|N|N|NA||3||39||BASELINE|1968-11-11|1963-02-12|||||1973-01-15||1963-04-05
TRIAL STUDY 134XCP|IS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||10^8 PFU|||||MMHG*MIN/L||||ABNORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|CONTAMINATED|Y|LANDOLT RING|U|U|NA||4||88||LONG-TERM FOLLOW-UP|1962-05-30|1972-03-03|||||1971-07-18||1968-07-19
TRIAL STUDY 134XCP|IS|C651B2EE-281E-4CC6-ACC6-E91B19138A7D||5||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||IU/MMOL|||||KIT||||LOW|NOT DONE|||ATHEROSCLEROTIC PLAQUE|DRIED|Y|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|U|U|Y||5||7||INDUCTION TREATMENT|1966-10-07|1972-03-17|||||1962-11-10||1964-06-12
TRIAL STUDY 134XCP|IS|F4718E0D-4DD9-442E-8907-076551C83AEE||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||CG|||||TABLET||||NORMAL|NOT DONE|||HAIR|HEMOLYZED|U|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|U|U||1||38||CONTINUATION TREATMENT|1970-05-24|1966-02-28|||||1972-09-20||1961-08-09
TRIAL STUDY 134XCP|IS|F4718E0D-4DD9-442E-8907-076551C83AEE||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||L/KG|||||COPIES/ML||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|ICTERIC|NA|IMMUNOFIXATION ELECTROPHORESIS|N|Y|N||2||58||CONTINUATION TREATMENT|1965-03-21|1960-05-29|||||1966-03-13||1967-09-20
TRIAL STUDY 134XCP|IS|F4718E0D-4DD9-442E-8907-076551C83AEE||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||GBQ|||||10^9 CFU/ML||||HIGH|NOT DONE|||ATHEROSCLEROTIC PLAQUE|DRIED|U|LAPAROSCOPY|Y|Y|NA||3||39||LONG-TERM FOLLOW-UP|1960-01-23|1960-12-22|||||1964-06-20||1963-05-10
TRIAL STUDY 134XCP|IS|F4718E0D-4DD9-442E-8907-076551C83AEE||4||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MEQ/ML|||||U/L||||ABNORMAL|NOT DONE|||BUFFY COAT|CONTAMINATED|U|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|N|NA|NA||4||88||OBSERVATION|1964-11-20|1967-09-26|||||1968-06-03||1971-04-20
TRIAL STUDY 134XCP|IS|F4718E0D-4DD9-442E-8907-076551C83AEE||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||LOG10 TCID 50/ML|||||STRIP||||HIGH|NOT DONE|||NAIL|ICTERIC|NA|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y|Y|Y||5||7||CONTINUATION TREATMENT|1972-01-10|1967-05-11|||||1960-11-29||1968-11-09
TRIAL STUDY 134XCP|IS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9||1||||ADA_X|CROSS-REACTIVE BINDING ANTIDRUG ANTIBODY|||||||||MOL/MG|||||M/SEC2||||HIGH|NOT DONE|||SUPERNATANT, PLASMA|ROOM TEMPERATURE|NA|IMMUNOASSAY|N|U|N||1||38||RUN-IN|1965-03-23|1968-10-31|||||1962-10-09||1961-12-19
TRIAL STUDY 134XCP|IS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9||2||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||SV|||||NG/DAY||||ABNORMAL|NOT DONE|||BLOOD|CLOTTED|U|LIGHT SCATTERING SPECTROSCOPY|NA|U|NA||2||58||SCREENING|1970-02-05|1972-08-07|||||1960-01-05||1971-01-04
TRIAL STUDY 134XCP|IS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9||3||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||BE/ML|||||PACKET||||LOW|NOT DONE|||LOCHIA|THAWED|N|WHOLE TRANSCRIPTOME SEQUENCING|Y|N|N||3||39||OBSERVATION|1972-04-06|1960-05-09|||||1966-12-06||1965-04-02
TRIAL STUDY 134XCP|IS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9||4||||ADA_NAB|NEUTRALIZING BINDING ANTIDRUG ANTIBODY|||||||||HOMEOPATHIC DILUTION|||||G/CAGE/WK||||HIGH|NOT DONE|||BUFFY COAT|LIPEMIC|N|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|NA|N|N||4||88||OBSERVATION|1963-11-19|1972-07-23|||||1960-07-27||1966-11-16
TRIAL STUDY 134XCP|IS|AC095369-9EEF-47F5-938C-DAF5D4FAF7C9||5||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||BREATHS/MIN|||||10^9/G||||HIGH|NOT DONE|||SOFT TISSUE|NON-HEMOLYZED|U|FLUORIMETRY|N|U|N||5||7||CONTINUATION TREATMENT|1971-09-17|1966-08-01|||||1964-12-21||1962-09-05
TRIAL STUDY 134XCP|IS|E86F996D-3A96-4C36-82B2-1AC4B4906F49||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||MMOL2/L2|||||/MONTH||||LOW|NOT DONE|||ARTERIAL BLOOD|NON-HEMOLYZED|NA|DOPPLER ULTRASOUND|U|U|NA||1||38||SCREENING|1969-07-07|1973-01-15|||||1965-09-28||1966-09-21
TRIAL STUDY 134XCP|IS|E86F996D-3A96-4C36-82B2-1AC4B4906F49||2||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||COPIES/UL|||||MG||||LOW|NOT DONE|||SKIN TISSUE|HEMOLYZED|U|FREEZING POINT DEPRESSION|Y|NA|Y||2||58||INDUCTION TREATMENT|1970-05-30|1968-04-09|||||1964-08-02||1967-10-31
TRIAL STUDY 134XCP|IS|E86F996D-3A96-4C36-82B2-1AC4B4906F49||3||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||ABSORBANCE U|||||UM||||ABNORMAL|NOT DONE|||CELL PELLET|NON-HEMOLYZED|NA|SANGER SEQUENCING|Y|NA|NA||3||39||WASHOUT|1965-07-31|1972-09-18|||||1960-12-12||1968-05-25
TRIAL STUDY 134XCP|IS|E86F996D-3A96-4C36-82B2-1AC4B4906F49||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||APL U|||||CYLINDER||||NORMAL|NOT DONE|||ERYTHROCYTES|AGGLUTINATED|Y|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|N|U|NA||4||88||BLINDED TREATMENT|1964-02-28|1964-04-19|||||1960-04-24||1971-04-07
TRIAL STUDY 134XCP|IS|E86F996D-3A96-4C36-82B2-1AC4B4906F49||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^11/L|||||DISK||||LOW|NOT DONE|||BUFFY COAT|FROZEN|U|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|N|Y|U||5||7||WASHOUT|1964-09-08|1968-01-14|||||1971-06-07||1972-10-12
TRIAL STUDY 134XCP|IS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||COPIES/ML|||||KBQ/UL||||NORMAL|NOT DONE|||FLUID|ICTERIC|Y|DIGITAL PCR|U|Y|Y||1||38||OBSERVATION|1963-09-09|1970-08-28|||||1963-06-23||1969-08-07
TRIAL STUDY 134XCP|IS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C||2||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7 CFU/ML|||||MG/G/H||||ABNORMAL|NOT DONE|||ISOLATE|FROZEN|Y|ENDOSCOPY|N|U|N||2||58||INDUCTION TREATMENT|1970-05-10|1963-09-05|||||1971-10-07||1962-10-05
TRIAL STUDY 134XCP|IS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C||3||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||ML/G/H|||||MPL U||||HIGH|NOT DONE|||CERUMEN|PARAFFIN-EMBEDDED|NA|IMPULSE OSCILLOMETRY|U|N|Y||3||39||BASELINE|1969-09-24|1964-05-05|||||1960-06-12||1969-02-11
TRIAL STUDY 134XCP|IS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C||4||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||SEC|||||MMOL/MIN/KPA||||LOW|NOT DONE|||MONOCYTE|FRESH|NA|RULER MEASUREMENT METHOD|Y|U|N||4||88||CONTINUATION TREATMENT|1963-12-29|1965-07-21|||||1966-01-07||1972-04-23
TRIAL STUDY 134XCP|IS|10DEC5CB-7A18-4A1D-9138-4F2C83A7737C||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||CG|||||MG/KG/DOSE||||LOW|NOT DONE|||BREAST MILK|PARAFFIN-EMBEDDED|Y|CELL BASED BIOASSAY|N|U|Y||5||7||SCREENING|1972-03-21|1971-12-23|||||1964-07-16||1969-07-18
TRIAL STUDY 134XCP|IS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF||1||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/L|||||FT3||||ABNORMAL|NOT DONE|||BONE MARROW MONONUCLEAR CELL|UNEXPECTED ODOR|Y|MICRODENSITOMETRY|Y|N|U||1||38||SCREENING|1963-04-23|1961-10-12|||||1963-05-24||1964-09-03
TRIAL STUDY 134XCP|IS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||POINT|||||%(W/W)||||LOW|NOT DONE|||SPUTUM|CONTAMINATED|N|CONTACT SPECULAR MICROSCOPY|Y|NA|NA||2||58||CONTINUATION TREATMENT|1969-06-08|1971-04-15|||||1960-05-11||1963-09-27
TRIAL STUDY 134XCP|IS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF||3||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||IN|||||HZ||||LOW|NOT DONE|||MENSTRUAL BLOOD|PARAFFIN-EMBEDDED|Y|SPECULAR MICROSCOPY|Y|NA|Y||3||39||BLINDED TREATMENT|1962-09-23|1971-07-18|||||1967-12-28||1962-09-22
TRIAL STUDY 134XCP|IS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF||4||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||PPB|||||NMOL/L/H||||NORMAL|NOT DONE|||EXUDATE|REFRIGERATED|U|CYSTOMETRY|N|N|Y||4||88||RUN-IN|1960-12-13|1961-05-29|||||1964-07-06||1965-11-13
TRIAL STUDY 134XCP|IS|5E3C9256-B0B9-4221-B5B6-FB2B76DA9BEF||5||||EVIGMASC|EBOV SPECIFIC IGM AB SECRETING CELLS|||||||||DAYS/WK|||||ABSORBANCE U||||ABNORMAL|NOT DONE|||TRANSUDATE|NON-HEMOLYZED|U|FISH|Y|N|Y||5||7||WASHOUT|1973-08-11|1971-08-25|||||1969-06-20||1960-10-24
TRIAL STUDY 134XCP|IS|28E9B15E-4757-42F5-8AE7-2C868904F88B||1||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||MOSM/KG|||||KS||||NORMAL|NOT DONE|||DISCHARGE|UNEXPECTED ODOR|U|PERIODIC ACID SCHIFF STAIN|NA|N|NA||1||38||OPEN LABEL TREATMENT|1961-01-22|1973-04-07|||||1961-02-21||1972-02-23
TRIAL STUDY 134XCP|IS|28E9B15E-4757-42F5-8AE7-2C868904F88B||2||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||NMOL/L/H|||||MG/KG/H||||NORMAL|NOT DONE|||WHITE MATTER TISSUE|FRESH|NA|KINETIC CHROMOGENIC ASSAY|U|Y|N||2||58||WASHOUT|1962-11-18|1966-11-05|||||1970-04-10||1962-11-13
TRIAL STUDY 134XCP|IS|28E9B15E-4757-42F5-8AE7-2C868904F88B||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||U.CARR|||||AG||||NORMAL|NOT DONE|||SMOOTH MUSCLE TISSUE|AGGLUTINATED|U|PEAK FLOWMETRY|N|NA|Y||3||39||TREATMENT|1967-11-27|1964-05-02|||||1972-01-09||1962-08-17
TRIAL STUDY 134XCP|IS|28E9B15E-4757-42F5-8AE7-2C868904F88B||4||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||10^7 TCID 50/DOSE|||||ML/DOSE||||HIGH|NOT DONE|||EPITHELIAL CELL|FROZEN|NA|DYNAMOMETRY|Y|U|Y||4||88||INDUCTION TREATMENT|1965-03-04|1966-11-15|||||1963-03-22||1965-06-04
TRIAL STUDY 134XCP|IS|28E9B15E-4757-42F5-8AE7-2C868904F88B||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||DNA COPIES/ML|||||VP/ML||||ABNORMAL|NOT DONE|||SERUM|GELLED|Y|FLUOROSCOPY|U|N|N||5||7||OPEN LABEL TREATMENT|1970-05-30|1964-09-25|||||1963-08-24||1969-01-08
TRIAL STUDY 134XCP|IS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||IU/DAY|||||UG/KG/DAY||||ABNORMAL|NOT DONE|||VITREOUS HUMOR|FROZEN|NA|MANUAL COUNT|Y|U|Y||1||38||TREATMENT|1960-11-05|1960-01-17|||||1964-05-06||1962-11-25
TRIAL STUDY 134XCP|IS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B||2||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||ML/(MIN*100ML)|||||MG/MOL||||HIGH|NOT DONE|||LYSATE|FRESH|Y|SICKLE CELL SOLUBILITY TEST|N|N|U||2||58||LONG-TERM FOLLOW-UP|1969-05-06|1966-06-24|||||1961-06-26||1967-06-01
TRIAL STUDY 134XCP|IS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B||3||||H3IGGASC|H3 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||MG|||||PG||||NORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|FRESH|N|RULER MEASUREMENT METHOD|U|Y|N||3||39||INDUCTION TREATMENT|1969-08-25|1972-04-06|||||1964-01-18||1960-11-20
TRIAL STUDY 134XCP|IS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B||4||||IGMABSC|IGM ANTIBODY SECRETING CELLS|||||||||10^9 CFU|||||ML/CAGE||||NORMAL|NOT DONE|||MONOCYTE|ROOM TEMPERATURE|N|MOUSE PROTECTION ASSAY|N|N|NA||4||88||BASELINE|1964-12-05|1963-07-07|||||1970-06-27||1965-07-17
TRIAL STUDY 134XCP|IS|1547C5B8-C63D-4A54-8FCF-8BC022E0A52B||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||MMU/ML|||||UM2||||LOW|NOT DONE|||EPITHELIAL CELL|GELLED|NA|U-HPLC/MS/MS|NA|Y|NA||5||7||RUN-IN|1963-03-23|1963-07-29|||||1970-02-10||1969-01-14
TRIAL STUDY 134XCP|IS|2E1011F1-A091-4E7E-B661-477A1F6DD39A||1||||HIV1SR|HIV-1 SEROREACTIVITY|||||||||NG/MOL|||||MEQ/G||||HIGH|NOT DONE|||BONE|AGGLUTINATED|NA|TONOMETRY|U|U|N||1||38||LONG-TERM FOLLOW-UP|1961-06-10|1965-12-05|||||1968-10-23||1972-07-20
TRIAL STUDY 134XCP|IS|2E1011F1-A091-4E7E-B661-477A1F6DD39A||2||||HIV2SR|HIV-2 SEROREACTIVITY|||||||||10^9 ORGANISMS|||||G/M2/DAY||||NORMAL|NOT DONE|||DIALYSIS FLUID, PERITONEAL|HEMOLYZED|NA|HPLC/MS/MS|N|Y|N||2||58||CONTINUATION TREATMENT|1961-07-03|1968-04-22|||||1968-06-09||1962-10-10
TRIAL STUDY 134XCP|IS|2E1011F1-A091-4E7E-B661-477A1F6DD39A||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||ECL UNIT|||||MEQ/ML||||HIGH|NOT DONE|||VENOUS BLOOD|CONTAMINATED|NA|TARGETED TRANSCRIPTOME SEQUENCING|U|N|N||3||39||BASELINE|1968-10-07|1973-05-25|||||1966-09-12||1960-01-19
TRIAL STUDY 134XCP|IS|2E1011F1-A091-4E7E-B661-477A1F6DD39A||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||UM|||||DRINK||||HIGH|NOT DONE|||SALIVA|DRIED|Y|RAJI CELL RIA|U|U|NA||4||88||FOLLOW-UP|1970-08-30|1962-04-08|||||1960-06-01||1970-09-17
TRIAL STUDY 134XCP|IS|2E1011F1-A091-4E7E-B661-477A1F6DD39A||5||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||APPLICATION|||||GLOBULE||||LOW|NOT DONE|||COLOSTRUM|UNEXPECTED ODOR|U|SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION|U|Y|N||5||7||INDUCTION TREATMENT|1964-08-05|1961-05-21|||||1962-09-09||1968-09-22
TRIAL STUDY 134XCP|IS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49||1||||H1IGGASC|H1 SPECIFIC IGG ANTIBODY SECRETING CELLS|||||||||COULOMB|||||U/M2/H||||ABNORMAL|NOT DONE|||EPIDERMAL TISSUE|HEMOLYZED|U|X-RAY FLUORESCENCE SPECTROMETRY|N|Y|NA||1||38||SCREENING|1967-02-09|1966-02-10|||||1968-03-12||1966-08-12
TRIAL STUDY 134XCP|IS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49||2||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||10^12/L|||||NG/DL||||NORMAL|NOT DONE|||URINE SEDIMENT|GELLED|N|PHOTOMETRIC CLOT DETECTION|Y|U|U||2||58||OBSERVATION|1960-05-02|1964-05-29|||||1964-03-24||1971-12-14
TRIAL STUDY 134XCP|IS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49||3||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||CI/ML|||||PMOL/L/H||||LOW|NOT DONE|||FLUID|CONTAMINATED|NA|FLUOROSCOPY|U|Y|U||3||39||BLINDED TREATMENT|1960-06-02|1966-07-05|||||1960-02-23||1961-03-15
TRIAL STUDY 134XCP|IS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49||4||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||MG/KG/DAY|||||KBQ/UL||||ABNORMAL|NOT DONE|||SKELETAL MUSCLE TISSUE|AUTOLYZED|NA|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|NA|NA|NA||4||88||RUN-IN|1962-07-05|1971-09-02|||||1965-04-07||1970-07-24
TRIAL STUDY 134XCP|IS|7227F990-6CFE-49BD-BB46-5B2DDAD9CB49||5||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||PACKAGE|||||BQ/ML||||HIGH|NOT DONE|||VITREOUS HUMOR|CLOTTED|Y|SPIRAL CT SCAN WITHOUT CONTRAST|N|Y|NA||5||7||FOLLOW-UP|1973-08-12|1961-10-23|||||1965-06-29||1966-07-15
TRIAL STUDY 134XCP|IS|176B6882-0C9E-435E-9842-FF8714BC9CAF||1||||EVIGGASC|EBOV SPECIFIC IGG AB SECRETING CELLS|||||||||TESLA|||||CS||||ABNORMAL|NOT DONE|||TUMOR TISSUE|FROZEN|N|SEQUENCING|NA|U|Y||1||38||OBSERVATION|1962-09-09|1961-12-20|||||1965-11-27||1973-08-01
TRIAL STUDY 134XCP|IS|176B6882-0C9E-435E-9842-FF8714BC9CAF||2||||TIGGASC|TOTAL IGG ANTIBODY SECRETING CELLS|||||||||PFU|||||PM||||HIGH|NOT DONE|||MIXED VENOUS BLOOD|ROOM TEMPERATURE|N|FUNDUS PHOTOGRAPHY|NA|NA|Y||2||58||RUN-IN|1960-05-02|1971-04-14|||||1966-09-20||1966-12-30
TRIAL STUDY 134XCP|IS|176B6882-0C9E-435E-9842-FF8714BC9CAF||3||||ADA_NX|NEUTRALIZ CROSS-REACT BIND ANTIDRUG AB|||||||||WATT|||||MSEC||||ABNORMAL|NOT DONE|||LYSATE|ICTERIC|Y|DC SHEATH FLOW|U|U|N||3||39||TREATMENT|1970-05-19|1961-10-20|||||1960-02-20||1972-12-05
TRIAL STUDY 134XCP|IS|176B6882-0C9E-435E-9842-FF8714BC9CAF||4||||TLYMPIDX|T-LYMPHOCYTE PROLIFERATION INDEX|||||||||U/10^12 RBC|||||WEEKS||||NORMAL|NOT DONE|||MONOCYTE|SOLIDIFIED|Y|PUPILLOMETRY|N|Y|NA||4||88||WASHOUT|1966-03-20|1970-07-13|||||1964-04-19||1964-02-15
TRIAL STUDY 134XCP|IS|176B6882-0C9E-435E-9842-FF8714BC9CAF||5||||ADA_BAB|BINDING ANTIDRUG ANTIBODY|||||||||G/G|||||LOG10 PFU||||NORMAL|NOT DONE|||HAIR|AGGLUTINATED|N|CORONARY ANGIOGRAPHY|N|NA|NA||5||7||OPEN LABEL TREATMENT|1967-04-01|1964-01-25|||||1972-07-27||1970-04-06
